PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, XX; LeDuc, RD; Fornelli, L; Schunter, AJ; Bennett, RL; Kelleher, NL; Licht, JD				Huang, Xiaoxiao; LeDuc, Richard D.; Fornelli, Luca; Schunter, Alissa J.; Bennett, Richard L.; Kelleher, Neil L.; Licht, Jonathan D.			Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone methylation; DNA damage; protein complex; proteomics; epigenetics; NSD2; PARP1; PARylation	LYSINE 36; METHYLATION; TRANSCRIPTION; REVEALS; PROTEINS; COMPLEX; GROWTH; CONTRIBUTES; INHIBITORS; REGULATOR	NSD2 is a histone methyltransferase that specifically dimethylates histone H3 lysine 36 (H3K36me2), a modification associated with gene activation. Dramatic overexpression of NSD2 in t(4;14) multiple myeloma (MM) and an activating mutation of NSD2 discovered in acute lymphoblastic leukemia are significantly associated with altered gene activation, transcription, and DNA damage repair. The partner proteins through which NSD2 may influence critical cellular processes remain poorly defined. In this study, we utilized proximity-based labeling (BioID) combined with label-free quantitative MS to identify high confidence NSD2 interacting partners in MM cells. The top 24 proteins identified were involved in maintaining chromatin structure, transcriptional regulation, RNA pre-spliceosome assembly, and DNA damage. Among these, an important DNA damage regulator, poly(ADP-ribose) polymerase 1 (PARP1), was discovered. PARP1 and NSD2 have been found to be recruited to DNA double strand breaks upon damage and H3K36me2 marks are enriched at damage sites. We demonstrate that PARP1 regulates NSD2 via PARylation upon oxidative stress. In vitro assays suggest the PARylation significantly reduces NSD2 histone methyltransferase activity. Furthermore, PARylation of NSD2 inhibits its ability to bind to nucleosomes and further get recruited at NSD2-regulated genes, suggesting PARP1 regulates NSD2 localization and H3K36me2 balance. This work provides clear evidence of cross-talk between PARylation and histone methylation and offers new directions to characterize NSD2 function in DNA damage response, transcriptional regulation, and other pathways.	[Huang, Xiaoxiao; Bennett, Richard L.; Licht, Jonathan D.] Univ Florida, Hlth Canc Ctr, Div Hematol Oncol, Gainesville, FL 32608 USA; [Huang, Xiaoxiao; LeDuc, Richard D.; Fornelli, Luca; Schunter, Alissa J.; Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Huang, Xiaoxiao; LeDuc, Richard D.; Fornelli, Luca; Schunter, Alissa J.; Kelleher, Neil L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Huang, Xiaoxiao; LeDuc, Richard D.; Fornelli, Luca; Schunter, Alissa J.; Kelleher, Neil L.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Schunter, Alissa J.] Cell Signaling Technol, 3 Trask Lane, Danvers, MA 01923 USA	State University System of Florida; University of Florida; Northwestern University; Northwestern University; Northwestern University	Licht, JD (corresponding author), Univ Florida, Hlth Canc Ctr, Div Hematol Oncol, Gainesville, FL 32608 USA.	jdlicht@ufl.edu	Huang, Xiaoxiao/ABG-2564-2020; Bennett, Richard/ABF-9211-2021; Licht, Jonathan/AAL-9184-2020; Fornelli, Luca/K-7772-2013	Huang, Xiaoxiao/0000-0002-4623-2005; Licht, Jonathan/0000-0002-3942-1369; Fornelli, Luca/0000-0001-6334-1046; LeDuc, Richard/0000-0002-6951-2923; Bennett, Richard/0000-0002-0243-2443	National Institutes of Health [P41 GM108569, R01 CA195732]; Leukemia and Lymphoma Society Specialized Center of Excellence grant; NATIONAL CANCER INSTITUTE [R01CA195732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM108569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Specialized Center of Excellence grant(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 CA195732 (to J.D.L.), a Leukemia and Lymphoma Society Specialized Center of Excellence grant (to J.D.L.), and National Institutes of Health Grant P41 GM108569 (to N.L.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amendola PG, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006632; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026708; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Brown JS, 2016, BRIT J CANCER, V114, P713, DOI 10.1038/bjc.2016.67; Cao LL, 2016, ONCOGENE, V35, P402, DOI 10.1038/onc.2015.311; Caruso Lisa B, 2018, Oncotarget, V9, P10585, DOI 10.18632/oncotarget.24291; Ciccarone F, 2017, SEMIN CELL DEV BIOL, V63, P123, DOI 10.1016/j.semcdb.2016.11.010; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Ding LW, 2017, CANCER RES, V77, P390, DOI 10.1158/0008-5472.CAN-16-1303; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Gagne JP, 2012, NUCLEIC ACIDS RES, V40, P7788, DOI 10.1093/nar/gks486; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Nguyen HV, 2017, P NATL ACAD SCI USA, V114, pE10560, DOI 10.1073/pnas.1701366114; Hajdu I, 2011, P NATL ACAD SCI USA, V108, P13130, DOI 10.1073/pnas.1110081108; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Koh DI, 2014, P NATL ACAD SCI USA, V111, P15078, DOI 10.1073/pnas.1318780111; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Le May N, 2012, MOL CELL, V48, P785, DOI 10.1016/j.molcel.2012.09.021; Li X, 2014, P NATL ACAD SCI USA, V111, P7096, DOI 10.1073/pnas.1324036111; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Martiniano R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10326; Min DJ, 2013, LEUKEMIA, V27, P686, DOI 10.1038/leu.2012.269; Mirabella F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.9; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Park JW, 2018, ONCOGENE, V37, P6212, DOI 10.1038/s41388-018-0393-y; Pei HD, 2013, J IMMUNOL, V190, P756, DOI 10.4049/jimmunol.1201811; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Roux K. J., 2013, CURR PROTOC PROTEIN, V74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sarai N, 2013, EMBO J, V32, P2392, DOI 10.1038/emboj.2013.176; Shah MY, 2016, ONCOGENE, V35, P5905, DOI 10.1038/onc.2016.116; Swaroop A, 2019, ONCOGENE, V38, P671, DOI 10.1038/s41388-018-0474-y; Wildburger NC., 2015, EUPA OPEN PROTEOMICS, V8, P94, DOI [DOI 10.1016/J.EUPROT.2015.06.006, 10.1016/j.euprot.2015.06.006]; Wildburger NC, 2015, MOL CELL PROTEOMICS, V14, P1288, DOI 10.1074/mcp.M114.040055; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Yamaguchi H, 2018, ONCOGENE, V37, P208, DOI 10.1038/onc.2017.311; Zhang JH, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.824.824; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhen YL, 2018, BIOCHEMISTRY-US, V57, P429, DOI 10.1021/acs.biochem.7b01022; Zheng YP, 2012, P NATL ACAD SCI USA, V109, P13549, DOI 10.1073/pnas.1205707109	56	9	10	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12459	12471		10.1074/jbc.RA118.006159	http://dx.doi.org/10.1074/jbc.RA118.006159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248990	hybrid, Green Published			2022-12-26	WOS:000484402700017
J	Talmon, M; Rossi, S; Lim, D; Pollastro, F; Palattella, G; Ruffinatti, FA; Marotta, P; Boldorini, R; Genazzani, AA; Fresu, LG				Talmon, Maria; Rossi, Silvia; Lim, Dmitry; Pollastro, Federica; Palattella, Gioele; Ruffinatti, Federico A.; Marotta, Patrizia; Boldorini, Renzo; Genazzani, Armando A.; Fresu, Luigia G.			Absinthin, an agonist of the bitter taste receptor hTAS2R46, uncovers an ER-to-mitochondria Ca2+-shuttling event	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; intracellular calcium release; smooth muscle; signal transduction; mitochondria; airway smooth muscle; asthma; mitochondrial calcium; bitter taste receptors; cell signaling; type 2 taste receptor (TAS2R); bronchodilator	AIRWAY SMOOTH-MUSCLE; SESQUITERPENE LACTONES; RETICULUM INTERACTIONS; INTRACELLULAR CA2+; PLASMA-MEMBRANE; CAMP; OSCILLATIONS; COMPARTMENTS; AEQUORIN; CELLS	Type 2 taste receptors (TAS2R) are G protein-coupled receptors first described in the gustatory system, but have also been shown to have extraoral localizations, including airway smooth muscle (ASM) cells, in which TAS2R have been reported to induce relaxation. TAS2R46 is an unexplored subtype that responds to its highly specific agonist absinthin. Here, we first demonstrate that, unlike other bitter-taste receptor agonists, absinthin alone (1 mu m) in ASM cells does not induce Ca2+ signals but reduces histamine-induced cytosolic Ca2+ increases. To investigate this mechanism, we introduced into ASM cells aequorin-based Ca2+ probes targeted to the cytosol, subplasma membrane domain, or the mitochondrial matrix. We show that absinthin reduces cytosolic histamine-induced Ca2+ rises and simultaneously increases Ca2+ influx into mitochondria. We found that this effect is inhibited by the potent human TAS2R46 (hTAS2R46) antagonist 3 beta-hydroxydihydrocostunolide and is no longer evident in hTAS2R46-silenced ASM cells, indicating that it is hTAS2R46-dependent. Furthermore, these changes were sensitive to the mitochondrial uncoupler carbonyl cyanide p-(trifluoromethoxy)phenyl-hydrazone (FCCP); the mitochondrial calcium uniporter inhibitor KB-R7943 (carbamimidothioic acid); the cytoskeletal disrupter latrunculin; and an inhibitor of the exchange protein directly activated by cAMP (EPAC), ESI-09. Similarly, the beta 2 agonist salbutamol also could induce Ca2+ shuttling from cytoplasm to mitochondria, suggesting that this new mechanism might be generalizable. Moreover, forskolin and an EPAC activator mimicked this effect in HeLa cells. Our findings support the hypothesis that plasma membrane receptors can positively regulate mitochondrial Ca2+ uptake, adding a further facet to the ability of cells to encode complex Ca2+ signals.	[Talmon, Maria; Rossi, Silvia; Palattella, Gioele; Boldorini, Renzo; Fresu, Luigia G.] Univ Piemonte Orientale, Sch Med, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy; [Lim, Dmitry; Pollastro, Federica; Ruffinatti, Federico A.; Marotta, Patrizia; Genazzani, Armando A.] Univ Piemonte Orientale, Dept Pharmaceut Sci, Via Bovio 6, I-28100 Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Fresu, LG (corresponding author), Univ Piemonte Orientale, Sch Med, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy.; Genazzani, AA (corresponding author), Univ Piemonte Orientale, Dept Pharmaceut Sci, Via Bovio 6, I-28100 Novara, Italy.	armando.genazzani@uniupo.it; luigia.fresu@med.uniupo.it	RUFFINATTI, FEDERICO ALESSANDRO/ABA-8065-2020; Genazzani, Armando/AAI-8280-2020; BOLDORINI, Renzo Luciano/J-5330-2016	RUFFINATTI, FEDERICO ALESSANDRO/0000-0002-3084-0380; Pollastro, Federica/0000-0002-0949-2799; BOLDORINI, Renzo Luciano/0000-0003-1183-2737; Genazzani, Armando/0000-0003-1923-7430; Talmon, Maria/0000-0002-3914-5034	Regione Piemonte Grant on Autoimmunity and Allergic Diseases D.D. [195 18/07/2014]	Regione Piemonte Grant on Autoimmunity and Allergic Diseases D.D.	This work was supported by Regione Piemonte Grant on Autoimmunity and Allergic Diseases D.D. n. 195 18/07/2014 (to L.G.F.). The authors declare that they have no conflicts of interest with the contents of this article.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; An SS, 2017, CELL SIGNAL, V41, P82, DOI 10.1016/j.cellsig.2017.02.002; Bachmanov AA, 2009, AM J CLIN NUTR, V90, p756S, DOI 10.3945/ajcn.2009.27462L; Bai Y, 2016, AM J RESP CELL MOL, V54, P656, DOI 10.1165/rcmb.2015-0290MA; BEAUHAIRE J, 1980, TETRAHEDRON LETT, V21, P3191, DOI 10.1016/S0040-4039(00)77442-9; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Billington CK, 2017, HANDB EXP PHARMACOL, V237, P23, DOI 10.1007/164_2016_64; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Camoretti-Mercado B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131582; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Cieri D, 2018, CELL DEATH DIFFER, V25, P1131, DOI 10.1038/s41418-017-0033-z; Colombini M, 2016, BBA-MOL CELL RES, V1863, P2498, DOI 10.1016/j.bbamcr.2016.01.019; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dale P, 2018, CELL CALCIUM, V71, P53, DOI 10.1016/j.ceca.2017.12.002; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fazal L, 2017, CIRC RES, V120, P645, DOI 10.1161/CIRCRESAHA.116.309859; Grassin-Delyle S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-134; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; He X, 2015, ARTERIOSCL THROM VAS, V35, P1623, DOI 10.1161/ATVBAHA.115.305469; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; Lim D, 2016, CELL CALCIUM, V59, P228, DOI 10.1016/j.ceca.2016.03.001; LUSH IE, 1995, GENET RES, V66, P167, DOI 10.1017/S0016672300034510; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mishra J, 2017, HANDB EXP PHARMACOL, V240, P129, DOI 10.1007/164_2017_1; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Pan S, 2017, AM J PHYSIOL-LUNG C, V313, pL154, DOI 10.1152/ajplung.00106.2017; Parekh AB, 2003, NEWS PHYSIOL SCI, V18, P252, DOI 10.1152/nips.01458.2003; Pulkkinen V, 2012, AM J PHYSIOL-LUNG C, V303, pL956, DOI 10.1152/ajplung.00205.2012; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robinett KS, 2014, AM J RESP CELL MOL, V50, P678, DOI 10.1165/rcmb.2013-0439RC; Santo-Domingo J, 2007, BRIT J PHARMACOL, V151, P647, DOI 10.1038/sj.bjp.0707260; SAUVE R, 1991, CELL CALCIUM, V12, P165, DOI 10.1016/0143-4160(91)90018-A; Szanda G, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215178; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Taylor CW, 2017, CELL CALCIUM, V63, P48, DOI 10.1016/j.ceca.2016.10.005; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Wang Z, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.106; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501	50	10	10	6	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12472	12482		10.1074/jbc.RA119.007763	http://dx.doi.org/10.1074/jbc.RA119.007763			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248983	hybrid, Green Published			2022-12-26	WOS:000484402700018
J	Parakala, ML; Zhang, YH; Modgil, A; Chadchankar, J; Vien, TN; Ackley, MA; Doherty, JJ; Davies, PA; Moss, SJ				Parakala, Manasa L.; Zhang, Yihui; Modgil, Amit; Chadchankar, Jayashree; Vien, Thuy N.; Ackley, Michael A.; Doherty, James J.; Davies, Paul A.; Moss, Stephen J.			Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABA(A) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GABA receptor; phosphorylation; gamma-aminobutyric acid (GABA); progesterone; protein phosphorylation; neurosteroid; tonic inhibition; membrane protein; epilepsy; neurotransmission; neuroactive steroid; membrane progesterone receptor (mPR)	KINASE-C ACTIVITY; PROTEIN-KINASE; SYNAPTIC INHIBITION; MEMBRANE INSERTION; MODULATION; BRAIN; INVOLVEMENT; ALPHA; TRAFFICKING; EFFICACY	Neuroactive steroids (NASs) are synthesized within the brain and exert profound effects on behavior. These effects are primarily believed to arise from the activities of NASs as positive allosteric modulators (PAMs) of the GABA-type A receptor (GABA(A)R). NASs also activate a family of G protein-coupled receptors known as membrane progesterone receptors (mPRs). Here, using surface-biotinylation assays and electrophysiology techniques, we examined mPRs' role in mediating the effects of NAS on the efficacy of GABAergic inhibition. Selective mPR activation enhanced phosphorylation of Ser-408 and Ser-409 (Ser-408/9) within the GABA(A)R beta 3 subunit, which depended on the activity of cAMP-dependent protein kinase A (PKA) and protein kinase C (PKC). mPR activation did not directly modify GABA(A)R activity and had no acute effects on phasic or tonic inhibition. Instead, mPR activation induced a sustained elevation in tonic current, which was blocked by PKA and PKC inhibition. Substitution of Ser-408/9 to alanine residues also prevented the effects of mPR activation on tonic current. Furthermore, this substitution abolished the effects of sustained NAS exposure on tonic inhibition. Interestingly, the allosteric effects of NAS on GABAergic inhibition were independent of Ser-408/9 in the beta 3 subunit. Additionally, although allosteric effects of NAS on GABAergic inhibition were sensitive to a recently developed NAS antagonist, the sustained effects of NAS on tonic inhibition were not. We conclude that metabotropic effects of NAS on GABAergic inhibition are mediated by mPR-dependent modulation of GABA(A)R phosphorylation. We propose that this mechanism may contribute to the varying behavioral effects of NAS.	[Parakala, Manasa L.; Zhang, Yihui; Modgil, Amit; Chadchankar, Jayashree; Vien, Thuy N.; Davies, Paul A.; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA; [Ackley, Michael A.; Doherty, James J.] Sage Therapeut, Cambridge, MA 02142 USA; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Tufts University; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu	Davies, Paul A/P-4595-2017	Davies, Paul A/0000-0002-3973-3143	NINDS, National Institutes of Health (NIH) [NS051195, NS056359, NS081735, R21NS080064, NS087662]; NIMH, NIH [MH097446]	NINDS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by NINDS, National Institutes of Health (NIH), Grants NS051195, NS056359, NS081735, R21NS080064, and NS087662 and NIMH, NIH, Grant MH097446. To whom correspondence should be addressed: Dept. of Neuroscience, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111. Tel.: 617-636-3976; Fax: 617-636-2413; E-mail:Stephen.Moss@Tufts.edu.	Abramian AM, 2014, P NATL ACAD SCI USA, V111, P7132, DOI 10.1073/pnas.1403285111; Abramian AM, 2010, J BIOL CHEM, V285, P41795, DOI 10.1074/jbc.M110.149229; Adams JM, 2015, NEUROPHARMACOLOGY, V88, P63, DOI 10.1016/j.neuropharm.2014.09.021; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brown AR, 2015, J PHYSIOL-LONDON, V593, P267, DOI 10.1113/jphysiol.2014.280263; Collier PN, 2015, J MED CHEM, V58, P517, DOI 10.1021/jm500362j; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; El Bitar F, 2014, PSYCHOPHARMACOLOGY, V231, P3293, DOI 10.1007/s00213-014-3435-3; Fernandes MS, 2008, STEROIDS, V73, P942, DOI 10.1016/j.steroids.2007.12.004; Foster H, 2010, MOL MED REP, V3, P27, DOI 10.3892/mmr_00000214; Hanson E, 2019, J NEUROSCI, V39, P3611, DOI 10.1523/JNEUROSCI.1392-18.2019; Hines RM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05481-1; Hosie AM, 2009, NEUROPHARMACOLOGY, V56, P149, DOI 10.1016/j.neuropharm.2008.07.050; Johansson M, 2018, PSYCHOPHARMACOLOGY, V235, P1533, DOI 10.1007/s00213-018-4864-1; Johansson M, 2015, AM J PHYSIOL-GASTR L, V309, pG400, DOI 10.1152/ajpgi.00073.2015; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kanes S, 2017, LANCET, V390, P480, DOI 10.1016/S0140-6736(17)31264-3; Kasubuchi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05423-9; Kelder J, 2010, STEROIDS, V75, P314, DOI 10.1016/j.steroids.2010.01.010; Kretschmannova K, 2013, J NEUROSCI, V33, P7264, DOI 10.1523/JNEUROSCI.5475-12.2013; Krietsch T, 2006, MOL ENDOCRINOL, V20, P3146, DOI 10.1210/me.2006-0129; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Mendell AL, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00359; Mitchell EA, 2008, NEUROCHEM INT, V52, P588, DOI 10.1016/j.neuint.2007.10.007; Modgil A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00015; Modgil A, 2017, NEUROPHARMACOLOGY, V113, P314, DOI 10.1016/j.neuropharm.2016.10.010; Nakamura Y, 2015, ADV PHARMACOL, V72, P97, DOI 10.1016/bs.apha.2014.11.008; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Pang YF, 2013, ENDOCRINOLOGY, V154, P283, DOI 10.1210/en.2012-1772; Stefanits H, 2018, J COMP NEUROL, V526, P324, DOI 10.1002/cne.24337; Terunuma M, 2008, J NEUROSCI, V28, P376, DOI 10.1523/JNEUROSCI.4346-07.2008; Thomas P, 2017, MOL CELL ENDOCRINOL, V447, P23, DOI 10.1016/j.mce.2017.02.025; Thomas P, 2012, NEUROENDOCRINOLOGY, V96, P162, DOI 10.1159/000339822; Vien TN, 2016, ANESTH ANALG, V123, P1220, DOI 10.1213/ANE.0000000000001349; Vien TN, 2015, P NATL ACAD SCI USA, V112, P14805, DOI 10.1073/pnas.1514657112; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	40	23	23	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12220	12230		10.1074/jbc.RA119.008875	http://dx.doi.org/10.1074/jbc.RA119.008875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31239352	Green Published, hybrid			2022-12-26	WOS:000484284500024
J	Lew, B; Huen, J; Yu, PP; Yuan, L; Wang, DF; Ping, F; Abu Talib, M; Lester, D; Jia, CX				Lew, Bob; Huen, Jenny; Yu, Pengpeng; Yuan, Lu; Wang, Dong-Fang; Ping, Fan; Abu Talib, Mansor; Lester, David; Jia, Cun-Xian			Associations between depression, anxiety, stress, hopelessness, subjective well-being, coping styles and suicide in Chinese university students	PLOS ONE			English	Article							REVISED SBQ-R; COLLEGE-STUDENTS; MEDIATING ROLE; IDEATION; LIFE; BEHAVIORS; QUESTIONNAIRE; ADOLESCENTS; PREVALENCE; PREDICTORS	Suicide is a major public health concern worldwide. This study aimed to predict the suicidal behavior of Chinese university students by studying psychological measures such as hopelessness, orientation to happiness, meaning in life, depression, anxiety, stress, and coping styles. In November 2016, a stratified-clustered-random sampling approach was utilized to select subjects from two large public medical-related universities in Shandong province, China. This sample consisted of 2,074 undergraduate students (706 males, 1,368 females; mean age = 19.79 +/- 1.39 years). The students' major risk factors for suicide were depression, anxiety, stress, and hopelessness, and the students' minor risk factors included orientation to happiness and coping styles (including self-distraction, self-blame and substance use). Notably, the presence of meaning in life had a positive effect on preventing suicide and acted as a protective factor, which suggests that it is important to identify risk factors as well as protective factors relevant to the target population group in order to increase the effectiveness of counseling and suicide prevention programs.	[Lew, Bob] Putra Univ Malaysia, Dept Social Psychol, Fac Human Ecol, Serdang, Selangor, Malaysia; [Huen, Jenny] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Peoples R China; [Yu, Pengpeng; Yuan, Lu; Jia, Cun-Xian] Shandong Univ, Sch Publ Hlth, Dept Epidemiol, Jinan, Shandong, Peoples R China; [Yu, Pengpeng; Yuan, Lu; Jia, Cun-Xian] Shandong Univ, Ctr Suicide Prevent Res, Jinan, Shandong, Peoples R China; [Wang, Dong-Fang] Shandong Univ Tradit Chinese Med, Dept Prevent Med, Sch Basic Med Sci, Jinan Changqing, Shandong, Peoples R China; [Ping, Fan] Shandong Univ, Qilu Hosp, Informat Network Ctr, Jinan, Shandong, Peoples R China; [Abu Talib, Mansor] Putra Univ Malaysia, Dept Human Dev & Family Study, Serdang, Selangor, Malaysia; [Lester, David] Stockton Univ, Galloway, NJ USA	Universiti Putra Malaysia; University of Hong Kong; Shandong University; Shandong University; Shandong University of Traditional Chinese Medicine; Shandong University; Universiti Putra Malaysia	Jia, CX (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol, Jinan, Shandong, Peoples R China.; Jia, CX (corresponding author), Shandong Univ, Ctr Suicide Prevent Res, Jinan, Shandong, Peoples R China.	jiacunxian@sdu.edu.cn	Abu Talib, Mansor/ABD-7552-2021; Huen, Jenny/AAS-1507-2021	Huen, Jenny/0000-0001-7189-5284	Shandong University International Collaboration Project "Religion and suicidal behavior" [21320005281601]	Shandong University International Collaboration Project "Religion and suicidal behavior"	Shandong University International Collaboration Project "Religion and suicidal behavior" (21320005281601) to Prof. Jia Cun-Xian.	Aloba O, 2017, ASIAN J PSYCHIATR, V26, P46, DOI 10.1016/j.ajp.2017.01.017; Arria AM, 2009, ARCH SUICIDE RES, V13, P230, DOI 10.1080/13811110903044351; Bauer RL, 2014, CRISIS, V35, P36, DOI 10.1027/0227-5910/a000226; Baumstarck K, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-016-0581-9; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Byrd DR, 2012, J AM COLL HEALTH, V60, P185, DOI 10.1080/07448481.2011.584334; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chang EC, 2017, DEATH STUD, V41, P455, DOI 10.1080/07481187.2017.1299255; Cleary Michelle, 2011, Issues Ment Health Nurs, V32, P250, DOI 10.3109/01612840.2010.548906; DIXON WA, 1991, J COUNS PSYCHOL, V38, P51, DOI 10.1037/0022-0167.38.1.51; Dogan T, 2012, PROCD SOC BEHV, V55, P612, DOI 10.1016/j.sbspro.2012.09.543; Drum DJ, 2009, PROF PSYCHOL-RES PR, V40, P213, DOI 10.1037/a0014465; Edwards MJ, 2001, J CLIN PSYCHOL, V57, P1517, DOI 10.1002/jclp.1114; Eskin M, 2016, SCAND J PSYCHOL, V57, P554, DOI 10.1111/sjop.12318; Evans E, 2004, CLIN PSYCHOL REV, V24, P957, DOI 10.1016/j.cpr.2004.04.005; Farabaugh A, 2012, PSYCHOPATHOLOGY, V45, P228, DOI 10.1159/000331598; Furr SR, 2001, PROF PSYCHOL-RES PR, V32, P97, DOI 10.1037/0735-7028.32.1.97; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; [龚栩 Gong Xu], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P443; Henry JD, 2011, BR J CLIN PSYCHOL, V44, P227; Hill RM, 2011, CLIN PSYCHOL REV, V31, P1133, DOI 10.1016/j.cpr.2011.07.008; Ho MY, 2010, PERS INDIV DIFFER, V48, P658, DOI 10.1016/j.paid.2010.01.008; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; [孔媛媛 KONG YuanYuan], 2007, [中国心理卫生杂志, Chinese Mental Health Journal], V21, P686; Konick LC, 2005, SUICIDE LIFE-THREAT, V35, P181, DOI 10.1521/suli.35.2.181.62875; KOVACS M, 1975, SUICIDE, V5, P98; Krause N, 2009, J GERONTOL B-PSYCHOL, V64, P517, DOI 10.1093/geronb/gbp047; Lamis DA, 2016, J CLIN PSYCHOL, V72, P919, DOI 10.1002/jclp.22295; Lee K, 2017, J AFFECT DISORDERS, V221, P198, DOI 10.1016/j.jad.2017.06.025; Lent RW, 2004, J COUNS PSYCHOL, V51, P482, DOI 10.1037/0022-0167.51.4.482; Lester D, 2014, PSYCHOL REP, V114, P293, DOI 10.2466/12.02.PR0.114k10w7; Lester D, 2013, J AFFECT DISORDERS, V150, P1204, DOI 10.1016/j.jad.2013.04.055; Li ZY, 2012, J NERV MENT DIS, V200, P885, DOI 10.1097/NMD.0b013e31826b6ecc; [刘思斯 Liu Sisi], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P478; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mackenzie S, 2011, AM J ORTHOPSYCHIAT, V81, P101, DOI 10.1111/j.1939-0025.2010.01077.x; Miranda R, 2013, PSYCHIAT RES, V210, P174, DOI 10.1016/j.psychres.2013.02.033; Murray S, 1992, POCKET BOOKS, V67, P671; Nock MK, 2013, JAMA PSYCHIAT, V70, P300, DOI 10.1001/2013.jamapsychiatry.55; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Osman A, 2012, J CLIN PSYCHOL, V68, P1322, DOI 10.1002/jclp.21908; Parker JDA, 2004, PERS INDIV DIFFER, V36, P163, DOI 10.1016/S0191-8869(03)00076-X; Peterson C., 2005, J HAPPINESS STUD, V6, P25, DOI [https://doi.org/10.1007/s10902-004-1278-z, DOI 10.1007/S10902-004-1278-Z]; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Pompili M, 2015, DRUG AGING, V32, P21, DOI 10.1007/s40266-014-0233-x; Saffer BY, 2015, SUICIDE LIFE-THREAT, V45, P518, DOI 10.1111/sltb.12146; Shandong Provincial Bureau of Statistics, 2017, 2017 SHAND STAT YB; Spirito A, 2006, ANNU REV CLIN PSYCHO, V2, P237, DOI 10.1146/annurev.clinpsy.2.022305.095323; Steger MF, 2006, J COUNS PSYCHOL, V53, P80, DOI 10.1037/0022-0167.53.1.80; Sun L, 2015, J CLIN PSYCHOL, V71, P258, DOI 10.1002/jclp.22140; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Tang KNS, 2016, J PSYCHOPATHOL BEHAV, V38, P631, DOI 10.1007/s10862-016-9551-0; Toprak S, 2011, PSYCHIAT RES, V187, P140, DOI 10.1016/j.psychres.2010.09.009; Van Orden KA, 2008, SUICIDE LIFE-THREAT, V38, P427, DOI 10.1521/suli.2008.38.4.427; Wilcox HC, 2010, J AFFECT DISORDERS, V127, P287, DOI 10.1016/j.jad.2010.04.017; Woosley JA, 2014, J CLIN SLEEP MED, V10, P1223, DOI 10.5664/jcsm.4208; World Health Organization, 2019, SUIC DAT; Xie Xingli, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P1482; Yang Y, 2017, CHILD INDIC RES, V10, P881, DOI 10.1007/s12187-016-9410-2; Zhang J, 2014, SUICIDE LIFE-THREAT, V44, P560, DOI 10.1111/sltb.12090; Zhang WC, 2015, DEATH STUD, V39, P442, DOI 10.1080/07481187.2014.970300; Zhang XY, 2012, J ADOLESCENCE, V35, P683, DOI 10.1016/j.adolescence.2011.10.003; Zhao SB, 2015, INT J ENV RES PUB HE, V12, P131, DOI 10.3390/ijerph120100131	64	75	77	16	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0217372	10.1371/journal.pone.0217372	http://dx.doi.org/10.1371/journal.pone.0217372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3YW	31260454	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000484918700008
J	Freebairn, L; Atkinson, JA; Osgood, ND; Kelly, PM; McDonnell, G; Rychetnik, L				Freebairn, Louise; Atkinson, Jo-An; Osgood, Nathaniel D.; Kelly, Paul M.; McDonnell, Geoff; Rychetnik, Lucie			Turning conceptual systems maps into dynamic simulation models: An Australian case study for diabetes in pregnancy	PLOS ONE			English	Article							PUBLIC-HEALTH; PARTICIPATORY PROCESSES; KNOWLEDGE EXCHANGE; SCIENCE; FRAMEWORK; MELLITUS; THINKING; POLICY; CLASSIFICATION; COMPLEXITY	Background System science approaches are increasingly used to explore complex public health problems. Quantitative methods, such as participatory dynamic simulation modelling, can mobilise knowledge to inform health policy decisions. However, the analytic and practical steps required to turn collaboratively developed, qualitative system maps into rigorous and policy-relevant quantified dynamic simulation models are not well described. This paper reports on the processes, interactions and decisions that occurred at the interface between modellers and end-user participants in an applied health sector case study focusing on diabetes in pregnancy. Methods An analysis was conducted using qualitative data from a participatory dynamic simulation modelling case study in an Australian health policy setting. Recordings of participatory model development workshops and subsequent meetings were analysed and triangulated with field notes and other written records of discussions and decisions. Case study vignettes were collated to illustrate the deliberations and decisions made throughout the model development process. Results The key analytic objectives and decision-making processes included: defining the model scope; analysing and refining the model structure to maximise local relevance and utility; reviewing and incorporating evidence to inform model parameters and assumptions; focusing the model on priority policy questions; communicating results and applying the models to policy processes. These stages did not occur sequentially; the model development was cyclical and iterative with decisions being re-visited and refined throughout the process. Storytelling was an effective strategy to both communicate and resolve concerns about the model logic and structure, and to communicate the outputs of the model to a broader audience. Conclusion The in-depth analysis reported here examined the application of participatory modelling methods to move beyond qualitative conceptual mapping to the development of a rigorously quantified and policy relevant, complex dynamic simulation model. The analytic objectives and decision-making themes identified provide guidance for interpreting, understanding and reporting future participatory modelling projects and methods.	[Freebairn, Louise; Kelly, Paul M.] ACT Hlth, Canberra, ACT, Australia; [Freebairn, Louise; Atkinson, Jo-An; Osgood, Nathaniel D.; Kelly, Paul M.; Rychetnik, Lucie] Australian Prevent Partnership Ctr, Sax Inst, Sydney, NSW, Australia; [Freebairn, Louise; Rychetnik, Lucie] Univ Notre Dame, Sydney, NSW, Australia; [Atkinson, Jo-An; McDonnell, Geoff] Sax Inst, Decis Analyt, Sydney, NSW, Australia; [Atkinson, Jo-An; Rychetnik, Lucie] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Osgood, Nathaniel D.] Univ Saskatchewan, Comp Sci, Saskatoon, SK, Canada; [Osgood, Nathaniel D.] Univ Saskatchewan, Dept Community Hlth & Epidemiol, Saskatoon, SK, Canada; [Kelly, Paul M.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia	University of Sydney; University of Notre Dame Australia; University of Sydney; University of Sydney; University of Saskatchewan; University of Saskatchewan; Australian National University	Freebairn, L (corresponding author), ACT Hlth, Canberra, ACT, Australia.; Freebairn, L (corresponding author), Australian Prevent Partnership Ctr, Sax Inst, Sydney, NSW, Australia.; Freebairn, L (corresponding author), Univ Notre Dame, Sydney, NSW, Australia.	louise.freebairn@act.gov.au	Occhipinti, Jo-An/AAA-3870-2021	Occhipinti, Jo-An/0000-0002-2380-1092; Freebairn, Louise/0000-0002-7434-870X; Rychetnik, Lucie/0000-0001-6855-2897	Australian Prevention Partnership Centre - National Health and Medical Research Council of Australia (NHMRC) [GNT9100001]; Hospitals Contribution Fund of Australia Research Foundation; University of Notre Dame; Australian Postgraduate Award scholarship; CRN top-up scholarship; NSW Health; ACT Health; Australian Government Department of Health	Australian Prevention Partnership Centre - National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hospitals Contribution Fund of Australia Research Foundation; University of Notre Dame; Australian Postgraduate Award scholarship; CRN top-up scholarship; NSW Health; ACT Health; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This research was funded through The Australian Prevention Partnership Centre, which receives funds from the National Health and Medical Research Council of Australia (NHMRC) through its partnership centre grant scheme (Grant ID: GNT9100001) with NSW Health, ACT Health, The Australian Government Department of Health and the Hospitals Contribution Fund of Australia Research Foundation. The contents of this paper are solely the responsibility of the individual authors and do not reflect the views of the NHMRC or funding partners. University of Notre Dame have provided the following financial support for this case study: Australian Postgraduate Award scholarship and CRN top-up scholarship for supervision travel expenses.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Atkinson JA, 2018, ADDICTION; Atkinson JA, 2018, INT J PUBLIC HEALTH, V63, P537, DOI 10.1007/s00038-017-1041-y; Atkinson JA, 2017, PUBLIC HEALTH RES PR, V27, DOI 10.17061/phrp2711707; Atkinson JA, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0221-5; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Bain E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010443.pub2; Bammer G, 2017, PALGR COMMUN, V3, DOI 10.1057/s41599-017-0039-7; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Best A, 2010, EVID POLICY, V6, P145, DOI 10.1332/174426410X502284; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Borshchev A, 2013, THE BIG BOOK OF SIMU; Boyko JA, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0374-1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burke JG, 2015, INT J BEHAV MED, V22, P283, DOI 10.1007/s12529-014-9417-3; Contandriopoulos D, 2010, MILBANK Q, V88, P444, DOI 10.1111/j.1468-0009.2010.00608.x; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Davies H., 2015, HEALTH SERV DELIVERY, V3, DOI [DOI 10.3310/HSDR03270, 10.3310/hsdr03270]; Davies HTO, 2015, NIHR JOURNALS LIBRAR; Elsawah S, 2017, ENVIRON MODELL SOFTW, V93, P127, DOI 10.1016/j.envsoft.2017.03.001; Epstein JM, 2008, JASSS-J ARTIF SOC S, V11; Finegood DT, 2010, OBESITY, V18, pS13, DOI 10.1038/oby.2009.426; Freebairn L, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0143-y; Freebairn L, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0707-6; Freebairn L, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0245-1; Friel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188872; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Gilbert N, 2018, JASSS-J ARTIF SOC S, V21, DOI 10.18564/jasss.3669; Gray S, 2018, ECOL APPL, V28, P46, DOI 10.1002/eap.1627; Greenhalgh T, 2011, J ROY SOC MED, V104, P501, DOI 10.1258/jrsm.2011.110285; Hammond RA, 2015, CONSIDERATIONS AND B; Happach R, 2012, THE 30TH INTERNATION; Hassenforder E, 2015, J ENVIRON MANAGE, V157, P84, DOI 10.1016/j.jenvman.2015.04.012; Homer J, 2004, SYST DYNAM REV, V20, P199, DOI 10.1002/sdr.295; Homer J, 2014, SYST DYNAM REV, V30, P75, DOI 10.1002/sdr.1514; Hovmand PS, 2012, SYST RES BEHAV SCI, V29, P179, DOI 10.1002/sres.2105; HOVMAND PETER S., 2014, COMMUNITY BASED SYST; HUANG TT, 2009, PREV CHRONIC DIS, V6; Karnon J, 2012, MED DECIS MAKING, V32, P701, DOI 10.1177/0272989X12455462; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kislov R, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0805-y; Kontos PC, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-1; Lane DC, 2018, J SIMUL, V12, P90, DOI 10.1080/17477778.2017.1404205; Lapolla A, 2018, ACTA DIABETOL, P1; Lich KH, 2013, PREV SCI, V14, P279, DOI 10.1007/s11121-012-0285-2; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Luna-Reyes LF, 2019, SYST RES BEHAV SCI, V36, P494, DOI 10.1002/sres.2564; Mabry PL, 2010, AM J PUBLIC HEALTH, V100, P1161, DOI 10.2105/AJPH.2010.198176; Maedows D, 1999, LEVERAGE POINTS PLAC; Marshall N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171950; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Nankervis AMH., ADIPS CONSENSUS GUID; O'Donnell E, 2017, J PUBLIC HLTH POLICY, P1; Osgood ND, 2017, SYSTEMS SCI POPULATI, P191, DOI DOI 10.1093/ACPROF:OSO/9780190492397.003.0016; Page A, 2018, AUST NZ J PSYCHIAT, V52, P660, DOI 10.1177/0004867417752866; Radinsky J, 2017, J ENVIRON PLANN MAN, V60, P1296, DOI 10.1080/09640568.2016.1221795; Riley B, 2012, EVID POLICY, V8, P417, DOI 10.1332/174426412X660089; Roberts N, 2019, SYST RES BEHAV SCI, V36, P36, DOI 10.1002/sres.2555; Rouwette EAJA, 2011, SYST DYNAM REV, V27, P1, DOI 10.1002/sdr.441; Rusoja E, 2018, J EVAL CLIN PRACT, V24, P600, DOI 10.1111/jep.12856; Schaefer-Graf U, 2018, DIABETOLOGIA, V61, P1012, DOI 10.1007/s00125-018-4545-y; Seidl R, 2015, AMBIO, V44, P750, DOI 10.1007/s13280-015-0670-8; Senge P., 2006, 5 DISCIPLINE; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Smajgl A, 2013, FUTURES, V52, P52, DOI 10.1016/j.futures.2013.07.002; Smith G., 2004, 22 INT C SYST DYN SO, P25; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Sterman JD, 2002, SYST DYNAM REV, V18, P501, DOI 10.1002/sdr.261; Vennix JAM, 1999, SYST DYNAM REV, V15, P379, DOI 10.1002/(SICI)1099-1727(199924)15:4<379::AID-SDR179>3.0.CO;2-E; Voinov A, 2018, ENVIRON MODELL SOFTW, V109, P232, DOI 10.1016/j.envsoft.2018.08.028; Voinov A, 2016, ENVIRON MODELL SOFTW, V77, P196, DOI 10.1016/j.envsoft.2015.11.016; Voinov A, 2010, ENVIRON MODELL SOFTW, V25, P1268, DOI 10.1016/j.envsoft.2010.03.007; Ward V, 2012, SOC SCI MED, V74, P297, DOI 10.1016/j.socscimed.2011.09.021; Wutzke S, 2016, PUBLIC HEALTH RES PR, V26, DOI 10.17061/phrp2631632	74	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218875	10.1371/journal.pone.0218875	http://dx.doi.org/10.1371/journal.pone.0218875			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3WH	31247006	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900048
J	Coulter, DP; Wang, P; Coulter, AA; Van Susteren, GE; Eichmiller, JJ; Garvey, JE; Sorensen, PW				Coulter, David P.; Wang, Ping; Coulter, Alison A.; Van Susteren, Grace E.; Eichmiller, Jessica J.; Garvey, James E.; Sorensen, Peter W.			Nonlinear relationship between Silver Carp density and their eDNA concentration in a large river	PLOS ONE			English	Article							ENVIRONMENTAL DNA; BIGHEADED CARPS; ILLINOIS RIVER; SPAWNING ACTIVITY; INVASIVE BIGHEAD; FISH DENSITY; QUANTIFICATION; SURVEILLANCE; COMMUNITIES; QUANTIFY	Although environmental DNA (eDNA) is increasingly being used to survey for the presence of rare and/or invasive fishes in aquatic systems, the utility of this technique has been limited by a poor understanding of whether and how eDNA concentrations relate to fish density, especially in rivers. We conducted a field study to systematically test whether the eDNA released by a model invasive fish, Silver Carp (Hypophthalmichthys molitrix), was related to the density of this species in a large river. We quantified fish density throughout the 460 km long Illinois River using hydroacoustic surveys at 23 sites while concurrently collecting 192 surface water samples for eDNA analysis. We found that Silver Carp numerical density and biomass density were positively and non-linearly related to eDNA concentration and detection rate. Both eDNA concentration (copy number) and detection rate increased rapidly as Silver Carp density increased but plateaued at moderate densities. These relationships could prove useful for estimating Silver Carp relative abundance in newly invaded locations where population numbers are low to moderate. Future studies should explore the causes of this nonlinear relationship as it would ultimately benefit aquatic species monitoring and management programs.	[Coulter, David P.; Coulter, Alison A.; Garvey, James E.] Southern Illinois Univ, Dept Zool, Ctr Fisheries Aquaculture & Aquat Sci, Carbondale, IL 62901 USA; [Wang, Ping] Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA; [Wang, Ping; Van Susteren, Grace E.; Eichmiller, Jessica J.; Sorensen, Peter W.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Van Susteren, Grace E.] Univ Bonn, Bonn, Germany; [Eichmiller, Jessica J.] Thermo Fisher Sci, Ann Arbor, MI USA	Southern Illinois University System; Southern Illinois University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Bonn; Thermo Fisher Scientific	Coulter, DP (corresponding author), Southern Illinois Univ, Dept Zool, Ctr Fisheries Aquaculture & Aquat Sci, Carbondale, IL 62901 USA.	dcoulter@siu.edu	Garvey, James/AAO-5698-2021; Garvey, Jim/A-4919-2012	Garvey, Jim/0000-0001-5393-9351; Sorensen, Peter/0000-0003-0321-1279	Great Lakes Restoration Initiative, via the Illinois Department of Natural Resources [CAFWS-123A]; Minnesota Environment and Natural Resources Trust Fund; Minnesota Aquatic Invasive Species Research Center	Great Lakes Restoration Initiative, via the Illinois Department of Natural Resources; Minnesota Environment and Natural Resources Trust Fund; Minnesota Aquatic Invasive Species Research Center	Funding was provided by the Great Lakes Restoration Initiative, via the Illinois Department of Natural Resources (Grant CAFWS-123A; https://www.dnr.illinois.gov) to DPC, AAC, and JEG. Funding was also provided by the Minnesota Environment and Natural Resources Trust Fund as recommended by the Legislative-Citizen Commission on Minnesota Resources (LCCMR; https://www.lccmr.leg.mn) to PWS. The Minnesota Aquatic Invasive Species Research Center (https://www.maisrc.umn.edu) administered LCCMR funds. The funders provided support in the form of salaries for authors [DPC, PW, AAC, GEV, JJE, PWS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Following completion of this study, JJE became employed by Fisher Scientific Inc. Fisher Scientific Inc. had no official collaboration with this study, did not influence study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian-Kalchhauser I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147558; Asian Carp Regional Coordinating Committee (ACRCC), 2018, AS CARP ACT PLAN FIS; Baldigo BP, 2017, T AM FISH SOC, V146, P99, DOI 10.1080/00028487.2016.1243578; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Breen MJ, 2006, N AM J FISH MANAGE, V26, P32, DOI 10.1577/M05-013.1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CASSELMAN J M, 1990, Polskie Archiwum Hydrobiologii, V37, P521; Collins SF, 2017, OECOLOGIA, V184, P521, DOI 10.1007/s00442-017-3872-x; Coulter AA, 2016, J GREAT LAKES RES, V42, P83, DOI 10.1016/j.jglr.2015.10.009; Coulter DP, 2018, BIOL CONSERV, V221, P118, DOI 10.1016/j.biocon.2018.02.020; Cowart DA, 2018, MANAG BIOL INVASION, V9, P27, DOI 10.3391/mbi.2018.9.1.03; De Ventura L, 2017, MANAG BIOL INVASION, V8, P101, DOI 10.3391/mbi.2017.8.1.10; DeBoer JA, 2018, FRESHWATER BIOL, V63, P597, DOI 10.1111/fwb.13097; Doi H, 2017, FRESHWATER BIOL, V62, P30, DOI 10.1111/fwb.12846; Dolan CR, 2002, N AM J FISH MANAGE, V22, P1442, DOI 10.1577/1548-8675(2002)022<1442:EFCESI>2.0.CO;2; Dougherty MM, 2016, J APPL ECOL, V53, P722, DOI 10.1111/1365-2664.12621; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Eichmiller JJ, 2016, MOL ECOL RESOUR, V16, P56, DOI 10.1111/1755-0998.12421; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Erickson RA, 2016, MOL ECOL RESOUR, V16, P957, DOI 10.1111/1755-0998.12533; Farrington HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117803; Ghosal R, 2018, ECOL EVOL, V8, P6714, DOI 10.1002/ece3.4169; Hinlo R, 2018, BIOL INVASIONS, V20, P3079, DOI 10.1007/s10530-018-1760-x; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kolar CS, 2007, AM FISHERIES SOC SPE, P33; Lacoursiere-Roussel A, 2016, J APPL ECOL, V53, P1148, DOI 10.1111/1365-2664.12598; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; LOVE RH, 1971, FISH BULL NATL OC AT, V69, P703; MacNamara R, 2018, RIVER RES APPL, V34, P555, DOI 10.1002/rra.3279; MacNamara R, 2016, BIOL INVASIONS, V18, P3293, DOI 10.1007/s10530-016-1220-4; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; McClelland MA, 2012, FISHERIES, V37, P340, DOI 10.1080/03632415.2012.704815; Nelson KA, 2017, FUNCT ECOL, V31, P2157, DOI 10.1111/1365-2435.12922; Perez CR, 2017, N AM J FISH MANAGE, V37, P1010, DOI 10.1080/02755947.2017.1342721; Plough LV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205578; Ruetz CR, 2007, N AM J FISH MANAGE, V27, P825, DOI 10.1577/M06-147.1; Sass GG, 2014, J GREAT LAKES RES, V40, P911, DOI 10.1016/j.jglr.2014.08.010; Song JW, 2017, SCI TOTAL ENVIRON, V605, P713, DOI 10.1016/j.scitotenv.2017.06.255; Spear SF, 2015, BIOL CONSERV, V183, P38, DOI 10.1016/j.biocon.2014.11.016; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Woldt A, 2015, QUALITY ASSURANCE PR, P168; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786	45	10	11	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218823	10.1371/journal.pone.0218823	http://dx.doi.org/10.1371/journal.pone.0218823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242242	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600058
J	Song, YJ; Gyarmati, P				Song, Yajing; Gyarmati, Peter			Optimized detection of bacteria in bloodstream infections	PLOS ONE			English	Article							TARGET	Bloodstream infection (BSI) is a life-threatening condition characterized by the presence of pathogens in the blood. It is associated with increased morbidity and mortality, and has to be treated promptly as mortality increases with every hour of delayed treatment. Therefore, rapid and sensitive diagnosis of BSI is essential. The routine diagnostic method for BSI is blood culture, which can only detect culturable pathogens and takes several days to obtain results. The 16S rRNA gene is present in all bacteria and is commonly used as a target for universal bacterial detection in rapid molecular assays such as PCR. However, molecular detection of the 16S gene is hampered by the large amount of human DNA found in blood samples, making diagnostic results aspecific and less sensitive. We have optimized the selection of PCR primers targeting the 16S rRNA gene to avoid cross-reaction with human DNA background. The developed method increases specificity and sensitivity for pathogen diagnosis, and provides rapid and accurate pathogen detection for rare bacterial DNA in the presence of abundant host DNA.	[Song, Yajing; Gyarmati, Peter] Univ Illinois, Coll Med, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria	Gyarmati, P (corresponding author), Univ Illinois, Coll Med, Peoria, IL 61656 USA.	gyarmati@uic.edu	Gyarmati, Peter/F-4887-2013	Gyarmati, Peter/0000-0001-7362-316X	University of Illinois College of Medicine at Peoria	University of Illinois College of Medicine at Peoria	This study was supported by the University of Illinois College of Medicine at Peoria start-up fund to PG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amir A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1070; Crisp A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0607-3; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Gijavanekar C, 2012, ANAL BIOCHEM, V421, P81, DOI 10.1016/j.ab.2011.11.010; Gray MW, 2001, GENOME BIOL, V2; Greuter D, 2016, NUCLEIC ACIDS RES, V44, pD586, DOI 10.1093/nar/gkv1232; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Khoruts A, 2017, TRANSL RES, V179, P116, DOI 10.1016/j.trsl.2016.07.013; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Labbe D, 2007, FEMS MICROBIOL ECOL, V59, P466, DOI 10.1111/j.1574-6941.2006.00250.x; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P492, DOI 10.1111/1469-0691.12144; Pfeiffer CD, 2011, J CLIN MICROBIOL, V49, P2879, DOI 10.1128/JCM.00609-11; Song YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103610	15	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0219086	10.1371/journal.pone.0219086	http://dx.doi.org/10.1371/journal.pone.0219086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242256	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600076
J	Josephy-Hernandez, S; Pirvulescu, I; Maira, M; Aboulkassim, T; Wong, TP; McKinney, RA; Saragovi, HU				Josephy-Hernandez, Sylvia; Pirvulescu, Iulia; Maira, Mario; Aboulkassim, Tahar; Wong, Tak Pan; McKinney, R. Anne; Saragovi, H. Uri			Pharmacological interrogation of TrkA-mediated mechanisms in hippocampal-dependent memory consolidation	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; MOLECULE PEPTIDOMIMETIC LIGANDS; ALZHEIMERS-DISEASE; NEUROTROPHIN RECEPTORS; ADULT NEUROGENESIS; NUCLEUS BASALIS; ERK5; DYSFUNCTION; ACTIVATION; EXPRESSION	In the brain, the TrkA receptor for Nerve Growth Factor (NGF) is expressed primarily in the cholinergic system. TrkA/NGF support neuronal health and function, and deficiencies in this axis are associated with progressive cholinergic neuron atrophy and death, and with cognitive deficit in disorders such as Down's syndrome and Alzheimer's disease. These observations led to the hypothesis that TrkA agonists may rescue atrophic cholinergic neurons and benefit cognition. Indeed, a small molecule TrkA partial agonist called D3 normalized TrkA signals and improved memory in cognitive impairment models of ageing and an APP mouse model of Alzheimer's disease. Paradoxically, in young healthy mice chronic delivery of D3 caused impaired memory without impairing learning, a form of anterograde amnesia. Here, we use this as a model to study the mechanisms of impaired memory. In young healthy mice acute or chronic treatment with D3 induces hyperactivation of TrkA-mediated signals in hippocampus, and causes a deficit in hippocampal-dependent memory consolidation proximal to drug exposure, without affecting learning or memory retrieval. The impairment after acute drug exposure is reversible. The impairment after long-term drug exposure is irreversible, likely due to a decrease in hippocampal CA1 neuron basal arborization. These findings support the notion of a homeostatic role for TrkA in memory, and demonstrate the differential outcomes of TrkA (hyper) activation in healthy versus disease states.	[Josephy-Hernandez, Sylvia; Pirvulescu, Iulia; Maira, Mario; Aboulkassim, Tahar; Saragovi, H. Uri] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada; [Josephy-Hernandez, Sylvia; Wong, Tak Pan; McKinney, R. Anne; Saragovi, H. Uri] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada; [Pirvulescu, Iulia; McKinney, R. Anne; Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Wong, Tak Pan] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Wong, Tak Pan] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Saragovi, HU (corresponding author), Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada.; Saragovi, HU (corresponding author), McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada.; Saragovi, HU (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	uri.saragovi@mcgill.ca	Josephy-Hernandez, Sylvia/ABD-8449-2021	Josephy-Hernandez, Sylvia/0000-0002-5447-1073; Pirvulescu, Iulia/0000-0003-1550-4060	Canadian Institutes of Health Research; Integrated Program in Neuroscience; Lady Davis Institute/TD Bank	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Integrated Program in Neuroscience; Lady Davis Institute/TD Bank	This work was funded by Canadian Institutes of Health Research (grant to HUS). SJH received scholarships from the Integrated Program in Neuroscience and the Lady Davis Institute/TD Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Aboulkassim T, 2011, MOL PHARMACOL, V80, P498, DOI 10.1124/mol.111.071332; Bai YJ, 2010, J BIOL CHEM, V285, P39392, DOI 10.1074/jbc.M110.147801; Birch AM, 2013, NEUROPHARMACOLOGY, V75, P255, DOI 10.1016/j.neuropharm.2013.07.023; Bonifacino J.S., 2001, CURR PROTOC MOL BIOL, V10; Bourne JN, 2011, HIPPOCAMPUS, V21, P354, DOI 10.1002/hipo.20768; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Bruno MA, 2004, J NEUROSCI, V24, P8009, DOI 10.1523/JNEUROSCI.1508-04.2004; Buchsbaum B. R., 2008, LEARNING MEMORY COMP, P237; Counts SE, 2004, ANN NEUROL, V56, P520, DOI 10.1002/ana.20233; Debeir T, 1999, P NATL ACAD SCI USA, V96, P4067, DOI 10.1073/pnas.96.7.4067; Deinhardt Katrin, 2014, Handb Exp Pharmacol, V220, P103, DOI 10.1007/978-3-642-45106-5_5; DeVos SL, 2013, JOVE-J VIS EXP, DOI 10.3791/50326; Duan LS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-3; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferreira D, 2015, J ALZHEIMERS DIS, V43, P1059, DOI 10.3233/JAD-141068; Fortress AM, 2011, J AGING RES, V2011; Iulita MF, 2014, TRENDS PHARMACOL SCI, V35, P338, DOI 10.1016/j.tips.2014.04.010; Josephy-Hernandez S, 2017, NEUROBIOL DIS, V97, P139, DOI 10.1016/j.nbd.2016.08.004; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Magno L, 2011, EUR J NEUROSCI, V34, P1767, DOI 10.1111/j.1460-9568.2011.07890.x; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Mendiola-Precoma J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2589276; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moser MB, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021808; Muller M, 2012, J NEUROSCI, V32, P14885, DOI 10.1523/JNEUROSCI.2849-12.2012; Mufson Elliott J., 2000, Journal of Comparative Neurology, V427, P19, DOI 10.1002/1096-9861(20001106)427:1<19::AID-CNE2>3.0.CO;2-A; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Niewiadomska G, 2011, BEHAV BRAIN RES, V221, P515, DOI 10.1016/j.bbr.2010.02.024; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Pan YW, 2013, NEUROBIOL LEARN MEM, V105, P81, DOI 10.1016/j.nlm.2013.07.011; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Sanchez-Ortiz E, 2012, J NEUROSCI, V32, P4065, DOI 10.1523/JNEUROSCI.6314-11.2012; Saragovi HU, 2005, J NEUROCHEM, V95, P1472, DOI 10.1111/j.1471-4159.2005.03479.x; Saragovi HU, 2002, CURR PHARM DESIGN, V8, P2201, DOI 10.2174/1381612023393215; SCOTT SA, 1995, J NEUROSCI, V15, P6213; Sekar S, 2013, PSYCHOPHARMACOLOGY, V227, P479, DOI 10.1007/s00213-013-2966-3; Sendera TJ, 2000, J NEUROCHEM, V74, P1185; Sharifi KA, 2017, NEUROSCIENCE, V353, P7, DOI 10.1016/j.neuroscience.2017.03.036; Swanger SA, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-38; van Oterendorp C, 2014, INVEST OPHTH VIS SCI, V55, P658, DOI 10.1167/iovs.13-12985; Wang WB, 2014, J NEUROSCI, V34, P2130, DOI 10.1523/JNEUROSCI.3324-13.2014; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Zaccaro MC, 2005, CHEM BIOL, V12, P1015, DOI 10.1016/j.chembiol.2005.06.015; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218036	10.1371/journal.pone.0218036	http://dx.doi.org/10.1371/journal.pone.0218036			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233568	gold, Green Published, Green Submitted			2022-12-26	WOS:000484896700010
J	Oeverhaus, M; Copei, A; Mattheis, S; Ringelstein, A; Tiemessen, M; Esser, J; Eckstein, A; Stahr, K				Oeverhaus, Michael; Copei, Anna; Mattheis, Stefan; Ringelstein, Adrian; Tiemessen, Madeleine; Esser, Joachim; Eckstein, Anja; Staehr, Kerstin			Influence of orbital morphology on proptosis reduction and ocular motility after decompression surgery in patients with Graves' orbitopathy	PLOS ONE			English	Article							QUALITY-OF-LIFE; SURGICAL DECOMPRESSION; EUROPEAN GROUP; OPHTHALMOPATHY; DISEASE; OUTCOMES; PATHOGENESIS; STRABISMUS; NAVIGATION	Purpose Orbital decompression surgery is performed in patients with Graves' orbitopathy to treat dysthyroid optical neuropathy (DON) and reduce disfiguring proptosis. The intended proptosis reduction can deviate from the postoperative result and changes of motility with consecutive diplopia can occur. We performed a retrospective study to identify anatomical factors in computed tomography (CT), which influence the surgical effect and postoperative ocular motility and diplopia. Methods Pre- and postoperative CT-scans of 125 eyes of 68 patients, who mainly underwent a balanced orbital decompression for disfiguring proptosis (>= 18mm Hertel Index), have been analyzed. Proptosis, ductions, misalignment and diplopia were assessed before and after surgery. Medial and lateral orbital wall length, conus angle, depth of ethmoidal sinus, orbital surface, length of medial and orbital defect, depth of tissue prolapse and horizontal muscle diameters were analyzed in CT scans before and after surgery. With linear regression and multivariate analyses these parameters have been correlated with postoperative proptosis, abduction deficit, deviation and binocular single vision (BSV). Results Proptosis could be reduced by 5.3 +/- 2mm. Patients with <5mm proptosis reduction had significantly less often new onset of diplopia compared to patients with >5mm reduction (13% vs. 56%, p = 0.02). Multiple linear regression showed a significant correlation between tissue prolapse and depth of the ethmoidal sinus as well as age (p<0.001, r = 0.71). Proptosis reduction could not be predicted by tissue prolapse, defect length or depth of ethmoidal sinus. The abduction deficit correlated significantly with tissue prolapse and orbital surface area (p<0.001, r = 0.37) but not with the horizontal muscle diameter. Conclusion We were able to show that orbital morphology influences the outcome of balanced orbital decompression surgery in terms of proptosis reduction and motility. However, the rather low coefficients of correlation show that the surgical outcome cannot be predicted with simple CT measurements, although risk factors for postoperative abduction deficit could be found. Therefore, preoperative planning should consider especially the orbital surface area and depth of ethmoidal sinus. Patients should be informed about the higher risk of diplopia with higher proptosis reduction.	[Oeverhaus, Michael; Copei, Anna; Esser, Joachim; Eckstein, Anja] Univ Hosp Essen, Dept Ophthalmol, Essen, Germany; [Copei, Anna; Staehr, Kerstin] Univ Hosp Oldenburg, Dept Gynecol, Oldenburg, Germany; [Mattheis, Stefan] Univ Hosp Essen, Dept Otorhinolaryngol Head & Neck Surg, Essen, Germany; [Ringelstein, Adrian] Maria Hilf Hosp, Dept Radiol, Monchengladbach, Germany; [Tiemessen, Madeleine] Alfried Krupp Hosp Essen, Dept Radiol & Neuroradiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Stahr, K (corresponding author), Univ Hosp Oldenburg, Dept Gynecol, Oldenburg, Germany.	Kerstin.staehr@uk-essen.de	Oeverhaus, Michael/AAA-5356-2019; Oeverhaus, Michael/AAK-3084-2021	Oeverhaus, Michael/0000-0003-0807-7689; Mattheis, Stefan/0000-0001-5498-0575				Abramoff MD, 2002, INVEST OPHTH VIS SCI, V43, P300; Bahn RS, 2015, HORM METAB RES, V47, P773, DOI 10.1055/s-0035-1555762; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Banga JP, 2015, HORM METAB RES, V47, P797, DOI 10.1055/s-0035-1555956; BARTALENA L, 1983, J CLIN ENDOCR METAB, V56, P1139, DOI 10.1210/jcem-56-6-1139; Bartalena L, 2016, EUR THYROID J, V5, P9, DOI 10.1159/000443828; Boboridis KG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007630.pub2; Borumandi F, 2013, BRIT J OPHTHALMOL, V97, P659, DOI 10.1136/bjophthalmol-2012-302825; Borumandi F, 2011, BRIT J OPHTHALMOL, V95, P1625, DOI 10.1136/bjo.2010.181313; BURCH HB, 1993, ENDOCR REV, V14, P747, DOI 10.1210/er.14.6.747; Campi I, 2013, OPHTHALMOLOGY, V120, P1092, DOI 10.1016/j.ophtha.2012.10.041; Dagi LR, 2011, OPHTHAL PLAST RECONS, V27, P102, DOI 10.1097/IOP.0b013e3181e9a063; Eckstein A, 2012, BEST PRACT RES CL EN, V26, P339, DOI 10.1016/j.beem.2011.11.002; Gerding MN, 1997, THYROID, V7, P885, DOI 10.1089/thy.1997.7.885; Graham SM, 2003, LARYNGOSCOPE, V113, P1206, DOI 10.1097/00005537-200307000-00017; Hierl T, 2017, BRIT J ORAL MAX SURG, V55, P330, DOI 10.1016/j.bjoms.2016.09.008; Johnson KTM, 2010, GRAEF ARCH CLIN EXP, V248, P103, DOI 10.1007/s00417-009-1214-3; Kahaly GJ, 2005, CLIN ENDOCRINOL, V63, P395, DOI 10.1111/j.1365-2265.2005.02352.x; Kamer L, 2012, OPHTHAL PLAST RECONS, V28, P251, DOI 10.1097/IOP.0b013e31824ddbfd; Kamer L, 2010, OPHTHAL PLAST RECONS, V26, P348, DOI 10.1097/IOP.0b013e3181c9bb52; Kaminsky J, 2011, OPHTHALMOLOGE, V108, P432, DOI 10.1007/s00347-010-2188-6; Kikkawa DO, 2002, OPHTHALMOLOGY, V109, P1219, DOI 10.1016/S0161-6420(02)01068-0; Kim JW, 2016, AM J OPHTHALMOL, V171, P11, DOI 10.1016/j.ajo.2016.08.010; Kingdom TT, 2015, LARYNGOSCOPE, V125, P2034, DOI 10.1002/lary.25320; Krause M, 2017, J CRANIO MAXILL SURG, V45, P485, DOI 10.1016/j.jcms.2017.01.015; Krieger CC, 2016, J CLIN ENDOCR METAB, V101, P2340, DOI 10.1210/jc.2016-1315; Lee KYC, 2009, OPHTHAL PLAST RECONS, V25, P300, DOI 10.1097/IOP.0b013e3181ab6795; Leong SC, 2010, CURR OPIN OTOLARYNGO, V18, P37, DOI 10.1097/MOO.0b013e328335017c; Leong SC, 2009, LARYNGOSCOPE, V119, P1106, DOI 10.1002/lary.20213; Macri Francesco, 2013, Recenti Progressi in Medicina, V104, P70, DOI 10.1701/1241.13708; Mahoney N, 2015, CRANIOMAX TRAUM REC, V8, P211, DOI 10.1055/s-0034-1393731; MARCOCCI C, 1991, J ENDOCRINOL INVEST, V14, P853, DOI 10.1007/BF03347943; McKeag D, 2007, BRIT J OPHTHALMOL, V91, P455, DOI 10.1136/bjo.2006.094607; Millar MJ, 2009, EYE, V23, P1565, DOI 10.1038/eye.2009.24; Neumann S, 2015, HORM METAB RES, V47, P789, DOI 10.1055/s-0035-1555901; Oeverhaus M, 2019, OPHTHALMOLOGE, V116, P164, DOI 10.1007/s00347-017-0643-3; Oeverhaus M, 2017, HORM METAB RES, V49, DOI 10.1055/s-0043-116945; Oeverhaus M, 2018, KLIN MONATSBL AUGENH, V235, P1105, DOI 10.1055/a-0719-5354; Oeverhaus M, 2018, STRABISMUS, V26, P62, DOI 10.1080/09273972.2018.1450430; Paridaens D, 2006, EYE, V20, P154, DOI 10.1038/sj.eye.6701827; Ponto KA, 2011, AM J OPHTHALMOL, V152, P483, DOI 10.1016/j.ajo.2011.02.018; Rootman DB, 2017, OPHTHAL PLAST RECONS, V33, P289, DOI 10.1097/IOP.0000000000000758; Schluter A, 2018, CLIN EXP IMMUNOL, V191, P255, DOI 10.1111/cei.13075; Sellari-Franceschini S, 2005, OTOLARYNG HEAD NECK, V133, P185, DOI 10.1016/j.otohns.2005.02.006; Shan Shannon J C, 2014, J Neuroophthalmol, V34, P177, DOI 10.1097/WNO.0000000000000132; Smith TJ, 2017, NEW ENGL J MED, V376, P1748, DOI 10.1056/NEJMoa1614949; Stahr K, 2018, INFLUENCE ORBITAL DE; SULLIVAN TJ, 1992, OPHTHALMOLOGY, V99, P575; Takahashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114220; Tavassol F, 2012, J ORAL MAXIL SURG, V70, P1152, DOI 10.1016/j.joms.2011.02.127; Verity DH, 2013, EYE, V27, P308, DOI 10.1038/eye.2012.284; Wiersinga WM, 2006, EUR J ENDOCRINOL, V155, P387, DOI 10.1530/eje.1.02230; Wu CY, 2017, ORBIT, V36, P95, DOI 10.1080/01676830.2017.1279660	53	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218701	10.1371/journal.pone.0218701	http://dx.doi.org/10.1371/journal.pone.0218701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233522	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700029
J	Joyce, S; Nour, AM				Joyce, Sean; Nour, Adel M.			Blocking transmembrane219 protein signaling inhibits autophagy and restores normal cell death	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; ENDOPLASMIC-RETICULUM; DAP-KINASE; BECLIN 1; IGFBP-3 BINDS; GROWTH; CANCER; BREAST; PROMOTES; PEPTIDE	Autophagy plays a vital role in tumor therapy and survival of dormant tumor cells. Here we describe a novel function of a protein known as Transmembrane 219 (TM219) as an autophagy activator. TM219 is a small membrane protein expressed in all known human tissues except the thymus. We used biochemical approaches to identify calmodulin and calmodulin dependent protein kinase II as a part of TM219 protein complex. Then, we employed in vitro reconstitution system and fluorescence anisotropy to study the requirements of TM219 to bind calmodulin in vitro. We also used this system to study the effects of a synthetic peptide derived from the sequence of the short cytoplasmic tail of TM219 (SCTT) on calmodulin-TM219 receptor interactions. We conjugated SCTT peptide with a pH Low Insertion peptide (pHLIP) for optimal cellular delivery. We finally tested the effects of SCTT-pHLIP on triple negative human breast cancer cells in three dimension culture. Our data defined a novel function of TM219 protein and an efficient approach to inhibit it.	[Joyce, Sean; Nour, Adel M.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA	Brown University	Nour, AM (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	adel_m_nour@brown.edu		Joyce, Sean/0000-0002-1820-4381				Andreev OA, 2009, CHIM OGGI, V27, P34; BAXTER RC, 1994, ENDOCRINOLOGY, V134, P848, DOI 10.1210/en.134.2.848; Campbell PG, 1998, AM J PHYSIOL-ENDOC M, V275, pE321, DOI 10.1152/ajpendo.1998.275.2.E321; Chan YX, 2018, CLIN ENDOCRINOL, V88, P333, DOI 10.1111/cen.13499; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Cufi S, 2011, CELL CYCLE, V10, P3871, DOI 10.4161/cc.10.22.17976; Czogalla KJ, 2014, BLOOD, V124, P1354, DOI 10.1182/blood-2013-12-545988; Deacon JC, 2015, ARCH BIOCHEM BIOPHYS, V565, P40, DOI 10.1016/j.abb.2014.11.002; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Goehe RW, 2012, J PHARMACOL EXP THER, V343, P763, DOI 10.1124/jpet.112.197590; Gomis RR, 2016, MOL ONCOL; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Grkovic S, 2013, ONCOGENE, V32, P2412, DOI 10.1038/onc.2012.264; Gui YT, 2001, J CLIN ENDOCR METAB, V86, P2104, DOI 10.1210/jc.86.5.2104; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Horibata S, 2015, JOVE-J VIS EXP, DOI 10.3791/52727; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; INGLESE J, 1989, J MED CHEM, V32, P937, DOI 10.1021/jm00125a002; Janes KA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005966; Janji B, 2016, ONCOTARGET, V7, P17591, DOI 10.18632/oncotarget.7540; Jiang S, 2013, J INNATE IMMUN, V5, P471, DOI 10.1159/000346707; Johnson MA, 2014, GROWTH HORM IGF RES, V24, P164, DOI 10.1016/j.ghir.2014.04.007; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Kumar Priyank, 2012, Cells, V1, P558, DOI 10.3390/cells1030558; Lee CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12752; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; Levin-Salomon V, 2014, APOPTOSIS, V19, P346, DOI 10.1007/s10495-013-0918-3; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01272-2; Lin MZ, 2014, ONCOGENE, V33, P85, DOI 10.1038/onc.2012.538; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Natsuizaka M, 2014, AM J CANCER RES, V4, P29; Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Pfisterer SG, 2011, MOL PHARMACOL, V80, P1066, DOI 10.1124/mol.111.071761; Prager AJ, 2013, BIOMARK MED, V7, P831, DOI 10.2217/bmm.13.112; Qian X, 2017, MOL CELL, V65, P917, DOI 10.1016/j.molcel.2017.01.027; Qiang L, 2016, AUTOPHAGY, V12, P357, DOI 10.1080/15548627.2015.1110667; Ricort JM, 2002, FEBS LETT, V527, P293, DOI 10.1016/S0014-5793(02)03250-7; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rocha RL, 1996, J NATL CANCER I, V88, P601, DOI 10.1093/jnci/88.9.601; Rodriguez-Mora OG, 2006, CANCER BIOL THER, V5, P1022, DOI 10.4161/cbt.5.8.2910; Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; SHEAVES RM, 1982, BRAZ J MED BIOL RES, V15, P1; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Sosunov EA, 2013, P NATL ACAD SCI USA, V110, P82, DOI 10.1073/pnas.1220038110; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; Veraldi KL, 2009, AM J RESP CRIT CARE, V180, P611, DOI 10.1164/rccm.200810-1555OC; Wang Z, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.503; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Wijesinghe D, 2011, BIOCHEMISTRY-US, V50, P10215, DOI 10.1021/bi2009773; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Wolf J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3576; Xie XQ, 2015, CANCER DISCOV, V5, P410, DOI 10.1158/2159-8290.CD-14-1473; Yang YZ, 2019, J BIOL CHEM, V294, P772, DOI 10.1074/jbc.RA118.005166; Yao L, 2013, P NATL ACAD SCI USA, V110, P465, DOI 10.1073/pnas.1219665110; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Yue ZY, 2010, J MOL CELL BIOL, V2, P305, DOI 10.1093/jmcb/mjq028; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang XH, 2014, J IMMUNOL, V193, P2405, DOI 10.4049/jimmunol.1302798; Zoonens M, 2008, BIOPHYS J, V95, P225, DOI 10.1529/biophysj.107.124156	75	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218091	10.1371/journal.pone.0218091	http://dx.doi.org/10.1371/journal.pone.0218091			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220095	Green Submitted, gold, Green Published			2022-12-26	WOS:000484893500021
J	Lopes, TG; de Souza, ML; da Silva, VD; dos Santos, M; da Silva, WIC; Itaquy, TP; Garbin, HI; Veronese, FV				Lopes, Tiago Giulianni; de Souza, Maysa Lucena; da Silva, Vinicius Duval; dos Santos, Mariane; Cardoso da Silva, William Israel; Itaquy, Thiago Pereira; Garbin, Henrique Iahnke; Veronese, Francisco Verissimo			Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; TGF-BETA; MESENCHYMAL TRANSITION; MONOCLONAL-ANTIBODY; EXPRESSION; PROGRESSION; INJURY; NEPHROPATHY; PROTEINURIA; CTGF	Background Renal fibrosis is the result of the interaction of cellular and molecular pathways, which is induced by sustained glomerular injury and involves the podocytes and multiple profibrotic factors. In this study, we investigated the correlation of the mRNA expression of podocyte proteins and profibrotic factors with renal fibrosis measured in renal biopsies of patients with primary and secondary glomerulopathies. Methods Eighty-four adult patients with primary or secondary glomerular diseases and 12 controls were included. Demographic and clinical data were collected. Seventy-two percent of the renal biopsies were done less than one year from clinical disease manifestation. The quantification of the podocyte-associated mRNAs of alpha-actinin-4, podocin, and podocalyxin, as well as of the profibrotic factors TGF-beta 1, CTGF, and VEGF-A were quantified by real-time polymerase chain reaction. The percent positive area of renal fibrosis was measured by immunohistochemistry staining, using anti-CTGF and anti-HHF35 antibodies and unpolarized Sirius Red. Correlations between the expression of tissue mRNAs and the positive area of fibrosis for the measured markers were made by Spearman's rank correlation coefficient. Results In relation to control biopsies, podocyte-specific proteins were downregulated in podocytopathies, in proliferative nephritis, in diabetic kidney disease (DRD), and in IgA nephropathy (IgAN). Messenger RNA of TGF-beta 1, CTGF, and VEGF-A was upregulated in patients with podocytopathies and in DRD but not in proliferative nephritis and IgAN. Tissue mRNA expression of TGF-beta 1, CTGF, and VEGF-A were strongly correlated with renal fibrosis, as measured by HHF35; however, the correlation, albeit significant, was moderate for Sirius Red and weak for CTGF. The percent positive area of renal fibrosis measured by Sirius Red was similar between podocytopathies and DRD and significantly higher in podocytopathies compared to IgAN or proliferative nephritis. Conclusions In patients with glomerular diseases, the mRNA of TGF-beta 1, CTGF, and VEGF-A correlated positively with the extent of renal fibrosis, and the positive area of fibrosis was larger in the podocytopathies and in DRD as measured by Sirius Red. The pathways connecting podocyte damage and activation of profibrotic factors to kidney tissue fibrosis need to be better investigated.	[Lopes, Tiago Giulianni; de Souza, Maysa Lucena; dos Santos, Mariane; Veronese, Francisco Verissimo] Univ Fed Rio Grande do Sul, Postgrad Program Med Med Sci, Porto Alegre, RS, Brazil; [Lopes, Tiago Giulianni; de Souza, Maysa Lucena; dos Santos, Mariane; Cardoso da Silva, William Israel; Itaquy, Thiago Pereira; Garbin, Henrique Iahnke; Veronese, Francisco Verissimo] Hosp Clin Porto Alegre, Lab Mol Biol Appl Nephrol, Ctr Expt Res, Porto Alegre, RS, Brazil; [da Silva, Vinicius Duval] Barretos Canc Hosp, Barretos, SP, Brazil; [Veronese, Francisco Verissimo] Hosp Clin Porto Alegre, Div Nephrol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Hospital de Cancer de Barretos	Veronese, FV (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Med Med Sci, Porto Alegre, RS, Brazil.; Veronese, FV (corresponding author), Hosp Clin Porto Alegre, Lab Mol Biol Appl Nephrol, Ctr Expt Res, Porto Alegre, RS, Brazil.; Veronese, FV (corresponding author), Hosp Clin Porto Alegre, Div Nephrol, Porto Alegre, RS, Brazil.	fveronese@hcpa.edu.br	da Silva, Vinicius Duval/AAE-9220-2021; Veronese, Francisco JV/H-5172-2016	da Silva, Vinicius Duval/0000-0003-3515-0263; Garbin, Henrique/0000-0001-5950-632X; dos Santos, Mariane/0000-0001-6273-1317	Research Incentive Fund (FIPE) of the Research and Postgraduate Group, Hospital de Clinicas of Porto Alegre, Porto Alegre, RS, Brazil; Francisco Verissimo Veronese; Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil; Brazilian Research Council (CNPq), Brazil	Research Incentive Fund (FIPE) of the Research and Postgraduate Group, Hospital de Clinicas of Porto Alegre, Porto Alegre, RS, Brazil; Francisco Verissimo Veronese; Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Research Council (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful to the Research Incentive Fund (FIPE) of the Research and Postgraduate Group, Hospital de Clinicas of Porto Alegre, Porto Alegre, RS, Brazil, to Francisco Verissimo Veronese; to the Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil, for granting a postgraduate scholarship to Maysa Lucena de Souza; and to the Brazilian Research Council (CNPq), Brazil, for granting a Productivity Research Scholarship to Vinicius Duval da Silva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SG, 2010, CLIN J AM SOC NEPHRO, V5, P1420, DOI 10.2215/CJN.09321209; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; Boor P, 2011, CLIN EXP PHARMACOL P, V38, P391, DOI 10.1111/j.1440-1681.2011.05487.x; Campanholle G, 2013, AM J PHYSIOL-CELL PH, V304, pC591, DOI 10.1152/ajpcell.00414.2012; Cho ME, 2007, CLIN J AM SOC NEPHRO, V2, P906, DOI 10.2215/CJN.01050207; Christensen EI, 2008, KIDNEY INT, V74, P1233, DOI 10.1038/ki.2008.421; Couser WG, 2012, J AM SOC NEPHROL, V23, P381, DOI 10.1681/ASN.2011030304; dos Santos M, 2015, INT J CLIN EXP PATHO, V8, P4600; Farris AB, 2014, KIDNEY INT SUPPL, V4, P9, DOI 10.1038/kisup.2014.3; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Frazier KS, 2000, VET PATHOL, V37, P328, DOI 10.1354/vp.37-4-328; Fuchshofer R, 2011, HISTOCHEM CELL BIOL, V136, P301, DOI 10.1007/s00418-011-0844-9; Goumenos DS, 2002, NEPHRON, V92, P287, DOI 10.1159/000063293; Guha M, 2007, FASEB J, V21, P3355, DOI 10.1096/fj.06-6713com; Hilhorst M, 2015, NEPHROL DIAL TRANSPL, V30, P1291, DOI 10.1093/ndt/gfv088; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Ito Y, 2010, AM J PHYSIOL-RENAL, V299, pF545, DOI 10.1152/ajprenal.00120.2009; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Kim HW, 2002, NEPHROLOGY, V7, pS131, DOI 10.1046/j.1440-1797.7.s3.9.x; Kim JH, 2003, KIDNEY INT, V64, P1715, DOI 10.1046/j.1523-1755.2003.00288.x; Kim TS, 1999, J PATHOL, V189, P425; Klinkhammer BM, 2017, ADV CHRONIC KIDNEY D, V24, P117, DOI 10.1053/j.ackd.2016.11.002; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Lee HS, 2012, HISTOL HISTOPATHOL, V27, P1131, DOI 10.14670/HH-27.1131; Lee HS, 2012, CELL TISSUE RES, V347, P129, DOI 10.1007/s00441-011-1169-7; Liu RJ, 2017, J AM SOC NEPHROL, V28, P2133, DOI 10.1681/ASN.2016080841; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lu W, 2014, RENAL FAILURE, V36, P1420, DOI 10.3109/0886022X.2014.934692; Mariani LH, 2018, NEPHROL DIAL TRANSPL, V33, P310, DOI 10.1093/ndt/gfw443; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Peters I, 2006, J AM SOC NEPHROL, V17, P1644, DOI 10.1681/ASN.2005111209; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Rodriguez-Iturbe B, 2005, KIDNEY INT, V68, P82; Srivastava A, 2018, J AM SOC NEPHROL, V29, P2213, DOI 10.1681/ASN.2017121260; Street JM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12088; Sutariya B, 2016, IMMUNOPHARM IMMUNOT, V38, P39, DOI 10.3109/08923973.2015.1127382; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; TSUKADA T, 1987, AM J PATHOL, V127, P389; Vincenti F, 2017, KIDNEY INT REP, V2, P800, DOI 10.1016/j.ekir.2017.03.011; Wickman L, 2013, J AM SOC NEPHROL, V24, P2081, DOI 10.1681/ASN.2013020173; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159	48	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0217585	10.1371/journal.pone.0217585	http://dx.doi.org/10.1371/journal.pone.0217585			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220088	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500012
J	Medina-Salguero, AX; Cornejo-Franco, JF; Grinstead, S; Mollov, D; Mowery, JD; Flores, F; Quito-Avila, DF				Medina-Salguero, Andres X.; Cornejo-Franco, Juan F.; Grinstead, Samuel; Mollov, Dimitre; Mowery, Joseph D.; Flores, Francisco; Quito-Avila, Diego F.			Sequencing, genome analysis and prevalence of a cytorhabdovirus discovered in Carica papaya	PLOS ONE			English	Article							RNA VIRUSES; RHABDOVIRUSES; EVOLUTION; TAXONOMY; DISEASE; PLANT	The complete genome of a new rhabdovirus infecting papaya (Carica papaya L.) in Ecuador, named papaya virus E, was sequenced and characterized. The negative-sense single-stranded RNA genome consists of 13,469 nucleotides with six canonical open reading frames (ORFs) and two accessory short ORFs predicted between ORFs corresponding to P3 (movement protein) and M (matrix protein). Phylogenetic analyses using amino acid sequences from the nucleocapsid, glycoprotein and polymerase, grouped the virus with members of the genus Cytorhabdovirus, with rice stripe mosaic virus, yerba mate chlorosis-associated virus and Colocasia bobone disease-associated virus as closest relatives. The 3' leader and 5' trailer sequences were 144 and 167 nt long, respectively, containing partially complementary motifs. The motif 3'-AUUCUUUUUG-5', conserved across rhabdoviruses, was identified in all but one intergenic regions; whereas the motif 3'-ACAAAAACACA-5' was found in three intergenic junctions. This is the first complete genome sequence of a cytorhabdovirus infecting papaya. The virus was prevalent in commercial plantings of Los Rios,the most important papaya producing province of Ecuador. Recently, the genome sequence of bean-associated cytorhabdovirus was reported. The genome is 97% identical to that of papaya virus E, indicating that both should be considered strains of the same virus.	[Medina-Salguero, Andres X.; Quito-Avila, Diego F.] ESPOL, Escuela Super Politecn Litoral, Fac Ciencias Vida, Guayaquil, Guayas, Ecuador; [Cornejo-Franco, Juan F.; Quito-Avila, Diego F.] ESPOL, Escuela Super Politecn Litoral, CIBE, Guayaquil, Guayas, Ecuador; [Grinstead, Samuel; Mollov, Dimitre] ARS, Natl Germplasm Resources Lab, USDA, Beltsville, MD USA; [Mowery, Joseph D.] ARS, Electron & Confocal Microscopy Unit, USDA, Beltsville, MD USA; [Flores, Francisco] UTE, Fac Ciencias Ingn & Ind, Ctr Invest Alimentos, CIAL, Quito, Pichincha, Ecuador; [Flores, Francisco] Univ Fuerzas Armadas ESPE, Dept Ciencias Vida & Agr, Sangolqui, Pichincha, Ecuador	Escuela Superior Politecnica del Litoral; Escuela Superior Politecnica del Litoral; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Escuela Politecnica Superior del Ejercito	Quito-Avila, DF (corresponding author), ESPOL, Escuela Super Politecn Litoral, Fac Ciencias Vida, Guayaquil, Guayas, Ecuador.; Quito-Avila, DF (corresponding author), ESPOL, Escuela Super Politecn Litoral, CIBE, Guayaquil, Guayas, Ecuador.	dquito@espol.edu.ec		Mollov, Dimitre/0000-0002-4750-6194; Flores, Francisco/0000-0001-8092-3750; Mowery, Joseph/0000-0001-7128-1397; Grinstead, Samuel/0000-0002-1708-8235	Escuela Superior Politecnica del Litoral (ESPOL), through the Ecuadorean Universities Network for Research and Postdoctoral Studies (REDU) grant [PREDU-2016-001]	Escuela Superior Politecnica del Litoral (ESPOL), through the Ecuadorean Universities Network for Research and Postdoctoral Studies (REDU) grant	This work was funded by Escuela Superior Politecnica del Litoral (ESPOL), through the Ecuadorean Universities Network for Research and Postdoctoral Studies (REDU) grant #PREDU-2016-001 to DFQ-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2016, ARCH VIROL, V161, P2921, DOI 10.1007/s00705-016-2977-6; Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Alves-Freitas DMT, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010090; [Anonymous], 2018, MICROSC MICROANAL; Becerra EN, 1999, AGRON MESOAM, V10, P85; Bejerman N, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030230; Bejerman N, 2017, ARCH VIROL, V162, P2481, DOI 10.1007/s00705-017-3363-8; Bourhy H, 2005, J GEN VIROL, V86, P2849, DOI 10.1099/vir.0.81128-0; Brown JC, 2010, VIRUSES-BASEL, V2, P995, DOI 10.3390/v2040995; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Cornejo-Franco JF, 2018, CROP PROT, V110, P99, DOI 10.1016/j.cropro.2018.04.006; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dietzgen RG, 2017, VIRUS RES, V227, P158, DOI 10.1016/j.virusres.2016.10.010; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Guo HY, 2013, MOL PLANT MICROBE IN, V26, P927, DOI 10.1094/MPMI-02-13-0040-R; Higgins CM, 2016, ARCH VIROL, V161, P745, DOI 10.1007/s00705-015-2713-7; Huang YW, 2005, J VIROL, V79, P2108, DOI 10.1128/JVI.79.4.2108-2114.2005; Huang YW, 2003, J GEN VIROL, V84, P2259, DOI 10.1099/vir.0.19195-0; Jackson AO, 2005, ANNU REV PHYTOPATHOL, V43, P623, DOI 10.1146/annurev.phyto.43.011205.141136; Jackson RJ, 2012, ADV PROTEIN CHEM STR, V86, P45, DOI [10.1016/B978-0-12-386497-0.00002-5, 10.1016/B978-0-12.386497.000002-5]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumin IV, 2009, INFECT GENET EVOL, V9, P541, DOI 10.1016/j.meegid.2009.02.005; LASTRA R, 1981, PLANT DIS, V65, P439, DOI 10.1094/PD-65-439; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Longdon B, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev014; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; Maes P, 2019, ARCH VIROL, V164, P1233, DOI 10.1007/s00705-018-04126-4; Mann KS, 2016, VIROLOGY, V489, P20, DOI 10.1016/j.virol.2015.11.028; Mann KS, 2014, ARCH VIROL, V159, P1889, DOI 10.1007/s00705-014-2029-z; Maurino F, 2018, ARCH VIROL, V163, P291, DOI 10.1007/s00705-017-3579-7; Merckel MC, 2005, MOL CELL, V18, P161, DOI 10.1016/j.molcel.2005.03.019; Quito-Avila DF, 2015, EUR J PLANT PATHOL, V143, P199, DOI 10.1007/s10658-015-0675-y; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Walker PJ, 2018, J GEN VIROL, V99, P447, DOI 10.1099/jgv.0.001020; Walker PJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004664; Walker PJ, 2011, VIRUS RES, V162, P110, DOI 10.1016/j.virusres.2011.09.004; WAN SH, 1981, P FL ST HORTIC SOC, V94, P318; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang X, 2017, FRONT MICROBIOL, V7, P1	42	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0215798	10.1371/journal.pone.0215798	http://dx.doi.org/10.1371/journal.pone.0215798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220099	gold, Green Published, Green Submitted			2022-12-26	WOS:000484893500005
J	Nowacka-Woszuk, J; Szczerbal, I; Stachowiak, M; Szydlowski, M; Nizanski, W; Dzimira, S; Maslak, A; Payan-Carreira, R; Wydooghe, E; Nowak, T; Switonski, M				Nowacka-Woszuk, Joanna; Szczerbal, Izabela; Stachowiak, Monika; Szydlowski, Maciej; Nizanski, Wojciech; Dzimira, Stanislaw; Maslak, Artur; Payan-Carreira, Rita; Wydooghe, Eline; Nowak, Tomasz; Switonski, Marek			Association between polymorphisms in the SOX9 region and canine disorder of sex development (78,XX; SRY-negative) revisited in a multibreed case-control study	PLOS ONE			English	Article							COPY NUMBER VARIATION; TESTICULAR DISORDER; XX; DOGS; REVERSAL; GENE; EXPRESSION; COMPLEX	Testicular or ovotesticular disorders of sex development (DSD) in individuals with female karyotype (XX) lacking the SRY gene has been observed in several mammalian species, including dogs. A genetic background for this abnormality has been extensively sought, and the region harboring the SOX9 gene has often been considered key in canine DSD. Three types of polymorphism have been studied in this region to date: a) copy number variation (CNV) in a region about 400 kb upstream of SOX9, named CNVR1; b) duplication of SOX9; and c) insertion of a single G-nucleotide (rs852549625) approximately 2.2 Mb upstream of SOX9. The aim of this study was thus to comprehensively analyze these polymorphisms in a large multibreed case-control cohort containing 45 XX DSD dogs, representing 23 breeds. The control set contained 57 fertile females. Droplet digital PCR (ddPCR) was used to study CNVR1 and the duplication of SOX9. Fluorescent in situ hybridization (FISH) was used to visualize copy numbers on a cellular level. The Sanger sequencing approach was performed to analyze the region harboring the G-insertion. We confirmed that CNVR1 is highly polymorphic and that copy numbers varied between 0 and 7 in the case and control cohorts. Interestingly, the number of copies was significantly higher (P = 0.038) in XX DSD dogs (mean = 2.7) than in the control females (mean = 2.0) but not in all studied breeds. Duplication of the SOX9 gene was noted only in a single XX DSD dog (an American Bully), which had three copies of SOX9. Distribution of the G-nucleotide insertion was similar in the XX DSD (frequency 0.20) and control (frequency 0.14) cohorts. Concluding, our study showed that CNVR1, located upstream of SOX9, is associated with the XX DSD phenotype, though in a breed-specific manner. Duplication of the SOX9 gene is a rare cause of this disorder in dogs. Moreover, we did not observe any association of G-insertion with the DSD phenotype. We assume that the genetic background of XX DSD can be different in certain breeds.	[Nowacka-Woszuk, Joanna; Szczerbal, Izabela; Stachowiak, Monika; Szydlowski, Maciej; Switonski, Marek] Poznan Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland; [Nizanski, Wojciech] Wroclaw Univ Environm & Life Sci, Dept Reprod & Clin Farm Anim, Wroclaw, Poland; [Dzimira, Stanislaw] Wroclaw Univ Environm & Life Sci, Dept Pathol, Wroclaw, Poland; [Maslak, Artur] Vital Vet Vet Clin, Pniewy, Poland; [Payan-Carreira, Rita] Univ Tras Os Montes & Alto Douro, CECAV, Ctr Ciencia Anim & Vet, Vila Real, Portugal; [Wydooghe, Eline] Univ Ghent, Dept Reprod Obstet & Herd Hlth, Clin Small Anim Reprod, Merelbeke, Belgium; [Nowak, Tomasz] Poznan Univ Life Sci, Dept Anim Reprod, Poznan, Poland	Poznan University of Life Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; University of Tras-os-Montes & Alto Douro; Ghent University; Poznan University of Life Sciences	Switonski, M (corresponding author), Poznan Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland.	switonsk@up.poznan.pl	Szczerbal, Izabela/AFM-9268-2022; Dzimira, Stanisław/S-5801-2016; Payan Carreira, Rita/D-2757-2012	Dzimira, Stanisław/0000-0001-7203-2392; Szczerbal, Izabela/0000-0002-4238-0414; Nizanski, Wojciech/0000-0003-1056-0784; Payan Carreira, Rita/0000-0001-5225-4510; Szydlowski, Maciej/0000-0002-5127-5173; Switonski, Marek/0000-0003-2539-9508; Dragan (Stachowiak), Monika/0000-0003-3485-1359; Nowak, Tomasz Andrzej/0000-0002-1820-5202; Nowacka-Woszuk, Joanna/0000-0002-1041-3576	National Science Centre (Poland) [2016/23/B/NZ9/03424]	National Science Centre (Poland)	All the analysis was funded by the National Science Centre (Poland), project no. 2016/23/B/NZ9/03424. The funder Vital-Vet Veterinary Clinic provided support in the form of salaries for authors [AM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; All the analysis was funded by the National Science Centre (Poland), project no. 2016/23/B/NZ9/03424.	Cantsilieris S, 2013, GENOMICS, V101, P86, DOI 10.1016/j.ygeno.2012.10.004; Croft B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07784-9; Croft B, 2018, SEX DEV, V12, P19, DOI 10.1159/000481896; De Lorenzi L, 2017, SEX DEV, V11, P210, DOI 10.1159/000479175; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Georg I, 2010, SEX DEV, V4, P321, DOI 10.1159/000320142; Gonen N, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006520; Gordon CT, 2009, J MED GENET, V46, P649, DOI 10.1136/jmg.2009.068361; Grinspon RP, 2016, SEX DEV, V10, P1, DOI 10.1159/000445088; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Kothapalli K, 2005, J HERED, V96, P759, DOI 10.1093/jhered/esi129; Lupianez DG, 2016, TRENDS GENET, V32, P225, DOI 10.1016/j.tig.2016.01.003; Marcinkowska-Swojak M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14696; Meyers-Wallen VN, 2012, SEX DEV, V6, P46, DOI 10.1159/000332740; Meyers-Wallen VN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186331; Meyers-Wallen VN, 2003, MOL REPROD DEV, V65, P373, DOI 10.1002/mrd.10317; MEYERSWALLEN VN, 1988, HUM GENET, V80, P23, DOI 10.1007/BF00451450; Nowacka J, 2005, J HERED, V96, P797, DOI 10.1093/jhered/esi106; Nowacka-Woszuk J, 2017, ANIM GENET, V48, P330, DOI 10.1111/age.12538; Rossi E, 2015, SEX DEV, V9, P155, DOI 10.1159/000435871; Rossi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101244; Rousseau S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079882; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Smyk M, 2017, NUCLEUS-PHILA, V8, P182, DOI 10.1080/19491034.2017.1279776; Stachowiak M, 2017, LIVEST SCI, V203, P48, DOI 10.1016/j.livsci.2017.07.002; Switonski M, 2012, SEX DEV, V6, P128, DOI 10.1159/000330921; Szczerbal I, 2019, LIVEST SCI, V219, P52, DOI 10.1016/j.livsci.2018.11.009; Szczerbal I, 2016, SEX DEV, V10, P74, DOI 10.1159/000445464; Usher CL, 2015, BRIEF FUNCT GENOMICS, V14, P329, DOI 10.1093/bfgp/elv028; Villagomez DAF, 2009, CYTOGENET GENOME RES, V126, P110, DOI 10.1159/000245911	30	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218565	10.1371/journal.pone.0218565	http://dx.doi.org/10.1371/journal.pone.0218565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220175	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500066
J	Syahputra, K; Kania, PW; Al-Jubury, A; Marnis, H; Setyawan, AC; Buchmann, K				Syahputra, Khairul; Kania, Per W.; Al-Jubury, Azmi; Marnis, Huria; Setyawan, Agung Cahyo; Buchmann, Kurt			Differential immune gene response in gills, skin, and spleen of rainbow trout Oncorhynchus mykiss infected by Ichthyophthirius multifiliis	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; COMPLEMENT-SYSTEM; INNATE IMMUNITY; HOST RESPONSES; RELEVANT GENES; LIVE THERONTS; EXPRESSION; FISH; CHEMOKINES; CYTOKINES	Infection of rainbow trout with the parasitic ciliate Ichthyopthirius multifiliis induces differential responses in gills, skin and spleen. A controlled experimental infection was performed and expression of immune-relevant genes in skin, gills, and spleen were recorded by qPCR at day 1 and 8 after parasite exposure. Infection induced a marked reaction involving regulation of innate and adaptive immune genes in rainbow trout at day 8 post-infection. The expression level of a total of 22 out of 24 investigated genes was significantly higher in gills compared to skin reflecting the more sensitive and delicate structure of gills. Especially proinflammatory cytokines IL-6, IL-17 C1, regulatory cytokines IL-4/13A, IL-10, TGF beta, complement factor C5, chemokines CK10, CK12, acute phase proteins (precerebellin, hepcidin) and immunoglobulins (IgM, IgT) displayed differential expression levels. The spleen, a central immune organ with no trace of the parasite, showed elevated expression of IgM, IgT, complement factor C5 and chemokine CK10 (compared to skin and gills directly exposed to the parasite), indicating an interaction between the infected surface sites and central immune organs. This communication could be mediated by chemokines CK10 and CK12 and cytokine IL-4/13A and may at least partly explain the establishment of a systemic response in rainbow trout against the parasite.	[Syahputra, Khairul; Kania, Per W.; Al-Jubury, Azmi; Marnis, Huria; Setyawan, Agung Cahyo; Buchmann, Kurt] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg C, Denmark	University of Copenhagen	Syahputra, K (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg C, Denmark.	khairul@sund.ku.dk	Syahputra, Khairul/AAR-3116-2020; marnis, huria/AAR-3117-2020	Syahputra, Khairul/0000-0002-1429-8421; marnis, huria/0000-0002-2152-9953; Setyawan, Agung Cahyo/0000-0002-2434-6124; Buchmann, Kurt/0000-0002-2747-237X	European Union [634429]	European Union(European Commission)	This work was supported by the European Union as a Horizon 2020 project Parafishcontrol (www.parafishcontrol.eu) grant No. 634429 received by KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ballesteros NA, 2014, DEV COMP IMMUNOL, V44, P195, DOI 10.1016/j.dci.2013.12.009; Bayne CJ, 2001, DEV COMP IMMUNOL, V25, P725, DOI 10.1016/S0145-305X(01)00033-7; Bird Steve, 2015, Biology-Basel, V4, P756, DOI 10.3390/biology4040756; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Buchmann K, 1999, J HELMINTHOL, V73, P189, DOI 10.1017/S0022149X9900030X; Buchmann K, 2001, VET PARASITOL, V100, P105, DOI 10.1016/S0304-4017(01)00487-3; Castro R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111084; Chettri JK, 2014, J FISH DIS, V37, P771, DOI 10.1111/jfd.12169; Chettri JK, 2012, DEV COMP IMMUNOL, V36, P463, DOI 10.1016/j.dci.2011.08.014; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Dickerson HW, 2014, DEV COMP IMMUNOL, V43, P290, DOI 10.1016/j.dci.2013.06.004; Dickerson H. W., 1996, Annual Review of Fish Diseases, V6, P107, DOI 10.1016/S0959-8030(96)90008-3; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Duarte-Costa S, 2014, PHYSIOL RES, V63, P669, DOI 10.33549/physiolres.932712; Engelsma MY, 2002, VET IMMUNOL IMMUNOP, V87, P467, DOI 10.1016/S0165-2427(02)00077-6; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gerwick L, 2002, FISH SHELLFISH IMMUN, V12, P229, DOI 10.1006/fsim.2001.0367; Gerwick L, 2000, DEV COMP IMMUNOL, V24, P597, DOI 10.1016/S0145-305X(00)00016-1; Gonzalez SF, 2007, VET IMMUNOL IMMUNOP, V115, P172, DOI 10.1016/j.vetimm.2006.09.007; Grayson TH, 2002, IMMUNOLOGY, V106, P273, DOI 10.1046/j.1365-2567.2002.01420.x; Haarder S, 2016, OJI, V6, P154, DOI DOI 10.4236/0JI.2016.64016; Heidarieh M, 2015, REV MED VET-TOULOUSE, V166, P234; Holland MCH, 2002, FISH SHELLFISH IMMUN, V12, P399, DOI 10.1006/fsim.2001.0408; Jorgensen LV, 2011, J FISH DIS, V34, P749, DOI 10.1111/j.1365-2761.2011.01291.x; Jorgensen LV, 2008, DIS AQUAT ORGAN, V80, P189, DOI 10.3354/dao01935; Jorgensen LV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203297; Jorgensen LV, 2017, FISH SHELLFISH IMMUN, V67, P586, DOI 10.1016/j.fsi.2017.06.044; Kato G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02116; Korenaga H, 2010, FISH SHELLFISH IMMUN, V28, P809, DOI 10.1016/j.fsi.2010.01.016; Matthews RA, 2005, ADV PARASIT, V59, P159, DOI 10.1016/S0065-308X(05)59003-1; Montero J, 2011, J VIROL, V85, P4046, DOI 10.1128/JVI.02519-10; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Munoz-Atienza E, 2019, J IMMUNOL, V202, P857, DOI 10.4049/jimmunol.1800568; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Olsen MM, 2011, FISH SHELLFISH IMMUN, V30, P859, DOI 10.1016/j.fsi.2011.01.010; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Philip AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129299; Raida MK, 2008, FISH SHELLFISH IMMUN, V25, P533, DOI 10.1016/j.fsi.2008.07.008; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Secombes CJ, 2001, DEV COMP IMMUNOL, V25, P713, DOI 10.1016/S0145-305X(01)00032-5; Shepherd BS, 2018, FISH SHELLFISH IMMUN, V74, P410, DOI 10.1016/j.fsi.2018.01.003; Sigh J, 2004, J FISH DIS, V27, P409, DOI 10.1111/j.1365-2761.2004.00558.x; Sigh J, 2004, FISH SHELLFISH IMMUN, V17, P75, DOI 10.1016/j.fsi.2003.12.005; Singh B, 2012, ROLE HEPCIDIN DYSREG; Skov J, 2018, AQUACULTURE, V492, P237, DOI 10.1016/j.aquaculture.2018.04.011; Stoltze K, 2001, J HELMINTHOL, V75, P291; Syahputra K, 2019, FISH SHELLFISH IMMUN, V86, P486, DOI 10.1016/j.fsi.2018.11.075; Takizawa F, 2011, MOL IMMUNOL, V48, P1360, DOI 10.1016/j.molimm.2011.02.014; Wang QC, 2019, DEV COMP IMMUNOL, V93, P93, DOI 10.1016/j.dci.2019.01.002; Wood P., 2011, UNDERSTANDING IMMUNO, V3rd; XU CH, 1995, J EUKARYOT MICROBIOL, V42, P558, DOI 10.1111/j.1550-7408.1995.tb05905.x; Xu DH, 2017, FISH SHELLFISH IMMUN, V66, P540, DOI 10.1016/j.fsi.2017.05.051; Xu DH, 2016, FISH SHELLFISH IMMUN, V54, P86, DOI 10.1016/j.fsi.2016.03.166; Xu Z, 2013, P NATL ACAD SCI USA, V110, P13097, DOI 10.1073/pnas.1304319110; Yang Q, 2016, FISH SHELLFISH IMMUN, V49, P243, DOI 10.1016/j.fsi.2015.12.031; Zou Jun, 2016, Biology-Basel, V5, P23, DOI 10.3390/biology5020023	61	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218630	10.1371/journal.pone.0218630	http://dx.doi.org/10.1371/journal.pone.0218630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220151	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500076
J	Fletcher, S; Kulnik, ST; Demain, S; Jones, F				Fletcher, Simon; Kulnik, Stefan Tino; Demain, Sara; Jones, Fiona			The problem with self-management: Problematising self-management and power using a Foucauldian lens in the context of stroke care and rehabilitation	PLOS ONE			English	Article							CHRONIC ILLNESS; HEALTH; RISK; PARTICIPATION; INTERVENTION; SURVIVORS; EXERCISE; PROGRAM; SUPPORT; PEOPLE	Self-management is a concept which is now firmly established in Western healthcare policy and practice. However, the term remains somewhat ambiguous, multi-faceted and contentious. This is evident in stroke care and rehabilitation, in which a self-management approach is increasingly adopted and advocated, yet interpreted in different ways, resulting in contradictions and tensions around control, responsibility, power and discipline. This paper aims to further our understanding of tensions and contradictions in stroke self-management, by critically examining contemporary self-management practices. We use a Foucauldian theoretical lens to explore the various power dynamics in the operationalisation of self-management, in addition to the complexity of the term self-management itself. Conducting a secondary analysis of interview and focus group data from the Self-Management VOICED study, supplemented with analysis of relevant documentary evidence from policy and practice, we describe the multiple aspects of power in operation. These include rhetorical, hierarchical, personal and mutual forms of power, representing interweaving dynamics evident in the data. These aspects of power demonstrate underlying agendas and tacit and explicit understandings of self-management which exist in clinical practice. These aspects of power also give insight into the multiple identities of 'self-management', acting as a simultaneous repressor and liberator, directly in keeping with Foucauldian thinking. The findings are also consistent with Foucault's notions of bodily docility, discussions around governance and bio-power, and contemporary discipline. Our analysis positions self-management as a highly nuanced and complex concept, which can fluctuate in its conceptualisation depending on the structures, routines, and the individual. We encourage healthcare professionals, policymakers and commissioners in the field of self-management to reflect on these complexities, to make transparent their assumptions and to explicitly position their own practice accordingly.	[Fletcher, Simon; Kulnik, Stefan Tino; Jones, Fiona] Kingston Univ & St Georges Univ London, Fac Hlth Social Care & Educ, London, England; [Demain, Sara] Univ Plymouth, Sch Hlth Profess, Plymouth, Devon, England; [Jones, Fiona] Bridges Self Management Ltd, London, England	Kingston University; University of Plymouth	Kulnik, ST (corresponding author), Kingston Univ & St Georges Univ London, Fac Hlth Social Care & Educ, London, England.	s.t.kulnik@sgul.kingston.ac.uk		Jones, Fiona/0000-0002-1452-3895; Kulnik, Stefan Tino/0000-0001-5419-6713	Health Foundation	Health Foundation	This research was part-funded by an Insight 2013 award to SD and FJ from the Health Foundation (https://health.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2017, STROK ASS RESP NHS E; [Anonymous], 2016, COMM GUID REH; Audulv A, 2016, J ADV NURS, V72, P2629, DOI 10.1111/jan.13037; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Barlow JH, 2002, HLTH ED J, V61, P365, DOI DOI 10.1177/001789690206100408; Boger EJ, 2015, INT J NURS STUD, V52, P175, DOI 10.1016/j.ijnurstu.2014.05.006; Damush TM, 2016, TRANSL BEHAV MED, V6, P457, DOI 10.1007/s13142-015-0348-6; Demain S, 2014, WORKING PAPERS HLTH, V1, P7; Department of Health, 2005, SELF CAR REAL CHOIC; Dobkin BH, 2017, NEUROREHAB NEURAL RE, V31, P217, DOI 10.1177/1545968316680490; Dobkin BH, 2016, CURR OPIN NEUROL, V29, P693, DOI 10.1097/WCO.0000000000000380; Ellis J, 2017, SOC SCI MED, V176, P25, DOI 10.1016/j.socscimed.2017.01.018; FOUCAULT M, 1979, IC, P5; Foucault M., 1977, DISCIPLINE PUNISH BI, DOI DOI 10.2307/2065008; Foucault M., 1980, POWER KNOWLEDGE SELE; Fryer CE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010442.pub2; Galvin R, 2002, HEALTH-LONDON, V6, P107, DOI 10.1177/136345930200600201; Great Britain. Department of Health, 2001, EXP PAT NEW APPR CHR; Great Britain. Department of Health, 2006, SUPP PEOPL LONG TERM; Harwood M, 2012, CLIN REHABIL, V26, P493, DOI 10.1177/0269215511426017; Hill VA, 2017, J STROKE CEREBROVASC, V26, P2806, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.058; Horrocks C, 2014, SOCIOL HEALTH ILL, V36, P175, DOI 10.1111/1467-9566.12114; Intercollegiate Stroke Working Party, 2016, NAT CLIN GUID STROK; Intercollegiate Stroke Working Party, 2008, NAT CLIN GUID STROK; Jones F., 2015, REHABILITATION GOAL, P265; Jones F, 2018, PHYS MANAGEMENT NEUR, P379; Jones F, 2016, NEUROREHABILITATION, V39, P471, DOI 10.3233/NRE-161379; Kendall E, 2007, DISABIL SOC, V22, P129, DOI 10.1080/09687590601141535; Kendall E, 2011, CHRONIC ILLN, V7, P87, DOI 10.1177/1742395310380281; Kulnik ST, 2019, DESIGN HLTH     0416, P1; Kulnik ST, 2019, DISABIL REHABIL, V41, P1296, DOI 10.1080/09638288.2018.1424953; Kulnik ST, 2017, J INTERPROF CARE, V31, P75, DOI 10.1080/13561820.2016.1246432; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Mansfield A, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/9476541; Mayo NE, 2016, STROKE, V47, P1685, DOI 10.1161/STROKEAHA.116.011309; Moore SA, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1628-2; Morden A, 2012, SOC THEOR HEALTH, V10, P78, DOI 10.1057/sth.2011.20; Parke HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131448; Pearce G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141803; Sajatovic M, 2018, AM J HEALTH PROMOT, V32, P282, DOI 10.1177/0890117117695218; Satink T, 2015, DISABIL REHABIL, V37, P223, DOI 10.3109/09638288.2014.918187; Stroke Association, 2010, STROK ASS MAN 2010 2; Stroke Association, 2015, TOG WE CAN CONQ STRO; Stroke Association, 2016, NEW ER STROK OUR CAM; Taylor D, 2007, SOCIOL HEALTH ILL, V29, P27, DOI 10.1111/j.1467-9566.2007.00516.x; The Scottish Government, 2009, IMPR SELF MAN SUPP; Tielemans NS, 2015, J REHABIL MED, V47, P901, DOI 10.2340/16501977-2020; WHO, 2015, WHO GLOB STRAT PEOPL; Wolf TJ, 2016, TOP STROKE REHABIL, V23, P284, DOI 10.1080/10749357.2016.1155278; Woodman P, 2014, DISABIL REHABIL, V36, P2031, DOI 10.3109/09638288.2014.887796; Wray F, 2018, DISABIL REHABIL, V40, P1237, DOI 10.1080/09638288.2017.1294206	51	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218517	10.1371/journal.pone.0218517	http://dx.doi.org/10.1371/journal.pone.0218517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5EM	31216337	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000482885300051
J	Jiang, YZ; Tuan, RS				Jiang, Yangzi; Tuan, Rocky S.			Role of NGF-TrkA signaling in calcification of articular chondrocytes	FASEB JOURNAL			English	Article						IHH-PTHrP; osteoarthritis; pathological calcification	NERVE GROWTH-FACTOR; IN-VIVO MODEL; INTRAARTICULAR INJECTION; OSTEOARTHRITIS; CARTILAGE; PAIN; EXPRESSION; DIFFERENTIATION; RECEPTORS; APOPTOSIS	Nerve growth factor (NGF) is a key regulator of chronic osteoarthritic pain, but the exact targets of NGF action on human articular cartilage is unknown. This study aimed to test the hypothesis that the NGF-tropomyosin receptor kinase A (TrkA) (high-affinity NGF receptor) pathway plays a role in the calcification process of human articular chondrocytes (hACs). A 14-aa small peptide of NGF (Nsp) previously shown to activate NGF signaling in rat PC12 cells was used as an NGF signaling agonist, and recombinant NGF and the pan-Trk inhibitor GNF-5837 were employed as signaling modulating agents. The functional consequences of NGF-TrkA signaling were examined in human healthy articular chondrocytes maintained under conditions supportive of osteogenesis in vitro. The NGF-mimetic bioactivity of Nsp was first confirmed on the basis of maintenance of neurite outgrowth in PC12 cells. Primary human chondrocytes responded to Nsp in vitro. Perturbation of NGF signaling with NGF, Nsp, and GNF-5837 resulted in a strong induction of chondrocyte calcification, and gene expression data suggested that the Indian Hedgehog-parathyroid hormone-related protein signaling axis was involved. These findings suggest functional involvement of NGF signaling in calcification of hACs and the importance of NGF signaling in articular cartilage homeostasis.-Jiang, Y., Tuan, R. S. Role of NGF-TrkA signaling in calcification of articular chondrocytes.	[Jiang, Yangzi; Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, 450 Technol Dr, Pittsburgh, PA 15219 USA; [Jiang, Yangzi; Tuan, Rocky S.] Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Hong Kong, Peoples R China; [Jiang, Yangzi; Tuan, Rocky S.] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; Chinese University of Hong Kong	Tuan, RS (corresponding author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, 450 Technol Dr, Pittsburgh, PA 15219 USA.; Jiang, YZ (corresponding author), Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Shatin, R412,Lo Kwee Seong Integrated Biomed Sci Bldg, Hong Kong, Peoples R China.	yangzjiang21@cuhk.edu.hk; rst13@pitt.edu	Jiang, Yangzi/AAY-9232-2020	Jiang, Yangzi/0000-0002-7475-3182	Commonwealth of Pennsylvania Department of Health [SAP4100050913]; Arthur J. Rooney, Sr. Endowment (University of Pittsburgh); Chinese University of Hong Kong	Commonwealth of Pennsylvania Department of Health; Arthur J. Rooney, Sr. Endowment (University of Pittsburgh); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported, in part, by funding from Commonwealth of Pennsylvania Department of Health (SAP4100050913) (to R.S.T.), Arthur J. Rooney, Sr. Endowment (University of Pittsburgh) (to R.S.T.), and The Chinese University of Hong Kong (to Y.J.). The authors declare no conflicts of interest.	Albaugh P, 2012, ACS MED CHEM LETT, V3, P140, DOI 10.1021/ml200261d; Alman BA, 2015, NAT REV RHEUMATOL, V11, P552, DOI 10.1038/nrrheum.2015.84; Ashraf S, 2014, ANN RHEUM DIS, V73, P1710, DOI 10.1136/annrheumdis-2013-203416; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Center for Drug Evaluation and Research, 2018, VOICE PATIENT; Chang DS, 2016, J PAIN RES, V9, P373, DOI 10.2147/JPR.S89061; Chang JK, 2009, ARTHRITIS RHEUM-US, V60, P3049, DOI 10.1002/art.24843; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dvir-Ginzberg M, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0591-y; Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Gigante A, 2003, EUR J HISTOCHEM, V47, P339, DOI 10.4081/844; Grassel S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0485-1; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Iannone F, 2002, RHEUMATOLOGY, V41, P1413, DOI 10.1093/rheumatology/41.12.1413; Jiang J, 2008, OSTEOARTHR CARTILAGE, V16, P70, DOI 10.1016/j.joca.2007.05.014; Jiang YZ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0840-x; Jiang YZ, 2015, NAT REV RHEUMATOL, V11, P206, DOI 10.1038/nrrheum.2014.200; Kc R, 2016, ANN RHEUM DIS, V75, P2133, DOI 10.1136/annrheumdis-2015-208444; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; LESAUTEUR L, 1995, J BIOL CHEM, V270, P6564, DOI 10.1074/jbc.270.12.6564; Malfait AM, 2009, OSTEOARTHR CARTILAGE, V17, P627, DOI 10.1016/j.joca.2008.10.005; Mapp PI, 2012, NAT REV RHEUMATOL, V8, P390, DOI 10.1038/nrrheum.2012.80; Matsushita T, 2013, J ORTHOP RES, V31, P531, DOI 10.1002/jor.22268; Oppenheimer H, 2012, ARTHRITIS RHEUM-US, V64, P718, DOI 10.1002/art.33407; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Tomlinson RE, 2017, P NATL ACAD SCI USA, V114, pE3632, DOI 10.1073/pnas.1701054114; Tomlinson RE, 2016, CELL REP, V16, P2723, DOI 10.1016/j.celrep.2016.08.002; Travaglia A, 2015, ACS CHEM NEUROSCI, V6, P1379, DOI 10.1021/acschemneuro.5b00069; Travaglia A, 2011, CHEM-EUR J, V17, P3726, DOI 10.1002/chem.201002294; Tsang KY, 2014, BIRTH DEFECTS RES C, V102, P52, DOI 10.1002/bdrc.21060; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wheaton AJ, 2004, ACAD RADIOL, V11, P21, DOI 10.1016/S1076-6332(03)00574-9; Wood JN, 2010, NEW ENGL J MED, V363, P1572, DOI 10.1056/NEJMe1004416; Zhang W, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4025	35	14	15	5	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10231	10239		10.1096/fj.201900970	http://dx.doi.org/10.1096/fj.201900970			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31238006				2022-12-26	WOS:000482214200041
J	Liang, X; Samways, DSK; Cox, J; Egan, TM				Liang, Xin; Samways, Damien S. K.; Cox, Jane; Egan, Terrance M.			Ca2+ flux through splice variants of the ATP-gated ionotropic receptor P2X7 is regulated by its cytoplasmic N terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; purinergic receptor; calcium transport; patch clamp; permeability; calcium channel; fractional calcium current; ligand-gated; P2X 7 (P2X7) P2RX7; patch-clamp fluorometry; splice variant	AMINO-TERMINUS; CATION PERMEABILITY; PORE; DESENSITIZATION; PHYSIOLOGY; RESIDUES; REGIONS; INNATE	Activation of ionotropic P2X receptors increases free intracellular Ca2+ ([Ca2+](i)) by initiating a transmembrane cation flux. We studied the a and k splice variants of the rat purinergic P2X7 receptor (rP2X7aR and rP2X7kR) to exhibit a significant difference in Ca2+ flux through this channel. This difference is surprising because the variants share absolute sequence identity in the area of the pore that defines ionic selectivity. Here, we used patch-clamp fluorometry and chimeric receptors to show that the fraction of the total current carried by Ca2+ is a function of the primary sequence of the cytoplasmic N terminus. Using scanning mutagenesis, we identified five sites within the N terminus that respond to mutagenesis with a decrease in fractional calcium current and an increase in permeability to the polyatomic cation, N-methyl-d-glucamine (NMDG(+)), relative to Na+ (P-NMDG/P-Na). We tested the hypothesis that these sites line the permeation pathway by measuring the ability of thiol-reactive MTSET+ to alter the current of cysteine-substituted variants, but we detected no effect. Finally, we studied the homologous sites of the rat P2X2 receptor (rP2X2R) and observed that substitutions at Glu(17) significantly reduced the fractional calcium current. Taken together, our results suggest that a change in the structure of the N terminus alters the ability of an intra-pore Ca2+ selectivity filter to discriminate among permeating cations. These results are noteworthy for two reasons: they identify a previously unknown outcome of mutagenesis of the N-terminal domain, and they suggest caution when assigning structure to function for truncated P2X receptors that lack a part of the N terminus.	[Liang, Xin] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China; [Samways, Damien S. K.] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA; [Cox, Jane; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol, 1402 South Grand Blvd, St Louis, MO 63104 USA; [Cox, Jane; Egan, Terrance M.] St Louis Univ, Sch Med, Henry & Amelia Nasrallah Ctr Neurosci, St Louis, MO 63104 USA	Sun Yat Sen University; Clarkson University; Saint Louis University; Saint Louis University	Egan, TM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol, 1402 South Grand Blvd, St Louis, MO 63104 USA.	terrance.egan@health.slu.edu		Egan, Terrance/0000-0002-7249-3161	National Institutes of Health [1R01GM112188]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM112188. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adinolfi E, 2018, BIOCHEM PHARMACOL, V151, P234, DOI 10.1016/j.bcp.2017.12.021; Allsopp RC, 2015, J BIOL CHEM, V290, P14556, DOI 10.1074/jbc.M115.642033; Allsopp RC, 2013, J BIOL CHEM, V288, P21412, DOI 10.1074/jbc.M113.464651; Allsopp RC, 2011, J BIOL CHEM, V286, P44691, DOI 10.1074/jbc.M111.303917; Allsopp RC, 2010, J BIOL CHEM, V285, P32770, DOI 10.1074/jbc.M110.148940; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Di Virgilio F, 2018, CURR OPIN IMMUNOL, V52, P51, DOI 10.1016/j.coi.2018.03.026; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Di Virgilio F, 2015, CURR MED CHEM, V22, P866; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Fryatt AG, 2019, J GEN PHYSIOL, V151, P146, DOI 10.1085/jgp.201812108; He ML, 2003, AM J PHYSIOL-CELL PH, V285, pC467, DOI 10.1152/ajpcell.00042.2003; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hille B., 2001, ION CHANNELS EXCITAB, P13; Janks L, 2019, J IMMUNOL, V202, P883, DOI 10.4049/jimmunol.1801101; Jimenez-Mateos EM, 2019, BRAIN RES BULL, V151, P153, DOI 10.1016/j.brainresbull.2018.12.008; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Lalo U, 2011, J BIOL CHEM, V286, P30591, DOI 10.1074/jbc.M111.253153; Li MF, 2015, NAT NEUROSCI, V18, P1577, DOI 10.1038/nn.4120; Liang X, 2015, J BIOL CHEM, V290, P7930, DOI 10.1074/jbc.M114.627810; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nicke A., 2018, OXFORD HDB NEURONAL, P1; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Pippel A, 2017, P NATL ACAD SCI USA, V114, pE2156, DOI 10.1073/pnas.1610414114; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00006; Savio LEB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00052; Schmid R, 2019, ANNU REV PHYSIOL, V81, P43, DOI 10.1146/annurev-physiol-020518-114259; Schwarz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041269; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sluyter R, 2017, ADV EXP MED BIOL, V1051, P17, DOI 10.1007/5584_2017_59; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Sperlagh B, 2014, TRENDS PHARMACOL SCI, V35, P537, DOI 10.1016/j.tips.2014.08.002; Stojilkovic SS, 2005, ANN NY ACAD SCI, V1048, P116, DOI 10.1196/annals.1342.011; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Taylor SRJ, 2008, J IMMUNOL, V180, P300, DOI 10.4049/jimmunol.180.1.300; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wen HR, 2009, J NEUROCHEM, V108, P331, DOI 10.1111/j.1471-4159.2008.05761.x; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Yan ZH, 2010, J NEUROSCI, V30, P14213, DOI 10.1523/JNEUROSCI.2390-10.2010; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458	51	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12521	12533		10.1074/jbc.RA119.009666	http://dx.doi.org/10.1074/jbc.RA119.009666			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248985	hybrid, Green Published			2022-12-26	WOS:000484402700022
J	Xu, ZL; Li, LC; Qian, YY; Song, Y; Qin, LP; Duan, YY; Wang, ML; Li, PS; Jiang, BC; Ma, CH; Shao, CS; Gong, YQ				Xu, Zhiliang; Li, Linchuan; Qian, Yanyan; Song, Yu; Qin, Liping; Duan, Yuyao; Wang, Molin; Li, Peishan; Jiang, Baichun; Ma, Chunhong; Shao, Changshun; Gong, Yaoqin			Upregulation of IL-6 in CUL4B-deficient myeloid-derived suppressive cells increases the aggressiveness of cancer cells	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; TUMOR PROGRESSION; METHYLATION; TUMORIGENESIS; INTERLEUKIN-6; DYSREGULATION; PROMOTER; PATHWAY; CUL4A; STAT3	Cancer progression depends on a tumor-supportive microenvironment. Myeloid-derived suppressor cells (MDSCs) represent key cellular components in tumor microenvironment and have been demonstrated to facilitate tumor progression by restricting host immune responses and by sustaining the malignancy of cancer cells. CUL4B, which assembles the CUL4B-RING E3 ligase complex (CRL4B), possesses a potent oncogenic property in cancer cells by epigenetically inactivating many tumor suppressors. However, CUL4B in hematopoietic cells exerts tumor-suppressive effect by restricting the accumulation and function of MDSCs. How CUL4B regulates the function of MDSCs is not fully characterized. In the present study, we demonstrate that the enhanced growth and metastasis of transplanted tumor cells in hematopoietic or myeloid cell-specific Cul4b knockout recipient mice is mediated by increased production of IL-6 in MDSCs. CUL4B complex epigenetically represses IL-6 transcription in myeloid cells. The IL-6 produced by MDSCs renders cancer cells stem cell-like properties by activating IL-6/STAT3 signaling. This crosstalk was effectively blocked either by blocking IL-6 in MDSCs or by inhibition of STAT3 activation in tumor cells. These findings provide a new mechanistic insight into the cancer-promoting property of MDSCs.	[Xu, Zhiliang; Li, Linchuan; Qian, Yanyan; Song, Yu; Qin, Liping; Duan, Yuyao; Wang, Molin; Li, Peishan; Jiang, Baichun; Gong, Yaoqin] Shandong Univ, Key Lab Expt Teratol, Inst Mol Med & Genet, Minist Educ,Sch Basic Med Sci, Jinan, Shandong, Peoples R China; [Ma, Chunhong] Shandong Univ, Key Lab Expt Teratol, Minist Educ, Dept Immunol,Sch Basic Med Sci, Jinan, Shandong, Peoples R China; [Shao, Changshun] Soochow Univ, Inst Translat Med, State Key Lab Radiat Med & Protect, Suzhou, Jiangsu, Peoples R China	Shandong University; Shandong University; Soochow University - China	Gong, YQ (corresponding author), Shandong Univ, Key Lab Expt Teratol, Inst Mol Med & Genet, Minist Educ,Sch Basic Med Sci, Jinan, Shandong, Peoples R China.	yxg8@sdu.edu.cn	ma, chunhong/C-6043-2008; Shao, Changshun/AAD-8977-2022	ma, chunhong/0000-0002-8121-4718; Shao, Changshun/0000-0003-2618-9342; Qian, Yanyan/0000-0002-1759-5835	National Natural Science Foundation of China [81330050, 81571523]; Natural Science Foundation of Shandong Province [ZR2016HZ01]; Key Research and Development Program of Shandong Province [2016ZDJS07A08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Key Research and Development Program of Shandong Province	This work was supported by the National Natural Science Foundation of China (81330050 and 81571523), the Natural Science Foundation of Shandong Province (ZR2016HZ01), and the Key Research and Development Program of Shandong Province (2016ZDJS07A08).	Albini A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00527; Chen Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01344-9; Chin AR, 2014, MOL CELL ENDOCRINOL, V382, P598, DOI 10.1016/j.mce.2013.03.024; Dandrea M, 2009, NUCLEIC ACIDS RES, V37, P6681, DOI 10.1093/nar/gkp723; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hannah J, 2015, GENE, V573, P33, DOI 10.1016/j.gene.2015.08.064; He YM, 2018, J CELL BIOCHEM, V119, P5308, DOI 10.1002/jcb.26643; Hu HL, 2012, CANCER CELL, V22, P781, DOI 10.1016/j.ccr.2012.10.024; Ishida K, 2012, J PERIODONTOL, V83, P917, DOI 10.1902/jop.2011.110356; Ji QH, 2014, J CELL SCI, V127, P4679, DOI 10.1242/jcs.154245; Jia L, 2017, J BIOL CHEM, V292, P2966, DOI 10.1074/jbc.M116.765230; Jiang BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037070; Jiang T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0534-7; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Khoshbin AP, 2019, ARCH IMMUNOL THER EX, V67, P89, DOI 10.1007/s00005-018-0531-9; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mi J, 2017, MOL ONCOL, V11, P305, DOI 10.1002/1878-0261.12038; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Peng DJ, 2016, CANCER RES, V76, P3156, DOI 10.1158/0008-5472.CAN-15-2528; Qian YY, 2015, CANCER RES, V75, P5070, DOI 10.1158/0008-5472.CAN-15-0898; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Safarzadeh E, 2018, J CELL PHYSIOL, V233, P3024, DOI 10.1002/jcp.26075; Tang BK, 2011, MOL IMMUNOL, V48, P1001, DOI 10.1016/j.molimm.2011.01.003; Umansky V, 2013, CANCER MICROENVIRON, V6, P169, DOI 10.1007/s12307-012-0126-7; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; Xiong S, 2018, AM J CANCER RES, V8, P302; Yang Y, 2015, ONCOGENE, V34, P104, DOI 10.1038/onc.2013.522; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yuan JP, 2015, J PATHOL, V235, P784, DOI 10.1002/path.4492	35	15	16	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2019	38	30					5860	5872		10.1038/s41388-019-0847-x	http://dx.doi.org/10.1038/s41388-019-0847-x			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3FY	31235785				2022-12-26	WOS:000482739300002
J	Meaney, C; Stastna, M; Kardar, M; Kohandel, M				Meaney, Cameron; Stastna, Marek; Kardar, Mehran; Kohandel, Mohammad			Spatial optimization for radiation therapy of brain tumours	PLOS ONE			English	Article							MALIGNANT GLIOMA; MATHEMATICAL-MODEL; DOSE DISTRIBUTION; RADIOTHERAPY; GROWTH; CHEMOTHERAPY; INDEX	Glioblastomas are the most common primary brain tumours. They are known for their highly aggressive growth and invasion, leading to short survival times. Treatments for glioblastomas commonly involve a combination of surgical intervention, chemotherapy, and external beam radiation therapy ( XRT). Previous works have not only successfully modelled the natural growth of glioblastomas in vivo, but also show potential for the prediction of response to radiation prior to treatment. This suggests that the efficacy of XRT can be optimized before treatment in order to yield longer survival times. However, while current efforts focus on optimal scheduling of radiotherapy treatment, they do not include a similarly sophisticated spatial optimization. In an effort to improve XRT, we present a method for the spatial optimization of radiation profiles. We expand upon previous results in the general problem and examine the more physically reasonable cases of 1-step and 2-step radiation profiles during the first and second XRT fractions. The results show that by including spatial optimization in XRT, while retaining a constant prescribed total dose amount, we are able to increase the total cell kill from the clinically-applied uniform case.	[Meaney, Cameron; Stastna, Marek; Kohandel, Mohammad] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Kardar, Mehran] MIT, Dept Phys, Cambridge, MA 02139 USA	University of Waterloo; Massachusetts Institute of Technology (MIT)	Kohandel, M (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.	kohandel@uwateroo.ca		Stastna, Marek/0000-0003-1770-2044; Kohandel, Mohammad/0000-0003-0667-7269	Natural Sciences and Engineering Research Council of Canada (NSERC); NSF [DMR-1708280]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF))	Financial support by the Natural Sciences and Engineering Research Council of Canada (NSERC) (Kohandel, Meaney), and by NSF grant DMR-1708280 (Kardar) is gratefully acknowledged.	Alfonso JCL, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0569-3; Alfonso JCL, 2014, B MATH BIOL, V76, P1017, DOI 10.1007/s11538-014-9945-7; Bentzen SM, 2011, SEMIN RADIAT ONCOL, V21, P101, DOI 10.1016/j.semradonc.2010.10.001; Berg G, 2003, ACTA ONCOL, V42, P582, DOI 10.1080/02841860310014679; Black P, 1998, J NEUROVIROL, V4, P227, DOI 10.3109/13550289809114522; BRAHME A, 1987, ACTA ONCOL, V26, P377, DOI 10.3109/02841868709104364; Burgess PK, 2018, J NEUROPATHOLOGY EXP, V56, P704; DeAngelis LM, 1998, ANN NEUROL, V44, P691, DOI 10.1002/ana.410440418; Duckett S., 1991, PATHOLOGY AGING HUMA; Feuvret L, 2006, INT J RADIAT ONCOL, V64, P333, DOI 10.1016/j.ijrobp.2005.09.028; Galochkina T, 2015, MATH BIOSCI, V267, P1, DOI 10.1016/j.mbs.2015.05.006; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Jones L., 2001, Australasian Physical and Engineering Sciences in Medicine, V24, P132, DOI 10.1007/BF03178355; Kohandel M, 2007, PHYS MED BIOL, V52, P3665, DOI 10.1088/0031-9155/52/13/001; Lonardi S, 2005, CANCER TREAT REV, V31, P79, DOI 10.1016/j.ctrv.2004.12.005; Alfonso JCL, 2012, DISCRETE CONT DYN-B, V17, P1651, DOI 10.3934/dcdsb.2012.17.1651; Mason WP, 2005, NAT CLIN PRACT NEURO, V1, P88, DOI 10.1038/ncpneuro0045; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Rockne R, 2009, J MATH BIOL, V58, P561, DOI 10.1007/s00285-008-0219-6; Stavreva NA, 1996, ACTA ONCOL, V35, P727, DOI 10.3109/02841869609084006; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; TRACQUI P, 1995, CELL PROLIFERAT, V28, P17, DOI 10.1111/j.1365-2184.1995.tb00036.x; Unkelbach J, 2014, PHYS MED BIOL, V59, P771, DOI 10.1088/0031-9155/59/3/771; WEBB S, 1994, PHYS MED BIOL, V39, P2091, DOI 10.1088/0031-9155/39/11/018; Yoon MG, 2007, J APPL CLIN MED PHYS, V8, P9, DOI 10.1120/jacmp.v8i2.2390	26	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0217354	10.1371/journal.pone.0217354	http://dx.doi.org/10.1371/journal.pone.0217354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251755	Green Submitted, Green Published, gold			2022-12-26	WOS:000484915000005
J	Radkiewicz, C; Dickman, PW; Johansson, ALV; Wagenius, G; Edgren, G; Lambe, M				Radkiewicz, Cecilia; Dickman, Paul William; Johansson, Anna Louise Viktoria; Wagenius, Gunnar; Edgren, Gustaf; Lambe, Mats			Sex and survival in non-small cell lung cancer: A nationwide cohort study	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; GENDER-DIFFERENCES; PERFORMANCE STATUS; STAGING PROJECT; SMOKING STATUS; FEMALE GENDER; POPULATION; WOMEN; CLASSIFICATION; COMORBIDITY	Aim To in detail delineate sex differences in non-small cell lung cancer outcome and investigate possible underlying drivers. Methods We performed a nationwide, population-based cohort study using data on all incident cases of lung squamous cell carcinoma (n = 10,325) and adenocarcinoma (n = 23,465) recorded in the Swedish Lung Cancer Register in 2002-2016. Flexible parametric models were applied to compute adjusted female-to-male hazard ratios (aHRs) and standardized survival proportions over follow-up including age, calendar year, education, marital status, birth country, health care region, performance status, smoking history, comorbidities, and tumor location in the final model. Results Women presented with better performance status, were younger, and more often never-smokers. Women with adenocarcinoma also had lower comorbidity burden, less advanced stage, and were more often EGFR positive. Men with adenocarcinoma had a consistently poorer lung cancer-specific survival across stage; HR 0.69; 95% CI 0.63-0.76 (stage IA-IIB) to 0.94; 95% CI 0.88-0.99 (stage IIIB-IV), remaining largely unchanged after adjustments; aHR 0.74; 95% CI 0.66-0.82 to 0.84; 95% CI 0.81-0.87. The same pattern was observed in squamous cell carcinoma, except in stage IIIA disease, where we found no sex differences in survival. Conclusions Men with non-small cell lung cancer have a consistently poorer prognosis, even after careful adjustments for a wide range of prognostic factors. While the pattern was similar in both squamous cell and adenocarcinoma, it was larger and more consistent in the latter.	[Radkiewicz, Cecilia; Dickman, Paul William; Johansson, Anna Louise Viktoria; Lambe, Mats] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Radkiewicz, Cecilia] Soder Sjukhuset, Dept Oncol, Stockholm, Sweden; [Johansson, Anna Louise Viktoria] Canc Registry Norway, Oslo, Norway; [Wagenius, Gunnar] Karolinska Univ Hosp, Canc Theme, Stockholm, Sweden; [Edgren, Gustaf] Karolinska Inst, Dept Med Solna, Clin Epidemiol Div T2, Stockholm, Sweden; [Edgren, Gustaf] Soder Sjukhuset, Dept Cardiol, Stockholm, Sweden; [Lambe, Mats] Reg Canc Ctr Uppsala Orebro, Uppsala, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; University of Oslo; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Sodersjukhuset Hospital	Radkiewicz, C (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.; Radkiewicz, C (corresponding author), Soder Sjukhuset, Dept Oncol, Stockholm, Sweden.	cecilia.radkiewicz@ki.se	Dickman, Paul W/B-4572-2013; Edgren, Gustaf/F-4013-2014	Dickman, Paul W/0000-0002-5788-3380; Lambe, Mats/0000-0002-4624-3767; Edgren, Gustaf/0000-0002-2198-4745; Radkiewicz, Cecilia/0000-0003-0683-1537	FORTE -The Swedish Research Council for Health, Working Life and Welfare [2012-03047]; Swedish research council [2017-01954]; Stockholm County Council	FORTE -The Swedish Research Council for Health, Working Life and Welfare; Swedish research council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council)	This work was supported by grants from FORTE -The Swedish Research Council for Health, Working Life and Welfare (2012-03047 to ML); the Swedish research council (2017-01954 to GE); and Stockholm County Council (clinical research appointment to GE). The funding bodies had no role in the data collection and analysis and was not involved in the interpretation of results, writing, revision, or approval of the manuscript.	ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618, DOI 10.1200/JCO.1991.9.9.1618; Alexiou C, 2002, EUR J CARDIO-THORAC, V21, P319, DOI 10.1016/S1010-7940(01)01114-9; [Anonymous], 2016, REPORT NO 19; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Batevik R, 2005, LUNG CANCER, V47, P173, DOI 10.1016/j.lungcan.2004.08.014; Caldarella A, 2007, EJSO-EUR J SURG ONC, V33, P763, DOI 10.1016/j.ejso.2007.01.001; Cerfolio RJ, 2006, CHEST, V130, P1796, DOI 10.1378/chest.130.6.1796; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Debieuvre D, 2016, LUNG CANCER, V91, P1, DOI 10.1016/j.lungcan.2015.11.001; Donington JS, 2011, SEMIN THORAC CARDIOV, V23, P137, DOI 10.1053/j.semtcvs.2011.07.001; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Foegle J, 2007, J THORAC ONCOL, V2, P466, DOI 10.1097/01.JTO.0000275340.39960.25; Fu JB, 2005, CHEST, V127, P768, DOI 10.1378/chest.127.3.768; Gazdar AF, 2010, ANN ONCOL, V21, P225, DOI 10.1093/annonc/mdq372; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Harichand-Herdt S, 2009, SEMIN ONCOL, V36, P572, DOI 10.1053/j.seminoncol.2009.10.007; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Kawaguchi T, 2010, J THORAC ONCOL, V5, P1001, DOI 10.1097/JTO.0b013e3181e2f607; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Nakamura H, 2011, ANN THORAC CARDIOVAS, V17, P469, DOI 10.5761/atcs.oa.10.01637; Ou SHI, 2007, CANCER-AM CANCER SOC, V110, P1532, DOI 10.1002/cncr.22938; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Pitz MW, 2013, CAN RESPIR J, V20, P30, DOI 10.1155/2013/618691; Planchard D, 2009, SEMIN ONCOL, V36, P553, DOI 10.1053/j.seminoncol.2009.09.004; Postmus PE, 2017, ANN ONCOL, V28, P1, DOI 10.1093/annonc/mdx222; Radzikowska E, 2002, ANN ONCOL, V13, P1087, DOI 10.1093/annonc/mdf187; Rena O, 2013, TUMORI, V99, P661, DOI 10.1700/1390.15453; Sagerup CMT, 2011, THORAX, V66, P301, DOI 10.1136/thx.2010.151621; Sakurai H, 2010, J THORAC ONCOL, V5, P1594, DOI 10.1097/JTO.0b013e3181f1923b; Sarfati D, 2012, J CLIN EPIDEMIOL, V65, P924, DOI 10.1016/j.jclinepi.2012.02.017; Schwartz AG, 2005, CLIN CANCER RES, V11, P7280, DOI 10.1158/1078-0432.CCR-05-0498; Siddiqui F, 2010, J THORAC ONCOL, V5, P631, DOI 10.1097/JTO.0b013e3181d5e46a; Sjolander A, 2016, EUR J EPIDEMIOL, V31, P563, DOI 10.1007/s10654-016-0157-3; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Wainer Z, 2018, CLIN LUNG CANCER, V19, pE933, DOI 10.1016/j.cllc.2018.08.004; Werner-Wasik M, 2000, INT J RADIAT ONCOL, V48, P1475, DOI 10.1016/S0360-3016(00)00801-4; Wheatley-Price P, 2010, J THORAC ONCOL, V5, P640, DOI 10.1097/JTO.0b013e3181d40a1b; Xiao DK, 2016, ONCOTARGET, V7, P22857, DOI 10.18632/oncotarget.8213	40	42	43	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219206	10.1371/journal.pone.0219206	http://dx.doi.org/10.1371/journal.pone.0219206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247015	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900086
J	Winde, F; Geipel, G; Espina, C; Schuz, J				Winde, Frank; Geipel, Gerhard; Espina, Carolina; Schuz, Joachim			Human exposure to uranium in South African gold mining areas using barber-based hair sampling	PLOS ONE			English	Article							NEUTRON-ACTIVATION ANALYSIS; HUMAN SCALP HAIR; DRINKING-WATER; URINE; TAILINGS; NAILS; INGESTION; TRACE	Uranium (U) measurements in water, soil, and food related to gold mining activities in populated areas in Gauteng Province, South Africa, suggest the possibility of exposure levels that may lead to adverse health consequences, including cancer. Theoretical considerations on pathways of human uptake of significant exposures are plausible, but few data on directly measured human exposure are available. A cross-sectional study was conducted using human measurements to compare U levels with other settings around the globe (based on literature review), to explore potential exposure variability within the province, and to test the feasibility of recruiting subjects partially coming from vulnerable and difficult-to-reach populations. Wards of potentially high (HE) and low exposure (LE) were identified. Composite hair samples representing the respective local populations were collected from regular customers of selected barber shops over a period of 1-2 months. A total of 70 U concentrations were determined in 27 composite samples from 1332 individuals. U concentrations ranged from 31 mu g/kg to 2524 mu g/kg, with an arithmetic mean of 192 mu g/kg (standard deviation, 310 mu g/kg) and a median of 122 mu g/kg. Although HE wards collectively showed higher U levels than LE wards (184 vs 134 mu g/kg), differences were smaller than expected. In conclusion, detected U levels were higher than those from most other surveys of the general public. The barber-based approach was an efficient hair collection approach. Composite hair samples are not recommended, due to technical challenges in measuring U, and individual hair samples are needed in follow-up studies to determine predictors of exposure.	[Winde, Frank] North West Univ, Res Unit Environm Sci & Management, Mine Water Res Grp, Vaal Triangle Campus, Vanderbijlpark, South Africa; [Geipel, Gerhard] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany; [Espina, Carolina; Schuz, Joachim] IARC, Sect Environm & Radiat, Lyon, France	North West University - South Africa; Vaal University of Technology (VUT); Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); World Health Organization; International Agency for Research on Cancer (IARC)	Schuz, J (corresponding author), IARC, Sect Environm & Radiat, Lyon, France.	Schuzj@iarc.fr		Schuz, Joachim/0000-0001-9687-2134	Ministry of Health, Labour and Welfare of Japan [2012-02-21-01]; UNESCO Sida Programme on Environmental and health effects of abandoned mines in Sub-Saharan Africa; International Agency for Research on Cancer (IARC)	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); UNESCO Sida Programme on Environmental and health effects of abandoned mines in Sub-Saharan Africa; International Agency for Research on Cancer (IARC)(World Health Organization)	This work was supported by the Ministry of Health, Labour and Welfare of Japan (Grant agreement number 2012-02-21-01 to JS at IARC) and UNESCO Sida Programme on Environmental and health effects of abandoned mines in Sub-Saharan Africa to CE at IARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by grants made to the International Agency for Research on Cancer (IARC) by the Ministry of Health, Labour and Welfare of Japan (grant agreement number 2012-02-21-01; to JS) and by the UNESCO Sida Programme on Environmental and Health Effects of Abandoned Mines in Sub-Saharan Africa (to CE), for which we are most grateful.	Akamine AU, 2007, J RADIOANAL NUCL CH, V271, P607, DOI 10.1007/s10967-007-0315-x; [Anonymous], 2011, IRAQ CONFL HLTH; Bensoussan H, 2009, TOXICOLOGY, V261, P59, DOI 10.1016/j.tox.2009.04.054; Blight GE, 2007, J S AFR I MIN METALL, V107, P99; BS Associates, 2007, RRDRP012006 BS ASS, P133; BYRNE AR, 1991, SCI TOTAL ENVIRON, V107, P143, DOI 10.1016/0048-9697(91)90256-E; Canu IG, 2011, ENVIRON HEALTH PERSP, V119, P1676, DOI 10.1289/ehp.1003224; Chung Y.S., 2001, J KOREAN NUCL SOC, V33, P225; Coetzee H, 2006, 1214106 WRC, P202; Domingo JL, 2001, REPROD TOXICOL, V15, P603, DOI 10.1016/S0890-6238(01)00181-2; DuToit JS, 2007, BACKGROUND REPORT CO, P78; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; GDARD-Gauteng Department of Agriculture and Rural Development, 2009, CONC STUD RECL MIN R; Gonnen R, 2000, J RADIOANAL NUCL CH, V243, P559, DOI 10.1023/A:1016031726512; Hindin Rita, 2005, Environ Health, V4, P17, DOI 10.1186/1476-069X-4-17; Igarashi Y, 1984, RADIOISOTOPES, V33, P9; IMAHORI A, 1979, J RADIOANAL CHEM, V52, P167, DOI 10.1007/BF02517711; International Agency for Research on Cancer (IARC), 1999, IARC MON EV CARC R 1, V75; Israelsson A, 2014, HEALTH PHYS, V107, P143, DOI 10.1097/HP.0000000000000075; IWQS (Institute for Water Quality Studies), 1999, NC20000RPQ2399 IWQS, P26; Joksic AS, 2014, J ENVIRON SCI HEAL A, V49, P1578, DOI 10.1080/10934529.2014.938535; Karpas Z, 2005, HEALTH PHYS, V88, P229, DOI 10.1097/01.HP.0000149883.69107.ab; Kehagia K, 2011, RADIAT PROT DOSIM, V144, P423, DOI 10.1093/rpd/ncq324; Kneen MA, 2015, S AFR J SCI, V111, P142; Mathuthu M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060570; McDiarmid MA, 2012, ENVIRON RES, V82, P168; Mogale City Local Municipality, 2011, RAD TOX INF SETTL TU, P43; Muikku M, 2009, HEALTH PHYS, V96, P646, DOI 10.1097/01.HP.0000345026.98668.c4; NIELSEN PE, 1992, J AM CHEM SOC, V114, P4967, DOI 10.1021/ja00039a003; Raymond-Whish S, 2007, ENVIRON HEALTH PERSP, V115, P1711, DOI 10.1289/ehp.9910; Rodushkin I, 2000, SCI TOTAL ENVIRON, V262, P21, DOI 10.1016/S0048-9697(00)00531-3; Sahoo SK, 2015, J ENVIRON RADIOACTIV, V145, P66, DOI 10.1016/j.jenvrad.2015.03.020; Schonfeld SJ, 2014, CANCER EPIDEMIOL, V38, P628, DOI 10.1016/j.canep.2014.06.003; Schroder H, 2003, RADIAT PROT DOSIM, V103, P211, DOI 10.1093/oxfordjournals.rpd.a006135; Science Kudzu, 2018, 18031401 SCI KUDZ, p[7, 13]; Wade PW, 2002, 1095102 WRC; Winde F, 2011, NEW UR MIN BOOM CHAL, P529; Winde F, 2010, WATER SA, V36, P257; Zaire R, 1997, RADIAT RES, V147, P579, DOI 10.2307/3579624; Zunic ZS, 2012, RADIAT PROT DOSIM, V152, P220, DOI 10.1093/rpd/ncs225; [No title captured]	41	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219059	10.1371/journal.pone.0219059	http://dx.doi.org/10.1371/journal.pone.0219059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247044	gold, Green Published, Green Submitted			2022-12-26	WOS:000484911900071
J	Awan, SE; Bennamoun, M; Sohel, F; Sanfilippo, FM; Chow, BJ; Dwivedi, G				Awan, Saqib E.; Bennamoun, Mohammed; Sohel, Ferdous; Sanfilippo, Frank M.; Chow, Benjamin J.; Dwivedi, Girish			Feature selection and transformation by machine learning reduce variable numbers and improve prediction for heart failure readmission or death	PLOS ONE			English	Article								Background The prediction of readmission or death after a hospital discharge for heart failure (HF) remains a major challenge. Modern healthcare systems, electronic health records, and machine learning (ML) techniques allow us to mine data to select the most significant variables (allowing for reduction in the number of variables) without compromising the performance of models used for prediction of readmission and death. Moreover, ML methods based on transformation of variables may potentially further improve the performance. Objective To use ML techniques to determine the most relevant and also transform variables for the prediction of 30-day readmission or death in HF patients. Methods We identified all Western Australian patients aged 65 years and above admitted for HF between 2003-2008 in linked administrative data. We evaluated variables associated with HF readmission or death using standard statistical and ML based selection techniques. We also tested the new variables produced by transformation of the original variables. We developed multi-layer perceptron prediction models and compared their predictive performance using metrics such as Area Under the receiver operating characteristic Curve (AUC), sensitivity and specificity. Results Following hospital discharge, the proportion of 30-day readmissions or death was 23.7% in our cohort of 10,757 HF patients. The prediction model developed by us using a smaller set of variables (n = 8) had comparable performance (AUC 0.62) to the traditional model (n = 47, AUC 0.62). Transformation of the original 47 variables further improved (p<0.001) the performance of the predictive model (AUC 0.66). Conclusions A small set of variables selected using ML matched the performance of the model that used the full set of 47 variables for predicting 30-day readmission or death in HF patients. Model performance can be further significantly improved by transforming the original variables using ML methods.	[Awan, Saqib E.; Bennamoun, Mohammed; Sohel, Ferdous] Univ Western Australia, Dept Comp Sci & Software Engn, Perth, WA, Australia; [Sohel, Ferdous] Murdoch Univ, Discipline Informat Technol Math & Stat, Perth, WA, Australia; [Sanfilippo, Frank M.] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Chow, Benjamin J.] Univ Ottawa, Heart Inst, Ottawa, ON, Canada; [Dwivedi, Girish] Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA, Australia; [Dwivedi, Girish] Univ Western Australia, Fiona Stanley Hosp, Perth, WA, Australia; [Dwivedi, Girish] Univ Western Australia, Med Sch, Perth, WA, Australia	University of Western Australia; Murdoch University; University of Western Australia; University of Ottawa; University of Ottawa Heart Institute; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; University of Western Australia	Dwivedi, G (corresponding author), Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA, Australia.; Dwivedi, G (corresponding author), Univ Western Australia, Fiona Stanley Hosp, Perth, WA, Australia.; Dwivedi, G (corresponding author), Univ Western Australia, Med Sch, Perth, WA, Australia.	girish.dwivedi@perkins.uwa.edu.au	Bennamoun, Mohammed/C-2789-2013; Sohel, Ferdous/C-2428-2013; Dwivedi, Girish/AAF-2726-2021; Sanfilippo, Frank/H-9334-2013	Bennamoun, Mohammed/0000-0002-6603-3257; Sohel, Ferdous/0000-0003-1557-4907; Dwivedi, Girish/0000-0003-0717-740X; Sanfilippo, Frank/0000-0003-3639-0787	University of Western Australia; National Health and Medical Research Council (Australia, NHMRC) [1066242]	University of Western Australia; National Health and Medical Research Council (Australia, NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Our work was supported by a Scholarships for International Research Fees (SIRF) scholarship awarded by the University of Western Australia (for SE Awan), and funding from a project grant from the National Health and Medical Research Council (Australia, NHMRC project grant 1066242) supported this work. The NHMRC had no input into the study design, data collection, analyses and interpretation of the data, preparing the manuscript and the decision to submit for publication.	Awan SE, 2018, CURR OPIN CARDIOL, V33, P190, DOI 10.1097/HCO.0000000000000491; Awan SE, 2019, ESC HEART FAILURE; Cai J, 2018, NEUROCOMPUTING, V300, P70, DOI 10.1016/j.neucom.2017.11.077; Cateni S, 2013, MULTIVARIATE ANAL MA, P103; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Futoma J, 2015, J BIOMED INFORM, V56, P229, DOI 10.1016/j.jbi.2015.05.016; Gunnell AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006258; Gupta A, 2018, EUR J HEART FAIL, V20, P1169, DOI 10.1002/ejhf.1212; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hakim MA, 2018, CLIN EPIDEMIOL, V10, P51, DOI 10.2147/CLEP.S149574; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Jain AK., 1988, TECHNOMETRICS; Jolliffe I, 2011, INT ENCY STAT SCI, DOI 10.1007/978-3-642-04898-2_455; Khalid S, 2014, SCI INF C SAI 2014; Koulaouzidis G, 2016, INT J CARDIOL, V216, P78, DOI 10.1016/j.ijcard.2016.04.149; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Marcano-Cedeno A, 2010, 36 ANN C IEEE IND EL; Mortazavi BJ, 2016, CIRC-CARDIOVASC QUAL, V9, P629, DOI 10.1161/CIRCOUTCOMES.116.003039; Papatheocharous E, 2012, ARXIV12101161; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Popescu Marius-Constantin, 2009, WSEAS Transactions on Circuits and Systems, V8, P579; Qin XW, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-014397; Saluk JL, 2017, J UROLOGY, V197, pE668, DOI 10.1016/j.juro.2017.02.1550; Savarese Gianluigi, 2017, Card Fail Rev, V3, P7, DOI 10.15420/cfr.2016:25:2; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Wang H, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-97; WHO Collaborating Centre for Drug Statistics Methodology, 2019, ATC DDD IND 2019; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	28	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218760	10.1371/journal.pone.0218760	http://dx.doi.org/10.1371/journal.pone.0218760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242238	Green Published, gold, Green Submitted			2022-12-26	WOS:000482883600051
J	Quiroz, EN; Quiroz, RN; Lugo, LP; Martinez, GA; Escorcia, LG; Torres, HG; Bonfanti, AC; Marmolejo, MD; Sanchez, E; Camacho, JLV; Lorenzi, H; Torres, A; Navarro, KF; Rodriguez, PN; Villa, JL; Fernandez-Ponce, C				Navarro Quiroz, Elkin; Quiroz, Roberto Navarro; Pacheco Lugo, Lisandro; Aroca Martinez, Gustavo; Gomez Escorcia, Lorena; Gonzalez Torres, Henry; Cadena Bonfanti, Andres; del Carmen Marmolejo, Maria; Sanchez, Eduardo; Villarreal Camacho, Jose Luis; Lorenzi, Hernan; Torres, Augusto; Fernando Navarro, Kelvin; Navarro Rodriguez, Pablo; Luis Villa, Joe; Fernandez-Ponce, Cecilia			Integrated analysis of microRNA regulation and its interaction with mechanisms of epigenetic regulation in the etiology of systemic lupus erythematosus	PLOS ONE			English	Article							DNA METHYLATION; HISTONE MODIFICATION; CD4+T CELLS; DATABASE; HYPOMETHYLATION; HETEROCHROMATIN; DEREGULATION; ASSOCIATION; PATTERN; GENES	The aim of this study was to identity in silico the relationships among microRNAs (miRNAs) and genes encoding transcription factors, ubiquitylation, DNA methylation, and histone modifications in systemic lupus erythematosus (SLE). To identify miRNA dysregulation in SLE, we used miR2Disease and PhenomiR for information about miRNAs exhibiting differential regulation in disease and other biological processes, and HMDD for information about experimentally supported human miRNA-disease association data from genetics, epigenetics, circulating miRNAs, and miRNA-target interactions. This information was incorporated into the miRNA analysis. High-throughput sequencing revealed circulating miRNAs associated with kidney damage in patients with SLE. As the main finding of our in silico analysis of miRNAs differentially expressed in SLE and their interactions with disease-susceptibility genes, post-translational modifications, and transcription factors; we highlight 226 miRNAs associated with genes and processes. Moreover, we highlight that alterations of miRNAs such as hsa-miR-30a-5p, hsa-miR-16-5p, hsa-miR-142-5p, and hsa-miR-324-3p are most commonly associated with post-translational modifications. In addition, altered miRNAs that are most frequently associated with susceptibility-related genes are hsa-miR-16-5p, hsa-miR-374a-5p, hsa-miR-34a-5p, hsa-miR-31-5p, and hsa-miR-1-3p.	[Navarro Quiroz, Elkin; Pacheco Lugo, Lisandro; Aroca Martinez, Gustavo; Gomez Escorcia, Lorena; Gonzalez Torres, Henry; Cadena Bonfanti, Andres; Torres, Augusto] Univ Simon Bolivar, Basic & Biomed Fac, Barranquilla, Colombia; [Quiroz, Roberto Navarro] Univ Fed ABC, LBCB, CMCC, Sao Paulo, Brazil; [Cadena Bonfanti, Andres; Fernando Navarro, Kelvin] Dept Nephrol, Clin Costa, Barranquilla, Colombia; [del Carmen Marmolejo, Maria; Fernandez-Ponce, Cecilia] Univ Cadiz, Dept Biomed Biotechnol & Publ Hlth, Cadiz, Spain; [Sanchez, Eduardo] Univ Norte, Sch Med, Barranquilla, Colombia; [Villarreal Camacho, Jose Luis] Univ Libre, Sch Med, Barranquilla, Colombia; [Lorenzi, Hernan] J Craig Venter Inst, Dept Infect Dis, Rockville, MD USA; [Torres, Augusto] Univ Popular Cesar, Basic & Biomed Fac, Valledupar, Colombia; [Fernando Navarro, Kelvin] ACCONP, Barranquilla, Colombia; [Navarro Rodriguez, Pablo] ColNalPinillos, Mompos, Colombia; [Luis Villa, Joe] Procaps SA, Res & Dev, Barranquilla, Colombia	Universidade Federal do ABC (UFABC); Universidad de Cadiz; Universidad del Norte; J. Craig Venter Institute	Quiroz, EN (corresponding author), Univ Simon Bolivar, Basic & Biomed Fac, Barranquilla, Colombia.	enavarro26@unisimonbolivar.edu.co	Aroca Martinez, Gustavo/N-9133-2013; González-Torres, Henry Joseth/AAW-4602-2020; Aroca, Gustavo/P-9173-2016; Aroca-Martínez, Gustavo/AAV-7952-2021; Villarreal, Jose/AAS-4964-2021; Ponce, Cecilia Matilde Fernández/L-4752-2014; Quiroz, Elkin Navarro/AAB-6381-2019	Aroca Martinez, Gustavo/0000-0002-9222-3257; González-Torres, Henry Joseth/0000-0001-7434-4568; Aroca, Gustavo/0000-0002-9222-3257; Villarreal, Jose/0000-0002-7240-7462; Ponce, Cecilia Matilde Fernández/0000-0002-0027-1703; Quiroz, Elkin Navarro/0000-0001-7567-6409; GOMEZ ESCORCIA, LORENA/0000-0002-9736-6417; Lorenzi, Hernan/0000-0003-0910-7894; Pacheco-Lugo, Lisandro/0000-0002-9248-4596	Simon Bolivar University, Barranquilla, Colombia; Administrative Department of Science, Technology and Innovation of Colombia - COLCIENCIAS [125380763038, 125380763188]	Simon Bolivar University, Barranquilla, Colombia; Administrative Department of Science, Technology and Innovation of Colombia - COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	We declare that the funds or sources of support received in this specific internal report study of Simon Bolivar University, Barranquilla, Colombia, and external funding by the Administrative Department of Science, Technology and Innovation of Colombia - COLCIENCIAS, subsidy 125380763038 to ENQ and 125380763188 to GAM. We clarified that the funder had no role in the design of the study, the collection and analysis of data, the decision to publish or the preparation of the manuscript.	Abd-Elkareem MI, 2010, CLIN EXP NEPHROL, V14, P548, DOI 10.1007/s10157-010-0322-z; Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; CHITRABAMRUNG S, 1981, RHEUMATOL INT, V1, P55, DOI 10.1007/BF00541153; Coit P, 2013, J AUTOIMMUN, V43, P78, DOI 10.1016/j.jaut.2013.04.003; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hu N, 2008, J RHEUMATOL, V35, P804; Javierre BM, 2011, DISCOV MED, V12, P535; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Long MD, 2017, GENOMIC IMPACT DNA C, DOI [10.3390/biom7010015, DOI 10.3390/BIOM7010015]; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mazari L, 2007, P NATL ACAD SCI USA, V104, P6317, DOI 10.1073/pnas.0610434104; Mohammadoo-Khorasani M, 2016, CLIN RHEUMATOL, V35, P101, DOI 10.1007/s10067-015-3111-y; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Navarro-Quiroz E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187973; Navarro-Quiroz E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166202; ORIAN A, 1995, J BIOL CHEM, V270, P21707, DOI 10.1074/jbc.270.37.21707; Pacheco-Lugo L, 2019, LUPUS, V28, P34, DOI 10.1177/0961203318812679; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Perl A, 2013, NAT REV RHEUMATOL, V9, P674, DOI 10.1038/nrrheum.2013.147; Rice GI, 2015, J CLIN IMMUNOL, V35, P235, DOI 10.1007/s10875-015-0147-3; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Vuckovic F, 2015, ARTHRITIS RHEUMATOL, V67, P2978, DOI 10.1002/art.39273; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang S, 2012, GENES IMMUN, V13, P380, DOI 10.1038/gene.2012.6; Wang ZJ, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0378-7; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Weinhold B, 2006, ENVIRON HEALTH PERSP, V114, pA160, DOI 10.1289/ehp.114-a160; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Zhao M, 2014, J AUTOIMMUN, V54, P127, DOI 10.1016/j.jaut.2014.07.002; Zhao S, 2010, CLIN REV ALLERG IMMU, V39, P3, DOI 10.1007/s12016-009-8165-7; Zhao X, 2010, ARTHRITIS RHEUM-US, V62, P3425, DOI 10.1002/art.27632; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815	46	10	11	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218116	10.1371/journal.pone.0218116	http://dx.doi.org/10.1371/journal.pone.0218116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237906	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000014
J	Mzyk, DA; Bublitz, CM; Martinez, MN; Davis, JL; Baynes, RE; Smith, GW				Mzyk, Danielle A.; Bublitz, Claire M.; Martinez, Marilyn N.; Davis, Jennifer L.; Baynes, Ronald E.; Smith, Geof W.			Impact of bovine respiratory disease on the pharmacokinetics of danofloxacin and tulathromycin in different ages of calves	PLOS ONE			English	Article							LUNG-TISSUE CONCENTRATIONS; EPITHELIAL LINING FLUID; PLASMA PHARMACOKINETICS; DRUG CONCENTRATIONS; BLOOD-FLOW; HEALTHY; ENROFLOXACIN; SECRETIONS; PNEUMONIA; INFECTION	Pneumonia is one of the most economically important respiratory diseases of calves and knowledge of the impact of clinical disease on pharmacokinetics (PK) in young calves is limited. This study was undertaken to investigate the efficacy and PK of two antibiotics, tulathromycin and danofloxacin, in two age groups of calves experimentally infected with Pasteurella multocida. Both danofloxacin, a fluoroquinolone antibiotic, and tulathromycin, a macrolide antibiotic is approved for the treatment of bovine respiratory disease (BRD). To evaluate potential influences of age and disease on drug distribution and elimination in calves, plasma, interstitial fluid (ISF), and pulmonary epithelial lining fluid (PELF) were analyzed for drug concentrations. Concentrations for both drugs in the PELF were estimated by a urea dilution assay of the collected bronchoalveolar lavage fluids. Age was determined to be a significant covariate for calves administered danofloxacin and tulathromycin for plasma PK parameters. For calves administered danofloxacin, the area under the curve (AUC) in the plasma was lower in 6-month old calves (18.9 +/- 12.6 hr* mu g/mL) vs. 3-week old calves (32.0 +/- 8.2 hr* mu g/mL). Clearance (CL/F) of danofloxacin was higher in 6-month old calves. In contrast, tulathromycin plasma concentrations were higher in 6 month old calves and CL/F was higher in 3-week old calves. Age did not significantly influence the ISF concentrations of danofloxacin or tulathromycin in calves with respiratory disease, unlike previous studies which reported higher ISF concentrations of danofloxacin and tulathromycin in 6-month old calves when compared to younger calves. PELF concentrations were higher than plasma and ISF for both danofloxacin and tulathromycin, but did not differ between age groups. Potential reasons for age-related differences on plasma concentration-time profiles and the impact of disease on the partitioning of the drug from the blood to the lungs and ISF as a function of age are explored.	[Mzyk, Danielle A.; Bublitz, Claire M.; Baynes, Ronald E.; Smith, Geof W.] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Martinez, Marilyn N.] Ctr Vet Med, Off New Anim Drug Evaluat, Rockville, MD USA; [Davis, Jennifer L.] Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA	University of North Carolina; North Carolina State University	Smith, GW (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	gwsmith@ncsu.edu		Smith, Geof/0000-0001-5700-8810	Food Animal Residue Avoidance Databank (United States Department of Agriculture - National Institutes of Food and Agriculture) [2017 41480-27309]	Food Animal Residue Avoidance Databank (United States Department of Agriculture - National Institutes of Food and Agriculture)	Funding for this project was provided by the Food Animal Residue Avoidance Databank (United States Department of Agriculture - National Institutes of Food and Agriculture [Grant #2017 41480-27309]).	Agrawal A K, 2001, J Vet Sci, V2, P91; Altan F, 2017, J VET MED SCI, V79, P1245, DOI 10.1292/jvms.16-0641; Ames TR, 1997, VET CLIN N AM-FOOD A, V13, P379, DOI 10.1016/S0749-0720(15)30303-0; APLEY MD, 1993, AM J VET RES, V54, P944; Batista CF, 2012, J DAIRY SCI, V95, P5909, DOI 10.3168/jds.2012-5321; Benet LZ, 2002, CLIN PHARMACOL THER, V71, P115, DOI 10.1067/mcp.2002.121829; Berghaus LJ, 2012, J VET PHARMACOL THER, V35, P59, DOI 10.1111/j.1365-2885.2011.01292.x; Bladek T, 2015, FOOD ADDIT CONTAM A, V32, P1823, DOI 10.1080/19440049.2015.1078915; BODEM CR, 1983, AM REV RESPIR DIS, V127, P39, DOI 10.1164/arrd.1983.127.1.39; BRYSON DG, 1985, VET CLIN N AM-FOOD A, V1, P237, DOI 10.1016/S0749-0720(15)31326-8; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; BURROWS GE, 1985, AM J VET RES, V46, P798; Dagleish MP, 2010, J COMP PATHOL, V142, P157, DOI 10.1016/j.jcpa.2009.10.015; De Paepe P, 2002, CLIN PHARMACOKINET, V41, P1135, DOI 10.2165/00003088-200241140-00002; Drusano GL, 2005, PHARMACOTHERAPY, V25, p150S, DOI 10.1592/phco.2005.25.12part2.150S; Fischer H, 2002, AM J PHYSIOL-CELL PH, V282, pC736, DOI 10.1152/ajpcell.00369.2001; Foster DM, 2017, J VET PHARMACOL THER, V40, pe45, DOI 10.1111/jvp.12412; FRIIS C, 1993, AM J VET RES, V54, P1122; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; GILES CJ, 1991, J VET PHARMACOL THER, V14, P400, DOI 10.1111/j.1365-2885.1991.tb00854.x; GILMOUR NJL, 1984, RES VET SCI, V37, P374, DOI 10.1016/S0034-5288(18)31887-3; Gorden PJ, 2016, J DAIRY SCI, V99, P505, DOI 10.3168/jds.2015-10239; Kissell LW, 2015, JAVMA-J AM VET MED A, V246, P118, DOI 10.2460/javma.246.1.118; Langenberg C, 2005, CRIT CARE, V9, pR363, DOI 10.1186/cc3540; Martinez M, 2010, J VET PHARMACOL THER, V33, P213, DOI 10.1111/j.1365-2885.2009.01139.x; McGuirk SM, 2008, VET CLIN N AM-FOOD A, V24, P139, DOI 10.1016/j.cvfa.2007.10.003; McKellar Q, 1999, ANTIMICROB AGENTS CH, V43, P1988, DOI 10.1128/AAC.43.8.1988; Modric S, 1999, LAB ANIM SCI, V49, P248; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Mzyk DA, 2017, J VET PHARMACOL THER, V40, P179, DOI 10.1111/jvp.12346; Mzyk DA, 2018, AM J VET RES, V79, P1193, DOI 10.2460/ajvr.79.11.1193; Ng AW, 2004, LUNG, V182, P297, DOI 10.1007/s00408-004-2511-6; Nowakowski MA, 2004, VET THER, V5, P60; Ollivett TL, 2015, J VET INTERN MED, V29, P1728, DOI 10.1111/jvim.13605; Panciera RJ, 2010, VET CLIN N AM-FOOD A, V26, P191, DOI 10.1016/j.cvfa.2010.04.001; Poulsen KP, 2009, VET CLIN N AM-FOOD A, V25, P121, DOI 10.1016/j.cvfa.2008.10.007; Praveena PE, 2014, VET PATHOL, V51, P1109, DOI 10.1177/0300985813516647; Sarasola P, 2002, ANTIMICROB AGENTS CH, V46, P3013, DOI 10.1128/AAC.46.9.3013-3019.2002; Stern ST, 2016, DRUG METAB DISPOS, V44, P1934, DOI 10.1124/dmd.116.073148; TerHune TN, 2005, AM J VET RES, V66, P342, DOI 10.2460/ajvr.2005.66.342; Toutain PL, 2002, J VET PHARMACOL THER, V25, P460, DOI 10.1046/j.1365-2885.2002.00442.x; Villarino N, 2014, J VET PHARMACOL THER, V37, P211, DOI 10.1111/jvp.12080; Winther L, 2012, VET J, V193, P326, DOI 10.1016/j.tvjl.2012.02.010	44	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218864	10.1371/journal.pone.0218864	http://dx.doi.org/10.1371/journal.pone.0218864			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233558	gold, Green Published, Green Submitted			2022-12-26	WOS:000484896700046
J	Carlsson, T; Kukkola, L; Ljungman, L; Hoven, E; von Essen, L				Carlsson, Tommy; Kukkola, Laura; Ljungman, Lisa; Hoven, Emma; von Essen, Louise			Psychological distress in parents of children treated for cancer: An explorative study	PLOS ONE			English	Article							QUALITATIVE CONTENT-ANALYSIS; CHILDHOOD-CANCER; POSTTRAUMATIC-STRESS; INFORMATION NEEDS; RATING-SCALE; SURVIVORS; TERM; CARE; COMMUNICATION; GROWTH	Objective To explore psychological distress experienced by parents who express a need for psychotherapy after curative treatment for their child's cancer. Methods 15 parents (eight mothers and seven fathers) of children treated for cancer (median time since end of curative treatment: two years) were recruited via a pediatric oncology center. Each parent was interviewed twice and data was analyzed with inductive latent qualitative content analysis. Results Two overarching themes emerged. One theme, An unfamiliar and frightening situation during treatment, portrayed experiences during the treatment period, and included the sub-themes Initial reactions to the uncontrollable situation, Adjustment to the situation, and Focus on supporting the child. Another theme, Emotional struggles after end of curative treatment, portrayed experiences following curative treatment, and included the sub-themes Transitioning back to life as it was before the diagnosis, Emotional scars, Uncontrollable fears and worries of diseases, and New perspectives on life. Conclusions Parents of children with cancer experience existential, physical, psychological, and social struggles. They describe an unstable situation after diagnosis and having focused their attention towards protecting their child during treatment. After the end of curative treatment, they experience challenges with transitioning back to life as it was before the diagnosis and dealing with their own emotional scars and fears related to the child's cancer. The findings indicate an unmet need for psychological support among parents of children treated for cancer.	[Carlsson, Tommy; Kukkola, Laura; Hoven, Emma; von Essen, Louise] Uppsala Univ, Dept Womens & Childrens Hlth, Clin Psychol Healthcare, Uppsala, Sweden; [Carlsson, Tommy] Sophiahemmet Univ, Stockholm, Sweden; [Ljungman, Lisa] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden	Uppsala University; Sophiahemmet University; Karolinska Institutet	Hoven, E (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Clin Psychol Healthcare, Uppsala, Sweden.	emma.hoven@kbh.uu.se		Ljungman, Lisa/0000-0002-4512-8900; Hoven, Emma/0000-0001-9335-9714	Swedish Research Council [K2015-99X-20836-08-4]; Swedish Cancer Society [140790]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by funding to Louise von Essen from The Swedish Research Council (grant number K2015-99X-20836-08-4) and the Swedish Cancer Society (grant number 140790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker DA, 2001, PATIENT EDUC COUNS, V43, P61, DOI 10.1016/S0738-3991(00)00147-6; Bally JMG, 2014, J FAM NURS, V20, P287, DOI 10.1177/1074840714532716; Barakat LP, 2006, J PEDIATR PSYCHOL, V31, P413, DOI 10.1093/jpepsy/jsj058; Berg-Nielsen T.S., 2002, CLIN CHILD PSYCHOL P, V7, P529, DOI [10.1177/1359104502007004006, DOI 10.1177/1359104502007004006]; Bjork Maria, 2005, J Pediatr Oncol Nurs, V22, P265, DOI 10.1177/1043454205279303; Bousquet G, 2015, J CLIN ONCOL, V33, P2437, DOI 10.1200/JCO.2014.59.6759; Bruce M, 2006, CLIN PSYCHOL REV, V26, P233, DOI 10.1016/j.cpr.2005.10.002; CREAMER M, 1992, J ABNORM PSYCHOL, V101, P452, DOI 10.1037/0021-843X.101.3.452; Denollet J, 2009, J CLIN EPIDEMIOL, V62, P452, DOI 10.1016/j.jclinepi.2008.08.006; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Graneheim UH, 2017, NURS EDUC TODAY, V56, P29, DOI 10.1016/j.nedt.2017.06.002; Gustafsson G., 2013, CHILDHOOD CANC INCID; Hoven E, 2018, ACTA ONCOL, V57, P649, DOI 10.1080/0284186X.2017.1406136; Johansson R, 2013, PEERJ, V1, DOI 10.7717/peerj.98; Kearney JA, 2015, PEDIATR BLOOD CANCER, V62, pS632, DOI 10.1002/pbc.25761; Kukkola L, 2017, ACTA ONCOL, V56, P1705, DOI 10.1080/0284186X.2017.1374554; LaGarde G, 2010, PSYCHIAT RES, V177, P144, DOI 10.1016/j.psychres.2009.02.002; LERMAN C, 1993, CANCER, V72, P2612, DOI 10.1002/1097-0142(19931101)72:9<2612::AID-CNCR2820720916>3.0.CO;2-F; Ljungman L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157076; Ljungman L, 2015, PSYCHO-ONCOLOGY, V24, P1792, DOI 10.1002/pon.3856; Ljungman L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103340; Mckenzie SE, 2012, PSYCHO-ONCOLOGY, V21, P647, DOI 10.1002/pon.1953; Norberg AL, 2005, SOC SCI MED, V60, P965, DOI 10.1016/j.socscimed.2004.06.030; Norberg AL, 2007, J PSYCHOSOC ONCOL, V25, P113, DOI 10.1300/J077v25n03_07; Norberg AL, 2017, CANCER-AM CANCER SOC, V123, P1238, DOI 10.1002/cncr.30436; Ong LML, 2000, PATIENT EDUC COUNS, V41, P145, DOI 10.1016/S0738-3991(99)00108-1; Phipps S, 2015, J PEDIATR PSYCHOL, V40, P914, DOI 10.1093/jpepsy/jsv047; Phipps S, 2014, J CLIN ONCOL, V32, P641, DOI 10.1200/JCO.2013.49.8212; Picoraro JA, 2014, J PALLIAT MED, V17, P209, DOI 10.1089/jpm.2013.0280; Quin S, 2004, SOC WORK HEALTH CARE, V39, P129, DOI 10.1300/J010v39n01_09; Salters-Pedneault K, 2004, APPL PREV PSYCHOL, V11, P95, DOI 10.1016/j.appsy.2004.09.001; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sultan S, 2016, EUR J CANCER CARE, V25, P616, DOI 10.1111/ecc.12361; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Svanborg P, 2001, J AFFECT DISORDERS, V64, P203, DOI 10.1016/S0165-0327(00)00242-1; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vetsch J, 2017, PATIENT EDUC COUNS, V100, P355, DOI 10.1016/j.pec.2016.09.013; Vetsch J, 2015, PEDIATR BLOOD CANCER, V62, P859, DOI 10.1002/pbc.25418; Wakefield CE, 2011, PEDIATR BLOOD CANCER, V56, P524, DOI 10.1002/pbc.22725; Wikman A, 2018, ACTA ONCOL, V57, P950, DOI 10.1080/0284186X.2018.1445286	40	27	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218860	10.1371/journal.pone.0218860	http://dx.doi.org/10.1371/journal.pone.0218860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226159	gold, Green Published, Green Submitted			2022-12-26	WOS:000484894700047
J	Soesanti, F; Uiterwaal, CSPM; Grobbee, DE; Hendarto, A; Dalmeijer, GW; Idris, NS				Soesanti, Frida; Uiterwaal, Cuno S. P. M.; Grobbee, Diederick E.; Hendarto, Aryono; Dalmeijer, Geertje W.; Idris, Nikmah Salamia			Antenatal exposure to second hand smoke of non-smoking mothers and growth rate of their infants	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SECONDHAND SMOKE; BIRTH-WEIGHT; MATERNAL SMOKING; COTININE LEVEL; PREGNANCY; AGE; ASSOCIATION; OUTCOMES; CHILDREN	Objectives There is limited evidence on the effect of exposure to second hand smoke (SHS) in non-smoking pregnant mothers and infant health. We assessed the effects of maternal antenatal exposure to SHS on infant growth rate, and secondarily, on birth weight, birth length and head circumference at birth. Methods In this prospective cohort, 305 mother-infant pairs were studied. Mothers filled out questionnaires about exposure to SHS in pregnancy at the 3 rd trimester of pregnancy. Infant anthropometry was performed at birth, day 7, and months 1, 2, 4, and 6, postnatally. Linear mixed modeling and linear regression were used to calculate growth rates over the first 6 months. The association between SHS-exposure with growth rate and birth sizes was assessed using multivariate linear regression adjusted for confounders, with SHS as both number of cigarettes and as groups (no exposure, SHS < 23 cigarettes, SHS >= 23 cigarettes). Results Seventy-three mothers were not exposed and 232 were exposed. SHS exposure (per cigarette) was not related to gain in weight, length, head circumference, and weight for length. However, infants born to mothers exposed to >= 23 cigarettes/d had lower head circumference gain (-0.32 mm/m, 95% CI -0.60, -0.03) than those born to non-exposed mothers. SHS exposure (per cigarette) was not related to birth weight, length, and head circumference, but exposure to >= 23 cigarettes was related to lower head circumference at birth (-11.09 mm, -20.03, -2.16). Conclusions Heavy antenatal exposure to SHS in non-smoking mothers results in reduced neonatal head circumference at birth and head circumference gain over the first 6 months of life. Our findings show no clear relations between exposure to SHS during pregnancy and other markers of neonatal growth and birth size.	[Soesanti, Frida; Hendarto, Aryono; Idris, Nikmah Salamia] Univ Indonesia, Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Child Hlth, Jakarta, Indonesia; [Soesanti, Frida; Uiterwaal, Cuno S. P. M.; Grobbee, Diederick E.; Dalmeijer, Geertje W.; Idris, Nikmah Salamia] Univ Med Ctr, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Idris, Nikmah Salamia] Pulm Hypertens Unit, London, England	University of Indonesia; Utrecht University; Utrecht University Medical Center	Soesanti, F (corresponding author), Univ Indonesia, Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Child Hlth, Jakarta, Indonesia.; Soesanti, F (corresponding author), Univ Med Ctr, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	fridasoesanti@ikafkui.net	Soesanti, Frida/AAB-3107-2019; Grobbee, Diederick/C-7651-2014	Soesanti, Frida/0000-0002-4319-5528; Grobbee, Diederick/0000-0003-4472-4468				Abdullah B, 2017, EUR J OBSTET GYN R B, V214, P86, DOI 10.1016/j.ejogrb.2017.05.002; Baheiraei Azam, 2015, Acta Med Iran, V53, P39; Banderali G, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0690-y; Braun JM, 2010, PAEDIATR PERINAT EP, V24, P524, DOI 10.1111/j.1365-3016.2010.01146.x; Chen RL, 2013, ANN EPIDEMIOL, V23, P652, DOI 10.1016/j.annepidem.2013.07.001; Ekblad M, 2010, J PEDIATR-US, V156, P185, DOI 10.1016/j.jpeds.2009.07.061; Evelein AMV, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/141656; Evelein AMV, 2013, J CLIN ENDOCR METAB, V98, P794, DOI 10.1210/jc.2012-3208; Hawsawi AM, 2015, RESP CARE, V60, P135, DOI 10.4187/respcare.02798; Hegaard HK, 2006, ACTA OBSTET GYN SCAN, V85, P675, DOI 10.1080/00016340600607032; Inoue S, 2017, J PUBLIC HEALTH-UK, V39, P557, DOI 10.1093/pubmed/fdw050; Johnson L, 2014, INT J OBESITY, V38, P980, DOI 10.1038/ijo.2014.61; Kanellopoulos TA, 2007, EUR J PEDIATR, V166, P685, DOI 10.1007/s00431-006-0308-8; Kyu HH, 2009, INT J EPIDEMIOL, V38, P1342, DOI 10.1093/ije/dyp253; Lee NL, 2012, INT J ENV RES PUB HE, V9, P3398, DOI 10.3390/ijerph9103398; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Leonardi-Bee J, 2011, PEDIATRICS, V127, P734, DOI 10.1542/peds.2010-3041; Moore BF, 2017, PEDIATR OBES, V12, P111, DOI 10.1111/ijpo.12233; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Peacock JL, 1998, INT J EPIDEMIOL, V27, P647, DOI 10.1093/ije/27.4.647; Raum E, 2011, OBESITY, V19, P2411, DOI 10.1038/oby.2011.129; Roza SJ, 2007, EUR J NEUROSCI, V25, P611, DOI 10.1111/j.1460-9568.2007.05393.x; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Savitri AI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1397-y; Wahabi HA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1058; Windham GC, 1999, PAEDIATR PERINAT EP, V13, P35, DOI 10.1046/j.1365-3016.1999.00150.x; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Yilmaz G, 2009, PEDIATR INT, V51, P352, DOI 10.1111/j.1442-200X.2008.02757.x; Zhou S, 2014, CURR PROB PEDIATR AD, V44, P219, DOI 10.1016/j.cppeds.2014.03.007	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218577	10.1371/journal.pone.0218577	http://dx.doi.org/10.1371/journal.pone.0218577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220162	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500068
J	Hu, YM; Boehm, DM; Chung, H; Wilson, S; Bird, AJ				Hu, Ya-Mei; Boehm, Derek M.; Chung, Hak; Wilson, Stevin; Bird, Amanda J.			Zinc-dependent activation of the Pho8 alkaline phosphatase in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						yeast genetics; transport metal; protein stability; protein processing; gene expression; cation diffusion facilitator; hypophosphatemia; metal homeostasis; transition metal; zinc transport	GENE-EXPRESSION; IRON-DEFICIENCY; TRANSPORTERS; HOMEOSTASIS; COPPER; METAL; PROTEINS; TURNOVER; BINDING; LOZ1	Genome-wide analyses have revealed that during metal ion starvation, many cells undergo programmed changes in their transcriptome or proteome that lower the levels of abundant metalloproteins, conserving metal ions for more critical functions. Here we investigated how changes in cellular zinc status affect the expression and activity of the zinc-requiring Pho8 alkaline phosphatase from fission yeast (Schizosaccharomyces pombe). In S. pombe, Pho8 is a membrane-tethered and processed glycoprotein that resides in the vacuole. Using alkaline phosphatase activity assays along with various biochemical analyses, we found that Pho8 is active when zinc is plentiful and inactive when zinc is limited. Although Pho8 activity depended on zinc, we also found that higher levels of pho8 mRNAs and Pho8 protein accumulate in zinc-deficient cells. To gain a better understanding of the inverse relationship between pho8 mRNA levels and Pho8 activity, we examined the effects of zinc on the stability and processing of the Pho8 protein. We show that Pho8 is processed regardless of zinc status and that mature Pho8 accumulates under all conditions. We also noted that alkaline phosphatase activity is rapidly restored when zinc is resupplied to cells, even in the presence of the protein synthesis inhibitor cycloheximide. Our results suggest that S. pombe cells maintain inactive pools of Pho8 proteins under low-zinc conditions and that these pools facilitate rapid restoration of Pho8 activity when zinc ions become available.	[Hu, Ya-Mei; Bird, Amanda J.] Ohio State Univ, Dept Human Nutr, 1787 Neil Ave, Columbus, OH 43210 USA; [Boehm, Derek M.; Wilson, Stevin; Bird, Amanda J.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Chung, Hak] Ohio State Univ, Interdisciplinary Nutr Program, Columbus, OH 43210 USA; [Bird, Amanda J.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bird, AJ (corresponding author), Ohio State Univ, Dept Human Nutr, 1787 Neil Ave, Columbus, OH 43210 USA.	bird.96@osu.edu	Bird, Amanda Jane/ABD-2295-2021	Bird, Amanda Jane/0000-0002-1846-7050; Hu, Ya-Mei/0000-0002-2575-1770; Wilson, Stevin/0000-0002-9662-5501	National Institutes of Health [RO1 GM105695]; Office of the Director of the National Institutes of Health [S10OD023582]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105695] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant RO1 GM105695 (to A. J. B.) and by the Office of the Director of the National Institutes of Health under Award S10OD023582. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bird AJ, 2015, J NUTR BIOCHEM, V26, P1103, DOI 10.1016/j.jnutbio.2015.08.002; Boch A, 2008, FEMS YEAST RES, V8, P883, DOI 10.1111/j.1567-1364.2008.00414.x; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Choi S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007262; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Corkins ME, 2013, P NATL ACAD SCI USA, V110, P15371, DOI 10.1073/pnas.1300853110; Ehrensberger KM, 2014, J BIOL CHEM, V289, P18087, DOI 10.1074/jbc.M114.551333; Ehrensberger KM, 2013, J BIOL CHEM, V288, P759, DOI 10.1074/jbc.M112.406165; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Fujimoto S, 2016, BIOCHEM J, V473, P2611, DOI 10.1042/BCJ20160324; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; Idiris A, 2006, APPL MICROBIOL BIOT, V73, P404, DOI 10.1007/s00253-006-0489-0; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; Li M, 2015, J CELL BIOL, V211, P639, DOI 10.1083/jcb.201505062; Lock A, 2019, NUCLEIC ACIDS RES, V47, pD821, DOI 10.1093/nar/gky961; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; MacDiarmid CW, 2013, J BIOL CHEM, V288, P31313, DOI 10.1074/jbc.M113.512384; Mann KJ, 2001, BIOCHEMISTRY-US, V40, P1205, DOI 10.1021/bi0024512; Martinez-Pastor M, 2013, MOL CELL BIOL, V33, P2178, DOI 10.1128/MCB.01458-12; MERCHANT S, 1987, EMBO J, V6, P2531, DOI 10.1002/j.1460-2075.1987.tb02540.x; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Mukaiyama H, 2011, APPL MICROBIOL BIOT, V90, P203, DOI 10.1007/s00253-010-3031-3; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Nunez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121059; Palm-Espling ME, 2012, BBA-MOL CELL RES, V1823, P1594, DOI 10.1016/j.bbamcr.2012.01.013; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Qiao W, 2009, MOL MICROBIOL, V72, P320, DOI 10.1111/j.1365-2958.2009.06644.x; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; SAMBROOK J, 2000, MOL CLONING LAB MANU; Smith AD, 2017, ANNU REV MICROBIOL, V71, P597, DOI 10.1146/annurev-micro-030117-020444; Solovyov A, 2004, PROTEIN SCI, V13, P1902, DOI 10.1110/ps.04716104; Wang YR, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00269j; Wilson S, 2016, ARCH BIOCHEM BIOPHYS, V611, P30, DOI 10.1016/j.abb.2016.02.031	41	3	3	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12392	12404		10.1074/jbc.RA119.007371	http://dx.doi.org/10.1074/jbc.RA119.007371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31239353	Green Published, hybrid			2022-12-26	WOS:000484402700012
J	Yu, QF; Gratzke, C; Wang, RX; Li, BS; Kuppermann, P; Herlemann, A; Tamalunas, A; Wang, YM; Rutz, B; Ciotkowska, A; Wang, XL; Strittmatter, F; Waidelich, R; Stief, CG; Hennenberg, M				Yu, Qingfeng; Gratzke, Christian; Wang, Ruixiao; Li, Bingsheng; Kuppermann, Paul; Herlemann, Annika; Tamalunas, Alexander; Wang, Yiming; Rutz, Beata; Ciotkowska, Anna; Wang, Xiaolong; Strittmatter, Frank; Waidelich, Raphaela; Stief, Christian G.; Hennenberg, Martin			A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						smooth muscle; pharmacology; molecular pharmacology; adrenergic receptor; small GTPase; ADP ribosylation factor (ARF); benign prostatic hyperplasia; lower urinary tract symptoms; prostate; NAV2729; smooth muscle contraction; benign prostatic hyperplasia (BPH); lower urinary tract symptoms (LUTS)	RHO-KINASE; G-PROTEINS; ARF6; INHIBITION; HYPERPLASIA; ACTIVATION; RAC1; PROLIFERATION; THERAPY; GTPASE	Voiding symptoms in benign prostatic hyperplasia (BPH) are driven by prostate smooth muscle contraction and prostate growth. Smooth muscle contraction in the prostate and other organs critically depends on activation of the small monomeric GTPase RhoA and probably Rac1. A role of another GTPase, ADP-ribosylation factor 6 (ARF6), for smooth muscle contraction has been recently suggested by indirect evidence but remains to be proven for any organ. Here, we report effects of NAV2729, an inhibitor with assumed specificity for ARF6, in human prostate tissues and cultured prostate stromal cells (WPMY-1). NAV2729 (5 mu m) inhibited neurogenic and alpha(1)-adrenergic contractions of human prostate tissues. Contractions induced by endothelin-1, by the thromboxane A(2) agonist U46619, or by high molar KCl were not inhibited. Correlation analyses suggested up-regulation of prostatic ARF6 expression with increasing degree of BPH, as ARF6 expression increased with the content of prostate-specific antigen (PSA) of prostate tissues. NAV2729 inhibited ARF6 activity but not other GTPases (ARF1, RhoA, Rac1) in prostate tissues and in WPMY-1 cells. Proliferation of WPMY-1 cells was inhibited concentration-dependently by NAV2726, as reflected by decreased viability, 5-ethynyl-2 '-deoxyuridine (EdU) assay, colony formation assay, and expression of Ki-67. Silencing of ARF6 expression mimicked effects of NAV2729 on viability and in the EdU assay. Effects of NAV2729 on viability and proliferation were attenuated in cells with silenced ARF6 expression. Our findings suggest that a NAV2729-sensitive mechanism promotes adrenergic contraction and stromal cell growth in the human prostate, which is probably ARF6-mediated. Similar actions in other organs and urodynamic effects of NAV2729 appear possible.	[Yu, Qingfeng; Gratzke, Christian; Wang, Ruixiao; Li, Bingsheng; Kuppermann, Paul; Herlemann, Annika; Tamalunas, Alexander; Wang, Yiming; Rutz, Beata; Ciotkowska, Anna; Wang, Xiaolong; Strittmatter, Frank; Waidelich, Raphaela; Stief, Christian G.; Hennenberg, Martin] Ludwig Maximilians Univ Munchen, Dept Urol, Univ Hosp, D-81377 Munich, Germany; [Yu, Qingfeng] Guangzhou Med Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510230, Guangdong, Peoples R China; [Yu, Qingfeng] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Key Lab Urol, Guangzhou 510230, Guangdong, Peoples R China; [Gratzke, Christian] Univ Freiburg, Dept Urol, D-79106 Freiburg, Germany	University of Munich; Guangzhou Medical University; Guangzhou Medical University; University of Freiburg	Hennenberg, M (corresponding author), Urol Forschungslab, Feodor Lynen Str 19, D-81377 Munich, Germany.	martin.hennenberg@med.uni-muenchen.de	li, bing/GWQ-9617-2022; Tamalunas, Alexander/AAW-3850-2021	Tamalunas, Alexander/0000-0002-4659-2262; Stief, Christian/0000-0003-3291-9460	Deutsche Forschungsgemeinschaft [HE 5825/2-1, GR 3333/2-1]; Chinese Scholarship Council (CSC); Friedrich-Baur-Stiftung [71/16]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chinese Scholarship Council (CSC)(China Scholarship Council); Friedrich-Baur-Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Grants HE 5825/2-1 and GR 3333/2-1, the Chinese Scholarship Council (CSC), and Friedrich-Baur-Stiftung Grant 71/16. The authors declare that they have no conflicts of interest with the contents of this article.	Alcaraz A, 2009, EUR UROL, V55, P864, DOI 10.1016/j.eururo.2008.11.011; Andre-Gregoire G, 2018, J ALLERGY CLIN IMMUN, V142, P824, DOI 10.1016/j.jaci.2017.09.049; Benabdi S, 2017, BIOCHEMISTRY-US, V56, P5125, DOI 10.1021/acs.biochem.7b00706; Bond M, 2008, CARDIOVASC RES, V80, P290, DOI 10.1093/cvr/cvn188; Bourmoum M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148097; Charles R, 2016, J BIOL CHEM, V291, P3967, DOI 10.1074/jbc.M115.684357; Chiba Y, 2010, J PHARMACOL SCI, V114, P239, DOI 10.1254/jphs.10R03CR; Christ GJ, 2007, NEUROUROL URODYNAM, V26, P948, DOI 10.1002/nau.20475; Chughtai B, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.31; Cindolo L, 2015, EUR UROL, V68, P418, DOI 10.1016/j.eururo.2014.11.006; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Dahma P, 2017, EUR UROL, V71, P570, DOI 10.1016/j.eururo.2016.09.032; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Hennenberg M, 2017, PROSTATE, V77, P697, DOI 10.1002/pros.23293; Hennenberg M, 2014, NEUROUROL URODYNAM, V33, P1074, DOI 10.1002/nau.22467; Hennenberg M, 2013, AM J PHYSIOL-RENAL, V305, pF1383, DOI 10.1152/ajprenal.00380.2013; Herlemann A, 2018, AM J PHYSIOL-RENAL, V314, pF47, DOI 10.1152/ajprenal.00125.2017; Hongu Tsunaki, 2014, Advances in Biological Regulation, V54, P59, DOI 10.1016/j.jbior.2013.09.014; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Koumakpayi IH, 2011, MOL CARCINOGEN, V50, P901, DOI 10.1002/mc.20766; Levitt Jonathan M, 2007, Curr Urol Rep, V8, P269, DOI 10.1007/s11934-007-0072-y; Li R, 2017, LIFE SCI, V182, P80, DOI 10.1016/j.lfs.2017.06.008; Loirand Gervaise, 2014, Small GTPases, V5, P1, DOI 10.4161/sgtp.28846; Madersbacher S, 2007, EUR UROL, V51, P1522, DOI 10.1016/j.eururo.2007.03.034; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Orsted DD, 2013, NAT REV UROL, V10, P49, DOI 10.1038/nrurol.2012.192; Pradidarcheep Wisuit, 2011, Handb Exp Pharmacol, P117, DOI 10.1007/978-3-642-16499-6_7; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Rattan S, 2010, GASTROENTEROLOGY, V138, P13, DOI 10.1053/j.gastro.2009.11.016; Rees RW, 2003, J UROLOGY, V170, P2517, DOI 10.1097/01.ju.0000085024.47406.6c; Sakai H, 2018, EUR J PHARMACOL, V818, P74, DOI 10.1016/j.ejphar.2017.10.032; Shaikhibrahim Z, 2012, MOL MED REP, V5, P313, DOI 10.3892/mmr.2011.647; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Strand DW, 2017, DIFFERENTIATION, V96, P49, DOI 10.1016/j.diff.2017.07.005; Ventura S, 2011, BRIT J PHARMACOL, V163, P891, DOI 10.1111/j.1476-5381.2011.01332.x; Wang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107593; Wang Y, 2015, BRIT J PHARMACOL, V172, P2905, DOI 10.1111/bph.13099; Wang YM, 2016, BRIT J PHARMACOL, V173, P3342, DOI 10.1111/bph.13623; Yamauchi Yohei, 2017, Advances in Biological Regulation, V63, P115, DOI 10.1016/j.jbior.2016.10.004; Yoo JH, 2019, CANCER RES, V79, P2892, DOI 10.1158/0008-5472.CAN-18-3026; Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015	42	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12231	12249		10.1074/jbc.RA119.007958	http://dx.doi.org/10.1074/jbc.RA119.007958			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31243101	hybrid, Green Published			2022-12-26	WOS:000484284500025
J	Jost, F; Schalk, E; Rinke, K; Fischer, T; Sager, S				Jost, Felix; Schalk, Enrico; Rinke, Kristine; Fischer, Thomas; Sager, Sebastian			Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED NEUTROPENIA; COLONY-STIMULATING-FACTOR; G-CSF; PHARMACOKINETIC/PHARMACODYNAMIC MODEL; HUMAN GRANULOPOIESIS; PHARMACOLOGY MODELS; GROWTH-FACTOR; DYNAMICS; THERAPY; TRANSIT	We investigate the personalisation and prediction accuracy of mathematical models for white blood cell (WBC) count dynamics during consolidation treatment using intermediate or high-dose cytarabine (Ara-C) in acute myeloid leukaemia (AML). Ara-C is the clinically most relevant cytotoxic agent for AML treatment. We extend a mathematical model of myelosuppression and a pharmacokinetic model of Ara-C with different hypotheses of Ara-C's pharmacodynamic effects. We cross-validate the 12 model variations using dense WBC count measurements from 23 AML patients. Surprisingly, the prediction accuracy remains satisfactory in each of the models despite different modelling hypotheses. Therefore, we compare average clinical and calculated WBC recovery times for different Ara-C schedules as a successful methodology for model discrimination. As a result, a new hypothesis of a secondary pharmacodynamic effect on the proliferation rate seems plausible. Furthermore, we demonstrate the impact of treatment timing on subsequent nadir values based on personalised predictions as a possibility for influencing/controlling myelosuppression.	[Jost, Felix; Rinke, Kristine; Sager, Sebastian] Otto von Guericke Univ, Fac Math, Inst Math Optimizat, Magdeburg, Germany; [Schalk, Enrico; Fischer, Thomas] Otto von Guericke Univ, Dept Hematol & Oncol, Univ Med Ctr, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Jost, F (corresponding author), Otto von Guericke Univ, Fac Math, Inst Math Optimizat, Magdeburg, Germany.	felix.jost@ovgu.de	Schalk, Enrico/X-9283-2019	Schalk, Enrico/0000-0003-1892-5098; Sager, Sebastian/0000-0002-0283-9075	European Research Council (ERC) under the European Unions Horizon 2020 research and innovation programme [647573]; "International Max Planck Research School (IMPRS) for Advanced Methods in Process and System Engineering" in Magdeburg	European Research Council (ERC) under the European Unions Horizon 2020 research and innovation programme(European Research Council (ERC)); "International Max Planck Research School (IMPRS) for Advanced Methods in Process and System Engineering" in Magdeburg	This project has received funding from the European Research Council (ERC) under the European Unions Horizon 2020 research and innovation programme (grant agreement No 647573) and from the "International Max Planck Research School (IMPRS) for Advanced Methods in Process and System Engineering" in Magdeburg.	Andersson J., 2013, GEN PURPOSE SOFTWARE; [Anonymous], [No title captured]; BATINIC D, 1990, BONE MARROW TRANSPL, V6, P103; Brown G, 2007, TRENDS IMMUNOL, V28, P442, DOI 10.1016/j.it.2007.07.007; Clairambault J, 2009, MATH MODEL NAT PHENO, V4, P12, DOI 10.1051/mmnp/20094302; Craig M, 2017, CPT-PHARMACOMET SYST, V6, P293, DOI 10.1002/psp4.12191; Craig M, 2016, B MATH BIOL, V78, P2304, DOI 10.1007/s11538-016-0179-8; Craig M, 2015, J THEOR BIOL, V385, P77, DOI 10.1016/j.jtbi.2015.08.015; De Souza DC, 2018, J PHARMACOKINET PHAR, V45, P59, DOI 10.1007/s10928-017-9560-y; Derendorf H, 1999, PHARMACEUT RES, V16, P176, DOI 10.1023/A:1011907920641; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Engel C, 2004, BLOOD, V104, P2323, DOI 10.1182/blood-2004-01-0306; Evans ND, 2018, J PHARMACOKINET PHAR, V45, P79, DOI 10.1007/s10928-018-9569-x; Felmlee Melanie A, 2012, Methods Mol Biol, V929, P583; Fornari C, 2018, CLIN PHARMACOL THER, V104, P644, DOI 10.1002/cpt.1080; Henrich A, 2017, J PHARMACOL EXP THER, V362, P347, DOI 10.1124/jpet.117.240309; Herold N, 2017, NAT MED, V23, P256, DOI 10.1038/nm.4265; Hing J, 2008, CLIN PHARMACOL THER, V83, P130, DOI 10.1038/sj.clpt.6100259; Hoffbrand AV, 2016, POSTGRADUATE HAEMATOLOGY, 7TH EDITION, P1; Jacqmin P, 2007, J PHARMACOKINET PHAR, V34, P57, DOI 10.1007/s10928-006-9035-z; Jaramillo S, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.45; Jost F, 2017, PROCESSES, V5, DOI 10.3390/pr5010010; Kavgaci H, 2002, J EXP CLIN CANC RES, V21, P475; Kern W, 1997, CANCER-AM CANCER SOC, V79, P59, DOI 10.1002/(SICI)1097-0142(19970101)79:1<59::AID-CNCR9>3.3.CO;2-T; Kloft C, 2006, CLIN CANCER RES, V12, P5481, DOI 10.1158/1078-0432.CCR-06-0815; Krogh-Madsen M, 2012, CANCER CHEMOTH PHARM, V69, P1155, DOI 10.1007/s00280-011-1800-z; Li Z, 2017, MOLECULES, V22, DOI 10.3390/molecules22030499; Lowenberg B, 2011, NEW ENGL J MED, V364, P1027, DOI 10.1056/NEJMoa1010222; Malka R, 2012, J CLIN INVEST, V122, P3002, DOI 10.1172/JCI59832; Manesso E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0817; Mangas-Sanjuan V, 2015, J PHARMACOL EXP THER, V354, P55, DOI 10.1124/jpet.115.223776; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; MENDOZA JF, 1990, EXP HEMATOL, V18, P903; Minami H, 1998, CLIN PHARMACOL THER, V64, P511, DOI 10.1016/S0009-9236(98)90134-5; NETTERBERG I, 2017, CANCER CHEMOTH PHARM, P1; Nock V., 2013, THESIS; Ostby I, 2003, J MATH BIOL, V47, P101, DOI 10.1007/s00285-003-0198-6; Owen J., 2014, INTRO POPULATION PHA; Pefani E, 2014, IEEE T BIO-MED ENG, V61, P2049, DOI 10.1109/TBME.2014.2313226; Pefani E, 2013, COMPUT CHEM ENG, V57, P187, DOI 10.1016/j.compchemeng.2013.02.003; Perry MC, 2012, CHEMOTHERAPY SOURCE; PLUNKETT W, 1987, CANCER RES, V47, P3005; Quartino A., 2011, THESIS; Quartino AL, 2014, PHARM RES-DORDR, V31, P3390, DOI 10.1007/s11095-014-1429-9; Quartino AL, 2012, INVEST NEW DRUG, V30, P833, DOI 10.1007/s10637-010-9603-3; Rinke K, 2016, IFAC PAPERSONLINE, V49, P44, DOI 10.1016/j.ifacol.2016.12.101; Savic RM, 2007, J PHARMACOKINET PHAR, V34, P711, DOI 10.1007/s10928-007-9066-0; Schenkendorf R, 2018, PROCESSES, V6, DOI 10.3390/pr6040027; Scholz M, 2005, J MATH BIOL, V50, P397, DOI 10.1007/s00285-004-0295-1; Solans BP, 2018, CLIN PHARMACOKINET, V57, P379, DOI 10.1007/s40262-017-0566-9; Stiehl T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21115-4; Takatani H, 1996, ANTIMICROB AGENTS CH, V40, P988, DOI 10.1128/AAC.40.4.988; Tetschke M, 2018, PROCESSES, V6, DOI 10.3390/pr6090157; Vainas O, 2012, BRIT J CANCER, V107, P814, DOI 10.1038/bjc.2012.316; Wallin JE, 2010, BASIC CLIN PHARMACOL, V106, P234, DOI 10.1111/j.1742-7843.2009.00520.x; Wang WW, 2017, HAEMATOLOGICA, V102, P1567, DOI 10.3324/haematol.2016.163584	58	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0204540	10.1371/journal.pone.0204540	http://dx.doi.org/10.1371/journal.pone.0204540			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260449	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700002
J	Lee, S; Sergeeva, LI; Vreugdenhil, D				Lee, Sangseok; Sergeeva, Lidiya I.; Vreugdenhil, Dick			Quantitative trait loci analysis of hormone levels in Arabidopsis roots	PLOS ONE			English	Article							NATURAL ALLELIC VARIATION; GENE-EXPRESSION; FLOWERING TIME; QTL ANALYSIS; CYTOKININ; THALIANA; AUXIN; PATHWAY; ACID; REVEALS	Quantitative trait loci ( QTL) analyses for five groups of hormones, including cytokinins in Arabidopsis roots were performed using recombinant inbred lines ( LerxCvi). Significant QTLs were detected for cytokinins, jasmonic acid and salicylic acid. Separate analysis of two sub-populations, viz., vegetative and flowering plants revealed that many of the QTLs were development-specific. Using near-isogenic lines, several significant QTLs were confirmed; three co-localized QTL regions were responsible for determining several cytokinin metabolites. Using a knock-out plant, a functional role of zeatin N-glucosyltransferase gene ( UGT76C2) underlying a large-effect QTL for levels of tZ-N-glucosides and tZRMP was evaluated in the metabolism of cytokinins. Pleotropic effects of this gene were found for cytokinin levels in both roots and leaves, but significant changes of morphological traits were observed only in roots. Hormone QTL analysis reveals development-specific and organ-dependent aspects of the regulation of plant hormone content and metabolism.	[Lee, Sangseok; Sergeeva, Lidiya I.; Vreugdenhil, Dick] Wageningen Univ & Res, Lab Plant Physiol, Wageningen, Netherlands; [Lee, Sangseok] Organ Agr Res Inst, Gyeongsangbuk Do Agr Res & Extens Serv Ctr, Uiseong, Gyeongbuk, South Korea	Wageningen University & Research	Lee, S (corresponding author), Wageningen Univ & Res, Lab Plant Physiol, Wageningen, Netherlands.; Lee, S (corresponding author), Organ Agr Res Inst, Gyeongsangbuk Do Agr Res & Extens Serv Ctr, Uiseong, Gyeongbuk, South Korea.	lsseok@korea.kr		Lee, Sangseok/0000-0002-8804-6745	Lab of Plant Physiology, Wageningen University (WUR), The Netherlands; GBARES, South Korea	Lab of Plant Physiology, Wageningen University (WUR), The Netherlands(Netherlands Government); GBARES, South Korea	The study of the submitted article was funded by Lab of Plant Physiology, Wageningen University (WUR), to DV, The Netherlands, and partly supported by GBARES, South Korea, as abroad-training of official duty for S. Lee. There was no specific grant number for it.	Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Alonso-Blanco C, 1998, GENETICS, V149, P749; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; ALVIM R, 1978, PLANT PHYSIOL, V62, P779, DOI 10.1104/pp.62.5.779; Antoniadi I, 2015, PLANT CELL, V27, P1955, DOI 10.1105/tpc.15.00176; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Bentsink L, 2003, THEOR APPL GENET, V106, P1234, DOI 10.1007/s00122-002-1177-9; Bentsink L, 2010, P NATL ACAD SCI USA, V107, P4264, DOI 10.1073/pnas.1000410107; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chayut N, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0661-8; Dobon A, 2011, PLANTA, V234, P671, DOI 10.1007/s00425-011-1436-6; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Han YP, 2011, THEOR APPL GENET, V122, P1481, DOI 10.1007/s00122-011-1547-2; Harpaz-Saad S, 2007, PLANT CELL, V19, P1007, DOI 10.1105/tpc.107.050633; Hasunuma T, 2010, J EXP BOT, V61, P1041, DOI 10.1093/jxb/erp374; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kollmer I, 2014, PLANT J, V78, P359, DOI 10.1111/tpj.12477; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Korstanje R, 2002, NAT GENET, V31, P235, DOI 10.1038/ng0702-235; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Lee S, 2018, J INTEGR PLANT BIOL, V60, P292, DOI 10.1111/jipb.12617; Leon S, 1998, CHEM PHYS LETT, V296, P292, DOI 10.1016/S0009-2614(98)01070-7; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Nonomura AM, 2011, J PLANT NUTR, V34, P653, DOI 10.1080/01904167.2011.540622; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; Novakova M, 2005, J EXP BOT, V56, P2877, DOI 10.1093/jxb/eri282; Ooijen V., 2004, SOFTWARE MAPPING QUA; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Pfalz M, 2009, PLANT CELL, V21, P985, DOI 10.1105/tpc.108.063115; Powell AE, 2013, PLANT PHYSIOL BIOCH, V64, P33, DOI 10.1016/j.plaphy.2012.12.010; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sergeeva LI, 2006, P NATL ACAD SCI USA, V103, P2994, DOI 10.1073/pnas.0511015103; Sergeeva LI, 2004, PLANT PHYSIOL, V134, P237, DOI 10.1104/pp.103.027615; Smehilova M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01264; Spiess GM, 2014, PLANT PHYSIOL, V165, P1092, DOI 10.1104/pp.114.236026; Tanaka K, 2014, PLANT CELL PHYSIOL, V55, P218, DOI 10.1093/pcp/pct173; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Tuberosa R, 1998, THEOR APPL GENET, V97, P744, DOI 10.1007/s001220050951; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; Wang J, 2011, PLANT CELL PHYSIOL, V52, P2200, DOI 10.1093/pcp/pcr152; Wang XD, 2015, THEOR APPL GENET, V128, P1175, DOI 10.1007/s00122-015-2498-9; Weng YQ, 2015, THEOR APPL GENET, V128, P1747, DOI 10.1007/s00122-015-2544-7; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xing LB, 2015, PLANT CELL PHYSIOL, V56, P2052, DOI 10.1093/pcp/pcv124; Yamaguchi N, 2014, SCIENCE, V344, P638, DOI 10.1126/science.1250498; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhao ZG, 2013, DEV CELL, V27, P113, DOI 10.1016/j.devcel.2013.09.005	51	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219008	10.1371/journal.pone.0219008	http://dx.doi.org/10.1371/journal.pone.0219008			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251768	gold, Green Published, Green Submitted			2022-12-26	WOS:000484915000034
J	Obiri-Yeboah, D; Awuku, YA; Adjei, G; Cudjoe, O; Benjamin, AH; Obboh, E; Amoako-Sakyi, D				Obiri-Yeboah, Dorcas; Awuku, Yaw Asante; Adjei, George; Cudjoe, Obed; Benjamin, Anna Hayfron; Obboh, Evans; Amoako-Sakyi, Daniel			Post Hepatitis B vaccination sero-conversion among health care workers in the Cape Coast Metropolis of Ghana	PLOS ONE			English	Article							IMMUNE-RESPONSE; VIRUS INFECTION; PERSISTENCE; SEROPREVALENCE; PROTECTION; ANTIBODY; MEMORY	Background HBV vaccine is known to offer protection against transmission of HBV infection. Health care workers are mandated to have this vaccination as part of their occupational health safety measures. Post vaccination response data for HCWs in our setting is not available. This study therefore aimed to evaluate the anti-HBs titre levels after Hepatitis B vaccination among HCWs from selected heath facilities in the Cape Coast Metropolis, Ghana. Methods A multicenter (3 selected sites) analytical cross-sectional study involving 711 HCWs was conducted. Five (5mls) of blood samples were collected from each study participant and the serum used for HBV immunological profile testing anti-HBs quantification by ELISA test (Fortress Diagnostics Limited, Northern Ireland, United Kingdom). Data analyses were performed using Stata version 14.0 software (STATA Corp, Texas USA). Results The median age of participants was 29 years (IQR = 26-35 years). Majority (80.9%, n = 575) took their vaccination from Government health facilities compared with 19.1% (n = 136) from private vaccination sources. A total of 7 (3 males and 4 females) were found to be HBsAg positive giving prevalence of 1%. In all, 8.2% (n = 58) of the HCWs had anti-HBs titre levels <10IU/ml giving a sero-protection rate of 91.8%. HCWs who received 3 doses of HBV vaccine were more likely to be sero-protected as compared to those who received only one dose in multivariate analysis (aOR = 3.39, 95% CI: 1.08-10.67), p< 0.037). Gender, cigarette smoking and alcohol consumption were not found to be associated with seroprotection. Conclusion There is a high HBV vaccine efficacy among HCWs in the Cape Coast Metropolis of Ghana with higher prevalence of anti-HBs titre level associated with full vaccine dose adherence. Post vaccination antibody titre determination could be an integral part of HBV vaccination protocol for HCWs in Ghana.	[Obiri-Yeboah, Dorcas; Cudjoe, Obed; Obboh, Evans; Amoako-Sakyi, Daniel] Univ Cape Coast, Sch Med Sci, Dept Microbiol & Immunol, Cape Coast, Ghana; [Awuku, Yaw Asante] Univ Cape Coast, Sch Med Sci, Dept Internal Med & Therapeut, Cape Coast, Ghana; [Adjei, George] Univ Cape Coast, Sch Med Sci, Dept Community Med, Cape Coast, Ghana; [Benjamin, Anna Hayfron] Univ Cape Coast, Sch Nursing & Midwifery, Dept Maternal & Child Hlth, Cape Coast, Ghana	University of Cape Coast; University of Cape Coast; University of Cape Coast; University of Cape Coast	Obiri-Yeboah, D (corresponding author), Univ Cape Coast, Sch Med Sci, Dept Microbiol & Immunol, Cape Coast, Ghana.	dobiri-yeboah@ucc.edu.gh	Obiri-Yeboah, Dorcas/AAE-7672-2019	OBIRI-YEBOAH, DORCAS/0000-0003-4562-9294	Directorate of Research, Innovation and Consultancy (DRIC), University of Cape Coast, Ghana [RSG/INT/CoHAS/2018/101]	Directorate of Research, Innovation and Consultancy (DRIC), University of Cape Coast, Ghana	The Directorate of Research, Innovation and Consultancy (DRIC), University of Cape Coast, Ghana grant RSG/INT/CoHAS/2018/101 to DO-Y provided some financial support for this work. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaron D, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2893-8; Abe M, 2006, HEPATOL RES, V35, P1, DOI 10.1016/j.hepres.2006.02.010; Auta A, 2018, VACCINE, V36, P4851, DOI 10.1016/j.vaccine.2018.06.043; Ayerbe MC, 2001, EUR J EPIDEMIOL, V17, P151, DOI 10.1023/A:1017922302854; Biset Ayalew M, 2017, HEPATITIS RES TREATM, V2017, P8; Biswas R.S.R., 2015, J SCI SOC, V42, P176, DOI [10.4103/0974-5009.165561, DOI 10.4103/0974-5009.165561]; Borch A., 2017, COCHRANE DATABASE SY; Bruce MG, 2016, J INFECT DIS, V214, P16, DOI 10.1093/infdis/jiv748; CDC, 2011, IMM HLTH CAR PERS RE; Chathuranga LS, 2013, INT J INFECT DIS, V17, pE1078, DOI 10.1016/j.ijid.2013.04.009; Chaves SS, 2012, VACCINE, V30, P1644, DOI 10.1016/j.vaccine.2011.12.106; Elzouki AN, 2014, J INFECT PUBLIC HEAL, V7, P534, DOI 10.1016/j.jiph.2014.07.006; Gilca V, 2010, HUM VACCINES, V6, P212, DOI 10.4161/hv.6.2.10299; Grabenstien R, 2005, J CLIN GASTROENTEROL, V5, P169; Irungu E, 2013, J INFECT DIS, V207, P402, DOI 10.1093/infdis/jis695; Kateera F, 2015, T ROY SOC TROP MED H, V109, P203, DOI 10.1093/trstmh/trv004; Kollathodi N., 2017, J ACAD CLIN MICROBIO, V19, P42, DOI [10.4103/jacm.jacm_63_16, DOI 10.4103/JACM.JACM_63_16]; Konlan KD, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2182-7; Meriki HD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200157; Nagashima S, 2019, VACCINE, V37, P145, DOI 10.1016/j.vaccine.2018.11.019; Nashibi R, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.19579; Nelson NP, 2016, CLIN LIVER DIS, V20, P607, DOI 10.1016/j.cld.2016.06.006; Norouzirad R, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.13625; Ofori-Asenso R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1467-5; Poovorawan Y, 2012, HUM VACC IMMUNOTHER, V8, P896, DOI 10.4161/hv.19989; Sahana HV, 2017, BIOMED RES INT, V2017, P5; Schillie S, 2013, MMWR RECOMM REP, V62, P1; Shao ER, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3376-2; Weinberger B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01035; Yang SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27251	30	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219148	10.1371/journal.pone.0219148	http://dx.doi.org/10.1371/journal.pone.0219148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251790	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000045
J	Oliveira, PD; Wehrmeister, FC; Goncalves, H; Assuncao, MC; Perez-Padilla, R; Barros, FC; Menezes, AMB				Oliveira, Paula Duarte; Wehrmeister, Fernando C.; Goncalves, Helen; Assuncao, Maria Cecilia; Perez-Padilla, Rogelio; Barros, Fernando C.; Baptista Menezes, Ana Maria			Body composition from 18 to 22 years and pulmonary function at 22 years-1993 Pelotas Birth Cohort	PLOS ONE			English	Article							LUNG-FUNCTION; FAT DISTRIBUTION; MASS INDEX; ASSOCIATION; OBESITY; WEIGHT; OVERWEIGHT; ADIPOSITY; HEALTH	The objective was to verify the association between body composition from 18 to 22 years and pulmonary function at 22 years of age. This longitudinal analysis was conducted with a Brazilian birth cohort data. The outcomes were the forced expiratory volume in the first second and forced vital capacity (FVC), measured at 22 years follow-up. Main exposures: obesity (body mass index >= 30kg/m(2)), and highest tertiles of fat mass (FM) and fat mass index (air displacement plethysmography) measured at 18 and 22 years-old follow-ups. The reference category (not exposed) was defined by those individuals who were not classified in the highest adiposity categories mentioned, in both ages. Multivariable linear regressions stratified by sex were used. The sample comprised 3,511 participants. Those who belonged to the highest adiposity categories in 18 and 22 years follow-ups showed lower pulmonary function at 22 years when compared to those who were not classified in the higher adiposity categories in both ages (reference category); those in the highest tertile of FM showed a mean FVC -313mL (95% CI -421; -206) and -259mL (95% CI -336; -182) in men and women, compared to the reference category, respectively. Those who changed from the higher to the lower adiposity categories (from 18 to 22 years) showed pulmonary function similar to the reference, and those who presented the opposite body composition trajectory, showed decreased pulmonary function results at 22 years, mainly among women. We concluded that high body adiposity in two follow-ups and especially contemporary adiposity was associated with lower pulmonary function at 22 years.	[Oliveira, Paula Duarte; Wehrmeister, Fernando C.; Goncalves, Helen; Assuncao, Maria Cecilia; Baptista Menezes, Ana Maria] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Perez-Padilla, Rogelio] Inst Resp Dis, Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Barros, Fernando C.] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, Brazil	Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Oliveira, PD (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	pauladuartedeoliveira@gmail.com	Menezes, Ana MB/G-7266-2012; Wehrmeister, Fernando/A-3006-2014	Menezes, Ana MB/0000-0002-2996-9427; Wehrmeister, Fernando/0000-0001-7137-1747; Barros, Fernando/0000-0001-5973-1746; Reis, AlessanRSS/0000-0001-8486-7469	Science and Technology Department, Brazilian Ministry of Health, with resources transferred through the Brazilian National Council for Scientific and Technological Development (CNPq) [400943/2013-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]; Wellcome Trust [086974/Z/08/Z]; European Union; Brazilian National Program for Centers of Excellence (PRONEX); National Research Council (CNPq); Ministry of Health	Science and Technology Department, Brazilian Ministry of Health, with resources transferred through the Brazilian National Council for Scientific and Technological Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Brazilian National Program for Centers of Excellence (PRONEX); National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health	This work was supported by the Science and Technology Department, Brazilian Ministry of Health, with resources transferred through the Brazilian National Council for Scientific and Technological Development (CNPq) [grant number 400943/2013-1]. The study 'Pelotas Birth Cohort, 1993' was conducted by the Postgraduate Program in Epidemiology at Universidade Federal de Pelotas, with the collaboration of the Brazilian Public Health Association (ABRASCO) and was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001. From 2004 to 2013, the Wellcome Trust supported the 1993 Birth Cohort study [grant number 086974/Z/08/Z]. The initial phases of the cohort were funded by the European Union and the Brazilian National Program for Centers of Excellence (PRONEX), the National Research Council (CNPq), and the Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsumali A, 2018, SURG OBES RELAT DIS, V14, P225, DOI 10.1016/j.soard.2017.09.533; Bottai M, 2002, EUR RESPIR J, V20, P665, DOI 10.1183/09031936.02.01282001; Byberg KK, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-017-0567-3; Ceylan E, 2009, SOUTH MED J, V102, P30, DOI 10.1097/SMJ.0b013e31818c9585; Chen Y, 2007, AM J CLIN NUTR, V85, P35, DOI 10.1093/ajcn/85.1.35; Chinn DJ, 1996, THORAX, V51, P699, DOI 10.1136/thx.51.7.699; Chinn S, 2005, LANCET, V365, P1629, DOI 10.1016/S0140-6736(05)66511-7; Cimen AR, 2011, OPEN OBESITY J, V3, P63; Curry BA, 2011, OBESITY, V19, P2069, DOI 10.1038/oby.2011.47; Davidson WJ, 2013, PEDIAT PULMONOL; de Oliveira PD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163428; Fenger RV, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-208; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fogarty AW, 2011, RESP MED, V105, P1896, DOI 10.1016/j.rmed.2011.07.024; Forno E, 2018, J ALLER CL IMM-PRACT, V6, P570, DOI 10.1016/j.jaip.2017.07.010; Goncalves H, 2017, INT J EPIDEMIOL; Goncalves H, 2014, INT J EPIDEMIOL, V43, P1082, DOI 10.1093/ije/dyu077; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; He QQ, 2009, PEDIATR PULM, V44, P997, DOI 10.1002/ppul.21091; Held M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107480; Hewitt S, 2014, OBES SURG, V24, P705, DOI 10.1007/s11695-013-1159-9; Knuiman MW, 1999, ANN EPIDEMIOL, V9, P297, DOI 10.1016/S1047-2797(98)00066-0; Li AM, 2003, ARCH DIS CHILD, V88, P361, DOI 10.1136/adc.88.4.361; Lim S, 2011, OBESITY, V19, P631, DOI 10.1038/oby.2010.167; Menezes A. M. B., 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0UR-NAL.P0NE.0109732; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pakhale S, 2015, CHEST, V147, P1582, DOI 10.1378/chest.14-3105; Peters U, 2018, CHEST, V153, P702, DOI 10.1016/j.chest.2017.07.010; Pistelli F, 2008, RESP MED, V102, P674, DOI 10.1016/j.rmed.2007.12.022; Rossi A, 2008, INT J OBESITY, V32, P1423, DOI 10.1038/ijo.2008.103; Rowe A, 2017, RESP MED, V131, P199, DOI 10.1016/j.rmed.2017.08.030; Santana H, 2001, AM J CLIN NUTR, V73, P827; Scott HA, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-10; Sociedade Brasileira de Pneumologia e Tisiologia, 2002, J PNEUMOL, V28, pS(3); Sutherland TJT, 2008, EUR RESPIR J, V32, P85, DOI 10.1183/09031936.00112407; Sutherland TJT, 2016, EUR RESPIR J, V48, P734, DOI 10.1183/13993003.02216-2015; Ubilla C, 2008, ANN HUM BIOL, V35, P322, DOI 10.1080/03014460801978937; Wang R, 2013, PEDIAT PULMONOL; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Ziyab AH, 2014, J EPIDEMIOL COMMUNIT	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219077	10.1371/journal.pone.0219077	http://dx.doi.org/10.1371/journal.pone.0219077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247010	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900074
J	Croft, S; Aegerter, JN; Massei, G; Smith, GC				Croft, Simon; Aegerter, James N.; Massei, Giovanna; Smith, Graham C.			The risk of foot-and-mouth disease becoming endemic in a wildlife host is driven by spatial extent rather than density	PLOS ONE			English	Article							INTEGRATED MODELING APPROACH; CLASSICAL SWINE-FEVER; WIND-BORNE SPREAD; BOAR SUS-SCROFA; VIRUS; INFECTION	In the past 20 years, free living populations of feral wild boar have re-established in several locations across the UK. One of the largest populations is in the Forest of Dean where numbers have been steadily increasing since monitoring began in 2008, with estimates from 2016 reporting a population of more than 1500. Feral wild boar have significant ecological and environmental impacts and may present a serious epidemiological risk to neighbouring livestock as they are a vector for a number of important livestock diseases. This includes foot-and-mouth disease (FMD) which is currently absent from the UK. We developed an individual-based spatially explicit modelling approach to simulate feral wild boar populations in the Forest of Dean (England, UK) and use it to explore whether current or future populations might be sufficient to produce long-lived outbreaks of FMD in this potential wildlife reservoir. Our findings suggest that if you exclude the spread from feral wild boar to other susceptible species, the current population of boar is insufficient to maintain FMD, with 95% of unmanaged simulations indicating disease burn-out within a year (not involving boar management specifically for disease). However, if boar are allowed to spread beyond their current range into the adjacent landscape, they might maintain a self-sustaining reservoir of infection for the disease.	[Croft, Simon; Aegerter, James N.; Massei, Giovanna; Smith, Graham C.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England	Animal & Plant Health Agency UK	Croft, S (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	simon.croft@apha.gov.uk	Smith, Graham/J-2593-2013	Smith, Graham/0000-0002-9897-6794	Defra [SE0430]	Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This research was funded by Defra under project SE0430. The funders had no role in study design, data collection and analysis, or preparation of the manuscript but were consulted on, and are in agreement with, the decision to publish.	[Anonymous], 2018, GREEN FUT OUR 25 YEA; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; Botner A, 2012, VET MICROBIOL, V157, P41, DOI 10.1016/j.vetmic.2011.12.010; Breithaupt A, 2012, VET MICROBIOL, V159, P33, DOI 10.1016/j.vetmic.2012.03.021; Budgey R, 2017, VET PARASITOL, V237, P47, DOI 10.1016/j.vetpar.2017.02.022; Chauvenet ALM, 2017, ECOL MODEL, V350, P79, DOI 10.1016/j.ecolmodel.2017.02.007; Croft S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0178; Croft S, 2013, ECOL COMPLEX, V16, P77, DOI 10.1016/j.ecocom.2012.06.002; Defra APHA, 2018, EX BLACKTH NAT FOOT; Depner KR, 2000, DEUT TIERARZTL WOCH, V107, P66; EFSA Panel on Animal Health and Welfare, 2012, EFSA Journal, V10, P2635; French NP, 2002, EPIDEMIOL INFECT, V128, P325, DOI 10.1017/S0950268801006446; Garner MG, 2006, ENVIRON MODEL ASSESS, V11, P195, DOI 10.1007/s10666-005-9023-5; Gill R., 2015, FERAL WILD BOAR DEER; Gill R, 2016, FERAL WILD BOAR DEER; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Hess GD, 2008, ENVIRON MODEL ASSESS, V13, P209, DOI 10.1007/s10666-007-9097-3; Holland EP, 2007, PLOS COMPUT BIOL, V3, P1979, DOI 10.1371/journal.pcbi.0030200; Holland EP, 2008, MODELLING POPULATION; Lange M., 2012, EFSA SUPP PUBL, V9; Massei G, 2008, WILDLIFE RES, V35, P540, DOI 10.1071/WR07132; Massei Giovanna, 2004, Galemys, V16, P135; Massei G, 2018, PEST MANAG SCI, V74, P853, DOI 10.1002/ps.4763; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Massei G, 2014, WILDLIFE RES, V41, P1, DOI 10.1071/WR13141; Massei G, 2010, J WILDLIFE MANAGE, V74, P333, DOI 10.2193/2008-489; Met Office, UKCP09 MET OFF GRIDD; Mohamed F, 2011, TRANSBOUND EMERG DIS, V58, P358, DOI 10.1111/j.1865-1682.2011.01213.x; Moore N., 2004, VC0325 DEFR; More S, 2018, EFSA J, V16; Pepin KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183441; Smith GC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167206; Sorensen JH, 2000, EPIDEMIOL INFECT, V124, P577, DOI 10.1017/S095026889900401X; Ward MP, 2007, PREV VET MED, V80, P9, DOI 10.1016/j.prevetmed.2007.01.009; Weaver GV, 2013, J WILDLIFE DIS, V49, P759, DOI 10.7589/2012-11-276	36	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218898	10.1371/journal.pone.0218898	http://dx.doi.org/10.1371/journal.pone.0218898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242228	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600064
J	Ekshtain, R; Malinsky-Buller, A; Greenbaum, N; Mitki, N; Stahlschmidt, MC; Shahack-Gross, R; Nir, N; Porat, N; Mayer, DEBY; Yeshurun, R; Been, E; Rak, Y; Agha, N; Brailovsky, L; Krakovsky, M; Spivak, P; Ullman, M; Vered, A; Barzilai, O; Hovers, E				Ekshtain, Ravid; Malinsky-Buller, Ariel; Greenbaum, Noam; Mitki, Netta; Stahlschmidt, Mareike C.; Shahack-Gross, Ruth; Nir, Nadav; Porat, Naomi; Mayer, Daniella E. Bar-Yosef; Yeshurun, Reuven; Been, Ella; Rak, Yoel; Agha, Nuha; Brailovsky, Lena; Krakovsky, Masha; Spivak, Polina; Ullman, Micka; Vered, Ariel; Barzilai, Omry; Hovers, Erella			Persistent Neanderthal occupation of the open-air site of 'Ein Qashish, Israel	PLOS ONE			English	Article							MIDDLE PALEOLITHIC SITE; NEUMARK-NORD 2; AMUD CAVE; KEBARA CAVE; NESHER RAMLA; RAW-MATERIAL; HAIFA BAY; TECHNOLOGY; FEATURES; FIRE	Over the last two decades, much of the recent efforts dedicated to the Levantine Middle Paleolithic has concentrated on the role of open-air sites in the settlement system in the region. Here focus on the site of Ein Qashish as a cases study. Located in present-day northern Israel, the area of this site is estimated to have been >1300 m(2), of which ca. 670 were excavated. The site is located at the confluence of the Qishon stream with a small tributary running off the eastern flanks of the Mt. Carmel. At the area of this confluence, water channels and alluvial deposits created a dynamic depositional environment. Four Archaeological Units were identified in a 4.5-m thick stratigraphic sequence were dated by Optically Stimulated Luminescence (OSL) to between-71 and 54 ka, and probably shorter time span-similar to 70-similar to 60 ka. Here we present the diverse material culture remains from the site (lithics, including refitted sequences; modified limestone pieces; molluscs; faunal remains) against their changing paleogeographic backdrop. Skeletal evidence suggests that these remains were associated with Neanderthals. The large-scale repeated accumulation of late Middle Paleolithic remains in the same place on the landscape provides a unique opportunity to address questions of occupation duration and intensity in open-air sites. We find that each occupation was of ephemeral nature, yet presents a range of activities, suggesting that the locale has been used as a generalized residential site rather than specialized task-specific ones. This role of 'Ein Qashish did not change through time, suggesting that during the late Middle Paleolithic settlement system in this part of the southern Levant were stable.	[Ekshtain, Ravid; Mitki, Netta; Nir, Nadav; Krakovsky, Masha; Ullman, Micka; Hovers, Erella] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel; [Malinsky-Buller, Ariel] MONREPOS Archaeol Res Ctr & Museum Human Behav Ev, Neuwied, Germany; [Greenbaum, Noam] Univ Haifa, Dept Geog & Environm Studies, Haifa, Israel; [Stahlschmidt, Mareike C.] Univ Coll Dublin, Sch Archaeol, Dublin, Ireland; [Shahack-Gross, Ruth] Univ Haifa, Charney Sch Marine Sci, Recanati Inst Maritime Studies, Dept Maritime Civilizat, Haifa, Israel; [Porat, Naomi] Geol Survey Israel, Jerusalem, Israel; [Mayer, Daniella E. Bar-Yosef] Tel Aviv Univ, Steinhardt Museum Nat Hist, Tel Aviv, Israel; [Yeshurun, Reuven; Agha, Nuha] Univ Haifa, Zinman Inst Archaeol, Haifa, Israel; [Been, Ella] Ono Acad Coll, Fac Hlth Profess, Kiryat Ono, Israel; [Been, Ella; Rak, Yoel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Brailovsky, Lena; Spivak, Polina; Barzilai, Omry] Israel Antiqu Author, Jerusalem, Israel; [Vered, Ariel] Ben Gurion Univ Negev, Dept Bible Archaeol & Ancient Near Eastern Studie, Beer Sheva, Israel; [Stahlschmidt, Mareike C.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Hovers, Erella] Arizona State Univ, Inst Human Origins, Int Res Affiliate, Tempe, AZ USA	Hebrew University of Jerusalem; University of Haifa; University College Dublin; University of Haifa; Geological Survey Israel; Tel Aviv University; University of Haifa; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Max Planck Society; Arizona State University; Arizona State University-Tempe	Ekshtain, R (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel.	ravid.ekshtain@mail.huji.ac.il	Yeshurun, Reuven/A-3182-2013; Hovers, Erella/AAA-9234-2019; Nir, nadav/AFN-4347-2022; Hovers, Erella/B-7211-2008; Been, Ella/AAB-5828-2020	Hovers, Erella/0000-0002-7855-6573; Been, Ella/0000-0002-6279-6935; Ekshtain, Ravid/0000-0003-4718-9608; Yeshurun, Reuven/0000-0002-1734-0138	Derekh Eretz Inc.; National Geographic Society [8943-11]; Leakey Foundation; Irene-Levi Sala CARE Foundation; Israel Science Foundation [1232-2015]; Kimmel Center for Archaeological Science, Weizmann Institute of Science; David Gita & Michael Hoffman Memorial Scholarship; Palumbo Carasso Scholarship Fund in Archeology, the Institute of Archaeology, Hebrew University of Jerusalem; Athene programme of the University of Tubingen	Derekh Eretz Inc.; National Geographic Society(National Geographic Society); Leakey Foundation; Irene-Levi Sala CARE Foundation; Israel Science Foundation(Israel Science Foundation); Kimmel Center for Archaeological Science, Weizmann Institute of Science; David Gita & Michael Hoffman Memorial Scholarship; Palumbo Carasso Scholarship Fund in Archeology, the Institute of Archaeology, Hebrew University of Jerusalem; Athene programme of the University of Tubingen	This research was funded by Derekh Eretz Inc. (E.H., O.B., R.E., A.M.-B.), National Geographic Society grant #8943-11 and The Leakey Foundation, (E.H.), Irene-Levi Sala CARE Foundation (E.H., R.E.); Israel Science Foundation Grant #1232-2015 (E.H.); Kimmel Center for Archaeological Science, Weizmann Institute of Science (R.S.-G.); David Gita & Michael Hoffman Memorial Scholarship and the Palumbo Carasso Scholarship Fund in Archeology, the Institute of Archaeology, Hebrew University of Jerusalem (N. N.); Athene programme of the University of Tubingen (M.C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affek HP, 2008, GEOCHIM COSMOCHIM AC, V72, P5351, DOI 10.1016/j.gca.2008.06.031; Aldeias V, 2016, J ARCHAEOL SCI, V67, P64, DOI 10.1016/j.jas.2016.01.016; ALONI R, 1972, ISRAEL J BOT, V21, P209; Alperson-Afil N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188091; AlpersonAfil N, 2010, VERTEBR PALEOBIOL PA, P1; [Anonymous], [No title captured]; Avnaim-Katav S, 2012, J QUATERNARY SCI, V27, P675, DOI 10.1002/jqs.2537; Ayalon A., 2017, QUATERNARY LEVANT EN, P423, DOI [10.1017/9781316106754.049, DOI 10.1017/9781316106754.049]; Bailey G, 2007, J ANTHROPOL ARCHAEOL, V26, P198, DOI 10.1016/j.jaa.2006.08.002; Bar-David S, 2005, ECOL APPL, V15, P1833, DOI 10.1890/04-0798; Bar-Matthews M., 2017, QUATERNARY LEVANT, P151; Bar-Yosef Mayer D.E., 2005, PAL ORIENT, V31, P176, DOI DOI 10.3406/PALEO.2005.4796; Bar-Yosef O, 2007, MIDDLE UPPER PALEO 1; BARYOSEF O, 1980, ISRAEL EXPLOR J, V30, P1; BARYOSEF O, 1992, CURR ANTHROPOL, V33, P497, DOI 10.1086/204112; Barzilai O, 2015, HADASHOT ARKHEOLOGIO, V127; Been E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03025-z; Boeda E, 1999, AM ANTIQ; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Boeda E., 2001, PALEORIENT, V27, P13, DOI DOI 10.3406/PALE0.2001.4729; Boness D., 2016, J ISRAEL PREHISTORY, V46, P5; Crouvi O, 2018, QUATERNARY SCI REV, V191, P101, DOI 10.1016/j.quascirev.2018.04.030; de Beaune S., 2000, ARCHEOLOGIE GESTE BR; Dibble HL, 1997, AM ANTIQUITY, V62, P629, DOI 10.2307/281882; Druck D., 2004, THESIS; Dubreuil L, 2014, J ARCHAEOL SCI, V48, P139, DOI 10.1016/j.jas.2013.06.023; Ekshtain R., 2019, QASHISH, DOI [10.17605/OSF.IO/AMGQ7, DOI 10.17605/OSF.IO/AMGQ7]; Ekshtain R., 2014, THESIS; Ekshtain R, 2012, PALEORIENT, V37, P107, DOI DOI 10.3406/PALE0.2011.5426; Ekshtain R, 2017, GEOARCHAEOLOGY, V32, P189, DOI 10.1002/gea.21585; Ekshtain R, 2014, QUATERN INT, V331, P248, DOI 10.1016/j.quaint.2013.07.025; Enloe JG, 2006, GEOARCHAEOLOGY, V21, P523, DOI 10.1002/gea.20122; Enzel Y, 2008, GLOBAL PLANET CHANGE, V60, P165, DOI 10.1016/j.gloplacha.2007.02.003; Fleisch S.J., 1970, B MUSEE BEYROUTJ, V23, P25; Frick JA, 2012, ANTHROPOL-INT J HUM, V50, P295; Friesem DE, 2014, QUATERN INT, V331, P128, DOI 10.1016/j.quaint.2013.03.023; Gilead I., 1984, P PREHIST SOC, V50, P71, DOI DOI 10.1017/S0079497X00007489; Goren-Inbar N, 1990, MONOGRAPHS I ARCHAEO, V31; Goren-Inbar N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0353; Greenbaum N, 2014, QUATERN INT, V331, P203, DOI 10.1016/j.quaint.2013.10.037; Griggo C., 2011, HUNTING CAMPS PREHIS; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hauck TC, 2011, J HUM EVOL, V61, P519, DOI 10.1016/j.jhevol.2011.01.014; Herisson D, 2013, ANTHROPOLOGIE, V117, P541, DOI 10.1016/j.anthro.2013.10.002; Hovers E, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P143; Hovers E., 2004, ARKHEOLOGIYA PALEOEK, P218; Hovers E, 2009, LITHIC ASSEMBLAGES Q; Hovers E., QUATERNARY LEVANT EN; Hovers E., 2008, J ISRAEL PREHIST SOC, V38, P7; Hovers E., 2007, CORES TOOLS IDENTIFI, P42, DOI DOI 10.1016/J.JENVRAD.2007.03.002; Hovers E., SETTLEMENT DYNAMICS; Hovers E, 2014, QUATERN INT, V331, P216, DOI 10.1016/j.quaint.2014.01.028; Hovers E, 2013, CURR ANTHROPOL, V54, pS337, DOI 10.1086/673880; Jaubert J, 1990, CHASSEURS AUROCHS BO; Jullien D., 1882, DRAGAGES TRAVAILLEUR; Keinan J., 2016, THESIS; Kuhn SL., 1995, MOUSTERIAN LITHIC TE, DOI [10.1515/9781400864034, DOI 10.1515/9781400864034]; Le Tensorer JM, 2007, GEOARCHAEOLOGY, V22, P621, DOI 10.1002/gea.20177; Lengyel G., 2009, ANN ORADEA U FASCIOL, V19; Lev E, 2005, J ARCHAEOL SCI, V32, P475, DOI 10.1016/j.jas.2004.11.006; Madella M, 2002, J ARCHAEOL SCI, V29, P703, DOI 10.1006/jasc.2001.0743; Malinsky-Buller A., 2011, FARMING, P1, DOI [10.3828/bfarm.2011.1.3, DOI 10.3828/BFARM.2011.1.3]; Malinsky-Buller A, 2014, QUATERN INT, V331, P234, DOI 10.1016/j.quaint.2013.05.004; Mallol C, 2013, J ARCHAEOL SCI, V40, P2515, DOI 10.1016/j.jas.2012.09.017; MARKS A, 1976, PREHISTORY PALAEOENV, V1; Marks AE, 1977, PREHISTORIC SETTLEME; Marks AE., 1977, PREHISTORY PALAEOENV, V2; Marks AE, 1976, PREHISTORY PALEOENVI, P75; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; Meignen L, EVOLUTION DISPERSAL; Meignen L, 1991, SQUELETTE MOUSTERIEN, P49; Meignen L., 2017, PALEORIENT, V43, P9; Meignen L, 2006, INTERD CONTRIB ARCH, P149, DOI 10.1007/0-387-24661-4_9; Mendelssohn H., 1999, MAMMALIA ISRAEL; Mentzer S.M., 2017, ENCY GEOARCHAEOLOGY, P411, DOI [10.1007/978-1-4020-4409-0_133, DOI 10.1007/978-1-4020-4409-0_133]; Morin E.S., 2016, OXFORD HDB ARCHAEOLO, P1, DOI DOI 10.1093/OXFORDHB/9780199694013.013.24; Munday F.C., 1977, PREHISTORY PALEOENVI, P35; Nir N., 2016, THESIS; Oron M, 2014, QUATERN INT, V331, P186, DOI 10.1016/j.quaint.2013.04.013; Pagli M., 2015, SETTLEMENT DYNAMICS, V4, P145; Patterson LW, 1995, LITHIC TECHNOL, V20, P72; Pop E, 2016, J FIELD ARCHAEOL, V41, P603, DOI 10.1080/00934690.2016.1208518; Pop E, 2015, QUATERNARY SCI REV, V117, P72, DOI 10.1016/j.quascirev.2015.03.020; Porat N, 2017, QUATERN INT, DOI [10.1016/j.quaint.2016.09.045, DOI 10.1016/J.QUAINT.2016.09.045]; Rabinovich R, 2004, INT J OSTEOARCHAEOL, V14, P287, DOI 10.1002/oa.762; Revedin A, 2010, P NATL ACAD SCI USA, V107, P18815, DOI 10.1073/pnas.1006993107; Richter D, 2011, ARCHAEOMETRY, V53, P842, DOI 10.1111/j.1475-4754.2010.00581.x; Ronen A., 1974, TIRAT CARMEL MOUSTER; Sackett J, 1991, PERSPECTIVES, P109; Salamon A, 2000, ISR GEOL SOC ANN M; Schick K.D., 1986, STONE AGE SITES MAKI; Sergant J, 2006, J ARCHAEOL SCI, V33, P999, DOI 10.1016/j.jas.2005.11.011; Shahack-Gross R, 2008, GEOARCHAEOLOGY, V23, P43, DOI 10.1002/gea.20203; Sharon G, 2018, REPLACE NEANDERTHAL, P35, DOI 10.1007/978-981-10-6826-3_3; Sharon G, 2014, QUATERN INT, V331, P1, DOI 10.1016/j.quaint.2014.03.055; Sharon G, 2014, QUATERN INT, V331, P167, DOI 10.1016/j.quaint.2013.10.024; Sivan D., 2017, QUATERNARY LEVANT, P447; Sivan D, 2011, QUATERNARY RES, V76, P83, DOI 10.1016/j.yqres.2011.04.006; Sorensen AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196777; Speth J. D., 2012, FARMING, V2012, P1, DOI [DOI 10.3828/BFARM.2012.2.1, 10.3828/bfarm.2012.2.1]; Speth JD, 2012, QUATERN INT, V247, P85, DOI 10.1016/j.quaint.2011.03.001; Stahlschmidt MC, 2018, J PALEOLITH ARCHAEOL, V1, P32, DOI 10.1007/s41982-018-0005-y; Stiner MC, 2001, J ARCHAEOL SCI, V28, P643, DOI 10.1006/jasc.2000.0634; Torfstein A, 2013, QUATERNARY SCI REV, V69, P1, DOI 10.1016/j.quascirev.2013.02.015; Ullman M., 2013, P 16 INT C SPEL BRNO, V1, P169; Van Vuure T., 2002, LUTRA, V45, P1; Verges JM, 2011, J ARCHAEOL SCI, V38, P1016, DOI 10.1016/j.jas.2010.11.016; Whelan R.J.., 1995, ECOLOGY FIRE; White M, 2016, QUATERNARY SCI REV, V140, P1, DOI 10.1016/j.quascirev.2016.03.004; Wojtczak D., 2011, LOWER MIDDLE PALAEOL, P289; Yaroshevich A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160687; Yeshurun R, 2014, CURR ANTHROPOL, V55, P591, DOI 10.1086/678275; Yeshurun Reuven, 2007, Journal of Taphonomy, V5, P137; Zaidner Y, 2018, REPLACE NEANDERTHAL, P11, DOI 10.1007/978-981-10-6826-3_2; Zaidner Y, 2014, J HUM EVOL, V66, P1, DOI 10.1016/j.jhevol.2013.06.005; Zaidner Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066851; Zviely D, 2006, HOLOCENE, V16, P849, DOI 10.1191/0959683606hol977rp	117	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0215668	10.1371/journal.pone.0215668	http://dx.doi.org/10.1371/journal.pone.0215668			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242180	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600005
J	De Bellis, R; Piacentini, MP; Meli, MA; Mattioli, M; Menotta, M; Mari, M; Valentini, L; Palomba, L; Desideri, D; Chiarantini, L				De Bellis, Roberta; Piacentini, Maria Piera; Meli, Maria Assunta; Mattioli, Michele; Menotta, Michele; Mari, Michele; Valentini, Laura; Palomba, Letizia; Desideri, Donatella; Chiarantini, Laura			In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism	PLOS ONE			English	Article							TUBULAR EPITHELIAL-CELLS; BIOCHEMICAL-CHARACTERIZATION; ANTIOXIDANT ACTIVITY; PROTEIN; ADHERENCE; ADHESION; SURFACE; CITRATE; URINE; SEEDS	Ceterach officinarum Willd is a plant widespread throughout Europe and used in southern Italy as a diuretic. Beliefs in the benefits of C. officinarum aqueous extract in the treatment of calcium oxalate kidney stones are widely held. Little is known, however, about the actual mechanism of its antilithiatic action. Our results in this in vitro study corroborate C. officinarum aqueous extract as a good source of antioxidants with a high antioxidant effects. Our results also demonstrate a major impact of C. officinarum aqueous extract on in vitro induced calcium oxalate crystallization kinetics and crystal morphology, showing its critical role in kidney stone formation and/or elimination. We show that progressively increasing doses of C. officinarum aqueous extract cause a sequence of effects. A powerful inhibitory action on calcium oxalate monohydrate (COM) growth and aggregation is first observed. C. officinarum aqueous extract also appears highly effective in stimulating nucleation increasing the number and reducing the size of COM crystals, which become progressively thinner, rounded and concave in a dose-dependent manner. These shape-modified COM crystals are known to be less adherent to renal tubular cells and more easily excreted through the urinary tract preventing kidney stone formation. Further, C. officinarum aqueous extract promotes the formation of calcium oxalate dihydrate (COD) rather than the monohydrate so that, at the highest concentrations used, only COD crystals are observed, in significant greater numbers with a clear reduction in their size, in a dose-dependent manner. Furthermore, AFM analyses allowed us to reveal the presence of C. officinarum component(s) on the surfaces of COD and modified COM crystals. The crystal surface adsorbed component (s) are shown to be similarly active as the total aqueous extract, suggesting a trigger factor which may direct crystal modification towards COD forms. In urolithiasis pathogenesis COD crystals are less dangerous than the COM forms due to their lower affinity for renal tubular cells. Our results are important in understanding the mechanisms which guide the modification induced by C. officinarum on the crystallization process. Based on these data, together with no adverse toxic effect being observed on the in vitro model of human intestinal enterocytes, C. officinarum aqueous extract could represent an attractive natural therapy for the treatment of urolithiasis.	[De Bellis, Roberta; Piacentini, Maria Piera; Meli, Maria Assunta; Menotta, Michele; Mari, Michele; Valentini, Laura; Palomba, Letizia; Desideri, Donatella; Chiarantini, Laura] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [Mattioli, Michele] Univ Urbino Carlo Bo, Dept Pure & Appl Sci, Urbino, PU, Italy	University of Urbino; University of Urbino	De Bellis, R (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy.	roberta.debellis@uniurb.it	Mari, Michele/K-1091-2016	Mari, Michele/0000-0002-3763-3587; Menotta, Michele/0000-0001-5206-6296; Mattioli, Michele/0000-0002-1672-130X; Valentini, Laura/0000-0001-8028-1233; Desideri, Donatella/0000-0002-0858-1888; De Bellis, Roberta/0000-0001-9623-3279				Aggarwal A, 2010, INT BRAZ J UROL, V36, P480, DOI 10.1590/S1677-55382010000400011; Ahmed S, 2016, PAK J PHARM SCI, V29, P2129; Ankur C., 2010, INT J DRUG DEV RES, V2, P431; Bag GC, 2014, INT J PHARM SCI REV, V28, P154; Barros ME, 2003, UROL RES, V30, P374, DOI 10.1007/s00240-002-0285-y; Basavaraj D. R., 2007, EAU EBU UPDATE SERIE, V5, P126, DOI DOI 10.1016/J.EEUS.2007.03.002; Bhandari A, 2002, J UROLOGY, V168, P253, DOI 10.1016/S0022-5347(05)64903-8; Bijarnia RK, 2009, PROTEIN J, V28, P161, DOI 10.1007/s10930-009-9179-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrio E, 2012, J ETHNOPHARMACOL, V141, P1021, DOI 10.1016/j.jep.2012.03.049; Chitme HR, 2010, INT J PHARM SCI RES, V1, P24, DOI 10.13040/IJPSR.0975-8232.1(2).24-31; De Yoreo JJ, 2006, AM J PHYSIOL-RENAL, V291, pF1123, DOI 10.1152/ajprenal.00136.2006; Di Sanzo P, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-19; Grases F, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/813737; Grases F, 2009, UROL RES, V37, P35, DOI 10.1007/s00240-008-0165-1; Grohe B, 2006, J CRYST GROWTH, V295, P148, DOI 10.1016/j.jcrysgro.2006.07.029; Grohe B, 2009, LANGMUIR, V25, P11635, DOI 10.1021/la901145d; Guarrera PM, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-23; Guerra A, 2006, UROL RES, V34, P359, DOI 10.1007/s00240-006-0067-z; Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+; Hess B, 2000, NEPHROL DIAL TRANSPL, V15, P366, DOI 10.1093/ndt/15.3.366; Itoh Y, 2005, J UROLOGY, V173, P271, DOI 10.1097/01.ju.0000141311.51003.87; Karadeniz A, 2015, NAT PROD RES, V29, P2308, DOI 10.1080/14786419.2015.1005618; Khan A, 2014, UROLOGY, V83, DOI 10.1016/j.urology.2013.10.038; Khan SR, 2004, NEPHRON EXP NEPHROL, V98, pE55, DOI 10.1159/000080257; KHAN SR, 1995, UROL RES, V23, P71, DOI 10.1007/BF00307936; Khaskhali MH, 2009, UROL RES, V37, P1, DOI 10.1007/s00240-008-0160-6; Kulaksizoglu S, 2008, INT UROL NEPHROL, V40, P589, DOI 10.1007/s11255-007-9256-0; Lieske JC, 2000, CURR OPIN NEPHROL HY, V9, P349, DOI 10.1097/00041552-200007000-00005; Ma MC, 2014, UROLOGY, V83, DOI 10.1016/j.urology.2013.09.050; Mittal A, 2016, UROLITHIASIS, V44, P117, DOI 10.1007/s00240-015-0822-0; Mittal A, 2015, INT BRAZ J UROL, V41, P935, DOI 10.1590/S1677-5538.IBJU.2014.0547; Mittal A, 2016, PLOS ONE, V11, P1; Mustapha B., 2015, INT J PHARM PHARM SC, V7, P329; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ninfali P, 2005, BRIT J NUTR, V93, P257, DOI 10.1079/BJN20041327; Palomba L, 2007, J NEUROCHEM, V103, P904, DOI 10.1111/j.1471-4159.2007.04793.x; Pieroni A, 2002, FITOTERAPIA, V73, P217, DOI 10.1016/S0367-326X(02)00063-1; Prasad K., 2007, PHCOG REV, V1, P175; Prezioso D, 2014, ARCH ITAL UROL ANDRO, V86, P99, DOI 10.4081/aiua.2014.2.99; Saltarelli R, 2015, J MOL MICROB BIOTECH, V25, P16, DOI 10.1159/000369212; Saltarelli R, 2009, FOOD CHEM, V116, P143, DOI 10.1016/j.foodchem.2009.02.023; Scheid CR, 2004, FRONT BIOSCI-LANDMRK, V9, P797, DOI 10.2741/1265; Schepers MSJ, 2005, KIDNEY INT, V68, P1543, DOI 10.1111/j.1523-1755.2005.00566.x; Schonherr H, 2002, P NATL ACAD SCI USA, V99, P5024, DOI 10.1073/pnas.072685399; Shang YF, 2013, BIOINORG CHEM APPL, V2013, DOI 10.1155/2013/637617; Sheng XX, 2005, J AM SOC NEPHROL, V16, P1904, DOI 10.1681/ASN.2005040400; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Spivacow FR, 2010, UROLOGY, V76, P1346, DOI 10.1016/j.urology.2010.02.029; TAZZOLI V, 1980, AM MINERAL, V65, P327; Thongboonkerd V, 2006, CLIN CHIM ACTA, V367, P120, DOI 10.1016/j.cca.2005.11.033; Tiselius HG, 2001, UROL RES, V29, P75, DOI 10.1007/s002400100174; Tiwari A, 2012, ASIAN J PHARM CLIN R, V5, P7; Tunisi L, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00219; van Breemen Richard B, 2005, Expert Opin Drug Metab Toxicol, V1, P175, DOI 10.1517/17425255.1.2.175; VERKOELEN CF, 1995, KIDNEY INT, V48, P129, DOI 10.1038/ki.1995.276; Viegi L, 2003, J ETHNOPHARMACOL, V89, P221, DOI 10.1016/j.jep.2003.08.003; Wang B.-H., 2014, PLOS ONE, V7, P1; Zivkovic S., 2017, Lekovite Sirovine, V37, P15	59	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218734	10.1371/journal.pone.0218734	http://dx.doi.org/10.1371/journal.pone.0218734			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31238335	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000036
J	Girard, N; Delomenie, M; Malhaire, C; Sebbag, D; Roulot, A; Sabaila, A; Couturaud, B; Feron, JG; Reyal, F				Girard, Noemie; Delomenie, Myriam; Malhaire, Caroline; Sebbag, Delphine; Roulot, Aurelie; Sabaila, Anne; Couturaud, Benoit; Feron, Jean-Guillaume; Reyal, Fabien			Innovative DIEP flap perfusion evaluation tool: Qualitative and quantitative analysis of indocyanine green-based fluorescence angiography with the SPY-Q proprietary software	PLOS ONE			English	Article							EPIGASTRIC PERFORATOR FLAP; BREAST RECONSTRUCTION; VASCULAR ANATOMY; TRAM FLAP; NECROSIS; COMPLICATIONS; PREDICT	Background Perfusion-related complications remain the most common concern in DIEP flap breast reconstruction. Indocyanine green-based fluorescence angiography can be used for the real-time intra operative assessment of flap perfusion. The SPY Elite system is the most widely used device in this setting. The main objective was to describe the use of SPY-Q proprietary software to perform qualitative and quantitative analysis of flap perfusion. Methods This retrospective cohort study was performed at the Curie Institute between 2013 and 2017. We included patients undergoing unilateral DIEP flap breast reconstruction for whom indocyanine green-based angiography videos were of sufficient quality for analysis. Videos were recorded with the SPY Elite System and analyzed with SPY-Q proprietary software. Results We included 40 patients. We used real-time dynamic color analysis to describe three different patterns of flap perfusion. SPY-Q proprietary software provides quantitative flap perfusion parameters. Our quantitative analysis confirmed that zone I is the best perfused part of the flap and zone IV the less perfused one. There was no significant association between flap perfusion pattern and perforator anatomy, patients' clinical characteristics or postoperative outcomes. After exploratory univariate analysis, quantitative perfusion parameters were significantly impaired in young patients with diabetes mellitus or under hormone therapy by tamoxifen. Conclusions We here describe a new approach to assess DIEP flap perfusion using the SPY Elite System proprietary software. It provides interesting qualitative and quantitative analysis that can be used in further studies to precisely assess DIEP flap perfusion.	[Girard, Noemie; Delomenie, Myriam; Roulot, Aurelie; Sabaila, Anne; Feron, Jean-Guillaume; Reyal, Fabien] Curie Inst, Dept Gynecol & Breast Oncol Surg, Paris, France; [Malhaire, Caroline; Sebbag, Delphine] Curie Inst, Dept Radiol, Paris, France; [Couturaud, Benoit] Curie Inst, Dept Plast & Reconstruct Surg, Paris, France; [Reyal, Fabien] Univ Paris 05, Univ Paris, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite	Reyal, F (corresponding author), Univ Paris 05, Univ Paris, Paris, France.	fabien.reyal@gmail.com	malhaire, caroline/AAE-9531-2020; Malhaire, Caroline/GSD-2458-2022; Malhaire, Caroline/AAD-8973-2020	Malhaire, Caroline/0000-0002-9235-9816; Malhaire, Caroline/0000-0002-9235-9816	Curie Institute	Curie Institute	The authors express their thanks to Novadaq for the loan of the SPY Elite System device. Writing assistance was requested and paid by Curie Institute.	ALLEN RJ, 1994, ANN PLAS SURG, V32, P32, DOI 10.1097/00000637-199401000-00007; Brunworth LS, 2011, PLAST RECONSTR SURG, V128, P585, DOI 10.1097/PRS.0b013e31821e71f6; Chang EI, 2016, ANN PLAS SURG, V77, P67, DOI 10.1097/SAP.0000000000000263; Duggal CS, 2014, AESTHET SURG J, V34, P61, DOI 10.1177/1090820X13514995; Fischer JP, 2013, PLAST RECONSTR SURG, V131, P195, DOI 10.1097/PRS.0b013e318277856f; Griffiths M, 2016, GLAND SURG, V5, P133, DOI 10.3978/j.issn.2227-684X.2016.02.01; Grover R, 2014, ARCH PLAST SURG-APS, V41, P63, DOI 10.5999/aps.2014.41.1.63; HARTRAMPF CR, 1982, PLAST RECONSTR SURG, V69, P216, DOI 10.1097/00006534-198202000-00006; Komorowska-Timek E, 2010, PLAST RECONSTR SURG, V125, P1065, DOI 10.1097/PRS.0b013e3181d17f80; Lam DL, 2012, BRIT J RADIOL, V85, pE1293, DOI 10.1259/bjr/30590223; Laporta R, 2017, MICROSURG, V37, P793, DOI 10.1002/micr.30203; Lee KT, 2018, MICROSURG, V38, P98, DOI 10.1002/micr.30024; MOON HK, 1988, PLAST RECONSTR SURG, V82, P815, DOI 10.1097/00006534-198811000-00014; Mothes H, 2009, J HAND SURG-EUR VOL, V34E, P238, DOI 10.1177/1753193408090399; Moyer HR, 2012, PLAST RECONSTR SURG, V129, P1043, DOI 10.1097/PRS.0b013e31824a2b02; Munabi NCO, 2014, J PLAST RECONSTR AES, V67, P449, DOI 10.1016/j.bjps.2013.12.040; Murray John D, 2010, Plast Reconstr Surg, V126, p33e, DOI 10.1097/PRS.0b013e3181dab2c2; Nahabedian MY, 2005, PLAST RECONSTR SURG, V115, P436, DOI 10.1097/01.PRS.0000149404.57087.8E; Newman MI, 2013, ANN PLAS SURG, V70, P595, DOI 10.1097/SAP.0b013e3182650b4e; Pestana IA, 2014, J RECONSTR MICROSURG, V30, P1, DOI [10.1055/s-0034-1372478, DOI 10.1055/S-0034-1372478]; Phillips BT, 2012, PLAST RECONSTR SURG, V129, p778E, DOI 10.1097/PRS.0b013e31824a2ae8; Rubino C, 2009, J PLAST RECONSTR AES, V62, P1666, DOI 10.1016/j.bjps.2008.05.045; Santanelli F, 2015, ANN PLAS SURG, V74, P47, DOI 10.1097/SAP.0b013e31828d994d; Scheer AS, 2006, ANN PLAS SURG, V56, P355, DOI 10.1097/01.sap.0000201549.83738.42; Wong C, 2010, PLAST RECONSTR SURG, V125, P772, DOI 10.1097/PRS.0b013e3181cb63e0; Wu C, 2013, ANN PLAS SURG, V70, P613, DOI 10.1097/SAP.0b013e31827565f3; Zhong T, 2014, PLAST RECONSTR SURG, V133, P774, DOI 10.1097/PRS.0000000000000024	27	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0217698	10.1371/journal.pone.0217698	http://dx.doi.org/10.1371/journal.pone.0217698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237884	gold, Green Published, Green Submitted			2022-12-26	WOS:000484856000010
J	Kim, J; Bogdan, DM; Elmes, MW; Awwa, M; Yan, S; Che, J; Lee, G; Deutsch, DG; Rizzo, RC; Kaczocha, M; Ojima, I				Kim, Jinwoo; Bogdan, Diane M.; Elmes, Matthew W.; Awwa, Monaf; Yan, Su; Che, Joyce; Lee, Garam; Deutsch, Dale G.; Rizzo, Robert C.; Kaczocha, Martin; Ojima, Iwao			Incarvillateine produces antinociceptive and motor suppressive effects via adenosine receptor activation	PLOS ONE			English	Article							A(2A) RECEPTORS; PAIN; STIMULATION; POTENT; AGENT	(-)-Incarvillateine (INCA) is a natural product that has garnered attention due to its purported analgesic effects and historical use as a pain reliever in China. alpha-Truxillic acid monoesters (TAMEs) constitute a class of inhibitors targeting fatty acid binding protein 5 (FABP5), whose inhibition produces analgesia in animal models. The structural similarity between INCA and TAMEs motivated us to assess whether INCA exerts its antinociceptive effects via FABP inhibition. We found that, in contrast to TAMEs, INCA did not exhibit meaningful binding affinities toward four human FABP isoforms (FABP3, FABP4, FABP5 and FABP7) in vitro. INCA-TAME, a putative monoester metabolite of INCA that closely resembles TAMEs also lacked affinity for FABPs. Administration of INCA to mice produced potent antinociceptive effects while INCA-TAME was without effect. Surprisingly, INCA also potently suppressed locomotor activity at the same dose that produces antinociception. The motor suppressive effects of INCA were reversed by the adenosine A2 receptor antagonist 3,7-dimethyl-1-propargylxanthine. Collectively, our results indicate that INCA and INCA-TAME do not inhibit FABPs and that INCA exerts potent antinociceptive and motor suppressive effects at equivalent doses. Therefore, the observed antinociceptive effects of INCA should be interpreted with caution.	[Kim, Jinwoo; Awwa, Monaf; Yan, Su; Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Kim, Jinwoo; Rizzo, Robert C.; Kaczocha, Martin; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Bogdan, Diane M.; Kaczocha, Martin] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Elmes, Matthew W.; Che, Joyce; Lee, Garam; Deutsch, Dale G.; Kaczocha, Martin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Rizzo, Robert C.] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ojima, I (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.; Kaczocha, M; Ojima, I (corresponding author), SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.; Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.; Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	martin.kaczocha@stonybrook.edu; iwao.ojima@stonybrook.edu		Yan, Su/0000-0002-9961-471X; Awwa, Monaf/0000-0002-5180-2025	National Institute on Drug Abuse, National Institutes of Health [DA042545, DA035949, DA035923]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035923, R01DA035949] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants (DA042545, DA035949, and DA035923) from the National Institute on Drug Abuse, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Butera JA, 2007, J MED CHEM, V50, P2543, DOI 10.1021/jm061015w; Chi YM, 2005, CHEM PHARM BULL, V53, P1178, DOI 10.1248/cpb.53.1178; Chi YM, 2005, BIOL PHARM BULL, V28, P1989, DOI 10.1248/bpb.28.1989; FERRE S, 1991, NEUROSCI LETT, V130, P162, DOI 10.1016/0304-3940(91)90387-9; Gereau RW, 2014, J PAIN, V15, P1203, DOI 10.1016/j.jpain.2014.09.004; Gfeller D, 2014, NUCLEIC ACIDS RES, V42, pW32, DOI 10.1093/nar/gku293; HAUBER W, 1995, NEUROSCI LETT, V196, P205, DOI 10.1016/0304-3940(95)11871-S; Hsu HC, 2017, BIOCHEMISTRY-US, V56, P3454, DOI 10.1021/acs.biochem.7b00194; Huang B, 2016, J MED CHEM, V59, P3953, DOI 10.1021/acs.jmedchem.6b00132; Ichikawa M, 2004, J AM CHEM SOC, V126, P16553, DOI 10.1021/ja0401702; Kaczocha M, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0056-8; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Luk J, 2018, J PAIN RES, V11, P473, DOI 10.2147/JPR.S157208; Mingote S, 2008, PHARMACOL BIOCHEM BE, V89, P345, DOI 10.1016/j.pbb.2008.01.006; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakamura M, 1999, J NAT PROD, V62, P1293, DOI 10.1021/np990041c; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips Ceri J, 2009, Rev Pain, V3, P2, DOI 10.1177/204946370900300102; SEALE TW, 1988, LIFE SCI, V43, P1671, DOI 10.1016/0024-3205(88)90478-X; Wang ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep16107; Wolfgang H, 1997, EUR J PHARMACOL, V323, P127, DOI 10.1016/S0014-2999(97)00040-X; Yan S, 2018, EUR J MED CHEM, V154, P233, DOI 10.1016/j.ejmech.2018.04.050; Yang M, 2007, N-S ARCH PHARMACOL, V375, P133, DOI 10.1007/s00210-007-0135-0	25	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218619	10.1371/journal.pone.0218619	http://dx.doi.org/10.1371/journal.pone.0218619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237895	Green Published, Green Submitted, gold			2022-12-26	WOS:000484856000029
J	Dabrowski, A; Dabrowski, L				Dabrowski, Adam; Dabrowski, Leszek			Inverse heat transfer problem solution of sounding rocket using moving window optimization	PLOS ONE			English	Article								An Inverse Heat Transfer Problem is solved for a sounding rocket module given its geometry and measured temperature profile. The solution is obtained via moving window optimization, a technique for solving inverse dynamics. An analysis is performed to modify the method to avoid oscillatory behavior of the resulting heat flux profile. The method parameters are tuned in relation to characteristic phases of the flight. Results are presented and correlated with measured flight data. Conclusions are drawn for better experiments for measuring heat flux on a sounding rocket skin.	[Dabrowski, Adam] Gdansk Univ Tech, Fac Mech Engn, Dept Mech & Mechatron, Gdansk, Poland; [Dabrowski, Leszek] Gdansk Univ Technol, Fac Mech Engn, Dept Mechine Design & Motor Vehicles, Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Gdansk University of Technology	Dabrowski, A (corresponding author), Gdansk Univ Tech, Fac Mech Engn, Dept Mech & Mechatron, Gdansk, Poland.	adadabro@pg.edu.pl	Dąbrowski, Leszek/AAF-6437-2019; Dąbrowski, Adam/AAF-6625-2019	Dąbrowski, Adam/0000-0002-7930-9064; Dabrowski, Leszek/0000-0003-1626-6084	Gdansk University of Technology	Gdansk University of Technology	We wish to confirm that there are no known conflicts of interest associated with this publication. The device described in this paper is patent pending in Republic of Poland Patent Office, application number P.423198. Authors of the patent are authors of the paper and it is fully funded by Gdansk University of Technology, where both authors are employed. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Alifanov O.M., 1995, EXTREME METHODS SOLV; Alifanov OM, 1994, INT SERIES HEAT MASS, DOI [10.1007/978-3-642-76436-3, DOI 10.1007/978-3-642-76436-3.]; [Anonymous], 1990, ASM HDB; ANSYS Inc, 2018, AC RES MECH HELP SYS; Beck J., 1985, INVERSE HEAT CONDUCT; Beck J.V, 1977, PARAMETER ESTIMATION; Bergman T.L., 2011, FUNDAMENTALS HEAT MA, Vsixth; Burggraf O. R., 1964, J HEAT TRANSFER, V86, P373, DOI [10.1115/1.3688700, DOI 10.1115/1.3688700]; Callens N, 2013, 21 ESA S EUR ROCK BA, P9; Dabrowski A, 2019, MOVING WINDOW OPTIMI; Davenas A., 1992, SOLID ROCKET PROPULS; Denisov A.M., 1999, ELEMENTS THEORY INVE; Felde I, 2013, MATER SCI FORUM, V729, P144, DOI 10.4028/www.scientific.net/MSF.729.144; Grulich M, 2015, 22 ESA S EUR ROCK BA, P8; Guo ZC, 2017, J THERM SCI, V26, P160, DOI 10.1007/s11630-017-0925-8; Hensel E., 1991, INVERSE THEORY APPL; Kimmel R. L., 2013, 20130377 AIAA, DOI [10. 2514/6. 2013-377, DOI 10.2514/6.2013-377, 10.2514/6.2013-377]; Krawczyk H, 2015, POL MARIT RES, V22, P99, DOI 10.1515/pomr-2015-0062; Li D, 2005, METALL MATER TRANS B, V36, P343, DOI 10.1007/s11663-005-0064-6; MEHTA RC, 1986, WARME STOFFUBERTRAG, V20, P27, DOI 10.1007/BF00999733; Mulcahy JM, 2009, INT J HEAT MASS TRAN, V52, P2343, DOI 10.1016/j.ijheatmasstransfer.2008.10.031; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Orlande H. R. B., 2000, INVERSE HEAT TRANSFE; Ozisik N., 2017, FINITE DIFFERENCE ME, V2nd; Perakis N, 2019, INT J HEAT MASS TRAN, V131, P150, DOI 10.1016/j.ijheatmasstransfer.2018.11.048; Quental C, 2016, MULTIBODY SYST DYN, V38, P157, DOI 10.1007/s11044-016-9529-4; Rumsey CB, 1961, MEASUREMENTS AERODYN; Stolz G., 1960, J HEAT TRANSFER, V82, P20, DOI 10.1115/1.3679871; Tesch K, 2009, ENG OPTIMIZ, V41, P855, DOI 10.1080/03052150903074239; Tikhonov A., 1977, SOLUTION ILL POSED P; Tikhonov A. N., 1975, Journal of Engineering Physics, V29, P816, DOI 10.1007/BF00860616; Woodbury K. A., 2003, INVERSE ENG HDB	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218600	10.1371/journal.pone.0218600	http://dx.doi.org/10.1371/journal.pone.0218600			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233533	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700024
J	Orter, S; Ravi, DK; Singh, NB; Vogl, F; Taylor, WR; Ignasiak, NK				Orter, Stefan; Ravi, Deepak K.; Singh, Navrag B.; Vogl, Florian; Taylor, William R.; Ignasiak, Niklas Konig			A method to concatenate multiple short time series for evaluating dynamic behaviour during walking	PLOS ONE			English	Article							LARGEST LYAPUNOV EXPONENT; ASSESSING GAIT STABILITY; SPACE RECONSTRUCTION; APPROXIMATE ENTROPY; ELDERLY INDIVIDUALS; SAMPLE ENTROPY; VARIABILITY; BALANCE	Gait variability is a sensitive metric for assessing functional deficits in individuals with mobility impairments. To correctly represent the temporal evolution of gait kinematics, nonlinear measures require extended and uninterrupted time series. In this study, we present and validate a novel algorithm for concatenating multiple time-series in order to allow the nonlinear analysis of gait data from standard and unrestricted overground walking protocols. The full-body gait patterns of twenty healthy subjects were captured during five walking trials (at least 5 minutes) on a treadmill under different weight perturbation conditions. The collected time series were cut into multiple shorter time series of varying lengths and subsequently concatenated using a novel algorithm that identifies similar poses in successive time series in order to determine an optimal concatenation time point. After alignment of the datasets, the approach then concatenated the data to provide a smooth transition. Nonlinear measures to assess stability (Largest Lyapunov Exponent, LyE) and regularity (Sample Entropy, SE) were calculated in order to quantify the efficacy of the concatenation approach using intra-class correlation coefficients, standard error of measurement and paired effect sizes. Our results indicate overall good agreement between the full uninterrupted and the concatenated time series for LyE. However, SE was more sensitive to the proposed concatenation algorithm and might lead to false interpretation of physiological gait signals. This approach opens perspectives for analysis of dynamic stability of gait data from physiological overground walking protocols, but also the re-processing and estimation of nonlinear metrics from previously collected datasets.	[Orter, Stefan; Ravi, Deepak K.; Singh, Navrag B.; Vogl, Florian; Taylor, William R.; Ignasiak, Niklas Konig] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Ignasiak, Niklas Konig] Chapman Univ, Dept Phys Therapy, Irvine, CA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Chapman University System; Chapman University	Taylor, WR (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	bt@ethz.ch	Ignasiak, Niklas/F-8617-2014; Ravi, Deepak Kumar/S-3490-2019; Singh, Navrag/F-5305-2012; Taylor, William R./F-8692-2010	Ignasiak, Niklas/0000-0001-9065-3344; Ravi, Deepak Kumar/0000-0002-5015-8901; Singh, Navrag/0000-0001-8074-041X; Taylor, William R./0000-0003-4060-4098				Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Batlkham B, 2014, VALUE HEALTH, V17, pA774, DOI 10.1016/j.jval.2014.08.337; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Decker LM, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-8; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Govindan RB, 2007, PHYSICA A, V376, P158, DOI 10.1016/j.physa.2006.10.077; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Konig N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0353; Konig N, 2014, GAIT POSTURE, V39, P615, DOI 10.1016/j.gaitpost.2013.06.014; Konig N, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00319; Kovar L, 2002, ACM T GRAPHIC, V21, P473, DOI 10.1145/566570.566605; LaFiandra M, 2003, J BIOMECH, V36, P87, DOI 10.1016/S0021-9290(02)00243-9; McCamley JD, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20100764; Mehdizadeh S, 2018, GAIT POSTURE, V60, P241, DOI 10.1016/j.gaitpost.2017.12.016; Mizuguchi Mark, 2001, EUROGRAPHICS SHORT P; MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Paterson KL, 2009, AGE AGEING, V38, P745, DOI 10.1093/ageing/afp159; Raffalt PC, 2019, ANN BIOMED ENG, V47, P913, DOI 10.1007/s10439-019-02216-1; Ramdani S, 2009, CHAOS, V19, DOI 10.1063/1.3081406; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rispens SM, 2014, J BIOMECH, V47, P470, DOI 10.1016/j.jbiomech.2013.10.037; ROSENSTEIN MT, 1994, COMPUT GRAPH, V18, P587, DOI 10.1016/0097-8493(94)90072-8; Stergiou N., 2016, NONLINEAR ANAL HUMAN; van Schooten KS, 2014, GAIT POSTURE, V39, P695, DOI 10.1016/j.gaitpost.2013.09.020; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wurdeman SR, 2013, GAIT POSTURE, V38, P73, DOI 10.1016/j.gaitpost.2012.10.017; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218594	10.1371/journal.pone.0218594	http://dx.doi.org/10.1371/journal.pone.0218594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226152	Green Published, Green Submitted, gold			2022-12-26	WOS:000484894700024
J	Wang, SP; Zheng, X; Xia, HJ; Shi, D; Fan, JT; Wang, PY; Yan, ZG				Wang, Shuping; Zheng, Xin; Xia, Huijuan; Shi, Di; Fan, Juntao; Wang, Pengyuan; Yan, Zhenguang			Archaeal community variation in the Qinhuangdao coastal aquaculture zone revealed by high-throughput sequencing	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; 16S RIBOSOMAL-RNA; BACTERIAL COMMUNITIES; MICROBIAL COMMUNITIES; QUALITY ASSESSMENT; POLLUTED MANGROVE; HIGH ABUNDANCE; BOHAI SEA; DIVERSITY; SEDIMENTS	The differences in archaeal diversity and community composition in the sediments and waters of the Qinhuangdao coastal aquaculture zone were investigated. Furthermore, the associations between dominant archaeal taxa with geographic and environmental variables were evaluated. High-throughput sequencing of archaeal 16S rRNA genes yielded a total of 176,211 quality-filtered reads and 1,178 operational taxonomic units (OTUs) overall. The most abundant phylum and class among all communities were Thaumarchaeota and Nitrososphaeria, respectively. Beta diversity analysis indicated that community composition was divided into two groups according to the habitat type (i.e., sediments or waters). Only 9.8% OTUs were shared by communities from the two habitats, while 73.9% and 16.3% of the OTUs were unique to sediment or water communities, respectively. Furthermore, the relative abundances of the dominant OTUs differed with habitat type. Investigations of relationships between dominant OTUs and environmental variables indicated that some dominant OTUs were more sensitive to variation in environmental factors, which could be due to individual taxonomic differences in lifestyles and biological processes. Overall, the investigation of archaeal community variation within the Qinhuangdao coastal aquaculture zone provides an important baseline understanding of the microbial ecology in this important ecosystem.	[Wang, Shuping; Zheng, Xin; Xia, Huijuan; Shi, Di; Fan, Juntao; Wang, Pengyuan; Yan, Zhenguang] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China	Chinese Research Academy of Environmental Sciences	Yan, ZG (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	zgyan@craes.org.cn	Wang, Shuping/ABD-1765-2021	Yan, Zhen-guang/0000-0002-5355-6446	Major Science and Technology Program for Water Pollution Control and Treatment [2017ZX07301002-01]	Major Science and Technology Program for Water Pollution Control and Treatment	ZY is supported by the Major Science and Technology Program for Water Pollution Control and Treatment under contract No. 2017ZX07301002-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer B, 2016, ISME J, V10, P1051, DOI 10.1038/ismej.2015.200; Berg C, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00786; Bernhard AE, 2010, APPL ENVIRON MICROB, V76, P1285, DOI 10.1128/AEM.02018-09; Bhattacharyya A, 2015, ARCHAEA, V2015, DOI 10.1155/2015/968582; Billard E, 2015, HYDROBIOLOGIA, V751, P159, DOI 10.1007/s10750-015-2184-6; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076946, 10.1371/journal.pone.0052853]; Cao HL, 2011, SYST APPL MICROBIOL, V34, P513, DOI 10.1016/j.syapm.2010.11.023; Cao XH, 2018, J OCEANOL LIMNOL, V36, P281, DOI 10.1007/s00343-017-5216-4; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Choi H, 2016, J MICROBIOL BIOTECHN, V26, P883, DOI 10.4014/jmb.1512.12036; Coci M, 2015, ARCHAEA, V2015, DOI 10.1155/2015/590434; Coolen MJL, 2004, ORG GEOCHEM, V35, P1151, DOI 10.1016/j.orggeochem.2004.06.009; Cui L, 2018, ECOTOX ENVIRON SAFE, V159, P85, DOI 10.1016/j.ecoenv.2018.04.043; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eme L, 2015, CURR BIOL, V25, P690, DOI [10.1016/j.cub.2015.01.014, DOI 10.1016/J.CUB.2015.01.014]; Gao XL, 2014, ENVIRON INT, V62, P12, DOI 10.1016/j.envint.2013.09.019; Gibtan A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00799; Gifford SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00185; Gomez-Pereira PR, 2010, ISME J, V4, P472, DOI 10.1038/ismej.2009.142; Groussin M, 2011, MOL BIOL EVOL, V28, P2661, DOI 10.1093/molbev/msr098; He YD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01579; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Jung MY, 2014, APPL ENVIRON MICROB, V80, P3645, DOI 10.1128/AEM.03730-13; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Keuter S, 2016, INT MICROBIOL, V19, P109, DOI 10.2436/20.1501.01.269; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kopke B, 2005, APPL ENVIRON MICROB, V71, P7819, DOI 10.1128/AEM.71.12.7819-7830.2005; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Li JL, 2013, MICROB ECOL, V66, P861, DOI 10.1007/s00248-013-0272-6; Li M, 2011, ECOTOXICOLOGY, V20, P1780, DOI 10.1007/s10646-011-0711-4; Lin XZ, 2017, ACTA OCEANOL SIN, V36, P146, DOI 10.1007/s13131-017-1030-2; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Liu SG, 2011, MAR POLLUT BULL, V62, P2220, DOI 10.1016/j.marpolbul.2011.06.021; Liu Y, 2016, MAR POLLUT BULL, V103, P211, DOI 10.1016/j.marpolbul.2015.12.017; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Nam YD, 2008, J MICROBIOL, V46, P125, DOI 10.1007/s12275-007-0189-1; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Ou LJ, 2018, HARMFUL ALGAE, V74, P1, DOI 10.1016/j.hal.2018.03.005; Parkes JR, 2000, HYDROGEOL J, V10, P346; Priscu JC, 1998, SCIENCE, V280, P2095, DOI 10.1126/science.280.5372.2095; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; Smith RJ, 2012, ENVIRON MICROBIOL, V14, P240, DOI 10.1111/j.1462-2920.2011.02614.x; Spang A, 2017, SCIENCE, V357, DOI 10.1126/science.aaf3883; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stoeck T, 2018, MAR POLLUT BULL, V127, P139, DOI 10.1016/j.marpolbul.2017.11.065; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urakawa H, 2010, APPL ENVIRON MICROB, V76, P2129, DOI 10.1128/AEM.02692-09; Valentine DL, 2002, ANTON LEEUW INT J G, V81, P271, DOI 10.1023/A:1020587206351; Vila-Costa M, 2013, FEMS MICROBIOL ECOL, V84, P387, DOI 10.1111/1574-6941.12068; Wang SP, 2019, J OCEANOL LIMNOL, V37, P1638, DOI 10.1007/s00343-019-8210-1; Wang XY, 2014, APPL MICROBIOL BIOT, V98, P1883, DOI 10.1007/s00253-013-5174-5; Webster G, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu025; Wemheuer F, 2019, ARCHAEA, V2019, DOI 10.1155/2019/3717239; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Xie W, 2018, ENVIRON MICROBIOL, V20, P734, DOI 10.1111/1462-2920.14004; Yang YZ, 2019, ENVIRON POLLUT, V245, P290, DOI 10.1016/j.envpol.2018.11.002; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Youssef NH, 2015, ISME J, V9, P447, DOI 10.1038/ismej.2014.141; Zhang C, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.01237, 10.3389/fmicb.2015.01108]; Zhang JX, 2015, APPL MICROBIOL BIOT, V99, P3291, DOI 10.1007/s00253-014-6262-x; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044593; Zhang YQ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00590; Zhou ZC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02148; Zhu X, 2018, 2018 2ND IEEE CONFERENCE ON ENERGY INTERNET AND ENERGY SYSTEM INTEGRATION (EI2), P349	72	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218611	10.1371/journal.pone.0218611	http://dx.doi.org/10.1371/journal.pone.0218611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226149	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700025
J	Cooper, RE; Hanratty, E; Morant, N; Moncrieff, J				Cooper, Ruth E.; Hanratty, Eanna; Morant, Nicola; Moncrieff, Joanna			Mental health professionals' views and experiences of antipsychotic reduction and discontinuation	PLOS ONE			English	Article							REMITTED 1ST-EPISODE PSYCHOSIS; SHARED DECISION-MAKING; MAINTENANCE TREATMENT; SCHIZOPHRENIA; MEDICATION; DRUGS; CARE; MANAGEMENT; POWER; RISK	Background The widely established treatment for psychosis is long-term antipsychotic medication. However, many people stop taking this treatment, and request other options. There are also growing concerns about adverse effects, but currently no professional guidelines to support reducing or stopping these drugs. The views and experiences of individual mental health professionals around reducing and stopping antipsychotics are therefore crucial in treatment decisions. Methods We conducted 7 focus groups with prescribing psychiatrists and other members of community-based statutory mental health services in London. Participants discussed their views about, experiences, and processes of antipsychotic reduction and discontinuation. Data were analysed using thematic analysis. Results Participants acknowledged that antipsychotics can have severe adverse effects. They were generally supportive of trying to reduce these drugs to the lowest effective dose, although stopping antipsychotics was less acceptable. Prior experiences of adverse events after reduction or discontinuation meant that both were approached with caution. Reduction was also reported to be hampered by organisational and knowledge barriers. Lack of resources, pressure to discharge, and poor continuity of care were seen as organisational barriers. Knowledge barriers included inadequate evidence about who might be best suited to reduction, and lack of guidance about how this could be done safely. This meant that reduction was often prompted by patients, and sometimes actively discouraged, and stability with maintenance treatment was often favoured. Conclusions Concerns about risk and other barriers means that clinicians are often reluctant to implement reduction or discontinuation of antipsychotic medication. In order to increase the treatment options available to service users, more research and guidance on how to minimise the risks of antipsychotic reduction and discontinuation is required to enable clinicians to engage more constructively with service users requests, offering people more choice and control in managing their mental health condition.	[Cooper, Ruth E.] Queen Mary Univ London, Newham Ctr Mental Hlth, Unit Social & Community Psychiat, London, England; [Hanratty, Eanna; Moncrieff, Joanna] North East London NHS Fdn Trust, Goodmayes Hosp, Res & Dev Dept, Rainham, Essex, England; [Morant, Nicola; Moncrieff, Joanna] UCL, Div Psychiat, London, England	University of London; Queen Mary University London; University of London; University College London	Cooper, RE (corresponding author), Queen Mary Univ London, Newham Ctr Mental Hlth, Unit Social & Community Psychiat, London, England.	ruth.cooper3@nhs.net		Cooper, Ruth/0000-0002-9735-4731; Moncrieff, Joanna/0000-0003-1214-6974; Morant, Nicola/0000-0003-4022-8133	National Institute for Health Research, Programme Grants for Applied Research, Research into Antipsychotic Discontinuation And Reduction (RADAR) [RP-PG-0514-20004]	National Institute for Health Research, Programme Grants for Applied Research, Research into Antipsychotic Discontinuation And Reduction (RADAR)	This report is independent research funded by the National Institute for Health Research, Programme Grants for Applied Research, Research into Antipsychotic Discontinuation And Reduction (RADAR), RP-PG-0514-20004, awarded to JM. URL: https://www.nihr.ac.uk/research-and-impact/research/nihr-studies/programme-grants-for-applied-research.htm. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker Elina, 2013, ADV PSYCHIAT TREATME, V19, P2, DOI [10.1192/apt.bp.110.008342, DOI 10.1192/APT.BP.110.008342]; Braun V, 2013, SUCCESSFUL QUALITATI, P19; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chen Eric Y H, 2010, BMJ, V341, pc4024, DOI 10.1136/bmj.c4024; Cooper RE, SCHIZOPHR RES; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; GILBERT PL, 1995, ARCH GEN PSYCHIAT, V52, P173; Goss C, 2008, BRIT J PSYCHIAT, V193, P416, DOI 10.1192/bjp.bp.107.048728; Hamann J, 2009, PSYCHIAT SERV, V60, P1107, DOI 10.1176/appi.ps.60.8.1107; Happell B, 2014, J CLIN NURS, V23, P1018, DOI 10.1111/jocn.12371; Harris J, 2011, PRINCIPLES AND PRACTICE OF GROUP WORK IN ADDICTIONS, P110; Harris K, 2017, CHRONIC ILLN, V13, P275, DOI 10.1177/1742395317694223; Hasan A, 2013, WORLD J BIOL PSYCHIA, V14, P2, DOI 10.3109/15622975.2012.739708; Hui CLM, 2018, LANCET PSYCHIAT, V5, P432, DOI 10.1016/S2215-0366(18)30090-7; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Kerwick S, 1997, BRIT J GEN PRACT, V47, P225; Knegtering H, 2003, PSYCHONEUROENDOCRINO, V28, P109, DOI 10.1016/S0306-4530(02)00130-0; Lacro JP, 2002, J CLIN PSYCHIAT, V63, P892, DOI 10.4088/JCP.v63n1007; Lambert H, 2002, BRIT MED J, V325, P210, DOI 10.1136/bmj.325.7357.210; Laugharne R, 2012, INT J SOC PSYCHIATR, V58, P496, DOI 10.1177/0020764011408658; Laxhman N, 2017, SCHIZOPHR RES, V190, P63, DOI 10.1016/j.schres.2017.03.005; LEFF JP, 1971, BRIT MED J, V3, P599, DOI 10.1136/bmj.3.5775.599; Lester H, 2004, BRIT J GEN PRACT, V54, P285; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Leucht S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008016.pub2; Lieberman JA, 2005, NEW ENGL J MED, P877, DOI [10.1056/NEJMoa044057, DOI 10.1056/NEJMOA044057]; Liegghio M., 2013, MAD MATTERS CRITICAL, P122; Lindenmayer JP, 2000, PSYCHIAT QUART, V71, P373, DOI 10.1023/A:1004640408501; Moncrieff J, 2009, ACTA PSYCHIAT SCAND, V120, P102, DOI 10.1111/j.1600-0447.2009.01356.x; Moncrieff J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001861; Moncrieff J, 2015, CURR OPIN PSYCHIATR, V28, P264, DOI 10.1097/YCO.0000000000000151; Moncrieff J, 2009, HARVARD REV PSYCHIAT, V17, P214, DOI 10.1080/10673220902979896; Morant Nicola, 2018, J Ment Health, V27, P322, DOI 10.1080/09638237.2017.1370637; Morant N, 2016, HEALTH EXPECT, V19, P1002, DOI 10.1111/hex.12392; Morrison AP, 2012, BRIT J PSYCHIAT, V201, P83, DOI 10.1192/bjp.bp.112.112110; Murray RM, 2016, BRIT J PSYCHIAT, V209, P363, DOI 10.1192/bjp.bp.116.182683; National Institute for Health and Care Excellence [NICE], 2014, PSYCH SCH AD PREV MA; Quirk A, 2012, SOCIOL HEALTH ILL, V34, P95, DOI 10.1111/j.1467-9566.2011.01363.x; Ray WA, 2009, NEW ENGL J MED, V360, P2137; Read J, 2009, EPIDEMIOL PSICHIAT S, V18, P299, DOI 10.1017/S1121189X00000257; Rogers A, 1998, MEANING MANAGEMENT N, P47; Royal College of Psychiatrists, 2014, REP 2 ROUND NAT AD S; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Simmons SF, 2018, GERONTOLOGIST, V58, pE239, DOI 10.1093/geront/gnx083; Stevenson FA, 2000, SOC SCI MED, V50, P829, DOI 10.1016/S0277-9536(99)00376-7; The Schizophrenia Commission, 2012, AB ILLN REP SCH COMM; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vanheule S, 2011, THEOR PSYCHOL, V21, P86, DOI 10.1177/0959354310369275; Vita A, 2015, BIOL PSYCHIAT, V78, P403, DOI 10.1016/j.biopsych.2015.02.008; Wunderink L, 2007, J CLIN PSYCHIAT, V68, P654, DOI 10.4088/JCP.v68n0502; Wunderink L, 2013, JAMA PSYCHIAT, V70, P913, DOI 10.1001/jamapsychiatry.2013.19	52	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218711	10.1371/journal.pone.0218711	http://dx.doi.org/10.1371/journal.pone.0218711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220160	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000484893500085
J	Carvajal-Castro, JD; Ospina, AM; Toro-Lopez, Y; Pulido, A; Cabrera-Casas, LX; Guerrero-Pelaez, S; Garcia-Merchan, VH; Vargas-Salinas, F				David Carvajal-Castro, Juan; Maria Ospina-L, Ana; Toro-Lopez, Yemay; Pulido-G, Anny; Ximena Cabrera-Casas, Laura; Guerrero-Pelaez, Sebastian; Hugo Garcia-Merchan, Victor; Vargas-Salinas, Fernando			Birds vs bricks: Patterns of species diversity in response to urbanization in a Neotropical Andean city	PLOS ONE			English	Article							ANTHROPOGENIC NOISE; FOREST BIRDS; URBAN; EXTRAPOLATION; COMMUNITIES; RAREFACTION; AVIFAUNA; BIODIVERSITY; LANDSCAPE; HOMOGENIZATION	Urbanization is currently one the most important causes of biodiversity loss. The Colombian Andes is a well-known hotspot for biodiversity, however, it also exhibit high levels of urbanization, making it a useful site to document how species assemblages respond to habitat transformation. To do this, we compared the structure and composition of bird assemblages between rural and urban habitats in Armenia, a medium sized city located in the Central Andes of Colombia. In addition, we examined the influence of urban characteristics on bird species diversity within the city of Armenia. From September 2016 to February 2017 we performed avian surveys in 76 cells (250 x 250 m each) embedded within Armenia city limits; and in 23 cells (250 x 250 m each) in rural areas around Armenia. We found that bird diversity was significantly lower in urban habitats than in rural habitats, and differed in species composition by 29%. In urban cells, with higher abiotic noise intensity and higher impervious surface area, we found lower bird diversity than that in urban cells with higher guadual (Guadua angustifolia patches), and forested surface areas. We did not find segregation of urban cells according to the species composition, although additional bird surveys inside urban forests remnant are needed to be more conclusive about this aspect. Altogether, our results highlight the importance of green areas embedded within cities to conserve bird diversity through reducing the ecological impact of urbanization on avian biodiversity.	[David Carvajal-Castro, Juan; Maria Ospina-L, Ana; Toro-Lopez, Yemay; Pulido-G, Anny; Ximena Cabrera-Casas, Laura; Guerrero-Pelaez, Sebastian; Hugo Garcia-Merchan, Victor; Vargas-Salinas, Fernando] Univ Quindio, Programa Biol, Grp Invest Evoluc Ecol & Conservac EECO, Armenia, Colombia; [David Carvajal-Castro, Juan; Maria Ospina-L, Ana] Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia	Universidad del Quindio; Alliance; International Center for Tropical Agriculture - CIAT	Carvajal-Castro, JD (corresponding author), Univ Quindio, Programa Biol, Grp Invest Evoluc Ecol & Conservac EECO, Armenia, Colombia.; Carvajal-Castro, JD (corresponding author), Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia.	carvajaljcastro@gmail.com		Ospina Larrea, Ana Maria/0000-0003-1398-7521; Cabrera Casas, Laura/0000-0002-1031-7736; Carvajal-Castro, Juan David/0000-0002-3182-9474; Toro Lopez, Yemay/0000-0001-9257-5925				ALVAREZ-LOPEZ H, 1984, Caldasia, V14, P85; Medina PA, 2010, BITACORA URBANO TERR, V17, P73; Andres Rojas-Morales Julian, 2012, PHYLLOMEDUSA, V11, P135; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Barth BJ, 2015, LANDSCAPE URBAN PLAN, V136, P122, DOI 10.1016/j.landurbplan.2014.11.003; Barton J., 2010, URBAN ECOL, V12, P202, DOI DOI 10.1017/CB09780511778483.010; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Cadena C. D., 2011, P ROYAL SOC B, V279, P194, DOI DOI 10.1098/RSPB.2011.0720; Catterall CP, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P129, DOI 10.1017/CBO9780511609763.009; Caula S, 2008, LANDSCAPE URBAN PLAN, V87, P1, DOI 10.1016/j.landurbplan.2008.03.006; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; CRQ-SIG, 2016, SIST INF GEORR; Curson J, 2017, HDB BIRDS WORLD ALIV; Dale S, 2018, URBAN ECOSYST, V21, P1, DOI 10.1007/s11252-017-0706-x; DANE, 2015, EST CENS DEM; Delgado CA, 2012, LANDSCAPE URBAN PLAN, V105, P5, DOI 10.1016/j.landurbplan.2011.12.019; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Ferenc M, 2014, GLOBAL ECOL BIOGEOGR, V23, P479, DOI 10.1111/geb.12130; Fernandez-Juricic E, 2000, CONSERV BIOL, V14, P513, DOI 10.1046/j.1523-1739.2000.98600.x; Filloy J, 2015, URBAN ECOSYST, V18, P777, DOI 10.1007/s11252-014-0429-1; Florez-Henao E, 2018, GUIA ARBOLES ARBUSTO; Fontana CS, 2011, URBAN ECOSYST, V14, P341, DOI 10.1007/s11252-011-0156-9; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Gagne SA, 2007, LANDSCAPE ECOL, V22, P205, DOI 10.1007/s10980-006-9012-3; Gagne SA, 2011, ECOL APPL, V21, P2297, DOI 10.1890/09-1905.1; Garcia C. M., 2017, ECOLOGY CONSERVATION, P91, DOI [10.1007/978-3-319-43314-1_6, DOI 10.1007/978-3-319-43314-1_6, 10.1007/978-3-319-43314-1]; Garden J, 2006, AUSTRAL ECOL, V31, P126, DOI 10.1111/j.1442-9993.2006.01578.x; Gil D, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P1; Gomez-Baggethun Erik, 2013, P175; Graham CH, 2010, J BIOGEOGR, V37, P1863, DOI 10.1111/j.1365-2699.2010.02356.x; Gregory RD, 2004, TECH ECOL CONSERVAT, P17; Haedo J, 2017, URBAN FOR URBAN GREE, V26, P57, DOI 10.1016/j.ufug.2017.04.017; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; Heezik YV., 2017, ECOLOGY CONSERVATION, P185; Helden AJ, 2012, URBAN ECOSYST, V15, P611, DOI 10.1007/s11252-012-0231-x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hilty SL, 1986, GUIDE BIRDS COLOMBIA; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Hu Y, 2009, BEHAV ECOL, V20, P1268, DOI 10.1093/beheco/arp131; Hutter CR, 2017, AM NAT, V190, P828, DOI 10.1086/694319; IBM Corp, 2013, IBM SPSS STAT WINDOW; IUCN, 2020, IUCN RED LIST THREAT; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jokimaki J, 2003, J BIOGEOGR, V30, P1183, DOI 10.1046/j.1365-2699.2003.00896.x; Jones G, 2008, CURR BIOL, V18, pR1098, DOI 10.1016/j.cub.2008.10.005; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kattan GH, 2004, J BIOGEOGR, V31, P1829, DOI 10.1111/j.1365-2699.2004.01109.x; Kattan GH., 2002, ECOLOGIA CONSERVACIO, P561; Kattan GH, 2006, CONSERV BIOL, V20, P1203, DOI 10.1111/j.1523-1739.2006.00402.x; Kattan Gustavo H., 1996, P3; Kight CR, 2011, ECOL LETT, V14, P1052, DOI 10.1111/j.1461-0248.2011.01664.x; Knop E, 2016, GLOBAL CHANGE BIOL, V22, P228, DOI 10.1111/gcb.13091; LANCASTER RK, 1979, CAN J ZOOL, V57, P2358, DOI 10.1139/z79-307; Lees AC, 2017, URBAN ECOSYST, V20, P1019, DOI 10.1007/s11252-017-0661-6; Leonard ML, 2012, BIOL LETTERS, V8, P530, DOI 10.1098/rsbl.2012.0032; Lepczyk CA, 2012, STUD AVIAN BIOL, V45, P1, DOI 10.1525/california/9780520273092.001.0001; Loss Scott R, 2013, Nat Commun, V4, P1396, DOI 10.1038/ncomms2380; Luck GW, 2011, J BIOGEOGR, V38, P894, DOI 10.1111/j.1365-2699.2010.02449.x; Luck Gary W., 2010, P88; MacGregor-Fors I, 2013, URBAN ECOSYST, V16, P389, DOI 10.1007/s11252-012-0267-y; MacGregor-Fors I, 2012, STUD AVIAN BIOL, V45, P33; Marin Gomez Oscar Humberto, 2005, Boletin SAO, V15, P42; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McMullan M., 2011, GUIA CAMPO AVES COLO, V1st ed.; Moller AP, 2011, ETHOLOGY, V117, P529, DOI 10.1111/j.1439-0310.2011.01899.x; MOORE KR, 1983, J RAPTOR RES, V17, P65; Munoz Marcia C., 2007, Ornitologia Colombiana, V5, P5; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ortega Catherine P., 2012, Ornithological Monographs, V74, P6; Ortega-Alvarez R, 2011, LANDSCAPE URBAN PLAN, V101, P1, DOI 10.1016/j.landurbplan.2010.12.020; Ortega-Alvarez R, 2009, LANDSCAPE URBAN PLAN, V90, P189, DOI 10.1016/j.landurbplan.2008.11.003; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pauchard Anibal, 2013, P589; Piratelli Augusto Joao, 2017, P143; Proppe DS, 2013, GLOBAL CHANGE BIOL, V19, P1075, DOI 10.1111/gcb.12098; QGIS Development Team, 2018, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; RALPH C. J., 1995, MONITORING BIRD POPU; Rana Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120580, 10.1371/journal.pone.0125187, 10.1371/journal.pone.0121992]; Reis E, 2012, LANDSCAPE URBAN PLAN, V107, P31, DOI 10.1016/j.landurbplan.2012.04.009; Remsen J.V.J., 2021, CLASSIFICATION BIRD; Renjifo LM, 2001, ECOL APPL, V11, P14, DOI 10.1890/1051-0761(2001)011[0014:EONAAL]2.0.CO;2; Renjifo LM, 1999, CONSERV BIOL, V13, P1124, DOI 10.1046/j.1523-1739.1999.98311.x; Renjifo LM, 2014, LIBRO ROJO AVES COLO, VI; Renjifo LM, 2016, LIBRO ROJO AVES COLO, VII; Robertson B, 2010, ACTA ZOOL ACAD SCI H, V56, P283; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; Rodriguez JV., 2002, LOROS COLOMBIA, V3; Rosselli L, 2017, ACTA BIOL COLOMB, V22, P181, DOI 10.15446/abc.v22n2.60688; Sadler J., 2010, URBAN ECOL, P230; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Salazar-Montoya A, 2005, DISENO CORREDORES CO; Salazar-Montoya A, 2005, CARACTERIZACION MICR; Salazar-Montoya A, 2005, PLAN ORDENAMIENTO MA; Shanahan DF, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P3; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Short L. L., 2017, HDB BIRDS WORLD ALIV; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Snow D, 2017, HDB BIRDS WORLD ALIV; Sol D, 2017, ECOL LETT, V20, P721, DOI 10.1111/ele.12769; Taylor B., 2017, HDB BIRDS WORLD ALIV; Tomasevic JA, 2017, URBAN ECOSYST, V20, P435, DOI 10.1007/s11252-016-0605-6; van Heezik Y, 2012, NEW ZEAL J ECOL, V36, P391; Vanegas-Guerrero Jhonattan, 2016, Herpetological Review, V47, P180; Villegas Mariana, 2010, Urban Ecosystems, V13, P375, DOI 10.1007/s11252-010-0126-7; Vitz AC, 2007, AUK, V124, P494, DOI 10.1642/0004-8038(2007)124[494:VAFRAD]2.0.CO;2; Wiley R.H., 2013, ANIMAL COMMUNICATION, P7, DOI [10.1007/978-3-642-41494-7_2, DOI 10.1007/978-3-642-41494-7_2]; Wittig TW, 2017, AVIAN CONSERV ECOL, V12, DOI [10.5751/ACE-01014-120117, 10.5751/ace-01014-120117]; Zipperer WC, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P274, DOI 10.1017/CBO9780511609763.018	125	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218775	10.1371/journal.pone.0218775	http://dx.doi.org/10.1371/journal.pone.0218775			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220178	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500090
J	McGregor, M; Hamilton, J; Hajnal, A; Thanos, PK				McGregor, Matthew; Hamilton, John; Hajnal, Andras; Thanos, Panayotis K.			Roux-en-Y gastric bypass in rat reduces mu-opioid receptor levels in brain regions associated with stress and energy regulation	PLOS ONE			English	Article							SURGERY PROSPECTIVE EVIDENCE; HIGH-FAT DIET; BARIATRIC SURGERY; WEIGHT-LOSS; NUCLEUS-ACCUMBENS; CALORIE RESTRICTION; INCREASES ETHANOL; PROGRESSIVE RATIO; NEUROPEPTIDE-Y; PALATABLE FOOD	Roux-en-Y gastric bypass surgery (RYGB) is the most common and effective weight loss procedure for severe obesity. However, a significant increase in addictive behaviors and new-onset substance use disorder (SUD) are sometimes observed post-surgery. The endogenous opioid system is known to play a major role in motivated behavior and reward, as well as the abuse of substances, including alcohol, tobacco, opioids and highly palatable foods. Here, we examined the effects of RYGB on mu-opioid receptor levels in the brain. Male Sprague-Dawley rats were assigned to one of four groups: standard diet with sham surgery (control), ad libitum high-energy high-fat (HF) diet with sham surgery, calorie restricted HF diet with sham surgery (Sham-FR), or HF diet with RYGB surgery. Control and HF groups were fed their respective diets for 8 weeks, with surgery performed on the eighth week. After 9 weeks on their respective diets post-surgery, animals were sacrificed for mu-opioid receptor autoradiography using the [H-3] [D-Ala2,N-Me-Phe4-Gly5-ol]- enkephalin (DAMGO) ligand. Rats with RYGB showed reduced DAMGO binding in the central amyg-dala compared to sham-operated HF diet controls, and in the hypothalamus compared to high-fat fed Sham-FR. Diet alone did not change [H-3] DAMGO binding in any region. These findings show that RYGB surgery, independent of diet or caloric restriction, decreases mu opioid signaling in specific regions important for stress and energy regulation. Thus, RYGB surgery may lead to greater stress sensitivity via downregulated mu opioid signaling in the central amygdala, which may contribute to the observed increased risk in some subjects for addictive behavior.	[McGregor, Matthew; Hamilton, John; Thanos, Panayotis K.] SUNY Buffalo, Jacobs Sch Med & Biosci, Behav Neuropharmacol & Neuroimaging Lab Addict, Clin Res Inst Addict,Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Hamilton, John; Thanos, Panayotis K.] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Hajnal, Andras] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Thanos, PK (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biosci, Behav Neuropharmacol & Neuroimaging Lab Addict, Clin Res Inst Addict,Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA.; Thanos, PK (corresponding author), SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA.	thanos@buffalo.edu		Hajnal, Andras/0000-0001-7297-7134	National Institutes of Health [AA024490]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by National Institutes of Health (AA024490) to PKT. https://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Alsio J, 2010, NEUROSCIENCE, V171, P779, DOI 10.1016/j.neuroscience.2010.09.046; Ardianto C, 2016, NEUROSCIENCE, V320, P183, DOI 10.1016/j.neuroscience.2016.02.002; Barnes MJ, 2008, AM J PHYSIOL-REG I, V295, pR1385, DOI 10.1152/ajpregu.00030.2008; Berthoud HR, 2012, ANN NY ACAD SCI, V1264, P36, DOI 10.1111/j.1749-6632.2012.06573.x; Biegler JM, 2016, BRAIN RES BULL, V123, P47, DOI 10.1016/j.brainresbull.2015.08.003; Blackburn AN, 2017, ADDICT BIOL, V22, P1540, DOI 10.1111/adb.12436; Blendy JA, 2005, PSYCHOPHARMACOLOGY, V180, P306, DOI 10.1007/s00213-005-2167-9; Blum K, 1996, J ROY SOC MED, V89, P396, DOI 10.1177/014107689608900711; Blum K, 2000, J PSYCHOACTIVE DRUGS, V32, P1, DOI [10.1080/02791072, DOI 10.1080/02791072, DOI 10.1080/02791072.2000.10736099]; Blum Kenneth, 2011, J Genet Syndr Gene Ther, V2012; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Conason A, 2013, JAMA SURG, V148, P145, DOI 10.1001/2013.jamasurg.265; Davis JF, 2013, OBES SURG, V23, P920, DOI 10.1007/s11695-013-0884-4; DUM J, 1983, PHARMACOL BIOCHEM BE, V18, P443, DOI 10.1016/0091-3057(83)90467-7; Dunn JP, 2010, BRAIN RES, V1350, P123, DOI 10.1016/j.brainres.2010.03.064; Ertelt TW, 2008, SURG OBES RELAT DIS, V4, P647, DOI 10.1016/j.soard.2008.01.004; Farias G, 2018, NEUROPEPTIDES, V69, P60, DOI 10.1016/j.npep.2018.04.005; Fox PD, 2017, J NEUROSCI, V37, P8667, DOI 10.1523/JNEUROSCI.1030-17.2017; Friend DM, 2017, CELL METAB, V25, P312, DOI 10.1016/j.cmet.2016.12.001; Gilpin NW, 2015, BIOL PSYCHIAT, V77, P859, DOI 10.1016/j.biopsych.2014.09.008; Glass MJ, 2000, AM J PHYSIOL-REG I, V279, pR86, DOI 10.1152/ajpregu.2000.279.1.R86; Gorelick DA, 2005, BIOL PSYCHIAT, V57, P1573, DOI 10.1016/j.biopsych.2005.02.026; GOSNELL BA, 1988, NEUROPHARMACOLOGY, V27, P319, DOI 10.1016/0028-3908(88)90050-0; Grayson BE, 2014, STRESS, V17, P484, DOI 10.3109/10253890.2014.967677; Gribsholt SB, 2017, SURG OBES RELAT DIS, V13, P581, DOI 10.1016/j.soard.2016.10.007; Hajnal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049121; Hajnal A, 2010, AM J PHYSIOL-GASTR L, V299, pG967, DOI 10.1152/ajpgi.00070.2010; Hamilton J, 2018, SYNAPSE, V72, DOI 10.1002/syn.22058; Hankir MK, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00620; Hatoum IJ, 2012, J CLIN ENDOCR METAB, V97, pE1023, DOI 10.1210/jc.2011-3432; Heinz A, 2005, ARCH GEN PSYCHIAT, V62, P57, DOI 10.1001/archpsyc.62.1.57; JOHNSON EO, 1992, NEUROSCI BIOBEHAV R, V16, P115, DOI 10.1016/S0149-7634(05)80175-7; Karlsson HK, 2016, MOL PSYCHIATR, V21, P1057, DOI 10.1038/mp.2015.153; King WC, 2017, SURG OBES RELAT DIS, V13, P1337, DOI 10.1016/j.soard.2017.04.003; King WC, 2017, SURG OBES RELAT DIS, V13, P1392, DOI 10.1016/j.soard.2017.03.021; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Mahler SV, 2012, PSYCHOPHARMACOLOGY, V221, P407, DOI 10.1007/s00213-011-2588-6; Mathes CM, 2015, AM J PHYSIOL-REG I, V309, pR864, DOI 10.1152/ajpregu.00029.2015; Mathes CM, 2015, PHYSIOL BEHAV, V142, P179, DOI 10.1016/j.physbeh.2015.02.004; Miras AD, 2012, AM J CLIN NUTR, V96, P467, DOI 10.3945/ajcn.112.036921; Mitchell JE, 2015, SURG OBES RELAT DIS, V11, P897, DOI 10.1016/j.soard.2014.10.026; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Olszewski PK, 2007, PHYSIOL BEHAV, V91, P506, DOI 10.1016/j.physbeh.2007.01.011; Pal G. K., 1993, Indian Journal of Experimental Biology, V31, P750; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Petrovich GD, 2009, J NEUROSCI, V29, P15205, DOI 10.1523/JNEUROSCI.3656-09.2009; Pitman KA, 2015, PHARMACOL THERAPEUT, V154, P110, DOI 10.1016/j.pharmthera.2015.07.005; Polston JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083741; Rada P, 2010, BRAIN RES, V1312, P1, DOI 10.1016/j.brainres.2009.11.055; Raebel MA, 2013, JAMA-J AM MED ASSOC, V310, P1369, DOI 10.1001/jama.2013.278344; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Romanova IV, 2004, J AM COLL SURGEONS, V199, P887, DOI 10.1016/j.jamcollsurg.2004.07.013; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Smith SL, 2002, BRAIN RES, V953, P215, DOI 10.1016/S0006-8993(02)03291-2; STANLEY BG, 1988, PHARMACOL BIOCHEM BE, V31, P825; Sundbom M, 2017, ANN SURG, V265, P1166, DOI 10.1097/SLA.0000000000001920; Thanos PK, 2012, OBES SURG, V22, P1884, DOI 10.1007/s11695-012-0749-2; Topart P, 2011, OBES SURG, V21, P1350, DOI 10.1007/s11695-011-0460-8; Touzani K, 1997, BEHAV BRAIN RES, V88, P133, DOI 10.1016/S0166-4328(96)02273-5; Tuulari JJ, 2017, J NEUROSCI, V37, P8284, DOI 10.1523/JNEUROSCI.0976-17.2017; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Westrin A, 1999, EUR NEUROPSYCHOPHARM, V9, P205, DOI 10.1016/S0924-977X(98)00026-1; Whitson BA, 2007, J SURG RES, V141, P31, DOI 10.1016/j.jss.2007.02.022; Will MJ, 2003, J NEUROSCI, V23, P2882; Wilson MA, 2008, NEUROPSYCHOPHARMACOL, V33, P2957, DOI 10.1038/sj.npp.1301675; Zechner JF, 2013, GASTROENTEROLOGY, V144, P580, DOI 10.1053/j.gastro.2012.11.022; Zhang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000437; Zhang M, 2003, BEHAV NEUROSCI, V117, P202, DOI 10.1037/0735-7044.117.2.202; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908	71	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218680	10.1371/journal.pone.0218680	http://dx.doi.org/10.1371/journal.pone.0218680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220174	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500084
J	Wang, YD; Palmfeldt, J; Gregersen, N; Makhov, AM; Conway, JF; Wang, MC; McCalley, SP; Basu, S; Alharbi, H; St Croix, C; Calderon, MJ; Watkins, S; Vockley, J				Wang, Yudong; Palmfeldt, Johan; Gregersen, Niels; Makhov, Alexander M.; Conway, James F.; Wang, Meicheng; McCalley, Stephen P.; Basu, Shrabani; Alharbi, Hana; St Croix, Claudette; Calderon, Michael J.; Watkins, Simon; Vockley, Jerry			Mitochondrial fatty acid oxidation and the electron transport chain comprise a multifunctional mitochondrial protein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid oxidation; mitochondrial respiratory chain complex; mitochondrial metabolism; protein structure; proteomics; electron microscopy (EM); primary metabolism; stimulated emission depletion microscopy (STED); supercomplex; trifunctional protein (TFP)	BETA-OXIDATION; SYNERGISTIC HETEROZYGOSITY; ENZYMES; SUPERCOMPLEXES; ARCHITECTURE; OXIDASE; IV	Three mitochondrial metabolic pathways are required for efficient energy production in eukaryotic cells: the electron transfer chain (ETC), fatty acid beta-oxidation (FAO), and the tricarboxylic acid cycle. The ETC is organized into inner mitochondrial membrane supercomplexes that promote substrate channeling and catalytic efficiency. Although previous studies have suggested functional interaction between FAO and the ETC, their physical interaction has never been demonstrated. In this study, using blue native gel and two-dimensional electrophoreses, nano-LC-MS/MS, immunogold EM, and stimulated emission depletion microscopy, we show that FAO enzymes physically interact with ETC supercomplexes at two points. We found that the FAO trifunctional protein (TFP) interacts with the NADH-binding domain of complex I of the ETC, whereas the electron transfer enzyme flavoprotein dehydrogenase interacts with ETC complex III. Moreover, the FAO enzyme very-long-chain acyl-CoA dehydrogenase physically interacted with TFP, thereby creating a multifunctional energy protein complex. These findings provide a first view of an integrated molecular architecture for the major energy-generating pathways in mitochondria that ensures the safe transfer of unstable reducing equivalents from FAO to the ETC. They also offer insight into clinical ramifications for individuals with genetic defects in these pathways.	[Wang, Yudong; Wang, Meicheng; Basu, Shrabani; Alharbi, Hana; Vockley, Jerry] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Makhov, Alexander M.; Conway, James F.] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15261 USA; [Palmfeldt, Johan; Gregersen, Niels] Aarhus Univ Hosp, Res Unit Mol Med, DK-8200 Aarhus, Denmark; [McCalley, Stephen P.; Vockley, Jerry] Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [St Croix, Claudette] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Calderon, Michael J.; Watkins, Simon; Vockley, Jerry] UPMC Childrens Hosp Pittsburgh, Ctr Rare Dis Therapy, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vockley, J (corresponding author), UPMC Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	gerard.vockley@chp.edu	Wang, Yudong/ABG-1086-2021; Vockley, Jerry/AAF-8523-2020; Watkins, Simon/ABG-2590-2021; Vockley, Jerry/B-5210-2016; St Croix, Claudette/AAA-3338-2022; Alharbi, Hana/GXG-0806-2022; Conway, James/A-2296-2010	Wang, Yudong/0000-0003-3224-4555; Vockley, Jerry/0000-0002-8180-6457; Watkins, Simon/0000-0003-4092-1552; Vockley, Jerry/0000-0002-8180-6457; Alharbi, Hana/0000-0002-6139-2816; Palmfeldt, Johan/0000-0001-5585-639X; Basu, Shrabani/0000-0001-5096-5490; Conway, James/0000-0002-6581-4748	National Institutes of Health [S10OD021540, 1S10OD025009-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078775] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021540, S10OD025009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant 1S10OD025009-01 (to J.F.C.) and in part by National Institutes of Health Grant S10OD021540 (to S.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Hua JF, 2017, MBIO, V8, DOI 10.1128/mBio.01579-17; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Kuhlbrandt W, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0201-x; Liang K, 2018, P NATL ACAD SCI USA, V115, P7039, DOI 10.1073/pnas.1801252115; Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Neumann Daniel, 2010, PMC Biophys, V3, P4, DOI 10.1186/1757-5036-3-4; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Parker A, 2000, BIOCHEM J, V345, P429, DOI 10.1042/0264-6021:3450429; Reifschneider NH, 2006, J PROTEOME RES, V5, P1117, DOI 10.1021/pr0504440; Sahebekhtiari N, 2016, PROTEOMICS, V16, P1166, DOI 10.1002/pmic.201500336; Saydmohammed M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05866-2; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schuler AM, 2005, MOL GENET METAB, V85, P7, DOI 10.1016/j.ymgme.2004.09.006; Shingler KL, 2015, J VIROL, V89, P1900, DOI 10.1128/JVI.03098-14; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; SUMEGI B, 1984, J BIOL CHEM, V259, P8748; SUMEGI B, 1991, BIOCHIM BIOPHYS ACTA, V1081, P121, DOI 10.1016/0005-2760(91)90016-B; Tao J, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224568; Van Laar VS, 2018, J NEUROSCI, V38, P7505, DOI 10.1523/JNEUROSCI.0541-18.2018; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Vockley J., 2016, ONLINE METABOLIC MOL; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Xia CW, 2019, P NATL ACAD SCI USA, V116, P6069, DOI 10.1073/pnas.1816317116; Zhang J, 2006, P NATL ACAD SCI USA, V103, P16212, DOI 10.1073/pnas.0604567103; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	37	37	37	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12380	12391		10.1074/jbc.RA119.008680	http://dx.doi.org/10.1074/jbc.RA119.008680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31235473	Green Published, hybrid			2022-12-26	WOS:000484402700011
J	Schumann, D; Kivel, N; Dressler, R				Schumann, Dorothea; Kivel, Niko; Dressler, Rugard			Production and characterization of Fe-60 standards for accelerator mass spectrometry	PLOS ONE			English	Article							SUPERNOVAE	Accelerator Mass Spectrometry ( AMS) is one of the most sensitive analysis techniques to measure long-lived radionuclides, reaching detection limits for isotopic ratios down to 10(-15)-10(-16) in special cases. Its application portfolio covers nearly every field of environmental research, considering processes in the atmosphere, biosphere, hydrosphere, cryosphere, lithosphere and the cosmosphere. Normally, AMS measures the content of isotopes in comparison to a validated standard. However, in some cases like for example Fe-60, well characterized standard materials are difficult to produce due to the extreme rareness of the isotope. We report here on the manufacturing of a set of Fe-60 standards, obtained by processing irradiated copper from a beam dump of the high-power proton accelerator ( HIPA) at the Paul Scherrer Institute ( PSI). The isotopic ratios of the standards have been adjusted via a dilution series of a master solution, isotopic content of which has been characterized by Multi Collector-Inductively Coupled Plasma-Mass Spectrometry ( MC-ICP-MS). In total, we produced three samples with isotopic ratios of 1.037(6).10(-8), 1.125(7).10(-10) and 1.234 (7).10(-12), respectively. The latter had already been applied in three pioneering AMS studies investigating the remaining signal of injected matter of nearby super novae explosions in sediment archives.	[Schumann, Dorothea; Dressler, Rugard] Paul Scherrer Inst Villigen, Dept Nucl Energy & Safety, Villigen, Switzerland; [Kivel, Niko] Paul Scherrer Inst Villigen, Div Large Res Facil, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Schumann, D (corresponding author), Paul Scherrer Inst Villigen, Dept Nucl Energy & Safety, Villigen, Switzerland.	dorothea.schumann@psi.ch						Binns WR, 2016, SCIENCE, V352, P677, DOI 10.1126/science.aad6004; Breitschwerdt D, 2016, NATURE, V532, P73, DOI 10.1038/nature17424; Fimiani L, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.151104; Fry BJ, 2016, ASTROPHYS J, V827, DOI 10.3847/0004-637X/827/1/48; Heftrich T, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.015806; Kivel N, 2013, ANAL BIOANAL CHEM, V405, P2965, DOI 10.1007/s00216-012-6587-1; Knie K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.171103; Knie K, 1999, METEORIT PLANET SCI, V34, P729, DOI 10.1111/j.1945-5100.1999.tb01385.x; Knie K, COMMUNICATION; Koster U., 2000, THESIS; KUTSCHERA W, 1984, NUCL INSTRUM METH B, V5, P430, DOI 10.1016/0168-583X(84)90555-X; Kutschera W, 1999, THESIS, DOI [10.3929/ethz-a-003837381, DOI 10.3929/ETHZ-A-003837381]; Ludwig P, 2016, P NATL ACAD SCI USA, V113, P9232, DOI 10.1073/pnas.1601040113; Ostdiek KM, 2017, PHYS REV C, V95, DOI 10.1103/PhysRevC.95.055809; Rugel G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.072502; Schumann D, 2013, RADIOCHIM ACTA, V101, P501, DOI 10.1524/ract.2013.2058; Schumann D, 2009, RADIOCHIM ACTA, V97, P123, DOI 10.1524/ract.2009.1585; Uberseder E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.151101; Wallner A, 2016, NATURE, V532, P69, DOI 10.1038/nature17196; Wallner A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.041101	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219039	10.1371/journal.pone.0219039	http://dx.doi.org/10.1371/journal.pone.0219039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251777	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000037
J	Neicun, J; Steenhuizen, M; van Kessel, R; Yang, JC; Negri, A; Czabanowska, K; Corazza, O; Roman-Urrestarazu, A				Neicun, Jessica; Steenhuizen, Marthe; van Kessel, Robin; Yang, Justin C.; Negri, Attilio; Czabanowska, Katarzyna; Corazza, Ornella; Roman-Urrestarazu, Andres			Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden	PLOS ONE			English	Article							DRUG POLICY; PATH DEPENDENCE; LEGAL HIGHS; CONVERGENCE	Introduction The rapid rise in trade and use of NPS and the lack of information concerning their potential toxicity pose serious challenges to public health authorities across the world. Policy measures towards NPS taken so far have a special focus on their legal status, while the implementation of a public health strategy seems to be still missing. The aim of this study is to perform a general assessment of NPS-related policy (including regulatory measures and public health strategies) implemented by six European countries: Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden. Methods Six EU countries were included in this scoping review study. Drug policies (including legal responses and public health strategies) were analysed. UNODC drug policy classification system was used as a benchmark, while path dependency approach was used for data analysis; a net of inter-dependencies between international, EU and national policies was highlighted. Results and discussion The countries included in this study can be placed in a wide spectrum according to their formulation of drug policy, from Portugal and the UK that have specific legal responses to NPS but have differently focused on harm reduction strategies at one end, to Sweden whose drug-free society goal is not translated into a specific regulation of NPS at the other end. Conclusion The findings of the study reveal limited development towards harmonisation of national drug policies particularly with regard to NPS. To tackle the challenge presented by NPS, EU Member states have formulated legislation and public health strategies independently. National approaches to NPS are therefore in line with their already existing drug policies, reflecting cultural values towards substance abuse and national political interests, while the homogenization at an international level has so far mostly been focused on law enforcement and drugs use preventive strategies.	[Neicun, Jessica; Czabanowska, Katarzyna; Roman-Urrestarazu, Andres] Univ Maastricht, Dept Int Hlth, Care & Publ Hlth Res Ctr, Maastricht, Netherlands; [Neicun, Jessica; Negri, Attilio; Corazza, Ornella] Univ Hertfordshire, Ctr Clin, Novel Psychoact Subst Unit, Hatfield, Herts, England; [Neicun, Jessica; Negri, Attilio; Corazza, Ornella] Univ Hertfordshire, Hlth Res Serv, Hatfield, Herts, England; [Steenhuizen, Marthe; van Kessel, Robin] Univ Maastricht, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Steenhuizen, Marthe; Yang, Justin C.; Roman-Urrestarazu, Andres] Univ Cambridge, Inst Publ Hlth, Cambridge, England	Maastricht University; University of Hertfordshire; University of Hertfordshire; Maastricht University; University of Cambridge	Roman-Urrestarazu, A (corresponding author), Univ Maastricht, Dept Int Hlth, Care & Publ Hlth Res Ctr, Maastricht, Netherlands.; Roman-Urrestarazu, A (corresponding author), Univ Cambridge, Inst Publ Hlth, Cambridge, England.	aer56@cam.ac.uk	van Kessel, Robin/GWV-1883-2022; Corazza, Ornella/AAJ-9363-2021; van Kessel, Robin/GYD-7902-2022; Yang, Justin Christopher/H-1780-2018; Roman-Urrestarazu, Andres/U-9224-2018; czbanowska, katarzyna/AAL-4033-2020; van Kessel, Robin/AAH-9768-2020	van Kessel, Robin/0000-0001-6309-6343; Corazza, Ornella/0000-0001-7371-319X; van Kessel, Robin/0000-0001-6309-6343; Yang, Justin Christopher/0000-0003-2881-4906; Roman-Urrestarazu, Andres/0000-0002-2405-9432; van Kessel, Robin/0000-0001-6309-6343; NEGRI, ATTILIO/0000-0002-1035-8095; Neicun, Jessica/0000-0002-8710-8238	Gillings Fellowship in Global Public Health [YOG054]	Gillings Fellowship in Global Public Health	This work was funded from the Gillings Fellowship in Global Public Health, Grant Award YOG054 to AR-U. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adviescommissie Drugsbeleid, 2009, GEEN DEUR MAAR DAD N; [Anonymous], 2018, SWED COUNTR DRUG REP; [Anonymous], 2000, INST COORD ASS MON N; [Anonymous], 2018, NETH COUNTR DRUG REP; [Anonymous], 2011, AANW OPIUMW STC 2001; [Anonymous], 2005, NATL DRUG POL STRAT; [Anonymous], 2010, NATL DRUG POLICY STR; [Anonymous], 2011, POL NAT PROGR COUNT; APDES, CHECK N FREE MIND FL; APDES, CHECK DRUG TEST; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Chatwin C, 2003, BRIT J CRIMINOL, V43, P567, DOI 10.1093/bjc/azg567; Chatwin C, 2017, INT J DRUG POLICY, V40, P111, DOI 10.1016/j.drugpo.2016.11.002; Chatwin C, 2010, DRUGS ALCOHOL TODAY, V10, P26, DOI 10.5042/daat.2010.0725; Corazza O., 2017, NOVEL PSYCHOACTIVE S, P125, DOI DOI 10.1007/978-3-319-60600-2_9; Corazza O, 2017, NOVEL PSYCHOACTIVE S; Corazza O, 2013, INT J DRUG POLICY, V24, P82, DOI 10.1016/j.drugpo.2012.06.005; Council of the European Union, 2004, EU DRUGS STRAT 2005; Dabrowska K, 2017, COUNTRY REPORT NEW P; Department of Health Social Services and Public Safety, 2011, NEW STRAT DIR ALC DR; Erhel C, 2005, EC SOC, P1531; Europe Against Drugs, 2012, PSYCH SUBST ISS POL; European Council, 2005, OFFICIAL J EUROPEAN; European Council, 2008, OFFICIAL J EUROPEAN; European Council, 2012, OFFICIAL J EUROPEAN; European Council, 2017, OFFICIAL J EUROPEAN; European Monitoring Center for Drugs and Drug Addiction, 2001, DECR EUR REC DEV LEG; European Monitoring Centre for Drugs and Drug Addiction, 2009, LEG RESP NEW PSYCH S; European Monitoring Centre for Drugs and Drug Addiction, 2017, EUR DRUG REP TRENDS; European Monitoring Centre for Drugs and Drug Addiction, 2018, PORT COUNTR DRUG REP; European Monitoring Centre for Drugs and Drug Addiction, 2018, COUNTR DRUG REP 2018; European Monitoring Centre forDrugs and Drug Addiction, 2015, NEW PSYCH SUBST EUR, DOI 10.2810/372415; Fleming N., 2010, GUARDIAN; General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD), 2015, NAT PLAN RED ADD BEH; Griffiths P, 2010, ADDICTION, V105, P951, DOI 10.1111/j.1360-0443.2009.02874.x; Henriques S., 2017, HOME2014JDRUAGDRUG70; Home Office, 2015, GUID LOC AUTH TAK AC; Jablonski P, 2014, NEW PSYCHOACTIVE SUB; Jellinek, INFORM ALCOHOL DRUGS; Knill C, 2005, J EUR PUBLIC POLICY, V12, P764, DOI 10.1080/13501760500161332; Laqueur H, 2015, LAW SOCIAL INQUIRY, V40, P746, DOI 10.1111/lsi.12104; Madras BK, 2017, CURR TOP BEHAV NEURO, V32, P1, DOI 10.1007/7854_2016_34; Mahoney J, 2000, THEOR SOC, V29, P507, DOI 10.1023/A:1007113830879; Malczewski A, 2015, REPORT 2014 POLAND; Mentor ADEPIS, 2016, PSYCH SUBST WHAT SCH; Ministerie van Volksgezondheid Welzijn en Sport, 2015, BEL DRUGSPR; Ministerie van Volksgezondheid Welzijn en Sport, 1995, DRUG POL NETH CONT C; Mravoik V, 2014, NATL REPORT CZECH RE; Nekola M, 2015, J COMP POLICY ANAL, V17, P229, DOI 10.1080/13876988.2014.979553; Noy C, 2008, INT J SOC RES METHOD, V11, P327, DOI 10.1080/13645570701401305; Pardo B, 2014, INT J DRUG POLICY, V25, P727, DOI 10.1016/j.drugpo.2014.05.010; Pierson P, 2000, AM POLIT SCI REV, V94, P251, DOI 10.2307/2586011; Press Association, 2003, GUARDIAN; Public Health Agency of Sweden, 2014, CANN LET FACTS GUID; Public Health Agency of Sweden, 2014, 2014 NAT REP 2013 DA; Public Health England, 2017, REP ILL DRUG REACT; Ritter A, 2008, DRUG-EDUC PREV POLIC, V15, P15, DOI 10.1080/09687630701204344; Ritter A, 2016, INT J DRUG POLICY, V31, P39, DOI 10.1016/j.drugpo.2016.02.004; Santos AS, 2014, 2014 NATL REPORT 201; Schifano F, 2015, WORLD PSYCHIATRY, V14, P15, DOI 10.1002/wps.20174; Schifano F, 2011, PSYCHOTHER PSYCHOSOM, V80, P118, DOI 10.1159/000321079; Scottish Government, 2008, ROAD REC NEW APPR TA; Secretariat of the Government Council for Drug Policy Coordination, 2017, CZECH DRUG POL ITS A; Servico de Intervencao nos Comportamentos Aditivos e nas Dependencias (SICAD), 2013, EX SUMM EXT EV NAT P; Servico de Intervencao nos Comportamentos Aditivos e nas Dependencias (SICAD), 2015, REL AT 2014; Soares da Silva A., 2015, MAPS B SPEC ED, V25, P1; Soh YNA, 2014, DRUG TEST ANAL, V6, P696, DOI 10.1002/dta.1576; Standring A, 2012, DRUGS ALCOHOL TODAY, V12, P12, DOI 10.1108/17459261211211656; Stephenson G., 2014, GOVUK BLOG; Stevens A, 2013, DRUG-EDUC PREV POLIC, V20, P169, DOI 10.3109/09687637.2013.793892; The New Psychoactive Substances Review Expert Panel, 2014, NEW PSYCH SUBST REV; The Scottish Government, 2018, RIGHTS RESP REC SCOT; The UK Prime Minister, 1998, GOVT 10 YEAR STRAT T; Tyrkko E, 2016, THER DRUG MONIT, V38, P190, DOI 10.1097/FTD.0000000000000263; United Kingdom, 2002, UPD DRUG STRAT 2002; United Kingdom, 1995, TACKL DRUGS TOG DRUG; United Kingdom, 2010, DRUG STRAT 2010 RED; United Kingdom, 2017, 2017 DRUG STRAT; United Nations Office on Drugs and Crime, 2013, INT DRUG CONTR CONV; United Nations Office on Drugs and Crime, 1996, ERES199629 UN OFF DR; United Nations Office on Drugs and Crime, 2017, WHAT AR NPS; United Nations Office on Drugs and Crime, 2007, SWED SUCC DRUG POL R; van der Gouwe D, 2009, DRUGSBELEID NEDERLAN; Gine CV, 2014, DRUG TEST ANAL, V6, P819, DOI 10.1002/dta.1610; Wall S, 2016, SWEDISH PUBLIC HLTH; Welsh Assembly Government, 2008, WORK TOG RED HARM SU, P84; Wilkins C, 2017, NOVEL PSYCHOACTIVE S, P57, DOI DOI 10.1007/978-3-319-60600-2_5; Winstock AR, 2010, ADDICTION, V105, P1685, DOI [10.1111/j.1360-0443.2010.02934.x, 10.1111/j.1360-0443.2010.03163.x]; World Health Organization, 2014, 36 M EXP COMM DRUG D; Wouters M, 2017, NATL REPORT NEW PSYC; Zabransky T, 2004, J DRUG ISSUES, V34, P661, DOI 10.1177/002204260403400309	91	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218011	10.1371/journal.pone.0218011	http://dx.doi.org/10.1371/journal.pone.0218011			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242225	gold, Green Published, Green Submitted			2022-12-26	WOS:000482883600019
J	Krug, S; Mordhorst, JP; Moser, F; Theuerkorn, K; Ruffert, C; Egidi, M; Rinke, A; Gress, TM; Michl, P				Krug, Sebastian; Mordhorst, Jan-Philipp; Moser, Fabian; Theuerkorn, Katharina; Ruffert, Claudia; Egidi, Maren; Rinke, Anja; Gress, Thomas M.; Michl, Patrick			Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells	PLOS ONE			English	Article							RECEPTOR SUBTYPE-1; EVEROLIMUS; EPIDEMIOLOGY; EXPRESSION; SURVIVAL; DISEASE	Somatostatin analogues (SSA) represent the standard of care for symptom control in patients with functional gastro-entero-pancreatic neuroendocrine tumors (GEP-NET). In addition, SSA exert significant anti-proliferative effects in mid-gut and pancreatic NET (PanNET). In parallel, molecularly targeted therapies (MTT) have been shown to improve progression free survival (PFS) in patients with PanNET. However, due to either primary or acquired resistance to MTT, their impact on overall survival (OS) remains unclear. To date, various hypotheses exist to explain differences in patient responsiveness to SSA and MTT. However, data addressing one of the most pivotal questions, whether combining SSA with novel MTT will result in synergistic or additive efficacy compared to monotherapy, are lacking. The aim of this study is to characterize the interaction, optimal sequence and dosing of SSA-based and molecularly targeted therapies in PanNET. Somatostatin receptor subtypes 1-5 (SSTR) were evaluated in the neuroendocrine cell lines Bon1, QGP1 and Ins-1 via immunoblot and qRT-PCR. The impact of the SSA-analogue lanreotide alone or in combination with the MTT sunitinib, everolimus and regorafenib on intracellular signalling, hormone secretion and cell proliferation was determined in cell lysates and supernatants. In addition, synergistic effects of SSA and MTT in various sequential therapeutic approaches were investigated. SSTR were differently expressed in the examined neuroendocrine tumor cell lines. SSTR modulation via lanreotide moderately influenced proliferation, mainly via modulating AKT and ERK signalling, which was paralleled by decreased chromogranin A (CgA) expression and secretion. Interestingly, MTT treatment with regorafenib upregulated the expression of SSTR-2 and -5, while sunitinib and everolimus did not significantly alter SSTR expression. Cell viability was significantly reduced by all MTT, with regorafenib exerting the most significant effects. However, compared to the marked effects of MTT alone, synergistic effects of combined MTT and lanreotide treatment were only modest and time-and dosedependent. SSTR are differentially expressed in various NEN cell lines. Their expression is influenced by MTT treatment. Various sequential or simultaneous combinations of lanreotide and MTT did not lead to significant synergistic effects.	[Krug, Sebastian; Mordhorst, Jan-Philipp; Moser, Fabian; Theuerkorn, Katharina; Ruffert, Claudia; Egidi, Maren; Michl, Patrick] Martin Luther Univ Halle Wittenberg, Dept Internal Med 1, Halle, Saale, Germany; [Krug, Sebastian; Rinke, Anja; Gress, Thomas M.] Philipps Univ, Dept Gastroenterol & Endocrinol, Marburg, Germany	Martin Luther University Halle Wittenberg; Philipps University Marburg	Michl, P (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Internal Med 1, Halle, Saale, Germany.	patrick.michl@uk-halle.de	Michl, Patrick/HDN-4172-2022; Krug, Sebastian/ABE-2890-2020; Michl, Patrick/AAG-3987-2021	Krug, Sebastian/0000-0003-1672-7995; 	Ipsen Inc.	Ipsen Inc.(Ipsen)	The project was supported by a research grant from Ipsen Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony LB, 2015, NEUROENDOCRINOLOGY, V102, P18, DOI 10.1159/000381715; Arnold R, 2008, CLIN GASTROENTEROL H, V6, P820, DOI 10.1016/j.cgh.2008.02.052; Bajetta E, 2018, NEUROENDOCRINOLOGY, V106, P307, DOI 10.1159/000479587; Campana D, 2010, J NUCL MED, V51, P353, DOI 10.2967/jnumed.109.066662; Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI 10.1056/NEJMoa1316158; Ferolla P, 2017, LANCET ONCOL, V18, P1652, DOI 10.1016/S1470-2045(17)30681-2; Fjallskog ML, 2003, MED ONCOL, V20, P59, DOI 10.1385/MO:20:1:59; Fjallskog MLH, 2003, CLIN CANCER RES, V9, P1469; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Kaemmerer D, 2011, EUR J NUCL MED MOL I, V38, P1659, DOI 10.1007/s00259-011-1846-5; Kulaksiz H, 2002, GUT, V50, P52, DOI 10.1136/gut.50.1.52; Kulke MH, 2017, ANN ONCOL, V28, P1309, DOI 10.1093/annonc/mdx078; Lawrence B, 2011, ENDOCRIN METAB CLIN, V40, P1, DOI 10.1016/j.ecl.2010.12.005; Modlin IM, 2010, ALIMENT PHARM THER, V31, P169, DOI 10.1111/j.1365-2036.2009.04174.x; Panzuto F, 2011, J CLIN ONCOL, V29, P2372, DOI 10.1200/JCO.2010.33.0688; Pavel M, 2016, NEUROENDOCRINOLOGY, V103, P172, DOI 10.1159/000443167; Pavel ME, 2017, CLIN PHARMACOL THER, V101, P462, DOI 10.1002/cpt.559; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Reubi JC, 2013, TRENDS PHARMACOL SCI, V34, P676, DOI 10.1016/j.tips.2013.10.001; Ripka S, 2010, GUT, V59, P1101, DOI 10.1136/gut.2009.189720; Segal NH, 2009, ANNU REV MED, V60, P207, DOI 10.1146/annurev.med.60.041807.132435; Somvanshi RK, 2012, PHARMACEUTICALS, V5, P417, DOI 10.3390/ph5050417; Strosberg J, 2017, NEW ENGL J MED, V376, P125, DOI 10.1056/NEJMoa1607427; Theodoropoulou M, 2013, FRONT NEUROENDOCRIN, V34, P228, DOI 10.1016/j.yfrne.2013.07.005; Wilson BJ, 2009, J BIOL CHEM, V284, P36, DOI 10.1074/jbc.M803808200; Woltering EA, 2003, CANCER BIOTHER RADIO, V18, P601, DOI 10.1089/108497803322287691; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669	32	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218953	10.1371/journal.pone.0218953	http://dx.doi.org/10.1371/journal.pone.0218953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237925	gold, Green Published, Green Submitted			2022-12-26	WOS:000484856000055
J	Santamaria-Hernando, S; Senovilla, M; Gonzalez-Mula, A; Martinez-Garcia, PM; Nebreda, S; Rodriguez-Palenzuela, P; Lopez-Solanilla, E; Rodriguez-Herva, JJ				Santamaria-Hernando, Saray; Senovilla, Marta; Gonzalez-Mula, Almudena; Manuel Martinez-Garcia, Pedro; Nebreda, Sandra; Rodriguez-Palenzuela, Pablo; Lopez-Solanilla, Emilia; Juan Rodriguez-Herva, Jose			The Pseudomonas syringae pv. tomato DC3000 PSPTO_0820 multidrug transporter is involved in resistance to plant antimicrobials and bacterial survival during tomato plant infection	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; EFFLUX PUMP; RALSTONIA-SOLANACEARUM; CHLOROGENIC ACID; GENE-EXPRESSION; MEXAB-OPRM; PATHOGEN; DEFENSE; METABOLITES; FLAVONOIDS	Multidrug resistance efflux pumps protect bacterial cells against a wide spectrum of antimicrobial compounds. PSPTO_0820 is a predicted multidrug transporter from the phytopathogenic bacterium Pseudomonas syringae pv. tomato DC3000. Orthologs of this protein are conserved within many Pseudomonas species that interact with plants. To study the potential role of PSPTO_0820 in plant-bacteria interaction, a mutant in this gene was isolated and characterized. In addition, with the aim to find the outer membrane channel for this efflux system, a mutant in PSPTO_4977, a TolC-like gene, was also analyzed. Both mutants were more susceptible to trans-cinnamic and chlorogenic acids and to the flavonoid (+)-catechin, when added to the culture medium. The expression level of both genes increased in the presence of (+)-catechin and, in the case of PSPTO_0820, also in response to trans-cinnamic acid. PSPTO_0820 and PSPTO_4977 mutants were unable to colonize tomato at high population levels. This work evidences the involvement of these two proteins in the resistance to plant antimicrobials, supporting also the importance of chlorogenic acid, trans-cinnamic acid, and (+)-catechin in the tomato plant defense response against P. syringae pv. tomato DC3000 infection.	[Santamaria-Hernando, Saray; Senovilla, Marta; Gonzalez-Mula, Almudena; Manuel Martinez-Garcia, Pedro; Nebreda, Sandra; Rodriguez-Palenzuela, Pablo; Lopez-Solanilla, Emilia; Juan Rodriguez-Herva, Jose] Univ Politecn Madrid, Inst Nacl Invest & Tecnol Agr & Alimentaria, CBGP, Madrid, Spain; [Rodriguez-Palenzuela, Pablo; Lopez-Solanilla, Emilia; Juan Rodriguez-Herva, Jose] Univ Politecn Madrid, Escuela Tecn Super Ingn Agron Alimentaria & Biosi, Dept Biotecnol Biol Vegetal, Madrid, Spain; [Manuel Martinez-Garcia, Pedro] Univ Pablo Olavide, Univ Sevilla, CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP); Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Rodriguez-Herva, JJ (corresponding author), Univ Politecn Madrid, Inst Nacl Invest & Tecnol Agr & Alimentaria, CBGP, Madrid, Spain.; Rodriguez-Herva, JJ (corresponding author), Univ Politecn Madrid, Escuela Tecn Super Ingn Agron Alimentaria & Biosi, Dept Biotecnol Biol Vegetal, Madrid, Spain.	jj.rodriguez@upm.es	Hernando, Saray Santamaría/G-9662-2015; RODRIGUEZ-PALENZUELA, PABLO/A-9149-2012; Rodriguez-Herva, Jose J/A-7827-2012; Lopez-Solanilla, Emilia/A-6759-2012; SOLANILLA, EMILIA ANTONIA LOPEZ/M-9181-2019	Hernando, Saray Santamaría/0000-0001-6763-3839; RODRIGUEZ-PALENZUELA, PABLO/0000-0002-4963-9177; Rodriguez-Herva, Jose J/0000-0001-9962-2261; Lopez-Solanilla, Emilia/0000-0002-8578-7433; SOLANILLA, EMILIA ANTONIA LOPEZ/0000-0002-8578-7433; Martinez Garcia, Pedro Manuel/0000-0002-2119-2465	Spanish Plan Nacional I+D+i grants [AGL-2012-32516, AGL 2015-63851-R]; Spanish Ministry of Science and Innovation [RYC-2007-01045]; Campus de Excelencia Internacional Andalucia TECH	Spanish Plan Nacional I+D+i grants; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Campus de Excelencia Internacional Andalucia TECH	This research has been supported by the Spanish Plan Nacional I+D+i grants AGL-2012-32516 and AGL 2015-63851-R. JJRH was funded by the Ramon y Cajal program from the Spanish Ministry of Science and Innovation (RYC-2007-01045). PMMG was supported by the Campus de Excelencia Internacional Andalucia TECH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; Ausubel FM, 2014, CURRENT PROTOCOLS MO; Baker CJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00649; Barabote RD, 2003, J BACTERIOL, V185, P5772, DOI 10.1128/JB.185.19.5772-5778.2003; Beckman CH, 2000, PHYSIOL MOL PLANT P, V57, P101, DOI 10.1006/pmpp.2000.0287; Blanco P, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4010014; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Brown DG, 2007, APPL ENVIRON MICROB, V73, P2777, DOI 10.1128/AEM.00984-06; Buckner MMC, 2016, MBIO, V7, DOI 10.1128/mBio.01916-16; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Carvajal V., 2014, THESIS; Chatnaparat T, 2016, MOL PLANT MICROBE IN, V29, P508, DOI 10.1094/MPMI-01-16-0007-R; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Cushnie TPT, 2014, INT J ANTIMICROB AG, V44, P377, DOI 10.1016/j.ijantimicag.2014.06.001; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Du DJ, 2018, NAT REV MICROBIOL, V16, P523, DOI 10.1038/s41579-018-0048-6; Dulla GFJ, 2009, ISME J, V3, P825, DOI 10.1038/ismej.2009.30; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Fan J, 2011, SCIENCE, V331, P1185, DOI 10.1126/science.1199707; Gonzalez-Hernandez AI, 2018, PEST MANAG SCI, V74, P2601, DOI 10.1002/ps.5050; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Hammerschmidt R, 2014, PHYSIOL MOL PLANT P, V88, pIII, DOI 10.1016/j.pmpp.2014.11.002; Harris V, 2010, APPL MICROBIOL BIOT, V86, P721, DOI 10.1007/s00253-009-2352-6; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; KING EO, 1954, J LAB CLIN MED, V44, P301; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Llama-Palacios A, 2002, APPL ENVIRON MICROB, V68, P1624, DOI 10.1128/AEM.68.4.1624-1630.2002; Lowe TM, 2015, MOL PLANT MICROBE IN, V28, P286, DOI 10.1094/MPMI-09-14-0292-FI; Mandal S, 2008, BIOTECHNOL LETT, V30, P1253, DOI 10.1007/s10529-008-9666-9; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Neuberger A, 2018, RES MICROBIOL, V169, P401, DOI 10.1016/j.resmic.2018.05.003; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Lopez-Gresa MP, 2011, ENVIRON EXP BOT, V74, P216, DOI 10.1016/j.envexpbot.2011.06.003; Pletzer D, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-185; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Rio-Alvarez I, 2012, MOL PLANT MICROBE IN, V25, P523, DOI 10.1094/MPMI-09-11-0247; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sawada H, 1999, J MOL EVOL, V49, P627, DOI 10.1007/PL00006584; Slimestad R, 2008, J AGR FOOD CHEM, V56, P2436, DOI 10.1021/jf073434n; Stoitsova SO, 2008, APPL ENVIRON MICROB, V74, P3387, DOI 10.1128/AEM.02866-07; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; Valecillos AM, 2006, MOL PLANT MICROBE IN, V19, P607, DOI 10.1094/MPMI-19-0607; Vargas P, 2013, ENV MICROBIOL REP, V5, P841, DOI 10.1111/1758-2229.12086; Vargas P, 2011, MOL PLANT MICROBE IN, V24, P1207, DOI 10.1094/MPMI-03-11-0077; Villarino M, 2011, J AGR FOOD CHEM, V59, P3205, DOI 10.1021/jf104251z; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; von Roepenack-Lahaye E, 2003, J BIOL CHEM, V278, P43373, DOI 10.1074/jbc.M305084200; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; WILSON KJ, 1995, MICROBIOL-SGM, V141, P1691, DOI 10.1099/13500872-141-7-1691; Wojciechowska E, 2014, EUR J PLANT PATHOL, V139, P735, DOI 10.1007/s10658-014-0428-3; Zacares L, 2007, MOL PLANT MICROBE IN, V20, P1439, DOI 10.1094/MPMI-20-11-1439; Zeiss DR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092558	65	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218815	10.1371/journal.pone.0218815	http://dx.doi.org/10.1371/journal.pone.0218815			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237890	gold, Green Published, Green Submitted			2022-12-26	WOS:000484856000042
J	Silver, D; Macinko, J; Giorgio, M; Bae, JY				Silver, Diana; Macinko, James; Giorgio, Margaret; Bae, Jin Yung			Evaluating the relationship between binge drinking rates and a replicable measure of US state alcohol policy environments	PLOS ONE			English	Article								Excessive alcohol consumption contributes significantly to premature mortality, injuries and morbidity, and a range of U.S. state policies have been shown to reduce these behaviors. Monitoring state alcohol policy environments is essential, but methodologically challenging given that new laws may be passed (or repealed) each year, resulting in considerable variation across states. Existing measures have not been made public or have only a single year available. We develop a new replicable measure, the state alcohol policy score, for each state and year 2004-2009, that captures the essential features of a state's evidence-based alcohol policies. We evaluate its similarity to two existing alcohol policy measures and validate it by replicating findings from a previous study that used one of those measures to assess its relationship with several binge drinking outcomes. Estimates of the association between one-year lagged state alcohol policy scores and state binge drinking outcomes, obtained from the 2005-2010 Behavioral Risk Factor Surveillance System surveys (n = 440,951, 2010), were produced using Generalized Linear Models that controlled for state and individual-level co-variates, with fixed effects for year and region. We find a 10-percentage point increase in the state alcohol policy score was associated with a 9% lower odds of binge drinking (aOR = 0.91, 95% CI 0.89, 0.92; N = 1,992,086), a result consistent for men, women and for most age and race subgroups. We find that gender gaps in binge drinking behaviors narrowed in states with higher state alcohol policy scores. These results were nearly identical to those found in other studies using different scores obtained with the aid of expert opinions. We conclude that the score developed here is a valid measure that can be readily updated for monitoring and evaluating the variation and impact of state alcohol policies and make available our state scores for the years of the study.	[Silver, Diana; Giorgio, Margaret] NYU, Dept Publ Hlth Policy & Management, Coll Global Publ Hlth, New York, NY 10012 USA; [Macinko, James] Univ Calif Los Angeles, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Macinko, James] Univ Calif Los Angeles, Dept Community Hlth Sci, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Bae, Jin Yung] NYU, Steinhardt Sch Culture Educ & Human Dev, New York, NY USA	New York University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University	Silver, D (corresponding author), NYU, Dept Publ Hlth Policy & Management, Coll Global Publ Hlth, New York, NY 10012 USA.	diana.silver@nyu.edu		Silver, Diana/0000-0002-8135-0306; Macinko, James/0000-0001-8055-5441	National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health [1R01AA021436-0, 1R21AA021523-01A1]	National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding for this study was provided by the National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health (grants 1R01AA021436-0 and 1R21AA021523-01A1). The research presented in this paper is that of the authors and does not reflect the official policy of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoholism NIoAAa, 2015, ALC POL INF SYST 201; [Anonymous], 2018, LANCET, DOI DOI 10.1016/S0140-6736(18)31310-2; Babor TF, 2018, ALCOHOL CLIN EXP RES, V42, p85A; Cronce JM, 2018, ALCOHOL RES-CURR REV, V39, P43; Deyoung DJ, 1999, ACCIDENT ANAL PREV, V31, P45, DOI 10.1016/S0001-4575(98)00043-8; Erickson DJ, 2016, DRUG ALCOHOL REV, V35, P6, DOI 10.1111/dar.12339; Erickson DJ, 2014, WORLD MED HEALTH POL, V6, P171, DOI 10.1002/wmh3.97; Macinko J, 2012, AM J PUBLIC HEALTH, V102, P1697, DOI 10.2105/AJPH.2012.300716; Naimi TS, 2014, AM J PREV MED, V46, P10, DOI 10.1016/j.amepre.2013.07.015; Nelson TF, 2005, AM J PUBLIC HEALTH, V95, P441, DOI 10.2105/AJPH.2004.043810; Nichols J.L., 1988, EFFECTIVENESS LEGAL; Pierannunzi Carol, 2012, Morbidity and Mortality Weekly Report, V61, P410; Rodgers A., 1995, J SAFETY RES, V26, P125; SAMSHA SAaMHSA, 2015, SUBST US DIS; StataCorp, 2017, STAT US GUID REL 15; U.S. Department of Health and Human Services, 2012, HLTH PEOPL 2020 OBJ; Wagenaar A, 2014, PUBLIC HLTH LAW RES; Wagenaar AC, 2007, ACCIDENT ANAL PREV, V39, P982, DOI 10.1016/j.aap.2007.01.003; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Xuan ZM, 2015, AM J PUBLIC HEALTH, V105, P816, DOI 10.2105/AJPH.2014.302112; YU J, 1994, J CRIM JUST, V22, P355, DOI 10.1016/0047-2352(94)90082-5	21	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218718	10.1371/journal.pone.0218718	http://dx.doi.org/10.1371/journal.pone.0218718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3BT	31237888	gold, Green Submitted, Green Published			2022-12-26	WOS:000484856000035
J	Bergmann, F; Zimmermann, W				Bergmann, Fabian; Zimmermann, Walter			On system-spanning demixing properties of cell polarization	PLOS ONE			English	Article							PATTERN-FORMATION; POLARITY; MODEL; DIFFUSION; MECHANISMS; PROTEINS; GTPASES; YEAST	A number of mathematical models have been suggested to describe cell polarization in eukaryotic cells. One class of models takes into account that certain proteins are conserved on the time scale of cell polarization and may switch between a fast and a slow diffusing state. We raise the question whether models sharing this design feature can be condensed into one system-spanning model. We show exemplarily for the mass-conserved reaction-diffusion model of Otsuji et al. (Otsuji M et al. (2007) PLoS Comput Biol 3(6):e108) that cell polarization can be classified as active phase separation. This includes a fundamental connection between a number of non-equilibrium demixing phenomena such as cell polarization to phase separation. As shown recently, generic properties of active phase separation close to its onset are described by the Cahn-Hilliard model. By a systematic perturbation analysis we directly map the basic cell polarization model to the universal Cahn-Hilliard model. Comparing the numerical solutions of the polarization model and the Cahn-Hilliard equation also provides the parameter range where the basic cell polarization model behaves like other systems showing active phase separation. Polarization models of the active phase separation type cover essential properties of cell polarization, e.g. the adaptability of cell polarity to the length of growing cells. Our approach highlights how basic principles of pattern formation theory allow the identification of common basic properties in different models for cell polarization.	[Bergmann, Fabian; Zimmermann, Walter] Univ Bayreuth, Theoret Phys 1, D-95440 Bayreuth, Germany	University of Bayreuth	Zimmermann, W (corresponding author), Univ Bayreuth, Theoret Phys 1, D-95440 Bayreuth, Germany.	walter.zimmermann@uni-bayreuth.de			Elite Study Program Biological Physics	Elite Study Program Biological Physics	Fruitful discussions with L. Rapp and support by the Elite Study Program Biological Physics is gratefully acknowledged.	Alberts B, 2001, MOL BIOL CELL; Alonso S, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046012; Aranson IS, 2002, REV MOD PHYS, V74, P99, DOI 10.1103/RevModPhys.74.99; Ball P., 1998, SELF MADE TAPESTRY P; Bergmann F, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.020603; Bergmann F, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aad457; Bialke J, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/30008; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; CAHN JW, 1961, ACTA METALL MATER, V9, P795, DOI 10.1016/0001-6160(61)90182-1; Cross M, 2009, PATTERN FORMATION DY, DOI 10.1017/CBO9780511627200; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Desai R. C., 2009, DYNAMICS SELF ORG SE; FROMHERZ P, 1991, EUROPHYS LETT, V15, P313, DOI 10.1209/0295-5075/15/3/014; Goehring NW, 2013, TRENDS CELL BIOL, V23, P72, DOI 10.1016/j.tcb.2012.10.009; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; Holmes WR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002366; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jilkine A, 2007, B MATH BIOL, V69, P1943, DOI 10.1007/s11538-007-9200-6; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Liu QX, 2013, P NATL ACAD SCI USA, V110, P11905, DOI 10.1073/pnas.1222339110; Meron E., 2015, NONLINEAR PHYS ECOSY; Meyer M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022711; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; Palacci J, 2013, SCIENCE, V339, P936, DOI 10.1126/science.1230020; Pismen LM., 2006, PATTERNS INTERFACES; Rubinstein B, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045006; Speck T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.218304; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stenhammar J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.145702; Theurkauff I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268303; Thompson BJ, 2013, DEVELOPMENT, V140, P13, DOI 10.1242/dev.083634; Tindall MJ, 2008, B MATH BIOL, V70, P1570, DOI 10.1007/s11538-008-9322-5; Trong PK, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/6/065009; Wedlich-Soldner R, 2003, NAT CELL BIOL, V5, P267, DOI 10.1038/ncb0403-267	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218328	10.1371/journal.pone.0218328	http://dx.doi.org/10.1371/journal.pone.0218328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226118	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700012
J	Agarbati, A; Canonico, L; Ciani, M; Comitini, F				Agarbati, Alice; Canonico, Laura; Ciani, Maurizio; Comitini, Francesca			The impact of fungicide treatments on yeast biota of Verdicchio and Montepulciano grape varieties	PLOS ONE			English	Article							METSCHNIKOWIA-PULCHERRIMA; SACCHAROMYCES-CEREVISIAE; WINE YEAST; WICKERHAMOMYCES-ANOMALUS; COMMUNITIES; BIODIVERSITY; IDENTIFICATION; FERMENTATION; POPULATIONS; DIVERSITY	Yeast species that colonize the surface of grape berries at harvest time play an important role during the winemaking process. In this study, the use of culturable microbial techniques permitted a quantitative and qualitative inventory of the different yeast species present on the grape berry surfaces of Montepulciano and Verdicchio varieties when treated with conventional and organic fungicides. The results show that the most widespread yeast species at harvest time were Aureobasidium pullulans and Hanseniaspora uvarum, which are considered normal resident species and independent of the grape varieties and treatments applied. Specific differences when comparing the grape varieties were observed in species and were detected at a lower frequency; Pichia spp. were prevalent in Verdicchio, whereas Lachancea thermotolerans and Zygoascus meyerae were found in Montepulciano. In both vineyards, the farming treatments improved the competitiveness of A. pullulans, which was probably due to its reduced susceptibility to treatments that improved the competition toward other fungi. In contrast, the fermenting yeast H. uvarum was negatively affected by fungicide treatments and showed a reduced presence if compared with untreated grapes. Organic treatments directly impacted the occurrence of Issachenkia terricola in Montepulciano grapes and Debaryomyces hansenii and Pichia membranifaciens in Verdicchio. Conversely, a negative effect of organic treatments was found toward Metschnikowia pulcherrima and Starmerella bacillaris. Overall, the data suggest that the yeast community colonizing the grape berry surface was influenced by both grape variety and farming treatments, which characterized the yeast biota of spontaneous must fermentation.	[Agarbati, Alice; Canonico, Laura; Ciani, Maurizio; Comitini, Francesca] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy	Marche Polytechnic University	Comitini, F (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	f.comitini@univpm.it	Agarbati, Alice/AAG-8735-2021; Ciani, Maurizio/A-2525-2010	Ciani, Maurizio/0000-0003-3778-1835; COMITINI, Francesca/0000-0003-2394-2925				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bagheri B, 2015, S AFR J ENOL VITIC, V36, P243; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Barata A, 2008, FEMS YEAST RES, V8, P1008, DOI 10.1111/j.1567-1364.2008.00399.x; Barbosa C, 2018, FERMENTATION-BASEL, V4, DOI 10.3390/fermentation4010008; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Cabras P, 1999, J AGR FOOD CHEM, V47, P3854, DOI 10.1021/jf990005j; Cadez N, 2010, FEMS YEAST RES, V10, P619, DOI 10.1111/j.1567-1364.2010.00635.x; Combina M, 2005, INT J FOOD MICROBIOL, V99, P237, DOI 10.1016/j.ijfoodmicro.2004.08.017; Comitini F, 2006, LETT APPL MICROBIOL, V42, P248, DOI 10.1111/j.1472-765X.2005.01837.x; Comitini F, 2011, FOOD MICROBIOL, V28, P873, DOI 10.1016/j.fm.2010.12.001; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V145, P132, DOI 10.1016/j.ijfoodmicro.2010.11.040; Corrales M, 2010, FOOD CHEM TOXICOL, V48, P3471, DOI 10.1016/j.fct.2010.09.025; Haas ICD, 2016, PLANT FOOD HUM NUTR, V71, P422, DOI 10.1007/s11130-016-0579-9; David V, 2014, J IND MICROBIOL BIOT, V41, P811, DOI 10.1007/s10295-014-1427-2; Diaz C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/540465; Esteve-Zarzoso B, 1999, INT J SYST BACTERIOL, V49, P329, DOI 10.1099/00207713-49-1-329; Fleet GH, 2002, BIODIVERSITY AND BIOTECHNOLOGY OF WINE YEASTS, P1; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Francesca N, 2012, ENV MICROBIOL REP, V4, P105, DOI 10.1111/j.1758-2229.2011.00310.x; GADD GM, 1988, APPL MICROBIOL BIOT, V29, P610, DOI 10.1007/BF00260993; Ganga MA, 2004, J APPL MICROBIOL, V96, P76, DOI 10.1046/j.1365-2672.2003.02080.x; Gayevskiy V, 2012, ISME J, V6, P1281, DOI 10.1038/ismej.2011.195; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; KILLHAM K, 1981, APPL ENVIRON MICROB, V42, P629, DOI 10.1128/AEM.42.4.629-631.1981; Martini A, 1996, AM J ENOL VITICULT, V47, P435; Meier MS, 2015, J ENVIRON MANAGE, V149, P193, DOI 10.1016/j.jenvman.2014.10.006; Milanovic V, 2013, INT J FOOD MICROBIOL, V161, P240, DOI 10.1016/j.ijfoodmicro.2012.12.019; Oro L, 2014, J APPL MICROBIOL, V116, P1209, DOI 10.1111/jam.12446; Oro L, 2018, INT J FOOD MICROBIOL, V265, P18, DOI 10.1016/j.ijfoodmicro.2017.10.027; Pinto C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00905; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Renouf V, 2005, AUST J GRAPE WINE R, V11, P316, DOI 10.1111/j.1755-0238.2005.tb00031.x; Renouf V, 2007, APPL MICROBIOL BIOT, V75, P149, DOI 10.1007/s00253-006-0798-3; Sabel A, 2014, ANN MICROBIOL, V64, P483, DOI 10.1007/s13213-013-0678-x; Sadoudi M, 2012, FOOD MICROBIOL, V32, P243, DOI 10.1016/j.fm.2012.06.006; Schmid F, 2011, APPL ENVIRON MICROB, V77, P2188, DOI 10.1128/AEM.02187-10; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; Sipiczki M, 2006, APPL ENVIRON MICROB, V72, P6716, DOI 10.1128/AEM.01275-06; Spadaro D, 2002, POSTHARVEST BIOL TEC, V24, P123, DOI 10.1016/S0925-5214(01)00172-7; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Stringini M, 2008, INT J FOOD MICROBIOL, V127, P184, DOI 10.1016/j.ijfoodmicro.2008.07.017; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Vigentini I, 2015, MICROBIOL-SGM, V161, P362, DOI 10.1099/mic.0.000004; Viviani-Nauer A., 1995, SCHWEIZ Z OBST WEINB, V131, P390, DOI DOI 10.1016/J.IJF00DMICR0.2011.11.025; Walker GM, 2011, ANTON LEEUW INT J G, V99, P25, DOI 10.1007/s10482-010-9491-8; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	48	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0217385	10.1371/journal.pone.0217385	http://dx.doi.org/10.1371/journal.pone.0217385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220090	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500010
J	Nivukoski, U; Niemela, M; Bloigu, A; Bloigu, R; Aalto, M; Laatikainen, T; Niemela, O				Nivukoski, Ulla; Niemela, Markus; Bloigu, Aini; Bloigu, Risto; Aalto, Mauri; Laatikainen, Tiina; Niemela, Onni			Impacts of unfavourable lifestyle factors on biomarkers of liver function, inflammation and lipid status	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; ALANINE AMINOTRANSFERASE; CARDIOVASCULAR-DISEASES; RISK-FACTOR; MORTALITY; DRINKING; POPULATION; MODERATE	Background Adopting a healthy lifestyle is associated with prolonged life expectancy. The main modifiable lifestyle-related risk factors are hazardous alcohol drinking, smoking, excess body weight and lack of physical activity. Our aim was to estimate the impact of unfavourable lifestyle factors on abnormalities in laboratory tests reflecting liver status, inflammation and lipid metabolism in a population-based cross-sectional study. Methods The study included 22,273 participants (10,561 men, 11,712 women) aged 25-74 years from the National FINRISK Study. Data on alcohol use, smoking, body weight, and physical activity were recorded from structured interviews. The risk scores for the various life style factors were established on a 0-8 scale and used to stratify the population in classes to allow estimates of their joint effects. Serum liver enzymes (GGT, ALT), C-reactive protein (CRP) and lipid profiles were measured using standard laboratory techniques. Results Consistent dose-response relationships were observed between the number of unfavourable risk factors and serum levels of GGT, ALT, CRP, cholesterol, HDL, LDL and triglycerides (p < 0.0005 for linear trend in all comparisons). When compared with those with zero risk factors, the multivariable-adjusted odds ratios (ORs) for abnormalities in all biomarkers were significantly higher in those with a sum of risk score two or more. The most striking increases in ORs in the group with the highest numbers of risk factors were observed among men in serum GGT: 26.6 (12.4-57.0), ALT: 40.3 (5.3-307.8), CRP: 16.2 (7.8-33.7) and serum triglycerides: 14.4 (8.6-24.0). Conclusions The data support the view that the presence of unfavourable life style risk factors is associated with distinct abnormalities in laboratory tests for liver function, inflammation and lipid status. Such biomarkers may prove to be of value in the assessment of interventions aimed at reducing unfavourable risk factors and in helping individuals in long-term maintenance of lifestyle modifications.	[Nivukoski, Ulla; Niemela, Markus; Niemela, Onni] Seinajoki Cent Hosp, Dept Lab Med, Seinajoki, Finland; [Nivukoski, Ulla; Niemela, Markus; Niemela, Onni] Seinajoki Cent Hosp, Med Res Unit, Seinajoki, Finland; [Nivukoski, Ulla; Niemela, Markus; Niemela, Onni] Tampere Univ, Seinajoki, Finland; [Niemela, Markus] Univ Oulu, Dept Med, Oulu, Finland; [Bloigu, Aini] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Bloigu, Risto] Univ Oulu, Infrastruct Populat Studies, Oulu, Finland; [Aalto, Mauri] Seinajoki Cent Hosp, Dept Psychiat, Tampere, Finland; [Aalto, Mauri] Tampere Univ, Tampere, Finland; [Laatikainen, Tiina] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Laatikainen, Tiina] Joint Municipal Author North Karelia Social & Hlt, Joensuu, Finland	Seinajoki Central Hospital; Seinajoki Central Hospital; Tampere University; University of Oulu; University of Oulu; University of Oulu; Seinajoki Central Hospital; Tampere University; Finland National Institute for Health & Welfare; University of Eastern Finland	Niemela, O (corresponding author), Seinajoki Cent Hosp, Dept Lab Med, Seinajoki, Finland.; Niemela, O (corresponding author), Seinajoki Cent Hosp, Med Res Unit, Seinajoki, Finland.; Niemela, O (corresponding author), Tampere Univ, Seinajoki, Finland.	onni.niemela@epshp.fi	Laatikainen, Tiina/ABD-6622-2021	Laatikainen, Tiina/0000-0002-6614-4782; Aalto, Mauri/0000-0003-3424-3767	Competitive State Research Financing of the Expert Responsibility area of Seinajoki Central Hospital and University of Tampere [VTR 5300/3116]; Finnish Foundation for the Promotion of Laboratory Medicine [10/2014]	Competitive State Research Financing of the Expert Responsibility area of Seinajoki Central Hospital and University of Tampere; Finnish Foundation for the Promotion of Laboratory Medicine	This work was supported by: Competitive State Research Financing of the Expert Responsibility area of Seinajoki Central Hospital and University of Tampere, Grant no: VTR 5300/3116 to ON; and by the Finnish Foundation for the Promotion of Laboratory Medicine Grant no 10/2014 to ON. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Bagnardi V, 2013, ANN ONCOL, V24, P301, DOI 10.1093/annonc/mds337; Behrens G, 2013, EUR J EPIDEMIOL, V28, P361, DOI 10.1007/s10654-013-9796-9; Bjorngaard JH, 2017, INT J EPIDEMIOL, V46, P1958, DOI 10.1093/ije/dyx147; Breitling LP, 2009, HEPATOLOGY, V49, P802, DOI 10.1002/hep.22727; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704; Catena C, 2016, HYPERTENSION, V68, P1208, DOI 10.1161/HYPERTENSIONAHA.116.08145; Choi YJ, 2018, CANCER RES TREAT, V50, P474, DOI 10.4143/crt.2017.094; Connor JP, 2016, LANCET, V387, P988, DOI 10.1016/S0140-6736(15)00122-1; Danielsson J, 2014, WORLD J GASTROENTERO, V20, P11743, DOI 10.3748/wjg.v20.i33.11743; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945; Halsted CH, 2002, P NATL ACAD SCI USA, V99, P10072, DOI 10.1073/pnas.112336399; Hao G, 2015, ANGIOLOGY, V66, P753, DOI 10.1177/0003319714549557; Joshi PK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00934-5; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Klatsky AL, 2015, J INTERN MED, V278, P238, DOI 10.1111/joim.12390; Koenig W, 2017, CLIN CHEM, V63, P1897, DOI 10.1373/clinchem.2017.273243; Kozakova M, 2012, HEPATOLOGY, V55, P1406, DOI 10.1002/hep.25555; Kuulasmaa K, 2006, EUROPEAN HLTH RISK M; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Latvala J, 2005, AM J GASTROENTEROL, V100, P1303, DOI 10.1111/j.1572-0241.2005.41509.x; Lau K, 2015, ALIMENT PHARM THER, V41, P467, DOI 10.1111/apt.13067; Lawlor DA, 2005, AM J EPIDEMIOL, V161, P1081, DOI 10.1093/aje/kwi125; Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090; Li KR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-59; Li YP, 2018, CIRCULATION, V138, P345, DOI [10.1161/CIRCULATIONAHA.117.032047, 10.1161/circulationaha.117.032047]; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c912; Luepker R. V., 2004, Cardiovascular survey methods; Manuel DG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002082; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; McManus DD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004060; Moradi H, 2017, J THORAC DIS, V9, P4849, DOI 10.21037/jtd.2017.10.155; Niemela O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188574; Niemela O, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020166; Oh S, 2015, HEPATOLOGY, V61, P1205, DOI 10.1002/hep.27544; Oliveira A, 2010, ALCOHOL ALCOHOLISM, V45, P119, DOI 10.1093/alcalc/agp092; Park EY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063439; Perreault K, 2017, BRIT J SPORT MED, V51, P651, DOI 10.1136/bjsports-2016-096194; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Romaguera D, 2011, J SPORT SCI, V29, P989, DOI 10.1080/02640414.2011.578149; Romero-Gomez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Rutten-Jacobs LC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4168; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Schwarzinger M, 2018, LANCET PUBLIC HEALTH, V3, pE124, DOI 10.1016/S2468-2667(18)30022-7; Sipila P, 2016, ADDICTION, V111, P245, DOI 10.1111/add.13152; Smith AD, 2016, DIABETOLOGIA, V59, P2527, DOI 10.1007/s00125-016-4079-0; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Sundberg CJ, 2016, BRIT J SPORT MED, V50, P319, DOI 10.1136/bjsports-2016-096026; Tamakoshi A, 2009, PREV MED, V48, P486, DOI 10.1016/j.ypmed.2009.02.017; Tapper EB, 2018, BMJ-BRIT MED J, V362, DOI [10.1136/bm1k2817, 10.1136/bmj.k2817]; Teeriniemi AM, 2018, J INTERN MED, V284, P534, DOI 10.1111/joim.12802; Topiwala A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2353; Tsai J, 2012, J BEHAV MED, V35, P200, DOI 10.1007/s10865-011-9353-5; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; Wang HJ, 2012, ANNU REV NUTR, V32, P343, DOI 10.1146/annurev-nutr-072610-145138; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X; Zaccardi F, 2019, MAYO CLIN PROC, V94, P985, DOI 10.1016/j.mayocp.2018.10.029; Zheng JS, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0968-4	67	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218463	10.1371/journal.pone.0218463	http://dx.doi.org/10.1371/journal.pone.0218463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220128	Green Published, gold			2022-12-26	WOS:000484893500053
J	van der Kooi, TII; Boshuizen, H; Wille, JC; de Greeff, SC; van Dissel, JT; Schoffelen, AF; van Gaalen, RD				van der Kooi, Tjallie I. I.; Boshuizen, Hendriek; Wille, Jan C.; de Greeff, Sabine C.; van Dissel, Jaap T.; Schoffelen, Annelot F.; van Gaalen, Rolina D.			Using flexible methods to determine risk factors for ventilator-associated pneumonia in the Netherlands	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; ATTRIBUTABLE MORTALITY; SURVEILLANCE; IMPACT	Seven hospitals participated in the Dutch national surveillance for ventilator-associated pneumonia (VAP) and its risk factors. We analysed time-independent and time-dependent risk factors for VAP using the standard Cox regression and the flexible Weighted Cumulative Effects method (WCE) that evaluates both current and past exposures. The prospective surveillance of intensive care patients aged. 16 years and ventilated. 48 hours resulted in the inclusion of 940 primary ventilation periods, comprising 7872 ventilation days. The average VAP incidence density was 10.3/1000 ventilation days. Independent risk factors were age (16-40 years at increased risk: HR 2.42 95% confidence interval 1.07-5.50), COPD (HR 0.19 [0.04-0.78]), current sedation score (higher scores at increased risk), current selective oropharyngeal decontamination (HR 0.19 [0.04-0.91]), jet nebulizer (WCE, decreased risk), intravenous antibiotics for selective decontamination of the digestive tract (ivSDD, WCE, decreased risk), and intravenous antibiotics not for SDD (WCE, decreased risk). The protective effect of ivSDD was afforded for 24 days with a delay of 3 days. For some time-dependent variables, the WCE model was preferable over standard Cox proportional hazard regression. The WCE method can furthermore increase insight into the active time frame and possible delay herein of a time-dependent risk factor.	[van der Kooi, Tjallie I. I.; Wille, Jan C.; de Greeff, Sabine C.; Schoffelen, Annelot F.] Natl Inst Publ Hlth & Environm, Dept Healthcare Associated Infect & Antimicrobial, Epidemiol & Surveillance, Ctr Infect Dis Control, Bilthoven, Netherlands; [Boshuizen, Hendriek] Natl Inst Publ Hlth & Environm, Dept Stat Informat & Math Modeling, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [van Dissel, Jaap T.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [van Gaalen, Rolina D.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Dept Infect Dis Modelling Epidemiol & Surveillanc, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	van der Kooi, TII (corresponding author), Natl Inst Publ Hlth & Environm, Dept Healthcare Associated Infect & Antimicrobial, Epidemiol & Surveillance, Ctr Infect Dis Control, Bilthoven, Netherlands.	tjallie.van.der.kooi@rivm.nl	Boshuizen, Hendriek C/B-3718-2014	van der Kooi, Tjallie/0000-0002-5346-7224				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Dorzi HM, 2012, AM J INFECT CONTROL, V40, P794, DOI 10.1016/j.ajic.2011.10.004; Alp Emine, 2004, Ann Clin Microbiol Antimicrob, V3, P17, DOI 10.1186/1476-0711-3-17; [Anonymous], 2021, LANG ENV STAT COMP; Apostolopoulou Eleni, 2003, Respir Care, V48, P681; Bekaert M, 2011, AM J RESP CRIT CARE, V184, P1133, DOI 10.1164/rccm.201105-0867OC; Cassini A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002150; Chen WS, 2015, J THORAC DIS, V7, P746, DOI 10.3978/j.issn.2072-1439.2015.04.21; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; de Smet AMGA, 2011, LANCET INFECT DIS, V11, P372, DOI 10.1016/S1473-3099(11)70035-4; Dubosky MN, 2017, RESP CARE, V62, P391, DOI 10.4187/respcare.04823; ECDC, 2012, SURV HEALTHC INF EUR; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Funk GC, 2013, EUR RESPIR J, V41, P792, DOI 10.1183/09031936.00226411; Kerlin MP, 2017, INFECT CONT HOSP EP, V38, P172, DOI 10.1017/ice.2016.262; Klompas M, 2014, INFECT CONT HOSP EP, V35, P915, DOI [10.1017/S0899823X00193894, 10.1086/677144]; Kollef MH, 2008, JAMA-J AM MED ASSOC, V300, P805, DOI 10.1001/jama.300.7.805; Koulenti D, 2017, EUR J CLIN MICROBIOL, V36, P1999, DOI 10.1007/s10096-016-2703-z; Krag M, 2014, INTENS CARE MED, V40, P11, DOI 10.1007/s00134-013-3125-3; Luize AP, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.75; Mahmud M, 2006, COMMUN STAT-SIMUL C, V35, P27, DOI 10.1080/03610910500415928; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Muscedere JG, 2008, J CRIT CARE, V23, P5, DOI 10.1016/j.jcrc.2007.11.012; Myny D, 2005, ACTA CLIN BELG, V60, P114, DOI 10.1179/acb.2005.022; Pawar M, 2003, J CARDIOTHOR VASC AN, V17, P22, DOI 10.1053/jcan.2003.4; Quantin C, 1999, AM J EPIDEMIOL, V150, P1188; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Rouze A, 2014, CURR OPIN CRIT CARE, V20, P525, DOI 10.1097/MCC.0000000000000123; Sofianou DC, 2000, EUR J CLIN MICROBIOL, V19, P460, DOI 10.1007/s100960000236; Sylvestre MP, 2009, STAT MED, V28, P3437, DOI 10.1002/sim.3701; Sylvestre MP, 2015, WCE WEIGHTED CUMULAT; Tejerina E, 2006, J CRIT CARE, V21, P56, DOI 10.1016/j.jcrc.2005.08.005; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Timsit JF, 2011, CURR OPIN CRIT CARE, V17, P464, DOI 10.1097/MCC.0b013e32834a5ae9; van der Kooi TII, 2007, INTENS CARE MED, V33, P271, DOI 10.1007/s00134-006-0464-3; Wang L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009946.pub2; Zuschneid I, 2007, INFECT CONT HOSP EP, V28, P314, DOI 10.1086/507823	37	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218372	10.1371/journal.pone.0218372	http://dx.doi.org/10.1371/journal.pone.0218372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220122	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500041
J	Weist, P; Schade, FM; Damerau, M; Barth, JMI; Dierking, J; Andre, C; Petereit, C; Reusch, T; Jentoft, S; Hanel, R; Krumme, U				Weist, Peggy; Schade, Franziska M.; Damerau, Malte; Barth, Julia M. I.; Dierking, Jan; Andre, Carl; Petereit, Christoph; Reusch, Thorsten; Jentoft, Sissel; Hanel, Reinhold; Krumme, Uwe			Assessing SNP-markers to study population mixing and ecological adaptation in Baltic cod	PLOS ONE			English	Article							ATLANTIC COD; GADUS-MORHUA; GENOMIC DIVERGENCE; STATIONARY ECOTYPES; SPAWNING AREAS; BELT SEA; EASTERN; DIFFERENTIATION; FISH; BIODIVERSITY	Atlantic cod (Gadus morhua) is a species of great ecological and economical importance in the Baltic Sea. Here, two genetically differentiated stocks, the western and the eastern Baltic cod, display substantial mechanical mixing, hampering our understanding of cod ecology and impeding stock assessments and management. Based on whole-genome re-sequencing data from reference samples obtained from the study area, we designed two different panels of Single Nucleotide Polymorphisms markers (SNPs), which take into account the exceptional genome architecture of cod. A minimum panel of 20 diagnostic SNPs and an extended panel (20 diagnostic and 18 biologically informative SNPs, 38 in total) were developed and validated to distinguish unambiguously between the western and the eastern Baltic cod stocks and to enable studies of local adaptation to the specific environment in the Baltic Sea, respectively. We tested both panels on cod sampled from the southern Baltic Sea (n = 603) caught in 2015 and 2016. Genotyping results showed that catches from the mixing zone in the Arkona Sea, were composed of similar proportions of individuals of the western and the eastern stock. Catches from adjacent areas to the east, the Bornholm Basin and Gdansk Deep, were exclusively composed of eastern Baltic cod, whereas catches from adjacent western areas (Belt Sea and Oresund) were composed of western Baltic cod. Interestingly, the two Baltic cod stocks showed strong genetic differences at loci associated with life-history trait candidate genes, highlighting the species' potential for ecological adaptation even at small geographical scales. The minimum and the extended panel of SNP markers presented in this study provide powerful tools for future applications in research and fisheries management to further illuminate the mixing dynamics of cod in the Baltic Sea and to better understand Baltic cod ecology.	[Weist, Peggy; Damerau, Malte; Hanel, Reinhold] Thunen Inst Fisheries Ecol, Bremerhaven, Germany; [Schade, Franziska M.; Krumme, Uwe] Thunen Inst Balt Sea Fisheries, Rostock, Germany; [Barth, Julia M. I.] Univ Basel, Zool Inst, Basel, Switzerland; [Barth, Julia M. I.; Jentoft, Sissel] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Dierking, Jan; Petereit, Christoph; Reusch, Thorsten] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [Andre, Carl] Univ Gothenburg, Dept Marine Sci Tjarno, Stromstad, Sweden; [Petereit, Christoph] Bruno Lorenzen Schule, Schleswig, Germany	Johann Heinrich von Thunen Institute; Johann Heinrich von Thunen Institute; University of Basel; University of Oslo; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Gothenburg	Weist, P (corresponding author), Thunen Inst Fisheries Ecol, Bremerhaven, Germany.	peggy.weist@thuenen.de	Dierking, Jan/C-5170-2014; Hanel, Reinhold/AAO-4887-2021	Dierking, Jan/0000-0002-4660-6919; Weist, Peggy/0000-0002-3715-6936; Barth, Julia/0000-0001-5125-819X	European Maritime and Fisheries Fund (EMFF) of the European Union (EU) under the Data Collection Framework (DCF) [2017/1004]; BONUS BIO-C3 project - BONUS (Art 185) - EU; BONUS BIO-C3 project - BONUS (Art 185) - German BMBF [03F0682]; "The Aqua Genome Project" through the Research Council of Norway [221734/O30]	European Maritime and Fisheries Fund (EMFF) of the European Union (EU) under the Data Collection Framework (DCF); BONUS BIO-C3 project - BONUS (Art 185) - EU; BONUS BIO-C3 project - BONUS (Art 185) - German BMBF(Federal Ministry of Education & Research (BMBF)); "The Aqua Genome Project" through the Research Council of Norway	This project was partly funded by the European Maritime and Fisheries Fund (EMFF) of the European Union (EU) under the Data Collection Framework (DCF, Regulation 2017/1004 of the European Parliament and of the Council). Cod individuals from the Bornholm Basin were collected during RV ALKOR cruises. CP and JD were supported by the BONUS BIO-C3 project, which has received funding from BONUS (Art 185), funded jointly by the EU and from national funding institutions including the German BMBF under grant No. 03F0682. Computational analyses were performed on the Abel Cluster owned by the UiO and the Norwegian metacenter for High Performance Computing (NOTUR) and operated by the UiO Department for Research Computing. The whole genome sequencing of cod samples and SNP identification for the minimal panel were funded by "The Aqua Genome Project" (221734/O30) through the Research Council of Norway.	Andersen O, 2009, P ROY SOC B-BIOL SCI, V276, P833, DOI 10.1098/rspb.2008.1529; Anderson EC, 2010, MOL ECOL RESOUR, V10, P701, DOI 10.1111/j.1755-0998.2010.02846.x; Bagge Ole, 1994, Dana, V10, P1; Barth JMI, 2019, MOL ECOL, V28, P1394, DOI 10.1111/mec.15010; Barth JMI, 2017, MOL ECOL, V26, P4452, DOI 10.1111/mec.14207; Berg PR, 2017, HEREDITY, V119, P418, DOI 10.1038/hdy.2017.54; Berg PR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23246; Berg PR, 2015, GENOME BIOL EVOL, V7, P1644, DOI 10.1093/gbe/evv093; Birjukov NP., 1969, SPAWNING COMMUNITIES; Bleil M, 2009, J APPL ICHTHYOL, V25, P10, DOI 10.1111/j.1439-0426.2008.01172.x; Borza T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-51; Cadrin S.X., 2014, STOCK IDENTIFICATION, P1, DOI [DOI 10.1016/B978-0-12-397003-9.00001-1, 10.1016/B978-0-12-397003-9.00001-1]; Carstensen J, 2014, P NATL ACAD SCI USA, V111, P5628, DOI 10.1073/pnas.1323156111; Chabot D, 2008, MAR POLLUT BULL, V57, P287, DOI 10.1016/j.marpolbul.2008.04.001; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eero M, 2015, ICES J MAR SCI, V72, P2180, DOI 10.1093/icesjms/fsv109; Eero M, 2014, ICES J MAR SCI, V71, P1458, DOI 10.1093/icesjms/fsu060; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hemmer-Hansen J, 2019, EVOL APPL, V12, P830, DOI 10.1111/eva.12760; Hemmer-Hansen J, 2014, CONSERV GENET, V15, P213, DOI 10.1007/s10592-013-0532-5; Hinrichsen HH, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150338; Hinrichsen HH, 2016, PROG OCEANOGR, V143, P13, DOI 10.1016/j.pocean.2016.02.004; Hussy K, 2016, ICES J MAR SCI, V73, P293, DOI 10.1093/icesjms/fsv227; Hussy K, 2011, ICES J MAR SCI, V68, P1459, DOI 10.1093/icesjms/fsr088; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Karlsen BO, 2013, MOL ECOL, V22, P5098, DOI 10.1111/mec.12454; Kijewska A, 2011, ACTA ICHTHYOL PISCAT, V41, P307, DOI 10.3750/AIP2011.41.4.07; Kirubakaran TG, 2016, MOL ECOL, V25, P2130, DOI 10.1111/mec.13592; Koster FW, 2017, ICES J MAR SCI, V74, P3, DOI 10.1093/icesjms/fsw172; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Nissling A, 1997, MAR ECOL PROG SER, V152, P261, DOI 10.3354/meps152261; Ogden R, 2015, FORENSIC SCI INT-GEN, V18, P152, DOI 10.1016/j.fsigen.2015.02.008; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petereit C, 2014, PROG OCEANOGR, V122, P131, DOI 10.1016/j.pocean.2014.01.001; Pocwierz-Kotus A, 2015, MAR GENOM, V19, P17, DOI 10.1016/j.margen.2014.05.010; Pritchard JK, 2000, GENETICS, V155, P945; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; R Core Team R Development Core Team, 2015, R LANG ENV STAT COMP, DOI [10.1038/sj.hdy.6800737, DOI 10.1038/SJ.HDY.6800737, 10. 1038/sj. hdy. 6800737]; Reusch TBH, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8195; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RYMAN N, 1995, REV FISH BIOL FISHER, V5, P417, DOI 10.1007/BF01103814; SICK K, 1965, HEREDITAS-GENETISK A, V54, P19, DOI 10.1111/j.1601-5223.1965.tb02004.x; Sodeland M, 2016, GENOME BIOL EVOL, V8, P1012, DOI 10.1093/gbe/evw057; Star B, 2016, SCI REP-UK, V6, DOI 10.1038/srep31235; Stroganov AN, 2018, J APPL ICHTHYOL, V34, P527, DOI 10.1111/jai.13550; Stroganov AN, 2013, RUSS J GENET+, V49, P937, DOI 10.1134/S1022795413080152; Tomkiewicz J, 2003, J FISH BIOL, V62, P253, DOI 10.1046/j.1095-8649.2003.00001.x; Torresen OK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3448-x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Winter DJ, 2012, MOL ECOL RESOUR, V12, P1158, DOI 10.1111/j.1755-0998.2012.03174.x	56	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218127	10.1371/journal.pone.0218127	http://dx.doi.org/10.1371/journal.pone.0218127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220098	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500024
J	Chen, PYT; DeColli, AA; Meyers, CLF; Drennan, CL				Chen, Percival Yang-Ting; DeColli, Alicia A.; Meyers, Caren L. Freel; Drennan, Catherine L.			X-ray crystallography-based structural elucidation of enzyme-bound intermediates along the 1-deoxy-d-xylulose 5-phosphate synthase reaction coordinate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; pyruvate; decarboxylase; crystallography; bacterial metabolism; 1-deoxy-D-xylulose 5-phosphate synthase (DXPS); conformational dynamics; DXP synthase; methylerythritol phosphate (MEP) pathway; thiamine diphosphate (ThDP)	THIAMIN DIPHOSPHATE; PYRUVATE-DEHYDROGENASE; CRYSTAL-STRUCTURE; RATE CONSTANTS; DXP SYNTHASE; OXIDOREDUCTASE; BIOSYNTHESIS; INHIBITION; COMPLEX; BINDING	1-Deoxy-d-xylulose 5-phosphate synthase (DXPS) uses thiamine diphosphate (ThDP) to convert pyruvate and d-glyceraldehyde 3-phosphate (d-GAP) into 1-deoxy-d-xylulose 5-phosphate (DXP), an essential bacterial metabolite. DXP is not utilized by humans; hence, DXPS has been an attractive antibacterial target. Here, we investigate DXPS from Deinococcus radiodurans (DrDXPS), showing that it has similar kinetic parameters K-m(d-GAP) andK(m)(pyruvate) (54 +/- 3 and 11 +/- 1 mu m, respectively) and comparable catalytic activity (k(cat) = 45 +/- 2 min(-1)) with previously studied bacterial DXPS enzymes and employing it to obtain missing structural data on this enzyme family. In particular, we have determined crystallographic snapshots of DrDXPS in two states along the reaction coordinate: a structure of DrDXPS bound to C2 alpha-phosphonolactylThDP (PLThDP), mimicking the native pre-decarboxylation intermediate C2 alpha-lactylThDP (LThDP), and a native post-decarboxylation state with a bound enamine intermediate. The 1.94-angstrom-resolution structure of PLThDP-bound DrDXPS delineates how two active-site histidine residues stabilize the LThDP intermediate. Meanwhile, the 2.40-angstrom-resolution structure of an enamine intermediate-bound DrDXPS reveals how a previously unknown 17-angstrom conformational change removes one of the two histidine residues from the active site, likely triggering LThDP decarboxylation to form the enamine intermediate. These results provide insight into how the bi-substrate enzyme DXPS limits side reactions by arresting the reaction on the less reactive LThDP intermediate when its cosubstrate is absent. They also offer a molecular basis for previous low-resolution experimental observations that correlate decarboxylation of LThDP with protein conformational changes.	[Chen, Percival Yang-Ting; Drennan, Catherine L.] MIT, Dept Chem, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [DeColli, Alicia A.; Meyers, Caren L. Freel] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Johns Hopkins University	Drennan, CL (corresponding author), MIT, Dept Chem, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.; Meyers, CLF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	cmeyers@jhmi.edu; cdrennan@mit.edu		Drennan, Catherine/0000-0001-5486-2755; Chen, Percival Yang-Ting/0000-0001-7362-9801	National Institutes of Health [R35 GM126982, R01 GM084998]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124165, T32GM008763, R01GM084998, R35GM126982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35 GM126982 (to C. L. D.) and R01 GM084998 (C. L. F. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; Bartee D, 2018, ACCOUNTS CHEM RES, V51, P2546, DOI 10.1021/acs.accounts.8b00321; Bartee D, 2018, BIOCHEMISTRY-US, V57, P4349, DOI 10.1021/acs.biochem.8b00548; Basta LAB, 2014, FEBS J, V281, P2820, DOI 10.1111/febs.12823; Battistini MR, 2016, PROTEIN EXPRES PURIF, V120, P16, DOI 10.1016/j.pep.2015.12.003; Brammer LA, 2011, J BIOL CHEM, V286, P36522, DOI 10.1074/jbc.M111.259747; Brammer LA, 2009, ORG LETT, V11, P4748, DOI 10.1021/ol901961q; Chen PYT, 2019, JOULE, V3, P595, DOI 10.1016/j.joule.2018.12.006; Chen PYT, 2018, P NATL ACAD SCI USA, V115, P3846, DOI 10.1073/pnas.1722329115; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Costelloe SJ, 2008, J MOL EVOL, V66, P36, DOI 10.1007/s00239-007-9056-2; DeColli AA, 2018, J BIOL CHEM, V293, P10857, DOI 10.1074/jbc.RA118.001980; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eubanks LM, 2003, BIOCHEMISTRY-US, V42, P1140, DOI 10.1021/bi0205303; Gibson MI, 2016, CURR OPIN STRUC BIOL, V41, P54, DOI 10.1016/j.sbi.2016.05.011; Gibson MI, 2016, P NATL ACAD SCI USA, V113, P320, DOI 10.1073/pnas.1518537113; Handa Sumit, 2018, Biochem Mol Biol J, V4, DOI 10.21767/2471-8084.100051; Jordan F, 2005, BIOORG CHEM, V33, P190, DOI 10.1016/j.bioorg.2005.02.001; Jordan F, 2002, BIOORG CHEM, V30, P188, DOI 10.1006/bioo.2002.1249; Jordan F, 2014, BIOORG CHEM, V57, P251, DOI 10.1016/j.bioorg.2014.08.002; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon S, 1996, BIOCHEMISTRY-US, V35, P15814, DOI 10.1021/bi9615598; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morris F, 2013, CHEMBIOCHEM, V14, P1309, DOI 10.1002/cbic.201300187; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria NS, 2016, BIOCHEMISTRY-US, V55, P1135, DOI 10.1021/acs.biochem.5b01300; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; OBRIEN TA, 1980, BIOCHIM BIOPHYS ACTA, V613, P10, DOI 10.1016/0005-2744(80)90186-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel H, 2014, BIOCHEMISTRY-US, V53, P2145, DOI 10.1021/bi4015743; Patel H, 2012, J AM CHEM SOC, V134, P18374, DOI 10.1021/ja307315u; Querol-Audi J., 2014, CATALYTICALLY IMPORT; Reed GH, 2012, BBA-PROTEINS PROTEOM, V1824, P1291, DOI 10.1016/j.bbapap.2011.11.010; Sanders S, 2017, ACS INFECT DIS, V3, P467, DOI 10.1021/acsinfecdis.6b00168; Smith JM, 2014, J ANTIBIOT, V67, P77, DOI 10.1038/ja.2013.105; Smith JM, 2012, MEDCHEMCOMM, V3, P65, DOI 10.1039/c1md00233c; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; TURANO A, 1982, J AM CHEM SOC, V104, P3089, DOI 10.1021/ja00375a024; Wang X, 2018, ACS INFECT DIS, V4, P278, DOI 10.1021/acsinfecdis.7b00176; White JK, 2016, J PHYS CHEM B, V120, P9922, DOI 10.1021/acs.jpcb.6b07248; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Zhou JY, 2017, P NATL ACAD SCI USA, V114, P9355, DOI 10.1073/pnas.1619981114	50	12	12	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12405	12414		10.1074/jbc.RA119.009321	http://dx.doi.org/10.1074/jbc.RA119.009321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31239351	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000484402700013
J	Tam, SW; Feng, R; Lau, WKW; Law, ACK; Yeung, PKK; Chung, SK				Tam, Sze-Wah; Feng, Rui; Lau, Way Kwok-Wai; Law, Andrew Chi-Kin; Yeung, Patrick Ka-Kit; Chung, Sookja Kim			Endothelin type B receptor promotes cofilin rod formation and dendritic loss in neurons by inducing oxidative stress and cofilin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cofilin; dendrite; NADPH oxidase; oxidative stress; neurodegeneration; Alzheimer's disease; endothelin type B receptor; endothelin-1	ACTIN REORGANIZATION; ALZHEIMERS-DISEASE; NADPH OXIDASE; EXPRESSION; PROLIFERATION; DYSFUNCTION; ASTROCYTES; SLINGSHOT; IMMUNOREACTIVITY; MITOCHONDRIAL	Endothelin-1 (ET-1) is a neuroactive peptide produced by neurons, reactive astrocytes, and endothelial cells in the brain. Elevated levels of ET-1 have been detected in the post-mortem brains of individuals with Alzheimer's disease (AD). We have previously demonstrated that overexpression of astrocytic ET-1 exacerbates memory deficits in aged mice or in APP(K670/M671) mutant mice. However, the effects of ET-1 on neuronal dysfunction remain elusive. ET-1 has been reported to mediate superoxide formation in the vascular system via NADPH oxidase (NOX) and to regulate the actin cytoskeleton of cancer cell lines via the cofilin pathway. Interestingly, oxidative stress and cofilin activation were both reported to mediate one of the AD histopathologies, cofilin rod formation in neurons. This raises the possibility that ET-1 mediates neurodegeneration via oxidative stress- or cofilin activation-driven cofilin rod formation. Here, we demonstrate that exposure to 100 nm ET-1 or to a selective ET type B receptor (ETB) agonist (IRL1620) induces cofilin rod formation in dendrites of primary hippocampal neurons, accompanied by a loss of distal dendrites and a reduction in dendritic length. The 100 nm IRL1620 exposure induced superoxide formation and cofilin activation, which were abolished by pretreatment with a NOX inhibitor (5 mu m VAS2870). Moreover, IRL1620-induced cofilin rod formation was partially abolished by pretreatment with a calcineurin inhibitor (100 nm FK506), which suppressed cofilin activation. In conclusion, our findings suggest a role for ETB in neurodegeneration by promoting cofilin rod formation and dendritic loss via NOX-driven superoxide formation and cofilin activation.	[Tam, Sze-Wah; Feng, Rui; Yeung, Patrick Ka-Kit; Chung, Sookja Kim] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Tam, Sze-Wah; Lau, Way Kwok-Wai; Law, Andrew Chi-Kin] Univ Hong Kong, Dept Psychiat, Hong Kong, Peoples R China; [Chung, Sookja Kim] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Peoples R China; [Chung, Sookja Kim] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Peoples R China; [Lau, Way Kwok-Wai] Educ Univ Hong Kong, Dept Special Educ & Counseling, Hong Kong, Peoples R China; [Law, Andrew Chi-Kin] Perdana Univ, Dept Psychiat, Royal Coll Surg Ireland, Selangor, Malaysia	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Education University of Hong Kong (EdUHK); Perdana University; Royal College of Surgeons - Ireland	Tam, SW (corresponding author), Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China.; Tam, SW (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Peoples R China.; Chung, SK (corresponding author), Univ Hong Kong, Fac Med, Sch Biomed Sci, Pokfulam, 21 Sassoon Rd, Hong Kong, Peoples R China.	cathy_tsw@connect.hku.hk; skchung@hku.hk		Lau, Way/0000-0003-1493-5002	University Grants Council of Hong Kong on "Molecular Neuroscience: Basic Research and Drug Discovery" [AoE/B-15/01]; University of Hong Kong	University Grants Council of Hong Kong on "Molecular Neuroscience: Basic Research and Drug Discovery"; University of Hong Kong(University of Hong Kong)	This work was supported by a generous donation from the Henderson Warmth Foundation and Chow Tai Fook Charity Foundation for dementia research (to A. C.-K. L.), the Research Grants Council and the University Grants Council of Hong Kong on "Molecular Neuroscience: Basic Research and Drug Discovery" (Grant AoE/B-15/01), and University of Hong Kong matching funds for the State Key Laboratory of Pharmaceutical Biotechnology (to S. K. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Briyal S, 2015, NEUROSCIENCE, V301, P1, DOI 10.1016/j.neuroscience.2015.05.044; Briyal S, 2014, PHARMACOL BIOCHEM BE, V120, P65, DOI 10.1016/j.pbb.2014.02.008; Briyal S, 2011, J ALZHEIMERS DIS, V23, P491, DOI 10.3233/JAD-2010-101245; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Dong F, 2005, BRIT J PHARMACOL, V145, P323, DOI 10.1038/sj.bjp.0706193; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Grimm A, 2018, ISCIENCE, V6, P114, DOI 10.1016/j.isci.2018.07.015; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Hung K. L. V., 2008, THESIS, DOI [10.5353/th_b4218198, DOI 10.5353/TH_B4218198]; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Koizumi K, 2016, CELL MOL NEUROBIOL, V36, P155, DOI 10.1007/s10571-015-0256-9; Koyama Y, 1996, GLIA, V16, P342, DOI 10.1002/(SICI)1098-1136(199604)16:4<342::AID-GLIA6>3.0.CO;2-1; Li JJ, 2010, NEUROSCIENCE, V167, P665, DOI 10.1016/j.neuroscience.2010.02.062; Li LX, 2003, CIRCULATION, V107, P1053, DOI 10.1161/01.CIR.0000051459.74466.46; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Loomis ED, 2005, J PHARMACOL EXP THER, V315, P1058, DOI 10.1124/jpet.105.091728; MINAMI M, 1995, PROG NEURO-PSYCHOPH, V19, P509, DOI 10.1016/0278-5846(95)00031-P; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Minton AZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043199; Morigi M, 2006, AM J PATHOL, V169, P1965, DOI 10.2353/ajpath.2006.051331; Naidoo V, 2004, J CHEM NEUROANAT, V27, P87, DOI 10.1016/j.jchemneu.2003.12.002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Palmer JC, 2012, J ALZHEIMERS DIS, V29, P853, DOI 10.3233/JAD-2012-111760; Panettieri RA, 1996, BRIT J PHARMACOL, V118, P191, DOI 10.1111/j.1476-5381.1996.tb15385.x; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Rahman T, 2014, J ALZHEIMERS DIS, V42, P1443, DOI 10.3233/JAD-140393; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sato Y, 2000, AM J RESP CELL MOL, V23, P404, DOI 10.1165/ajrcmb.23.3.4057; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Semprucci E, 2016, ONCOGENE, V35, P3432, DOI 10.1038/onc.2015.403; Walsh KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095995; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Woo JA, 2015, CELL DEATH DIFFER, V22, P921, DOI 10.1038/cdd.2015.5; ZHANG WW, 1994, J NEUROL SCI, V122, P90, DOI 10.1016/0022-510X(94)90057-4	43	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12495	12506		10.1074/jbc.RA118.005155	http://dx.doi.org/10.1074/jbc.RA118.005155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248984	Green Published, hybrid			2022-12-26	WOS:000484402700020
J	Soomro, I; Hong, A; Lie, Z; Duncan, JS; Skolnik, EY				Soomro, Irfana; Hong, Aram; Lie, Zhai; Duncan, James S.; Skolnik, Edward Y.			Discoidin Domain Receptor 1 (DDR1) tyrosine kinase is upregulated in PKD kidneys but does not play a role in the pathogenesis of polycystic kidney disease	PLOS ONE			English	Article							ONE-STEP GENERATION; CYST GROWTH; INHIBITION; FIBROSIS; MICE	Tolvaptan is the only drug approved to slow cyst growth and preserve kidney function in patients with autosomal dominant polycystic kidney disease (ADPKD). However, its limited efficacy combined with significant side effects underscores the need to identify new and safe therapeutic drug targets to slow progression to end stage kidney disease. We identified Discoidin Domain Receptor 1 (DDR1) as receptor tyrosine kinase upregulated in vivo in 3 mouse models of ADPKD using a novel mass spectrometry approach to identify kinases upregulated in ADPKD. Previous studies demonstrating critical roles for DDR1 to cancer progression, its potential role in the pathogenesis of a variety of other kidney disease, along with the possibility that DDR1 could provide new insight into how extracellular matrix impacts cyst growth led us to study the role of DDR1 in ADPKD pathogenesis. However, genetic deletion of DDR1 using CRISPR/Cas9 failed to slow cyst growth or preserve kidney function in both a rapid and slow mouse model of ADPKD demonstrating that DDR1 does not play a role in PKD pathogenesis and is thus a not viable drug target. In spite of the negative results, our studies will be of interest to the nephrology community as it will prevent others from potentially conducting similar experiments on DDR1 and reinforces the potential of performing unbiased screens coupled with in vivo gene editing using CRISPR/Cas9 to rapidly identify and confirm new potential drug targets for ADPKD.	[Soomro, Irfana; Skolnik, Edward Y.] NYU, Langone Med Ctr, Div Nephrol, 550 1St Ave, New York, NY 10016 USA; [Hong, Aram; Lie, Zhai; Skolnik, Edward Y.] NYU, Dept Biochem, Langone Med Ctr, New York, NY 10016 USA; [Hong, Aram; Lie, Zhai; Skolnik, Edward Y.] NYU, Dept Mol Pharmacol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Skolnik, Edward Y.] NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Duncan, James S.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Fox Chase Cancer Center	Skolnik, EY (corresponding author), NYU, Langone Med Ctr, Div Nephrol, 550 1St Ave, New York, NY 10016 USA.; Skolnik, EY (corresponding author), NYU, Dept Biochem, Langone Med Ctr, New York, NY 10016 USA.; Skolnik, EY (corresponding author), NYU, Dept Mol Pharmacol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.; Skolnik, EY (corresponding author), NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	Edwarci.Skolnik@nyumc.org		Skolnik, Edward/0000-0003-4375-8279	PKD foundation	PKD foundation	Portions of this work was supported by grants from the PKD foundation to IS and EYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogio C, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000076; Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Borza CM, 2017, MATRIX BIOL, V57-58, P258, DOI 10.1016/j.matbio.2016.11.009; Chen L, 2015, J CLIN INVEST, V125, P2399, DOI 10.1172/JCI80467; Cooper MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066755; Dorison A, 2018, CELL ADHES MIGR, V12, P299, DOI 10.1080/19336918.2018.1441661; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Elliott J, 2011, AM J PHYSIOL-CELL PH, V301, pC522, DOI 10.1152/ajpcell.00163.2010; Gao H, 2016, CELL, V166, P47, DOI 10.1016/j.cell.2016.06.009; Graves LM, 2013, BIOCHEM J, V450, P1, DOI 10.1042/BJ20121456; Gross O, 2010, MATRIX BIOL, V29, P346, DOI 10.1016/j.matbio.2010.03.002; Guerrot D, 2011, AM J PATHOL, V179, P83, DOI 10.1016/j.ajpath.2011.03.023; Kerroch M, 2012, FASEB J, V26, P4079, DOI 10.1096/fj.11-194902; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; McPherson EA, 2004, J AM SOC NEPHROL, V15, P493, DOI 10.1097/01.ASN.0000109782.28991.26; Patel V, 2013, P NATL ACAD SCI USA, V110, P10765, DOI 10.1073/pnas.1301693110; Rammal H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00055; Rubel D, 2014, MATRIX BIOL, V34, P13, DOI 10.1016/j.matbio.2014.01.006; Soomro I, 2018, NEPHROL DIAL TRANSPL, V33, P1343, DOI 10.1093/ndt/gfx349; Sweeney WE, 2008, J AM SOC NEPHROL, V19, P1331, DOI 10.1681/ASN.2007060665; Swenson-Fields KI, 2013, KIDNEY INT, V83, P855, DOI 10.1038/ki.2012.446; Talbot JJ, 2014, J AM SOC NEPHROL, V25, P1737, DOI 10.1681/ASN.2013091026; Torres VE, 2010, ADV CHRONIC KIDNEY D, V17, P190, DOI 10.1053/j.ackd.2010.01.006; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhdanova O, 2011, KIDNEY INT, V80, P719, DOI 10.1038/ki.2011.122	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0211670	10.1371/journal.pone.0211670	http://dx.doi.org/10.1371/journal.pone.0211670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260458	Green Submitted, Green Published, gold			2022-12-26	WOS:000484918700005
J	Beumer, W; Swildens, J; Leal, T; Noel, S; Anthonijsz, H; van der Horst, G; Kuiperij-Boersma, H; Potman, M; van Putten, C; Biasutto, P; Platenburg, G; de Jonge, H; Henig, N; Ritsema, T				Beumer, Wouter; Swildens, Jim; Leal, Teresinha; Noel, Sabrina; Anthonijsz, Herma; van der Horst, Geert; Kuiperij-Boersma, Hester; Potman, Marko; van Putten, Charlotte; Biasutto, Patricia; Platenburg, Gerard; de Jonge, Hugo; Henig, Noreen; Ritsema, Tita			Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p. Phe508del cystic fibrosis	PLOS ONE			English	Article							SALIVARY SECRETION ASSAY; ANTISENSE OLIGONUCLEOTIDES; POTENTIAL DIFFERENCE; MOUSE MODEL; GENE; MUTATION; DELTA-F508-CFTR; EXPRESSION; EPITHELIA; SIRNA	Cystic fibrosis (CF) is caused by mutations in the gene encoding the epithelial chloride channel CF transmembrane conductance regulator (CFTR) protein. The most common mutation is a deletion of three nucleotides leading to the loss of phenylalanine at position 508 (p. Phe508del) in the protein. This study evaluates eluforsen, a novel, single-stranded, 33-nucleotide antisense oligonucleotide designed to restore CFTR function, in in vitro and in vivo models of p. Phe508del CF. The aims of the study were to demonstrate cellular uptake of eluforsen, and its efficacy in functional restoration of p. Phe508del-CFTR both in vitro and in vivo. In vitro, the effect of eluforsen was investigated in human CF pancreatic adenocarcinoma cells and human bronchial epithelial cells. Two mouse models were used to evaluate eluforsen in vivo. In vitro, eluforsen improved chloride efflux in CF pancreatic adenocarcinoma cell cultures and increased short-circuit current in primary human bronchial epithelial cells, both indicating restoration of CFTR function. In vivo, eluforsen was taken up by airway epithelium following oro-tracheal administration in mice, resulting in systemic exposure of eluforsen. In female F508del-CFTR mice, eluforsen significantly increased CFTR-mediated saliva secretion (used as a measure of CFTR function, equivalent to the sweat test in humans). Similarly, intranasal administration of eluforsen significantly improved nasal potential difference (NPD), and therefore CFTR conductance, in two CF mouse models. These findings indicate that eluforsen improved CFTR function in cell and animal models of p. Phe508del-CFTR-mediated CF and supported further development of eluforsen in human clinical trials, where eluforsen has also been shown to improve CFTR activity as measured by NPD.	[Beumer, Wouter; Swildens, Jim; Anthonijsz, Herma; van der Horst, Geert; Kuiperij-Boersma, Hester; Potman, Marko; van Putten, Charlotte; Biasutto, Patricia; Platenburg, Gerard; Henig, Noreen; Ritsema, Tita] ProQR Therapeut, Leiden, Netherlands; [Leal, Teresinha; Noel, Sabrina] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, Brussels, Belgium; [de Jonge, Hugo] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Kuiperij-Boersma, Hester] LabPON Lab Pathol Oost Nederland, Hengelo, Netherlands; [Henig, Noreen] Breath Therapeut Inc, Menlo Pk, CA USA	Universite Catholique Louvain; Erasmus University Rotterdam; Erasmus MC	Beumer, W (corresponding author), ProQR Therapeut, Leiden, Netherlands.	wbeumer@proqr.com			Cystic Fibrosis Foundation [RITSEM12G0]; Netherlands Enterprise Agency (RVO) [IK12062]; European Research Council (ERC) under the European Union [633545]; ProQR Therapeutics	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Netherlands Enterprise Agency (RVO); European Research Council (ERC) under the European Union(European Research Council (ERC)); ProQR Therapeutics	This work was supported by the Cystic Fibrosis Foundation (grant number: RITSEM12G0) and the Netherlands Enterprise Agency (RVO) for InnovatieKrediet (grant number: IK12062), both awarded to TR. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no 633545, awarded to ProQR Therapeutics). WB, JS, HA, GH, HKB, MP, CP, PB, GP, NH, and TR are or were employees of ProQR Therapeutics. TL and SN received funding from ProQR Therapeutics. HdJ received consultancy fees from ProQR Therapeutics. The specific roles of these authors are articulated in the 'author contributions' section. The funder provided support in the form of salaries for authors indicated above (WB, JS, HA, GH, HKB, MP, CP, PB, GP, NH, and TR) as ProQR Therapeutics employees, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ProQR Therapeutics is developing eluforsen/QR-010 as a treatment for cystic fibrosis. No other sponsors participated in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; ATCC, 2013, CFPAC 1 ATCC CRL 191; BARGON J, 1992, MOL CELL BIOL, V12, P1872, DOI 10.1128/MCB.12.4.1872; Barker PM, 2005, AM J RESP CRIT CARE, V171, P868, DOI 10.1164/rccm.200311-1508OC; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Best JA, 2005, EXP PHYSIOL, V90, P189, DOI 10.1113/expphysiol.2004.028720; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Caci E, 2009, AM J RESP CELL MOL, V40, P211, DOI 10.1165/rcmb.2007-0456OC; Chanson M, 1999, J CLIN INVEST, V103, P1677, DOI 10.1172/JCI5645; Char JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088564; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Colas J, 2012, HUM MOL GENET, V21, P623, DOI 10.1093/hmg/ddr496; Cooney AL, 2018, GENES-BASEL, V9, DOI 10.3390/genes9110538; Cystic Fibrosis Foundation, 2014, CYST FIBR FDN PAT RE CYST FIBR FDN PAT RE; Davies JC, 2018, NEW ENGL J MED, V379, P1599, DOI 10.1056/NEJMoa1807119; DEAN M, 1994, HUM GENET, V93, P364; Dhooghe B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077314; Drevinek P, 2020, J CYST FIBROS, V19, P99, DOI 10.1016/j.jcf.2019.05.014; Droebner K, 2013, J CYST FIBROS, V12, P630, DOI 10.1016/j.jcf.2013.05.001; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Griesenbach U, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-26; Griesenbach Uta, 2005, J Cyst Fibros, V4, P89, DOI 10.1016/j.jcf.2005.02.002; Keating D, 2018, NEW ENGL J MED, V379, P1612, DOI 10.1056/NEJMoa1807120; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Leal T, 2006, LAB ANIM-UK, V40, P43, DOI 10.1258/002367706775404480; Liu XM, 2002, NAT BIOTECHNOL, V20, P47, DOI 10.1038/nbt0102-47; Odolczyk N, 2013, EMBO MOL MED, V5, P1484, DOI 10.1002/emmm.201302699; Platz J, 2005, OLIGONUCLEOTIDES, V15, P132, DOI 10.1089/oli.2005.15.132; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Reautschnig P, 2017, RNA BIOL, V14, P651, DOI 10.1080/15476286.2016.1208323; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066955; Sermet-Gaudelus I, 2019, J CYST FIBROS, V18, P536, DOI 10.1016/j.jcf.2018.10.015; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Sorio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022212; Stein CA, 2001, J CLIN INVEST, V108, P641, DOI 10.1172/JCI13885; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; WAGNER JA, 1992, P NATL ACAD SCI USA, V89, P6785, DOI 10.1073/pnas.89.15.6785; West MR, 1996, ANAL BIOCHEM, V241, P51, DOI 10.1006/abio.1996.0377; World Health Organisation, GEN RES CTR MON DIS; Zamecnik PC, 2004, P NATL ACAD SCI USA, V101, P8150, DOI 10.1073/pnas.0401933101; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253	52	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219182	10.1371/journal.pone.0219182	http://dx.doi.org/10.1371/journal.pone.0219182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251792	gold, Green Published, Green Submitted			2022-12-26	WOS:000484915000049
J	Raihan, R; Akbar, SMF; Al Mahtab, M; Takahashi, K; Masumoto, J; Tabassum, S; Tee, KK; Mohamed, RB				Raihan, Ruksana; Akbar, Sheikh Mohammad Fazle; Al Mahtab, Mamun; Takahashi, Kazuaki; Masumoto, Junya; Tabassum, Shahina; Tee, Kok Keng; Mohamed, Rosmawati Binti			Genomic analysis of Hepatitis B virus and its association with disease manifestations in Bangladesh	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA PATIENTS; NATURAL-HISTORY; GENOTYPES; MUTATIONS; CARRIERS; RELEVANCE; RISK	The direct cytopathic effects of the hepatitis B virus ( HBV) on subsequent liver damage are not fully understood in HBV-infected patients. However, associations between the prevalence of various HBV genotypes and the extent of liver damage have been reported from different parts of the world. The purpose of this study was to determine the distribution of HBV genotypes in patients with chronic HBV infection in Bangladesh, a country of 160 million people, of which approximately 3-6 million are chronically infected HBV patients. In addition, whole and partial genome sequencing of HBV was performed to evaluate the relationship between HBV mutations and genotypes. We found that 42% of the patients with low HBV DNA and normal levels of alanine aminotransferase ( ALT) had HBV genotype D. In contrast, the HBV genotype C was dominant among patients with high HBV DNA levels (> 2000 IU/ml) and elevated ALT and in patients with liver cirrhosis ( LC) and hepatocellular carcinomas ( HCC). Whole and partial genome sequences of HBV revealed that most patients with LC and HCC had HBV genotype C with mutations at the T1762/A1764 positions. It seems that Bangladesh represents a borderline country, situated within East Asia, which mainly consists of individuals with HBV genotypes B and C, whereas in the western parts of Asia, HBV genotypes A and D are prevalent. Bangladesh is, therefore, an excellent model for the comparison of the pathophysiology of three major HBV genotypes in a single population. The findings of this study suggest a possible association between HBV viral factors and the extent of liver damage in chronic HBV-infected patients.	[Raihan, Ruksana; Mohamed, Rosmawati Binti] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Akbar, Sheikh Mohammad Fazle; Masumoto, Junya] Ehime Univ, Grad Sch Med, Proteosci Ctr, Dept Pathol, Toon City, Ehime, Japan; [Al Mahtab, Mamun] Bangabandhu Sheikh Mujib Med Univ, Dept Hepatol, Dhaka, Bangladesh; [Takahashi, Kazuaki] Tokyo Shinagawa Hosp, Dept Med Sci, Shinagawa Ku, Tokyo, Japan; [Tabassum, Shahina] Bangabandhu Sheikh Mujib Med Univ, Dept Virol, Dhaka, Bangladesh; [Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Tee, Kok Keng] Sunway Univ, Sch Healthcare & Med Sci, Bandar Sunway, Selangor Darul, Malaysia	Universiti Malaya; Ehime University; Bangabandhu Sheikh Mujib Medical University (BSMMU); Bangabandhu Sheikh Mujib Medical University (BSMMU); Universiti Malaya; Sunway University	Raihan, R (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia.	ruksanaraihan@gmail.com; sheikhmohammadfazle@gmail.com	Tee, Kok Keng/A-8148-2008	Tee, Kok Keng/0000-0002-7923-5448				Al Mahtab M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201236; Al-Mahtab M, 2012, DIGESTION, V86, P1, DOI 10.1159/000337529; Al-Mahtab M, 2010, J MED VIROL, V82, P1350, DOI 10.1002/jmv.21830; Chu CJ, 2003, GASTROENTEROLOGY, V125, P444, DOI 10.1016/S0016-5085(03)00895-3; Fang ZL, 2008, AM J GASTROENTEROL, V103, P2254, DOI 10.1111/j.1572-0241.2008.01974.x; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Liaw YF, 2010, ANTIVIR THER, V15, P25, DOI 10.3851/IMP1621; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Matsuo J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177248; Mayerat C, 1999, J VIRAL HEPATITIS, V6, P299, DOI 10.1046/j.1365-2893.1999.00174.x; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Munshi SU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188944; Orito E, 2005, INTERVIROLOGY, V48, P239, DOI 10.1159/000084601; Rahman MA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1840-2; Raihan R, 2017, J CLIN EXP HEPAT, V7, pS119; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shaha M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3174-5; Shen T, 2014, WORLD J GASTROENTERO, V20, P5435, DOI 10.3748/wjg.v20.i18.5435; Sumi H, 2003, HEPATOLOGY, V37, P19, DOI 10.1053/jhep.2003.50036; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Takahashi K, 1998, ARCH VIROL, V143, P2313, DOI 10.1007/s007050050463; Tian QJ, 2016, HEPATOL INT, V10, P854, DOI 10.1007/s12072-016-9745-2; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yuan JM, 2009, CANCER EPIDEM BIOMAR, V18, P590, DOI 10.1158/1055-9965.EPI-08-0966	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218744	10.1371/journal.pone.0218744	http://dx.doi.org/10.1371/journal.pone.0218744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251754	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000019
J	Yang, CT; Yip, PSF; Cha, ES; Zhang, Y				Yang, Chi Ting; Yip, Paul S. F.; Cha, Eun Shil; Zhang, Yi			Seasonal changes in suicide in South Korea, 1991 to 2015	PLOS ONE			English	Article							SELF-HARM; HONG-KONG; PUBLIC HOLIDAYS; RATES; SEX; ADMISSIONS; SUNSHINE; CLIMATE; DEATHS; TRENDS	Seasonality of suicidal behavior has been widely reported in many epidemiological studies with a well replicated suicide peak in spring followed by a trough in winter season. Research from some regions over the past few decades has shown a diminishing seasonal pattern of suicides and this introduced a new perspective on the suicide study. Data on all suicide deaths from the period 1991 to 2015 was extracted from the South Korean National Death Registration data set which was made available by Statistics Korea. Our findings confirmed a strong seasonal effect of suicides in South Korea throughout the study period and a marked diminishing pattern was observed since the period of 2006-2010. The rhythm of suicides kept changing across the time intervals with a spring peak followed by a second peak in late summer/autumn. The seasonality varied across age groups and the seasonal effect among the Korean elderly suicides was still found to be significant though a diminishing pattern was observed recently.	[Yang, Chi Ting] Univ Hong Kong, Dept Stat & Actuarial Sci, Hong Kong, Peoples R China; [Yip, Paul S. F.] Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Peoples R China; [Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Peoples R China; [Cha, Eun Shil] Korea Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Zhang, Yi] Chinese Acad Social Sci, Inst Populat & Labor Econ, Beijing, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Korea University; Korea University Medicine (KU Medicine); Chinese Academy of Social Sciences	Yip, PSF (corresponding author), Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Peoples R China.; Yip, PSF (corresponding author), Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Peoples R China.; Zhang, Y (corresponding author), Chinese Acad Social Sci, Inst Populat & Labor Econ, Beijing, Peoples R China.	sfpyip@hku.hk; zhangyipku@126.com		Yang, Chi-Ting/0000-0002-8501-158X	Research Grants Council (RGC) of Hong Kong [GRF106160261]	Research Grants Council (RGC) of Hong Kong(Hong Kong Research Grants Council)	The current research is supported by the Research Grants Council (RGC) of Hong Kong. Specific grant numbers: GRF106160261 (https://cerg1.ugc.edu.hk/) to PSFY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdacic-Gross V, 2005, J EPIDEMIOL COMMUN H, V59, P967, DOI 10.1136/jech.2004.030981; Ajdacic-Gross V, 2010, SOC SCI MED, V71, P657, DOI 10.1016/j.socscimed.2010.05.030; Fernandez-Nino JA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071313; Atmaca M, 2002, NEUROPSYCHOBIOLOGY, V45, P124, DOI 10.1159/000054950; Bando DH, 2009, REV BRAS PSIQUIATR, V31, P101, DOI 10.1590/S1516-44462009000200004; Ben Park BC, 2012, PSYCHOL REP, V111, P495, DOI 10.2466/12.17.PR0.111.5.495-497; Brewerton T., 1989, ANN CLIN PSYCHIATRY, V1, P153, DOI [10.3109/10401238909149974, DOI 10.3109/10401238909149974]; Cantor CH, 2000, PSYCHOPATHOLOGY, V33, P303, DOI 10.1159/000029162; Chan CMH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001799corr1; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; CHEW KSY, 1995, SOC SCI MED, V40, P223, DOI 10.1016/0277-9536(94)E0070-9; Cho YS, 2007, 8 C KOR LAB INC PAN; Choi YR, 2014, J AFFECT DISORDERS, V167, P322, DOI 10.1016/j.jad.2014.06.026; Christodulou C, 2012, SEASONAL VARIATION S, V49, P73; Cowgill D. O., 1972, AGING MODERNIZATION; Fu KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053870; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Griffin E, 2017, J AFFECT DISORDERS, V218, P30, DOI 10.1016/j.jad.2017.04.058; Hakko H., 2000, SEASONAL VARIATION O; Im JS, 2011, COMPR PSYCHIAT, V52, P231, DOI 10.1016/j.comppsych.2010.07.005; Jee HJ, 2016, INT J NEUROPSYCHOPH, V19, P146; Kim C, 2010, AM J PSYCHIAT, V167, P1100, DOI 10.1176/appi.ajp.2010.09050706; KOK LP, 1993, MED SCI LAW, V33, P247, DOI 10.1177/002580249303300311; Kothari R, 2018, INT J ADV RES DEV, V3, P7; Kwok CL, 2017, J AFFECT DISORDERS, V207, P63, DOI 10.1016/j.jad.2016.09.025; Lee HC, 2006, J AFFECT DISORDERS, V92, P221, DOI 10.1016/j.jad.2006.01.026; MAES M, 1993, AM J PSYCHIAT, V150, P1380; Malone K, 1998, NAT MED, V4, P25; MCCLEARY R, 1991, AM J PUBLIC HEALTH, V81, P1494, DOI 10.2105/AJPH.81.11.1494; MICCIOLO R, 1989, PSYCHOL MED, V19, P199, DOI 10.1017/S0033291700011156; Miller TR, 2012, CRISIS, V33, P169, DOI 10.1027/0227-5910/a000126; Ministry of Science and ICT, 2017, 2017 SURV INT US; Morken G, 2002, J AFFECT DISORDERS, V69, P39, DOI 10.1016/S0165-0327(00)00373-6; Nakaji S, 2004, EUR J EPIDEMIOL, V19, P905, DOI 10.1007/s10654-004-4695-8; Nam M, 2011, J KOREAN MED ASSOC, V54, P358, DOI 10.5124/jkma.2011.54.4.358; NAYHA S, 1982, BRIT J PSYCHIAT, V141, P512, DOI 10.1192/bjp.141.5.512; OECD, 2017, HLTH AT A GLANC, DOI [10.1787/health_glance-2017-en, DOI 10.1787/HEALTH_GLANCE-2017-EN]; Oravecz R, 2006, J AFFECT DISORDERS, V95, P135, DOI 10.1016/j.jad.2006.04.027; Park S, 2016, PSYCHIAT INVEST, V13, P184, DOI 10.4306/pi.2016.13.2.184; POCOCK SJ, 1974, ROY STAT SOC C-APP, V23, P103; Shin HY, 2016, J KOREAN MED ASSOC, V59, P221, DOI 10.5124/jkma.2016.59.3.221; Sohn K, 2017, SUICIDE LIFE-THREAT, V47, P217, DOI 10.1111/sltb.12281; TIETJEN GH, 1994, PSYCHIAT RES, V53, P161, DOI 10.1016/0165-1781(94)90107-4; Vyssoki B, 2014, JAMA PSYCHIAT, V71, P1231, DOI 10.1001/jamapsychiatry.2014.1198; Vyssoki B, 2012, COMPR PSYCHIAT, V53, P535, DOI 10.1016/j.comppsych.2011.06.003; Woo JM, 2012, INT J ENV RES PUB HE, V9, P531, DOI 10.3390/ijerph9020531; World Health Organization, 2017, MON HLTH SDGS SUST D; Yang HJ, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015046; Yip PSF, 1998, INT J GERIATR PSYCH, V13, P631, DOI 10.1002/(SICI)1099-1166(199809)13:9<631::AID-GPS836>3.3.CO;2-1; Yip PSF, 2000, BRIT J PSYCHIAT, V177, P366, DOI 10.1192/bjp.177.4.366; Yip PSF, 2004, J AFFECT DISORDERS, V81, P251, DOI 10.1016/j.jad.2003.09.001; Yip PSF, 1998, J AFFECT DISORDERS, V47, P141, DOI 10.1016/S0165-0327(97)00135-3; Zonda T, 2008, OMEGA-J DEATH DYING, V58, P153, DOI 10.2190/OM.58.2.e	53	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219048	10.1371/journal.pone.0219048	http://dx.doi.org/10.1371/journal.pone.0219048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3XM	31251776	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000039
J	Araque, O; Arzola, N; Varon, O				Araque, Oscar; Arzola, Nelson; Varon, Omar			Computational modeling of fatigue crack propagation in butt welded joints subjected to axial load	PLOS ONE			English	Article							PARIS LAW; FRACTURE MODEL; GROWTH; SIMULATION; STRENGTH; STRESS; STEEL; LIFE	This article addresses the study of crack behavior elicited on axial fatigue in specimens joined by butt weld made of steel ASTM A36 by using fracture mechanics and simulation software of finite elements (Ansys APDL, Franc3D). The computational model was initially to define the geometry model by using CAD software. Specimens with Weld Reinforcement of 2 mm and 3mm were simulated. Subsequently, the type of element for the mesh, the information inclusion concerning material mechanical properties and load conditions were selected. By using Franc3D software, the crack propagation phenomenon is analyzed, and its growth parameters have been established. In this way, it is possible to calculate the magnitude of stress intensity factor (SIF) along the crack front. It is concluded that the stress located in the weld toe is maximized proportionately to the size of the weld reinforcement due to the concentration effect of geometric stress. In addition, it is observed that the propagation rate obtained from Paris law has a similar behavior for the studied weld reinforcements; the latter as there were short cracks.	[Araque, Oscar; Varon, Omar] Univ Ibague, Dept Mech Engn, Ibague, Colombia; [Arzola, Nelson] Univ Nacl Colombia, Res Grp Multidisciplinary Optimal Design, Dept Ingn Mecan & Mecaton, Bogota, Colombia	Universidad Nacional de Colombia	Araque, O (corresponding author), Univ Ibague, Dept Mech Engn, Ibague, Colombia.	oscar.araque@unibague.edu.co		Araque de los Rios, Oscar Javier/0000-0001-9400-1140	Universidad de Ibague; Research Department at the Universidad de Ibague; Universidad Nacional de Colombia	Universidad de Ibague; Research Department at the Universidad de Ibague; Universidad Nacional de Colombia	This work was funded by the Universidad de Ibague and Universidad Nacional de Colombia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Research Department at the Universidad de Ibague and the Universidad Nacional de Colombia for their support provided for the development of this research.	Adolf Hobbacher, 2015, RECOMMENDATIONS FATI; Ancona F, 2016, ENG FRACT MECH, V163, P206, DOI 10.1016/j.engfracmech.2016.06.016; [Anonymous], 2013, 7910 BS; Araque O, 2018, MATERIALS, V11, DOI 10.3390/ma11010081; Arzola de la Peña Nelson, 2014, Ingeniare. Rev. chil. ing., V22, P196, DOI 10.4067/S0718-33052014000200006; Barsoum R. S., 1976, International Journal for Numerical Methods in Engineering, V10, P25, DOI 10.1002/nme.1620100103; Berrios David R., 2018, Inf. tecnol., V29, P19; Bowness D, 2000, INT J FATIGUE, V22, P369, DOI 10.1016/S0142-1123(00)00012-8; Carrascal I, 2014, POLYM TEST, V40, P39, DOI 10.1016/j.polymertesting.2014.08.005; Chin PL, 2011, STRESS ANAL CRACK PR; Ciavarella M, 2018, ENG FRACT MECH, V191, P111, DOI 10.1016/j.engfracmech.2018.01.019; Citarella R, 2016, PROCEDIA STRUCT INTE, V2, P2631, DOI 10.1016/j.prostr.2016.06.329; Fumiaki T, 2017, PROCEDIA STRUCT INTE, V6, P269, DOI 10.1016/j.prostr.2017.11.041; Guo LW, 2016, ENG FRACT MECH, V151, P70, DOI 10.1016/j.engfracmech.2015.11.006; Kirane K, 2016, INT J FATIGUE, V83, P209, DOI 10.1016/j.ijfatigue.2015.10.015; Kirane K, 2015, MECH RES COMMUN, V68, P60, DOI 10.1016/j.mechrescom.2015.03.003; Lewandowski J, 2016, THEOR APPL FRACT MEC, V86, P342, DOI 10.1016/j.tafmec.2016.09.003; Liu R, 2018, ANN NUCL ENERGY, V112, P779, DOI 10.1016/j.anucene.2017.10.021; NEWMAN JC, 1981, ENG FRACT MECH, V15, P185, DOI 10.1016/0013-7944(81)90116-8; PANG HLJ, 1994, INT J PRES VES PIP, V58, P171, DOI 10.1016/0308-0161(94)90080-9; Rajabipour A, 2015, INT J FATIGUE, V80, P357, DOI 10.1016/j.ijfatigue.2015.06.027; RITCHIE MD, 2003, COMPREHENSIVE STRUCT, V4, P28; Saucedo-Mora L, 2015, ENG FRACT MECH, V147, P355, DOI 10.1016/j.engfracmech.2015.05.059; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P3; Seko Y, 2016, PROCEDIA STRUCT INTE, V2, P1708, DOI 10.1016/j.prostr.2016.06.216; Serizawa H, 2011, PROCEDIA ENGINEER, V10, DOI 10.1016/j.proeng.2011.04.093; Shiozaki T, 2018, INT J FATIGUE, V116, P409, DOI 10.1016/j.ijfatigue.2018.06.050; Szavai S, 2016, PROCEDIA STRUCT INTE, V2, P1023, DOI 10.1016/j.prostr.2016.06.131; Toribio J, 2017, PROCEDIA STRUCT INTE, V5, P1299, DOI 10.1016/j.prostr.2017.07.115; Xiao XK, 2008, ENG FAIL ANAL, V15, P188, DOI 10.1016/j.engfailanal.2006.11.015; Yang Y, 2017, INT J FATIGUE, V102, P37, DOI 10.1016/j.ijfatigue.2017.04.014; Younise B, 2016, PROCEDIA STRUCT INTE, V2, P753, DOI 10.1016/j.prostr.2016.06.097; Zerbst U, 2017, PROCEDIA STRUCT INTE, V7, P407, DOI 10.1016/j.prostr.2017.11.106	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218973	10.1371/journal.pone.0218973	http://dx.doi.org/10.1371/journal.pone.0218973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247041	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900060
J	Erlandson, MA; Mori, BA; Coutu, C; Holowachuk, J; Olfert, OO; Gariepy, TD; Hegedus, DD				Erlandson, Martin A.; Mori, Boyd A.; Coutu, Cathy; Holowachuk, Jennifer; Olfert, Owen O.; Gariepy, Tara D.; Hegedus, Dwayne D.			Examining population structure of a bertha armyworm, Mamestra configurata (Lepidoptera: Noctuidae), outbreak in western North America: Implications for gene flow and dispersal	PLOS ONE			English	Article							MICROSATELLITES REVEAL; INSECTICIDE RESISTANCE; R-PACKAGE; GENOTYPE; MOTH; DIFFERENTIATION; DIVERSITY; SOFTWARE; HAPLOTYPES; INFERENCE	The bertha armyworm (BAW), Mamestra configurata, is a significant pest of canola (Brassica napus L. and B. rapa L.) in western North America that undergoes cyclical outbreaks every 6-8 years. During peak outbreaks millions of dollars are spent on insecticidal control and, even with control efforts, subsequent damage can result in losses worth millions of dollars. Despite the importance of this pest insect, information is lacking on the dispersal ability of BAW and the genetic variation of populations from across its geographic range which may underlie potential differences in their susceptibility to insecticides or pathogens. Here, we examined the genetic diversity of BAW populations during an outbreak across its geographic range in western North America. First, mitochondrial cytochrome oxidase 1 (CO1) barcode sequences were used to confirm species identification of insects captured in a network of pheromone traps across the range, followed by haplotype analyses. We then sequenced the BAW genome and used double-digest restriction site associated DNA sequencing, mapped to the genome, to identify 1000s of single nucleotide polymorphisms (SNP) markers. CO1 haplotype analysis identified 9 haplotypes distributed across 28 sample locations and three laboratory-reared colonies. Analysis of genotypic data from both the CO1 and SNP markers revealed little population structure across BAW's vast range. The CO1 haplotype pattern showed a star-like phylogeny which is often associated with species whose population abundance and range has recently expanded and combined with pheromone trap data, indicates the outbreak may have originated from a single focal point in central Saskatchewan. The relatively recent introduction of canola and rapid expansion of the canola growing region across western North America, combined with the cyclical outbreaks of BAW caused by precipitous population crashes, has likely selected for a genetically homogenous BAW population adapted to this crop.	[Erlandson, Martin A.; Mori, Boyd A.; Coutu, Cathy; Holowachuk, Jennifer; Olfert, Owen O.; Hegedus, Dwayne D.] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Gariepy, Tara D.] Agr & Agri Food Canada, London Res & Dev Ctr, London, ON, Canada	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Erlandson, MA; Hegedus, DD (corresponding author), Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada.	martin.erlandson@canada.ca; dwayne.hegedus@canada.ca	Mori, Boyd/HIK-2697-2022; Coutu, Cathy/O-1474-2018	Mori, Boyd/0000-0003-2787-5950; Holowachuk, Jennifer/0000-0002-9387-1782; Coutu, Cathy/0000-0002-2570-9994	Agriculture and Agri-Food Canada, Canadian Crop Genomics Initiative [J-000197, J-001033]; Agriculture and Agri-Food Canada, A-Base [J-000778]; Western Grains Research Foundation [AGR1417]; Agriculture and Agri-Food Canada [AGR-10566]; Saskatchewan Pulse Growers [AGR1431]; Alberta Wheat Commission [14AWC10A]; Saskatchewan Canola Development Commission [CARP WGRF 2013-17]; Manitoba Canola Growers Association	Agriculture and Agri-Food Canada, Canadian Crop Genomics Initiative(Agriculture & Agri Food Canada); Agriculture and Agri-Food Canada, A-Base(Agriculture & Agri Food Canada); Western Grains Research Foundation; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Saskatchewan Pulse Growers; Alberta Wheat Commission; Saskatchewan Canola Development Commission; Manitoba Canola Growers Association	This work was supported by: Agriculture and Agri-Food Canada, Canadian Crop Genomics Initiative grant J-000197: ME, DH, TG, OO. Agriculture and Agri-Food Canada, A-Base grant J-000778: ME, DH, TG, OO. Agriculture and Agri-Food Canada, Canadian Crop Genomics Initiative grant J-001033: ME, DH. Prairie Insect Pest Monitoring Network (http://www.westernforum.org/ipmnmain.html) was funded by a consortium led by Western Grains Research Foundation (Grant No. AGR1417) and Agriculture and Agri-Food Canada (Grant No. AGR-10566). Additional Funding from: Saskatchewan Pulse Growers, No. AGR1431, Alberta Wheat Commission, No. 14AWC10A, Saskatchewan Canola Development Commission, No. CARP WGRF 2013-17, Manitoba Canola Growers Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2017, MOL ECOL, V26, P420, DOI 10.1111/mec.13948; Alvarez N, 2007, EVOLUTION, V61, P2986, DOI 10.1111/j.1558-5646.2007.00235.x; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; BEERWINKLE KR, 1995, ENVIRON ENTOMOL, V24, P1122, DOI 10.1093/ee/24.5.1122; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal JS, 2019, INSECT SCI, V26, P569, DOI 10.1111/1744-7917.12555; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BUCHER GE, 1979, CAN ENTOMOL, V111, P977, DOI 10.4039/Ent111977-9; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chen MH, 2010, B ENTOMOL RES, V100, P75, DOI 10.1017/S0007485309006786; Cheng TC, 2017, NAT ECOL EVOL, V1, P1747, DOI 10.1038/s41559-017-0314-4; Chevillon C, 1999, BIOL J LINN SOC, V68, P147, DOI 10.1111/j.1095-8312.1999.tb01163.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dixon G. R., 2007, VEGETABLE BRASSICAS; Dupuis JR, 2018, BIOL INVASIONS, V20, P1211, DOI 10.1007/s10530-017-1621-z; Endersby NM, 2006, MOL ECOL, V15, P107, DOI 10.1111/j.1365-294X.2005.02789.x; ERLANDSON MA, 1990, J INVERTEBR PATHOL, V56, P47, DOI 10.1016/0022-2011(90)90143-T; Erlandson MA, 2013, BIOLOGICAL CONTROL PROGRAMMES IN CANADA 2001-2012, P228, DOI 10.1079/9781780642574.0228; Ersts PJ, 2019, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Franklin MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096679; Fritz ML, 2016, INSECT MOL BIOL, V25, P385, DOI 10.1111/imb.12234; Gouin A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10461-4; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Groot AT, 2011, MOL ECOL, V20, P2676, DOI 10.1111/j.1365-294X.2011.05129.x; Hare EE, 2011, METHODS MOL BIOL, V772, P3, DOI 10.1007/978-1-61779-228-1_1; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; James PMA, 2015, MOL ECOL, V24, P296, DOI 10.1111/mec.13025; JOHNSON SJ, 1987, INSECT SCI APPL, V8, P543, DOI 10.1017/S1742758400022591; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kim KS, 2013, J ASIA-PAC ENTOMOL, V16, P87, DOI 10.1016/j.aspen.2012.11.004; King KM, 1928, J ECON ENTOMOL, V21, P279, DOI 10.1093/jee/21.2.279; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Le Roux J, 2009, ANN APPL BIOL, V154, P1, DOI 10.1111/j.1744-7348.2008.00280.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2002, VIROLOGY, V297, P226, DOI 10.1006/viro.2002.1411; Li WJ, 2017, MOB INF SYST, V2017, DOI 10.1155/2017/8940709; Li YL, 2018, MOL ECOL RESOUR, V18, P176, DOI 10.1111/1755-0998.12719; LMC International, 2016, EC IMP CAN CAN EC; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MANTEL N, 1967, CANCER RES, V27, P209; Maruki T, 2017, G3-GENES GENOM GENET, V7, P1393, DOI 10.1534/g3.117.039008; Mason P. G., 2002, BIOL CONTROL PROGRAM, P169; Mason PG, 1998, CAN ENTOMOL, V130, P321, DOI 10.4039/Ent130321-3; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Myers JH, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2841; Nei M., 1987, MOLECULAR EVOLUTIONA; Noren K, 2014, BIOL REV, V89, P493, DOI 10.1111/brv.12070; Oliver JC, 2006, OIKOS, V112, P456, DOI 10.1111/j.0030-1299.2006.14185.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0402-6; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; R Core Team, 2000, R LANG ENV STAT COMP; RILEY JR, 1983, ECOL ENTOMOL, V8, P395, DOI 10.1111/j.1365-2311.1983.tb00519.x; Rousset F, 1997, GENETICS, V145, P1219; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SWAILES GE, 1975, CAN ENTOMOL, V107, P781, DOI 10.4039/Ent107781-7; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1992, GENETICS, V132, P619; Tiroesele B, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.62; WAKAMURA S, 1990, APPL ENTOMOL ZOOL, V25, P447, DOI 10.1303/aez.25.447; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; Wright S, 1943, GENETICS, V28, P114	84	1	1	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218993	10.1371/journal.pone.0218993	http://dx.doi.org/10.1371/journal.pone.0218993			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247053	Green Submitted, Green Published, gold			2022-12-26	WOS:000484911900063
J	Ouattara, EN; MacLean, RL; Danel, C; Borre, ED; Gabillard, D; Huang, MS; Moh, R; Paltiel, AD; Eholie, SP; Walensky, RP; Anglaret, X; Freedberg, KA				Ouattara, Eric N.; MacLean, Rachel L.; Danel, Christine; Borre, Ethan D.; Gabillard, Delphine; Huang, Mingshu; Moh, Raoul; Paltiel, A. David; Eholie, Serge P.; Walensky, Rochelle P.; Anglaret, Xavier; Freedberg, Kenneth A.			Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Cote d'Ivoire: A model-based analysis	PLOS ONE			English	Article							VIRAL LOAD; ADULTS; TRIAL; TRANSMISSION; MORTALITY; AFRICA; HEALTH; AIDS	Introduction The Temprano and START trials provided evidence to support early ART initiation recommendations. We projected long-term clinical and economic outcomes of immediate ART initiation in Cote d'Ivoire. Methods We used a mathematical model to compare three potential ART initiation criteria: 1) CD4 <350/mu L (ART<350/mu L); 2) CD4 <500/mu L (ART<500/mu L); and 3) ART at presentation (Immediate ART). Outcomes from the model included life expectancy, 10-year medical resource use, incremental cost-effectiveness ratios (ICERs) in $/year of life saved (YLS), and 5-year budget impact. We simulated people with HIV (PWH) in care (mean CD4: 259/mu L, SD 198/mu L) and transmitted cases. Key input parameters to the analysis included first-line ART efficacy (80% suppression at 6 months) and ART cost ($90/person-year). We assessed cost-effectiveness relative to Cote d'Ivoire's 2017 per capita annual gross domestic product ($1,600). Results Immediate ART increased life expectancy by 0.34 years compared to ART<350/mu L and 0.17 years compared to ART<500/mu L. Immediate ART resulted in 4,500 fewer 10-year transmissions per 170,000 PWH compared to ART<350/mu L. In cost-effectiveness analysis, Immediate ART had a 10-year ICER of $680/YLS compared to ART<350/mu L, ranging from cost-saving to an ICER of $1,440/YLS as transmission rates varied. ART<500/mu L was "dominated" (an inefficient use of resources), compared with Immediate ART. Immediate ART increased the 5-year HIV care budget from $801.9M to $812.6M compared to ART<350/mu L. Conclusions In Cote d'Ivoire, immediate compared to later ART initiation will increase life expectancy, decrease HIV transmission, and be cost-effective over the long-term, with modest budget impact. Immediate ART initiation is an appropriate, high-value standard of care in Cote d'Ivoire and similar settings.	[Ouattara, Eric N.; Danel, Christine; Gabillard, Delphine; Anglaret, Xavier] Univ Bordeaux, Ctr Inserm 1219, Bordeaux, France; [Ouattara, Eric N.] Univ Hosp Ctr, Div Infect & Trop Dis, Dept Med, Interdept Ctr Trop Med & Clin Int Hlth, Bordeaux, France; [Ouattara, Eric N.; Danel, Christine; Moh, Raoul; Eholie, Serge P.; Anglaret, Xavier] CHU Treichville, Programme PAC CI ANRS Res Site, Abidjan, Cote Ivoire; [MacLean, Rachel L.; Borre, Ethan D.; Huang, Mingshu; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Paltiel, A. David] Yale Sch Publ Hlth, New Haven, CT USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res, Harvard Med Sch, Boston, MA 02115 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Harvard University; Massachusetts General Hospital; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Freedberg, KA (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Freedberg, KA (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.; Freedberg, KA (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.; Freedberg, KA (corresponding author), Harvard Univ, Ctr AIDS Res, Harvard Med Sch, Boston, MA 02115 USA.; Freedberg, KA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.; Freedberg, KA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA.	kfreedberg@mgh.harvard.edu	Anglaret, Xavier/T-2757-2019	Borre, Ethan/0000-0002-8666-5382; Anglaret, Xavier/0000-0003-3319-8423; Moh, Desmorys Raoul/0000-0002-1678-3340	National Institute of Allergy and Infectious Diseases [R01 AI058736, R37 AI093269]; Agence Nationale de Recherches sur le SIDA et les hepatites virales in Paris, France [ANRS 12136]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI093269, R01AI058736, R37AI058736] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agence Nationale de Recherches sur le SIDA et les hepatites virales in Paris, France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by: The National Institute of Allergy and Infectious Diseases: https://www.niaid.nih.gov/. (R01 AI058736 (KAF) and R37 AI093269 (RPW)). The Agence Nationale de Recherches sur le SIDA et les hepatites virales in Paris, France: http://www.anrs.fr/fr (ANRS 12136 (EO, CD, DG, XA)). The Steve and Deborah Gorlin MGH Research Scholar Award: https://www.massgeneral.org/research/support/2015-ResearchScholars.aspx (RPW). The manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or other funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg N, 2018, CLIN INFECT DIS, V66, P893, DOI 10.1093/cid/cix915; Anglaret X, 2013, ANTIVIR THER, V18, P45, DOI 10.3851/IMP2231; Anglaret X, 2012, CLIN INFECT DIS, V54, P714, DOI 10.1093/cid/cir898; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bassett IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085197; Bert F, 2018, HEALTH POLICY, V122, P533, DOI 10.1016/j.healthpol.2018.03.007; Clinton Health Access Initiative (CHAI), 2016, 2016 ANT ARV CHAI RE; Danel C, 2006, LANCET, V367, P1981, DOI 10.1016/S0140-6736(06)68887-9; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Departement de Prise en Charge Programme National de Lutte contre le Sida, 2015, DIR NAT PEC AD AD; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Igumbor J, 2013, SAHARA J-J SOC ASP H, V10, P25, DOI 10.1080/17290376.2013.807070; Inghels M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185117; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Knoema, COT IV GDP CAP 1980; Kuznik A, 2016, AIDS, V30, P2865, DOI 10.1097/QAD.0000000000001251; Losina E, 2007, ANTIVIR THER, V12, P543; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Maddali MV, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20217; McCreesh N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2664-6; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Mwesigire DM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0332-3; Ouattara EN, 2016, CLIN INFECT DIS, V62, P1454, DOI 10.1093/cid/ciw117; Ouattara EN, 2014, JAIDS-J ACQ IMM DEF, V66, P294, DOI 10.1097/QAI.0000000000000166; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanne I, 2005, J INFECT DIS, V191, P825, DOI 10.1086/428093; Sempa J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-736; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; The Clinton Health Access Initiative (CHAI), 2017, 2017 ANT ARV CHAI RE; UNAIDS, 2017, AIDSINFO; Venkatesh KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064604; Walensky RP, 2016, ANN INTERN MED, V165, P325, DOI 10.7326/M16-0799; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WHO, 2010, ANT THER HIV INF AD; WHO (World Health Organization), 2017, TREAT ALL POL AD IMP; Wilson N, 2016, ECON HUM BIOL, V21, P221, DOI 10.1016/j.ehb.2016.02.003; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2008, WORLD POP PROSP 2008; World Health Organization, 2006, ANT THER HIV INF AD; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Yazdanpanah Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084173; Zheng A, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25085	47	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219068	10.1371/journal.pone.0219068	http://dx.doi.org/10.1371/journal.pone.0219068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247009	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900073
J	Seekaew, P; Lujintanon, S; Pongtriang, P; Nonnoi, S; Hongchookait, P; Tongmuang, S; Srisutat, Y; Phanuphak, P; Phanuphak, N				Seekaew, Pich; Lujintanon, Sita; Pongtriang, Praditporn; Nonnoi, Siriporn; Hongchookait, Piranun; Tongmuang, Sumitr; Srisutat, Yarinda; Phanuphak, Praphan; Phanuphak, Nittaya			Sexual patterns and practices among men who have sex with men and transgender women in Thailand: A qualitative assessment	PLOS ONE			English	Article							PARTNER SELECTION; HIV; RISK; GENDER; PREVENTION; BEHAVIOR	The global trend in HIV incidence overall is declining; however, there is a plateau in new HIV infection among men who have sex with men (MSM) and transgender women (TGW) despite extensive investment in HIV prevention targeting these populations. Many studies usually conflate these two groups together, which may overlook many disparate characteristics unique to each population, impeding the efficacy of HIV interventions. To better understand the vulnerable diversity that may put these individuals at risk of HIV infection, we conducted qualitative analysis among Thai MSM and TGW, aiming to identify sexual pattern themes of MSM and TGW in Bangkok in order to better understand their distinctive sexual life context. Convenient and purposive samplings were used to recruit Thai MSM and TGW aged >= 18 years old and living in Bangkok, Thailand, for focused group discussions and one-on-one in-depth interviews, respectively. Total of 12 MSM and 13 TGW participated in focused group discussions, which were conducted separately for MSM and TGW. Additionally, 5 MSM and 5 TGW were involved in one-on-one in-depth interviews. Thematic analyses were performed separately for MSM and TGW. The results show that MSM and TGW have distinct and diverse sexual patterns, and within the identified themes: partnering, partner finding, protection, and enhancing sexual pleasure (only for MSM). Participants reported having varying sexual experiences. Recognizing the difference and diversity in partnering and sexual practice of MSM and TGW is crucial in order to develop tailored interventions that suit the vulnerability of the key populations in Thailand.	[Seekaew, Pich; Lujintanon, Sita; Nonnoi, Siriporn; Hongchookait, Piranun; Tongmuang, Sumitr; Srisutat, Yarinda; Phanuphak, Praphan; Phanuphak, Nittaya] Thai Red Cross AIDS Res Ctr, PREVENTION, Bangkok, Thailand; [Pongtriang, Praditporn] Suratthani Rajabhat Univ, Fac Nursing, Surat Thani, Thailand	Thai Red Cross Society; Suratthani Rajabhat University	Seekaew, P (corresponding author), Thai Red Cross AIDS Res Ctr, PREVENTION, Bangkok, Thailand.	pich@prevention-trcarc.org	Phanuphak, Nittaya/AAA-8579-2019; Seekaew, Pich/GPJ-9576-2022; Lujintanon, Sita/GYU-2219-2022; Pongtriang, Praditporn/AAJ-5437-2020	Pongtriang, Praditporn/0000-0001-6477-5284				Anand T, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21326; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bavinton BR, 2018, LANCET HIV, V5, pE438, DOI 10.1016/S2352-3018(18)30132-2; Bengtsson L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-108; Brady SS, 2013, AIDS BEHAV, V17, P1499, DOI 10.1007/s10461-012-0316-9; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cakeres CF, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000327436.36161.80; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Clark J, 2013, AIDS BEHAV, V17, P1313, DOI 10.1007/s10461-012-0210-5; Corliss HL, 2010, ADDICT BEHAV, V35, P517, DOI 10.1016/j.addbeh.2009.12.019; Glick SN, 2012, JAIDS-J ACQ IMM DEF, V60, P83, DOI 10.1097/QAI.0b013e318247925e; Granich R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131353; Gupta S, 2014, CURR HIV-AIDS REP, V11, P479, DOI 10.1007/s11904-014-0230-z; Hoff CC, 2010, ARCH SEX BEHAV, V39, P774, DOI 10.1007/s10508-008-9393-2; Hughto JMW, 2015, AM J PUBLIC HEALTH, V105, pE14, DOI 10.2105/AJPH.2015.302877; Jung Minsoo, 2016, Open AIDS J, V10, P104, DOI 10.2174/1874613601610010104; Lecher S, 2015, MMWR-MORBID MORTAL W, V64, P1287, DOI 10.15585/mmwr.mm6446a3; Lewnard JA, 2014, SEX TRANSM INFECT, V90, P290, DOI 10.1136/sextrans-2013-051332; Melendez RM, 2007, CULT HEALTH SEX, V9, P233, DOI 10.1080/13691050601065909; National AIDS Committee, 2014, THAIL NAT OP PLAN AC; Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a; Paul JP, 2010, J SEX RES, V47, P528, DOI 10.1080/00224490903244575; Reisner SL, 2016, JAIDS-J ACQ IMM DEF, V72, pS235, DOI 10.1097/QAI.0000000000001088; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Sarkar S, 2010, SEX TRANSM INFECT, V86, pI2, DOI 10.1136/sti.2009.039289; Techasrivichien T, 2016, ARCH SEX BEHAV, V45, P367, DOI 10.1007/s10508-014-0429-5; van den Boom W, 2016, SEX TRANSM DIS, V43, P99, DOI 10.1097/OLQ.0000000000000389; Zou HC, 2017, ARCH SEX BEHAV, V46, P885, DOI 10.1007/s10508-016-0709-3	29	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219169	10.1371/journal.pone.0219169	http://dx.doi.org/10.1371/journal.pone.0219169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3WH	31247030	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900082
J	Chen, Z; Liu, X; Niu, JP; Zhou, WN; Zhao, T; Jiang, WB; Cui, J; Kallenbach, R; Wang, QZ				Chen, Zhao; Liu, Xv; Niu, Junpeng; Zhou, Wennan; Zhao, Tian; Jiang, Wenbo; Cui, Jian; Kallenbach, Robert; Wang, Quanzhen			Optimizing irrigation and nitrogen fertilization for seed yield in western wheatgrass [Pascopyrum smithii (Rydb.) A. Love] using a large multi-factorial field design	PLOS ONE			English	Article							WATER-USE EFFICIENCY; LEAF SENESCENCE; GRAIN-YIELD; SUGAR-BEET; COMPONENTS; PHOSPHORUS; STRESS; GROWTH; RICE; PHOTOSYNTHESIS	It is crucial for agricultural production to identify the trigger that switches plants from vegetative to reproductive growth. Agricultural sustainability in semiarid regions is challenged by nitrogen (N) fertilizer overuse, inadequate soil water, and heavy carbon emissions. Previous studies focused on the short-term effects of a single application of N and water but have not investigated the long-term effects of different irrigation and N fertilizer regimens on crop yields and yield components. N application is routinely coupled with water availability, and crop yields can be maximized by optimizing both. We examined the growth of western wheatgrass [Pascopyrum smithii (Rydb.) A. Love], a temperate-region forage and turf grass, using multiple different combinations of N fertilizer [(NH4)(2)center dot CO3] and irrigation levels over 3 years to determine optimal field management. We conducted multifactorial, orthogonally designed field experiments with large sample sizes, and measured fertile tillers m(-2) (Y-1), spikelets/fertile tillers (Y-2), florets/spikelet (Y-3), seed numbers/spikelet (Y-4), seed weight (Y-5), and seed yield (Z) to study factors associated with the switch between vegetative and reproductive growth. Fertilization had a greater effect on seed yield and yield components than irrigation. Y-1 had the strongest positive effect on Z, whereas Y-5 had a negative effect on Z. Irrigation and fertilization affected Z, Y-1, and Y-5. Fertilizer concentrations were positively correlated with Z, Y-1, and Y-5, whereas irrigation levels were negatively correlated. The ridge regression linear model results suggested N application rate and irrigation had antagonistic effects on Y-1 (X-3 = 867.6-4.23xX(2); R-2 = 0.988, F = Infinity, P<0.0001). We conclude that the optimal amount of N fertilizer and irrigation was 156 kg ha(-1) + 115 mm for seed yield, 120 kg ha(-1) + 146 mm for spikelets/fertile tillers, and 108 kg ha(-1) + 119 mm for seed numbers/spikelets. These results will improve yield and reduce agricultural inputs for P. smithii in semiarid and arid regions, thereby reducing fertilizer pollution and conserving water.	[Chen, Zhao; Liu, Xv; Niu, Junpeng; Zhou, Wennan; Zhao, Tian; Jiang, Wenbo; Wang, Quanzhen] Northwest A&F Univ, Coll Grassland Agr, Dept Grassland Sci, Yangling, Shaanxi, Peoples R China; [Cui, Jian] Northwest A&F Univ, Coll Life Sci, Dept Plant Sci, Yangling, Shaanxi, Peoples R China; [Kallenbach, Robert] Univ Missouri, Div Plant Sci, Columbia, MO USA	Northwest A&F University - China; Northwest A&F University - China; University of Missouri System; University of Missouri Columbia	Wang, QZ (corresponding author), Northwest A&F Univ, Coll Grassland Agr, Dept Grassland Sci, Yangling, Shaanxi, Peoples R China.	wangquanzhen191@163.com		Wang, Quanzhen/0000-0002-5788-034X; Kallenbach, Robert/0000-0001-9581-3386	National Key R&D Program of China [2017YFE0111000]; National Natural Science Foundation of China [31472138]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key R&D Program of China (2017YFE0111000) URL: http://www.most.gov.cn/and The National Natural Science Foundation of China (31472138), URL: http://www.nsfc.gov.cn/, funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadi J, 2008, PLANT SOIL, V306, P167, DOI 10.1007/s11104-008-9569-5; Ahumada-Orellana LE, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01280; Ali S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01408; Amanullah, 2016, SCI REP-UK, V6, DOI 10.1038/srep34627; Amanullah, 2009, PAK J BOT, V41, P761; Asay KH, 2001, CAN J PLANT SCI, V81, P45, DOI 10.4141/P99-131; Badr MA, 2012, AGR WATER MANAGE, V110, P9, DOI 10.1016/j.agwat.2012.03.008; Bashir MU, 2016, INT J AGRIC BIOL, V18, P16; Belesky DP, 2010, ENVIRON EXP BOT, V67, P515, DOI 10.1016/j.envexpbot.2009.09.009; Brevedan RE, 2003, CROP SCI, V43, P2083, DOI 10.2135/cropsci2003.2083; Cakir R, 2004, FIELD CROP RES, V89, P1, DOI 10.1016/j.fcr.2004.01.005; Cechin I, 2004, PLANT SCI, V166, P1379, DOI 10.1016/j.plantsci.2004.01.020; Chang GY, 2016, J ENVIRON MANAGE, V181, P455, DOI 10.1016/j.jenvman.2016.07.007; Chatterjee S, 1977, REGRESSION ANAL EXAM; Deng L.-Y., 2000, TECHNOMETRICS, V42, P440, DOI [10.2307/1270971, DOI 10.1080/00401706.2000.10485735]; DeSouza PI, 1997, AGRON J, V89, P807, DOI 10.2134/agronj1997.00021962008900050015x; Dessureault-Rompre J, 2010, GEODERMA, V157, P97, DOI 10.1016/j.geoderma.2010.04.001; ELGERSMA A, 1990, EUPHYTICA, V49, P141, DOI 10.1007/BF00027264; Garcia-Lopez J, 2014, CLIMATIC CHANGE, V124, P147, DOI 10.1007/s10584-014-1067-6; Gheysari M, 2009, AGR WATER MANAGE, V96, P809, DOI 10.1016/j.agwat.2008.11.003; Gheysari M, 2015, ADV AGRON, V130, P175, DOI 10.1016/bs.agron.2014.12.001; Gheysari M, 2009, AGR WATER MANAGE, V96, P946, DOI 10.1016/j.agwat.2009.01.005; Gregory S, 1978, STAT METHODS GEOGRAP; GRIFFITH SM, 1992, ANN BOT-LONDON, V69, P243, DOI 10.1093/oxfordjournals.aob.a088337; Han YH, 2013, CROP SCI, V53, P2623, DOI 10.2135/cropsci2013.04.0222; Hebblethwaite P, 1978, P EAST SCH AGR SCI U; Huettig KD, 2013, FIELD CROP RES, V144, P297, DOI 10.1016/j.fcr.2013.01.023; Ihtisham M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00487; Jespersen D, 2015, PROTEOMICS, V15, P798, DOI 10.1002/pmic.201400393; Jiang Y, 2009, J ENVIRON MANAGE, V90, P3185, DOI 10.1016/j.jenvman.2009.04.016; Jiao Y, 2007, CAN J PLANT SCI, V87, P461, DOI 10.4141/P05-212; Jungers JM, 2017, AGRON J, V109, P462, DOI 10.2134/agronj2016.07.0438; Lee EDH, 2005, J NEUROVIROL, V14, P41; Lee G, 2008, ENVIRON EXP BOT, V63, P19, DOI 10.1016/j.envexpbot.2007.10.009; Liu K, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00357; Liu LJ, 2013, FIELD CROP RES, V154, P226, DOI 10.1016/j.fcr.2013.08.016; Loeppky HA, 1999, CAN J SOIL SCI, V79, P265, DOI 10.4141/S98-031; Ma ChunHui, 2004, Agricultural Sciences in China, V3, P553; Mahajan G, 2012, FIELD CROP RES, V134, P59, DOI 10.1016/j.fcr.2012.04.011; MAILER RJ, 1987, AUST J EXP AGR, V27, P707, DOI 10.1071/EA9870707; Massignam AM, 2009, FIELD CROP RES, V113, P256, DOI 10.1016/j.fcr.2009.06.001; Mehboob-ur-Rahman, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01157; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Ofori I, 1996, EUPHYTICA, V91, P103, DOI 10.1007/BF00035280; Pardon L, 2017, FIELD CROP RES, V210, P20, DOI 10.1016/j.fcr.2017.05.016; Peng SB, 2006, FIELD CROP RES, V96, P37, DOI 10.1016/j.fcr.2005.05.004; RAO IM, 1995, PLANT PHYSIOL, V107, P1313, DOI 10.1104/pp.107.4.1313; RAO IM, 1993, PLANT PHYSIOL BIOCH, V31, P223; Ren BB, 2015, PLANT SOIL, V396, P397, DOI 10.1007/s11104-015-2603-5; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Saleem M., 2002, International Journal of Agriculture and Biology, V4, P404; Sanchez-Bragado R, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01986; Schwabe R., 1996, OPTIMUM DESIGNS MULT; Seassau C, 2010, FIELD CROP RES, V115, P99, DOI 10.1016/j.fcr.2009.10.009; Seghatoleslami MJ, 2012, PAK J BOT, V44, P1551; Sun YJ, 2012, FIELD CROP RES, V127, P85, DOI 10.1016/j.fcr.2011.11.015; Sun YongJian, 2010, Acta Agronomica Sinica, V36, P655, DOI 10.3724/SP.J.1006.2010.00655; Tang JJ, 2015, FOOD POLICY, V50, P43, DOI 10.1016/j.foodpol.2014.10.008; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Walker E., 1989, TECHNOMETRICS, V31, P117, DOI DOI 10.1080/00401706.1989.10488486; Wang JF, 2010, AGRON J, V102, P277, DOI 10.2134/agronj2009.0254; Wang QZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018245; Wang XY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02105-4; WANG XR, 1996, MODERN FERTILIZER EX; Wang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151656; Xie YP, 2014, CROP SCI, V54, P1729, DOI 10.2135/cropsci2013.10.0672; Zhang G., 2014, 2013 6 INT C ADV COM, V5, P183, DOI [10.1109/ICACI.2013.6748498, DOI 10.1109/ICACI.2013.6748498]; Zheng JH, 2013, IRRIGATION SCI, V31, P995, DOI 10.1007/s00271-012-0378-5; Zhong C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01079; Zhu XD, 2014, BIORESOURCES, V9, P4834	70	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218599	10.1371/journal.pone.0218599	http://dx.doi.org/10.1371/journal.pone.0218599			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242244	Green Published, gold, Green Submitted			2022-12-26	WOS:000482883600038
J	Howison, T; Hughes, J; Giardina, F; Iida, F				Howison, Toby; Hughes, Josie; Giardina, Fabio; Iida, Fumiya			Physics driven behavioural clustering of free-falling paper shapes	PLOS ONE			English	Article							CHAOTIC DYNAMICS; ZIGZAG; DECOMPOSITION; OPTIMIZATION; AUTOROTATION; TRANSITION; LOCOMOTION; FLUTTER; TUMBLE; STEADY	Many complex physical systems exhibit a rich variety of discrete behavioural modes. Often, the system complexity limits the applicability of standard modelling tools. Hence, understanding the underlying physics of different behaviours and distinguishing between them is challenging. Although traditional machine learning techniques could predict and classify behaviour well, typically they do not provide any meaningful insight into the underlying physics of the system. In this paper we present a novel method for extracting physically meaningful clusters of discrete behaviour from limited experimental observations. This method obtains a set of physically plausible functions that both facilitate behavioural clustering and aid in system understanding. We demonstrate the approach on the V-shaped falling paper system, a new falling paper type system that exhibits four distinct behavioural modes depending on a few morphological parameters. Using just 49 experimental observations, the method discovered a set of candidate functions that distinguish behaviours with an error of 2.04%, while also aiding insight into the physical phenomena driving each behaviour.	[Howison, Toby; Hughes, Josie; Iida, Fumiya] Univ Cambridge, Dept Engn, Bioinspired Robot Lab, Cambridge, England; [Giardina, Fabio] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	University of Cambridge; Harvard University	Howison, T (corresponding author), Univ Cambridge, Dept Engn, Bioinspired Robot Lab, Cambridge, England.	th533@cam.ac.uk		Howison, Toby/0000-0001-8548-5550; Giardina, Fabio/0000-0002-2660-5935; Iida, Fumiya/0000-0001-9246-7190	EPSRC [RG92738]; Mathworks Ltd [RG90950 378]; UK Engineering and Physical Sciences Research Council (EPSRC) [RG92738]; EPSRC MOTION Project [EP/N029003/1]; The MathWorks Ltd.; EPSRC [1949869] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Mathworks Ltd; UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC MOTION Project(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); The MathWorks Ltd.; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TH was supported by EPSRC RG92738 (https://epsrc.ukri.org/) and Mathworks Ltd RG90950 378 (https://uk.mathworks.com/?requestedDomain=). JH was supported by EP/N029003/1 (https://gow.epsrc.ukri.org/NGBOViewGrant.aspx?GrantRef=EP/N029003/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FG and FI received no specific funding for this work.; This work was supported by the UK Engineering and Physical Sciences Research Council (EPSRC) grant RG92738 for the University of Cambridge Centre for Doctoral Training, the EPSRC MOTION Project grant EP/N029003/1 and The MathWorks Ltd.	ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Andersen A, 2005, J FLUID MECH, V541, P65, DOI 10.1017/S002211200500594X; Andersen A, 2005, J FLUID MECH, V541, P91, DOI 10.1017/S0022112005005847; Auguste F, 2013, J FLUID MECH, V719, P388, DOI 10.1017/jfm.2012.602; Begg RK, 2005, IEEE T BIO-MED ENG, V52, P828, DOI 10.1109/TBME.2005.845241; Belmonte A, 1998, PHYS REV LETT, V81, P345, DOI 10.1103/PhysRevLett.81.345; Bongard JC, 2005, IEEE T EVOLUT COMPUT, V9, P361, DOI 10.1109/TEVC.2005.850293; Brodbeck L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128444; Brunton S.L., 2016, P NATL ACAD SCI; Chrust M, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4799179; Corucci F, 2018, SOFT ROBOT, V5, P475, DOI 10.1089/soro.2017.0055; Cully A, 2018, IEEE T EVOLUT COMPUT, V22, P245, DOI 10.1109/TEVC.2017.2704781; Fernandes PC, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2061609; Field SB, 1997, NATURE, V388, P252, DOI 10.1038/40817; Finn D.L., 2007, SIAM NEWS, V40, P4; Gandomi A, 2015, INT J INFORM MANAGE, V35, P137, DOI 10.1016/j.ijinfomgt.2014.10.007; Gerhart PM., 2016, MUNSON YOUNG OKIISHI; Goto Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6994; Goza A, 2018, J FLUID STRUCT, V81, P728, DOI 10.1016/j.jfluidstructs.2018.06.014; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Heisinger L, 2014, J FLUID MECH, V742, P243, DOI 10.1017/jfm.2014.6; Huang WT, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.053008; IVERSEN JD, 1979, J FLUID MECH, V92, P327, DOI 10.1017/S0022112079000641; Jones MA, 2005, J FLUID MECH, V540, P393, DOI 10.1017/S0022112005005859; Kutz JN, 2016, OTHER TITL APPL MATH, V149; Kutz JN, 2017, J FLUID MECH, V814, P1, DOI 10.1017/jfm.2016.803; Kuznetsov SP, 2015, REGUL CHAOTIC DYN, V20, P345, DOI 10.1134/S1560354715030090; Lauga E, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/64004; Lee CB, 2013, J FLUID MECH, V732, P77, DOI 10.1017/jfm.2013.390; Lentink D, 2009, SCIENCE, V324, P1438, DOI 10.1126/science.1174196; Mahadevan L, 1999, PHYS FLUIDS, V11, P1, DOI 10.1063/1.869919; Mahadevan L, 1995, COMMENT BEHAV FALLIN, DOI [10.1103/PhysRevLett.75.1420, DOI 10.1103/PHYSREVLETT.75.1420]; Maxwell JC, 1854, SCI PAPERS JC MAXWEL, V9, P115; MCCUTCHEN CW, 1977, SCIENCE, V197, P691, DOI 10.1126/science.197.4304.691; Mittal R, 2004, THEOR COMP FLUID DYN, V17, P165, DOI 10.1007/s00162-003-0101-5; Mouret Jean-Baptiste, 2015, ARXIV; NORBERG RA, 1973, BIOL REV, V48, P561, DOI 10.1111/j.1469-185X.1973.tb01569.x; Nurzaman SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084090; Pesavento U, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.144501; Quiroz M, 2019, J AM STAT ASSOC, V114, P831, DOI 10.1080/01621459.2018.1448827; Rosendo A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186107; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sano M, 2016, NAT PHYS, V12, P249, DOI [10.1038/nphys3659, 10.1038/NPHYS3659]; Schmid PJ, 2010, J FLUID MECH, V656, P5, DOI 10.1017/S0022112010001217; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; SKEWS BW, 1990, J FLUID MECH, V217, P33, DOI 10.1017/S0022112090000611; SMITH EH, 1971, J FLUID MECH, V50, P513, DOI 10.1017/S0022112071002738; Strogatz S.H., 2018, NONLINEAR DYNAMICS C, DOI DOI 10.1201/9780429399640; TANABE Y, 1994, PHYS REV LETT, V73, P1372, DOI 10.1103/PhysRevLett.73.1372; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; Varshney K, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.053021; Vincent L, 2016, J FLUID MECH, V801, P250, DOI 10.1017/jfm.2016.432; Wang WB, 2013, J FLUID MECH, V733, P650, DOI 10.1017/jfm.2013.461; WILLMARTH WW, 1964, PHYS FLUIDS, V7, P197, DOI 10.1063/1.1711133; Yang Y, 2015, INT J COMPUT VISION, V113, P113, DOI 10.1007/s11263-014-0781-x; Zhong HJ, 2013, J FLUID MECH, V716, P228, DOI 10.1017/jfm.2012.543; Zhong HJ, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3541844	57	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0217997	10.1371/journal.pone.0217997	http://dx.doi.org/10.1371/journal.pone.0217997			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IK4OR	31242203	Green Published, Green Submitted, gold			2022-12-26	WOS:000476566700001
J	Long, HT; Zheng, Z; Zhang, YJ; Xing, PZ; Wan, XR; Zheng, YX; Li, L				Long, Haitao; Zheng, Zhao; Zhang, Yajun; Xing, Pengzhan; Wan, Xiaorong; Zheng, Yixiong; Li, Ling			An abscisic acid (ABA) homeostasis regulated by its production, catabolism and transport in peanut leaves in response to drought stress	PLOS ONE			English	Article							9-CIS-EPOXYCAROTENOID DIOXYGENASE; ALDEHYDE OXIDASE; ARACHIS-HYPOGAEA; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; KEY ENZYME; ARABIDOPSIS; BIOSYNTHESIS; TOLERANCE; 8'-HYDROXYLASE	ABA is an important messenger that acts as a signaling mediator for regulating the adaptive response of plants to drought stress. Two production pathways, de novo biosynthesis and hydrolysis of glucose-conjugated ABA by ss-glucosidase (BG), increase cellular ABA levels in plants. ABA catabolism via hydroxylation by 8-hydroxylase (CYP707A), or conjugation by uridine diphosphate glucosyltransferase (UGT), decreases cellular ABA levels. The transport of ABA through ATP-binding cassette (ABC)-containing transporter proteins, members of ABC transporter G family (ABCG), across plasma membrane (PM) is another important pathway to regulate cellular ABA levels. In this study, based on our previously constructed transcriptome of peanut leaves in response to drought stress, fourteen candidate genes involved in ABA production (including AhZEP, AhNCED1 and AhNCED3, AhABA2, AhAAO1 and AhAAO2, AhABA3, AhBG11 and AhBG24), catabolism (including AhCYP707A3, AhUGT71K1 and AhUGT73B4) and transport (including AhABCG22-1 and AhABCG22-2), were identified homologously and phylogenetically, and further analyzed at the transcriptional level by real-time RT-PCR, simultaneously determining ABA levels in peanut leaves in response to drought. The high sequence identity and very similar subcellular localization of the proteins deduced from 14 identified genes involved in ABA production, catabolism and transport with the reported corresponding enzymes in databases suggest their similar roles in regulating cellular ABA levels. The expression analysis showed that the transcripts of AhZEP, AhNCED1, AhAAO2 and AhABA3 instead of AhABA2, AhNCED3 and AhAAO1 in peanut leaves increased significantly in response to drought stress; and that the AhBG11 and AhBG24 mRNA levels were rapidly and significantly up-regulated, with a 4.83- and 4.58-fold increase, respectively at 2-h of drought stress. The genes involved in ABA catabolism AhCYP707A3, AhUGT71K1 instead of AhUGT73B4 were significantly induced in response to drought stress. The expression of two closely related peanut ABCG genes, AhABCG22.1 and AhABCG22.2, was significantly up-regulated in response to drought stress. The ABA levels rapidly began to accumulate within 2 h (a 56.6-fold increase) from the start of drought stress, and peaked at 10 h of the stress. The highly and rapidly stress up-regulated expressions of genes involved in ABA production and transport, particularly AhNCED1, AhBG11 and AhBG24, and AhABCG22.1 and AhABCG22.2, might contribute to the rapid ABA accumulation in peanut leaves in response to drought. In response to drought stress, ABA accumulation levels in peanut leaves agree well with the up-regulated expressions of ABA-producing genes (AhZEP, AhNCED1, AhAAO2, AhABA3, AhBG11 and AhBG24) and PM-localized ABA importer genes (AhABCG22-1 and AhABCG22-2), in spite of the simultaneously induced ABA catabolic genes (AhCYP707A3 and AhUGT71K1), although the induction of catabolic genes was much lower than that of biosynthetic gene (AhNCED1). This difference in induction kinetics of gene expression may define the significant accumulation of drought-induced ABA levels. These results suggest that ABA homeostasis in peanut leaves in response to drought maintained through a balance between the production, catabolism and transport, rather than simply by the biosynthesis.	[Long, Haitao; Li, Ling] South China Normal Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zheng, Zhao; Zhang, Yajun; Xing, Pengzhan; Wan, Xiaorong; Zheng, Yixiong] Zhongkai Univ Agr & Engn, Coll Agr & Biol, Guangzhou, Guangdong, Peoples R China	South China Normal University; Zhongkai University of Agriculture & Engineering	Li, L (corresponding author), South China Normal Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.; Wan, XR (corresponding author), Zhongkai Univ Agr & Engn, Coll Agr & Biol, Guangzhou, Guangdong, Peoples R China.	bioxrwan@hotmail.com; liling502@126.com		Wan, Xiaorong/0000-0003-0892-8906	National Natural Science Foundation of China [31471422, 31671600, 30800077, 31770652]; Guangdong Natural Science Foundation [2016A030313370]; "Climbing Program" Special Funds [pdjhb0256]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); "Climbing Program" Special Funds	This work was jointly supported by the grants from the National Natural Science Foundation of China (approved Nos. 31471422, 31671600 granted to LL and 30800077, 31770652 granted to XW), Guangdong Natural Science Foundation (approved No. 2016A030313370 granted to XW) and the "Climbing Program" Special Funds (pdjhb0256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; CHEN XM, 1992, PLANT PHYSL COMMUN, V28, P368; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Dong T, 2015, ESSAYS BIOCHEM, V58, P29, DOI [10.1042/BSE0580029, 10.1042/bse0580029]; Dong T, 2014, PLANT PHYSIOL, V165, P277, DOI 10.1104/pp.114.239210; Ge K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01150; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Hu B, 2016, SCI REP-UK, V6, DOI 10.1038/srep32143; Huang Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00162; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Kang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9113; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Kuromori T, 2011, PLANT J, V67, P885, DOI 10.1111/j.1365-313X.2011.04641.x; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Li XY, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-58; Liang JH, 2009, BIOSCI BIOTECH BIOCH, V73, P2103, DOI 10.1271/bbb.90133; Liu SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20212; Liu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097025; Liu X, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-35613-y, 10.1038/s41598-018-20542-7]; Liu X, 2011, BIOSCI BIOTECH BIOCH, V75, P443, DOI 10.1271/bbb.100614; Liu Z, 2015, PLANT PHYSIOL, V167, P1659, DOI 10.1104/pp.15.00053; Ma YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113643; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Ng LM, 2014, ACTA PHARMACOL SIN, V35, P567, DOI 10.1038/aps.2014.5; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Park Y, 2016, PLANT CELL, V28, P2528, DOI 10.1105/tpc.16.00359; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Sah SK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00571; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Sauter A, 2002, PLANT CELL ENVIRON, V25, P223, DOI 10.1046/j.1365-3040.2002.00747.x; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Seo M, 2000, PLANT J, V23, P481, DOI 10.1046/j.1365-313x.2000.00812.x; Seo M, 2004, PLANT CELL PHYSIOL, V45, P1694, DOI 10.1093/pcp/pch198; Seo M, 2011, J PLANT RES, V124, P501, DOI 10.1007/s10265-011-0411-4; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Wan XR, 2006, BIOCHEM BIOPH RES CO, V347, P1030, DOI 10.1016/j.bbrc.2006.07.026; Wan XR, 2011, J BIOSCI BIOENG, V111, P478, DOI 10.1016/j.jbiosc.2010.11.021; Wan XR, 2005, DNA SEQUENCE, V16, P217, DOI 10.1080/10425170500129785; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xu ZY, 2013, PLANT CELL REP, V32, P807, DOI 10.1007/s00299-013-1396-3; Xu ZY, 2012, PLANT CELL, V24, P2184, DOI 10.1105/tpc.112.095935; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; Yang LX, 2011, PLANT MOL BIOL REP, V29, P544, DOI 10.1007/s11105-010-0259-0; Yang LX, 2009, J ENVIRON BIOL, V30, P93; Yang SH, 2006, BIOCHEM BIOPH RES CO, V350, P685, DOI 10.1016/j.bbrc.2006.09.098; Zeevaart J. A. D., 1999, ABSCISIC ACID METABO, P189; Zhang BH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051441; Zhang HW, 2014, MOL PLANT, V7, P1522, DOI 10.1093/mp/ssu063; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	67	15	16	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0213963	10.1371/journal.pone.0213963	http://dx.doi.org/10.1371/journal.pone.0213963			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242187	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600003
J	Mutalipassi, M; Mazzella, V; Zupo, V				Mutalipassi, Mirko; Mazzella, Valerio; Zupo, Valerio			Ocean acidification influences plant-animal interactions: The effect of Cocconeis scutellum parva on the sex reversal of Hippolyte inermis	PLOS ONE			English	Article							FATTY-ACID PROFILE; MARINE DIATOM; LEACH CRUSTACEA; GROWTH-RATE; PHOTOBIOREACTOR; LIGHT; DECAPODA; CULTURE; BACILLARIOPHYCEAE; STRATEGIES	Ocean acidification (O.A.) influences the ecology of oceans and it may impact plant-animal interactions at various levels. Seagrass meadows located at acidified vents in the Bay of Naples (Italy) are considered an open window to forecast the effects of global-changes on aquatic communities. Epiphytic diatoms of the genus Cocconeis are abundant in seagrass meadows, including acidified environments, where they play key ecological roles. A still-unknown apoptogenic compound produced by Cocconeis triggers the suicide of the androgenic gland of Hippolyte inermis Leach 1816, a protandric hermaphroditic shrimp distributed in P. oceanica meadows located both at normal pH and in acidified vents. Feeding on Cocconeis sp. was proven important for the stability of the shrimp's natural populations. Since O.A. affects the physiology of diatoms, we investigated if, in future scenarios of O.A., Cocconeis scutellum parva will still produce an effect on shrimp's physiology. Cell densities of Cocconeis scutellum parva cultivated in custom-designed photobioreactors at two pH conditions (pH 7.7 and 8.2) were compared. In addition, we determined the effects of the ingestion of diatoms on the process of sex reversal of H. inermis and we calculated the% female on the total of mature individuals(-1) (F/mat). We observed significant differences in cell densities of C. scutellum parva at the two pH conditions. In fact, the highest cell densities (148,808 +/- 13,935 cells. mm(-2)) was obtained at day 13 (pH 7.7) and it is higher than the highest cell densities (38,066 (+/- 4,166) cells. mm(-2), day 13) produced at pH 8.2. Diatoms cultured at acidified conditions changed their metabolism. In fact, diatoms grown in acidified conditions produced in H. inermis a proportion of females (F/mat 36.3 +/- 5.9%) significantly lower than diatoms produced at normal pH (68.5 +/- 2.8), and it was not significantly different from that elicited by negative controls (31.7 +/- 5.6%).	[Mutalipassi, Mirko; Mazzella, Valerio; Zupo, Valerio] Stn Zool Anton Dohrn, Benth Ecol Ctr, Integrated Ecol Dept, Ischia, Italy	Stazione Zoologica Anton Dohrn di Napoli	Mutalipassi, M (corresponding author), Stn Zool Anton Dohrn, Benth Ecol Ctr, Integrated Ecol Dept, Ischia, Italy.	Mirko.mutalipassi@gmail.com	Mutalipassi, Mirko/AAP-2473-2021	Mutalipassi, Mirko/0000-0002-5521-5303; Mazzella, Valerio/0000-0001-8708-2392	Italian Ministry of Foreign Affairs	Italian Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy))	M. Mutalipassi conducted these researches within the project EXCITE funded by the Italian Ministry of Foreign Affairs within Italy-Israel cooperation activities. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affan A, 2007, J PHYCOL, V43, P823, DOI 10.1111/j.1529-8817.2007.00367.x; Avendano-Herrera RE, 2007, AQUACULT ENG, V36, P97, DOI 10.1016/j.aquaeng.2006.08.001; Barreiro A, 2011, J EXP MAR BIOL ECOL, V401, P13, DOI 10.1016/j.jembe.2011.03.007; Bauer BT, 2000, J CRUSTAC BIOL JSTOR, V2, P116; Beuzenberg V, 2017, NEW ZEAL J BOT, V55, DOI 10.1080/0028825X.2016.1238398; Bradassi F, 2013, MAR BIOL, V160, P2261, DOI 10.1007/s00227-013-2260-2; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Buttino I, 1999, MAR BIOL, V134, P147, DOI 10.1007/s002270050533; Calado R, 2005, AQUACULTURE, V245, P221, DOI 10.1016/j.aquaculture.2004.11.034; Calado R, 2009, AQUACULT NUTR, V15, P484, DOI 10.1111/j.1365-2095.2008.00614.x; Chundi L, 2007, ACTA OCEANOL SIN, V26, P51; Diaz-Pulido G, 2016, CORAL REEFS, V35, P1327, DOI 10.1007/s00338-016-1481-5; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Eker-Develi E, 2006, AQUAT SCI, V68, P28, DOI 10.1007/s00027-005-0810-5; GAMBI MC, 1992, PSZNI MAR ECOL, V13, P17, DOI 10.1111/j.1439-0485.1992.tb00337.x; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Garrard SL, 2014, J EXP MAR BIOL ECOL, V461, P31, DOI 10.1016/j.jembe.2014.07.011; Gattuso JP, 2010, APPROACHES TOOLS MAN; Goksan T, 2003, AQUACULTURE, V217, P431, DOI 10.1016/S0044-8486(01)00854-7; Granum E, 2002, J PLANKTON RES, V24, P557, DOI 10.1093/plankt/24.6.557; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; James RK, 2014, MAR BIOL, V161, P1687, DOI 10.1007/s00227-014-2453-3; Khairy H.M., 2014, EGYPT J AQUATIC RES, V40, P243, DOI DOI 10.1016/j.ejar.2014.08.002; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Lebeau T, 2002, APPL MICROBIOL BIOT, V59, P153, DOI 10.1007/s00253-002-0993-9; Lee K, 2010, GEOCHIM COSMOCHIM AC, V74, P1801, DOI 10.1016/j.gca.2009.12.027; Li WD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044230, 10.1371/journal.pone.0044099]; Liu F, 2016, SCI REPORTS, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Maibam C., 2012, THESIS; Maibam C, 2014, MAR BIOL, V161, P1639, DOI 10.1007/s00227-014-2448-0; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Michel R, 2007, INT REV GESAMTEN HYD, V54, P749, DOI 10.10026roh.19690540506; Millero FJ, 2010, MAR FRESHWATER RES, V61, P139, DOI 10.1071/MF09254; Miralto A, 2003, MAR ECOL PROG SER, V254, P253, DOI 10.3354/meps254253; Mouget JL, 2005, J APPL PHYCOL, V17, P437, DOI 10.1007/s10811-005-0561-7; Mutalipassi M, 2018, ANIMAL, V12, P155, DOI 10.1017/S1751731117000908; Mutalipassi M, 2018, ZOOMORPHOLOGY, V137, P377, DOI 10.1007/s00435-018-0405-z; Ozkan A, 2017, ALGAL RES, V26, P422, DOI 10.1016/j.algal.2017.07.003; Perez-Barros P, 2004, SCI MAR, V68, P237; Pierrot D., 2006, ORNLCDIAC105A US DEP; Poore AGB, 2013, OECOLOGIA, V173, P1113, DOI 10.1007/s00442-013-2683-y; Porzio L, 2013, MAR BIOL, V160, P2247, DOI 10.1007/s00227-013-2251-3; Porzio L, 2012, 22 INT DIAT S, P205; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Racotta IS, 2003, AQUACULTURE, V227, P107, DOI 10.1016/S0044-8486(03)00498-8; Raniello R, 2007, J APPL PHYCOL, V19, P383, DOI 10.1007/s10811-006-9145-4; Riebesell U., 2011, GUIDE BEST PRACTICES; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Silva-Aciares FR, 2008, AQUACULT ENG, V38, P26, DOI 10.1016/j.aquaeng.2007.10.005; VEILLET A, 1963, CR HEBD ACAD SCI, V256, P790; Wu Y, 2014, LIMNOL OCEANOGR, V59, P1027, DOI 10.4319/lo.2014.59.3.1027; YALDWYN JC, 1966, NATURE, V209, P1366, DOI 10.1038/2091366a0; Yen HW, 2014, BIOFUELS FROM ALGAE, P23; Zupi V., 1985, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V29, P189; Zupo V, 2001, MAR BIOL, V138, P965, DOI 10.1007/s002270000523; Zupo V, 2000, MAR ECOL PROG SER, V201, P251, DOI 10.3354/meps201251; ZUPO V, 1994, J EXP MAR BIOL ECOL, V178, P131, DOI 10.1016/0022-0981(94)90229-1; Zupo V, 2001, HYDROBIOLOGIA, V449, P131, DOI 10.1023/A:1017553422113; Zupo V, 2007, MAR BIOL, V151, P907, DOI 10.1007/s00227-006-0524-9; Zupo V, 2014, MAR DRUGS, V12, P547, DOI 10.3390/md12010547; Zupo V, 2008, INVERTEBR REPROD DEV, V52, P93, DOI 10.1080/07924259.2008.9652276	62	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218238	10.1371/journal.pone.0218238	http://dx.doi.org/10.1371/journal.pone.0218238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242214	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600024
J	Garcia, CD; Bezerra, IMP; Ramos, JLS; do Valle, JETMR; de Oliveira, MLB; de Abreu, LC				Garcia, Cintia de Lima; Pinheiro Bezerra, Italla Maria; Souza Ramos, Jose Lucas; Mendes Rossette do Valle, Joseane Elza Tonussi; Bezerra de Oliveira, Maryldes Lucena; de Abreu, Luiz Carlos			Association between culture of patient safety and burnout in pediatric hospitals	PLOS ONE			English	Article							QUALITY-OF-CARE; JOB-SATISFACTION; EMOTIONAL EXHAUSTION; WORK ENVIRONMENTS; PREVALENCE; OUTCOMES; IMPACT; INTENSIVISTS; NURSES; STAFF	Introduction Providing safety culture is the first and undoubtedly most important feature that patient care should have, as it is the basis for other measures. There are associations between Burnout Syndrome and lower perceptions of safety culture and greater risks in patient safety. Objective To analyze the relationship between patient safety culture and burnout in pediatric hospitals. Method This is a cross-sectional study with a quantitative approach performed with health professionals who work in pediatric hospitals located in the Metropolitan Region of Cariri, North-eastern Brazil. The study enrolled 148 professionals who performed direct health care for the child in three different hospitals. For the evaluation of the Patient Safety Culture, the version, translated and validated for Brazil, of the Survey on Patient Safety Culture (HSOPSC) questionnaire was applied and to evaluate the occurrence of Burnout, we chose the Maslach Burnout Inventory (MBI). Results Among the dimensions of burnout that presented the most moderate to high, depersonalization and low professional achievement stand out. When considering the syndrome with the professional who presented a "high" score in only one of the three dimensions, it was identified that 44.6% presented the disease. All patient safety dimensions studied correlated with some dimension of burnout. Conclusion The study evidenced the influence of all patient safety domains for the development of burnout syndrome in pediatric professionals. Also, it was identified that the organizational climate is the main determinant of burnout, especially in what refers to "teamwork between units".	[Garcia, Cintia de Lima; Pinheiro Bezerra, Italla Maria; Mendes Rossette do Valle, Joseane Elza Tonussi; Bezerra de Oliveira, Maryldes Lucena; de Abreu, Luiz Carlos] Ctr Univ Saude ABC, FMABC, Setor Posgrad Pesquisa & Inovacao, Santo Andre, SP, Brazil; [Garcia, Cintia de Lima] Fac Med Estacio Juazeiro do Norte, FMJ, Juazeiro Do Norte, Ceara, Brazil; [Pinheiro Bezerra, Italla Maria; de Abreu, Luiz Carlos] Escola Super Ciencias Santa Casa Misericordia Vit, EMESCAM, Programa Posgrad Polit Publ & Desenvolvimento Loc, Vitoria, ES, Brazil; [Pinheiro Bezerra, Italla Maria; Souza Ramos, Jose Lucas] Escola Super Ciencias Santa Casa Misericordia Vit, Lab Escrita Cient, Vitoria, ES, Brazil; [Bezerra de Oliveira, Maryldes Lucena] Ctr Univ Doutor Leao Sampaio, Juazeiro Do Norte, Ceara, Brazil	Faculdade de Medicina do ABC; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria	Bezerra, IMP (corresponding author), Ctr Univ Saude ABC, FMABC, Setor Posgrad Pesquisa & Inovacao, Santo Andre, SP, Brazil.; Bezerra, IMP (corresponding author), Escola Super Ciencias Santa Casa Misericordia Vit, EMESCAM, Programa Posgrad Polit Publ & Desenvolvimento Loc, Vitoria, ES, Brazil.; Bezerra, IMP (corresponding author), Escola Super Ciencias Santa Casa Misericordia Vit, Lab Escrita Cient, Vitoria, ES, Brazil.	Italla.bezerra@emescam.br	de Abreu, Luiz Carlos/AAL-8219-2021; BEZERRA, ITALLA MARIA/N-9130-2016	de Abreu, Luiz Carlos/0000-0002-7618-2109; BEZERRA, ITALLA MARIA/0000-0002-8604-587X	 [007/2015-FMABC/UFAC/SESACRE]		Thanks to the agreement 007/2015-FMABC/UFAC/SESACRE.	Aiken Linda H, 2012, BMJ, V344, pe1717, DOI 10.1136/bmj.e1717; Akman O, 2016, J NURS MANAGE, V24, P923, DOI 10.1111/jonm.12399; Alves DFS, 2016, INT NURS REV, V63, P328, DOI 10.1111/inr.12276; Amaya SL, 2009, CENTRO GESTION HOS V, P6; Antonucci Roberto, 2014, World J Clin Pediatr, V3, P37, DOI 10.5409/wjcp.v3.i3.37; Ashkar K, 2010, POSTGRAD MED J, V86, P266, DOI 10.1136/pgmj.2009.092106; Bezerra IMP, 2017, J HUM GROWTH DEV, V27, P6; Caravaca Sánchez F, 2018, Rev. esp. sanid. penit., V20, P40; Cavalcanti Ismar Lima, 2018, Rev. bras. educ. med., V42, P190, DOI 10.1590/1981-52712018v42n1rb20170078; Claro Carla Matilde, 2011, Rev. esc. enferm. USP, V45, P167; Davis S, 2013, ONCOLOGY NURSING FOR, V40, P4; de Franca FM, 2012, REV LAT-AM ENFERM, V20, P961, DOI 10.1590/S0104-11692012000500019; Ebrahimi Sedigheh, 2018, J Adv Med Educ Prof, V6, P162; El-Jardali F, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-122; Embriaco N, 2007, AM J RESP CRIT CARE, V175, P686, DOI 10.1164/rccm.200608-1184OC; Faivre G, 2018, ORTHOPAEDICS TRAUMAT; GABBARD GO, 1985, JAMA-J AM MED ASSOC, V254, P2926, DOI 10.1001/jama.254.20.2926; Galindo RH, 2012, REV ESC ENFERM USP, V46, P420, DOI 10.1590/S0080-62342012000200021; Garcia TT, 2014, PEDIATR CRIT CARE ME, V15, pE347, DOI 10.1097/PCC.0000000000000218; GIL-MONTE P., 1999, ANALES PSICOLOGIA, V15, P261; Goncalves S., 2004, PSICOL ESTUD, V9, P499, DOI DOI 10.1590/S1413-73722004000300018; Granek L, 2016, J PSYCHOSOC ONCOL, V34, P39, DOI 10.1080/07347332.2015.1127306; Grunfeld E, 2000, CAN MED ASSOC J, V163, P166; Jagneaux T, 2017, J PATIENT SAFETY; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Khoo EJ, 2017, ARCH ARGENT PEDIATR, V115, P212, DOI [10.5546/aap.2017.eng.212, 10.5546/aap.2017.212]; Kohn LT, 2000, ERR IS HUMAN BUILDIN, P6; Laschinger HKS, 2006, J NURS ADMIN, V36, P259; Leiter M P, 1999, J Health Hum Serv Adm, V21, P472; Leiter MP., 2005, BANISHING BURNOUT 6; Liu X, 2018, INT J NURS STUD, V86, P82, DOI 10.1016/j.ijnurstu.2018.05.005; Loera B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114987; Macedo TR, 2016, REV ESC ENFERM USP, V50, P756, DOI [10.1590/s0080-623420160000600007, 10.1590/S0080-623420160000600007]; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 1998, APPL PREV PSYCHOL, V7, P63, DOI 10.1016/S0962-1849(98)80022-X; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Meeusen VCH, 2011, HEALTH CARE MANAGE R, V36, P155, DOI 10.1097/HMR.0b013e3181fb0f41; Moreira DD, 2009, CAD SAUDE PUBLICA, V25, P1559, DOI 10.1590/S0102-311X2009000700014; de Magalhaes AMM, 2013, REV LAT-AM ENFERM, V21, P146, DOI 10.1590/S0104-11692013000700019; Mukherjee S, 2009, PSYCHO-ONCOLOGY, V18, P1019, DOI 10.1002/pon.1534; Patterson MD, 2013, BMJ QUAL SAF, V22, P383, DOI 10.1136/bmjqs-2012-000951; Piko BF, 2006, INT J NURS STUD, V43, P311, DOI 10.1016/j.ijnurstu.2005.05.003; Pradas-Hernandez L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195039; Profit J, 2014, BMJ QUAL SAF, V23, P806, DOI 10.1136/bmjqs-2014-002831; Reis CT, 2016, CAD SAUDE PUBLICA, V32, DOI [10.1590/0102-311X00115614, 10.1590/0102-311x00115614]; Rochefort CM, 2010, J ADV NURS, V66, P2213, DOI 10.1111/j.1365-2648.2010.05376.x; Sexton JB, 2018, BMJ QUAL SAF, V27, P261, DOI 10.1136/bmjqs-2016-006399; Shenoi AN, 2018, CRIT CARE MED, V46, P116, DOI 10.1097/CCM.0000000000002751; Silva GM, 2018, J HUMAN GROWTH DEV, V28, P307, DOI DOI 10.7322/jhgd.152192; Sorra J., 2004, HOSP SURVEY PATIENT; Sorskar LIK, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3576-x; Stacciarini J M, 2001, Rev Lat Am Enfermagem, V9, P17, DOI 10.1590/S0104-11692001000200003; Tironi Márcia Oliveira Staffa, 2016, Rev. bras. ter. intensiva, V28, P270, DOI 10.5935/0103-507X.20160053; Ulgen M, 2017, TURKISH ARCH PEDIAT, V52, P66, DOI [10.5152/TurkPediatriArs.2017.4982, DOI 10.5152/TURKPEDIATRIARS.2017.4982]; Van Bogaert P, 2009, J ADV NURS, V65, P2175, DOI 10.1111/j.1365-2648.2009.05082.x; Welp A, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01573; WHO, 2009, TECHNICAL REPORT; Zanatta AB, 2015, REV ESC ENFERM USP, V49, P251, DOI 10.1590/S0080-623420150000200010	58	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218756	10.1371/journal.pone.0218756	http://dx.doi.org/10.1371/journal.pone.0218756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3QN	31233543	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700038
J	Karbownik, MS; Paul, E; Nowicka, M; Nowicka, Z; Kowalczyk, RP; Kowalczyk, E; Pietras, T				Karbownik, Michal Seweryn; Paul, Ewelina; Nowicka, Maja; Nowicka, Zuzanna; Kowalczyk, Radoslaw Przemyslaw; Kowalczyk, Edward; Pietras, Tadeusz			Knowledge about dietary supplements and trust in advertising them: Development and validation of the questionnaires and preliminary results of the association between the constructs	PLOS ONE			English	Article							PHARMACEUTICAL ADVERTISEMENTS; CARDIOVASCULAR-DISEASE; MINERAL SUPPLEMENTS; MEDICAL JOURNALS; PRESCRIPTION; VITAMIN; HEALTH; PREVENTION; BEHAVIOR; CONSEQUENCES	Background Despite offering little overall benefit and emerging concerns about their safety, dietary supplements have become increasingly popular. Trust in advertising them may contribute to high confidence in dietary supplements in public opinion. Aim To develop and validate a screening questionnaire intended for the general public regarding knowledge about dietary supplements and a questionnaire on trust in advertising dietary supplements, and to identify the association between these constructs. Materials and methods The development and validation of the measures was overseen by the panels of experts. The conceptual frameworks of the constructs were scientifically well grounded. A set of semi-structured interviews and anonymous web-based surveys was performed. The final questionnaire was applied to 220 non-medically educated people and 121 medically educated people. Results A 17-item questionnaire on knowledge about dietary supplements and eight-item questionnaire on trust in advertising dietary supplements were developed. The measures presented satisfactory proof of validity, however, the psychometric properties of the questionnaire on knowledge were modest. Both the knowledge about dietary supplements in the study group and trust in advertising them were low. A significant negative relationship was found between knowledge about dietary supplements and trust in advertising them among the general public (Pearson's r = -0.42, 95%CI: -0.52 to -0.30, p<0.0001). This association was especially pronounced in people who reported not taking dietary supplements (Pearson's r = -0.61, 95%CI: -0.76 to -0.39, p<0.0001). Conclusions The extensive advertising of dietary supplements appears to be in conflict with promoting evidence-based knowledge about them, which raises substantial concerns for the public health. The results of the study are only preliminary and require further confirmation and exploration.	[Karbownik, Michal Seweryn; Kowalczyk, Edward] Med Univ Lodz, Dept Pharmacol & Toxicol, Lodz, Poland; [Paul, Ewelina] OSOM STUDIO, Lodz, Poland; [Nowicka, Maja; Pietras, Tadeusz] Med Univ Lodz, Dept Clin Pharmacol, Lodz, Poland; [Nowicka, Zuzanna] Med Univ Lodz, Dept Biostat & Translat Med, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz	Karbownik, MS (corresponding author), Med Univ Lodz, Dept Pharmacol & Toxicol, Lodz, Poland.	michal.karbownik@umed.lodz.pl	Karbownik, Michal S./AAX-4472-2020; Nowicka, Maja/AAB-7820-2022	Karbownik, Michal S./0000-0002-4416-2736; Kowalczyk, Edward/0000-0002-2250-6040; Nowicka, Maja/0000-0001-6587-2502; Pietras, Tadeusz/0000-0003-1771-3819; Nowicka, Zuzanna/0000-0001-7814-5830	Medical University of Lodz, Poland [503/1-151-07/503-11-001]	Medical University of Lodz, Poland	This work was supported by the Medical University of Lodz, Poland (https://umed.pl/) with the grant received by TP (503/1-151-07/503-11-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid AS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003177.pub4; Aina Bolajoko A, 2014, J Basic Clin Pharm, V5, P34, DOI 10.4103/0976-0105.134952; [Anonymous], FORBES; [Anonymous], 2015, GLOBAL TRUST ADVERTI; [Anonymous], 2000, DIET REF INT VIT C V; [Anonymous], HDB CONSUMER PSYCHOL; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Axon DR, 2017, AM J PHARM EDUC, V81, DOI 10.5688/ajpe81592; Ball JG, 2016, INT J ADVERT, V35, P216, DOI 10.1080/02650487.2015.1009346; Bar-Hillel M, 2002, AM STAT, V56, P299, DOI 10.1198/000313002623; Begdache L, 2020, J DIET SUPPL, V17, P67, DOI 10.1080/19390211.2018.1482983; Bleich S, 2007, OBESITY, V15, P2145, DOI 10.1038/oby.2007.255; Bolland MJ, 2018, LANCET DIABETES ENDO, V6, P847, DOI [10.1016/S2213-8587(18)30265-1, 10.1016/s2213-8587(18)30265-1]; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carpenter S, 2018, COMMUN METHODS MEAS, V12, P25, DOI 10.1080/19312458.2017.1396583; Carr AC, 2013, NUTRIENTS, V5, P4284, DOI 10.3390/nu5114284; Chatterjee S.C., 2005, MARK MANAG, V15, P1; Cohen PA, 2016, JAMA-J AM MED ASSOC, V316, P1453, DOI 10.1001/jama.2016.14252; Conner M, 2001, SOC SCI MED, V52, P621, DOI 10.1016/S0277-9536(00)00165-9; Coolbrandt A, 2013, EUR J ONCOL NURS, V17, P275, DOI 10.1016/j.ejon.2012.07.008; Dodge T, 2007, HEALTH PSYCHOL, V26, P513, DOI 10.1037/0278-6133.26.4.513; Dodge T, 2011, J HEALTH COMMUN, V16, P230, DOI 10.1080/10810730.2010.529493; Douglas RM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000980.pub3; Duff JP, 2013, RESUSCITATION, V84, P365, DOI 10.1016/j.resuscitation.2012.07.018; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Faerber AE, 2014, J GEN INTERN MED, V29, P110, DOI 10.1007/s11606-013-2604-0; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Garrison SR, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009402.pub2, 10.1002/14651858.CD009402.pub3]; Grossman DC, 2018, JAMA-J AM MED ASSOC, V319, P1592, DOI 10.1001/jama.2018.3185; HEMILA H, 2013, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000980.PUB4; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hilton CE, 2017, INT J SOC RES METHOD, V20, P21, DOI 10.1080/13645579.2015.1091640; Hobbs R, 2006, HEALTH EDUC RES, V21, P719, DOI 10.1093/her/cyl077; Hoffmann D, 2016, AM J LAW MED, V42, P53, DOI 10.1177/0098858816644715; Huh J, 2005, J HEALTH COMMUN, V10, P711, DOI 10.1080/10810730500326716; Jenkins DJA, 2018, J AM COLL CARDIOL, V71, P2570, DOI 10.1016/j.jacc.2018.04.020; Kamangar F, 2012, INT J PREVENTIVE MED, V3, P221; Kantor ED, 2016, JAMA-J AM MED ASSOC, V316, P1464, DOI 10.1001/jama.2016.14403; Karbownik MLS, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw045; Kotler P.T., 2018, PRINCIPLES MARKETING, V17th ed., Global edition; Krot K., 2016, ZAUFANIE ORG INNOWAC; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Kwan D., 2006, BMC Complementary and Alternative Medicine, V6; LAU RR, 1986, HEALTH PSYCHOL, V5, P25, DOI 10.1037/0278-6133.5.1.25; LEWIS JD, 1985, SOC FORCES, V63, P967, DOI 10.2307/2578601; Longworth G, 2012, ANALYSIS-UK, V72, P623, DOI 10.1093/analys/ans083; MACKIE JL, 1966, PHILOS REV, V75, P441, DOI 10.2307/2183223; Makowska M, 2019, HEALTH POLICY, V123, P544, DOI 10.1016/j.healthpol.2019.04.001; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Marinac JS, 2007, J AM OSTEOPATH ASSOC, V107, P13; Mason MJ, 2007, J CONSUM AFF, V41, P74, DOI 10.1111/j.1745-6606.2006.00069.x; Mendelsohn AR, 2014, REJUV RES, V17, P306, DOI 10.1089/rej.2014.1577; Menon Ajit M, 2002, Health Mark Q, V20, P17, DOI 10.1300/J026v20n01_03; Millar CCJM, 2003, J BUS ETHICS, V48, P267, DOI 10.1023/B:BUSI.0000005788.90079.5d; Molinero O, 2009, NUTR HOSP, V24, P128; MOZAFFARIAN D, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2392; Myung SK, 2010, ANN ONCOL, V21, P166, DOI 10.1093/annonc/mdp286; National Institutes of Health Office of Dietary Supplements, 2016, STRAT PLAN 2017 2021; Nichter M, 2006, CULT MED PSYCHIAT, V30, P175, DOI 10.1007/s11013-006-9016-0; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Othman N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006350; Parmenter K, 1999, EUR J CLIN NUTR, V53, P298, DOI 10.1038/sj.ejcn.1600726; Pfafflin M, 2012, EPILEPSY BEHAV, V25, P11, DOI 10.1016/j.yebeh.2012.06.012; Polish Supreme Audit Office, 2017, AUTH DIET SUPPL; Rautiainen S, 2015, AM J CLIN NUTR, V101, P144, DOI 10.3945/ajcn.114.088310; Rivers J M, 1989, Int J Vitam Nutr Res Suppl, V30, P95; Rosenman Robert, 2011, Int J Behav Healthc Res, V2, P320; ROTTER JB, 1971, AM PSYCHOL, V26, P443, DOI 10.1037/h0031464; Schenker Y, 2014, AM J BIOETHICS, V14, P34, DOI 10.1080/15265161.2013.879943; Schneyder A., 2014, AUST PRESCR, V37, P120, DOI [10.18773/austprescr.2014.047, DOI 10.18773/AUSTPRESCR.2014.047]; Sebo P, 2014, FAM PRACT, V31, P7, DOI 10.1093/fampra/cmt065; Sharp B., 2010, BRANDS GROW WHAT MAR; Sirico F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191424; Soh H, 2009, J ADVERTISING, V38, P83, DOI 10.2753/JOA0091-3367380206; Spedding S, 2013, AUSTRALAS MED J, V6, P104, DOI 10.4066/AMJ.2013.1588; Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine, 1999, DIET REF INT CALC PH; Starr RR, 2015, AM J PUBLIC HEALTH, V105, P478, DOI 10.2105/AJPH.2014.302348; Statistics Poland Social Surveys Department, 2018, HLTH CAR HOUS 2016; Steyn NP, 2005, NUTRITION, V21, P51, DOI 10.1016/j.nut.2004.09.008; Torok CB, 2008, GLYCOBIOLOGY, V18, P660, DOI 10.1093/glycob/cwn060; Trakman GL, 2017, PUBLIC HEALTH NUTR, V20, P2670, DOI 10.1017/S1368980017001471; Tsai AC, 2003, INT J HEALTH SERV, V33, P751, DOI 10.2190/K0JG-EXG1-FB12-0ANF; Vali I, 2013, PROCD SOC BEHV, V76, P388, DOI 10.1016/j.sbspro.2013.04.133; van der Eijk C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118900; Wierzbinski J, 2009, BADANIE ZAUFANIA ORG; Wierzejska Regina, 2016, Wiad Lek, V69, P14; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912; Wong Michelle K, 2016, Prim Care Companion CNS Disord, V18, DOI 10.4088/PCC.16l01940a; Zhang X, 2005, 7 INT C EL COMM XIAN; Zhao JG, 2017, JAMA-J AM MED ASSOC, V318, P2466, DOI 10.1001/jama.2017.19344; Ziegler M, 2014, J INDIVID DIFFER, V35, P185, DOI 10.1027/1614-0001/a000148; Zielinski T., 2012, J MANAG BUS ADM CENT, V20, P73	93	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218398	10.1371/journal.pone.0218398	http://dx.doi.org/10.1371/journal.pone.0218398			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3QN	31233516	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700017
J	Soler-Arango, J; Figoli, C; Muraca, G; Bosch, A; Brelles-Marino, G				Soler-Arango, Juliana; Figoli, Cecilia; Muraca, Giuliana; Bosch, Alejandra; Brelles-Marino, Graciela			The Pseudomonas aeruginosa biofilm matrix and cells are drastically impacted by gas discharge plasma treatment: A comprehensive model explaining plasma-mediated biofilm eradication	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; FT-IR; ESCHERICHIA-COLI; BACTERIAL BIOFILMS; CYSTIC-FIBROSIS; POLYSACCHARIDE; IDENTIFICATION; INACTIVATION; SECONDARY; RAMAN	Biofilms are microbial communities encased in a protective matrix composed of exopolymeric substances including exopolysaccharides, proteins, lipids, and extracellular DNA. Biofilms cause undesirable effects such as biofouling, equipment damage, prostheses colonization, and disease. Biofilms are also more resilient than free-living cells to regular decontamination methods and therefore, alternative methods are needed to eradicate them. The use of non-thermal atmospheric pressure plasmas is a good alternative as plasmas contain reactive species, free radicals, and UV photons well-known for their decontamination potential against free microorganisms. Pseudomonas aeruginosa biofilms colonize catheters, indwelling devices, and prostheses. Plasma effects on cell viability have been previously documented for P. aeruginosa biofilms. Nonetheless, the effect of plasma on the biofilm matrix has received less attention and there is little evidence regarding the changes the matrix undergoes. The aim of this work was to study the effect plasma exerts mostly on the P. aeruginosa biofilm matrix and to expand the existing knowledge about its effect on sessile cells in order to achieve a better understanding of the mechanism/s underlying plasma-mediated biofilm inactivation. We report a reduction in the amount of the biofilm matrix, the loss of its tridimensional structure, and morphological changes in sessile cells at long exposure times. We show chemical and structural changes on the biofilm matrix (mostly on carbohydrates and eDNA) and cells (mostly on proteins and lipids) that are more profound with longer plasma exposure times. We also demonstrate the presence of lipid oxidation products confirming cell membrane lipid peroxidation as plasma exposure time increases. To our knowledge this is the first report providing detailed evidence of the variety of chemical and structural changes that occur mostly on the biofilm matrix and sessile cells as a consequence of the plasma treatment. Based on our results, we propose a comprehensive model explaining plasma-mediated biofilm inactivation.	[Soler-Arango, Juliana; Muraca, Giuliana; Brelles-Marino, Graciela] Univ Nacl La Plata, Biofilm Eradicat Lab, Consejo Nacl Invest Cient & Tecn, CINDEFI,CCT LA PLATA,CONICET,Ctr Res & Dev Ind Fe, La Plata, Buenos Aires, Argentina; [Figoli, Cecilia; Bosch, Alejandra] Univ Nacl La Plata, Consejo Nacl Invest Cient & Tecn, Bioespect Lab,Ctr Res & Dev Ind Fermentat, CINDEFI,CCT LA PLATA,CONICET,Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Brelles-Marino, G (corresponding author), Univ Nacl La Plata, Biofilm Eradicat Lab, Consejo Nacl Invest Cient & Tecn, CINDEFI,CCT LA PLATA,CONICET,Ctr Res & Dev Ind Fe, La Plata, Buenos Aires, Argentina.; Bosch, A (corresponding author), Univ Nacl La Plata, Consejo Nacl Invest Cient & Tecn, Bioespect Lab,Ctr Res & Dev Ind Fermentat, CINDEFI,CCT LA PLATA,CONICET,Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina.	bosch@quimica.unlp.edu.ar; gracielabrelles@gmail.com		Figoli, Cecilia Beatriz/0000-0002-0287-2633; Brelles-Marino, Graciela/0000-0002-8900-7035	Universidad Nacional de La Plata, Argentina [X764, X775]; National Scientific and Technical Research Council (CONICET); Fundacion FUNPRECIT; CONICET	Universidad Nacional de La Plata, Argentina(National University of La Plata); National Scientific and Technical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion FUNPRECIT; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Universidad Nacional de La Plata, Argentina provided support for this study in the form of grants to GBM and AB (Grants #X764 and #X775 respectively). The National Scientific and Technical Research Council (CONICET) provided support for this study in the form of a doctoral fellowship to JSA and a post doctoral fellowship to CF. Fundacion FUNPRECIT, a non profit organization that promotes research and development, innovation and competitiveness and cooperation for economic and social development, provided support for publication of this study in the form of a payment for technological services to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Dr. Diana Grondona and Dr. Leandro Giuliani (INFIP, UBA-CONICET) for providing the plasma device, Dr. German Islan (CINDEFI-CCT-CONICET) for his help with SEM experiments, and Dr. Evelina Ferrer (CEQUINOR-CONICET) for her contribution in A/T FT-IR spectral acquisition and useful discussions and comments. JSA is indebted to CONICET for a doctoral fellowship. CF is a postdoctoral fellow of CONICET and AB is member of CIC PBA.	Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515; Akishev, 2012, PLASMA BIODECONTAMIN, P135, DOI DOI 10.1007/978-94-007-2852-3_11; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Ben Belgacem Z, 2016, IRBM, V37, P68, DOI 10.1016/j.irbm.2016.02.006; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Bosch A, 2006, APPL MICROBIOL BIOT, V71, P736, DOI 10.1007/s00253-005-0202-8; Bosch A, 2008, J CLIN MICROBIOL, V46, P2535, DOI 10.1128/JCM.02267-07; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Bryers JD, 2004, ASM NEWS, V70, P232; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Chan BK, 2018, EVOL MED PUBLIC HLTH, P60, DOI 10.1093/emph/eoy005; CHOU KC, 1982, J MOL BIOL, V162, P89, DOI 10.1016/0022-2836(82)90163-2; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; EVANS LR, 1973, J BACTERIOL, V116, P915, DOI 10.1128/JB.116.2.915-924.1973; Fabian H., 2006, HDB VIB SPECTROSC, DOI [10.1002/0470027320.s8201, DOI 10.1002/0470027320.S8201]; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Ferrer EG, 2008, BIOORGAN MED CHEM, V16, P3878, DOI 10.1016/j.bmc.2008.01.060; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fong SA, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00418; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gabriel AA, 2016, INNOV FOOD SCI EMERG, V36, P311, DOI 10.1016/j.ifset.2016.07.015; Gillis RJ, 2004, J CLIN MICROBIOL, V42, P5842, DOI 10.1128/JCM.42.12.5842-5845.2004; Gilmanshin R, 1997, P NATL ACAD SCI USA, V94, P3709, DOI 10.1073/pnas.94.8.3709; Graciela B-M, 2012, J BIOPROCESS BIOTECH, V2, pe107, DOI DOI 10.4172/2155-9821.1000E107; Guillen MD, 2007, J AGR FOOD CHEM, V55, P10729, DOI 10.1021/jf071712c; Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; HELM D, 1995, FEMS MICROBIOL LETT, V126, P75, DOI 10.1111/j.1574-6968.1995.tb07393.x; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Holman HYN, 2009, ANAL CHEM, V81, P8564, DOI 10.1021/ac9015424; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Khan MSI, 2016, SCI REP-UK, V6, DOI 10.1038/srep37072; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Laroussi M, 2015, IEEE T PLASMA SCI, V43, P703, DOI 10.1109/TPS.2015.2403307; Liang PJ, 2013, J SPECTROSC, V2013, DOI 10.1155/2013/138728; Lu XN, 2011, FOOD BIOPROCESS TECH, V4, P919, DOI 10.1007/s11947-011-0516-8; Mai-Prochnow A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130373; Marchal F, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/34/345202; Miller LM, 2013, BBA-BIOMEMBRANES, V1828, P2339, DOI 10.1016/j.bbamem.2013.01.014; Modic M, 2017, INT J ANTIMICROB AG, V49, P375, DOI 10.1016/j.ijantimicag.2016.11.022; Muik B, 2007, ANAL CHIM ACTA, V593, P54, DOI 10.1016/j.aca.2007.04.050; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; NAUMANN D, 2000, ENCY ANAL CHEM, P1; NICHOLS PD, 1985, J MICROBIOL METH, V4, P79, DOI 10.1016/0167-7012(85)90023-5; Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001; Ojeda JJ, 2008, LANGMUIR, V24, P4032, DOI 10.1021/la702284b; Oleszko A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/245607; Pei X, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/16/165205; Pires D, 2011, RES MICROBIOL, V162, P798, DOI 10.1016/j.resmic.2011.06.010; Puligundla P, 2017, J APPL MICROBIOL, V122, P1134, DOI 10.1111/jam.13404; Santos J., 2009, PROTEINAS ESTRUCTURA, P192; Schleicher E, 2005, FEBS J, V272, P1855, DOI 10.1111/j.1742-4658.2005.04617.x; Schmitt J, 1998, P SOC PHOTO-OPT INS, V3257, P236, DOI 10.1117/12.306103; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9; Soler-Arango J, 2017, PLASMA MED, V7, DOI [10.1615/PlasmaMed.2017019506, DOI 10.1615/PLASMAMED.2017019506]; Soler-Arango J, 2018, PLASMA CHEM PLASMA P, V38, P535, DOI 10.1007/s11090-018-9877-3; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Synytsya A, 2003, CARBOHYD POLYM, V54, P97, DOI 10.1016/S0144-8617(03)00158-9; Tanaka G, 2000, CHEMOTHERAPY, V46, P36, DOI 10.1159/000007254; Tang MJ, 2013, ANAL BIOANAL CHEM, V405, P1577, DOI 10.1007/s00216-012-6556-8; Tummler B, 1999, MOL MED TODAY, V5, P351, DOI 10.1016/S1357-4310(99)01506-3; Vandervoort KG, 2008, IEEE T PLASMA SCI, V36, P1296, DOI 10.1109/TPS.2008.917953; Vandervoort KG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108512; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100; Zelaya AJ, 2010, IEEE T PLASMA SCI, V38, P3398, DOI 10.1109/TPS.2010.2082570; Ziuzina D, 2013, J APPL MICROBIOL, V114, P778, DOI 10.1111/jam.12087; Ziuzina D., 2014, PLASMA MED, V4, P137, DOI [DOI 10.1615/PLASMAMED.2014011996, 10.1615/PlasmaMed.2014011996]; Ziuzina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138209	78	28	29	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0216817	10.1371/journal.pone.0216817	http://dx.doi.org/10.1371/journal.pone.0216817			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233528	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700005
J	Wessels, DJ; Pradhan, N; Park, YN; Klepitsch, MA; Lusche, DF; Daniels, KJ; Conway, KD; Voss, ER; Hegde, SV; Conway, TP; Soll, DR				Wessels, Deborah J.; Pradhan, Nikash; Park, Yang-Nim; Klepitsch, Megan A.; Lusche, Daniel F.; Daniels, Karla J.; Conway, Kayla D.; Voss, Edward R.; Hegde, Suchaeta, V; Conway, Thomas P.; Soll, David R.			Reciprocal signaling and direct physical interactions between fibroblasts and breast cancer cells in a 3D environment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STROMAL FIBROBLASTS; TUMOR-GROWTH; DIFFERENTIATION; ORGANIZATION; ACTIVATION; EXPRESSION; DIVERSITY; ENHANCE; BIOLOGY	Tumorigenic cells undergo cell aggregation and aggregate coalescence in a 3D Matrigel environment. Here, we expanded this 3D platform to assess the interactions of normal human dermal fibroblasts (NHDFs) and human primary mammary fibroblasts (HPMFs) with breast cancer-derived, tumorigenic cells (MDA-MB-231). Medium conditioned by MDA-MB-231 cells activates both types of fibroblasts, imbuing them with the capacity to accelerate the rate of aggregation and coalescence of MDA-MB-231 cells more than four fold. Acceleration is achieved 1) by direct physical interactions with MDA-MB-231 cells, in which activated fibroblasts penetrate the MDA-MB-231/Matrigel 3D environment and function as supporting scaffolds for MDA-MB-231 aggregation and coalescence, and 2) through the release of soluble accelerating factors, including matrix metalloproteinase (MMPs) and, in the case of activated NHDFs, SDF-1/CXCL12. Fibroblast activation includes changes in morphology, motility, and gene expression. Podoplanin (PDPN) and fibroblast activation protein (FAP) are upregulated by more than nine-fold in activated NHDFs while activated HPMFs upregulate FAP, vimentin, desmin, platelet derived growth factor receptor A and S100A4. Overexpression of PDPN, but not FAP, in NHDF cells in the absence of MDA-MB-231-conditioned medium, activates NHDFs. These results reveal that complex reciprocal signaling between fibroblasts and cancer cells, coupled with their physical interactions, occurs in a highly coordinated fashion that orchestrates aggregation and coalescence, behaviors specific to cancer cells in a 3D environment. These in vitro interactions may reflect events involved in early tumorigenesis, particularly in cases of field cancerization, and may represent a new mechanism whereby cancer-associated fibroblasts (CAFs) promote tumor growth.	[Wessels, Deborah J.; Pradhan, Nikash; Park, Yang-Nim; Klepitsch, Megan A.; Lusche, Daniel F.; Daniels, Karla J.; Conway, Kayla D.; Voss, Edward R.; Hegde, Suchaeta, V; Conway, Thomas P.; Soll, David R.] Univ Iowa, Dept Biol, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA; [Wessels, Deborah J.; Pradhan, Nikash; Park, Yang-Nim; Klepitsch, Megan A.; Lusche, Daniel F.; Daniels, Karla J.; Conway, Kayla D.; Voss, Edward R.; Hegde, Suchaeta, V; Conway, Thomas P.; Soll, David R.] Univ Iowa, Dept Biol, WM Keck Dynam Image Anal Facil, Iowa City, IA USA	University of Iowa; University of Iowa	Soll, DR (corresponding author), Univ Iowa, Dept Biol, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA.	david-soll@uiowa.edu		Lusche, Daniel Felix/0000-0002-8848-4198	Developmental Studies Hybridoma Bank (DSHB)	Developmental Studies Hybridoma Bank (DSHB)	This work was supported by the Developmental Studies Hybridoma Bank (DSHB; http://dshb.biology.uiowa.edu/), a National resource created by the National Institutes of Health (NIH) and housed at the University of Iowa. The DSHB had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi Y, 2010, CANCER RES, V70, P9650, DOI 10.1158/0008-5472.CAN-10-1146; Ahirwar DK, 2018, ONCOGENE, V37, P4428, DOI 10.1038/s41388-018-0263-7; Ambrose J, 2015, AM J CANCER RES, V5, P3485; Attieh Y, 2016, EUR J CELL BIOL, V95, P493, DOI 10.1016/j.ejcb.2016.07.004; Aung PP, 2015, J CLIN PATHOL, V68, P963, DOI 10.1136/jclinpath-2015-202887; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bresson L, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160382; Brouty-Boye D, 2005, PROG MOLEC, V40, P55; Buchsbaum RJ, 2016, CANCERS, V8, DOI 10.3390/cancers8020019; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Busch S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0642-7; Chan JSK, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.492; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Costa S, 2016, AM J SURG PATHOL, V40, P368, DOI 10.1097/PAS.0000000000000568; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Franklin WA, 1997, J CLIN INVEST, V100, P2133, DOI 10.1172/JCI119748; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gao MQ, 2010, J CELL SCI, V123, P3507, DOI 10.1242/jcs.072900; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Glentis A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00985-8; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; Hugo HJ, 2012, CANCER MICROENVIRON, V5, P83, DOI 10.1007/s12307-012-0098-7; Jones TD, 2005, CLIN CANCER RES, V11, P6512, DOI 10.1158/1078-0432.CCR-05-0891; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kelley LC, 2014, J CELL BIOL, V204, P291, DOI 10.1083/jcb.201311112; Knuchel S, 2015, ONCOTARGET, V6, P14300, DOI 10.18632/oncotarget.3883; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Kuhl S, 2016, CHEMOTAXIS METHODS P; Kutzner H, 2012, MODERN PATHOL, V25, P838, DOI 10.1038/modpathol.2012.35; Kuzet SE, 2016, CELL TISSUE RES, V365, P607, DOI 10.1007/s00441-016-2467-x; Labernadie A, 2017, NAT CELL BIOL, V19, P224, DOI 10.1038/ncb3478; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liakou E, 2016, AGING-US, V8, P1650, DOI 10.18632/aging.100989; Lusche DF, 2019, MABS-AUSTIN, V11, P691, DOI 10.1080/19420862.2019.1583987; Lusche Daniel F, 2018, Oncotarget, V9, P21100, DOI 10.18632/oncotarget.24941; Lynch SP, 2013, ONCOLOGIST, V18, P1167, DOI 10.1634/theoncologist.2013-0167; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Papadopoulou A, 2011, INT J ONCOL, V39, P989, DOI 10.3892/ijo.2011.1132; Pure E, 2016, CANCER IMMUNOL RES, V4, P269, DOI 10.1158/2326-6066.CIR-16-0011; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sanchez Philip, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P80, DOI 10.1089/mab.2013.0089; Scherer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118628; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Soll David R., 2007, P365, DOI 10.1007/978-3-540-71331-9_13; Soll DR, 1998, TECH MOD B, P25; Soon PSH, 2013, ENDOCR-RELAT CANCER, V20, P1, DOI 10.1530/ERC-12-0227; Spaw M, 2017, MOL CARCINOGEN, V56, P1199, DOI 10.1002/mc.22583; Suchanski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184970; Sun LP, 2018, J IMMUNOL RES, V2018, DOI [10.1155/2018/5429513, 10.1155/2018/5429543]; Tao LL, 2017, ONCOL LETT, V14, P2611, DOI 10.3892/ol.2017.6497; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wessels D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173400; Wessels DJ, 2016, METHODS MOL BIOL, V1365, P265, DOI 10.1007/978-1-4939-3124-8_14; Yamauchi M, 2018, J CLIN INVEST, V128, P16, DOI 10.1172/JCI93554; Yang N, 2011, AM J PATHOL, V178, P325, DOI 10.1016/j.ajpath.2010.11.039; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	64	21	21	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218854	10.1371/journal.pone.0218854	http://dx.doi.org/10.1371/journal.pone.0218854			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IG2LO	31233557	Green Submitted, Green Published, gold			2022-12-26	WOS:000473628900002
J	Moradi, F; Soderberg, M; Moradi, F; Daka, B; Olin, AC; Larstad, M				Moradi, Faraidoun; Soderberg, Mia; Moradi, Fazil; Daka, Bledar; Olin, Anna-Carin; Larstad, Mona			Health perspectives among Halabja's civilian survivors of sulfur mustard exposure with respiratory symptoms-A qualitative study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; POSTTRAUMATIC-STRESS-DISORDER; OF-LIFE; POISON GAS; ANXIETY; COMPLICATIONS; DEPRESSION; PREVALENCE; INJURY; IMPACT	Background In 1988, Halabja came under heavy chemical warfare attack using chemicals such as sulfur mustard (SM). Thousands of survivors of SM exposure in the city today live with multiple health complaints, such as severe, long-lasting respiratory symptoms; but their perceptions of health have never been adequately researched. We aimed to explore current major health concern topics in civilian survivors with long-term respiratory symptoms. Method Sixteen subjects (f:m10:6, mean age 45.5 years (range 34-67)) were interviewed. Study participants were recruited in 2016 via a purposive sampling strategy among civilian survivors of chemical warfare in the city of Halabja in Kurdistan-Iraq. A qualitative research design was applied including semi-structured, face-to-face interviews. Data was analyzed using systematic text condensation. Results The analysis yielded fourteen themes related to: (1) General health: all participants described a deterioration in physical and psychological health, following the SM exposure, foremost involving respiratory symptoms, fatigue, sleeping disorders, ocular problems, depressive symptoms, and anxiety; (2) Quality of life: most notably, they reported a limited family life, limited social relations, lack of work ability, and concern about their financial situation. Moreover, many lived in constant fear of a renewed attack; (3) access to health care services: all participants reported that they had no, or only poor, access to health care services and limited access to specialist care, and all reported lack of financial resources to obtain treatment. Conclusions The post-exposure somatic and psychosocial effects such as respiratory symptoms of CWA are plausible contributor to poor general health and quality of life among survivors. We conclude that multidisciplinary interventions are needed to tackle the biopsychosocial complications in survivors of SM exposure to minimize further health damage in the future, as well as to promote their health-related quality of life.	[Moradi, Faraidoun; Soderberg, Mia; Olin, Anna-Carin; Larstad, Mona] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Sect Occupat & Environm Med, Gothenburg, Sweden; [Moradi, Faraidoun] Reg Vastra Gotaland, Narhalsan Res & Dev, Primary Hlth Care, Gothenburg, Sweden; [Moradi, Fazil] Martin Luther Univ Halle Wittenberg, Dept Anthropol & Philosophy, Halle, Germany; [Daka, Bledar] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med,Primary Hlth Care, Gothenburg, Sweden; [Larstad, Mona] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Resp Med & Allergol, Gothenburg, Sweden	University of Gothenburg; Martin Luther University Halle Wittenberg; University of Gothenburg; University of Gothenburg	Moradi, F (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Sect Occupat & Environm Med, Gothenburg, Sweden.; Moradi, F (corresponding author), Reg Vastra Gotaland, Narhalsan Res & Dev, Primary Hlth Care, Gothenburg, Sweden.	moradi.faraidoun@gu.se	Olin, Anna-Carin/ABH-2627-2021	Soderberg, Mia/0000-0003-0662-6541; Moradi, Faraidoun/0000-0002-8984-1660; Moradi, Fazil/0000-0002-9309-7408	Region Vastra Gotaland, Narhalsan Research and Development Primary Health Care, Gothenburg; Section of Occupational and Environmental Medicine, Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg	Region Vastra Gotaland, Narhalsan Research and Development Primary Health Care, Gothenburg; Section of Occupational and Environmental Medicine, Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg	The study funded as part of a PhD thesis doctoral study grant (DOS) awarded to Faraidoun M. by Region Vastra Gotaland, Narhalsan Research and Development Primary Health Care, Gothenburg and supported by Section of Occupational and Environmental Medicine, Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2000, EUR CHILD ADOLES PSY, V9, P235, DOI 10.1007/s007870070026; Al-Hamzawi AO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131937; Balali-Mood M, 2006, BASIC CLIN PHARMACOL, V99, P273, DOI 10.1111/j.1742-7843.2006.pto_429.x; Beheshti J, 2006, PATHOL RES PRACT, V202, P739, DOI 10.1016/j.prp.2006.04.008; Brenes GA, 2003, PSYCHOSOM MED, V65, P963, DOI 10.1097/01.PSY.0000097339.75789.81; Dabirian A, 2011, PATIENT PREFER ADHER, V5, P1, DOI 10.2147/PPA.S14508; Dworkin J, 2008, J NERV MENT DIS, V196, P772, DOI 10.1097/NMD.0b013e3181878b69; Eisenkraft A, 2014, AM J EMERG MED, V32, P186, DOI 10.1016/j.ajem.2013.11.005; Fleehart S, 2014, INT J CHRONIC OBSTR, V9, P1321, DOI 10.2147/COPD.S65507; Foo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152618; Ghanei M, 2010, INHAL TOXICOL, V22, P719, DOI 10.3109/08958371003686016; Hardi Choman, 2011, VOICE DEV MANAGE; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hashemian F, 2006, JAMA-J AM MED ASSOC, V296, P560, DOI 10.1001/jama.296.5.560; HAY A, 1990, JAMA-J AM MED ASSOC, V263, P1065; Hefazi M, 2005, INHAL TOXICOL, V17, P587, DOI 10.1080/08958370591000591; Hiltermann JR, 2007, POISONOUS AFFAIR: AMERICA, IRAQ, AND THE GASSING OF HALABJA, P1; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Jones E, 2007, BMJ-BRIT MED J, V335, P1313, DOI 10.1136/bmj.39420.533461.25; Kemple M, 2016, J CLIN NURS, V25, P3363, DOI 10.1111/jocn.13462; Khateri S, 2017, ASIA-PAC PSYCHIAT, V9, DOI 10.1111/appy.12252; Lynch EB, 2008, J REHABIL MED, V40, P518, DOI 10.2340/16501977-0203; MACILWAIN C, 1993, NATURE, V363, P3, DOI 10.1038/363003b0; Malterud K, 2012, SCAND J PUBLIC HEALT, V40, P795, DOI 10.1177/1403494812465030; McLeay SC, 2017, MED J AUSTRALIA, V206, P251, DOI 10.5694/mja16.00935; Moradi F, 2017, MEM STUD GLOB CONST, P1; Moradi F, 2017, MEM STUD GLOB CONST, P57; Mousavi B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-2; Nishimura Y, 2016, INHAL TOXICOL, V28, P343, DOI 10.3109/08958378.2016.1173133; Okubadejo AA, 1996, THORAX, V51, P44, DOI 10.1136/thx.51.1.44; Panahi Yunes, 2015, Asian Pac J Cancer Prev, V16, P7567; Ralph NL, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130159; Roth T, 2000, Clin Cornerstone, V2, P28, DOI 10.1016/S1098-3597(00)90038-3; Rowell M, 2009, TOXICOLOGY, V263, P9, DOI 10.1016/j.tox.2009.05.015; Satkin Mojtaba, 2017, Tanaffos, V16, P115; Sezigen S, 2019, TOXICOL LETT, V303, P9, DOI 10.1016/j.toxlet.2018.12.006; Strang S, 2014, PALLIAT SUPPORT CARE, V12, P465, DOI 10.1017/S1478951513000369; Summerhill EM, 2017, ANN AM THORAC SOC, V14, P1060, DOI 10.1513/AnnalsATS.201704-297WS; Talabani JM, 2017, HUMAN EXPT TOXICOLOG; White CW, 2016, ANN NY ACAD SCI, V1378, P87, DOI 10.1111/nyas.13130; Woosley JA, 2014, J CLIN SLEEP MED, V10, P1223, DOI 10.5664/jcsm.4208; World Health Organization, SUIC RAT PER 100000; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218648	10.1371/journal.pone.0218648	http://dx.doi.org/10.1371/journal.pone.0218648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226143	gold, Green Published, Green Submitted			2022-12-26	WOS:000484894700027
J	Harvey, BM; Baxter, M; Granato, M				Harvey, Beth M.; Baxter, Melissa; Granato, Michael			Optic nerve regeneration in larval zebrafish exhibits spontaneous capacity for retinotopic but not tectum specific axon targeting	PLOS ONE			English	Article							SPINAL-CORD TRANSECTION; RETINAL GANGLION-CELLS; RETINOTECTAL PROJECTION; VISUAL-SYSTEM; INJURY; HEDGEHOG; MUTATIONS; PATHWAYS; NEURONS; TRACT	In contrast to mammals, retinal ganglion cells (RGC) axons of the optic nerve even in mature zebrafish exhibit a remarkable capacity for spontaneous regeneration. One constraint of using adult zebrafish is the limited ability to visualize the regeneration process in live animals. To dynamically visualize and trace the degree of target specific optic nerve regeneration, we took advantage of the optical transparency still preserved in post developmental larval zebrafish. We developed a rapid and robust assay to physically transect the larval optic nerve and find that by 96 hours post injury RGC axons have robustly regrown onto the optic tectum. We observe functional regeneration by 8 days post injury, and demonstrate that similar to adult zebrafish, optic nerve transection in larval zebrafish does not prominently induce cell death or proliferation of RGC neurons. Furthermore, we find that partial optic nerve transection results in axonal growth predominantly to the original, contralateral tectum, while complete transection results in innervation of both the correct contralateral and 'incorrect' ipsilateral tectum. Axonal tracing reveals that although regenerating axons innervate the 'incorrect' ipsilateral tectum, they successfully target their topographically appropriate synaptic areas. Combined, our results validate post developmental larval zebrafish as a powerful model for optic nerve regeneration, and reveal intricate mechanistic differences between axonal growth, midline guidance and synaptic targeting during zebrafish optic nerve regeneration.	[Harvey, Beth M.; Baxter, Melissa; Granato, Michael] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Granato, M (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.	granatom@pennmedicine.upenn.edu		Harvey, Beth/0000-0002-9291-5640	National institute of health [EY024861, NS097914]; NATIONAL EYE INSTITUTE [R01EY024861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097914] Funding Source: NIH RePORTER	National institute of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National institute of health to Michael Granato (EY024861 and NS097914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTARDI DG, 1963, EXP NEUROL, V7, P46, DOI 10.1016/0014-4886(63)90093-1; Becker CG, 2000, J COMP NEUROL, V427, P469; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Becker T, 2005, MOL CELL NEUROSCI, V30, P265, DOI 10.1016/j.mcn.2005.07.008; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Benowitz LI, 2017, EXP NEUROL, V287, P365, DOI 10.1016/j.expneurol.2015.12.015; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bilotta J, 2000, BEHAV BRAIN RES, V116, P81, DOI 10.1016/S0166-4328(00)00264-3; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; BURRILL JD, 1994, J COMP NEUROL, V346, P583, DOI 10.1002/cne.903460410; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Clark D. T., 1981, THESIS; Culverwell J, 2002, SEMIN CELL DEV BIOL, V13, P497, DOI 10.1016/S1084952102001039; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Easter SS, 1996, DEV BIOL, V180, P646; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; HORDER TJ, 1971, J PHYSIOL-LONDON, V217, pP53; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Kaneda M, 2008, NEUROSCI RES, V61, P281, DOI 10.1016/j.neures.2008.03.008; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; LANNERS HN, 1980, J NEUROCYTOL, V9, P733, DOI 10.1007/BF01205016; Li SS, 2015, NEUROBIOL DIS, V73, P366, DOI 10.1016/j.nbd.2014.09.019; Luo XT, 2013, EXP NEUROL, V247, P653, DOI 10.1016/j.expneurol.2013.03.001; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Marcus RC, 1999, VISUAL NEUROSCI, V16, P417, DOI 10.1017/S095252389916303X; Marquart GD, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix056; McElligott MB, 2005, BRAIN BEHAV EVOLUT, V66, P177, DOI 10.1159/000087158; MEYER RL, 1978, EXP NEUROL, V59, P99, DOI 10.1016/0014-4886(78)90204-2; Mokalled MH, 2016, SCIENCE, V354, P630, DOI 10.1126/science.aaf2679; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; MURRAY M, 1976, J COMP NEUROL, V168, P175, DOI 10.1002/cne.901680202; Nakano Y, 2004, DEV BIOL, V269, P381, DOI 10.1016/j.ydbio.2004.01.022; Norsworthy MW, 2017, NEURON, V94, P1112, DOI 10.1016/j.neuron.2017.05.035; Orger MB, 2005, VISUAL NEUROSCI, V22, P275, DOI 10.1017/S0952523805223039; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Randlett O, 2015, NAT METHODS, V12, P1039, DOI 10.1038/NMETH.3581; Rasmussen JP, 2017, EXP NEUROL, V287, P318, DOI 10.1016/j.expneurol.2016.02.022; Robles E, 2014, CURR BIOL, V24, P2085, DOI 10.1016/j.cub.2014.07.080; Robles E, 2013, J NEUROSCI, V33, P5027, DOI 10.1523/JNEUROSCI.4990-12.2013; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SPRINGER AD, 1977, BRAIN RES, V128, P405, DOI 10.1016/0006-8993(77)90167-6; STUERMER CAO, 1984, J NEUROSCI, V4, P1045; STUERMER CAO, 1984, J COMP NEUROL, V223, P57, DOI 10.1002/cne.902230106; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Trowe T, 1996, DEVELOPMENT, V123, P439; Vajn K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105857; Van Houcke J, 2017, NEUROBIOL AGING, V60, P1, DOI 10.1016/j.neurobiolaging.2017.08.013; van Raamsdonk W, 1998, ACTA HISTOCHEM, V100, P117, DOI 10.1016/S0065-1281(98)80021-4; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Welsbie DS, 2017, NEURON, V94, P1142, DOI 10.1016/j.neuron.2017.06.008; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zou SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057280	65	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218667	10.1371/journal.pone.0218667	http://dx.doi.org/10.1371/journal.pone.0218667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220164	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500080
J	Akpan, GE; Adepoju, KA; Oladosu, OR				Akpan, Godwin E.; Adepoju, Kayode A.; Oladosu, Olakunle R.			Potential distribution of dominant malaria vector species in tropical region under climate change scenarios	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; GLOBAL CLIMATE; NICHE MODELS; DISEASE; EXTENSIONS; ARABIENSIS; NIGERIA; AFRICA	Risk assessment regarding the distribution of malaria vectors and environmental variables underpinning their distribution under changing climates is crucial towards malaria control and eradication. On this basis, we used Maximum Entropy (MaxEnt) Model to estimate the potential future distribution of major transmitters of malaria in Nigeria-Anopheles gambiae sensu lato and its siblings: Anopheles gambiae sensu stricto, and Anopheles arabiensis under low and high emissions scenarios. In the model, we used mosquito occurrence data sampled from 1900 to 2010 alongside land use and terrain variables, and bioclimatic variables for baseline climate 1960-1990 and future climates of 2050s (2041-2060) and 2070s (2061-2080) that follow RCP2.6 and RCP8.5 scenarios. The Anopheles gambiae species are projected to experience large shift in potential range and population with increased distribution density, higher under high emissions scenario (RCP8.5) and 2070s than low emission scenario (RCP2.6) and 2050s. Anopheles gambiae sensu stricto and Anopheles arabiensis are projected to have highest invasion with 47-70% and 10-14% percentage increase, respectively in Sahel and Sudan savannas within northern states in 2041-2080 under RCP8.5. Highest prevalence is predicted for Humid forest and Derived savanna in southern and North Central states in 2041-2080; 91-96% and 97-99% for Anopheles gambiae sensu stricto, and 67-71% and 72-75% for Anopheles arabiensis under RCP2.6 and RCP8.5, respectively. The higher magnitude of change in species prevalence predicted for the later part of the 21st century under high emission scenario, driven mainly by increasing and fluctuating temperature, alongside longer seasonal tropical rainfall accompanied by drier phases and inherent influence of rapid land use change, may lead to more significant increase in malaria burden when compared with other periods and scenarios during the century; especially in Humid forest, Derived savanna, Sahel and Sudan savannas.	[Akpan, Godwin E.; Oladosu, Olakunle R.] OAU, ARCSSTEE, Ife, Osun State, Nigeria; [Adepoju, Kayode A.] Univ Free State, Dept Geog, Qwaqwa Campus, Qwaqwa, Phuthaditjhaba, South Africa	Obafemi Awolowo University; University of the Free State	Akpan, GE (corresponding author), OAU, ARCSSTEE, Ife, Osun State, Nigeria.	profjedidiah@yahoo.com	Akpan, Godwin/AAY-2541-2021; Adepoju, Kayode/E-2976-2015	Akpan, Godwin/0000-0001-8204-9219; Adepoju, Kayode/0000-0001-7906-3415				Afrane YA, 2012, ANN NY ACAD SCI, V1249, P204, DOI 10.1111/j.1749-6632.2011.06432.x; Akpan GE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204233; Altamiranda-Saavedra M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179093; [Anonymous], 2017, BRIEF TUTORIAL MAXEN; [Anonymous], 2015, CLIM HLTH COUNTR PRO; Arndt C, 2011, SUSTAIN SCI, V6, P7, DOI 10.1007/s11625-010-0118-9; Ayala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-307; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Blackburn JK, 2010, NATO SCI PEACE SEC A, P59, DOI 10.1007/978-90-481-9637-1_7; Carabine E., 2014, IPCCS 5 ASSESSMENT R; CDC, 2015, ANOPHELES MOSQUITOES; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; Consultative Group on International Agricultural Research Consortium for Spatial Information (CGIAR-CSI), 2017, SRTM 90M DIG EL DAT; Dimitrov NB, 2009, OPER RES COMPUT SCI, P167, DOI 10.1007/978-0-387-88843-9_9; Drake JM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-213; Dutta S., 2006, MALARIA EPIDEMIOLOGY; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Evangelista P., 2011, MAXENT MODEL V3 3 3E; Fahey D.W., 2017, CLIMATE SCI SPECIAL, VI, P73, DOI [10.7930/J0513WCR, DOI 10.7930/J0513WCR]; FAO, 1996, GUID AGR ZON; Federal Ministry of Environment of the Federal Republic of Nigeria, 2014, 2 NAT COMM CLIM CHAN; Federal Ministry of Environment of the Federal Republic of Nigeria, 2003, 1 NAT COMM CLIM CHAN; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Gillies M.T., 1968, PUBL S AFRICAN I MED, V54, P3; Gordy M., 2016, SPRINGER BRIEFS CLIM, DOI [10.1007/978-3-319-41667-0_10, DOI 10.1007/978-3-319-41667-0_10]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayhoe K., 2017, CLIMATE SCI SPECIAL, P133, DOI DOI 10.7930/J0WH2N54; Jain P. C., 1993, Renewable Energy, V3, P403, DOI 10.1016/0960-1481(93)90108-S; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Legese W., 2017, J CLIMATOL WEATHER F, V5, P10, DOI [10.4172/2332-2594.1000212, DOI 10.4172/2332-2594.1000212]; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Marais EA, 2014, ATMOS ENVIRON, V99, P32, DOI 10.1016/j.atmosenv.2014.09.055; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Metz, 1991, NIGERIA COUNTRY STUD; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650; National Malaria Control Programme suNMaP World Health Organization and the INFORM Project, 2013, DESCR EP MAL GUID PL; Nelson GC, 2006, ECOL SOC, V11; Okorie PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028347; Okwa OO, 2009, ANN AFR MED, V8, P1, DOI 10.4103/1596-3519.55756; Olayemi IK, 2014, APP SCI REPORT, V5, P110, DOI [10.15192/PSCP.ASR.2014.1.3.110117, DOI 10.15192/PSCP.ASR.2014.1.3.110117]; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Ostfeld RS, 2009, ECOLOGY, V90, P903, DOI 10.1890/08-0659.1; Owoseye A., 2017, PREMIUM TIMES; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Ramasamy R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00198; Ren ZP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20604; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Riede JO, 2016, ADAPTATION CLIMATE C, DOI [10.1007/978-3-319-31499-0_2, DOI 10.1007/978-3-319-31499-0_2]; Ritchie H, 2018, CO2 OTHER GREENHOUSE; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Rosenzweig C, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/12/1/010301; Siteti MC., 2016, CHRISMED J HEALTH RE, V3, P45; Smith BA, 2015, FOOD RES INT, V68, P78, DOI 10.1016/j.foodres.2014.07.006; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Tonnang HEZ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-12; Tonnang HEZ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-111; Tsy JMLP, 2003, MALARIA J, V2; UCAR, 2011, CLIM CHANG VECT BORN; United Nations, 2004, WORLD URB PROSP 2003; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 UN DEP EC; USAID, 2002, LAGI00990001300 USAI; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Watson R.T., 1998, REGIONAL IMPACTS CLI; Watson RT, 1995, CLIMATE CHANGE 1995; Weber T, 2018, EARTHS FUTURE, V6, P643, DOI 10.1002/2017EF000714; WHO, 2018, WORLD MAL REP 2018; WHO, 2019, MALARIA; World Health Organization, 2018, TOP 10 CAUS DEATH; World Meteorological Organization, 2017, 1203 WMO; Zeng WH, 2006, INT GEOSCI REMOTE SE, P1443, DOI 10.1109/IGARSS.2006.372	86	13	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218523	10.1371/journal.pone.0218523	http://dx.doi.org/10.1371/journal.pone.0218523			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216349	Green Submitted, Green Published, gold			2022-12-26	WOS:000482885300053
J	Mahumud, RA; Alam, K; Renzaho, AMN; Sarker, AR; Sultana, M; Sheikh, N; Rawal, LB; Gow, J				Mahumud, Rashidul Alam; Alam, Khorshed; Renzaho, Andre M. N.; Sarker, Abdur Razzaque; Sultana, Marufa; Sheikh, Nurnabi; Rawal, Lal B.; Gow, Jeff			Changes in inequality of childhood morbidity in Bangladesh 1993-2014: A decomposition analysis	PLOS ONE			English	Article							INFECTIOUS-DISEASE MORBIDITY; SOCIOECONOMIC INEQUALITY; CHILDREN; HEALTH; MALNUTRITION; DIARRHEA; RISK; COUNTRIES; GOALS	Introduction Child health remains an important public health concern at the global level, with preventable diseases such as diarrheal disease, acute respiratory infection (ARI) and fever posing a large public health burden in low-and middle-income countries including Bangladesh. Improvements in socio-economic conditions have tended to benefit advantaged groups in societies, which has resulted in widespread inequalities in health outcomes. This study examined how socioeconomic inequality is associated with childhood morbidity in Bangladesh, and identified the factors affecting three illnesses: diarrhea, ARI and fever. Materials and methods A total of 43,860 sample observations from the Bangladesh Demographic and Health Survey, spanning a 22-year period (1993-2014), were analysed. Concentration curve and concentration index methods were used to evaluate changes in the degree of household wealth-related inequalities and related trends in childhood morbidity. Regression-based decomposition analyses were used to attribute the inequality disparities to individual determinants for the three selected causes of childhood morbidity. Results The overall magnitude of inequality in relation to childhood morbidity has been declining slowly over the 22-year period. The magnitude of socio-economic inequality as a cause of childhood morbidity varied during the period. Decomposition analyses attributed the inequalities to poor maternal education attainment, inadequate pre-delivery care, adverse chronic undernutrition status and low immunisation coverage. Conclusions High rates of childhood morbidity were observed, although these have declined over time. Socio-economic inequality is strongly associated with childhood morbidity. Socio-economically disadvantaged communities need to be assisted and interventions should emphasise improvements of, and easier access to, health care services. These will be key to improving the health status of children in Bangladesh and should reduce economic inequality through improved health over time.	[Mahumud, Rashidul Alam; Alam, Khorshed; Gow, Jeff] Univ Southern Queensland, Ctr Hlth Informat & Econ Res, Fac Business Educ Law & Arts, Sch Commerce,Hlth Econ & Policy Res, Toowoomba, Qld, Australia; [Mahumud, Rashidul Alam; Sarker, Abdur Razzaque; Sultana, Marufa; Sheikh, Nurnabi] Int Ctr Diarrhoeal Dis Res, Hlth Econ & Financing Res, Dhaka, Bangladesh; [Renzaho, Andre M. N.; Rawal, Lal B.] Western Sydney Univ, Sch Social Sci & Psychol, Sydney, NSW, Australia; [Sarker, Abdur Razzaque] Univ Strathclyde, Business Sch, Dept Management Sci, Glasgow, Lanark, Scotland; [Sultana, Marufa] Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia; [Gow, Jeff] Univ KwaZulu Natal, Sch Accounting Econ & Finance, Durban, South Africa	University of Southern Queensland; International Centre for Diarrhoeal Disease Research (ICDDR); Western Sydney University; University of Strathclyde; Deakin University; University of Kwazulu Natal	Mahumud, RA (corresponding author), Univ Southern Queensland, Ctr Hlth Informat & Econ Res, Fac Business Educ Law & Arts, Sch Commerce,Hlth Econ & Policy Res, Toowoomba, Qld, Australia.; Mahumud, RA (corresponding author), Int Ctr Diarrhoeal Dis Res, Hlth Econ & Financing Res, Dhaka, Bangladesh.	rashed.mahumud@usq.edu.au	Renzaho, Andre M.N./AAH-7679-2021; Gow, Jeff/L-9647-2017; Mahumud, Rashidul Alam/O-2477-2018	Gow, Jeff/0000-0002-5726-298X; Mahumud, Rashidul Alam/0000-0001-9788-1868; Sheikh, Nurnabi/0000-0002-5185-9996; RENZAHO, ANDRE/0000-0002-6844-0833; Rawal, Lal/0000-0003-1106-0108; Alam, Khorshed/0000-0003-2232-0745	University of Southern Queensland, Toowoomba, Queensland, Australia	University of Southern Queensland, Toowoomba, Queensland, Australia	This study was funded by the University of Southern Queensland, Toowoomba, Queensland, Australia.	Ahmed S, 2010, J HEALTH POPUL NUTR, V28, P399; Ahmed SM, 2016, B WORLD HEALTH ORGAN, V94, P351, DOI 10.2471/BLT.15.168450; Amugsi DA, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.29349; [Anonymous], 2001, BANGLADESH DEMOGRAPH; Bado AR, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.30166; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boerma T, 2018, LANCET, V391, P1538, DOI 10.1016/S0140-6736(18)30104-1; Buttery JP, 2009, LANCET, V373, P1499, DOI 10.1016/S0140-6736(09)60340-8; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; Diouf K, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24895; Emerson E, 2017, PUBLIC HEALTH, V142, P85, DOI 10.1016/j.puhe.2016.10.014; Erreygers G, 2012, J HEALTH ECON, V31, P257, DOI 10.1016/j.jhealeco.2011.10.009; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Ferdous F, 2013, AM J TROP MED HYG, V89, P223, DOI 10.4269/ajtmh.12-0743; Bernardes ACF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-266; Finlay JE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000226; Fischer Walker CL, 2012, BMC PUBLIC HEALTH, V12, P220, DOI DOI 10.1186/1471-2458-12-220; Gamper-Rabindran S, 2010, J DEV ECON, V92, P188, DOI 10.1016/j.jdeveco.2009.02.006; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Haddad L, 2003, WORLD BANK ECON REV, V17, P107, DOI 10.1093/wber/lhg012; Halder AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008145; Hanifi SMA, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25473; Haque U, 2014, LANCET GLOB HEALTH, V2, pE98, DOI 10.1016/S2214-109X(13)70176-1; Hoffmann R, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0390-0; Iannotti LL, 2015, J PAEDIATR CHILD H, V51, P387, DOI 10.1111/jpc.12711; Jalan J, 2003, J ECONOMETRICS, V112, P153, DOI 10.1016/S0304-4076(02)00158-6; Jani JV, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-161; Kabir AL, 2016, J RESP MED RES TREAT, V11, DOI [10.5171/2016.183615, DOI 10.5171/2016.183615]; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Kamal MM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007538; Khang YH, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0341-9; Khatun S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003907; Kilabuko James H, 2007, Int J Environ Res Public Health, V4, P283, DOI 10.3390/ijerph200704040003; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mitra SN, 1995, BANGLADESH DEMOGRAPH; Mustafa M, 2017, MATERN CHILD HLTH J, V21, P1095, DOI 10.1007/s10995-016-2208-5; Nasreen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089978; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; Nikolay B, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002218; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; O'Donnell O., 2008, Analyzing health equity using household survey data: a guide to techniques and their implementation; O'Donnell O., 2008, ANAL HLTH EQUITY USI, DOI [10.2471/BLT.08.052357, DOI 10.2471/BLT.08.052357]; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Pande RP, COUNTRY REPORTS HNP; Rahman M, 2002, EMERG INFECT DIS, V8, P738, DOI 10.3201/eid0807.010398; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Sarker Abdur Razzaque, 2016, Glob Pediatr Health, V3, p2333794X16680901, DOI 10.1177/2333794X16680901; Semba Richard D., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P120; Sridhar D, 2010, LANCET, V376, P1444, DOI 10.1016/S0140-6736(10)61418-3; Sultana M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210433; UN, 2015, UN TRANSF OUR WORLD, DOI [10.1201/b20466-7, DOI 10.1201/B20466-7]; UNICEF, 2015, COMM CHILD SURV PROM, P1; UNICEF, 2022, DEM WSPOLCZ DZIETN; United Nations, 2015, MILL DEV GOALS REP 2; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; WHO, 2018, GLOB HLTH OBS GOB DA; Wierzba TF, 2018, LANCET GLOB HEALTH, V6, pE230, DOI 10.1016/S2214-109X(18)30047-0; World Health Organization (WHO), TRAINING COURSE ON C; Wu LF, 2015, ASIA PAC J CLIN NUTR, V24, P665, DOI 10.6133/apjcn.2015.24.4.24; Zhang Q, 2007, INT J EPIDEMIOL, V36, P916, DOI 10.1093/ije/dym064	73	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218515	10.1371/journal.pone.0218515	http://dx.doi.org/10.1371/journal.pone.0218515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5EM	31216352	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000482885300050
J	Martinsen, A; Tejera, N; Vauzour, D; Harden, G; Dick, J; Shinde, S; Barden, A; Mori, TA; Minihane, AM				Martinsen, Anneloes; Tejera, Noemi; Vauzour, David; Harden, Glenn; Dick, James; Shinde, Sujata; Barden, Anne; Mori, Trevor A.; Minihane, Anne Marie			Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice	FASEB JOURNAL			English	Article						Alzheimer disease; fatty acids; specialized proresolving mediators; neuroinflammation; cortex	FATTY-ACID SUPPLEMENTATION; APOLIPOPROTEIN-E GENOTYPE; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; PRORESOLVING MEDIATORS; COGNITIVE DEFICITS; NEUROPROTECTIN D1; RISK; INCREASES; SEX	An apolipoprotein E (APOE) 4 genotype is the most important, common genetic determinant for Alzheimer disease (AD), and female APOE4 carriers present with an increased risk compared with males. The study quantified cortical and hippocampal fatty acid and phospholipid profiles along with select eicosapentaenoic acid (EPA)- and docosahexaenoic acid (DHA)-derived specialized proresolving mediators (SPMs) in 2-, 9-, and 18-mo-old APOE3 and APOE4 male and female mice. A 10% lower cortical DHA was evident in APOE4 females at 18 mo compared with 2 mo, with no significant decrease in APOE3 or APOE4 males. This decrease was associated with a reduction in DHA-phosphatidylethanolamine. Older APOE4 females had a 15% higher oleic acid content compared with young mice. Although no sex*APOE genotype interactions were observed for SPMs expressed as a ratio of their parent compound, higher cortical 18R/S-hydroxy-5Z,8Z,11Z,14Z,16E-EPA, resolvin D3, protectin D1, 10S,17S-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-DHA (10S,17S-diHDHA), maresin 1, 17S-hydroxy-4Z,7Z,10Z,13Z,15E,19Z-DHA, and 14S-hydroxy-4Z,7Z,10Z,12E,16Z,19Z-DHA were evident in females, and lower cortical 17R-resolvin D1, 10S,17S-diHDHA, and 18-HEPE in APOE4. Our findings show a strong association between age, female sex, and an APOE4 genotype, with decreased cortical DHA and a number of SPMs, which together may contribute to the development of cognitive decline and AD pathology.-Martinsen, A., Tejera, N., Vauzour, D., Harden, G., Dick, J., Shinde, S., Barden, A., Mori, T. A., Minihane, A. M. Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice.	[Martinsen, Anneloes; Tejera, Noemi; Vauzour, David; Harden, Glenn; Minihane, Anne Marie] Univ East Anglia, Norwich Med Sch, Dept Nutr & Prevent Med, Norwich, Norfolk, England; [Dick, James] Univ Stirling, Nutr Analyt Serv, Inst Aquaculture, Stirling, Scotland; [Shinde, Sujata; Barden, Anne; Mori, Trevor A.] Univ Western Australia, Med Sch, Perth, WA, Australia	University of East Anglia; University of Stirling; University of Western Australia	Minihane, AM (corresponding author), UEA, Norwich Med Sch, BCRE, Dept Nutr & Prevent Med, James Watson Rd, Norwich NR4 7UQ, Norfolk, England.	a.minihane@uea.ac.uk	Vauzour, Dr David/C-2245-2008	Vauzour, Dr David/0000-0001-5952-8756; Mori, Trevor A/0000-0002-5264-9229; Minihane, Anne Marie/0000-0001-9042-4226; Barden, Anne/0000-0001-7631-0767	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Programme Grant [BB/J004545/1]; BBSRC [BB/M004449/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the staff of the Disease Modelling Unit at the University of East Anglia for expertise and help with the conduct of the rodent studies. The research was funded as part of a Biotechnology and Biological Sciences Research Council (BBSRC) Institute Programme Grant (BB/J004545/1). The authors declare no conflicts of interest.	Abdullah L, 2017, AGING-US, V9, P964, DOI 10.18632/aging.101203; Ackman R.G., 1980, ADV FISH SCI TECHNOL, P83; Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Astarita G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024777; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Barden A, 2014, J LIPID RES, V55, P2401, DOI 10.1194/jlr.M045583; Barden AE, 2016, CURR OPIN LIPIDOL, V27, P26, DOI 10.1097/MOL.0000000000000262; Bazan NG, 2013, PROSTAG LEUKOTR ESS, V88, P127, DOI 10.1016/j.plefa.2012.08.008; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Chouinard-Watkins R, 2017, NEUROBIOL AGING, V57, P28, DOI 10.1016/j.neurobiolaging.2017.05.003; Christie W.W., 2003, LIPID ANAL ISOLATION, V3rd ed., P205; Cunnane SC, 2013, PROSTAG LEUKOTR ESS, V88, P61, DOI 10.1016/j.plefa.2012.04.006; da Silva-Santi LG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091277; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Ghioni C, 1996, COMP BIOCHEM PHYS B, V114, P161, DOI 10.1016/0305-0491(96)00019-3; Hamilton J, 2000, LIPIDS, V35, P863, DOI 10.1007/S11745-000-0595-x; Heffernan AL, 2016, J MOL NEUROSCI, V60, P316, DOI 10.1007/s12031-016-0804-x; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hussain G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00144; Kariv-Inbal Z, 2012, J ALZHEIMERS DIS, V28, P667, DOI 10.3233/JAD-2011-111265; Lacombe RJS, 2018, MOL ASPECTS MED, V64, P109, DOI 10.1016/j.mam.2017.12.004; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Massey KA, 2013, FREE RADICAL BIO MED, V59, P45, DOI 10.1016/j.freeradbiomed.2012.08.565; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; Nock TG, 2017, BBA-MOL CELL BIOL L, V1862, P1068, DOI 10.1016/j.bbalip.2017.07.004; Pontifex M, 2018, NEUROBIOL AGING, V69, P209, DOI 10.1016/j.neurobiolaging.2018.05.017; Pottala JV, 2014, NEUROLOGY, V82, P435, DOI 10.1212/WNL.0000000000000080; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rathod KS, 2017, J CLIN INVEST, V127, P169, DOI 10.1172/JCI89429; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Sharman MJ, 2010, J ALZHEIMERS DIS, V20, P105, DOI 10.3233/JAD-2010-1348; Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266; Somjen D, 2016, J STEROID BIOCHEM, V163, P28, DOI 10.1016/j.jsbmb.2016.03.032; Tao QS, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3597; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Vandal M, 2014, J NEUROCHEM, V129, P516, DOI 10.1111/jnc.12640; Whittington RA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01464; Yassine HN, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0194-x; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	53	13	13	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10315	10326		10.1096/fj.201900423R	http://dx.doi.org/10.1096/fj.201900423R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31251078	Green Accepted, Bronze			2022-12-26	WOS:000482214200048
J	O'Brien, DP; Cannella, SE; Voegele, A; Raoux-Barbot, D; Davi, M; Douche, T; Matondo, M; Brier, S; Ladant, D; Chenal, A				O'Brien, Darragh P.; Cannella, Sara E.; Voegele, Alexis; Raoux-Barbot, Dorothee; Davi, Marilyne; Douche, Thibaut; Matondo, Mariette; Brier, Sebastien; Ladant, Daniel; Chenal, Alexandre			Post-translational acylation controls the folding and functions of the CyaA RTX toxin	FASEB JOURNAL			English	Article						post-translational modification; protein folding; calcium-binding protein; adenylate cyclase; bordetella pertussis	PERTUSSIS ADENYLATE-CYCLASE; BORDETELLA-PERTUSSIS; CATALYTIC DOMAIN; HDX-MS; CALCIUM; PROTEIN; IDENTIFICATION; TRANSLOCATION; CALMODULIN; SECRETION	The adenylate cyclase (CyaA) toxin is a major virulence factor of Bordetella pertussis, the causative agent of whooping cough. CyaA is synthetized as a pro-toxin, pro-CyaA, and converted into its cytotoxic form upon acylation of two lysines. After secretion, CyaA invades eukaryotic cells and produces cAMP, leading to host defense subversion. To gain further insights into the effect of acylation, we compared the functional and structural properties of pro-CyaA and CyaA proteins. HDX-MS results show that the refolding process of both proteins upon progressive urea removal is initiated by calcium binding to the C-terminal RTX domain. We further identified a critical hydrophobic segment, distal from the acylation region, that folds at higher urea concentration in CyaA than in pro-CyaA. Once refolded into monomers, CyaA is more compact and stable than pro-CyaA, due to a complex set of interactions between domains. Our HDX-MS data provide direct evidence that the presence of acyl chains in CyaA induces a significant stabilization of the apolar segments of the hydrophobic domain and of most of the acylation region. We propose a refolding model dependent on calcium and driven by local and distal acylation-dependent interactions within CyaA. Therefore, CyaA acylation is not only critical for cell intoxication, but also for protein refolding into its active conformation. Our data shed light on the complex relationship between post-translational modifications, structural disorder and protein folding. Coupling calcium-binding and acylation-driven folding is likely pertinent for other repeat-in-toxin cytolysins produced by many Gram-negative bacterial pathogens.-O'Brien, D. P., Cannella, S. E., Voegele, A., Raoux-Barbot, D., Davi, M., Douche, T., Matondo, M., Brier, S., Ladant, D., Chenal, A. Post-translational acylation controls the folding and functions of the CyaA RTX toxin.	[O'Brien, Darragh P.; Cannella, Sara E.; Voegele, Alexis; Raoux-Barbot, Dorothee; Davi, Marilyne; Brier, Sebastien; Ladant, Daniel; Chenal, Alexandre] Inst Pasteur, Chem & Struct Biol Dept, Paris, France; [Brier, Sebastien] CNRS, UMR 3528, Ctr Technol Resources & Res, Biol NMR Tech Platform, Paris, France; [Voegele, Alexis] Univ Paris Diderot Paris VII, Sorbonne Paris Cite, Paris, France; [Douche, Thibaut; Matondo, Mariette] Inst Pasteur, CNRS, USR 2000, Mass Spectrometry Biol Unit,Prote Platform, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ladant, D (corresponding author), Inst Pasteur, CNRS, UMR 3528, Chem & Struct Biol Dept, F-75724 Paris 15, France.; Chenal, A (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris, France.	daniel.ladant@pasteur.fr; alexandre.chenal@pasteur.fr	Matondo, Mariette/AAA-4163-2020	Matondo, Mariette/0000-0003-3958-7710; Voegele, Alexis/0000-0002-0452-6814; LADANT, Daniel/0000-0003-1955-548X; Chenal, Alexandre/0000-0002-4959-1003; Brier, Sebastien/0000-0003-1758-8237; Douche, Thibaut/0000-0001-8627-6726	CACSICE Equipex [ANR-11-EQPX-0008]; Pasteur-Paris University (PPU) International PhD Program; DIM MalInf (infectious diseases) grant from Conseil Regional Ile-de-France; Institut Pasteur, PasteurInnov [PIV15-197]; PTR grant [PTR451]; CNRS; Fondation Recherche Medicale [FRM DBS20140930771];  [PasteurInnov2015-197]	CACSICE Equipex; Pasteur-Paris University (PPU) International PhD Program; DIM MalInf (infectious diseases) grant from Conseil Regional Ile-de-France; Institut Pasteur, PasteurInnov; PTR grant; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation Recherche Medicale; 	The authors thank Bertrand Raynal and Sebastien Brule from the Plate-forme de Biophysique Moleculaire (PFBMI) for excellent technical expertise with analytical ultracentrifugation. The authors thank the CACSICE Equipex ANR-11-EQPX-0008. D.P.O. was supported by PasteurInnov2015-197 and PTR451 grants. S.E.C. was supported by a stipend from the Pasteur-Paris University (PPU) International PhD Program. A.V. was supported by a DIM MalInf (infectious diseases) grant from Conseil Regional Ile-de-France. Running costs were supported by Institut Pasteur, PasteurInnov (PIV15-197), PTR grant (PTR451), CNRS, and Fondation Recherche Medicale (FRM DBS20140930771). The authors declare no conflicts of interest.	BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; Basar T, 2001, J BIOL CHEM, V276, P348, DOI 10.1074/jbc.M006463200; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BELLALOU J, 1990, INFECT IMMUN, V58, P1195, DOI 10.1128/IAI.58.5.1195-1200.1990; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; Benz R, 2016, BBA-BIOMEMBRANES, V1858, P526, DOI 10.1016/j.bbamem.2015.10.025; Bouchez V, 2017, TOXINS, V9, DOI 10.3390/toxins9100304; Bumba L, 2016, MOL CELL, V62, P47, DOI 10.1016/j.molcel.2016.03.018; Cannella SE, 2017, SCI REP-UK, V7, DOI 10.1038/srep42065; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Chenal A, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P677, DOI 10.1016/B978-0-12-800188-2.00023-9; Chenal A, 2018, TOXINS, V10, DOI 10.3390/toxins10070302; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fedele G, 2017, TOXINS, V9, DOI 10.3390/toxins9100293; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; Guiso N, 2017, TOXINS, V9, DOI 10.3390/toxins9090277; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Hourdel V, 2016, BIOINFORMATICS, V32, P3413, DOI 10.1093/bioinformatics/btw420; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Karst JC, 2014, J BIOL CHEM, V289, P30702, DOI 10.1074/jbc.M114.580852; Karst Johanna C, 2012, Methods Mol Biol, V896, P163, DOI 10.1007/978-1-4614-3704-8_10; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1988, J BIOL CHEM, V263, P2612; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Martin C, 2004, J BACTERIOL, V186, P3760, DOI 10.1128/JB.186.12.3760-3765.2004; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Masin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29137; Novak J, 2017, TOXINS, V9, DOI 10.3390/toxins9100300; O'Brien DP, 2018, TOXICON, V149, P37, DOI 10.1016/j.toxicon.2018.01.007; O'Brien DP, 2018, BIOTECHNOL APPL BIOC, V65, P62, DOI 10.1002/bab.1577; O'Brien DP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004486; O'Brien DP, 2015, SCI REP-UK, V5, DOI 10.1038/srep14223; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; Ryslava H, 2013, J PROTEOMICS, V92, P80, DOI 10.1016/j.jprot.2013.03.025; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; SEBO P, 1991, GENE, V104, P19, DOI 10.1016/0378-1119(91)90459-O; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Siman P, 2012, ORG BIOMOL CHEM, V10, P5684, DOI 10.1039/c2ob25149c; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; Sotomayor-Perez Ana Cristina, 2012, Methods Mol Biol, V896, P331, DOI 10.1007/978-1-4614-3704-8_22; Sotomayor-Perez AC, 2011, J BIOL CHEM, V286, P16997, DOI 10.1074/jbc.M110.210393; Sotomayor-Perez AC, 2015, TOXINS, V7, P1, DOI 10.3390/toxins7010001; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; Veneziano R, 2013, P NATL ACAD SCI USA, V110, P20473, DOI 10.1073/pnas.1312975110; Voegele A, 2017, TOXINS, V9, DOI 10.3390/toxins9110369; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Westrop GD, 1996, GENE, V180, P91, DOI 10.1016/S0378-1119(96)00412-X	59	16	16	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10065	10076		10.1096/fj.201802442RR	http://dx.doi.org/10.1096/fj.201802442RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31226003	Green Submitted			2022-12-26	WOS:000482214200028
J	Denisov, SS; Ippel, JH; Heinzmann, ACA; Koenen, RR; Ortega-Gomez, M; Soehnlein, O; Hackeng, TM; Dijkgraaf, I				Denisov, Stepan S.; Ippel, Johannes H.; Heinzmann, Alexandra C. A.; Koenen, Rory R.; Ortega-Gomez, Mudena; Soehnlein, Oliver; Hackeng, Tilman M.; Dijkgraaf, Ingrid			Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; peptide chemical synthesis; nuclear magnetic resonance (NMR); protein structure; protein-protein interaction; C-X-C motif chemokine ligand (CXCL)	CHEMOKINE-BINDING-PROTEINS; CYSTINE KNOT; WEB SERVER; MONOCLONAL-ANTIBODY; RECEPTOR CXCR1; XPLOR-NIH; INTERLEUKIN-8; RECOGNITION; SELECTIVITY; STABILITY	Chemokines are a group of chemotaxis proteins that regulate cell trafficking and play important roles in immune responses and inflammation. Ticks are blood-sucking parasites that secrete numerous immune-modulatory agents in their saliva to evade host immune responses. Evasin-3 is a small salivary protein that belongs to a class of chemokine-binding proteins isolated from the brown dog tick, Rhipicephalus sanguineus. Evasin-3 has been shown to have a high affinity for chemokines CXCL1 and CXCL8 and to diminish inflammation in mice. In the present study, solution NMR spectroscopy was used to investigate the structure of Evasin-3 and its CXCL8-Evasin-3 complex. Evasin-3 is found to disrupt the glycosaminoglycan-binding site of CXCL8 and inhibit the interaction of CXCL8 with CXCR2. Structural data were used to design two novel CXCL8-binding peptides. The linear tEv3 17-56 and cyclic tcEv3 16-56 dPG Evasin-3 variants were chemically synthesized by solid-phase peptide synthesis. The affinity of these newly synthesized variants to CXCL8 was measured by surface plasmon resonance biosensor analysis. The K-d values of tEv3 17-56 and tcEv3 16-56 dPG were 27 and 13 nm, respectively. Both compounds effectively inhibited CXCL8-induced migration of polymorphonuclear neutrophils. The present results suggest utility of synthetic Evasin-3 variants as scaffolds for designing and fine-tuning new chemokine-binding agents that suppress immune responses and inflammation.	[Denisov, Stepan S.; Ippel, Johannes H.; Heinzmann, Alexandra C. A.; Koenen, Rory R.; Hackeng, Tilman M.; Dijkgraaf, Ingrid] Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Univ Singel 50, NL-6229 ER Maastricht, Netherlands; [Ortega-Gomez, Mudena; Soehnlein, Oliver] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, D-80336 Munich, Germany; [Soehnlein, Oliver] German Ctr Cardiovasc Res, D-13316 Berlin, Germany; [Soehnlein, Oliver] Partner Site Munich Heart Alliance, D-80802 Munich, Germany; [Soehnlein, Oliver] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Soehnlein, Oliver] Karolinska Inst, Dept Med, SE-17177 Stockholm, Sweden	Maastricht University; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Karolinska Institutet; Karolinska Institutet	Dijkgraaf, I (corresponding author), Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.	i.dijkgraaf@maastrichtuniversity.nl	Koenen, Rory/H-4172-2012; Denisov, Stepan/AAJ-4022-2020; Ortega-Gomez, Almudena/AAA-9572-2020	Koenen, Rory/0000-0002-9955-9730; Ortega-Gomez, Almudena/0000-0002-3762-6934; Hackeng, Tilman/0000-0003-0142-0843; Dijkgraaf, Ingrid/0000-0003-4586-3646; Ippel, Hans/0000-0001-6589-6678; Denisov, Stepan S./0000-0001-5460-940X	Netherlands Organisation for Scientific Research [VIDI 723.013.009, Aspasia 015.010.005]; Landsteiner Foundation for Blood Transfusion Research [1638]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Landsteiner Foundation for Blood Transfusion Research	This work was supported in part by Netherlands Organisation for Scientific Research Grants VIDI 723.013.009 and Aspasia 015.010.005 (to I. D.). Further financial support for the appointment of A.C.A.H. was from Landsteiner Foundation for Blood Transfusion Research Grant 1638 (to R.R.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Akcan M, 2015, BIOPOLYMERS, V104, P682, DOI 10.1002/bip.22699; Bao ZY, 2010, INT IMMUNOPHARMACOL, V10, P259, DOI 10.1016/j.intimp.2009.11.005; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Berkamp S, 2017, J BIOMOL NMR, V69, P111, DOI 10.1007/s10858-017-0128-3; Bonvin P, 2014, J BIOL CHEM, V289, P31846, DOI 10.1074/jbc.M114.599233; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI [10.3791/1724, DOI 10.3791/1724/J0VE.C0M/VIDE0/1724]; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Chand KK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29446; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Denisov SS, 2019, CHEM COMMUN, V55, P1374, DOI 10.1039/c8cc08777f; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Eaton JRO, 2018, J BIOL CHEM, V293, P6134, DOI 10.1074/jbc.RA117.000487; Espinosa JF, 2000, ANGEW CHEM INT EDIT, V39, P2330, DOI 10.1002/1521-3773(20000703)39:13<2330::AID-ANIE2330>3.0.CO;2-C; Ezerzer C, 2009, PEPTIDES, V30, P1296, DOI 10.1016/j.peptides.2009.03.016; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Hafsa NE, 2015, NUCLEIC ACIDS RES, V43, pW370, DOI 10.1093/nar/gkv494; Heidarieh H, 2015, VIRUS RES, V209, P67, DOI 10.1016/j.virusres.2015.02.028; Herzig V, 2015, TOXINS, V7, P4366, DOI 10.3390/toxins7104366; Hughes CE, 2018, FEBS J, V285, P2944, DOI 10.1111/febs.14466; Joseph PRB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170168; Joseph PRB, 2015, BIOCHEM J, V472, P121, DOI 10.1042/BJ20150059; Joseph PRB, 2013, BIOPHYS J, V105, P1491, DOI 10.1016/j.bpj.2013.08.008; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mahler DA, 2004, CHEST, V126, P926, DOI 10.1378/chest.126.3.926; Mamik MK, 2016, CURR DRUG TARGETS, V17, P111, DOI 10.2174/1389450116666150626124544; Mikolka P, 2018, EXP LUNG RES, V44, P40, DOI 10.1080/01902148.2017.1420272; Miles LA, 2002, J BIOL CHEM, V277, P43033, DOI 10.1074/jbc.M206690200; Montecucco F, 2010, ARTERIOSCL THROM VAS, V30, P1371, DOI 10.1161/ATVBAHA.110.206011; Ning Y, 2012, EXPERT OPIN THER TAR, V16, P491, DOI 10.1517/14728222.2012.677440; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Proudfoot AEI, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10030070; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; RAJARATHNAM K, 1995, BIOCHEMISTRY-US, V34, P12983, DOI 10.1021/bi00040a008; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Ryu H, 2016, BIOINFORMATICS, V32, P611, DOI 10.1093/bioinformatics/btv595; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Singh K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05204-4; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Tanaka K, 2001, J AM CHEM SOC, V123, P2530, DOI 10.1021/ja0035708; Tsai YC, 2017, THER ADV MUSCULOSKEL, V9, P277, DOI 10.1177/1759720X17735756; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vink S, 2014, TOXICON, V90, P308, DOI 10.1016/j.toxicon.2014.08.068; von Hundelshausen P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6650; Wang X, 2013, PROG MOL BIOL TRANSL, V117, P531, DOI 10.1016/B978-0-12-386931-9.00020-9; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002	57	13	13	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12370	12379		10.1074/jbc.RA119.008902	http://dx.doi.org/10.1074/jbc.RA119.008902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31235521	Green Published, hybrid			2022-12-26	WOS:000484402700010
J	Leitner, G; Lavon, Y; Merin, U; Jacoby, S; Blum, SE; Krifucks, O; Silanikove, N				Leitner, Gabriel; Lavon, Yaniv; Merin, Uzi; Jacoby, Shamay; Blum, Shlomo E.; Krifucks, Oleg; Silanikove, Nissim			Milk quality and milk transformation parameters from infected mammary glands depends on the infecting bacteria species	PLOS ONE			English	Article							SOMATIC-CELL COUNT; REAL-TIME EVALUATION; COAGULATION PROPERTIES; RENNET COAGULATION; DAIRY SHEEP; COWS MILK; MASTITIS; CASEIN; PROTEOLYSIS; PEPTIDES	The current study measured the influence of milk of subclinically infected glands by different bacteria species on the cow's milk. The effects of bacterial infection or inflammation on gland milk yield were related to the bacteria species that caused the infection. The volume of milk of the inflamed gland from the cow's milk yield was significantly lower (P<0.001) for the glands previously infected by Escherichia colt (PIEc) and those infected with Streptococcus dysgalactiae. Coagulation properties, rennet clotting time (RCT) and curd firmness (CF) also depended on the bacteria causing the infection. RCT values of all the inflamed glands were significantly longer (P<0.001) and CF values were significantly lower than that of the healthy ones. Moreover, in the whole milk, CF was also significantly lower and not proportional to the volume of the milk from the inflamed gland of the cow's milk. Calculation of the predicted 40% dry matter curd weight (PCW) on the cow level, including the healthy and inflamed glands or the healthy glands alone, showed that for 10 of 13 PIEc cows, the presence of the affected gland's milk in the whole cow milk resulted in a lower PCW value. Likewise, 7 of 20 cows infected by S. dysgalactiae had negative delta values. Unlike the latter bacteria, PCW from milk of glands infected with CNS increased, although in a lower magnitude than in the healthy glands. No correlation was found between logSCC in the whole cow milk (healthy and inflamed glands) and PCW.	[Leitner, Gabriel; Blum, Shlomo E.; Krifucks, Oleg] Kimron Vet Inst, Natl Mastitis Reference Ctr, Bet Dagan, Israel; [Lavon, Yaniv] Israel Cattle Breeders Assoc, Caesarea, Israel; [Merin, Uzi] Volcani Ctr Bet Dagan, Inst Technol & Storage Agr Prod, Bet Dagan, Israel; [Jacoby, Shamay; Silanikove, Nissim] ARO, Inst Anim Sci, Volcani Ctr, Bet Dagan, Israel	Kimron Veterinary Institute; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Leitner, G (corresponding author), Kimron Vet Inst, Natl Mastitis Reference Ctr, Bet Dagan, Israel.	leitnerg1@gmail.com	Lavon, Yaniv/ABZ-1072-2022					Abdelgawad AR, 2016, J FOOD ENG, V168, P180, DOI 10.1016/j.jfoodeng.2015.07.018; Andreatta E, 2007, AUST J DAIRY TECHNOL, V62, P166; [Anonymous], 2008, DAIRY SCI TECHNOL, V88, P407; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Bobbo T, 2017, J DAIRY SCI, V100, P4868, DOI 10.3168/jds.2016-12353; Bobbo T, 2016, J DAIRY SCI, V99, P5104, DOI 10.3168/jds.2015-10512; Fleminger G, 2013, INT DAIRY J, V30, P74, DOI 10.1016/j.idairyj.2012.11.013; Fleminger G, 2011, INT DAIRY J, V21, P914, DOI 10.1016/j.idairyj.2011.05.012; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; Huijps K, 2008, J DAIRY RES, V75, P113, DOI 10.1017/S0022029907002932; Jesse E, 2008, EC RES, V180, P200; Katz G, 2016, J DAIRY SCI, V99, P4178, DOI 10.3168/jds.2015-10599; Larsen LB, 2010, J DAIRY SCI, V93, P5613, DOI 10.3168/jds.2010-3409; Larsen LB, 2004, INT DAIRY J, V14, P899, DOI 10.1016/j.idairyj.2004.03.006; Leitner G, 2006, INT DAIRY J, V16, P648, DOI 10.1016/j.idairyj.2005.10.020; Leitner G, 2016, ISR J VET MED, V71, P10; Leitner G, 2012, ANIMAL, V6, P1170, DOI 10.1017/S175173111100245X; Leitner G, 2011, J DAIRY SCI, V94, P2923, DOI 10.3168/jds.2010-3946; Leitner G, 2003, J VET MED B, V50, P45, DOI 10.1046/j.1439-0450.2003.00602.x; Leitner G, 2008, INT DAIRY J, V18, P109, DOI 10.1016/j.idairyj.2007.09.001; Leitner G, 2013, ANIMAL, V7, P1551, DOI 10.1017/S1751731113000542; Li N, 2014, DAIRY SCI TECHNOL, V94, P517, DOI 10.1007/s13594-014-0176-3; Losinger WC, 2005, JAVMA-J AM VET MED A, V226, P1652, DOI 10.2460/javma.2005.226.1652; Mainau E., 2014, WELFARE ISSUES RELAT; Malacarne M, 2014, J DAIRY RES, V81, P129, DOI 10.1017/S0022029913000630; Maristela R, 2015, SMALL RUMINANT RES, V125, P127, DOI 10.1016/j.smallrumres.2015.02.019; Murphy SC, 2016, J DAIRY SCI, V99, P10128, DOI 10.3168/jds.2016-11172; Pearson LJ, 2013, J DAIRY SCI, V96, P158, DOI 10.3168/jds.2012-5508; Ruegg P., 2015, DAIRY COW WELFARE UD; SAS Institute, 2009, SAS STAT 9 1 US GUID; Siivonen J, 2011, APPL ANIM BEHAV SCI, V132, P101, DOI 10.1016/j.applanim.2011.04.005; Summer A, 2015, J DAIRY RES, V82, P222, DOI 10.1017/S0022029915000102; Todde G, 2017, AGRICULTURE-BASEL, V7, DOI 10.3390/agriculture7100079; Tomazi T, J DAIRY S, V98, P3071	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0213817	10.1371/journal.pone.0213817	http://dx.doi.org/10.1371/journal.pone.0213817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260459	gold, Green Submitted, Green Published			2022-12-26	WOS:000484918700006
J	Roncallo, PF; Beaufort, V; Larsen, AO; Dreisigacker, S; Echenique, V				Federico Roncallo, Pablo; Beaufort, Valeria; Olga Larsen, Adelina; Dreisigacker, Susanne; Echenique, Viviana			Genetic diversity and linkage disequilibrium using SNP (KASP) and AFLP markers in a worldwide durum wheat (Triticum turgidum L. var durum) collection	PLOS ONE			English	Article							POPULATION-STRUCTURE; CULTIVARS; SSR; SOFTWARE; POLYMORPHISMS; ACCESSIONS; RESISTANCE; INFERENCE; GENOME; RANGE	The aim of this work was to analyze the genetic diversity and linkage disequilibrium in a collection of 168 durum wheat accessions ( Triticum turgidum L. var. durum) of different origins. Our collection was mainly composed of released and unreleased Argentinian germplasm, with additional genotypes from Italy, Chile, France, CIMMYT, Cyprus, USA and WANA region. To this end, the entire collection was characterized with 85 Single Nucleotide Polymorphism ( SNP) markers obtained by Kompetitive Allele Specific PCR ( KASP), giving a heterozygosity ( He) mean value of 0.183 and a coefficient of genetic differentiation ( Gst) value of 0.139. A subset of 119 accessions was characterized with six Amplified Fragment Length Polymorphism ( AFLP) primer combinations. A total of 181 polymorphic markers ( 125 AFLP and 56 SNP) amplified across this subset revealed He measures of 0.352 and 0.182, respectively. Of these, 134 were selected to estimate the genome-wide linkage disequilibrium obtaining low significant values ( r(2) = 0.11) in the subset, indicating its suitability for future genome-wide association studies ( GWAS). The structure analysis conducted in the entire collection with SNP detected two subpopulations. However, the structure analysis conducted with AFLP markers in the subset of 119 accessions proved to have greater degree of resolution and detect six subpopulations. The information provided by both marker types was complementary and showed a strong association between old Argentinian and Italian germplasm and a contribution of CIMMYT germplasm to modern Argentinian, Chilean and Cypriot accessions. The influence of Mediterranean germplasm, mainly from Italy, on part of the modern Argentinian cultivars or breeding lines was also clearly evidenced. Although our analysis yields conclusive results and useful information for association mapping studies, further analyses are needed to refine the number of subpopulations present in the germplasm collection analyzed.	[Federico Roncallo, Pablo; Beaufort, Valeria; Echenique, Viviana] CONICET Bahia Blanca, CERZOS CCT, Bahia Blanca, Buenos Aires, Argentina; [Federico Roncallo, Pablo; Beaufort, Valeria; Echenique, Viviana] Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina; [Olga Larsen, Adelina] INTA, Buenos Aires, DF, Argentina; [Dreisigacker, Susanne] Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico	National University of the South; Instituto Nacional de Tecnologia Agropecuaria (INTA); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Echenique, V (corresponding author), CONICET Bahia Blanca, CERZOS CCT, Bahia Blanca, Buenos Aires, Argentina.; Echenique, V (corresponding author), Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina.	echeniq@criba.edu.ar	Echenique, Viviana/GRX-7389-2022	Echenique, Viviana/0000-0003-3755-9062	ANPCYT AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA [PICT 2012 - 0660, PICT 2015 - 1401]; Universidad Nacional del Sur/MINISTERIO DE EDUCACION [NUTRIPASTA PCESU9-UNS993]; EUROPEAN COMMISION [691109]; International Maize and Wheat Improvement Center; CONICET, CERZOS - CCT CONICET Bahia Blanca; UNIVERSIDAD NACIONAL. DEL SUR [R630/12]	ANPCYT AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA(ANPCyT); Universidad Nacional del Sur/MINISTERIO DE EDUCACION; EUROPEAN COMMISION; International Maize and Wheat Improvement Center; CONICET, CERZOS - CCT CONICET Bahia Blanca; UNIVERSIDAD NACIONAL. DEL SUR	Funded by VCE. ANPCYT (PICT 2012 - 0660, PICT 2015 - 1401). AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA. http://www.agencia.mincyt.gob.ar/index.php. VCE. NUTRIPASTA PCESU9-UNS993. Universidad Nacional del Sur/MINISTERIO DE EDUCACION. https://www.argentina.gob.ar/education/universidades/programa-de-cooperativismo. VCE. MSCA-RISE-2015 project ExpoSEED (grant no. 691109). EUROPEAN COMMISION. https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/home. SD. International Maize and Wheat Improvement Center. https://www.cimmyt.org/es/. VCE PFR. CONICET, CERZOS - CCT CONICET Bahia Blanca. https://www.cerzos-conicet.gob.ar/. PFR. R630/12. UNIVERSIDAD NACIONAL. DEL SUR. https://www.uns.edu.ar/contenidos/40/482#pasantias-en-centros-de-investigacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Altintas S, 2008, PLANT BREEDING, V127, P9, DOI 10.1111/j.1439-0523.2007.01424.x; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Berard A, 2009, PLANT BIOTECHNOL J, V7, P364, DOI 10.1111/j.1467-7652.2009.00404.x; Blignaut M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061704; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; Di Salvo H., 1969, REV BOLSA CEREALES, V96, P60; Dreisigacker S, 2016, CIMMYT WHEAT MOL GEN, DOI [10.1093/bioinformatics/btm308, DOI 10.1093/BIOINFORMATICS/BTM308]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Garcia AAF, 2004, GENET MOL BIOL, V27, P579, DOI 10.1590/S1415-47572004000400019; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Gerber S, 2000, MOL ECOL, V9, P1037, DOI 10.1046/j.1365-294x.2000.00961.x; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hartl D., 1989, PRINCIPLES POPULATIO; Helguera M, 2000, THEOR APPL GENET, V100, P1137, DOI 10.1007/s001220051397; Hurtado P., 2008, Plant Genetic Resources: Characterization and Utilization, V6, P208, DOI 10.1017/S1479262108994181; Incirli A, 2001, GENET RESOUR CROP EV, V48, P233, DOI 10.1023/A:1011244204655; Ivaro F, 2010, FIELD CROPS RES, V119, P91, DOI [10.1016/j.fcr.2010.06.020, DOI 10.1016/J.FCR.2010.06.020]; Jauhar PP, 2008, J PLANT REGIST, V2, P167, DOI 10.3198/jpr2007.01.0048crgs; Joukhadar R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02115; Kabbaj H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01277; Laido G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095211; Lantican M.A., 2016, IMPACTS INT WHEAT IM; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li W, 2006, RUSS J GENET+, V42, P311, DOI 10.1134/S1022795406030124; Maccaferri M, 2007, GENOME, V50, P373, DOI 10.1139/G06-151; Maccaferri M, 2007, GENOME, V50, P385, DOI 10.1139/G07-017; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2003, THEOR APPL GENET, V107, P783, DOI 10.1007/s00122-003-1319-8; Maccaferri M, 2010, MOL BREEDING, V26, P189, DOI 10.1007/s11032-009-9353-0; Malomane DK, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4416-9; Manifesto MM, 2001, CROP SCI, V41, P682, DOI 10.2135/cropsci2001.413682x; MANTEL N, 1967, CANCER RES, V27, P209; Martos V, 2005, FIELD CROP RES, V91, P107, DOI 10.1016/j.fcr.2004.06.003; Medini M, 2005, GENET RESOUR CROP EV, V52, P21, DOI 10.1007/s10722-005-0225-0; Soriano JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160983; Moragues M, 2007, GENET RESOUR CROP EV, V54, P1133, DOI 10.1007/s10722-006-9005-8; Nalley LL, 2010, AGR ECON-BLACKWELL, V41, P453, DOI 10.1111/j.1574-0862.2010.00457.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; OLeary JJ, 2003, MOL BIOL CELLULAR PA, P251; Otto CD, 2002, PLANT MOL BIOL, V48, P625, DOI 10.1023/A:1014821929830; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rajaram S, 1992, 9 CIMMYT INT MAIZ WH; Ray S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00367; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Royo C, 2016, J AGR SCI-CAMBRIDGE, V154, P612, DOI 10.1017/S0021859615000507; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scarascia Mugnozza G.T, 2005, CONTRIBUTION ITALIAN; Sciacca F, 2010, BIOL PLANTARUM, V54, P198, DOI 10.1007/s10535-010-0035-x; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Soleimani VD, 2002, CAN J PLANT SCI, V82, P35, DOI 10.4141/P01-021; Soleimani VD, 2002, THEOR APPL GENET, V104, P350, DOI 10.1007/s001220100714; Stack RW, 2002, CROP SCI, V42, P637, DOI 10.2135/cropsci2002.0637; Targonska M, 2016, PLANT MOL BIOL REP, V34, P37, DOI 10.1007/s11105-015-0896-4; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; Vallega J., 1973, Proceedings of the symposium on genetics and breeding of durum wheat, 14-18 May, 1973, Bari (Italy)., P373; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Weir BS, 1996, SINAUER ASS SUNDERL; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003	78	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218562	10.1371/journal.pone.0218562	http://dx.doi.org/10.1371/journal.pone.0218562			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251752	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000014
J	Chen, X; Xin, YG; Hu, WY; Zhao, YN; Zhang, ZX; Zhou, YP				Chen, Xin; Xin, Yanguo; Hu, Wenyu; Zhao, Yinan; Zhang, Zixin; Zhou, Yinpin			Quality of life and outcomes in heart failure patients with ejection fractions in different ranges	PLOS ONE			English	Article							CITY CARDIOMYOPATHY QUESTIONNAIRE; HEALTH-STATUS; DEATH	Aims Guidelines divide patients with heart failure (HF) into 3 distinct groups based on left ventricular ejection fraction (LVEF) We used the Minnesota Living with Heart Failure Questionnaire (MLHFQ) to quantify the health-related quality of life in patients with HF. Methods Patients were stratified into three cohorts: preserved LVEF (>50%), mid-range LVEF (40-49%) and reduced LVEF (<40%). The MLHFQ scores were evaluated using one-way ANOVA, and differences were observed among the groups. The association of New York Heart Association (NYHA) class with the physical scores was analyzed by Spearman's correlation analysis. The predictive utility of the total MLHFQ scores was assessed with Kaplan-Meier curves for death and HF-related hospitalization. The Cox proportional hazards model was used to identify the risk factors for prognosis. Internal reliability was assessed with Cronbach's alpha. Results There were significant differences in the total MLHFQ scores and the MLHFQ subscale scores among the three groups (p<0.05). MLHFQ domains demonstrated high internal consistency among the three groups (Cronbach's alpha = 0.92, 0.96 and 0.93). The MLHFQ physical subscale scores were significantly associated with NYHA class in HFrEF (r = 0.59, p<0.001) and HFmrEF patients (r = 0.537, p<0.001). The survival analysis indicated that there was a significant difference among the three groups regarding high MLHFQ scores (p = 0.038). In the groups with low MLHFQ scores, the HFmrEF group exhibited significantly increased rates of death and HF-related hospitalization compared with the HFpEF group (p = 0.035). Conclusions The features and clinical outcomes varied among heart failure patients with different EF values. The MLHFQ appears to be a valid and reliable measurement of health status and offers excellent prognostic ability.	[Chen, Xin; Hu, Wenyu; Zhao, Yinan; Zhang, Zixin] China Med Univ, Affiliated Hosp 1, Dept Cardiol, Shenyang, Liaoning, Peoples R China; [Chen, Xin; Zhou, Yinpin] Fuling Cent Hosp, Dept Cardiol, Chongqing, Peoples R China; [Xin, Yanguo] Sichuan Univ, Dept Cardiol, West China Hosp, Chengdu, Sichuan, Peoples R China	China Medical University; Sichuan University	Zhou, YP (corresponding author), Fuling Cent Hosp, Dept Cardiol, Chongqing, Peoples R China.	zhouyinpin1234@163.com		Zhao, Yinan/0000-0001-5196-0325; Hu, Wenyu/0000-0001-6508-897X				Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bilbao A, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0425-7; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Butler J, 2014, JACC-HEART FAIL, V2, P97, DOI 10.1016/j.jchf.2013.10.006; Garin O, 2013, QUAL LIFE RES, V22, P2675, DOI 10.1007/s11136-013-0383-z; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; He KL, 2009, AM J CARDIOL, V103, P845, DOI 10.1016/j.amjcard.2008.11.050; Hoekstra T, 2013, EUR J HEART FAIL, V15, P94, DOI 10.1093/eurjhf/hfs148; Joseph SM, 2013, CIRC-HEART FAIL, V6, P1139, DOI 10.1161/CIRCHEARTFAILURE.113.000359; Kapoor JR, 2016, JACC-HEART FAIL, V4, P464, DOI 10.1016/j.jchf.2016.02.017; Lewis EF, 2007, EUR J HEART FAIL, V9, P83, DOI 10.1016/j.ejheart.2006.10.012; McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Parissis JT, 2009, EUR J HEART FAIL, V11, P163, DOI 10.1093/eurjhf/hfn032; Pokharel Y, 2017, JAMA CARDIOL, V2, P1315, DOI 10.1001/jamacardio.2017.3983; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Punnoose LR, 2011, J CARD FAIL, V17, P527, DOI 10.1016/j.cardfail.2011.03.005; Rajati F, 2016, ARCH PHYS MED REHAB, V97, P1953, DOI 10.1016/j.apmr.2016.05.010; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Sullivan MD, 2007, J CARD FAIL, V13, P560, DOI 10.1016/j.cardfail.2007.04.001; Zile MR, 2010, CIRCULATION, V121, P1393, DOI 10.1161/CIRCULATIONAHA.109.909614	22	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218983	10.1371/journal.pone.0218983	http://dx.doi.org/10.1371/journal.pone.0218983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247042	gold, Green Published, Green Submitted			2022-12-26	WOS:000484911900062
J	Minami, R; Takahama, S; Yamamoto, M				Minami, Rumi; Takahama, Soichiro; Yamamoto, Masahiro			Correlates of telomere length shortening in peripheral leukocytes of HIV-infected individuals and association with leukoaraiosis	PLOS ONE			English	Article							MECHANISMS; THERAPY; PATHOGENESIS; DYNAMICS; CD4(+)	Telomere length (TL) is a marker of cellular and biological aging. Human immunodeficiency virus (HIV) infection has been reported to be associated with short TLs, which suggests that accelerated biological aging occurs in some cellular compartments of HIV+ individuals. In this study, we measured the TLs of peripheral leukocytes of HIV+ and healthy individuals and examined the biological and environmental correlates of TL. We also investigated the influence of TL on leukoaraiosis, an indicator of cerebral small vessel disease, in HIV+ individuals. Three hundred and twenty-five HIV+ individuals who received stable combination antiretroviral therapy (cART) for > 1 year and achieved viral loads of < 40 RNA copies/mL were enrolled along with 147 healthy individuals. Relative TLs of leukocytes were estimated by quantitative real-time polymerase chain reaction. Leukoaraiosis was assessed in 184 HIV+ individuals by fluid-attenuated inversion recovery magnetic resonance imaging. We analyzed several covariates, including markers of HIV infection, cART, and social/environmental factors; variables associated with TL length in univariate analyses were incorporated into multivariate models. The TLs of peripheral leukocytes of HIV+ individuals were significantly shorter than those of healthy individuals, and the rate of LT length decline with increasing age was greater. Linear regression analysis showed that in HIV+ individuals, increasing age, cART without integrase-stand transfer inhibitors (INSTI), failure to achieve viral loads of < 40 copies/mL within 1 year of initiating cART, and substance use were significantly associated with shorter TLs, even after adjustment for the effects of age. Logistic regression analysis indicated an increasing risk of leukoaraiosis was associated with older age, shorter TLs, hypertension, and carotid artery plaque. Multivariate regression analysis indicated that older age and shorter TLs were significant risk factors for leukoaraiosis. In summary, our data showed that TL shortening in HIV+ individuals was independently associated with leukoaraiosis, and was associated with age, control of viral loads, use of INSTI, and substance use. Our results suggest that effective viral control and less toxic cART can help reduce TL shortening and improve outcomes among HIV+ individuals.	[Minami, Rumi; Takahama, Soichiro; Yamamoto, Masahiro] Kyushu Med Ctr, Internal Med, Clin Res Inst, Natl Hosp Org, Fukuoka, Fukuoka, Japan		Yamamoto, M (corresponding author), Kyushu Med Ctr, Internal Med, Clin Res Inst, Natl Hosp Org, Fukuoka, Fukuoka, Japan.	minami.rumi.ad@mail.hosp.go.jp			Health Science Research Grants on HIV/AIDS [H29-AIDS-001]; Ministry of Health, Labor and Welfare of the Japanese Government	Health Science Research Grants on HIV/AIDS; Ministry of Health, Labor and Welfare of the Japanese Government(Ministry of Health, Labour and Welfare, Japan)	For this study, RM, MY were partly supported by Health Science Research Grants on HIV/AIDS (H29-AIDS-001) from the Ministry of Health, Labor and Welfare of the Japanese Government (https://www.mhlw.go.jp/index.html). The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Barnes RP, 2019, MECH AGEING DEV, V177, P37, DOI 10.1016/j.mad.2018.03.013; Beirne C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108964; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Comandini A, 2013, MOL IMMUNOL, V54, P181, DOI 10.1016/j.molimm.2012.12.003; D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485; de Araujo ML, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860016, 10.1590/s1678-9946201860016]; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Eguchi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176138; Fazekas F, 1998, DEMENT GERIATR COGN, V9, P2, DOI 10.1159/000051182; Gardner JP, 2007, J GERONTOL A-BIOL, V62, P367, DOI 10.1093/gerona/62.4.367; Haddow LJ, 2014, AIDS PATIENT CARE ST, V28, P341, DOI 10.1089/apc.2013.0230; Herrmann M, 2018, CLIN CHEM LAB MED, V56, P1210, DOI 10.1515/cclm-2017-0870; Hoenigl M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003162; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Hornsby PJ, 2007, EXP GERONTOL, V42, P575, DOI 10.1016/j.exger.2007.03.007; Kaushal S, 1999, CLIN IMMUNOL, V92, P14, DOI 10.1006/clim.1999.4726; Kimura M, 2010, EXP HEMATOL, V38, P854, DOI 10.1016/j.exphem.2010.06.010; Lagathu C, 2017, AIDS, V31, pS105, DOI [10.1097/QAD.0000000000001441, 10.1097/qad.0000000000001441]; Lai SH, 2018, PROG NEURO-PSYCHOPH, V84, P11, DOI 10.1016/j.pnpbp.2018.01.015; Li M, 2015, J CLIN PHARMACOL, V55, P1119, DOI 10.1002/jcph.520; Lin J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9372050; Montejano R, 2018, J INFECT DIS, V218, P1531, DOI 10.1093/infdis/jiy364; Nielsen BR, 2015, EXP GERONTOL, V66, P25, DOI 10.1016/j.exger.2015.04.004; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Raina A, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-016-0302-6; Saberi S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212273; Seider TR, 2016, J NEUROVIROL, V22, P201, DOI 10.1007/s13365-015-0386-3; Stella-Ascariz N, 2018, J INFECT DIS, V218, P1523, DOI 10.1093/infdis/jiy399; Torres RA, 2014, LAB INVEST, V94, P120, DOI 10.1038/labinvest.2013.142; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wang XW, 2009, LAB INVEST, V89, P1355, DOI 10.1038/labinvest.2009.85; Yuen T, 2017, JAIDS-J ACQ IMM DEF, V76, P48, DOI 10.1097/QAI.0000000000001466; Zanet DL, 2014, CLIN INFECT DIS, V58, P1322, DOI 10.1093/cid/ciu051; Zhang XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090856	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218996	10.1371/journal.pone.0218996	http://dx.doi.org/10.1371/journal.pone.0218996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246986	Green Submitted, Green Published, gold			2022-12-26	WOS:000484911900064
J	Kim, JA; Bayo, J; Cha, J; Choi, YJ; Jung, MY; Kim, DH; Kim, Y				Kim, Jung-Ae; Bayo, Joel; Cha, Juncheol; Choi, Yeon Jae; Jung, Min Young; Kim, Dae-Hyuk; Kim, Yangseon			Investigating the probiotic characteristics of four microbial strains with potential application in feed industry	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; STREPTOCOCCAL CELL-WALLS; EGG-WHITE LYSOZYME; ANTIMICROBIAL SUSCEPTIBILITY; MARINE YEAST; TOLERANCE; BIFIDOBACTERIA; LACTOBACILLI; DEGRADATION; ADDITIVES	The present study aimed to evaluate the probiotic characteristics of certain microbial strains for potential use as feed additives. Three bacterial strains and a yeast previously isolated from different environments were investigated. The strains were subjected to molecular identification and established as Lactobacillus paracasei CP133, Lactobacillus plantarum CP134, Bacillus subtilis CP350 and Saccharomyces cerevisiae CP605. Lactobacillus sp. CP133 and CP134 exhibited antibiosis, antibiotic activity, and relative odor reduction ability. Bacillus subtilis CP350 was thermotolerant, reduced hydrogen sulfide gas and showed significant proteolytic activity, whereas Saccharomyces cerevisiae CP605 exhibited high acid and bile salt tolerance. In general, the isolates in this study demonstrated improved functional characteristics, particularly acid and bile tolerance and relative cell adhesion to HT-29 monolayer cell line. Results in this work provides multifunctional probiotic characteristics of the strains for potential development of probiotics and cleaning of the environment.	[Kim, Jung-Ae; Jung, Min Young; Kim, Dae-Hyuk; Kim, Yangseon] Ctr Industrializat Agr & Livestock Microorganisms, Jeongeup Si, South Korea; [Bayo, Joel] Chonbuk Natl Univ, Dept Agr Convergence Technol, Jeonju Si, South Korea; [Cha, Juncheol] Chemport Inc, Naju Si, South Korea; [Choi, Yeon Jae] Chonbuk Natl Univ, Int Agr Dev & Cooperat Ctr, Jeonju Si, South Korea; [Kim, Dae-Hyuk] Chonbuk Natl Univ, Dept Mol Biol, Jeonju Si, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Kim, Y (corresponding author), Ctr Industrializat Agr & Livestock Microorganisms, Jeongeup Si, South Korea.	yangseon@cialm.or.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01322304]; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [918002-4]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of Korea)	This research was supported by the Next-Generation BioGreen 21 Program (Project No. PJ01322304), Rural Development Administration, Republic of Korea to YK and the Strategic Initiative for Microbiomes in Agriculture and Food grant no. 918002-4, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea to YK. Chemport Inc. provided support in the form of salaries for author J. Cha, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aissi E. A., 2001, Microbial Ecology in Health and Disease, V13, P32, DOI 10.1080/089106001750071681; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amin M., 2009, Journal of Biological Sciences, V9, P810, DOI 10.3923/jbs.2009.810.814; Arasu MV, 2016, SAUDI J BIOL SCI, V23, pS6, DOI 10.1016/j.sjbs.2015.09.022; ARNOSTI DN, 1986, J BACTERIOL, V168, P1243, DOI 10.1128/jb.168.3.1243-1249.1986; Bao Y, 2010, FOOD CONTROL, V21, P695, DOI 10.1016/j.foodcont.2009.10.010; Braga AA, 1998, SYST APPL MICROBIOL, V21, P353, DOI 10.1016/S0723-2020(98)80044-1; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Charteris WP, 2001, J FOOD PROTECT, V64, P2007, DOI 10.4315/0362-028X-64.12.2007; Deza MAC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179242; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; Ding WK, 2007, J FOOD SCI, V72, pM446, DOI 10.1111/j.1750-3841.2007.00565.x; Dowarah R, 2017, ANIM NUTR, V3, P1, DOI 10.1016/j.aninu.2016.11.002; FAO WHO, 2001, REP JOINT FAO WHO EX, DOI DOI 10.1201/9781420009613.CH16; Fietto JLR, 2004, CAN J MICROBIOL, V50, P615, DOI [10.1139/w04-050, 10.1139/W04-050]; Fossi Bertrand Tatsinkou, 2017, Journal of Applied Biology & Biotechnology, V5, P1, DOI 10.7324/JABB.2017.50401; Fukumoto Y, 2003, BIORESOURCE TECHNOL, V89, P109, DOI 10.1016/S0960-8524(03)00060-9; GALLIS HA, 1976, INFECT IMMUN, V13, P1459, DOI 10.1128/IAI.13.5.1459-1466.1976; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Giraffa G, 2010, RES MICROBIOL, V161, P480, DOI 10.1016/j.resmic.2010.03.001; GLICK AD, 1972, INFECT IMMUN, V6, P403, DOI 10.1128/IAI.6.3.403-413.1972; Gorbach SL, 2002, DIGEST LIVER DIS, V34, pS2, DOI 10.1016/S1590-8658(02)80155-4; Greetham D, 2019, SUSTAIN ENERG FUELS, V3, P1545, DOI 10.1039/c9se00029a; Greetham D, 2018, CURR OPIN GREEN SUST, V14, P53, DOI 10.1016/j.cogsc.2018.06.008; Guo X, 2016, FISH SHELLFISH IMMUN, V52, P74, DOI 10.1016/j.fsi.2016.03.017; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Hamdan AM, 2016, J APPL MICROBIOL, V120, P1061, DOI 10.1111/jam.13081; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hummel AS, 2007, APPL ENVIRON MICROB, V73, P730, DOI 10.1128/AEM.02105-06; Joint F., 2002, WHO WORKING GROUP RE, P30; Jones RM, 2017, MICROBIOTA IN GASTROINTESTINAL PATHOPHYSIOLOGY: IMPLICATIONS FOR HUMAN HEALTH, PREBIOTICS, PROBIOTICS, AND DYSBIOSIS, P99; Joo HS, 2005, PROCESS BIOCHEM, V40, P1263, DOI 10.1016/j.procbio.2004.05.010; Jordan KN, 1999, LETT APPL MICROBIOL, V29, P136, DOI 10.1046/j.1365-2672.1999.00607.x; Kabir SML, 2009, INT J MOL SCI, V10, P3531, DOI 10.3390/ijms10083531; Kalus K, 2017, FRONT ENV SCI ENG, V11, DOI 10.1007/s11783-017-0928-4; Katla AK, 2001, INT J FOOD MICROBIOL, V67, P147, DOI 10.1016/S0168-1605(00)00522-5; Kim SJ, 2008, LWT-FOOD SCI TECHNOL, V41, P493, DOI 10.1016/j.lwt.2007.03.025; Konings WN, 2000, CURR OPIN MICROBIOL, V3, P276, DOI 10.1016/S1369-5274(00)00089-8; Korabecna M, 2007, COMMUN CURR RES ED T, V2, P783, DOI DOI 10.1128/JCM.39.10.3617; Kosin B, 2006, FOOD TECHNOL BIOTECH, V44, P371; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lankaputhra W. E. V., 1998, Bioscience and Microflora, V17, P105; Lee J, 2012, REV COLOMB CIENC PEC, V25, P577; Liong MT, 2005, J DAIRY SCI, V88, P55, DOI 10.3168/jds.S0022-0302(05)72662-X; Mainville I, 2005, INT J FOOD MICROBIOL, V99, P287, DOI 10.1016/j.ijfoodmicro.2004.08.020; Mandal S, 2006, INT DAIRY J, V16, P1190, DOI 10.1016/j.idairyj.2005.10.005; Maragkoudakis PA, 2006, INT DAIRY J, V16, P189, DOI 10.1016/j.idairyj.2005.02.009; Mccoy S, 2007, J FOOD SCI, V72, pM94, DOI 10.1111/j.1750-3841.2007.00310.x; Microbiology F, 2005, NATURE REV MICROBIOL, V3, P777, DOI [10.1038/nrmicro1273, DOI 10.1038/NRMICRO1273]; Morelli L, 2012, J CLIN GASTROENTEROL, V46, pS1, DOI 10.1097/MCG.0b013e318269fdd5; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Oh NS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192021; Park SY, 2015, KOREAN J FOOD SCI AN, V35, P615, DOI 10.5851/kosfa.2015.35.5.615; Peres CM, 2012, TRENDS FOOD SCI TECH, V26, P31, DOI 10.1016/j.tifs.2012.01.006; Posteraro B, 2005, INT J FOOD MICROBIOL, V103, P295, DOI 10.1016/j.ijfoodmicro.2004.12.031; Ragavan M. L., 2017, ASIAN J PHARM CLIN R, V10, P451, DOI [10.22159/ajpcr.2017.v10i4.17067, DOI 10.22159/AJPCR.2017.V10I4.17067]; Rodarte MP, 2011, ACTA SCI-AGRON, V33, P457, DOI 10.4025/actasciagron.v33i3.6734; Romero-Luna HE, 2018, PROBIOTICS ANTIMICRO; Sahadeva R. P. K., 2011, International Food Research Journal, V18, P1515; Saidi N., 2011, GLOB J BIOTECH BIOCH, V6, P154; Sanz Yolanda, 2007, Recent Pat Antiinfect Drug Discov, V2, P148, DOI 10.2174/157489107780832596; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Shewale RN, 2014, INT J PROBIOTICS PRE, P9; Suskovic J, 2001, FOOD TECHNOL BIOTECH, V39, P227; SWENSON JM, 1990, ANTIMICROB AGENTS CH, V34, P543, DOI 10.1128/AAC.34.4.543; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Nguyen VD, 2014, FISH SHELLFISH IMMUN, V40, P49, DOI 10.1016/j.fsi.2014.06.017; Vijayaraghavan P, 2013, J BIOTECHNOL TECHNOL, V4, P628; Wiles MC, 2001, COMPOST SCI UTIL, V9, P27; Woo JY, 2014, ANAEROBE, V27, P22, DOI 10.1016/j.anaerobe.2014.03.003; Zaky AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30660-x; Zaky AS, 2014, FEMS YEAST RES, V14, P813, DOI 10.1111/1567-1364.12158; Zheng JS, 2015, ENVIRON MICROBIOL, V17, P2133, DOI 10.1111/1462-2920.12662; Zhu J, 964068 ASAE	76	22	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218922	10.1371/journal.pone.0218922	http://dx.doi.org/10.1371/journal.pone.0218922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242260	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600065
J	Pem, D; Hyde, KD; Doilom, M; Camporesi, E; Hongsanan, S; Rampadarath, S; Bhoyroo, V; Jeewon, R				Pem, Dhandevi; Hyde, Kevin D.; Doilom, Mingkwan; Camporesi, Erio; Hongsanan, Sinang; Rampadarath, Sillma; Bhoyroo, Vishwakalyan; Jeewon, Rajesh			Multigene phylogenetic analyses to establish new Valsaria species and taxonomic significance of spore ornamentation	PLOS ONE			English	Article							RIBOSOMAL DNA; ALLIED GENERA; REVISION; FUNGI; IDENTIFICATION; HELVELLACEAE; ASCOMYCOTA; MORPHOLOGY; SEQUENCES; NORTHERN	During our studies on fungal diversity from plant substrates, a new species of Valsaria was isolated from dead branches of Ostrya carpinifolia. The taxon is morphologically similar to other taxa in Valsariaceae and is characterized by pseudostromata, apically free pseudo-paraphyses, bitunicate asci, and dark brown, 2-celled ascospores. However, it differs from extant species in number of guttules and ornamentation of spore. It is introduced herein as Valsaria ostryae sp. nov. within the family Valsariaceae. Multigene phylogenies based on combined LSU, ITS and RPB2 DNA sequence data generated from maximum likelihood, maximum parsimony and MrBayes analyses indicate that V. ostryae is basal to V. lopadostomoides and V. rudis and its establishment as a new species is strongly supported. No discordance was found between our morphological and phylogenetic species boundaries as postulated by other researchers and our molecular data strongly supports ornamentation of spore as useful for species delineation. Valsaria species do not appear to be host specific. Full morphological details are provided herein and phylogenetic relationships of Valsaria species are also discussed in light with host association.	[Pem, Dhandevi; Doilom, Mingkwan] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Pem, Dhandevi; Hongsanan, Sinang] Mae Fah Luang Univ, Ctr Excellence Fungal Res, Chiang Rai, Thailand; [Hyde, Kevin D.] Mushroom Res Fdn, 128 M-3 Ban Deng T Pae, Chiang Mai, Thailand; [Hyde, Kevin D.; Doilom, Mingkwan] World Agroforestry Ctr, Kunming, Yunnan, Peoples R China; [Camporesi, Erio] AMB Grp Micol Forlivese Antonio Cicognani, Via Roma, Forli, Italy; [Camporesi, Erio] AMB Circolo Micol Giovanni Carini, Brescia, Italy; [Camporesi, Erio] Soc Naturalist Romagna, Bagnacavallo, RA, Italy; [Hongsanan, Sinang] Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Peoples R China; [Rampadarath, Sillma; Bhoyroo, Vishwakalyan] Univ Mauritius, Fac Agr, Reduit, Mauritius; [Jeewon, Rajesh] Univ Mauritius, Fac Sci, Dept Hlth Sci, Reduit, Mauritius	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Mae Fah Luang University; Shenzhen University; University of Mauritius; University of Mauritius	Doilom, M (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.; Doilom, M (corresponding author), World Agroforestry Ctr, Kunming, Yunnan, Peoples R China.; Jeewon, R (corresponding author), Univ Mauritius, Fac Sci, Dept Hlth Sci, Reduit, Mauritius.	j_hammochi@hotmail.com; r.jeewon@uom.ac.mu	Jeewon, Rajesh/AAB-8163-2021; Hongsanan, Sinang/ABD-1290-2020; Hyde, Kevin D/F-7890-2010; Jeewon, Rajesh/I-9508-2019	Jeewon, Rajesh/0000-0002-8563-957X; Hongsanan, Sinang/0000-0003-0550-3152; Bhoyroo, Vishwakalyan/0000-0002-5819-9687				Abbott SP, 1997, MYCOTAXON, V62, P1; Baral HO, VITAL TAXONOMY ECOLO; Cai L, 2006, MYCOL RES, V110, P137, DOI 10.1016/j.mycres.2005.09.014; Cai L, 2005, FUNGAL DIVERS, V19, P1; Cai L, 2006, MYCOL RES, V110, P359, DOI 10.1016/j.mycres.2006.01.007; Cesati V, 1863, COMMENTARIO SOC CRIT, V1, P177; Chesters CGC, 1970, MYCOL PAP, V120, P1; Chomnunti P, 2014, FUNGAL DIVERS, V66, P1, DOI 10.1007/s13225-014-0278-5; CREPET WL, 1989, AM J BOT, V76, P842, DOI 10.2307/2444540; de Gruyter J, 2002, PERSOONIA, V18, P85; Doweld AB, 2001, PLANT SYST EVOL, V227, P75, DOI 10.1007/s006060170058; Doyle JJ, 2001, ENCY GENETICS, P1081, DOI DOI 10.1006/RWGN.2001.1642; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hyde KD, 2013, FUNGAL DIVERS, V63, P1, DOI 10.1007/s13225-013-0263-4; Jaklitsch WM, 2015, FUNGAL DIVERS, V73, P159, DOI 10.1007/s13225-015-0330-0; Jayasiri SC, 2015, FUNGAL DIVERS, V74, P3, DOI 10.1007/s13225-015-0351-8; Jeewon R, 2016, MYCOSPHERE, V7, P1669, DOI 10.5943/mycosphere/7/11/4; Jeewon R, 2004, FUNGAL DIVERS, V17, P39; Jeewon R, 2003, MYCOLOGIA, V95, P911, DOI 10.2307/3762019; Jeewon R, 2002, MOL PHYLOGENET EVOL, V25, P378, DOI 10.1016/S1055-7903(02)00422-0; Ju YM, 1996, MYCOTAXON, V58, P419; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kodsueb R, 2007, BOT J LINN SOC, V155, P283, DOI 10.1111/j.1095-8339.2007.00685.x; Kunner R., 1976, B MENS SOC LINN LYON, V45, P19; Larsson E, 2003, MYCOLOGIA, V95, P1037, DOI 10.2307/3761912; Lawrence DP, 2015, MYCOLOGIA, V107, P926, DOI 10.3852/14-353; Liu AR, 2010, MOL PHYLOGENET EVOL, V57, P528, DOI 10.1016/j.ympev.2010.07.017; Liu JK, 2017, FUNGAL DIVERS, V84, P75, DOI 10.1007/s13225-017-0385-1; Liu JK, 2014, PHYTOTAXA, V181, P1; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Maharachchikumbura SSN, 2014, STUD MYCOL, P121, DOI 10.1016/j.simyco.2014.09.005; MONOD M, 1983, SYDOWIA S1, V9, P1, DOI DOI 10.5248/131.145; Morgado L. N., 2016, MYCOLOGICAL PROGR, V15, P1; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; PEGLER DN, 1979, T BRIT MYCOL SOC, V72, P353, DOI 10.1016/S0007-1536(79)80143-6; PEGLER DN, 1981, T BRIT MYCOL SOC, V76, P103, DOI 10.1016/S0007-1536(81)80013-7; Petersen R, 1973, MYCOLOGIA, V65, P257; Phookamsak R, 2014, FUNGAL DIVERS, V68, P159, DOI 10.1007/s13225-014-0308-3; Pinnoi A, 2007, MYCOLOGIA, V99, P378, DOI 10.3852/mycologia.99.3.378; PUNITHALINGAM E, 1970, T BRIT MYCOL SOC, V55, P497, DOI 10.1016/S0007-1536(70)80074-2; Rambaut A, 2012, FIGTREE TREE FIGURE; Silva DM, 2011, BRAZ J MICROBIOL, V42, P761, DOI [10.1590/S1517-83822011000200044, 10.1590/S1517-838220110002000044]; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Southworth D., 2018, Fungal Systematics and Evolution, V2, P11, DOI 10.3114/fuse.2018.02.02; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P873; Thongkantha S, 2009, FUNGAL DIVERS, V34, P157; Udagawa S, 1973, T MYCOL SOC JAPAN, V14, P370; VANDERAA HA, 1973, STUD MYCOL, V5, P1; Vijaykrishna D, 2005, SYDOWIA, V57, P267; Vijaykrishna D, 2004, STUD MYCOL, P387; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Villegas M, 2005, FUNGAL DIVERS, V18, P157; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wijayawardene NN, 2018, FUNGAL DIVERS, V88, P167, DOI 10.1007/s13225-018-0394-8; Wijayawardene NN, 2016, FUNGAL DIVERS, V77, P1, DOI 10.1007/s13225-016-0360-2; Zhang Y, 2008, MYCOL RES, V112, P1186, DOI 10.1016/j.mycres.2008.04.004	56	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0217982	10.1371/journal.pone.0217982	http://dx.doi.org/10.1371/journal.pone.0217982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242234	gold, Green Published, Green Submitted			2022-12-26	WOS:000482883600018
J	Chong, PL; Singh, AK; Kok, SL				Chong, Peng Lean; Singh, Ajay Kumar; Kok, Swee Leong			Characterization of Aloe Barbadensis Miller leaves as a potential electrical energy source with optimum experimental setup conditions	PLOS ONE			English	Article							AVOCADO TREES; LIGHT; SIGNALS; VIBRATION; RESPONSES; PLANT; ROOT	Electrical energy can be harvested from the living plants as a new potential renewable energy source. Characterization of the electrical signal is needed to enable an optimum energy harvesting setup condition. In the present paper, an investigation is conducted to analyze the characteristic of Aloe Barbadensis Miller (Aloe Vera) leaves in terms of electrical energy generation under specific experimental setups. The experimental results show that 1111.55uW electrical power can be harvested from the Aloe Vera with 24 pairs of electrodes and this energy is capable to be stored in a capacitor. This energy has a high potential to be used to power up a low power consumption device.	[Chong, Peng Lean; Singh, Ajay Kumar] Multimedia Univ, Fac Engn & Technol, Ctr Commun Syst & IC Design CSID, Melaka, Malaysia; [Kok, Swee Leong] Univ Teknikal Malaysia Melaka UTeM, FKEKK, CeTRI, Melaka, Malaysia	Multimedia University; University Teknikal Malaysia Melaka	Chong, PL (corresponding author), Multimedia Univ, Fac Engn & Technol, Ctr Commun Syst & IC Design CSID, Melaka, Malaysia.	plchong@mmu.edu.my	SINGH, ANIL KUMAR/M-4786-2017; Lean, Chong Peng/AAX-4316-2020; Singh, Ajay/AAF-4414-2020; Kok, Swee Leong/N-1109-2014	SINGH, ANIL KUMAR/0000-0003-2933-4058; Lean, Chong Peng/0000-0003-3277-9533; Kok, Swee Leong/0000-0002-0998-8970; SINGH, AJAY KUMAR/0000-0002-3740-6667	Multimedia University Malaysia	Multimedia University Malaysia	This work was supported in part by the Mini Fund 2016/2017 and R&D Capital Expenditure (CAPEX) 2018 from Multimedia University Malaysia to PLC.	Choo Y. Y., 2013, J SCI TECHNOL, V5, P79, DOI DOI 10.1109/19.387319; Choo YY, 2014, INT J RENEW ENERGY R, V4, P198; Choo YY, 2014, THESIS; Clark WG, 1935, P NATL ACAD SCI USA, V21, P681, DOI 10.1073/pnas.21.12.681; Dincer I, 2015, INT J ENERG RES, V39, P585, DOI 10.1002/er.3329; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; Gil PM, 2008, J PLANT PHYSIOL, V165, P1070, DOI 10.1016/j.jplph.2007.07.014; Gil PM, 2009, PLANT SIGNAL BEHAV, V4, P100, DOI 10.4161/psb.4.2.7872; Gurovich LA, 2009, J PLANT PHYSIOL, V166, P290, DOI 10.1016/j.jplph.2008.06.004; Hao ZB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136639; Himes C, 2010, IEEE T NANOTECHNOL, V9, P2, DOI 10.1109/TNANO.2009.2032293; Konstantopoulos C, 2016, IEEE T INSTRUM MEAS, V65, P388, DOI 10.1109/TIM.2015.2495718; Krinker M, 2010, 2010 IEEE LONG ISL S; Labady A, 2002, BIOELECTROCHEMISTRY, V57, P47, DOI 10.1016/S1567-5394(01)00175-X; Lautner S, 2005, PLANT PHYSIOL, V138, P2200, DOI 10.1104/pp.105.064196; Lautner S, 2006, PLANT CELL ENVIRON, V30, P79, DOI [10.1016/j.jplph.2013.01.009, DOI 10.1016/J.JPLPH.2013.01.009]; Manzella Veronica, 2013, P 11 ACM EMB NETW SE, DOI [10.1145/2517351.2517403, DOI 10.1145/2517351.2517403]; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; Oyarce P, 2010, PLANT SIGNAL BEHAV, V5, P34, DOI 10.4161/psb.5.1.10157; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Remeli MF, 2015, ENERG CONVERS MANAGE, V91, P110, DOI 10.1016/j.enconman.2014.12.001; Rodriguez-Barreiro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056358; Saadon S, 2011, ENERG CONVERS MANAGE, V52, P500, DOI 10.1016/j.enconman.2010.07.024; SCHRANK AR, 1946, PLANT PHYSIOL, V21, P467, DOI 10.1104/pp.21.4.467; Suzuki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106012; Tanaka A, 2012, IEEE SENSOR, P311; Uchida A, 2002, PLANT CELL PHYSIOL, V43, P647, DOI 10.1093/pcp/pcf079; Volkov AG, 2013, J PLANT PHYSIOL, V170, P838, DOI 10.1016/j.jplph.2013.01.009; WILDON DC, 1992, NATURE, V360, P62, DOI 10.1038/360062a0; Zeiger Taiz, 2002, PLANT PHYSIOL, P33	30	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218758	10.1371/journal.pone.0218758	http://dx.doi.org/10.1371/journal.pone.0218758			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237903	gold, Green Submitted, Green Published			2022-12-26	WOS:000484856000038
J	Nagano, H; Obara, H; Takayama, Y				Nagano, Hiroaki; Obara, Haruo; Takayama, Yoshihiro			A brief home-based palliative care learning experience for medical students and resident doctors in Okinawa, Japan	PLOS ONE			English	Article								Background The clinical component of medical education for students and resident doctors in Japan occurs almost entirely in the hospital setting. Because of this inpatient focus, graduate medical education clinical training often fails to expose physicians-in-training to the challenges that patients may face in the outpatient or home setting. This is a descriptive study in which we explore what participating students and resident doctors learned through our brief home-based teaching experience. Methods From June 2016 to December 2017, attending physicians on the internal medicine service had medical students and resident doctors accompany them on home care visits. Participants were selected by convenience sampling based on their rotation availability. After the home visit and the interactive discussion, the participants were expected to prepare a reflective journal on their experience and learning. Thematic analysis was applied, and key themes were developed based on Kolb's ELT (Experiential learning theory). Three months after completion of the experience, semi-structured interviews were individually conducted assessing participants' self-perceived changes. Results Thirty-two medical students(10) or residents(22) participated in a home visit. Thirty of these learners were able to complete a reflective journal. Using thematic analysis, we identified 2 domains and 6 key themes from the participants' perceptions. Participants recognized the importance of patient-centered care, inter-professional collaboration of the home care team, and reconceptualized the meaning of medical practice and their professional identity as a doctor. Three month post-experience interviews were completed on 12 of the original 30 participants who completed the reflective journal. 2 domains and 6 key themes from the residents' experiences and perceptions were generated. The participants reported an increased attention to the daily lives and social situations of their hospitalized patients, and an extension of their focus beyond the clinical medical treatment of the patient. Conclusion The experience of a brief visit to a patient's home is a novel educational approach that may potentially provide medical students and resident doctors with opportunities to learn about out-of-hospital, patient-centered, home-based medical care.	[Nagano, Hiroaki] Okinawa Chubu Hosp, Dept Resp Med, Uruma, Okinawa, Japan; [Obara, Haruo] Okinawa Chubu Hosp, Dept Gen Internal Med, Uruma, Okinawa, Japan; [Takayama, Yoshihiro] Okinawa Chubu Hosp, Dept Infect Dis, Uruma, Okinawa, Japan	Okinawa Chubu Central Hospital; Okinawa Chubu Central Hospital; Okinawa Chubu Central Hospital	Nagano, H (corresponding author), Okinawa Chubu Hosp, Dept Resp Med, Uruma, Okinawa, Japan.	hiroakinoko322violin@gmail.com		Nagano, Hiroaki/0000-0001-5587-5662				Buchman S, 2012, CAN FAM PHYSICIAN, V58, P114; Chandran Rabin, 2014, R I Med J (2013), V98, P35; Difat J, 2015, CAN FAM PHYSICIAN, V61, P189; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Franco P, 2010, ARCH ONCOL, V18, P31; Cardenas LAG, 2013, INTERFACE-BOTUCATU, V17, P649, DOI 10.1590/S1414-32832013000300012; Garcia-Huidobro Diego, 2014, ISRN Family Med, V2014, P631732, DOI 10.1155/2014/631732; Gomes B, 2004, J ROY SOC MED, V97, P413, DOI 10.1258/jrsm.97.9.413; Groh G, 2013, J PALLIAT MED, V16, P848, DOI 10.1089/jpm.2012.0491; Helen CR, 2005, BRIT MED J, V331, P239, DOI [10.1136/bmj.331.7528.sgp239, DOI 10.1136/BMJ.331.7528.SGP239]; Hervada-Page Maria, 2007, Care Manag J, V8, P206, DOI 10.1891/152109807782590628; Hudson P, 2009, J PAIN SYMPTOM MANAG, V38, P299, DOI 10.1016/j.jpainsymman.2008.08.010; Ivy O, 2005, J INTERPROF CARE, V1, P39; Kazuko A, 2017, BMC MED EDUC, V17, P1, DOI [10.1186/s12909-016-0842-7, DOI 10.1186/S12909-016-0842-7]; Kolb A.Y., 2009, SAGE HDB MANAGEMENT, V42, P68, DOI [10.4135/9780857021038.n3, DOI 10.4135/9780857021038.N3]; Landers S, 2016, HOME HLTH CARE MAN P, V28, P262, DOI 10.1177/1084822316666368; Parent Kelly, 2016, AMA J Ethics, V18, P24, DOI 10.1001/journalofethics.2016.18.1.medu1-1601; Rabow M, 2013, J PALLIAT MED, V16, P1540, DOI 10.1089/jpm.2013.0153; Roane DM, 2002, GERONTOLOGIST, V42, P109, DOI 10.1093/geront/42.1.109; Sairenji Tomoko, 2017, J Grad Med Educ, V9, P90, DOI 10.4300/JGME-D-16-00249.1; Shepperd S, 2009, CAN MED ASSOC J, V180, P175, DOI 10.1503/cmaj.081491; Taro T, 2010, IGAKUKYOUIKU, V41, P161; YOUNG R, 1981, J MED EDUC, V56, P341	23	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218780	10.1371/journal.pone.0218780	http://dx.doi.org/10.1371/journal.pone.0218780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237900	Green Submitted, Green Published, gold			2022-12-26	WOS:000484856000039
J	Meyer, L; Lopez, T; Espinosa, R; Arias, CF; Vollmers, C; DuBois, RM				Meyer, Lena; Lopez, Tomas; Espinosa, Rafaela; Arias, Carlos F.; Vollmers, Christopher; DuBois, Rebecca M.			A simplified workflow for monoclonal antibody sequencing	PLOS ONE			English	Article							VARIABLE REGIONS; PHAGE DISPLAY; DNA; AMPLIFICATION; EXPRESSION; PRIMERS; CLONING; MURINE; MOUSE; CELLS	The diversity of antibody variable regions makes cDNA sequencing challenging, and conventional monoclonal antibody cDNA amplification requires the use of degenerate primers. Here, we describe a simplified workflow for amplification of IgG antibody variable regions from hybridoma RNA by a specialized RT-PCR followed by Sanger sequencing. We perform three separate reactions for each hybridoma: one each for kappa, lambda, and heavy chain transcripts. We prime reverse transcription with a primer specific to the respective constant region and use a template-switch oligonucleotide, which creates a custom sequence at the 5' end of the antibody cDNA. This template-switching circumvents the issue of low sequence homology and the need for degenerate primers. Instead, subsequent PCR amplification of the antibody cDNA molecules requires only two primers: one primer specific for the template-switch oligonucleotide sequence and a nested primer to the respective constant region. We successfully sequenced the variable regions of five mouse monoclonal IgG antibodies using this method, which enabled us to design chimeric mouse/human antibody expression plasmids for recombinant antibody production in mammalian cell culture expression systems. All five recombinant antibodies bind their respective antigens with high affinity, confirming that the amino acid sequences determined by our method are correct and demonstrating the high success rate of our method. Furthermore, we also designed RT-PCR primers and amplified the variable regions from RNA of cells transfected with chimeric mouse/human antibody expression plasmids, showing that our approach is also applicable to IgG antibodies of human origin. Our monoclonal antibody sequencing method is highly accurate, user-friendly, and very cost-effective.	[Meyer, Lena; Vollmers, Christopher; DuBois, Rebecca M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Lopez, Tomas; Espinosa, Rafaela; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca, Morelos, Mexico	University of California System; University of California Santa Cruz; Universidad Nacional Autonoma de Mexico	Vollmers, C; DuBois, RM (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	vollmers@ucsc.edu; rmdubois@ucsc.edu		Ricemeyer, Lena/0000-0001-5543-6117; DuBois, Rebecca/0000-0003-4185-5673	National Institutes of Health [1RO1AI130073-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI130073, R01AI144090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	R.M.D. received support from the National Institutes of Health under grant #1RO1AI130073-01A1, https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babrak L, 2017, MOL IMMUNOL, V90, P287, DOI 10.1016/j.molimm.2017.08.014; Bandeira N, 2008, NAT BIOTECHNOL, V26, P1336, DOI 10.1038/nbt1208-1336; Bogdanoff WA, 2016, ACS INFECT DIS, V2, P313, DOI 10.1021/acsinfecdis.6b00026; Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487; COCOMARTIN JM, 1991, ANAL CHIM ACTA, V249, P257, DOI 10.1016/0003-2670(91)87031-2; Doenecke A, 1997, LEUKEMIA, V11, P1787, DOI 10.1038/sj.leu.2400781; DUBEL S, 1994, J IMMUNOL METHODS, V175, P89, DOI 10.1016/0022-1759(94)90334-4; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Frenzel A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00217; GenScript, ANT SEQ SERV; Henry KA, 2018, METHODS MOL BIOL, V1701, P425, DOI 10.1007/978-1-4939-7447-4_24; Ihle O, 2003, SCAND J IMMUNOL, V57, P453, DOI 10.1046/j.1365-3083.2003.01255.x; Koren S, 2008, APPL MICROBIOL BIOT, V78, P1071, DOI 10.1007/s00253-008-1386-5; Kosmac M, 2009, DNA FINGERPRINTING S; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kuniyoshi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165473; Rickert KW, 2016, MABS-AUSTIN, V8, P501, DOI 10.1080/19420862.2016.1145865; RUBERTI F, 1994, J IMMUNOL METHODS, V173, P33, DOI 10.1016/0022-1759(94)90280-1; Schanz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111726; Sen KI, 2017, J AM SOC MASS SPECTR, V28, P803, DOI 10.1007/s13361-016-1580-0; SydLabs, 2018, ANT SEQ HYBR SEQ; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2	22	20	20	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218717	10.1371/journal.pone.0218717	http://dx.doi.org/10.1371/journal.pone.0218717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233538	Green Published, gold			2022-12-26	WOS:000484896700034
J	Woon, FC; Chin, YS; Ismail, IH; Batterham, M; Latiff, AHA; Gan, WY; Appannah, G; Hussien, SHM; Edi, M; Tan, ML; Chan, YM				Woon, Fui Chee; Chin, Yit Siew; Ismail, Intan Hakimah; Batterham, Marijka; Latiff, Amir Hamzah Abdul; Gan, Wan Ying; Appannah, Geeta; Hussien, Siti Huzaifah Mohammed; Edi, Muliana; Tan, Meng Lee; Chan, Yoke Mun			Vitamin D deficiency during pregnancy and its associated factors among third trimester Malaysian pregnant women	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; HIGH PREVALENCE; LIFE-STYLE; METAANALYSIS; ADULTS; RISK	Background Despite perennial sunshine, vitamin D deficiency is prevalent among Malaysians especially pregnant women. This study determines the vitamin D status and its associated factors among third trimester pregnant women attending government health clinics in Selangor and Kuala Lumpur, Malaysia. Methods Information on socio-demographic characteristics, obstetrical history, and sun exposure were obtained through face-to-face interviews. Vitamin D intake was assessed using a semi-quantitative food frequency questionnaire (FFQ). Serum 25-hydroxyvitamin D concentration was measured and classified as deficient (< 30 nmol/L), insufficient (30-50 nmol/L), and sufficient (>= 50 nmol/L). Results Of the 535 pregnant women recruited, 42.6% were vitamin D deficient. They consumed an average of 8.7 +/- 6.7 mu g of vitamin D daily. A total of 80.4% of the vitamin D were obtained from the food sources, while 19.6% were from dietary supplements. Fish and fish products showed the highest contribution to vitamin D intake (35.8%). The multivariable generalized linear mixed models, with clinic as a random effect, indicates that higher intake of vitamin D is associated with lower odds of vitamin D deficiency among pregnant women (OR = 0.96; 95% CI = 0.93-0.99). The odds of having vitamin D deficiency was reduced by 87% in non-Malays (OR = 0.14; 95% CI = 0.05-0.41) compared to Malays. No associations were found between age, educational level, monthly household income, work status, gravidity, parity, pre-pregnancy body mass index, total hours of sun exposure, total percentage of body surface area, and sun exposure index per day with vitamin D deficiency. Conclusion Vitamin D deficiency is prevalent among Malaysian pregnant women. Considering the possible adverse obstetric and fetal outcomes of vitamin D deficiency during pregnancy, future nutrition education should emphasise on vitamin D-fortified foods consumption among pregnant women by taking into consideration ethnic differences.	[Woon, Fui Chee; Chin, Yit Siew; Gan, Wan Ying; Appannah, Geeta; Hussien, Siti Huzaifah Mohammed; Edi, Muliana; Tan, Meng Lee; Chan, Yoke Mun] Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Chin, Yit Siew; Chan, Yoke Mun] Univ Putra Malaysia, Res Ctr Excellence Nutr & Noncommunicable Dis, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Ismail, Intan Hakimah] Univ Putra Malaysia, Dept Paediat, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Batterham, Marijka] Univ Wollongong, Natl Inst Appl Stat Res Australia, Northfields Ave, Wollongong, NSW, Australia; [Latiff, Amir Hamzah Abdul] Pantai Hosp Kuala Lumpur, Allergy & Immunol Ctr, Kuala Lumpur, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; University of Wollongong	Chin, YS (corresponding author), Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia.; Chin, YS (corresponding author), Univ Putra Malaysia, Res Ctr Excellence Nutr & Noncommunicable Dis, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia.	chinys@upm.edu.my	Woon, Fui Chee/GLN-2978-2022; Chin, Yit Siew/G-2001-2015; Chan, Yoke Mun Yoke/L-2965-2015; Woon, Fui Chee/GXG-9689-2022; Gan, Wan Ying/N-2445-2019	Woon, Fui Chee/0000-0002-8669-0035; Chin, Yit Siew/0000-0002-7609-1944; Chan, Yoke Mun Yoke/0000-0002-3853-736X; Woon, Fui Chee/0000-0002-8669-0035; Gan, Wan Ying/0000-0002-9016-3414; Batterham, Marijka/0000-0002-9520-6508; Ismail, Intan Hakimah/0000-0003-4614-0140	Ministry of Higher Education of Malaysia [04-01-15-1670FR]	Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia)	This research was funded by the Ministry of Higher Education of Malaysia (http://mygrants.gov.my/main.php) under the Fundamental Research Grant Scheme (Project's code: 04-01-15-1670FR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Aji AS, 2018, ASIA PAC J CLIN NUTR, V27, P1286, DOI 10.6133/apjcn.201811_27(6).0016; Bodnar LM, 2015, OBSTET GYNECOL, V125, P439, DOI 10.1097/AOG.0000000000000621; Bukhary NBI, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0939-3; Centers for Disease Control and Prevention, 2017, STAND MEAS PROC; Chen YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21944-3; Chin KY, 2014, NUTRIENTS, V6, P5419, DOI 10.3390/nu6125419; Christakos S, 2010, ENDOCRIN METAB CLIN, V39, P243, DOI 10.1016/j.ecl.2010.02.002; Daraki V, 2018, PEDIATR OBES, V13, P467, DOI 10.1111/ijpo.12267; Do HJ, 2014, PEDIATR GASTROENTERO, V17, P47, DOI 10.5223/pghn.2014.17.1.47; Greene-Finestone LS, 2011, OSTEOPOROSIS INT, V22, P1389, DOI 10.1007/s00198-010-1362-7; Hall LM, 2010, J NUTR, V140, P542, DOI 10.3945/jn.109.115253; Hanieh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099005; Hilger J, 2014, BRIT J NUTR, V111, P23, DOI 10.1017/S0007114513001840; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; IOM, 2011, DIETARY REFERENCE IN; Kennel KA, 2010, MAYO CLIN PROC, V85, P752, DOI 10.4065/mcp.2010.0138; Lee CL, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2017-0005; MOH, 2010, GUID NUTR LAB CLAIMS; Mohamed HJJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100705; Muhammad T. J., 2015, EUROPEAN SCI J, P438; Nasir JA, 2018, JCPSP-J COLL PHYSICI, V28, P233, DOI 10.29271/jcpsp.2018.03.233; National Coordinating Committee for Food and Nutrition, 2017, REC NUTR INT MAL 201; Perez-Lopez FR, 2015, FERTIL STERIL, V103, P1278, DOI 10.1016/j.fertnstert.2015.02.019; Pirdehghan Azar, 2016, J Reprod Infertil, V17, P34; Pratumvinit B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131126; Scholl TO, 2012, NUTRIENTS, V4, P319, DOI 10.3390/nu4040319; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; Shibata M, 2011, J BONE MINER METAB, V29, P615, DOI 10.1007/s00774-011-0264-x; Shiraishi M, 2014, J NUTR SCI VITAMINOL, V60, P420, DOI 10.3177/jnsv.60.420; Tabrizi R, 2018, IRAN J MED SCI, V43, P125; U.S. Department of Agriculture Agricultural Research Service, 2009, USDA NAT NUTR DAT ST; Vanchinathan V, 2012, MAYO CLIN PROC, V87, P372, DOI 10.1016/j.mayocp.2011.12.010; WHO. World Health Organization, 1995, TECHNICAL REPORT SER, V854; Woon FC, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1219-3; Yong HY, 2017, FAM MED PRIM CARE RE, V19, P417, DOI 10.5114/fmpcr.2017.70819; Zaleha M. I., 2015, Malaysian Journal of Nutrition, V21, P179; Zerwekh JE, 2008, AM J CLIN NUTR, V87, p1087S, DOI 10.1093/ajcn/87.4.1087S; Zhang MX, 2015, NUTRIENTS, V7, P8366, DOI 10.3390/nu7105398	41	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0216439	10.1371/journal.pone.0216439	http://dx.doi.org/10.1371/journal.pone.0216439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233513	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000484896700004
J	Sharma, S; Schlatt, S; Van Pelt, A; Neuhaus, N				Sharma, Swati; Schlatt, Stefan; Van Pelt, Ans; Neuhaus, Nina			Characterization and population dynamics of germ cells in adult macaque testicular cultures	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; EXTRACELLULAR-MATRIX; SEMINIFEROUS EPITHELIUM; FERTILITY PRESERVATION; REPRODUCTIVE-ORGANS; IN-VITRO; SPERMATOGENESIS; PRIMATES; ORGANIZATION; MOUSE	Background From a biological and clinical perspective, it is imperative to establish primate spermatogonial cultures. Due to limited availability of human testicular tissues, the macaque (Macaca fascicularis) was employed as non-human primate model. The aim of this study was to characterize the expression of somatic as well as germ cell markers in testicular tissues and to establish macaque testicular primary cell cultures. Materials and methods Characterization of macaque testicular cell population was performed by immunohistochemical analyses for somatic cell markers (SOX9, VIM, SMA) as well as for germ cell markers (UTF1, MAGEA4, VASA). Testicular cells from adult macaque testes (n = 4) were isolated and cultured for 21 days using three stem cell culture media (SSC, PS and SM). An extended marker gene panel (SOX9, VIM, ACTA2; UTF1, FGFR3, MAGEA4, BOLL, DDX4) was then employed to assess the changes in gene expression levels and throughout the in vitro culture period. Dynamics of the spermatogonial population was further investigated by quantitative analysis of immunofluorescence-labeled MAGEA4-positive cells (n = 3). Results RNA expression analyses of cell cultures revealed that parallel to decreasing SOX9-expressing Sertoli cells, maintenance of VIM and ACTA2-expressing somatic cells was observed. Expression levels of germ cell marker genes UTF1, FGFR3 and MAGEA4 were maintained until day 14 in SSC and SM media. Findings from MAGEA4 immunofluorescence staining corroborate mRNA expression profiling and substantiate the overall maintenance of MAGEA4-positive pre-and early meiotic germ cells until day 14. Conclusions Our findings demonstrate maintenance of macaque germ cell subpopulations in vitro. This study provides novel perspective and proof that macaques could be used as a research model for establishing in vitro germ cell-somatic cell cultures, to identify ideal culture conditions for long-term maintenance of primate germ cell subpopulation in vitro.	[Sharma, Swati; Schlatt, Stefan; Neuhaus, Nina] Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, Munster, North Rhine Wes, Germany; [Van Pelt, Ans] Univ Amsterdam, Ctr Reprod Med, Amsterdam, Netherlands	University of Amsterdam	Schlatt, S (corresponding author), Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, Munster, North Rhine Wes, Germany.	stefan.schlatt@ukmuenster.de	SHARMA, SWATI/AAO-5946-2020	SHARMA, SWATI/0000-0001-6212-9879; van Pelt, Ans/0000-0001-9155-548X; Neuhaus, Nina/0000-0003-0181-6194	EU [EU-FP7-PEOPLE-2013-ITN603568]; Cells-in-Motion Excellence Cluster at the University Munster [EXC1003]; Clinical Research Group (DFG) [CRU 326]	EU(European Commission); Cells-in-Motion Excellence Cluster at the University Munster; Clinical Research Group (DFG)(German Research Foundation (DFG))	This work was primarily supported by funding from EU FP7 Marie Sklodowska Curie Initial Training Network Growsperm (EU-FP7-PEOPLE-2013-ITN603568) to S. Schlatt. Additional funds became available via the Cells-in-Motion Excellence Cluster (EXC1003) at the University Munster and the Clinical Research Group (DFG CRU 326) "Male Germ Cells: from genes to function" to S. Schlatt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baert Y, 2015, FERTIL STERIL, V104, P1244, DOI 10.1016/j.fertnstert.2015.07.1134; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chandolia RK, 2006, REPRODUCTION, V132, P355, DOI 10.1530/rep.1.01186; CHANDOLIA RK, 1991, ACTA ENDOCRINOL-COP, V125, P547, DOI 10.1530/acta.0.1250547; Chen SR, 2015, REPRODUCTION, V149, pR159, DOI 10.1530/REP-14-0481; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; de Rooij DG, 2017, DEVELOPMENT, V144, P3022, DOI 10.1242/dev.146571; DORRINGTON JH, 1975, MOL CELL ENDOCRINOL, V3, P57, DOI 10.1016/0303-7207(75)90031-3; Dreef HC, 2007, TOXICOL PATHOL, V35, P395, DOI 10.1080/01926230701230346; Ehmcke J, 2005, BIOL REPROD, V72, P293, DOI 10.1095/biolreprod.104.033092; Ehmcke J, 2008, REPRODUCTION, V136, P717, DOI 10.1530/REP-08-0093; Ehmcke J, 2006, REPRODUCTION, V132, P673, DOI 10.1530/rep.1.01081; Fayomi AP, 2018, STEM CELL RES, V29, P207, DOI 10.1016/j.scr.2018.04.009; Gassei K, 2010, J MED PRIMATOL, V39, P83, DOI 10.1111/j.1600-0684.2009.00397.x; HADLEY MA, 1985, J CELL BIOL, V101, P1511, DOI 10.1083/jcb.101.4.1511; Haruyama E, 2012, TOXICOL PATHOL, V40, P918, DOI 10.1177/0192623312444620; Haruyama E, 2012, TOXICOL PATHOL, V40, P935, DOI 10.1177/0192623312444619; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Hermann BP, 2010, REPRODUCTION, V139, P479, DOI 10.1530/REP-09-0255; Hermann BP, 2009, HUM REPROD, V24, P1704, DOI 10.1093/humrep/dep073; Jabarpour Masoome, 2018, Stem Cell Investig, V5, P1, DOI 10.21037/sci.2018.01.01; JANECKI A, 1987, MOL CELL ENDOCRINOL, V52, P125, DOI 10.1016/0303-7207(87)90105-5; KODANI M, 1966, P NATL ACAD SCI USA, V56, P1200, DOI 10.1073/pnas.56.4.1200; Kossack N, 2013, HUM REPROD, V28, P3012, DOI 10.1093/humrep/det336; Langenstroth D, 2014, HUM REPROD, V29, P2018, DOI 10.1093/humrep/deu157; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATHER JP, 1984, ANN NY ACAD SCI, V438, P572, DOI 10.1111/j.1749-6632.1984.tb38340.x; Medrano JV, 2016, FERTIL STERIL, V106, P1539, DOI 10.1016/j.fertnstert.2016.07.1065; Nickkholgh B, 2014, FERTIL STERIL, V102, P1700, DOI 10.1016/j.fertnstert.2014.08.022; Nickkholgh B, 2014, FERTIL STERIL, V102, P558, DOI 10.1016/j.fertnstert.2014.04.022; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Schlatt S, 2009, PEDIATR BLOOD CANCER, V53, P274, DOI 10.1002/pbc.22002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith JF, 2014, STEM CELL TRANSL MED, V3, P1043, DOI 10.5966/sctm.2014-0045; STEINBER.A, 1966, EXP CELL RES, V44, P443, DOI 10.1016/0014-4827(66)90451-4; STEINBERGER A, 1975, ENDOCR RES COMMUN, V2, P261, DOI 10.3109/07435807509053853; Steinberger A, 1975, METHODS ENZYMOLOGY D, V39, P238; Steinberger A, 1975, CURRENT TOPICS MOL E, V2, P339; Steinberger AJ, 1993, SERTOLI CELL, P155; Trondle I, 2017, MOL HUM REPROD, V23, P141, DOI 10.1093/molehr/gax003; von Schonfedt V, 1999, BIOL REPROD, V61, P582, DOI 10.1095/biolreprod61.3.582; WELSH MJ, 1975, ENDOCRINOLOGY, V96, P618, DOI 10.1210/endo-96-3-618; Wistuba J, 2003, BIOL REPROD, V69, P582, DOI 10.1095/biolreprod.103.015925; Zheng Y, 2014, HUM REPROD, V29, P2497, DOI 10.1093/humrep/deu232	45	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218194	10.1371/journal.pone.0218194	http://dx.doi.org/10.1371/journal.pone.0218194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226129	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700011
J	Shaw, MK; Porterfield, HS; Favaloro, S; Dehon, PM; Van der Pol, B; Quayle, AJ; McGowin, CL				Shaw, Meredith K.; Porterfield, Harry S.; Favaloro, Sue; Dehon, Patricia M.; Van der Pol, Barbara; Quayle, Alison J.; McGowin, Chris L.			Prevalence and cervical organism burden among Louisiana women with Trichomonas vaginalis infections	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; HUMAN-PAPILLOMAVIRUS; CANCER; GUIDELINES; CYTOLOGY	Trichomonas vaginalis is the most common curable sexually transmitted infection (STI) worldwide. Although predominately asymptomatic, the disease spectrum of trichomoniasis in women is characterized primarily by signs and symptoms of vaginitis, including purulent discharge and localized vulvar pruritus and erythema. Several FDA-cleared nucleic acid amplification tests (NAATs) are available for the diagnosis of T. vaginalis infections, but laboratory developed tests (LDTs) are widely utilized and cost-effective solutions in both the research and clinical diagnostic settings. LDT diagnosis of T. vaginalis is particularly appealing since it can be performed using remnant specimens collected for other STI testing. Using a LDT implemented as part of this study, T. vaginalis was detected in 7% of participating Louisiana women (14/199). The mean T. vaginalis organism burden was 1.0x10(6) +/- 4.5x10(5) organisms per mL of ThinPrep PreservCyt. Using DNA eluates obtained after HPV testing on the cobas 4800 system, the T. vaginalis LDT was characterized by excellent intra-and interassay reproducibility (coefficient of variation values all <3.5%). Compared with two commercially available NAATs from TIB MOLBIOL, the sensitivity and specificity of the LDT was 92.9 and 99.5%, respectively. Collectively, this study details the diagnostic and quantitative utility of a LDT for T. vaginalis. When applied in the clinical research setting, we confirmed the high prevalence of T. vaginalis, but also observed extraordinarily high organism burdens in the cervix. These findings highlight the unique host-pathogen relationship of T. vaginalis with lower reproductive tract tissues, and substantiate the need for continued investigation of this highly prevalent STI.	[Shaw, Meredith K.; Dehon, Patricia M.; Quayle, Alison J.; McGowin, Chris L.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Porterfield, Harry S.] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA USA; [Favaloro, Sue] Univ New Orleans, Med Ctr, Mol Pathol Lab, New Orleans, LA 70148 USA; [Van der Pol, Barbara] Univ Alabama Birmingham, Sch Med, Div Infect Dis, Birmingham, AL USA; [McGowin, Chris L.] Louisiana State Univ, Hlth Sci Ctr, Dept Internal Med, Infect Dis Sect, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Louisiana System; University of New Orleans; University of Alabama System; University of Alabama Birmingham; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Quayle, AJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA.	aquayl@lsuhsc.edu		Mott, Patricia/0000-0002-2333-4738	National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; Roche Diagnostics, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Roche Diagnostics, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health (1 U54 GM104940) to CLM, which funds the Louisiana Clinical and Translational Science Center and by the Investigator-initiated study support from Roche Diagnostics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Sarkodie Y, 2007, SEX TRANSM INFECT, V83, P130, DOI 10.1136/sti.2006.020941; Allsworth JE, 2009, SEX TRANSM DIS, V36, P738, DOI 10.1097/OLQ.0b013e3181b38a4b; [Anonymous], 2012, GLOB INC PREV SEL CU; Coleman JS, 2013, OBSTET GYNECOL SURV, V68, P43, DOI 10.1097/OGX.0b013e318279fb7d; Crucitti T, 2010, SEX TRANSM DIS, V37, P223, DOI 10.1097/OLQ.0b013e3181c21f93; Dehon PM, 2014, J CLIN MICROBIOL, V52, P2398, DOI 10.1128/JCM.00159-14; Hoots BE, 2013, SEX TRANSM DIS, V40, P113, DOI 10.1097/OLQ.0b013e31827c08c3; Kissinger P, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0484-7; Kissinger P, 2013, SEX TRANSM INFECT, V89, P426, DOI 10.1136/sextrans-2012-051005; Massad LS, 2012, J LOW GENIT TRACT DI, V16, P172, DOI 10.1097/LGT.0b013e31824bc178; Moodley P, 2002, CLIN INFECT DIS, V34, P519, DOI 10.1086/338399; Muzny CA, 2013, SEX TRANSM INFECT, V89, P423, DOI 10.1136/sextrans-2012-050893; Nathan B, 2015, INT J STD AIDS, V26, P251, DOI 10.1177/0956462414534833; PAISARNTANTIWONG R, 1995, SEX TRANSM DIS, V22, P344, DOI 10.1097/00007435-199511000-00004; RESNICK RM, 1990, JNCI-J NATL CANCER I, V82, P1477, DOI 10.1093/jnci/82.18.1477; Satterwhite CL, 2008, SEX TRANSM DIS, V35, pS3, DOI 10.1097/OLQ.0b013e31816b3219; Silver BJ, 2014, SEX TRANSM DIS, V41, P369, DOI 10.1097/OLQ.0000000000000134; Sutton M, 2007, CLIN INFECT DIS, V45, P1319, DOI 10.1086/522532; Van Der Pol B, 2016, J CLIN MICROBIOL, V54, P7, DOI 10.1128/JCM.02025-15; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	21	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0217041	10.1371/journal.pone.0217041	http://dx.doi.org/10.1371/journal.pone.0217041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220094	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500008
J	Sherer, ML; Khanal, P; Talham, G; Brannick, EM; Parcells, MS; Schwarz, JM				Sherer, Morgan L.; Khanal, Pragyan; Talham, Gwen; Brannick, Erin M.; Parcells, Mark S.; Schwarz, Jaclyn M.			Zika virus infection of pregnant rats and associated neurological consequences in the offspring	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; MICROGLIA; BRAIN; PATHOGENESIS; CHEMOKINES; OUTBREAK; AUTISM; STATES; MODEL	Zika virus (ZIKV) is a mosquito-borne flavivirus associated with microcephaly and other neurological disorders in infants born to infected mothers. Despite being declared an international emergency by the World Health Organization, very little is known about the mechanisms of ZIKV pathogenesis or the long-term consequences of maternal ZIKV infection in the affected offspring, largely due to the lack of appropriate rodent models. To address this issue, our lab has developed a working model of prenatal ZIKV infection in rats. In this study, we infected immune competent pregnant female rats with 10(5)-10(7) PFU of ZIKV (PRVABC59, Puerto Rico/Human/Dec 2015) in order to examine its pathogenesis in the dams and pups. We examined the febrile response and sickness behavior in the dams, in addition to neonatal mortality, microglia morphology, cortical organization, apoptosis, and brain region-specific volumes in the offspring. Here, we demonstrate that pregnant and non-pregnant female rats have a distinct febrile response to ZIKV infection. Moreover, prenatal ZIKV infection increased cell death and reduced tissue volume in the hippocampus and cortex in the neonatal offspring. For the first time, we demonstrate the efficacy and validity of an immunocompetent rat model for maternal ZIKV infection that results in significant brain malformations in the neonatal offspring.	[Sherer, Morgan L.; Khanal, Pragyan; Schwarz, Jaclyn M.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Talham, Gwen] Univ Delaware, Off Lab Anim Med, Newark, DE USA; [Brannick, Erin M.; Parcells, Mark S.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA	University of Delaware; University of Delaware; University of Delaware	Sherer, ML (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.	msherer@psych.udel.edu	Yue, Yuhang/AAW-9279-2021	Brannick, Erin/0000-0002-7045-3430	NIH-NIGMS [P20 GM103446]; NSF [IIA-1301765]; State of Delaware;  [S10 RR027273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); State of Delaware; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Microscopy access was supported by grants from the NIH-NIGMS (P20 GM103446), the NSF (IIA-1301765) and the State of Delaware. LSM780 confocal microscope (Wolf Hall): Microscopy equipment was acquired with a shared instrumentation grant (S10 RR027273) and access was supported by the NIH-NIGMS (P20 GM103446), the NSF (IIA-1301765) and the State of Delaware. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare no competing financial interests. The authors would like to recognize Julie Gomez for collecting data presented in this manuscript and Joanne Cooper of the University of Delaware Comparative Pathology Laboratory for performing the Hematoxylin and Eosin stain. Microscopy access was supported by grants from the NIH-NIGMS (P20 GM103446), the NSF (IIA-1301765) and the State of Delaware. LSM780 confocal microscope (Wolf Hall): Microscopy equipment was acquired with a shared instrumentation grant (S10 RR027273) and access was supported by the NIH-NIGMS (P20 GM103446), the NSF (IIA-1301765) and the State of Delaware.	Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158; Bilbo SD, 2018, EXP NEUROL, V299, P241, DOI 10.1016/j.expneurol.2017.07.002; Bilbo SD, 2010, PSYCHONEUROENDOCRINO, V35, P369, DOI 10.1016/j.psyneuen.2009.07.014; Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dantzer R, 2001, ANN NY ACAD SCI; de Noronha L, ZIKA VIRUS DAMAGES H; Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004; Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201; Gladwyn-Ng I, 2017, NAT NEUROSCI; Glaser J, 2007, STEREOLOGY BIOL RES; Gomez-Gonzalez B, 2010, ACTA NEUROPATHOL, V119, P303, DOI 10.1007/s00401-009-0590-4; Perez-Alvarez MJ, 2016, CURR PHARM DESIGN, V22, P1334, DOI 10.2174/138161282210160304112834; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005; Lledo P, 2012, J NEUROCHEM, P948, DOI [10.1111/j.1471-4159.2011.07630.x, DOI 10.1111/J.1471-4159.2011.07630.X]; Manangeeswaran M, 2016, ZIKA PRVABC59 INFECT, P1; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17; Mouton P.R., 2001, PRINCIPLES PRACTICES; van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI [10.1523/jneurosci.3124-16.2017, 10.1523/JNEUROSCI.3124-16.2017]; Nem I, 2018, ACUTE CHRONIC NEUROL, P1; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768; Sherer ML, 2017, BRAIN BEHAV IMMUN, V66, P201, DOI 10.1016/j.bbi.2017.06.016; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118; Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077; Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; WU CH, 1992, J ANAT, V181, P423; Zhang Z, 2015, BRAIN BEHAV IMMUN, V45, P60, DOI 10.1016/j.bbi.2014.10.010	49	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218539	10.1371/journal.pone.0218539	http://dx.doi.org/10.1371/journal.pone.0218539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220154	Green Submitted, gold, Green Published			2022-12-26	WOS:000484893500061
J	Wu, XJ; Yu, HY; Yang, RW; Zhou, YY; Zhu, XF; Wang, YY; Liu, XY; Fan, HY; Chen, LJ; Duan, YX				Wu, Xiaojing; Yu, Hongyan; Yang, Rouwei; Zhou, Yuanyuan; Zhu, Xiaofeng; Wang, Yuanyuan; Liu, Xiaoyu; Fan, Haiyan; Chen, Lijie; Duan, Yuxi			Evaluation of suitable reference genes for gene expression analysis in the northern root-knot nematode, Meloidogyne hapla	PLOS ONE			English	Article							TIME RT-PCR; REAL-TIME; QUANTITATIVE-PCR; HOUSEKEEPING GENES; IDENTIFICATION; NORMALIZATION; SELECTION; VALIDATION	The northern root-knot nematode (Meloidogyne hapla) is a critical pathogen with a wide host range. Quantitative real-time polymerase chain reaction (qRT-PCR) has been used to elucidate gene expression and function of M. hapla. Suitable reference genes are required to ensure accurate results of qRT-PCR for normalising gene expression. Eleven candidate reference genes of M. hapla were selected to evaluate gene expression stability under different conditions. The stability of candidate reference genes was ranked using RefFinder analysis, and the optimal number of reference genes was recommended with geNorm. Notably, the most stable reference genes were SDHA, Mdh, and RpS6 for all samples; SDHA and RpS6 were particularly stable during development stage treatments, whereas Mdh and RpS6 were appropriate for temperature and inorganic compound treatments. In contrast, the least stable reference genes were Actin1 during development stages and all other treatments, GAPDH for temperature treatments, and a-Tub for inorganic compound treatments. One target gene, Mh-Hsp90, was used to verify the selection of reference genes, results showed Mdh and RpS6 could be used as suitable reference genes for M. hapla, and Mdh plus RpS6 were better. Our finding contributes to further work on gene transcription analysis in M. hapla.	[Wu, Xiaojing; Yu, Hongyan; Yang, Rouwei; Zhou, Yuanyuan; Zhu, Xiaofeng; Fan, Haiyan; Chen, Lijie; Duan, Yuxi] Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China; [Wang, Yuanyuan] Shenyang Agr Univ, Coll Biol Sci & Technol, Shenyang, Liaoning, Peoples R China; [Liu, Xiaoyu] Shenyang Agr Univ, Coll Sci, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University; Shenyang Agricultural University	Chen, LJ; Duan, YX (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China.	chen-0210@syau.edu.cn; duanyx6407@163.com	Wang, Yu/GZL-9655-2022; Wang, Yuan/HHC-1520-2022; Zhu, Xiaofeng/AFT-5278-2022; Lv, Yuanjie/AER-0767-2022; wangwangwang, yuanyaun/HHN-6432-2022		National Natural Science Foundation of China [31471748]; Major Fund for National Natural Science Foundation of China [31330063]; Mount Tianzhu Scholar Funding Scheme, Special Fund for Agro-scientific Research in the Public Interest [201103018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Fund for National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mount Tianzhu Scholar Funding Scheme, Special Fund for Agro-scientific Research in the Public Interest	This work was supported by National Natural Science Foundation of China (grant number: 31471748), Major Fund for National Natural Science Foundation of China (grant number: 31330063), and Mount Tianzhu Scholar Funding Scheme, Special Fund for Agro-scientific Research in the Public Interest (grant number: 201103018).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bai CM, 2014, INT J AGRIC BIOL, V16, P451; Blanc-Mathieu R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006777; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; De Luca F, 2009, GENE, V440, P16, DOI 10.1016/j.gene.2009.03.020; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; FORGE TA, 1990, J NEMATOL, V22, P101; Gleason C, 2017, MOL PLANT MICROBE IN, V30, P101, DOI 10.1094/MPMI-06-16-0107-R; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jaramillo ML, 2017, GENE, V598, P97, DOI 10.1016/j.gene.2016.11.001; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Koenning SR, 1999, J NEMATOL, V31, P587; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Li MY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01481; Li M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00037; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052126; Mbeunkui F, 2010, J PROTEOME RES, V9, P5370, DOI 10.1021/pr1006069; Moens M, 2010, ROOT-KNOT NEMATODES, P1; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ransbotyn V, 2006, LIMNOL OCEANOGR-METH, V4, P367, DOI 10.4319/lom.2006.4.367; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; ROBLEDO D, 2014, BMC GENOMICS, V15; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Su YL, 2013, J ECON ENTOMOL, V106, P1446, DOI 10.1603/EC12459; Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979; Taylor A, 1978, BIOL IDENTIFICATION, P35; TAYLOR A.L., 1982, RELATIONSHIP CLIMATE; Tian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117569; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Wu X, 2017, NO HORTICULTURE, V24, P53; Wu XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190531; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]	47	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218610	10.1371/journal.pone.0218610	http://dx.doi.org/10.1371/journal.pone.0218610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216347	Green Submitted, Green Published, gold			2022-12-26	WOS:000482885300060
J	Farkas, Z; Petric, M; Liu, XH; Herit, F; Rajnavolgyi, E; Szondy, Z; Budai, Z; Orban, LI; Sandor, S; Mehta, A; Bajtay, Z; Kovacs, T; Jung, SY; Shakir, MA; Qin, J; Zhou, Z; Niedergang, F; Boissan, M; Takacs-Vellai, K				Farkas, Zsolt; Petric, Metka; Liu, Xianghua; Herit, Floriane; Rajnavolgyi, Eva; Szondy, Zsuzsa; Budai, Zsofia; Orban, Limas, I; Sandor, Sara; Mehta, Anil; Bajtay, Zsuzsa; Kovacs, Tibor; Jung, Sung Yun; Shakir, Muhammed Afaq; Qin, Jun; Zhou, Zheng; Niedergang, Florence; Boissan, Mathieu; Takacs-Vellai, Krisztina			The nucleoside diphosphate kinase NDK-1/NME1 promotes phagocytosis in concert with DYN-1/Dynamin	FASEB JOURNAL			English	Article						metastasis inhibitor; apoptotic clearance; phagosome formation; phagosome maturation; actin cup	PHAGOSOME MATURATION; RECEPTOR CED-1; DYNAMIN; GTP; ENGULFMENT; PROTEINS; NEMATODE	Phagocytosis of various targets, such as apoptotic cells or opsonized pathogens, by macrophages is coordinated by a complex signaling network initiated by distinct phagocytic receptors. Despite the different initial signaling pathways, each pathway ends up regulating the actin cytoskeletal network, phagosome formation and closure, and phagosome maturation leading to degradation of the engulfed particle. Herein, we describe a new phagocytic function for the nucleoside diphosphate kinase 1 (NDK-1), the nematode counterpart of the first identified metastasis inhibitor NM23-H1 (nonmetastatic clone number 23) nonmetastatic clone number 23 or nonmetastatic isoform 1 (NME1). We reveal by coimmunoprecipitation, Duolink proximity ligation assay, and mass spectrometry that NDK-1/NME1 works in a complex with DYN-1/Dynamin (Caenorhabditis elegans/human homolog proteins), which is essential for engulfment and phagosome maturation. Time-lapse microscopy shows that NDK-1 is expressed on phagosomal surfaces during cell corpse clearance in the same time window as DYN-1. Silencing of NM23-M1 in mouse bone marrow-derived macrophages resulted in decreased phagocytosis of apoptotic thymocytes. In human macrophages, NM23-H1 and Dynamin are corecruited at sites of phagosome formation in F-actin-rich cups. In addition, NM23-H1 was required for efficient phagocytosis. Together, our data demonstrate that NDK-1/NME1 is an evolutionarily conserved element of successful phagocytosis.-Farkas, Z., Petric, M., Liu, X., Herit, F., Rajnavolgyi, e., Szondy, Z., Budai, Z., Orban, T. I., Sandor, S., Mehta, A., Bajtay, Z., Kovacs, T., Jung, S. Y., Afaq Shakir, M., Qin, J., Zhou, Z., Niedergang, F., Boissan, M., Takacs-Vellai, K. The nucleoside diphosphate kinase NDK-1/NME1 promotes phagocytosis in concert with DYN-1/dynamin.	[Farkas, Zsolt; Takacs-Vellai, Krisztina] Eotvos Lorand Univ, Dept Biol Anthropol, Pazmany Peter Stny 1-C, H-1117 Budapest, Hungary; [Bajtay, Zsuzsa] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Bajtay, Zsuzsa] Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, Budapest, Hungary; [Kovacs, Tibor] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Petric, Metka; Herit, Floriane; Niedergang, Florence] INSERM, Unite 1016, Inst Cochin, Paris, France; [Petric, Metka; Herit, Floriane; Niedergang, Florence] CNRS, UMR 8104, Paris, France; [Petric, Metka; Herit, Floriane; Niedergang, Florence] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Liu, Xianghua; Jung, Sung Yun; Shakir, Muhammed Afaq; Qin, Jun; Zhou, Zheng] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Verna & Marrs McLean Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Rajnavolgyi, Eva] Univ Debrecen, Dept Immunol, Debrecen, Hungary; [Szondy, Zsuzsa; Budai, Zsofia] Univ Debrecen, Dept Biochem & Mol Biol, Debrecen, Hungary; [Orban, Limas, I; Sandor, Sara] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Mehta, Anil] Ninewells Hosp Med Sch, Div Med Sci, Dundee, Scotland; [Boissan, Mathieu] UPMC Paris 06, Sorbonne Univ, INSERM, UMR S938,St Antoine Res Ctr, Paris, France; [Boissan, Mathieu] Hosp Tenon, AP HP, Serv Biochim & Hormonol, Paris, France	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; Baylor College of Medicine; University of Debrecen; University of Debrecen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Dundee; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Takacs-Vellai, K (corresponding author), Eotvos Lorand Univ, Dept Biol Anthropol, Pazmany Peter Stny 1-C, H-1117 Budapest, Hungary.	takacsk@falco.elte.hu	Takacs-Vellai, Krisztina/AAF-9062-2020; bajtay, zsuzsa/AAI-1267-2020; Kovács, Tibor/AAF-9714-2020; Farkas, Zsolt/AAF-9966-2020; Orban, Tamas/N-1160-2016	Takacs-Vellai, Krisztina/0000-0002-4472-0363; Farkas, Zsolt/0000-0001-8531-8912; Jung, Sung Yun/0000-0003-1521-7977; Orban, Tamas/0000-0002-3424-3428; Kovacs, Tibor/0000-0002-0632-9128; Sandor, Sara/0000-0002-2945-8379; Niedergang, Florence/0000-0002-7064-830X	Hungarian Scientific Research Fund (OTKA) [K115587, K112112, K124244]; European Union [GINOP-2.3.2-15-2016-00006]; European Regional Development Fund; uNKP-17-3 New National Excellence Program of the Ministry of Human Capacities grant; Hungarian Ministry of Human Capacities [1783-3/2018/FEKUTSRAT]; Centre National de la Recherche Scientifique (CNRS); INSERM; Universite Paris Descartes; Agence Nationale de la Recherche [ANR 16-CE13-0007-01]; U.S. National Institutes of Health, National Institute of General Medical Sciences [R01GM067848]; Sorbonne Universite; Groupe des Entreprises Francaises de Lutte Contre le Cancer (GEFLUC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104279, R01GM067848] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Regional Development Fund(European Commission); uNKP-17-3 New National Excellence Program of the Ministry of Human Capacities grant; Hungarian Ministry of Human Capacities; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; Agence Nationale de la Recherche(French National Research Agency (ANR)); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Sorbonne Universite; Groupe des Entreprises Francaises de Lutte Contre le Cancer (GEFLUC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Hungarian Scientific Research Fund (OTKA) Grants K115587 (to K.T.-V.), K112112 (to T.I.O.), and K124244 (to Z.S.); the GINOP-2.3.2-15-2016-00006 Project (cofinanced by the European Union and the European Regional Development Fund) (to Z.S.); and the uNKP-17-3 New National Excellence Program of the Ministry of Human Capacities grant (to Z.F.). This work was completed in the ELTE Institutional Excellence Program (1783-3/2018/FEKUTSRAT) supported by the Hungarian Ministry of Human Capacities. Work in the F.N. laboratory was supported by Centre National de la Recherche Scientifique (CNRS), INSERM, Universite Paris Descartes, and the Agence Nationale de la Recherche (ANR 16-CE13-0007-01). The work of the Z.Z. laboratory was financed by U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01GM067848. Work in the M.B. laboratory was supported by INSERM, Sorbonne Universite, and Groupe des Entreprises Francaises de Lutte Contre le Cancer (GEFLUC). Z.Z., F.N., M.B., and K.T.-V. are colast authors. The authors declare no conflicts of interest.	Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Boissan M, 2014, SCIENCE, V344, P1510, DOI 10.1126/science.1253768; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; BRENNER S, 1974, GENETICS, V77, P71; Chiu H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07291-x; Conradt B, 2016, GENETICS, V203, P1533, DOI 10.1534/genetics.115.186247; Dumas A, 2015, J CELL BIOL, V211, P359, DOI 10.1083/jcb.201503124; Fancsalszky L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092687; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; He B, 2010, MOL BIOL CELL, V21, P610, DOI 10.1091/mbc.E09-05-0440; Jin YS, 1999, PRACT APPROACH SER, V213, P69; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Li Zao, 2013, Methods Mol Biol, V1004, P183, DOI 10.1007/978-1-62703-383-1_14; Lu N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001245; Lu N, 2012, INT REV CEL MOL BIO, V293, P269, DOI 10.1016/B978-0-12-394304-0.00013-0; Marie-Anais F, 2016, TRAFFIC, V17, P487, DOI 10.1111/tra.12386; Marion S, 2012, DEV CELL, V23, P954, DOI 10.1016/j.devcel.2012.09.021; Masoudi N, 2013, DEVELOPMENT, V140, P3486, DOI 10.1242/dev.094011; Mazzolini J, 2010, BLOOD, V115, P4226, DOI 10.1182/blood-2009-12-259473; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steeg PS, 2003, CANCER LETT, V190, P1, DOI 10.1016/S0304-3835(02)00499-8; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	34	5	5	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11606	11614		10.1096/fj.201900220R	http://dx.doi.org/10.1096/fj.201900220R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31242766	Green Published, Bronze			2022-12-26	WOS:000489166300082
J	Kennedy, L; Francis, H; Invernizzi, P; Venter, J; Wu, N; Carbone, M; Gershwin, ME; Bernuzzi, F; Franchitto, A; Alvaro, D; Marzioni, M; Onori, P; Gaudio, E; Sybenga, A; Fabris, L; Meng, FY; Glaser, S; Alpini, G				Kennedy, Lindsey; Francis, Heather; Invernizzi, Pietro; Venter, Julie; Wu, Nan; Carbone, Marco; Gershwin, M. Eric; Bernuzzi, Francesca; Franchitto, Antonio; Alvaro, Domenico; Marzioni, Marco; Onori, Paolo; Gaudio, Eugenio; Sybenga, Amelia; Fabris, Luca; Meng, Fanyin; Glaser, Shannon; Alpini, Gianfranco			Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis	FASEB JOURNAL			English	Article						angiogenesis; cellular senescence; cholangiopathies; miR-125b; liver damage	NONSUPPURATIVE DESTRUCTIVE CHOLANGITIS; PLACEBO-CONTROLLED TRIAL; FUNCTIONAL-HETEROGENEITY; CELLULAR SENESCENCE; OBETICHOLIC ACID; UP-REGULATION; BILE-DUCTS; EXPRESSION; CIRRHOSIS; SECRETIN	Primary biliary cholangitis (PBC) primarily targets cholangiocytes and is characterized by liver fibrosis and biliary proliferation. Activation of the secretin (Sct)/secretin receptor (SR) axis, expressed only by cholangiocytes, increases biliary proliferation, liver fibrosis, and bicarbonate secretion. We evaluated the effectiveness of SR antagonist treatment for early-stage PBC. Male and female dominant-negative TGF-beta receptor II (dnTGF-beta RII) (model of PBC) and wild-type mice at 12 wk of age were treated with saline or the SR antagonist, Sec 5-27, for 1 wk. dnTGF-beta RII mice expressed features of early-stage PBC along with enhanced Sct/SR axis activation and Sct secretion. dnTGF-beta RII mice had increased biliary proliferation or senescence, inflammation, and liver fibrosis. In dnTGF-beta RII mice, there was increased microRNA-125b/TGF-beta 1/TGF-beta receptor 1/VEGF-A signaling. Human early-stage PBC patients had an increase in hepatobiliary Sct and SR expression and serum Sct levels. Increased biliary Sct/SR signaling promotes biliary and hepatic damage during early-stage PBC.-Kennedy, L., Francis, H., Invernizzi, P., Venter, J., Wu, N., Carbone, M., Gershwin, M. E., Bernuzzi, F., Franchitto, A., Alvaro, D., Marzioni, M., Onori, P., Gaudio, E., Sybenga, A., Fabris, L., Meng, F., Glaser, S., Alpini, G. Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis.	[Kennedy, Lindsey; Francis, Heather; Meng, Fanyin; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Res, Temple, TX USA; [Kennedy, Lindsey; Francis, Heather; Venter, Julie; Wu, Nan; Glaser, Shannon; Alpini, Gianfranco] Texas A&M Univ, Coll Med, Dept Med Physiol, Temple, TX 76508 USA; [Francis, Heather; Meng, Fanyin; Glaser, Shannon; Alpini, Gianfranco] Baylor Scott & White Hlth, Digest Dis Res Ctr, Temple, TX USA; [Invernizzi, Pietro; Carbone, Marco; Bernuzzi, Francesca] Humanitas Clin & Res Ctr, Rozzano, MI, Italy; [Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Franchitto, Antonio] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy; [Alvaro, Domenico] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rome, Italy; [Onori, Paolo; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy; [Marzioni, Marco] Univ Politecn Marche, Clin Gastroenterol & Hepatol, Ancona, Italy; [Sybenga, Amelia] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Fabris, Luca] Univ Padua, Sch Med, Dept Mol Med, Padua, Italy; [Fabris, Luca] Yale Univ, Sch Med, Digest Dis Sect, New Haven, CT USA; [Kennedy, Lindsey; Francis, Heather; Venter, Julie; Wu, Nan; Meng, Fanyin; Alpini, Gianfranco] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Invernizzi, Pietro; Carbone, Marco; Bernuzzi, Francesca] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy	Texas A&M University System; Baylor Health Care System; IRCCS Humanitas Research Hospital; University of California System; University of California Davis; Sapienza University Rome; Sapienza University Rome; Marche Polytechnic University; Vanderbilt University; University of Padua; Yale University; Indiana University System; Indiana University Bloomington; University of Milano-Bicocca	Alpini, G (corresponding author), Indiana Univ Sch Med, Indiana Ctr Liver Res, Div Gastroenterol & Hepatol, Dept Med,Richard L Roudebush VA Med Ctr, 1481 W 10th St Dedicat Wing Room C-7151, Indianapolis, IN 46202 USA.	galpini@iu.edu	bernuzzi, francesca/AAQ-7073-2020; Fabris, Luca/J-7565-2018; Marzioni, Marco/A-8153-2011; Invernizzi, Pietro/AAB-8367-2022; Onori, Paolo/J-9394-2013; ALVARO, Domenico/J-8600-2018	Fabris, Luca/0000-0001-8538-6317; Marzioni, Marco/0000-0001-6014-6165; Invernizzi, Pietro/0000-0003-3262-1998; Onori, Paolo/0000-0002-7195-3760; ALVARO, Domenico/0000-0003-3771-9644; Cadamuro, Massimiliano/0000-0002-0899-7613	Veterans Affairs Merit Awards from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service [1I01BX003031, 4I01BX000574, 1I01BX001724]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK054811, DK076898, DK107310, DK110035, DK062975, DK108959]; NIH National Institute on Alcohol Abuse and Alcoholism Grants [AA025997, AA025157]; Partners Seeking a Cure (PSC) [460933-00001]; Baylor Scott White Health; University of Rome "La Sapienza"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108959, R01DK076898, R01DK110035, R01DK054811, R01DK107310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA025997, R21AA025157] Funding Source: NIH RePORTER; Veterans Affairs [IK6BX004601, I01BX001724, I01BX000574, I01BX003031] Funding Source: NIH RePORTER	Veterans Affairs Merit Awards from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Alcohol Abuse and Alcoholism Grants; Partners Seeking a Cure (PSC); Baylor Scott White Health; University of Rome "La Sapienza"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	Portions of this work were supported by Veterans Affairs Merit Awards (1I01BX003031 to H.F., 4I01BX000574 to G.A., and 1I01BX001724 to F.M.) from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK054811, DK076898, DK107310, DK110035, DK062975 (to G.A., S.G., and F.M.), DK108959 (to H.F.), and NIH National Institute on Alcohol Abuse and Alcoholism Grants AA025997 and AA025157 to F.M., S.G., and G.A.; The Partners Seeking a Cure (PSC) Grant Award 460933-00001 and Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Baylor Scott & White Health (to G.A.); and Development Service by University of Rome "La Sapienza" (to P.O.). This material is the result of work supported with resources and the use of facilities at the Central Texas Veterans Health Care System (Temple, Texas, USA). The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Veteran's Affairs or the United States Government. F.M., S.G., and G.A. share senior authorship. The authors declare no conflicts of interest.	Aiba Y, 2014, LIVER INT, V34, P679, DOI 10.1111/liv.12296; ALPINI G, 1994, AM J PHYSIOL, V266, pG922, DOI 10.1152/ajpgi.1994.266.5.G922; Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073; Alpini Gianfranco, 1997, American Journal of Physiology, V272, pG1064; ALVARO D, 1993, J CLIN INVEST, V92, P1314, DOI 10.1172/JCI116705; Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Barnes BH, 2009, LIVER INT, V29, P1253, DOI 10.1111/j.1478-3231.2008.01921.x; Berg PA, 1997, SEMIN LIVER DIS, V17, P115, DOI 10.1055/s-2007-1007189; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Corpechot C, 2000, HEPATOLOGY, V32, P1196, DOI 10.1053/jhep.2000.20240; Erice O, 2018, HEPATOLOGY, V67, P1420, DOI 10.1002/hep.29533; Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030; Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657; Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6; Harada K, 2005, HEPATOLOGY, V41, P1329, DOI 10.1002/hep.20705; Harada K, 1997, HEPATOLOGY, V26, P1399; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Hisamoto S, 2016, J AUTOIMMUN, V75, P150, DOI 10.1016/j.jaut.2016.08.006; Hohenester S, 2011, DIGEST DIS, V29, P62, DOI 10.1159/000324687; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; KNITTEL T, 1995, HEPATOLOGY, V21, P470, DOI 10.1002/hep.1840210231; Korner M, 2006, J HEPATOL, V45, P825, DOI 10.1016/j.jhep.2006.06.016; Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; LeSage GD, 1999, AM J PHYSIOL-GASTR L, V276, pG1289, DOI 10.1152/ajpgi.1999.276.5.G1289; Lleo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25906; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Mancinelli R, 2010, AM J PATHOL, V176, P1790, DOI 10.2353/ajpath.2010.090677; MARTINEZANSO E, 1994, HEPATOLOGY, V19, P1400, DOI 10.1002/hep.1840190613; Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Podda M, 2013, J AUTOIMMUN, V46, P81, DOI 10.1016/j.jaut.2013.06.015; ROLL J, 1983, NEW ENGL J MED, V308, P1, DOI 10.1056/NEJM198301063080101; Rudic JS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000551.pub3; Salas JT, 2008, GASTROENTEROLOGY, V134, P1482, DOI 10.1053/j.gastro.2008.02.020; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005; Sasaki M, 2014, DIGEST DIS SCI, V59, P358, DOI 10.1007/s10620-013-2920-6; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Sood S, 2004, GASTROENTEROLOGY, V127, P470, DOI 10.1053/j.gastro.2004.04.064; Tsuda M, 2013, HEPATOLOGY, V57, P806, DOI 10.1002/hep.25829; VUORISTO M, 1995, GASTROENTEROLOGY, V108, P1470, DOI 10.1016/0016-5085(95)90696-7; Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138; Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622; Yin H, 2015, EXP CELL RES, V339, P252, DOI 10.1016/j.yexcr.2015.09.015; Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9	51	20	20	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10269	10279		10.1096/fj.201802606R	http://dx.doi.org/10.1096/fj.201802606R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31251081	Bronze, Green Published			2022-12-26	WOS:000482214200044
J	Rasmuson, J; Kenne, E; Wahlgren, M; Soehnlein, O; Lindbom, L				Rasmuson, Joel; Kenne, Ellinor; Wahlgren, Mats; Soehnlein, Oliver; Lindbom, Lennart			Heparinoid sevuparin inhibits Streptococcus-induced vascular leak through neutralizing neutrophil-derived proteins	FASEB JOURNAL			English	Article						inflammation; vascular permeability; heparin; sepsis	NONANTICOAGULANT HEPARIN; BINDING PROTEIN; IN-VITRO; INCREASE; SEPSIS; MYELOPEROXIDASE; PERMEABILITY	Acute lung injury (ALI) and respiratory distress can develop as a consequence of sepsis with pathogens such as group A Streptococcus (GAS). In the pathogenesis of sepsis-associated ALI, endothelial barrier disruption brought on by phagocyte activation is considered a causative factor. Here, we find that sevuparin, a heparinoid with low anticoagulant activity, prevents neutrophil-induced lung plasma leakage in a murine model of systemic inflammation evoked by heat-killed GAS (hkGAS). Furthermore, using human neutrophils and endothelial cell monolayers, we demonstrate that sevuparin inhibits hkGAS-induced endothelial barrier disruption by neutralizing the activity of neutrophil-derived proteins. By mass spectrometry of neutrophil secretion, we identify proteins, including serprocidins, S100 proteins, and histone H4, that interact with sevuparin and that are responsible for the disruptive effect on endothelial integrity. Collectively, our results demonstrate the critical role of neutrophil-derived proteins in vascular hyperpermeability caused by GAS and suggest sevuparin as a potential therapeutic in acute neutrophilic inflammation.-Rasmuson, J., Kenne, E., Wahlgren, M., Soehnlein, O., Lindbom, L. Heparinoid sevuparin inhibits Streptococcus-induced vascular leak through neutralizing neutrophil-derived proteins.	[Rasmuson, Joel; Kenne, Ellinor; Soehnlein, Oliver; Lindbom, Lennart] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Wahlgren, Mats] Modus Therapeut AB, Stockholm, Sweden; [Soehnlein, Oliver] Ludwig Maximilian Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Soehnlein, Oliver] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Berlin, Germany	Karolinska Institutet; Karolinska Institutet; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Lindbom, L (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	lennart.lindbom@ki.se	Kenne, Ellinor/HCH-1218-2022		Swedish Research Council; Swedish Heart-Lung Foundation; Torsten Soderberg Foundation; Lars Hierta Memorial Fund; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten Soderberg Foundation; Lars Hierta Memorial Fund; Karolinska Institutet(Karolinska Institutet)	The authors acknowledge Drs. Anna Leitgeb (Dilaforette, Stockholm, Sweden) and Alexey Chernobrovkin (Karolinska Institutet, Stockholm, Sweden) for contributing valuable information and advice. Proteomic analysis was carried out at Proteomics Karolinska (PK/KI; http://ki.se/en/mbb/proteomics-karolinska-pkki). This work was supported by the Swedish Research Council, the Swedish Heart-Lung Foundation, the Torsten Soderberg Foundation, the Lars Hierta Memorial Fund, and Karolinska Institutet. M.W. holds shares in and is the chief scientific officer of Modus Therapeutics. The other authors declare no conflicts of interest.	ARDITI M, 1994, INFECT IMMUN, V62, P3930, DOI 10.1128/IAI.62.9.3930-3936.1994; Bentzer Peter, 2016, Intensive Care Med Exp, V4, P33; Brown RA, 2003, BRIT J PHARMACOL, V139, P845, DOI 10.1038/sj.bjp.0705291; Byfield FJ, 2011, AM J PHYSIOL-CELL PH, V300, pC105, DOI 10.1152/ajpcell.00158.2010; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Erga KS, 2001, ACTA PHYSIOL SCAND, V171, P419, DOI 10.1046/j.1365-201X.2001.00810.x; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Kenne E, 2019, FASEB J, V33, P2599, DOI 10.1096/fj.201801329R; Kim SH, 2012, BLOOD, V120, P4892, DOI 10.1182/blood-2012-05-428243; Lewis SM, 2013, INT IMMUNOPHARMACOL, V17, P1226, DOI 10.1016/j.intimp.2013.10.002; Li X, 2017, BRIT J HAEMATOL, V179, P389, DOI 10.1111/bjh.14885; Lin QH, 2013, CRIT CARE, V17, DOI 10.1186/cc12834; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; Malmstrom E, 2014, THROMB HAEMOSTASIS, V112, P1230, DOI 10.1160/TH14-04-0312; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; MINNICOZZI M, 1994, J IMMUNOL, V153, P2664; Mulloy B, 2016, PHARMACOL REV, V68, P76, DOI 10.1124/pr.115.011247; Patterson EK, 2014, FREE RADICAL BIO MED, V70, P167, DOI 10.1016/j.freeradbiomed.2014.02.020; Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533; PETERSON MW, 1987, J APPL PHYSIOL, V62, P1521, DOI 10.1152/jappl.1987.62.4.1521; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Telen MJ, 2016, BRIT J HAEMATOL, V175, P935, DOI 10.1111/bjh.14303; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; Wang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096765; Wildhagen KCAA, 2014, BLOOD, V123, P1098, DOI 10.1182/blood-2013-07-514984; Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zhou JY, 2013, PROTEOM CLIN APPL, V7, P571, DOI 10.1002/prca.201200109	37	14	15	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10443	10452		10.1096/fj.201900627R	http://dx.doi.org/10.1096/fj.201900627R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31216421				2022-12-26	WOS:000482214200057
J	Gospe, SM; Travis, AM; Kolesnikov, AV; Klingeborn, M; Wang, LY; Kefalov, VJ; Arshaysky, VY				Gospe, Sidney M., III; Travis, Amanda M.; Kolesnikov, Alexander, V; Klingeborn, Mikael; Wang, Luyu; Kefalov, Vladimir J.; Arshaysky, Vadim Y.			Photoreceptors in a mouse model of Leigh syndrome are capable of normal light-evoked signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retina; photoreceptor; gene knockout; transgenic mice; phototransduction; neurological disease; NADH:ubiquinone oxidoreductase subunit S4 (NDUFS4); optic atrophy	HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL; TRANSDUCIN; GLUCOSE; CELLS; MICE; TRANSLOCATION; CHILDREN	Mitochondrial dysfunction is an important cause of heritable vision loss. Mutations affecting mitochondrial bioenergetics may lead to isolated vision loss or life-threatening systemic disease, depending on a mutation's severity. Primary optic nerve atrophy resulting from death of retinal ganglion cells is the most prominent ocular manifestation of mitochondrial disease. However, dysfunction of other retinal cell types has also been described, sometimes leading to a loss of photoreceptors and retinal pigment epithelium that manifests clinically as pigmentary retinopathy. A popular mouse model of mitochondrial disease that lacks NADH:ubiquinone oxidoreductase subunit S4 (NDUFS4), a subunit of mitochondrial complex I, phenocopies many traits of the human disease Leigh syndrome, including the development of optic atrophy. It has also been reported that ndufs4(-/-) mice display diminished light responses at the level of photoreceptors or bipolar cells. By conducting electroretinography (ERG) recordings in live ndufs4(-/-) mice, we now demonstrate that this defect occurs at the level of retinal photoreceptors. We found that this deficit does not arise from retinal developmental anomalies, photoreceptor degeneration, or impaired regeneration of visual pigment. Strikingly, the impairment of ndufs4(-/-) photoreceptor function was not observed in ex vivo ERG recordings from isolated retinas, indicating that photoreceptors with complex I deficiency are intrinsically capable of normal signaling. The difference in electrophysiological phenotypes in vivo and ex vivo suggests that the energy deprivation associated with severe mitochondrial impairment in the outer retina renders ndufs4(-/-) photoreceptors unable to maintain the homeostatic conditions required to operate at their normal capacity.	[Gospe, Sidney M., III; Klingeborn, Mikael; Wang, Luyu; Arshaysky, Vadim Y.] Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA; [Travis, Amanda M.; Arshaysky, Vadim Y.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Kolesnikov, Alexander, V; Kefalov, Vladimir J.] Washington Univ, Dept Ophthalmol & Visual Sci, Sch Med, St Louis, MO 63110 USA; [Travis, Amanda M.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA	Duke University; Duke University; Washington University (WUSTL); University of Michigan System; University of Michigan	Gospe, SM (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA.	sid.gospe@duke.edu	Klingeborn, Mikael/AAC-2471-2019; Kolesnikov, Alexander V/O-1840-2016	Klingeborn, Mikael/0000-0003-2907-0371; Kefalov, Vladimir/0000-0002-1659-008X; Gospe III, Sidney/0000-0003-2838-7983	NEI, National Institutes of Health [EY028610, EY022959, EY025696, EY027387, EY005722, EY002687]; Duke University School of Medicine Strong Start award; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022959, R01EY019312, R01EY027387, P30EY002687, K08EY028610, P30EY005722, R01EY025696] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Duke University School of Medicine Strong Start award; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health Grants EY028610 (to S.M.G.), EY022959 (to V.Y.A.), EY025696 and EY027387 (to V.J.K.), and Core Grants EY005722 (to Duke University) and EY002687 (to Washington University) as well as a Duke University School of Medicine Strong Start award (to S.M.G.) and an unrestricted Research to Prevent Blindness grant (to Duke Eye Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akebrand R, 2016, ACTA OPHTHALMOL, V94, P609, DOI 10.1111/aos.12983; BORGULA GA, 1989, VISION RES, V29, P1069, DOI 10.1016/0042-6989(89)90054-0; BOWNDS D, 1971, J GEN PHYSIOL, V58, P225, DOI 10.1085/jgp.58.3.225; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Contreras L, 2016, MOL VIS, V22, P1198; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; Gronlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187; Herrmann R, 2010, J NEUROSCI, V30, P3239, DOI 10.1523/JNEUROSCI.4775-09.2010; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kirches E, 2011, CURR GENOMICS, V12, P44, DOI 10.2174/138920211794520150; KNOSPE V, 1988, CURR EYE RES, V7, P1137, DOI 10.3109/02713688809001885; Kolesnikov AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3424; Korsten A, 2010, BBA-BIOENERGETICS, V1797, P197, DOI 10.1016/j.bbabio.2009.10.003; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551; Lefevere E, 2017, MITOCHONDRION, V36, P66, DOI 10.1016/j.mito.2017.03.006; Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Ogilvie JM, 2007, P NATL ACAD SCI USA, V104, P8514, DOI 10.1073/pnas.0702899104; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Philp NJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1319, DOI 10.1152/ajpcell.2001.280.5.C1319; Sadun Alfredo A, 2006, Trans Am Ophthalmol Soc, V104, P51; Sadun Alfredo A, 2002, Semin Ophthalmol, V17, P29, DOI 10.1076/soph.17.1.29.10290; Salomao SR, 2004, DOC OPHTHALMOL, V108, P147, DOI 10.1023/B:DOOP.0000036829.37053.31; SCHNETKAMP PPM, 1995, BIOCHEMISTRY-US, V34, P7282, DOI 10.1021/bi00021a045; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Smith BJ, 2017, NEUROSCIENCE, V340, P279, DOI 10.1016/j.neuroscience.2016.10.054; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Song LY, 2017, BRAIN RES, V1657, P232, DOI 10.1016/j.brainres.2016.12.019; TAKATA K, 1992, INVEST OPHTH VIS SCI, V33, P377; Travis AM, 2018, J NEUROSCI, V38, P723, DOI 10.1523/JNEUROSCI.1994-17.2017; Vinberg F, 2015, HUM MOL GENET, V24, P5915, DOI 10.1093/hmg/ddv319; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462; Yu AK, 2015, HUM MOL GENET, V24, P2848, DOI 10.1093/hmg/ddv045	45	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12432	12443		10.1074/jbc.RA119.007945	http://dx.doi.org/10.1074/jbc.RA119.007945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248988	Green Published, hybrid			2022-12-26	WOS:000484402700015
J	Bowin, CF; Inoue, A; Schulte, G				Bowin, Carl-Fredrik; Inoue, Asuka; Schulte, Gunnar			WNT-3A-induced beta-catenin signaling does not require signaling through heterotrimeric G proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); WNT pathway; cell signaling; CRISPR; Cas; beta-catenin; conformational selection; Frizzled (FZD); WNT signaling; WNT-3A	WNT/BETA-CATENIN; GROWTH; INHIBITION; ACTIVATION; COMPLEX	The network of Wingless/Int-1 (WNT)-induced signaling pathways includes beta-catenin-dependent and -independent pathways. beta-Catenin regulates T cell factor/lymphoid enhancer-binding factor (TCF/LEF)-mediated gene transcription, and in response to WNTs, beta-catenin signaling is initiated through engagement of a Frizzled (FZD)/LDL receptor-related protein 5/6 (LRP5/6) receptor complex. FZDs are G protein-coupled receptors, but the question of whether heterotrimeric G proteins are involved in WNT/beta-catenin signaling remains unanswered. Here, we investigate whether acute activation of WNT/beta-catenin signaling by purified WNT-3A requires functional signaling through heterotrimeric G proteins. Using genome editing, we ablated expression of G(s)/G(olf)/G(q)/G(11)/G(12)/G(13)/G(z) in HEK293 (Delta G7) cells, leaving the expression of pertussis toxin (PTX)-sensitive G(i/o) proteins unchanged, to assess whether WNT-3A activates WNT/beta-catenin signaling in WT and Delta G7 cells devoid of functional G protein signaling. We monitored WNT-3A-induced activation by detection of phosphorylation of LDL receptor-related protein 6 (LRP6), electrophoretic mobility shift of the phosphoprotein Dishevelled (DVL), beta-catenin stabilization and dephosphorylation, and TCF-dependent transcription. We found that purified, recombinant WNT-3A efficiently induces WNT/beta-catenin signaling in Delta G7 cells in both the absence and presence of G(i/o)-blocking PTX. Furthermore, cells completely devoid of G protein expression, so called G alpha-depleted HEK293 cells, maintain responsiveness to WNT-3A with regard to the hallmarks of WNT/beta-catenin signaling. These findings corroborate the concept that heterotrimeric G proteins are not required for this FZD- and DVL-mediated signaling branch. Our observations agree with previous results arguing for FZD conformation-dependent functional selectivity between DVL and heterotrimeric G proteins. In conclusion, WNT/beta-catenin signaling through FZDs does not require the involvement of heterotrimeric G proteins.	[Bowin, Carl-Fredrik; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, Biomed 6D,Solnavagen 9, SE-17165 Stockholm, Sweden; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Karolinska Institutet; Tohoku University	Schulte, G (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sec Receptor Biol & Signaling, S-17177 Stockholm, Sweden.	gunnar.schulte@ki.se		Bowin, Carl-Fredrik/0000-0001-9090-9493; Schulte, Gunnar/0000-0002-2700-7013	Karolinska Institutet; Swedish Research Council [2017-04676]; Swedish Cancer Society [CAN2017/561]; Novo Nordisk Foundation [NNF17OC0026940]; Stiftelsen Olle Engkvist Byggmastare [2016/193]; Emil and Wera Cornells Stiftelse	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Emil and Wera Cornells Stiftelse	This work was supported by a grant from the Karolinska Institutet, Swedish Research Council Grant 2017-04676, Swedish Cancer Society Grant CAN2017/561, Novo Nordisk Foundation Grant NNF17OC0026940, Stiftelsen Olle Engkvist Byggmastare Grant 2016/193, and the Emil and Wera Cornells Stiftelse.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; DeBruine ZJ, 2017, BRIT J PHARMACOL, V174, P4564, DOI 10.1111/bph.14048; Driehuis E, 2017, BRIT J PHARMACOL, V174, P4547, DOI 10.1111/bph.13758; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Fujino H, 2001, J BIOL CHEM, V276, P12489, DOI 10.1074/jbc.C100039200; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Halleskog C, 2013, CELL SIGNAL, V25, P822, DOI 10.1016/j.cellsig.2012.12.006; Hisano Y, 2019, J EXP MED, V216, P1582, DOI 10.1084/jem.20181895; Hot B, 2017, CELL SIGNAL, V32, P93, DOI 10.1016/j.cellsig.2017.01.023; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Koval A, 2016, BIOCHEM J, V473, P371, DOI 10.1042/BJ20150913; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Malbon Craig C, 2011, Biochem J, V433, pe3, DOI 10.1042/BJ20102111; Milligan G, 2018, TRENDS PHARMACOL SCI, V39, P481, DOI 10.1016/j.tips.2018.02.005; Nag JK, 2018, CANCER METAST REV, V37, P147, DOI 10.1007/s10555-017-9711-z; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2018, TRENDS PHARMACOL SCI, V39, P828, DOI 10.1016/j.tips.2018.07.001; SUNYER T, 1989, MOL ENDOCRINOL, V3, P1115, DOI 10.1210/mend-3-7-1115; Valnohova J, 2018, J BIOL CHEM, V293, P17875, DOI 10.1074/jbc.RA118.004763; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright SC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08630-2; Wu CL, 2000, DEVELOPMENT, V127, P2773	33	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11677	11684		10.1074/jbc.AC119.009412	http://dx.doi.org/10.1074/jbc.AC119.009412			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31235524	Green Published, hybrid			2022-12-26	WOS:000486127800005
J	Scofield, JE; Johnson, JD; Wood, PK; Geary, DC				Scofield, John E.; Johnson, Jeffrey D.; Wood, Phillip K.; Geary, David C.			Latent resting-state network dynamics in boys and girls with attention-deficit/hyperactivity disorder	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; FUNCTIONAL CONNECTIVITY; GENDER-DIFFERENCES; SUSTAINED ATTENTION; RESPONSE-INHIBITION; ADHD; CHILDREN; ADOLESCENTS; ACTIVATION; OUTCOMES	Neuroimaging studies of subjects with ADHD typically show altered functional connectivity in prefrontal, striatal, and several temporal brain regions. While the majority of studies have focused on connectivity that is averaged over time, we investigated the temporal dynamics of brain network changes in resting-state fMRI. Using the ADHD-200 consortium, we characterized the time course of latent state changes using Hidden Markov Modeling, and compared state changes between boys and girls with ADHD along with typically developing controls. Sex differences were found in latent state switching, with boys dwelling longer in a given state than girls, and concurrently having fewer overall state transitions. These sex differences were found in children with ADHD and in typically developing controls. Children with ADHD were also found to be more variable in terms of state transitions than controls. These findings add to the growing literature on neural sex differences and may be related to the sex difference in focal versus diffuse attention.	[Scofield, John E.; Johnson, Jeffrey D.; Wood, Phillip K.; Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Scofield, JE (corresponding author), Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA.	jel7c5@mail.missouri.edu	Wood, Phillip Karl/J-3176-2019	Wood, Phillip Karl/0000-0002-5802-3948; Johnson, Jeffrey/0000-0001-7651-6992; Scofield, John/0000-0001-6345-1181				Adamou M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-59; Alba G, 2016, CLIN NEUROPHYSIOL, V127, P1321, DOI 10.1016/j.clinph.2015.09.134; Barkley RA, 2003, BRAIN DEV-JPN, V25, P77, DOI 10.1016/S0387-7604(02)00152-3; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bellec P, 2017, NEUROIMAGE, DOI [10.1016/j.neuroimage.2016.06, DOI 10.1016/J.NEUROIMAGE.2016.06]; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; Biswal B, 1996, MAGNET RESON MED, V35, P107, DOI 10.1002/mrm.1910350114; Boker SM, 2009, PSYCHOL AGING, V24, P858, DOI 10.1037/a0017912; Booth JR, 2005, J CHILD PSYCHOL PSYC, V46, P94, DOI 10.1111/j.1469-7610.2004.00337.x; Bos DJ, 2017, J CHILD PSYCHOL PSYC, V58, P810, DOI 10.1111/jcpp.12712; Cao M, 2014, MOL NEUROBIOL, V50, P1111, DOI 10.1007/s12035-014-8685-x; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Choe AS, 2017, NEUROIMAGE, V158, P155, DOI 10.1016/j.neuroimage.2017.07.005; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Cubillo A, 2012, CORTEX, V48, P194, DOI 10.1016/j.cortex.2011.04.007; de Boo GM, 2007, CLIN PSYCHOL REV, V27, P78, DOI 10.1016/j.cpr.2006.03.006; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gaub M, 1997, J AM ACAD CHILD PSY, V36, P1036, DOI 10.1097/00004583-199708000-00011; Gershon J, 2002, J Atten Disord, V5, P143, DOI 10.1177/108705470200500302; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Hindriks R, 2016, NEUROIMAGE, V127, P242, DOI 10.1016/j.neuroimage.2015.11.055; Hoekzema E, 2014, HUM BRAIN MAPP, V35, P1261, DOI 10.1002/hbm.22250; Hutchison RM, 2015, J NEUROSCI, V35, P6849, DOI 10.1523/JNEUROSCI.4638-14.2015; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Johnson W, 2007, INTELLIGENCE, V35, P23, DOI 10.1016/j.intell.2006.03.012; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Kucyi A, 2015, HUM BRAIN MAPP, V36, P3373, DOI 10.1002/hbm.22850; Li T-H., 1998, J AM STAT ASSOC, V93, P1525, DOI [10.2307/2670072, DOI 10.2307/2670072]; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; Molenaar P.C.M., 2004, MEAS-INTERDISCIP RES, V2, P201, DOI [10.1207/s15366359mea0204_1, DOI 10.1207/S15366359MEA0204_1]; Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x; Mostert JC, 2016, PROG NEURO-PSYCHOPH, V67, P82, DOI 10.1016/j.pnpbp.2016.01.011; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Ramtekkar UP, 2010, J AM ACAD CHILD PSY, V49, P217, DOI 10.1016/j.jaac.2009.11.011; Ritchie SJ, 2018, CEREB CORTEX, V28, P2959, DOI 10.1093/cercor/bhy109; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Rucklidge JJ, 2010, PSYCHIAT CLIN N AM, V33, P357, DOI 10.1016/j.psc.2010.01.006; Schulz KP, 2004, AM J PSYCHIAT, V161, P1650, DOI 10.1176/appi.ajp.161.9.1650; Semrud-Clikeman M, 2000, J AM ACAD CHILD PSY, V39, P477, DOI 10.1097/00004583-200004000-00017; Simon V, 2009, BR J PSYCHIAT; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tabachnik B. G., 2012, USING MULTIVARIATE S, V6th; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; Vidaurre D, 2017, P NATL ACAD SCI USA, V114, P12827, DOI 10.1073/pnas.1705120114; Visser I, 2011, J MATH PSYCHOL, V55, P403, DOI 10.1016/j.jmp.2011.08.002; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wolf LE, 2001, ANN NY ACAD SCI, V931, P385; Wolf RC, 2009, HUM BRAIN MAPP, V30, P2252, DOI 10.1002/hbm.20665; Zang YF, 2005, BRAIN DEV-JPN, V27, P544, DOI 10.1016/j.braindev.2004.11.009; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang C, 2018, HUM BRAIN MAPP, V39, P1765, DOI 10.1002/hbm.23950	67	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218891	10.1371/journal.pone.0218891	http://dx.doi.org/10.1371/journal.pone.0218891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3XM	31251765	Green Submitted, gold, Green Published			2022-12-26	WOS:000484915000029
J	Hillmann, A; Paebst, F; Brehm, W; Piehler, D; Schubert, S; Tarnok, A; Burk, J				Hillmann, Aline; Paebst, Felicitas; Brehm, Walter; Piehler, Daniel; Schubert, Susanna; Tarnok, Attila; Burk, Janina			A novel direct co-culture assay analyzed by multicolor flow cytometry reveals context and cell type-specific immunomodulatory effects of equine mesenchymal stromal cells	PLOS ONE			English	Article							REGULATORY T-CELLS; STEM-CELLS; IMMUNOSUPPRESSIVE PROPERTIES; INTERNATIONAL-SOCIETY; GENE-EXPRESSION; TNF-ALPHA; PROLIFERATION; MECHANISMS; ADULT; INHIBITION	The immunomodulatory potential of multipotent mesenchymal stromal cells (MSC) provides a basis for current and future regenerative therapies. In this study, we established an approach that allows to address the effects of pro-inflammatory stimulation and co-culture with MSC on different specific leukocyte subpopulations. Equine peripheral blood leukocyte recovery was optimized to preserve all leukocyte subpopulations and leukocyte activation regimes were evaluated. Allogeneic labeled equine adipose-derived MSC were then subjected to direct co-culture with either non-stimulated, concanavalin A (ConA)-activated or phosphate 12-myristate 13-acetate and ionomycin (PMA/I)-activated leukocytes. Subsequently, production of the cytokines interferon-gamma (IFN-gamma), interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) and presence of FoxP3 were determined in specific cell populations using multicolor flow cytometry. Prostaglandin E2 (PGE2) was measured in the supernatants. ConA-stimulation induced mild activation of leukocytes, whereas PMA/I-stimulation led to strong activation. In T cells, PMA/I promoted production of all cytokines, with no distinct suppressive effects of MSC. However, increased numbers of CD25/FoxP3-positive cells indicated that MSC supported regulatory T cell differentiation in PMA/I-activated leukocyte cultures. MSC also reduced numbers of cytokine-producing B cells and granulocytes, mostly irrespective of preceding leukocyte activation, and reversed the stimulatory effect of ConA on IFN-gamma production in monocytes. Illustrating the possible suppressive mechanisms, higher numbers of MSC produced IL-10 when co-cultured with non-stimulated or ConA-activated leukocytes. This was not observed in co-culture with PMA/I-activated leukocytes. However, PGE2 concentration in the supernatant was highest in the co-culture with PMA/activated leukocytes, suggesting that PGE2 could still mediate modulatory effects in strongly inflammatory environment. These context- and cell type-specific modulatory effects observed give insight into the interactions between MSC and different types of immune cells and highlight the roles of IL-10 and PGE2 in MSC-mediated immunomodulation. The approach presented could provide a basis for further functional MSC characterization and the development of potency assays.	[Hillmann, Aline; Brehm, Walter; Schubert, Susanna; Burk, Janina] Univ Leipzig, Saxon Incubator Clin Translat SIKT, Leipzig, Germany; [Hillmann, Aline; Paebst, Felicitas; Brehm, Walter] Univ Leipzig, Fac Vet Med, Equine Clin & Hosp, Leipzig, Germany; [Hillmann, Aline; Schubert, Susanna; Burk, Janina] Univ Leipzig, Inst Vet Physiol, Fac Vet Med, Leipzig, Germany; [Paebst, Felicitas] Horse Power Vet Ctr, Nahariyya, Israel; [Piehler, Daniel] Vaxxinova GmbH Diagnost, Leipzig, Germany; [Tarnok, Attila] Univ Leipzig, Fac Med, IMISE, Leipzig, Germany; [Tarnok, Attila] Fraunhofer Inst Cell Therapy & Immunol, Dept Therapy Validat, Leipzig, Germany; [Burk, Janina] Justus Liebig Univ Giessen, Equine Clin Surg, Giessen, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Fraunhofer Gesellschaft; Justus Liebig University Giessen	Hillmann, A (corresponding author), Univ Leipzig, Saxon Incubator Clin Translat SIKT, Leipzig, Germany.; Hillmann, A (corresponding author), Univ Leipzig, Fac Vet Med, Equine Clin & Hosp, Leipzig, Germany.; Hillmann, A (corresponding author), Univ Leipzig, Inst Vet Physiol, Fac Vet Med, Leipzig, Germany.	aline.hillmann@sikt.uni-leipzig.de	Burk, Janina/X-6512-2019	Burk, Janina/0000-0002-7868-0355	German Research Foundation [BU 3110/1-1]; Saxon Ministry of Science and the Fine Arts; German Research Foundation (DFG) [BU 3110/1-1]; Saxon Ministry of Science and the Fine Arts (SMWK)	German Research Foundation(German Research Foundation (DFG)); Saxon Ministry of Science and the Fine Arts; German Research Foundation (DFG)(German Research Foundation (DFG)); Saxon Ministry of Science and the Fine Arts (SMWK)	The company Vaxxinova GmbH diagnostics provided support in the form of salaries for the author [DP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The author [DP] contributed to this study in his free time. The study was funded by German Research Foundation (BU 3110/1-1, Dr. Janina Burk) and The Saxon Ministry of Science and the Fine Arts.; The work presented in this article was made possible by funding from the German Research Foundation (DFG BU 3110/1-1) and the Saxon Ministry of Science and the Fine Arts (SMWK). The authors acknowledge Carolin Horstmeier, Amelie Plenge and Susanne Pauline Roth, all University of Leipzig, for helping with MSC recovery.	Andreeva E, 2017, CYTOTHERAPY, V19, P1152, DOI 10.1016/j.jcyt.2017.07.001; Arcanjo AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124888; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Baratelli F, 2010, AM J TRANSL RES, V2, P356; Barrachina L, 2016, VET IMMUNOL IMMUNOP, V171, P57, DOI 10.1016/j.vetimm.2016.02.007; Bertolo A, 2017, J STEM CELLS REGEN, V13, P62; Burk J, 2016, CELL TRANSPLANT, V25, P2199, DOI 10.3727/096368916X692104; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Carrade DD, 2012, CELL MED, V4, P1, DOI 10.3727/215517912X647217; Cassano JM, 2018, VET IMMUNOL IMMUNOP, V202, P25, DOI 10.1016/j.vetimm.2018.06.008; Cassano JM, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0840-2; Castro-Manrreza ME, 2014, STEM CELLS DEV, V23, P1217, DOI 10.1089/scd.2013.0363; Clift MJD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00369-4; Colbath AC, 2017, STEM CELLS DEV, V26, P503, DOI 10.1089/scd.2016.0266; De Schauwer C, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt395; de Witte SFH, 2018, STEM CELLS, V36, P602, DOI 10.1002/stem.2779; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Galipeau J, 2016, CYTOTHERAPY, V18, P151, DOI 10.1016/j.jcyt.2015.11.008; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Hanson SE, 2011, TISSUE ENG PT A, V17, P2463, DOI [10.1089/ten.tea.2010.0716, 10.1089/ten.TEA.2010.0716]; HART PH, 1989, IMMUNOLOGY, V66, P376; Hedi H, 2004, CELL IMMUNOL, V228, P99, DOI 10.1016/j.cellimm.2004.04.003; Hillmann A, 2016, CELL TRANSPLANT, V25, P109, DOI 10.3727/096368915X687822; Holt DDC, 2014, STEM CELLS DEV, V23, P1258, DOI 10.1089/scd.2013.0537; Jiang DS, 2016, STEM CELLS, V34, P2393, DOI 10.1002/stem.2417; Jones E, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0144-8; Karger GmbH S, 2009, TRANSFUS MED HEMOTH, V36, P383; Khosravi M, 2017, GENE, V627, P327, DOI 10.1016/j.gene.2017.06.012; Killer MC, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0553-y; Kim DS, 2018, EBIOMEDICINE, V28, P261, DOI 10.1016/j.ebiom.2018.01.002; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kota DJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04565; Kovach TK, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/752510; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; KUNKEL SL, 1986, J IMMUNOL, V136, P186; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le T., 2008, 1 AID USMLE STEP 1 2; Li XY, 2014, INT J MOL MED, V34, P695, DOI 10.3892/ijmm.2014.1821; Lu X., 2016, INT J ADV MANUF TECH, V9, P1599, DOI DOI 10.1109/TSG.2016.2594811; Luk F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01042; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Molina-Holgado E, 2000, BRIT J PHARMACOL, V131, P152, DOI 10.1038/sj.bjp.0703557; Mougiakakos D, 2011, BLOOD, V117, P4826, DOI 10.1182/blood-2010-12-324038; Qin Y, 2015, CELL PHYSIOL BIOCHEM, V37, P117, DOI 10.1159/000430338; Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140; Redondo-Castro E, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-017-0753-5; Ribeiro A, 2016, IMMUNOL LETT, V177, P38, DOI 10.1016/j.imlet.2016.07.010; Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129; Sato K, 2010, J CLIN EXP HEMATOP, V50, P79, DOI 10.3960/jslrt.50.79; Southwood LL, 2013, PRACTICAL GUIDE TO EQUINE COLIC, P1; Tessier L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122954; Tomlinson JE, 2018, VET IMMUNOL IMMUNOP, V199, P22, DOI 10.1016/j.vetimm.2018.03.010; Uder C, 2018, CYTOM PART A, V93A, P32, DOI 10.1002/cyto.a.23239; Valles G, 2015, BIOMATERIALS, V37, P124, DOI 10.1016/j.biomaterials.2014.10.028; van den Akker F, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00642; Vasandan AB, 2016, SCI REP-UK, V6, DOI 10.1038/srep38308; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762	61	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218949	10.1371/journal.pone.0218949	http://dx.doi.org/10.1371/journal.pone.0218949			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247035	Green Submitted, gold, Green Published			2022-12-26	WOS:000484911900055
J	Fujiwara, D; Iwahara, N; Sebori, R; Hosoda, R; Shimohama, S; Kuno, A; Horio, Y				Fujiwara, Daisuke; Iwahara, Naotoshi; Sebori, Rio; Hosoda, Ryusuke; Shimohama, Shun; Kuno, Atsushi; Horio, Yoshiyuki			SIRT1 deficiency interferes with membrane resealing after cell membrane injury	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; REPAIR; RESVERATROL; ACTIVATION; CAVEOLIN-3; MUTATIONS; SECRETION; PATHOLOGY; DEFECTS; PROTEIN	Activation of SIRT1, an NAD(+)-dependent protein deacetylase, ameliorates muscular pathophysiology of delta-sarcoglycan-deficient TO-2 hamsters and dystrophin-deficient mdx mice. We found that SIRT1 was highly expressed beneath the cellular membranes of muscle cells. To elucidate functional roles of SIRT1 on muscles, skeletal muscle-specific SIRT1 knockout mice (SIRT1-MKO) were generated. SIRT1-MKO mice showed muscular pathology similar to mild muscular dystrophies with increased numbers of centrally nucleated small myofibers and decreased numbers of middle-sized (2000-3001 mu m(2)) myofibers compared to those of wild-type (WT) mice. Accordingly, SIRT1-MKO mice showed significantly decreased exercise capacity in treadmill and inverted hanging tests with higher levels of serum creatine kinase activities compared with those in WT mice. Evans blue dye uptake after exercise was greater in the muscles of SIRT1-MKO than those of WT mice, suggesting membrane fragility in SIRT1-MKO mice. Because SIRT1 was dominantly localized beneath the membranes of muscular cells, SIRT1 may have a new role in the membranes. We found that levels of fluorescent FM1-43 dye intake after laser-induced membrane disruption in C2C12 cells were significantly increased by SIRT1 inhibitors or Sirt1-siRNA compared with those of control cells. Inhibition of SIRT1 or SIRT1-knockdown severely disturbed the dynamic aggregation of membrane vesicles under the injured site but did not affect expression levels of membrane repair proteins. These data suggested that SIRT1 had a critical role in the resealing of membrane-ruptured muscle cells, which could affect phenotypes of SIRT1-MKO mice. To our knowledge, this report is the first to demonstrate that SIRT1 affected plasma-membrane repair mechanisms.	[Fujiwara, Daisuke; Iwahara, Naotoshi; Sebori, Rio; Hosoda, Ryusuke; Kuno, Atsushi; Horio, Yoshiyuki] Sapporo Med Univ, Dept Pharmacol, Sch Med, Sapporo, Hokkaido, Japan; [Iwahara, Naotoshi; Shimohama, Shun] Sapporo Med Univ, Dept Neurol, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University	Horio, Y (corresponding author), Sapporo Med Univ, Dept Pharmacol, Sch Med, Sapporo, Hokkaido, Japan.	horio@sapmed.ac.jp		Horio, Yoshiyuki/0000-0002-5021-5929; KUNO, ATSUSHI/0000-0001-6873-1297	Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant [15K08312, 17K08600, 17K15582, 18K06965, JP16H06280]; Osaka Foundation for Promotion of Fundamental Medical Research; Osaka Medical Research Foundation for Intractable Diseases; Japan Research Foundation for Clinical Pharmacology; MSD Life Science Foundation; Setsuro Fujii Memorial; Public Interest Incorporates Foundation	Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant; Osaka Foundation for Promotion of Fundamental Medical Research; Osaka Medical Research Foundation for Intractable Diseases; Japan Research Foundation for Clinical Pharmacology; MSD Life Science Foundation; Setsuro Fujii Memorial; Public Interest Incorporates Foundation	This study was supported in part by the Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant (https://kaken.nii.ac.jp/ja/index/) Numbers 15K08312 (YH), 17K08600 (AK), 17K15582 (RH), 18K06965 (YH) and JP16H06280 (YH) (Grant-in-Aid for Scientific Research on Innovative Areas -Platforms for Advanced Technologies and Research Resources "Advanced Bioimaging Support") (http://www.nibb.ac.jp/abis/acknowledgements); and grants from the Setsuro Fujii Memorial, the Osaka Foundation for Promotion of Fundamental Medical Research (YH) (https://www.weblio.jp/content/% E4% B8% 80% E8% 88% AC% E8% B2% A1% E5% 9B% A3% E6% B3% 95% E4% BA% BA% E8% 97% A4% E4% BA% 95% E7% AF% 80% E9% 83% 8E% E8% A8% 98% E5% BF% B5% E5% A4% A7% E9% 98% AA% E5% 9F % BA% E7% A4% 8E% E5% 8C% BB% E5% AD% A6% E7% A0% 94% E7% A9% B6% E5% A5% A8% E5% 8A % B1% E4% BC% 9A), the Osaka Medical Research Foundation for Intractable Diseases (RH, NI) (http://www.nanbyo.or.jp/), the Japan Research Foundation for Clinical Pharmacology (AK) (https://www.rinyaku-fdn.or.jp/), and MSD Life Science Foundation, Public Interest Incorporates Foundation (AK, NI) (https://www.msd-lifescience-foundation.or.jp/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akieda-Asai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011755; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Davenport NR, 2016, MOL BIOL CELL, V27, P2272, DOI 10.1091/mbc.E16-04-0223; Demonbreun AR, 2015, SEMIN CELL DEV BIOL, V45, P48, DOI 10.1016/j.semcdb.2015.10.026; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Fanin M, 2016, MUSCLE NERVE, V54, P821, DOI 10.1002/mus.25367; Han R, 2010, J CLIN INVEST, V120, P4366, DOI 10.1172/JCI42390; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210; Horio Y, 2011, CLIN SCI, V121, P191, DOI 10.1042/CS20100587; Kunimoto R, 2014, J INVEST DERMATOL, V134, P1693, DOI 10.1038/jid.2014.50; Kuno A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33930-w; Kuno A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6714686; Kuno A, 2013, J BIOL CHEM, V288, P5963, DOI 10.1074/jbc.M112.392050; Leikina E, 2015, SCI REP-UK, V5, DOI 10.1038/srep18246; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Luu L, 2013, DIABETOLOGIA, V56, P2010, DOI 10.1007/s00125-013-2946-5; McDade JR, 2014, HUM MOL GENET, V23, P1677, DOI 10.1093/hmg/ddt557; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Moore UR, 2018, J NEUROL NEUROSUR PS, V89, P1224, DOI 10.1136/jnnp-2017-317329; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Sebori R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9179270; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218329	10.1371/journal.pone.0218329	http://dx.doi.org/10.1371/journal.pone.0218329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IH3VI	31242212	Green Published, gold, Green Submitted			2022-12-26	WOS:000474420300001
J	Sakai, R; Suzuki, M; Ueyama, M; Takeuchi, T; Minakawa, EN; Hayakawa, H; Baba, K; Mochizuki, H; Nagai, Y				Sakai, Ryusuke; Suzuki, Mari; Ueyama, Morio; Takeuchi, Toshihide; Minakawa, Eiko N.; Hayakawa, Hideki; Baba, Kousuke; Mochizuki, Hideki; Nagai, Yoshitaka			E46K mutant alpha-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type alpha-synuclein in Drosophila models of Parkinson's disease	PLOS ONE			English	Article							MUTATION; AGGREGATION; TRANSFORMATION; NEUROTOXICITY; DUPLICATION; EXPRESSION; INTEGRASE; SECRETION; BINDING; EYE	Parkinson's disease (PD) is one of the most common neurodegenerative diseases, which is characterized by progressive motor dysfunction as well as non-motor symptoms. Pathological and genetic studies have demonstrated that alpha-synuclein (alpha Syn) plays key roles in the pathogenesis of PD. Although several missense mutations in the alpha Syn gene have been identified as causes of familial PD, the mechanisms underlying the variance in the clinical phenotypes of familial PD caused by different mutations remain elusive. Here, we established novel Drosophila models expressing either wild-type (WT) alpha Syn or one of five alpha Syn mutants (A30P, E46K, H50Q, G51D, and A53T) using site-specific transgenesis, which express transgenes at equivalent levels. Expression of either WT or mutant alpha Syn in the compound eyes by the GMR-GAL4 driver caused mild rough eye phenotypes with no obvious difference among the mutants. Upon pan-neuronal expression by the nSyb-GAL4 driver, these alpha Syn-expressing flies showed a progressive decline in locomotor function. Notably, we found that E46K, H50Q, G51D, and A53T aSyn-expressing flies showed earlier onset of locomotor dysfunction than WT alpha Syn-expressing flies, suggesting their enhanced toxic effects. Whereas mRNA levels of WT and mutant alpha Syn were almost equivalent, we found that protein expression levels of E46K alpha Syn were higher than those of WT alpha Syn. In vivo chase experiments using the drug-inducible GMR-GeneSwitch driver demonstrated that degradation of E46K alpha Syn protein was significantly slower than WT alpha Syn protein, indicating that the E46K alpha Syn mutant gains resistance to degradation in vivo. We therefore conclude that our novel site-specific transgenic fly models expressing either WT or mutant alpha Syn are useful to explore the mechanisms by which different alpha Syn mutants gain toxic functions in vivo.	[Sakai, Ryusuke; Suzuki, Mari; Ueyama, Morio; Takeuchi, Toshihide; Nagai, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Neurotherapeut, Suita, Osaka, Japan; [Sakai, Ryusuke; Hayakawa, Hideki; Baba, Kousuke; Mochizuki, Hideki; Nagai, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Suzuki, Mari] Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, Diabet Neuropathy Project, Setagaya Ku, Tokyo, Japan; [Minakawa, Eiko N.] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo, Japan	Osaka University; Osaka University; Tokyo Metropolitan Institute of Medical Science; National Center for Neurology & Psychiatry - Japan	Nagai, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurotherapeut, Suita, Osaka, Japan.; Nagai, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan.	nagai@neurother.med.osaka-u.ac.jp	Minakawa, Eiko N./AAB-2167-2019	Minakawa, Eiko/0000-0002-6204-9104; Ueyama, Morio/0000-0002-2950-7361	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [17K19658, 17H05699, 15K19502, 17K16134]; Japan Agency for Medical Research and Development [JP16ek0109018, JP 18ek0109222]; Intramural Research Grants for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry [27-7, 27-9, 30-3, 30-9]; Japan Foundation for Neuroscience and Mental Health, Japan; The Ichiro Kanehara Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Intramural Research Grants for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry; Japan Foundation for Neuroscience and Mental Health, Japan; The Ichiro Kanehara Foundation	This work was supported in part by Grants-in-Aid for Challenging Exploratory Research (17K19658 to Y.N), for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control 17H05699 to Y.N.), and for Young Scientists (B) (15K19502 and 17K16134 to M.S.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; by a grant for Practical Research Projects for Rare/Intractable Diseases (JP16ek0109018, JP 18ek0109222 to Y.N) from the Japan Agency for Medical Research and Development; by Intramural Research Grants for Neurological and Psychiatric Disorders (27-7, 27-9, 30-3, and 30-9 to Y.N.) from the National Center of Neurology and Psychiatry; by a grant from the Japan Foundation for Neuroscience andS Mental Health, Japan (to Y. N.); by a grant provided by The Ichiro Kanehara Foundation (to M.S.).	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Breda C, 2015, HUM MOL GENET, V24, P1077, DOI 10.1093/hmg/ddu521; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Fantini J, 2011, J MOL BIOL, V408, P654, DOI 10.1016/j.jmb.2011.03.009; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inigo-Marco I, 2017, P NATL ACAD SCI USA, V114, pE8274, DOI 10.1073/pnas.1703420114; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; M'Angale PG, 2016, PEERJ, V4, DOI 10.7717/peerj.2461; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Mbefo MK, 2015, J BIOL CHEM, V290, P9412, DOI 10.1074/jbc.M114.610774; Mohite GM, 2018, ACS CHEM NEUROSCI, V9, P2628, DOI 10.1021/acschemneuro.8b00107; Tue NT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/252049; Nuber S, 2018, NEURON, V100, P75, DOI 10.1016/j.neuron.2018.09.014; Ono K, 2011, NEUROBIOL DIS, V43, P715, DOI 10.1016/j.nbd.2011.05.025; Ordonez DG, 2018, NEURON, V97, P108, DOI 10.1016/j.neuron.2017.11.036; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Riemensperger T, 2013, CELL REP, V5, P952, DOI 10.1016/j.celrep.2013.10.032; Roman G, 2002, GENESIS, V34, P127, DOI 10.1002/gene.10133; Roy B, 2014, HUM MOL GENET, V23, P3008, DOI 10.1093/hmg/ddu011; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ruf VC, 2019, ACS CHEM NEUROSCI, V10, P1649, DOI 10.1021/acschemneuro.8b00579; Saitoh Y, 2015, J BIOL CHEM, V290, P1442, DOI 10.1074/jbc.M114.590281; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Suzuki M, 2015, HUM MOL GENET, V24, P6675, DOI 10.1093/hmg/ddv372; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113; Yan JQ, 2018, MOLECULES, V23, DOI 10.3390/molecules23112839; Yoshida S, 2018, HUM MOL GENET, V27, P823, DOI 10.1093/hmg/ddy003; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218261	10.1371/journal.pone.0218261	http://dx.doi.org/10.1371/journal.pone.0218261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242217	gold, Green Submitted, Green Published			2022-12-26	WOS:000482883600027
J	Streletskaya, NA; Liaukonyte, J; Kaiser, HM				Streletskaya, Nadia A.; Liaukonyte, Jura; Kaiser, Harry M.			Absence labels: How does information about production practices impact consumer demand?	PLOS ONE			English	Article							WINE; PREFERENCES; PRICE; QUALITY; MILK	Absence labels promote the absence of a particular ingredient or production practice. Consumers usually perceive organic labels as an umbrella absence label for a variety of ingredients and production practices. Such organic labels often use similar language but are based on different certification requirements. For example, both organic wine and wine made with organic grapes are available to U.S. consumers, but little is known about consumer preferences for such labeled products when information about the certification standards is available. Moreover, while absence labels, which advertise the absence of certain attributes or practices, are prevalent on the market, little is known about how information on conventional production practices impacts consumer behavior. Using an artefactual experiment with 128 adult non-student participants, we investigate consumer demand for conventional wine, organic wine, and wine made with organic grapes when information about production standards is provided to participants with and without details regarding conventional wine-making practices. We find that while both organic labels carry a significant and very similar willingness-to-pay (WTP) premium, information about certification standards and conventional wine making practices can reduce WTP for all wines. Providing information about the two organic certification standards reduces consumer WTP for both absence labeled and conventional wine categories. This effect largely disappears for organic wine, but not wine made with organic grapes, when information about conventional wine-making practices is also provided.	[Streletskaya, Nadia A.] Oregon State Univ, Appl Econ Dept, Corvallis, OR 97331 USA; [Liaukonyte, Jura; Kaiser, Harry M.] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA	Oregon State University; Cornell University	Streletskaya, NA (corresponding author), Oregon State Univ, Appl Econ Dept, Corvallis, OR 97331 USA.	nadia.streletskaya@oregonstate.edu	Streletskaya, Nadia/GOV-5233-2022	Streletskaya, Nadia/0000-0001-7306-8426	USDA NIFA [1003974]	USDA NIFA(United States Department of Agriculture (USDA))	We acknowledge funding under USDA NIFA (https://portal.nifa.usda.gov/lmdr/projects?) Hatch grant #1003974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEMIYA T, 1984, J ECONOMETRICS, V24, P3, DOI 10.1016/0304-4076(84)90074-5; [Anonymous], 2012, WINE SPECTATOR; [Anonymous], 2013, GRAS NOT N 120; [Anonymous], 2010, CONSUMER REPORTS; [Anonymous], 2013, ORG 101 ORG WIN; Azrieli Y, 2018, J POLIT ECON, V126, P1472, DOI 10.1086/698136; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Bernard JC, 2009, AM J AGR ECON, V91, P826, DOI 10.1111/j.1467-8276.2009.01258.x; Beverland M, 2005, J ADVERTISING, V34, P103, DOI 10.1080/00913367.2005.10639207; Brugarolas M, 2010, RENEW AGR FOOD SYST, V25, P35, DOI 10.1017/S1742170509990202; Brugarolas Molla-Bauza M., 2005, Spanish Journal of Agricultural Research, V3, P43; Castellini A., 2014, WINE EC POLICY, V3, P71, DOI [10.1016/j.wep.2014.12.001, DOI 10.1016/J.WEP.2014.12.001]; Chang CC, 2008, PSYCHOL MARKET, V25, P881, DOI 10.1002/mar.20242; Charters S., 2005, Journal of Wine Research, V16, P121, DOI 10.1080/09571260500327663; Combris P, 1997, ECON J, V107, P390, DOI 10.1111/j.0013-0133.1997.165.x; Costanigro M, 2014, FOOD POLICY, V49, P259, DOI 10.1016/j.foodpol.2014.08.005; Costanigro M, 2014, FOOD QUAL PREFER, V31, P94, DOI 10.1016/j.foodqual.2013.08.008; Delmas MA, 2014, BUS SOC, V53, P6, DOI 10.1177/0007650310362254; Gerrard C, 2013, BRIT FOOD J, V115, P727, DOI 10.1108/00070701311331517; Gordinier J., 2016, NY TIMES; Gorrman-McAdams, 2017, KITCHN; Gracia A, 2016, FOOD CONTROL, V61, P39, DOI 10.1016/j.foodcont.2015.09.023; Hamm U., 2011, CONSUMER PREFERENCES; Hughner R.S., 2007, J CONSUM BEHAV, V6, P94, DOI 10.1002/cb.210; Janssen M, 2012, FOOD QUAL PREFER, V25, P9, DOI 10.1016/j.foodqual.2011.12.004; KALTON G, 1980, STATISTICIAN, V29, P65, DOI 10.2307/2987495; Kanter C, 2009, AM J AGR ECON, V91, P1097, DOI 10.1111/j.1467-8276.2009.01317.x; Krystallis A, 2006, J INT CONSUM MARK, V19, P81, DOI 10.1300/J046v19n01_05; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Li TZ, 2018, ECOL ECON, V153, P100, DOI 10.1016/j.ecolecon.2018.07.004; Liaukonyte J, 2015, J AGR RESOUR ECON, V40, P179; Liaukonyte J, 2013, APPL ECON PERSPECT P, V35, P476, DOI 10.1093/aepp/ppt015; Lockshin L. S., 1993, International Journal of Wine Marketing, V5, P13, DOI 10.1108/eb008614; Loureiro ML, 2005, ECOL ECON, V53, P129, DOI 10.1016/j.ecolecon.2004.11.002; Lusk J. L., 2012, Journal of Agricultural & Food Industrial Organization, V10, P1373, DOI 10.1515/1542-0485.1373; Mann S, 2012, BRIT FOOD J, V114, P272, DOI 10.1108/00070701211202430; McFadden BR, 2018, APPL ECON PERSPECT P, V40, P259, DOI 10.1093/aepp/ppx040; Messer KD, 2017, APPL ECON PERSPECT P, V39, P407, DOI 10.1093/aepp/ppx028; Napolitano F, 2010, FOOD QUAL PREFER, V21, P207, DOI 10.1016/j.foodqual.2009.08.007; Nerlove M, 1995, EUR ECON REV, V39, P1697, DOI 10.1016/0014-2921(95)00013-5; Puckette M., 2014, WINE FOLLY; Puckette M., 2016, WINE FOLLY; Puckette M., 2012, WINE FOLLY; Rahman I, 2014, CORNELL HOSP Q, V55, P127, DOI 10.1177/1938965513496314; Remaud H, 2008, 4 INT C AC WIN BUS R, P1; Saltman Y., 2015, INT J WINE RES, V7, P83, DOI [DOI 10.2147/IJWR.S90802, 10.2147/IJWR.S90802]; Stolz H, 2018, 16 IFOAM ORG WORLD C; Timbo B, 2004, J FOOD PROTECT, V67, P1806, DOI 10.4315/0362-028X-67.8.1806; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; van Doorn J, 2011, INT J RES MARK, V28, P167, DOI 10.1016/j.ijresmar.2011.02.005; Van Loo EJ, 2011, FOOD QUAL PREFER, V22, P603, DOI 10.1016/j.foodqual.2011.02.003; Veale R, 2008, J WINE ECON, V3, P10, DOI 10.1017/S1931436100000535; Vega-Zamora M, 2014, PSYCHOL MARKET, V31, P349, DOI 10.1002/mar.20699; Waldrop ME, 2017, EUR REV AGRIC ECON, V44, P658, DOI 10.1093/erae/jbx010; Wiedmann KP, 2014, BRIT FOOD J, V116, P197, DOI 10.1108/BFJ-04-2012-0090	55	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0217934	10.1371/journal.pone.0217934	http://dx.doi.org/10.1371/journal.pone.0217934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242219	gold, Green Published, Green Submitted			2022-12-26	WOS:000482883600017
J	Chimberengwa, PT; Naidoo, M; Maphosa, P; Ncube, S; Ncube, J; Dube, B; Ndlovu, D; Ndlovu, N; Moyo, J; Ndlovu, E; Ndlovu, P; Maphosa, L; Masuku, S; Hleza, S; Sibanda, B; Nkala, D; Siziba, E; Ncube, G; Ngulube, S; Mbedzi, M; Ncube, E; Sibanda, M; Sibanda, L				Chimberengwa, Pugie Tawanda; Naidoo, Mergan; Maphosa, Phineas; Ncube, Sithabile; Ncube, Jesinath; Dube, Betina; Ndlovu, Duduzile; Ndlovu, Nomusa; Moyo, Janet; Ndlovu, Evelinah; Ndlovu, Pinky; Maphosa, Limakatso; Masuku, Sikhanyisiwe; Hleza, Samukeliso; Sibanda, Belina; Nkala, Daniel; Siziba, Ereviah; Ncube, Gladys; Ngulube, Siphathisiwe; Mbedzi, Medium; Ncube, Ellen; Sibanda, Marvis; Sibanda, Lizzie		Cooperative Inquiry Grp	Knowledge, attitudes and practices related to hypertension among residents of a disadvantaged rural community in southern Zimbabwe	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; BLOOD-PRESSURE; NONCOMMUNICABLE DISEASES; EPIDEMIOLOGIC TRANSITION; GLOBAL BURDEN; AWARENESS; PREVALENCE	Background Hypertension contributes significantly to cardiovascular and renal diseases. It can be controlled by lifestyle modifications, however in poor communities there is lack of awareness, and treatment and control of hypertension is often poor. The aim of this study was to determine hypertension knowledge, attitudes and practices in a disadvantaged rural community in Matebeleland South province of Zimbabwe. Methods We conducted a descriptive cross-sectional survey on hypertensive patients in the community. A pre-tested and validated interviewer-administered questionnaire was used to collect demographic, awareness, treatment and control data among consenting hypertensive patients. Results 304 respondents were enrolled into the study (mean age, 59 years), and a majority were women (65.4%). The treatment default rate was 30.9%, and 25% of respondents on medication did not know their blood pressure control status. Knowledge on hypertension was poor, with 64.8% of respondents stating that stress was its main cause, 85.9% stated that palpitations were a symptom of hypertension and 59.8% of respondents added salt on the table. The more education respondents had received, the more likely they were knowledgeable about hypertension (odds ratio for secondary education, 3.68 [95% CI: 1.61-8.41], and for tertiary education, 7.52 [95% CI: 2.76-20.46], compared to those without formal education). Those who believed in herbal medicines (50.7%) and those who used traditional medicines (14.5%) were 53% (95% CI: 0.29-0.76) and 68% (95% CI: 0.29-0.76) less likely to be knowledgeable about hypertension compared to those who did not believe in or use traditional medicines, respectively. Conclusion Members of the community had poor knowledge on hypertension. This was associated with a lack of education and with strong beliefs in herbal and traditional medicines in the community, which influenced attitudes and practices on hypertension. Dietary risk factors were linked to poor knowledge. Hypertensive medicine shortages at the clinic resulted in worsened hypertension care and poor hypertension outcomes in the community.	[Chimberengwa, Pugie Tawanda; Naidoo, Mergan] Univ KwaZulu Natal, Discipline Publ Hlth Med, Sch Nursing & Publ Hlth, Durban, South Africa; [Chimberengwa, Pugie Tawanda] Minist Hlth & Child Care, Prov Med Directorate, Matebeleland North, Bulawayo, Zimbabwe; [Naidoo, Mergan] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Chimberengwa, PT (corresponding author), Univ KwaZulu Natal, Discipline Publ Hlth Med, Sch Nursing & Publ Hlth, Durban, South Africa.; Chimberengwa, PT (corresponding author), Minist Hlth & Child Care, Prov Med Directorate, Matebeleland North, Bulawayo, Zimbabwe.	drchimberengwa@gmail.com	Chimberengwa, Pugie/Z-6104-2019	Chimberengwa, Pugie/0000-0002-4051-0916; Naidoo, Mergan/0000-0002-4287-1168	University of Kwa-Zulu Natal	University of Kwa-Zulu Natal	The study received ZAR 40000 from the University of Kwa-Zulu Natal as operational research funding. The PI self-funded the additional needs for the study.	Agyemang C, 2004, J HUM HYPERTENS, V18, P229, DOI 10.1038/sj.jhh.1001658; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Atim C, 2008, HLTH FINANCING AFRIC, DOI [10.1093/ije/dyt215, DOI 10.1093/IJE/DYT215]; Chimberengwa Pugie T., 2019, Afr. j. prim. health care fam. med. (Online), V11, P1, DOI 10.4102/phcfm.v11i1.1839; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Hakim JG, 2005, WHO STEPS SURVEY ZIM; Heller DJ, 2017, BMJ GLOB HLTH, V2; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Marwiro A., 2012, PREVALENCE RISK FACT, DOI [10.1111/j.1525-1497.2005.30353.x, DOI 10.1111/J.1525-1497.2005.30353.X]; Matenga JA, 1997, S AFR MED J, V87, P1371; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Ministry of Health and Child Welfare Zimbabwe, 2009, NAT HLTH STRAT ZIMB; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Mohan V, 2007, J Assoc Physicians India, V55, P326; Mutowo MP, 2015, WORLD J META-ANAL, V3, P54, DOI 10.13105/wjma.v3.i1.54; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Oliveria SA, 2005, J GEN INTERN MED, V20, P219, DOI 10.1111/j.1525-1497.2005.30353.x; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Pires JE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-90; Rao V, 2014, NATL J COMMUNITY MED, V5, P333; Ulasi II, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/869675; Viera AJ, 2008, J AM BOARD FAM MED, V21, P300, DOI 10.3122/jabfm.2008.04.070254; Vivian E.M., 2010, DIABETES SPECTRUM, V23, P213, DOI [10.2337/diaspect.23.4.213, DOI 10.2337/DIASPECT.23.4.213]; WHO, 2011, GLOBAL STATUS REPORT; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization (WHO), 2013, NONC DIS SURV; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zimbabwe National Statistics Agency, CENS 2012 PROV REP	31	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0215500	10.1371/journal.pone.0215500	http://dx.doi.org/10.1371/journal.pone.0215500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237883	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000005
J	Mafra, GS; do Amaral, AT; de Almeida, JE; Vivas, M; Santos, PHAD; Santos, JS; Pena, GF; de Lima, VJ; Kamphorst, SH; de Oliveira, FT; de Souza, YP; Schwantes, IA; Santos, TD; Bispo, RB; Maldonado, C; Mora, F				Mafra, Gabrielle Sousa; do Amaral Junior, Antonio Teixeira; de Almeida Filho, Janeo Eustaquio; Vivas, Marcelo; Araujo Diniz Santos, Pedro Henrique; Santos, Juliana Saltires; Pena, Guilherme Ferreira; de Lima, Valter Jario; Kamphorst, Samuel Henrique; de Oliveira, Fabio Tomaz; de Souza, Yure Pequeno; Schwantes, Ismael Albino; Santos, Talles de Oliveira; Bispo, Rosimeire Barbosa; Maldonado, Carlos; Mora, Freddy			SNP-based mixed model association of growth- and yield-related traits in popcorn	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POLYAMINE OXIDASE; TRANSCRIPTION FACTOR; EXPRESSION ANALYSIS; MAIZE; POPULATION; SELECTION; GENE; AMMONIUM; IDENTIFICATION	The identification of the genes responsible for complex traits is highly promising to accelerate crop breeding, but such information is still limited for popcorn. Thus, in the present study, a mixed linear model-based association analysis (MLMA) was applied for six important popcorn traits: plant and ear height, 100-grain weight, popping expansion, grain yield and expanded popcorn volume per hectare. To this end, 196 plants of the open-pollinated popcorn population UENF-14 were sampled, selfed (S-1), and then genotyped with a panel of 10,507 single nucleotide polymorphisms (SNPs) markers distributed throughout the genome. The six traits were studied under two environments [Campos dos Goytacazes-RJ (ENV1) and Itaocara-RJ (ENV2)] in an incomplete block design. Based on the phenotypic data of the S1 progenies and on the genetic characteristics of the parents, the MLMA was performed. Thereafter, genes annotated in the MaizeGDB platform were screened for potential linkage disequilibrium with the SNPs associated to the six evaluated traits. Overall, seven and eight genes were identified as associated with the traits in ENV1 and ENV2, respectively, and proteins encoded by these genes were evaluated for their function. The results obtained here contribute to increase knowledge on the genetic architecture of the six evaluated traits and might be used for marker-assisted selection in breeding programs.	[Mafra, Gabrielle Sousa; do Amaral Junior, Antonio Teixeira; Vivas, Marcelo; Araujo Diniz Santos, Pedro Henrique; Santos, Juliana Saltires; de Lima, Valter Jario; Kamphorst, Samuel Henrique; de Oliveira, Fabio Tomaz; de Souza, Yure Pequeno; Schwantes, Ismael Albino; Santos, Talles de Oliveira; Bispo, Rosimeire Barbosa] UENF, CCTA, Lab Melhoramento Genet Vegetal, Rio De Janeiro, Brazil; [de Almeida Filho, Janeo Eustaquio] Bayer, Coxilha, RS, Brazil; [Pena, Guilherme Ferreira] Univ Estadual Mato Grosso, Alta Floresta, Mato Grosso, Brazil; [Maldonado, Carlos; Mora, Freddy] Univ Talca, Talca, Chile	Bayer AG; Universidade do Estado de Mato Grosso; Universidad de Talca	do Amaral, AT (corresponding author), UENF, CCTA, Lab Melhoramento Genet Vegetal, Rio De Janeiro, Brazil.	amaraljr@uenf.br	de Lima, Valter Jário/AAM-2489-2020; Mora-Poblete, Freddy/AAZ-1585-2020; Vivas, Marcelo/H-5653-2013; do Amaral, Antônio Teixeira/AAD-6291-2021; Santos, Talles De Oliveira/Q-7503-2018; Kamphorst, Samuel Henrique/AAJ-3687-2020	de Lima, Valter Jário/0000-0002-2982-085X; Vivas, Marcelo/0000-0002-7048-4149; do Amaral, Antônio Teixeira/0000-0003-4831-7878; Santos, Talles De Oliveira/0000-0003-0473-4282; Kamphorst, Samuel Henrique/0000-0001-9727-3539; Santos, PedroHenrique Araujo Diniz/0000-0002-7781-215X; Mafra, Gabrielle/0000-0002-5911-7401	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Rio de Janeiro State Research Support Foundation (FAPERJ) [E26/200.585/2016, E26/202.310/2017]; Bayer	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rio de Janeiro State Research Support Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Bayer(Bayer AG)	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 to JSS, VJdL, SHK, YPdS, IAS, TdOS and RBB. Funding was also provided by Rio de Janeiro State Research Support Foundation (FAPERJ), with the project E26/200.585/2016 to GSM and E26/202.310/2017 to ATdAJ, and Bayer for providing support in the form of salary to the author JEdAF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andorf CM, 2010, BIOINFORMATICS, V26, P434, DOI 10.1093/bioinformatics/btp556; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bloom AJ, 2002, J PLANT GROWTH REGUL, V21, P416, DOI 10.1007/s00344-003-0009-8; Borrmann D, 2009, CIENCIA TECNOL ALIME, V29, P676, DOI 10.1590/S0101-20612009000300034; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19665; Cheng XQ, 2017, PLANT CELL TISS ORG, V129, P237, DOI 10.1007/s11240-017-1172-0; Daros M., 2002, Crop Breeding and Applied Biotechnology, V2, P339; Daros M, 2004, SCI AGR, V61, P609, DOI 10.1590/S0103-90162004000600008; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Ding JQ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0589-z; do Amaral Junior A. T., 2016, GENET MOL RES, V15, DOI [10.4238/gmr15049309, DOI 10.4238/GMR15049309]; do Amaral AT, 2013, CROP BREED APPL BIOT, V13, P218, DOI 10.1590/S1984-70332013000300013; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Freitas ILJ, 2014, GENET MOL RES, V13, P518, DOI 10.4238/2014.January.21.21; Freitas SD, 2009, CROP BREED APPL BIOT, V9, P1; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Gu RL, 2013, PLANT CELL PHYSIOL, V54, P1515, DOI 10.1093/pcp/pct099; Guimaraes AG, 2018, ACTA SCI-AGRON, V40, DOI 10.4025/actasciagron.v40i1.35218; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Han S, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-017-2090-2; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Howitt SM, 2000, BBA-BIOMEMBRANES, V1465, P152, DOI 10.1016/S0005-2736(00)00136-X; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Jurkuta RJ, 2009, PLANT CELL, V21, P1957, DOI 10.1105/tpc.108.065284; Kotera M, 20 INT C GEN INF, P124; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li YL, 2007, GENOME, V50, P357, DOI 10.1139/G07-018; Liao CY, 2001, THEOR APPL GENET, V103, P104, DOI 10.1007/s001220000528; Liu XH, 2008, GENOMICS, V91, P378, DOI 10.1016/j.ygeno.2007.12.002; Lovegrove A, 2013, PLANT PHYSIOL, V163, P95, DOI 10.1104/pp.113.222653; Lynn K, 1999, DEVELOPMENT, V126, P469; Mo HJ, 2015, PLANT J, V83, P962, DOI 10.1111/tpj.12941; Morosini JS, 2017, PLANT SOIL, V421, P453, DOI 10.1007/s11104-017-3479-3; Mun BG, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0858-7; Neves LG, 2014, G3-GENES GENOM GENET, V4, P29, DOI 10.1534/g3.113.008714; Overvoorde Paul, 2010, Cold Spring Harb Perspect Biol, V2, pa001537, DOI 10.1101/cshperspect.a001537; Pace J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1226-9; Paes GP, 2016, GENET MOL BIOL, V39, P97, DOI 10.1590/1678-4685-GMB-2015-0126; Pereira M. G., 2001, Crop Breeding and Applied Biotechnology, V1, P3; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Rangel RM, 2011, REV CIENC AGRON, V42, P473, DOI 10.1590/S1806-66902011000200029; Rashid Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18690-3; Terra Thiago Gledson Rios, 2013, Pesqui. Agropecu. Trop., V43, P201, DOI 10.1590/S1983-40632013000200013; Santos Fabrício Santana, 2007, Bragantia, V66, P389, DOI 10.1590/S0006-87052007000300004; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sharma M, 2016, FRONT PLANT SCI, P6, DOI [10.3389/fpls.2016.00006, DOI 10.3389/FPLS.2016.00006]; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Singh SK, 2017, INT J CURR MICROBIOL, V6, P1187, DOI [10.20546/ijcmas, DOI 10.20546/ijcmas.2017.602.134]; Sonoda Y, 2003, PLANT CELL PHYSIOL, V44, P726, DOI 10.1093/pcp/pcg083; Sun RH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00063; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vittorazzi C, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16039769; Wang W, 2015, GENE, V555, P421, DOI 10.1016/j.gene.2014.11.042; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; Xiao YJ, 2017, MOL PLANT, V10, P359, DOI 10.1016/j.molp.2016.12.008; Xu XH, 2014, HYPERTENSION, V63, P490, DOI 10.1161/HYPERTENSIONAHA.113.02219; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Zain NAM, 2014, CIENC RURAL, V44, P2136, DOI 10.1590/0103-8478cr20131154; Zhai LH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020208; Zhai LH, 2014, J INTEGR PLANT BIOL, V56, P1042, DOI 10.1111/jipb.12205; Zhang M, 2015, PLANT J, V83, P582, DOI 10.1111/tpj.12911; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711	71	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218552	10.1371/journal.pone.0218552	http://dx.doi.org/10.1371/journal.pone.0218552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237892	Green Submitted, Green Published, gold			2022-12-26	WOS:000484856000025
J	Allen, J; Guo, K; Zhang, DX; Ince, M; Jammes, F				Allen, Jeffrey; Guo, Konnie; Zhang, Dongxiu; Ince, Michaela; Jammes, Fabien			ABA-glucose ester hydrolyzing enzyme ATBG1 and PHYB antagonistically regulate stomatal development	PLOS ONE			English	Article							ABSCISIC-ACID; PHYTOCHROME-B; ARABIDOPSIS MUTANTS; OSMOTIC-STRESS; LIGHT; RESPONSES; PERSPECTIVE; SPEECHLESS; INSIGHTS; SIGNALS	The integration of conflicting signals in response to environmental constraints is essential to efficient plant growth and development. The light-dependent and the stress hormone abscisic acid (ABA)-dependent signaling pathways play opposite roles in many aspects of plant development. While these pathways have been extensively studied, the complex nature of their molecular dialogue is still obscure. When mobilized by the Arabidopsis thaliana beta-glucosidase 1 (AtBG1), the glucose ester-conjugated inactive form of ABA has proven to be a source of the active hormone that is essential for the adaptation of the plant to water deficit, as evidenced by the impaired stomatal closure of atbg1 mutants in response to water stress. In a suppressor screen designed to identify the molecular components of AtBG1-associated physiological and developmental mechanisms, we identified the mutation variant of AtBG1 traits (vat1), a new mutant allele of the red light/far-red light photoreceptor PHYTOCHROME B (PHYB). Our study reveals that atbg1 plants harbor increased stomatal density in addition to impaired stomatal closure. We also provide evidence that the vat1/phyb mutation can restore the apparent transpiration of the atbg1 mutant by decreasing stomatal aperture and restoring a stomatal density similar to wild-type plants. Expression of key regulators of stomatal development showed a crosstalk between AtBG1-mediated ABA signaling and PHYB-mediated stomatal development. We conclude that the AtBG1-dependent regulation of ABA homeostasis and the PHYB-mediated light signaling pathways act antagonistically in the control of stomatal development.	[Allen, Jeffrey; Guo, Konnie; Ince, Michaela; Jammes, Fabien] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Allen, Jeffrey; Guo, Konnie; Ince, Michaela; Jammes, Fabien] Pomona Coll, Program Mol Biol, Claremont, CA 91711 USA; [Zhang, Dongxiu] USDA, ARS, Systemat Mycol & Microbiol Lab, Beltsville, MD 20705 USA	Claremont Colleges; Pomona College; Claremont Colleges; Pomona College; United States Department of Agriculture (USDA)	Jammes, F (corresponding author), Pomona Coll, Dept Biol, Claremont, CA 91711 USA.; Jammes, F (corresponding author), Pomona Coll, Program Mol Biol, Claremont, CA 91711 USA.	fabien.jammes@pomona.edu	Jammes, Fabien/AAB-6235-2020	Allen, Jeffrey/0000-0003-0148-3860; Guo, Konnie/0000-0002-9530-6840	Pomona College Start-up Funds; National Science Foundation [DBI-0521250]; NSF [1126080, 1626618]	Pomona College Start-up Funds; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	The work was supported by Pomona College Start-up Funds (to FJ). The ABA quantification performed by the Donald Danforth Plant Science Center Proteomics and Mass Spectrometry Facility was supported by the National Science Foundation under Grant No. DBI-0521250 for acquisition of the QTRAP LC-MS/MS. The scanning electron microscope at Rancho Santa Ana Botanic Garden SEM was acquired with a NSF Major Research Instrumentation grant NSF (Award #1626618). The acquisition of the fieldemission scanning microscope at Pomona College was supported by the NSF award #1126080.	Araujo WL, 2011, PLANT SIGNAL BEHAV, V6, P1305, DOI 10.4161/psb.6.9.16425; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Assmann SM, 2016, CURR OPIN PLANT BIOL, V33, P157, DOI 10.1016/j.pbi.2016.07.003; Berendzen K, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-4; Boccalandro HE, 2009, PLANT PHYSIOL, V150, P1083, DOI 10.1104/pp.109.135509; Burgie ES, 2014, PLANT CELL, V26, P4568, DOI 10.1105/tpc.114.131623; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Casson SA, 2009, CURR BIOL, V19, P229, DOI 10.1016/j.cub.2008.12.046; Chater CCC, 2014, NEW PHYTOL, V202, P376, DOI 10.1111/nph.12713; Conklin PA, 2019, NEW PHYTOL, V221, P706, DOI 10.1111/nph.15371; Gechev T, 2013, METHOD ENZYMOL, V527, P203, DOI 10.1016/B978-0-12-405882-8.00011-8; Geisler M, 2002, NEW PHYTOL, V153, P469, DOI 10.1046/j.0028-646X.2001.00332.x; Han SK, 2016, DEVELOPMENT, V143, P1259, DOI 10.1242/dev.127712; Hofmann K., 1996, PRETTY PRINTING SHAD; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; Jammes F, 2014, PLANT J, V79, P322, DOI 10.1111/tpj.12564; Jander G, 2003, PLANT PHYSIOL, V131, P139, DOI 10.1104/pp.102.010397; Joshi-Saha A, 2011, MOL PLANT, V4, P562, DOI 10.1093/mp/ssr055; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kang CY, 2009, PLANT CELL, V21, P2624, DOI 10.1105/tpc.109.069765; Kumari A, 2014, PLANT CELL PHYSIOL, V55, P2037, DOI 10.1093/pcp/pcu159; Lau OS, 2018, CURR BIOL, V28, P1273, DOI 10.1016/j.cub.2018.02.054; Lau OS, 2014, SCIENCE, V345, P1605, DOI 10.1126/science.1256888; Lau OS, 2012, DEVELOPMENT, V139, P3683, DOI 10.1242/dev.080523; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Leung J, 2016, MOL PLANT, V9, P7, DOI 10.1016/j.molp.2015.07.007; Lin R, 2014, ABSCISIC ACID METABO, P255; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Merilo E, 2015, MOL PLANT, V8, P1321, DOI 10.1016/j.molp.2015.06.006; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Pillitteri Lynn Jo, 2013, Arabidopsis Book, V11, pe0162, DOI 10.1199/tab.0162; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qi XY, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0488-5; RASCHKE K, 1976, PHILOS T ROY SOC B, V273, P551, DOI 10.1098/rstb.1976.0031; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Sanchez-Serrano JJ, 2014, ARABIDOPSIS PROTOCOL; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Tanaka Y, 2013, PLANT J, V74, P448, DOI 10.1111/tpj.12136; Viczian A, 2017, PLANT CELL ENVIRON, V40, P2457, DOI 10.1111/pce.12880; Wang FF, 2010, MOL PLANT, V3, P246, DOI 10.1093/mp/ssp097; Xu DQ, 2018, TRENDS PLANT SCI, V23, P749, DOI 10.1016/j.tplants.2018.07.003; Xu ZY, 2012, PLANT CELL, V24, P2184, DOI 10.1105/tpc.112.095935	46	7	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218605	10.1371/journal.pone.0218605	http://dx.doi.org/10.1371/journal.pone.0218605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233537	Green Submitted, gold, Green Published			2022-12-26	WOS:000484896700025
J	de Lima, BM; Cappa, EP; Silva, OB; Garcia, C; Mansfield, SD; Grattapaglia, D				de Lima, Bruno Marco; Cappa, Eduardo P.; Silva-Junior, Orzenil B.; Garcia, Carla; Mansfield, Shawn D.; Grattapaglia, Dario			Quantitative genetic parameters for growth and wood properties in Eucalyptus "urograndis" hybrid using near-infrared phenotyping and genome-wide SNP-based relationships	PLOS ONE			English	Article							SYRINGYL/GUAIACYL RATIO; CHEMICAL-PROPERTIES; PULPING EFFICIENCY; CELLULOSE CONTENT; BASIC DENSITY; E-UROPHYLLA; AGE TRENDS; LIGNIN; SPECTROSCOPY; PREDICTION	A thorough understanding of the heritability, genetic correlations and additive and non-additive variance components of tree growth and wood properties is a requisite for effective tree breeding. This knowledge is essential to maximize genetic gain, that is, the amount of increase in trait performance achieved annually through directional selection. Understanding the genetic attributes of traits targeted by breeding is also important to sustain decade-long genetic progress, that is, the progress made by increasing the average genetic value of the offspring as compared to that of the parental generation. In this study, we report quantitative genetic parameters for fifteen growth, wood chemical and physical traits for the world-famous Eucalyptus urograndis hybrid (E. grandis x E. urophylla). These traits directly impact the optimal use of wood for cellulose pulp, paper, and energy production. A population of 1,000 trees sampled in a progeny trial was phenotyped directly or following the development and use of near-infrared spectroscopy calibration models. Trees were genotyped with 33,398 SNPs and 24,001 DArT-seq genome-wide markers and genomic realized relationship matrices (GRM) were used for parameter estimation with an individual-tree additive-dominant mixed model. Wood chemical properties and wood density showed stronger genetic control than growth, cellulose and fiber traits. Additive effects are the main drivers of genetic variation for all traits, but dominance plays an equally or more important role for growth, singularly in this hybrid. GRM's with >10,000 markers provided stable relationships estimates and more accurate parameters than pedigrees by capturing the full genetic relationships among individuals and disentangling the non-additive from the additive genetic component. Low correlations between growth and wood properties indicate that simultaneous selection for wood traits can be applied with minor effects on genetic gain for growth. Conversely, moderate to strong correlations between wood density and chemical traits exist, likely due to their interdependency on cell wall structure such that responses to selection will be connected for these traits. Our results illustrate the advantage of using genome-wide marker data to inform tree breeding in general and have important consequences for operational breeding of eucalypt urograndis hybrids.	[de Lima, Bruno Marco; Silva-Junior, Orzenil B.; Grattapaglia, Dario] EMBRAPA Genet Resources & Biotechnol, Brasilia, DF, Brazil; [de Lima, Bruno Marco] Univ Sao Paulo, Dept Genet, Piracicaba, SP, Brazil; [Cappa, Eduardo P.] INTA, Inst Recursos Biol, Ctr Invest Recursos Nat, Buenos Aires, DF, Argentina; [Cappa, Eduardo P.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Silva-Junior, Orzenil B.; Grattapaglia, Dario] Univ Catolica Brasilia, Grad Program Genom Sci, Brasilia, DF, Brazil; [Garcia, Carla] Int Paper Brasil Rod, Sao Paulo, Brazil; [Mansfield, Shawn D.] Univ British Columbia, Dept Wood Sci, Fac Forestry, Vancouver, BC, Canada; [de Lima, Bruno Marco] SUZANO Papel & Celulose SA, Ctr Technol, Jacarei, SP, Brazil; [Garcia, Carla] Veracel Celulose SA, Eunapolis, BA, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Catolica de Brasilia; University of British Columbia	Grattapaglia, D (corresponding author), EMBRAPA Genet Resources & Biotechnol, Brasilia, DF, Brazil.; Grattapaglia, D (corresponding author), Univ Catolica Brasilia, Grad Program Genom Sci, Brasilia, DF, Brazil.	dario.grattapaglia@embrapa.br	Silva-Junior, Orzenil/B-3488-2013; Grattapaglia, Dario/B-5864-2014; Grattapaglia, Dario/AAB-6805-2020; de Lima, Bruno Marco/AAP-1856-2020	Silva-Junior, Orzenil/0000-0002-2104-2010; Grattapaglia, Dario/0000-0002-0050-970X; Grattapaglia, Dario/0000-0002-0050-970X; de Lima, Bruno Marco/0000-0003-0472-368X	FAP-DF grant "NEXTREE" [193.000.570-2009]; CNPq [400663-2012/0, 308431-2013/8]; FAPESP [2010/13185-0]; Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina [PICT-2016 1048]	FAP-DF grant "NEXTREE"; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina(ANPCyT)	This work was partially supported by FAP-DF (www.fap.df.gov.br) grant "NEXTREE" 193.000.570-2009, CNPq (www.cnpq.br) grants 400663-2012/0 and 308431-2013/8 to DG and a FAPESP (www.fapesp.br) doctoral fellowship (2010/13185-0) to BML. EPC's research was partially supported by the Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (www.argentina.gob.ar) grant PICT-2016 1048. These public funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. International Paper do Brasil provided support in the form of salaries for author CG and access to the study population but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is specified in the 'author contributions' section.	Alves A, 2011, J NEAR INFRARED SPEC, V19, P343, DOI 10.1255/jnirs.946; Amadeu RR, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.01.0009; Apiolaza LA, 2005, SILVAE GENET, V54, P160, DOI 10.1515/sg-2005-0024; Assis TF, 2011, CROP BREED APPL BIOT, V11, P44, DOI 10.1590/S1984-70332011000500007; ATTIA, 2017, AD; Bailleres H, 2002, ANN FOR SCI, V59, P479, DOI [10.1051/forest:2002032, 10.1051/forest:20032]; Bouvet JM, 2016, HEREDITY, V116, P146, DOI 10.1038/hdy.2015.78; Bouvet JM, 2009, EUPHYTICA, V165, P35, DOI 10.1007/s10681-008-9746-x; Bouvet JM, 1995, SILVAE GENET, V44, P206; Bouvet JM, 1996, SILVAE GENET, V45, P171; Brandao L.G., 1984, PULP PAP INT, V26, P38; Bush D, 2011, TREE GENET GENOMES, V7, P23, DOI 10.1007/s11295-010-0312-z; Chen SK, 2018, ANN FOREST SCI, V75, DOI 10.1007/s13595-018-0694-x; Silva JCE, 2012, TREE GENET GENOMES, V8, P249, DOI 10.1007/s11295-011-0437-8; Silva JCE, 2009, TREE GENET GENOMES, V5, P291, DOI 10.1007/s11295-008-0174-9; de Almeida JED, 2016, HEREDITY, V117, P33, DOI 10.1038/hdy.2016.23; Denis M, 2013, TREE GENET GENOMES, V9, P927, DOI [10.1007/s11295-013-0606-z, 10.1007/s11295-012-0528-1]; Downes GM, 2011, SOUTH FORESTS, V73, P181, DOI 10.2989/20702620.2011.639489; Dungey HS, 2001, FOREST ECOL MANAG, V148, P243, DOI 10.1016/S0378-1127(00)00539-9; El-Dien OG, 2016, G3-GENES GENOM GENET, V6, P743, DOI 10.1534/g3.115.025957; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; Faria DA, 2011, TREE GENET GENOMES, V7, P63, DOI 10.1007/s11295-010-0315-9; Hein PRG, 2009, J NEAR INFRARED SPEC, V17, P141, DOI 10.1255/jnirs.833; Gilmour AR, 2009, ASREML USER GUIDE RE; Grattapaglia D, 2008, NEW PHYTOL, V179, P911, DOI 10.1111/j.1469-8137.2008.02503.x; Grattapaglia D, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01693; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Hamilton MG, 2009, TREE GENET GENOMES, V5, P307, DOI 10.1007/s11295-008-0179-4; Harwood C, 2011, DEV EUCALYPT RESOURC, P10; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; He XD, 2012, NEW FOREST, V43, P383, DOI 10.1007/s11056-011-9287-3; Hein PRG, 2012, ANN FOREST SCI, V69, P681, DOI 10.1007/s13595-012-0186-3; Hodge GR, 2018, J NEAR INFRARED SPEC, V26, P117, DOI 10.1177/0967033518770211; Huntley SK, 2003, J AGR FOOD CHEM, V51, P6178, DOI 10.1021/jf034320o; Inglis PW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206085; Kain DP, 2003, GENETIC PARAMETERS I; Kellison RC, 2013, INT J FOREST RES, V2013, P9, DOI DOI 10.1155/2013/189393.ARTICLE; KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770; Kerr RJ, 2004, CAN J FOREST RES, V34, P209, DOI [10.1139/x03-180, 10.1139/X03-180]; Klapste J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185137; Kumar S, 2005, MOL BREEDING, V15, P55, DOI 10.1007/s11032-004-2059-4; Muller BSF, 2019, NEW PHYTOL, V221, P818, DOI 10.1111/nph.15449; Muller BSF, 2017, BMC GENOMICS, V18, P1, DOI [10.1186/s12864-016-3406-7, DOI 10.1186/S12864-016-3406-7]; Munoz PR, 2014, GENETICS, V198, P1759, DOI 10.1534/genetics.114.171322; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Poke FS, 2006, ANN FOREST SCI, V63, P813, DOI 10.1051/forest:2006080; Porth I, 2013, NEW PHYTOL, V197, P777, DOI 10.1111/nph.12014; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Ramadevi P, 2016, J NEAR INFRARED SPEC, V24, P529, DOI 10.1255/jnirs.1251; Raymond CA, 2002, ANN FOREST SCI, V59, P525, DOI 10.1051/forest:2002037; Raymond CA, 2002, CAN J FOREST RES, V32, P170, DOI 10.1139/x01-174; Reina L, 2014, J ANAL APPL PYROL, V107, P284, DOI 10.1016/j.jaap.2014.03.013; Resende MDV, 2010, DOCUMENTOS EMBRAPA 2; Resende RT, 2017, HEREDITY, V119, P245, DOI 10.1038/hdy.2017.37; Resende RT, 2017, NEW PHYTOL, V213, P1287, DOI 10.1111/nph.14266; Retief ECL, 2009, SOUTH FORESTS, V71, P133, DOI 10.2989/SF.2009.71.2.8.823; Rezende G. D. S. P., 2014, EUCALYPTUS BREEDING, DOI [10.1007/978-94-007-7076-8_16, DOI 10.1007/978-94-007-7076-8_16]; Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x; Sandak J, 2016, J NEAR INFRARED SPEC, V24, P485, DOI 10.1255/jnirs.1255; Sansaloni CP, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-16; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Schimleck LR, 2000, APPITA J, V53, P458; Schumacher FX, 1933, J AGRIC RES, V47, P0719; Silva JCE, 2004, THEOR APPL GENET, V108, P1113, DOI 10.1007/s00122-003-1524-5; Silva OB, 2015, NEW PHYTOL, V206, P1527, DOI 10.1111/nph.13322; Stackpole DJ, 2011, G3-GENES GENOM GENET, V1, P151, DOI 10.1534/g3.111.000372; Stewart JJ, 2006, HOLZFORSCHUNG, V60, P111, DOI 10.1515/HF.2006.019; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Tan BY, 2018, PLANT SCI, V267, P84, DOI 10.1016/j.plantsci.2017.11.011; TAN BY, 2017, BMC GENOMICS, V17, P60943, DOI DOI 10.1186/S12870-017-1059-6; Tsuchikawa S, 2015, J WOOD SCI, V61, P213, DOI 10.1007/s10086-015-1467-x; van den Berg GJ, 2018, SOUTH FORESTS, V80, P9, DOI 10.2989/20702620.2016.1263010; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vitezica ZG, 2013, GENETICS, V195, P1223, DOI 10.1534/genetics.113.155176; Volker PW, 2008, TREE GENET GENOMES, V4, P445, DOI 10.1007/s11295-007-0122-0; Wu SJ, 2011, NEW FOREST, V42, P35, DOI 10.1007/s11056-010-9235-7	76	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218747	10.1371/journal.pone.0218747	http://dx.doi.org/10.1371/journal.pone.0218747			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233563	gold, Green Published, Green Submitted			2022-12-26	WOS:000484896700037
J	Hamid, R; Marashi, H; Tomar, RS; Shafaroudi, SM; Sabara, PH				Hamid, Rasmieh; Marashi, Hassan; Tomar, Rukam S.; Shafaroudi, Saeid Malekzadeh; Sabara, Pritesh H.			Transcriptome analysis identified aberrant gene expression in pollen developmental pathways leading to CGMS in cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; PENTATRICOPEPTIDE REPEAT PROTEIN; TAPETUM DEVELOPMENT; ANTHER DEVELOPMENT; WALL FORMATION; EXINE FORMATION; RNA; RESTORER; ENCODES; LINE	Male sterility (induced or natural) is a potential tool for commercial hybrid seed production in different crops. Despite numerous endeavors to understand the physiological, hereditary, and molecular cascade of events governing CMS in cotton, the exact biological process controlling sterility and fertility reconstruction remains obscure. During current study, RNA-Seq using Ion Torrent S5 platform is carried out to identify 'molecular portraits' in floral buds among the Cytoplasmic Genic Male Sterility (CGMS) line, its near-isogenic maintainer, and restorer lines. A total of 300, 438 and 455 genes were differentially expressed in CGMS, Maintainer, and Restorer lines respectively. The functional analysis using AgriGo revealed suppression in the pathways involved in biogenesis and metabolism of secondary metabolites which play an important role in pollen and anther maturation. Enrichment analysis showed dearth related to pollen and anther's development in sterile line, including anomalous expression of genes and transcription factors that have a role in the development of the reproductive organ, abnormal cytoskeleton formation, defects in cell wall formation. The current study found aberrant expression of DYT1, AMS and cytochrome P450 genes involved in tapetum formation, pollen development, pollen exine and anther cuticle formation associated to male sterility as well as fertility restoration of CGMS. In the current study, more numbers of DEGs were found on Chromosome D05 and A05 as compared to other chromosomes. Expression pattern analysis of fourteen randomly selected genes using qRT-PCR showed high concurrence with gene expression profile of RNA-Seq analysis accompanied by a strong correlation of 0.82. The present study provides an important support for future studies in identifying interaction between cyto-nuclear molecular portraits, to accelerate functional genomics and molecular breeding related to cytoplasmic male sterility studies in cotton.	[Hamid, Rasmieh; Marashi, Hassan; Shafaroudi, Saeid Malekzadeh] Ferdowsi Univ Mashhad, Dept Biotechnol & Plant Breeding, Mashhad, Razavi Khorasan, Iran; [Tomar, Rukam S.] Junagadh Agr Univ, Dept Biotechnol & Biochem, Junagadh, Gujarat, India; [Sabara, Pritesh H.] Anand Agr Univ, Dept Anim Biotechnol, Anand, Gujarat, India	Ferdowsi University Mashhad; Anand Agricultural University	Marashi, H (corresponding author), Ferdowsi Univ Mashhad, Dept Biotechnol & Plant Breeding, Mashhad, Razavi Khorasan, Iran.	marashi@um.ac.ir	Tomar, Rukam Singh/I-3474-2013; Hamid, Rasmieh/AAH-1551-2019; marashi, hassan/S-9889-2018	Tomar, Rukam Singh/0000-0001-9156-5311; marashi, hassan/0000-0002-2499-6725	Ministry of Science Research and Technology of Iran	Ministry of Science Research and Technology of Iran	Financial assistance in the form of 'Travel grant award' was given to selected scholar student (Miss Rasmieh Hamid) by the Ministry of Science Research and Technology of Iran, during research work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackmore S, 2007, NEW PHYTOL, V174, P483, DOI 10.1111/j.1469-8137.2007.02060.x; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Chen P, 2014, MOL BREEDING, V34, P1879, DOI 10.1007/s11032-014-0146-8; Chen ZW, 2017, CRIT REV PLANT SCI, V36, P55, DOI 10.1080/07352689.2017.1327762; Dahan J, 2013, RNA BIOL, V10, P1469, DOI 10.4161/rna.25568; Datta R, 2002, PLANT PHYSIOL, V130, P1645, DOI 10.1104/pp.006908; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engelke T, 2002, PLANT BREEDING, V121, P254, DOI 10.1046/j.1439-0523.2002.00704.x; Fang WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133425; Feng BM, 2012, PLANT J, V72, P612, DOI 10.1111/j.1365-313X.2012.05104.x; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Gu JN, 2014, PLANT J, V80, P1005, DOI 10.1111/tpj.12694; Hamid R, 2018, GENE, V660, P80, DOI 10.1016/j.gene.2018.03.070; Han ZF, 2017, PLANT PHYSIOL BIOCH, V116, P106, DOI 10.1016/j.plaphy.2017.04.018; Han ZF, 2016, APPL BIOCHEM BIOTECH, V180, P1243, DOI 10.1007/s12010-016-2164-y; Higginson T, 2003, PLANT J, V35, P177, DOI 10.1046/j.1365-313X.2003.01791.x; Jhuang HY, 2017, EMBO REP, V18, P87, DOI 10.15252/embr.201643311; Kapu NUS, 2010, J EXP BOT, V61, P4097, DOI 10.1093/jxb/erq225; Koringa PG, 2016, VET COMP ONCOL, V14, P122, DOI 10.1111/vco.12079; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Li DD, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01559; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Li J., 2015, IEEE T CLOUD COMPUT, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0126771; Li L, 2015, PLANTA, V241, P157, DOI 10.1007/s00425-014-2160-9; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; Liu QC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071058; Liu YJ, 2013, PLANT CELL, V25, P868, DOI 10.1105/tpc.112.106781; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longin CFH, 2013, THEOR APPL GENET, V126, P2791, DOI 10.1007/s00122-013-2172-z; Lu TT, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00009; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Miranda RG, 2018, NUCLEIC ACIDS RES, V46, P2613, DOI 10.1093/nar/gkx1288; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; Nadeau JA, 2009, CURR OPIN PLANT BIOL, V12, P29, DOI 10.1016/j.pbi.2008.10.006; Nie HS, 2018, FUNCT INTEGR GENOMIC, V18, P457, DOI 10.1007/s10142-018-0606-z; Niu EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145725; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Omidvar V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170715; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; PRUITT KD, 1991, MOL GEN GENET, V227, P348, DOI 10.1007/BF00273922; Qiu Y.-Q., 2013, ENCY SYSTEMBIOL, P1068, DOI [10.1007/978-1-4419-9863-7_472, DOI 10.1007/978-1-4419-9863-7_472]; Qiu YL, 2018, GENE, V641, P8, DOI 10.1016/j.gene.2017.10.022; Salih H, 2018, MOL GENET GENOMICS, P1; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; Suzuki H, 2013, PLANT CELL REP, V32, P1531, DOI 10.1007/s00299-013-1465-7; Tang HW, 2014, MOL PLANT, V7, P1497, DOI 10.1093/mp/ssu047; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang S, 2016, PLANT PHYSIOL BIOCH, V105, P224, DOI 10.1016/j.plaphy.2016.04.027; Wolfe D, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-18; Wu JY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3841-0; Wu YR, 2002, PLANT MOL BIOL REP, V20, P213, DOI 10.1007/BF02782456; Wu YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09608; Xie Y, 2016, FUNCT INTEGR GENOMIC, V16, P529, DOI 10.1007/s10142-016-0504-1; Xu J, 2014, PLANT CELL, V26, P1544, DOI 10.1105/tpc.114.122986; Yang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112320; [喻树迅 Yu Shuxun], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P3465; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhang YJ, 2015, J PLANT GROWTH REGUL, V34, P223, DOI 10.1007/s00344-014-9458-5; Zhang ZB, 2007, PLANT J, V52, P528, DOI 10.1111/j.1365-313X.2007.03254.x; Zhao CP, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4406-y; Zhu EG, 2015, PLANT J, V83, P976, DOI 10.1111/tpj.12942; Zhu T, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1039-x	67	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218381	10.1371/journal.pone.0218381	http://dx.doi.org/10.1371/journal.pone.0218381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233531	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700015
J	Aranha, PCD; Rasmussen, LH; Wolf-Jackel, GA; Jensen, HME; Hansen, HCB; Friis, C				Aranha, Paulo Cesar dos Reis; Rasmussen, Lars Holm; Wolf-Jackel, Godelind Alma; Jensen, Henrik Michael Elvang; Hansen, Hans Christian Bruun; Friis, Christian			Fate of ptaquiloside-A bracken fern toxin-In cattle	PLOS ONE			English	Article							ENZOOTIC BOVINE HEMATURIA; PTERIDIUM-AQUILINUM; NORSESQUITERPENE GLYCOSIDES; PTEROSIN B; CARCINOGEN; MILK; ESCULENTUM; QUERCETIN; PASSAGE; PLASMA	Ptaquiloside is a natural toxin present in bracken ferns (Pteridium sp.). Cattle ingesting bracken may develop bladder tumours and excrete genotoxins in meat and milk. However, the fate of ptaquiloside in cattle and the link between ptaquiloside and cattle carcinogenesis is unresolved. Here, we present the toxicokinetic profile of ptaquiloside in plasma and urine after intravenous administration of ptaquiloside and after oral administration of bracken. Administered intravenously ptaquiloside, revealed a volume of distribution of 1.3 L kg(-1) with a mean residence-time of 4 hours. A large fraction of ptaquiloside was converted to nontoxic pterosin B in the blood stream. Both ptaquiloside and pterosin B were excreted in urine (up to 41% of the dose). Oral administration of ptaquiloside via bracken extract or dried ferns did not result in observations of ptaquiloside in body fluids, indicating deglycosolidation in the rumen. Pterosin B was detected in both plasma and urine after oral administration. Hence, transport of carcinogenic ptaquiloside metabolites over the rumen membrane is indicated. Pterosin B recovered from urine counted for 7% of the dose given intravenously. Heifers exposed to bracken for 7 days (2 mg ptaquiloside kg(-1)) developed preneoplastic lesions in the urinary bladder most likely caused by genotoxic ptaquiloside metabolites.	[Aranha, Paulo Cesar dos Reis; Wolf-Jackel, Godelind Alma; Jensen, Henrik Michael Elvang; Friis, Christian] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg, Denmark; [Rasmussen, Lars Holm] Univ Coll Copenhagen, Dept Technol, Copenhagen, Denmark; [Hansen, Hans Christian Bruun] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Wolf-Jackel, Godelind Alma] Natl Vet Inst, DTU Vet, Lyngby, Denmark	University of Copenhagen; University College Copenhagen; University of Copenhagen; Technical University of Denmark	Rasmussen, LH (corresponding author), Univ Coll Copenhagen, Dept Technol, Copenhagen, Denmark.	LHRA@KP.DK	Rasmussen, Lars Holm/S-3729-2018	Rasmussen, Lars Holm/0000-0002-7301-3182; Wolf-Jackel, Godelind/0000-0002-5719-3443; Jensen, Henrik Elvang/0000-0001-7277-7829	Danish State; European Union [722493]	Danish State; European Union(European Commission)	The project was funded by Danish State funding to University of Copenhagen and University College Copenhagen and by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 722493 (NaToxAq - Natural Toxins and Drink-ing Water Quality - From Source to Tap). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Gerda Larsen (Veterinary Pharmacology and Toxicology group, Department of Veterinary and Animal Sciences, University of Copenhagen, Denmark) for her friendship and precious technical support and enthusiasm on solving the coming adversities. The project was funded by Danish State funding to University of Copenhagen and University College Copenhagen and by funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 722493 (NaToxAq-Natural Toxins and Drinking Water Quality-From Source to Tap).	Alonso-Amelot ME, 2002, CURR MED CHEM, V9, P675, DOI 10.2174/0929867023370743; Alonso-Amelot ME, 1998, LAIT, V78, P413, DOI 10.1051/lait:1998440; ALONSOAMELOT ME, 1993, LAIT, V73, P323, DOI 10.1051/lait:1993330; Aranha PCR, 2014, J CHROMATOGR B, V951, P44, DOI 10.1016/j.jchromb.2014.01.022; Ayala-Luis KB, 2006, ENVIRON TOXICOL CHEM, V25, P2623, DOI 10.1897/05-695R.1; Bonadies F, 2011, FOOD CHEM, V124, P660, DOI 10.1016/j.foodchem.2010.05.059; Carvalho T, 2006, J COMP PATHOL, V134, P336, DOI 10.1016/j.jcpa.2006.01.001; DAWRA RK, 1991, VET RES COMMUN, V15, P421; Der JP, 2009, AM J BOT, V96, P1041, DOI 10.3732/ajb.0800333; EVANS IA, 1972, NATURE, V237, P107, DOI 10.1038/237107a0; FENWICK G R, 1988, Journal of the Science of Food and Agriculture, V46, P147; Fletcher MT, 2011, J AGR FOOD CHEM, V59, P8518, DOI 10.1021/jf201342t; Fletcher MT, 2011, J AGR FOOD CHEM, V59, P5133, DOI 10.1021/jf104267c; Funahashi M, 1998, MED BIOL TOKYO, V136, P5; Gabrielsson Johan, 2012, Methods Mol Biol, V929, P377; Gomes J, 2012, TOXICOL SCI, V126, P60, DOI 10.1093/toxsci/kfr329; Hide C, 2004, IEEE POSITION LOCAT, P227; KIGOSHI H, 1992, TETRAHEDRON LETT, V33, P6647, DOI 10.1016/S0040-4039(00)61008-0; Latorre AO, 2011, FOOD CHEM TOXICOL, V49, P464, DOI 10.1016/j.fct.2010.11.026; Latorre AO, 2013, TOXICOLOGY, V304, P100, DOI 10.1016/j.tox.2012.12.010; Marcussen D, 2008, BASIC DAIRY CATTLE P, P207; Marrs RH, 2006, J ECOL, V94, P1272, DOI 10.1111/j.1365-2745.2006.01177.x; MORI H, 1985, MUTAT RES, V143, P75, DOI 10.1016/0165-7992(85)90108-3; Ngomuo AJ, 1996, VET HUM TOXICOL, V38, P14; OJIKA M, 1987, TETRAHEDRON, V43, P5261, DOI 10.1016/S0040-4020(01)87702-4; Oliveros-Bastidas A, 2016, MED HYPOTHESES, V88, P91, DOI 10.1016/j.mehy.2015.11.007; PAMUKCU AM, 1978, CANCER RES, V38, P1556; Peixoto PV, 2003, PESQUISA VET BRASIL, V23, P65, DOI 10.1590/S0100-736X2003000200004; Perez-Alenza MD, 2006, NEW ZEAL VET J, V54, P185, DOI 10.1080/00480169.2006.36693; Rai SK, 2017, TOXICON, V138, P31, DOI 10.1016/j.toxicon.2017.08.010; Rasmussen LH, 2008, NEW ZEAL VET J, V56, P304, DOI 10.1080/00480169.2008.36851; Rasmussen LH, 2017, PHYTOCHEM ANALYSIS, V28, P575, DOI 10.1002/pca.2707; Rasmussen LH, 2015, J ENVIRON MANAGE, V151, P258, DOI 10.1016/j.jenvman.2014.12.052; SAITO K, 1989, PHYTOCHEMISTRY, V28, P1605, DOI 10.1016/S0031-9422(00)97808-7; Shahin M, 1998, BIOCHEM BIOPH RES CO, V244, P192, DOI 10.1006/bbrc.1998.8240; Sharma R, 2013, REV ENVIRON CONTAM T, V224, P53, DOI 10.1007/978-1-4614-5882-1_3; Siman SE, 2000, BRIT J CANCER, V83, P69, DOI 10.1054/bjoc.2000.1204; Skourti-Stathaki E, 2016, CHEMOSPHERE, V165, P453, DOI 10.1016/j.chemosphere.2016.09.050; TAKANASHI H, 1983, J FOOD SAFETY, V5, P55, DOI 10.1111/j.1745-4565.1983.tb00455.x; Tennant BC, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P379, DOI 10.1016/B978-0-12-370491-7.00013-1; TSUCHIYA R, 1994, J VET MED SCI, V56, P21, DOI 10.1292/jvms.56.21; Virgilio A, 2015, J AGR FOOD CHEM, V63, P4886, DOI 10.1021/acs.jafc.5b01937; Yamada K, 2007, NAT PROD REP, V24, P798, DOI 10.1039/b614160a	43	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218628	10.1371/journal.pone.0218628	http://dx.doi.org/10.1371/journal.pone.0218628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226154	Green Published, Green Submitted, gold			2022-12-26	WOS:000484894700026
J	Biswal, JK; Ranjan, R; Subramaniam, S; Mohapatra, JK; Patidar, S; Sharma, MK; Bertram, MR; Brito, B; Rodriguez, LL; Pattnaik, B; Arzt, J				Biswal, Jitendra K.; Ranjan, Rajeev; Subramaniam, Saravanan; Mohapatra, Jajati K.; Patidar, Sanjay; Sharma, Mukesh K.; Bertram, Miranda R.; Brito, Barbara; Rodriguez, Luis L.; Pattnaik, Bramhadev; Arzt, Jonathan			Genetic and antigenic variation of foot-and-mouth disease virus during persistent infection in naturally infected cattle and Asian buffalo in India	PLOS ONE			English	Article							CARRIER STATE; AFRICAN BUFFALO; SEROTYPE O; REAL-TIME; PATHOGENESIS; AFGHANISTAN; PAKISTAN; VACCINATION; PROTECTION; DIAGNOSIS	The role of foot-and-mouth disease virus (FMDV) persistently infected ruminants in initiating new outbreaks remains controversial, and the perceived threat posed by such animals hinders international trade in FMD-endemic countries. In this study we report longitudinal analyses of genetic and antigenic variations of FMDV serotype O/ME-SA/Ind2001d sublineage during naturally occurring, persistent infection in cattle and buffalo at an organised dairy farm in India. The proportion of animals from which FMDV RNA was recovered was not significantly different between convalescent (post-clinical) and sub-clinically infected animals or between cattle and buffalo across the sampling period. However, infectious virus was isolated from a higher proportion of buffalo samples and for a longer duration compared to cattle. Analysis of the P1 sequences from recovered viruses indicated fixation of mutations at the rate of 1.816 x 10(-2) substitution/site/year (s/s/y) (95% CI 1.362-2.31 x 10(-2) s/s/y). However, the majority of point mutations were transitional substitutions. Within individual animals, the mean dN/dS (omega) value for the P1 region varied from 0.076 to 0.357, suggesting the selection pressure acting on viral genomes differed substantially across individual animals. Statistical parsimony analysis indicated that all of the virus isolates from carrier animals originated from the outbreak virus. The antigenic relationship value as determined by 2D-VNT assay revealed fluctuation of antigenic variants within and between carrier animals during the carrier state which suggested that some carrier viruses had diverged substantially from the protection provided by the vaccine strain. This study contributes to understanding the extent of within-host and within-herd evolution that occurs during the carrier state of FMDV.	[Biswal, Jitendra K.; Ranjan, Rajeev; Subramaniam, Saravanan; Mohapatra, Jajati K.; Pattnaik, Bramhadev] ICAR Directorate Foot & Mouth Dis, Naini Tal, Uttarakhand, India; [Patidar, Sanjay; Sharma, Mukesh K.] ABIS Dairy, Rajnandgaon, Chhattisgarh, India; [Bertram, Miranda R.; Brito, Barbara; Rodriguez, Luis L.; Arzt, Jonathan] USDA ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA; [Bertram, Miranda R.; Brito, Barbara] Oak Ridge Inst Sci & Educ, PIADC Res Participat Program, Oak Ridge, TN USA	Indian Council of Agricultural Research (ICAR); ICAR - Directorate on Foot & Mouth Disease; United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Pattnaik, B (corresponding author), ICAR Directorate Foot & Mouth Dis, Naini Tal, Uttarakhand, India.; Arzt, J (corresponding author), USDA ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA.	pattnaikb@gmail.com; jonathan.arzt@ars.usda.gov	Subramaniam, Saravanan/J-8444-2014	Subramaniam, Saravanan/0000-0003-1737-4976; Arzt, Jonathan/0000-0002-7517-7893; Pattnaik, Bramhadev/0000-0003-0869-7722	U.S. Department of Agriculture, Agricultural Research Service-CRIS project [1940-32000-061-00D]; Biosecurity Engagement Program of the US Department of State; Plum Island Animal Disease Center Research Participation fellowships	U.S. Department of Agriculture, Agricultural Research Service-CRIS project; Biosecurity Engagement Program of the US Department of State; Plum Island Animal Disease Center Research Participation fellowships	This work was funded in part by the U.S. Department of Agriculture, Agricultural Research Service-CRIS project 1940-32000-061-00D and by the Biosecurity Engagement Program of the US Department of State. The output of the study described herein is based upon samples collected during an investigation of foot-and-mouth disease at a commercial dairy farm: Abis Exports, Chattisgarh, India. The investigation was conducted by the authors of the paper, including two employees of the farm (SP & MS). The specific roles of these authors are articulated in the 'author contributions' section. Thus, Abis Exports provided support in the form of salaries for authors (SP & MS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the supporting staff of the dairy farm of their cooperation during the sample collection. Technical assistance of Mr N.S. Singh and Mr B. Das are highly acknowledged. Miranda Bertram and Barbara Brito were recipients of Plum Island Animal Disease Center Research Participation fellowships, administered by the Oak Ridge Institute for Science and Education through an inter-agency agreement with the US Department of Energy. This work was funded in part by the U.S. Department of Agriculture, Agricultural Research Service-CRIS project 1940-32000-061-00D and by the Biosecurity Engagement Program of the US Department of State. The funders had no role in study design, data collection and analysis, or the decision to publish the work.	Ahmed Z, 2018, TRANSBOUND EMERG DIS, V65, P534, DOI 10.1111/tbed.12737; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Lavoria MA, 2012, VACCINE, V30, P6845, DOI 10.1016/j.vaccine.2012.09.011; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Arzt J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210847; Arzt J, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00365-18, 10.1128/msphere.00365-18]; Barros JJF, 2007, VET MICROBIOL, V120, P50, DOI 10.1016/j.vetmic.2006.10.023; BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Bertram MR, 2018, FRONTIERS VET SCI, V5; Biswal JK, 2012, INDIAN J ANIM SCI, V82, P109; Brito BP, 2017, TRANSBOUND EMERG DIS, V64, P316, DOI 10.1111/tbed.12373; Brito B, 2017, VET RES, V48, DOI 10.1186/s13567-017-0424-7; Bronsvoort BMD, 2016, SCI REP-UK, V6, DOI 10.1038/srep29059; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Eschbaumer M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162750; Farooq U, 2018, TRANSBOUND EMERG DIS, V65, P1836, DOI 10.1111/tbed.12963; Ferreira HCD, 2017, TRANSBOUND EMERG DIS, V64, P547, DOI 10.1111/tbed.12403; GEBAUER F, 1988, J VIROL, V62, P2041, DOI 10.1128/JVI.62.6.2041-2049.1988; Giridharan P, 2005, J VIROL METHODS, V126, P1, DOI 10.1016/j.jviromet.2005.01.015; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Hargreaves S, 1994, OIE SCIENTIFIC CONFE; Hayer SS, 2018, TRANSBOUND EMERG DIS, V65, pe404, DOI 10.1111/tbed.12774; Hayer SS, 2018, TRANSBOUND EMERG DIS, V65, P253, DOI 10.1111/tbed.12627; HEDGER RS, 1970, J HYG-CAMB, V68, P53, DOI 10.1017/S0022172400028497; Horsington J, 2007, VIRUS RES, V125, P114, DOI 10.1016/j.virusres.2006.12.008; Ilott MC, 1997, EPIDEMIOL INFECT, V118, P181, DOI 10.1017/S0950268896007376; Jamal SM, 2012, TRANSBOUND EMERG DIS, V59, P429, DOI 10.1111/j.1865-1682.2011.01295.x; Jamal SM, 2011, INFECT GENET EVOL, V11, P2049, DOI 10.1016/j.meegid.2011.09.015; Jamal SM, 2011, J GEN VIROL, V92, P2849, DOI 10.1099/vir.0.035626-0; Jamal SM, 2011, INFECT GENET EVOL, V11, P1229, DOI 10.1016/j.meegid.2011.03.006; Kitching P, 2007, VACCINE, V25, P5660, DOI 10.1016/j.vaccine.2006.10.052; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Mahapatra M, 2015, VACCINE, V33, P693, DOI 10.1016/j.vaccine.2014.11.058; MALIRAT V, 1994, VIRUS RES, V34, P31, DOI 10.1016/0168-1702(94)90117-1; Maree F, 2016, J VIROL, V90, P5132, DOI 10.1128/JVI.00166-16; MARTINEZ MA, 1992, J VIROL, V66, P3557; Moonen P, 2000, VET QUART, V22, P193, DOI 10.1080/01652176.2000.9695056; Pacheco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125698; Parida S, 2009, EXPERT REV VACCINES, V8, P347, DOI 10.1586/14760584.8.3.347; Parthiban ABR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128815; Brito BP, 2014, VACCINE, V32, P433, DOI 10.1016/j.vaccine.2013.12.007; Pauszek SJ, 2016, VIROL REP, V6, P90, DOI DOI 10.1016/J.VIREP.2016.10.001; Pauszek SJ, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomea.00849-17, 10.1128/genomeA.00849-17]; RCore Team, 2020, R LANG ENV STAT COMP; Reeve R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001027; Reid SM, 2002, J VIROL METHODS, V105, P67, DOI 10.1016/S0166-0934(02)00081-2; Rweyemamu M, 2008, TRANSBOUND EMERG DIS, V55, P57, DOI 10.1111/j.1865-1682.2007.01013.x; RWEYEMAMU MM, 1978, J HYG-CAMBRIDGE, V81, P107, DOI 10.1017/S002217240005381X; RWEYEMAMU MM, 1984, J BIOL STAND, V12, P323, DOI 10.1016/S0092-1157(84)80013-X; Salt J, 2004, FOOT AND MOUTH DISEASE: CURRENT PERSPECTIVES, P103; Salt JS, 1996, ARCH VIROL, V141, P1407, DOI 10.1007/BF01718244; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Sharma GK, 2017, TRANSBOUND EMERG DIS, V64, P1133, DOI 10.1111/tbed.12478; Shaw AE, 2004, REV SCI TECH OIE, V23, P1003, DOI 10.20506/rst.23.3.1544; Stenfeldt C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18112-4; Stenfeldt C, 2016, J VIROL, V90, P6344, DOI 10.1128/JVI.00388-16; Subramaniam S, 2015, VET MICROBIOL, V178, P181, DOI 10.1016/j.vetmic.2015.05.015; SUTMOLLER P, 1968, ARCH GES VIRUSFORSCH, V23, P227, DOI 10.1007/BF01241895; SUTMOLLER P, 1965, VET REC, V77, P968, DOI 10.1136/vr.77.33.968; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tenzin, 2008, RISK ANAL, V28, P303, DOI 10.1111/j.1539-6924.2008.01020.x; Vosloo W, 1996, J GEN VIROL, V77, P1457, DOI 10.1099/0022-1317-77-7-1457; Vu LT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177361	67	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0214832	10.1371/journal.pone.0214832	http://dx.doi.org/10.1371/journal.pone.0214832			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226113	Green Submitted, Green Published, gold			2022-12-26	WOS:000484894700004
J	McDermott, EJ; Himmelbach, M				McDermott, Eric James; Himmelbach, Marc			Effects of arm weight and target height on hand selection: A low-cost virtual reality paradigm	PLOS ONE			English	Article							PERFORMANCE ASYMMETRIES; LIMB SELECTION; HANDEDNESS; TASK	We evaluated the ability of a virtual reality (VR) system to reliably detect the reaching frequency midline position of a user; the distinguishing plane between free-choice use of the left and right hand. The paradigm utilized the Leap Motion Hand Tracker along with a custom script written in C# and was realized through a Unity3D application. Stimuli appeared in random locations on the computer screen and required the participant to reach with the hand of their choice to contact them with a virtually coupled hand inside the virtual space. We investigated the effects of two manipulations of effort on the free-choice reaching of either the left or right hand. We varied the height of target positions and applied an additional weight to the non-dominant, left hand. We observed main effects of height and weight on reaching frequency midline positions across the group. We found increased use of the dominant hand as stimuli height increased, as well as a significant increase in overall use of the dominant, right hand when a weighted-glove was worn by the non-dominant, left hand. Our results are in line with previously published research on hand selection from similar paradigms, supporting the use of our VR paradigm in future experiments and applications.	[McDermott, Eric James; Himmelbach, Marc] Univ Tubingen, Hertie Inst Clin Brain Res, Div Neuropsychol, Ctr Neurol, Tubingen, Germany; [McDermott, Eric James] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Stroke, Ctr Neurol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Himmelbach, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Div Neuropsychol, Ctr Neurol, Tubingen, Germany.	marc.himmelbach@uni-tuebingen.de			Graduate Training Center of Neuroscience, Tubingen, Germany; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen; Graduate Training Center of Neuroscience, Tuebingen, Germany	Graduate Training Center of Neuroscience, Tubingen, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen; Graduate Training Center of Neuroscience, Tuebingen, Germany	This work was supported by funds from the Graduate Training Center of Neuroscience, Tubingen, Germany. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen.; This work was supported by funds from the Graduate Training Center of Neuroscience, Tuebingen, Germany. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. We thank Winfried Ilg and Bjorn Muller, Section for Computational Sensomotorics, Tubingen for discussions of VR setups and Unity3D programming. We also thank Amin Dadashi for discussions of experimental design and data analysis.	Baldwin J.M., 1895, MENTAL DEV CHILD RAC; BRADSHAW JL, 1987, BEHAV BRAIN SCI, V10, P264, DOI 10.1017/S0140525X00047713; Bradshaw JL, 1990, NEUROPSYCHOLOGY, P225; Coelho CJ, 2013, J NEUROPHYSIOL, V109, P825, DOI 10.1152/jn.00885.2012; ELLIOTT D, 1993, CAN J EXP PSYCHOL, V47, P570, DOI 10.1037/h0078856; FITTS PM, 1992, J EXP PSYCHOL GEN, V121, P262, DOI 10.1037/0096-3445.121.3.262; Gabbard C, 1997, CAN J EXP PSYCHOL, V51, P176, DOI 10.1037/1196-1961.51.2.176; Gabbard C, 2004, EXP BRAIN RES, V156, P325, DOI 10.1007/s00221-003-1792-y; Gabbard C, 2003, INT J NEUROSCI, V113, P143, DOI 10.1080/00207450390161994; Gabbard C, 1998, INT J NEUROSCI, V96, P205, DOI 10.3109/00207459808986468; Gabbard C, 2000, J GEN PSYCHOL, V127, P178, DOI 10.1080/00221300009598577; Grimm F, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00518; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; HELLIGE JB, 1990, ADV PSYCHOL, V70, P635; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P280, DOI 10.1007/BF00419688; Hopkins, 1993, PRIMATE LATERALITY C, P285, DOI [10.1007/978-1-4612-4370-0_13, DOI 10.1017/S0140525X00054339]; Kiper P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/752128; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peters M., 1995, HANDEDNESS ITS RELAT, P183; Piron L, 2007, 2007 VIRTUAL REHABILITATION, P119; Piron L, 2010, NEUROREHAB NEURAL RE, V24, P501, DOI 10.1177/1545968310362672; Piron L, 2009, J REHABIL MED, V41, P1016, DOI 10.2340/16501977-0459; Przybyla A, 2013, NEUROSCIENCE, V228, P349, DOI 10.1016/j.neuroscience.2012.10.046; ROSENBAUM DA, 1990, ATTENTION PERFORM, P321; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Scharoun SM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00082; Schweighofer N, 2015, J NEUROPHYSIOL, V114, P551, DOI 10.1152/jn.00593.2014; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Stins JF, 2001, LATERALITY, V6, P347; Stins JF, 1997, J EXP PSYCHOL HUMAN, V23, P756; Turolla A, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-85; Umilta C., 1992, ANAL APPROACHES HUMA, P331; VERFAELLIE M, 1990, BRAIN COGNITION, V14, P70, DOI 10.1016/0278-2626(90)90061-R	34	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0207326	10.1371/journal.pone.0207326	http://dx.doi.org/10.1371/journal.pone.0207326			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226117	Green Submitted, Green Published, gold			2022-12-26	WOS:000484894700001
J	Badimon, L; Casani, L; Camino-Lopez, S; Juan-Babot, O; Borrell-Pages, M				Badimon, Lina; Casani, Laura; Camino-Lopez, Sandra; Juan-Babot, Oriol; Borrell-Pages, Maria			GSK3 beta inhibition and canonical Wnt signaling in mice hearts after myocardial ischemic damage	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; FRIZZLED-RELATED PROTEIN-2; ENDOTHELIAL GROWTH-FACTOR; CELL-MIGRATION; INFARCT SIZE; EXPRESSION; LRP5; PATHWAY; DIFFERENTIATION; INVOLVEMENT	Aims Myocardial infarction induces myocardial injury and tissue damage. During myocardial infarction strong cellular response is initiated to salvage the damaged tissues. This response is associated with the induction of different signaling pathways. Of these, the canonical Wnt signaling is increasingly important for its prosurvival cellular role, making it a good candidate for the search of new molecular targets to develop therapies to prevent heart failure in infarcted patients. Methods Herein we report that GSK3 beta regulates the canonical Wnt signaling in C57Bl6 mice hearts. GSK3 beta is a canonical Wnt pathway inhibitor. Using GSK3 beta inhibitors and inducing myocardial injury (MI) in Lrp5(-/-) mice model we show that GSK3 beta phosphorylation levels regulate downstream canonical Wnt pathway genes in the ischemic heart. In the setting of MI, myocardial damage assessment usually correlates with functional and clinical outcomes. Therefore, we measured myocardial injury size in Wt and Lrp5(-/-) mice in the presence and absence of two different GSK3 inhibitors prior to MI. Myocardial injury was independent of GSK3 inhibitor treatments and GSK3 beta expression levels. Results These studies support a central role for GSK3 beta in the activation of the canonical Wnt pathway in the Wt heart. Although LRP5 is protective against myocardial injury, GSK3 beta expression levels do not regulate heart damage.	[Badimon, Lina; Casani, Laura; Camino-Lopez, Sandra; Juan-Babot, Oriol; Borrell-Pages, Maria] Hosp Santa Creu & Sant Pau, Inst Recerca, Cardiovasc Program ICCC, Barcelona, Spain; [Badimon, Lina; Borrell-Pages, Maria] Inst Salud Carlos III, CIBER CV, Madrid, Spain; [Badimon, Lina] UAB, Cardiovasc Res Chair, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; Autonomous University of Barcelona	Borrell-Pages, M (corresponding author), Hosp Santa Creu & Sant Pau, Inst Recerca, Cardiovasc Program ICCC, Barcelona, Spain.; Borrell-Pages, M (corresponding author), Inst Salud Carlos III, CIBER CV, Madrid, Spain.	mborrellpa@santpau.cat	Camino, Sandra/AAF-8006-2019; Borrell-Pages, Maria/Q-6307-2019; Juan-Babot, Oriol/AAB-8580-2019; Badimon, Lina/O-4711-2014	Camino, Sandra/0000-0002-2737-4892; Borrell-Pages, Maria/0000-0002-1759-9756; Juan-Babot, Oriol/0000-0002-4328-0335; Badimon, Lina/0000-0002-9162-2459	Ministerio de Ciencia e Innovacion [SAF2016-76819-R]; Instituto de Salud Carlos III [CIBERCV CN16/11/00411, TERCEL RD16/0011/018, FIS2016-02014]; Generalitat of Catalunya-Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat [2014SGR1303]; Fundacion Investigacion Cardiovascular; Spanish Society of Cardiology (SEC2015)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat of Catalunya-Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat; Fundacion Investigacion Cardiovascular; Spanish Society of Cardiology (SEC2015)	This work was supported by the Ministerio de Ciencia e Innovacion (SAF2016-76819-R to LB); the Instituto de Salud Carlos III (CIBERCV CN16/11/00411 to LB, TERCEL RD16/0011/018 to LB and FIS2016-02014 to MBP); the Generalitat of Catalunya-Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat (2014SGR1303 to LB); the Fundacion Investigacion Cardiovascular to LB, and the Spanish Society of Cardiology (SEC2015 to MBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Birot OJG, 2003, J PHYSIOL-LONDON, V552, P213, DOI 10.1113/jphysiol.2003.043026; Borrell-Pages M, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0585-y; Borrell-Pages M, 2014, ATHEROSCLEROSIS, V235, P363, DOI 10.1016/j.atherosclerosis.2014.05.922; Borrell-Pages M, 2015, IMMUNOL CELL BIOL, V93, P653, DOI 10.1038/icb.2015.41; Borrell-Pages M, 2015, J CELL MOL MED, V19, P770, DOI 10.1111/jcmm.12396; Borrell-Pages M, 2014, J CELL MOL MED, V18, P314, DOI 10.1111/jcmm.12190; Borrell-Pages M, 2011, EUR HEART J, V32, P2841, DOI 10.1093/eurheartj/ehr062; Chen LJ, 2004, J CELL MOL MED, V8, P257, DOI 10.1111/j.1582-4934.2004.tb00281.x; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gross ER, 2004, CIRC RES, V94, P960, DOI 10.1161/01.RES.0000122392.33172.09; Hahn JY, 2006, J BIOL CHEM, V281, P30979, DOI 10.1074/jbc.M603916200; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hoppler S, 2014, WNT SIGNALING IN DEVELOPMENT AND DISEASE: MOLECULAR MECHANISMS AND BIOLOGICAL FUNCTIONS, P293; Howe LR, 1999, CANCER RES, V59, P1572; Iwahana E, 2004, EUR J NEUROSCI, V19, P2281, DOI 10.1111/j.0953-816X.2004.03322.x; Jiang XY, 2014, INT J RADIAT ONCOL, V89, P714, DOI 10.1016/j.ijrobp.2014.04.018; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Lin TN, 1997, STROKE, V28, P412, DOI 10.1161/01.STR.28.2.412; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Nishino Y, 2008, CIRC RES, V103, P307, DOI 10.1161/CIRCRESAHA.107.169953; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Pagel PS, 2006, ANESTH ANALG, V102, P1348, DOI 10.1213/01.ane.0000202379.61338.37; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Sayas CL, 2002, J NEUROSCI, V22, P6863; Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55; Varea O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005153; Zea AH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157907; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3; Zhang XB, 2001, CANCER RES, V61, P6050; Zhu Q, 2011, PROSTATE, V71, P835, DOI 10.1002/pros.21300	50	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218098	10.1371/journal.pone.0218098	http://dx.doi.org/10.1371/journal.pone.0218098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220102	gold, Green Published, Green Submitted			2022-12-26	WOS:000484893500022
J	Ruifang, LG; Hughes, DA; le Cessie, S; de Mutsert, R; den Heijer, M; Rosendaal, FR; van Dijk, KW; Timpson, NJ; Mook-Kanamori, DO				Ruifang Li-Gao; Hughes, David A.; le Cessie, Saskia; de Mutsert, Renee; den Heijer, Martin; Rosendaal, Frits R.; van Dijk, Ko Willems; Timpson, Nicholas J.; Mook-Kanamori, Dennis O.			Assessment of reproducibility and biological variability of fasting and postprandial plasma metabolite concentrations using H-1 NMR spectroscopy	PLOS ONE			English	Article							METABOLOMICS; EPIDEMIOLOGY	Introduction It is crucial to understand the factors that introduce variability before applying metabolomics to clinical and biomarker research. Objectives We quantified technical and biological variability of both fasting and postprandial metabolite concentrations measured using H-1 NMR spectroscopy in plasma samples. Methods In the Netherlands Epidemiology of Obesity study (n = 6,671), 148 metabolite concentrations (101 metabolites belonging to lipoprotein subclasses) were measured under fasting and postprandial states (150 minutes after a mixed liquid meal). Technical variability was evaluated among 265 fasting and 851 postprandial samples, with the identical blood plasma sample being measured twice by the same laboratory protocol. Biological reproducibility was assessed by measuring 165 individuals twice across time for evaluation of short- (<6 months) and long-term (>3 years) biological variability. Intra-class coefficients (ICCs) were used to assess variability. The ICCs of the fasting metabolites were compared with the postprandial metabolites using two-sided paired Wilcoxon test separately for short- and long-term measurements. Results Both fasting and postprandial metabolite concentrations showed high technical reproducibility using H-1 NMR spectroscopy (median ICC = 0.99). Postprandial metabolite concentrations revealed slightly higher ICC scores than fasting ones in short-term repeat measures (median ICC in postprandial and fasting metabolite concentrations 0.72 versus 0.67, Wilcoxon p-value = 8.0x10(-14)). Variability did not increase further in a long-term repeat measure, with median ICC in postprandial of 0.64 and in fasting metabolite concentrations 0.66. Conclusion Technical reproducibility is excellent. Biological reproducibility of postprandial metabolite concentrations showed a less or equal variability than fasting metabolite concentrations over time.	[Ruifang Li-Gao; le Cessie, Saskia; de Mutsert, Renee; den Heijer, Martin; Rosendaal, Frits R.; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Hughes, David A.; Timpson, Nicholas J.] Univ Bristol, MRC Integrat Epidemiol Unit, Sch Social & Community Med, Bristol, Avon, England; [le Cessie, Saskia] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [den Heijer, Martin] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Internal Med, Div Endocrinol, Leiden, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bristol; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ruifang, LG (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	r.li@lumc.nl	le+Cessie, Saskia/HGC-8966-2022; Li-Gao, Ruifang/B-7172-2018; Timpson, Nicholas John/O-7548-2015; van Dijk, Ko Willems/AAT-4681-2021; Hughes, David/E-7190-2015	Li-Gao, Ruifang/0000-0003-0650-1351; Timpson, Nicholas John/0000-0002-7141-9189; van Dijk, Ko Willems/0000-0002-2172-7394; Hughes, David/0000-0002-9644-8998	Dutch Heart Foundation [CVON2014-02 ENERGISE]; Netherlands Cardiovascular Research Initiative; University of Bristol NIHR Biomedical Research Centre [BRC-1215-20011]; MRC Integrative Epidemiology Unit [MC_UU_12013/3]; CRUK Integrative Cancer Epidemiology Programme [C18281/A19169]	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Cardiovascular Research Initiative; University of Bristol NIHR Biomedical Research Centre; MRC Integrative Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK Integrative Cancer Epidemiology Programme	The study is supported from the Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foundation (CVON2014-02 ENERGISE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nicholas J. Timpson is a Wellcome Trust Investigator (202802/Z/16/Z), is the PI of the Avon Longitudinal Study of Parents and Children (MRC & WT 102215/2/13/2), is supported by the University of Bristol NIHR Biomedical Research Centre (BRC-1215-20011), the MRC Integrative Epidemiology Unit (MC_UU_12013/3) and works within the CRUK Integrative Cancer Epidemiology Programme (C18281/A19169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all individuals who participated in the Netherlands Epidemiology of Obesity study, and all participating general practitioners for inviting eligible participants. We also thank the NEO study group, Pat van Beelen and all research nurses for data collection, Petra Noordijk and her team for laboratory management, and Ingeborg de Jonge for data management of the NEO study. We thank Nutricia Research, Utrecht, The Netherlands, for providing the mixed meal. Nicholas J. Timpson is a Wellcome Trust Investigator (202802/Z/16/Z), and the PI of the Avon Longitudinal Study of Parents and Children (MRC & WT 102215/2/13/2), which is supported by the University of Bristol NIHR Biomedical Research Centre (BRC-1215-20011), the MRC Integrative Epidemiology Unit (MC_UU_12013/3) and works within the CRUK Integrative Cancer Epidemiology Programme (C18281/A19169).	Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; de Mutsert R, 2013, EUR J EPIDEMIOL, V28, P513, DOI 10.1007/s10654-013-9801-3; Floegel A, 2011, PLOS ONE, V6; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lang JS, 2018, NEPHROL DIAL TRANSPL, V33, P986, DOI 10.1093/ndt/gfx229; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; LEVEY AS, 1988, ANNU REV MED, V39, P465, DOI 10.1146/annurev.me.39.020188.002341; Li-Gao Ruifang, 2018, Metabolomics, V14, P13, DOI 10.1007/s11306-017-1307-7; Lima AR, 2016, TRANSL ONCOL, V9, P357, DOI 10.1016/j.tranon.2016.05.004; Maitre L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46082; McShane LM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-220; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Nicholson G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.57; Nkuipou-Kenfack E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096955; Plesser HE, 2018, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00076; Sampson JN, 2013, CANCER EPIDEM BIOMAR, V22, P631, DOI 10.1158/1055-9965.EPI-12-1109; Soininen P, 2015, CIRC-CARDIOVASC GENE, V8, P192, DOI 10.1161/CIRCGENETICS.114.000216; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Winnike JH, 2009, AM J CLIN NUTR, V90, P1496, DOI 10.3945/ajcn.2009.28234; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x	23	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218549	10.1371/journal.pone.0218549	http://dx.doi.org/10.1371/journal.pone.0218549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220183	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500063
J	Deuss, FA; Watson, GM; Goodall, KJ; Leece, I; Chatterjee, S; Fu, ZH; Thaysen-Andersen, M; Andrews, DM; Rossjohn, J; Berry, R				Deuss, Felix A.; Watson, Gabrielle M.; Goodall, Katharine J.; Leece, Isobel; Chatterjee, Sayantani; Fu, Zhihui; Thaysen-Andersen, Morten; Andrews, Daniel M.; Rossjohn, Jamie; Berry, Richard			Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural killer cells (NK cells); protein structure; immunology; immunoglobulin fold; cell adhesion; cancer immunotherapy; CD226 molecule; DNAX accessory molecule-1 (DNAM-1); nectin-like protein-5 (NECL-5); PVR cell adhesion molecule	CRYSTAL-STRUCTURE; CELL IMMUNOGLOBULIN; CUTTING EDGE; NK CELLS; T-CELLS; CD226; CYTOTOXICITY; ADHESION; SUSCEPTIBILITY; GLYCOSYLATION	Nectin and nectin-like (Necl) adhesion molecules are broadly overexpressed in a wide range of cancers. By binding to these adhesion molecules, the immunoreceptors DNAX accessory molecule-1 (DNAM-1), CD96 molecule (CD96), and T-cell immunoreceptor with Ig and ITIM domains (TIGIT) play a crucial role in regulating the anticancer activities of immune effector cells. However, within this axis, it remains unclear how DNAM-1 recognizes its cognate ligands. Here, we determined the structure of human DNAM-1 in complex with nectin-like protein-5 (Necl-5) at 2.8 angstrom resolution. Unexpectedly, we found that the two extracellular domains (D1-D2) of DNAM-1 adopt an unconventional collapsed arrangement that is markedly distinct from those in other immunoglobulin-based immunoreceptors. The DNAM-1/Necl-5 interaction was underpinned by conserved lock-and-key motifs located within their respective D1 domains, but also included a distinct interface derived from DNAM-1 D2. Mutation of the signature DNAM-1 key motif within the D1 domain attenuated Necl-5 binding and natural killer cell-mediated cytotoxicity. Altogether, our results have implications for understanding the binding mode of an immune receptor family that is emerging as a viable candidate for cancer immunotherapy.	[Deuss, Felix A.; Watson, Gabrielle M.; Fu, Zhihui; Rossjohn, Jamie; Berry, Richard] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Deuss, Felix A.; Watson, Gabrielle M.; Fu, Zhihui; Rossjohn, Jamie; Berry, Richard] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Watson, Gabrielle M.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Goodall, Katharine J.; Leece, Isobel] Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic 3800, Australia; [Chatterjee, Sayantani; Thaysen-Andersen, Morten; Andrews, Daniel M.] Macquarie Univ, Fac Sci & Engn, Dept Mol Sci, Sydney, NSW 2109, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; Monash University; Monash University; Macquarie University; Cardiff University	Rossjohn, J; Berry, R (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J; Berry, R (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Rossjohn, J; Berry, R (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	jamie.rossjohn@monash.edu; richard.berty@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Andrews, Dan/0000-0002-5896-7885; Chatterjee, Sayantani/0000-0002-7007-0333; Watson, Gabrielle/0000-0003-0056-7528; Thaysen-Andersen, Morten/0000-0001-8327-6843	Macquarie University Research Seeding grant; International Macquarie University Research Excellence Scholarship iMQRES [2017152]; Australian Research Council [FL160100049]; Career Development Fellowship from the National Health and Medical Research Council of Australia [APP1109901]	Macquarie University Research Seeding grant; International Macquarie University Research Excellence Scholarship iMQRES; Australian Research Council(Australian Research Council); Career Development Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Macquarie University Research Seeding grant (to M.T.-A.), International Macquarie University Research Excellence Scholarship iMQRES 2017152 (to S.C.), Australian Research Council Laureate Fellowship FL160100049 (to J.R.), and by Career Development Fellowship APP1109901 from the National Health and Medical Research Council of Australia (to R.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar OA, 2017, CELL, V169, P58, DOI 10.1016/j.cell.2017.03.002; Ashwood C, 2018, J AM SOC MASS SPECTR, V29, P1194, DOI 10.1007/s13361-018-1932-z; Balaji GR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06989-2; Berry R, 2014, IMMUNOL CELL BIOL, V92, P214, DOI 10.1038/icb.2013.100; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; Borrego F, 2006, IMMUNOL RES, V35, P263, DOI 10.1385/IR:35:3:263; Burshtyn DN, 2016, J IMMUNOL, V196, P947, DOI 10.4049/jimmunol.1501937; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Deuss FA, 2019, STRUCTURE, V27, P219, DOI 10.1016/j.str.2018.10.023; Deuss FA, 2017, J BIOL CHEM, V292, P11413, DOI 10.1074/jbc.M117.786483; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Foster CE, 2003, J BIOL CHEM, V278, P46081, DOI 10.1074/jbc.M308491200; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Harrison OJ, 2012, NAT STRUCT MOL BIOL, V19, P906, DOI 10.1038/nsmb.2366; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Kirkham CL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00214; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Lofgren SE, 2010, ARTHRITIS RHEUM-US, V62, P3404, DOI 10.1002/art.27677; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Meyer D, 2009, J BIOL CHEM, V284, P2235, DOI 10.1074/jbc.M807698200; Mohammed F, 2017, ONCOTARGET, V8, P54160, DOI 10.18632/oncotarget.16952; Mysling S, 2010, ANAL CHEM, V82, P5598, DOI 10.1021/ac100530w; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Oshima T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-60; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Ramsbottom KM, 2014, J IMMUNOL, V192, P553, DOI 10.4049/jimmunol.1302197; Reinards THCM, 2015, ANN RHEUM DIS, V74, P2193, DOI 10.1136/annrheumdis-2013-205138; Sansom DM, 2000, IMMUNOLOGY, V101, P169, DOI 10.1046/j.1365-2567.2000.00121.x; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stengel KF, 2012, P NATL ACAD SCI USA, V109, P5399, DOI 10.1073/pnas.1120606109; Sumer-Bayraktar Z, 2012, PROTEOMICS, V12, P3315, DOI 10.1002/pmic.201200354; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Verhoeven DHJ, 2008, MOL IMMUNOL, V45, P3917, DOI 10.1016/j.molimm.2008.06.016; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Wang H, 2019, P NATL ACAD SCI USA, V116, P988, DOI 10.1073/pnas.1815716116; Zhang Q, 2018, NAT IMMUNOL, V19, P723, DOI 10.1038/s41590-018-0132-0	53	8	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12534	12546		10.1074/jbc.RA119.009261	http://dx.doi.org/10.1074/jbc.RA119.009261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31253644	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000484402700023
J	Gomez, ML; Shah, N; Kenny, TC; Jenkins, EC; Germain, D				Gomez, Maria L.; Shah, Nagma; Kenny, Timothy C.; Jenkins, Edmund C., Jr.; Germain, Doris			SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation	ONCOGENE			English	Article							SUPEROXIDE-DISMUTASE 1; TRANSGENIC MICE; ESTROGEN-RECEPTOR; CANCER; BREAST; UPRMT; NEU; ADENOCARCINOMA; IDENTIFICATION; ACTIVATION	We previously reported that the dismutase SOD1 is overexpressed in breast cancer. However, whether SOD1 plays an active role in tumor formation in vivo has never been demonstrated. Further, as luminal cells of normal breast epithelial cells are enriched in SOD1, whether SOD1 is essential for normal mammary gland development has never been determined. We initiated this study to investigate the role of SOD1 in mammary gland tumorigenesis as well as in normal mammary gland development. We crossed the inducible erbB2 (MMTV-iErbB2) and Wnt (MMTV-Wnt) transgenic mice to the SOD1 heterozygote or knockout mice. Our results show that SOD1 is essential for oncogene-driven proliferation, but not normal proliferation of the mammary gland associated with pregnancy or other normal proliferative tissues such as skin and intestines. We show that activation of the oncogene ErbB2 is associated with increased ROS and that high ROS subpopulation of ErbB2 cancer cells show elevated SOD1. In the same cells, decrease in SOD1 is associated with an elevation in both apoptosis as well as oncogene-induced senescence. Based on these results, we suggest that SOD1 carries a housekeeping function that maintains ROS levels below a threshold that supports oncogene-dependent proliferation, while allowing escape from oncogene-induced senescence, independently of the oncogene driving tumor formation. These results identify SOD1 as an ideal target for cancer therapy as SOD1 inhibitors hold the potential to prevent the growth of cancers cells of diverse genotypes, activate multiple modes of cell death therefore making acquired resistance more difficult, while sparing normal tissues.	[Gomez, Maria L.; Shah, Nagma; Kenny, Timothy C.; Jenkins, Edmund C., Jr.; Germain, Doris] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol Oncol, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Germain, D (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Hematol Oncol, Tisch Canc Inst, New York, NY 10029 USA.	doris.germain@mssm.edu		Jenkins, Edmund/0000-0002-6448-090X; Gomez, Maria Lucia/0000-0003-3682-9219; Kenny, Timothy Cole/0000-0001-8258-5716	NIH [R01CA172046]; NIH; P30 grant [CA196521]; NATIONAL CANCER INSTITUTE [F31CA228259, P30CA196521, R01CA172046] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P30 grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank all members of the Germain lab and of the Mount Sinai Flow Cytometry Core, Microscopy Core and Biorepository Core Facility. This study was supported by the NIH R01CA172046 to DG and the NIH supplement to MG. The core facilities used in this study are supported by P30 grant CA196521.	Bae J, 2000, MCL 1S SPLICING VARI, DOI [10.1074/JBC.M909826199, DOI 10.1074/JBC.M909826199]; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; Elster N, 2015, BREAST CANCER RES TR, V149, P5, DOI 10.1007/s10549-014-3250-x; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Germain D, 2017, J BIOENERG BIOMEMBR, V49, P291, DOI 10.1007/s10863-017-9716-x; Glasauer A, 2014, J CLIN INVEST, V124, P117, DOI 10.1172/JCI71714; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hart PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7053; He CX, 2016, TRENDS BIOCHEM SCI, V41, P568, DOI 10.1016/j.tibs.2016.04.004; Hempel N, 2011, ANTI-CANCER AGENT ME, V11, P191, DOI 10.2174/187152011795255911; Ho YS, 1998, J BIOL CHEM, V273, P7765, DOI 10.1074/jbc.273.13.7765; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Kannan N, 2014, P NATL ACAD SCI USA, V111, P7789, DOI 10.1073/pnas.1403813111; Kenny TC, 2017, ONCOGENE, V36, P4393, DOI 10.1038/onc.2017.52; Kenny TC, 2017, J BIOENERG BIOMEMBR, V49, P297, DOI 10.1007/s10863-017-9722-z; Kenny TC, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00159; Kenny TC, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00037; Li S., 2018, INT J CHEM REACT ENG, V16, P1; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Lombard David B, 2011, Handb Exp Pharmacol, V206, P163, DOI 10.1007/978-3-642-21631-2_8; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; OBERLEY LW, 1979, CANCER RES, V39, P1141; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Palechor-Ceron N, 2013, AM J PATHOL, V183, P1862, DOI 10.1016/j.ajpath.2013.08.009; Papa Luena, 2014, Genes Cancer, V5, P15; Papa L, 2014, J BIOL CHEM, V289, P5412, DOI 10.1074/jbc.C113.526475; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Riar AK, 2017, HUM MOL GENET, V26, P1318, DOI 10.1093/hmg/ddx049; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sajesh BV, 2015, ONCOTARGET, V6, P27907, DOI 10.18632/oncotarget.4875; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Somwar R, 2011, P NATL ACAD SCI USA, V108, P16375, DOI 10.1073/pnas.1113554108; Somwar R, 2009, J BIOMOL SCREEN, V14, P1176, DOI 10.1177/1087057109350919; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tsang CK, 2018, MOL CELL, V70, P502, DOI 10.1016/j.molcel.2018.03.029; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107	50	21	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2019	38	29					5751	5765		10.1038/s41388-019-0839-x	http://dx.doi.org/10.1038/s41388-019-0839-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IQ4WS	31222103	Green Accepted			2022-12-26	WOS:000480752800001
J	Cruz-Rosas, HI; Riquelme, F; Santiago, P; Rendon, L; Buhse, T; Ortega-Gutierrez, F; Borja-Urby, R; Mendoza, D; Gaonal, C; Miramontes, P; Cocho, G				Cruz-Rosas, Hugo I.; Riquelme, Francisco; Santiago, Patricia; Rendon, Luis; Buhse, Thomas; Ortega-Gutierrez, Fernando; Borja-Urby, Raul; Mendoza, Doroteo; Gaonal, Carlos; Miramontes, Pedro; Cocho, Germinal			Multiwall and bamboo-like carbon nanotubes from the Allende chondrite: A probable source of asymmetry	PLOS ONE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; MAGNETIC-FIELD; AMINO-ACIDS; CHIRALITY; METEORITES; ORIGIN; FULLERENES; HOMOCHIRALITY; AMPLIFICATION; ENANTIOMERS	This study presents multiwall and bamboo-like carbon nanotubes found in samples from the Allende carbonaceous chondrite using high-resolution transmission electron microscopy (HRTEM). A highly disordered lattice observed in this material suggests the presence of chiral domains in it. Our results also show amorphous and poorly-graphitized carbon, nanodiamonds, and onion-like fullerenes. The presence of multiwall and bamboo-like carbon nanotubes have important implications for hypotheses that explain how a probable source of asymmetry in carbonaceous chondrites might have contributed to the enantiomeric excess in soluble organics under extraterrestrial scenarios. This is the first study proving the existence of carbon nanotubes in carbonaceous chondrites.	[Cruz-Rosas, Hugo I.; Gaonal, Carlos; Miramontes, Pedro] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico; [Riquelme, Francisco] Univ Nacl Autonoma Mexico, Escuela Estudios Super Jicarero, Lab Sistemat Mol, Jicarero, Morelos, Mexico; [Santiago, Patricia; Rendon, Luis; Cocho, Germinal] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City, DF, Mexico; [Buhse, Thomas] Univ Autonoma Estado Morelos, Ctr Invest Quim, Cuernavaca, Morelos, Mexico; [Ortega-Gutierrez, Fernando] Univ Nacl Autonoma Mexico, Inst Geol, Mexico City, DF, Mexico; [Borja-Urby, Raul] Inst Politecn Nacl, Ctr Nanociencias & Micro & Nanotecnol, Mexico City, DF, Mexico; [Mendoza, Doroteo] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Cruz-Rosas, HI (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico.; Riquelme, F (corresponding author), Univ Nacl Autonoma Mexico, Escuela Estudios Super Jicarero, Lab Sistemat Mol, Jicarero, Morelos, Mexico.	quetzal@ciencies.unam.mx; francisco.riquelme@uaem.mx	Riquelme, Francisco/P-8551-2014; Buhse, Thomas/H-9156-2019	Riquelme, Francisco/0000-0001-9893-7413; Cruz-Rosas, Hugo I./0000-0003-2451-544X; Buhse, Thomas/0000-0001-5082-0873; BORJA-URBY, RAUL/0000-0003-1303-910X	DGAPA-UNAM posdoctoral grant; PAPIIT-UNAM [IN108318]; CONACYT Mexican-French Bilateral grant [188689-ANR 12-IS07-0006]; CONACYT-SEP Basic Research [257931]; DGAPA-UNAM	DGAPA-UNAM posdoctoral grant; PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACYT Mexican-French Bilateral grant; CONACYT-SEP Basic Research; DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	This work was funded by: HICR: DGAPA-UNAM posdoctoral grant, GC and PM: PAPIIT-UNAM grant IN108318, CONACYT Mexican-French Bilateral grant 188689-ANR 12-IS07-0006 to TB, CONACYT-SEP Basic Research grant 257931 to PS.; Professor G. Cocho died while this paper was under revision: the authors are grateful for his friendship, talks and invaluable academic teachings. HICR wants to acknowledge to the DGAPA-UNAM for the postdoctoral scholarship.	Alekseev NI, 2006, PHYS SOLID STATE+, V48, P1605, DOI 10.1134/S1063783406080294; Amelin Y, 2007, METEORIT PLANET SCI, V42, P1321, DOI 10.1111/j.1945-5100.2007.tb00577.x; Andrews R, 2002, ACCOUNTS CHEM RES, V35, P1008, DOI 10.1021/ar010151m; Aoki T, 2008, J MINER PETROL SCI, V103, P173, DOI 10.2465/jmps.070301; Arteaga O, 2010, ORIGINS LIFE EVOL B, V40, P27, DOI 10.1007/s11084-009-9184-3; Az'hari S, 2014, MOL SIMULAT, V40, P392, DOI 10.1080/08927022.2013.812210; Banhart F, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.241408; BARRON LD, 1986, J AM CHEM SOC, V108, P5539, DOI 10.1021/ja00278a029; Barron LD, 2000, NATURE, V405, P895, DOI 10.1038/35016183; Becker L, 1997, METEORIT PLANET SCI, V32, P479, DOI 10.1111/j.1945-5100.1997.tb01292.x; Becker L, 1999, NATURE, V400, P227, DOI 10.1038/22250; BONNER WA, 1995, ORIGINS LIFE EVOL B, V25, P175, DOI 10.1007/BF01581581; BONNER WA, 1991, ORIGINS LIFE EVOL B, V21, P59, DOI 10.1007/BF01809580; BONNER WA, 1987, BIOSYSTEMS, V20, P99, DOI 10.1016/0303-2647(87)90025-6; Bonner William A., 1991, Origins of Life and Evolution of the Biosphere, V21, P407, DOI 10.1007/BF01808311; Breslow R, 2009, P NATL ACAD SCI USA, V106, P9144, DOI 10.1073/pnas.0904350106; Burton AS, 2018, LIFE-BASEL, V8, DOI 10.3390/life8020014; Carroll JD, 2009, CHIRALITY, V21, P354, DOI 10.1002/chir.20590; Cooper G, 2016, P NATL ACAD SCI USA, V113, pE3322, DOI 10.1073/pnas.1603030113; Cruz-Rosas HI, 2017, INT J ASTROBIOL, V16, P28, DOI 10.1017/S147355041500049X; Daulton TL, 1996, GEOCHIM COSMOCHIM AC, V60, P4853, DOI 10.1016/S0016-7037(96)00223-2; de Marcellus P, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L27; DRESSELHAUS MS, 1995, CARBON, V33, P883, DOI 10.1016/0008-6223(95)00017-8; Dubey P, 2013, RSC ADV, V3, P7306, DOI 10.1039/c3ra22933e; Ehrenfreund P, 2010, SCIENCE, V329, P1159, DOI 10.1126/science.1194855; Ehrenfreund P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002097; Elkins-Tanton LT, 2011, EARTH PLANET SC LETT, V305, P1, DOI 10.1016/j.epsl.2011.03.010; Fejes D, 2010, MATERIALS, V3, P2618, DOI 10.3390/ma3042618; Garvie LAJ, 2004, EARTH PLANET SC LETT, V224, P431, DOI 10.1016/j.epsl.2004.05.024; Glavin DP, 2010, METEORIT PLANET SCI, V45, P1948, DOI 10.1111/j.1945-5100.2010.01132.x; Gonzalez-Campo A, 2013, TOP CURR CHEM, V333, P109, DOI 10.1007/128_2012_405; Harris P. J. F., 2001, Carbon, V39, P909, DOI 10.1016/S0008-6223(00)00195-0; Harris PJF, 2003, P ROY SOC A-MATH PHY, V459, P2069, DOI 10.1098/rspa.2003.1125; Harris PJF, 1997, J MICROSC-OXFORD, V186, P88, DOI 10.1046/j.1365-2818.1997.1930754.x; Hashimoto A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.045504; HAYES JM, 1967, GEOCHIM COSMOCHIM AC, V31, P1395, DOI 10.1016/0016-7037(67)90019-1; Hitosugi S, 2014, ORG LETT, V16, P645, DOI 10.1021/ol403384q; Hu M, 2012, J PHYS CHEM C, V116, P24233, DOI 10.1021/jp3064323; Huss GR, 2005, ELEMENTS, V1, P97, DOI 10.2113/gselements.1.2.97; Islas JR, 2004, ORIGINS LIFE EVOL B, V34, P497, DOI 10.1023/B:ORIG.0000043115.95561.23; Kauffman Stuart A., 2011, Life-Basel, V1, P34, DOI 10.3390/life1010034; Kawasaki T, 2006, GEOCHIM COSMOCHIM AC, DOI [10.1016/j.gca.2006.09.019, DOI 10.1016/J.GCA.2006.09.019]; Kitagawa Y, 2011, ANGEW CHEM INT EDIT, V50, P9133, DOI 10.1002/anie.201101809; Krot AN, 1998, METEORIT PLANET SCI, V33, P1065, DOI 10.1111/j.1945-5100.1998.tb01713.x; Krot AN, 2007, GEOCHIM COSMOCHIM AC, DOI [10.1016/j.gca.2006.09.019, DOI 10.1016/J.GCA.2006.09.019]; Laerdahl JK, 2000, PHYS REV LETT, V84, P3811, DOI 10.1103/PhysRevLett.84.3811; Le Guillou C, 2012, METEORIT PLANET SCI, V47, P345, DOI 10.1111/j.1945-5100.2012.01336.x; Louchev OA, 2002, PHYS STATUS SOLIDI A, V193, P585, DOI 10.1002/1521-396X(200210)193:3<585::AID-PSSA585>3.0.CO;2-Y; Lozano-Santa Cruz R, 1992, B MINERAL, V5, P56; Maurette M., 2006, ADV ASTROBIO BIOGEOP, P325; Meyer RR, 2003, J MICROSC-OXFORD, V212, P152, DOI 10.1046/j.1365-2818.2003.01240.x; Micali N, 2012, NAT CHEM, V4, P201, DOI [10.1038/NCHEM.1264, 10.1038/nchem.1264]; Mlsna PA, 2006, 7TH IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS AND INTERPRETATION, P95; Muhulet A, 2018, MAT TODAY ENERGY, DOI [10.1016/j.mtener.2018.08.005, DOI 10.1016/J.MTENER.2018.08.005]; Odom TW, 1998, J MATER RES, V13, P2380, DOI 10.1557/JMR.1998.0331; Pavlov VA, 2014, CURR ORG CHEM, V18, P93, DOI 10.2174/13852728113179990033; Pizzarello S, 2006, ACCOUNTS CHEM RES, V39, P231, DOI 10.1021/ar050049f; Pizzarello S, 2017, ORIGINS LIFE EVOL B, V47, P249, DOI 10.1007/s11084-016-9530-1; Pizzarello Sandra, 2016, Life-Basel, V6, P18, DOI 10.3390/life6020018; Pizzarello S, 2012, P NATL ACAD SCI USA, V109, P11949, DOI 10.1073/pnas.1204865109; Quack M, 2002, ANGEW CHEM INT EDIT, V41, P4618, DOI 10.1002/anie.200290005; Rance GA, 2013, CHEM PHYS LETT, V557, P10, DOI 10.1016/j.cplett.2012.12.037; Ribo JM, 2001, SCIENCE, V292, P2063, DOI 10.1126/science.1060835; Rikken GLJA, 2000, NATURE, V405, P932, DOI 10.1038/35016043; Rikken GLJA, 1997, NATURE, V390, P493, DOI 10.1038/37323; Rotelli L, 2016, SCI REP-UK, V6, DOI 10.1038/srep38888; RUBENSTEIN E, 1983, NATURE, V306, P118, DOI 10.1038/306118a0; Rummeli MH, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-303; Saladino R, 2018, LIFE-BASEL, V8, DOI 10.3390/life8010006; Saladino R, 2013, CHEM-EUR J, V19, P16916, DOI 10.1002/chem.201303690; Sanchez-Rubio G, 1992, B MINERAL, V5, P38; Santiago P, 2004, ENERG FUEL, V18, P390, DOI 10.1021/ef034049c; Schaefer HE, 2010, NANOSCIENCE: SCIENCE OF THE SMALL IN PHYSICS, ENGINEERING, CHEMISTRY, BIOLOGY AND MEDICINE, P209, DOI 10.1007/978-3-642-10559-3_5; Sephton MA, 2002, NAT PROD REP, V19, P292, DOI 10.1039/b103775g; Soai K, 2008, TOP CURR CHEM, DOI [10.1007/128-2007-138, DOI 10.1007/128-2007-138]; Sonkar SK, 2014, J NANOSCI NANOTECHNO, V14, P2532, DOI 10.1166/jnn.2014.8524; Sumpter BG, 2007, ACS NANO, V1, P369, DOI 10.1021/nn700143q; THIEMANN W, 1981, ORIGINS LIFE EVOL B, V11, P85, DOI 10.1007/BF00928000; Vis RD, 2002, METEORIT PLANET SCI, V37, P1391, DOI 10.1111/j.1945-5100.2002.tb01036.x; WAGNIERE G, 1983, EXPERIENTIA, V39, P1090, DOI 10.1007/BF01943122; Wepasnick KA, 2010, ANAL BIOANAL CHEM, V396, P1003, DOI 10.1007/s00216-009-3332-5; Wu M, 2012, ASTROBIOLOGY, V12, P818, DOI 10.1089/ast.2012.0819	82	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218750	10.1371/journal.pone.0218750	http://dx.doi.org/10.1371/journal.pone.0218750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260466	gold, Green Published, Green Submitted			2022-12-26	WOS:000484918700022
J	Matsumoto, S; Kutsuna, N; Daubnerova, I; Roller, L; Zitnan, D; Nagasawa, H; Nagata, S				Matsumoto, Sumihiro; Kutsuna, Natsumaro; Daubnerova, Ivana; Roller, Ladislav; Zitnan, Dusan; Nagasawa, Hiromichi; Nagata, Shinji			Enteroendocrine peptides regulate feeding behavior via controlling intestinal contraction of the silkworm Bombyx mori	PLOS ONE			English	Article							MANDUCA-SEXTA ALLATOTROPIN; SHORT NEUROPEPTIDE-F; ENDOCRINE-CELLS; FRONTAL GANGLION; MOLECULAR CHARACTERIZATION; INSECT NEUROPEPTIDES; LACANOBIA-OLERACEA; ION-TRANSPORT; FOOD-INTAKE; IDENTIFICATION	Our previous study demonstrated that predominant feeding inhibitory effects were found in the crude extracts of foregut and midgut of the silkworm Bombyx mori larvae. To address the entero-intestinal control crucial for the regulation of insect feeding behavior, the present study identified and functionally characterized feeding inhibitory peptides from the midgut of B. mori larvae. Purification and structural analyses revealed that the predominant inhibitory factors in the crude extracts were allatotropin (AT) and GSRYamide after its C-terminal sequence. In situ hybridization revealed that AT and GSRYamide were expressed in enteroendocrine cells in the posterior and anterior midgut, respectively. Receptor screening using Ca2+-imaging technique showed that the B. mori neuropeptide G protein-coupled receptor (BNGR)-A19 and -A22 acted as GSRYamide receptors and BNGR-A5 acted as an additional AT receptor. Expression analyses of these receptors and the results of the peristaltic motion assay indicated that these peptides participated in the regulation of intestinal contraction. Exposure of pharynx and ileum to AT and GSRYamide inhibited spontaneous contraction in ad libitum-fed larvae, while exposure of pharynx to GSRYamide did not inhibit contraction in non-fed larvae, indicating that the feeding state changed their sensitivity to inhibitory peptides. These different responses corresponded to different expression levels of their receptors in the pharynx. In addition, injection of AT and GSRYamide decreased esophageal contraction frequencies in the melamine-treated transparent larvae. These findings strongly suggest that these peptides exert feeding inhibitory effects by modulating intestinal contraction in response to their feeding state transition, eventually causing feeding termination.	[Matsumoto, Sumihiro; Kutsuna, Natsumaro; Nagata, Shinji] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan; [Daubnerova, Ivana; Roller, Ladislav; Zitnan, Dusan] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Nagasawa, Hiromichi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan	University of Tokyo; Slovak Academy of Sciences; University of Tokyo	Nagata, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan.	shinjin@edu.k.u-tokyo.ac.jp	Roller, Ladislav/ABB-2988-2021	Roller, Ladislav/0000-0002-9824-2096	Japan Society for the Promotion of Science (JSPS) KAKENHI [16K15066]; Slovak Research and Development Agency (SRDA) [APW-14-0556, APW-16-0395, VEGA 2/0080/18]; European Regional Development Fund (ERDF) [ITMS: 26240220044]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Slovak Research and Development Agency (SRDA)(Slovak Research and Development Agency); European Regional Development Fund (ERDF)(European Commission)	This study was partially supported by the Japan Society for the Promotion of Science (JSPS) (https Prom jsps go Dr) KAKENHI (Grant Number 16K15066) to SN and grants from the Slovak Research and Development Agency (SRDA) (http://www.apvv.sk/) (APW-14-0556, APW-16-0395 and VEGA 2/0080/18) and the European Regional Development Fund (ERDF) (http://ec.europa.eu/regional_policy/ent/funding/erdf/) (ITMS: 26240220044) to DZ and LR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABISGOLD JD, 1988, J EXP BIOL, V135, P215; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; Ayali A, 2004, NEUROSIGNALS, V13, P20, DOI 10.1159/000076156; Bechtold DA, 2007, J ENDOCRINOL, V192, P3, DOI 10.1677/JOE-06-0069; Bednar B, 2017, CELL TISSUE RES, V368, P259, DOI 10.1007/s00441-016-2556-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Collin C, 2011, BIOCHEM BIOPH RES CO, V412, P578, DOI 10.1016/j.bbrc.2011.07.131; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Deng XY, 2014, INSECT BIOCHEM MOLEC, V45, P77, DOI 10.1016/j.ibmb.2013.12.007; Dillen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053604; Duve H, 1999, J COMP NEUROL, V413, P405, DOI 10.1002/(SICI)1096-9861(19991025)413:3&lt;405::AID-CNE4&gt;3.0.CO;2-R; Duve H, 2000, CELL TISSUE RES, V300, P153, DOI 10.1007/s004410050056; ENDO Y, 1982, CELL TISSUE RES, V222, P515, DOI 10.1007/BF00213851; ENDO Y, 1981, BIOMED RES-TOKYO, V2, P270, DOI 10.2220/biomedres.2.270; Hartenstein V, 1996, DEV BIOL, V173, P213, DOI 10.1006/dbio.1996.0018; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Hernandez-Martinez S, 2005, CELL TISSUE RES, V321, P105, DOI 10.1007/s00441-005-1133-5; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P329, DOI 10.1016/0742-8413(86)90202-1; HUKUHARA T, 1985, Journal of Sericultural Science of Japan, V54, P82; Ida T, 2011, BIOCHEM BIOPH RES CO, V410, P872, DOI 10.1016/j.bbrc.2011.06.081; Jiang HB, 2013, P NATL ACAD SCI USA, V110, pE3526, DOI 10.1073/pnas.1310676110; Villalobos-Sambucaro MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124131; Kamioka S, 1953, J SERICULT SCI JAPAN, V22, P1, DOI [10.11416/kontyushigen1930.22.1, DOI 10.11416/KONTYUSHIGEN1930.22.1]; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Koladich PM, 2002, PEPTIDES, V23, P645, DOI 10.1016/S0196-9781(01)00658-1; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KY, 1998, J EXP BIOL, V201, P3067; Leite ACR, 2001, J MED ENTOMOL, V38, P749, DOI 10.1603/0022-2585-38.5.749; Lismont E, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00084; Lu D, 2002, J COMP NEUROL, V446, P377, DOI 10.1002/cne.10205; Ma Q, 2017, J BIOL CHEM, V292, P20599, DOI 10.1074/jbc.M117.815191; Maeda T, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-015-0034-z; Matthews HJ, 2008, ARCH INSECT BIOCHEM, V69, P60, DOI 10.1002/arch.20265; Matthews HJ, 2007, J INSECT PHYSIOL, V53, P75, DOI 10.1016/j.jinsphys.2006.10.007; MILES CI, 1993, DEV BIOL, V155, P147, DOI 10.1006/dbio.1993.1014; Miles CI, 1998, J EXP BIOL, V201, P1785; Nagai C, 2014, J BIOL CHEM, V289, P32166, DOI 10.1074/jbc.M114.590646; Nagai-Okatani C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156501; Nagata Shinji, 2012, Front Endocrinol (Lausanne), V3, P3, DOI 10.3389/fendo.2012.00003; Nagata S, 2012, PEPTIDES, V34, P98, DOI 10.1016/j.peptides.2012.01.002; Nagata S, 2011, GEN COMP ENDOCR, V172, P90, DOI 10.1016/j.ygcen.2011.03.004; Nagata S, 2009, ANN NY ACAD SCI, V1163, P481, DOI 10.1111/j.1749-6632.2009.04454.x; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Oeh U, 2003, J INSECT PHYSIOL, V49, P323, DOI 10.1016/S0022-1910(03)00017-9; Oeh U, 2001, INVERTEBR REPROD DEV, V39, P239, DOI 10.1080/07924259.2001.9652488; Park C, 2002, ZOOL SCI, V19, P287, DOI 10.2108/zsj.19.287; REICHWALD K, 1994, P NATL ACAD SCI USA, V91, P11894, DOI 10.1073/pnas.91.25.11894; Riccillo FL, 2010, TISSUE CELL, V42, P355, DOI 10.1016/j.tice.2010.07.011; Roller L, 2017, BOMBASE WEB ATLAS NE; Roller L, 2016, PEPTIDES, V80, P72, DOI 10.1016/j.peptides.2016.02.003; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Sakai T, 2004, ENDOCRINOLOGY, V145, P5671, DOI 10.1210/en.2004-0722; Santini MS, 2007, J EXP BIOL, V210, P1986, DOI 10.1242/jeb.004291; Sarkar NRS, 2003, PEPTIDES, V24, P1553, DOI 10.1016/j.peptides.2003.07.015; Sasaki K, 2006, J INSECT PHYSIOL, V52, P528, DOI 10.1016/j.jinsphys.2006.02.001; SCHOOFS L, 1990, FEBS LETT, V261, P397, DOI 10.1016/0014-5793(90)80601-E; SCHOOFS L, 1990, REGUL PEPTIDES, V31, P199, DOI 10.1016/0167-0115(90)90006-I; Schoonhoven L. M., 2005, Insect-plant biology; Shi Y, 2011, J BIOL CHEM, V286, P42390, DOI 10.1074/jbc.M111.275602; SIMPSON SJ, 1993, PHYSIOL ENTOMOL, V18, P395, DOI 10.1111/j.1365-3032.1993.tb00613.x; Song W, 2014, CELL REP, V9, P40, DOI 10.1016/j.celrep.2014.08.060; Spit J, 2012, CAN J ZOOL, V90, P489, DOI 10.1139/Z2012-014; Sterkel M, 2010, COMP BIOCHEM PHYS A, V155, P371, DOI 10.1016/j.cbpa.2009.12.002; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; TIMMINS WA, 1992, PHYSIOL ENTOMOL, V17, P81, DOI 10.1111/j.1365-3032.1992.tb00993.x; TSUJITA M, 1963, P JPN ACAD, V39, P513, DOI 10.2183/pjab1945.39.513; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Vernon WI, 2002, BIOTECHNIQUES, V33, P730, DOI 10.2144/02334bm02; Weaver RJ, 2009, ANN NY ACAD SCI, V1163, P316, DOI 10.1111/j.1749-6632.2009.04459.x; WILLEY RB, 1961, J MORPHOL, V108, P219, DOI 10.1002/jmor.1051080207; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yang JW, 2013, J BIOL CHEM, V288, P11662, DOI 10.1074/jbc.M112.441675	77	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219050	10.1371/journal.pone.0219050	http://dx.doi.org/10.1371/journal.pone.0219050			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260470	Green Submitted, Green Published, gold			2022-12-26	WOS:000484918700027
J	Blanco-Moreno, C; Gomez, B; Marugan-Lobon, J; Daviero-Gomez, V; Buscalioni, AD				Blanco-Moreno, Candela; Gomez, Bernard; Marugan-Lobon, Jesus; Daviero-Gomez, Veronique; Buscalioni, Angela D.			A novel approach for the metric analysis of fern fronds: Growth and architecture of the Mesozoic fern Weichselia reticulata in the light of modern ferns	PLOS ONE			English	Article							PLANT ARCHITECTURE; IBERIAN RANGES; TREE; SERRANIA; COMPLEX; CUENCA	The architecture of primary and secondary pinnae of the fossil fern Weichselia reticulata (C. Stokes et Webb) Fontaine is studied based on 28 large specimens from the upper Barremian La Huerguina Formation of the fossil locality Las Hoyas, Cuenca, Spain. The study of the specimens is performed through a morphometric analysis consisting in a reformulation of the Branching Algorithms method of shape description including measurements (insertion angle, distance between pinnae, first segment length and rachis width) and ratios (interval ratio, branching ratio and tapering ratio). A protocol to relocate isolated fragments of fossil pinnae is also established using the interval ratio (distance between pinnae/previous distance between pinnae) and insertion angle of the pinnae. All specimens show a similar architecture, having elliptic primary pinnae with a sinuous apically tapering primary rachis and triangular secondary pinnae with pinnules of different morphologies. The analysis of the architecture allows to propose that the position of the frond was plaglotropic and that the frond growth was basiplastic for the petiole head and acroplastic for the primary pinnae. The metric method is applied to explore the architecture of four living fern species (Angiopteris evecta (Forst.) Hoffm., Matonia pectinata R.Br., Sphaeropteris cooperi (F.Muell.) R.M. Tryon, and Woodwardia unigemmata (Makino) Nakai). Weichselia architecture results extremely ordered and regular in comparison with the primary pinnae variation of the living species.	[Blanco-Moreno, Candela; Marugan-Lobon, Jesus; Buscalioni, Angela D.] Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, Madrid, Spain; [Gomez, Bernard; Daviero-Gomez, Veronique] Univ Lyon 1 Claude Bernard, CNRS, UMR 5276 Terre Planetes Environm, Villeurbanne, France; [Marugan-Lobon, Jesus] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA	Autonomous University of Madrid; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Blanco-Moreno, C (corresponding author), Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, Madrid, Spain.	candela.blanco@uam.es	Buscalioni, Angela D./AAA-5874-2019; /AAU-2978-2021; Marugán-Lobón, Jesús/AAA-7614-2019	Delgado Buscalioni, Angela/0000-0003-1598-7963; Blanco-Moreno, Candela/0000-0001-6614-286X; Marugan Lobon, Jesus Carlos/0000-0002-3766-8560	Spanish Ministry of Economy and Competitiveness [CGL-2013-42643 P]; Universidad Autonoma de Madrid [FPI-UAM-2015]; Spanish Ministry MINECO [CGL-2013-42643 P]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Universidad Autonoma de Madrid; Spanish Ministry MINECO(Spanish Government)	ADB received the grant CGL-2013-42643 P. from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/) for the study of Las Hoyas fossil site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CBM received the grant FPI-UAM-2015 from the Universidad Autonoma de Madrid (http://uam.es/UAM/Home.htm? language= es) for her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Santiago Langreo and Mercedes Llandres from the Museo de Paleontologia de Castilla-La Mancha, Cuenca, Spain, for enabling the study of the specimens from Las Hoyas. We would also like to thank Abel Barral for his valuable comments on plant morphometry. J.C. Pavon contributed to enhance the written English. This work is part of the project CGL-2013-42643 P of the Spanish Ministry MINECO. No permits were required for the described study, which complied with all relevant regulations.	Abu Hamad AMB, 2016, CRETACEOUS RES, V66, P82, DOI 10.1016/j.cretres.2016.06.001; ALVIN K L, 1974, Palaeontology (Oxford), V17, P587; Alvin K.L., 1971, M MOIRE LINSTITUT RO, V166, P1; Alvin K.L., 1968, J LINNEAN SOC LONDON, V61, P87; Arens NC, 2000, AM FERN J, V90, P1, DOI 10.2307/1547257; Bailleul A, 2011, CR PALEVOL, V10, P367, DOI 10.1016/j.crpv.2011.05.002; Barale G., 1979, GEOBIOS, V12, P313, DOI DOI 10.1016/S0016-6995(79)80087-X; Barnard P.D.W., 1973, SP PAP PALAEONTOL, V12, P175; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Blanco-Moreno C, 2018, GEOBIOS-LYON, V51, P571, DOI 10.1016/j.geobios.2018.05.001; Bommer C, 1910, B SOC ROY BOT BELG, V3, P296; Bower F.O., 1926, FERNS FILICALES EUSP, VII; Boyer JS, 2008, THESIS; Buscalioni AD, 2010, J IBER GEOL, V36, P297, DOI 10.5209/rev_JIGE.2010.v36.n2.13; Campbell RD, 1996, ACTA BIOTHEOR, V44, P119, DOI 10.1007/BF00048419; DABER R, 1968, Journal of the Linnean Society of London Botany, V61, P75; DABER R, 1990, Feddes Repertorium, V101, P319; de Gibert JM., 2016, HOYAS CRETACEOUS WET, P195; Dieguez C, 1995, HOYAS KONSERVAT LAGE; Diez JB, 2005, REV PALAEOBOT PALYNO, V135, P99, DOI 10.1016/j.revpalbo.2005.02.007; Edwards WN, 1933, ANN BOT-LONDON, V47, P317, DOI 10.1093/oxfordjournals.aob.a090387; Florin R, 1919, SVENSK BOT TIDSKR, V13, P305; Fregenal-Martinez MA, 2016, HOYAS CRETACEOUS WET; Fregenal-Martinez M, 2017, REV SOC GEOL ESPANA, V30, P113; GAY H, 1993, BOT J LINN SOC, V111, P343; Godin C, 2000, ANN FOREST SCI, V57, P413; Hagemann W., 1984, CONT PROBLEMS PLANT; Halle F., 1970, ESSAI ARCHITECTURE D; HARRIS T M, 1981, Proceedings of the Geologists' Association, V92, P47; Horgan GW, 2001, COMPUT ELECTRON AGR, V31, P169, DOI 10.1016/S0168-1699(00)00190-3; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Lipps T., 1923, BOT ARCH, V4, P329; Niklas KJ., 1992, PLANT BIOMECHANICS E, DOI DOI 10.1007/BF01875445; Poyato-Ariza FJ, 1998, PALAEOGEOGR PALAEOCL, V144, P65, DOI 10.1016/S0031-0182(98)00085-6; PRUSINKIEWICZ P, 1989, LECT NOTES BIOMATH, V79, P3; Robinson DF, 1996, BOT J LINN SOC, V121, P243, DOI 10.1111/j.1095-8339.1996.tb00756.x; Saiki K, 2003, J ASIAN EARTH SCI, V21, P813, DOI 10.1016/S1367-9120(02)00107-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sender LM, 2015, HIST BIOL, V27, P460, DOI 10.1080/08912963.2014.953140; Seward A. C., 1899, PHILOS T ROYAL SOC B PHILOS T ROYAL SOC B, V191, P171, DOI [10.1098/rstb.1899.0006, DOI 10.1098/RSTB.1899.0006]; Silantieva Natalia, 2006, Acta Palaeobotanica, V46, P119; Stein WE, 2006, PALEOBIOLOGY, V32, P450, DOI 10.1666/04036.1; Stokes C., 1824, T GEOLOGICAL SOC LON, V1, P421; Tomescu AMF, 2008, PLANT SYST EVOL, V270, P209, DOI 10.1007/s00606-007-0599-x; TRIVETT ML, 1993, BOT J LINN SOC, V111, P301, DOI 10.1111/j.1095-8339.1993.tb01906.x; Vakhrameev V.A., 1991, JURASSIC CRETACEOUS; Vicente A, 2013, CRETACEOUS RES, V40, P227, DOI 10.1016/j.cretres.2012.07.006; WAGNER WH, 1952, AM J BOT, V39, P578, DOI 10.2307/2438706; WARDLAW C. W., 1963, J LINNEAN SOC LONDON BOT, V58, P385; Watson J, 1996, CRETACEOUS RES, V17, P5, DOI 10.1006/cres.1996.0002	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219192	10.1371/journal.pone.0219192	http://dx.doi.org/10.1371/journal.pone.0219192			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247026	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900085
J	Lee, N; White, LV; Marin, FP; Saludar, NR; Solante, MB; Tactacan-Abrenica, RJC; Calapis, RW; Suzuki, M; Saito, N; Ariyoshi, K; Parry, CM; Edwards, T; Cox, SE				Lee, Nathaniel; White, Laura V.; Marin, Flora P.; Saludar, Naomi R.; Solante, Marietta B.; Tactacan-Abrenica, Rosario J. C.; Calapis, Rugaiya W.; Suzuki, Motoi; Saito, Nobuo; Ariyoshi, Koya; Parry, Christopher M.; Edwards, Tansy; Cox, Sharon E.			Mid-upper arm circumference predicts death in adult patients admitted to a TB ward in the Philippines: A prospective cohort study	PLOS ONE			English	Article							TUBERCULOSIS PATIENTS; RISK-FACTORS; MALNUTRITION; DISORDERS; MANILA	Background The Philippines is ranked 3rd globally for tuberculosis incidence (554/100,000 population). The tuberculosis ward at San Lazaro Hospital, Manila receives 1,800-2,000 admissions of acutely unwell patients per year with high mortality. Objectives of this prospective cohort study were to quantify the association of under-nutrition (primary) and diabetes (secondary) with inpatient mortality occurring between 3-28 days of hospital admission in patients with suspected or previously diagnosed TB. Methods and results We enrolled 360 adults (>= 18 years); 348 were eligible for the primary analysis (alive on day 3). Clinical, laboratory, anthropometric and enhanced tuberculosis diagnostic data were collected at admission with telephone tracing for mortality up to 6 months post-discharge. In the primary analysis population (mean age 45 years, SD = 15.0 years, 70% male), 58 (16.7%) deaths occurred between day 3-28 of admission; 70 (20.1%) between day 3 and discharge and documented total post-day 3 mortality including follow-up was 96 (27.6%). In those in whom it could be assessed, body mass index (BMI) ranged from 11.2-30.6 kg/m(2) and 141/303 (46.5%) had moderate/severe undernutrition (BMI<17 kg/m(2)). A sex-specific cut-off for mid-upper arm circumference predictive of BMI<17 kg/m(2) was associated with inpatient Day 3-28 mortality in males (AOR = 5.04, 95% CI: 1.50-16.86; p = 0.009; p = 0.032 for interaction by sex). The inability to stand for weight/height for BMI assessment was also associated with mortality (AOR = 5.59; 95% CI 2.25-13.89; p<0.001) as was severe compared to normal/mild anaemia (AOR = 9.67; 95% CI 2.48-37.76; p<0.001). No TB specific variables were associated with Day 3-28 mortality, nor was diabetes (HbA1c >= 6.5% or diabetes treatment). Similar effects were observed when the same multivariable model was applied to confirmed TB patients only and to the outcome of all post-day 3 inpatient mortality. Conclusion This research supports the use of mid-upper arm circumference for triaging acutely unwell patients and the design and testing of nutrition-based interventions to improve patient outcomes.	[Lee, Nathaniel; White, Laura V.; Parry, Christopher M.; Edwards, Tansy; Cox, Sharon E.] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Lee, Nathaniel] Royal Free Hosp, London, England; [Marin, Flora P.; Saludar, Naomi R.; Solante, Marietta B.; Tactacan-Abrenica, Rosario J. C.] San Lazaro Hosp, Manila, Philippines; [Solante, Marietta B.] Lung Ctr, Manila, Philippines; [Calapis, Rugaiya W.] San Lazaro Hosp, PMDT Treatment Ctr, Manila, Philippines; [Suzuki, Motoi; Saito, Nobuo; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Nagasaki, Japan; [Parry, Christopher M.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Edwards, Tansy] London Sch Hyg & Trop Med, Trop Epidemiol Grp, London, England; [Cox, Sharon E.] London Sch Hyg & Trop Med, Fac Populat Hlth, London, England	Nagasaki University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Nagasaki University; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Cox, SE (corresponding author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan.; Cox, SE (corresponding author), London Sch Hyg & Trop Med, Fac Populat Hlth, London, England.	Sharon.cox@lshtm.ac.uk	Cox, Sharon E/ABA-7986-2020	Cox, Sharon E/0000-0002-9908-2936; Marin, Francisco/0000-0001-7246-7708; Edwards, Tansy/0000-0002-6110-014X; Suzuki, Motoi/0000-0002-8340-0880	Nagasaki University; MRC [MR/R010161/1] Funding Source: UKRI	Nagasaki University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by funding from Nagasaki University to Professor Sharon E Cox. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brito NB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160480; Bhargava S, 2013, ARCH OROFAC SCI, V8, P1; Bien Matawaran J, 2008, PREVALENCE DIABETES, V53, P1; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brunette W., 2013, P 14 WORKSHOP MOBILE, P1; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chandrasekaran P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01316; Chiang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121698; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Food and Nutrition Research Institute, 2013, 2 NATL NUTR SUMM 8 N; Harrison GG, 1988, ANTHROPOMETRIC STAND, P55; Hayashi S, 2018, TROP MED INT HEALTH, V23, P1058, DOI 10.1111/tmi.13133; HILL AR, 1990, AM J MED, V88, P357, DOI 10.1016/0002-9343(90)90489-Z; Horton KC., 2016, SEX DIFFERENCES TUBE, V21, P1; Jain A, 2008, NEPHROL DIAL TRANSPL, V23, P2884, DOI 10.1093/ndt/gfn186; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; Jeremiah K, 2014, ANTIMICROB AGENTS CH, V58, P3468, DOI 10.1128/AAC.02307-13; Lai HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170104; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Madden AM, 2016, J HUM NUTR DIET, V29, P7, DOI 10.1111/jhn.12278; Mehanna H, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-4; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Paton NI, 2006, NUTRITION, V22, P245, DOI 10.1016/j.nut.2005.06.009; POLASA K, 1984, BRIT J CLIN PHARMACO, V17, P481, DOI 10.1111/j.1365-2125.1984.tb02377.x; Powell-Tuck J, 2003, CLIN NUTR, V22, P307, DOI 10.1016/S0261-5614(03)00009-8; Ralph AP, 2010, SIMPLE VALID NUMERIC, P863, DOI [10.1136/thx.2010.136242, DOI 10.1136/THX.2010.136242]; Ramachandran G, 2013, INT J TUBERC LUNG D, V17, P800, DOI 10.5588/ijtld.12.0628; Riza AL, 2014, LANCET DIABETES ENDO, V2, P740, DOI 10.1016/S2213-8587(14)70110-X; Ronco C, 2008, CRITICAL CARE NEPHRO; Satyaraddi A, 2014, INT J TUBERC LUNG D, V18, P188, DOI 10.5588/ijtld.13.0128; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Sharma SK, 2006, INT J TUBERC LUNG D, V10, P429; Shimazaki T, 2018, INT J TUBERC LUNG D, V22, P65, DOI 10.5588/ijtld.17.0389; Shimazaki T, 2013, INT J TUBERC LUNG D, V17, P1420, DOI 10.5588/ijtld.12.0848; Sinclair D, 2016, COCHRANE DB SYST REV; Tang A.M., 2017, DETERMINING GLOBAL M; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; White LV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215968; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, 2017, GLOB TUB REP; World Health Organization, 2013, NUTR CAR SUPP PAT TU; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3; Zietse R, 2009, NAT REV NEPHROL, V5, P193, DOI 10.1038/nrneph.2009.17	43	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218193	10.1371/journal.pone.0218193	http://dx.doi.org/10.1371/journal.pone.0218193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246958	Green Published, gold			2022-12-26	WOS:000484911900014
J	Chang, Y; Chusri, S; Sangthong, R; McNeil, E; Hu, JQ; Du, W; Li, D; Fan, XY; Zhou, HN; Chongsuvivatwong, V; Tang, L				Chang, Yue; Chusri, Sarunyou; Sangthong, Rassamee; McNeil, Edward; Hu, Jiaqi; Du, Wei; Li, Duan; Fan, Xingying; Zhou, Hanni; Chongsuvivatwong, Virasakdi; Tang, Lei			Clinical pattern of antibiotic overuse and misuse in primary healthcare hospitals in the southwest of China	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; PRESCRIBING PATTERNS; PRESCRIPTION	Purpose Overuse and misuse of antibiotics are the primary risk factors for antibiotics resistance. Inadequate professional competence of primary care physicians might exacerbate these problems in China. This retrospective study aims to document the clinical pattern of antibiotics use and its overuse and misuse rates in rural primary care institutions and to evaluate the association between antibiotics use and characteristics of physicians and their patients. Methods Medical records from 16 primary care hospitals in rural areas of Guizhou province, China were obtained from the Health Information System in 2018. Classification of unnecessary use, incorrect spectrum of antibiotic, escalated use of extended spectrum and combined antibiotics use was based on the Guiding Principle of Clinical Use of Antibiotics (2015, China) and guidelines from the US Centers for Disease Control and Prevention. Generalized Estimating Equations were employed to determine predictive factors for inappropriate antibiotics use. Results A total of 74,648 antibiotics prescriptions were retrieved. Uncomplicated respiratory infection was the most common disease accounting for 58.6% of all prescriptions. The main antibiotic group used was penicillins (51.5%) followed by cephalosporins and macrolides (14% each). Of 57,009 patient visits, only 8.7% of the antibiotic prescriptions were appropriate. Combined use, escalated use of extended spectrum antibiotics, incorrect spectrum and unnecessary antibiotics use was found in 7.8%, 1.9%, 4.3% and 77.3% of patient visits, respectively, of which 28.7% were given intravenously. Antibiotics misuse was significantly more likely among newly employed physicians with lower levels of professional education. Adult patients and those who had public insurance had a higher risk of being prescribed unnecessary antibiotics. Conclusion Overuse of antibiotics for uncomplicated respiratory infection and use of cephalosporins, macrolides and injection antibiotics in primary care are the major problems of clinical practice in rural areas of Guizhou.	[Chang, Yue; Hu, Jiaqi; Du, Wei; Li, Duan; Fan, Xingying; Zhou, Hanni; Tang, Lei] Guizhou Med Univ, Sch Med & Hlth Management, Guiyang, Guizhou, Peoples R China; [Chang, Yue; Sangthong, Rassamee; McNeil, Edward; Chongsuvivatwong, Virasakdi] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkhla, Thailand; [Chusri, Sarunyou] Prince Songkla Univ, Dept Internal Med, Div Infect Dis, Hat Yai, Songkhla, Thailand; [Chusri, Sarunyou] Prince Songkla Univ, Dept Biomed Sci, Hat Yai, Songkhla, Thailand	Guizhou Medical University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Tang, L (corresponding author), Guizhou Med Univ, Sch Med & Hlth Management, Guiyang, Guizhou, Peoples R China.; Chongsuvivatwong, V (corresponding author), Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkhla, Thailand.	cvirasak@medicine.psu.ac.th; tlei1974@163.com		Chongsuvivatwong, Virasakdi/0000-0002-9850-4463; McNeil, Edward Braddon/0000-0002-9492-1040	Guizhou innovative talent foundation [2016-4015]	Guizhou innovative talent foundation	This study is part of author YC's thesis in partial fulfillment of the requirements for a PhD at Prince of Songkla University, Thailand, and the China Medical Board under the project "A second collaborative program to improve the health research capacity of western medical universities in China and Prince of Songkla University (PSU)". This study was also possible due to a grant obtained from Guizhou innovative talent foundation (2016-4015) to LT.	Anderson A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204878; Batzing-Feigenbaum J, 2016, DTSCH ARZTEBL INT, V113, P454, DOI 10.3238/arztebl.2016.0454; Bhartiy S S, 2008, Kathmandu Univ Med J (KUMJ), V6, P55; Bianco A, 2018, INFECT DRUG RESIST, V11, P2199, DOI 10.2147/IDR.S170349; Butt AA, 2017, INT J INFECT DIS, V55, P20, DOI 10.1016/j.ijid.2016.12.004; Center for Disease Dynamics, 2015, EC POL STAT WORLDS A; Centers for Disease Control and Prevention, 2017, ANT PRESCR US DOCT O; Centers for Disease Control and Prevention, 2018, ANT PRESCR US; Choi KH, 2012, J KOREAN MED SCI, V27, P120, DOI 10.3346/jkms.2012.27.2.120; Dancer SJ, 2004, LANCET INFECT DIS, V4, P611, DOI 10.1016/S1473-3099(04)01145-4; Davis ME, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6040023; Dong HJ, 1999, HEALTH POLICY, V48, P29, DOI 10.1016/S0168-8510(99)00026-3; Durkin MJ, 2018, INFECT CONT HOSP EP, V39, P584, DOI 10.1017/ice.2018.26; Segura-Egea JJ, 2017, INT DENT J, V67, P197, DOI 10.1111/idj.12287; Li YB, 2012, HEALTH AFFAIR, V31, P1075, DOI 10.1377/hlthaff.2010.0965; Lindberg BH, 2017, SCAND J PRIM HEALTH, V35, P178, DOI 10.1080/02813432.2017.1333301; Mao WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117710; Milder E, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.016; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; National Health and Family Planning Commission of China, 2015, CHIN HLTH FAM PLANN; Qu XY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196668; Sharma P, 2017, PLOS ONE, V12, P181; Sun Q, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0009-x; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Wang J, 2014, JAMA INTERN MED, V174, P1914, DOI 10.1001/jamainternmed.2014.5214; Wang YY, 2016, INT J ANTIMICROB AG, V48, P666, DOI 10.1016/j.ijantimicag.2016.09.008; WHO, 2014, INT STAT CLASS DIS R; World Health Organization, 2017, ANT PRESCR RES VIEWS; Xiao YH, 2016, INT J ANTIMICROB AG, V48, P409, DOI 10.1016/j.ijantimicag.2016.06.017; Zucco R, 2018, INT J MED INFORM, V111, P131, DOI 10.1016/j.ijmedinf.2017.12.005	30	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0214779	10.1371/journal.pone.0214779	http://dx.doi.org/10.1371/journal.pone.0214779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242185	Green Submitted, gold, Green Published			2022-12-26	WOS:000482883600004
J	Dennis, PM; Raghanti, MA; Meindl, RS; Less, E; Henthorn, E; Devlin, W; Murray, S; Meehan, T; Kutinsky, I; Murphy, H				Dennis, Patricia M.; Raghanti, Mary Ann; Meindl, Richard S.; Less, Elena; Henthorn, Eric; Devlin, William; Murray, Suzan; Meehan, Thomas; Kutinsky, Ilana; Murphy, Hayley			Cardiac disease is linked to adiposity in male gorillas (Gorilla gorilla gorilla)	PLOS ONE			English	Article							HYPERTROPHY; CHIMPANZEES; OBESITY	Cardiac disease is a major cause of morbidity and mortality for adult gorillas. Previous research indicates a sex-based difference with predominantly males demonstrating evidence of left ventricular hypertrophy. To evaluate these findings, we analyzed serum markers with cardiac measures in a large sample of gorillas. The study sample included 44 male and 25 female gorillas housed at American Association of Zoo and Aquariums (AZA)-accredited zoos. Serum samples were collected from fasted gorillas during routine veterinary health exams and analyzed to measure leptin, adiponectin, IGF-1, insulin, ferritin, glucose, triglycerides, and cholesterol. Cardiac ultrasonography via transthoracic echocardiogram was performed simultaneously. Three echocardiographic parameters were chosen to assess cardiac disease according to parameters established for captive lowland gorillas: left ventricular internal diameter, inter-ventricular septum thickness, and left ventricular posterior wall thickness. Our data revealed that high leptin, low adiponectin, and lowered cholesterol were significantly and positively correlated with measures of heart thickness and age in males but not in females. Lowered cholesterol in this population would be categorized as elevated in humans. High leptin and low adiponectin are indicative of increased adiposity and suggests a potential parallel with human obesity and cardiovascular disease in males. Interestingly, while females exhibited increased adiposity with age, they did not progress to cardiac disease.	[Dennis, Patricia M.; Less, Elena] Cleveland Metropk Zoo, Cleveland, OH 44109 USA; [Dennis, Patricia M.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Raghanti, Mary Ann; Meindl, Richard S.] Kent State Univ, Dept Anthropol, Kent, OH 44242 USA; [Raghanti, Mary Ann; Meindl, Richard S.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Raghanti, Mary Ann] Kent State Univ, Brain Hlth Res Inst, Kent, OH 44242 USA; [Henthorn, Eric] Fortis Coll, Cuyahoga Falls, OH USA; [Devlin, William; Kutinsky, Ilana] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Devlin, William; Kutinsky, Ilana] Beaumont Michigan Heart Grp, Troy, MI USA; [Murray, Suzan] Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC USA; [Meehan, Thomas] Brookfield Zoo, Brookfield, IL USA; [Murphy, Hayley] Zoo Atlanta, Great Ape Heart Project Based Zoo Atlanta, Atlanta, GA USA	University System of Ohio; Ohio State University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Oakland University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Dennis, PM (corresponding author), Cleveland Metropk Zoo, Cleveland, OH 44109 USA.; Dennis, PM (corresponding author), Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA.; Raghanti, MA (corresponding author), Kent State Univ, Dept Anthropol, Kent, OH 44242 USA.; Raghanti, MA (corresponding author), Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA.; Raghanti, MA (corresponding author), Kent State Univ, Brain Hlth Res Inst, Kent, OH 44242 USA.	pmd@clevelandmetroparks.com; mraghant@kent.edu		Dennis, Patricia/0000-0002-1905-0900	Institute of Museum and Library Services [LG-26-12-0526-12]	Institute of Museum and Library Services	The Great Ape Heart Project was made possible in part by funding from the Institute of Museum and Library Services Grant #LG-26-12-0526-12 to HM and PMD (https://www.imls.gov).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti-Rosei E, 2002, J HYPERTENS, V20, pS34; Amin RH, AM J PHYSL HEART CIR; Baitchman EJ, 2006, J ZOO WILDLIFE MED, V37, P126, DOI 10.1638/05-064.1; Banerjee Stacy, 2007, Curr Cardiol Rep, V9, P143, DOI 10.1007/BF02938341; Duran J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168255; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Fui MNT, 2014, ASIAN J ANDROL, V16, P223, DOI 10.4103/1008-682X.122365; Haines CD, 2012, ENDOCRINOLOGY, V153, P4480, DOI 10.1210/en.2012-1353; Hall ME, 2015, WORLD J CARDIOL, V7, P511, DOI 10.4330/wjc.v7.i9.511; Kriaa A, 2019, J LIPID RES, V60, P323, DOI 10.1194/jlr.R088989; Krynak KL, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx149; Less EH, 2014, ZOO BIOL, V33, P74, DOI 10.1002/zoo.21115; Less EH, 2012, THESIS; Lowenstine LJ, 2016, VET PATHOL, V53, P250, DOI 10.1177/0300985815612154; Murphy HW, 2011, J ZOO WILDLIFE MED, V42, P572, DOI 10.1638/2010-0139.1; Nelson RH, 2013, PRIMARY CARE, V40, P195, DOI 10.1016/j.pop.2012.11.003; Richardson J, 2000, J AM DIET ASSOC, V100, P237, DOI 10.1016/S0002-8223(00)00072-9; Strindberg S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2964; Strong V, 2017, J ZOO WILDLIFE MED, V48, P277, DOI [10.1638/2016-0132R.1, 10.1638/2016-0132r.1]; Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715; Tong LJ, 2014, VET PATHOL, V51, P858, DOI 10.1177/0300985813501333	21	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218763	10.1371/journal.pone.0218763	http://dx.doi.org/10.1371/journal.pone.0218763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242268	Green Published, gold, Green Submitted			2022-12-26	WOS:000482883600052
J	Zhang, W; Rho, JH; Roehrl, MW; Roehrl, MH; Wang, JY				Zhang, Wei; Rho, Jung-hyun; Roehrl, Michael W.; Roehrl, Michael H.; Wang, Julia Y.			A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY BILIARY-CIRRHOSIS; HEPATOCELLULAR-CARCINOMA; SERUM ANTIBODIES; CELL ANTIBODIES; TARGET ANTIGEN; AUTOANTIBODIES; EPITOPE; ONSET; ASSOCIATION	Autoantigens are the molecular targets in autoimmune diseases. They are a cohort of seemingly unrelated self-molecules present in different parts of the body, yet they can trigger a similar chain of autoimmune responses such as autoantibody production. We previously reported that dermatan sulfate (DS) can bind self-molecules of dying cells to stimulate autoreactive CD5+ B cells to produce autoantibodies. The formation of autoantigen-DS complexes converts the normally non-antigenic self-molecules to none-self antigens, and thus DS-affinity represents a common underlying biochemical property for autoantigens. This study sought to apply this property to identify potential autoantigens in the kidney. Total proteins were extracted from mouse kidney tissues and loaded onto DS-Sepharose resins. Proteins without affinity were washed off the resins, whereas those with increasing DS-affinity were eluted with step gradients of increasing salt strength. Fractions with strong and moderate DS-affinity were sequenced by mass spectrometry and yielded 25 and 99 proteins, respectively. An extensive literature search was conducted to validate whether these had been previously reported as autoantigens. Of the 124 proteins, 79 were reported autoantigens, and 19 out of 25 of the strong-DS-binding ones were well-known autoantigens. Moreover, these proteins largely fell into the two most common autoantibody categories in autoimmune kidney diseases, including 40 ANA (anti-nuclear autoantibodies) and 25 GBM (glomerular basement membrane) autoantigens. In summary, this study compiles a large repertoire of potential autoantigens for autoimmune kidney diseases. This autoantigen-ome sheds light on the molecular etiology of autoimmunity and further supports our hypothesis DS-autoantigen complexes as a unifying principle of autoantigenicity.	[Zhang, Wei] Guizhou Med Univ, Affiliated Hosp, Dept Gastroenterol, Guiyang, Guizhou, Peoples R China; [Rho, Jung-hyun] MP Biomed, Auckland, New Zealand; [Roehrl, Michael W.; Wang, Julia Y.] Curandis, Scarsdale, NY 10583 USA; [Roehrl, Michael H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Roehrl, Michael H.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA	Guizhou Medical University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Wang, JY (corresponding author), Curandis, Scarsdale, NY 10583 USA.; Roehrl, MH (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.; Roehrl, MH (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	roehrlm@mskcc.org; julia@curandis.com	Roehrl, Michael/AAU-8506-2020	Roehrl, Michael/0000-0003-4892-1098	Nation Institutes of Health [NIH R01 AI068826]; Curandis; NIH	Nation Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Curandis; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was partially funded by the Nation Institutes of Health (NIH R01 AI068826 to JYW) and Curandis. Wei Zhang (WZ) and Junghyun Rho (JHR) were supported by the NIH during the course of this study. MP Biomedicals is the current employer of JHR but has neither relation to nor made any contribution, financial or otherwise, to the study. Curandis provided support in the form of salary to Julia Y. Wang who is a co-founder and shareholder of Curandis. None of the other authors received remuneration from Curandis. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	ABSI M, 1989, IMMUNOL LETT, V23, P35, DOI 10.1016/0165-2478(89)90152-1; Aran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012875; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Becker AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067003; BISCHOFF FR, 1990, P NATL ACAD SCI USA, V87, P8617, DOI 10.1073/pnas.87.21.8617; Bouillet L, 2013, LAB INVEST, V93, P1194, DOI 10.1038/labinvest.2013.106; Bradley SV, 2005, CANCER RES, V65, P4126, DOI 10.1158/0008-5472.CAN-04-4658; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Braus BK, 2017, VET IMMUNOL IMMUNOP, V187, P48, DOI 10.1016/j.vetimm.2017.04.002; Bremer HD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23034-w; BRITO J, 1994, J IMMUNOL, V153, P2268; Bruschi M, 2015, J AM SOC NEPHROL, V26, P1905, DOI 10.1681/ASN.2014050493; BURLINGAME RW, 1994, J CLIN INVEST, V94, P184, DOI 10.1172/JCI117305; Caster DJ, 2015, PROTEOM CLIN APPL, V9, P1012, DOI 10.1002/prca.201400175; Chen M, 2000, INFECT IMMUN, V68, P4893, DOI 10.1128/IAI.68.9.4893-4899.2000; Chen XH, 2008, ONCOL REP, V20, P979, DOI 10.3892/or_00000099; COLLARD JF, 1990, BIOCHEM BIOPH RES CO, V173, P363, DOI 10.1016/S0006-291X(05)81066-6; Dallmann K, 2004, INT J CANCER, V108, P342, DOI 10.1002/ijc.11459; DASS PD, 1981, CAN J BIOCHEM CELL B, V59, P383, DOI 10.1139/o81-053; Diaz-Munoz MD, 2015, NAT IMMUNOL, V16, P415, DOI 10.1038/ni.3115; Dieker J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165373; Dummer R, 2004, INT J CANCER, V111, P720, DOI 10.1002/ijc.20310; FAWWAZ RA, 1985, J NUCL MED, V26, P488; FREGEAU DR, 1990, HEPATOLOGY, V11, P975, DOI 10.1002/hep.1840110611; Furuta K, 1998, J MOL MED-JMM, V76, P54, DOI 10.1007/s109-1998-8104-5; Gajbhiye R, 2012, HUM REPROD, V27, P408, DOI 10.1093/humrep/der410; Genevay S, 2002, ANN RHEUM DIS, V61, P734, DOI 10.1136/ard.61.8.734; Geng X, 1998, GASTROENTEROLOGY, V114, P912, DOI 10.1016/S0016-5085(98)70310-5; Hanrotel-Saliou C, 2011, CLIN REV ALLERG IMMU, V40, P151, DOI 10.1007/s12016-010-8204-4; Hassfeld W, 1998, NUCLEIC ACIDS RES, V26, P439, DOI 10.1093/nar/26.2.439; Hellmark T, 2014, J AUTOIMMUN, V48-49, P108, DOI 10.1016/j.jaut.2014.01.024; Hwang HM, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1546-z; IMAI H, 1993, J CLIN INVEST, V92, P2419, DOI 10.1172/JCI116848; Ivanova LV, 2000, KIDNEY INT, V58, P1603, DOI 10.1046/j.1523-1755.2000.00321.x; IWAYAMA T, 1991, J AUTOIMMUN, V4, P769, DOI 10.1016/0896-8411(91)90172-9; JONES CM, 1991, EUR J BIOCHEM, V197, P49, DOI 10.1111/j.1432-1033.1991.tb15881.x; Karasawa R, 2005, MICROBIOL IMMUNOL, V49, P57, DOI 10.1111/j.1348-0421.2005.tb03640.x; Katsumata Y, 2013, MOD RHEUMATOL, V23, P71, DOI 10.1007/s10165-012-0624-y; Kenderov A, 2002, CLIN EXP IMMUNOL, V129, P169, DOI 10.1046/j.1365-2249.2002.01887.x; Kimura A, 2012, CURR NEUROVASC RES, V9, P296, DOI 10.2174/156720212803530726; Kishore U, 1997, CLIN EXP IMMUNOL, V108, P181, DOI 10.1046/j.1365-2249.1997.3761273.x; Kistner A, 2017, RHEUMATOLOGY, V56, P829, DOI 10.1093/rheumatology/kew469; Kit Y, 2014, CROAT MED J, V55, P259, DOI 10.3325/cmj.2014.55.259; KRATZ A, 1992, CLIN EXP IMMUNOL, V90, P422; Kubo M, 2002, RHEUMATOLOGY, V41, P531, DOI 10.1093/rheumatology/41.5.531; Larsen CP, 2018, J AM SOC NEPHROL, V29, P644, DOI 10.1681/ASN.2017060664; Lassuthova P, 2018, AM J HUM GENET, V102, P505, DOI 10.1016/j.ajhg.2018.01.023; Li FJ, 2017, J IMMUNOL, V199, P1596, DOI 10.4049/jimmunol.1700473; Li L, 2008, J PROTEOME RES, V7, P611, DOI 10.1021/pr070525r; Manson JJ, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000013; McAdoo SP, 2017, CLIN J AM SOC NEPHRO, V12, P1162, DOI 10.2215/CJN.01380217; Miyachi K, 2004, CLIN EXP IMMUNOL, V136, P568, DOI 10.1111/j.1365-2249.2004.02456.x; Mooney CJ, 2006, INT J UROL, V13, P211, DOI 10.1111/j.1442-2042.2006.01263.x; Moreau K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9045; Musante L, 2005, CLIN EXP IMMUNOL, V141, P491, DOI 10.1111/j.1365-2249.2005.02862.x; Nabors LB, 1998, J NEUROIMMUNOL, V92, P152, DOI 10.1016/S0165-5728(98)00196-9; Okano Y, 1996, CLIN IMMUNOL IMMUNOP, V81, P41, DOI 10.1006/clin.1996.0155; Ooka S, 2003, ARTHRITIS RES THER, V5, pR174, DOI 10.1186/ar754; Qin ZQ, 2011, TRANSPLANTATION, V92, P829, DOI 10.1097/TP.0b013e31822d0977; Rajkumar VS, 1999, ARTHRITIS RHEUM-US, V42, P930, DOI 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1; Rauhavirta T, 2019, CLIN REV ALLERG IMMU, V57, P23, DOI 10.1007/s12016-016-8557-4; Rho JH, 2011, AM J PATHOL, V178, P2177, DOI 10.1016/j.ajpath.2011.01.031; Schmits R, 2002, CLIN EXP IMMUNOL, V127, P379, DOI 10.1046/j.1365-2249.2002.01751.x; Shimizu F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai9111; Shinoda M, 2004, AUTOIMMUNITY, V37, P473, DOI 10.1080/08916930400001891; Sugimoto K, 2018, J NEUROIMMUNOL, V325, P54, DOI 10.1016/j.jneuroim.2018.09.013; SURH CD, 1989, HEPATOLOGY, V9, P63, DOI 10.1002/hep.1840090110; Suzuki K, 2014, NEPHROL DIAL TRANSPL, V29, P1168, DOI 10.1093/ndt/gft469; van Beers-Tas MH, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0975-4; vonMikecz A, 1997, ARTHRITIS RHEUM-US, V40, P295; VONMUHLEN CA, 1995, CLIN EXP IMMUNOL, V100, P67; WAKUI H, 1988, BLOOD, V72, P408; Wang JY, 2011, AM J PATHOL, V178, P2168, DOI 10.1016/j.ajpath.2011.01.028; Wang YG, 2017, NATURE, V552, P273, DOI 10.1038/nature25003; Weber CK, 2010, RHEUMATOLOGY, V49, P2255, DOI 10.1093/rheumatology/keq272; Weerasekara VK, 2014, MOL CELL BIOL, V34, P4379, DOI 10.1128/MCB.00740-14; WESIERSKAGADEK J, 1990, ARTHRITIS RHEUM, V33, P1273; Wieczorek M, 2016, CLIN COSMET INVESTI, V9, P291, DOI 10.2147/CCID.S100802; Xu XL, 2017, J PEDIATR GASTR NUTR, V64, P76, DOI 10.1097/MPG.0000000000001266; Yau WY, 2013, J PROTEOMICS, V94, P346, DOI 10.1016/j.jprot.2013.10.003; YEAMAN SJ, 1988, LANCET, V1, P1067; Zaninoni A, 2015, TRANSFUSION, V55, P2930, DOI 10.1111/trf.13257; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091816	83	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0219018	10.1371/journal.pone.0219018	http://dx.doi.org/10.1371/journal.pone.0219018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237920	gold, Green Published, Green Submitted			2022-12-26	WOS:000484856000058
J	Brinker, TJ; Hekler, A; Enk, AH; von Kalle, C				Brinker, Titus J.; Hekler, Achim; Enk, Alexander H.; von Kalle, Christof			Enhanced classifier training to improve precision of a convolutional neural network to identify images of skin lesions	PLOS ONE			English	Article							LEVEL CLASSIFICATION; MELANOMA; DIAGNOSIS; DERMATOLOGISTS; ALGORITHMS; DISCORDANCE; DERMOSCOPY; CANCER; BURDEN	Background In recent months, multiple publications have demonstrated the use of convolutional neural networks (CNN) to classify images of skin cancer as precisely as dermatologists. However, these CNNs failed to outperform the International Symposium on Biomedical Imaging (ISBI) 2016 challenge which ranked the average precision for classification of dermoscopic melanoma images. Accordingly, the technical progress represented by these studies is limited. In addition, the available reports are impossible to reproduce, due to incomplete descriptions of training procedures and the use of proprietary image databases or non-disclosure of used images. These factors prevent the comparison of various CNN classifiers in equal terms. Objective To demonstrate the training of an image-classifier CNN that outperforms the winner of the ISBI 2016 CNNs challenge by using open source images exclusively. Methods A detailed description of the training procedure is reported while the used images and test sets are disclosed fully, to insure the reproducibility of our work. Results Our CNN classifier outperforms all recent attempts to classify the original ISBI 2016 challenge test data (full set of 379 test images), with an average precision of 0.709 (vs. 0.637 of the ISBI winner) and with an area under the receiver operating curve of 0.85. Conclusion This work illustrates the potential for improving skin cancer classification with enhanced training procedures for CNNs, while avoiding the use of costly equipment or proprietary image data.	[Brinker, Titus J.; Hekler, Achim; von Kalle, Christof] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Brinker, Titus J.; Enk, Alexander H.] Univ Hosp Heidelberg, Dept Dermatol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Brinker, TJ (corresponding author), German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Heidelberg, Germany.; Brinker, TJ (corresponding author), Univ Hosp Heidelberg, Dept Dermatol, Heidelberg, Germany.	titus.brinker@nct-heidelberg.de		von Kalle, Christof/0000-0001-9221-3297; Brinker, Titus Josef/0000-0002-3620-5919				Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Brinker TJ, 2019, EUR J CANCER, V113, P47, DOI 10.1016/j.ejca.2019.04.001; Brinker TJ, 2019, EUR J CANCER, V111, P148, DOI 10.1016/j.ejca.2019.02.005; Brinker TJ, 2019, EUR J CANCER, V111, P30, DOI 10.1016/j.ejca.2018.12.016; Brinker TJ, 2018, JAMA DERMATOL, V154, P1085, DOI 10.1001/jamadermatol.2018.1907; Brinker TJ, 2018, J MED INTERNET RES, V20, DOI 10.2196/11936; Brinker TJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018299; Brinker TJ, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9794; Brinker TJ, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8661; Brinker TJ, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.8231; Carli P, 2003, BRIT J DERMATOL, V148, P981, DOI 10.1046/j.1365-2133.2003.05023.x; Dolianitis C, 2005, ARCH DERMATOL, V141, P1008, DOI 10.1001/archderm.141.8.1008; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Haenssle H A, 2019, Ann Oncol, V30, p130e, DOI 10.1093/annonc/mdy520; Han SS, 2018, J INVEST DERMATOL, V138, P1529, DOI 10.1016/j.jid.2018.01.028; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Heal CF, 2009, INT J DERMATOL, V48, P1366, DOI 10.1111/j.1365-4632.2009.04185.x; Hekler A, 2019, EUR J CANCER, V115, P79, DOI 10.1016/j.ejca.2019.04.021; Kaiser M, 2018, EUR J HEALTH ECON, V19, P355, DOI 10.1007/s10198-017-0888-4; Karimkhani C, 2017, BRIT J DERMATOL, V177, P134, DOI 10.1111/bjd.15510; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Loshchilov I., 2016, ARXIV; Marchetti MA, 2018, J AM ACAD DERMATOL, V78, P270, DOI 10.1016/j.jaad.2017.08.016; Patrawala S, 2016, J AM ACAD DERMATOL, V74, P75, DOI 10.1016/j.jaad.2015.09.008; Salerni G, 2013, J EUR ACAD DERMATOL, V27, P805, DOI 10.1111/jdv.12032; Shoo BA, 2010, J AM ACAD DERMATOL, V62, P751, DOI 10.1016/j.jaad.2009.09.043; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Whiteman DC, 2016, J INVEST DERMATOL, V136, P1161, DOI 10.1016/j.jid.2016.01.035	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218713	10.1371/journal.pone.0218713	http://dx.doi.org/10.1371/journal.pone.0218713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233565	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700031
J	Nam, MW; Kim, JM; Cheong, JH; Ryu, JI; Han, MH				Nam, Min Woo; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Han, Myung-Hoon			Paradoxical relationship between body mass index and bone mineral density in patients with non-small cell lung cancer with brain metastasis	PLOS ONE			English	Article							BETA-CATENIN; BREAST-CANCER; OSTEOBLASTOGENESIS; OBESITY; INTERLEUKIN-6; ADIPOGENESIS; OVERWEIGHT	Background and purpose Low body mass index (BMI) at presentation has been reported to be associated with higher incidence and mortality of lung cancer, but studies on the relationship between brain metastasis and BMI at presentation are lacking. This study aimed to evaluate the association between brain metastasis and BMI and bone mineral density (BMD) in NSCLC. Methods We retrospectively enrolled patients with non-small cell lung cancer who underwent brain magnetic resonance imaging with contrast within 3 months of diagnosis. The BMI was collected, and the BMD was measured in Hounsfield unit (HU) on initial staging computed tomography scans. The independent relationship between BMI and BMD was assessed using multivariable linear regression according to the presence of brain metastasis. Results A total of 356 consecutive NSCLC patients were enrolled in the study over a 8-year period in a single institution. Lower BMI with higher BMD was an independent predictive factor for brain metastasis in patients with NSCLC, relative to the other group (HR, 2.03; 95% CI, 1.21 to 3.40; P = 0.007). We also found a significant negative correlation between BMI and BMD among patients with NSCLC with brain metastases (B, -3.343; 95% confidence interval, -6.352 to -0.333; P = 0.030). Conclusions Brain metastasis may possibly be associated with lower BMI and higher BMD in NSCLC patients. We expect that these results may facilitate future predictions of brain metastases during the clinical course of NSCLC and enhance our understanding of the underlying mechanisms that link brain metastases and lung cancer.	[Nam, Min Woo; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Han, Myung-Hoon] Hanyang Univ, Guri Hosp, Dept Neurosurg, Guri, Gyonggi Do, South Korea	Hanyang University	Han, MH (corresponding author), Hanyang Univ, Guri Hosp, Dept Neurosurg, Guri, Gyonggi Do, South Korea.	gksmh80@gmail.com			Hanyang University [HY-201800000002600]	Hanyang University	This work was supported by the research fund of Hanyang University (HY-201800000002600), http://www.hanyang.ac.kr/web/eng, to HMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the research fund of Hanyang University (HY-201800000002600).	An N, 2018, CANCER MED-US, V7, P6357, DOI 10.1002/cam4.1865; Baek MY, 2018, KOREAN J INTERN MED, V33, P168, DOI 10.3904/kjim.2015.158; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Dey N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-537; Dey N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077425; Ding X, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-119; Duan P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16938; Duchartre Y, 2016, CRIT REV ONCOL HEMAT, V99, P141, DOI 10.1016/j.critrevonc.2015.12.005; Edge S, 2010, AJCC CANC STAGING HD; Feeman T.G., 2015, MATH MED IMAGING BEG; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Hakimi AA, 2013, JNCI-J NATL CANCER I, V105, P1862, DOI 10.1093/jnci/djt310; Han MH, 2018, STROKE, V49, P1850, DOI 10.1161/STROKEAHA.118.021063; Horst D, 2012, CANCER RES, V72, P1547, DOI 10.1158/0008-5472.CAN-11-3222; Hubbs JL, 2010, CANCER-AM CANCER SOC, V116, P5038, DOI 10.1002/cncr.25254; Jih J, 2014, PREV MED, V65, P1, DOI 10.1016/j.ypmed.2014.04.010; Kafka A, 2014, INT J MOL SCI, V15, P10635, DOI 10.3390/ijms150610635; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; Kuroda K, 2007, UROLOGY, V69, P113, DOI 10.1016/j.urology.2006.09.039; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028133; Li HX, 2008, MOL CELL ENDOCRINOL, V291, P116, DOI 10.1016/j.mce.2008.05.005; Masel EK, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12707; Nayak L, 2012, CURR ONCOL REP, V14, P48, DOI 10.1007/s11912-011-0203-y; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Palmieri D., 2012, CENTRAL NERVOUS SYST; Park S, 2018, J BIOL CHEM, V293, P9759, DOI 10.1074/jbc.RA118.002743; Pedrosa RMSM, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00159; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Popper HH, 2016, CANCER METAST REV, V35, P75, DOI 10.1007/s10555-016-9618-0; Ramalingam S, 2008, ONCOLOGIST, V13, P5, DOI 10.1634/theoncologist.13-S1-5; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schreiber JJ, 2011, J BONE JOINT SURG AM, V93A, P1057, DOI 10.2106/JBJS.J.00160; SEYFRIED TN, 2010, NUTR METAB, V7, DOI DOI 10.1371/JOURNAL.PONE.0028133; Shen N, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007721; Sinnberg T, 2018, MOL CANCER, V17, DOI [10.1186/s12943-018-0770-8, DOI 10.1186/S12943-018-0770-8]; Song LG, 2012, J BONE MINER RES, V27, P2344, DOI 10.1002/jbmr.1694; Stewart DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt356; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sun DS, 2014, ASIAN PAC J CANCER P, V15, P1233, DOI 10.7314/APJCP.2014.15.3.1233; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Tsang NM, 2016, CANCER MED-US, V5, P665, DOI 10.1002/cam4.634; Wang J, 2018, EUR J CLIN NUTR, V72, P4, DOI 10.1038/ejcn.2017.70; Waqar SN, 2018, CLIN LUNG CANCER, V19, pE373, DOI 10.1016/j.cllc.2018.01.007; Waqar SN, 2018, AM J CLIN ONCOL-CANC, V41, P36, DOI 10.1097/COC.0000000000000230; Xu CY, 2016, CURR STEM CELL RES T, V11, P247, DOI 10.2174/1574888X10666150723145707; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	52	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218825	10.1371/journal.pone.0218825	http://dx.doi.org/10.1371/journal.pone.0218825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226155	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700045
J	Gupta, A; Bhatt, RR; Naliboff, BD; Kutch, JJ; Labus, JS; Vora, PP; Alaverdyan, M; Schrepf, A; Lutgendorf, S; Mayer, EA				Gupta, Arpana; Bhatt, Ravi R.; Naliboff, Bruce D.; Kutch, Jason J.; Labus, Jennifer S.; Vora, Priten P.; Alaverdyan, Mher; Schrepf, Andrew; Lutgendorf, Susan; Mayer, Emeran A.		MAPP Res Network	Impact of early adverse life events and sex on functional brain networks in patients with urological chronic pelvic pain syndrome (UCPPS): A MAPP Research Network study	PLOS ONE			English	Article							DEFAULT MODE NETWORK; SURFACE-BASED ANALYSIS; RESTING-STATE; CHILDHOOD MALTREATMENT; MULTIDISCIPLINARY APPROACH; INTERSTITIAL CYSTITIS; GRAY-MATTER; CONNECTIVITY; WOMEN; MEN	Pain is a highly complex and individualized experience with biopsychosocial components. Neuroimaging research has shown evidence of the involvement of the central nervous system in the development and maintenance of chronic pain conditions, including urological chronic pelvic pain syndrome (UCPPS). Furthermore, a history of early adverse life events (EALs) has been shown to adversely impact symptoms throughout childhood and into adulthood. However, to date, the role of EAL's in the central processes of chronic pain have not been adequately investigated. We studied 85 patients (56 females) with UCPPS along with 86 healthy controls (HCs) who had resting-state magnetic resonance imaging scans (59 females), and data on EALs as a part of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Study. We used graph theory methods in order to investigate the impact of EALs on measures of centrality, which characterize information flow, communication, influence, and integration in a priori selected regions of interest. Patients with UCPPS exhibited lower centrality in the right anterior insula compared to HCs, a key node in the salience network. Males with UCPPS exhibited lower centrality in the right anterior insula compared the HC males. Females with UCPPS exhibited greater centrality in the right caudate nucleus and left angular gyrus compared to HC females. Males with UCPPS exhibited lower centrality in the left posterior cingulate, angular gyrus, middle temporal gyrus, and superior temporal sulcus, but greater centrality in the precuneus and anterior mid-cingulate cortex (aMCC) compared to females with UCPPS. Higher reports of EALs was associated with greater centrality in the left precuneus and left aMCC in females with UCPPS. This study provides evidence for disease and sex-related alterations in the default mode, salience, and basal ganglia networks in patients with UCPPS, which are moderated by EALs, and associated with clinical symptoms and quality of life (QoL).	[Gupta, Arpana; Bhatt, Ravi R.; Naliboff, Bruce D.; Labus, Jennifer S.; Vora, Priten P.; Alaverdyan, Mher; Mayer, Emeran A.] UCLA, G Oppenheimer Ctr Neurobiol Stress & Resilience, Los Angeles, CA 90032 USA; [Gupta, Arpana; Bhatt, Ravi R.; Naliboff, Bruce D.; Labus, Jennifer S.; Vora, Priten P.; Mayer, Emeran A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Gupta, Arpana; Naliboff, Bruce D.; Labus, Jennifer S.; Vora, Priten P.; Mayer, Emeran A.] UCLA, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90032 USA; [Kutch, Jason J.] USC, Div Biokinesiol & Phys Therapy, Los Angeles, CA USA; [Schrepf, Andrew] Univ Michigan, Chron Pain & Fatigue Res Ctr, Ann Arbor, MI 48109 USA; [Schrepf, Andrew] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Lutgendorf, Susan] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Lutgendorf, Susan] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA; [Lutgendorf, Susan] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Mayer, Emeran A.] UCLA, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90032 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Southern California; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Iowa; University of Iowa; University of Iowa; University of California System; University of California Los Angeles	Mayer, EA (corresponding author), UCLA, G Oppenheimer Ctr Neurobiol Stress & Resilience, Los Angeles, CA 90032 USA.; Mayer, EA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.; Mayer, EA (corresponding author), UCLA, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90032 USA.; Mayer, EA (corresponding author), UCLA, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90032 USA.	emayer@ucla.edu	Labus, Jennifer S/M-4567-2017	Labus, Jennifer S/0000-0002-6634-2551	NIDDK [K23 DK106528, R01 DK048351]; NIH CURE [P30-DK04130]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) [DK82370, DK82342, DK82315, DK82344, DK82325, DK82345, DK82333, DK82316]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048351, U01DK082325, K23DK106528, U01DK082344] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH CURE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.G. has been supported form the NIDDK K23 DK106528. E.A.M. has been supported from the NIDDK R01 DK048351. Support for the Center of Neurobiology of Stress and Resilience was provided by NIH CURE P30-DK04130. Funding for the MAPP Research Network was obtained under a cooperative agreement from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) (DK82370, DK82342, DK82315, DK82344, DK82325, DK82345, DK82333, and DK82316).	Aas M, 2012, SCHIZOPHR RES, V137, P73, DOI 10.1016/j.schres.2012.01.035; Adenzato M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41219; Ahangari A, 2014, PAIN PHYSICIAN, V17, pE141; Alger JR, 2016, NEUROIMAGE-CLIN, V12, P65, DOI 10.1016/j.nicl.2015.12.009; Arslan S, 2018, NEUROIMAGE, V170, P5, DOI 10.1016/j.neuroimage.2017.04.014; Bagarinao E, 2014, PAIN, V155, P2502, DOI 10.1016/j.pain.2014.09.002; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Bogart LM, 2007, J UROLOGY, V177, P450, DOI 10.1016/j.juro.2006.09.032; Boggero IA, 2015, PAIN MED, V16, P341, DOI 10.1111/pme.12598; Borsook D, 2013, PROG NEUROBIOL, V104, P93, DOI 10.1016/j.pneurobio.2013.02.003; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; Brown CA, 2015, PAIN, V156, P2267, DOI 10.1097/j.pain.0000000000000299; Budell L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107526; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Calero CI, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00281; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Clemens JQ, 2007, J UROLOGY, V178, P1354, DOI 10.1016/j.juro.2007.05.157; Clemens JQ, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-57; Clemens JQ, 2009, UROLOGY, V74, P983, DOI 10.1016/j.urology.2009.06.078; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis KD, 2017, NAT REV NEUROL, V13, P624, DOI 10.1038/nrneurol.2017.122; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Downar J, 2003, NEUROIMAGE, V20, P1540, DOI 10.1016/S1053-8119(03)00407-5; Farmer MA, 2015, J UROLOGY, V194, P118, DOI 10.1016/j.juro.2015.02.082; Fenske S, 2017, PAIN, V158, P1, DOI DOI 10.1097/J.PAIN.0000000000000745; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Goffaux P, 2014, BRAIN TOPOGR, V27, P366, DOI 10.1007/s10548-013-0291-0; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Grant MM, 2011, J PSYCHIATR RES, V45, P886, DOI 10.1016/j.jpsychires.2010.12.004; Gupta A, 2016, J NEUROSICENCE RES; Gupta A, 2017, NEUROBIOL STRESS, V7, P16, DOI 10.1016/j.ynstr.2017.02.003; Gupta A, 2015, PAIN, V156, P809, DOI 10.1097/01.j.pain.0000461289.65571.54; Gupta A, 2014, PSYCHOSOM MED, V76, P404, DOI 10.1097/PSY.0000000000000089; Hanno P, 2014, J UROLOGY; Harper DE, 2018, NEUROIMAGE-CLIN, V17, P570, DOI 10.1016/j.nicl.2017.11.014; Hemington KS, 2016, BRAIN STRUCT FUNCT, V221, P4203, DOI 10.1007/s00429-015-1161-1; Henschke N, 2015, MAYO CLIN PROC, V90, P139, DOI 10.1016/j.mayocp.2014.09.010; Huang L, 2016, PAIN, V157, P2782, DOI 10.1097/j.pain.0000000000000703; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; JONES AKP, 1991, NEUROSCI LETT, V126, P25, DOI 10.1016/0304-3940(91)90362-W; Kairys AE, 2015, J UROLOGY, V193, P131, DOI 10.1016/j.juro.2014.08.042; Kilpatrick LA, 2014, J UROLOGY, V192, P947, DOI 10.1016/j.juro.2014.03.093; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Kleinhans NM, 2016, J UROLOGY, V195, P639, DOI 10.1016/j.juro.2015.09.092; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Kucyi A, 2014, J NEUROSCI, V34, P3969, DOI 10.1523/JNEUROSCI.5055-13.2014; Kucyi A, 2013, P NATL ACAD SCI USA, V110, P18692, DOI 10.1073/pnas.1312902110; Kutch JJ, 2017, PAIN, V158, P1979, DOI 10.1097/j.pain.0000000000001001; Kutch JJ, 2015, NEUROIMAGE-CLIN, V8, P493, DOI 10.1016/j.nicl.2015.05.013; Labus J, 2017, NEUROIMAGE-CLIN; Landis JR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-58; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Loggia ML, 2013, PAIN, V154, P24, DOI 10.1016/j.pain.2012.07.029; Mak LE, 2017, BRAIN CONNECT, V7, P25, DOI 10.1089/brain.2016.0438; Martucci KT, 2018, ANESTHESIOLOGY, V128, P1241, DOI 10.1097/ALN.0000000000002137; Martucci KT, 2015, PAIN, V156, P1755, DOI 10.1097/j.pain.0000000000000238; Mayer EA, 2015, NAT REV GASTRO HEPAT, V12, P592, DOI 10.1038/nrgastro.2015.121; Naliboff BD, 2015, UROLOGY, V85, P1319, DOI 10.1016/j.urology.2015.02.047; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074935; PENNEBAKER JW, 1988, SOC SCI MED, V26, P327, DOI 10.1016/0277-9536(88)90397-8; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Rasakham K, 2011, LIFE SCI, V88, P2, DOI 10.1016/j.lfs.2010.10.007; Ross LA, 2010, NEUROIMAGE, V49, P3452, DOI 10.1016/j.neuroimage.2009.11.012; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Simons LE, 2014, NEUROSCI BIOBEHAV R, V39, P61, DOI 10.1016/j.neubiorev.2013.12.006; Solomon SR, 2009, J MOD APPL STAT METH, V8, P448, DOI 10.22237/jmasm/1257034080; Spielberg JM, 2014, BRAIN CONNECT, V4, pA1, DOI DOI 10.1089/BRAIN.2014.1501.ABSTRACTS; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stones RW, 2000, BEST PRACT RES CL OB, V14, P415, DOI 10.1053/beog.1999.0084; Suskind AM, 2013, J UROLOGY, V189, P141, DOI 10.1016/j.juro.2012.08.088; Teicher MH, 2016, NAT REV NEUROSCI, V17, P652, DOI 10.1038/nrn.2016.111; Teicher MH, 2014, BIOL PSYCHIAT, V76, P297, DOI 10.1016/j.biopsych.2013.09.016; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; Teicher MH, 2002, PSYCHIAT CLIN N AM, V25, P397, DOI 10.1016/S0193-953X(01)00003-X; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; van den Heuvel MP, 2017, NEUROIMAGE, V152, P437, DOI 10.1016/j.neuroimage.2017.02.005; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062789; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Woodworth D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140250; Zhang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep11563; Zubieta JK, 1999, AM J PSYCHIAT, V156, P842, DOI 10.1176/ajp.156.6.842	95	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0217610	10.1371/journal.pone.0217610	http://dx.doi.org/10.1371/journal.pone.0217610			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IN4WS	31220089	gold, Green Published, Green Submitted			2022-12-26	WOS:000478678500001
J	Ramesh, A; Nakielny, S; Hsu, J; Kyohere, M; Byaruhanga, O; de Bourcy, C; Egger, R; Dimitrov, B; Juan, YF; Sheu, J; Wang, J; Kalantar, K; Langelier, C; Ruel, T; Mpimbaza, A; Wilson, MR; Rosenthal, PJ; DeRisi, JL				Ramesh, Akshaya; Nakielny, Sara; Hsu, Jennifer; Kyohere, Mary; Byaruhanga, Oswald; de Bourcy, Charles; Egger, Rebecca; Dimitrov, Boris; Juan, Yun-Fang; Sheu, Jonathan; Wang, James; Kalantar, Katrina; Langelier, Charles; Ruel, Theodore; Mpimbaza, Arthur; Wilson, Michael R.; Rosenthal, Philip J.; DeRisi, Joseph L.			Metagenomic next-generation sequencing of samples from pediatric febrile illness in Tororo, Uganda	PLOS ONE			English	Article							MALARIA; CHILDREN; VIRUS; FEVER; INFECTIONS; PNEUMONIA; ETIOLOGY; PROTEIN; CLASSIFICATION; EPIDEMIOLOGY	Febrile illness is a major burden in African children, and non-malarial causes of fever are uncertain. In this retrospective exploratory study, we used metagenomic next-generation sequencing (mNGS) to evaluate serum, nasopharyngeal, and stool specimens from 94 children (aged 2-54 months) with febrile illness admitted to Tororo District Hospital, Uganda. The most common microbes identified were Plasmodium falciparum (51.1% of samples) and parvovirus B19 (4.4%) from serum; human rhinoviruses A and C (40%), respiratory syncytial virus (10%), and human herpesvirus 5 (10%) from nasopharyngeal swabs; and rotavirus A (50% of those with diarrhea) from stool. We also report the near complete genome of a highly divergent orthobunyavirus, tentatively named Nyangole virus, identified from the serum of a child diagnosed with malaria and pneumonia, a Bwamba orthobunyavirus in the nasopharynx of a child with rash and sepsis, and the genomes of two novel human rhinovirus C species. In this retrospective exploratory study, mNGS identified multiple potential pathogens, including 3 new viral species, associated with fever in Ugandan children.	[Ramesh, Akshaya; Wilson, Michael R.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Ramesh, Akshaya; Wilson, Michael R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Nakielny, Sara; Kalantar, Katrina; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Hsu, Jennifer; Langelier, Charles; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Kyohere, Mary; Byaruhanga, Oswald] Infect Dis Res Collaborat, Kampala, Uganda; [de Bourcy, Charles; Egger, Rebecca; Dimitrov, Boris; Juan, Yun-Fang; Sheu, Jonathan; Wang, James; DeRisi, Joseph L.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Ruel, Theodore] Univ Calif San Francisco, Dept Pediat, Div Pediat Infect Dis & Global Hlth, San Francisco, CA USA; [Mpimbaza, Arthur] Makerere Univ, Child Hlth & Dev Ctr, Kampala, Uganda	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University	Ramesh, A (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Ramesh, A (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.; DeRisi, JL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA.; DeRisi, JL (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA USA.	Akshaya.Ramesh@ucsf.edu; joe@derisilab.ucsf.edu	Ramesh, Akshaya/GWR-3496-2022	Wilson, Michael/0000-0002-8705-5084	Chan Zuckerberg Biohub; Chan Zuckerberg Initiative; Howard Hughes Medical Institute; National Institutes of Health; Doris Duke Charitable Foundation; Rachleff Foundation; NINDS [K08NS096117]; University of California, San Francisco Center for Next-Gen Precision Diagnostics - Sandler Foundation; William K. Bowes, Jr. Foundation; NHLBI [K23HL138461-01A1]; Nina Ireland Foundation; Marcus Program in Precision Medicine; UC Berkeley UC San Francisco Joint Program in Bioengineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL138461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS096117] Funding Source: NIH RePORTER	Chan Zuckerberg Biohub; Chan Zuckerberg Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Rachleff Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of California, San Francisco Center for Next-Gen Precision Diagnostics - Sandler Foundation(University of California System); William K. Bowes, Jr. Foundation; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Nina Ireland Foundation; Marcus Program in Precision Medicine; UC Berkeley UC San Francisco Joint Program in Bioengineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JLD is supported by the Chan Zuckerberg Biohub. CdB, BD, YJ, JS, RE and JW are funded by the Chan Zuckerberg Initiative. SN was supported by Howard Hughes Medical Institute. PJR is funded by the National Institutes of Health, and work on this project by JH, MK, OB, and PJR was funded by the Doris Duke Charitable Foundation. MRW is supported by the Rachleff Foundation, NINDS K08NS096117 and the University of California, San Francisco Center for Next-Gen Precision Diagnostics, which is supported by the Sandler Foundation and the William K. Bowes, Jr. Foundation. AR is supported by the Rachleff Foundation. CL is supported by NHLBI K23HL138461-01A1, Nina Ireland Foundation and Marcus Program in Precision Medicine. KK is supported by the UC Berkeley UC San Francisco Joint Program in Bioengineering.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Agarwal Rakesh, 2017, Trop Parasitol, V7, P47, DOI 10.4103/2229-5070.202299; Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bibby K, 2013, TRENDS BIOTECHNOL, V31, P11, DOI 10.1016/j.tibtech.2013.01.016; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; CALISHER CH, 1987, AM J TROP MED HYG, V36, P114, DOI 10.4269/ajtmh.1987.36.114; Chipwaza B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003750; Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; De Vlaminck I, 2015, P NATL ACAD SCI USA, V112, P13336, DOI 10.1073/pnas.1517494112; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duedu Kwabena Obeng, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P129, DOI 10.1016/S2221-1691(13)60037-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hafez MM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-135; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Jacob ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070305; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kibuuka A, 2015, AM J TROP MED HYG, V93, P276, DOI 10.4269/ajtmh.14-0494; Kozlowska A., 2018, BIOACTIVE MOL FOOD, P1; Langelier C, 2018, AM J RESP CRIT CARE, V197, P524, DOI 10.1164/rccm.201706-1097LE; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loens K, 2009, J CLIN MICROBIOL, V47, P21, DOI 10.1128/JCM.02037-08; Lukashev AN, 2017, J GEN VIROL, V98, P2968, DOI 10.1099/jgv.0.000966; Lutwama Julius J, 2002, Afr Health Sci, V2, P24; Maina AN, 2016, EMERG INFECT DIS, V22, P883, DOI 10.3201/eid2205.150953; Maze MJ, 2018, CLIN MICROBIOL INFEC, V24, P808, DOI 10.1016/j.cmi.2018.02.011; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; Mekonnen SK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-48; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mohamed M, 2009, J VIROL, V83, P7612, DOI 10.1128/JVI.02080-08; Mwenda JM, 2017, MMWR-MORBID MORTAL W, V66, P1192, DOI 10.15585/mmwr.mm6643a7; Naoumov NV, 2000, J HEPATOL, V33, P157, DOI 10.1016/S0168-8278(00)80173-7; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; O'Meara WP, 2015, AM J TROP MED HYG, V92, P1030, DOI [10.4269/ajtmh.14-0560, 10.4269/ajtmh.14.0560]; Oguttu DW, 2017, MALARIA J, V16, P1, DOI [10.1186/s12936-016-1650-6, DOI 10.1186/S12936-016-1650-6]; Onyango CO, 2012, J MED VIROL, V84, P823, DOI 10.1002/jmv.23251; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Park DE, 2017, CLIN INFECT DIS, V64, pS328, DOI 10.1093/cid/cix104; Perez-Losada M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170543; Plyusnin A, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P1; Prasad N, 2015, AM J TROP MED HYG, V93, P178, DOI 10.4269/ajtmh.14-0646; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Scully EJ, 2018, EMERG INFECT DIS, V24, P267, DOI 10.3201/eid2402.170778; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Smuts HE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-65; TeKippe EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050937; Doan T, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0377-x; Toan NL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-375; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; WHO, 2010, GUID TREATM MAL, V2nd; WILLIAMS JE, 1976, B WORLD HEALTH ORGAN, V53, P365; Wilson MR, 2018, JAMA NEUROL, V75, P947, DOI 10.1001/jamaneurol.2018.0463; Wilson MR, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00058-16; Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; World Health Organization, 2017, STAT HLTH IN IND; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5	68	36	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218318	10.1371/journal.pone.0218318	http://dx.doi.org/10.1371/journal.pone.0218318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220115	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500035
J	Xiao, QQ; Zhong, ZY; Lai, XZ; Qin, HB				Xiao, Qiaoqin; Zhong, Zhenyu; Lai, Xiaozheng; Qin, Huabiao			A multiple modulation synthesis method with high spatial resolution for noninvasive neurostimulation	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ELECTRICAL-STIMULATION; SIMULATION	Noninvasive neurostimulation plays a pivotal role in the direct control of neural circuits and the modulation of neuronal function. However, it is difficult to balance both spatial resolution and penetration depth when stimulating deep neurons. Here, we designed a multiple (time-division, frequency and polarity) modulation synthesis (MMS) method for noninvasively stimulating deep neurons with low-frequency envelopes. Compared to conventional transcranial electrical stimulation, we demonstrated that it can stimulate deep neurons at the desired firing rate (beat frequency) with higher spatial resolution via a computational model combining finite element analysis and Hodgkin-Huxley action potential model. Additionally, we measured the distribution of stimulus waveforms in saline solution to validate its effect. Taken together, the results of this study indicate that MMS stimulation with higher spatial resolution is steerable and might be a potential alternative to traditional implanted electrodes.	[Xiao, Qiaoqin; Qin, Huabiao] South China Univ Technol, Sch Elect & Informat Engn, Guangzhou, Guangdong, Peoples R China; [Zhong, Zhenyu; Lai, Xiaozheng] South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Lai, XZ (corresponding author), South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China.	laixz@scut.edu.cn		lai, xiao zheng/0000-0002-3850-0057				Andreuccetti D, 2002, DIELECTRIC PROPERTIE; Bhadra N, 2007, J COMPUT NEUROSCI, V22, P313, DOI [10.1007/s10827-006-0015-5, 10.1007/S10827-006-0015-5]; Carnevale NT, 2006, NEURON BOOK; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; Deng ZD, 2013, BRAIN STIMUL, V6, P1, DOI 10.1016/j.brs.2012.02.005; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; GRILL WM, 1995, IEEE ENG MED BIOL, V14, P375, DOI 10.1109/51.395310; Grossman N, 2017, CELL, V169, P1029, DOI 10.1016/j.cell.2017.05.024; Hamid NA, 2005, J NEUROL NEUROSUR PS, V76, P409, DOI 10.1136/jnnp.2003.032029; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoppensteadt FC, 2010, MODELING SIMULATION; Huang Y, 2019, BRAIN STIMUL, V12, P30, DOI 10.1016/j.brs.2018.09.010; Huang Y, 2016, NEUROIMAGE, V140, P150, DOI 10.1016/j.neuroimage.2015.12.019; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Negahbani E, 2018, NEUROIMAGE, V173, P3, DOI 10.1016/j.neuroimage.2018.02.005; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Pierce P. A., 1995, FATIGUE NEURAL MUSCU; Rezayat E, 2016, BASIC CLIN NEUROSCI, V7, P187, DOI 10.15412/J.BCN.03070303; Stoykov NS, 2002, IEEE T BIO-MED ENG, V49, P763, DOI 10.1109/TBME.2002.800754; Voroslakos M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02928-3; Ward AR, 2009, PHYS THER, V89, P181, DOI 10.2522/ptj.20080060; Ward AR, 2001, MUSCLE NERVE, V24, P1303, DOI 10.1002/mus.1148	24	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218293	10.1371/journal.pone.0218293	http://dx.doi.org/10.1371/journal.pone.0218293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220139	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500032
J	Feng, Y; Xie, Y; Xu, MS; Li, LH; Selce, KW; Oberly, PJ; Poloyac, SM; Wang, HB; Li, CJ; Dong, FQ; Yu, CH; Xie, W				Feng, Ye; Xie, Yang; Xu, Meishu; Li, Linhao; Selce, Kyle W.; Oberly, Patrick J.; Poloyac, Samuel M.; Wang, Hongbing; Li, Chengjiang; Dong, Fengqin; Yu, Chaohui; Xie, Wen			Hepatic steroid sulfatase critically determines estrogenic activities of conjugated equine estrogens in human cells in vitro and in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						steroid hormone; metabolism; sulfotransferase; estrogen; gene regulation; conjugated equine estrogens; hormone replacement therapy (HRT); inflammation; menopause; steroid sulfatase (STS)	PREGNANE-X-RECEPTOR; HORMONE REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; BINDING; HEALTH; BREAST; ACTIVATION; GROWTH; PROTEIN-1; ELEMENT	Conjugated equine estrogens (CEEs), whose brand name is Premarin, are widely used as a hormone-replacement therapy (HRT) drug to manage postmenopausal symptoms in women. Extracted from pregnant mare urine, CEEs are composed of nearly a dozen estrogens existing in an inactive sulfated form. To determine whether the hepatic steroid sulfatase (STS) is a key contributor to the efficacy of CEEs in HRT, we performed estrogen-responsive element (ERE) reporter gene assay, real-time PCR, and UPLC-MS/MS to assess the STS-dependent and inflammation-responsive estrogenic activity of CEEs in HepG2 cells and human primary hepatocytes. Using liver-specific STS-expressing transgenic mice, we also evaluated the effect of STS on the estrogenic activity of CEEs in vivo. We observed that CEEs induce activity of the ERE reporter gene in an STS-dependent manner and that genetic or pharmacological inhibition of STS attenuates CEE estrogenic activity. In hepatocytes, inflammation enhanced CEE estrogenic activity by inducing STS gene expression. The inflammation-responsive estrogenic activity of CEEs, in turn, attenuated inflammation through the anti-inflammatory activity of the active estrogens. In vivo, transgenic mice with liver-specific STS expression exhibited markedly increased sensitivity to CEE-induced estrogenic activity in the uterus resulting from increased levels of liver-derived and circulating estrogens. Our results reveal a critical role of hepatic STS in mediating the hormone-replacing activity of CEEs. We propose that caution needs to be applied when Premarin is used in patients with chronic inflammatory liver diseases because such patients may have heightened sensitivity to CEEs due to the inflammatory induction of STS activity.	[Feng, Ye; Xie, Yang; Xu, Meishu; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Feng, Ye; Xie, Yang; Xu, Meishu; Oberly, Patrick J.; Poloyac, Samuel M.; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Feng, Ye; Li, Chengjiang; Dong, Fengqin] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Endocrinol & Metab Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Linhao; Wang, Hongbing] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA; [Selce, Kyle W.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Yu, Chaohui] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Wen] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Zhejiang University; University System of Maryland; University of Maryland Baltimore; Duquesne University; Zhejiang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA.; Xie, W (corresponding author), Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.; Yu, CH (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	zyyyych@zju.edu.cn; wex6@pitt.edu	Xie, Wen/M-1768-2016	Xie, Yang/0000-0002-2190-6966	National Institutes of Health [DK083952, ES023438, GM121550]; University of Pittsburgh School of Pharmacy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Pharmacy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants DK083952, ES023438 (to W.X.), and GM121550 (to H.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Joseph Koslow Endowed Professorship from the University of Pittsburgh School of Pharmacy.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Barkhem T, 2002, MOL PHARMACOL, V61, P1273, DOI 10.1124/mol.61.6.1273; Bhavnani BR, 2014, J STEROID BIOCHEM, V142, P16, DOI 10.1016/j.jsbmb.2013.10.011; Cardim HJP, 2001, FERTIL STERIL, V75, P282, DOI 10.1016/S0015-0282(00)01691-5; Christopoulos PF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0291-7; Della Torre S, 2011, ENDOCRINOLOGY, V152, P2256, DOI 10.1210/en.2011-0173; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; Gong HB, 2007, MOL ENDOCRINOL, V21, P1781, DOI 10.1210/me.2007-0187; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Jiang MX, 2016, J HEPATOL, V64, P44, DOI 10.1016/j.jhep.2015.07.022; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lee YJ, 2003, ARCH PHARM RES, V26, P58, DOI 10.1007/BF03179933; Li JY, 2016, J STEROID BIOCHEM, V163, P113, DOI 10.1016/j.jsbmb.2016.04.013; Lobo RA, 2016, ATHEROSCLEROSIS, V254, P282, DOI 10.1016/j.atherosclerosis.2016.10.005; Miller VM, 2017, AM J PHYSIOL-HEART C, V313, pH1013, DOI 10.1152/ajpheart.00383.2017; Mu Y, 2006, J PHARMACOL EXP THER, V316, P1369, DOI 10.1124/jpet.105.094342; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; PAN CC, 1985, J CLIN ENDOCR METAB, V61, P499, DOI 10.1210/jcem-61-3-499; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Selcer KW, 2012, STEROIDS, V77, P696, DOI 10.1016/j.steroids.2012.02.024; Sengupta S, 2010, HORM MOL BIOL CLIN I, V2, P235, DOI 10.1515/HMBCI.2010.025; Stanway SJ, 2006, CLIN CANCER RES, V12, P1585, DOI 10.1158/1078-0432.CCR-05-1996; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Stuenkel CA, 2012, MENOPAUSE, V19, P846, DOI 10.1097/gme.0b013e31826226f2; Suwanvesh N, 2017, MENOPAUSE, V24, P210, DOI 10.1097/GME.0000000000000742; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	30	3	3	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12112	12121		10.1074/jbc.RA119.009181	http://dx.doi.org/10.1074/jbc.RA119.009181			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217279	hybrid, Green Published			2022-12-26	WOS:000484284500015
J	McCann, JL; Klein, MM; Leland, EM; Law, EK; Brown, WL; Salamango, DJ; Harris, RS				McCann, Jennifer L.; Klein, Madeline M.; Leland, Evelyn M.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.			The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA viruses; cell cycle; virus; proteomics; retrovirus; APOBEC3B; cancer mutagenesis; CDK4; innate antiviral immunity	SUBCELLULAR-LOCALIZATION; STRUCTURAL BASIS; SUBSTRATE-SPECIFICITY; MUTATIONAL SIGNATURES; THERAPEUTIC TARGET; CYTOSINE DEAMINASE; CRYSTAL-STRUCTURE; FAMILY PROTEINS; MESSENGER-RNA; UP-REGULATION	Apolipoprotein B mRNA editing enzyme catalytic subunit-like protein 3B (APOBEC3B or A3B), as other APOBEC3 members, is a single-stranded (ss)DNA cytosine deaminase with antiviral activity. A3B is also overexpressed in multiple tumor types, such as carcinomas of the bladder, cervix, lung, head/neck, and breast. A3B generates both dispersed and clustered C-to-T and C-to-G mutations in intrinsically preferred trinucleotide motifs (TCA/TCG/TCT). A3B-catalyzed mutations are likely to promote tumor evolution and cancer progression and, as such, are associated with poor clinical outcomes. However, little is known about cellular processes that regulate A3B. Here, we used a proteomics approach involving affinity purification coupled to MS with human 293T cells to identify cellular proteins that interact with A3B. This approach revealed a specific interaction with cyclin-dependent kinase 4 (CDK4). We validated and mapped this interaction by co-immunoprecipitation experiments. Functional studies and immunofluorescence microscopy experiments in multiple cell lines revealed that A3B is not a substrate for CDK4-Cyclin D1 phosphorylation nor is its deaminase activity modulated. Instead, we found that A3B is capable of disrupting the CDK4-dependent nuclear import of Cyclin D1. We propose that this interaction may favor a more potent antiviral response and simultaneously facilitate cancer mutagenesis.	[McCann, Jennifer L.; Klein, Madeline M.; Leland, Evelyn M.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [McCann, Jennifer L.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [McCann, Jennifer L.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [McCann, Jennifer L.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Harris, Reuben S.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Salamango, DJ (corresponding author), 2231 6th St SE,4-230B, Minneapolis, MN 55455 USA.	dsalaman@umn.edu	Brown, William/GXN-2777-2022	Harris, Reuben/0000-0002-9034-9112	University of Minnesota Masonic Cancer Center, Academic Health Center, and College of Biological Sciences; National Science Foundation [00039202]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER	University of Minnesota Masonic Cancer Center, Academic Health Center, and College of Biological Sciences; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Minnesota Masonic Cancer Center, Academic Health Center, and College of Biological Sciences and in part by National Science Foundation Graduate Research Fellowship Grant 00039202 (to J.L.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Ayaz P, 2016, ACS CHEM BIOL, V11, P1710, DOI 10.1021/acschembio.6b00074; Baker Stacey J, 2012, Genes Cancer, V3, P658, DOI 10.1177/1947601913478972; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Bertucci F, 2019, NATURE, V569, P560, DOI 10.1038/s41586-019-1056-z; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bransteitter R, 2009, CELL MOL LIFE SCI, V66, P3137, DOI 10.1007/s00018-009-0070-y; Brown W., 2019, RABBIT MONOCLONAL AN, DOI [10.1101/513341, DOI 10.1101/513341]; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carpenter MA, 2019, METHODS, V156, P79, DOI 10.1016/j.ymeth.2018.12.006; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chen HB, 2017, J BIOL CHEM, V292, P10131, DOI 10.1074/jbc.M116.773226; Cheng AZ, 2019, NAT MICROBIOL, V4, P78, DOI 10.1038/s41564-018-0284-6; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Davy CE, 2005, J VIROL, V79, P3998, DOI 10.1128/JVI.79.7.3998-4011.2005; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Dhar KK, 1999, BRIT J CANCER, V81, P1174, DOI 10.1038/sj.bjc.6690826; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fanourakis G, 2016, EXP MOL PATHOL, V101, P314, DOI 10.1016/j.yexmp.2016.11.001; Feng YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00450; Grafstrom RH, 1999, CARCINOGENESIS, V20, P193, DOI 10.1093/carcin/20.2.193; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Holland TA, 2001, INT J CANCER, V95, P302, DOI 10.1002/1097-0215(20010920)95:5<302::AID-IJC1052>3.0.CO;2-#; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Italiano A, 2009, CLIN CANCER RES, V15, P5696, DOI 10.1158/1078-0432.CCR-08-3185; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kouno T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15024; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lackey L, 2013, CELL CYCLE, V12, P762, DOI 10.4161/cc.23713; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Land AM, 2013, J BIOL CHEM, V288, P17253, DOI 10.1074/jbc.M113.458661; Law EK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601737; Lee CR, 2019, J MICROBIOL, V57, P93, DOI 10.1007/s12275-019-9021-y; Lefebvre C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002201; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Ma W, 2019, MOL CARCINOGEN, V58, P643, DOI 10.1002/mc.22956; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martin LG, 1998, J VIROL, V72, P975, DOI 10.1128/JVI.72.2.975-985.1998; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; McNamara RP, 2013, CELL REP, V5, P1256, DOI 10.1016/j.celrep.2013.11.003; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nascimento R, 2009, ARCH VIROL, V154, P1143, DOI 10.1007/s00705-009-0420-y; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nigg E A, 1991, Semin Cell Biol, V2, P261; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nikkila J, 2017, BRIT J CANCER, V117, P113, DOI 10.1038/bjc.2017.133; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohba K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097787; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Paladino P, 2014, J VIROL, V88, P4480, DOI 10.1128/JVI.00059-14; Pan WJ, 1998, CARCINOGENESIS, V19, P765, DOI 10.1093/carcin/19.5.765; Parker GA, 1996, ONCOGENE, V13, P2541; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Refsland EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004761; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Salamango DJ, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00356-18; Salamango DJ, 2018, J MOL BIOL, V430, P2695, DOI 10.1016/j.jmb.2018.04.044; Sheppard KE, 2013, CLIN CANCER RES, V19, P5320, DOI 10.1158/1078-0432.CCR-13-0259; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Sieuwerts AM, 2014, MOL ONCOL, V8, P1679, DOI 10.1016/j.molonc.2014.07.003; Starrett GJ, 2019, MBIO, V10, DOI 10.1128/mBio.02690-18; Stavrou S, 2015, J IMMUNOL, V195, P4565, DOI 10.4049/jimmunol.1501504; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stevenson-Lindert LM, 2003, J BIOL CHEM, V278, P50956, DOI 10.1074/jbc.M306546200; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Tokunaga E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168090; Tsuboi M, 2016, BREAST CANCER-TOKYO, V23, P780, DOI 10.1007/s12282-015-0641-8; Ullah I, 2018, J CLIN INVEST, V128, P1355, DOI 10.1172/JCI96149; Venkatesan S, 2018, ANN ONCOL, V29, P563, DOI 10.1093/annonc/mdy003; Verhalen B, 2016, J VIROL, V90, P6379, DOI 10.1128/JVI.00771-16; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; Wagner JR, 2019, J CHEM INF MODEL, V59, P2264, DOI 10.1021/acs.jcim.8b00427; Walker BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7997; Warren CJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080233; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; Xiao X, 2017, NUCLEIC ACIDS RES, V45, P7494, DOI 10.1093/nar/gkx362; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yim Eun-Kyoung, 2005, Cancer Res Treat, V37, P319, DOI 10.4143/crt.2005.37.6.319	99	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12099	12111		10.1074/jbc.RA119.008443	http://dx.doi.org/10.1074/jbc.RA119.008443			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217276	Green Published, hybrid			2022-12-26	WOS:000484284500014
J	Hess, BM; Thomas, DG; Weber, TJ; Hutchison, JR; Straub, TM; Bruckner-Lea, CJ; Powell, JD; Kabilan, S; Corley, RA				Hess, Becky M.; Thomas, Dennis G.; Weber, Thomas J.; Hutchison, Janine R.; Straub, Timothy M.; Bruckner-Lea, Cynthia J.; Powell, Joshua D.; Kabilan, Senthil; Corley, Richard A.			An integrated experimental-computational approach for predicting virulence in New Zealand white rabbits and humans following inhalation exposure to Bacillus anthracis spores	PLOS ONE			English	Article							DEPOSITION; MODEL	Inhalation of Bacillus anthracis spores can lead to an anthrax infection that can be fatal. Previously published mathematical models have extrapolated kinetic rates associated with bacterial growth in New Zealand White (NZW) rabbits to humans, but to date, actual measurements of the underlying processes associated with anthrax virulence between species have not been conducted. To address this knowledge gap, we have quantified species specific rate constants associated with germination, proliferation, and immune cell inactivation of B. anthracis Sterne using an in vitro test platform that includes primary lung epithelial and immune cells. The generated data was then used to develop a physiologically based biokinetic model (PBBK) which quantitatively compares bacterial growth and mean time to death under lethal conditions in rabbits and humans. Simulations based upon our in vitro data and previously published in vivo data from rabbits indicate that disease progression is likely to be faster in humans than in NZW rabbits under comparable total deposited dose conditions. With the computational framework established, PBBK parameters can now be refined using experimental data for lethal B. anthracis strains (e.g. Ames) under identical conditions in future studies. The PBBK model can also be linked to existing aerosol dosimetry models that account for species-specific differences in aerosol deposition patterns to further improve the human health risk assessment of inhalation anthrax.	[Hess, Becky M.; Hutchison, Janine R.; Straub, Timothy M.; Bruckner-Lea, Cynthia J.; Powell, Joshua D.] Pacific Northwest Natl Lab, Chem & Biol Signature Sci, Richland, WA 99352 USA; [Thomas, Dennis G.; Weber, Thomas J.; Kabilan, Senthil; Corley, Richard A.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Powell, Joshua D.] ARS, USDA, Natl Anim Dis Ctr, Ames, IA USA; [Kabilan, Senthil] EMD Serono, Billerica, MA USA; [Corley, Richard A.] Greek Creek Toxicokinet Consulting LLC, Boise, ID USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Agriculture (USDA)	Hess, BM (corresponding author), Pacific Northwest Natl Lab, Chem & Biol Signature Sci, Richland, WA 99352 USA.	becky.hess@pnnl.gov	Corley, Richard/AAM-3579-2021	Corley, Richard/0000-0003-2877-9194; Powell, Joshua/0000-0003-0869-3481; Hess, Becky/0000-0003-1093-5478	Department of Homeland Security, Science and Technology Directorate [HSHQPM-14-X-00037]; Battelle Memorial Institute for the United States Department of Energy [DE-AC06-76RLO]	Department of Homeland Security, Science and Technology Directorate(United States Department of Homeland Security (DHS)); Battelle Memorial Institute for the United States Department of Energy(United States Department of Energy (DOE))	RC and TS received the funding award. The Department of Homeland Security, Science and Technology Directorate provided funding for this research through contract HSHQPM-14-X-00037 to Pacific Northwest National Laboratory. Pacific Northwest National Laboratory is operated by Battelle Memorial Institute for the United States Department of Energy under contract DE-AC06-76RL0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Justin Teeguarden for helpful discussions. The Department of Homeland Security, Science and Technology Directorate provided funding for this research through contract HSHQPM-14-X-00037 to Pacific Northwest National Laboratory. Pacific Northwest National Laboratory is operated by Battelle Memorial Institute for the United States Department of Energy under contract DE-AC06-76RLO.	Asgharian B, 2016, INHAL TOXICOL, V28, P80, DOI 10.3109/08958378.2016.1140850; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Coleman ME, 2008, BIOSECUR BIOTERROR, V6, P147, DOI 10.1089/bsp.2007.0066; Crabbe A, 2011, CELL MICROBIOL, V13, P469, DOI 10.1111/j.1462-5822.2010.01548.x; Gutting B, 2014, BIOSECUR BIOTERROR, V12, P29, DOI 10.1089/bsp.2013.0067; Gutting BW, 2016, RISK ANAL, V36, P2031, DOI 10.1111/risa.12564; Kabilan S, 2016, J AEROSOL SCI, V99, P64, DOI 10.1016/j.jaerosci.2016.01.011; Koehler T., 2009, INT J FOOD MICROBIOL, V30, P386, DOI DOI 10.1016/J.MAM.2009.07.004; Little SF, 1999, MICROBES INFECT, V1, P131, DOI 10.1016/S1286-4579(99)80004-5; Powell JD, 2015, J APPL MICROBIOL, V119, P711, DOI 10.1111/jam.12872; Powell JD, 2015, IN VITRO CELL DEV-AN, V51, P433, DOI 10.1007/s11626-014-9853-z; Riedel Stefan, 2004, Proc (Bayl Univ Med Cent), V17, P400; Tamplin ML, 2008, APPL ENVIRON MICROB, V74, P1111, DOI 10.1128/AEM.01292-07; U. S. Environmental Protection Agency, 2012, EPA600R110075 OFF RE; U. S. Environmental Protection Agency, 2012, EPA600R11145 OFF RES; Yee SB, 2010, COMPARATIVE MED, V60, P461; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219160	10.1371/journal.pone.0219160	http://dx.doi.org/10.1371/journal.pone.0219160			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260462	Green Published, Green Submitted, gold			2022-12-26	WOS:000484918700037
J	Lasry, A; Kalou, MB; Young, PR; Rurangirwa, J; Parekh, B; Behel, S				Lasry, Arielle; Kalou, Mireille B.; Young, Paul R.; Rurangirwa, Jacqueline; Parekh, Bharat; Behel, Stephanie			Cost implications of HIV retesting for verification in Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TESTING STRATEGIES; SOUTH-AFRICA; SCALE-UP; PERFORMANCE; ALGORITHMS; INFECTION; SERVICES; FACILITY; FIELD	Introduction HIV misdiagnosis leads to severe individual and public health consequences. Retesting for verification of all HIV-positive cases prior to antiretroviral therapy initiation can reduce HIV misdiagnosis, yet this practice has not been not widely implemented. Methods We evaluated and compared the cost of retesting for verification of HIV seropositivity (retesting) to the cost of antiretroviral treatment (ART) for misdiagnosed cases in the absence of retesting (no retesting), from the perspective of the health care system. We estimated the number of misdiagnosed cases based on a review of misdiagnosis rates, and the number of positives persons needing ART initiation by 2020. We presented the total and per person costs of retesting as compared to no retesting, over a ten-year horizon, across 50 countries in Africa grouped by income level. We conducted univariate sensitivity analysis on all model input parameters, and threshold analysis to evaluate the parameter values where the total costs of retesting and the costs no retesting are equivalent. Cost data were adjusted to 2017 United States Dollars. Results and discussion The estimated number of misdiagnoses, in the absence of retesting was 156,117, 52,720 and 29,884 for lower-income countries (LICs), lower-middle income countries (LMICs), and upper middle-income countries (UMICs), respectively, totaling 240,463 for Africa. Under the retesting scenario, costs per person initially diagnosed were: $40, $21, and $42, for LICs, LMICs, and UMICs, respectively. When retesting for verification is implemented, the savings in unnecessary ART were $125, $43, and $75 per person initially diagnosed, for LICs, LMICs, and UMICs, respectively. Over the ten-year horizon, the total costs under the retesting scenario, over all country income levels, was $475 million, and was $1.192 billion under the no retesting scenario, representing total estimated savings of $717 million in HIV treatment costs averted. Conclusions Results show that to reduce HIV misdiagnosis, countries in Africa should implement the WHO's recommendation of retesting for verification prior to ART initiation, as part of a comprehensive quality assurance program for HIV testing services.	[Lasry, Arielle; Kalou, Mireille B.; Young, Paul R.; Rurangirwa, Jacqueline; Parekh, Bharat; Behel, Stephanie] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Lasry, A (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Atlanta, GA 30333 USA.	alasry@cdc.gov		PAREKH, BHARAT/0000-0002-1088-4263	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	This work has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC). The authors received no specific funding for this work.; This work has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC).	Adler M, 2015, CONSOLIDATED GUIDELI; Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702; Alexander Keith, 2012, WASHINGTON POST; Aliyu HB, 2012, JAIDS-J ACQ IMM DEF, V61, P221, DOI 10.1097/QAI.0b013e3182683b04; Alzahrani H, 2015, CRIT ULTRASOUND J, V7, DOI 10.1186/s13089-015-0022-8; [Anonymous], 1997, Wkly Epidemiol Rec, V72, P81; [Anonymous], 2016, CHINA DAILY; [Anonymous], 2014, WHO REMINDS NATL PRO; Atieno W, 2017, DAILY NATION; Baltazar CS, 2014, J CLIN MICROBIOL, V52, P3544, DOI 10.1128/JCM.01098-14; Bassett IV, 2011, HIV MED, V12, P46, DOI 10.1111/j.1468-1293.2010.00850.x; Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Bautista-Arredondo S, 2016, AIDS, V30, P2495, DOI 10.1097/QAD.0000000000001208; Baveewo Steven, 2012, BMC Res Notes, V5, P154, DOI 10.1186/1756-0500-5-154; Bock P, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21780; Boeras DI, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-18; Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11; Del Solar ASK, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25177; Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Dinh T-H, 2017, 9 INT AIDS SOC C HIV; Eaton JW, 2017, CLIN INFECT DIS, V65, P522, DOI 10.1093/cid/cix341; Eller LA, 2007, J CLIN MICROBIOL, V45, P3281, DOI 10.1128/JCM.00894-07; Flynn D, 2015, CONSOLIDATED GUIDELI; Fogel JM, 2015, JAIDS-J ACQ IMM DEF, V69, P430, DOI 10.1097/QAI.0000000000000610; Gigma D, 2008, THE NATIONAL; Granade TC, 2004, J CLIN VIROL, V30, P229, DOI 10.1016/j.jcv.2003.12.006; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Hsiao NY, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21758; Jentsch U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042322; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21755; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.22190; Kanal Koum, 2005, AIDS Res Ther, V2, P5, DOI 10.1186/1742-6405-2-5; Khan S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21756; Khanh VN, 2015, THANH NIEN NEWS 0723; Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Kosack CS, 2017, J CLIN MICROBIOL, V55, P3006, DOI [10.1128/JCM.00962-17, 10.1128/jcm.00962-17]; Kosack CS, 2017, J INT AIDS SOC, V20, P1; Kufa T, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21753; Lecher S, 2016, MMWR-MORBID MORTAL W, V65, P1332, DOI 10.15585/mmwr.mm6547a2; Madec Y, 2005, CLIN INFECT DIS, V40, P1350, DOI 10.1086/429318; Maheswaran H, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0577-7; Manak MM, 2015, J CLIN MICROBIOL, V53, P3501, DOI 10.1128/JCM.01432-15; Maparo T, 2015, INT C AIDS STIS AFR; Martin EG, 2011, J CLIN VIROL, V52, pS11, DOI 10.1016/j.jcv.2011.09.014; Masina T., 2017, IMPLEMENTING HTS QUA; Mayaphi SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164943; Mehra B, 2014, ISRN AIDS, V2014, DOI [10.1155/2014/296840, DOI 10.1155/2014/296840]; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Merchant M, 2014, J CLIN VIROL, V59, P172, DOI 10.1016/j.jcv.2013.11.012; Mine M, 2015, JAIDS-J ACQ IMM DEF, V68, P365, DOI 10.1097/QAI.0000000000000434; Mulinda N, 2011, MALAWI MED J, V23, P124; Mulogo EM, 2013, AFR HEALTH SCI, V13, P423, DOI 10.4314/ahs.v13i2.32; Nelson R, 2016, CROI 2016 C RETR OPP; Obure CD, 2012, SEX TRANSM INFECT, V88, P498, DOI 10.1136/sextrans-2012-050544; Odaibo Georgina N, 2013, Virology (Auckl), V4, P35, DOI 10.4137/VRT.S12677; Olaru ID, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21751; Olson AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086719; Paul H, 2015, JAMAICA OBSERVER; Quigley R, 2013, DAILY MAIL; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Sacks R, 2012, INT J STD AIDS, V23, P644, DOI 10.1258/ijsa.2012.011422; Shanks L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132422; Shanks L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0769-3; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Stetler HC, 1997, AIDS, V11, P369, DOI 10.1097/00002030-199703110-00015; Stover J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154893; Tabana H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135048; UNAIDS, 2016, FAST TRACK UPD INV N; Viani RM, 2013, AIDS RES HUM RETROV, V29, P429, DOI [10.1089/aid.2012.0190, 10.1089/AID.2012.0190]; WHO, 2015, CONSOLIDATED GUIDELI; WHO, 2016, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2012, SERV DEL APPR HIV TE; World Health Organization, 2015, IMPR QUAL HIV REL PO	76	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218936	10.1371/journal.pone.0218936	http://dx.doi.org/10.1371/journal.pone.0218936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260467	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700025
J	Cudkowicz, NA; Schuldiner, S				Cudkowicz, Noemie Alon; Schuldiner, Shimon			Deletion of the major Escherichia coli multidrug transporter AcrB reveals transporter plasticity and redundancy in bacterial cells	PLOS ONE			English	Article							EFFLUX PUMPS; ANTIBIOTIC-RESISTANCE; MOLECULAR-MECHANISMS; DRUG-RESISTANCE; EXPRESSION; PROTEIN; ACTIVATION; PROFILES; OPERON; CANCER	Multidrug Transporters ( MDTs) are major contributors to the acquisition and maintenance of Antimicrobial Resistance ( AMR), a growing public health threat of broad concern. Despite the large number of MDTs, the overwhelming majority of the studies performed thus far in Gram-negative bacteria emphasize the supremacy of the AcrAB-TolC complex. To unveil the potential role of other MDTs we studied the behavior of a null AcrB Escherichia coli strain when challenged with chloramphenicol, a bacteriostatic antibiotic. We found that such a strain developed an extremely high-level of resistance to chloramphenicol, cross resistance to quinolones and erythromycin and displayed high levels of expression of the single component MFS transporter MdfA and multiple TolC-dependent transporters. The results suggest that the high versatility of the whole ensemble of transporters, the bacterial Effluxome, is an essential part of a strategy of survival in everchanging, at times noxious, environments. The concept of a functional Effluxome presents an alternative to the existing paradigms in the field and provides novel targets for the search for inhibitors of transporters as adjuvants of existing antibiotics.	[Cudkowicz, Noemie Alon; Schuldiner, Shimon] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, Jerusalem, Israel.	shimon.schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	Rosetrees Trust [A1004]; Israel Science Foundation [143/16]	Rosetrees Trust(Rosetrees Trust); Israel Science Foundation(Israel Science Foundation)	This research was funded by Grant A1004 from the Rosetrees Trust to SS and Grant 143/16 from the Israel Science Foundation to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; COHEN SP, 1993, J BACTERIOL, V175, P1484, DOI 10.1128/JB.175.5.1484-1492.1993; Costa Sofia Santos, 2013, Open Microbiol J, V7, P59, DOI 10.2174/1874285801307010059; Costa SS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-241; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Du DJ, 2018, NAT REV MICROBIOL, V16, P523, DOI 10.1038/s41579-018-0048-6; Du DJ, 2015, CURR OPIN STRUC BIOL, V33, P76, DOI 10.1016/j.sbi.2015.07.015; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Farha MA, 2013, NAT BIOTECHNOL, V31, P120, DOI 10.1038/nbt.2500; Fluman N, 2009, BBA-PROTEINS PROTEOM, V1794, P738, DOI 10.1016/j.bbapap.2008.11.020; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Holdsworth SR, 2012, BIOCHIMIE, V94, P1334, DOI 10.1016/j.biochi.2012.03.001; Jellen-Ritter AS, 2001, ANTIMICROB AGENTS CH, V45, P1467, DOI 10.1128/AAC.45.5.1467-1472.2001; Kinana AD, 2013, BIOCHEMISTRY-US, V52, P8342, DOI 10.1021/bi401303v; Kobayashi K, 2001, J BACTERIOL, V183, P2646, DOI 10.1128/JB.183.8.2646-2653.2001; Lee A, 2000, J BACTERIOL, V182, P3142, DOI 10.1128/JB.182.11.3142-3150.2000; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Ma Dzwokai, 1994, Trends in Microbiology, V2, P489, DOI 10.1016/0966-842X(94)90654-8; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; Masi M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.1; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Nishino K, 2004, J BACTERIOL, V186, P1423, DOI 10.1128/JB.186.5.1423-1429.2004; Olliver A, 2005, ANTIMICROB AGENTS CH, V49, P289, DOI 10.1128/AAC.49.1.289-301.2005; Opperman TJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00421; Palmer AC, 2013, NAT REV GENET, V14, P243, DOI 10.1038/nrg3351; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuldiner S, 2018, RES MICROBIOL, V169, P357, DOI 10.1016/j.resmic.2018.02.006; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Shuster Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152917; Sugiyama Y, 2016, J BIOL CHEM, V291, P26343, DOI 10.1074/jbc.M116.762450; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; Weston N, 2018, RES MICROBIOL, V169, P425, DOI 10.1016/j.resmic.2017.10.005; Wright GD, 2016, TRENDS MICROBIOL, V24, P862, DOI 10.1016/j.tim.2016.06.009; Yardeni EH, 2018, RES MICROBIOL, V169, P455, DOI 10.1016/j.resmic.2017.09.004; Zhang CZ, 2018, MICROB DRUG RESIST, V24, P120, DOI 10.1089/mdr.2017.0086; Zhang CZ, 2018, MICROB DRUG RESIST, V24, P18, DOI 10.1089/mdr.2016.0207	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218828	10.1371/journal.pone.0218828	http://dx.doi.org/10.1371/journal.pone.0218828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251753	gold, Green Submitted, Green Published			2022-12-26	WOS:000484915000025
J	Kasamatsu, E; Riveros, MIR; Soilan, AM; Ortega, M; Mongelos, P; Paez, M; Castro, A; Cristaldo, C; Baez, FR; Centurion, CC; Vester, J; Barrios, H; Villalba, G; Amarilla, ML; Gimenez, G; Caubere, E; Hernandez, MD; Baena, A; Almonte, M; Herrero, R; Mendoza, LP; Mendoza, LP; Kasamatsu, E; Riveros, MIR; Soilan, AM; Ortega, M; Mongelos, P; Paez, M; Castro, A; Cristaldo, C; Baez, FR; Centurion, CC; Vester, J; Barrios, H; Villalba, G; Amarilla, ML; Gimenez, G				Kasamatsu, Elena; Rodriguez Riveros, Maria Isabel; Maria Soilan, Ana; Ortega, Marina; Mongelos, Pamela; Paez, Malvina; Castro, Amalia; Cristaldo, Carmen; Romina Baez, Fatima; Carolina Centurion, Claudia; Vester, Jaime; Barrios, Hernan; Villalba, Griselda; Luisa Amarilla, Maria; Gimenez, Graciela; Caubere, Elodie; Hernandez, Maria de la Luz; Baena, Armando; Almonte, Maribel; Herrero, Rolando; Patricia Mendoza, Laura; Patricia Mendoza, Laura; Kasamatsu, Elena; Rodriguez Riveros, Maria Isabel; Maria Soilan, Ana; Ortega, Marina; Mongelos, Pamela; Paez, Malvina; Castro, Amalia; Cristaldo, Carmen; Romina Baez, Fatima; Carolina Centurion, Claudia; Vester, Jaime; Barrios, Hernan; Villalba, Griselda; Luisa Amarilla, Maria; Gimenez, Graciela		ESTAMPA Paraguay Ctr Study Grp	Factors associated with high-risk human papillomavirus infection and high-grade cervical neoplasia: A population-based study in Paraguay	PLOS ONE			English	Article							LATIN-AMERICA; HPV INFECTION; CANCER PREVENTION; POOLED ANALYSIS; WOMEN; PREVALENCE; COFACTORS; DNA; DETERMINANTS; CYTOLOGY	Background Cervical cancer (CC) is one of the leading causes of cancer mortality among women from Paraguay, with high incidence and mortality rates (31.2 and 16 per 100 000 women, respectively). Although the risk factors associated with high-risk human papillomavirus (hrHPV) infection and preneoplastic cervical lesions are widely studied, population-based characteristics of particular settings may influence the feasibility of HPV-based CC screening implementation. This study aimed to explore factors associated with hrHPV infection and high-grade cervical neoplasia in hrHPV-positive (hrHPV+) women from Paraguay. Methods A total of 5677 women aged 30-64 years from the Central Department of Paraguay were screened with HPV test (Hybrid Capture 2) and Pap smear. Sociodemographic and risk factor interviews were conducted. hrHPV+ women were referred to colposcopy and women with an abnormal colposcopy had a biopsy taken. The outcomes recorded were the hrHPV status and the presence of high-grade cervical intraepithelial neoplasia or worse (CIN2+) among hrHPV+ women. Associations were investigated using multivariate logistic regressions. Results hrHPV prevalence was 13.8% (95% CI 13.0-14.8). This value decreased with the age of women (p-trend<0.001) and increased with the lifetime number of sexual partners (p-trend<0.001) and number of previous female partners of their current male partner if women had had one lifetime sexual partner (p-trend<0.001), increasing from 3.06 (95% CI 0.073-20.9) if partners had had one previous female partner to 9.19 (95% CI 2.36-61.1) if they had had eight or more. In hrHPV+ women, CIN2+ prevalence was 10.7% (95% CI 8.58-13.2) and increased with time since the last Pap smear (p-trend<0.001) and with the increasing number of pregnancies (p-trend = 0.05). Conclusion In these settings, the sexual behavior of women and their male partners is associated with hrHPV infection. In hrHPV+ women, underscreening practices and multiple pregnancies are associated with CIN2+. This knowledge can contribute to public health policies for CC prevention and control in Paraguay.	[Kasamatsu, Elena; Rodriguez Riveros, Maria Isabel; Mongelos, Pamela; Paez, Malvina; Castro, Amalia; Romina Baez, Fatima; Carolina Centurion, Claudia; Vester, Jaime; Barrios, Hernan; Gimenez, Graciela; Patricia Mendoza, Laura] UNA, IICS, San Lorenzo, Paraguay; [Maria Soilan, Ana; Villalba, Griselda] Minist Salud Publ & Bienestar Social, Hosp Materno Infantil San Lorenzo, San Lorenzo, Paraguay; [Ortega, Marina; Cristaldo, Carmen; Luisa Amarilla, Maria] Minist Salud Publ & Bienestar Social, Hosp Nacl, Itaugua, Paraguay; [Caubere, Elodie; Hernandez, Maria de la Luz; Baena, Armando; Almonte, Maribel; Herrero, Rolando] WHO, IARC, Lyon, France	Research Institute for Health Sciences (IICS); Universidad Nacional de Asuncion; Ministerio de Salud Publica y Bienstar Social; Ministerio de Salud Publica y Bienstar Social; World Health Organization; International Agency for Research on Cancer (IARC)	Mendoza, LP (corresponding author), UNA, IICS, San Lorenzo, Paraguay.	lauramendozatorres@gmail.com	Vester, Jaime/AAE-2860-2021; Rodriguez-Riveros, Maria Isabel/GQZ-3581-2022; Baena, Armando/GQA-7070-2022; Baena, Armando/GRR-9813-2022; Almonte, Maribel/O-3286-2016; Baena, Armando/AAH-9991-2021	Baena, Armando/0000-0001-8717-6911; Baena, Armando/0000-0001-8717-6911; Mendoza Torres, Laura Patricia/0000-0001-6124-1244; RODRIGUEZ-RIVEROS, MARIA ISABEL/0000-0002-7692-8628; Vester, Jaime/0000-0002-9617-6283	National Council for Science and Technology, Asuncion, Paraguay [CONACYT-14-INV-036]; International Agency for Research on Cancer (IARC); Ministry of Health and Science of Paraguay (Hospital Nacional de Itaugua); Ministry of Health and Science of Paraguay (Hospital Materno Infantil de San Lorenzo); Ministry of Health and Science of Paraguay (Primary Health Care Units); Instituto de Investigaciones en Ciencias de la Salud	National Council for Science and Technology, Asuncion, Paraguay; International Agency for Research on Cancer (IARC)(World Health Organization); Ministry of Health and Science of Paraguay (Hospital Nacional de Itaugua); Ministry of Health and Science of Paraguay (Hospital Materno Infantil de San Lorenzo); Ministry of Health and Science of Paraguay (Primary Health Care Units); Instituto de Investigaciones en Ciencias de la Salud	This work was funded by the National Council for Science and Technology (CONACYT-14-INV-036), Asuncion, Paraguay, received by Elena Kasamatsu, Laura Mendoza, IICS, UNA, and QIAGEN (Collaboration Agreement received by IICS, UNA). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; The authors thank the International Agency for Research on Cancer (IARC), the Ministry of Health and Science of Paraguay (Hospital Nacional de Itaugua, Hospital Materno Infantil de San Lorenzo and Primary Health Care Units), and Instituto de Investigaciones en Ciencias de la Salud for all their support.	Almonte M, 2008, VACCINE, V26, pL16, DOI 10.1016/j.vaccine.2008.06.008; Almonte M, 2011, INT J GYNECOL CANCER, V21, P1654, DOI 10.1097/IGC.0b013e3182288104; Almonte M, 2010, SALUD PUBLICA MEXICO, V52, P544, DOI 10.1590/S0036-36342010000600010; [Anonymous], 2013, WHO GUIDELINES SCREE; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle PE, 2012, VACCINE, V30, pF117, DOI 10.1016/j.vaccine.2012.05.071; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DGEEC, PROYECC POBL SEX ED, P452; Ferreccio C, 2004, CANCER EPIDEM BIOMAR, V13, P2271; Franceschi S, 2009, BRIT J CANCER, V101, P865, DOI 10.1038/sj.bjc.6605224; Ginindza TG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170189; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 2001, BRIT J CANCER, V84, P1219, DOI 10.1054/bjoc.2001.1779; Kasamatsu E, 2012, J MED VIROL, V84, P1628, DOI 10.1002/jmv.23373; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Lazcano-Ponce E, 2001, INT J CANCER, V91, P412, DOI 10.1002/1097-0215(20010201)91:3&lt;412::AID-IJC1071&gt;3.0.CO;2-M; Lazcano-Ponce E, 2010, CANCER CAUSE CONTROL, V21, P1693, DOI 10.1007/s10552-010-9598-2; Mendoza LP, 2011, J MED VIROL, V83, P1351, DOI 10.1002/jmv.22112; Mendoza L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-531; Ministerio de Salud Publica y Bienestar Social Paraguay. OPS/OMS, 2010, MAN NAC NORM PROC PR; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2008, VACCINE, V26, pL96, DOI 10.1016/j.vaccine.2008.05.062; Murillo R, 2008, VACCINE, V26, pL37, DOI 10.1016/j.vaccine.2008.06.013; Muwonge R, 2016, CANCER CAUSE CONTROL, V27, P1437, DOI 10.1007/s10552-016-0823-5; Ortiz AP, 2016, PAPILLOMAVIRUS RES, V2, P89, DOI 10.1016/j.pvr.2016.04.002; Páez B Malvina, 2016, Rev. Univ. Ind. Santander. Salud, V48, P37, DOI 10.18273/revsal.v48n1-2016004; Rolon PA, 2000, INT J CANCER, V85, P486, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;486::AID-IJC7&gt;3.0.CO;2-S; Rositch AF, 2013, INT J CANCER, V133, P1271, DOI 10.1002/ijc.27828; Roura E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147029; Roura E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-145; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P326, DOI 10.1158/1055-9965.EPI-05-0577; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P2148, DOI 10.1158/1055-9965.EPI-06-0556; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218016	10.1371/journal.pone.0218016	http://dx.doi.org/10.1371/journal.pone.0218016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246959	gold, Green Published, Green Submitted			2022-12-26	WOS:000484911900010
J	Sunguti, JL; Tiam, A; Masaba, R; Waweru, M; Kose, J; Odionyi, J; Matu, L; Mwangi, E				Sunguti, Joram Luke; Tiam, Appolinaire; Masaba, Rose; Waweru, Michael; Kose, Judith; Odionyi, Justine; Matu, Lucy; Mwangi, Eliud			Assessing treatment outcomes among peer educators living with HIV in Kenya	PLOS ONE			English	Article							PATIENT NAVIGATION; CARE	Background People living with HIV (PLHIV) often face barriers in accessing quality and comprehensive HIV care, including stigma and discrimination, which results in poor retention and viral non-suppression. Peer-led interventions can help address these barriers. In Kenya, peer educators (PEs) are PLHIV who support other PLHIV to adhere to clinic schedules and antiretroviral medication uptake. In spite of their status as role models and their key role in supporting clients receiving HIV care and treatment, little is known about the characteristics and treatment outcomes of PEs themselves, specifically viral suppression. Methods This is a retrospective descriptive analysis of program data on treatment outcomes of PEs engaged in active patient support activities between October 2010 and January 2017. All eligible PEs from 140 health facilities located in 23 counties of Kenya were included in the study. Data from 230 PEs were abstracted from the electronic medical records, patient files, and registers between June and August 2017. Study variables included key sociodemographic characteristics (sex, marital status, and age), duration on antiretroviral therapy (ART), WHO clinical staging, baseline CD4 count, current antiretroviral regimen and uptake of isoniazid preventive therapy (IPT). The outcome variable was viral suppression, defined as a viral load <1000 copies/ml. Results Overall, 173/230 (75%) of the PEs were female, 144/230 (63%) were married, and median age (LQ, UQ) was 38.5 (33.0, 42.0) years. The PEs had been on ART for a median (LQ, UQ) duration of 76.0 (37.0, 105.0) months. Six months IPT completion was high at 97%. Of the 222 (97%) PEs with an up-to-date viral load taken within the last one year, 211 (95%) were virally suppressed. Conclusion Our study showed that peer educators actively engaged in patient support activities have achieved high viral suppression rates.	[Sunguti, Joram Luke; Masaba, Rose; Waweru, Michael; Odionyi, Justine; Matu, Lucy; Mwangi, Eliud] Elizabeth Glaser Pediat AIDS Fdn, Nairobi, Kenya; [Tiam, Appolinaire; Kose, Judith] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA		Sunguti, JL (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Nairobi, Kenya.	jsunguti82@gmail.com			President's Emergency Plan for AIDS Relief (PEPFAR); Centers for Disease Control (CDC) Kenya [NU2GGH001948-01-00]; Pediatric AIDS Foundation	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Centers for Disease Control (CDC) Kenya; Pediatric AIDS Foundation	This study was made possible by the generous support of the President's Emergency Plan for AIDS Relief (PEPFAR: https://www.pepfar.gov/) and the Centers for Disease Control (CDC: https://www.cdc.gov/) Kenya under Grant #: NU2GGH001948-01-00, awarded to the Elizabeth Glaser Pediatric AIDS Foundation to JSL, AT, RM, MW, JK, JO, LM, EM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayu B, 2017, HIV AIDS-RES PALLIAT, V9, P153, DOI 10.2147/HIV.S139516; Bulage L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2428-3; Campbell SM, 1996, FAM PRACT, V13, P75, DOI 10.1093/fampra/13.1.75; Cherutich P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154318; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0738-8; Enard KR, 2015, CANCER CAUSE CONTROL, V26, P1351, DOI 10.1007/s10552-015-0620-6; Enriquez Maithe, 2015, J Int Assoc Provid AIDS Care, V14, P441, DOI 10.1177/2325957414558301; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; ICAP, 2016, SUMM SHEET PREL FIND; Jain V, 2017, LANCET HIV, V4, pE122, DOI 10.1016/S2352-3018(16)30220-X; Janssen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140746; Karwa R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002355; Kioko MT, 2017, AFR J PRIM HEALTH CA, V9, DOI 10.4102/phcfm.v9i1.1343; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Lasser Karen E, 2013, J Ethn Subst Abuse, V12, P374, DOI 10.1080/15332640.2013.819311; Lazarus L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166942; Maman D, 2015, AIDS, V29, P1557, DOI 10.1097/QAD.0000000000000741; McBrien KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191980; Ministry of Health, 2016, GUIDELINES USE ANTIR; NACC, 2016, KEN AIDS RESP PROGR; National AIDS and STI Control Programme (NASCOP), 2014, KEN AIDS IND SURV 20; Ruria EC, 2017, AIDS, V31, pS253, DOI 10.1097/QAD.0000000000001538; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; Sreedevi A, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1574-x; Thom DH, 2013, ANN FAM MED, V11, P137, DOI 10.1370/afm.1443; Turan B, 2017, AM J PUBLIC HEALTH, V107, P863, DOI 10.2105/AJPH.2017.303744; Venables E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164634	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218774	10.1371/journal.pone.0218774	http://dx.doi.org/10.1371/journal.pone.0218774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3WH	31247036	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900039
J	Monteiro, LJ; Varas-Godoy, M; Monckeberg, M; Realini, O; Hernandez, M; Rice, G; Romero, R; Saavedra, JF; Illanes, SE; Chaparro, A				Monteiro, Lara J.; Varas-Godoy, Manuel; Monckeberg, Max; Realini, Ornella; Hernandez, Marcela; Rice, Gregory; Romero, Roberto; Saavedra, Jose F.; Illanes, Sebastian E.; Chaparro, Alejandra			Oral extracellular vesicles in early pregnancy can identify patients at risk of developing gestational diabetes mellitus	PLOS ONE			English	Article							PLACENTA-DERIVED EXOSOMES; INTERNATIONAL ASSOCIATION; PERIODONTAL-DISEASE; HYPERGLYCEMIA; BIOMARKERS; CLASSIFICATION; CIRCULATION; DIAGNOSIS; GLUCOSE	Aim To isolate and characterize oral extracellular vesicles from gingival crevicular fluid at 11-14 weeks and evaluate their capacity to identify patients at risk of developing gestational diabetes mellitus. Methods A case-control study was conducted, including patients who developed gestational diabetes mellitus (n = 11) and healthy pregnant controls (n = 23). Obstetric and periodontal histories were recorded at 11-14 weeks of gestation, and samples of gingival crevicular fluid obtained. Extracellular vesicles were isolated from gingival crevicular fluid by ExoQuick. Nanoparticle tracking analysis, ELISA and transmission electron microscopy were used to characterize extracellular vesicles. Results Total extracellular vesicles isolated from gingival crevicular fluid were significantly higher in patients who developed gestational diabetes mellitus later in pregnancy compared to normoglycemic pregnant women (6.3x10(9) vs 1.7 x10(10), p value = 0.0026), and the concentration of the extracellular vesicles delivered an area under the ROC curve of 0.81. The distribution size of extracellular vesicles obtained using ExoQuick was around 148 +/- 57 nm. There were no significant differences in the periodontal status between cases and controls. The exosome transmembrane protein CD63 was also detected in the extracellular vesicles of gingival crevicular fluid. Conclusion We were able to isolate extracellular vesicles from gingival crevicular fluid using a method that is suitable to be applied in a clinical setting. Our results provide an insight into the potential capacity of first trimester oral extracellular vesicles as early biomarkers for the prediction of gestational diabetes mellitus in pre-symptomatic women.	[Monteiro, Lara J.; Varas-Godoy, Manuel; Monckeberg, Max; Rice, Gregory; Illanes, Sebastian E.] Univ Los Andes, Fac Med, Ctr Biomed Res, Dept Obstet & Gynecol, Santiago, Chile; [Realini, Ornella; Chaparro, Alejandra] Univ Los Andes, Fac Dent, Ctr Biomed Res, Dept Periodontol, Santiago, Chile; [Hernandez, Marcela] Univ Chile, Fac Dent, Dept Pathol, Santiago, Chile; [Hernandez, Marcela] Univ Autonoma Chile, Fac Hlth Sci, Dent Unit, Santiago, Chile; [Rice, Gregory] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia; [Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res,NIH, Bethesda, MD USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Saavedra, Jose F.] Hlth Family Ctr CESFAM Karol Wojtyla, Santiago, Chile	Universidad de los Andes - Chile; Universidad de los Andes - Chile; Universidad de Chile; Universidad Autonoma de Chile; University of Queensland; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Michigan System; University of Michigan; Michigan State University; Wayne State University	Illanes, SE (corresponding author), Univ Los Andes, Fac Med, Ctr Biomed Res, Dept Obstet & Gynecol, Santiago, Chile.; Chaparro, A (corresponding author), Univ Los Andes, Fac Dent, Ctr Biomed Res, Dept Periodontol, Santiago, Chile.	sillanes@uandes.cl; chaparro.ale@gmail.com	Hernández, Marcela/I-3266-2013; Monteiro, Lara J/AAU-8518-2020; RICE, GREGORY/F-2412-2010; Romero, Roberto/A-5268-2019	Hernández, Marcela/0000-0001-8289-7314; RICE, GREGORY/0000-0001-7177-0246; Chaparro, Alejandra/0000-0003-0791-7746; Illanes, Sebastian/0000-0001-5433-9315; Varas-Godoy, Manuel/0000-0001-5857-4793; Romero, Roberto/0000-0002-4448-5121	FONDEF [ID16I10452]; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); NICHD, NIH [HSN275201300006C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002401] Funding Source: NIH RePORTER	FONDEF; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	AC and SEI were supported by FONDEF IDeA [ID16I10452] (https://www.conicyt.cl/fondef/) RR was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH) (https://www.nichd.nih.gov/); and, in part, with Federal funds from NICHD, NIH under Contract No. HSN275201300006C (https://www.nichd.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal MM, 2010, DIABETES CARE, V33, P2018, DOI 10.2337/dc10-0572; Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Ashwal E, 2015, CLIN CHIM ACTA, V451, P14, DOI 10.1016/j.cca.2015.01.021; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x; Barros SP, 2016, PERIODONTOL 2000, V70, P53, DOI 10.1111/prd.12107; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chaparro A, 2013, J PERIODONTAL RES, V48, P302, DOI 10.1111/jre.12008; Chaparro A, 2018, J PERIODONTOL, V89, P1052, DOI 10.1002/JPER.17-0497; Chaparro A, 2016, PRENATAL DIAG, V36, P476, DOI 10.1002/pd.4811; Chokwiriyachit A, 2013, J PERIODONTOL, V84, P857, DOI 10.1902/jop.2012.120344; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Delima AJ, 2003, PERIODONTOL 2000, V31, P55, DOI 10.1034/j.1600-0757.2003.03105.x; Ghiran I, 2010, J APPL ORAL SCI, V18; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P176, DOI 10.1016/j.diabres.2013.11.003; Helal O, 2011, NUTR METAB CARDIOVAS, V21, P665, DOI 10.1016/j.numecd.2010.01.004; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; Katsuda T, 2014, PROTEOMICS, V14, P412, DOI 10.1002/pmic.201300389; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Mitchell MD, 2015, AM J OBSTET GYNECOL, V213, pS173, DOI 10.1016/j.ajog.2015.07.001; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Revenfeld ALS, 2014, CLIN THER, V36, P830, DOI 10.1016/j.clinthera.2014.05.008; Rice MM, 2016, SEMIN PERINATOL, V40, P298, DOI 10.1053/j.semperi.2016.03.006; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Saenz-Cuesta M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00050; Salomon C, 2016, DIABETES, V65, P598, DOI 10.2337/db15-0966; Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; de Aguiar MCS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3257235; Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245; Surapaneni T, 2013, OBSTET MED, V6, P125, DOI 10.1177/1753495X13482895; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Varner MW, 2017, OBSTET GYNECOL, V129, P273, DOI 10.1097/AOG.0000000000001863; Wen X, 2018, EUR J ORTHODONT, V40, P414, DOI 10.1093/ejo/cjx082; Winkler G, 2002, DIABETES RES CLIN PR, V56, P93, DOI 10.1016/S0168-8227(01)00355-2; Wolf M, 2003, DIABETES CARE, V26, P819, DOI 10.2337/diacare.26.3.819; Xiong X, 2006, AM J OBSTET GYNECOL, V195, P1086, DOI 10.1016/j.ajog.2006.06.035; Xiong X, 2009, J PERIODONTOL, V80, P1742, DOI 10.1902/jop.2009.090250; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yuana Y, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29260; Zhu WW, 2013, DIABETES CARE, V36, P2038, DOI 10.2337/dc12-2465	46	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218616	10.1371/journal.pone.0218616	http://dx.doi.org/10.1371/journal.pone.0218616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242249	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600039
J	Peng, CH; Lee, HC; Jiang, CB; Hsu, CK; Yeung, CY; Chan, WT; Chang, SW; Weng, SC				Peng, Chia-Huei; Lee, Hung-Chang; Jiang, Chuen-Bin; Hsu, Cheng-Kai; Yeung, Chun-Yan; Chan, Wai-Tao; Chang, Szu-Wen; Weng, Shu-Chao			Serum vitamin D level is inversely associated with liver fibrosis in post Kasai's portoenterostomy biliary atresia patients living with native liver	PLOS ONE			English	Article							D DEFICIENCY; LONG-TERM; CHILDREN; INFANTS; PREVENTION; TAIWAN	Objective This study aims to investigate the association of serum vitamin D (VD) levels with the severity of liver fibrosis (LF) in post Kasai's portoenterostomy biliary atresia (PKBA) patients living with their native liver. Methods In this cross-sectional study, carried out in a tertiary Children's Hospital in Taipei, Taiwan, PKBA patients living with their native liver were enrolled. Liver biochemistry data, serum 25-hydroxyvitamin D (25-OHVD), acoustic radiation force impulse (ARFI), and scores of Pediatric Quality of Life questionnaire (PedsQL) were collected. Results All the enrolled 33 PKBA patients (36.4% males), aged 1-23 years, possessed 25-OHVD less than 30ng/ml. An inverse correlation was detected between serum 25-OHVD and ARFI (r(2) = 0.175; p = 0.024). We selected a cutoff value of 23ng/mL to divide PKBA patients into two groups, as the p-value was the most significant at this point when comparing the median ARFI of two groups (p = 0.003). Ten (30.3%) had 25-OHVD >= 23ng/ml (HVD group), whereas 23(69.7%) had 25-OHVD<23ng/ml (LVD group). HVD group had lower ARFI (1.13m/s vs. 1.52m/s, p = 0.003), lower aspartate transaminase (AST) (29U/L vs. 64U/L, p = 0.033), and higher scores of self-reported health-related quality of life in psychosocial functioning (86.7 vs. 77.1, p = 0.047) than LVD group. Conclusion VD levels are inversely associated with severity of LF in PKBA patients with native liver.	[Peng, Chia-Huei; Lee, Hung-Chang; Jiang, Chuen-Bin; Yeung, Chun-Yan; Chan, Wai-Tao; Chang, Szu-Wen; Weng, Shu-Chao] MacKay Childrens Hosp, Dept Pediat Gastroenterol Hepatol & Nutr, Taipei, Taiwan; [Hsu, Cheng-Kai] Chang Gung Mem Hosp, Dept Nephrol, Keelung, Taiwan	Chang Gung Memorial Hospital	Lee, HC (corresponding author), MacKay Childrens Hosp, Dept Pediat Gastroenterol Hepatol & Nutr, Taipei, Taiwan.	8231boss@gmail.com		Peng, Chia-Huei/0000-0001-7424-1462; Hsu, Cheng-Kai/0000-0002-6812-526X				Adela R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37593; Altamirano-Barrera A, 2017, ANN HEPATOL, V16, P48, DOI 10.5604/16652681.1226814; Ashour AS, 2018, HEALTH INF SCI SYST, V6, DOI 10.1007/s13755-018-0059-8; Bijl EJ, 2013, NETH J MED, V71, P170; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Ding N, 2013, EXPERT REV CLIN PHAR, V6, P597, DOI 10.1586/17512433.2013.841078; Dong R, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/7496860; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Houghton LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104825; Jensen M, 2015, J PEDIATR GASTR NUTR, V61, P187, DOI 10.1097/MPG.0000000000000751; Kasahara M, 2017, PEDIATR SURG INT, V33, P1289, DOI 10.1007/s00383-017-4173-5; Kongsbak M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00148; Konstantakis C, 2016, ANN GASTROENTEROL, V29, P297, DOI 10.20524/aog.2016.0037; Lee WS, 2019, PEDIATR NEONATOL, V60, P12, DOI 10.1016/j.pedneo.2018.03.011; Lee WS, 2017, WORLD J GASTROENTERO, V23, P7776, DOI 10.3748/wjg.v23.i43.7776; Lien TH, 2011, HEPATOLOGY, V53, P202, DOI 10.1002/hep.24023; Lin YC, 2011, PEDIATRICS, V128, pE530, DOI 10.1542/peds.2011-0742; Malham M, 2011, WORLD J GASTROENTERO, V17, P922, DOI 10.3748/wjg.v17.i7.922; Munns CF, 2016, HORM RES PAEDIAT, V85, P83, DOI [10.1159/000443136, 10.1210/jc.2015-2175]; Ng J, 2016, J PEDIATR GASTR NUTR, V62, P746, DOI 10.1097/MPG.0000000000001074; Ng VL, 2014, J PEDIATR-US, V165, P539, DOI 10.1016/j.jpeds.2014.05.038; Nobili V, 2014, EUR J ENDOCRINOL, V170, P547, DOI 10.1530/EJE-13-0609; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Shneider BL, 2012, PEDIATRICS, V130, pE607, DOI 10.1542/peds.2011-1423; Shu-Chi M, 2006, EARLY HUM DEV, V82, P677, DOI 10.1016/j.earlhumdev.2006.01.012; Tiao MM, 2008, J GASTROEN HEPATOL, V23, P62, DOI 10.1111/j.1440-1746.2007.05114.x	26	5	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218896	10.1371/journal.pone.0218896	http://dx.doi.org/10.1371/journal.pone.0218896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242241	gold, Green Published, Green Submitted			2022-12-26	WOS:000482883600063
J	Williams, M; Contet, A; Hou, CFD; Levashina, EA; Baxter, RHG				Williams, Marni; Contet, Alicia; Hou, Chun-Feng David; Levashina, Elena A.; Baxter, Richard H. G.			Anopheles gambiae TEP1 forms a complex with the coiled-coil domain of LRIM1/APL1C following a conformational change in the thioester domain	PLOS ONE			English	Article							RESISTANCE	The complement-like protein thioester-containing protein 1 (TEP1) is a key factor in the immune response of the malaria vector Anopheles gambiae to pathogens. Multiple allelic variants of TEP1 have been identified in laboratory strains and in the field, and are correlated with distinct immunophenotypes. TEP1 is tightly regulated by conformational changes induced by cleavage in a protease-sensitive region. Cleaved TEP1 forms exhibit significant variation in stability from hours to days at room temperature. In particular, the refractory allele TEP1*R1 is significantly more stable than the susceptible allele TEP1*S1. This raises the question of whether the stability of cleaved TEP1 is linked to allelic variation and varying immunophenotypes. We have analyzed the stability of the cleaved form of additional TEP1 alleles and constructs. We show that stability is correlated with allelic variation within two specific loops in direct proximity to the thioester bond. The variable loops are part of an interface between the TED and MG8 domains of TEP1 that protect the thioester from hydrolysis. Engineering specific disulfide bonds to prevent separation of the TED-MG8 interface stabilizes the cleaved form of TEP1 for months at room temperature. Cleaved TEP1 forms a soluble complex with a heterodimer of two leucine-rich repeat proteins, LRIM1 and APL1C, and precipitates in the absence of this complex. The molecular structure and oligomeric state of the TEP1/LRIM1/APL1C complex is unclear. The C-terminal coiled-coil domain of the LRIM1/APL1C complex is sufficient to stabilize the cleaved form of TEP1 in solution but cleaved forms of disulfide-stabilized TEP1 do not interact with LRIM1/APL1C. This implies that formation of the TEP1cut/LRIM1/APL1C complex is related to the conformational change that induces the precipitation of cleaved TEP1.	[Williams, Marni; Contet, Alicia; Baxter, Richard H. G.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Williams, Marni; Contet, Alicia; Baxter, Richard H. G.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hou, Chun-Feng David; Baxter, Richard H. G.] Temple Univ, Dept Med Genet & Mol Biochem, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Levashina, Elena A.] Max Planck Inst Infect Biol, Vector Biol Unit, Berlin, Germany; [Williams, Marni] Shift Hlth, Toronto, ON, Canada; [Contet, Alicia] Ctr Immunol Pierre Fabre, St Julien En Genevois, France	Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Max Planck Society; Centre d'Immunologie Pierre Fabre	Baxter, RHG (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.; Baxter, RHG (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Baxter, RHG (corresponding author), Temple Univ, Dept Med Genet & Mol Biochem, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.	rbaxter@temple.edu	Baxter, Richard/F-3027-2013	Baxter, Richard/0000-0001-5140-1726; HOU, CHUN-FENG D./0000-0002-1820-9588; Contet, Alicia/0000-0003-0829-0316	National Institute of General Medical Sciences [1R01GM114358]; National Institutes of Health; Yale University; Lewis Katz School of Medicine at Temple University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114358] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; Lewis Katz School of Medicine at Temple University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institute of General Medical Sciences (1R01GM114358) of the National Institutes of Health to RHGB. This work was also supported by internal funding from Yale University and internal funding from the Lewis Katz School of Medicine at Temple University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2009, SPRINGER PROTOC HAND, P1053, DOI 10.1007/978-1-59745-198-7_114; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; DAVIDSON G, 1964, B WORLD HEALTH ORGAN, V31, P625; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Le BV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002958; Levashina EA., 2018, COMPLEMENT ACTIVATIO, P139; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; White BJ, 2011, P NATL ACAD SCI USA, V108, P244, DOI 10.1073/pnas.1013648108; Williams Marni, 2014, Biophysical Reviews, V6, P261, DOI 10.1007/s12551-014-0142-6; Williams MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118817	18	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218203	10.1371/journal.pone.0218203	http://dx.doi.org/10.1371/journal.pone.0218203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237887	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000016
J	Espa, P; Batalla, RJ; Brignoli, ML; Crosa, G; Gentili, G; Quadroni, S				Espa, Paolo; Batalla, Ramon J.; Brignoli, Maria Laura; Crosa, Giuseppe; Gentili, Gaetano; Quadroni, Silvia			Tackling reservoir siltation by controlled sediment flushing: Impact on downstream fauna and related management issues	PLOS ONE			English	Article							SMALL ALPINE RESERVOIR; FINE SEDIMENT; MACROINVERTEBRATE COMMUNITIES; STREAM INVERTEBRATES; FISH; HYDROPOWER; RIVER; TRANSPORT; REMOVAL; FIELD	Sediment flushing can tackle reservoirs siltation and improve sediment flux through dammed rivers. However, the increase of the sediment loading below the dam can trigger a suite of undesired ecological effects in the downstream river reaches. To limit these drawbacks, sediment flushing can be controlled, by jointly regulating the sediment concentration of the evacuated water and the streamflow in the downstream channel. In this paper, we report on ten controlled sediment flushing operations (CSFOs), carried out between 2006 and 2012 in the central Italian Alps, at four hydropower reservoirs. These CSFOs displayed specific common traits: (i) Limits were set by the local environmental authorities concerning the allowable suspended sediment concentration. (ii) Reservoirs were fully drawn-down, earth-moving equipment was used to dislodge sediment, and the downstream water discharge was increased, compared to baseflow, by operating upstream intakes. (iii) Abiotic and biotic measurements in selected downstream reaches (before, during, and after the CSFOs) represented an integral part of the operations. In contrast, significant differences characterize the hydropower facilities (elevation and storage of reservoirs, in particular) as well as the basic CSFOs parameters (i.e., season, duration, mass and grain-size of the evacuated sediment, suspended sediment concentration). The macroinvertebrate assemblages resulted noticeably impacted by the CSFOs. In the short term, a significant density drop was observed, slightly influenced by the extent of the perturbation. In contrast, the latter appeared to control the assemblages contraction in terms of richness, according to the different sensitivity to sediment stress of the different taxa. The time employed to recover pre-CSFO standard ranged from few months to just under one year, and the related patterns would seem mostly correlated to the flushing season and to further site specificities. The density of trout populations was impacted as well, thus suggesting the adoption of mitigating strategies as removal by electrofishing before, and repopulation after the CSFO.	[Espa, Paolo; Quadroni, Silvia] Univ Insubria, Dept Sci & High Technol, Varese, Italy; [Batalla, Ramon J.] Univ Lleida, Fluvial Dynam Res Grp RIUS, Lleida, Catalonia, Spain; [Batalla, Ramon J.] ICRA, Catalan Inst Water Res, Girona, Catalonia, Spain; [Batalla, Ramon J.] Univ Austral Chile, Fac Forest Sci & Nat Resources, Valdivia, Chile; [Brignoli, Maria Laura] Pavia Acque Scarl, Pavia, Italy; [Crosa, Giuseppe] Univ Insubria, Dept Theoret & Appl Sci, Varese, Italy; [Gentili, Gaetano] Graia Srl, Varano Borghi, Italy	University of Insubria; Universitat de Lleida; Institut Catala de Recerca de l'Aigua (ICRA); Universidad Austral de Chile; University of Insubria	Crosa, G (corresponding author), Univ Insubria, Dept Theoret & Appl Sci, Varese, Italy.	giuseppe.crosa@uninsubria.it	Batalla, Ramon J./L-5572-2014; Quadroni, Silvia/T-1972-2019	Batalla, Ramon J./0000-0001-8454-2314; Quadroni, Silvia/0000-0003-1295-2108	INTERREG Italy/Switzerland project ECOIDRO (Water Use and Safeguard of Environment and Biodiversity in the River Basins of Adda, Mera, Poschiavino and Inn) [7630754]; University of Insubria; Economy and Knowledge Department of the Catalan Government through the Consolidated Research Group Fluvial Dynamics Research Group - RIUS; CERCA Program	INTERREG Italy/Switzerland project ECOIDRO (Water Use and Safeguard of Environment and Biodiversity in the River Basins of Adda, Mera, Poschiavino and Inn); University of Insubria; Economy and Knowledge Department of the Catalan Government through the Consolidated Research Group Fluvial Dynamics Research Group - RIUS; CERCA Program	Most of the field sampling presented in this study was financed by the INTERREG Italy/Switzerland project ECOIDRO (Water Use and Safeguard of Environment and Biodiversity in the River Basins of Adda, Mera, Poschiavino and Inn ID 7630754). University of Insubria financed a PhD position (MLB) and a post-doc project (SQ) concerning CSFOs. This work was also supported from the Economy and Knowledge Department of the Catalan Government through the Consolidated Research Group Fluvial Dynamics Research Group - RIUS (2017 SGR 459), and within the CERCA Program. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge two commercial affiliations, Graia S.r.l. and Pavia Acque S.c.a.r.l. The first one (Graia S.r.l.) was involved as sub-contractor by the University of Insubria in the INTERREG project ECOIDRO, and thus had a role in the study design, and data collection and analysis (see specific roles of GG articulated in the 'author contributions' section). Pavia Acque S.c.a.r.l. had no any role in all the phases of this work; in fact, it is the current affiliation of MLB, but all her work for this study (see specific roles of MLB articulated in the 'author contributions' section) was carried out before and during her PhD at the University of Insubria.	Annandale G.W., 2016, EXTENDING LIFE RESER; Atkinson E, 1996, OD137 HR WALL; Baoligao B, 2016, J HYDRO-ENVIRON RES, V13, P26, DOI 10.1016/j.jher.2015.11.003; Bejar M, 2017, RIVER RES APPL, V33, P1655, DOI 10.1002/rra.3146; Bilotta GS, 2008, WATER RES, V42, P2849, DOI 10.1016/j.watres.2008.03.018; Brignoli ML, 2017, J SOIL SEDIMENT, V17, P2187, DOI 10.1007/s11368-017-1661-0; Buermann Y., 1995, Koedoe, V38, P11; Bunte K., 2001, SAMPLING SURFACE SUB; Carlson PE, 2018, J APPL ECOL, V55, P1896, DOI 10.1111/1365-2664.13102; Cattaneo F, 2018, I S RIVERS 2018; Chamoun S, 2017, J ENVIRON MANAGE, V204, P519, DOI 10.1016/j.jenvman.2017.09.030; Chapman JM, 2014, WATER RES, V56, P190, DOI 10.1016/j.watres.2014.02.047; Cohen M., 1989, HOUILLE BLANCHE, P301; Crosa G, 2010, AQUAT SCI, V72, P85, DOI 10.1007/s00027-009-0117-z; DOEG TJ, 1994, REGUL RIVER, V9, P263, DOI 10.1002/rrr.3450090407; Doretto A, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7232-7; Doretto A, 2018, ECOL INDIC, V84, P60, DOI 10.1016/j.ecolind.2017.08.041; Espa P, 2015, RIVER RES APPL, V31, P931, DOI 10.1002/rra.2788; Espa P, 2016, J ENVIRON MANAGE, V182, P1, DOI 10.1016/j.jenvman.2016.07.021; Espa P, 2013, ENVIRON MANAGE, V52, P261, DOI 10.1007/s00267-013-0090-0; European Environment Agency, 2010, EROS RAT ALPS; Foley MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180107; Gabbud C, 2019, SCI TOTAL ENVIRON, V650, P2164, DOI 10.1016/j.scitotenv.2018.09.180; Gabbud C, 2016, WIRES WATER, V3, P41, DOI 10.1002/wat2.1124; Gallerano F, 2011, J HYDRAUL ENG, V137, P1111, DOI 10.1061/(ASCE)HY.1943-7900.0000419; GARRIC J, 1990, WATER RES, V24, P59, DOI 10.1016/0043-1354(90)90065-E; George MW, 2017, J WATER RES PLAN MAN, V143, DOI 10.1061/(ASCE)WR.1943-5452.0000720; Gobiet A, 2014, SCI TOTAL ENVIRON, V493, P1138, DOI 10.1016/j.scitotenv.2013.07.050; Graf WL, 2006, GEOMORPHOLOGY, V79, P336, DOI 10.1016/j.geomorph.2006.06.022; Graf WL, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008836; GRAY LJ, 1982, HYDROBIOLOGIA, V96, P177, DOI 10.1007/BF02185433; Grimardias D, 2017, J ENVIRON MANAGE, V197, P239, DOI 10.1016/j.jenvman.2017.03.096; Guertault L, 2018, EARTH SURF PROC LAND, V43, P373, DOI 10.1002/esp.4249; Guertault L, 2016, J HYDRAUL ENG, V142, DOI 10.1061/(ASCE)HY.1943-7900.0001157; Hauer C, 2018, RENEW SUST ENERG REV, V98, P40, DOI 10.1016/j.rser.2018.08.031; Hesse L.W., 1982, North American Journal of Fisheries Management, V2, P45, DOI 10.1577/1548-8659(1982)2<45:EOFSHO>2.0.CO;2; Ho M, 2017, WATER RESOUR RES, V53, P982, DOI 10.1002/2016WR019905; Jones JI, 2012, RIVER RES APPL, V28, P1055, DOI 10.1002/rra.1516; Juracek KE, 2015, J AM WATER RESOUR AS, V51, P168, DOI 10.1111/jawr.12238; Kemp P, 2011, HYDROL PROCESS, V25, P1800, DOI 10.1002/hyp.7940; Kondolf GM, 2014, EARTHS FUTURE, V2, P256, DOI 10.1002/2013EF000184; Lai JS, 1996, J HYDRAUL RES, V34, P237, DOI 10.1080/00221689609498499; Lane SN, 2017, GEOMORPHOLOGY, V277, P210, DOI 10.1016/j.geomorph.2016.02.015; Larsen S, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1361; Martin EJ, 2017, RIVER RES APPL, V33, P925, DOI 10.1002/rra.3145; Mathers KL, 2017, SCI TOTAL ENVIRON, V599, P513, DOI 10.1016/j.scitotenv.2017.04.096; Meile T, 2014, RESERVOIR SEDIMENTAT, P245; Molinos JG, 2011, OECOLOGIA, V166, P795, DOI 10.1007/s00442-011-1923-2; Moridi A, 2017, WATER RESOUR MANAG, V31, P1899, DOI 10.1007/s11269-017-1620-y; Morris G. L., 1997, RESERVOIR SEDIMENTAT; Mustonen KR, 2016, ECOL APPL, V26, P2116, DOI 10.1890/15-1841.1; Newcombe Charles P., 1996, North American Journal of Fisheries Management, V16, P693, DOI 10.1577/1548-8675(1996)016<0693:CSSAFA>2.3.CO;2; Parkyn SM, 2011, ENVIRON MANAGE, V48, P602, DOI 10.1007/s00267-011-9694-4; Permanent Secretariat of the Alpine Convention, 2009, WAT WAT MAN ISS REP; Peteuil C., 2013, INT S RIV SED KYOT, P1147; Platform Water Management in the Alps, 2011, SIT REP HYDR GEN ALP; Quadroni S, 2016, ECOHYDROLOGY, V9, P1276, DOI 10.1002/eco.1725; Quadroni S, 2017, SCI TOTAL ENVIRON, V609, P484, DOI 10.1016/j.scitotenv.2017.07.099; Ramezani J, 2014, FRESHWATER BIOL, V59, P2584, DOI 10.1111/fwb.12456; Reckendorfer W, 2019, ECOL EVOL, P1; Renofalt BM, 2013, RIVER RES APPL, V29, P1082, DOI 10.1002/rra.2592; Schleiss AJ, 2016, J HYDRAUL RES, V54, P595, DOI 10.1080/00221686.2016.1225320; Schmidt JC, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005092; Serrana JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28624-2; Sumi T, 2006, 22 INT C LARG DAMS B, P219; Wagner T, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-016-6318-6; Wang GQ, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003919; Wang HW, 2018, WATER-SUI, V10, DOI 10.3390/w10081034; Warrick JA, 2015, GEOMORPHOLOGY, V246, P729, DOI 10.1016/j.geomorph.2015.01.010; Wenger AS, 2017, FISH FISH, V18, P967, DOI 10.1111/faf.12218; Wharton G, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1231; Wild TB, 2016, J WATER RES PLAN MAN, V142, DOI 10.1061/(ASCE)WR.1943-5452.0000560; Wilkes MA, 2019, WIRES WATER, V6, DOI 10.1002/wat2.1331; Winking C, 2016, AQUAT SCI, V78, P683, DOI 10.1007/s00027-015-0459-7; Wohl E, 2015, BIOSCIENCE, V65, P358, DOI 10.1093/biosci/biv002; Xu FR, 2018, RIVER RES APPL, V34, P1298, DOI 10.1002/rra.3375; Yang C.T., 2006, EROSION SEDIMENTATIO; Zhao GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091048	78	24	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218822	10.1371/journal.pone.0218822	http://dx.doi.org/10.1371/journal.pone.0218822			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233544	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700044
J	Erdogan, O; Abbak, M; Demirbolat, GM; Birtekocak, F; Aksel, M; Pasa, S; Cevik, O				Erdogan, Omer; Abbak, Muruvvet; Demirbolat, Gulen Melike; Birtekocak, Fatih; Aksel, Mehran; Pasa, Salih; Cevik, Ozge			Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: The characterization, anticancer potential with photodynamic therapy in MCF7 cells	PLOS ONE			English	Article							SKIN-CANCER; ARTICHOKE; ANTIOXIDANT; METAL	In this study, we report on the synthesis of silver nanoparticles (AgNPs) from the leaf extracts of Cynara scolymus (Artichoke) using microwave irradiation and the evaluation of its anti-cancer potential with photodynamic therapy (PDT). Silver nanoparticles formation was characterized by scanning electron microscopy with energy dispersive x-ray spectroscopy and Fourier transform infrared (FTIR) spectroscopy. Silver nanoparticles formation was also investigated the surface charge, particle size and distribution using zetasizer analysis. The cytotoxic effect of AgNPs and/or PDT was studied by MTT assay and migration by the scratch assay. The apoptotic inducing ability of the AgNPs and/or PDT was investigated by intracellular ROS analysis, antioxidant enzyme levels (SOD, CAT, GPx and GSH), Hoechst staining and Bax/Bcl-2 analysis using western blotting. The mean particle size of produced AgNPs was found 98.47 +/- 2.04 nm with low polydispersity (0.301 +/- 0.033). Zeta potential values of AgNPs show -32.3 +/- 0.8 mV. These results clearly indicate the successful formation of AgNPs for cellular uptake. Mitochondrial damage and intracellular ROS production were observed upon treatment with AgNPs (10 mu g/mL) and PDT (0.5 mJ/cm(2)) showed significant reducing cell migration, expression of Bax and suppression of Bcl-2. Significantly, biosynthesized AgNPs showed a broad-spectrum anti-cancer activity with PDT therapy and therefore represent promoting ROS generation by modulating mitochondrial apoptosis induction in MCF7 breast cancer cells.	[Erdogan, Omer; Birtekocak, Fatih; Cevik, Ozge] Adnan Menderes Univ, Sch Med, Dept Biochem, Aydin, Turkey; [Abbak, Muruvvet; Cevik, Ozge] Adnan Menderes Univ, Sci Technol Res & Applicat Ctr, Aydin, Turkey; [Demirbolat, Gulen Melike] Sivas Cumhuriyet Univ, Dept Pharmaceut Technol, Fac Pharm, Sivas, Turkey; [Aksel, Mehran] Aydin Adnan Univ, Sch Med, Dept Biophys, Aydin, Turkey; [Pasa, Salih] Afyon Kocatepe Univ, Dept Sci, Fac Educ, Afyon, Turkey	Adnan Menderes University; Adnan Menderes University; Cumhuriyet University; Afyon Kocatepe University	Cevik, O (corresponding author), Adnan Menderes Univ, Sch Med, Dept Biochem, Aydin, Turkey.; Cevik, O (corresponding author), Adnan Menderes Univ, Sci Technol Res & Applicat Ctr, Aydin, Turkey.	ozge.cevik@adu.edu.tr	Paşa, Salih/AAC-9404-2019; Erdogan, Omer/AAW-5497-2021; Cevik, Ozge/F-1326-2014	Paşa, Salih/0000-0002-4792-8821; DEMIRBOLAT, Gulen Melike/0000-0001-5621-5818; erdogan, omer/0000-0002-8327-7077; AKSEL, Mehran/0000-0002-3942-2257; Aksel, Mehran/0000-0002-9510-8553; Cevik, Ozge/0000-0002-9325-3757	Adnan Menderes University [ADU-MARL-18001, TPF-18012]; Scientific and Technological Research Council of Turkey (TUBITAK) [214Z057]	Adnan Menderes University(Adnan Menderes University); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by Adnan Menderes University Research Grant (ADU-MARL-18001, TPF-18012 to OC) and by a partly grant (214Z057 to OC) from the Scientific and Technological Research Council of Turkey (TUBITAK). The analysis conducted by the Adnan Menderes University Science and Technology Research Center (ADU-BILTEM) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel F, 2005, EUR J CANCER, V41, P635, DOI 10.1016/j.ejca.2004.12.021; Agarwal Happy, 2017, Resource-Efficient Technologies, V3, P406, DOI 10.1016/j.reffit.2017.03.002; Agarwal H, 2019, BIOMED PHARMACOTHER, V109, P2561, DOI 10.1016/j.biopha.2018.11.116; Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007; Antonenko YN, 2014, BBA-BIOMEMBRANES, V1838, P793, DOI 10.1016/j.bbamem.2013.11.012; Balasubramanian S, 2019, INT J NANOSCI, V18, DOI 10.1142/S0219581X18500114; Bendale Y, 2017, INTEGR MED RES, V6, P141, DOI [10.1016/j.imr.2017.01.006, 10.1016/j.imr.2017.01.006|]; Benov L, 2015, MED PRIN PRACT, V24, P14, DOI 10.1159/000362416; Bharathiraja S, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6040078; Braathen LR, 2007, J AM ACAD DERMATOL, V56, P125, DOI 10.1016/j.jaad.2006.06.006; Cao HQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181018; Cevik O, 2017, J BIOL CHEM, V292, P21676, DOI [10.1074/jbc.m117.792721, 10.1074/jbc.M117.792721]; Chen J, 2015, J HAZARD MATER, V297, P173, DOI 10.1016/j.jhazmat.2015.04.077; Coruh I, 2018, ARCH PHARM, V351, DOI 10.1002/ardp.201700195; Demirbolat GM, 2018, J PHARM SCI-US, V107, P1398, DOI 10.1016/j.xphs.2018.01.006; dos Santos KC, 2012, NANOTECHNOL SCI APPL, V5, P37, DOI 10.2147/NSA.S32837; El-Hussein A, 2017, IET NANOBIOTECHNOL, V11, P173, DOI 10.1049/iet-nbt.2015.0083; Ferrin G, 2011, CURR PHARM DESIGN, V17, P2002, DOI 10.2174/138161211796904803; George BPA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32480-5; Huang Z, 2005, TECHNOL CANCER RES T, V4, P283, DOI 10.1177/153303460500400308; Jesus VPS, 2018, PHOTODIAGN PHOTODYN, V23, P212, DOI 10.1016/j.pdpdt.2018.06.011; Khan ST, 2016, COLLOID SURFACE B, V146, P70, DOI 10.1016/j.colsurfb.2016.05.046; Latha M, 2015, MICROB PATHOGENESIS, V82, P43, DOI 10.1016/j.micpath.2015.03.008; Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g; Logeswari P, 2013, SCI IRAN, V20, P1049, DOI 10.1016/j.scient.2013.05.016; Lombardo S, 2017, FOOD RES INT, V100, P95, DOI 10.1016/j.foodres.2017.08.028; Lopes CRB, 2018, J LUMIN, V199, P183, DOI 10.1016/j.jlumin.2018.03.030; Lucky SS, 2015, CHEM REV, V115, P1990, DOI 10.1021/cr5004198; Machado I., 2015, AM J FOOD SCI TECHNO, V3, P55, DOI DOI 10.12691/AJFST-3-3-1; Machado I, 2016, MICROCHEM J, V128, P128, DOI 10.1016/j.microc.2016.04.016; Mariselvam R, 2014, SPECTROCHIM ACTA A, V129, P537, DOI 10.1016/j.saa.2014.03.066; Mfouo-Tynga I, 2014, INT J NANOMED, V9, P3771, DOI 10.2147/IJN.S63371; Nassar MI, 2013, J SCI FOOD AGR, V93, P2494, DOI 10.1002/jsfa.6065; Oves M, 2018, MAT SCI ENG C-MATER, V89, P429, DOI 10.1016/j.msec.2018.03.035; Patil MJ, 2016, IEEE C ELECTR PERFOR, P79, DOI 10.1109/EPEPS.2016.7835422; Patil MP, 2018, MICROB PATHOGENESIS, V121, P184, DOI 10.1016/j.micpath.2018.05.040; Pereira C, 2013, IND CROP PROD, V49, P61, DOI 10.1016/j.indcrop.2013.04.032; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1177, DOI 10.1111/j.1751-1097.2009.00555.x; Pugazhendhi A, 2018, MICROB PATHOGENESIS, V114, P41, DOI 10.1016/j.micpath.2017.11.013; Pugazhendhi A, 2018, INT J PHARMACEUT, V539, P104, DOI 10.1016/j.ijpharm.2018.01.034; Rafique M, 2017, ARTIF CELL NANOMED B, V45, P1272, DOI 10.1080/21691401.2016.1241792; Saber MM, 2018, J DRUG DELIV SCI TEC, V47, P375, DOI 10.1016/j.jddst.2018.08.004; Saha J, 2017, SUSTAIN ENVIRON RES, V27, P245, DOI 10.1016/j.serj.2017.04.003; Saratale RG, 2018, COLLOID SURFACE B, V170, P20, DOI 10.1016/j.colsurfb.2018.05.045; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Senthil B, 2017, J PHOTOCH PHOTOBIO B, V177, P1, DOI 10.1016/j.jphotobiol.2017.10.010; Shanmuganathan R, 2018, ENVIRON SCI POLLUT R, V25, P10362, DOI 10.1007/s11356-017-9367-9; Silva CO, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11010022; Dzul-Erosa MS, 2018, MAT SCI ENG C-MATER, V91, P838, DOI 10.1016/j.msec.2018.06.007; Sumitha S, 2019, PHARMACOGN MAG, V15, P52, DOI 10.4103/pm.pm_400_18; Tang XC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091000; Vijayan R, 2019, BIOPROC BIOSYST ENG, V42, P305, DOI 10.1007/s00449-018-2035-8; Wittemer SM, 2005, PHYTOMEDICINE, V12, P28, DOI 10.1016/j.phymed.2003.11.002; Yi G, 2018, QUANT IMAG MED SURG, V8, P433, DOI 10.21037/qims.2018.05.04; Zomorodian K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5435397	56	113	116	15	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0216496	10.1371/journal.pone.0216496	http://dx.doi.org/10.1371/journal.pone.0216496			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220110	gold, Green Submitted, Green Published			2022-12-26	WOS:000484893500007
J	Hettegger, P; Huber, J; Passecker, K; Soldo, R; Kegler, U; Nohammer, C; Weinhausel, A				Hettegger, Peter; Huber, Jasmin; Passecker, Katharina; Soldo, Regina; Kegler, Ulrike; Noehammer, Christa; Weinhaeusel, Andreas			High similarity of IgG antibody profiles in blood and saliva opens opportunities for saliva based serology	PLOS ONE			English	Article							PERMUTATION TESTS; AUTOANTIBODIES; DIAGNOSTICS; BIOMARKERS	Saliva based diagnostics is a rapidly evolving field due to the large diagnostic potential and simple sample collection. Currently only few individual molecules were investigated for their diagnostic capabilities in saliva. A systematic comparison of IgG antibody profiles in saliva and plasma is still missing in scientific literature. Our hypothesis is that IgG profiles in plasma and saliva are highly similar for each individual. As a consequence, one could implement practically any plasma based IgG assay (classical serology) as saliva based assay. In other words, the IgG antibodies found in blood are also accessible from saliva. We confirm our hypothesis by comparing IgG reactivities towards protein and peptide antigens. We isolated saliva IgG with high purity and demonstrate that plasma IgG reactivities (classical serology) can be inferred from saliva. As a showcase we perform Hepatitis B virus antibody (plasma-) titer determination from saliva. Additionally we show that plasma and saliva IgG profiles of 20 individuals are highly similar for 256 peptide antigens and match (unsupervised) with high probabilities. Finally, we argue for generalisation to the complete IgG antibody profile. The presented findings could contribute greatly to the development of saliva based diagnostic methods of numerous antibody based tests.	[Hettegger, Peter; Huber, Jasmin; Passecker, Katharina; Soldo, Regina; Kegler, Ulrike; Noehammer, Christa; Weinhaeusel, Andreas] Austrian Inst Technol, Ctr Hlth & Bioresources, Mol Diagnost, Vienna, Austria	Austrian Institute of Technology (AIT)	Weinhausel, A (corresponding author), Austrian Inst Technol, Ctr Hlth & Bioresources, Mol Diagnost, Vienna, Austria.	Andreas.Weinhaeusel@ait.ac.at	Weinhaeusel, Andreas/A-7644-2018		Jubilaumsfond (Anniversary Fund) of the Austrian National Bank (Osterreichische Nationalbank) [15952]; research programme Research Studios Austria by the FFG (Osterreichische Forschungsforderungsgesellschaft mbH) [859182]; Austrian Institute of Technology (AIT); Anniversary Fund of the Austrian National Bank (Oesterreichische Nationalbank OeNB) [15952]	Jubilaumsfond (Anniversary Fund) of the Austrian National Bank (Osterreichische Nationalbank); research programme Research Studios Austria by the FFG (Osterreichische Forschungsforderungsgesellschaft mbH); Austrian Institute of Technology (AIT); Anniversary Fund of the Austrian National Bank (Oesterreichische Nationalbank OeNB)	This study was supported by the Jubilaumsfond (Anniversary Fund) of the Austrian National Bank (Osterreichische Nationalbank) project number 15952 (grant recipient -Andreas Weinhausel) and by the research programme Research Studios Austria by the FFG (Osterreichische Forschungsforderungsgesellschaft mbH) under grant agreement number 859182, project PepPipe (grant recipient - Andreas Weinhausel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all study participants for their generosity. We would like to thank H. Hettegger for many fruitful discussions. This work was funded by the Austrian Institute of Technology (AIT) and Anniversary Fund of the Austrian National Bank (Oesterreichische Nationalbank OeNB) project number 15952.	Al Kawas S, 2012, ARCH ORAL BIOL, V57, P1, DOI 10.1016/j.archoralbio.2011.06.013; Alberts B, 2002, MOL BIOL CELL, DOI [10.3389/fimmu.2015.00171, DOI 10.3389/FIMMU.2015.00171]; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bellagambi FG, 2018, MICROCHEM J, V136, P177, DOI 10.1016/j.microc.2017.04.033; Chapman CJ, 2012, TUMOR BIOL, V33, P1319, DOI 10.1007/s13277-012-0379-2; Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Cuzzubbo AJ, 1998, J CLIN MICROBIOL, V36, P3737, DOI 10.1128/JCM.36.12.3737-3739.1998; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Ghimenti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028182; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Greenwald Jeffrey L, 2006, Curr Infect Dis Rep, V8, P125, DOI 10.1007/s11908-006-0008-6; Heo CK, 2012, BMB REP, V45, P677, DOI 10.5483/BMBRep.2012.45.12.236; Hofman LF, 2001, J NUTR, V131, p1621S, DOI 10.1093/jn/131.5.1621S; Jasim H, 2016, SCI REP-UK, V6, DOI 10.1038/srep39073; Kaczor-Urbanowicz KE, 2017, EXP BIOL MED, V242, P459, DOI 10.1177/1535370216681550; Kamat HA, 1999, NATL MED J INDIA, V12, P159; Liu JY, 2012, ORAL ONCOL, V48, P569, DOI 10.1016/j.oraloncology.2012.01.021; Lomonaco T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114430; Madar R, 2002, Bratisl Lek Listy, V103, P38; Mitsuyama K, 2016, WORLD J GASTROENTERO, V22, P1304, DOI 10.3748/wjg.v22.i3.1304; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Pepe MS., 2007, CANC RES, V153; PERRY KR, 1993, J MED VIROL, V40, P235, DOI 10.1002/jmv.1890400312; R Core Team, 2017, R A LANGUAGE AND ENV; Roehr B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4636; Schafer CA, 2014, MONOGR ORAL SCI, V24, P88, DOI 10.1159/000358791; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spielmann N, 2011, ORAL DIS, V17, P345, DOI 10.1111/j.1601-0825.2010.01773.x; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; Tan HT, 2009, FEBS J, V276, P6880, DOI 10.1111/j.1742-4658.2009.07396.x; Wang J, 2016, J THORAC ONCOL, V11, P334, DOI 10.1016/j.jtho.2015.11.011; Yoshizawa JM, 2013, CLIN MICROBIOL REV, V26, P781, DOI 10.1128/CMR.00021-13	35	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218456	10.1371/journal.pone.0218456	http://dx.doi.org/10.1371/journal.pone.0218456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220138	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500050
J	Stranahan, LW; Khalaf, OH; Garcia-Gonzalez, DG; Arenas-Gamboa, AM				Stranahan, Lauren W.; Khalaf, Omar H.; Garcia-Gonzalez, Daniel G.; Arenas-Gamboa, Angela M.			Characterization of Brucella canis infection in mice	PLOS ONE			English	Article							ABORTUS INFECTION; IMMUNE-RESPONSE; DOGS; DIAGNOSIS; VIRULENT; INTERFERON; PROTECTION; RESISTANT; ANTIGENS; GAMMA	Canine brucellosis, caused by Brucella canis, is a disease of dogs and represents a public health concern as it can be transmitted to humans. Canine brucellosis is on the rise in the United States and there is currently no vaccine for use in dogs. Mice have been extensively utilized to investigate host-pathogen interactions and vaccine candidates for smooth Brucella species and could serve a similar role for studying B. canis. However, comparatively little is known about B. canis infection in mice. The objective of this study was to characterize the kinetics of colonization and pathogenicity of B. canis in mice in order to evaluate the mouse as a model for studying this pathogen. C57BL/6 mice were inoculated intraperitoneally with 10(5), 10(7), or 10(9) CFU of Brucella canis RM6/66 and euthanized 1-, 2-, 4-, 6-, 9-, and 12-weeks post-inoculation. B. canis induced splenomegaly in mice infected with 10(9) CFU at 1-and 2 weeks post-inoculation while no gross lesions were observed in other dose groups. Infection at the two higher doses resulted in dose-dependent granulomatous hepatitis and histiocytic infiltration of the spleen and mesenteric lymph nodes by 1-2 weeks. B. canis was cultured from the liver, spleen, uterus, bone marrow, lung, and kidney in all groups with colonization declining at a slow but steady rate throughout the experiment. Clearance was achieved by 9 weeks 10(5) CFU group and by 12 weeks in the 10(7) CFU group, while B. canis persisted in the spleen until 12 weeks in the highest dose group. Although B. canis does not demonstrate significant replication in C57BL/6 mice, it has the ability to establish an infection, induce splenomegaly, and persist for several weeks in multiple organs. Moreover, 1 x 10(7) CFU appears to be a suitable challenge dose for investigating vaccine safety.	[Stranahan, Lauren W.; Khalaf, Omar H.; Garcia-Gonzalez, Daniel G.; Arenas-Gamboa, Angela M.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Khalaf, Omar H.] Univ Baghdad, Coll Vet Med, Dept Vet Pathol & Poultry Dis, Baghdad, Iraq	Texas A&M University System; Texas A&M University College Station; University of Baghdad	Arenas-Gamboa, AM (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	aarenas@cvm.tamu.edu	Stranahan, Lauren/AAU-5474-2021	Khalaf, Omar/0000-0001-9793-7921; Stranahan, Lauren/0000-0002-0746-5949	National Institute of Health International Research Scientist Development Award [(IRSDA/K01) K01 TW009981-01]; FOGARTY INTERNATIONAL CENTER [K01TW009981] Funding Source: NIH RePORTER	National Institute of Health International Research Scientist Development Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Research support provided by the National Institute of Health International Research Scientist Development Award (IRSDA/K01) K01 TW009981-01 (AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas-Gamboa Angela M, 2016, Curr Trop Med Rep, V3, P164, DOI 10.1007/s40475-016-0092-0; Ayala SM, 2014, EUR J CLIN MICROBIOL, V33, P1239, DOI 10.1007/s10096-014-2066-2; Baldwin CL, 2002, VET MICROBIOL, V90, P367, DOI 10.1016/S0378-1135(02)00222-5; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; BRAUDE AI, 1951, J INFECT DIS, V89, P87, DOI 10.1093/infdis/89.1.87; Brooks CHS, 1937, J INFECT DIS, V60, P265; CARMICHAEL LE, 1968, J AM VET MED ASSOC, V152, P605; CARMICHAEL LE, 1968, CORNELL VET, V58, P579; CARMICHAEL LE, 1988, CORNELL VET, V78, P63; Chacon-Diaz C, 2015, INFECT IMMUN, V83, P4861, DOI 10.1128/IAI.00995-15; Clausse M, 2014, CLIN VACCINE IMMUNOL, V21, P1689, DOI 10.1128/CVI.00527-14; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Dentinger CM, 2015, ZOONOSES PUBLIC HLTH, V62, P407, DOI 10.1111/zph.12163; ENRIGHT FM, 1990, VET IMMUNOL IMMUNOP, V26, P171, DOI 10.1016/0165-2427(90)90065-Z; Fernandes DM, 1996, FEMS IMMUNOL MED MIC, V16, P193, DOI 10.1016/S0928-8244(96)00083-1; FernandezLago L, 1996, FEMS IMMUNOL MED MIC, V15, P109, DOI 10.1016/0928-8244(96)00050-8; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Hensel ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212457; Hensel ME, 2018, EMERG INFECT DIS, V24, P1401, DOI 10.3201/eid2408.171171; High KP, 2007, BIOGERONTOLOGY, V8, P583, DOI 10.1007/s10522-007-9106-6; Hollett RB, 2006, THERIOGENOLOGY, V66, P575, DOI 10.1016/j.theriogenology.2006.04.011; Keid LB, 2017, TRANSBOUND EMERG DIS, V64, P691, DOI 10.1111/tbed.12632; Keid LB, 2009, RES VET SCI, V86, P22, DOI 10.1016/j.rvsc.2008.05.012; Lucero NE, 2010, EPIDEMIOL INFECT, V138, P280, DOI 10.1017/S0950268809990525; Lucero NE, 2005, J MED MICROBIOL, V54, P457, DOI 10.1099/jmm.0.45927-0; Lucero NE, 2005, J MED MICROBIOL, V54, P505, DOI 10.1099/jmm.0.45928-0; Marzetti S, 2013, COMP IMMUNOL MICROB, V36, P55, DOI 10.1016/j.cimid.2012.09.002; MOORE JA, 1969, J AM VET MED ASSOC, V155, P1352; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Olsen SC, 2005, EXPERT REV VACCINES, V4, P915, DOI 10.1586/14760584.4.6.915; Palomares-Resendiz E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00035; PARDON P, 1976, ANN INST PASTEUR IMM, VC127, P57; Pollak CN, 2015, CLIN VACCINE IMMUNOL, V22, P274, DOI 10.1128/CVI.00653-14; POLT SS, 1982, ANN INTERN MED, V97, P717, DOI 10.7326/0003-4819-97-5-717; Qian J, 2017, VET MICROBIOL, V204, P121, DOI 10.1016/j.vetmic.2017.04.027; Rolan HG, 2007, INFECT IMMUN, V75, P2965, DOI 10.1128/IAI.01896-06; Wanke MM, 2002, VET MICROBIOL, V88, P367, DOI 10.1016/S0378-1135(02)00152-9; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283; ZOHA SJ, 1982, VET MICROBIOL, V7, P35, DOI 10.1016/0378-1135(82)90004-9	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218809	10.1371/journal.pone.0218809	http://dx.doi.org/10.1371/journal.pone.0218809			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220185	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500093
J	van der Meulen, SB; Hesseling-Meinders, A; de Jong, A; Kok, J				van der Meulen, Sjoerd Bouwe; Hesseling-Meinders, Anne; de Jong, Anne; Kok, Jan			The protein regulator ArgR and the sRNA derived from the 3 '-UTR region of its gene, ArgX, both regulate the arginine deiminase pathway in Lactococcus lactis	PLOS ONE			English	Article							BACILLUS-SUBTILIS; MEMBRANE STRESS; MESSENGER-RNA; ANTISENSE RNA; PLASMID; AHRC; METABOLISM; REVEALS; CONSTRUCTION; TRANSPORTER	Small regulatory RNAs (sRNAs) and their enormous potential and versatility have provided us with an astounding insight in the complexity of bacterial transcriptomes. sRNAs have been shown to be involved in a variety of cellular processes that range from stress to general metabolism. Here we report that the gene encoding the transcriptional regulator ArgR is immediately followed by the gene of the small regulatory RNA ArgX. The latter is transcribed from its own promoter. The production of ArgX is induced by increasing arginine concentrations and repressed by CcpA. Previously, ArgR was shown to act as a transcriptional repressor of the catabolic arginine deiminase pathway (arc operon) by binding in the promoter region of arcA. Here we demonstrate that ArgX downregulates arc mRNA levels. Furthermore, ArgX putatively blocks the translation of one of the genes in the operon, arcC1, a process that would redirect an intermediate in arginine degradation, carbamoyl phosphate, towards pyrimidine synthesis. Our findings exemplify, for the first time, the combinatorial power of a transcription factor and a small regulatory RNA derived from the 3'-UTR region. The regulators ArgR and ArgX share a common target, but act on transcription and on RNA level, respectively.	[van der Meulen, Sjoerd Bouwe; Hesseling-Meinders, Anne; de Jong, Anne; Kok, Jan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands; [van der Meulen, Sjoerd Bouwe; de Jong, Anne; Kok, Jan] TIFN, Wageningen, Netherlands	University of Groningen; Top Institute Food & Nutrition	Kok, J (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands.; Kok, J (corresponding author), TIFN, Wageningen, Netherlands.	jan.kok@rug.nl			Top Institute for Food and Nutrition (TiFN)	Top Institute for Food and Nutrition (TiFN)	Our study was partly funded by the Top Institute for Food and Nutrition (TiFN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Bandyra KJ, 2012, MOL CELL, V47, P943, DOI 10.1016/j.molcel.2012.07.015; Budin-Verneuil A, 2004, LAIT, V84, P61, DOI 10.1051/lait:2003033; Chao YJ, 2016, MOL CELL, V61, P352, DOI 10.1016/j.molcel.2015.12.023; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; de Jong A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1834-4; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; Desnoyers G, 2013, TRENDS GENET, V29, P92, DOI 10.1016/j.tig.2012.10.004; Dijkstra AR, 2014, APPL ENVIRON MICROB, V80, P603, DOI 10.1128/AEM.03434-13; Gajic O, 2003, RELATIONSHIPS BETWEE; GASSON MJ, 1983, J BACTERIOL, V154, P1; Georg J., 2018, FRONT GENET, V9, P124, DOI DOI 10.3389/FGENE.2018.00124; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Goel A, 2012, APPL ENVIRON MICROB, V78, P134, DOI 10.1128/AEM.05276-11; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Jousselin A, 2009, TRENDS MICROBIOL, V17, P399, DOI 10.1016/j.tim.2009.06.003; Kery MB, 2014, NUCL ACIDS RES; Kim HM, 2014, NUCLEIC ACIDS RES, V42, P2003, DOI 10.1093/nar/gkt1071; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen R, 2005, J BIOL CHEM, V280, P19319, DOI 10.1074/jbc.M413983200; Larsen R, 2004, J BACTERIOL, V186, P1147, DOI 10.1128/JB.186.4.1147-1157.2004; Larsen R, 2008, APPL ENVIRON MICROB, V74, P4768, DOI 10.1128/AEM.00117-08; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Mandin P, 2013, CURR OPIN MICROBIOL, V16, P125, DOI 10.1016/j.mib.2012.12.005; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Miyakoshi M, 2015, CURR OPIN MICROBIOL, V24, P132, DOI 10.1016/j.mib.2015.01.013; Noens EEE, 2015, J BACTERIOL, V197, P3545, DOI 10.1128/JB.00526-15; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Overkamp W, 2013, APPL ENVIRON MICROB, V79, P6481, DOI 10.1128/AEM.02033-13; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Peng T, 2016, RNA BIOL, V13, P988, DOI 10.1080/15476286.2016.1212152; Pinto JPC, 2011, APPL ENVIRON MICROB, V77, P6687, DOI 10.1128/AEM.05196-11; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Sharma CM, 2014, CURR OPIN MICROBIOL, V19, P97, DOI 10.1016/j.mib.2014.06.010; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Solem C, 2008, APPL ENVIRON MICROB, V74, P4772, DOI 10.1128/AEM.00134-08; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Udekwu KI, 2007, NUCLEIC ACIDS RES, V35, P1279, DOI 10.1093/nar/gkl1154; van der Meulen SB, 2016, RNA BIOL, V13, P353, DOI 10.1080/15476286.2016.1146855; Van Pijkeren JP, 2012, BIOENGINEERED, V3, P209, DOI 10.4161/bioe.21049; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Vecerek B, 2007, EMBO J, V26, P965, DOI 10.1038/sj.emboj.7601553; Visweswaran GRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072167; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218508	10.1371/journal.pone.0218508	http://dx.doi.org/10.1371/journal.pone.0218508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220124	gold, Green Published, Green Submitted			2022-12-26	WOS:000484893500055
J	Zhu, SM; Soutto, M; Chen, Z; Piazuelo, MB; Washington, MK; Belkhiri, A; Zaika, A; Peng, DF; El, WERA				Zhu, Shoumin; Soutto, Mohammed; Chen, Zheng; Piazuelo, M. Blanca; Washington, M. Kay; Belkhiri, Abbes; Zaika, Alexander; Peng, Dunfa; El-Rifai, Wael			Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; NEGATIVE REGULATION; INSULIN; EXPRESSION; INFLAMMATION; BLOCKADE; PATHWAY; GENE; OVEREXPRESSION	Dopamine and cAMP-regulated phosphoprotein, Mr 32000 (DARPP-32), is frequently overexpressed in early stages of gastric cancers. We utilized in vitro assays, 3D gastric gland organoid cultures, mouse models, and human tissue samples to investigate the biological and molecular impact of DARPP-32 on activation of IGF1R and STAT3 signaling and gastric tumorigenesis. DARPP-32 enhanced phosphorylation of IGF1R (Y1135), a step that was critical for STAT3 phosphorylation at Y705, nuclear localization, and transcription activation. By using proximity ligation and co-immunoprecipitation assays, we found that IGF1R and DARPP-32 co-existed in the same protein complex. Binding of DARPP-32 to IGF1R promoted IGF1R phosphorylation with subsequent activation of downstream SRC and STAT3. Analysis of gastric tissues from the TFF1 knockout (KO) mouse model of gastric neoplasia, demonstrated phosphorylation of STAT3 in the early stages of gastric tumorigenesis. By crossing the TFF1 KO mice with DARPP-32 (DP) knockout (KO) mice, that have normal stomach, we obtained double knockout (TFF1 KO/DP KO). The gastric mucosa from the double KO mice did not show phosphorylation of IGF1R or STAT3. In addition, the TFF1 KO/DP KO mice had a significant delay in developing neoplastic gastric lesions. Analysis of human gastric cancer tissue microarrays, showed high levels of DARPP-32 and positive immunostaining for nuclear STAT3 in cancer tissues, as compared to non-cancer histologically normal tissues. In summary, the DARPP-32-IGF1R signaling axis plays a key role in regulating the STAT3 signaling, a critical step in gastric tumorigenesis.	[Zhu, Shoumin; Soutto, Mohammed; Chen, Zheng; Zaika, Alexander; Peng, Dunfa; El-Rifai, Wael] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Soutto, Mohammed; Chen, Zheng; Zaika, Alexander; El-Rifai, Wael] Miami Healthcare Syst, Dept Vet Affairs, Miami, FL 33125 USA; [Zaika, Alexander; Peng, Dunfa; El-Rifai, Wael] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Piazuelo, M. Blanca] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Washington, M. Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Belkhiri, Abbes] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA	University of Miami; University of Miami; Vanderbilt University; Vanderbilt University; Vanderbilt University	El, WERA (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.; El, WERA (corresponding author), Miami Healthcare Syst, Dept Vet Affairs, Miami, FL 33125 USA.; El, WERA (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	wxe45@miami.edu			U.S. National Institutes of Health [R01CA93999]; U.S. Department of Veterans affairs [I01BX001179, 1IK6BX003787]; NATIONAL CANCER INSTITUTE [R01CA138833, R01CA093999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [IK6BX003787, I01BX002115, I01BX001179] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the U.S. National Institutes of Health (R01CA93999), Research Career Scientist award (1IK6BX003787), and a merit award (I01BX001179) from the U.S. Department of Veterans affairs (W. El-Rifai). The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Veterans Affairs, National Institutes of Health, or the University of Miami.	Adachi Y, 2014, TUMOR BIOL, V35, P973, DOI 10.1007/s13277-013-1131-2; Adachi Y, 2009, CARCINOGENESIS, V30, P1305, DOI 10.1093/carcin/bgp134; Ahn JH, 2015, MOL HUM REPROD, V21, P792, DOI 10.1093/molehr/gav039; Beckler A, 2003, CANCER, V98, P1547, DOI 10.1002/cncr.11654; Belkhiri A, 2005, CANCER RES, V65, P6583, DOI 10.1158/0008-5472.CAN-05-1433; Cafferkey C, 2016, EXPERT OPIN INV DRUG, V25, P1023, DOI 10.1080/13543784.2016.1195807; Carboni JM, 2005, CANCER RES, V65, P3781, DOI 10.1158/0008-5472.CAN-04-4602; Chen Z, 2017, GENE CHROMOSOME CANC, V56, P535, DOI 10.1002/gcc.22456; Chen Z, 2016, GUT, V65, P925, DOI 10.1136/gutjnl-2014-308416; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; El-Rifai W, 2002, CANCER RES, V62, P4061; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Ge J, 2015, MOL MED REP, V11, P633, DOI 10.3892/mmr.2014.2746; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gryko M, 2014, POL J PATHOL, V65, P135, DOI 10.5114/PJP.2014.42678; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Li CJ, 2013, J CANCER RES THER, V9, pS67, DOI 10.4103/0973-1482.119100; Li SL, 2015, TUMOR BIOL, V36, P4519, DOI 10.1007/s13277-015-3096-9; Ma YF, 2016, CLIN CANCER RES, V22, P1767, DOI 10.1158/1078-0432.CCR-15-1677; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Mitchell TJ, 2005, IMMUNOLOGY, V114, P301, DOI 10.1111/j.1365-2567.2005.02091.x; Mukherjee K, 2010, SURGERY, V148, P354, DOI 10.1016/j.surg.2010.05.011; Numata K, 2016, J CANCER RES CLIN, V142, P415, DOI 10.1007/s00432-015-2039-6; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Soutto M, 2011, J CLIN INVEST, V121, P1753, DOI 10.1172/JCI43922; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vangamudi B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-240; Wang MSJ, 2005, INT J CLIN PRACT, V59, P58, DOI 10.1111/j.1742-1241.2004.00305.x; Werner H, 2012, ONCOGENE, V31, P2703, DOI 10.1038/onc.2011.447; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200; Yoshimura A, 2003, CURR OPIN IMMUNOL, V15, P704, DOI 10.1016/j.coi.2003.09.004; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741; Zhao GB, 2016, ONCOL REP, V35, P1787, DOI 10.3892/or.2016.4544; Zhou JD, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0386-9; Zhu SM, 2017, GUT, V66, P802, DOI 10.1136/gutjnl-2016-312141; Zhu SM, 2011, GASTROENTEROLOGY, V141, P1738, DOI 10.1053/j.gastro.2011.06.070	41	13	14	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2019	38	29					5805	5816		10.1038/s41388-019-0843-1	http://dx.doi.org/10.1038/s41388-019-0843-1			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IQ4WS	31235784	Green Accepted			2022-12-26	WOS:000480752800005
J	Allali, S; Dietrich, C; Machavoine, F; Rignault-Bricard, R; Brousse, V; de Montalembert, M; Hermine, O; Maciel, TT; Leite-de-Moraes, M				Allali, Slimane; Dietrich, Celine; Machavoine, Francois; Rignault-Bricard, Rachel; Brousse, Valentine; de Montalembert, Mariane; Hermine, Olivier; Maciel, Thiago Trovati; Leite-de-Moraes, Maria			Innate-like T cells in children with sickle cell disease	PLOS ONE			English	Article							ACTIVATION; CYTOKINE; GAMMA; MAIT; INFLAMMATION; ANEMIA; STATE; INKT	Background The implication of lymphocytes in sickle cell disease pathogenesis is supported by a number of recent reports. These studies provided evidence for the activation of invariant natural killer T ( iNKT) cells in adult patients, but did not investigate the involvement of other innate-like T cell subsets so far. Methods Here we present a monocentric prospective observational study evaluating the number and functional properties of both circulating conventional and innate-like T cells, namely iNKT, Mucosal-Associated Invariant T ( MAIT) and gammadelta (gamma delta) T cells in a cohort of 39 children with sickle cell disease. Results Relative to age-matched healthy controls, we found that patients had a higher frequency of IL-13- and IL-17-producing CD4(+) T cells, as well as higher MAIT cell counts with an increased frequency of IL-17-producing MAIT cells. Patients also presented increased V delta 2 gamma delta T cell counts, especially during vaso-occlusive crisis, and a lower frequency of IFN gamma-producing V delta 2 gamma delta T cells, except during crisis. iNKT cell counts and the frequency of IFN gamma-producing iNKT cells were unchanged compared to controls. Our study revealed positive correlations between 1) the frequency of IFN gamma-producing CD4(+), CD8(+) and V delta 2 gamma delta T cells and the number of hospitalizations for vaso-occlusive crisis in the previous year; 2) the frequency of IFN gamma-producing iNKT cells and patients' age and 3) the frequency of IL-17-producing V delta 2 gamma delta T cells and hemoglobin S level. Conclusion These results strongly suggest a role of innate-like T cells in sickle cell disease pathophysiology, especially that of IL-17-producing MAIT and gamma delta T cells.	[Allali, Slimane; Brousse, Valentine; de Montalembert, Mariane] Paris Descartes Sorbonne Paris Cite Univ, Hop Necker Enfants Malad, AP HP, Dept Gen Pediat & Pediat Infect Dis, Paris, France; [Allali, Slimane; Rignault-Bricard, Rachel; Hermine, Olivier; Maciel, Thiago Trovati] Paris Descartes Sorbonne Paris Cite Univ, Lab Cellular & Mol Mech Hematol Disorders & Thera, Imagine Inst, Inserm U1163, Paris, France; [Allali, Slimane; Brousse, Valentine; de Montalembert, Mariane; Hermine, Olivier; Maciel, Thiago Trovati] Lab Excellence GR Ex, Paris, France; [Dietrich, Celine; Machavoine, Francois; Rignault-Bricard, Rachel; Leite-de-Moraes, Maria] Paris Descartes Sorbonne Paris Cite Univ, CNRS, Inst Necker Enfants Malad, Lab Immunoregulat & Immunopathol,UMR 8253,Inserm, Paris, France; [Hermine, Olivier] Paris Descartes Sorbonne Paris Cite Univ, Hop Necker Enfants Malad, AP HP, Dept Hematol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Allali, S (corresponding author), Paris Descartes Sorbonne Paris Cite Univ, Hop Necker Enfants Malad, AP HP, Dept Gen Pediat & Pediat Infect Dis, Paris, France.; Allali, S (corresponding author), Paris Descartes Sorbonne Paris Cite Univ, Lab Cellular & Mol Mech Hematol Disorders & Thera, Imagine Inst, Inserm U1163, Paris, France.; Allali, S (corresponding author), Lab Excellence GR Ex, Paris, France.; Leite-de-Moraes, M (corresponding author), Paris Descartes Sorbonne Paris Cite Univ, CNRS, Inst Necker Enfants Malad, Lab Immunoregulat & Immunopathol,UMR 8253,Inserm, Paris, France.	slimaneallali@hotmail.fr; maria.leite-de-moraes@parisdescartes.fr	de Moraes, Maria Leite/AAV-9159-2020; Maciel, Thiago Trovati/AAF-5462-2021; Hermine, Olivier/Q-7072-2018; Allali, Slimane/AGW-0037-2022	de Moraes, Maria Leite/0000-0002-2891-2269; Maciel, Thiago Trovati/0000-0002-9347-981X; 	INSERM; CNRS; Paris Descartes University, Paris, France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Paris Descartes University, Paris, France	This work was supported by funds from INSERM, CNRS and Paris Descartes University, Paris, France (MLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandeira ICJ, 2014, CYTOKINE, V65, P217, DOI 10.1016/j.cyto.2013.10.009; Baron M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105422; Chandra S, 2015, ADV IMMUNOL, V127, P145, DOI 10.1016/bs.ai.2015.03.003; CROIZAT H, 1994, BRIT J HAEMATOL, V87, P592, DOI 10.1111/j.1365-2141.1994.tb08318.x; Crosby CM, 2018, NAT REV IMMUNOL, V18, P559, DOI 10.1038/s41577-018-0034-2; Field JJ, 2013, BLOOD, V121, P3329, DOI 10.1182/blood-2012-11-465963; FRANCIS RB, 1992, J NATL MED ASSOC, V84, P611; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Godfrey DI, 2018, IMMUNITY, V48, P453, DOI 10.1016/j.immuni.2018.03.009; Graido-Gonzalez E, 1998, BLOOD, V92, P2551, DOI 10.1182/blood.V92.7.2551.2551_2551_2555; Hinks TSC, 2015, J ALLERGY CLIN IMMUN, V136, P323, DOI 10.1016/j.jaci.2015.01.014; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Keikhaei B, 2013, EUR CYTOKINE NETW, V24, P45, DOI 10.1684/ecn.2013.0328; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Konya C, 2015, CYTOKINE, V75, P207, DOI 10.1016/j.cyto.2015.01.003; Lanier LL, 2013, NAT REV IMMUNOL, V13, P73, DOI 10.1038/nri3389; Lezmi G, 2018, CLIN IMMUNOL, V188, P7, DOI 10.1016/j.clim.2017.11.009; Li-Thiao-Te V, 2018, PEDIATR RHEUMATOL, V16, DOI 10.1186/s12969-017-0221-x; Lin GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056171; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; Manwani D, 2013, BLOOD, V122, P3892, DOI 10.1182/blood-2013-05-498311; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moreira-Teixeira L, 2011, J IMMUNOL, V186, P5758, DOI 10.4049/jimmunol.1003043; Mortier C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01489; Musa BOP, 2010, CLIN VACCINE IMMUNOL, V17, P602, DOI 10.1128/CVI.00145-09; Nickel RS, 2015, BRIT J HAEMATOL, V169, P574, DOI 10.1111/bjh.13326; Papotto PH, 2017, NAT IMMUNOL, V18, P604, DOI 10.1038/ni.3726; Parlakgul G, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4147; Pathare A, 2004, AM J HEMATOL, V77, P323, DOI 10.1002/ajh.20196; Pathare Anil, 2003, Hematology, V8, P329; Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726; Qari MH, 2012, CLIN APPL THROMB-HEM, V18, P195, DOI 10.1177/1076029611420992; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Salou M, 2017, CURR OPIN IMMUNOL, V48, P7, DOI 10.1016/j.coi.2017.07.009; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Trottein F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01750; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Venken K, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0507-2; Vilas-Boas W, 2016, HEMATOLOGY, V21, P126, DOI 10.1179/1607845415Y.0000000048; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Ware RE, 2017, LANCET, V390, P311, DOI 10.1016/S0140-6736(17)30193-9; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538	45	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219047	10.1371/journal.pone.0219047	http://dx.doi.org/10.1371/journal.pone.0219047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251783	gold, Green Published, Green Submitted			2022-12-26	WOS:000484915000038
J	Czajkowska, BI; Jones, G; Brown, TA				Czajkowska, Beata I.; Jones, Glynis; Brown, Terence A.			Diversity of a wall-associated kinase gene in wild and cultivated barley	PLOS ONE			English	Article							PLANT DOMESTICATION; UNCONSCIOUS SELECTION; EVOLUTION; BOTTLENECK; NETWORKS; PATTERNS; REVEALS; ORIGINS; SYSTEM; RATES	Domestication of barley and other cereals was accompanied by an increase in seed size which has been ascribed to human selection, large seeds being preferred by early farmers or favoured by cultivation practices such as deep sowing. An alternative suggestion is that the increase in seed size was an indirect consequence of selection for plants with more vigorous growth. To begin to address the latter hypothesis we studied the diversity of HvWAK1, a wall-associated kinase gene involved in root proliferation, in 220 wild barley accessions and 200 domesticated landraces. A 3655-bp sequence comprising the gene and upstream region contained 69 single nucleotide polymorphisms (SNPs), one indel and four short tandem repeats. A network of 50 haplotypes revealed a complex evolutionary relationship, but with landraces largely restricted to two parts of the topology. SNPs in the HvWAK1 coding region resulted in nonsynonymous substitutions at nine positions in the translation product, but none of these changes were predicted to have a significant effect on the protein structure. In contrast, the region upstream of the coding sequence contained five SNPs that were invariant in the domesticated population, fixation of these SNPs decreasing the likelihood that the upstream of a pair of TATA boxes and transcription start sites would be used to promote transcription of HvWAK1. The sequence diversity therefore suggests that the cis-regulatory region of HvWAK1 might have been subject to selection during barley domestication. The extent of root proliferation has been linked with traits such as aboveground biomass, so selection for particular cis-regulatory variants of HvWAK1 would be consistent with the hypothesis that seed size increases during domestication were the indirect consequence of selection for plants with increased growth vigour.	[Czajkowska, Beata I.; Brown, Terence A.] Univ Manchester, Manchester Inst Biotechnol, Sch Earth & Environm Sci, Manchester, Lancs, England; [Jones, Glynis] Univ Sheffield, Dept Archaeol, Northgate House, Sheffield, S Yorkshire, England	University of Manchester; University of Sheffield	Brown, TA (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Earth & Environm Sci, Manchester, Lancs, England.	terry.brown@manchester.ac.uk		Czajkowska, Dr Beata I./0000-0002-8596-9288	European Research Council [339941, 269830]	European Research Council(European Research Council (ERC)European Commission)	Funding was provided by the European Research Council, grants 339941 to TAB and 269830 to GJ, https://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2017, TRENDS PLANT SCI, V22, P491, DOI 10.1016/j.tplants.2017.03.010; Abbo S, 2014, TRENDS PLANT SCI, V19, P351, DOI 10.1016/j.tplants.2013.12.002; Abbo S, 2014, J EXP BOT, V65, P1917, DOI 10.1093/jxb/eru068; Abbo S, 2010, CRIT REV PLANT SCI, V29, P317, DOI 10.1080/07352689.2010.502823; Allaby R, 2010, J EXP BOT, V61, P935, DOI 10.1093/jxb/erp382; Allaby RG, 2019, EVOL APPL, V12, P29, DOI 10.1111/eva.12680; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brown TA, 2019, NAT PLANTS, V5, P337, DOI 10.1038/s41477-019-0404-1; Brown TA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01287; Brown TA, 2009, TRENDS ECOL EVOL, V24, P103, DOI 10.1016/j.tree.2008.09.008; Chow CN, 2016, NUCLEIC ACIDS RES, V44, pD1154, DOI 10.1093/nar/gkv1035; Colombi T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00420; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2010, WORLD ARCHAEOL, V42, P13, DOI 10.1080/00438240903429680; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Hammer K., 1984, KULTURPFLANZE, V32, P11, DOI [DOI 10.1007/BF02098682, 10.1007/BF02098682]; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Harlan JR, 1992, CROPS MAN, V2nd; Huang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142977; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Kaur R, 2013, FUNCT INTEGR GENOMIC, V13, P167, DOI 10.1007/s10142-013-0310-y; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kluyver TA, 2017, EVOL LETT, V1, P64, DOI 10.1002/evl3.6; Kluyver TA, 2013, J EXP BOT, V64, P4101, DOI 10.1093/jxb/ert304; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kohorn BD, 2016, J EXP BOT, V67, P489, DOI 10.1093/jxb/erv467; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lemmon ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004745; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Milla R, 2017, PLANT BIOLOGY, V19, P475, DOI 10.1111/plb.12545; Milla R, 2018, NAT ECOL EVOL, V2, P1808, DOI 10.1038/s41559-018-0690-4; Pourkheirandish M, 2015, CELL, V162, P527, DOI 10.1016/j.cell.2015.07.002; Preece C, 2017, FUNCT ECOL, V31, P387, DOI 10.1111/1365-2435.12760; Purugganan MD, 2011, EVOLUTION, V65, P171, DOI 10.1111/j.1558-5646.2010.01093.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rong J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-895; Sauvage C, 2017, PLANT J, V91, P631, DOI 10.1111/tpj.13592; Schulman AH, 2005, CYTOGENET GENOME RES, V110, P598, DOI 10.1159/000084993; Shahmuradov IA, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1353; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SNEATH PHA, 1966, J THEOR BIOL, V12, P157, DOI 10.1016/0022-5193(66)90112-3; Swanson-Wagner R, 2012, P NATL ACAD SCI USA, V109, P11878, DOI 10.1073/pnas.1201961109; Swinnen G, 2016, TRENDS PLANT SCI, V21, P506, DOI 10.1016/j.tplants.2016.01.014; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Tanno K, 2012, VEG HIST ARCHAEOBOT, V21, P107, DOI 10.1007/s00334-011-0316-0; Wang MJ, 2017, NAT GENET, V49, P579, DOI 10.1038/ng.3807; Yoo MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004073; Yu C, 2017, PLANT CELL REP, V36, P1417, DOI 10.1007/s00299-017-2165-5; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary D, 2004, ECON BOT, V58, P5, DOI 10.1663/0013-0001(2004)058[0005:USATEO]2.0.CO;2; Zohary D, 1996, ORIGINS SPREAD AGR P, P142	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218526	10.1371/journal.pone.0218526	http://dx.doi.org/10.1371/journal.pone.0218526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247008	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000484911900026
J	Krings, A; Dunyo, P; Pesic, A; Tetteh, S; Hansen, B; Gedzah, I; Wormenor, CM; Amuah, JE; Behnke, AL; Hofler, D; Pawlita, M; Kaufmann, AM				Krings, Amrei; Dunyo, Priscilla; Pesic, Aleksandra; Tetteh, Saviour; Hansen, Benjamin; Gedzah, Isaac; Wormenor, Comfort M.; Amuah, Joseph E.; Behnke, Anna-Lisa; Hofler, Daniela; Pawlita, Michael; Kaufmann, Andreas M.			Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana	PLOS ONE			English	Article							INFECTION; WOMEN; HPV; HIV	Introduction This population-based study aimed to fill the knowledge gap on Human Papillomavirus (HPV) prevalence and associated sociodemographic risk factors of the general population in the North Tongu District, Ghana. These results are needed to guide cervical cancer prevention efforts, as the leading type of female cancers. Methods A cross-sectional study including 2002 women in the North Tongu District, Ghana investigated HPV prevalence and associated sociodemographic risk factors. Women were recruited by geographical distribution through the local community-based health system and samples collected using a self-sampling device. For HPV genotyping BSGP5+/6+-PCR with Luminex-MPG readout was used. Multivariate logistic regression analyzed sociodemographic risk factors for HPV positivity. Results Of 2002 self-collected samples, 1943 were eligible, contained sufficient DNA and provided valid HPV genotyping results. Prevalence of single high risk HPV types was 32.3% and of multiple high risk types 9.7%. The five most common detected HPV types were HPV16 (7.4%; 95% CI: 6.3-8.7), HPV52 (7.2%; 95% CI: 6.1-8.5), HPV35 (4.8%; 95% CI: 3.9-5.8), HPV59 (4.7%; 95% CI: 3.8-5.8), HPV56 (3.9%; 95% CI: 3.1-4.8). Highest prevalence was observed among women aged 18-24 years, while age 25-54 years was inversely associated with high risk HPV positivity in multivariate analysis. Sociodemographic risk factors identified were i) having any sexual partner, ii) more partners increased the odds for high risk HPV positivity, iii) independently from this marital status, in particular not being married. Discussion & conclusion Most importantly, the high risk HPV prevalence detected from this study is higher than estimates reported for Western Africa. This needs be considered, when deciding on the cervical cancer screening algorithms introduced on a wider scale. Follow-up and triage, depending on the methods chosen, can easily overburden the health system. Self-sampling worked well and provided adequate samples for HPV-based screening. Women with increasing number of sexual partners and not being married were found to have higher odds of being high risk HPV positive, therefore could be a higher prioritized screening target group.	[Krings, Amrei; Pesic, Aleksandra; Behnke, Anna-Lisa; Kaufmann, Andreas M.] Charite Univ Med Berlin, Clin Gynecol, Lab Gynecol Tumor Immunol, Campus Benjamin Franklin, Berlin, Germany; [Krings, Amrei; Pesic, Aleksandra; Behnke, Anna-Lisa; Kaufmann, Andreas M.] Free Univ Berlin, Campus Benjamin Franklin, Berlin, Germany; [Krings, Amrei; Pesic, Aleksandra; Behnke, Anna-Lisa; Kaufmann, Andreas M.] Humboldt Univ, Campus Benjamin Franklin, Berlin, Germany; [Krings, Amrei; Pesic, Aleksandra; Behnke, Anna-Lisa; Kaufmann, Andreas M.] Berlin Inst Hlth, Campus Benjamin Franklin, Berlin, Germany; [Dunyo, Priscilla; Tetteh, Saviour; Hansen, Benjamin; Gedzah, Isaac; Wormenor, Comfort M.] Catholic Hosp Battor, Battor, Volta Region, Ghana; [Amuah, Joseph E.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Hofler, Daniela; Pawlita, Michael] German Canc Res Ctr, Res Program Infect Inflammat & Canc, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Ottawa; Helmholtz Association; German Cancer Research Center (DKFZ)	Kaufmann, AM (corresponding author), Charite Univ Med Berlin, Clin Gynecol, Lab Gynecol Tumor Immunol, Campus Benjamin Franklin, Berlin, Germany.; Kaufmann, AM (corresponding author), Free Univ Berlin, Campus Benjamin Franklin, Berlin, Germany.; Kaufmann, AM (corresponding author), Humboldt Univ, Campus Benjamin Franklin, Berlin, Germany.; Kaufmann, AM (corresponding author), Berlin Inst Hlth, Campus Benjamin Franklin, Berlin, Germany.	andreas.kaufmann@charite.de		Behnke, Anna-Lisa/0000-0002-8118-7051; Krings, Amrei/0000-0001-9638-0885; Kaufmann, Andreas/0000-0001-7732-3009	German Corporation for International Development (GIZ), ESTHER Network for clinical partnerships [81163705]; German Research Foundation (DFG); Charite - Universitatsmedizin Berlin; German Rotary Voluntary Doctors (GRVD)	German Corporation for International Development (GIZ), ESTHER Network for clinical partnerships; German Research Foundation (DFG)(German Research Foundation (DFG)); Charite - Universitatsmedizin Berlin; German Rotary Voluntary Doctors (GRVD)	The ACCESSING study was supported by a grant from the German Corporation for International Development (GIZ) as part of the ESTHER Network for clinical partnerships (81163705), the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitatsmedizin Berlin, and a financial support by the German Rotary Voluntary Doctors (GRVD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the support of all partners involved at the Department of Obstetrics and Gynaecology, Catholic Hospital Battor, and at the Clinic for Gynaecology, Charite - Universitatsmedizin Berlin for their substantial and continuous contribution to this study. In addition, we acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitatsmedizin Berlin.	[Anonymous], 2009, REV HUM CARC B; Antony K, 2014, AM J OBSTET GYNECOL, V210, pS45, DOI 10.1016/j.ajog.2013.10.102; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Awua AK, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0050-4; Bosu W K, 2012, Ghana Med J, V46, P69; Bruni L.A.G., 2018, ICO IARC INFORM CTR; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Burk RD, 1996, J INFECT DIS, V174, P679, DOI 10.1093/infdis/174.4.679; Chelimo C, 2013, J INFECTION, V66, P207, DOI 10.1016/j.jinf.2012.10.024; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; Delere Y, 2011, J CLIN MICROBIOL, V49, P3519, DOI 10.1128/JCM.01026-11; Denny L., 2006, VACCINE S3, V24, p[S3, 71]; Denny L, 2014, INT J CANCER, V134, P1389, DOI 10.1002/ijc.28425; Domfeh Ab, 2008, Ghana Med J, V42, P71; Dunyo P, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6065-6; Ferlay J, GLOBAL CANC OBSERVAT, DOI DOI 10.1016/J.EJCA.2020.09.035; Geraets DT, 2014, J CLIN MICROBIOL, V52, P3996, DOI 10.1128/JCM.01962-14; Ghana AIDS Commission, 2016, SUMM 2016 HIV SENT S; Ghana Statistical Service, 2013, GHAN POP HOUS CENS 2; Goodman MT, 2008, CANCER RES, V68, P8813, DOI 10.1158/0008-5472.CAN-08-1380; Holanda F, 2006, INT J GYNECOL OBSTET, V95, P179, DOI 10.1016/j.ijgo.2006.07.012; Huyen TTH, 2013, J MED VIROL, V85, P288, DOI 10.1002/jmv.23456; Kaliff Malin, 2018, Oncotarget, V9, P18786, DOI 10.18632/oncotarget.24666; Ketelaars PJW, 2017, PREV MED, V101, P96, DOI 10.1016/j.ypmed.2017.05.021; Looker KJ, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25110; Moscicki AB, 2008, J ADOLESCENT HEALTH, V43, pS1, DOI 10.1016/j.jadohealth.2008.07.008; Nkyekyer K, 2000, E AFR MED J, V77, P534; Okunade KS, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.227.13979; Ouedraogo RA, 2018, PAPILLOMAVIRUS RES, V6, P22, DOI 10.1016/j.pvr.2018.09.001; Piras F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-514; Rosner B, 1995, FUNFDAMENTALS BIOSTA, P237; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Schulze MH, 2016, MED MICROBIOL IMMUN, V205, P595, DOI 10.1007/s00430-016-0475-9; Serrano B., 2021, HUMAN PAPILLOMAVIRUS; Shrestha Aamod Dhoj, 2018, Asian Pac J Cancer Prev, V19, P319; Smith-McCune KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010094; Traore I M A, 2016, Pak J Biol Sci, V19, P306, DOI 10.3923/pjbs.2016.306.311; Tsu VD, 2018, PREV MED, V114, P205, DOI 10.1016/j.ypmed.2018.07.012; Vinodhini K, 2012, ARCH GYNECOL OBSTET, V285, P771, DOI 10.1007/s00404-011-2155-8; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization, 2014, STRAT PLANN CERV CAN; Yar DD, 2016, TROP MED INT HEALTH, V21, P275, DOI 10.1111/tmi.12645	44	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218762	10.1371/journal.pone.0218762	http://dx.doi.org/10.1371/journal.pone.0218762			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246997	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900037
J	Aliyu, IA; Yusuf, AA; Uyovbisere, EO; Masso, C; Sanders, IR				Aliyu, Ibrahim A.; Yusuf, Ado A.; Uyovbisere, Edward O.; Masso, Cargele; Sanders, Ian R.			Effect of co-application of phosphorus fertilizer and in vitro-produced mycorrhizal fungal inoculants on yield and leaf nutrient concentration of cassava	PLOS ONE			English	Article							SOILS; DIVERSITY; MULCH	The adaptability of cassava to low fertile and marginal soils facilitates its production in subsistent agriculture. As a result, smallholder farmers rarely apply fertilizers. The current yield gap is therefore very large, calling for application of fertilizers and soil amendments to improve its productivity. Field experiments were carried out to assess the potential of partially substituting Phosphorus (P) fertilizers by in vitro-produced arbuscular mycorrhizal fungal (AMF) inoculants in cassava production in two agro-ecologies of Nigeria: Northern Guinea Savanna (Samaru) and Sudan Savanna (Minjibir). The experiments were laid out in a split plot design with P levels (0, 17.5, 35 and 52.5 kg P2O5 ha(-1)) as main plot and AMF inoculants (Control, Glomygel, Glomygel carrier, Mycodrip, Mycodrip carrier) as subplots. The results in Samaru showed that there was significant interaction between AMF and P in root fresh weight, total biomass and root to shoot ratio. The root fresh weights of the inoculated cassava increased proportionally with application of P. However, highest root fresh weight of cassava inoculated with Glomygel was observed at 35 kg P2O5 ha(-1) recording 25% yield increase compared to 52.5 kg P2O5 ha(-1) application. Interestingly, Cassava inoculated with Glomygel at 17.5 kg P2O5 ha(-1) gave root fresh yield statistically similar to where 35 kg P2O5 ha(-1) was applied. This represented a 50% reduction in P fertilizer use. Also, cassava inoculated with Glomygel increased leaf nutrient concentrations, which strongly correlated with the root fresh yield. However, no effects of inoculant carriers were observed in yield and nutrient concentrations. Contrarily, there was no significant treatment effect in Minjibir for nearly all the measured parameters. Cassava yield was however, higher in Minjibir than Samaru probably due to soil fertility and structural differences, which resulted in few observable effects of AMF and P treatments at Minjibir. We conclude that under low P conditions inoculation with in vitro produced AMF inoculants could be employed to reduce P fertilizer requirements for cassava and improve yields, but the variability of the responses as a result of soil heterogeneity and the identity of the fungal strain in the inoculant require further investigations before recommending the practice.	[Aliyu, Ibrahim A.; Yusuf, Ado A.; Uyovbisere, Edward O.] Ahmadu Bello Univ, Dept Soil Sci, Zaria, Nigeria; [Masso, Cargele] Int Inst Trop Agr, Yaounde, Cameroon; [Sanders, Ian R.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Ahmadu Bello University; University of Lausanne	Masso, C (corresponding author), Int Inst Trop Agr, Yaounde, Cameroon.	C.Masso@cgiar.org	; Sanders, Ian/T-9988-2017	Aliyu, Ibrahim A./0000-0002-1435-8826; Sanders, Ian/0000-0002-9591-8214; Yusuf, Ado/0000-0003-2869-4625	Bill and Melinda Gates Foundation [OPPGD1398]; International Institute of Tropical Agriculture (IITA); COMPRO II project	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International Institute of Tropical Agriculture (IITA)(CGIAR); COMPRO II project	This work was supported by the Bill and Melinda Gates Foundation (OPPGD1398).; The authors would like to express their sincere gratitude to the International Institute of Tropical Agriculture (IITA) for sponsoring this work under the auspices of COMPRO II project. We thank the University of Lausanne for buying and providing the required inoculum.	Ande O. T., 2011, International Journal of Soil Science, V6, P142, DOI 10.3923/ijss.2011.142.149; Anderson JM, 1993, HDB METHOD TROPICAL, P82; Anikwe M. A. N., 1999, Journal of Sustainable Agriculture and the Environment, V1, P80; Arumugam R., 2010, Journal of Applied Sciences and Environmental Management, V14, P113; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; AzconAguilar C, 1997, SCI HORTIC-AMSTERDAM, V68, P1, DOI 10.1016/S0304-4238(96)00954-5; BOUYOUCOS GJ, 1951, AGRON J, V43, P434, DOI 10.2134/agronj1951.00021962004300090005x; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; Brundrett M, 1994, CAN J BOT, V62, P2128; Cavagnaro TR, 2008, PLANT SOIL, V304, P315, DOI 10.1007/s11104-008-9559-7; Ceballos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070633; Dare MO, 2013, ARCH AGRON SOIL SCI, V59, P521, DOI 10.1080/03650340.2011.653682; Gosling P, 2013, NEW PHYTOL, V198, P546, DOI 10.1111/nph.12169; HEANES DL, 1984, COMMUN SOIL SCI PLAN, V15, P1191, DOI 10.1080/00103628409367551; Howeler R.H., 2012, CASSAVA HDB REFERENC, P626; Howeler R. H., 2013, CASSAVA GUIDE SUSTAI, P15; Howeler Reinhardt H., 2001, P115, DOI 10.1079/9780851995243.0115; Howeler RH, 1988, INT S TROP ROOT TUB, P519; Kamara AY, 2008, AFR J BIOTECHNOL, V7, P2593; Lekberg Y, 2005, NEW PHYTOL, V168, P189, DOI 10.1111/j.1469-8137.2005.01490.x; Liasu MO, 2006, AFR J BIOTECHNOL, V5, P1341; Liu A, 2000, PLANT SOIL, V221, P157, DOI 10.1023/A:1004777821422; LIU W, 2016, SCI REP-UK, V6, P24902, DOI DOI 10.1038/SREP24902; MALGWI W.B., 2001, THESIS AHMADU BELLO; Nwoke OC, 2004, NUTR CYCL AGROECOSYS, V69, P127, DOI 10.1023/B:FRES.0000029677.09424.ef; Ogunwole JO., 2001, SAM J AGR RES, V17, P71; Okalebo JR, 2002, LAB METHODS SOIL PLA, P22; Okon IE, 2010, THESCIENTIFICWORLDJO, V10, P505, DOI 10.1100/tsw.2010.59; Olsson PA, 1997, APPL ENVIRON MICROB, V63, P3531, DOI 10.1128/AEM.63.9.3531-3538.1997; Oyetunji O, 2007, ADV BIOL RES, V1, P108; Oyetunji OJ, 2003, J AGR SCI, V140, P1; Rodriguez A, 2015, ISME J, V9, P1053, DOI 10.1038/ismej.2014.207; Rodríguez Javier, 2008, Agron. colomb., V26, P308; Savary R, 2018, ISME J, V12, P17, DOI 10.1038/ismej.2017.153; Sieverding E., 1991, SCHRIFTENREIHE GTZ G; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tsado P. A., 2012, International Journal of AgriScience, V2, P613; TSBF, 1993, HDB METH, P221; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Verbruggen E, 2013, NEW PHYTOL, V197, P1104, DOI 10.1111/j.1469-8137.2012.04348.x; Vierheilig H, 2004, CAN J BOT, V82, P1166, DOI [10.1139/B04-015, 10.1139/b04-015]; Wang XR, 2011, MYCORRHIZA, V21, P173, DOI 10.1007/s00572-010-0319-1; Zafar M, 2011, AFR J BIOTECHNOL, V10, P16793, DOI 10.5897/AJB11.1395	43	16	18	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218969	10.1371/journal.pone.0218969	http://dx.doi.org/10.1371/journal.pone.0218969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242274	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600074
J	de Paula, LL; Dechoum, M; Fonseca-Kruel, VS; Tamaio, N; Hanazaki, N				de Paula, Lais Lima; Dechoum, Michele; Fonseca-Kruel, Viviane Stern; Tamaio, Neusa; Hanazaki, Natalia			Artisans and dugout canoes reveal pieces of Atlantic Forest history	PLOS ONE			English	Article							CAICARA COMMUNITY; KNOWLEDGE; DIVERSITY; BIODIVERSITY; COAST	Dugout canoes are boats made from a single tree trunk. Even with the modernization of fishing, they are still made and used for artisanal fishing on the coast of southern and southeastern Brazil and in other regions of the world. Various tree species are used to construct these canoes and choosing a species is related to characteristics of the location, available raw materials and purpose of the boat. Our objective was to better understand the variation in dugout canoes in relation to tree species, tree size and fishing use, over time, along a coastal strip of southern and southeastern Brazil within the Atlantic Forest domain. We interviewed 53 artisans and analyzed 358 canoes that ranged from 1 to around 200 years old. Schizolobium parahyba is currently used the most. In the past, species of the family Lauraceae (Nectandra sp. / Ocotea sp.) were frequently used, as well as Cedrela fissilis and Ficus sp. The size of the canoes varied based on time, coastal region, environment where the boat is used (exposed or sheltered) and type of fishing. The average size of recent canoes was smaller than older canoes for more common species (S. parahyba and C. fissilis), reflecting changes in the vegetation of the biome over time, both in the species and size of individuals available. Latitudinal variation can also influence the availability of tree species along the studied regions. An increase in environmental monitoring has contributed to a decline in constructing dugout canoes, resulting in the use of fiberglass canoes and other motorized boats. Although canoe size varied based on region, location and use, today some of the older canoes represent large trees of the past and pieces of Atlantic Forest history.	[de Paula, Lais Lima; Hanazaki, Natalia] Univ Fed Santa Catarina, Programa Posgrad Biol Fungos Algas & Plantas, Florianopolis, SC, Brazil; [Dechoum, Michele; Hanazaki, Natalia] Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil; [Fonseca-Kruel, Viviane Stern; Tamaio, Neusa] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Jardim Botanico do Rio de Janeiro	Hanazaki, N (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Biol Fungos Algas & Plantas, Florianopolis, SC, Brazil.; Hanazaki, N (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil.	natalia.hanazaki@ufsc.br	Hanazaki, Natalia/AAT-3830-2021; Dechoum, Michele/K-1298-2015	Hanazaki, Natalia/0000-0002-7876-6044; Dechoum, Michele/0000-0002-3484-2498	CNPq - National Council for Scientific and Technological Development (Brazil) [309613/2015-9, 444343/2014-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	CNPq - National Council for Scientific and Technological Development (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Our research received financial support of CNPq - National Council for Scientific and Technological Development (Brazil) through productivity grant supporting the research of NH (309613/2015-9). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 and MSc grant for LLP. This study was financed by CNPq - National Council for Scientific and Technological Development (Brazil) project 444343/2014-8 to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2000, CAICARAS MATA ATLANT; Albuquerque UP, 2010, METODOS TECNICAS PES, P331; Almeida DS, 2016, RECUPERACAO AMBIENTA, P42; [Anonymous], SABERES USOS PLANTAS; Araujo D. S. D., 1997, CTR PLANT DIVERSITY, P373; ARAUJO L. G., 2007, THESIS; BARBU E, 1984, ROMANIAN REV, P3; Berger P., 1979, ILHA SANTA CATARINA; Bohrer Claudio Belmonte de Athayde, 2009, Rodriguésia, V60, P1, DOI 10.1590/2175-7860200960101; Borges R., 2007, THESIS; Borges R, 2009, ACTA BOT BRAS, V23, P769, DOI 10.1590/S0102-33062009000300017; Brosi BJ, 2007, CONSERV BIOL, V21, P875, DOI 10.1111/j.1523-1739.2007.00654.x; Cabral DC, 2007, LUSO-BRAZ REV, V44, P50; Callado Cátia Henriques, 2010, Braz. J. Bot., V33, P84, DOI 10.1590/S0100-84042010000100008; Camara AA, 1937, ENSAIO CONSTRUCOES N; Campanili M, 2010, MATA ATLANTICA PATRI; Caruso M. M. L., 1990, DESMATAMENTO ILHA SA; Carvalho P. E. R., 2008, ESPECIES ARBOREAS BR, V3; Cassetari AS, 2010, THESIS; Coradin VTR, 1991, NORMAS PROCEDIMENTOS; Cufar K, 2010, J ARCHAEOL SCI, V37, P2031, DOI 10.1016/j.jas.2010.03.008; da Silva ED, 2011, BIOTA NEOTROP, V11, P299, DOI 10.1590/S1676-06032011000400026; de Brito MR, 2012, ACTA BOT BRAS, V26, P735, DOI 10.1590/S0102-33062012000400003; Denadai M. R., 2009, COM QUANTAS MEMORIAS; Diegues A.C., 2005, NOSSO LUGAR VIROU PA; DIEGUES A.C., 2000, SABERES TRADICIONAIS; Fagundes M, 2007, REV BRASILEIRA BIOCI, V5, P144; Ferreira MP, 2016, ESPECIES ARVORES MAT; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Hanazaki N, 2000, BIODIVERS CONSERV, V9, P597, DOI 10.1023/A:1008920301824; Huller LM, 1986, REV I ESTUD BRAS, V26, P47; Klein RM, 1969, INSULA REV BOT, V3, P1; Lee RA, 2001, ECON BOT, V55, P9, DOI 10.1007/BF02864542; Lewis GP, 2015, LISTA ESPECIES FLORA; Lorenzi H., 2002, ARVORES BRASILEIRAS, V1; Luz EPA, 2014, THESIS; Machado MV, 2010, EMBARCACAES MARITIMA; Maffi L, 1998, NATURE RESOUR, V34, P12; Maldonado W., 2004, ENCICLOPEDIA CAICARA, V1; Maldonado W., 2001, THESIS; Mesquita JL, 2009, EMBARCACOES TIPICAS; Miranda Tatiana Mota, 2011, Rodriguésia, V62, P153, DOI 10.1590/2175-7860201162111; Museu Nacional do Mar, AC MUS NAC MAR SAO F; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nascimento LB, 2017, 68 C NAC BOT; Nemeth P. S., 2011, FEITIO CANOA CAICARA; Oliveira R., 2011, ESBOCOS, V18, P9, DOI [10.5007/2175-7976.2011v18n25p9, DOI 10.5007/2175-7976.2011V18N25P9]; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orofino G, 2017, ENV DEV SUSTAIN, P1; Orofino G., 2017, THESIS; Pickard F, 2011, DENDROCHRONOLOGIA, V29, P3, DOI 10.1016/j.dendro.2010.08.004; Reitz R., 1979, MADEIRAS BRASIL SANT, V1st; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues ACD, 2005, THESIS; de Campos MCR, 2011, BIOTA NEOTROP, V11, P301, DOI 10.1590/S1676-06032011000200030; Rolim S.G., 1999, SCI FOR, V55, P49; Roque T. V., 2017, THESIS; SCHAEFFERNOVELLI Y, 1990, ESTUARIES, V13, P193, DOI 10.2307/1351589; Schaffer W. B., 1989, QUANTO VALE SEMENTE; Seguchi S, 2014, J WORLD PREHIST, V27, P225, DOI 10.1007/s10963-014-9078-9; Shimamoto CY, 2014, FOREST ECOL MANAG, V329, P1, DOI 10.1016/j.foreco.2014.06.002; Tarazi R., 2006, THESIS; TESSLER M.G., 2005, REV DEPARTAMENTO GEO, V17, P11, DOI DOI 10.7154/RDG.2005.0017.0001; Tongco M. D. C., 2007, Ethnobotany Research and Applications, V5, P147; Tozzi AMG, 2016, FLORA FANERO GARNICA, V8; Varzea VR, 1984, SANTA CATARINA ILHA; Vibrans AC, 2013, INVENTARIO FLORISTIC, V4; Vieira FD, 2003, CONSTRUCAO NAVAL TRA	69	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0219100	10.1371/journal.pone.0219100	http://dx.doi.org/10.1371/journal.pone.0219100			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242263	Green Published, gold, Green Submitted			2022-12-26	WOS:000482883600078
J	Falk, S; Foster, G; Comont, R; Conroy, J; Bostock, H; Salisbury, A; Kilbey, D; Bennett, J; Smith, B				Falk, Steven; Foster, Gemma; Comont, Richard; Conroy, Judith; Bostock, Helen; Salisbury, Andrew; Kilbey, Dave; Bennett, James; Smith, Barbara			Evaluating the ability of citizen scientists to identify bumblebee (Bombus) species	PLOS ONE			English	Article							EMERGING TECHNOLOGIES; DATA QUALITY; SCIENCE; ACCURACY; PLANTS; IDENTIFICATION; VOLUNTEER; DECLINES; BRITAIN	Citizen science is an increasingly popular way of engaging volunteers in the collection of scientific data. Despite this, data quality remains a concern and there is little published evidence about the accuracy of records generated by citizen scientists. Here we compare data generated by two British citizen science projects, Blooms for Bees and BeeWatch, to determine the ability of volunteer recorders to identify bumblebee (Bombus) species. We assessed recorders' identification ability in two ways-as recorder accuracy (the proportion of expert-verified records correctly identified by recorders) and recorder success (the proportion of recorder-submitted identifications confirmed correct by verifiers). Recorder identification ability was low (<50% accuracy; <60% success), despite access to project specific bumblebee identification materials. Identification ability varied significantly depending on bumblebee species, with recorders most able to correctly identify species with distinct appearances. Blooms for Bees recorders (largely recruited from the gardening community) were markedly less able to identify bumblebees than BeeWatch recorders (largely individuals with a more specific interest in bumblebees). Within both projects, recorders demonstrated an improvement in identification ability over time. Here we demonstrate and quantify the essential role of expert verification within citizen science projects, and highlight where resources could be strengthened to improve recorder ability.	[Falk, Steven; Foster, Gemma; Conroy, Judith; Bennett, James; Smith, Barbara] Coventry Univ, Ctr Agroecol Water & Resilience, Coventry, W Midlands, England; [Comont, Richard] Bumblebee Conservat Trust, Eastleigh, England; [Bostock, Helen; Salisbury, Andrew] Royal Hort Soc, Wisley, England; [Kilbey, Dave] Nat Apptitude, Bristol, Avon, England	Coventry University	Foster, G (corresponding author), Coventry Univ, Ctr Agroecol Water & Resilience, Coventry, W Midlands, England.	gemma.foster@coventry.ac.uk		Bennett, James/0000-0002-7233-6203; Conroy, Judith/0000-0001-5996-5753; Smith, Barbara/0000-0002-0506-0331; Foster, Gemma/0000-0002-6268-0641	Heritage Lottery Fund [OH-15-04892]; Coventry University; Engineering and Physical Sciences Research Council (EPSRC) through the RCUK dot.rural Digital Economy Research Hub [EP/G066051/1]; EPSRC [EP/G066051/1] Funding Source: UKRI	Heritage Lottery Fund; Coventry University; Engineering and Physical Sciences Research Council (EPSRC) through the RCUK dot.rural Digital Economy Research Hub(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Blooms for Bees was supported by the Heritage Lottery Fund (www.hlf.org.uk) through grant OH-15-04892 to GF, and match-funding was provided by Coventry University (www.coventry.ac.uk). The funders provided support in the form of salaries for authors SF, GF, RC, and JC, and funded the production of the Blooms for Bees app by the commercial company Natural Apptitude which employs DK. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Between 2011 and 2015, BeeWatch was funded by the Engineering and Physical Sciences Research Council (EPSRC) (https://epsrc.ukri.org/) through the RCUK dot.rural Digital Economy Research Hub, grant number EP/G066051/1 to Professor Peter Edwards. The funder did not provide support in the form of salary to any of the authors, or have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are extremely grateful to all the participants who volunteered their time to submit data and interact with the projects, especially members of the Bumblebee Conservation Trust, Royal Horticultural Society and Garden Organic. We would also like to thank the Blooms for Bees project partners for their support, including the RHS Wisley Trials Team. We also thank Coventry University student interns, Giri Kiritharan and Hannah Murphy, who contributed significantly to the Blooms for Bees project. We are grateful to the BeeWatch team at the University of Aberdeen for supporting the project and providing comments on this manuscript. We also thank the reviewers whose comments improved this manuscript.	Aceves-Bueno E., 2017, B ECOL SOC AM, V98, P278, DOI DOI 10.1002/BES2.1336; August T, 2015, BIOL J LINN SOC, V115, P731, DOI 10.1111/bij.12534; Austen G. E., 2016, SCI REPORTS, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blake S, 2012, P COLING 2012, P311; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brandon A, 2003, NAT AREA J, V23, P254; Burgess HK, 2017, BIOL CONSERV, V208, P113, DOI 10.1016/j.biocon.2016.05.014; Burnham K. P., 2002, MODEL SELECTION MULT; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Comont RF, 2017, BIOCONTROL, V62, P309, DOI 10.1007/s10526-016-9771-y; Cosquer A, 2012, ECOL SOC, V17, DOI 10.5751/ES-04955-170402; Crall AW, 2011, CONSERV LETT, V4, P433, DOI 10.1111/j.1755-263X.2011.00196.x; Crall AW, 2010, BIOL INVASIONS, V12, P3419, DOI 10.1007/s10530-010-9740-9; Cubey J, 2018, RHS PLANT FINDER 201; DEFRA, 2014, NAT POLL STRAT BEES; Dehnen-Schmutz K, 2018, BIOL INVASIONS, V20, P3069, DOI 10.1007/s10530-018-1759-3; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Gardiner MM, 2012, FRONT ECOL ENVIRON, V10, P471, DOI 10.1890/110185; Harvey E, 2002, FISH RES, V57, P255, DOI 10.1016/S0165-7836(01)00356-3; Hoyer Mark V., 2001, Lake and Reservoir Management, V17, P82; Isaac NJB, 2015, BIOL J LINN SOC, V115, P522, DOI 10.1111/bij.12532; James TJ., 2006, IMPROVING WILDLIFE D; JNCC, UK BAP PRIOR SPEC; Kosmala M, 2018, FRONT ECOL ENVIRON, V16, P1; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Lewandowski E, 2015, CONSERV BIOL, V29, P713, DOI 10.1111/cobi.12481; Luther K, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P239; Moyer-Horner L, 2012, J WILDLIFE MANAGE, V76, P1472, DOI 10.1002/jwmg.373; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Novacek MJ, 2008, P NATL ACAD SCI USA, V105, P11571, DOI 10.1073/pnas.0802599105; Oldekop JA, 2011, BIODIVERS CONSERV, V20, P2615, DOI 10.1007/s10531-011-0094-0; Pescott OL, 2015, BIOL J LINN SOC, V115, P505, DOI 10.1111/bij.12581; Pocock MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172579; Pocock MJO, 2015, BIOL J LINN SOC, V115, P475, DOI 10.1111/bij.12548; POLLARD E, 1994, MONITORING BUTTERFLI; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2018, R LANG ENV STAT COMP; Ratnieks FLW, 2016, METHODS ECOL EVOL, V7, P1226, DOI 10.1111/2041-210X.12581; Roy H.E., 2016, PLOS ONE, P1; Roy HE, UNDERSTANDING CITIZE; Sharma N, PEER J; Siddharthan A, 2016, ACM T INTEL SYST TEC, V7, DOI 10.1145/2776896; Silvertown J, 2015, ZOOKEYS, P125, DOI 10.3897/zookeys.480.8803; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Suzuki-Ohno Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10581-x; van der Wal R, 2016, CONSERV BIOL, V30, P550, DOI 10.1111/cobi.12705; Zandbergen PA, 2011, J NAVIGATION, V64, P381, DOI 10.1017/S0373463311000051	50	34	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218614	10.1371/journal.pone.0218614	http://dx.doi.org/10.1371/journal.pone.0218614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233521	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700026
J	Ma, LQ; Qin, F; Wang, H; Qin, YC; Xia, HM				Ma, Liqun; Qin, Fen; Wang, Hao; Qin, Yaochen; Xia, Haoming			Asymmetric seasonal daytime and nighttime warming and its effects on vegetation in the Loess Plateau	PLOS ONE			English	Article							NORTHERN ECOSYSTEMS; MINIMUM TEMPERATURE; CLIMATE-CHANGE; MAXIMUM; GROWTH; TRENDS	Over the period 1982-2015, temperatures have exhibited an asymmetric warming pattern diurnally, as well as seasonally across the Loess Plateau. However, very limited research has studied the implications and effects of such seasonally heterogeneous warming across the Loess Plateau. In this study, we also analyzed the time series trends and seasonal spatial patterns of the maximum (T-max) and minimum (T-min) temperatures and evaluated how different vegetation responded to daytime and nighttime warming in the Loess Plateau from 1982 to 2015 based on the NDVI and meteorological parameters (precipitation or temperature). We found that T-max and T-min significantly increased throughout the years except for T-max in autumn, and the diurnal asymmetric warming showed some striking seasonal differences. For example, the increasing rates of T-min in spring, summer, autumn, and winter were 0.75, 1.20, 1.88, and 1.10 times larger than that of T-max, respectively. NDVI showed significantly positive correlation with T-max and T-min in spring and winter, while NDVI presented significantly positive correlation with T-min in summer and T-max in autumn across entire Loess Plateau. Furthermore, we also discovered diverse seasonal responses in terms of vegetation types to daytime and nighttime warming. For instance, Spring NDVI showed significantly positive partial correlations with T-max and T-min. In summer, grasslands and wetlands merely displayed significantly positive partial correlations with T-min. Cultivated land presented significantly positive partial correlation between the NDVI and T-max (T-min) in autumn. In winter, cultivated land, forest, and grassland exhibited significantly positive partial correlation with T-max and T-min, while only wetland showed a significantly positive partial correlation with T-max. Our results demonstrated responses of vegetation to climate extremes and enhance a better understanding of the seasonally different responses of vegetation under global climate change at different scale.	[Ma, Liqun; Qin, Fen; Qin, Yaochen; Xia, Haoming] Henan Univ, Henan Collaborat Innovat Ctr Urban Rural Coordina, Minist Educ,Coll Environm & Planning, Key Lab Geospatial Technol Middle & Lower Yellow, Kaifeng, Henan, Peoples R China; [Wang, Hao] Henan Univ, Sch Civil Engn & Architecture, Kaifeng, Henan, Peoples R China	Henan University; Henan University	Xia, HM (corresponding author), Henan Univ, Henan Collaborat Innovat Ctr Urban Rural Coordina, Minist Educ,Coll Environm & Planning, Key Lab Geospatial Technol Middle & Lower Yellow, Kaifeng, Henan, Peoples R China.	xiahm2002@163.com	Xia, Haoming/J-4390-2014	Xia, Haoming/0000-0003-0106-6709	Education Department of Henan Province [18a170002]; China Meteorological Administration [AMF201809]; Henan province Key Laboratory of Agrometeorological Support and Applied Technique [AMF201809]	Education Department of Henan Province; China Meteorological Administration; Henan province Key Laboratory of Agrometeorological Support and Applied Technique	The Program for Key Scientific Research in the University of Henan Province (18a170002) is supported by the Education Department of Henan Province. The Open Fund of China Meteorological Administration and Henan province Key Laboratory of Agrometeorological Support and Applied Technique (AMF201809) is supported by the China Meteorological Administration and Henan province Key Laboratory of Agrometeorological Support and Applied Technique. The funders had roles in the study design, data collection of the manuscript.	Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Atkin OK, 2013, PLANT SOIL, V367, P163, DOI 10.1007/s11104-013-1686-0; Baba K, 2004, AUST NZ J STAT, V46, P657, DOI 10.1111/j.1467-842X.2004.00360.x; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Fensholt R, 2012, REMOTE SENS ENVIRON, V119, P131, DOI 10.1016/j.rse.2011.12.015; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; He B, 2015, REMOTE SENS-BASEL, V7, P9998, DOI 10.3390/rs70809998; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; [李月臣 Li Yuechen], 2014, [地理科学进展, Progress in Geography], V33, P1019; Liang C., 2015, TROP GEOGR, V35, P422, DOI DOI 10.13284/j.cnki.rddl.002746; [刘宪锋 Liu Xianfeng], 2015, [生态学报, Acta Ecologica Sinica], V35, P5331; Ma LQ, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081832; Ma LQ, 2018, J RESOURCES SCI, V40, P1684; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Melillo JM, 2011, P NATL ACAD SCI USA, V108, P9508, DOI 10.1073/pnas.1018189108; Morita S, 2005, ANN BOT-LONDON, V95, P695, DOI 10.1093/aob/mci071; Nicholls N, 1997, NATURE, V387, P484, DOI 10.1038/387484a0; Peng SS, 2013, NATURE, V501, P88, DOI 10.1038/nature12434; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7911; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2011, AGR FOREST METEOROL, V151, P1599, DOI 10.1016/j.agrformet.2011.06.016; Robock A, 2000, B AM METEOROL SOC, V81, P1281, DOI [10.1175/1520-0477(2000)081<1281:TGSMDB>2.3.CO;2, 10.1175/1520-0477(2000)081&lt;1281:TGSMDB&gt;2.3.CO;2]; Rouse Jr J. W., 1973, MONITORING VERNAL AD; Shen MG, 2016, GLOBAL CHANGE BIOL, V22, P3057, DOI 10.1111/gcb.13301; Stocker T. F., 2013, CLIMATE CHANGE 2013; Tan JG, 2015, GLOBAL CHANGE BIOL, V21, P377, DOI 10.1111/gcb.12724; Vose RS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024379; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; Wang XLL, 2007, J APPL METEOROL CLIM, V46, P916, DOI 10.1175/JAM2504.1; [王学春 Wang Xuechun], 2017, [自然资源学报, Journal of Natural Resources], V32, P1398; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Wu XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19000; [武正丽 Wu Zhengli], 2015, [干旱区地理, Arid Land Geography], V38, P1241; Xia HM, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041103; Xu HJ, 2017, SCI TOTAL ENVIRON, V579, P1658, DOI 10.1016/j.scitotenv.2016.11.182; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Yan L., 2015, J EARTH ENV, V6, P276, DOI DOI 10.7515/JEE201505003; Yang ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23267; [易浪 Yi Lang], 2014, [资源科学, Resources Science], V36, P166; [张翀 Zhang Chong], 2013, [资源科学, Resources Science], V35, P2017; [张翀 Zhang Chong], 2011, [资源科学, Resources Science], V33, P2143; Zhang Chun-sen, 2016, Journal of Applied Sciences - Electronics and Information Engineering, V34, P702, DOI 10.3969/j.issn.0255-8297.2016.06.006; [赵安周 Zhao Anzhou], 2017, [自然资源学报, Journal of Natural Resources], V32, P449	46	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218480	10.1371/journal.pone.0218480	http://dx.doi.org/10.1371/journal.pone.0218480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233567	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700021
J	Xia, Q; Chen, HH; Yang, TY; Miller, G; Shi, W				Xia, Qing; Chen, Huaihai; Yang, Tianyou; Miller, Grady; Shi, Wei			Defoliation management and grass growth habits modulated the soil microbial community of turfgrass systems	PLOS ONE			English	Article							ROOT ARCHITECTURE; EXTRACTION METHOD; LOLIUM-PERENNE; RHIZOSPHERE; PLANT; DIVERSITY; BACTERIAL; NITROGEN; CARBON; RESPONSES	Grass species selection and regular mowing are essential for maintaining aesthetic and environmentally sound turfgrass systems. However, their impacts on the soil microbial community, the driving force for soil N cycle and thus the environmental fate of N, are largely unknown. Here, the high throughput sequencing of 16S rRNA gene and internal transcribed spacer (ITS) region was used to evaluate how long-term defoliation management and grass growth habits (propagation types and photosynthetic pathways) modulated the soil microbial community. The investigation included three cool-season C3 grasses (creeping bentgrass, Kentucky bluegrass, and tall fescue) and three warm-season C4 grasses (bermudagrass, St. Augustinegrass, and zoysiagrass). Creeping bentgrass and bermudagrass were managed as putting greens with a lower mowing height; tall fescue spread in a tussock manner via tiller production whereas other grasses propagated in a creeping manner via rhizomes and/or stolons. Ordination analysis showed that both bacterial and fungal communities were primarily separated between putting green and non-putting green systems; and so were N-cycle gene relative abundances, with the putting greens being greater in N mineralization but lower in nitrification. Compared to warm-season grasses, cool-season grasses slightly and yet significantly enhanced the relative abundances of Chloroflexi, Verrucomicrobia, and Glomeromycota. Tall fescue yielded significantly greater bacterial and fungal richness than non-tussock grasses. As the main explanatory soil property, pH only contributed to < 18% of community compositional variations among turfgrass systems. Our results indicate that defoliation management was the main factor in shaping the soil microbial community and grass growth habits was secondary in modulating microbial taxon distribution.	[Xia, Qing; Chen, Huaihai; Miller, Grady; Shi, Wei] North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA; [Yang, Tianyou] Henan Inst Sci & Technol, Coll Life Sci & Technol, Xinxiang, Henan, Peoples R China	University of North Carolina; North Carolina State University; Henan Institute of Science & Technology	Shi, W (corresponding author), North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA.	wei_shi@ncsu.edu	Chen, Huaihai/G-4462-2015; Shi, Weisong/D-2233-2016	Chen, Huaihai/0000-0002-2121-1822; Shi, Weisong/0000-0001-5864-4675; Xia, Qing/0000-0002-6316-9941; Shi, Wei/0000-0001-6869-0288; Miller, Grady/0000-0003-4363-3388	Center for Environmental Turfgrass Research and Education, North Carolina; US-EPA ORD; China Scholarship Council; National Natural Science Foundation of China [11305047]	Center for Environmental Turfgrass Research and Education, North Carolina; US-EPA ORD; China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Center for Environmental Turfgrass Research and Education, North Carolina, to WS; US-EPA ORD to HC; and China Scholarship Council and the National Natural Science Foundation of China #11305047 to TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; ANGERS DA, 1992, SOIL SCI SOC AM J, V56, P1244, DOI 10.2136/sssaj1992.03615995005600040039x; Arredondo JT, 1999, NEW PHYTOL, V143, P373, DOI 10.1046/j.1469-8137.1999.00460.x; Arredondo JT, 1998, J RANGE MANAGE, V51, P207, DOI 10.2307/4003209; Bartlett MD, 2008, EUR J SOIL SCI, V59, P835, DOI 10.1111/j.1365-2389.2008.01056.x; BEARD JB, 1994, J ENVIRON QUAL, V23, P452, DOI 10.2134/jeq1994.00472425002300030007x; Beard JB., 2001, TURFAX, V9, P4; Bowman DC, 2002, CROP SCI, V42, P833, DOI 10.2135/cropsci2002.0833; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CAMBARDELLA CA, 1993, SOIL SCI SOC AM J, V57, P1071, DOI 10.2136/sssaj1993.03615995005700040032x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen HH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01776; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Frank DA, 1998, ECOLOGY, V79, P2229, DOI 10.1890/0012-9658(1998)079[2229:UVLCOS]2.0.CO;2; Fu SL, 2004, PLANT SOIL, V263, P345, DOI 10.1023/B:PLSO.0000047745.30929.32; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; Gevao B, 2000, ENVIRON POLLUT, V108, P3, DOI 10.1016/S0269-7491(99)00197-9; Gould IJ, 2016, ECOL LETT, V19, P1140, DOI 10.1111/ele.12652; Griffiths BS, 2001, APPL SOIL ECOL, V16, P49, DOI 10.1016/S0929-1393(00)00081-0; Guitian R, 2000, PLANT SOIL, V220, P271, DOI 10.1023/A:1004787710886; Guo X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00954; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Hartman GL, 2015, CROP PROT, V73, P60, DOI 10.1016/j.cropro.2015.01.017; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; Huang XF, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0225; Kaiser K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33696; Kalam A, 2004, J ENVIRON BIOL, V25, P201; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Macdonald LM, 2004, SOIL BIOL BIOCHEM, V36, P489, DOI 10.1016/j.soilbio.2003.11.001; Marilley L, 1998, PLANT SOIL, V198, P219, DOI 10.1023/A:1004309008799; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miethling R, 2000, MICROB ECOL, V40, P43, DOI 10.1007/s002480000021; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Navarrete AA, 2015, MOL ECOL, V24, P2433, DOI 10.1111/mec.13172; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Qian YL, 2002, AGRON J, V94, P930; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; SCHIMEL J, 1995, ECOL STU AN, V113, P239; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SEXSTONE AJ, 1985, SOIL SCI SOC AM J, V49, P645, DOI 10.2136/sssaj1985.03615995004900030024x; Shi SJ, 2015, MBIO, V6, DOI 10.1128/mBio.00746-15; Simmons M, 2011, ECOL ENG, V37, P1095, DOI 10.1016/j.ecoleng.2011.03.004; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Stratmann JW, 2003, TRENDS PLANT SCI, V8, P247, DOI 10.1016/S1360-1385(03)00106-7; Stuefer JF, 2004, EVOL ECOL, V18, P647, DOI 10.1007/s10682-004-5148-2; Thaler JS, 2002, OECOLOGIA, V131, P227, DOI 10.1007/s00442-002-0885-9; Tilman D, 1997, SPATIAL ECOLOGY THE; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wherley BG, 2009, ENVIRON EXP BOT, V67, P372, DOI 10.1016/j.envexpbot.2009.07.003; Williams M, 2008, FOREST ECOL MANAG, V254, P145, DOI 10.1016/j.foreco.2007.07.033; Willis A, 2013, CRIT REV PLANT SCI, V32, P1, DOI 10.1080/07352689.2012.683375; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084210	69	2	2	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218967	10.1371/journal.pone.0218967	http://dx.doi.org/10.1371/journal.pone.0218967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233561	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700054
J	Mettler, E; Clyde-Brockway, CE; Honarvar, S; Paladino, FV				Mettler, Emily; Clyde-Brockway, Chelsea E.; Honarvar, Shaya; Paladino, Frank V.			Migratory corridor linking Atlantic green turtle, Chelonia mydas, nesting site on Bioko Island, Equatorial Guinea to Ghanaian foraging grounds	PLOS ONE			English	Article							SEA-TURTLES; SATELLITE TELEMETRY; MARINE TURTLES; MIGRATIONS; MOVEMENT; PATTERNS; CONSERVATION; TORTUGUERO; MANAGEMENT; NAVIGATION	This study uses satellite telemetry to track post-nesting movements of endangered green turtles (Chelonia mydas) (n = 6) in the Gulf of Guinea. It identifies a migratory corridor linking breeding grounds of Atlantic green turtles nesting on Bioko Island, Equatorial Guinea, to foraging grounds in the coastal waters of Accra, Ghana. Track lengths of 20-198 days were analyzed, for a total of 536 movement days for the six turtles. Migratory pathways and foraging grounds were identified by applying a switching state space model to locational data, which provides daily position estimates to identify shifts between migrating and foraging behavior. Turtles exhibited a combination of coastal and oceanic migrations pathways that ranged from 957 km to 1,131 km. Of the six turtles, five completed their migration and maintained residency at the same foraging ground near the coastal waters of Accra, Ghana until transmission was lost. These five resident turtles inhabit heavily fished waters and are vulnerable to a variety of anthropogenic threats. The identification of these foraging grounds highlights the importance of these coastal waters for the protection of the endangered Atlantic green turtle.	[Mettler, Emily; Honarvar, Shaya; Paladino, Frank V.] Purdue Univ, Dept Biol, Ft Wayne, IN 47907 USA; [Clyde-Brockway, Chelsea E.] Purdue Univ, Dept Biol, W Lafayette, IN 47907 USA; [Honarvar, Shaya] Bioko Marine Turtle Program, Malabo, Equat Guinea	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Mettler, E (corresponding author), Purdue Univ, Dept Biol, Ft Wayne, IN 47907 USA.	mettek01@pfw.edu		Paladino, Frank V./0000-0002-6452-0086; Clyde-Brockway, Chelsea/0000-0001-7713-8348; Mettler, Emily/0000-0003-4518-239X	Kosmos Trident Energy grant [F.90001149.02.005]; National University of Equatorial Guinea (UNGE); Instituto Nacional de Desarrollo Forestal y Gestion del Sistema deAreas Protegidas (INDEFORAP); Kosmos Trident Equatorial Guinea, Inc.; Fort Wayne Children's Zoo; Sonoma County Community Foundation	Kosmos Trident Energy grant; National University of Equatorial Guinea (UNGE); Instituto Nacional de Desarrollo Forestal y Gestion del Sistema deAreas Protegidas (INDEFORAP); Kosmos Trident Equatorial Guinea, Inc.; Fort Wayne Children's Zoo; Sonoma County Community Foundation	This work was supported by the Kosmos Trident Energy grant, Grant #F.90001149.02.005 (http://www.kosmosenergy.com/equatorial-guinea/) to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Lisa Sinclair for help with on the ground field operations, as well as research assistants with Purdue University Fort Wayne and the Bioko Marine Turtle Program, Brian Dennis, Amanda Rohr, Abby Khraling, and Sam Riley for help with transmitter attachment. We would also like to thank the National University of Equatorial Guinea (UNGE) and Instituto Nacional de Desarrollo Forestal y Gestion del Sistema deAreas Protegidas (INDEFORAP) for their support. This study would not have been possible without financial support from Kosmos Trident Equatorial Guinea, Inc. grant. Funds from the Fort Wayne Children's Zoo and the Sonoma County Community Foundation were also used to support this project.	Amiteye BT, 2002, THESIS; Auge AA, 2018, MAR POLICY, V92, P61, DOI 10.1016/j.marpol.2018.02.017; Balazs GH, 1995, P 15 ANN WORKSH SEA, P21; Baudouin M, 2015, BIOL CONSERV, V184, P36, DOI 10.1016/j.biocon.2014.12.021; Benson SR, 2007, CHELONIAN CONSERV BI, V6, P150, DOI 10.2744/1071-8443(2007)6[150:PMOLTD]2.0.CO;2; Blanco Gabriela S., 2012, Endangered Species Research, V18, P233, DOI 10.3354/esr00451; Bonjean F, 2002, J PHYS OCEANOGR, V32, P2938, DOI 10.1175/1520-0485(2002)032<2938:DMAAOT>2.0.CO;2; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Brownfield M, 2011, ASSESSMENT UNDISCOVE; CARR A, 1980, COPEIA, P366, DOI 10.2307/1444022; Carranza A, 2006, BIOL CONSERV, V131, P52, DOI 10.1016/j.biocon.2006.02.003; Cerritelli G, 2019, BEHAV ECOL, V30, P68, DOI 10.1093/beheco/ary166; Cheng IJ, 2000, MAR BIOL, V137, P747, DOI 10.1007/s002270000375; Cynthia L., 2011, Research Journal of Environmental and Earth Sciences, V3, P417; Dossa Justine S., 2007, Marine Turtle Newsletter, P10; Dujon AM, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3216-8; ESR (Earth & Space Research), 2009, OSCAR 3 DEGR RES OC; Fitzgerald DB, 2011, CHELONIAN CONSERV BI, V10, P177, DOI 10.2744/CCAB-0889.1; Flanders Marine Institute, 2014, UNION OF THE ESRI CO; Formia Angela, 2003, Marine Turtle Newsletter, V100, P33; Gleiss AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1350; Godley BJ, 2003, J EXP MAR BIOL ECOL, V287, P119, DOI 10.1016/S0022-0981(02)00547-6; Godley BJ, 2002, ECOGRAPHY, V25, P352, DOI 10.1034/j.1600-0587.2002.250312.x; Godley BJ, 2003, USING SATELLITE TELE; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hart CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116225; Hays G, 2002, BIPHASAL LONG DISTAN; Hays GC, 2019, TRENDS ECOL EVOL, V34, P459, DOI 10.1016/j.tree.2019.01.009; Hays GC, 2016, TRENDS ECOL EVOL, V31, P463, DOI 10.1016/j.tree.2016.02.015; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Honarvar S, 2016, CHELONIAN CONSERV BI, V15, P79, DOI 10.2744/CCB-1194.1; Hughes G, 1998, 7000 KM OCEANIC JOUR; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Lohmann KJ, 2008, J EXP MAR BIOL ECOL, V356, P83, DOI 10.1016/j.jembe.2007.12.017; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; Mahu Edem, 2015, MAR POLLUT B; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Morreale SJ, 1996, NATURE, V384, P319, DOI 10.1038/384319a0; Nichols W, 2000, TRANSPACIFIC MIGRATI; Ogburn MB, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00070; Riskas KA, 2012, MUNIBE MONOGR-NAT SE, V1, P71; Seminoff J.A., 2004, 2004 IUCN RED LIST T, DOI [https://dx.doi.org/10.2305/IUCN.UK.2004.RLTS.T4615A11037468.en, DOI 10.2305/IUCN.UK.2004.RLTS.T4615A11037468.EN]; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Shaver Donna J., 2008, Endangered Species Research, V4, P43, DOI 10.3354/esr00061; Shimada T, 2017, OCEAN COAST MANAGE, V142, P163, DOI 10.1016/j.ocecoaman.2017.03.028; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Stokes KL, 2015, DIVERS DISTRIB, V21, P665, DOI 10.1111/ddi.12317; Tanner Claire, 2014, Marine Turtle Newsletter; Tomas J., 2001, Marine Turtle Newsletter, V94, P3; Tomas J, 2010, BIODIVERS CONSERV, V19, P2699, DOI 10.1007/s10531-010-9868-z; Troeng S, 2005, MAR BIOL, V148, P435, DOI 10.1007/s00227-005-0076-4; Troeng S, 2005, ECOGRAPHY, V28, P394, DOI 10.1111/j.0906-7590.2005.04110.x; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Whittock PA, 2014, ENDANGER SPECIES RES, V26, P25, DOI 10.3354/esr00628; Witherington B, 2009, ANCIENT MARINERS ANC, P4	60	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0213231	10.1371/journal.pone.0213231	http://dx.doi.org/10.1371/journal.pone.0213231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226114	Green Submitted, Green Published, gold			2022-12-26	WOS:000484894700002
J	Chami, N; Hauid, DK; Masoza, TS; Smart, LR; Kayange, NM; Hokororo, A; Ambrose, EE; Moschovis, PP; Wiens, MO; Peck, RN				Chami, Neema; Hauid, Duncan K.; Masoza, Tulla S.; Smart, Luke R.; Kayange, Neema M.; Hokororo, Adolfine; Ambrose, Emmanuela E.; Moschovis, Peter P.; Wiens, Matthew O.; Peck, Robert N.			Very severe anemia and one year mortality outcome after hospitalization in Tanzanian children: A prospective cohort study	PLOS ONE			English	Article							BLOOD-TRANSFUSION; YOUNG-CHILDREN; MALARIA; DISCHARGE; TRENDS	Background Africa has the highest rates of child mortality. Little is known about outcomes after hospitalization for children with very severe anemia. Objective To determine one year mortality and predictors of mortality in Tanzanian children hospitalized with very severe anemia. Methods We conducted a prospective cohort study enrolling children 2-12 years hospitalized from August 2014 to November 2014 at two public hospitals in northwestern Tanzania. Children were screened for anemia and followed until 12 months after discharge. The primary outcome measured was mortality. Predictors of mortality were determined using Cox regression analysis. Results Of the 505 children, 90 (17.8%) had very severe anemia and 415 (82.1%) did not. Mortality was higher for children with very severe anemia compared to children without over a one year period from admission, 27/90 (30.0%) vs. 59/415 (14.2%) respectively (Hazard Ratio (HR) 2.42, 95% Cl 1.53-3.83). In-hospital mortality was 11/90 (12.2%) and post-hospital mortality was 16/79 (20.2%) for children with very severe anemia. The strongest predictors of mortality were age (HR 1.01, 95% Cl 1.00-1.03) and decreased urine output (HR 4.30, 95% Cl 1.04-17.7). Conclusions Children up to 12 years of age with very severe anemia have nearly a 30% chance of mortality following admission over a one year period, with over 50% of mortality occurring after discharge. Post-hospital interventions are urgently needed to reduce mortality in children with very severe anemia, and should include older children.	[Chami, Neema; Masoza, Tulla S.; Kayange, Neema M.; Hokororo, Adolfine; Ambrose, Emmanuela E.; Peck, Robert N.] Catholic Univ Hlth & Allied Sci, Dept Pediat, Mwanza, Tanzania; [Hauid, Duncan K.] Weill Cornell Med Coll, Dept Pediat, New York, NY 10065 USA; [Smart, Luke R.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Hematol Oncol, Cincinnati, OH 45229 USA; [Moschovis, Peter P.] Massachusetts Gen Hosp, Dept Pediat, Div Pediat Global Hlth, Boston, MA 02114 USA; [Moschovis, Peter P.] Massachusetts Gen Hosp, Dept Pediat, Div Pulm Med, Boston, MA 02114 USA; [Wiens, Matthew O.] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda; [Wiens, Matthew O.] BC Childrens Hosp, Ctr Int Child Hlth, Vancouver, BC, Canada; [Wiens, Matthew O.] Univ British Columbia, Vancouver, BC, Canada; [Peck, Robert N.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA	Cornell University; Cincinnati Children's Hospital Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Mbarara University of Science & Technology; BC Childrens Hospital; University of British Columbia; University of British Columbia; Cornell University	Hauid, DK (corresponding author), Weill Cornell Med Coll, Dept Pediat, New York, NY 10065 USA.	dkh2001@med.cornell.edu	Moschovis, Peter/GRY-7498-2022; Smart, Luke R./AAI-1561-2020; Wiens, Matthew/J-9249-2019	Smart, Luke R./0000-0003-4083-0060; Wiens, Matthew/0000-0002-3287-5181; Peck, Robert/0000-0002-4526-2480	Weill Cornell Medical College Department of Pediatrics [87000213]; Medical Education Partnership Initiative Junior Faculty [D43TW010138]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL 1TR002541]; National Institutes of Health [K01 TW010281]; FOGARTY INTERNATIONAL CENTER [D43TW010138, K01TW010281] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002541] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL124951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES030399] Funding Source: NIH RePORTER	Weill Cornell Medical College Department of Pediatrics; Medical Education Partnership Initiative Junior Faculty; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by a pilot award from the Weill Cornell Medical College Department of Pediatrics [#87000213] to DH. NK is supported by a grant Medical Education Partnership Initiative Junior Faculty [#D43TW010138]. PM is supported by a grant from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award [UL 1TR002541]). RP is supported by a grant from the National Institutes of Health [#K01 TW010281]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi, 2011, AFR J TRADIT COMPLEM, V8, P115, DOI 10.4314/ajtcam.v8i5S.5; Ahmed MM, 2016, BMC NUTR, V2, P49, DOI [10.1186/s40795-016-0090-6, DOI 10.1186/S40795-016-0090-6, DOI 10.1186/s40795-016-0090-6]; Ambrose EE, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26735; BioMed Central, 2015, TRANSF TREATM SEV AN, DOI [10.1186/s13063-015-1112-4, DOI 10.1186/S13063-015-1112-4]; Bojang KA, 1997, ANN TROP PAEDIATR, V17, P355, DOI 10.1080/02724936.1997.11747910; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; English L, 2016, AFR HEALTH SCI, V16, P883, DOI 10.4314/ahs.v16i4.2; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; Hau DK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202334; Islam MA, 1996, J TROP PEDIATRICS, V42, P342, DOI 10.1093/tropej/42.6.342; Kagabo DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190739; Kidney Disease Improving Global Outcomes, 2013, KIDNEY INT, V3, P43; Kiguli S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0246-7; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Masquelier B, 2018, LANCET GLOB HEALTH, V6, pE1087, DOI [10.1016/S2214-109X(18)30353-X, 10.1016/s2214-109x(18)30353-x]; Moschovis PP, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019654; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Patton GC, 2018, LANCET GLOB HEALTH, V6, pE1048, DOI 10.1016/S2214-109X(18)30417-0; Phiri KS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002903; ROY SK, 1983, BRIT MED J, V287, P1097, DOI 10.1136/bmj.287.6399.1097; Scott SP, 2014, NUTRIENTS, V6, P5915, DOI 10.3390/nu6125915; Simbauranga Rehema H, 2015, BMC Hematol, V15, P13, DOI 10.1186/s12878-015-0033-5; Smart LR, 2016, ACTA TROP, V159, P36, DOI 10.1016/j.actatropica.2016.03.019; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; The United Republic of Tanzania, 2012, REPORT LAW MARRIAGE; Veirum JE, 2007, ACTA PAEDIATR, V96, P1832, DOI 10.1111/j.1651-2227.2007.00562.x; WHO, 2010, INT STAT CLASS DIS R; Wiens MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066698; World Health Organization, 2011, HAEM CONC DIAGN AN A; World Health Organization, 2012, WHO STEPS INSTR; Zucker JR, 1996, AM J TROP MED HYG, V55, P655, DOI 10.4269/ajtmh.1996.55.655	34	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0214563	10.1371/journal.pone.0214563	http://dx.doi.org/10.1371/journal.pone.0214563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220109	gold, Green Submitted, Green Published			2022-12-26	WOS:000484893500003
J	Giudici, F; Petracci, E; Nanni, O; Bottin, C; Pinamonti, M; Zanconati, F; Scaggiante, B				Giudici, Fabiola; Petracci, Elisabetta; Nanni, Oriana; Bottin, Cristina; Pinamonti, Maurizio; Zanconati, Fabrizio; Scaggiante, Bruna			Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis	PLOS ONE			English	Article							ELONGATION-FACTOR EEF1A2; GENE COPY NUMBER; FACTOR 1 ALPHA-2; MOLECULAR STRATIFICATION; FACTOR 1-ALPHA; TRANSLATION; ISOFORMS; SUBTYPES; METASTASIS; RECURRENCE	Eukaryotic elongation factor 1 alpha 2 (eEF1A2) is a translation factor selectively expressed by heart, skeletal muscle, nervous system and some specialized cells. Its ectopic expression relates with tumorigenesis in several types of human cancer. No data are available about the role of eEF1A2 in Triple Negative Breast Cancers (TNBC). This study investigated the relation between eEF1A2 protein levels and the prognosis of TNBC. A total of 84 TNBC diagnosed in the period 2002-2011 were included in the study. eEF1A2 protein level was measured in formalin-fixed paraffin-embedded tissues by immunohistochemistry in a semi-quantitative manner (sum of the percentage of positive cells x staining intensity) on a scale from 0 to 300. Cox regression assessed the association between eEF1A2 levels and disease-free survival (DFS) and breast cancer-specific survival (BCSS). Elevated values of eEF1A2 were associated with older age at diagnosis (p = 0.003), and androgen receptors positivity (p = 0.002). At univariate Cox analysis, eEF1A2 levels were not significantly associated with DFS and BCSS (p = 0.11 and p = 0.08, respectively) whereas adjusting for stage of disease, elevated levels of eEF1A2 protein resulted associated with poor prognosis (HR = 1.05, 95% CI: 1.01-1.11, p = 0.04 and HR = 1.07, 95% CI: 1.01-1.14, p = 0.03 for DFS and BCSS, respectively). This trend was confirmed analyzing negative versus positive samples by using categorized scores. Our data showed a negative prognostic role of eEF1A2 protein in TNBC, sustaining further investigations to confirm this result by wider and independent cohorts of patients.	[Giudici, Fabiola] Univ Trieste, Cattinara Acad Hosp, Dept Med Surg & Hlth Sci, Biostat Unit, Trieste, Italy; [Petracci, Elisabetta; Nanni, Oriana] Ist Sci Romagnolo Studio Cura Tumori, Unit Biostat & Clin Trials, Meldola, Italy; [Bottin, Cristina; Pinamonti, Maurizio; Zanconati, Fabrizio] Univ Trieste, Cattinara Acad Hosp, Dept Med Surg & Hlth Sci, Trieste, Italy; [Scaggiante, Bruna] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Trieste; IRCCS Meldola (IRST); University of Trieste; University of Trieste	Scaggiante, B (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	bscaggiante@units.it	nanni, oriana/K-3240-2016; GIUDICI, FABIOLA/AAJ-4919-2020; Giudici, Fabiola/R-8426-2016	nanni, oriana/0000-0001-7338-2896; GIUDICI, FABIOLA/0000-0002-4160-3479; Giudici, Fabiola/0000-0002-4160-3479; SCAGGIANTE, BRUNA/0000-0002-8662-138X	Ricerca Sanitaria 2015 LILT (5xmille 2013); Beneficentia Foundation Stiftung grants [BEN2016/16]; LILT Trieste	Ricerca Sanitaria 2015 LILT (5xmille 2013); Beneficentia Foundation Stiftung grants; LILT Trieste	This work was supported by Ricerca Sanitaria 2015 LILT (5xmille 2013), Beneficentia Foundation Stiftung grants BEN2016/16 and by LILT Trieste grant entitled to "Adriana Cartella". LILT had no input on the content, the study design, data selection, decision to publish or preparation of the manuscript.	Abbas W, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00075; Abubakar M, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0765-6; Adamo V, 2012, EUR J CANCER, V48, P642, DOI 10.1016/j.ejca.2011.06.028; Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; ANN DK, 1991, J BIOL CHEM, V266, P10429; Bender RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061788; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cadoo KA, 2013, Q J NUCL MED MOL IM, V57, P312; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Chen QX, 2017, ONCOTARGET, V8, P4773, DOI 10.18632/oncotarget.13976; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; de Gramont A, 2015, NAT REV CLIN ONCOL, V12, P197, DOI 10.1038/nrclinonc.2014.202; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Farra R, 2017, INT J PHARMACEUT, V525, P367, DOI 10.1016/j.ijpharm.2017.02.031; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gourgou-Bourgade S, 2015, ANN ONCOL, V26, P873, DOI 10.1093/annonc/mdv106; Grassi G, 2007, BIOCHIMIE, V89, P1544, DOI 10.1016/j.biochi.2007.07.007; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hassan MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191377; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hu DM, 2013, HEPATO-GASTROENTEROL, V60, P870, DOI 10.5754/hge12869; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; IWABUCHI H, 1995, CANCER RES, V55, P6172; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Kawamura M, 2014, ANTICANCER RES, V34, P651; Kim JY, 2016, CANCER RES TREAT, V48, P1338, DOI 10.4143/crt.2015.430; Kim M, 2016, CANCER RES TREAT, V48, P1330, DOI 10.4143/crt.2015.463; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kulkarni G, 2007, BREAST CANCER RES TR, V102, P31, DOI 10.1007/s10549-006-9315-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee MH, 2009, ANN NY ACAD SCI, V1171, P87, DOI 10.1111/j.1749-6632.2009.04909.x; Lee MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163254; LEE S, 1992, J BIOL CHEM, V267, P24064; Lin CY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32272-x; Lorenz E., 2019, BIOSTATISTICS EPIDEM, V3, P23, DOI [DOI 10.1080/24709360.2019.1580463, 10.1080/24709360.2019.1580463]; Lorenz E, 2017, AM J EPIDEMIOL, V185, P650, DOI 10.1093/aje/kww122; Losada A, 2018, BRIT J CANCER, V119, P1410, DOI 10.1038/s41416-018-0336-y; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Pan B, 2016, ONCOTARGET, V7, P38864, DOI 10.18632/oncotarget.8778; Pan YB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172324; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Pinke DE, 2008, GYNECOL ONCOL, V108, P561, DOI 10.1016/j.ygyno.2007.11.019; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Pogoda K, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0388-4; Qiu FN, 2016, WORLD J GASTROENTERO, V22, P4226, DOI 10.3748/wjg.v22.i16.4226; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Royston P, 2010, STAT MED, V29, P1219, DOI 10.1002/sim.3864; Russnes HG, 2017, AM J PATHOL, V187, P2152, DOI 10.1016/j.ajpath.2017.04.022; Scaggiante B, 2008, ONCOGENE PROTEINS NE, V6, P177; Scaggiante B, 2016, INT J PHARMACEUT, V506, P268, DOI 10.1016/j.ijpharm.2016.04.031; Scaggiante B, 2013, HEMATOL ONCOL, V31, P370, DOI 10.1002/hon.2022; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Steward L, 2014, ANN SURG ONCOL, V21, P2165, DOI 10.1245/s10434-014-3546-4; The American Society of Breast Surgeons, 2014, GUID PERF PRACT GUID; Therneau TMGPM, 2000, MODELING SURVIVAL DA; Tomlinson VAL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-113; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Van Poznak C, 2015, J CLIN ONCOL, V33, P2695, DOI 10.1200/JCO.2015.61.1459; Vislovukh A. A., 2013, Biopolymers and Cell, V29, P389, DOI 10.7124/bc.00082E; Worst TS, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0278-3; Xu C, 2013, CLIN EXP METASTAS, V30, P933, DOI 10.1007/s10585-013-9593-6; Yadav BS, 2015, WORLD J CLIN ONCOL, V6, P252, DOI 10.5306/wjco.v6.i6.252; Yang S, 2015, J CANCER RES CLIN, V141, P1265, DOI 10.1007/s00432-014-1897-7; Yao H, 2017, ONCOTARGET, V8, P1913, DOI 10.18632/oncotarget.12284; Yue Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149661; Zang WQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0315-3	71	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218030	10.1371/journal.pone.0218030	http://dx.doi.org/10.1371/journal.pone.0218030			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220107	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500018
J	Pedretti, S; Brulhart-Meynet, MC; Montecucco, F; Lecour, S; James, RW; Frias, MA				Pedretti, Sarah; Brulhart-Meynet, Marie-Claude; Montecucco, Fabrizio; Lecour, Sandrine; James, Richard W.; Frias, Miguel A.			HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEIN-A-I; ISCHEMIA/REPERFUSION INJURY; SIGNALING PATHWAY; TARGETING STAT3; HEART; MICRORNAS; CARDIOMYOCYTE; ATHEROSCLEROSIS; PROLIFERATION	Purpose High density lipoprotein (HDL) protects against myocardial infarction via mechanisms that remain unclear. STAT3 (signal transducer and activator of transcription 3) plays a key role in HDL-induced cardioprotection. In the heart, microRNAs (miRNAs) are involved in ischemia reperfusion injury. We therefore investigated whether the cardioprotective effect of HDL modulates miRNAs as a downstream target of STAT3 activation. Methods STAT3 cardiomyocyte deficient mice (STAT3-KO) and wildtype littermates (STAT3-WT) were submitted to left coronary ligature and reperfused (IR) with or without injection of HDL. Infarct size (IS) was determined and cardiac miRNA expression was evaluated after reperfusion in sham, IR and IR+HDL hearts by microarray analysis. In vitro, neonatal rat ventricular cardiomyocytes were submitted to hypoxia with or without HDL incubation. Cell viability and miRNA expression were analysed. Results In vivo, HDL reduced IS from 40.5 +/- 4.3% to 24.4 +/- 2.1% (p< 0.05) in STAT3-WT mice. HDL failed to protect in STAT3-KO mice. In STAT3-WT mice, both miR-34b and miR-337 were increased in IR compared to sham and IR+ HDL groups (p< 0.05). These miRNAs were not modulated in STAT3-KO mice. In vitro, incubation with HDL improved cell viability against hypoxia (p< 0.05). The expression of miR-34b and miR-337 was increased by hypoxia and reduced by HDL treatment (p< 0.05). In cardiomyocytes transfected with miRNA mimics, HDL failed to improve cell viability against hypoxia. Conclusions Our study, performed both in vivo and in vitro, delineates a novel cardioprotective signalling pathway activated by HDL, involving STAT3-mediated decrease of miR-34b and miR-337 expression.	[Pedretti, Sarah; Brulhart-Meynet, Marie-Claude; James, Richard W.; Frias, Miguel A.] Univ Geneva, Dept Med Specialties Endocrinol Diabetol Hyperten, Geneva, Switzerland; [Montecucco, Fabrizio] Univ Genoa, Dept Internal Med, Clin Internal Med 1, Sch Med, Genoa, Italy; [Montecucco, Fabrizio] IRCCS AOU San Martino IST, Genoa, Italy; [Montecucco, Fabrizio] Univ Genoa, CEBR, Genoa, Italy; [Lecour, Sandrine] Univ Cape Town, Hatter Inst Cardiovasc Res Africa, Dept Med, Fac Hlth Sci, Cape Town, South Africa; [Frias, Miguel A.] Geneva Univ Hosp, Div Lab Med, Diagnost Dept, Geneva, Switzerland	University of Geneva; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; University of Cape Town; University of Geneva	Frias, MA (corresponding author), Univ Geneva, Dept Med Specialties Endocrinol Diabetol Hyperten, Geneva, Switzerland.; Frias, MA (corresponding author), Geneva Univ Hosp, Div Lab Med, Diagnost Dept, Geneva, Switzerland.	Miguel.Frias@unige.ch			Swiss National Science Foundation (SNSF) [31-135221, 310030_152639]; Fondation Prevot; Fondation pour la lutte contre le cancer et investigations medicobiologiques; Jubilaumsstiftung SwissLife	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Fondation Prevot; Fondation pour la lutte contre le cancer et investigations medicobiologiques; Jubilaumsstiftung SwissLife	The present study was supported by the Swiss National Science Foundation (SNSF grant 31-135221 to R.W.J. and SNSF grant 310030_152639 to F.M.) and Fondation Prevot, Jubilaumsstiftung SwissLife and Fondation pour la lutte contre le cancer et investigations medicobiologiques (M.A.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Brulhart-Meynet MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119664; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Calabresi L, 2003, CIRC RES, V92, P330, DOI 10.1161/01.RES.0000054201.60308.1A; Cao Q, 2013, PHYSIOL GENOMICS, V45, P1206, DOI 10.1152/physiolgenomics.00122.2013; Clark AL, 2015, J BIOL CHEM, V290, P23162, DOI 10.1074/jbc.M115.672659; D'Alessandra Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080345; D'Alessandra Y, 2012, CURR OPIN CARDIOL, V27, P228, DOI 10.1097/HCO.0b013e3283522052; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Du WJ, 2014, CELL PHYSIOL BIOCHEM, V34, P955, DOI 10.1159/000366312; Durham KK, 2018, AM J PHYSIOL-HEART C, V314, pH31, DOI 10.1152/ajpheart.00521.2016; Feuerborn R, 2017, ATHEROSCLEROSIS, V257, P29, DOI 10.1016/j.atherosclerosis.2016.12.009; Forno I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130060; Frias MA, 2008, CARDIOVASC RES, V80, P69, DOI 10.1093/cvr/cvn171; Frias Miguel A, 2012, JAKSTAT, V1, P92, DOI 10.4161/jkst.19754; Frias MA, 2013, ATHEROSCLEROSIS, V228, P110, DOI 10.1016/j.atherosclerosis.2013.02.003; Frias MA, 2010, CARDIOVASC RES, V85, P118, DOI 10.1093/cvr/cvp289; Frias MA, 2009, CARDIOVASC RES, V82, P313, DOI 10.1093/cvr/cvp024; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Haghikia A, 2011, EUR HEART J, V32, P1287, DOI 10.1093/eurheartj/ehq369; Haider KH, 2010, CARDIOVASC RES, V88, P168, DOI 10.1093/cvr/cvq151; Hewing B, 2014, ARTERIOSCL THROM VAS, V34, P779, DOI 10.1161/ATVBAHA.113.303044; Hiyoshi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124899; JAMES RW, 1989, BIOCHIM BIOPHYS ACTA, V1002, P292, DOI 10.1016/0005-2760(89)90343-3; Kim SY, 2012, BIOCHEM BIOPH RES CO, V429, P173, DOI 10.1016/j.bbrc.2012.10.117; Levkau B, 2004, CIRCULATION, V110, P3355, DOI 10.1161/01.CIR.0000147827.43912.AE; Liu C, 2013, CURR MOL MED, V13, P467; Liu HL, 2014, CELL BIOCHEM BIOPHYS, V70, P635, DOI 10.1007/s12013-014-9967-7; Liu YM, 2013, GENET MOL RES, V12, P2937, DOI 10.4238/2013.August.12.9; Mishra M, 2018, INTERNATIONAL JOURNA, V19; Niculescu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140958; Nofer JR, 2002, ATHEROSCLEROSIS, V161, P1, DOI 10.1016/S0021-9150(01)00651-7; Redfors B, 2012, EXP CLIN CARDIOL, V17, P268; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Sun YY, 2015, CELL MOL NEUROBIOL, V35, P1117, DOI 10.1007/s10571-015-0205-7; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Tao R, 2010, AM J PHYSIOL-HEART C, V298, pH1022, DOI 10.1152/ajpheart.00902.2009; Thacker SG, 2016, IMMUNOLOGY, V149, P306, DOI 10.1111/imm.12638; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Tiniakou I, 2015, ATHEROSCLEROSIS, V243, P77, DOI 10.1016/j.atherosclerosis.2015.08.028; Varga ZV, 2014, AM J PHYSIOL-HEART C, V307, pH216, DOI 10.1152/ajpheart.00812.2013; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang AM, 2014, ONCOTARGET, V5, P5002, DOI 10.18632/oncotarget.2073; Wang LG, 2013, INT J ONCOL, V42, P957, DOI 10.3892/ijo.2013.1767; Xie YL, 2014, CLIN TRANSL ONCOL, V16, P898, DOI 10.1007/s12094-014-1166-x; Xu BQ, 2017, ARTERIOSCL THROM VAS, V37, P2260, DOI 10.1161/ATVBAHA.117.310290; Zhang R, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0171-2; Zhang Y, 2015, BIOCHEM BIOPH RES CO, V468, P300, DOI 10.1016/j.bbrc.2015.10.108; Zhang ZW, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20165760, 10.1590/1414-431x20165760]	53	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218432	10.1371/journal.pone.0218432	http://dx.doi.org/10.1371/journal.pone.0218432			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220137	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500046
J	Qiu, DJ; Huang, LM; Liu, X; Lin, SJ				Qiu, Dajun; Huang, Liangmin; Liu, Xin; Lin, Senjie			Flourishing deep-sea AAP bacteria detected by flow cytometric sorting and molecular analysis	PLOS ONE			English	Article							ANOXYGENIC PHOTOHETEROTROPHIC BACTERIA; GEN-NOV; QUANTIFICATION; BIOREMEDIATION; POPULATIONS; DIVERSITY; ABUNDANCE; GROWTH	Pigmented bacteria cells, including aerobic anoxygenic phototrophic (AAP) bacteria, contribute significantly to secondary production and aquatic carbon cycling but their distribution in the deep sea is still not well understood, especially in the South China Sea. In this study, microscopic, flow cytometric, and molecular analyses were carried out to investigate the abundance and diversity of AAP bacteria at seven stations in the South China Sea. The results revealed the existence of bacteriochlorophyll-containing bacteria below 500 m from two of seven stations. Flow cytometric analysis detected red and infra-red fluorescence under blue (488 nm) light excitation from fluorescent cells. Blue light-excited red fluorescence of these cells from the 1000 m depth at station E403 were verified using epifluorescence microscopy. Based on fluorescence and side scatter features, fluorescent cells were sorted and subjected to molecular analysis. DNA was extracted from these sorted cells from both stations for PCR amplification using 16S rDNA primers. Sequencing of the PCR products showed that the sorted cells from the 1000 m depth at station E403 belonged to the genus Porphyrobacter. The cell population sorted from 500 m at station E703 contained Sphingomonas and a Methylobacterium-like taxon. All these three taxa belong to aerobic anoxygenic phototrophic alpha-proteobacteria. Using flow cytometric analysis, we found that the abundance of Porphyrobacter sp. at 1000 m was 2.71-2.95x10(4) cells mL(-1) whereas cell counts of Sphingomonas sp. and Methylobacterium at 500 m were about 3.75-4.12x10(5) cells mL(-1). These results indicate that albeit not ubiquitous in deep water, bacteriochlorophyll-containing bacteria can be abundant in the deep-sea aphotic zone.	[Qiu, Dajun; Huang, Liangmin; Liu, Xin] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Qiu, Dajun; Huang, Liangmin] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, Guangzhou, Guangdong, Peoples R China; [Huang, Liangmin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Connecticut	Qiu, DJ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.; Qiu, DJ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, Guangzhou, Guangdong, Peoples R China.	djqiu@scsio.ac.cn	Lin, Senjie/A-7466-2011		Natural Science Foundation of China [411776154, 41129001, 41130855]; Science Technology Program Guangzhou of China [201607010289]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Program Guangzhou of China	This research work was supported by the program of the Natural Science Foundation of China (Grant 411776154 to DQ, 41129001 to SL, 41130855 to LH) and Science Technology Program Guangzhou of China (Grant 201607010289 to DQ).	Angelim AL, 2013, J ENVIRON MANAGE, V127, P10, DOI 10.1016/j.jenvman.2013.04.014; Basta T, 2005, MICROBIOL-SGM, V151, P2025, DOI 10.1099/mic.0.27965-0; Beatty JT, 2005, P NATL ACAD SCI USA, V102, P9306, DOI 10.1073/pnas.0503674102; Bibiloni-Isaksson J, 2016, ENVIRON MICROBIOL, V18, P4485, DOI 10.1111/1462-2920.13436; Brooijmans RJW, 2009, MICROB BIOTECHNOL, V2, P587, DOI 10.1111/j.1751-7915.2009.00151.x; Carpenter EJ, 2000, APPL ENVIRON MICROB, V66, P4514, DOI 10.1128/AEM.66.10.4514-4517.2000; Christner Brent C., 2008, P51, DOI 10.1007/978-3-540-74335-4_4; Cottrell MT, 2006, APPL ENVIRON MICROB, V72, P557, DOI 10.1128/AEM.72.1.557-564.2006; Eloe EA, 2011, ENV MICROBIOL REP, V3, P449, DOI 10.1111/j.1758-2229.2010.00223.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Ferrera I, 2017, ISME J, V11, P2391, DOI 10.1038/ismej.2017.79; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hiraishi A, 2002, ARCH MICROBIOL, V178, P45, DOI 10.1007/s00203-002-0423-5; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kasalicky V, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02116-17; Kato S, 2009, DEEP-SEA RES PT I, V56, P1844, DOI 10.1016/j.dsr.2009.05.004; Koblizek M, 2015, FEMS MICROBIOL REV, V39, P854, DOI 10.1093/femsre/fuv032; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; [李云 LI Yun], 2011, [沉积学报, Acta Sedimentologica Sinica], V29, P665; PIERSON BK, 1972, J GEN MICROBIOL, V73, P359, DOI 10.1099/00221287-73-2-359; Piwosz K, 2018, ENVIRON MICROBIOL, V20, P724, DOI 10.1111/1462-2920.14003; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ritchie AE, 2012, APPL ENVIRON MICROB, V78, P2858, DOI 10.1128/AEM.06268-11; Salka I, 2008, APPL ENVIRON MICROB, V74, P4398, DOI 10.1128/AEM.02447-07; SHIBA T, 1991, SYST APPL MICROBIOL, V14, P140, DOI 10.1016/S0723-2020(11)80292-4; SHIBA T, 1982, INT J SYST BACTERIOL, V32, P211, DOI 10.1099/00207713-32-2-211; Sieracki ME, 2006, LIMNOL OCEANOGR, V51, P38, DOI 10.4319/lo.2006.51.1.0038; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040784; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinas M, 2005, APPL ENVIRON MICROB, V71, P7008, DOI 10.1128/AEM.71.11.7008-7018.2005; Xue HJ, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2002JC001724; Yang TT, 2016, DEEP-SEA RES PT II, V129, P282, DOI 10.1016/j.dsr2.2014.01.014; Yurkov V, 1998, APPL ENVIRON MICROB, V64, P337; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002; Zhang Y, 2004, CHINESE SCI BULL, V49, P597, DOI 10.1360/03wc0447	37	0	0	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218753	10.1371/journal.pone.0218753	http://dx.doi.org/10.1371/journal.pone.0218753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216335	Green Submitted, Green Published, gold			2022-12-26	WOS:000482885300069
J	Jana, A; Nookaew, I; Singh, J; Behkam, B; Franco, AT; Nain, AS				Jana, Aniket; Nookaew, Intawat; Singh, Jugroop; Behkam, Bahareh; Franco, Aime T.; Nain, Amrinder S.			Crosshatch nanofiber networks of tunable interfiber spacing induce plasticity in cell migration and cytoskeletal response	FASEB JOURNAL			English	Article						persistent cell migration; 2D migration; 3D migration; nucleus geometry; cell-ECM interaction	NANONET FORCE MICROSCOPY; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; ACTIN CYTOSKELETON; ALIGNED NANOFIBERS; COLLAGEN-FIBERS; TISSUE; DYNAMICS; ADHESION; MECHANICS	Biomechanical cues within tissue microenvironments are critical for maintaining homeostasis, and their disruption can contribute to malignant transformation and metastasis. Once transformed, metastatic cancer cells can migrate persistently by adapting (plasticity) to changes in the local fibrous extracellular matrix, and current strategies to recapitulate persistent migration rely exclusively on the use of aligned geometries. Here, the controlled interfiber spacing in suspended crosshatch networks of nanofibers induces cells to exhibit plasticity in migratory behavior (persistent and random) and the associated cytoskeletal arrangement. At dense spacing (3 and 6 mu m), unexpectedly, elongated cells migrate persistently (in 1 dimension) at high speeds in 3-dimensional shapes with thick nuclei, and short focal adhesion cluster (FAC) lengths. With increased spacing (18 and 36 mu m), cells attain 2-dimensional morphologies, have flattened nuclei and longer FACs, and migrate randomly by rapidly detaching their trailing edges that strain the nuclei by similar to 35%. At 54-mu m spacing, kite-shaped cells become near stationary. Poorly developed filamentous actin stress fibers are found only in cells on 3-mu m networks. Gene-expression profiling shows a decrease in transcriptional potential and a differential up-regulation of metabolic pathways. The consistency in observed phenotypes across cell lines supports using this platform to dissect hallmarks of plasticity in migration in vitro.-Jana, A., Nookaew, I., Singh, J., Behkam, B., Franco, A. T., Nain, A. S. Crosshatch nanofiber networks of tunable interfiber spacing induce plasticity in cell migration and cytoskeletal response.	[Jana, Aniket; Behkam, Bahareh; Nain, Amrinder S.] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA; [Singh, Jugroop; Behkam, Bahareh; Nain, Amrinder S.] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Nookaew, Intawat; Franco, Aime T.] Univ Arkansas Med Sci, Coll Med, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Nookaew, Intawat] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Nain, AS (corresponding author), Virginia Tech, MC 0710,Randolph Hall, Blacksburg, VA 24061 USA.	nain@vt.edu		Jana, Aniket/0000-0003-2830-8210; Franco, Aime/0000-0002-1677-5228	Institute of Critical Technologies and Sciences (ICTAS) at Virginia Tech; National Science Foundation (NSF) [1437101, 1462916]; NSF [1454226]; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [P20GM125503]; U.S. NIH National Cancer Institute (NCI) [R01CA214511-01A1]; American Thyroid Association Thyroid Cancer Survivors Association (ThyCa); NATIONAL CANCER INSTITUTE [R01CA214511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM125503] Funding Source: NIH RePORTER	Institute of Critical Technologies and Sciences (ICTAS) at Virginia Tech; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); U.S. NIH National Cancer Institute (NCI); American Thyroid Association Thyroid Cancer Survivors Association (ThyCa); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.S.N. thanks the late Patricia Keely (University of Wisconsin-Madison, WI) for discussions and guidance on cell biology and dedicates this manuscript in her memory. A.S.N. also thanks Julie Phillippi and Thomas Gleason at University of Pittsburgh School of Medicine (Pittsburgh, PA, USA) for providing smooth muscle cells. A.J. and A.S.N. thank members of the Spinneret-based Tunable Engineering Parameters (STEP) Laboratory, Virginia Polytechnic Institute and State University (Virginia Tech), for helpful suggestions and discussions. The authors thank the Institute of Critical Technologies and Sciences (ICTAS) at Virginia Tech for the support to conduct this study. This work is supported by the National Science Foundation (NSF) (Grants 1437101 and 1462916 awarded to A.S.N.), the NSF Faculty Early Career Development Program (CAREER) (Grant 1454226 to B.B.), the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) (Grant P20GM125503 to I.N.), the U.S. NIH National Cancer Institute (NCI) (Grant R01CA214511-01A1 to A.T.F.), and an American Thyroid Association Thyroid Cancer Survivors Association (ThyCa) research grant to A.T.F. The authors declare no conflicts of interest.	Andresen V, 2009, CURR OPIN BIOTECH, V20, P54, DOI 10.1016/j.copbio.2009.02.008; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Chen B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02827; CHEN WT, 1981, J CELL BIOL, V90, P187, DOI 10.1083/jcb.90.1.187; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7; DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Fernandez M, 2002, PHYS MED BIOL, V47, P577, DOI 10.1088/0031-9155/47/4/303; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Glentis A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00985-8; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hall A, 2017, MOL BIOL CELL, V28, P1894, DOI 10.1091/mbc.E17-01-0053; Han WJ, 2016, P NATL ACAD SCI USA, V113, P11208, DOI 10.1073/pnas.1610347113; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Jolly LA, 2016, CANCER RES, V76, P1804, DOI 10.1158/0008-5472.CAN-15-2351; Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002; Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174; Kim DH, 2014, J CELL SCI, V127, P2528, DOI 10.1242/jcs.144345; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Ko YG, 2013, BIOMATERIALS, V34, P353, DOI 10.1016/j.biomaterials.2012.09.071; Koons B, 2017, ACS NANO, V11, P12037, DOI 10.1021/acsnano.7b04567; Kutys ML, 2014, NAT CELL BIOL, V16, P909, DOI 10.1038/ncb3026; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li S, 2001, BIORHEOLOGY, V38, P101; Liliensiek SJ, 2009, TISSUE ENG PT A, V15, P2643, DOI [10.1089/ten.tea.2008.0284, 10.1089/ten.TEA.2008.0284]; Liu QF, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0437-3; Lohela M, 2010, CURR OPIN GENET DEV, V20, P72, DOI 10.1016/j.gde.2009.10.011; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; McClendon MT, 2012, BIOMATERIALS, V33, P5713, DOI 10.1016/j.biomaterials.2012.04.040; Meehan S, 2014, BIOPHYS J, V107, P2604, DOI 10.1016/j.bpj.2014.09.045; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Metzner C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8516; Mukherjee RN, 2016, NUCLEUS-PHILA, V7, P167, DOI 10.1080/19491034.2016.1162933; Nain AS, 2008, SMALL, V4, P1153, DOI 10.1002/smll.200800101; Netti PA, 2000, CANCER RES, V60, P2497; Nisenholz N, 2014, SOFT MATTER, V10, P7234, DOI 10.1039/c4sm00780h; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Park J, 2018, BIOPHYS J, V114, P1257, DOI 10.1016/j.bpj.2017.11.3813; Passucci G, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006732; Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109; Paul CD, 2017, NAT REV CANCER, V17, P131, DOI 10.1038/nrc.2016.123; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Phillippi JA, 2009, CIRCULATION, V119, P2498, DOI 10.1161/CIRCULATIONAHA.108.770776; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Sharma P, 2017, MOL BIOL CELL, V28, P2579, DOI 10.1091/mbc.E17-05-0305; Sharma P, 2013, INTEGR BIOL-UK, V5, P1036, DOI 10.1039/c3ib40073e; Sheets K, 2016, BIOPHYS J, V111, P197, DOI 10.1016/j.bpj.2016.05.031; Sheets K, 2013, ACTA BIOMATER, V9, P7169, DOI 10.1016/j.actbio.2013.03.042; Shen MH, 2018, FRONT MED-PRC, V12, P426, DOI 10.1007/s11684-018-0663-7; Starke J, 2014, BIOCHEM SOC T, V42, P1356, DOI 10.1042/BST20140139; STOKES CL, 1991, J CELL SCI, V99, P419; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Taylor EN, 2015, BIOPHYS J, V108, P2740, DOI 10.1016/j.bpj.2015.03.061; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; van Helvert S, 2018, NAT CELL BIOL, V20, P8, DOI 10.1038/s41556-017-0012-0; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Wang J, 2014, LANGMUIR, V30, P13641, DOI 10.1021/la503011u; Weigelin Bettina, 2012, Intravital, V1, P32, DOI 10.4161/intv.21223; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Wong IY, 2014, NAT MATER, V13, P1063, DOI [10.1038/nmat4062, 10.1038/NMAT4062]; Woringer M, 2014, CURR OPIN CHEM BIOL, V20, P112, DOI 10.1016/j.cbpa.2014.05.009; Wu PH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.030; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	91	18	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10618	10632		10.1096/fj.201900131R	http://dx.doi.org/10.1096/fj.201900131R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31225977	Green Published, Bronze			2022-12-26	WOS:000489166300005
J	Govers, LC; Phillips, TR; Mattiske, DM; Rashoo, N; Black, JR; Sinclair, A; Baskin, LS; Risbridger, GP; Pask, AJ				Govers, Luke C.; Phillips, Tiffany R.; Mattiske, Deidre M.; Rashoo, Nineveh; Black, Jay R.; Sinclair, Adriane; Baskin, Laurence S.; Risbridger, Gail P.; Pask, Andrew J.			A critical role for estrogen signaling in penis development	FASEB JOURNAL			English	Article						hypospadias; urethral closure alpha ERKO; exogenous estrogen	MALE REPRODUCTIVE HEALTH; EXTERNAL GENITALIA; RECEPTOR-ALPHA; MOLECULAR-MECHANISMS; FEMALE MOUSE; HYPOSPADIAS; DIETHYLSTILBESTROL; BETA; DISRUPTION; EXPRESSION	Hypospadias, a developmental defect of the penis, is one of the most common congenital malformations in humans. Its incidence has rapidly increased over recent decades, and this has been largely attributed to our increased exposure to endocrine-disrupting chemicals. Penis development is primarily an androgen-driven process; however, estrogen and xenoestrogens are known to affect penis development in both humans and mice. Here, we investigated the role of estrogen in the developing penis. Using a novel penis culture system, we showed that exogenous estrogen directly targets the developing penis in utero to cause hypospadias. In addition, we also uncovered an unexpected endogenous role for estrogen in normal postnatal penis development and showed that a loss of estrogen signaling results in a mild hypospadias phenotype, the most common manifestation of this disease in humans. Our findings demonstrated that both androgen and estrogen signaling are intrinsically required for normal urethral closure. These findings confirmed that penis development is not an entirely androgen-driven process but one in which endogenous estrogen signaling also plays a critical role.-Govers, L. C., Phillips, T. R., Mattiske, D. M., Rashoo, N., Black, J. R., Sinclair, A., Baskin, L. S., Risbridger, G. P., Pask, A. J. A critical role for estrogen signaling in penis development.	[Govers, Luke C.; Phillips, Tiffany R.; Mattiske, Deidre M.; Rashoo, Nineveh; Pask, Andrew J.] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Black, Jay R.] Univ Melbourne, Sch Earth Sci, Melbourne, Vic, Australia; [Sinclair, Adriane; Baskin, Laurence S.] Univ Calif San Francisco, Benioff Childrens Hosp, Div Pediat Urol, San Francisco, CA 94143 USA; [Risbridger, Gail P.] Monash Univ, Monash Biomed Discovery Inst, Melbourne, Vic, Australia; [Risbridger, Gail P.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of California System; University of California San Francisco; Monash University; Monash University	Pask, AJ (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia.	ajpask@unimelb.edu.au	Risbridger, Gail P/B-8655-2008; Phillips, Tiffany/AAB-8067-2019; Black, Jay/K-3705-2013	Risbridger, Gail P/0000-0003-3089-4028; Phillips, Tiffany/0000-0001-6920-7710; Black, Jay/0000-0003-1872-9345; Pask, Andrew/0000-0002-1900-2263	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Grant [R01DK096263]; National Health and Medical Research Council of Australia [APP1098480]	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge technical support by the Melbourne Trace Analysis for Chemical, Earth, and Environmental Sciences (TrACEES) Platform for access to the GE Phoenix Nanotom M Micro-CT instrument. Research reported in this publication was supported by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Grant R01DK096263 (to A.J.P.), and by the National Health and Medical Research Council of Australia Project Grant APP1098480 (to G.P.R. and A.J.P.). The authors declare no conflicts of interest.	Abney TO, 1999, STEROIDS, V64, P610, DOI 10.1016/S0039-128X(99)00041-0; Agras K, 2007, J UROLOGY, V177, P2386, DOI 10.1016/j.juro.2007.01.111; Ban S, 2008, HUM REPROD, V23, P1466, DOI 10.1093/humrep/den098; Beleza-Meireles A, 2006, J ENDOCRINOL INVEST, V29, P5, DOI 10.1007/BF03349170; Beleza-Meireles A, 2007, J CLIN ENDOCR METAB, V92, P3712, DOI 10.1210/jc.2007-0543; Blaschko SD, 2013, ANAT REC, V296, P1127, DOI 10.1002/ar.22708; Blaschko SD, 2012, DIFFERENTIATION, V84, P261, DOI 10.1016/j.diff.2012.06.003; Buckanan DL, 1998, ENDOCRINOLOGY, V139, P4345, DOI 10.1210/en.139.10.4345; Carmichael SL, 2012, BIRTH DEFECTS RES A, V94, P499, DOI 10.1002/bdra.23021; Choudhry S, 2015, J UROLOGY, V193, P1625, DOI 10.1016/j.juro.2014.11.087; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Crescioli C, 2003, J CLIN ENDOCR METAB, V88, P1815, DOI 10.1210/jc.2002-021085; Cunha GR, 2014, DIFFERENTIATION, V87, P4, DOI 10.1016/j.diff.2013.12.003; Deng CK, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2288-0; Dietrich W, 2004, J HISTOCHEM CYTOCHEM, V52, P355, DOI 10.1177/002215540405200306; Fernandez MF, 2016, REPROD TOXICOL, V59, P89, DOI 10.1016/j.reprotox.2015.11.002; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Giordano F, 2010, BIRTH DEFECTS RES A, V88, P241, DOI 10.1002/bdra.20657; Goyal HO, 2004, BIOL REPROD, V70, P1504, DOI 10.1095/biolreprod.103.026328; Hynes PJ, 2004, BRIT J PLAST SURG, V57, P203, DOI 10.1016/j.bjps.2003.08.017; Jesmin S, 2004, J MOL ENDOCRINOL, V33, P343, DOI 10.1677/jme.1.01548; Jesmin S, 2002, ENDOCRINOLOGY, V143, P4764, DOI 10.1210/en.2002-220628; JONES TM, 1978, J CLIN ENDOCR METAB, V47, P1368, DOI 10.1210/jcem-47-6-1368; Kalfa N, 2015, EUR UROL, V68, P1023, DOI 10.1016/j.eururo.2015.05.008; Klip H, 2002, LANCET, V359, P1102, DOI 10.1016/S0140-6736(02)08152-7; Kojima Y, 2002, J UROLOGY, V167, P1532, DOI 10.1016/S0022-5347(05)65358-X; Korach KS, 2003, J STEROID BIOCHEM, V86, P387, DOI 10.1016/S0960-0760(03)00348-0; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Ma LM, 2009, J UROLOGY, V182, P2511, DOI 10.1016/j.juro.2009.07.008; Mahawong P, 2014, DIFFERENTIATION, V88, P70, DOI 10.1016/j.diff.2014.09.004; Mahawong P, 2014, DIFFERENTIATION, V88, P51, DOI 10.1016/j.diff.2014.09.005; Miyagawa S, 2002, ANAT RECORD, V266, P43, DOI 10.1002/ar.10033; Morales-Suarez-Varela MM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-3; MURAKAMI R, 1987, J ANAT, V153, P223; Ogino Y, 2001, ANN NY ACAD SCI, V948, P13; Paulozzi LJ, 1999, ENVIRON HEALTH PERSP, V107, P297, DOI 10.2307/3434597; Paulozzi LJ, 1997, PEDIATRICS, V100, P831, DOI 10.1542/peds.100.5.831; Phillips TR, 2015, SEX DEV, V9, P162, DOI 10.1159/000431010; Qiao L, 2012, J UROLOGY, V187, P1427, DOI 10.1016/j.juro.2011.12.008; Rodriguez E, 2012, DIFFERENTIATION, V84, P269, DOI 10.1016/j.diff.2012.07.003; Rodriguez E, 2011, BIOL REPROD, V85, P1216, DOI 10.1095/biolreprod.111.091504; Schlatt S, 1999, CELL TISSUE RES, V298, P335, DOI 10.1007/s004419900084; Schlomer BJ, 2013, J UROLOGY, V190, P1610, DOI 10.1016/j.juro.2013.02.3198; Schneuer FJ, 2015, ARCH DIS CHILD, V100, P1038, DOI 10.1136/archdischild-2015-308809; Scott S, 1999, MALE AND FEMALE CIRCUMCISION, P9, DOI 10.1007/978-0-585-39937-9_2; Skakkebaek NE, 2016, PHYSIOL REV, V96, P55, DOI 10.1152/physrev.00017.2015; Stewart MK, 2018, BIOL REPROD, V99, P1184, DOI 10.1093/biolre/ioy142; Syed F, 2005, BIOCHEM BIOPH RES CO, V328, P688, DOI 10.1016/j.bbrc.2004.11.097; Tannour-Louet M, 2014, NAT MED, V20, P715, DOI 10.1038/nm.3580; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Uda A, 2004, J UROLOGY, V171, P1362, DOI 10.1097/01.ju.0000100140.42618.54; van der Zanden LFM, 2010, J CLIN ENDOCR METAB, V95, P2384, DOI 10.1210/jc.2009-2101; Vignozzi L, 2004, ENDOCRINOLOGY, V145, P1823, DOI 10.1210/en.2003-0962; Vilela MLB, 2007, UROLOGY, V70, P618, DOI 10.1016/j.urology.2007.05.004; Watanabe M, 2007, HUM REPROD, V22, P1279, DOI 10.1093/humrep/del513; WILSON JD, 1981, HUM GENET, V58, P78, DOI 10.1007/BF00284153; Winston JJ, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0161-9; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Zheng ZG, 2015, P NATL ACAD SCI USA, V112, pE7194, DOI 10.1073/pnas.1515981112	59	19	19	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10383	10392		10.1096/fj.201802586RR	http://dx.doi.org/10.1096/fj.201802586RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31225966	Green Published			2022-12-26	WOS:000482214200053
J	Stepien, TL; Lynch, HE; Yancey, SX; Dempsey, L; Davidson, LA				Stepien, Tracy L.; Lynch, Holley E.; Yancey, Shirley X.; Dempsey, Laura; Davidson, Lance A.			Using a continuum model to decipher the mechanics of embryonic tissue spreading from time-lapse image sequences: An approximate Bayesian computation approach	PLOS ONE			English	Article							CELL-MIGRATION; MATHEMATICAL-MODEL; TRAVELING-WAVES; PROLIFERATION; GASTRULATION; PARAMETERS; MOVEMENT; TRACKING; SIGNALS	Advanced imaging techniques generate large datasets capable of describing the structure and kinematics of tissue spreading in embryonic development, wound healing, and the progression of many diseases. These datasets can be integrated with mathematical models to infer biomechanical properties of the system, typically identifying an optimal set of parameters for an individual experiment. However, these methods offer little information on the robustness of the fit and are generally ill-suited for statistical tests of multiple experiments. To overcome this limitation and enable efficient use of large datasets in a rigorous experimental design, we use the approximate Bayesian computation rejection algorithm to construct probability density distributions that estimate model parameters for a defined theoretical model and set of experimental data. Here, we demonstrate this method with a 2D Eulerian continuum mechanical model of spreading embryonic tissue. The model is tightly integrated with quantitative image analysis of different sized embryonic tissue explants spreading on extracellular matrix (ECM) and is regulated by a small set of parameters including forces on the free edge, tissue stiffness, strength of cell-ECM adhesions, and active cell shape changes. We find statistically significant trends in key parameters that vary with initial size of the explant, e.g., for larger explants cell-ECM adhesion forces are weaker and free edge forces are stronger. Furthermore, we demonstrate that estimated parameters for one explant can be used to predict the behavior of other similarly sized explants. These predictive methods can be used to guide further experiments to better understand how collective cell migration is regulated during development.	[Stepien, Tracy L.] Univ Arizona, Dept Math, Tucson, AZ 85721 USA; [Lynch, Holley E.] Stetson Univ, Dept Phys, Deland, FL 32720 USA; [Yancey, Shirley X.; Dempsey, Laura; Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Davidson, Lance A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15260 USA; [Davidson, Lance A.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Yancey, Shirley X.] George Washington Univ, Med Fac Associates, Washington, DC USA	University of Arizona; Stetson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University	Stepien, TL (corresponding author), Univ Arizona, Dept Math, Tucson, AZ 85721 USA.; Lynch, HE (corresponding author), Stetson Univ, Dept Phys, Deland, FL 32720 USA.; Davidson, LA (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Davidson, LA (corresponding author), Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15260 USA.; Davidson, LA (corresponding author), Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	stepien@math.arizona.edu; hlynch@stetson.edu; lance.a.davidson@pitt.edu		Stepien, Tracy/0000-0003-1683-0896	National Institutes of Health [R01 HD044750, R21 ES019259]; National Science Foundation [CAREER IOS-0845775, CMMI-1100515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	H.E.L. and L.A.D. acknowledge support from the National Institutes of Health (R01 HD044750 and R21 ES019259) and the National Science Foundation (CAREER IOS-0845775 and CMMI-1100515).	Allmaras M, 2013, SIAM REV, V55, P149, DOI 10.1137/100788604; Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Arciero JC, 2011, BIOPHYS J, V100, P535, DOI 10.1016/j.bpj.2010.11.083; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bindschadler M, 2007, J CELL SCI, V120, P876, DOI 10.1242/jcs.03395; Boyle JJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0685; Brodland G. W., 2004, Applied Mechanics Review, V57, P47, DOI 10.1115/1.1583758; Brodland GW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099116; Brodland GW, 2006, INT J PLASTICITY, V22, P965, DOI 10.1016/j.ijplas.2005.05.002; Browning AP, 2017, B MATH BIOL, V79, P1888, DOI 10.1007/s11538-017-0311-4; Callaghan T, 2006, J STAT PHYS, V122, P909, DOI 10.1007/s10955-006-9022-1; CHU TC, 1985, EXP MECH, V25, P232, DOI 10.1007/BF02325092; DALE PD, 1994, MATH BIOSCI, V124, P127, DOI 10.1016/0025-5564(94)90040-X; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Feroze R, 2015, DEV BIOL, V398, P57, DOI 10.1016/j.ydbio.2014.11.011; Ferrante E, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.268302; Fletcher AG, 2014, BIOPHYS J, V106, P2291, DOI 10.1016/j.bpj.2013.11.4498; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Fozard JA, 2010, MATH MED BIOL, V27, P39, DOI 10.1093/imammb/dqp015; Gaffney EA, 1999, J THEOR BIOL, V197, P15, DOI 10.1006/jtbi.1998.0852; Hock S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S10-S7; Irshad Humayun, 2014, IEEE Rev Biomed Eng, V7, P97, DOI 10.1109/RBME.2013.2295804; Javierre E, 2009, J MATH BIOL, V59, P605, DOI 10.1007/s00285-008-0242-7; Johnston ST, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0325; Kay B. K., 1991, XENOPUS LAEVIS PRACT; KELLER RE, 1980, J EMBRYOL EXP MORPH, V60, P201; Kopf MH, 2013, SOFT MATTER, V9, P3727, DOI 10.1039/c3sm26955h; Lai M.W., 2009, INTRO CONTINUUM MECH; Lee P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061920; Liepe J, 2014, NAT PROTOC, V9, P439, DOI 10.1038/nprot.2014.025; Longo D, 2004, DEV BIOL, V271, P210, DOI 10.1016/j.ydbio.2004.03.021; Luu O, 2011, P NATL ACAD SCI USA, V108, P4000, DOI 10.1073/pnas.1010331108; Maini PK, 2004, APPL MATH LETT, V17, P575, DOI 10.1016/S0893-9659(04)90128-0; Maini PK, 2004, TISSUE ENG, V10, P475, DOI 10.1089/107632704323061834; Mashburn DN, 2012, CYTOM PART A, V81A, P409, DOI 10.1002/cyto.a.22034; Mertz AF, 2013, P NATL ACAD SCI USA, V110, P842, DOI 10.1073/pnas.1217279110; Mertz AF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198101; Mi Q, 2007, BIOPHYS J, V93, P3745, DOI 10.1529/biophysj.107.112326; Murisic N, 2015, BIOPHYS J, V109, P154, DOI 10.1016/j.bpj.2015.05.019; Nieuwkoop PD, 1967, NORMAL TABLES XENOPU; Ouaknin GY, 2009, BIOPHYS J, V97, P1811, DOI 10.1016/j.bpj.2009.05.064; Ramos JW, 1996, J CELL BIOL, V134, P227, DOI 10.1083/jcb.134.1.227; Ramos JW, 1996, DEVELOPMENT, V122, P2873; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Rutter EM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02462-0; SATER AK, 1993, DEV DYNAM, V197, P268, DOI 10.1002/aja.1001970405; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheardown H, 1996, CHEM ENG SCI, V51, P4517, DOI 10.1016/0009-2509(96)00299-0; SHERRATT JA, 1990, P ROY SOC B-BIOL SCI, V241, P29, DOI 10.1098/rspb.1990.0061; SHERRATT JA, 1991, J MATH BIOL, V29, P389, DOI 10.1007/BF00160468; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Staple DB, 2010, EUR PHYS J E, V33, P117, DOI 10.1140/epje/i2010-10677-0; Stepien TL, 2014, SIAM J APPL DYN SYST, V13, P1489, DOI 10.1137/130941407; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; Sutton MA, 2009, IMAGE CORRELATION FOR SHAPE, MOTION AND DEFORMATION MEASUREMENTS: BASIC CONCEPTS, THEORY AND APPLICATIONS, P1, DOI [10.1007/978-0-387-78747-3, 10.1007/978-0-387-78747-3_5]; Tremel A, 2009, CHEM ENG SCI, V64, P247, DOI 10.1016/j.ces.2008.10.008; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; von Dassow M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095670; von Dassow M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015359; von Dassow M, 2009, DEV DYNAM, V238, P2, DOI 10.1002/dvdy.21809; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wearing HJ, 2000, MATH BIOSCI, V165, P41, DOI 10.1016/S0025-5564(00)00008-0; Wienert S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00503; Xue C, 2009, P NATL ACAD SCI USA, V106, P16782, DOI 10.1073/pnas.0909115106; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211	72	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218021	10.1371/journal.pone.0218021	http://dx.doi.org/10.1371/journal.pone.0218021			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246967	gold, Green Submitted, Green Published			2022-12-26	WOS:000484911900011
J	Wuyts, B; Champneys, AR; Verschueren, N; House, JI				Wuyts, Bert; Champneys, Alan R.; Verschueren, Nicolas; House, Jo I.			Tropical tree cover in a heterogeneous environment: A reaction-diffusion model	PLOS ONE			English	Article							FIRE-VEGETATION FEEDBACKS; SPATIAL-DISTRIBUTION; FOREST; SAVANNA; PRECIPITATION; BISTABILITY; EXPLAIN; SCALE; FIELD	Observed bimodal tree cover distributions at particular environmental conditions and theoretical models indicate that some areas in the tropics can be in either of the alternative stable vegetation states forest or savanna. However, when including spatial interaction in nonspatial differential equation models of a bistable quantity, only the state with the lowest potential energy remains stable. Our recent reaction-diffusion model of Amazonian tree cover confirmed this and was able to reproduce the observed spatial distribution of forest versus savanna satisfactorily when forced by heterogeneous environmental and anthropogenic variables, even though bistability was underestimated. These conclusions were solely based on simulation results for one set of parameters. Here, we perform an analytical and numerical analysis of the model. We derive the Maxwell point (MP) of the homogeneous reaction-diffusion equation without savanna trees as a function of rainfall and human impact and show that the front between forest and nonforest settles at this point as long as savanna tree cover near the front remains sufficiently low. For parameters resulting in higher savanna tree cover near the front, we also find irregular forest-savanna cycles and woodland-savanna bistability, which can both explain the remaining observed bimodality.	[Wuyts, Bert; Verschueren, Nicolas] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Wuyts, Bert] Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England; [Wuyts, Bert; Champneys, Alan R.; Verschueren, Nicolas] Univ Bristol, Appl Nonlinear Math, Bristol, Avon, England; [House, Jo I.] Univ Bristol, Sch Geog, Bristol, Avon, England	University of Exeter; University of Bristol; University of Bristol; University of Bristol	Wuyts, B (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England.; Wuyts, B (corresponding author), Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England.; Wuyts, B (corresponding author), Univ Bristol, Appl Nonlinear Math, Bristol, Avon, England.	b.wuyts@ex.ac.uk	Champneys, Alan R/A-2278-2013; Verschueren van Rees, Nicolas/ABG-1077-2021; House, Joanna/B-6477-2016	Verschueren van Rees, Nicolas/0000-0002-1086-4625; Champneys, Alan/0000-0001-7772-3686; House, Joanna/0000-0003-4576-3960; Wuyts, Bert/0000-0003-2549-1224	UK EPSRC [EP/N023544/1]; UK NERC (GGR Programme); EU [LU4C]	UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK NERC (GGR Programme); EU(European Commission)	For funding, BW and ARC acknowledge the UK EPSRC (BW: grant EP/N023544/1). JIH acknowledges the UK NERC (GGR Programme) and the EU FP7 (project LU4C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jan Sieber for comments and Daniele Avitabile for sharing and explaining the MATLAB code for numerical continuation. For funding, BW and ARC acknowledge the UK EPSRC (BW: grant EP/N023544/1). JIH acknowledges the UK NERC (GGR Programme) and the EU FP7 (project LU4C).	Avitabile D., 2016, NUMERICAL CALCULATIO; Beyn WJ, 2000, HDB DYNAMICAL SYSTEM; ELTAHIR EAB, 1994, Q J ROY METEOR SOC, V120, P861, DOI 10.1002/qj.49712051806; Gerard F, 2017, GLOBAL ECOL BIOGEOGR, V26, P854, DOI 10.1111/geb.12592; Good P, 2016, GLOBAL ECOL BIOGEOGR, V25, P16, DOI 10.1111/geb.12380; Grainger A., 1999, CONSTRAINTS MODELLIN; Hanan NP, 2014, GLOBAL ECOL BIOGEOGR, V23, P259, DOI 10.1111/geb.12122; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Huang K, 2009, INTRO STAT PHYS; McDonnell S, 2002, CONTRO ISSU CLIM MED, P17; Meron E., 2015, NONLINEAR PHYS ECOSY; Paiva AO, 2015, PLANT ECOL, V216, P775, DOI 10.1007/s11258-015-0466-8; Pausas JG, 2017, GLOBAL ECOL BIOGEOGR, V26, P395, DOI 10.1111/geb.12562; Pielke RA, 2001, REV GEOPHYS, V39, P151, DOI 10.1029/1999RG000072; Pismen LM., 2006, PATTERNS INTERFACES; Poschl U, 2010, SCIENCE, V329, P1513, DOI 10.1126/science.1191056; Rankin J, 2014, SIAM J SCI COMPUT, V36, pB70, DOI 10.1137/130918721; Ratajczak Z, 2012, SCIENCE, V336, DOI 10.1126/science.1219346; Scheffer M, 2005, GLOBAL CHANGE BIOL, V11, P1003, DOI 10.1111/j.1365-2486.2005.00962.x; SHERRATT JA, 1995, P NATL ACAD SCI USA, V92, P2524, DOI 10.1073/pnas.92.7.2524; Sherratt JA, 2008, J R SOC INTERFACE, V5, P483, DOI 10.1098/rsif.2007.1327; Staal A, 2016, ECOSYSTEMS, V19, P1080, DOI 10.1007/s10021-016-0011-1; Staver AC, 2012, AM NAT, V180, P211, DOI 10.1086/666648; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Strogatz S.H., 2014, NONLINEAR DYNAMICS C; Touboul J., 2018, P NATL ACAD SCI USA; van de Leemput IA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116859; van Nes EH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191027; van Nes EH, 2014, GLOBAL CHANGE BIOL, V20, P1016, DOI 10.1111/gcb.12398; Wuyts B, 2017, THESIS; Wuyts B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15519; Zemp DC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14681	32	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218151	10.1371/journal.pone.0218151	http://dx.doi.org/10.1371/journal.pone.0218151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246968	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900013
J	Alsaeedi, F; Wilson, R; Candlish, C; Ibrahim, I; Leitch, AC; Abdelghany, TM; Wilson, C; Armstrong, L; Wright, MC				Alsaeedi, Fouzeyyah; Wilson, Rachel; Candlish, Charlotte; Ibrahim, Ibrahim; Leitch, Alistair C.; Abdelghany, Tarek M.; Wilson, Colin; Armstrong, Lyle; Wright, Matthew C.			Expression of serine/threonine protein kinase SGK1F promotes an hepatoblast state in stem cells directed to differentiate into hepatocytes	PLOS ONE			English	Article							PROGENITOR; INDUCTION; PANCREAS	The rat pancreatic AR42J-B13 (B-13) cell line differentiates into non-replicative hepatocyte-like (B-13/H) cells in response to glucocorticoid. Since this response is dependent on an induction of serine/threonine protein kinase 1 (SGK1), this may suggest that a general pivotal role for SGK1 in hepatocyte maturation. To test this hypothesis, the effects of expressing adenoviral-encoded flag tagged human SGK1F (AdV-SGK1F) was examined at 3 stages of human induced pluripotent stem cell (iPSC) differentiation to hepatocytes. B-13 cells infected with AdV-SGK1F in the absence of glucocorticoid resulted in expression of flag tagged SGK1F protein; increases in beta-catenin phosphorylation; decreases in Tcf/Lef transcriptional activity; expression of hepatocyte marker genes and conversion of B-13 cells to a cell phenotype near-similar to B-13/H cells. Given this demonstration of functionality, iPSCs directed to differentiate towards hepatocyte-like cells using a standard protocol of chemical inhibitors and mixtures of growth factors were additionally infected with AdV-SGK1F, either at an early time point during differentiation to endoderm; during endoderm differentiation to anterior definitive endoderm and hepatoblasts and once converted to hepatocyte-like cells. SGK1F expression had no effect on differentiation to endoderm, likely due to low levels of expression. However, expression of SGK1F in both iPSCs-derived endoderm and hepatocyte-like cells both resulted in promotion of cells to an hepatoblast phenotype. These data demonstrate that SGK1 expression promotes an hepatoblast phenotype rather than maturation of human iPSC towards a mature hepatocyte phenotype and suggest a transient role for Sgk1 in promoting an hepatoblast state in B-13 trans-differentiation to B-13/H cells.	[Alsaeedi, Fouzeyyah; Ibrahim, Ibrahim; Leitch, Alistair C.; Abdelghany, Tarek M.; Wright, Matthew C.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Alsaeedi, Fouzeyyah] Taif Univ, Fac Med Sci, At Taif, Saudi Arabia; [Wilson, Rachel; Candlish, Charlotte; Armstrong, Lyle] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Ibrahim, Ibrahim; Wilson, Colin] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Abdelghany, Tarek M.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	Newcastle University - UK; Taif University; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Egyptian Knowledge Bank (EKB); Cairo University	Wright, MC (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	M.C.Wright@ncl.ac.uk		Wright, Matthew/0000-0003-3167-6743	Royal Government of Saudi Arabia; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Chemical and Radiation Threats and Hazards [HPRU2012-10076]; Public Health England (PHE); Newton-Mosharafa Fund	Royal Government of Saudi Arabia; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Chemical and Radiation Threats and Hazards; Public Health England (PHE); Newton-Mosharafa Fund	F. A. is supported by a studentship award from the Royal Government of Saudi Arabia. The research leading to these results has also received funding from the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Chemical and Radiation Threats and Hazards (HPRU2012-10076) in partnership with Public Health England (PHE), the Newton-Mosharafa Fund (in the form of a studentship supporting T.M.A).	Chen C, 2018, GASTROENTEROLOGY, V154, P1258, DOI 10.1053/j.gastro.2018.01.066; Dash A, 2013, AM J PHYSIOL-CELL PH, V304, pC1053, DOI 10.1152/ajpcell.00331.2012; DINGEMANSE MA, 1994, DIFFERENTIATION, V56, P153, DOI 10.1046/j.1432-0436.1994.5630153.x; Fairhall EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150959; Fairhall EA, 2013, TOXICOL RES-UK, V2, P80, DOI 10.1039/c2tx20061a; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Godoy P, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0221; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Harvey JL, 2000, DRUG METAB DISPOS, V28, P96; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Leitch AC, LIPOIC ACID MI UNPUB; Marek CJ, 2013, BIOCHEM J, V370, P763; Nagamoto Y, 2015, CELL TRANSPLANT, V24, P1127, DOI 10.3727/096368914X681702; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Neganova I, 2016, STEM CELLS, V34, P1198, DOI 10.1002/stem.2327; PADGHAM CRW, 1993, BIOCHEM BIOPH RES CO, V197, P599, DOI 10.1006/bbrc.1993.2521; Pan XP, 2016, HEPATOB PANCREAT DIS, V15, P173, DOI 10.1016/S1499-3872(16)60074-7; Pettinato G, 2016, SCI REP-UK, V6, DOI 10.1038/srep32888; Probert PME, 2015, TOXICOL RES-UK, V4, P203, DOI 10.1039/c4tx00214h; Richter M, 2016, TOXICOL RES-UK, V5, P278, DOI 10.1039/c5tx00187k; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Wallace K, 2011, J CELL SCI, V124, P405, DOI 10.1242/jcs.077503; Wallace K, 2010, TOXICOLOGY, V278, P277, DOI 10.1016/j.tox.2010.05.008; Wallace K, 2010, AM J PATHOL, V177, P1225, DOI 10.2353/ajpath.2010.100107; Wallace K, 2010, J CELL SCI, V123, P2102, DOI 10.1242/jcs.070722; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Williams DP, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0228; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	31	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218135	10.1371/journal.pone.0218135	http://dx.doi.org/10.1371/journal.pone.0218135			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242206	Green Published, gold, Green Submitted			2022-12-26	WOS:000482883600022
J	Nabel, CS; Sameroff, S; Shilling, D; Alapat, D; Ruth, JR; Kawano, M; Sato, Y; Stone, K; Spetalen, S; Valdivieso, F; Feldman, MD; Chadburn, A; Fossa, A; van Rhee, F; Lipkin, WI; Fajgenbaum, DC				Nabel, Christopher S.; Sameroff, Stephen; Shilling, Dustin; Alapat, Daisy; Ruth, Jason R.; Kawano, Mitsuhiro; Sato, Yasuharu; Stone, Katie; Spetalen, Signe; Valdivieso, Federico; Feldman, Michael D.; Chadburn, Amy; Fossa, Alexander; van Rhee, Frits; Lipkin, W. Ian; Fajgenbaum, David C.			Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HODGKINS-DISEASE; DNA; SYMPTOMS; CYTOKINE; HEALTH; LOAD	Castleman disease (CD) describes a spectrum of heterogeneous disorders defined by characteristic lymph node histopathology. Enlarged lymph nodes demonstrating CD histopathology can occur in isolation (unicentric CD; UCD) sometimes accompanied by mild symptoms, or at multiple sites (multicentric CD, MCD) with systemic inflammation and cytokine-driven multi-organ dysfunction. The discovery that Kaposi sarcoma herpesvirus/human herpesvirus (HHV)-8 drives MCD in a subset of patients has led to the hypotheses that UCD and MCD patients with negative HHV-8 testing by conventional methods may represent false negatives, or that these cases are driven by another virus, known or unknown. To investigate these hypotheses, the virome capture sequencing for vertebrate viruses (VirCapSeq-VERT) platform was employed to detect RNA transcripts from known and novel viruses in fresh frozen lymph node tissue from CD patients (12 UCD, 11 HHV-8-negative MCD [idiopathic MCD; iMCD], and two HHV-8-positive MCD) and related diseases (three T cell lymphoma and three Hodgkin lymphoma). This assay detected HHV-8 in both HHV-8-positive cases; however, HHV-8 was not found in clinically HHV-8-negative iMCD or UCD cases. Additionally, no novel viruses were discovered, and no single known virus was detected with apparent association to HHV-8-negative CD cases. Herpesviridae family members, notably including Epstein-Barr virus (EBV), were detected in 7 out of 12 UCD and 5 of 11 iMCD cases with apparent correlations with markers of disease severity in iMCD. Analysis of a separate cohort of archival formalin-fixed, paraffin-embedded lymph node tissue by In situ hybridization revealed significantly fewer EBV-positive cells in UCD and iMCD compared to tissue from HHV-8-positive MCD and EBV-associated lymphoproliferative disorder. In an additional cohort, quantitative testing for EBV by PCR in peripheral blood during disease flare did not detect systemic EBV viremia, suggesting detection lymph node tissue is due to occult, local reactivation in UCD and iMCD. This study confirms that HHV-8 is not present in UCD and iMCD patients. Further, it fails to establish a clear association between any single virus, novel or known, and CD in HHV-8-negative cases. Given that distinct forms of CD exist with viral and non-viral etiological drivers, CD should be considered a group of distinct and separate diseases with heterogeneous causes worthy of further study.	[Nabel, Christopher S.] Massachusetts Gen Hosp, Dana Farber Canc Inst, Canc Ctr, Boston, MA 02114 USA; [Sameroff, Stephen; Lipkin, W. Ian] Columbia Univ, New York, NY USA; [Shilling, Dustin; Ruth, Jason R.; Fajgenbaum, David C.] Castleman Dis Collaborat Network, Philadelphia, PA 19146 USA; [Alapat, Daisy; Stone, Katie; van Rhee, Frits] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR 72205 USA; [Kawano, Mitsuhiro] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Sato, Yasuharu] Okayama Univ, Grad Sch Hlth Sci, Div Pathophysiol, Okayama, Japan; [Spetalen, Signe; Fossa, Alexander] Oslo Univ Hosp, Oslo, Norway; [Valdivieso, Federico; Feldman, Michael D.] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA; [Chadburn, Amy] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Fajgenbaum, David C.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Harvard University; Dana-Farber Cancer Institute; Massachusetts General Hospital; Columbia University; University of Arkansas System; University of Arkansas Medical Sciences; Kanazawa University; Okayama University; University of Oslo; University of Pennsylvania; Pennsylvania Medicine; Cornell University; University of Pennsylvania	Fajgenbaum, DC (corresponding author), Castleman Dis Collaborat Network, Philadelphia, PA 19146 USA.; Fajgenbaum, DC (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	davidfa@pennmedicine.upenn.edu	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Sameroff, Stephen/0000-0001-8786-2057	Castleman Disease Collaborative Network (cdcn.org) Grant [CDCN-2015-002-R]	Castleman Disease Collaborative Network (cdcn.org) Grant	CSN, WIL and DCF were supported by the Castleman Disease Collaborative Network (cdcn.org) Grant# CDCN-2015-002-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1954, N Engl J Med, V250, P26; Barozzi P, 1996, J CLIN PATHOL-CL MOL, V49, pM232; Bowne WB, 1999, CANCER, V85, P706, DOI 10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7; Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15; CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4; Chen CH, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-31; DEACON EM, 1993, J EXP MED, V177, P339, DOI 10.1084/jem.177.2.339; Dossier A, 2013, CLIN INFECT DIS, V56, P833, DOI 10.1093/cid/cis1009; Dugdale C, 2017, AM J MED, V130, pE51, DOI 10.1016/j.amjmed.2016.08.029; Fajgenbaum DC, 2017, BLOOD, V129, P1646, DOI 10.1182/blood-2016-10-746933; Fajgenbaum DC, 2014, BLOOD, V123, P2924, DOI 10.1182/blood-2013-12-545087; Flavell KJ, 2000, J CLIN PATHOL-MOL PA, V53, P262, DOI 10.1136/mp.53.5.219; Focosi D, 2016, CLIN MICROBIOL INFEC, V22, P589, DOI 10.1016/j.cmi.2016.04.007; GABA AR, 1978, AM J CLIN PATHOL, V69, P86; Grandadam M, 1997, J INFECT DIS, V175, P1198, DOI 10.1086/593567; Kawabata H, 2013, J CLIN EXP HEMATOP, V53, P57, DOI 10.3960/jslrt.53.57; Kazazian HH, 2017, NEW ENGL J MED, V377, P361, DOI 10.1056/NEJMra1510092; Lipkin WI, 2015, J INFECT DIS, V212, pS26, DOI 10.1093/infdis/jiu649; Lipkin WI, 2015, VIROLOGY, V479, P194, DOI 10.1016/j.virol.2015.02.006; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292; MURRAY PG, 1995, HEMATOL PATHOL, V9, P17; Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073; Oksenhendler E, 1996, AIDS, V10, P61, DOI 10.1097/00002030-199601000-00009; Parravicini C, 1997, AM J PATHOL, V151, P1517; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Waterston A, 2004, ACTA ONCOL, V43, P698, DOI 10.1080/02841860410002752; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yu L, 2017, BLOOD, V129, P1658, DOI 10.1182/blood-2016-11-748855; Yuan XG, 2012, ANN HEMATOL, V91, P857, DOI 10.1007/s00277-011-1388-8	31	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218660	10.1371/journal.pone.0218660	http://dx.doi.org/10.1371/journal.pone.0218660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242229	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600043
J	Augustijn, D; de Groot, HJM; Alia, A				Augustijn, Dieuwertje; de Groot, Huub J. M.; Alia, A.			A robust circadian rhythm of metabolites in Arabidopsis thaliana mutants with enhanced growth characteristics	PLOS ONE			English	Article							GENE-EXPRESSION; BETAINE; CARBON; SUGARS; ACID	Climate change and the rising food demand provide a need for smart crops that yield more biomass. Recently, two Arabidopsis thaliana mutants with enhanced growth characteristics, VP16-02-003 and the VP16-05-014, were obtained by genome-wide reprogramming of gene expression, which led to the identification of novel biomarkers of these enhanced growth phenotypes. Since the circadian cycle strongly influences metabolic and physiological processes and exerts control over the photosynthetic machinery responsible for enhanced growth, in this study, we investigate the influences of the circadian clock on the metabolic rhythm of eighteen key biomarkers for the larger rosette surface area phenotype. The metabolic profile was studied in intact leaves at seven different time points throughout the circadian cycle using high-resolution magic angle spinning (HR-MAS) NMR. The results show that the circadian rhythm of biomarker metabolites are remarkably robust across wild-type Col-0 and VP16-02-003 and the VP16-05-014 mutants, with widely different metabolite levels of both mutants compared to Col-0 throughout the circadian cycle. Our analysis reveals that robustness is achieved through functional independence between the circadian clock and primary metabolic processes.	[Augustijn, Dieuwertje; de Groot, Huub J. M.; Alia, A.] Leiden Univ, Leiden Inst Chem, Leiden, Netherlands; [Alia, A.] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany	Leiden University; Leiden University - Excl LUMC; Leipzig University	de Groot, HJM; Alia, A (corresponding author), Leiden Univ, Leiden Inst Chem, Leiden, Netherlands.; Alia, A (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany.	groot_h@lic.leidenuniv.nl; a.alia@chem.leidenuniv.nl	de Groot, Huub J. M./J-4741-2012; de Groot, Huub/GXV-7380-2022	de Groot, Huub J. M./0000-0002-8796-1212; Augustijn, Dieuwertje/0000-0002-7990-3661	Foundation for Fundamental Research on Matter, NL [FOM23]; BioSolar Cell [U2.3]	Foundation for Fundamental Research on Matter, NL; BioSolar Cell	This work was financially supportedby the grant from Foundation for Fundamental Research on Matter, NL (http://www.fom.nl/live/english/home.pag), grant numberFOM23, and by the grant from BioSolar Cell (http://www.biosolarcells.nl/), grant number U2.3.	Augustijn D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163258; Augustijn D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209695; Barak S, 2000, TRENDS PLANT SCI, V5, P517, DOI 10.1016/S1360-1385(00)01785-4; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096889; Chia DW, 2000, PLANTA, V211, P743, DOI 10.1007/s004250000345; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fahnenstich H, 2007, PLANT PHYSIOL, V145, P640, DOI 10.1104/pp.107.104455; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Greenham K, 2015, NAT REV GENET, V16, P598, DOI 10.1038/nrg3976; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Huang H, 2016, TRENDS GENET, V32, P674, DOI 10.1016/j.tig.2016.08.002; Huang J, 2008, PLANT PHYSIOL BIOCH, V46, P647, DOI 10.1016/j.plaphy.2008.04.014; Igamberdiev AU, 2016, FRONT PLANT SCI, V7, P513, DOI [10.3389/FPLS.2016.00513, DOI 10.3389/FPLS.2016.00513]; Kamburova VS, 2017, INT J AGRON, V2017, DOI 10.1155/2017/7315351; Kim JA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122680; Kumar A, 2015, OMICS, V19, P581, DOI 10.1089/omi.2015.0106; Mba C., 2012, AGR FOOD SECURITY, V1, P7, DOI DOI 10.1186/2048-7010-1-7; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Meng PH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007364; Miller M, 2012, G3-GENES GENOM GENET, V2, P505, DOI 10.1534/g3.112.002162; Nakamichi N, 2011, PLANT CELL PHYSIOL, V52, P1709, DOI 10.1093/pcp/pcr118; Riewe D, 2016, PLANT J, V88, P826, DOI 10.1111/tpj.13303; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Sakamoto A, 2002, PLANT CELL ENVIRON, V25, P163, DOI 10.1046/j.0016-8025.2001.00790.x; Seki M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08325-y; Shim JS, 2017, PLANT PHYSIOL, V173, P5, DOI 10.1104/pp.16.01327; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Stitt M, 2014, TRENDS PLANT SCI, V19, P256, DOI 10.1016/j.tplants.2013.11.003; Thomas JD, 2004, ANNU REV BIOPH BIOM, V33, P75, DOI 10.1146/annurev.biophys.33.110502.132654; van Tol N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174236; van Tol N, 2014, PLANT SCI, V225, P58, DOI 10.1016/j.plantsci.2014.05.015; Virdi KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7386; Weiszmann J, 2017, VACUOLAR INVERTASE A, DOI [10.1101/168617, DOI 10.1101/168617]; Winter G, 2013, ENVIRON MICROBIOL, V15, P1901, DOI 10.1111/1462-2920.12064; Zell MB, 2010, PLANT PHYSIOL, V152, P1251, DOI 10.1104/pp.109.151795	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218219	10.1371/journal.pone.0218219	http://dx.doi.org/10.1371/journal.pone.0218219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237908	gold, Green Published, Green Submitted			2022-12-26	WOS:000484856000017
J	Malek-Ahmadi, M; Beach, TG; Zamrini, E; Adler, CH; Sabbagh, MN; Shill, HA; Jacobson, SA; Belden, CM; Caselli, RJ; Woodruff, BK; Rapscak, SZ; Ahern, GL; Shi, J; Caviness, JN; Driver-Dunckley, E; Mehta, SH; Shprecher, DR; Spann, BM; Tariot, P; Davis, KJ; Long, KE; Nicholson, LR; Intorcia, A; Glass, MJ; Walker, JE; Callan, M; Curry, J; Cutler, B; Oliver, J; Arce, R; Walker, DG; Lue, LF; Serrano, GE; Sue, LI; Chen, KW; Reiman, EM				Malek-Ahmadi, Michael; Beach, Thomas G.; Zamrini, Edward; Adler, Charles H.; Sabbagh, Marwan N.; Shill, Holly A.; Jacobson, Sandra A.; Belden, Christine M.; Caselli, Richard J.; Woodruff, Brian K.; Rapscak, Steven Z.; Ahern, Geoffrey L.; Shi, Jiong; Caviness, John N.; Driver-Dunckley, Erika; Mehta, Shyamal H.; Shprecher, David R.; Spann, Bryan M.; Tariot, Pierre; Davis, Kathryn J.; Long, Kathy E.; Nicholson, Lisa R.; Intorcia, Anthony; Glass, Michael J.; Walker, Jessica E.; Callan, Michael; Curry, Jasmine; Cutler, Brett; Oliver, Javon; Arce, Richard; Walker, Douglas G.; Lue, Lih-Fen; Serrano, Geidy E.; Sue, Lucia I.; Chen, Kewei; Reiman, Eric M.			Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; AMYLOID-BETA; BODIES; BRAIN; PATHOLOGY; IMPAIRMENT; NEUROPATHOLOGY; DIAGNOSIS	Background Neuropathology has demonstrated a high rate of comorbid pathology in dementia due to Alzheimer's disease (ADD). The most common major comorbidity is Lewy body disease (LBD), either as dementia with Lewy bodies (AD-DLB) or Alzheimer's disease with Lewy bodies (AD-LB), the latter representing subjects with ADD and LBD not meeting neuropathological distribution and density thresholds for DLB. Although it has been established that ADD subjects with undifferentiated LBD have a more rapid cognitive decline than those with ADD alone, it is still unknown whether AD-LB subjects, who represent the majority of LBD and approximately one-third of all those with ADD, have a different clinical course. Methods Subjects with dementia included those with "pure" ADD (n = 137), AD-DLB (n = 64) and ADLB (n = 114), all with two or more complete Mini Mental State Examinations (MMSE) and a full neuropathological examination. Results Linear mixed models assessing MMSE change showed that the AD-LB group had significantly greater decline compared to the ADD group (beta = -0.69, 95% CI: -1.05, -0.33, p<0.001) while the AD-DLB group did not (beta = -0.30, 95% CI: -0.73, 0.14, p = 0.18). Of those with AD-DLB and AD-LB, only 66% and 2.1%, respectively, had been diagnosed with LBD at any point during their clinical course. Compared with clinically-diagnosed AD-DLB subjects, those that were clinically undetected had significantly lower prevalences of parkinsonism (p = 0.046), visual hallucinations (p = 0.0008) and dream enactment behavior (0.013). Conclusions The probable cause of LBD clinical detection failure is the lack of a sufficient set of characteristic core clinical features. Core DLB clinical features were not more common in AD-LB as compared to ADD. Clinical identification of ADD with LBD would allow stratified analyses of ADD clinical trials, potentially improving the probability of trial success.	[Malek-Ahmadi, Michael; Tariot, Pierre; Chen, Kewei; Reiman, Eric M.] Banner Alzheimer Inst, Phoenix, AZ 85006 USA; [Beach, Thomas G.; Zamrini, Edward; Jacobson, Sandra A.; Belden, Christine M.; Shprecher, David R.; Spann, Bryan M.; Davis, Kathryn J.; Long, Kathy E.; Nicholson, Lisa R.; Intorcia, Anthony; Glass, Michael J.; Walker, Jessica E.; Callan, Michael; Curry, Jasmine; Cutler, Brett; Oliver, Javon; Arce, Richard; Lue, Lih-Fen; Serrano, Geidy E.; Sue, Lucia I.] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Adler, Charles H.; Caselli, Richard J.; Woodruff, Brian K.; Caviness, John N.; Driver-Dunckley, Erika; Mehta, Shyamal H.] Mayo Clin, Dept Neurol, Scottsdale, AZ USA; [Sabbagh, Marwan N.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Shill, Holly A.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Rapscak, Steven Z.; Ahern, Geoffrey L.] Univ Arizona, Dept Neurol, Tucson, AZ USA; [Shi, Jiong; Walker, Douglas G.] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga, Japan; [Chen, Kewei] Shanghai Green Valley Pharmaceut, Shanghai, Peoples R China; [Chen, Kewei] Arizona State Univ, Sch Math & Stat, Tempe, AZ USA; [Chen, Kewei] Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA; [Chen, Kewei] Beijing Normal Univ, Beijing, Peoples R China	Banner Research; Banner Health; Banner Alzheimer's Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Cleveland Clinic Foundation; Barrow Neurological Institute; University of Arizona; Shiga University of Medical Science; Arizona State University; Arizona State University-Tempe; University of Arizona; Beijing Normal University	Malek-Ahmadi, M (corresponding author), Banner Alzheimer Inst, Phoenix, AZ 85006 USA.	michael.malekahmadi@bannerhealth.com	Malek-Ahmadi, Michael/AAT-1052-2020; Adler, Charles/ABD-5276-2021	Malek-Ahmadi, Michael/0000-0001-9901-3650; 	National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; Shanghai Green Valley Pharmaceutical; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; Shanghai Green Valley Pharmaceutical; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Brain and Body Donation Program has been supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. Dr. Kewei Chen is employed by Shanghai Green Valley Pharmaceutical. Shanghai Green Valley Pharmaceutical provided support in the form of salary for author KC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adler CH, 2011, PARKINSONISM RELAT D, V17, P456, DOI 10.1016/j.parkreldis.2011.03.007; Akhtar RS, 2016, MOV DISORD CLIN PRAC, V3, P367, DOI 10.1002/mdc3.12290; [Anonymous], 1997, Neurobiol Aging, V18, pS1; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Beach TG, 2015, NEUROPATHOLOGY; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Bertrand E, 2004, FOLIA NEUROPATHOL, V42, P141; Boeve BF, 2013, SLEEP MED, V14, P754, DOI 10.1016/j.sleep.2012.10.015; Boeve BF, 2013, SLEEP MED; Boeve BF, 2013, J CLIN SLEEP MED, V9, P471, DOI 10.5664/jcsm.2670; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Brenowitz WD, 2017, ALZHEIMERS DEMENT, V13, P654, DOI 10.1016/j.jalz.2016.09.015; Brenowitz WD, 2017, NEUROBIOL AGING, V53, P83, DOI 10.1016/j.neurobiolaging.2017.01.017; Bugiani O, 2000, MICROSC RES TECHNIQ, V50, P10, DOI 10.1002/1097-0029(20000701)50:1<10::AID-JEMT3>3.3.CO;2-Y; Burack MA, 2010, NEUROLOGY, V74, P77, DOI 10.1212/WNL.0b013e3181c7da8e; Caselli RJ, 2017, MAYO CLIN PROC, V92, P978, DOI 10.1016/j.mayocp.2017.02.011; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Costa A, 2010, PARKINSONISM RELAT D, V16, P64, DOI 10.1016/j.parkreldis.2009.05.009; Deramecourt V, 2006, J NEUROPATH EXP NEUR, V65, P278, DOI 10.1097/01.jnen.0000205145.54457.ea; Ferman TJ, 2018, ALZHEIMERS DEMENT, V14, P330, DOI 10.1016/j.jalz.2017.09.014; Fujishiro H, 2013, PSYCHOGERIATRICS, V13, P128, DOI 10.1111/psyg.12005; Graff-Radford J, 2017, JAMA NEUROL, V74, P308, DOI 10.1001/jamaneurol.2016.4926; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hanyu H, 2009, EUR J NEUROL, V16, P212, DOI 10.1111/j.1468-1331.2008.02388.x; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Ishikawa A, 2005, ANN NEUROL, V57, P429, DOI 10.1002/ana.20393; Jellinger Kurt A., 2009, V24, P114, DOI 10.1159/000197890; Josephs KA, 2017, LANCET NEUROL, V16, P917, DOI 10.1016/S1474-4422(17)30284-3; Kaneko H, 2007, J NEUROSCI, V27, P13092, DOI 10.1523/JNEUROSCI.4244-07.2007; Kawas CH, 2015, NEUROLOGY, V85, P535, DOI 10.1212/WNL.0000000000001831; Kovari E, 2003, ACTA NEUROPATHOL, V106, P83, DOI 10.1007/s00401-003-0705-2; Kramberger MG, 2017, J ALZHEIMERS DIS, V57, P787, DOI 10.3233/JAD-161109; Kraybill ML, 2005, NEUROLOGY, V64, P2069, DOI 10.1212/01.WNL.0000165987.89198.65; LANTOS PL, 1994, NEUROSCI LETT, V172, P77, DOI 10.1016/0304-3940(94)90666-1; Lebouvier T, 2013, REV NEUROL-FRANCE, V169, P844, DOI 10.1016/j.neurol.2013.05.004; Leverenz JB, 2006, ARCH NEUROL-CHICAGO, V63, P370, DOI 10.1001/archneur.63.3.370; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; Mattila PM, ACTA NEUROPATHOL, DOI [10.1002/mds.21956, DOI 10.1002/MDS.21956]; McKeith I, 2016, J GERIATR PSYCH NEUR, V29, P249, DOI 10.1177/0891988716656083; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Molano J, 2010, BRAIN, V133, P540, DOI 10.1093/brain/awp280; Murray ME, 2013, NEUROLOGY, V81, P1681, DOI 10.1212/01.wnl.0000435299.57153.f0; Nag S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0531-3; Nelson PT, 2010, J NEUROL, V257, P359, DOI 10.1007/s00415-009-5324-y; Nelson PT, 2010, BRAIN PATHOL, V20, P66, DOI 10.1111/j.1750-3639.2008.00244.x; Olichney JM, 1998, NEUROLOGY, V51, P351, DOI 10.1212/WNL.51.2.351; Rongve A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010357; Rosenberg CK, 2000, ACTA NEUROPATHOL, V100, P145, DOI 10.1007/s004019900155; Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P295, DOI 10.1097/WAD.0b013e31819c5ef4; Savica R, 2018, ACTA NEUROL SCAND, P89, DOI [10.1111/neup.12189, DOI 10.1111/NEUP.12189]; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Shprecher DR, 2018, PARKINSONISM RELAT D; Spires-Jones TL, 2017, ACTA NEUROPATHOL, V134, P187, DOI 10.1007/s00401-017-1709-7; Tsuang DW, 2006, J ALZHEIMERS DIS, V9, P235; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; Walker Z, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000380; White LR, 2016, NEUROLOGY, V86, P1000, DOI 10.1212/WNL.0000000000002480; Williams MM, 2006, NEUROLOGY, V67, P1935, DOI 10.1212/01.wnl.0000247041.63081.98; Wilson RS, 2016, NEUROPSYCHOLOGY, V30, P591, DOI 10.1037/neu0000282; Wilson RS, 2011, CHEM SENSES, V36, P367, DOI 10.1093/chemse/bjq139; Winslow AR, 2014, BRAIN, V137, P1958, DOI 10.1093/brain/awu119	67	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0217566	10.1371/journal.pone.0217566	http://dx.doi.org/10.1371/journal.pone.0217566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237877	Green Submitted, gold, Green Published			2022-12-26	WOS:000484856000008
J	Tordai, A; Bors, A; Kiss, KP; Balassa, K; Andrikovics, H; Batai, A; Szilvasi, A; Rajczy, K; Inotai, D; Torbagyi, E; Lengyel, L; Barta, A; Remenyi, P; Masszi, T				Tordai, Attila; Bors, Andras; Kiss, Katalin Piroska; Balassa, Katalin; Andrikovics, Hajnalka; Batai, Arpad; Szilvasi, Aniko; Rajczy, Katalin; Inotai, Dora; Torbagyi, Eva; Lengyel, Lilla; Barta, Aniko; Remenyi, Peter; Masszi, Tamas			Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; CELL TRANSPLANTATION; ACUTE GVHD; NK CELLS; KIR; SURVIVAL; GRAFT; RELAPSE; REACTIVATION; EDUCATION	Background Recognition of HLA-C2 group alleles on recipient cells by activating killer immunoglobulin like receptors, KIR2DS1 on donor natural killer cells may lead to increased graft-versus-leukemia effect or immunomodulation in patients treated by allogeneic hematopoietic stem cell transplantation (allo-HSCT) influencing disease free and overall survival (OS). Objective In the present study, 314 consecutive, allo-HSCT recipient and donor pairs were included with retrospective donor KIR-genotyping and clinical parameters analyzes. Results After a median follow-up of 23.6 months, recipients with HLA-C2 group allele (rC2) showed improved (p = 0.046) OS if transplanted with KIR2DS1 positive donors (d2DS1) compared to those without one or both of this genetic attribute. Within the myeloablative conditioning (MAC) subgroup (n = 227), rC2 homozygous+ d2DS1 patients (n = 14) showed a 5 years OS of 93% followed by rC2 heterozygous+ d2DS1 patients (n = 48, 65%) compared to rC2 and/ or d2DS1 negatives (47%, p = 0.018). Multivariate analyses indicated rC2+ d2DS1 positivity as an independent predictor of OS (HR: 0.47, 0.26-0.86, p = 0.014) besides donor type, presence of CMV-reactivation or chemoresistant disease. Among MAC-treated patients, the combined rC2+ d2DS1 presence was associated with a markedly decreased cumulative incidence of transplant related mortality (p = 0.0045). Conclusion The combination of rC2+d2DS1 may be a favorable genetic constellation in allo-HSCT with MAC potentially reducing transplant related mortality.	[Tordai, Attila; Kiss, Katalin Piroska; Balassa, Katalin; Andrikovics, Hajnalka] Hungarian Natl Blood Transfus Serv, Lab Mol Diagnost, Budapest, Hungary; [Tordai, Attila] Semmelweis Univ, Dept Pathophysiol, Budapest, Hungary; [Bors, Andras; Andrikovics, Hajnalka] Natl Inst Haematol & Infectol, South Pest Cent Hosp, Lab Mol Diagnost, Budapest, Hungary; [Batai, Arpad; Torbagyi, Eva; Lengyel, Lilla; Barta, Aniko; Remenyi, Peter; Masszi, Tamas] Natl Inst Haematol & Infectol, South Pest Cent Hosp, Dept Haematol & Stem Cell Transplantat, Budapest, Hungary; [Szilvasi, Aniko; Inotai, Dora] Hungarian Natl Blood Transfus Serv, Transplantat Immunogenet Lab, Budapest, Hungary; [Rajczy, Katalin] Hungarian Natl Blood Transfus Serv, Hungarian Stem Cell Donor Registry, Budapest, Hungary; [Masszi, Tamas] Semmelweis Univ, Dept Internal Med 3, Budapest, Hungary	Semmelweis University; Semmelweis University	Tordai, A (corresponding author), Hungarian Natl Blood Transfus Serv, Lab Mol Diagnost, Budapest, Hungary.; Tordai, A (corresponding author), Semmelweis Univ, Dept Pathophysiol, Budapest, Hungary.	tordai.attila@med.semmelweis-univ.hu		Tordai, Attila/0000-0001-6966-1622	OTKA (Orszagos Tudomanyos Kutatasi Alap) [K104903]; FIKP (Felsooktatasi Intezmenyi Kivalosagi Palyazat); MTA (Magyar Tudomanyos Akademia)	OTKA (Orszagos Tudomanyos Kutatasi Alap)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); FIKP (Felsooktatasi Intezmenyi Kivalosagi Palyazat); MTA (Magyar Tudomanyos Akademia)	This work was supported by a grant from OTKA (Orszagos Tudomanyos Kutatasi Alap, K104903), and by a grant called FIKP (Felsooktatasi Intezmenyi Kivalosagi Palyazat) to AT. ABo and AH are recipients of the "Bolyai Scholarship" from MTA (Magyar Tudomanyos Akademia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos AT, 2011, TISSUE ANTIGENS, V77, P143, DOI 10.1111/j.1399-0039.2010.01588.x; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Babor F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00027; Bachanova V, 2016, BIOL BLOOD MARROW TR, V22, P1602, DOI 10.1016/j.bbmt.2016.05.016; Barrett AJ, 2010, EXPERT REV HEMATOL, V3, P429, DOI 10.1586/EHM.10.32; Boudreau JE, 2018, CURR OPIN IMMUNOL, V50, P102, DOI 10.1016/j.coi.2017.11.003; Brennan TV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00101; Chien JW, 2009, BIOL BLOOD MARROW TR, V15, P42, DOI 10.1016/j.bbmt.2008.11.003; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Crouse J, 2015, TRENDS IMMUNOL, V36, P49, DOI 10.1016/j.it.2014.11.001; Delgado J, 2014, HAEMATOLOGICA, V99, P1410, DOI 10.3324/haematol.2013.100784; Dickinson AM, 2008, INT J IMMUNOGENET, V35, P375, DOI 10.1111/j.1744-313X.2008.00790.x; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Foley B, 2014, IMMUNOL REV, V258, P45, DOI 10.1111/imr.12157; Fusco C, 2010, J NEUROIMMUNOL, V229, P232, DOI 10.1016/j.jneuroim.2010.08.004; Gaafar A, 2018, BONE MARROW TRANSPL, V53, P1170, DOI 10.1038/s41409-018-0123-7; Green ML, 2013, BLOOD, V122, P1316, DOI 10.1182/blood-2013-02-487074; Hansen JA, 2010, CURR OPIN HEMATOL, V17, P483, DOI 10.1097/MOH.0b013e32833eb770; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Hosokai R, 2017, BIOL BLOOD MARROW TR, V23, P606, DOI 10.1016/j.bbmt.2016.12.638; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; Jagasia M, 2012, BLOOD, V119, P296, DOI 10.1182/blood-2011-06-364265; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kannan GS, 2017, BLOOD REV, V31, P1, DOI 10.1016/j.blre.2016.08.007; Konya V, 2015, AM J TRANSPLANT, V15, P2795, DOI 10.1111/ajt.13394; Mancusi A, 2015, BLOOD, V125, P3173, DOI 10.1182/blood-2014-09-599993; Neuchel C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169512; Nowak J, 2015, BIOL BLOOD MARROW TR, V21, P829, DOI 10.1016/j.bbmt.2015.01.018; Nowak J, 2014, AM J HEMATOL, V89, pE176, DOI 10.1002/ajh.23802; Oevermann L, 2014, BLOOD, V124, P2744, DOI 10.1182/blood-2014-03-565069; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sebestyen A, 2015, OSTEOPOROSIS INT, V26, P1109, DOI 10.1007/s00198-014-2966-0; Sekine T, 2016, BLOOD, V128, P297, DOI 10.1182/blood-2016-03-706317; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Sivori S, 2011, BLOOD, V117, P4284, DOI 10.1182/blood-2010-10-316125; Stringaris K, 2017, CURR OPIN HEMATOL, V24, P489, DOI 10.1097/MOH.0000000000000384; Symons HJ, 2008, BONE MARROW TRANSPL, V42, P365, DOI 10.1038/bmt.2008.215; Teira P, 2016, BLOOD, V127, P2427, DOI 10.1182/blood-2015-11-679639; Venstrom JM, 2012, NEW ENGL J MED, V367, P805, DOI 10.1056/NEJMoa1200503	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218945	10.1371/journal.pone.0218945	http://dx.doi.org/10.1371/journal.pone.0218945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237928	Green Submitted, gold, Green Published			2022-12-26	WOS:000484856000054
J	Zainal, H; Dahlui, M; Soelar, SA; Su, TT				Zainal, Hadzri; Dahlui, Maznah; Soelar, Shahrul Aiman; Su, Tin Tin			Cost of preterm birth during initial hospitalization: A care provider's perspective	PLOS ONE			English	Article							NEONATAL INTENSIVE-CARE; LENGTH-OF-STAY; GESTATIONAL-AGE; INFANTS; OUTCOMES; IMPACT	Preterm birth incidence has risen globally and remains a major cause of neonatal mortality despite improved survival. Demand and cost of initial hospitalization has also increased. This study assessed the cost of preterm birth during initial hospitalization from care provider perspective in neonatal intensive care units (NICU) of two hospitals in the state of Kedah, Malaysia. It utilized universal sampling and prospectively followed up preterm infants till discharge. Care provider cost was assessed using mixed method of top down approach and activity based costing. A total of 112 preterm infants were recruited from intensive care (93 infants) and minimal care (19 infants) units. Majority were from the moderate (23%) and late (36%) preterm groups followed by very preterm (32%) and extreme preterm (9%). Median cost per infant increased with level of care and degree of prematurity. Cost was dominated by overhead (fixed) costs for general (hospital), intermediate (clinical support services) and final (NICU) cost centers where it constituted at least three quarters of admission cost per infant while the remainder was consumables (variable) cost. Breakdown of overhead cost showed NICU specific overhead contributing at least two thirds of admission cost per infant. Personnel salary made up three quarters of NICU specific overhead. Laboratory investigation was the cost driver for consumables. Gender, birth weight and length of stay were significant factors and cost prediction was developed with these variables. This study demonstrated the inverse relation between resource utilization, cost and prematurity and identified personnel salary as the cost driver. Cost estimates and prediction provide in-depth understanding of provider cost and are applicable for further economic evaluations. Since gender is non-modifiable and reducing LOS alone is not effective, birth weight as a cost predictive factor in this study can be addressed through measures to prevent or delay preterm birth.	[Zainal, Hadzri; Dahlui, Maznah; Su, Tin Tin] Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia; [Dahlui, Maznah] Univ Airlangga, Fac Publ Hlth, Surabaya, Indonesia; [Soelar, Shahrul Aiman] Minist Hlth, Clin Res Ctr, Alor Setar, Malaysia; [Su, Tin Tin] Monash Univ, South East Asia Community Observ, Jeffery Cheah Sch Med & Hlth Sci, Subang Jaya, Malaysia	Universiti Malaya; Airlangga University; Kementerian Kesihatan Malaysia; Monash University; Monash University Sunway	Zainal, H (corresponding author), Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia.	hadzrizainal@gmail.com	Dahlui, Maznah/F-9665-2010; Dahlui, Maznah/B-8976-2010	Su, Tin Tin/0000-0003-0387-6406; Dahlui, Maznah/0000-0003-4923-9410				Akman I, 2002, TURK J MED SCI, V32, P159; [Anonymous], 2012, R J PRELIMINARY REPO; [Anonymous], 2017, MAL NAT NEON REG REP; Behrman RE, 2007, PRETERM BIRTH CAUSES; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Cheah Irene Guat Sim, 2005, J Perinatol, V25, P47; Comert S, 2012, IRAN J PEDIATR, V22, P185; DeRienzo C, 2016, J PERINATOL, V36, P1128, DOI 10.1038/jp.2016.128; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; Evans J, 2018, CAN J ANESTH, V65, P627, DOI 10.1007/s12630-018-1087-1; Foundation. MoD, BAB BOYS HIGH RISK D; Geitona Mary, 2007, Cost Eff Resour Alloc, V5, P9, DOI 10.1186/1478-7547-5-9; Gilbert WM, 2003, OBSTET GYNECOL, V102, P488, DOI 10.1016/S0029-7844(03)00617-3; Hodek JM, 2011, HEALTH ECON REV, V1, DOI 10.1186/2191-1991-1-6; Ingemarsson I, 2003, BJOG-INT J OBSTET GY, V110, P34, DOI 10.1016/S1470-0328(03)00022-3; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; Kerlin MP, 2015, ANN AM THORAC SOC, V12, P1743, DOI 10.1513/AnnalsATS.201510-660ED; Kirkby Sharon, 2007, Adv Neonatal Care, V7, P80; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Moran JL, 2004, ANAESTH INTENS CARE, V32, P787, DOI 10.1177/0310057X0403200610; Narang A, 2005, INDIAN PEDIATR, V42, P989; NEWNS B, 1984, ARCH DIS CHILD, V59, P1064, DOI 10.1136/adc.59.11.1064; Petrou S, 2003, PEDIATRICS, V112, P1290, DOI 10.1542/peds.112.6.1290; Petrou S, 2003, BJOG-INT J OBSTET GY, V110, P17, DOI 10.1016/S1470-0328(03)00013-2; Richardson D K, 2001, J Perinatol, V21, P121, DOI 10.1038/sj.jp.7200501; Roberts RR, 1999, JAMA-J AM MED ASSOC, V281, P644, DOI 10.1001/jama.281.7.644; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; St John EB, 2000, AM J OBSTET GYNECOL, V182, P170, DOI 10.1016/S0002-9378(00)70509-6; Tommiska Viena, 2003, Pediatr Crit Care Med, V4, P157, DOI 10.1097/01.PCC.0000059731.74435.02; Tucker J, 2004, BRIT MED J, V329, P675, DOI 10.1136/bmj.329.7467.675; Zisk JL, 2011, AM J PERINAT, V28, P241, DOI 10.1055/s-0030-1268239	31	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0211997	10.1371/journal.pone.0211997	http://dx.doi.org/10.1371/journal.pone.0211997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237874	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000003
J	Holtrup, S; Heimerl, T; Linne, U; Altegoer, F; Noll, F; Waidner, B				Holtrup, Sven; Heimerl, Thomas; Linne, Uwe; Altegoer, Florian; Noll, Frank; Waidner, Barbara			Biochemical characterization of the Helicobacter pylori bactofilin-homolog HP1542	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BACTERIAL CYTOSKELETON; AMYLOID FIBRILS; CELL-SHAPE; PROTEIN; STOMACH; PEPTIDOGLYCAN; COLONIZATION; PREDICTION; MORPHOLOGY	The human pathogen Helicobacter pylori is known for its colonization of the upper digestive system, where it escapes the harsh acidic environment by hiding in the mucus layer. One factor promoting this colonization is the helical cell shape of H. pylori. Among shape determining proteins are cytoskeletal elements like the recently discovered bactofilins. Bactofilins constitute a widespread family of polymer-forming bacterial proteins whose biology is still poorly investigated. Here we describe the first biochemical analysis of the bactofilin HP1542 of H. pylori reference strain 26695. Purified HP1542 forms sheet-like 2D crystalline assemblies, which clearly depend on a natively structured C-terminus. Polymerization properties and protein stability were investigated. Additionally, we also could demarcate HP1542 from amyloid proteins that share similarities with the bactofilin DUF domain. By using zonal centrifugation of total H. pylori cell lysates and immunfluorescence analysis we revealed peripheral membrane association of HP1542 mostly pronounced near mid-cell. Interestingly our results indicate that H. pylori bactofilin does not contribute to cell wall stability. This study might act as a starting point for biophysical studies of the H. pylori bactofilin biology as well as for the investigation of bactofilin cell physiology in this organism. Importantly, this study is the first biochemical analysis of a bactofilin in a human pathogen.	[Holtrup, Sven; Heimerl, Thomas; Altegoer, Florian; Waidner, Barbara] Philipps Univ, LOEWE Ctr Synthet Microbiol, Marburg, Germany; [Holtrup, Sven; Linne, Uwe; Altegoer, Florian; Noll, Frank; Waidner, Barbara] Philipps Univ, Fac Chem, Marburg, Germany; [Heimerl, Thomas] Philipps Univ, Fac Biol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Waidner, B (corresponding author), Philipps Univ, LOEWE Ctr Synthet Microbiol, Marburg, Germany.; Waidner, B (corresponding author), Philipps Univ, Fac Chem, Marburg, Germany.	barbara.waidner@synmikro.uni-marburg.de	Altegoer, Florian/AAM-1354-2020	Altegoer, Florian/0000-0002-6012-9047; Holtrup, Sven/0000-0003-1708-1890	Deutsche Forschungsgemeinschaft [WA2574/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (https://www.dfg.de) WA2574/1-2 to BW.	An D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161489; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Blair KM, 2018, MOL MICROBIOL, V110, P114, DOI 10.1111/mmi.14087; BLASER MJ, 1990, J INFECT DIS, V161, P626, DOI 10.1093/infdis/161.4.626; Bulyha I, 2013, DEV CELL, V25, P119, DOI 10.1016/j.devcel.2013.02.017; Cho H, 2015, J MICROBIOL BIOTECHN, V25, P307, DOI 10.4014/jmb.1409.09047; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; DePas WH, 2012, RES MICROBIOL, V163, P592, DOI 10.1016/j.resmic.2012.10.009; El Andari J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141546; ELGHETANY MT, 1988, STAIN TECHNOL, V63, P201, DOI 10.3109/10520298809107185; Flores-Fernandez JM, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020050; Frick-Cheng AE, 2016, MBIO, V7, DOI 10.1128/mBio.02001-15; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gancz H, 2008, J BACTERIOL, V190, P4100, DOI 10.1128/JB.01728-07; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Goodwin A, 1998, MOL MICROBIOL, V28, P383, DOI 10.1046/j.1365-2958.1998.00806.x; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Hartmann R., 2018, BIORXIV, DOI [10.1101/360230, DOI 10.1101/360230]; Hay NA, 1999, J BACTERIOL, V181, P2008, DOI 10.1128/JB.181.7.2008-2016.1999; HAZELL SL, 1986, J INFECT DIS, V153, P658, DOI 10.1093/infdis/153.4.658; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jackson KM, 2018, MOL MICROBIOL, V108, P77, DOI 10.1111/mmi.13917; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P1, DOI 10.1016/S0065-3233(06)73001-7; Kamran M, 2018, FEBS J, V285, P2531, DOI 10.1111/febs.14499; Kassem MM, 2016, BIOPHYS J, V110, P2342, DOI 10.1016/j.bpj.2016.04.039; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Koch MK, 2011, MOL MICROBIOL, V80, P1031, DOI 10.1111/j.1365-2958.2011.07629.x; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Krzyzek P, 2018, GASTROENTEROL REV, V13, P182, DOI 10.5114/pg.2018.78284; Kuhn J, 2010, EMBO J, V29, P327, DOI 10.1038/emboj.2009.358; LEYING H, 1992, MOL MICROBIOL, V6, P2863, DOI 10.1111/j.1365-2958.1992.tb01466.x; Lin L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02015-z; Lin L, 2013, CYTOSKELETON, V70, P409, DOI 10.1002/cm.21126; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MARSHALL BJ, 1984, LANCET, V1, P1311; Okumura N, 2016, PROTEIN SCI, V25, P511, DOI 10.1002/pro.2842; PARSONNET J, 1994, WESTERN J MED, V161, P60; Peng ZY, 2017, BIOCHEMISTRY-US, V56, P6041, DOI 10.1021/acs.biochem.7b00364; Robinson K, 2017, CURR TOP MICROBIOL, V400, P1, DOI 10.1007/978-3-319-50520-6_1; Rovnyagina NR, 2018, INT J BIOL MACROMOL, V108, P284, DOI 10.1016/j.ijbiomac.2017.12.002; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schatzle S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121463; Shi CW, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501087; Specht M, 2011, J BACTERIOL, V193, P4523, DOI 10.1128/JB.00231-11; Stingl K, 2002, TRENDS MICROBIOL, V10, P70, DOI 10.1016/S0966-842X(01)02287-9; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Szwedziak P, 2013, CURR OPIN MICROBIOL, V16, P745, DOI 10.1016/j.mib.2013.09.003; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Teeseling MCF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01264; Vasa S, 2015, P NATL ACAD SCI USA, V112, pE127, DOI 10.1073/pnas.1418450112; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; Wang G, 2012, MBIO, V3, DOI 10.1128/mBio.00409-12; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Worku ML, 1999, MICROBIOL-SGM, V145, P2803, DOI 10.1099/00221287-145-10-2803; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7; Zuckerman DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121074	62	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218474	10.1371/journal.pone.0218474	http://dx.doi.org/10.1371/journal.pone.0218474			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233532	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700020
J	Pilotti-Riley, A; Stojanov, D; Arif, MS; McGregor, SJ				Pilotti-Riley, Aaron; Stojanov, Davor; Arif, Muhammad Sohaib; McGregor, Stephen J.			Video corroboration of player incurred impacts using trunk worn sensors among national ice-hockey team members	PLOS ONE			English	Article							BIOMECHANICS; INJURY; SPORTS	Purpose Video corroboration of player incurred impacts (PII) using trunk-worn wearable sensors (WS) among national ice-hockey team members. Methods 23 members of the U.S. National (NTDP) U18 team consented to procedures approved by EMU Human Subjects Committee. Bioharness-3 (Zephyr, MD) WS recorded occurrences of PII during games and impacts were generated using Impact Processor (Zephyr, MD). Eight players with the top activity levels each game determined by WS, were observed using video and synchronized with game video collected by NTDP staff. Impacts identified by WS of 6-7.9 g (Z3), 8-9.9 g (Z4) and 10+ g (Z5) were used to corroborate PII. Magnitude and duration of each identified impact were compared by category using MANOVA with Tukey post hoc (alpha = 0.05; SPSS 22.0, IBM, NY). Results Of 419 on-ice impacts, 358 were confirmed true PII (85.5%), 60 as other non-PII (14.3%) and 1 false positive (0.2%). For 358 PII, 17 (4.1%) were 1) Board contact/no check, 74 (17.7%), 2) Board contact/check, 202 (48.2%), 3) Open ice check, 65 (15.5%), 4) Player fall. Of 60 Non-PII, 19 (4.5%) as 5) other form of player to player event, 16 (3.8%) as 6) Hard Stop, 19 (4.5%) as 7) Slapshots and 6 (1.4%) as 8) other identifiable player events. 160 of the 200 Z3 events were PII (80%), 103 of 110 Z4 events (93.6%) and 95 of 109 Z5 events were PII (87.2%). The magnitude of impacts was not different by category, but the duration of category 6 (Hard stop;.058 s) was lower than categories 2, 4 and 7 (. 112, .112, .133 s, respectively, p<.05). Conclusion These data show that using some limited criteria (e.g. impact magnitude and duration), PII can be identified with relatively high accuracy in ice hockey using trunk-worn wearable sensors.	[Pilotti-Riley, Aaron; Stojanov, Davor; Arif, Muhammad Sohaib; McGregor, Stephen J.] Eastern Michigan Univ, Sport Performance Technol Lab, Sch Hlth Promot & Human Performance, Collage Hlth & Human Serv, Ypsilanti, MI 48197 USA	Eastern Michigan University	Pilotti-Riley, A (corresponding author), Eastern Michigan Univ, Sport Performance Technol Lab, Sch Hlth Promot & Human Performance, Collage Hlth & Human Serv, Ypsilanti, MI 48197 USA.	apilotti@emich.edu		Arif, Muhammad Sohaib/0000-0002-0180-0718	USA Hockey Foundation [18-0042]	USA Hockey Foundation	SJM received grant #18-0042, funded by USA Hockey Foundation (https://www.usahockeyfoundation.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckeridge E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127324; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Clark M, 2016, FRONTIERS NEUROSCIEN; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Cusimano Michael D, 2011, Open Med, V5, pe57; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P2319, DOI 10.1519/JSC.0b013e318277fd21; Gastin PB, 2014, J SPORT SCI, V32, P947, DOI 10.1080/02640414.2013.868920; Harris AW, 2012, CLIN J SPORT MED, V22, P455, DOI 10.1097/JSM.0b013e318259ed09; King B., 2015, SPORTS BUSINESS J; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Mckay CD, 2014, CAN J PUBLIC HEALTH, V105, pE445, DOI 10.17269/cjph.105.4653; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Popkin CA, 2016, OPEN ACCESS J SPORTS, V7, P167, DOI 10.2147/OAJSM.S118595; Trofa DP, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117741647; Upjohn T, 2008, SPORT BIOMECH, V7, P206, DOI 10.1080/14763140701841621; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218235	10.1371/journal.pone.0218235	http://dx.doi.org/10.1371/journal.pone.0218235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233527	Green Submitted, gold, Green Published			2022-12-26	WOS:000484896700014
J	Qaswar, M; Ahmed, W; Jing, H; Fan, HZ; Shi, XJ; Jiang, XJ; Liu, KL; Xu, YM; He, ZQ; Asghar, W; Shah, A; Zhang, HM				Qaswar, Muhammad; Ahmed, Waqas; Jing, Huang; Fan Hongzhu; Shi Xiaojun; Jiang Xianjun; Liu Kailou; Xu Yongmei; He Zhongqun; Asghar, Waleed; Shah, Asad; Zhang, Huimin			Soil carbon (C), nitrogen (N) and phosphorus (P) stoichiometry drives phosphorus lability in paddy soil under long-term fertilization: A fractionation and path analysis study	PLOS ONE			English	Article							ORGANIC-MATTER; ENZYME-ACTIVITIES; LAND-USE; MICROBIAL BIOMASS; USE EFFICIENCY; CROP YIELD; SORPTION; RICE; MANURE; AVAILABILITY	Soil C:N:P stoichiometry plays a vital role in nutrient cycling in ecosystems, but its importance to P transformation in paddy soil remains unclear. We investigated the effect of soil C: N: P stoichiometry on P mobility and uptake under long-term fertilization. Three treatments, CK (no fertilization), NPK (inorganic nitrogen, phosphorus and potassium fertilization) and NPKM (combined inorganic NPK fertilizer and manure application), were selected from two long-term experiments of paddy soil that were initiated in 1991 and 1982 in Chongqing and Suining, respectively. The results showed that in comparison the control treatment, under long-term fertilization, soil pH decreased. In comparison with the NPK and CK treatments, the NPKM treatment significantly increased soil nutrient contents, P uptake and phosphatase activities. In comparison to the CK treatment, the NPK and NPKM treatments significantly decreased soil C: N, C: P and N: P ratios. In comparison to NPK and CK treatments, the NPKM treatment decreased residual-P at both sites. Compared with CK treatment, the NPKM treatments increased labile-P and moderately labile-P by 987% and 144%, respectively, and NPK treatment increased these factors by 823% and 125%, respectively, at the Chongqing site. At the Suining site, with NPKM treatment, increases in labile-P and moderately labile-P were 706% and 73%, respectively, and with NPK treatment, the increases were 529% and 47%, respectively. In contrast, non-labile-P was significantly decreased with NPKM treatment in comparison to that with NPK and CK treatments. Moreover, increases in soil C: N and C: P ratios decreased the labile-P pools and increased non-labile-P pools. A path analysis indicated that soil C: N: P stoichiometry indirectly controlled P uptake by directly affecting P transformation from non-labile to labile-P pools. Moreover, the non-labile-P in soil with high SOM and P content directly affected P uptake, indicating that soil P transformation is mainly driven by soil C and P in paddy soil. In conclusion, understanding mechanism of P mobility influenced by soil C:N:P stoichiometry could be helpful to manage soil P fertility under long-term fertilization in paddy soils of these regions.	[Qaswar, Muhammad; Ahmed, Waqas; Jing, Huang; Liu Kailou; Shah, Asad; Zhang, Huimin] Chinese Acad Agr Sci, Natl Engn Lab Improving Qual Arable Land, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Jing, Huang; Zhang, Huimin] Chinese Acad Agr Sci, Natl Observat Stn Qiyang Agriecol Syst, Inst Agr Resources & Reg Planning, Qiyang, Hunan, Peoples R China; [Fan Hongzhu] Sichuan Acad Agr Sci, Soil & Fertilizer Res Inst, Chengdu, Sichuan, Peoples R China; [Shi Xiaojun; Jiang Xianjun] Southwest Univ, Coll Resources & Environm, Chongqing, Peoples R China; [Liu Kailou] Natl Engn & Technol Res Ctr Red Soil Improvement, Jiangxi Inst Red Soil, Nanchang, Jiangxi, Peoples R China; [Xu Yongmei] Xinjiang Acad Agr Sci, Inst Soil Fertilizer & Agr Water Conservat, Urumqi, Peoples R China; [He Zhongqun] Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China; [Asghar, Waleed] Beijing Normal Univ, Sch Environm, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Sichuan Academy of Agricultural Sciences (SAAS); Southwest University - China; Sichuan Agricultural University; Beijing Normal University	Zhang, HM (corresponding author), Chinese Acad Agr Sci, Natl Engn Lab Improving Qual Arable Land, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.; Zhang, HM (corresponding author), Chinese Acad Agr Sci, Natl Observat Stn Qiyang Agriecol Syst, Inst Agr Resources & Reg Planning, Qiyang, Hunan, Peoples R China.	zhanghuimin@caas.cn	Asghar, Waleed/ABB-9101-2020; Qaswar, Muhammad/ABF-5905-2021	Qaswar, Muhammad/0000-0002-0288-6250	National Key Research and Development Program of China [2016YFD0300901, 2016YFD0300902, 2017YFD0800101]; National Natural Science Foundation of China [41671301, 41371293, 41561070]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key Research and Development Program of China (2016YFD0300901, 2016YFD0300902 and 2017YFD0800101) and the National Natural Science Foundation of China (Nos. 41671301, 41371293 and 41561070) to H. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the staff at the two long-term experimental sites (Chongqing and Suining) for technical support to collect soil samples. We also appreciate Mr. Normatov Yodgor Mamanazarovich (Department of Soil Science, Gulistan State University, Uzbekistan) for his help during the sample analysis. This research was supported by the National Key Research and Development Program of China (2016YFD0300901, 2016YFD0300902 and 2017YFD0800101) and the National Natural Science Foundation of China (Nos. 41671301, 41371293 and 41561070).	Acosta-Martinez V, 2007, APPL SOIL ECOL, V35, P35, DOI 10.1016/j.apsoil.2006.05.012; Adhami E, 2013, J SOIL SCI PLANT NUT, V13, P11, DOI [10.4067/S0718-95162012005000002, 10.4067/S0718-95162013005000002]; Agbede TM, 2010, SOIL TILL RES, V110, P25, DOI 10.1016/j.still.2010.06.003; Ahmed W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216881; An N, 2018, EUR J AGRON, V93, P40, DOI 10.1016/j.eja.2017.11.001; [Anonymous], 2007, EXP AGR, DOI DOI 10.1017/S0014479706394902; Ayaga G, 2006, SOIL BIOL BIOCHEM, V38, P81, DOI 10.1016/j.soilbio.2005.04.019; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; Cao N, 2012, NUTR CYCL AGROECOSYS, V94, P161, DOI 10.1007/s10705-012-9530-0; Chen CR, 2015, GEODERMA, V257, P4, DOI 10.1016/j.geoderma.2015.04.027; Chen DM, 2017, EUR J AGRON, V90, P34, DOI 10.1016/j.eja.2017.07.007; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Condron LM, 2011, J SOIL SEDIMENT, V11, P830, DOI 10.1007/s11368-011-0363-2; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Cui X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18756-2; de Groot CC, 2003, PLANT SOIL, V248, P257, DOI 10.1023/A:1022323215010; Delgado A, 2002, PLANT SOIL, V245, P277, DOI 10.1023/A:1020445710584; Dobermann A, 2002, SOIL SCI SOC AM J, V66, P652, DOI 10.2136/sssaj2002.0652; Domagala-Swiatkiewicz I, 2013, BIOL AGRIC HORTIC, V29, P12, DOI 10.1080/01448765.2013.748362; Fan HZ, 2015, J INTEGR AGR, V14, P2417, DOI 10.1016/S2095-3119(15)61225-4; Fliessbach A, 2007, AGR ECOSYST ENVIRON, V118, P273, DOI 10.1016/j.agee.2006.05.022; Gama-Rodrigues AC, 2014, BIOGEOCHEMISTRY, V118, P453, DOI 10.1007/s10533-013-9946-x; Goll DS, 2012, BIOGEOSCIENCES, V9, P3547, DOI 10.5194/bg-9-3547-2012; Guerin JE, 2011, CAN J SOIL SCI, V91, P291, DOI [10.4141/CJSS10089, 10.4141/cjss10089]; Guppy CN, 2005, AUST J SOIL RES, V43, P189, DOI 10.1071/SR04049; Han TF, 2019, J SOIL SEDIMENT, V19, P1382, DOI 10.1007/s11368-018-2145-6; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Higgs B, 2000, J ENVIRON QUAL, V29, P80, DOI 10.2134/jeq2000.00472425002900010010x; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Huang J, 2017, J CLEAN PROD, V159, P171, DOI 10.1016/j.jclepro.2017.05.008; Janardhanan L, 2010, SOIL SCI SOC AM J, V74, P1597, DOI 10.2136/sssaj2009.0137; Jimenez JLG, 2019, GEODERMA, V338, P128, DOI 10.1016/j.geoderma.2018.11.049; Joshi R V, 2015, FORAGE RES, V41, P104; Kogel-Knabner I, 2010, GEODERMA, V157, P1, DOI 10.1016/j.geoderma.2010.03.009; Ladha JK, 2011, J ENVIRON QUAL, V40, P1756, DOI 10.2134/jeq2011.0064; Lehmann J, 2005, ENVIRON SCI TECHNOL, V39, P6672, DOI 10.1021/es047997g; Li GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102698; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Liu ZF, 2010, SOIL BIOL BIOCHEM, V42, P445, DOI 10.1016/j.soilbio.2009.11.027; Lu RK, 2000, ANALYTICAL METHODS O; Luo ZK, 2017, GLOBAL CHANGE BIOL, V23, P4430, DOI 10.1111/gcb.13767; Malik MA, 2012, SOIL BIOL BIOCHEM, V49, P106, DOI 10.1016/j.soilbio.2012.02.013; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Margalef O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01418-8; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Mi WH, 2016, SOIL TILL RES, V163, P64, DOI 10.1016/j.still.2016.05.009; Mohanty S, 2006, GEODERMA, V133, P225, DOI 10.1016/j.geoderma.2005.07.009; Nayak DR, 2007, SOIL BIOL BIOCHEM, V39, P1897, DOI 10.1016/j.soilbio.2007.02.003; Negassa W, 2009, J PLANT NUTR SOIL SC, V172, P305, DOI 10.1002/jpln.200800223; Ohm M, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0425-y; Olsen S.R., 1982, CHEM MICROBIOL PROP, P403; Reddy DD, 2005, J PLANT NUTR SOIL SC, V168, P241, DOI 10.1002/jpln.200421444; Sadeghpour A, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0416-z; Sharpley AN, 2007, J SOIL WATER CONSERV, V62, P375; Siddique MT, 2003, J ENVIRON QUAL, V32, P1114, DOI 10.2134/jeq2003.1114; Simonsson M, 2018, GEODERMA, V315, P208, DOI 10.1016/j.geoderma.2017.11.019; Sparks D.L., 1996, METHODS SOIL ANAL 3; Steel RGD, 1997, PRINCIPLES AND PROCE; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Tian J, 2013, PLANT SOIL, V372, P53, DOI 10.1007/s11104-013-1715-z; Tiecher T, 2018, SOIL TILL RES, V175, P276, DOI 10.1016/j.still.2017.09.015; Tiessen H., 1993, SOIL SAMPLING METHOD, P75, DOI [10.1201/9781420005271.ch25, DOI 10.1201/9781420005271.CH25]; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang WQ, 2015, CATENA, V133, P171, DOI 10.1016/j.catena.2015.05.003; Wang YP, 2010, BIOGEOSCIENCES, V7, P2261, DOI 10.5194/bg-7-2261-2010; Wei WL, 2016, AGR ECOSYST ENVIRON, V225, P86, DOI 10.1016/j.agee.2016.04.004; Williams A, 2013, SOIL BIOL BIOCHEM, V67, P41, DOI 10.1016/j.soilbio.2013.08.008; Wojciech P, 2019, CATENA, V179, P1, DOI 10.1016/j.catena.2019.03.025; Wu Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179957; Xin XL, 2017, FIELD CROP RES, V208, P27, DOI 10.1016/j.fcr.2017.03.011; Xu ZX, 2009, ACTA AGRIC ZHEJIANGE, V5, P485; Yan X, 2017, GEODERMA, V295, P80, DOI 10.1016/j.geoderma.2017.02.012; Yan Xiao, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P393; Ye GP, 2019, APPL SOIL ECOL, V133, P24, DOI 10.1016/j.apsoil.2018.09.008; Yuan ZY, 2015, NAT CLIM CHANGE, V5, P465, DOI [10.1038/nclimate2549, 10.1038/NCLIMATE2549]; Zhang HM, 2010, NUTR CYCL AGROECOSYS, V88, P341, DOI 10.1007/s10705-010-9359-3; Zhang W, 2019, GEODERMA, V337, P280, DOI 10.1016/j.geoderma.2018.09.042; Zhang ZS, 2013, J SOIL SCI PLANT NUT, V13, P871, DOI 10.4067/S0718-95162013005000069; Zhao YC, 2009, EUR J AGRON, V31, P36, DOI 10.1016/j.eja.2009.03.001	82	17	18	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218195	10.1371/journal.pone.0218195	http://dx.doi.org/10.1371/journal.pone.0218195			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233510	gold, Green Published, Green Submitted			2022-12-26	WOS:000484896700013
J	Ribera, J; Rodriguez-Vita, J; Cordoba, B; Portoles, I; Casals, G; Casals, E; Jimenez, W; Puntes, V; Morales-Ruiz, M				Ribera, Jordi; Rodriguez-Vita, Juan; Cordoba, Bernat; Portoles, Irene; Casals, Gregori; Casals, Eudald; Jimenez, Wladimiro; Puntes, Victor; Morales-Ruiz, Manuel			Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE; IN-VITRO; LIVER; HYPERTENSION; PRESSURE; CELLS; INTERLEUKIN-6; FIBROSIS; MODEL	Background and aims The occurrence of endothelial alterations in the liver and in the splanchnic vasculature of cirrhotic patients and experimental models of liver diseases has been demonstrated. However, the pathological role of the portal vein endothelium in this clinical context is scarcely studied and, therefore, deserves attention. In this context, we aimed to investigate whether pathological endothelial activation occurs in the portal vein of cirrhotic rats. Methods Cirrhosis was induced in wistar rats by CCl4 inhalation. We generated immortalized endothelial cells from the portal vein of control (CT-iPVEC) and cirrhotic rats (CH-iPVEC) by retroviral transduction of the SV40 T antigen. We assessed differential gene expression and intracellular reactive oxygen species (ROS) levels in iPVECs and in portal veins of control and cirrhotic rats. Finally, we assessed the therapeutic effectiveness of cerium oxide nanoparticles (CeO2NP) on reversing PVEC activation and macrophage polarization. Results CH-iPVECs overexpressed collagen-I, endothelin-1, TIMP-1, TIMP-2, IL-6 and PlGF genes. These results were consistent with the differential expression showed by whole portal veins from cirrhotic rats. In addition, CH-iPVECs showed a significant increase in intracellular ROS and the capacity of potentiating M1 polarization in macrophages. The treatment of CH-iPVECs with CeO(2)NPs blocked intracellular ROS formation and IL-6 and TIMP-2 gene overexpression. In agreement with the in vitro results, the chronic treatment of cirrhotic rats with CeO(2)NPs also resulted in the blockade of both ROS formation and IL-6 gene overexpression in whole portal veins. Conclusions Endothelial cells from portal vein of cirrhotic rats depicted an abnormal phenotype characterized by a differential gene expression and the induction of M1 polarization in macrophages. We identified the excess of intracellular reactive oxygen species (ROS) as a major contributor to this altered phenotype. In addition, we demonstrated the utility of the nanomaterial cerium oxide as an effective antioxidant capable of reverse some of these pathological features associated with the portal vein in the cirrhosis condition.	[Ribera, Jordi; Rodriguez-Vita, Juan; Cordoba, Bernat; Portoles, Irene; Casals, Gregori; Jimenez, Wladimiro; Morales-Ruiz, Manuel] Hosp Clin Barcelona, Biochem & Mol Genet Dept, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Rodriguez-Vita, Juan] German Canc Res Ctr, Heidelberg, Germany; [Casals, Eudald; Puntes, Victor] Catalan Inst Nanotechnol ICN, Bellaterra, Spain; [Jimenez, Wladimiro; Morales-Ruiz, Manuel] Univ Barcelona, Sch Med, Biochem Unit, Dept Biomed, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Helmholtz Association; German Cancer Research Center (DKFZ); Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); University of Barcelona	Morales-Ruiz, M (corresponding author), Hosp Clin Barcelona, Biochem & Mol Genet Dept, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.; Morales-Ruiz, M (corresponding author), Univ Barcelona, Sch Med, Biochem Unit, Dept Biomed, Barcelona, Spain.	morales@clinic.ub.es	Ribera, Jordi/Z-1395-2019; Puntes, Victor/AAL-6081-2021; Casals, Gregori/F-6506-2012; Morales-Ruiz, Manuel/Z-2332-2019; Morales-Ruiz, Manuel/AAM-1487-2020; Portolés, Irene/Z-1560-2019; Casals, Eudald/P-2382-2016; Rodriguez-Vita, Juan/U-6337-2019	Ribera, Jordi/0000-0002-0288-4220; Puntes, Victor/0000-0001-8996-9499; Casals, Gregori/0000-0002-3271-1371; Morales-Ruiz, Manuel/0000-0002-9074-2272; Casals, Eudald/0000-0002-2900-7295; Rodriguez-Vita, Juan/0000-0001-9547-5508	Ministerio de Economia y Competitividad [SAF 2015-64126-R, PI15-00077, SAF2016-75358-R]; FEDER, European Union, a way of making Europe; Fundacio La Marato de TV3 [Marato 120930]; Spanish MINECO [MAT2015-70725-R]; Catalan Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2017-SGR-143, 2016-BP-00301]; BIOTRACK Postdoctoral Fellowship - European Community; MINECO [229673]; Instituto de Salud Carlos III	Ministerio de Economia y Competitividad(Spanish Government); FEDER, European Union, a way of making Europe; Fundacio La Marato de TV3; Spanish MINECO(Spanish Government); Catalan Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); BIOTRACK Postdoctoral Fellowship - European Community; MINECO(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Supported by grants from the Ministerio de Economia y Competitividad (SAF 2015-64126-R to WJ, PI15-00077 to GC and SAF2016-75358-R to MM-R), co-financed by FEDER, European Union, a way of making Europe, Fundacio La Marato de TV3 (Marato 120930), Spanish MINECO (MAT2015-70725-R) and the Catalan Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) (2017-SGR-143 to VP and 2016-BP-00301 to EC). JR-V is the recipient of a BIOTRACK Postdoctoral Fellowship supported by the European Community's Seventh Framework Programme and the MINECO (Contract 229673). CIBERehd is financed by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SK, 2009, INT J EXP PATHOL, V90, P321, DOI 10.1111/j.1365-2613.2009.00658.x; Alili L, 2011, BIOMATERIALS, V32, P2918, DOI 10.1016/j.biomaterials.2010.12.056; Amin KA, 2011, INT J NANOMED, V6, P143, DOI 10.2147/IJN.S15308; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Cafun JD, 2013, ACS NANO, V7, P10726, DOI 10.1021/nn403542p; Caputo F, 2014, BIOCHEM PHARMACOL, V92, P112, DOI 10.1016/j.bcp.2014.08.015; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/NNANO.2011.58, 10.1038/nnano.2011.58]; Colell A, 1998, GASTROENTEROLOGY, V115, P1541, DOI 10.1016/S0016-5085(98)70034-4; Colon J, 2010, NANOMED-NANOTECHNOL, V6, P698, DOI 10.1016/j.nano.2010.01.010; D'Angelo B, 2009, CURR NANOSCI, V5, P167, DOI 10.2174/157341309788185523; Di Pascoli M, 2013, J HEPATOL, V58, P904, DOI 10.1016/j.jhep.2012.12.012; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Fernandez-Varo G, 2007, J HEPATOL, V46, P440, DOI 10.1016/j.jhep.2006.09.023; Fullstone G, 2015, SCI REP-UK, V5, DOI 10.1038/srep10649; GAMBLE JR, 1985, P NATL ACAD SCI USA, V82, P8667, DOI 10.1073/pnas.82.24.8667; Geller DA, 2009, PRINCIPLES SURG, P1; Giannitrapani L, 2002, ANN NY ACAD SCI, V963, P46, DOI 10.1111/j.1749-6632.2002.tb04093.x; Gimbrone MA, 2013, CARDIOVASC PATHOL, V22, P9, DOI 10.1016/j.carpath.2012.06.006; Grossman E, 2008, DIABETES CARE, V31, pS185, DOI 10.2337/dc08-s246; Groszmann RJ, 2004, HEPATOLOGY, V39, P280, DOI 10.1002/hep.20062; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Gupta TK, 1998, HEPATOLOGY, V28, P926, DOI 10.1002/hep.510280405; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Kim CK, 2012, ANGEW CHEM INT EDIT, V51, P11039, DOI 10.1002/anie.201203780; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Koh KK, 2009, CARDIOVASC RES, V81, P649, DOI 10.1093/cvr/cvn354; Lavina B, 2009, GUT, V58, P118, DOI 10.1136/gut.2008.149880; Lee PC, 2005, TOXICOL SCI, V85, P541, DOI 10.1093/toxsci/kfi101; LEIVAS A, 1995, GASTROENTEROLOGY, V108, P1842, DOI 10.1016/0016-5085(95)90148-5; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; McCord J M, 1985, Adv Myocardiol, V5, P183; Morales-Ruiz M, 2015, PANVASCULAR MED, P3631, DOI DOI 10.1007/978-3-642-37078-6_141; Niu JL, 2007, CARDIOVASC RES, V73, P549, DOI 10.1016/j.cardiores.2006.11.031; Niu JL, 2011, J PHARMACOL EXP THER, V338, P53, DOI 10.1124/jpet.111.179978; Oro D, 2016, J HEPATOL, V64, P691, DOI 10.1016/j.jhep.2015.10.020; POBER JS, 1986, J IMMUNOL, V136, P1680; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Pourkhalili N, 2012, TOXICOL MECH METHOD, V22, P476, DOI 10.3109/15376516.2012.673093; Pourkhalili N, 2011, WORLD J DIABETES, V2, P204, DOI 10.4239/wjd.v2.i11.204; Pratico D, 2005, ATHEROSCLEROSIS, V181, P215, DOI 10.1016/j.atherosclerosis.2005.03.005; Salonen JT, 2000, ATHEROSCLEROSIS, V148, P265, DOI 10.1016/S0021-9150(99)00272-5; Sarin SK, 2005, CLIN GASTROENT, P411; SCHLEIMER RP, 1986, J IMMUNOL, V136, P649; Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129; Shah V, 2010, SLEISENGER FORDTRANS, P1489; Shi Q, 2004, DNA CELL BIOL, V23, P502, DOI 10.1089/1044549041562294; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Soresi M, 2006, WORLD J GASTROENTERO, V12, P2563, DOI 10.3748/wjg.v12.i16.2563; Tan JF, 2013, MICROFLUID NANOFLUID, V14, P77, DOI 10.1007/s10404-012-1024-5; Teeguarden JG, 2007, TOXICOL SCI, V95, P300, DOI 10.1093/toxsci/kfl165; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; TIRKEY N, 2005, BMC PHARM, V5, P1, DOI [DOI 10.1186/1471-2210-5-2, 10.1186/1471-2210-5-2]; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Tugues S, 2005, GASTROENTEROLOGY, V129, P1686, DOI 10.1053/j.gastro.2005.09.006; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Van Steenkiste C, 2011, HEPATOLOGY, V53, P1629, DOI 10.1002/hep.24238; Wongcharatrawee S, 2000, BEST PRACT RES CL GA, V14, P881, DOI 10.1053/bega.2000.0136; Xu C, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2013.88; Xu SP, 2006, CAN J CARDIOL, V22, P947, DOI 10.1016/S0828-282X(06)70314-2; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	63	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218716	10.1371/journal.pone.0218716	http://dx.doi.org/10.1371/journal.pone.0218716			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233564	Green Submitted, gold, Green Published			2022-12-26	WOS:000484896700033
J	Yang, SC; Liu, JJ; Wang, CK; Lin, YT; Tsai, SY; Chen, WJ; Huang, WK; Tu, PWA; Lin, YC; Chang, CF; Cheng, CL; Lin, H; Lai, CY; Lin, CY; Lee, YH; Chiu, YC; Hsu, CC; Hsu, SC; Hsiao, M; Schuyler, SC; Lu, FL; Lu, J				Yang, Shang-Chih; Liu, Jan-Jan; Wang, Cheng-Kai; Lin, Yu-Tsen; Tsai, Su-Yi; Chen, Wei-Ju; Huang, Wei-Kai; Tu, Po-Wen A.; Lin, Yu-Chen; Chang, Ching-Fang; Cheng, Chih-Lun; Lin, Hsuan; Lai, Chien-Ying; Lin, Chun-Yu; Lee, Yi-Hsuan; Chiu, Yen-Chun; Hsu, Chiao-Ching; Hsu, Shu-Ching; Hsiao, Michael; Schuyler, Scott C.; Lu, Frank Leigh; Lu, Jean			Down-regulation of ATF1 leads to early neuroectoderm differentiation of human embryonic stem cells by increasing the expression level of SOX2	FASEB JOURNAL			English	Article						gatekeeper; early development; high-throughput screen	ACTIVATING TRANSCRIPTION FACTOR-1; BINDING-PROTEIN-BETA; PLURIPOTENCY FACTORS; FACTOR-I; NEURAL DIFFERENTIATION; RESPONSIVE ELEMENT; CEREBRAL ORGANOIDS; WIDE ANALYSIS; SELF-RENEWAL; MOUSE	We reveal by high-throughput screening that activating transcription factor 1 (ATF1) is a novel pluripotent regulator in human embryonic stem cells (hESCs). The knockdown of ATF1 expression significantly up-regulated neuroectoderm (NE) genes but not mesoderm, endoderm, and trophectoderm genes. Of note, down-regulation or knockout of ATF1 with short hairpin RNA (shRNA), small interfering RNA (siRNA), or clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) was sufficient to up-regulate sex-determining region Y-box (SOX)2 and paired box 6 (PAX6) expression under the undifferentiated or differentiated conditions, whereas overexpression of ATF1 suppressed NE differentiation. Endogenous ATF1 was spontaneously down-regulated after d 1-3 of neural induction. By double-knockdown experiments, up-regulation of SOX2 was critical for the increase of PAX6 and SOX1 expression in shRNA targeting Atf1 hESCs. Using the luciferase reporter assay, we identified ATF1 as a negative transcriptional regulator of Sox2 gene expression. A novel function of ATF1 was discovered, and these findings contribute to a broader understanding of the very first steps in regulating NE differentiation in hESCs.-Yang, S.-C., Liu, J.-J., Wang, C.-K., Lin, Y.-T., Tsai, S.-Y., Chen, W.-J., Huang, W.-K., Tu, P.-W. A., Lin, Y.-C., Chang, C.-F., Cheng, C.-L., Lin, H., Lai, C.-Y., Lin, C.-Y., Lee, Y.-H., Chiu, Y.-C., Hsu, C.-C., Hsu, S.-C., Hsiao, M., Schuyler, S. C., Lu, F. L., Lu, J. Down-regulation of ATF1 leads to early neuroectoderm differentiation of human embryonic stem cells by increasing the expression level of SOX2.	[Yang, Shang-Chih; Wang, Cheng-Kai; Lu, Jean] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Yang, Shang-Chih; Liu, Jan-Jan; Wang, Cheng-Kai; Lin, Yu-Tsen; Chen, Wei-Ju; Huang, Wei-Kai; Chang, Ching-Fang; Cheng, Chih-Lun; Lin, Hsuan; Lai, Chien-Ying; Lin, Chun-Yu; Lee, Yi-Hsuan; Chiu, Yen-Chun; Hsu, Chiao-Ching; Hsiao, Michael; Lu, Jean] Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan; [Tsai, Su-Yi; Lin, Yu-Chen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Life Sci, Taipei, Taiwan; [Tu, Po-Wen A.; Lin, Hsuan; Lu, Frank Leigh] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; [Hsu, Shu-Ching] Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Hsu, Shu-Ching] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Schuyler, Scott C.] Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan, Taiwan; [Schuyler, Scott C.] Chang Gung Mem Hosp, Div Head & Neck Surg, Dept Otolaryngol, Taoyuan, Taiwan; [Lu, Jean] Acad Sinica, Natl Core Facil, RNAi Core, Taipei, Taiwan; [Lu, Jean] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Lu, Jean] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Chang Gung University; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; Tzu Chi University; National Defense Medical Center	Lu, J (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.; Lu, FL (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 8 Zhongshan S Rd, Taipei 100, Taiwan.; Lu, FL (corresponding author), Natl Taiwan Univ, Med Coll, 8 Zhongshan S Rd, Taipei 100, Taiwan.	frankllu@ntu.edu.tw; jeanlu@gate.sinica.edu.tw	Chen, Wei-Ju/HCG-9205-2022; Lu, Frank Leigh/G-6196-2012; Huang, Wei-Kai/GRR-9057-2022; Hsiao, Michael/U-6238-2019	Lu, Frank Leigh/0000-0002-5225-7751; Hsiao, Michael/0000-0001-8529-9213; TSAI, SU-YI/0000-0002-7423-645X; Cheng, Chih-Lun/0000-0002-5409-823X	Data Science Statistical Cooperation Center of Academia Sinica [AS-CFII-108-117]; National Health Research Institute [NHRI-EX106-10415SI]; National Science Council [NSC 102-2321-B-001-013, 102-2321-B-039-002, 102-2325-B-039-002, 102-2320-B-008-002, 102-2311-B-182-004]; Ministry of Health and Welfare [MOHW102-TD-PB-111-NSC105]; Chang Gung Memorial Hospital [BMRPC59, CMRPD1F0353]; Taiwan Ministry of Science and Technology [103-2321-B-001-064, 104-2320-B-001-005, 104-0210-01-09-02, 105-0210-01-13-01, 105-2320-B-001-026-MY2, 106-0210-01-15-02, 107-0210-01-19-01, 107-2320-B-002-026, AS-Summit-108]; Academia Sinica [AS-CFII-108-106]	Data Science Statistical Cooperation Center of Academia Sinica; National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Taiwan Ministry of Science and Technology; Academia Sinica(Academia Sinica - Taiwan)	The authors thank Dr. Douglas A. Melton (Harvard University, Boston, MA, USA), Dr. Yoshiaki Tsuji (North Carolina State University, Raleigh, NC, USA), Dr. Cheng-Wen Wu (Academia Sinica), Dr. Joanne Jeou-Yuan Chen (Academia Sinica), Dr. Han-Chung Wu (Academia Sinica), Dr. Chih-Cheng Chen (Academia Sinica), Dr. Hung-Chih Kuo (Academia Sinica), and Dr. Ching Hwa Tsai (National Taiwan University) for assistance in this study. The authors also thank Dr. Yu-Chi Chou (RNAi Core Facility, Academia Sinica) and Dr. Sin-Jhong Cheng [Neuroscience Core Facility (AS-CFII-108-106), Academia Sinica] for technical support and the Data Science Statistical Cooperation Center of Academia Sinica (AS-CFII-108-117) for statistical support. This study was supported by the National Health Research Institute (NHRI-EX106-10415SI), the National Science Council (NSC 102-2321-B-001-013, 102-2321-B-039-002, 102-2325-B-039-002, 102-2320-B-008-002, and 102-2311-B-182-004), The Ministry of Health and Welfare (MOHW102-TD-PB-111-NSC105), Chang Gung Memorial Hospital (BMRPC59 and CMRPD1F0353), and the Taiwan Ministry of Science and Technology (103-2321-B-001-064, 104-2320-B-001-005, 104-0210-01-09-02, 105-0210-01-13-01,105-2320-B-001-026-MY2, 106-0210-01-15-02, 107-0210-01-19-01, 107-2320-B-002-026, and AS-Summit-108). The authors declare no conflicts of interest.	Aloia L, 2014, GENE DEV, V28, P182, DOI 10.1101/gad.228510.113; Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Atlas E, 2001, ONCOGENE, V20, P7110, DOI 10.1038/sj.onc.1204890; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Belmonte N, 2001, MOL ENDOCRINOL, V15, P2037, DOI 10.1210/me.15.11.2037; Berger RP, 2016, STEM CELLS, V34, P1742, DOI 10.1002/stem.2379; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Blum B, 2009, NAT BIOTECHNOL, V27, P281, DOI 10.1038/nbt.1527; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BROWN AD, 1995, ONCOGENE, V10, P1749; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chitilian JM, 2014, STEM CELLS, V32, P204, DOI 10.1002/stem.1564; Chou YT, 2013, STEM CELLS, V31, P2607, DOI 10.1002/stem.1518; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; Dong Y, 2002, EXP CELL RES, V276, P328, DOI 10.1006/excr.2002.5534; Du ZW, 2013, DEVELOPMENT, V140, P2611, DOI 10.1242/dev.092809; Ebert AD, 2012, J CARDIOVASC PHARM, V60, P408, DOI 10.1097/FJC.0b013e318247f642; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Foldy C, 2016, P NATL ACAD SCI USA, V113, pE5222, DOI 10.1073/pnas.1610155113; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; Hailemariam K, 2010, J CELL SCI, V123, P3863, DOI 10.1242/jcs.073627; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hou PS, 2013, NUCLEIC ACIDS RES, V41, P7753, DOI 10.1093/nar/gkt567; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; HSUEH YP, 1995, J IMMUNOL, V154, P5675; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jang J, 2016, CELL, V165, P410, DOI 10.1016/j.cell.2016.02.014; Jean D, 2000, ONCOGENE, V19, P2721, DOI 10.1038/sj.onc.1203569; Jin XL, 2014, REPRODUCTION, V148, P147, DOI 10.1530/REP-13-0535; Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005; Kingsley-Kallesen ML, 1999, J BIOL CHEM, V274, P34020, DOI 10.1074/jbc.274.48.34020; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee BK, 2015, CELL REP, V13, P52, DOI 10.1016/j.celrep.2015.08.067; Lee MG, 2003, J BIOL CHEM, V278, P41047, DOI 10.1074/jbc.M307031200; Li KR, 2016, DIS MODEL MECH, V9, P759, DOI 10.1242/dmm.025783; Li L, 2010, AM J HUM GENET, V87, P400, DOI 10.1016/j.ajhg.2010.08.003; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Lin YP, 2009, INVEST OPHTH VIS SCI, V50, P68, DOI 10.1167/iovs.07-1619; Lippmann ES, 2014, STEM CELLS, V32, P1032, DOI 10.1002/stem.1622; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mignone JL, 2010, CIRC J, V74, P2517, DOI 10.1253/circj.CJ-10-0958; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Okuyama Y, 1996, FEBS LETT, V397, P219, DOI 10.1016/S0014-5793(96)01178-7; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rizzino A, 2016, BBA-GENE REGUL MECH, V1859, P780, DOI 10.1016/j.bbagrm.2016.03.006; Rolli M, 1999, J BIOL CHEM, V274, P19559, DOI 10.1074/jbc.274.28.19559; Ryan SJ, 2016, BRAIN STRUCT FUNCT, V221, P839, DOI 10.1007/s00429-014-0939-x; Salnikow K, 1997, CANCER RES, V57, P5060; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Shen J, 2005, MOL CELL BIOL, V25, P3639, DOI 10.1128/MCB.25.9.3639-3647.2005; Shimomura A, 1998, J NEUROCHEM, V70, P1029; Sierra RA, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161075; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tripathy SJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005814; Tripathy SJ, 2015, J NEUROPHYSIOL, V113, P3474, DOI 10.1152/jn.00237.2015; Tzatzalos E, 2016, ADV DRUG DELIVER REV, V96, P234, DOI 10.1016/j.addr.2015.09.010; Wang CH, 2012, STEM CELLS, V30, P2199, DOI 10.1002/stem.1203; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wei WJ, 2015, STEM CELLS, V33, P2664, DOI 10.1002/stem.2057; Wen JH, 2008, NEUROREPORT, V19, P413, DOI 10.1097/WNR.0b013e3282f64377; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yang XD, 2016, J IMMUNOL, V197, P2369, DOI 10.4049/jimmunol.1600627; Yu HB, 2009, J BIOL CHEM, V284, P31327, DOI 10.1074/jbc.M109.016162; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaman K, 1999, J NEUROSCI, V19, P9821; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhang Shuchen, 2014, World J Stem Cells, V6, P305, DOI 10.4252/wjsc.v6.i3.305; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	87	4	4	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10577	10592		10.1096/fj.201800220RR	http://dx.doi.org/10.1096/fj.201800220RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31242772	Green Published, Bronze			2022-12-26	WOS:000482214200068
J	Zhang, XY; Tu, HJ; Yang, YZ; Jiang, XY; Hu, XL; Luo, QD; Li, J				Zhang, Xiaoyan; Tu, Huaijun; Yang, Yazhi; Jiang, Xiaoyan; Hu, Xianliang; Luo, Qidong; Li, Jian			Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell death; chronic myelogenous leukemia (CML); mesenchymal stem cells (MSCs); drug resistance; cytokine; cancer; kinase cascade; myeloproliferative disease	COLONY-STIMULATING FACTOR; IMATINIB MESYLATE; CHRONIC-PHASE; MOLECULAR RESPONSE; POOR RESPONSE; IL-7; MUTATIONS; STEM; CML; MICROENVIRONMENT	Chronic myeloid leukemia (CML) is caused by the fusion of the BCR activator of RhoGEF and GTPase activating protein (BCR) and ABL proto-oncogene, the nonreceptor tyrosine kinase (ABL) genes. Although the tyrosine kinase inhibitors (TKIs) imatinib (IM) and nilotinib (NI) have remarkable efficacy in managing CML, the malignancies in some patients become TKI-resistant. Here, we isolated bone marrow (BM)-derived mesenchymal stem cells (MSCs) from several CML patients by Ficoll-Hypaque density-gradient centrifugation for coculture with K562 and BV173 cells with or without TKIs. We used real-time quantitative PCR to assess the level of interleukin 7 (IL-7) expression in the MSCs and employed immunoblotting to monitor protein expression in the BCR/ABL, phosphatidylinositol 3-kinase (PI3K)/AKT, and JAK/STAT signaling pathways. We also used a xenograft tumor model to examine the in vivo effect of different MSCs on CML cells. MSCs from patients with IM-resistant CML protected K562 and BV173 cells against IM- or NI-induced cell death, and this protection was due to increased IL-7 secretion from the MSCs. Moreover, IL-7 levels in the BM of patients with IM-resistant CML were significantly higher than in healthy donors or IM-sensitive CML patients. IL-7 elicited IM and NI resistance via BCR/ABL-independent activation of JAK1/STAT5 signaling, but not of JAK3/STAT5 or PI3K/AKT signaling. IL-7 or JAK1 gene knockdown abrogated IL-7-mediated STAT5 phosphorylation and IM resistance in vitro and in vivo. Because high IL-7 levels in the BM mediate TKI resistance via BCR/ABL-independent activation of JAK1/STAT5 signaling, combining TKIs with IL-7/JAK1/STAT5 inhibition may have significant utility for managing CML.	[Zhang, Xiaoyan; Yang, Yazhi; Jiang, Xiaoyan; Hu, Xianliang; Luo, Qidong; Li, Jian] Nanchang Univ, Dept Hematol, Key Lab Hematol Jiangxi Prov, Affiliated Hosp 2, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Xiaoyan] Nanchang Univ, Sch Basic Med Sci, Lab Infect & Immunol, Nanchang 330006, Jiangxi, Peoples R China; [Tu, Huaijun] Nanchang Univ, Dept Neurol, Affiliated Hosp 2, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Xiaoyan; Yang, Yazhi; Jiang, Xiaoyan; Hu, Xianliang; Luo, Qidong] Nanchang Univ, Grad Sch Med, 465 Bayi Rd, Nanchang 330006, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University; Nanchang University	Li, J (corresponding author), Nanchang Univ, Affiliated Hosp 2, Key Lab Hematol Jiangxi Prov, Nanchang 330006, Jiangxi, Peoples R China.	ndefy03048@ncu.edu.cn	HU, XIAN LIANG/GPX-5936-2022	HU, XIAN LIANG/0000-0001-6373-638X	Major Basic Research Projects of Jiangxi Province [20143ACB20005]; National Natural Science Foundation of China [81260231, 81760033]; Graduate Student Innovation Fund of Jiangxi Province [YC2014-B023]; Jiangxi Provincial Health and Family Planning Commission Science and Technology Program [20155645]	Major Basic Research Projects of Jiangxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Fund of Jiangxi Province; Jiangxi Provincial Health and Family Planning Commission Science and Technology Program	This work was supported by Major Basic Research Projects of Jiangxi Province Grant 20143ACB20005, National Natural Science Foundation of China Grants 81260231 and 81760033, Graduate Student Innovation Fund of Jiangxi Province Grant YC2014-B023, and Jiangxi Provincial Health and Family Planning Commission Science and Technology Program Grant 20155645. The authors declare that they have no conflicts of interest with the contents of this article.	Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; Baba T, 2016, BLOOD, V127, P2607, DOI 10.1182/blood-2015-10-673087; Balciunaite G, 2005, EUR J IMMUNOL, V35, P1292, DOI 10.1002/eji.200425822; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bortolin MT, 2012, CYTOKINE, V60, P90, DOI 10.1016/j.cyto.2012.06.022; Cheng Y, 2016, J CLIN INVEST, V126, P1267, DOI 10.1172/JCI81468; Chomel JC, 2016, ONCOTARGET, V7, P35293, DOI 10.18632/oncotarget.9182; Chu S, 2005, BLOOD, V105, P2093, DOI 10.1182/blood-2004-03-1114; DIGEL W, 1991, BLOOD, V78, P753; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Eide CA, 2015, CURR HEMATOL MALIG R, V10, P158, DOI 10.1007/s11899-015-0248-3; Gonzalez-Garcia S, 2012, CURR TOP MICROBIOL, V360, P47, DOI 10.1007/82_2012_231; Held SAE, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1065368; Hochhaus A, 2016, LEUKEMIA, V30, P1044, DOI 10.1038/leu.2016.5; Hughes TP, 2015, LEUKEMIA, V29, P1832, DOI 10.1038/leu.2015.168; Jabbour E, 2006, LEUKEMIA, V20, P1767, DOI 10.1038/sj.leu.2404318; Jiang XY, 2007, J NATL CANCER I, V99, P680, DOI 10.1093/jnci/djk150; Jiang XY, 1999, P NATL ACAD SCI USA, V96, P12804, DOI 10.1073/pnas.96.22.12804; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Khorashad JS, 2013, BLOOD, V121, P489, DOI 10.1182/blood-2012-05-431379; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Melo JV, 2007, CANCER LETT, V249, P121, DOI 10.1016/j.canlet.2006.07.010; Mumprecht S, 2010, EUR J IMMUNOL, V40, P2720, DOI 10.1002/eji.201040404; Nair RR, 2010, BIOCHEM PHARMACOL, V80, P602, DOI 10.1016/j.bcp.2010.04.003; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Okada M, 2018, CL LYMPH MYELOM LEUK, V18, P353, DOI 10.1016/j.clml.2018.03.004; Parker WT, 2012, BLOOD, V119, P2234, DOI 10.1182/blood-2011-08-375535; Peterson LF, 2011, LEUKEMIA, V25, P761, DOI 10.1038/leu.2011.7; Quintarelli C, 2014, LEUKEMIA RES, V38, P236, DOI 10.1016/j.leukres.2013.11.006; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Ross DM, 2010, LEUKEMIA, V24, P1719, DOI 10.1038/leu.2010.185; Sasaki K, 2016, CANCER-AM CANCER SOC, V122, P238, DOI 10.1002/cncr.29745; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shahrabi S, 2014, TUMOR BIOL, V35, P10627, DOI 10.1007/s13277-014-2610-9; Silva A, 2011, LEUKEMIA, V25, P960, DOI 10.1038/leu.2011.56; Singh H, 2014, J BIOMOL SCREEN, V19, P158, DOI 10.1177/1087057113501081; Tabe Y, 2012, LEUKEMIA, V26, P883, DOI 10.1038/leu.2011.291; Vianello F, 2010, HAEMATOL-HEMATOL J, V95, P1081, DOI 10.3324/haematol.2009.017178; Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; Weisberg E, 2008, MOL CANCER THER, V7, P1121, DOI 10.1158/1535-7163.MCT-07-2331; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018	49	14	15	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12167	12179		10.1074/jbc.RA119.008037	http://dx.doi.org/10.1074/jbc.RA119.008037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31235520	Green Published, hybrid			2022-12-26	WOS:000484284500020
J	Tassone, E; Bradaschia-Correa, V; Xiong, XZ; Sastre-Perona, A; Josephson, AM; Khodadadi-Jamayran, A; Melamed, J; Bu, L; Kahler, DJ; Ossowski, L; Leucht, P; Schober, M; Wilson, EL				Tassone, Evelyne; Bradaschia-Correa, Vivian; Xiong, Xiaozhong; Sastre-Perona, Ana; Josephson, Anne Marie; Khodadadi-Jamayran, Alireza; Melamed, Jonathan; Bu, Lei; Kahler, David J.; Ossowski, Liliana; Leucht, Philipp; Schober, Markus; Wilson, Elaine L.			KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone	ONCOGENE			English	Article							MARROW MICROENVIRONMENT; TNF-ALPHA; CANCER; GENE; EXPRESSION; GROWTH; CELLS; DIFFERENTIATION; METASTASIS; SUPPRESSOR	We previously showed that KLF4, a gene highly expressed in murine prostate stem cells, blocks the progression of indolent intraepithelial prostatic lesions into aggressive and rapidly growing tumors. Here, we show that the anti-tumorigenic effect of KLF4 extends to PC3 human prostate cancer cells growing in the bone. We compared KLF4 null cells with cells transduced with a DOX-inducible KLF4 expression system, and find KLF4 function inhibits PC3 growth in monolayer and soft agar cultures. Furthermore, KLF4 null cells proliferate rapidly, forming large, invasive, and osteolytic tumors when injected into mouse femurs, whereas KLF4 re-expression immediately after their intra-femoral inoculation blocks tumor development and preserves a normal bone architecture. KLF4 re-expression in established KLF4 null bone tumors inhibits their osteolytic effects, preventing bone fractures and inducing an osteogenic response with new bone formation. In addition to these profound biological changes, KLF4 also induces a transcriptional shift from an osteolytic program in KLF4 null cells to an osteogenic program. Importantly, bioinformatic analysis shows that genes regulated by KLF4 overlap significantly with those expressed in metastatic prostate cancer patients and in three individual cohorts with bone metastases, strengthening the clinical relevance of the findings in our xenograft model.	[Tassone, Evelyne; Bradaschia-Correa, Vivian; Xiong, Xiaozhong; Josephson, Anne Marie; Leucht, Philipp; Schober, Markus; Wilson, Elaine L.] NYU, Dept Cell Biol, Sch Med, New York, NY 10016 USA; [Bradaschia-Correa, Vivian; Josephson, Anne Marie; Leucht, Philipp] NYU, Dept Orthoped Surg, Sch Med, New York, NY 10016 USA; [Sastre-Perona, Ana; Schober, Markus] NYU, Ronald O Perelman Dept Dermatol, Sch Med, New York, NY 10016 USA; [Khodadadi-Jamayran, Alireza; Melamed, Jonathan] NYU, Dept Pathol, Sch Med, New York, NY 10016 USA; [Khodadadi-Jamayran, Alireza] NYU, Appl Bioinformat Labs, Sch Med, New York, NY 10016 USA; [Bu, Lei] NYU, Dept Med, Sch Med, New York, NY 10016 USA; [Kahler, David J.] NYU, High Throughput Biol Lab, Sch Med, New York, NY 10016 USA; [Ossowski, Liliana] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Wilson, Elaine L.] NYU, Dept Urol, Sch Med, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University; New York University; New York University; Icahn School of Medicine at Mount Sinai; New York University	Schober, M; Wilson, EL (corresponding author), NYU, Dept Cell Biol, Sch Med, New York, NY 10016 USA.; Schober, M (corresponding author), NYU, Ronald O Perelman Dept Dermatol, Sch Med, New York, NY 10016 USA.; Wilson, EL (corresponding author), NYU, Dept Urol, Sch Med, New York, NY 10016 USA.	markus.schober@nyumc.org; elaine.wilson@nyumc.org	Melamed, Jonathan/AAV-3769-2020; Sastre-Perona, Ana/AAC-1202-2021	Melamed, Jonathan/0000-0003-2844-7990; Khodadadi-Jamayran, Alireza/0000-0003-2495-7504; Kahler, David/0000-0002-7144-2215; Tassone, Evelyne/0000-0003-0631-007X; Leucht, Philipp/0000-0002-8409-8513; BU, LEI/0000-0003-4476-2157	NIH [S10 OD010751, R01CA132641, R01AG056169, K08AR069099, R01CA181111, T32CA009161, T32AR064184]; American Cancer Society [RSG-16-033-01-DDC]; Department of Urology; Kimmel Center for Stem Cell Biology; Perlmutter Cancer Center [P30CA016087]; NYSTEM [C026719]; NATIONAL CANCER INSTITUTE [R01CA181111, P30CA016087, T32CA009161, R01CA132641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR069099, T32AR064184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Urology; Kimmel Center for Stem Cell Biology; Perlmutter Cancer Center; NYSTEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. E. Hernando-Monge (NYU School of Medicine) for the GFP-luciferase plasmid (BLIV513PA-1) and Drs. S. Logan and M. Garabedian (NYU School of Medicine) for helpful discussions. This study was supported by the NIH (R01CA132641 to E.L.W., R01AG056169 and K08AR069099 to P.L., R01CA181111 to M.S., T32CA009161 and T32AR064184 to A.S-P.), the American Cancer Society (RSG-16-033-01-DDC to M. S.), the Department of Urology and the Kimmel Center for Stem Cell Biology. Core funding (Applied Bioinformatics Laboratories, Genome Technology Center, High Throughput Biology Laboratory, Experimental Pathology Research Laboratory, Micro-CT) is partially supported by the Perlmutter Cancer Center (P30CA016087), NYSTEM (contract C026719), and NIH (S10 OD010751).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Armstrong AP, 2008, PROSTATE, V68, P92, DOI 10.1002/pros.20678; Barba M, 2012, J BIOMED BIOTECHNOL, V2012, P1; Body JJ, 2015, NAT REV UROL, V12, P340, DOI 10.1038/nrurol.2015.90; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fradet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075092; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghaleb AM, 2017, GENE, V611, P27, DOI 10.1016/j.gene.2017.02.025; Gooding S, 2016, CURR OPIN PHARMACOL, V28, P43, DOI 10.1016/j.coph.2016.02.013; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kudo O, 2002, J PATHOL, V198, P220, DOI 10.1002/path.1190; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Lee HL, 2010, EXP MOL MED, V42, P437, DOI 10.3858/emm.2010.42.6.045; LeRoy BE, 2006, PROSTATE, V66, P1213, DOI 10.1002/pros.20408; Leucht P, 2007, BONE, V40, P919, DOI 10.1016/j.bone.2006.10.027; Li ZG, 2008, J CLIN INVEST, V118, P2697, DOI 10.1172/JCI33093; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morcos MW, 2018, BONE JOINT RES, V7, P397, DOI 10.1302/2046-3758.76.BJR-2017-0140.R2; Nandana S, 2017, CANCER RES, V77, P1331, DOI 10.1158/0008-5472.CAN-16-0497; Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048; Park SH, 2018, CALCIFIED TISSUE INT, V102, P152, DOI 10.1007/s00223-017-0350-8; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Rucci N, 2009, J CELL BIOL, V187, P669, DOI 10.1083/jcb.200906014; Sanchez-Sweatman Otto H., 1998, Invasion and Metastasis, V18, P297, DOI 10.1159/000024522; Sastre-Perona A, 2019, CELL STEM CELL, V24, P390, DOI 10.1016/j.stem.2019.01.003; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sims NA, 2016, INT J BIOCHEM CELL B, V79, P14, DOI 10.1016/j.biocel.2016.08.003; Siu MK, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.79; Sottnik JL, 2013, CURR MOL MED, V13, P626; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Tsuji T, 2008, BIOCHEM BIOPH RES CO, V376, P186, DOI 10.1016/j.bbrc.2008.08.139; Uchimura T, 2017, DEVELOPMENT, V144, P3533, DOI 10.1242/dev.155598; Vela I, 2007, BJU INT, V99, P735, DOI 10.1111/j.1464-410X.2006.06670.x; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Xiong XZ, 2018, CELL REP, V25, P3006, DOI 10.1016/j.celrep.2018.11.065; Yoshida T, 2012, J BIOL CHEM, V287, P25706, DOI 10.1074/jbc.M112.361360; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	61	5	6	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2019	38	29					5766	5777		10.1038/s41388-019-0841-3	http://dx.doi.org/10.1038/s41388-019-0841-3			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IQ4WS	31239516	Green Published, Green Accepted			2022-12-26	WOS:000480752800002
J	Zhou, LS; Jiang, YY; Liu, XJ; Li, LH; Yang, XG; Dong, CS; Liu, XL; Lin, YL; Li, Y; Yu, JH; He, R; Huang, SL; Liu, GW; Zhang, YM; Jeong, LS; Hoffman, RM; Jia, LJ				Zhou, Lisha; Jiang, Yanyu; Liu, Xiaojun; Li, Lihui; Yang, Xuguang; Dong, Changsheng; Liu, Xiaoli; Lin, Yuli; Li, Yan; Yu, Jinha; He, Rui; Huang, Shenglin; Liu, Guangwei; Zhang, Yanmei; Jeong, Lak Shin; Hoffman, Robert M.; Jia, Lijun			Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-kappa B-CCL2 signaling in lung cancer	ONCOGENE			English	Article							NEDD8-ACTIVATING ENZYME-INHIBITOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PEVONEDISTAT TAK-924/MLN4924; BREAST-CANCER; PHASE-I; EXPRESSION; MLN4924; PROGRESSION; SURVIVAL; GROWTH	Tumor-associated macrophages (TAMs) are the most abundant cancer stromal cells and play an essential role in tumor immunosuppression, providing a suitable microenvironment for cancer development and progression. However, mechanisms of regulating TAMs infiltration in tumor sites are not fully understood. Here, we show that inactivation of neddylation pathway significantly inhibits infiltration of TAMs, leading to the suppression of lung cancer metastasis. RNA-sequencing analysis revealed that neddylation inactivation suppresses the transactivation of chemotactic cytokine ligand 2 (CCL2). Mechanistically, neddylation inactivation inhibits the activity of Cullin-RING ligases (CRLs) and induces the accumulation of its substrate I kappa B alpha to block NF-kappa B transcriptional activity and CCL2 transactivation. As a result, neddylation inactivation exhibits lower chemotaxis of monocytes, thereby decreasing TAMs infiltration, which can be alleviated by CCL2 addition. Moreover, the expression level of NEDD8 is positively correlated with high CCL2 expression in lung adenocarcinoma, conferring a worse overall patient survival. Together, neddylation pathway promotes CCL2 transactivation and TAMs infiltration in lung cancer to provide a tumor-promoting microenvironment, which validates neddylation pathway as a promising target for anti-TAMs therapeutic strategies.	[Zhou, Lisha; Li, Lihui; Yang, Xuguang; Dong, Changsheng; Jia, Lijun] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Canc Inst, Shanghai, Peoples R China; [Jiang, Yanyu; Liu, Xiaojun; Liu, Xiaoli; Huang, Shenglin] Fudan Univ, Shanghai Canc Ctr, Canc Inst, Shanghai, Peoples R China; [Lin, Yuli; He, Rui] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai, Peoples R China; [Li, Yan; Liu, Guangwei] Beijing Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Yu, Jinha; Jeong, Lak Shin] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Zhang, Yanmei] Fudan Univ, Huaong Hosp, Dept Lab Med, Shanghai, Peoples R China; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	Shanghai University of Traditional Chinese Medicine; Fudan University; Fudan University; Beijing Normal University; Seoul National University (SNU); Fudan University; University of California System; University of California San Diego	Jia, LJ (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Canc Inst, Shanghai, Peoples R China.	ljjia@shutcm.edu.cn	Liu, Xiaoli/HGE-7614-2022; Yang, Xuguang/GNP-2847-2022; He, Rui/P-7302-2019; Yu, Jinha/AAS-6463-2021; Dong, Changsheng/AAX-2495-2020; Dong, Changsheng/HCH-9181-2022; Huang, Shenglin/N-9472-2018	Yang, Xuguang/0000-0002-6198-6008; He, Rui/0000-0001-5288-9786; Dong, Changsheng/0000-0001-8385-7904; Huang, Shenglin/0000-0003-1279-0794; Liu, Guangwei/0000-0002-6008-2891; YU, JINHA/0000-0002-0495-5686	Chinese Minister of Science and Technology grant [2016YFA0501800]; National Natural Science Foundation of China [81820108022, 81625018, 81572340, 81772470, 81602072, 81401893, 81702244, 81871870]; Innovation Program of Shanghai Municipal Education Commission [2019-01-07-00-10-E00056]; National Thirteenth Five-Year Science and Technology Major Special Project for New Drug and Development [2017ZX09304001]; Program of Shanghai Academic/Technology Research Leader [18XD1403800]	Chinese Minister of Science and Technology grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Thirteenth Five-Year Science and Technology Major Special Project for New Drug and Development; Program of Shanghai Academic/Technology Research Leader	The Chinese Minister of Science and Technology grant (2016YFA0501800), National Natural Science Foundation of China (Grant Nos. 81820108022, 81625018, 81572340, 81772470, 81602072, 81401893, 81702244 and 81871870), Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-10-E00056), National Thirteenth Five-Year Science and Technology Major Special Project for New Drug and Development (2017ZX09304001), and Program of Shanghai Academic/Technology Research Leader (18XD1403800), supported this work.	Bhatia S, 2016, INVEST NEW DRUG, V34, P439, DOI 10.1007/s10637-016-0348-5; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; EZEKOWITZ RAB, 1984, CONTEMP TOP IMMUNOBI, V13, P33; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Gao Q, 2014, ONCOTARGET, V5, P7820, DOI 10.18632/oncotarget.2309; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hao JQ, 2018, CANCER RES, V78, P2343, DOI 10.1158/0008-5472.CAN-17-2465; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Hua W, 2015, NEURO-ONCOLOGY, V17, P1333, DOI 10.1093/neuonc/nov066; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Lee HW, 2011, J ORG CHEM, V76, P3557, DOI 10.1021/jo2001897; Li LH, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju083; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Li XJ, 2016, NAT CELL BIOL, V18, P561, DOI 10.1038/ncb3338; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Sarantopoulos J, 2016, CLIN CANCER RES, V22, P847, DOI 10.1158/1078-0432.CCR-15-1338; Shah JJ, 2016, CLIN CANCER RES, V22, P34, DOI 10.1158/1078-0432.CCR-15-1237; Soria G, 2008, CYTOKINE, V44, P191, DOI 10.1016/j.cyto.2008.08.002; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swords RT, 2018, BLOOD, V131, P1415, DOI 10.1182/blood-2017-09-805895; Swords RT, 2015, BRIT J HAEMATOL, V169, P534, DOI 10.1111/bjh.13323; Tan M, 2014, ONCOGENE, V33, P5211, DOI 10.1038/onc.2013.473; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Wang YC, 2015, CANCER BIOL THER, V16, P420, DOI 10.1080/15384047.2014.1003003; Williams CB, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2015.25; Xie P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.195; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Yao WT, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.21; Yoshidome H, 2009, INT J ONCOL, V34, P923, DOI 10.3892/ijo_00000218; Yu GZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0462-6; Zhang JX, 2013, LANCET ONCOL, V14, P1295, DOI 10.1016/S1470-2045(13)70491-1; Zhou LS, 2018, CELL SIGNAL, V44, P92, DOI 10.1016/j.cellsig.2018.01.009	47	38	39	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2019	38	29					5792	5804		10.1038/s41388-019-0840-4	http://dx.doi.org/10.1038/s41388-019-0840-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IQ4WS	31243299				2022-12-26	WOS:000480752800004
J	Jurowich, C; Lichthardt, S; Kastner, C; Haubitz, I; Prock, A; Filser, J; Germer, CT; Wiegering, A				Jurowich, Christian; Lichthardt, Sven; Kastner, Caroline; Haubitz, Imme; Prock, Andre; Filser, Joerg; Germer, Christoph-Thomas; Wiegering, Armin			Laparoscopic versus open right hemicolectomy in colon carcinoma: A propensity score analysis of the DGAV StuDoQ vertical bar ColonCancer registry	PLOS ONE			English	Article							COMPLETE MESOCOLIC EXCISION; CENTRAL VASCULAR LIGATION; RIGHT COLECTOMY; CANCER; SURGERY; DEFINITION; RESECTION; OUTCOMES	Objective To assess whether laparoscopy has any advantages over open resection for right-sided colon cancer. Summary background data Right hemicolectomy can be performed using either a conventional open or a minimally invasive laparoscopic technique. It is not clear whether these different access routes differ with regard to short-term postoperative outcomes. Methods Patients documented in the German Society for General and Visceral Surgery StuDoQ vertical bar ColonCancer registry who underwent right hemicolectomy were analyzed regarding early postoperative complications according to Clavien-Dindo (primary endpoint), operation (OP) time, length of postoperative hospital stay (LOS), MTL30 and number of lymph nodes retrieved (secondary endpoints). Results A total of 4.997 patients were identified as undergoing oncological right hemicolectomy without additional interventions. Of these, 4.062 (81.3%) underwent open, 935 (18.7%) laparoscopic surgery. Propensity score analysis showed a significantly shorter LOS (OR: 0.55 CI 95% 0.47-.64) and a significantly longer OP time (OR2.32 CI 1.98-2.71) for the laparoscopic route. Risk factors for postoperative complications, anastomotic insufficiency, ileus, reoperation and positive MTL30 were higher ASA status, higher age and increasing BMI. The surgical access route (open / lap) had no influence on these factors, but the laparoscopic group did have markedly fewer lymph nodes retrieved. Conclusion The present registry-based analysis could detect no relevant advantages for the minimally invasive laparoscopic access route. Further oncological analyses are needed to clarify the extent to which the smaller lymph node harvest in the laparoscopic group is accompanied by a poorer oncological outcome.	[Jurowich, Christian; Prock, Andre; Filser, Joerg] Kreiskliniken Altotting Burghausen, Dept Gen Visceral & Thorac Surg, Altotting, Germany; [Jurowich, Christian; Lichthardt, Sven; Kastner, Caroline; Haubitz, Imme; Germer, Christoph-Thomas; Wiegering, Armin] Univ Wurzburg, Univ Hosp, Dept Gen Visceral Vasc & Pediat Surg, Wurzburg, Germany; [Germer, Christoph-Thomas] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Med Ctr, Wurzburg, Germany; [Wiegering, Armin] Univ Wurzburg, Dept Biochem & Mol Biol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Jurowich, C (corresponding author), Kreiskliniken Altotting Burghausen, Dept Gen Visceral & Thorac Surg, Altotting, Germany.; Jurowich, C; Wiegering, A (corresponding author), Univ Wurzburg, Univ Hosp, Dept Gen Visceral Vasc & Pediat Surg, Wurzburg, Germany.	c.jurowich@krk-aoe.de; wiegering_a@ukw.de	Wiegering, Armin/X-7541-2018	Wiegering, Armin/0000-0001-7777-0909	"Open Access" program of the DFG	"Open Access" program of the DFG(German Research Foundation (DFG))	This publication is funded by the "Open Access" program of the DFG to AW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhamesi NA, 2011, SURG ENDOSC, V25, P3597, DOI 10.1007/s00464-011-1765-3; Arezzo A, 2015, INT J COLORECTAL DIS, V30, P1457, DOI 10.1007/s00384-015-2304-9; Athanasiou CD, 2016, COLORECTAL DIS, V18, pO224, DOI 10.1111/codi.13385; Bosker RJI, 2019, DIGEST SURG, V36, P27, DOI 10.1159/000486400; Bruce J, 2001, BRIT J SURG, V88, P1157, DOI 10.1046/j.0007-1323.2001.01829.x; Carnuccio P, 2014, TECH COLOPROCTOL, V18, P5, DOI 10.1007/s10151-013-1029-4; Cleary RK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206277; Fabozzi M, 2016, WORLD J GASTRO SURG, V8, P564, DOI 10.4240/wjgs.v8.i8.564; Feroci F, 2013, INT J COLORECTAL DIS, V28, P1177, DOI 10.1007/s00384-013-1651-7; Formisano G, 2016, UPDATES SURG, V68, P63, DOI 10.1007/s13304-016-0353-4; Gouvas N, 2016, INT J COLORECTAL DIS, V31, P1577, DOI 10.1007/s00384-016-2626-2; Hohenberger W, 2009, COLORECTAL DIS, V11, P354, DOI 10.1111/j.1463-1318.2008.01735.x; Kirchhoff P, 2010, PATIENT SAF SURG, V4, DOI 10.1186/1754-9493-4-5; Kobayashi H, 2014, ANN SURG ONCOL, V21, P398, DOI 10.1245/s10434-014-3578-9; Negoi I, 2017, WORLD J GASTRO ONCOL, V9, P475, DOI 10.4251/wjgo.v9.i12.475; Schwenk W, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003145.pub2; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; van Rooijen SJ, 2017, WORLD J GASTROENTERO, V23, P6172, DOI 10.3748/wjg.v23.i33.6172; Wellner UF, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1911-x; West NP, 2012, J CLIN ONCOL, V30, P1763, DOI 10.1200/JCO.2011.38.3992; West NP, 2010, J CLIN ONCOL, V28, P272, DOI 10.1200/JCO.2009.24.1448; Wooff D, 2004, J ROY STAT SOC A STA, V167, P192, DOI 10.1111/j.1467-985X.2004.298_12.x; Yamamoto S, 2014, ANN SURG, V260, P23, DOI 10.1097/SLA.0000000000000499	24	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218829	10.1371/journal.pone.0218829	http://dx.doi.org/10.1371/journal.pone.0218829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246985	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900041
J	Laessoe, U; Larsen, CB; Schunck, LN; Lehmann, LJ; Iversen, H				Laessoe, Uffe; Larsen, Camilla Bille; Schunck, Line Noerkjaer; Lehmann, Line Jensen; Iversen, Halla			Age related differences in balance approached by a novel dual-task test of anticipatory postural control strategies	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; FALLS; GO	Introduction Assessment of balance is key to identifying individuals with postural control deficits and an increased fall risk. Subjects may compensate for their deficits by utilizing other strategies; to avoid this, it is recommended to assess postural control using a dual-task test. In most dual-task tests, it is difficult to monitor the performance in the secondary task and the individual's task prioritisation. This study evaluated a new dual-task testing approach. Materials and methods A convenience sample of 54 community-dwelling elderly (age 65+ years) and a reference group of 20 young participants were included in the study. They performed a test in which they could utilize cues to improve their baseline performance, provided their level of postural control allowed them residual attention capacity for this cognitive task. Results Significant performance differences were seen between the young and the elderly. The young group improved their performance time by 23.9% (10.7) and 7.1% (14.2) with a cue and a reverse cue, respectively, whereas the elderly failed to improve their performance time. The test was unable to distinguish between individuals within the elderly group due to a floor effect. Discussion The test reveals an individual's capacity to use cues for anticipatory postural control strategies in a dual-task setting and thereby estimates automatization of postural control. While the young subjects were capable of improving their performance during dual-task conditions, the elderly subjects apparently had no residual attentional capacity allowing them to utilize the facilitating cues. Within the elderly group, the dual-task aspects of the test added no value with respect to differentiation in the level of postural control.	[Laessoe, Uffe; Larsen, Camilla Bille; Schunck, Line Noerkjaer; Lehmann, Line Jensen; Iversen, Halla] Univ Coll Northern Denmark, Phys Therapy Dept, Aalborg, Denmark; [Laessoe, Uffe] Univ Coll Northern Denmark, Dev Dept, Aalborg, Denmark		Laessoe, U (corresponding author), Univ Coll Northern Denmark, Phys Therapy Dept, Aalborg, Denmark.; Laessoe, U (corresponding author), Univ Coll Northern Denmark, Dev Dept, Aalborg, Denmark.	ufl@ucn.dk	Laessoe, Uffe/AAE-5563-2020	Laessoe, Uffe/0000-0001-5388-1671				ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Bier B, 2017, EXP AGING RES, V43, P161, DOI 10.1080/0361073X.2017.1276377; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hauer K, 2010, GERONTOLOGY, V56, P190, DOI 10.1159/000236027; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Laessoe U, 2008, HUM MOVEMENT SCI, V27, P496, DOI 10.1016/j.humov.2007.12.001; Laessoe U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157421; Menant JC, 2014, AGEING RES REV, V16, P83, DOI 10.1016/j.arr.2014.06.001; Montero-Odasso M, 2019, J GERONTOL A-BIOL, V74, P897, DOI 10.1093/gerona/gly148; Muir-Hunter SW, 2016, PHYSIOTHERAPY, V102, P29, DOI 10.1016/j.physio.2015.04.011; Mulder T, 2002, GAIT POSTURE, V16, P198, DOI 10.1016/S0966-6362(01)00157-6; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218371	10.1371/journal.pone.0218371	http://dx.doi.org/10.1371/journal.pone.0218371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3WH	31246971	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900021
J	Nair, M; Tripathi, S; Mazumdar, S; Mahajan, R; Harshana, A; Pereira, A; Jimenez, C; Halder, D; Burza, S				Nair, Mohit; Tripathi, Santanu; Mazumdar, Sumit; Mahajan, Raman; Harshana, Amit; Pereira, Alan; Jimenez, Carolina; Halder, Debasish; Burza, Sakib			"Without antibiotics, I cannot treat": A qualitative study of antibiotic use in Paschim Bardhaman district of West Bengal, India	PLOS ONE			English	Article							NEW-DELHI; RESISTANCE; PHYSICIANS; KNOWLEDGE; PERCEPTIONS; ATTITUDES; STUDENTS; BEHAVIOR; BELIEFS	Background Misuse of antibiotics is a well-known driver of antibiotic resistance. Given the decentralized model of the Indian health system and the shortage of allopathic doctors in rural areas, a wide variety of healthcare providers cater to the needs of patients in urban and rural settings. This qualitative study explores the drivers of antibiotic use among formal and informal healthcare providers as well as patients accessing care at primary health centers across Paschim Bardhaman district in West Bengal. Materials and methods We conducted 28 semi-structured, in-depth interviews with four groups of healthcare providers (allopathic doctors, informal health providers, nurses, and pharmacy shopkeepers) as well as patients accessing care at primary health centers and hospitals across Paschim Bardhaman district. Qualitative data was analyzed using the framework method in an inductive and deductive manner. Results Our results indicate that patients demand antibiotics from healthcare providers and seek the fastest cure possible, which influences the prescription choices of healthcare providers, particularly informal health providers. Many allopathic doctors provide antibiotics without any clinical indication due to inconsistent follow up, lack of testing facilities, risk of secondary infections, and unhygienic living conditions. Pharmaceutical company representatives actively network with informal health providers and formal healthcare providers alike, and regularly visit providers even in remote areas to market newer antibiotics. Allopathic doctors and informal health providers frequently blame the other party for being responsible for antibiotic resistance, and yet both display interdependence in referring patients to one another. Conclusions A holistic approach to curbing antibiotic resistance in West Bengal and other parts of India should focus on strengthening the capacity of the existing public health system to deliver on its promises, improving patient education and counseling, and including informal providers and pharmaceutical company representatives in community-level antibiotic stewardship efforts.	[Nair, Mohit; Mahajan, Raman; Harshana, Amit; Pereira, Alan; Burza, Sakib] Medecins Sans Frontieres, New Delhi, India; [Tripathi, Santanu] Calcutta Sch Trop Med, Kolkata, India; [Mazumdar, Sumit] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Jimenez, Carolina] Medecins Sans Frontieres, Barcelona, Spain	Calcutta School of Tropical Medicine (CSTM); University of York - UK; Doctors Without Borders	Burza, S (corresponding author), Medecins Sans Frontieres, New Delhi, India.	sakib.burza@barcelona.msf.org	Jimenez, Carolina/GYD-8755-2022	de Lima Pereira, Alan/0000-0001-7578-3626; Mahajan, Raman/0000-0001-6788-2835; Harshana, Amit Kumar Singh/0000-0003-1272-5087; Burza, Sakib/0000-0001-7886-8633	MSF fundraising activities	MSF fundraising activities	Funding for the study was provided through normal MSF fundraising activities. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosaimi FD, 2014, E MEDITERR HEALTH J, V20, P812, DOI 10.26719/2014.20.12.812; [Anonymous], 2018, 4 COMP MOV DEC ANT S; Barker AK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4261-4; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; Das J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7384; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Davis ME, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6040023; De Ferrari A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100114; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gautham M, 2014, HEALTH POLICY PLANN, V29, pI20, DOI 10.1093/heapol/czt050; Hawkings NJ, 2007, J ANTIMICROB CHEMOTH, V59, P1155, DOI 10.1093/jac/dkm103; Khan AKA, 2013, J CLIN DIAGN RES, V7, P1613, DOI 10.7860/JCDR/2013/6290.3230; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Kotwani A, 2016, INDIAN J PHARMACOL, V48, P365, DOI 10.4103/0253-7613.186208; Kotwani A, 2014, TROP MED INT HEALTH, V19, P761, DOI 10.1111/tmi.12327; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Krishna BY, 2015, IOSR J DENT MED SCI, V14, P2279; Ledingham K., ANTIBIOTIC RESISTANC; Lieb K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110130; McCullough AR, 2016, J ANTIMICROB CHEMOTH, V71, P27, DOI 10.1093/jac/dkv310; Nair M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217818; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Norris P, 2013, ANTIBIOTICS-BASEL, V2, P465, DOI 10.3390/antibiotics2040465; Padmanabha TS, 2016, INT J BASIC CLIN PHA, V5, P2432, DOI [10.18203/2319-2003.ijbcp20164100, DOI 10.18203/2319-2003.IJBCP20164100]; Porter G, 2016, J PUBLIC HEALTH-UK, V38, pE150, DOI 10.1093/pubmed/fdv072; PULLA P, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.I291; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Sahoo KC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-629; Sampath S., 2016, SCHOLARS J APPL MED, V4, P3294; Siddiqi A, 2011, AFR J PHARM PHARMACO, V5, P1623, DOI 10.5897/AJPP11.243; Varghese Joe, 2010, Indian J Med Ethics, V7, P70; Waheed KA, 2011, INT J PHARM HEALTHC, V5, P279, DOI 10.1108/17506121111190112; Workneh BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156795	33	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219002	10.1371/journal.pone.0219002	http://dx.doi.org/10.1371/journal.pone.0219002			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247028	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000484911900065
J	Almehizia, AA; AlEssa, RK; Alwusaidi, KM; Alzamil, KA; AlJumah, M; Aljohani, S; Almutairi, AF; Salam, M				Almehizia, Abdulmohsin A.; AlEssa, Reema K.; Alwusaidi, Khalid M.; Alzamil, Khalid A.; AlJumah, Modhi; Aljohani, Sarah; Almutairi, Adel F.; Salam, Mahmoud			Allergic rhinitis: Disease characteristics and coping measures in Saudi Arabia	PLOS ONE			English	Article							HOUSE-DUST MITES; ASTHMA; IMPACT; PREVALENCE; POLLEN	Background Despite allergic rhinitis (AR) being a highly prevalent disease, according to literature, it is often underdiagnosed or undertreated. Aim This study explored the disease characteristics of AR in the Saudi community and the non-conventional coping measures used to alleviate symptoms. Methods The study was a nationwide cross-sectional study, using a self-report electronic survey distributed via social media networks in 2018. The survey included an explanatory letter and consent. The sample size comprised 3,458 participants and 2,849 adults had at least one of the four signs of AR, i.e. watery-nose, sneezing, nasal obstruction, itchy nose, watery eyes, in the past year, not related to cold/flu. The outcomes of the study were the triggers, pattern, severity and the classification of AR (2016 ARIA guidelines) and coping measures. Descriptive statistics, univariate analytic statistics and binary logistic regression analyses were conducted. The P-value was considered statistically significant at <0.05. Results The leading reported trigger of AR was dust (74%, n = 2118), followed by pollen (17%, n = 477), mold (5%, n = 140) and fur (4%, n = 114). The prevalence of intermittent AR was (54%, n = 1,635), while that of persistent AR was (46%, n = 1,314). Almost one-third (34%, n = 959) complained of mild forms of AR, while others complained of moderate to severe forms (66%, n = 1890). The coping measures were mainly shower/humidification 368(12.9%) and herbal hot drinks 266(9.3%). Older participants (adj.OR = 1.3[1.1-1.5]) and overweight participants, (adj.OR = 1.2[1.1-1.4]) reported more persistent forms of rhinitis compared to their counter groups, (adj.P<0.001 and adj.P = 0.032) respectively. Female participants (adj.OR = 0.8[0.7-0.9]) had significantly milder forms of AR, in comparison to males, adj.P = 0.006. Conclusion This study presented the disease characteristics of self-reported AR and its associated factors in Saudi Arabia. Special attention should be paid to older age groups and overweight patients who reported persistent forms of AR. Males reported more severe and persistent forms of AR.	[Almehizia, Abdulmohsin A.; AlEssa, Reema K.; Aljohani, Sarah; Almutairi, Adel F.; Salam, Mahmoud] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Almehizia, Abdulmohsin A.; AlEssa, Reema K.; Aljohani, Sarah; Almutairi, Adel F.; Salam, Mahmoud] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Alwusaidi, Khalid M.; Alzamil, Khalid A.] Imam Saud bin Abdulaziz Univ, Riyadh, Saudi Arabia; [AlJumah, Modhi] Alfarabi Univ, Riyadh, Saudi Arabia; [Salam, Mahmoud] King Saud Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City, Minist Natl Guard Hlth Affairs,Sci & Technol Unit, Riyadh, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs	Salam, M (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia.; Salam, M (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.; Salam, M (corresponding author), King Saud Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City, Minist Natl Guard Hlth Affairs,Sci & Technol Unit, Riyadh, Saudi Arabia.	mahmoudsalam@hotmail.com		Salam, Mahmoud/0000-0003-4262-4201; Alzamil, Khalid/0000-0002-8610-1480; Almutairi, Adel F./0000-0003-0015-9524				Abdulrahman H, 2012, AM J RHINOL ALLERGY, V26, pS3, DOI 10.2500/ajra.2012.26.3836; Al Frayh AR, 2001, ANN ALLERG ASTHMA IM, V86, P292, DOI 10.1016/S1081-1206(10)63301-7; Alharethy S, 2017, ANN SAUDI MED, V37, P357, DOI 10.5144/0256-4947.2017.357; Alshehri H., 2017, J ADV MANAG SCI, V5, P127, DOI [10.18178/joams.5.2.127-132, DOI 10.18178/JOAMS.5.2.127-132]; AlShehri SS, 2016, OTOLARYNGOL SUNNYVAL, V6, P2; Amizadeh Maryam, 2013, Iran J Otorhinolaryngol, V25, P79; Andreae DA, 2013, PEDIAT S1, V132; Annesi-Maesano I, 2012, INT ARCH ALLERGY IMM, V158, P397, DOI 10.1159/000332964; [Anonymous], 2018, SAUD AR SOC MED STAT; Assarehzadegan MA, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-7; Baldacci S, 2015, RESP MED, V109, P1089, DOI 10.1016/j.rmed.2015.05.017; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brozek JL, 2017, J ALLERGY CLIN IMMUN, V140, P950, DOI 10.1016/j.jaci.2017.03.050; Cazzoletti L, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0101-1; Chang CC, 2006, J TOXICOL ENV HEAL A, V69, P229, DOI 10.1080/15287390500227415; Chang Christopher, 2005, Clin Dev Immunol, V12, P151, DOI 10.1080/17402520500131409; Gadi G, 2017, J EPIDEMIOL GLOB HEA, V7, P37, DOI 10.1016/j.jegh.2016.06.001; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Han YY, 2016, J ALLERGY CLIN IMMUN, V137, P1460, DOI 10.1016/j.jaci.2015.12.1307; Health NCfE, 2017, FACTS MOLD DAMPN; Huang YR, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0299-9; Ivanova JI, 2015, J MED ECON, V18, P909, DOI 10.3111/13696998.2015.1061533; KORSGAARD J, 1983, ALLERGY, V38, P85, DOI 10.1111/j.1398-9995.1983.tb01591.x; Kurukulaaratchy RJ, 2015, J ALLERGY CLIN IMMUN, V135, P143, DOI 10.1016/j.jaci.2014.06.017; Lee CH, 2008, CLIN EXP OTORHINOLAR, V1, P196, DOI 10.3342/ceo.2008.1.4.196; Lin SY, 2013, INT FORUM ALLERGY RH; Mahboub B, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-19; Mansouritorghabeh H, 2017, IRANIAN J MED SCI; Meo SA, 2013, PAK J MED SCI, V29, P642, DOI 10.12669/pjms.292.3065; Moran K., 2016, YOUNG ADULTS MILLENN; Mullol J, 2008, J INVEST ALLERG CLIN, V18, P327; Mullol Joaquim, 2005, Ther Clin Risk Manag, V1, P265; Mullol Joaquim, 2012, Clinical and Experimental Allergy Reviews, V12, P17, DOI 10.1111/j.1472-9733.2011.01158.x; Nathan RA, 2007, ALLERGY ASTHMA P; Pawankar R., 2011, WORLD ALLERGY ORG WA; Prezant B., 2008, RECOGNITION EVALUATI; Roxbury CR, 2018, INT FORUM ALLERGY RH; Sala-Cunill A, 2013, J INVEST ALLERG CLIN, V23, P145; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Shedden Arthur, 2005, Treat Respir Med, V4, P439, DOI 10.2165/00151829-200504060-00007; Simsim M. T., 2011, J KING SAUD U ENG SC, V23, P101, DOI DOI 10.1016/J.JKSUES.2011.03.006; Sin Betul, 2011, Proc Am Thorac Soc, V8, P106, DOI 10.1513/pats.201008-057RN; Stickley A, 2017, ENVIRON RES, V155, P134, DOI 10.1016/j.envres.2017.02.008; Valero A, 2007, J ALLERGY CLIN IMMUN, V120, P359, DOI 10.1016/j.jaci.2007.04.006; Wang DY, 2011, ASIA PAC ALLERGY, V1, P152, DOI 10.5415/apallergy.2011.1.3.152; Weber RW, 2008, PRIMARY CARE, V35, P1, DOI 10.1016/j.pop.2007.09.001; Wheatley LM, 2015, NEW ENGL J MED, V372, P456, DOI 10.1056/NEJMcp1412282; Yassin A, 2017, INT J LIFE SCI RES, V5, P10; Zahradnik E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00076; Ziyaei T, 2017, J ARTHROPOD-BORNE DI, V11, P309; Zohalinezhad ME, 2016, IRANIAN J MED SCI S, V41, pS46	51	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0217182	10.1371/journal.pone.0217182	http://dx.doi.org/10.1371/journal.pone.0217182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242201	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600008
J	Huang, CN; Wang, CJ; Lin, CL; Yen, AT; Li, HH; Peng, CH				Huang, Chien-Ning; Wang, Chau-Jong; Lin, Chih-Li; Yen, An-Ting; Li, Hsin-Hua; Peng, Chiung-Huei			Abelmoschus esculentus subfractions attenuate beta amyloid-induced neuron apoptosis by regulating DPP-4 with improving insulin resistance signals	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DIPEPTIDYL PEPTIDASE-4; CELL APOPTOSIS; INHIBITOR; VILDAGLIPTIN; GLUCOSAMINE; ACTIVATION; DEMENTIA; SURVIVAL; RECEPTOR	The association of Alzheimer disease (AD) and Diabetes (DM) is less clear. Accumulation of beta amyloid (A beta) and presence of hyperphosphorylated tau (p-tau) are hallmarks of AD, spreading in the region where insulin receptors are also found. A beta exerts neuron toxicity, and could disturb insulin signaling of phosphatidylinositol 3-kinase (PI3K), glycogen synthase kinase (GSK)-3 beta and AMP-activated protein kinase (AMPK), but increase IRS-1-Ser307 phosphorylation which is viewed as insulin resistance marker. Previously we reported dipeptidyl peptidase-4 (DPP-4) mediate insulin resistance signals, and Abelmoschus esculentus (AE) subfractions F1 (rich in quercetin glucosides and triterpene ester) and F2 (containing large amount of polysaccharides) attenuate DPP-4-mediated apoptosis. In the present study, we aim to investigate if A beta induce neuron death by regulating DPP-4 and insulin resistance signals, and the putative effect of F1 and F2. By MTT, microscopy, and Western blotting, we demonstrate treatment of appropriate doses of AE subfractions prevent A beta-induced neuron apoptosis. F1 attenuate A beta-induced caspase 3 expression especially at 25 mu g/mL, while F2 attenuate caspase 3 activation even at the low dose of 1 mu g/mL. Both AE subfractions decrease A beta-enhanced DPP-4, but increase A beta-reduced p-AMPK and p-PI3K. The activity analysis reveals that F2 is more valid than F1 to reduce DPP-4 activity. The inhibition of DPP-4 demonstrates it plays the pivotal role in A beta-induced neuron apoptosis. Moreover, although both F1 and F2 are effective to inhibit p-IRS-1-Ser307, F2 takes advantage to reduce p-Tau while F1 is superior to enhance p-GSK-3 beta. This implies AE subfractions act on different targets, and could be developed respectively. In conclusion, we demonstrate AE is potential to prevent A beta-induced neuron damage by regulating DPP-4 and the insulin resistance cascades. AE could be an adjuvant to protect neuron degenerative disease related to A beta and insulin resistance.	[Huang, Chien-Ning] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Huang, Chien-Ning; Lin, Chih-Li; Li, Hsin-Hua] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Chau-Jong; Yen, An-Ting] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Peng, Chiung-Huei] Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Hungkuang University	Peng, CH (corresponding author), Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan.	a222907@sunrise.hk.edu.tw	Lin, Chih-Li/H-9515-2019; Lin, Chih-Li/GQZ-6480-2022	Lin, Chih-Li/0000-0003-4553-3727; Peng, Chiung-Huei/0000-0003-1833-5522	Ministry of Science and Technology [MOST 107-2320-B-241-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Ministry of Science and Technology, grant MOST 107-2320-B-241-001 (https://www.most.gov.tw/) to CHP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe TK, 2014, FEBS OPEN BIO, V4, P162, DOI 10.1016/j.fob.2014.01.008; Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Chiu N, 1995, ILLUSTRATED MED PLAN, VI.; Choi Kangduk, 2010, Korean Journal of Internal Medicine, V25, P119, DOI 10.3904/kjim.2010.25.2.119; Choi YJ, 2005, J NUTR, V135, P707, DOI 10.1093/jn/135.4.707; Cole AR, 2007, NEUROSCI BIOBEHAV R, V31, P1046, DOI 10.1016/j.neubiorev.2007.04.004; Council NR, 2006, LOST CROPS AFR; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Han WP, 2010, P NATL ACAD SCI USA, V107, P6557, DOI 10.1073/pnas.1002555107; Hocher B, 2012, KIDNEY BLOOD PRESS R, V36, P65, DOI 10.1159/000339028; Huang CN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180285; Huang CN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189065; Huang CN, 2016, FOOD FUNCT, V7, P475, DOI [10.1039/C5FO00464K, 10.1039/c5fo00464k]; Huser CAM, 2008, OSTEOARTHR CARTILAGE, V16, P125, DOI 10.1016/j.joca.2007.05.021; Hwang HJ, 2014, MOL CELL ENDOCRINOL, V392, P1, DOI 10.1016/j.mce.2014.04.017; Isnaini Isnaini, 2019, Asian Pac J Cancer Prev, V20, P639, DOI 10.31557/APJCP.2019.20.2.639; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Kornelius E, 2015, CNS NEUROSCI THER, V21, P549, DOI 10.1111/cns.12404; Maher PA, 2009, EXPERT REV NEUROTHER, V9, P617, DOI 10.1586/ERN.09.18; Ng RCL, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0136-x; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Peng CH, 2019, J FOOD DRUG ANAL, V27, P135, DOI 10.1016/j.jfda.2018.07.004; Peng CH, 2016, FOOD FUNCT, V7, P728, DOI [10.1039/C5FO01214G, 10.1039/c5fo01214g]; Peterszegi G, 2003, BIOMED PHARMACOTHER, V57, P187, DOI 10.1016/S0753-3322(03)00031-3; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Takeda S, 2011, MOL BIOSYST, V7, P1822, DOI 10.1039/c0mb00302f; Tseng HL, 2012, TOXICOL APPL PHARM, V264, P104, DOI 10.1016/j.taap.2012.07.022; Wang XM, 2015, CELL PHYSIOL BIOCHEM, V37, P1914, DOI 10.1159/000438552; Wu YJ, 2015, METABOLISM, V64, P226, DOI 10.1016/j.metabol.2014.08.006; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5; Zhang DD, 2018, EXP THER MED, V15, P5100, DOI 10.3892/etm.2018.6016; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0217400	10.1371/journal.pone.0217400	http://dx.doi.org/10.1371/journal.pone.0217400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237881	gold, Green Published, Green Submitted			2022-12-26	WOS:000484856000007
J	Xiao, S; Liu, LT; Wang, H; Li, DX; Bai, ZY; Zhang, YJ; Sun, HC; Zhang, K; Li, CD				Xiao, Shuang; Liu, Liantao; Wang, Hao; Li, Dongxiao; Bai, Zhiying; Zhang, Yongjiang; Sun, Hongchun; Zhang, Ke; Li, Cundong			Exogenous melatonin accelerates seed germination in cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							ABIOTIC STRESS TOLERANCE; ROOT REGENERATION; OXIDATIVE STRESS; ANALYSES REVEAL; EDIBLE PLANTS; SENESCENCE; RESISTANCE; DORMANCY; GROWTH; LEAVES	Seed germination is considered the beginning of the spermatophyte lifecycle, and it is a crucial stage in determining subsequent plant growth and development. Although many previous studies have found that melatonin can promote seed germination, the role of melatonin in cotton germination remains unexamined. The main objective of this study is the characterization of potential promotional effects of melatonin (at doses of 0, 10, 20, 50, 100 and 200 mu M) on cotton seed germination. This experiment demonstrated that low concentrations of melatonin can promote germination, while high concentrations failed to promote germination and even inhibited germination. Together, these results indicate that a 20 mu M melatonin treatment optimally promotes cotton seed germination. Compared with the control, germination potential (GP), germination rate (GR), and final fresh weight (FW) increased by 16.67%, 12.30%, and 4.81%, respectively. Although low concentrations of melatonin showed some improvement in vigor index (VI), germination index (GI), and mean germination time (MGT), these effects were not statistically significant. Antioxidant enzyme activity during seed germination was most prominent under the 20 mu M melatonin treatment. Superoxide dismutase (SOD) and peroxidase (POD) activities were significantly increased by 10.37-59.73% and 17.79-47.68%, respectively, compared to the melatonin-free control. Malondialdehyde (MDA) content was reduced by 16.73-40.33%. Two important plant hormones in seed germination, abscisic acid (ABA) and gibberellins (GAs), were also studied. As melatonin concentration increased, ABA content in seeds decreased first and then increased, and GA3 content showed a diametrically opposite trend, in which the 20 mu M melatonin treatment was optimal. The 20 mu M melatonin treatment reduced ABA content in seeds by 42.13-51.68%, while the 20 mu M melatonin treatment increased GA3 content in seeds to about 1.7-2.5 times that of seeds germinated without melatonin. This study provides new evidence suggesting that low concentrations of melatonin can promote cotton seed germination by increasing the activity of antioxidant enzymes, thereby reducing the accumulation of MDA and regulating plant hormones. This has clear applications for improving the germination rate of cotton seeds using melatonin.	[Xiao, Shuang; Liu, Liantao; Wang, Hao; Li, Dongxiao; Bai, Zhiying; Zhang, Yongjiang; Sun, Hongchun; Zhang, Ke; Li, Cundong] Hebei Agr Univ, Key Lab Crop Growth Regulat Hebei Prov, Baoding, Hebei, Peoples R China	Hebei Agricultural University	Liu, LT; Li, CD (corresponding author), Hebei Agr Univ, Key Lab Crop Growth Regulat Hebei Prov, Baoding, Hebei, Peoples R China.	liultday@126.com; auhlcd@163.com	Zhang, Yongjiang/R-6250-2019; Liu/AAR-5480-2020	Zhang, Yongjiang/0000-0001-5846-6004; Xiao, Shuang/0000-0002-7451-6515; liu, lian tao/0000-0002-0455-3484	National Key R&D Program of China [2018YFD0100306]; National Natural Science Foundation of China [31871569, 31171495]; Modern Technology System of Agricultural Industry in Hebei [HBCT2018040201]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Technology System of Agricultural Industry in Hebei	This work was supported by the National Key R&D Program of China (2018YFD0100306, LL), National Natural Science Foundation of China (No. 31871569 to LL; 31171495) and Modern Technology System of Agricultural Industry in Hebei (HBCT2018040201, CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arnao MB, 2007, J PINEAL RES, V42, P147, DOI 10.1111/j.1600-079X.2006.00396.x; Arnao MB., 2014, ADV BOT, V2014, P1, DOI DOI 10.1155/2014/815769; Bajwa VS, 2014, J PINEAL RES, V56, P238, DOI 10.1111/jpi.12115; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Caniato R, 2003, ADV EXP MED BIOL, V527, P593; Chen Q, 2009, J PLANT PHYSIOL, V166, P324, DOI 10.1016/j.jplph.2008.06.002; Dakshayani KB, 2005, J PHARM PHARM SCI, V8, P316; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; DUBBELS R, 1995, J PINEAL RES, V18, P28, DOI 10.1111/j.1600-079X.1995.tb00136.x; Ellis R.H., 1978, RATIONAL BASIS TESTI; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Footitt S, 2011, P NATL ACAD SCI USA, V108, P20236, DOI 10.1073/pnas.1116325108; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hardeland R, 2011, PROG NEUROBIOL, V93, P350, DOI 10.1016/j.pneurobio.2010.12.004; HATTORI A, 1995, BIOCHEM MOL BIOL INT, V35, P627; Hauvermale AL, 2015, PLANT CELL PHYSIOL, V56, P1773, DOI 10.1093/pcp/pcv084; He Z., 1993, EXPT GUIDE CROP CHEM; Hernandez-Ruiz J, 2004, PLANTA, V220, P140, DOI 10.1007/s00425-004-1317-3; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Kang K, 2010, J PINEAL RES, V49, P176, DOI 10.1111/j.1600-079X.2010.00783.x; Lei XY, 2004, J PINEAL RES, V36, P126, DOI 10.1046/j.1600-079X.2003.00106.x; Li CX, 2007, J ENVIRON SCI, V19, P725, DOI 10.1016/S1001-0742(07)60121-1; Li XN, 2013, PLANT GROWTH REGUL, V71, P31, DOI 10.1007/s10725-013-9805-8; Liang CZ, 2015, J PINEAL RES, V59, P91, DOI 10.1111/jpi.12243; Luo Z, 2018, FIELD CROP RES, V218, P150, DOI 10.1016/j.fcr.2018.01.003; Manchester LC, 2000, LIFE SCI, V67, P3023, DOI 10.1016/S0024-3205(00)00896-1; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Nawaz MA, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01230; Obroucheva NV, 1997, RUSS J PLANT PHYSL+, V44, P250; Panuccio MR, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu047; Park S, 2012, J PINEAL RES, V52, P211, DOI [10.1111/j.1600-079X.2011.00930.x, 10.1111/j.1600-079X.2012.01029.x]; Posmyk MM, 2008, J PINEAL RES, V45, P24, DOI 10.1111/j.1600-079X.2007.00552.x; Posmyk MM, 2009, J PINEAL RES, V46, P214, DOI 10.1111/j.1600-079X.2008.00652.x; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Sarath G, 2006, PLANTA, V223, P1154, DOI 10.1007/s00425-005-0162-3; Sarropoulou V, 2012, PLANT PHYSIOL BIOCH, V61, P162, DOI 10.1016/j.plaphy.2012.10.001; Scebba F, 2001, BIOL PLANTARUM, V44, P41, DOI 10.1023/A:1017962102950; Shi H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01124; Shi Haitao, 2015, J Exp Bot, V66, P681, DOI 10.1093/jxb/eru373; Shi HT, 2015, J PINEAL RES, V59, P334, DOI 10.1111/jpi.12262; Shi HT, 2015, J PINEAL RES, V59, P120, DOI 10.1111/jpi.12246; Shi HT, 2015, J PINEAL RES, V58, P335, DOI 10.1111/jpi.12219; Simlat M, 2018, PEERJ, V6, DOI 10.7717/peerj.5009; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Thabet SG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206682; Tiryaki I, 2012, J PINEAL RES, V52, P332, DOI 10.1111/j.1600-079X.2011.00947.x; Wang P, 2012, J PINEAL RES, V53, P11, DOI 10.1111/j.1600-079X.2011.00966.x; Wang YP, 2018, J EXP BOT, V69, P963, DOI 10.1093/jxb/erx473; Wang YR, 2004, CROP SCI, V44, P535, DOI 10.2135/cropsci2004.0535; Wei W, 2015, J EXP BOT, V66, P695, DOI 10.1093/jxb/eru392; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Wen D, 2016, PROMOTING ROLES MELA, V7; Yamaguchi S., 2007, Seed development, dormancy and germination, P224; Zhang HJ, 2014, J PINEAL RES, V57, P269, DOI 10.1111/jpi.12167; Zhang J, 2017, ENVIRON EXP BOT, V138, P36, DOI 10.1016/j.envexpbot.2017.02.012; Zhang J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01500; Zhang N, 2015, J EXP BOT, V66, P647, DOI 10.1093/jxb/eru336; Zhang N, 2014, J PINEAL RES, V56, P39, DOI 10.1111/jpi.12095; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x; Zohar R, 2011, PHYTOCHEM LETT, V4, P222, DOI 10.1016/j.phytol.2011.04.002	64	54	56	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0216575	10.1371/journal.pone.0216575	http://dx.doi.org/10.1371/journal.pone.0216575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237880	Green Submitted, Green Published, gold			2022-12-26	WOS:000484856000006
J	Sakwe, N; Bigoga, J; Ngondi, J; Njeambosay, B; Esemu, L; Kouambeng, C; Nyonglema, P; Seumen, C; Gouado, I; Oben, J				Sakwe, Nobelle; Bigoga, Jude; Ngondi, Judith; Njeambosay, Boris; Esemu, Livo; Kouambeng, Celestin; Nyonglema, Philomena; Seumen, Clovis; Gouado, Inocent; Oben, Julius			Relationship between malaria, anaemia, nutritional and socio-economic status amongst under-ten children, in the North Region of Cameroon: A cross-sectional assessment	PLOS ONE			English	Article							MALNUTRITION; PREVALENCE; MORBIDITY; MORTALITY; AREA; RISK; AGE	Background Despite malaria, malnutrition and anaemia being major public-health challenges in Cameroon, very little has been reported on the interaction between these interconnected health determinants. This study therefore sought to investigate the relationship between malaria, anaemia, nutritional and socio-economic status amongst under-ten children living in six localities within two health districts in the North Region of Cameroon. Methods Accordingly, a cross-sectional survey was conducted during the peak malaria season in November 2014, in Pitoa and Mayo-Oulo Health Districts. Three hundred and sixty eight children aged 6 months-10 years were enrolled. Structured questionnaires were used to assess socio-economic status. Anthropometric indices were taken using standard methods and nutritional status assessed by calculating Height for Age (HA), Weight for Age (WA) and Weight for Height (WH) z-scores to determine stunting, underweight and wasting respectively. Finger-prick blood samples were used to prepare thin and thick blood smears for microscopy. Whole blood was collected to determine the PCV and blood spots on filter paper were used to extract plasmodium DNA for speciation by PCR. Results Overall prevalence rates of malaria, malnutrition and anaemia were 32.9%, 54.1% and 20.6% respectively. Stunting, underweight and wasting were detected in 56.9%, 63.5% and 34.8% of the children respectively. There was a significant association between malaria and malnutrition [OR = 1.89, (95% CI: 1.12-3.19); (p = 0.017)]. Malnutrition was also strongly associated with malaria status [OR = 2.07, (95% CI: 1.22-3.53); (p = 0.007)]. The prevalence rates of mild, moderate and severe anaemia were 8.1%, 9.2% and 3.3% respectively. Both malaria status and anaemia correlated with development index [OR = 0.75, (95% CI: 0.58-0.99); (p = 0.042)] and [OR = 1.45, (95% CI: 1.05-2.00); (p = 0.023)] respectively. Conclusion Our findings show a synergistic relationship between malaria and malnutrition. Effective collaboration between malaria control and nutrition intervention programmes is essential for proper case management and improved socio-economic status.	[Sakwe, Nobelle; Ngondi, Judith; Oben, Julius] Univ Yaounde I, Dept Biochem, Lab Nutr & Nutr Biochem, Yaounde, Cameroon; [Sakwe, Nobelle; Bigoga, Jude; Njeambosay, Boris; Esemu, Livo; Seumen, Clovis] Univ Yaounde I, Mol Parasitol & Dis Vector Res Lab, Biotechnol Ctr, Yaounde, Cameroon; [Bigoga, Jude; Kouambeng, Celestin] Natl Malaria Control Programme, Yaounde, Cameroon; [Nyonglema, Philomena] Univ Yaounde I, Lab Immunol, Yaounde, Cameroon; [Gouado, Inocent] Univ Douala, Lab Nutr & Food Sci, Dept Biochem, Douala, Cameroon	University of Yaounde I; University of Yaounde I; University of Yaounde I	Bigoga, J (corresponding author), Univ Yaounde I, Mol Parasitol & Dis Vector Res Lab, Biotechnol Ctr, Yaounde, Cameroon.; Bigoga, J (corresponding author), Natl Malaria Control Programme, Yaounde, Cameroon.	jbigoga@gmail.com		Bigoga, Jude/0000-0001-7206-3308	Biotechnology Center; University of Yaounde I	Biotechnology Center; University of Yaounde I	The authors acknowledge the community and the study participants for their contribution and appreciate the support and cooperation of the parents and guardians of the children in the Pitoa and Mayo-Oulo Health districts, who participated in this study. We are equally grateful to the Biotechnology Center and University of Yaounde I for their support in the accomplishment of this study. The authors are also thankful to officials of the National Malaria Control Programme of the North Region of Cameroon for providing necessary assistance for this study. We would also like to thank the field staff and data collectors for taking their precious time to collect the data. We specially acknowledge the statistical input of Mr. Nana Ce ' lestin of the Foundation of Applied Statistics and Data Management (FASTDAM) Buea.	Akonwi NF, 2015, AM J PHARM HLTH RES, V3; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2008, WORLDWIDE PREVALENCE; Benna C., 2001, MALARIA NUTR; Bigoga JD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-197; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Cheesbrough M., 2005, DISTRICT LAB PRACTIC, V2 nd, P176; Cogill B, 2003, ANTHROPOMETRIC INDIC; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; Deen JL, 2002, J TROP PEDIATRICS, V48, P78, DOI 10.1093/tropej/48.2.78; DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y; deOnis M, 1997, B WORLD HEALTH ORGAN, V75, P11; Deribew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010775; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Facer CA, 1994, INFECT HEMATOLOGY, P259; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Hassan SEH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-88; Helen Keller International WFP, 2013, WHAT AR CURR ISS CAM; Jourdan P M, 2008, West Afr J Med, V27, P7; Kamugisha ML, 2006, TANZANIA HLTH RES B, V8, P56; Kimbi H.K., 2012, J BACTERIOLOGY PARAS, V3, DOI [10.4172/2155-9597.1000153, DOI 10.4172/2155-9597.1000153]; Luckner D, 1998, T ROY SOC TROP MED H, V92, P478, DOI 10.1016/S0035-9203(98)90882-3; Torres REM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003248; Mfonkeu J B Pankoui, 2008, Pak J Biol Sci, V11, P2401, DOI 10.3923/pjbs.2008.2401.2406; Minardi Mitre Cotta Rosngela, 2011, CAD SAUDEPUBLICA S2, V27; Murphy GS, 1996, INFECT DIS CLIN N AM, V10, P747, DOI 10.1016/S0891-5520(05)70325-1; Nkuo-Akenji T. K., 2008, African Journal of Food, Agriculture, Nutrition and Development, V8, P252; Nussenblatt V, 2002, ACTA TROP, V82, P321, DOI 10.1016/S0001-706X(02)00049-9; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Pei LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-121; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Programme National de Lutte contre le Paludisme-Cameroun, PLAN STRAT CAM 2014; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Shariff ZM, 2000, ASIA PAC J CLIN NUTR, V9, P264, DOI 10.1046/j.1440-6047.2000.00191.x; Shuchismita Behera, ANAEMIA, DOI [10.1155/2016/1729147, DOI 10.1155/2016/1729147]; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SNOW RW, 1991, T ROY SOC TROP MED H, V85, P584, DOI 10.1016/0035-9203(91)90351-X; Sousa-Figueiredo JC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-245; Sumbele IUN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2462-2; Sumbele IUN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-123; Thorarinsdottir HK, 2005, SCAND J IMMUNOL, V61, P466, DOI 10.1111/j.1365-3083.2005.01588.x; Wamani H., 2007, BMC Pediatrics, V7; WHO, 2018, WORLD MAL REP 2018; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, DOI 10.1093/tropej/fmn002; Wierzba TF, 2001, J PEDIATR GASTR NUTR, V32, P189, DOI 10.1097/00005176-200102000-00018; World Health Organization, 2015, 2015 JOINT CHILD MAL; World Health Organization, 1995, PHYS STAT US INT ANT, V854; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218442	10.1371/journal.pone.0218442	http://dx.doi.org/10.1371/journal.pone.0218442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226133	Green Published, Green Submitted, gold			2022-12-26	WOS:000484894700019
J	Koo, EH; Feuer, WJ; Forster, RK				Koo, Ellen H.; Feuer, William J.; Forster, Richard K.			Graft-size selection and anisometropia reduction in penetrating keratoplasty (PKP)	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; SUTURE REMOVAL; RISK-FACTORS; ASTIGMATISM; SURVIVAL; MYOPIA; FALLS	Purpose To compare the amount of myopia induced by same-size donor-to-host penetrating keratoplasty with that of the amount of myopia induced by over-sized donor-to-host penetrating keratoplasty. Setting Tertiary referral academic center. Design Retrospective cohort study. Methods Charts from patients who underwent penetrating keratoplasty by the same technique at Bascom Palmer Eye Institute between Nov 1, 2002, and January 1, 2006, were reviewed. The patients underwent optical penetrating keratoplasty using 12 interrupted 10-0 nylon sutures and a 12-bite continuous 10-0 nylon suture by a single surgeon (R.K.F.). The surgical technique used would be considered standard of care at most institutions. The Institutional Review Board, University of Miami Human Subjects Research Office, approved the study protocol. The donor graft was over-sized by 0.25mm in eyes when the intended final refractive target was greater than -1.00 diopters spherical equivalent (SE). The same-size donor graft was used when the intended final refractive target was less than -1.00 diopters SE. The selection of donor graft size was entirely based upon clinical parameters, meaning that the intended final refractive target was determined per each patient's fellow eye refraction, with the intention of reducing anisometropia. All patients received postoperative refraction and corneal topography. These measurements were performed at 6-8 weeks when the initial removal of sutures commenced, then at 6 months, then after completion of selective suture removal, then again at 12 months. Results At 12 months, the over-sized group resulted in -1.35 diopters (SD = 2.25) SE of refraction, and the same-size group resulted in -0.14 diopters (SD = 2.42) SE. This approached statistical significance (p = 0.052) in comparison to -1.00 diopters spherical equivalent. Conclusions Using a donor graft that is over-sized by 0.25mm results in refraction of -1.00 diopters SE or more of myopia. Using a same-size donor-graft results in refraction of less than -1.00 diopters SE. Therefore, careful graft-size selection can result in a more favorable clinical outcome-namely, reduction in anisometropia-in patients undergoing penetrating keratoplasty.	[Koo, Ellen H.; Feuer, William J.; Forster, Richard K.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami	Koo, EH (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.	exk126@med.miami.edu			NIH Core Center Grant [P30EY014801]; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER	NIH Core Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study was funded in part by the NIH Core Center Grant P30EY014801. There was no additional external funding received for this study.	BINDER PS, 1985, OPHTHALMOLOGY, V92, P1412; Cottingham AJ, 1980, OPHTHALMOLOGY, V87, P113; DAVISON JA, 1981, ARCH OPHTHALMOL-CHIC, V99, P1591; Donnenfeld ED, 1999, OPHTHALMOLOGY, V106, P1966, DOI 10.1016/S0161-6420(99)90410-4; Dursun D, 2003, AM J OPHTHALMOL, V135, P807, DOI 10.1016/S0002-9394(02)02287-0; FILATOV V, 1993, AM J OPHTHALMOL, V115, P715, DOI 10.1016/S0002-9394(14)73637-2; Forseto AS, 1999, J CATARACT REFR SURG, V25, P479, DOI 10.1016/S0886-3350(99)80043-1; Forster R K, 1997, Trans Am Ophthalmol Soc, V95, P193; Haegerstrom-Portnoy G, 2014, OPTOMETRY VISION SCI, V91, P60, DOI 10.1097/OPX.0000000000000114; Hirst LW, 1998, AUST NZ J OPHTHALMOL, V26, P211, DOI 10.1111/j.1442-9071.1998.tb01313.x; Knudtson MD, 2009, ARCH GERONTOL GERIAT, V49, P22, DOI 10.1016/j.archger.2008.04.006; Kwitko S, 2001, J CATARACT REFR SURG, V27, P374, DOI 10.1016/S0886-3350(00)00642-8; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; Maeno A, 2000, CORNEA, V19, P7, DOI 10.1097/00003226-200001000-00002; MUSCH DC, 1989, OPHTHALMOLOGY, V96, P698; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; PRICE FW, 1993, ARCH OPHTHALMOL-CHIC, V111, P799, DOI 10.1001/archopht.1993.01090060087029; Rashad KM, 2000, J REFRACT SURG, V16, P701; SERDAREVIC ON, 1995, OPHTHALMOLOGY, V102, P1497; VAIL A, 1994, OPHTHALMOLOGY, V101, P120; Webber SK, 1999, BRIT J OPHTHALMOL, V83, P1013, DOI 10.1136/bjo.83.9.1013; Woods RL, 1991, J BR CONTACT LENS AS, V14, P115, DOI [10.1016/0141-7037(91)80004-6, DOI 10.1016/0141-7037(91)80004-6]	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218199	10.1371/journal.pone.0218199	http://dx.doi.org/10.1371/journal.pone.0218199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220145	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500030
J	Leopold, CR; Hess, SC				Leopold, Christina R.; Hess, Steven C.			Facilitating adaptation to climate change while restoring a montane plant community	PLOS ONE			English	Article							ELEVATION; RESPONSES; MOUNTAIN; SHIFTS; RESTORATION; MIGRATION; RECOVERY; ECOTONE	Montane plant communities throughout the world have responded to changes in temperature regimes by shifting ranges upward in elevation, and made downslope movements to track shifts in climatic water balance. Organisms that cannot disperse or adapt biologically to projected climate scenarios in situ may decrease in distributional range and abundance over time. Restoration strategies will need to incorporate the habitat suitability of future predicted conditions to ensure long-term persistence. We propagated seedlings of three native Hawaiian montane plant species from high-(similar to 2,500 m asl) and low-elevation (similar to 1,900 m asl) sources, planted them in 8 common plots along a 500 m elevation gradient, and monitored microclimate at each plot for 20 weeks. We explored how temperature and precipitation influenced survival and growth differently among high- and low-elevation origin seedlings. Significantly more seedlings of only one species, Dodonaea viscosa, from high-elevation origin (75.2%) survived than seedlings from low-elevation origin (58.7%) across the entire elevation gradient. Origin also influenced survival in generalized linear mixed models that controlled for temperature, precipitation, and elevation in D. viscosa and Chenopodium oahuense. Survival increased with elevation and soil moisture for Sophora chrysophylla, while it decreased for the other two species. Responses to microclimate varied between the three montane plant species; there were no common patterns of growth or survival. Although limited in temporal scope, our experiment represents one of the few attempts to examine local adaptation to prospective climate scenarios and addresses challenges to restoration efforts within species' current ranges.	[Leopold, Christina R.] Univ Hawaii, Hawaii Cooperat Studies Unit, Hawaii Natl Pk, Hilo, HI 96720 USA; [Hess, Steven C.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Kilauea Field Stn, Hawaii Natl Pk, Hilo, HI 96720 USA	University of Hawaii System; United States Department of the Interior; United States Geological Survey	Leopold, CR (corresponding author), Univ Hawaii, Hawaii Cooperat Studies Unit, Hawaii Natl Pk, Hilo, HI 96720 USA.	cleopold@usgs.gov		Hess, Steven/0000-0001-6403-9922; Leopold, Christina/0000-0003-0499-3196	U.S. Geological Survey [IAA 4500068407]; Pacific Islands Climate Change Cooperative [IAA 4500068407]	U.S. Geological Survey(United States Geological Survey); Pacific Islands Climate Change Cooperative	SCH received funding from the U.S. Geological Survey and the Pacific Islands Climate Change Cooperative; http://piccc.net/. The grant number was IAA 4500068407. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.; This work was funded by the Pacific Islands Climate Change Cooperative. We thank our collaborators D. Ball of the U.S. Fish and Wildlife Service Conservation Partnerships Program; C. Perry, J. Kern, and J. Uowolo of the Mauna Kea Forest Watershed Alliance; and, M. Robinson, formerly of Forestry and Natural Resources, Land Management Division, Department of Hawaiian Home Lands. The State of Hawaii Department of Land and Natural Resources, Division of Forestry and Wildlife issued access and collection permits. We thank the Pacific Internship Programs for Exploring Science program for project assistance from R. Dumo-Qualters, K. Kahaleua, and B. Palupe. We thank S. Judge and V. DeGuzman for assistance with field work. We gratefully acknowledge K. Brinck and D. Leopold for assistance with data analysis, S. Yelenik and L. Fortini for helpful comments on this manuscript, and P. Berkowitz and J. Jacobi for assistance with data release. Data used in this study are available at: https://www.sciencebase.gov; doi: 10.5066/F72N50FH.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alexander JM, 2015, NATURE, V525, P515, DOI 10.1038/nature14952; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Boshier D, 2015, ENVIRON EVID, V4, DOI 10.1186/s13750-015-0046-3; Bower AD, 2014, ECOL APPL, V24, P913, DOI 10.1890/13-0285.1; Breed MF, 2013, CONSERV GENET, V14, P1, DOI 10.1007/s10592-012-0425-z; Bucharova A, 2019, CONSERV GENET, V20, P7, DOI 10.1007/s10592-018-1067-6; Cao GX, 2007, J CLIMATE, V20, P1145, DOI 10.1175/JCLI4033.1; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Crausbay SD, 2010, J BIOGEOGR, V37, P1160, DOI 10.1111/j.1365-2699.2010.02277.x; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Cuddihy LW, 1984, 51 PCSU U HAW MAN CO; Daehler CC, 2005, PERSPECT PLANT ECOL, V7, P203, DOI 10.1016/j.ppees.2005.08.002; Diaz HF, 2011, GLOBAL PLANET CHANGE, V77, P21, DOI 10.1016/j.gloplacha.2011.02.007; Elsen PR, 2015, NAT CLIM CHANGE, V5, P772, DOI [10.1038/nclimate2656, 10.1038/NCLIMATE2656]; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Fortini LB, 2013, 44 HCSU U HAW HIL HA; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Godefroid S, 2011, BIOL CONSERV, V144, P672, DOI 10.1016/j.biocon.2010.10.003; Havens K, 2015, NAT AREA J, V35, P122, DOI 10.3375/043.035.0116; HilleRisLambers J, 2013, ANN NY ACAD SCI, V1297, P112, DOI 10.1111/nyas.12182; Hodgins KA, 2016, AM J BOT, V103, P590, DOI 10.3732/ajb.1600049; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Johnson G. R., 2004, Native Plants Journal, V5, P131, DOI 10.2979/NPJ.2004.5.2.131; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kilpatrick AM, 2006, BIOL CONSERV, V128, P475, DOI 10.1016/j.biocon.2005.10.014; Krushelnycky PD, 2013, GLOBAL CHANGE BIOL, V19, P911, DOI 10.1111/gcb.12111; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Leopold CR, 2017, BIOL INVASIONS, V19, P161, DOI 10.1007/s10530-016-1270-7; Mathiasen P, 2016, OECOLOGIA, V181, P607, DOI 10.1007/s00442-016-3568-7; Mazerolle M., 2011, R PACKAGE VERSION, V1, P17; Millar CI, 2004, ARCT ANTARCT ALP RES, V36, P181, DOI 10.1657/1523-0430(2004)036[0181:ROSCIT]2.0.CO;2; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Pouteau R, 2018, J BIOGEOGR, V45, P1326, DOI 10.1111/jbi.13228; R Core Development Team, 2015, R LANG ENV STAT COMP; Rehm EM, 2016, OECOLOGIA, V181, P1233, DOI 10.1007/s00442-016-3619-0; Tunison JT, 1995, 99 PCSU COOP NAT PAR; Van der Veken S, 2012, BASIC APPL ECOL, V13, P10, DOI 10.1016/j.baae.2011.10.007; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Yelenik SG, 2010, RESTOR ECOL, V18, P418, DOI 10.1111/j.1526-100X.2009.00598.x	44	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218516	10.1371/journal.pone.0218516	http://dx.doi.org/10.1371/journal.pone.0218516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220135	Green Submitted, gold, Green Published			2022-12-26	WOS:000484893500057
J	Szulczewski, MT				Szulczewski, Mikolaj Tytus			Training of paced breathing at 0.1 Hz improves CO2 homeostasis and relaxation during a paced breathing task	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SINUS ARRHYTHMIA BIOFEEDBACK; VOLUNTARY HYPERVENTILATION; BLOOD-PRESSURE; EFFICACY; RATIO; RESPIRATION; EXHALATION; FREQUENCY; DISORDER	Volitional control of breathing often leads to excessive ventilation (hyperventilation) among untrained individuals, which disrupts CO2 homeostasis and may elicit a set of undesirable symptoms. The present study investigated whether seven days of training without any anti-hyperventilation instructions improves CO2 homeostasis during paced breathing at a frequency of 0.1 Hz (6 breaths/minute). Furthermore, the present study investigated the effects of training on breathing-related changes in affective state to examine the hypothesis that training improves the influence of slow paced breathing on affect. A total of 16 participants performed ten minutes of paced breathing every day for seven days. Partial pressure of end-tidal CO2 (PetCO(2)), symptoms of hyperventilation, affective state (before and after breathing), and pleasantness of the task were measured on the first, fourth, and seventh days of training. Results showed that the drop in PetCO(2) significantly decreased with training and none of the participants experienced a drop in PetCO(2) below 30 mmHg by day seven of training (except one participant who already had PetCO(2) below 30 mmHg during baseline), in comparison to 37.5% of participants on the first day. Paced breathing produced hyperventilation symptoms of mild intensity which did not decrease with training. This suggests that some participants still experienced a drop of PetCO(2) that was deep enough to produce noticeable symptoms. Affective state was shifted towards calmness and relaxation during the second and third laboratory measurements, but not during the first measurement. Additionally, the breathing task was perceived as more pleasant during subsequent laboratory measurements. The obtained results showed that training paced breathing at 0.1 Hz led to decrease in hyperventilation. Furthermore, the present study suggests that training paced breathing is necessary to make the task more pleasant and relaxing.	[Szulczewski, Mikolaj Tytus] Univ Warsaw, Fac Psychol, Warsaw, Poland	University of Warsaw	Szulczewski, MT (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	mikolaj.szulczewski@psych.uw.edu.pl	Szulczewski, Mikołaj/AAU-5298-2021	Szulczewski, Mikolaj/0000-0003-1251-3498	Narodowe Centrum Nauki [2015/19/N/HS6/01601]	Narodowe Centrum Nauki(National Science Centre, Poland)	This research is funded by the Narodowe Centrum Nauki, Grant/Award Number: 2015/19/N/HS6/01601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2012, PSYCHOPHYSIOLOGY, V49, P690, DOI 10.1111/j.1469-8986.2011.01344.x; Anderson DE, 2009, PSYCHOL HEALTH MED, V14, P667, DOI 10.1080/13548500903322791; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; Boulding R, 2016, EUR RESPIR REV, V25, P287, DOI 10.1183/16000617.0088-2015; CAPPO BM, 1984, J PSYCHOSOM RES, V28, P265, DOI 10.1016/0022-3999(84)90048-5; Carter MM, 2001, J ANXIETY DISORD, V15, P217, DOI 10.1016/S0887-6185(01)00061-5; Chalaye P, 2009, PAIN MED, V10, P1334, DOI 10.1111/j.1526-4637.2009.00681.x; Chen S, 2016, J HUM HYPERTENS, V30, P105, DOI 10.1038/jhh.2015.27; CHONAN T, 1990, J APPL PHYSIOL, V69, P1290, DOI 10.1152/jappl.1990.69.4.1290; Christmann CA, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6471; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91, DOI 10.1113/jphysiol.1991.sp018824; Coulon SM, 2016, AM J PREV MED, V51, P95, DOI 10.1016/j.amepre.2016.01.026; Del Negro CA, 2018, NAT REV NEUROSCI, V19, P351, DOI 10.1038/s41583-018-0003-6; DenotLedunois S, 1996, BIOL PSYCHOL, V43, P26; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; GALLEGO J, 1991, PHYSIOL BEHAV, V49, P315, DOI 10.1016/0031-9384(91)90049-T; Goessl VC, 2017, PSYCHOL MED, V47, P2578, DOI 10.1017/S0033291717001003; Hassett AL, 2007, APPL PSYCHOPHYS BIOF, V32, P1, DOI 10.1007/s10484-006-9028-0; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; HORNSVELD H, 1990, J PSYCHOSOM RES, V34, P687, DOI 10.1016/0022-3999(90)90113-I; Jafari H, 2017, PAIN, V158, P995, DOI 10.1097/j.pain.0000000000000865; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kim SY, 2012, J CLIN PSYCHIAT, V73, P931, DOI 10.4088/JCP.11m07068; Laborde S, 2017, J INTELL DISABIL RES, V61, P560, DOI 10.1111/jir.12350; Laborde S, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020193; Lehrer PM, 2004, CHEST, V126, P352, DOI 10.1378/chest.126.2.352; Lehrer PM, 2000, APPL PSYCHOPHYS BIOF, V25, P177, DOI 10.1023/A:1009554825745; Lin GP, 2012, J ALTERN COMPLEM MED, V18, P143, DOI 10.1089/acm.2010.0607; Lin IM, 2014, INT J PSYCHOPHYSIOL, V91, P206, DOI 10.1016/j.ijpsycho.2013.12.006; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; McKay LC, 2003, J APPL PHYSIOL, V95, P1170, DOI 10.1152/japplphysiol.00641.2002; Meuret AE, 2008, J PSYCHIATR RES, V42, P560, DOI 10.1016/j.jpsychires.2007.06.005; Meuret AE, 2018, BIOL PSYCHIAT-COGN N, V3, P539, DOI 10.1016/j.bpsc.2018.01.010; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Mortola JP, 2019, RESP PHYSIOL NEUROBI, V261, P48, DOI 10.1016/j.resp.2018.12.005; OKU Y, 1993, ANN BIOMED ENG, V21, P509, DOI 10.1007/BF02584333; OTIS AB, 1954, PHYSIOL REV, V34, P449, DOI 10.1152/physrev.1954.34.3.449; POON CS, 1992, CONTROL OF BREATHING AND ITS MODELING PERSPECTIVE, P371; Prinsloo GE, 2013, INT J STRESS MANAGE, V20, P391, DOI 10.1037/a0034777; RAPEE RM, 1994, J ABNORM PSYCHOL, V103, P693, DOI 10.1037/0021-843X.103.4.693; Ritz T, 2014, CHEST, V146, P1237, DOI 10.1378/chest.14-0665; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sakairi Y, 2013, JPN PSYCHOL RES, V55, P338, DOI 10.1111/jpr.12021; Shenhav A, 2017, ANNU REV NEUROSCI, V40, P99, DOI 10.1146/annurev-neuro-072116-031526; Sherlin L, 2009, INT J STRESS MANAGE, V16, P233, DOI 10.1037/a0016047; Siepmann M, 2008, APPL PSYCHOPHYS BIOF, V33, P195, DOI 10.1007/s10484-008-9064-z; Sood R, 2013, MENOPAUSE, V20, P179, DOI 10.1097/gme.0b013e31826934b6; Stark R, 2000, PSYCHOPHYSIOLOGY, V37, P302, DOI 10.1017/S0048577200980570; Steffen PR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00222; Szulczewski MT, 2019, APPL PSYCHOPHYS BIOF, V44, P247, DOI 10.1007/s10484-019-09438-y; Szulczewski MT, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13221; Tan G, 2011, APPL PSYCHOPHYS BIOF, V36, P27, DOI 10.1007/s10484-010-9141-y; THYER BA, 1984, BEHAV RES THER, V22, P587, DOI 10.1016/0005-7967(84)90063-9; Tsai HJ, 2015, PSYCHOPHYSIOLOGY, V52, P388, DOI 10.1111/psyp.12333; Van de Borne P, 2000, AM J PHYSIOL-HEART C, V279, pH536, DOI 10.1152/ajpheart.2000.279.2.H536; Van Diest I, 2014, APPL PSYCHOPHYS BIOF, V39, P171, DOI 10.1007/s10484-014-9253-x; VANDIXHOORN J, 1985, J PSYCHOSOM RES, V29, P199, DOI 10.1016/0022-3999(85)90042-X; Vaschillo EG, 2006, APPL PSYCHOPHYS BIOF, V31, P129, DOI 10.1007/s10484-006-9009-3; Wang YP, 2013, J APPL PHYSIOL, V115, P1648, DOI 10.1152/japplphysiol.00163.2013; Wells R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046597; Wheat AL, 2010, APPL PSYCHOPHYS BIOF, V35, P229, DOI 10.1007/s10484-010-9133-y; Yik M, 2011, EMOTION, V11, P705, DOI 10.1037/a0023980; Yik MSM, 1999, J PERS SOC PSYCHOL, V77, P600, DOI 10.1037/0022-3514.77.3.600; Zaccaro A, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00353; Zautra AJ, 2010, PAIN, V149, P12, DOI 10.1016/j.pain.2009.10.001; Zou Y, 2017, AM J CARDIOL, V120, P148, DOI 10.1016/j.amjcard.2017.03.247; Zucker TL, 2009, APPL PSYCHOPHYS BIOF, V34, P135, DOI 10.1007/s10484-009-9085-2	67	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218550	10.1371/journal.pone.0218550	http://dx.doi.org/10.1371/journal.pone.0218550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220170	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500064
J	Venables, E; Towriss, C; Rini, Z; Nxiba, X; Cassidy, T; Tutu, S; Grimsrud, A; Myer, L; Wilkinson, L				Venables, Emilie; Towriss, Catriona; Rini, Zanele; Nxiba, Xoliswa; Cassidy, Tali; Tutu, Sindiso; Grimsrud, Anna; Myer, Landon; Wilkinson, Lynne			Patient experiences of ART adherence clubs in Khayelitsha and Gugulethu, Cape Town, South Africa: A qualitative study	PLOS ONE			English	Article							RETENTION	Background Globally, 37 million people are in need of lifelong antiretroviral treatment (ART). With the continual increase in the number of people living with HIV starting ART and the need for lifelong retention and adherence, increasing attention is being paid to differentiated service delivery (DSD), such as adherence clubs. Adherence clubs are groups of 25-30 stable ART patients who meet five times per year at their clinic or a community location and are facilitated by a lay health-care worker who distributes pre-packed ART. This qualitative study explores patient experiences of clubs in two sites in Cape Town, South Africa. Methods A total of 144 participants took part in 11 focus group discussions (FGDs) and 56 in-depth interviews in the informal settlements of Khayelitsha and Gugulethu in Cape Town, South Africa. Participants included current club members, stable patients who had never joined a club and club members referred back to clinician-led facility-based standard care. FGDs and interviews were conducted in isiXhosa, translated and transcribed into English, entered into NVivo, coded and thematically analysed. Results The main themes were 1) understanding and knowledge of clubs; 2) understanding of and barriers to enrolment; 3) perceived benefits and 4) perceived disadvantages of the clubs. Participants viewed membership as an achievement and considered returning to clinicianled care a 'failure'. Moving between clubs and the clinic created frustration and broke down trust in the health-care system. Conclusions Adherence clubs were appreciated by patients, particularly time-saving in relation to flexible ART collection. Improved patient understanding of enrolment processes, eligibility and referral criteria and the role of clinical oversight is essential for building relationships with healthcare workers and trust in the health-care system.	[Venables, Emilie] Medecins Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Venables, Emilie] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa; [Towriss, Catriona] Univ Cape Town, Fac Commerce, Ctr Actuarial Res, Cape Town, South Africa; [Towriss, Catriona; Rini, Zanele; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Nxiba, Xoliswa; Cassidy, Tali; Wilkinson, Lynne] Medecins Sans Frontieres, Khayelitsha, South Africa; [Cassidy, Tali] Univ Cape Town, Div Publ Hlth Med, Fac Hlth Sci, Cape Town, South Africa; [Tutu, Sindiso] Western Cape Govt Hlth Dept, Cape Town, South Africa; [Grimsrud, Anna] Int AIDS Soc, Cape Town, South Africa; [Myer, Landon; Wilkinson, Lynne] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Venables, E (corresponding author), Medecins Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa.; Venables, E (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa.	emilie.venables@brussels.msf.org			Division of Epidemiology & Biostatistics at the School of Public Health & Family Medicine, University of Cape Town; Centre for Infectious Diseases Epidemiology & Research at the School of Public Health & Family Medicine, University of Cape Town	Division of Epidemiology & Biostatistics at the School of Public Health & Family Medicine, University of Cape Town; Centre for Infectious Diseases Epidemiology & Research at the School of Public Health & Family Medicine, University of Cape Town	Research was supported in part by the Division of Epidemiology & Biostatistics and the Centre for Infectious Diseases Epidemiology & Research at the School of Public Health & Family Medicine, University of Cape Town.	Auld AF, 2016, JAIDS-J ACQ IMM DEF, V73, pE11, DOI 10.1097/QAI.0000000000001137; Beery M, AIDS 2018 C; Cawley C, 2016, 6 MONTHLY APPOINTMEN; Decroo T, 2014, TROP MED INT HEALTH, V19, P514, DOI 10.1111/tmi.12278; Grimsrud A, 2015, S AFRICA J INT AIDS, V18, P1, DOI DOI 10.7448/IAS.18.1.19984; Grimsrud A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21484; Grimsrud A, 2016, JAIDS-J ACQ IMM DEF, V71, pE16, DOI 10.1097/QAI.0000000000000863; Hagey JM, 2018, AIDS CARE, V30, P1477, DOI 10.1080/09540121.2018.1500995; Kaplan SR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002407; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; MacGregor H, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0351-z; National Department of health Republic of South Africa,, 2013, 2013 NAT ANT SENT HI; Okoboi S, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0077-4; Pellecchia U, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21374; Prust, PATIENT HLTH WORKER, DOI [10.1371/journal.pone.0196498, DOI 10.1371/JOURNAL.PONE.0196498]; Rasschaert F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-364; Rasschaert F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091544; Statistics South Africa, 2012, CENS 2011 STAT REL P; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tsondai PR, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21649; UNAIDS, GLOB AIDS UPD 2018; Venables E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164634; Vogt F, 2017, JAIDS-J ACQ IMM DEF, V74, P326, DOI 10.1097/QAI.0000000000001215; Wilkinson LS, 2013, S AFR J HIV MED, V14, P48, DOI [10.7196/SAJHIVMED.924, 10.7196/sajhivmed.924]; Wilkinson L, 2016, TROP MED INT HEALTH, V21, P743, DOI 10.1111/tmi.12699	25	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218340	10.1371/journal.pone.0218340	http://dx.doi.org/10.1371/journal.pone.0218340			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220116	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500037
J	Wang, HL; Zhang, Y; Mao, NY; Zhu, Z; Cui, AL; Xu, ST; Song, JH; Chen, M; Fang, XQ; Li, CS; Feng, DX; Zhou, SJ; Wang, SL; Shi, J; Ji, YX; Cao, L; Ren, L; Gao, LY; Xu, WB				Wang, Huiling; Zhang, Yan; Mao, Naiying; Zhu, Zhen; Cui, Aili; Xu, Songtao; Song, Jinhua; Chen, Meng; Fang, Xueqiang; Li, Chongshan; Feng, Daxing; Zhou, Shujie; Wang, Shulei; Shi, Jing; Ji, Yixin; Cao, Lei; Ren, Li; Gao, Lingyu; Xu, Wenbo			Molecular characterization of measles viruses in China: Circulation dynamics of the endemic H1 genotype from 2011 to 2017	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; MONITORING PROGRESS; GENETIC DIVERSITY; UNITED-STATES; ELIMINATION; OUTBREAK; EPIDEMIOLOGY; SURVEILLANCE	Due to the Expanded Program on Immunization (EPI) and supplementary immunization activities (SIAs) in China, the incidence of measles in China has decreased extensively. The incidence reached its lowest levels in contemporary history in 2012 and 2017, with incidence rates of 4.6 and 4.3 per million population, respectively. However, more than 147,000 measles cases were reported from 2013 to 2016. Furthermore, the proportions of cases in infants < 8 months and adults have been increasing since 2013, representing a considerable challenge for measles elimination in China. A total of 14,868 measles viruses were isolated from confirmed measles cases from 2011 to 2017, of which 14,631 were identified as the predominant endemic genotype, H1; 87 were identified as genotype A viruses that were vaccine associated strains; and 150 were identified as non-H1 genotype viruses. The non-H1 genotype viruses included 62 D8 viruses, 70 D9 viruses, 3 D11 viruses, 14 B3 viruses, and 1 G3 virus, which were identified as imported or import-related viruses that caused sporadic cases or small outbreaks. Most of the transmission chains detected during the period 2011-2012 were interrupted and were followed by many new transmission chains of unknown origin that spread, causing a large measles resurgence in China during 2013-2016. After 4 years of measles resurgence and continuous implementation of the routine immunization program and SIAs, the population immunity reached a sufficiently high level to interrupt most of the transmission chains; only a few strains survived, which continued to be sporadically detected in China in 2017. In the present study, the results from the combined epidemiological and molecular virological data demonstrated the great progress towards measles elimination in China by the further analysis of circulation dynamics for the endemic H1 genotype measles virus from 2011 to 2017. And this study accumulated critical baseline data on circulating wild-type measles viruses in China and provides comprehensive information to the world. These comprehensive baseline data provide evidence to support measles elimination in the future, not only in China but also in other countries worldwide. In addition, the information will be very useful to other countries for tracing their sources of measles cases and for identifying transmission links, which can help prevent potential measles outbreaks.	[Wang, Huiling; Zhang, Yan; Mao, Naiying; Zhu, Zhen; Cui, Aili; Xu, Songtao; Song, Jinhua; Ji, Yixin; Cao, Lei; Ren, Li; Gao, Lingyu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Lab Measles Rubella, NHC Key Lab Med Virol & Viral Dis, Beijing, Peoples R China; [Chen, Meng] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Fang, Xueqiang] Shandong Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Li, Chongshan] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Feng, Daxing] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Zhou, Shujie] Anhui Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China; [Wang, Shulei] Yantai Ctr Dis Control & Prevent, Yantai, Shandong, Peoples R China; [Shi, Jing] Yizhuang Hosp, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Zhang, Y; Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Lab Measles Rubella, NHC Key Lab Med Virol & Viral Dis, Beijing, Peoples R China.	zhangyan9876543@163.com; wenbo_xu1@aliyun.com		, Yan/0000-0001-7299-7215	Key Technologies R&D Program of the National Ministry of Science [2018ZX10713002, 2017ZX10104001-002, 2018ZX10713001-003, 2018ZX10711001]; National Natural Science Foundation [81371791]; US CDC; WHO	Key Technologies R&D Program of the National Ministry of Science; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); US CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); WHO(World Health Organization)	This study was supported by the following grants: the Key Technologies R&D Program of the National Ministry of Science (2018ZX10713002, 2017ZX10104001-002, 2018ZX10713001-003, 2018ZX10711001) and the National Natural Science Foundation (81371791).; The authors thank all of the provincial and prefecture measles laboratory staff and epidemiologists in Mainland China for providing clinical specimens, isolates and epidemiologic data. We thank the WHO and US CDC for providing technical and financial support.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P373; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P73; Augusto GF, 2018, EUROSURVEILLANCE, V23, P5, DOI 10.2807/1560-7917.ES.2018.23.28.1800328; Barrett P, 2018, EUROSURVEILLANCE, V23, P14, DOI 10.2807/1560-7917.ES.2018.23.31.1700655; Bellini WJ, 1998, EMERG INFECT DIS, V4, P29, DOI 10.3201/eid0401.980105; Chen M, 2015, EMERG INFECT DIS, V21, P477, DOI 10.3201/eid2103.140646; China Center for Disease Control and Prevention. National Measles Surveillance Plan, 2014, NAT MEASL SURV PLAN; CUTTS FT, 1994, J INFECT DIS, V170, pS32, DOI 10.1093/infdis/170.Supplement_1.S32; Fang XQ, 2014, JPN J INFECT DIS, V67, P300, DOI 10.7883/yoken.67.300; Gil H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199975; Goldani LZ, 2018, BRAZ J INFECT DIS, V22, P359, DOI 10.1016/j.bjid.2018.11.001; Hagan JE, 2017, EMERG INFECT DIS, V23, pS77, DOI 10.3201/eid2313.170594; Ji YX, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-105; Ji Yixin, 2009, Virol J, V6, P135, DOI 10.1186/1743-422X-6-135; Jiang YG, 2012, SCI TECHNOLOGY FOOD, V7, P16, DOI DOI 10.1371/J0URNAL.P0NE.0034401; Kalaycioglu AT, 2016, J MED VIROL, V88, P1867, DOI 10.1002/jmv.24548; Komabayashi K, 2018, JPN J INFECT DIS, V71, P413, DOI [10.7883/yoken.JJID.2018.083, 10.7883/yoken.jjid.2018.083]; Li SH, 2014, BRAZ J INFECT DIS, V18, P581, DOI 10.1016/j.bjid.2014.05.018; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Ma C, 2011, J INFECT DIS, V204, pS447, DOI 10.1093/infdis/jir103; McLean Huong, 2012, Morbidity and Mortality Weekly Report, V61, P253; Muscat M, 2014, CLIN MICROBIOL INFEC, V20, P12, DOI 10.1111/1469-0691.12584; Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081; Rota PA, 2002, EMERG INFECT DIS, V8, P902, DOI 10.3201/eid0809.020206; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Sun Xiao-Dong, 2013, Bing Du Xue Bao, V29, P583; Takashima Y, 2015, MMWR-MORBID MORTAL W, V64, P357; Thomas S, 2017, EMERG INFECT DIS, V23, P1063, DOI 10.3201/eid2307.161145; Tramuto F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195256; Wang Hui-ling, 2010, Chinese Journal of Virology, V26, P103; Wang LX, 2003, J INFECT DIS, V187, pS252, DOI 10.1086/368045; Wang SL, 2014, BING DU XUE BAO, V30, P3535; WHO, 2019, MEASLES MADAGASCAR; WHO, 2018, MEASL; World Health Organization, 2018, MEASL CAS SPIK GLOB; Xu WB, 1998, VIRUS RES, V54, P147, DOI 10.1016/S0168-1702(98)00020-3; Xu WB, 2017, INT HEALTH, V9, P184, DOI 10.1093/inthealth/ihx017; Yang TU, 2015, INT J INFECT DIS, V33, P12, DOI 10.1016/j.ijid.2014.09.016; Zhang Y, 2014, CLIN MICROBIOL INFEC, V20, pO566, DOI 10.1111/1469-0691.12530; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhang Y, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-120; Zhang Yan, 2009, Zhongguo Yi Miao He Mian Yi, V15, P304; Zhang Y, 2010, EMERG INFECT DIS, V16, P943, DOI 10.3201/eid1606.100089	43	12	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218782	10.1371/journal.pone.0218782	http://dx.doi.org/10.1371/journal.pone.0218782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220172	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500091
J	Yustres, I; del Cerro, JS; Martin, R; Gonzalez-Mohino, F; Logan, O; Gonzalez-Rave, JM				Yustres, Inmaculada; Santos del Cerro, Jesus; Martin, Raul; Gonzalez-Mohino, Fernando; Logan, Oliver; Maria Gonzalez-Rave, Jose			Influence of early specialization in world-ranked swimmers and general patterns to success	PLOS ONE			English	Article							YOUTH SPORT SPECIALIZATION; PERFORMANCE; TALENT	Objectives The primary goal was to examine the influence of early specialization on the performance of senior elite swimmers. Secondly, to provide information about the influence of swim style, distance, sex, status, country, years of high-level competition (YHLC) and age in swimmer's performance. Design Data was obtained from International Federation of Swimming (FINA) regarding the participants 2006-2017 of junior and senior World Championships (WCs). The final filtered database included 4076 swimmers after removing those participating only in junior WCs. Method Cramer V coefficient, double and triple-entry tables were used to measure the relationship between the positions occupied in junior and senior phases. A One-Way ANOVA analysis was used to explain the variables time and rank between swimmers who participated in junior and senior WC or just in senior in all the distances and swim styles (SS). A univariate general linear model (GLM) was used to examine the association between time/rank and category (swimmers that participated previously in junior WC or not); YHLC; country; status (highest finishing position: final/semi-final/heats) and age. Results Significant differences (p <.001) were found in the GLM, with Rank as dependent variable, for all the variables. Showing that swimmers that participated previously in junior categories obtained greater results in all the interactions, except in 1500m freestyle. Significant differences (p <.001) were found between the variables position and YHLC, showing the variable position improvements as swimmers attended more WCs. Conclusion Competing in junior WC has a positive influence in achieve posteriori success in FINA WC. YHLC have a positive impact to achieve better positions.	[Yustres, Inmaculada; Gonzalez-Mohino, Fernando; Maria Gonzalez-Rave, Jose] Univ Castilla La Mancha, Dept Phys Act & Sport Sci, Toledo, Spain; [Santos del Cerro, Jesus] Univ Castilla La Mancha, Dept Stat, Toledo, Spain; [Martin, Raul] Univ Castilla La Mancha, Dept Math, Toledo, Spain; [Gonzalez-Mohino, Fernando] Univ Nebrija, Fac Educ & Lenguas, Madrid, Spain; [Logan, Oliver] Loughborough Univ, British Swimming, Sportpk, Loughborough, Leics, England	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Antonio de Nebrija; Loughborough University	Gonzalez-Rave, JM (corresponding author), Univ Castilla La Mancha, Dept Phys Act & Sport Sci, Toledo, Spain.	josemaria.gonzalez@uclm.es	Martín, Raúl Martín/F-2331-2016; JESUS, SANTOS/F-1188-2015; Yustres Amores, Inmaculada/AGD-5930-2022; González-Mohíno, Fernando/AAR-6380-2021; GONZALEZ-RAVE, JOSE MARIA/L-1090-2015	Martín, Raúl Martín/0000-0001-9237-9238; JESUS, SANTOS/0000-0002-1384-6334; González-Mohíno, Fernando/0000-0002-6327-6958; GONZALEZ-RAVE, JOSE MARIA/0000-0001-5953-4742; Logan, Oliver/0000-0003-3871-4079; Yustres, Inmaculada/0000-0002-1392-5673	Ministerio de Economia, Industria y Competitividad [MTM2016-80539-C2-1-R]	Ministerio de Economia, Industria y Competitividad	Raul Martin received funding support from the Ministerio de Economia, Industria y Competitividad Project MTM2016-80539-C2-1-R. The funders have not played any role in the study.; Ministerio de Economia, Industria y Competitividad Project MTM2016-80539-C2-1-R has provided external financial support for this Project.	Allen SV, 2015, INT J SPORT PHYSIOL, V10, P431, DOI 10.1123/ijspp.2014-0314; Allen SV, 2014, EUR J SPORT SCI, V14, P643, DOI 10.1080/17461391.2014.893020; Anderson SJ, 2000, PEDIATRICS, V106, P154, DOI 10.1542/peds.106.1.154; Bailey R.P., 2010, PARTICIPANT DEV SPOR; Baker J, 2003, HIGH ABIL STUD, V14, P85, DOI 10.1080/13598130304091; Baker J, 2009, HIGH ABIL STUD, V20, P77, DOI 10.1080/13598130902860507; Balyi Istvan., 2013, LONG TERM ATHLETE DE; Barreiros A, 2014, EUR J SPORT SCI, V14, pS178, DOI 10.1080/17461391.2012.671368; Brenner JS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2148; Capranica L, 2011, INT J SPORT PHYSIOL, V6, P572, DOI 10.1123/ijspp.6.4.572; Costa MJ, 2010, J SPORT SCI MED, V9, P411; Cote J, 1999, SPORT PSYCHOL, V13, P395, DOI 10.1123/tsp.13.4.395; Durand-Bush N, 2002, J APPL SPORT PSYCHOL, V14, P154, DOI 10.1080/10413200290103473; Fabricant PD, 2016, PHYSICIAN SPORTSMED, V44, P257, DOI 10.1080/00913847.2016.1177476; Gould D, 1996, SPORT PSYCHOL, V10, P341, DOI 10.1123/tsp.10.4.341; Green B, 2015, J SPORT MANAGE, V19, P233; Gulbin J, 2013, EUR J SPORT SCI, V13, P605, DOI 10.1080/17461391.2012.756542; Harper TL, 2011, DIALOGUES IN URBAN AND REGIONAL PLANNING 4, P1; HILL GM, 1993, SOCIOL SPORT J, V10, P107, DOI 10.1123/ssj.10.1.107; Lang M, 2010, INT J SPORTS SCI COA, V5, P389, DOI 10.1260/1747-9541.5.3.389; Neeru J, 2013, SPORTS HLTH, V5; Pizzuto F, 2016, IJSPP, V12; Pyne D., 2014, J SPORTS SCI, V22, P613; Sokolovas G., 2006, P 10 INT S BIOM MED, P315; Stewart B., 2004, AUSTR SPORT BETTER D; Svendsen IS, 2018, INT J SPORT PHYSIOL, V13, P1287, DOI 10.1123/ijspp.2017-0824; West DJ, 2011, J STRENGTH COND RES, V25, P950, DOI 10.1519/JSC.0b013e3181c8656f; Wiersma LD, 2000, PEDIATR EXERC SCI, V12, P13, DOI 10.1123/pes.12.1.13; Yustres L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187462	29	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218601	10.1371/journal.pone.0218601	http://dx.doi.org/10.1371/journal.pone.0218601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220159	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500071
J	Zhao, BL; Cui, YJ; Fan, XD; Qi, P; Liu, CC; Zhou, XS; Zhang, XW				Zhao, Bingli; Cui, Yujiao; Fan, Xiaodan; Qi, Ping; Liu, Chunchen; Zhou, Xuesong; Zhang, Xuewu			Anti-obesity effects of Spirulina platensis protein hydrolysate by modulating brain-liver axis in high-fat diet fed mice	PLOS ONE			English	Article							LIPOPROTEIN SUBFRACTIONS; 3T3-L1 PREADIPOCYTES; LIPID-ACCUMULATION; INSULIN-RESISTANCE; OBESE-PATIENTS; EXTRACT; ADIPOGENESIS; DIFFERENTIATION; ASSOCIATION; CHOLESTEROL	Spirulina platensis is a blue-green algae with potential anti-obesity effects. In this study, the anti-obesity effects of whole Spirulina platensis (WSP), Spirulina platensis protein (SPP) and Spirulina platensis protein hydrolysate (SPPH) were compared in high-fat diet fed mice, and the potential acting mechanism of SPPH was also investigated. Totally, SPPH exhibited good anti-obesity effects (reducing 39.8%+/- 9.7% of body weight), lowering 23.8%+/- 1.6% of serum glucose, decreasing 20.8%+/- 1.4% of total cholesterol, while positive drug Simvastatin had the corresponding values: 8.3%+/- 4.6%, 24.8%+/- 1.9% and -2.1%+/- 0.2%, respectively. Subsequently, PCR array was used to conduct gene expression analysis in brain and liver tissues of SPPH-treated mice, which displayed distinctly different expression pattern. The most markedly changed genes included: Acadm (-34.7 fold), Gcg (2.5 fold), Adra2b (2 fold) and Ghsr (2 fold) in brain; Retn (39 fold), Fabp4 (15.5 fold), Ppard (6 fold) and Slc27a1 (5.4 fold) in liver. Further network analysis demonstrated that the significantly expressed genes in brain and liver tissues were mapped into an interacting network, suggesting a modulatory effect on brain-liver axis, major pathways were involved in the axis: PPAR, adipocytokine, AMPK, non-alcoholic fatty liver disease and MAPK. This study showed that Spirulina platensis protein hydrolysate possessed anti-obesity effect in mice.	[Zhao, Bingli; Cui, Yujiao; Fan, Xiaodan; Zhou, Xuesong; Zhang, Xuewu] South China Univ Technol, Coll Food Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Qi, Ping] Guangzhou Inst Food & Drug Control, Guangzhou, Guangdong, Peoples R China; [Liu, Chunchen] Zhongci Hlth Care Prod Technol Dev Co Ltd, Guangzhou, Guangdong, Peoples R China; [Zhou, Xuesong] Guangzhou Honsea Ind Co Ltd, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Zhang, XW (corresponding author), South China Univ Technol, Coll Food Sci & Engn, Guangzhou, Guangdong, Peoples R China.; Qi, P (corresponding author), Guangzhou Inst Food & Drug Control, Guangzhou, Guangdong, Peoples R China.	gzsp2000@163.com; snow_dance@sina.com						Barter P, 2019, ATHEROSCLEROSIS, V283, P7, DOI 10.1016/j.atherosclerosis.2019.01.001; Beraza Naiara, 2008, Hepatology, V48, P1011, DOI 10.1002/hep.22478; Choi HS, 2015, MOL NUTR FOOD RES, V59, P1458, DOI 10.1002/mnfr.201500021; Ding YL, 2017, EXCLI J, V16, P328, DOI 10.17179/excli2016-638; Drotningsvik A, 2016, BRIT J NUTR, V116, P1336, DOI 10.1017/S0007114516003548; Fan XD, 2018, J FUNCT FOODS, V47, P350, DOI 10.1016/j.jff.2018.05.066; Filippatos TD, 2008, DIABETES OBES METAB, V10, P476, DOI 10.1111/j.1463-1326.2007.00733.x; de los Monteros LAGE, 2011, PLANT FOOD HUM NUTR, V66, P355, DOI 10.1007/s11130-011-0263-z; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; Hwang HS, 2009, MAR BIOTECHNOL, V11, P531, DOI 10.1007/s10126-008-9171-0; Jung EY, 2012, ANN NUTR METAB, V61, P89, DOI 10.1159/000338441; Jung HA, 2014, ARCH PHARM RES, V37, P713, DOI 10.1007/s12272-013-0237-9; Kalogirou M, 2007, CURR MED RES OPIN, V23, P1169, DOI 10.1185/030079907X188062; Kang JH, 2017, NUTR RES PRACT, V11, P17, DOI 10.4162/nrp.2017.11.1.17; Kang MC, 2017, MAR DRUGS, V15, DOI 10.3390/md15040119; Kang MC, 2016, FOOD CHEM TOXICOL, V90, P36, DOI 10.1016/j.fct.2016.01.023; Keene D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4379; Kim CH, 2016, ANIM CELLS SYST, V20, P335, DOI 10.1080/19768354.2016.1254110; Kim MR, 2017, INT J MOL MED, V40, P784, DOI 10.3892/ijmm.2017.3063; Lee JA, 2017, PHYTOTHER RES, V31, P1694, DOI 10.1002/ptr.5892; Lee YS, 2015, ASIAN PAC J TROP MED, V8, P276, DOI 10.1016/S1995-7645(14)60330-8; Mithieux G, 2010, DIABETES METAB, V36, pS50, DOI 10.1016/S1262-3636(10)70467-5; Moon J, 2013, FOOD CHEM TOXICOL, V58, P347, DOI 10.1016/j.fct.2013.05.006; Mopuri R, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0598-3; Nakou ES, 2008, EXPERT OPIN PHARMACO, V9, P3151, DOI 10.1517/14656560802548430 ; Oh IH, 2019, ATHEROSCLEROSIS, V283, P43, DOI 10.1016/j.atherosclerosis.2019.01.035; Ohashi A, 2004, J NUTR SCI VITAMINOL, V50, P416, DOI 10.3177/jnsv.50.416; Park HJ, 2016, NUTR RES PRACT, V10, P418, DOI 10.4162/nrp.2016.10.4.418; Sirtori CR, 2004, J NUTR, V134, P18, DOI 10.1093/jn/134.1.18; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tsai YC, 2017, PHYTOMEDICINE, V31, P11, DOI 10.1016/j.phymed.2017.05.005; Vitali C, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0940-0; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wan-Loy C, 2016, MAR DRUGS, V14, DOI 10.3390/md14120222; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Wang ZJ, 2016, FOOD FUNCT, V7, P781, DOI [10.1039/c5fo01186h, 10.1039/C5FO01186H]; Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679; Xu F, 2005, YUNNAN J TRADITIONAL, V26, P34; Xu XF, 2015, FOOD FUNCT, V6, P2068, DOI 10.1039/c4fo01192a; Yang L, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-24; Yang N, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-261; Yuan HD, 2010, J GINSENG RES, V34, P369, DOI 10.5142/jgr.2010.34.4.369; Zeinalian R, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1670-y	43	19	19	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218543	10.1371/journal.pone.0218543	http://dx.doi.org/10.1371/journal.pone.0218543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220177	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500062
J	Zimmerman, LA; Bell, SO; Li, QF; Morzenti, A; Anglewicz, P; Guiella, G; Gichangi, P; Otupiri, E; Makumbi, F; Kibera, S; Shiferaw, S; Seme, A; Habi, O; Oumarou, S; Tsui, AO				Zimmerman, Linnea A.; Bell, Suzanne O.; Li, Qingfeng; Morzenti, Antonia; Anglewicz, Philip; Guiella, Georges; Gichangi, Peter; Otupiri, Easmon; Makumbi, Fred; Kibera, Simon; Shiferaw, Solomon; Seme, Assefa; Habi, Oumarou; Oumarou, Sani; Tsui, Amy O.		PMA2020 Principal Investigators G	Individual, community and service environment factors associated with modern contraceptive use in five Sub-Saharan African countries: A multilevel, multinomial analysis using geographically linked data from PMA2020	PLOS ONE			English	Article							FAMILY-PLANNING SERVICE; HEALTH-CARE; METHOD MIX; WOMEN; ACCESS; IMPACT; AVAILABILITY; PROVISION; CHOICE; NORMS	The importance of the family planning service environment and community-level factors on contraceptive use has long been studied. Few studies, however, have been able to link individual and health facility data from surveys that are nationally representative, concurrently fielded, and geographically linked. Data from Performance Monitoring and Accountability 2020 address these limitations. To assess the relative influences of the service delivery environment and community, household, and individual factors on a woman's likelihood of using a modern contraceptive in five geographically and culturally diverse sub-Saharan African countries. Nationally representative, cross-sectional data from PMA2020 were linked at the household and service delivery level. Country-specific and pooled multilevel multinomial logistic models, comparing non-users, short-and long-acting method users were used. The variables elected for inclusion in our multivariate analyses were guided by the conceptual framework to profile the different levels of influences on individual use of modern contraception. Average marginal effects were calculated to improve interpretability. We find that the effect of contextual factors varies widely but that being visited by a health worker who spoke about family planning in the past 12 months was consistently and positively associated with individual use of short-acting and long-acting contraception. Characteristics of the nearest health facility did not generally exercise their own independent influences on a woman's use of contraception, except in the case of Burkina Faso, where the average distance between individuals and the nearest family planning provider was significantly greater than other countries. Inclusion of country fixed effects in the pooled models and the relevance of covariates at different levels in the country-specific models demonstrate that there is significant variation across countries in how community, individual, and service delivery environment factors influence contraceptive use and method choice. Context must be taken into account when designing family planning programs.	[Zimmerman, Linnea A.; Bell, Suzanne O.; Anglewicz, Philip; Tsui, Amy O.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Li, Qingfeng] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Morzenti, Antonia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Ctr Commun Programs, Baltimore, MD USA; [Guiella, Georges] Univ Ouagadougou, Ouagadougou, Burkina Faso; [Gichangi, Peter] ICRH K, Mombasa, Kenya; [Otupiri, Easmon] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Makumbi, Fred; Kibera, Simon] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Shiferaw, Solomon; Seme, Assefa] Univ Addis Ababa, Addis Ababa, Ethiopia; [Habi, Oumarou; Oumarou, Sani] Inst Natl Stat, Niamey, Niger	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kwame Nkrumah University Science & Technology; Makerere University; Addis Ababa University	Zimmerman, LA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	linnea.zimmerman@jhu.edu	Li, Qingfeng/J-9520-2016	Li, Qingfeng/0000-0002-6390-6921; Zimmerman, Linnea A/0000-0002-0118-0889	Bill and Melinda Gates Foundation [OPP1079004]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	LZ, SB, QL, PA, AT all received partial salary support from the PMA2020 grant (OPP1079004) funded by the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The PMA2020 project relies on the work of many individuals, both in the United States and in survey countries. The project team is grateful for support from the Bill & Melinda Gates Foundation, particularly Win Brown for his technical support. Finally, thanks to the country teams and resident enumerators, now numbering more than 1,700, who are ultimately responsible for the success of PMA2020.	Achana FS, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0017-8; Adjiwanou V, 2014, HEALTH PLACE, V29, P67, DOI 10.1016/j.healthplace.2014.06.001; Asiimwe JB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-926; Bertrand JT, 2014, INT PERSPECT SEX R H, V40, P144, DOI 10.1363/4014414; Biddlecom Ann E, 2007, Afr J Reprod Health, V11, P99, DOI 10.2307/25549734; Casterline J. B., 1987, WORLD FERTILITY SURV; Chin-Quee D, 2013, GLOB HEALTH-SCI PRAC, V1, P316, DOI 10.9745/GHSP-D-13-00025; Clifton D, 2010, EXPANDING ACCESS FAM; Digitale J, 2017, ANN AM ACAD POLIT SS, V669, P93, DOI 10.1177/0002716216678591; Douthwaite M, 2005, HEALTH POLICY PLANN, V20, P117, DOI 10.1093/heapol/czi014; Dynes M, 2012, HEALTH PLACE, V18, P766, DOI 10.1016/j.healthplace.2012.04.006; Elfstrom KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040670; Eliason S, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-65; Ettarh Remare R, 2012, Afr J Reprod Health, V16, P48; Fabic MS, 2015, LANCET, V385, P1928, DOI 10.1016/S0140-6736(14)61055-2; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Heard Nathan J, 2004, Afr J Reprod Health, V8, P164, DOI 10.2307/3583189; Hutchinson PL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-203; IHE, 2014, EV PREST SERV SOINS; Jain AK, 2016, INT PERSPECT SEX R H, V42, P131, DOI 10.1363/42e1616; Kaggwa EB, 2008, INT FAM PLAN PERSPEC, V34, P79, DOI 10.1363/ifpp.34.079.08; Katz KR, 1998, INT FAM PLAN PERSPEC, V24, P104, DOI 10.2307/3038206; Magnani RJ, 1999, STUD FAMILY PLANN, V30, P120, DOI 10.1111/j.1728-4465.1999.00120.x; Okigbo C, 2017, WORLD MED HEALTH POL, V9, P65, DOI 10.1002/wmh3.215; Paek HJ, 2008, HEALTH EDUC BEHAV, V35, P461, DOI 10.1177/1090198106296769; Prata N, 2009, PHILOS T R SOC B, V364, P3093, DOI 10.1098/rstb.2009.0172; RamaRao S, 2003, STUD FAMILY PLANN, V34, P227, DOI 10.1111/j.1728-4465.2003.00227.x; Skiles MP, 2015, INT PERSPECT SEX R H, V41, P20, DOI 10.1363/4102015; Steele F, 1999, STUD FAMILY PLANN, V30, P28, DOI 10.1111/j.1728-4465.1999.00028.x; Stephenson R, 2008, INT FAM PLAN PERSPEC, V34, P62, DOI 10.1363/ifpp.34.062.08; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; Sullivan TM, 2006, J BIOSOC SCI, V38, P501, DOI 10.1017/S0021932005026647; Tsui AO, 2017, POPUL DEV REV, V43, P166, DOI 10.1111/padr.12051; TULADHAR JM, 1987, STUD FAMILY PLANN, V18, P49, DOI 10.2307/1966421; Wang W, 2012, 26 ICF INT; Wang WJ, 2017, GLOB HEALTH-SCI PRAC, V5, P244, DOI 10.9745/GHSP-D-16-00311; Yao J, 2013, SOC SCI MED, V96, P60, DOI [10.1016/j.socscimed.2013.07.025, 10.1016/j.socscimed.2012.11.005]; Zimmerman L, 2017, STUD FAMILY PLANN, V48, P293, DOI 10.1111/sifp.12031	38	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218157	10.1371/journal.pone.0218157	http://dx.doi.org/10.1371/journal.pone.0218157			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220114	gold, Green Published, Green Submitted			2022-12-26	WOS:000484893500026
J	Liang, S; Zhong, ZY; Kim, SY; Uchiyama, R; Roh, YS; Matsushita, H; Gottlieb, RA; Seki, E				Liang, Shuang; Zhong, Zhenyu; Kim, So Yeon; Uchiyama, Ryosuke; Roh, Yoon Seok; Matsushita, Hiroshi; Gottlieb, Roberta A.; Seki, Ekihiro			Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alcohol; inflammasome; macrophage; autophagy; chemokine; Toll-like receptor 4 (TLR4); cytokine; alcoholic liver disease; CC-chemokine ligand 10; CC-chemokine ligand 5; dysbiosis; innate immunity	INFLAMMASOME ACTIVATION; INNATE IMMUNITY; STEATOHEPATITIS; DISEASE; CONTRIBUTE; CROSSTALK; CELLS	Excessive alcohol consumption induces intestinal dysbiosis of the gut microbiome and reduces gut epithelial integrity. This often leads to portal circulation-mediated translocation of gut-derived microbial products, such as lipopolysaccharide (LPS), to the liver, where these products engage Toll-like receptor 4 (TLR4) and initiate hepatic inflammation, which promotes alcoholic liver disease (ALD). Although the key self-destructive process of autophagy has been well-studied in hepatocytes, its role in macrophages during ALD pathogenesis remains elusive. Using WT and myeloid cell-specific autophagy-related 7 (Atg7) knockout (Atg7(Delta Mye)) mice, we found that chronic ethanol feeding for 6 weeks plus LPS injection enhances serum alanine aminotransferase and IL-1 beta levels and augments hepatic C-C motif chemokine ligand 5 (CCL5) and C-X-C motif chemokine ligand 10 (CXCL10) expression in WT mice, a phenotype that was further exacerbated in Atg7(Delta Mye) mice. Atg7(Delta Mye) macrophages exhibited defective mitochondrial respiration and displayed elevated mitochondrial reactive oxygen species production and inflammasome activation relative to WT cells. Interestingly, compared with WT cells, Atg7(Delta Mye) macrophages also had a drastically increased abundance and nuclear translocation of interferon regulatory factor 1 (IRF1) after LPS stimulation. Mechanistically, LPS induced co-localization of IRF1 with the autophagy adaptor p62 and the autophagosome, resulting in subsequent IRF1 degradation. However, upon p62 silencing or Atg7 deletion, IRF1 started to accumulate in autophagy-deficient macrophages and translocated into the nucleus, where it induced CCL5 and CXCL10 expression. In conclusion, macrophage autophagy protects against ALD by promoting IRF1 degradation and removal of damaged mitochondria, limiting macrophage activation and inflammation.	[Liang, Shuang] Univ Calif San Diego, Dept Med, Div Gastroenterol, Sch Med, La Jolla, CA 92093 USA; [Kim, So Yeon; Uchiyama, Ryosuke; Roh, Yoon Seok; Matsushita, Hiroshi; Seki, Ekihiro] Cedars Sinai Med Ctr, Dept Med, Div Digest & Liver Dis, Los Angeles, CA 90048 USA; [Gottlieb, Roberta A.; Seki, Ekihiro] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Gottlieb, Roberta A.] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Liang, Shuang; Zhong, Zhenyu] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Roh, Yoon Seok] Chungbuk Natl Univ, Dept Pharm, Coll Pharm, Cheongju 28160, Chungbuk, South Korea	University of California System; University of California San Diego; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chungbuk National University	Seki, E (corresponding author), Cedars Sinai Med Ctr, Davis Bldg 2099,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	Ekihiro.Seki@cshs.org	Seki, Ekihiro/K-2481-2016	Seki, Ekihiro/0000-0002-9472-6085; Zhong, Zhenyu/0000-0002-9441-7645	National Institute on Alcohol Abuse and Alcoholism [R01AA027036, R21AA025841]; NIDDK, National Institutes of Health [R01DK085252]; American Liver Foundation Congressman John Joseph Moakley postdoctoral research fellowship; National Research Foundation of Korea [2017R1C1B2004423]; Cedars-Sinai Medical Center Winnick Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA027036, R21AA025841] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Liver Foundation Congressman John Joseph Moakley postdoctoral research fellowship; National Research Foundation of Korea(National Research Foundation of Korea); Cedars-Sinai Medical Center Winnick Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institute on Alcohol Abuse and Alcoholism Grants R01AA027036 and R21AA025841 (to E.S.); NIDDK, National Institutes of Health Grant R01DK085252 (to E.S.); an American Liver Foundation Congressman John Joseph Moakley postdoctoral research fellowship (to Y.S.R.); National Research Foundation of Korea Grant 2017R1C1B2004423 (to Y.S.R.); and a Cedars-Sinai Medical Center Winnick Research Award (to E.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, P1360, DOI 10.1111/j.1530-0277.2001.tb02359.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Ilyas G, 2016, J HEPATOL, V64, P118, DOI 10.1016/j.jhep.2015.08.019; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Li Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/498491; Liu K, 2015, AUTOPHAGY, V11, P271, DOI 10.1080/15548627.2015.1009787; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mandal P, 2010, WORLD J GASTROENTERO, V16, P1330, DOI 10.3748/wjg.v16.i11.1330; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Petrasek J, 2011, HEPATOLOGY, V53, P649, DOI 10.1002/hep.24059; Roh YS, 2015, AM J PHYSIOL-GASTR L, V309, pG30, DOI 10.1152/ajpgi.00031.2015; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Szabo G, 2012, DIGEST DIS, V30, P55, DOI 10.1159/000341126; Thomes PG, 2015, ALCOHOL CLIN EXP RES, V39, P2354, DOI 10.1111/acer.12904; Tsutsui H, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/641865; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; von Haefen C, 2011, ALCOHOL CLIN EXP RES, V35, P1381, DOI 10.1111/j.1530-0277.2011.01473.x; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057	32	16	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12359	12369		10.1074/jbc.RA119.007409	http://dx.doi.org/10.1074/jbc.RA119.007409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31235522	Green Published, hybrid			2022-12-26	WOS:000484402700009
J	Braman, JC; Sheffield, PJ				Braman, Jeffrey Carl; Sheffield, Peter J.			Seamless assembly of DNA parts into functional devices and higher order multi-device systems	PLOS ONE			English	Article							ESCHERICHIA-COLI; MAMMALIAN SEPTIN; BIOSYNTHESIS; RIBOFLAVIN; PURIFICATION; DEAMINASE; REDUCTASE; CLONING	A new method is introduced allowing seamless assembly of independent, functionally tested, blunt-end double strand nucleic acid parts ( DNA fragments not supplied in vectors such as plasmids) into more complex biological devices ( e. g. protein expression vectors) and higher order multi-device systems ( e. g. biochemical pathways). Individual parts include bacterial selection markers and origins of replication, promoters useful in a variety of species, transcription terminators, shuttle sequences and a variety of "N" and "C" terminal solubility/affinity protein tags. Parts are not subjected to pre-assembly manipulation with nucleic acid modifying enzymes. Instead, they are simply mixed in appropriate pre-defined combinations and concentrations and then seamlessly linked into devices employing a specialized thermostable enzyme blend. Combinatorial assembly of parts is an inherent time-saving feature of the new method, in contrast to hierarchical binary assembly ("one part at a time") methods. This feature substantially simplifies and speeds optimization of device and system development. The versatility and functionality of the new method was shown by combinatorial assembly of parts into vector devices, one of which optimally expressed protein from a model gene. Also, a four-enzyme biosynthetic pathway system was re-created by combinatorial construction from parts and devices. Concepts discussed in this paper provide synthetic biologists, chemists and bio-engineers with improved and expanded capability to create novel biological molecules and systems.	[Braman, Jeffrey Carl; Sheffield, Peter J.] Agilent Technol, La Jolla, CA 92037 USA	Agilent Technologies	Braman, JC; Sheffield, PJ (corresponding author), Agilent Technol, La Jolla, CA 92037 USA.	jeff.braman@agilent.com; peter.sheffield@agilent.com		Braman, Jeff/0000-0003-1726-7388	Agilent	Agilent	Agilent internally funded. The authors commercial affiliation did not play a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript and only provided financial support in the form of authors salaries and research materials. More specifically, the funder provided support in the form of salaries and research materials for authors (JCB and PJS) but did not have any additional role in the study design, data collection and analysis,decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section of the online submission form.	Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; BURROWS RB, 1978, J BACTERIOL, V136, P657, DOI 10.1128/JB.136.2.657-667.1978; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; FOOR F, 1975, J BIOL CHEM, V250, P3545; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Jin P, 2016, ACS SYNTH BIOL, V5, P1028, DOI 10.1021/acssynbio.6b00078; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Knight T., 2003, STRUCTURE, V1, P11, DOI 10.21236/ADA457791; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lin ZQ, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0104-5; MALEY GF, 1959, J BIOL CHEM, V234, P641; Mortl S, 1996, J BIOL CHEM, V271, P33201, DOI 10.1074/jbc.271.52.33201; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Richter G, 1997, J BACTERIOL, V179, P2022, DOI 10.1128/jb.179.6.2022-2028.1997; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sheffield PJ, 2001, PROTEIN ENG, V14, P513, DOI 10.1093/protein/14.7.513; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; VOLK R, 1990, J BIOL CHEM, V265, P19479; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	21	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0199653	10.1371/journal.pone.0199653	http://dx.doi.org/10.1371/journal.pone.0199653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251741	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000001
J	Brehm, A; Maus, V; Khadhraoui, E; Psychogios, MN				Brehm, Alex; Maus, Volker; Khadhraoui, Eya; Psychogios, Marios-Nikos			Image review on mobile devices for suspected stroke patients: Evaluation of the mRay software solution	PLOS ONE			English	Review							ALBERTA STROKE; RELIABILITY; SCORE	Purpose Software solutions such as mRay allow review of radiological images on handheld devices. We investigated if the quality is adequate for evaluating CT scans of patients with suspected stroke. Methods 50 patients ( Median age 80 years, 28 females) were retrospectively selected. All patients had undergone multidetector CT angiography +/- perfusion and presented with clinical signs of acute stroke. Out of the 50 patients, 19 had large-vessel occlusion ( LVO), 5 had intracranial hemorrhage ( ICH), 10 had severe intracranial stenosis of at least one major vessel, 2 had intracranial tumor and 15 had no or an unrelated pathology. One experienced neuroradiologist and one resident scored the anonymized pictures separately on two handheld devices ( iPhone 7 Plus, MED-TAB) equipped with mRay Software and on a PACS workstation. Each case was reviewed on all three devices with a break in-between of at least 12 weeks. The scoring on the traditional workstation was compared with the two handheld devices, regarding detection of early ischemic signs, LVOs, CBV/CBF-mismatch, ICHs and severe stenosis. Both raters were asked to rate the diagnostic quality of both handheld devices regarding detection of LVOs, ICHs, early ischemic signs and overall. Results All LVOs, intracranial tumors and ICHs were detected on both mobile devices. There was no significant difference in the rating of CCT and CBF ASPECTS between all three devices, while the sensitivity for detecting a CBF/CBV-mismatch was above 80% on both devices. Both raters assessed the diagnostic quality to be sufficient on both mobile devices to base treatment decisions on. Conclusion Software solutions such as mRay for handheld devices provide adequate diagnostic quality for the review of CT scans of suspected stroke patients.	[Brehm, Alex; Khadhraoui, Eya; Psychogios, Marios-Nikos] Univ Med Ctr Goettingen, Dept Neuroradiol, Gottingen, Germany; [Brehm, Alex; Psychogios, Marios-Nikos] Univ Hosp Basel, Dept Neuroradiol, Clin Radiol & Nucl Med, Basel, Switzerland; [Maus, Volker] Ruhr Univ Hosp Bochum, Knappschaftskrankenhaus Bochum, Dept Radiol Neuroradiol & Nucl Med, Bochum, Germany	University of Gottingen; University of Basel; Ruhr University Bochum	Brehm, A (corresponding author), Univ Med Ctr Goettingen, Dept Neuroradiol, Gottingen, Germany.; Brehm, A (corresponding author), Univ Hosp Basel, Dept Neuroradiol, Clin Radiol & Nucl Med, Basel, Switzerland.	Alex.brehm@med.uni-goettingen.de		khadhraoui, Eya/0000-0002-5433-1572				Choudhri AF, 2011, J DIGIT IMAGING, V24, P184, DOI 10.1007/s10278-010-9312-7; Dreyer KJ, 1998, J DIGIT IMAGING, V11, P8, DOI 10.1007/BF03168170; Kellner E, 2017, J COMPUT ASSIST TOMO, V41, P515, DOI 10.1097/RCT.0000000000000570; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Naylor J, 2017, J STROKE CEREBROVASC, V26, P2547, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.042; Naylor J, 2017, CEREBROVASC DIS, V44, P195, DOI 10.1159/000479707; Randhawa PA, 2016, CAN J NEUROL SCI, V43, P529, DOI 10.1017/cjn.2016.40; Sheth SA, 2019, STROKE, P1, DOI [10.1161/01.str.0000550737, DOI 10.1161/01.STR.0000550737]; Vanicek J, 2019, J STROKE CEREBROVASC, V28, P1085, DOI 10.1016/j.jstrokecerebrovasdis.2018.12.041; Wardlaw JM, 2006, LANCET, V367, P1503, DOI 10.1016/S0140-6736(06)68650-9	10	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219051	10.1371/journal.pone.0219051	http://dx.doi.org/10.1371/journal.pone.0219051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251781	Green Submitted, Green Published, gold			2022-12-26	WOS:000484915000040
J	Gupalova, T; Leontieva, G; Kramskaya, T; Grabovskaya, K; Kuleshevich, E; Suvorov, A				Gupalova, Tatiana; Leontieva, Galina; Kramskaya, Tatiana; Grabovskaya, Kornelya; Kuleshevich, Eugenia; Suvorov, Alexander			Development of experimental pneumococcal vaccine for mucosal immunization	PLOS ONE			English	Article							CONJUGATE VACCINE; IMMUNOGLOBULIN-A; ANTIGEN; MICE; IMMUNOGENICITY; MICROBIOTA; INFECTION; RESPONSES; DELIVERY; PARTICLE	Streptococcus pneumonia is an important human pathogen that causes various severe diseases such as pneumonia, otitis and meningitis. Vaccination against S. pneumoniae is implemented in many developed countries. The presently used vaccines are safe, well tolerated but relatively expensive and require modification due to the immunological changes of the epidemic strains. This paper describes the development of a new pneumococcal vaccine candidate for immunization on mucosal surfaces. For this purpose the antigens of chimeric protein PSPF, previously suggested for an injectable S. pneumoniae vaccine, were expressed on the surface of the live probiotic strain Enterococcus faecium L3. Experiments on laboratory mice vaccinated with live bacteria demonstrated the appearance of the specific IgA and IgG which provide protection against the lethal S. pneumoniae infection.	[Gupalova, Tatiana; Leontieva, Galina; Kramskaya, Tatiana; Grabovskaya, Kornelya; Kuleshevich, Eugenia; Suvorov, Alexander] Inst Expt Med, Dept Mol Microbiol, St Petersburg, Russia; [Suvorov, Alexander] St Petersburg State Univ, Fac Dent & Med Technol, Dept Fundamental Med & Med Technol, St Petersburg, Russia	Institute of Experimental Medicine; Saint Petersburg State University	Leontieva, G (corresponding author), Inst Expt Med, Dept Mol Microbiol, St Petersburg, Russia.	galeonte@yandex.ru	Kuleshevich, Eugenia/AAH-4331-2021; Kramskaya, Tatiana/AAH-2447-2021; Leontieva, Galina/AAH-1660-2019; Gupalova, Tatyana/E-1290-2014; Suvorov, Alexander/J-6921-2013	Leontieva, Galina/0000-0002-9876-6594; Gupalova, Tatyana/0000-0002-4824-3621; Suvorov, Alexander/0000-0003-2312-5589				Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; Aymeric L, 2015, MUCOSAL IMMUNOLOGY, P975, DOI DOI 10.1016/B978-0-12-415847-4.00050-1; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; BRANDTZAEG P, 1989, CURR TOP MICROBIOL, V146, P13; Clarke E, 2016, EXPERT REV VACCINES, V15, P1305, DOI 10.1586/14760584.2016.1167602; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; de Haan L, 2001, VACCINE, V19, P2898, DOI 10.1016/S0264-410X(00)00556-9; Durando P, 2013, CLIN MICROBIOL INFEC, V19, P1, DOI 10.1111/1469-0691.12320; Ermolenko E, 2018, BENEF MICROBES, V9, P937, DOI [10.3920/BM2017.0117, 10.3920/bm2017.0117]; Furuya Y, 2013, INFECT IMMUN, V81, P3434, DOI 10.1128/IAI.00408-13; Galen JE, 2014, VACCINE, V32, P4376, DOI 10.1016/j.vaccine.2013.12.026; Galen JE, 2009, J INFECT DIS, V199, P326, DOI 10.1086/596066; Gupalova T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196564; Jonczyk MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089831; Joseph A, 2006, VACCINE, V24, P3990, DOI 10.1016/j.vaccine.2005.12.017; Kang HY, 2003, FEMS IMMUNOL MED MIC, V37, P99, DOI 10.1016/S0928-8244(03)00063-4; Laino J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206661; Matassov D, 2007, VIRAL IMMUNOL, V20, P441, DOI 10.1089/vim.2007.0027; Meredith ME, 2015, AAPS J, V17, P780, DOI 10.1208/s12248-015-9719-7; Murthy AK, 2004, CELL IMMUNOL, V230, P56, DOI 10.1016/j.cellimm.2004.09.002; Principi N, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0607-z; Principi N, 2018, EXPERT OPIN BIOL TH, V18, P7, DOI 10.1080/14712598.2018.1384462; Rodriguez A, 2006, SCAND J IMMUNOL, V63, P177, DOI 10.1111/j.1365-3083.2006.01725.x; Saluja V, 2010, AAPS J, V12, P109, DOI 10.1208/s12248-009-9168-2; Shiramoto M, 2015, HUM VACC IMMUNOTHER, V11, P2198, DOI 10.1080/21645515.2015.1030550; Sugimoto N, 2017, BMC RES NOTES, V10, DOI 10.1186/s13104-016-2353-3; Suvorov A, 2015, J VACCINES VACCIN, V6, P6, DOI [10.1139/w08-077, DOI 10.1139/W08-077]; Suvorov A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01869; Tjanlund A, 2006, INT IMMUNOL, V18, P807, DOI 10.1093/intimm/dxl017; Tojo R, 2014, WORLD J GASTROENTERO, V20, P15163, DOI 10.3748/wjg.v20.i41.15163; Turner Allison E. B., 2017, SYNTHETIC SYSTEMS BI, V2, P49, DOI [10.1016/j.synbio.2016.12.002, DOI 10.1016/J.SYNBIO.2016.12.002]; van Roosmalen ML, 2006, METHODS, V38, P144, DOI 10.1016/j.ymeth.2005.09.015; Villena J, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5020017; Wang BH, 2017, ENGINEERING, V3, P71, DOI 10.1016/J.ENG.2017.01.008	34	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218679	10.1371/journal.pone.0218679	http://dx.doi.org/10.1371/journal.pone.0218679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251760	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000017
J	Tian, CC; Tang, XL; Zhu, XY; Zhou, Q; Guo, YT; Zhao, R; Wang, DJ; Gong, B				Tian, Congcong; Tang, Xinlong; Zhu, Xiyu; Zhou, Qing; Guo, Yuting; Zhao, Rui; Wang, Dongjin; Gong, Bing			Expression profiles of circRNAs and the potential diagnostic value of serum circMARK3 in human acute Stanford type A aortic dissection	PLOS ONE			English	Article							APOPTOSIS; ANEURYSMS; PREDISPOSE; ACTIVATION; RECEPTOR; RNAS	CircRNAs are involved in a variety of human diseases, however, the expression profiles and the potential diagnostic value of circRNAs in human acute Stanford type A aortic dissection ( AAAD) remains largely unknown. In this study, high-throughput RNA sequencing ( RNA-Seq) was used to investigate the differentially expressed circRNAs, microRNAs ( miRs) and mRNAs in human AAAD tissues ( n = 10) compared with normal aortic tissues ( n = 10). The results of RNA-Seq revealed that 506 circRNAs were significantly dysregulated ( P<0.05, false discovery rate, FDR<0.05, fold change>2). The subsequent weighted gene correlation network analysis and the following co-expression network analysis revealed that tyrosine-protein kinase Fgr might play important roles in the occurrence and development of AAAD. According to the circRNA-miRNA-mRNA network, we found that the upstream regulatory molecule of Fgr is circMARK3. Finally, a receiver operating characteristic ( ROC) curve was used to evaluate the diagnostic value of the serum circMARK3 as biomarkers for AAAD ( cutoff value = 1.497, area under the curve = 0.9344, P < 0.0001, sensitivity = 90.0%, specificity = 86.7%). These results provided a preliminary landscape of circRNAs expression profiles and indicated that circMARK3 was a potential biomarker for AAAD diagnosis.	[Tian, Congcong; Tang, Xinlong; Zhu, Xiyu; Zhou, Qing; Wang, Dongjin; Gong, Bing] Nanjing Univ, Affiliated Drum Tower Hosp, Med Sch, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Guo, Yuting] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Guo, Yuting] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Zhao, Rui] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Zhao, Rui] Peking Union Med Coll, Beijing, Peoples R China	Nanjing University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, DJ; Gong, B (corresponding author), Nanjing Univ, Affiliated Drum Tower Hosp, Med Sch, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China.	gulouyiyuanwdj@126.com; gongbing217124@outlook.com		Gong, Bing/0000-0002-3383-3610	Fundamental Research Funds for the Central Universities [0214-14380316]; National Natural Science Foundation of China [81670437]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Bing Gong received the Fundamental Research Funds for the Central Universities (Grant No. 0214-14380316), and Dongjin Wang received the National Natural Science Foundation of China (Grant No. 81670437). Bing Gong and Dongjin Wang participated in its design and coordination and helped to draft the manuscript.	ANAGNOSTOPOULOS CE, 1972, AM J CARDIOL, V30, P263, DOI 10.1016/0002-9149(72)90070-7; Anfossi S, 2018, NAT REV CLIN ONCOL, V15, P541, DOI 10.1038/s41571-018-0035-x; Anzai A, 2015, CIRC RES, V116, P612, DOI 10.1161/CIRCRESAHA.116.304918; Baruzzi A, 2015, J IMMUNOL, V195, P4900, DOI 10.4049/jimmunol.1500579; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Bersi MR, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0327; Han B, 2018, PHARMACOL THERAPEUT, V187, P31, DOI 10.1016/j.pharmthera.2018.01.010; Huang J, 2008, 14 WORLD C EARTHQ EN, P12, DOI DOI 10.1172/JCI33304; Huang JH, 2015, P NATL ACAD SCI USA, V112, P4447, DOI 10.1073/pnas.1420363112; Huang XF, 2018, ARTERIOSCL THROM VAS, V38, P1086, DOI 10.1161/ATVBAHA.117.310694; Ihling C, 1999, HEART, V82, P286, DOI 10.1136/hrt.82.3.286; Inamoto S, 2010, CARDIOVASC RES, V88, P520, DOI 10.1093/cvr/cvq230; Isselbacher EM, 2016, CIRCULATION, V133, P2516, DOI 10.1161/CIRCULATIONAHA.116.009762; Jia LX, 2015, J PATHOL, V236, P373, DOI 10.1002/path.4534; Kotlo K, 2007, HYPERTENSION, V49, P467, DOI 10.1161/01.HYP.0000256303.40359.38; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1; LeMaire SA, 2011, NAT REV CARDIOL, V8, P103, DOI 10.1038/nrcardio.2010.187; Li X, 2018, MOL CELL, V71, P428, DOI 10.1016/j.molcel.2018.06.034; Liu YL, 2015, J IMMUNOL, V194, P5851, DOI 10.4049/jimmunol.1401533; Lu H, 2008, CURR HYPERTENS REP, V10, P99, DOI 10.1007/s11906-008-0020-3; Nienaber CA, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.53, 10.1038/nrdp.2016.71]; Nienaber CA, 2015, LANCET, V385, P800, DOI 10.1016/S0140-6736(14)61005-9; Plubell DL, 2017, MOL CELL PROTEOMICS, V16, P873, DOI 10.1074/mcp.M116.065524; Shen H, 2018, J CARDIOVASC PHARM, V71, P275, DOI 10.1097/FJC.0000000000000568; Shen YH, 2017, CURR PROB SURG, V54, P95, DOI 10.1067/j.cpsurg.2017.01.001; Singer HA, 2012, J PHYSIOL-LONDON, V590, P1349, DOI 10.1113/jphysiol.2011.222232; Sun J, 2018, CELL PHYSIOL BIOCHEM, V46, P1027, DOI 10.1159/000488834; Suzuki R, 2014, SCIENCE, V343, P1021, DOI 10.1126/science.1246976; Szabo L, 2016, NAT REV GENET, V17, P679, DOI 10.1038/nrg.2016.114; Trachet B, 2017, CARDIOVASC RES, V113, P1230, DOI 10.1093/cvr/cvx128; Tsai TT, 2006, CIRCULATION, V114, pI350, DOI 10.1161/CIRCULATIONAHA.105.000497; Wang SQ, 2016, J CLIN INVEST, V126, P948, DOI 10.1172/JCI83778; Wang ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00479; Yan LP, 2018, BIOCHEM BIOPH RES CO, V498, P743, DOI 10.1016/j.bbrc.2018.03.051; Yu N, 2018, BIOCHEM BIOPH RES CO, V501, P838, DOI 10.1016/j.bbrc.2018.04.200; Yue YQ, 2018, BIOCHEM BIOPH RES CO, V495, P2030, DOI 10.1016/j.bbrc.2017.12.059; Zaina S, 2002, J BIOL CHEM, V277, P4505, DOI 10.1074/jbc.M108061200; Zhang WM, 2016, J MOL CELL CARDIOL, V99, P76, DOI 10.1016/j.yjmcc.2016.08.008; Zhang WB, 2015, MOL MED REP, V12, P4703, DOI 10.3892/mmr.2015.3899; Zhang ZR, 2018, EBIOMEDICINE, V34, P267, DOI 10.1016/j.ebiom.2018.07.036; Zou MS, 2017, ONCOTARGET, V8, P81825, DOI 10.18632/oncotarget.18998	42	14	16	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219013	10.1371/journal.pone.0219013	http://dx.doi.org/10.1371/journal.pone.0219013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251793	Green Submitted, Green Published, gold			2022-12-26	WOS:000484915000035
J	Beule, L; Corre, MD; Schmidt, M; Gobel, L; Veldkamp, E; Karlovsky, P				Beule, Lukas; Corre, Marife D.; Schmidt, Marcus; Goebel, Leonie; Veldkamp, Edzo; Karlovsky, Petr			Conversion of monoculture cropland and open grassland to agroforestry alters the abundance of soil bacteria, fungi and soil-N-cycling genes	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; GRADIENT GEL-ELECTROPHORESIS; LONG-TERM FERTILIZATION; NITROUS-OXIDE REDUCTASE; 16S RIBOSOMAL-RNA; COMMUNITY STRUCTURE; DENITRIFYING BACTERIA; MICROBIAL COMMUNITY; ENZYME-ACTIVITIES; NOSZ GENES	Integration of trees in agroforestry systems can increase the system sustainability compared to monocultures. The resulting increase in system complexity is likely to affect soil-N cycling by altering soil microbial community structure and functions. Our study aimed to assess the abundance of genes encoding enzymes involved in soil-N cycling in paired monoculture and agroforestry cropland in a Phaeozem soil, and paired open grassland and agroforestry grassland in Histosol and Anthrosol soils. The soil fungi-to-bacteria ratio was greater in the tree row than in the crop or grass rows of the monoculture cropland and open grassland in all soil types, possibly due to increased input of tree residues and the absence of tillage in the Phaeozem (cropland) soil. In the Phaeozem (cropland) soil, gene abundances of amoA indicated a niche differentiation between archaeal and bacterial ammonia oxidizers that distinctly separated the influence of the tree row from the crop row and monoculture system. Abundances of nitrate (napA and narG), nitrite (nirK and nirS) and nitrous oxide reductase genes (nosZ clade I) were largely influenced by soil type rather than management system. The soil types' effects were associated with their differences in soil organic C, total N and pH. Our findings show that in temperate regions, conversion of monoculture cropland and open grassland to agroforestry systems can alter the abundance of soil bacteria and fungi and soil-N-cycling genes, particularly genes involved in ammonium oxidation.	[Beule, Lukas; Karlovsky, Petr] Univ Goettingen, Fac Agr Sci, Mol Phytopathol & Mycotoxin Res, Gottingen, Germany; [Beule, Lukas; Corre, Marife D.; Schmidt, Marcus; Goebel, Leonie; Veldkamp, Edzo] Univ Goettingen, Fac Forest Sci & Forest Ecol, Soil Sci Trop & Subtrop Ecosyst, Gottingen, Germany	University of Gottingen; University of Gottingen	Beule, L (corresponding author), Univ Goettingen, Fac Agr Sci, Mol Phytopathol & Mycotoxin Res, Gottingen, Germany.; Beule, L (corresponding author), Univ Goettingen, Fac Forest Sci & Forest Ecol, Soil Sci Trop & Subtrop Ecosyst, Gottingen, Germany.	lukas.beule@agr.uni-goettingen.de	Schmidt, Marcus/H-9024-2019; Beule, Lukas/AAY-5667-2020; Veldkamp, Edzo/A-6660-2008	Schmidt, Marcus/0000-0002-5546-5521; Beule, Lukas/0000-0003-1107-7540; Veldkamp, Edzo/0000-0002-8318-8349; Karlovsky, Petr/0000-0002-6532-5856; Corre, Marife D./0000-0003-0359-2104; Gobel, Leonie/0000-0001-9707-3297	German Federal Ministry of Education and Research (BMBF) [031A562A, 031B0510A]; Gottingen University	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Gottingen University	This study was financed by the German Federal Ministry of Education and Research (BMBF) in the framework of the Bonares-SIGNAL project (funding codes: 031A562A and 031B0510A). We acknowledge support by the Open Access Publication Funds of the Gottingen University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SC, 2004, FOREST ECOL MANAG, V192, P395, DOI 10.1016/j.foreco.2004.02.009; Attard E, 2010, ENVIRON MICROBIOL, V12, P315, DOI 10.1111/j.1462-2920.2009.02070.x; Banerjee S, 2019, ISME J, V13, P1722, DOI 10.1038/s41396-019-0383-2; Banerjee S, 2016, ENVIRON MICROBIOL, V18, P1805, DOI 10.1111/1462-2920.12986; Banning NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep11146; Barta A, 2010, PLANT CELL, V22, P2926, DOI 10.1105/tpc.110.078352; Bergeron M, 2011, AGROFOREST SYST, V83, P321, DOI 10.1007/s10457-011-9402-7; Beule L, 2017, FORESTS, V8, DOI 10.3390/f8090316; Beuschel R, 2019, BIOL FERT SOILS, V55, P1, DOI 10.1007/s00374-018-1324-3; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; Brandfass C, 2008, INT J MOL SCI, V9, P2306, DOI 10.3390/ijms9112306; Bru D, 2007, APPL ENVIRON MICROB, V73, P5971, DOI 10.1128/AEM.00643-07; Cannell MGR, 1996, AGROFOREST SYST, V34, P27, DOI 10.1007/BF00129630; Chander K, 1998, BIOL FERT SOILS, V27, P168, DOI 10.1007/s003740050416; Chen YL, 2017, SOIL BIOL BIOCHEM, V110, P12, DOI 10.1016/j.soilbio.2017.02.015; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Culman SW, 2010, LANDSCAPE ECOL, V25, P1333, DOI 10.1007/s10980-010-9511-0; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Domeignoz-Horta LA, 2016, SOIL BIOL BIOCHEM, V103, P376, DOI 10.1016/j.soilbio.2016.09.010; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; Ferrarini A, 2017, GCB BIOENERGY, V9, P246, DOI 10.1111/gcbb.12340; Araujo ASF, 2012, AGRON SUSTAIN DEV, V32, P215, DOI 10.1007/s13593-011-0026-0; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fisk LM, 2015, SOIL BIOL BIOCHEM, V88, P380, DOI 10.1016/j.soilbio.2015.06.011; Fonte SJ, 2010, GEODERMA, V155, P320, DOI 10.1016/j.geoderma.2009.12.016; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Gomez E, 2000, APPL SOIL ECOL, V15, P273, DOI 10.1016/S0929-1393(00)00078-0; Gruning MM, 2018, FORESTS, V9, DOI 10.3390/f9080497; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Jones CM, 2014, NAT CLIM CHANGE, V4, P801, DOI [10.1038/NCLIMATE2301, 10.1038/nclimate2301]; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Jose S, 2004, AGROFOREST SYST, V61-2, P237, DOI 10.1023/B:AGFO.0000029002.85273.9b; Jose S, 2001, AGROFOREST SYST, V52, P161, DOI 10.1023/A:1010667921970; Jose S, 2009, AGROFOREST SYST, V76, P1, DOI 10.1007/s10457-009-9229-7; Kabir Z, 2005, CAN J PLANT SCI, V85, P23, DOI 10.4141/P03-160; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; KASSAMBARA A, 2017, PACKAGE FACTOEXTRA R; Kaur B, 2000, APPL SOIL ECOL, V15, P283, DOI 10.1016/S0929-1393(00)00079-2; Keil D, 2011, FEMS MICROBIOL ECOL, V77, P95, DOI 10.1111/j.1574-6941.2011.01091.x; Kelly JJ, 2011, APPL ENVIRON MICROB, V77, P6551, DOI 10.1128/AEM.02608-10; Lammel DR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01057; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Levicnik-Hofferle S, 2012, FEMS MICROBIOL ECOL, V80, P114, DOI 10.1111/j.1574-6941.2011.01275.x; Levy-Booth DJ, 2010, APPL ENVIRON MICROB, V76, P7116, DOI 10.1128/AEM.02188-09; Li QS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020622; Liu BB, 2010, FEMS MICROBIOL ECOL, V72, P407, DOI 10.1111/j.1574-6941.2010.00856.x; Liu XY, 2018, SCAND J GASTROENTERO, V53, P895, DOI 10.1080/00365521.2018.1473487; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Mungai NW, 2005, BIOL FERT SOILS, V42, P129, DOI 10.1007/s00374-005-0005-1; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; Niklaus PA, 2006, PLANT SOIL, V282, P83, DOI 10.1007/s11104-005-5230-8; Pardon P, 2017, AGR ECOSYST ENVIRON, V247, P98, DOI 10.1016/j.agee.2017.06.018; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Postma-Blaauw MB, 2010, ECOLOGY, V91, P460, DOI 10.1890/09-0666.1; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Quinkenstein A, 2009, ENVIRON SCI POLICY, V12, P1112, DOI 10.1016/j.envsci.2009.08.008; Rosenstock TS, 2014, CURR OPIN ENV SUST, V6, P15, DOI 10.1016/j.cosust.2013.09.001; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rughoft S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01638; Samad MDS, 2016, SCI REP-UK, V6, DOI 10.1038/srep35990; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Stempfhuber B, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01567; Sterngren AE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01350; Szukics U, 2010, FEMS MICROBIOL ECOL, V72, P395, DOI 10.1111/j.1574-6941.2010.00853.x; Thomson BC, 2015, SOIL BIOL BIOCHEM, V88, P403, DOI 10.1016/j.soilbio.2015.06.012; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; TISDALL JM, 1991, AUST J SOIL RES, V29, P729, DOI 10.1071/SR9910729; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tsonkova P, 2012, AGROFOREST SYST, V85, P133, DOI 10.1007/s10457-012-9494-8; Udawatta RP, 2008, APPL SOIL ECOL, V39, P153, DOI 10.1016/j.apsoil.2007.12.002; Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; van Noordwijk M, 2015, TREE-CROP INTERACTIONS: AGROFORESTRY IN A CHANGING CLIMATE, 2ND EDITION, P221, DOI 10.1079/9781780645117.0221; Vanparys B, 2007, SYST APPL MICROBIOL, V30, P297, DOI 10.1016/j.syapm.2006.11.006; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wang HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08016-8; Wang Y, 2011, AGR ECOSYST ENVIRON, V140, P441, DOI 10.1016/j.agee.2011.01.007; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wertz S, 2008, FEMS MICROBIOL ECOL, V63, P261, DOI 10.1111/j.1574-6941.2007.00416.x; Wertz S, 2012, FEMS MICROBIOL ECOL, V79, P142, DOI 10.1111/j.1574-6941.2011.01204.x; Wilson K., 2001, CURR PROTOC MOL BIOL, V71, P27, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433	94	26	26	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218779	10.1371/journal.pone.0218779	http://dx.doi.org/10.1371/journal.pone.0218779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246995	gold, Green Submitted, Green Published			2022-12-26	WOS:000484911900040
J	Wasielica-Poslednik, J; Schuster, AK; Politino, G; Marx-Gross, S; Bell, K; Pfeiffer, N; Pitz, S				Wasielica-Poslednik, Joanna; Schuster, Alexander K.; Politino, Giuseppe; Marx-Gross, Susanne; Bell, Katharina; Pfeiffer, Norbert; Pitz, Susanne			Corneal topometric, aberrometric and biomechanical parameters in mucopolysaccharidosis patients	PLOS ONE			English	Article							INDEXES	Aims To report corneal topometric and aberrometric values in mucopolysaccharidosis (MPS) and to investigate their correlation with biomechanical corneal parameters. Methods One randomly chosen eye of 20 MPS patients with no to moderate corneal clouding and one eye of 23 healthy controls with comparable age were prospectively included into this study. Corneal surface regularity was assessed by index of surface variance (ISV), -vertical asymmetry (IVA), -height asymmetry (IHA), -height decentration (IHD); keratoconus index (KI), central keratoconus index (CKI) and Zernike indices of anterior and posterior corneal surface using Scheimpflug imaging (Pentacam). Corneal resistance factor (CRF) and corneal hysteresis (CH) were assessed by Ocular Response Analyzer. Statistical analyses were performed using Mann-Whitney-Test and Spearman Correlation Coefficients. Results IVA, ISV, IHD, IHA, but not KI and CKI were significantly higher in MPS patients compared to age matched healthy controls. Spherical aberration and asphericity coefficients either at the anterior or at the posterior corneal surface differed significantly between both groups. The grade of the MPS-associated corneal opacity correlated significantly with ISV (rho = 0.52), IVA (rho = 0.54), IHA (rho = 0.57) and IHD (rho = 0.48). Density of the MPS-affected corneas correlated significantly with ISV (rho = 0.52), IVA (rho = 0.72), IHA (rho = 0.57), IHD (rho = 0.69), 3rd order horizontal trefoil aberration at the posterior (rho = 0.62) and anterior surface (rho = 0.48) as well as with CH (rho = 0.55) and CRF (rho = 0.57). Spherical aberration at the back surface correlated with CRF and CH in MPS and in healthy controls. Conclusions This is the first study analyzing shape of the corneal surface in MPS patients. Topometric indices of corneal asymmetry are significantly increased and correlate with MPS-related corneal opacity and density. Spherical aberration and asphericity coefficient at the front and at the back corneal surface differ significantly between MPS and healthy controls.	[Wasielica-Poslednik, Joanna; Schuster, Alexander K.; Politino, Giuseppe; Marx-Gross, Susanne; Bell, Katharina; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Pitz, Susanne] Burgerhospital, Frankfurt, Germany	Johannes Gutenberg University of Mainz	Wasielica-Poslednik, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany.	joanna.wasielica-poslednik@unimedizin-mainz.de	Pfeiffer, Norbert/AAO-7586-2020	Pfeiffer, Norbert/0000-0002-5766-2617; Politino, Giuseppe/0000-0001-6826-9266	Genzyme; Shire	Genzyme(Sanofi-AventisGenzyme Corporation); Shire	Ocular Response Analyzer was sponsored by Genzyme and Shire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; Chalita Maria Regina, 2004, Ophthalmol Clin North Am, V17, P135, DOI 10.1016/j.ohc.2004.02.008; Couprie J, 2010, J FR OPHTALMOL, V33, P617, DOI 10.1016/j.jfo.2010.09.008; Coutinho MF, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/471325; Elflein HM, 2013, BRIT J OPHTHALMOL, V97, P829, DOI 10.1136/bjophthalmol-2012-302913; Grupcheva CN, 2003, CORNEA, V22, P76, DOI 10.1097/00003226-200301000-00019; Hashemi H, 2019, EYE CONTACT LENS, V45, P46, DOI 10.1097/ICL.0000000000000531; Hashemi H, 2016, J CURR OPHTHALMOL, V28, P21, DOI 10.1016/j.joco.2016.01.009; Kanellopoulos AJ, 2013, CLIN OPHTHALMOL, V7, P1539, DOI 10.2147/OPTH.S44741; Koc M, 2016, ARQ BRAS OFTALMOL, V79, P380, DOI 10.5935/0004-2749.20160108; Kottler U, 2010, CORNEA, V29, P260, DOI 10.1097/ICO.0b013e3181b55cc1; Mocan MC, 2007, CORNEA, V26, P90, DOI 10.1097/ICO.0b013e31802be383; Nessim M, 2013, CONTACT LENS ANTERIO, V36, P57, DOI 10.1016/j.clae.2012.11.001; ORGUL S, 1991, KLIN MONATSBL AUGENH, V198, P430, DOI 10.1055/s-2008-1046001; Summers CG, 2011, RHEUMATOLOGY, V50, pV34, DOI 10.1093/rheumatology/ker392; Summers CG, 2010, CLIN EXP OPHTHALMOL, V38, P34, DOI 10.1111/j.1442-9071.2010.02366.x; WASIELICAPOSLEDNIK, 2017, PLOS ONE, V12, DOI DOI 10.1371/journal.pone.0168698; Yagi-Yaguchi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161075; ZABEL RW, 1989, OPHTHALMOLOGY, V96, P1631	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218108	10.1371/journal.pone.0218108	http://dx.doi.org/10.1371/journal.pone.0218108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246979	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900012
J	Krueger, K; Esch, L; Byrne, R				Krueger, Konstanze; Esch, Laureen; Byrne, Richard			Animal behaviour in a human world: A crowdsourcing study on horses that open door and gate mechanisms	PLOS ONE			English	Article							CONDITIONING TRIALS; INNOVATION; AGE; MOTIVATION; VULPES; BRAINS; TASKS; FOXES; RANK; SIZE	Anecdotal reports of horses opening fastened doors and gates are an intriguing way of exploring the possible scope of horses' problem-solving capacities. The species' natural environment has no analogues of the mechanisms involved. Scientific studies on the topic are missing, because the rate of occurrence is too low for exploration under controlled conditions. Therefore, we compiled from lay persons case reports of horses opening closed doors and gates. Additionally, we collected video documentations at the internet platform YouTube, taking care to select raw data footage of unedited, clearly described and clearly visible cases of animals with no distinct signs of training or reduced welfare. The data included individuals opening 513 doors or gates on hinges, 49 sliding doors, and 33 barred doors and gateways; mechanisms included 260 cases of horizontal and 155 vertical bars, 43 twist locks, 42 door handles, 34 electric fence handles, 40 carabiners, and 2 locks with keys. Opening was usually for escape, but also for access to food or stable-mates, or out of curiosity or playfulness. While 56 percent of the horses opened a single mechanism at one location, 44 percent opened several types of mechanism (median = 2, min. = 1, max. = 5) at different locations (median = 2, min. = 1, max. = 4). The more complex the mechanism was, the more movements were applied, varying from median 2 for door handles to 10 for carabiners. Mechanisms requiring head-or lip-twisting needed more movements, with significant variation between individuals. 74 horses reported in the questionnaire had options for observing the behaviour in stable mates, 183 did not, which indicates that the latter learned to open doors and gates either individually or from observing humans. Experience favours opening efficiency; subjects which opened several door types applied fewer movements per lock than horses which opened only one door type. We failed to identify a level of complexity of door-fastening mechanism that was beyond the learning capacity of the horse to open. Thus, all devices in frequent use, even carabiners and electric fence handles, are potentially vulnerable to opening by horses, something which needs to be considered in relation to keeping horses safely.	[Krueger, Konstanze] Univ Regensburg, Dept Zool & Evolutionary Biol, Regensburg, Germany; [Krueger, Konstanze; Esch, Laureen] Nurtingen Geislingen Univ, Dept Equine Econ, Sect Agr Econ & Management, Nurtingen, Germany; [Esch, Laureen] Ludwig Maximilian Univ Munich, Dept Anim Welf Ethol Anim Hyg & Anim Husb, Sect Vet Med, Munich, Germany; [Byrne, Richard] Univ St Andrews, Ctr Social Learning & Cognit Evolut, Sch Psychol & Neurosci, St Andrews, Scotland	University of Regensburg; Nuertingen-Geislingen University (NGU); University of Munich; University of St Andrews	Krueger, K (corresponding author), Univ Regensburg, Dept Zool & Evolutionary Biol, Regensburg, Germany.; Krueger, K (corresponding author), Nurtingen Geislingen Univ, Dept Equine Econ, Sect Agr Econ & Management, Nurtingen, Germany.	Konstanze.Krueger@hfwu.de		Byrne, Richard/0000-0001-9862-9373	Ministry of Science, Research and Art (MWK), Baden-Wurttemberg, Germany	Ministry of Science, Research and Art (MWK), Baden-Wurttemberg, Germany	This research received funding from the Ministry of Science, Research and Art (MWK), Baden-Wurttemberg, Germany.	[Anonymous], KLUGE HANS BEITRAG N; Bachmann I, 2003, EQUINE VET J, V35, P158, DOI 10.2746/042516403776114216; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Bates LA, 2007, METHODS, V42, P12, DOI 10.1016/j.ymeth.2006.11.006; Berger J., 1986, WILD HORSES GREAT BA; Bouchard J, 2002, THESIS MCGILL U MONT; Bucheler T, 2011, PROCEDIA COMPUT SCI, V7, P327, DOI 10.1016/j.procs.2011.09.014; Burn CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026553; Byrne R., 1988, MACHIAVELLIAN INTELL; BYRNE RW, 1993, BEHAV BRAIN SCI, V16, P696, DOI 10.1017/S0140525X00032362; Byrne RW, 1990, TACTICAL DECEPTION P, P1; Creswell JW, 2014, RES DESIGN, pXXIX; Devenport JA, 2005, J COMP PSYCHOL, V119, P352, DOI 10.1037/0735-7036.119.3.352; Esch L, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9050265; Griffin AS, 2017, ANIM COGN, V20, P1, DOI 10.1007/s10071-016-1051-9; Hanggi EB, 2003, APPL ANIM BEHAV SCI, V83, P201, DOI 10.1016/S0168-1591(03)00136-9; Henderson AJZ, 2007, J APPL ANIM WELF SCI, V10, P309, DOI 10.1080/10888700701555576; Henderson JV, 2001, ANIM WELFARE, V10, P73; Hiby EF, 2004, ANIM WELFARE, V13, P63; HOUPT KA, 1981, INT J STUD ANIM PROB, V2, P329; Kilic S., 2017, B LEG MED, V22, P73, DOI [10.17986/blm.2017227929, DOI 10.17986/BLM.2017227929]; Koistinen T, 2016, APPL ANIM BEHAV SCI, V176, P105, DOI 10.1016/j.applanim.2016.01.012; Krueger K, 2008, ANIM COGN, V11, P431, DOI 10.1007/s10071-007-0133-0; Kruger K, 2008, BEHAV PROCESS, V78, P76, DOI 10.1016/j.beproc.2008.01.009; Krueger K, 2014, ANIM COGN, V17, P645, DOI 10.1007/s10071-013-0696-x; Krueger K, 2014, BEHAV PROCESS, V103, P91, DOI 10.1016/j.beproc.2013.10.007; Krueger K, 2011, ANIM COGN, V14, P187, DOI 10.1007/s10071-010-0352-7; Krueger Koustanze, 2008, P195, DOI 10.1007/978-3-540-75957-7_9; Kusunose R, 2002, APPL ANIM BEHAV SCI, V78, P225, DOI 10.1016/S0168-1591(02)00089-8; Laland KN, 2004, LEARN BEHAV, V32, P4; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lockener S, 2016, J VET BEHAV, V11, P50, DOI 10.1016/j.jveb.2015.11.005; Biondi LM, 2010, ANIM COGN, V13, P701, DOI 10.1007/s10071-010-0319-8; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; MCCALL CA, 1993, APPL ANIM BEHAV SCI, V36, P291, DOI 10.1016/0168-1591(93)90127-B; McLean AN, 2004, APPL ANIM BEHAV SCI, V85, P93, DOI 10.1016/j.applanim.2003.09.009; Mench JA, 1998, LAB ANIMAL, V27, P32; Mersmann D, 2011, ETHOLOGY, V117, P675, DOI 10.1111/j.1439-0310.2011.01919.x; Mills DS, 2002, ANIMAL WEL, V1, P77; Momozawa Y, 2003, APPL ANIM BEHAV SCI, V84, P127, DOI 10.1016/j.applanim.2003.08.001; Nelson XJ, 2013, ANIM BEHAV, V85, P525, DOI 10.1016/j.anbehav.2012.12.009; Nicol CJ, 2002, APPL ANIM BEHAV SCI, V78, P193, DOI 10.1016/S0168-1591(02)00093-X; Petersen JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054997, 10.1371/journal.pone.0069819]; PETHERICK JC, 1990, APPL ANIM BEHAV SCI, V27, P159, DOI 10.1016/0168-1591(90)90015-6; Pirault P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061544; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Proops L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067000; Proops L, 2010, ANIM BEHAV, V79, P1205, DOI 10.1016/j.anbehav.2010.02.015; Proops L, 2010, ANIM COGN, V13, P197, DOI 10.1007/s10071-009-0257-5; Reader SM, 2003, ANIM BIOL, V53, P147, DOI 10.1163/157075603769700340; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Reader SM, 2001, INT J PRIMATOL, V22, P787, DOI 10.1023/A:1012069500899; Reader SM, 2009, ANIMAL INNOVATION; Rorvang MV, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00212; Rorvang MV, 2015, APPL ANIM BEHAV SCI, V171, P117, DOI 10.1016/j.applanim.2015.08.008; RUBIN L, 1980, J ANIM SCI, V50, P1184, DOI 10.2527/jas1980.5061184x; Sabou M., 2012, 12 INT C KNOWL MAN K, P17, DOI 10.1145/2362456.2362479; Schuetz A, 2017, ANIM COGN, V20, P567, DOI 10.1007/s10071-016-1060-8; Schwartz LP, 2017, ANIM COGN, V20, P299, DOI 10.1007/s10071-016-1052-8; Schwenk BK, 2016, PFERDEHEILKUNDE, V32, P192, DOI 10.21836/PEM20160301; Smith AV, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0907; Steidele N, 2011, THESIS; Thorndike E. L., 1898, PSYCHOL REV MONOGRAP, V2, P1, DOI DOI 10.1037/H0092987; Webster MM, 2008, P ROY SOC B-BIOL SCI, V275, P2869, DOI 10.1098/rspb.2008.0817; Whalen A, 2015, ANIM COGN, V18, P1093, DOI 10.1007/s10071-015-0877-x; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682; Whiten A, 2004, LEARN BEHAV, V32, P36; Wiggins Andrea, 2011, P HICSS, P1, DOI DOI 10.1109/HICSS.2011.207; Wolff A, 1996, APPL ANIM BEHAV SCI, V46, P137, DOI 10.1016/0168-1591(95)00659-1	70	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218954	10.1371/journal.pone.0218954	http://dx.doi.org/10.1371/journal.pone.0218954			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242266	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600071
J	Saito, Y; Hinoi, T; Adachi, T; Miguchi, M; Niitsu, H; Kochi, M; Sada, H; Sotomaru, Y; Sakamoto, N; Sentani, K; Oue, N; Yasui, W; Tashiro, H; Ohdan, H				Saito, Yasufumi; Hinoi, Takao; Adachi, Tomohiro; Miguchi, Masashi; Niitsu, Hiroaki; Kochi, Masatoshi; Sada, Haruki; Sotomaru, Yusuke; Sakamoto, Naoya; Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru; Tashiro, Hirotaka; Ohdan, Hideki			Synbiotics suppress colitis-induced tumorigenesis in a colon-specific cancer mouse model	PLOS ONE			English	Article							DEXTRAN SULFATE SODIUM; NF-KAPPA-B; LETHAL INFECTION; DNA-DAMAGE; INFLAMMATION; PREVENTION; CARCINOMA; CELLS; MICE; BIFIDOBACTERIA	Although synbiotics may be effective in maintaining remission of inflammatory bowel disease, their anticarcinogenic effects are still debated. To address this issue, we evaluated the effects of synbiotics, probiotics, and prebiotics on tumorigenesis using a CDX2P-Cre; Apc(+/flox) mouse model harboring a colon-specific Apc knock out, which develops adenoma and adenocarcinoma of the colon. Dextran sodium sulfate (DSS)-administration promoted colonic tumor development in CDX2P-Cre; Apc(+/flox) mice, and these tumors were associated with loss of Apc heterozygosity, as confirmed by observation of well-differentiated adenocarcinomas with beta-catenin accumulation in tumor cell cytoplasm. Synbiotics-treatment suppressed dextran sodium sulfate-induced colitis in CDX2P-Cre; Apc(+/flox) mice, thereby reducing mortality, and inhibited tumorigenesis accelerated by DSS-administration. Conversely, neither probiotics nor prebiotics had any effect on inflammation and tumorigenesis. Lactobacillus casei and Bifidobacterium breve were detected in the fecal microbiota of probiotics-treated mice. Synbiotics-treatment suppressed DSS-induced expression of IL-6, STAT-3, COX-2, and TNF-alpha gene transcripts in normal colonic epithelium, indicating the possibility of suppressing tumor development. Importantly, these genes may be potential therapeutic targets in inflammation-associated colon cancer.	[Saito, Yasufumi; Hinoi, Takao; Adachi, Tomohiro; Miguchi, Masashi; Niitsu, Hiroaki; Kochi, Masatoshi; Sada, Haruki; Tashiro, Hirotaka; Ohdan, Hideki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Biomed Sci Major, Div Med,Dept Gastroenterol & Transplant Surg, Hiroshima, Japan; [Hinoi, Takao] Hiroshima Univ Hosp, Dept Clin & Mol Genet, Hiroshima, Japan; [Hinoi, Takao; Tashiro, Hirotaka] Natl Hosp Org Kure Med Ctr, Inst Clin Res, Div Mol Oncol, Dept Surg, Hiroshima, Japan; [Hinoi, Takao; Tashiro, Hirotaka] Chugoku Canc Ctr, Hiroshima, Japan; [Niitsu, Hiroaki] Vanderbilt Univ, Med Ctr, GI Med, Nashville, TN USA; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Sakamoto, Naoya; Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru] Hiroshima Univ Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima, Japan	Hiroshima University; Hiroshima University; Vanderbilt University; Hiroshima University; Hiroshima University	Hinoi, T (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Biomed Sci Major, Div Med,Dept Gastroenterol & Transplant Surg, Hiroshima, Japan.; Hinoi, T (corresponding author), Hiroshima Univ Hosp, Dept Clin & Mol Genet, Hiroshima, Japan.; Hinoi, T (corresponding author), Natl Hosp Org Kure Med Ctr, Inst Clin Res, Div Mol Oncol, Dept Surg, Hiroshima, Japan.; Hinoi, T (corresponding author), Chugoku Canc Ctr, Hiroshima, Japan.	thinoi@hiroshima-u.ac.jp	Niitsu, Hiroaki/HHZ-1925-2022; Hinoi, Takao/AAI-1443-2020; Ohdan, Hideki/G-4719-2019	Hinoi, Takao/0000-0003-0462-6177; Ohdan, Hideki/0000-0002-9066-1288	JSPS KAKENHI [JP22390257, JP25293284, JP18K08694]; Japanese Society of Gastroenterology	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society of Gastroenterology(Japanese Society of Gastroenterology)	This work was supported by JSPS KAKENHI Grant Numbers JP22390257 (2010-2012), JP25293284 (2013-2016), JP18K08694 (2018-) and by The Japanese Society of Gastroenterology Grant-in-Aid 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128/IAI.72.4.2240-2247.2004; Asahara T, 2011, J APPL MICROBIOL, V110, P163, DOI 10.1111/j.1365-2672.2010.04884.x; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Beck PL, 2007, GASTROENTEROLOGY, V132, P1778, DOI 10.1053/j.gastro.2007.01.032; Burstein E, 2008, J CLIN INVEST, V118, P464, DOI [10.1172/JC134831, 10.1172/JCI34831]; Carothers AM, 2010, CANCER RES, V70, P4433, DOI 10.1158/0008-5472.CAN-09-4289; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Damiani CR, 2007, J GASTROEN HEPATOL, V22, P1846, DOI 10.1111/j.1440-1746.2007.04890.x; Dannenberg AJ, 2001, LANCET ONCOL, V2, P544, DOI 10.1016/S1470-2045(01)00488-0; del Reino P, 2014, CANCER RES, V74, P6150, DOI 10.1158/0008-5472.CAN-14-0870; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fujimori S, 2009, NUTRITION, V25, P520, DOI 10.1016/j.nut.2008.11.017; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Ghaleb AM, 2014, INFLAMM BOWEL DIS, V20, P811, DOI 10.1097/MIB.0000000000000022; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hasegawa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065494; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Jansen GJ, 1999, J MICROBIOL METH, V37, P215, DOI 10.1016/S0167-7012(99)00049-4; Kawaguchi Y, 2016, J GASTROENTEROL, V51, P447, DOI 10.1007/s00535-015-1121-9; Kim YJ, 2010, CANCER PREV RES, V3, P1314, DOI 10.1158/1940-6207.CAPR-09-0272; Kolida S, 2011, ANNU REV FOOD SCI T, V2, P373, DOI 10.1146/annurev-food-022510-133739; Komatsu S, 2016, SURG TODAY, V46, P479, DOI 10.1007/s00595-015-1178-3; LANGHOLZ E, 1994, GASTROENTEROLOGY, V107, P3, DOI 10.1016/0016-5085(94)90054-X; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Le Roy CI, 2015, ONCOTARGET, V6, P30545, DOI 10.18632/oncotarget.5906; Marino F, 2014, AM J CANCER RES, V4, P484; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Ni J, 1996, GUT, V39, P234, DOI 10.1136/gut.39.2.234; Ogata Y., 1993, Journal of Japanese Society of Nutrition and Food Science [Nihon Eiyo Shokuryo Gakkai-shi], V46, P317; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Okazaki M, 2013, NUTRITION, V29, P1224, DOI 10.1016/j.nut.2013.03.015; Peitsidou K, 2012, DIGEST SURG, V29, P426, DOI 10.1159/000345580; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Raman M, 2013, GUT MICROBES, V4, P181, DOI 10.4161/gmic.23919; Rasband W, IMAGEJ; ROSENSTOCK E, 1985, GASTROENTEROLOGY, V89, P1342, DOI 10.1016/0016-5085(85)90653-5; Sartor RB, 1997, RES IMMUNOL, V148, P567, DOI 10.1016/S0923-2494(98)80151-X; Sasada T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132435; Schneider MR, 2000, CANCER LETT, V151, P31, DOI 10.1016/S0304-3835(99)00401-2; Tanaka T, 2006, INT J CANCER, V118, P25, DOI 10.1002/ijc.21282; Tardieu D, 1998, CANCER LETT, V134, P1, DOI 10.1016/S0304-3835(98)00228-6; Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; van Zanten GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047212; Westbrook AM, 2010, CANCER RES, V70, P1875, DOI 10.1158/0008-5472.CAN-09-2584; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175	55	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0216393	10.1371/journal.pone.0216393	http://dx.doi.org/10.1371/journal.pone.0216393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242213	Green Submitted, gold, Green Published			2022-12-26	WOS:000482883600007
J	Ballega, E; Carballar, R; Samper, B; Ricco, N; Ribeiro, MP; Bru, S; Jimenez, J; Clotet, J				Ballega, Elisabet; Carballar, Reyes; Samper, Barbara; Ricco, Natalia; Ribeiro, Mariana P.; Bru, Samuel; Jimenez, Javier; Clotet, Josep			Comprehensive and quantitative analysis of G1 cyclins. A tool for studying the cell cycle	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; BUDDING YEAST; S-PHASE; TRANSLATIONAL CONTROL; EXPRESSION; CDC28; CLN1; IDENTIFICATION	In eukaryotes, the cell cycle is driven by the actions of several cyclin dependent kinases (CDKs) and an array of regulatory proteins called cyclins, due to the cyclical expression patterns of the latter. In yeast, the accepted pattern of cyclin waves is based on qualitative studies performed by different laboratories using different strain backgrounds, different growing conditions and media, and different kinds of genetic manipulation. Additionally, only the subset of cyclins regulating Cdc28 was included, while the Pho85 cyclins were excluded. We describe a comprehensive, quantitative and accurate blueprint of G(1) cyclins in the yeast Saccharomyces cerevisiae that, in addition to validating previous conclusions, yields new findings and establishes an accurate G1 cyclin blueprint. For the purposes of this research, we produced a collection of strains with all G1 cyclins identically tagged using the same and most respectful procedure possible. We report the contribution of each G1 cyclin for a broad array of growing and stress conditions, describe an unknown role for Pcl2 in heat-stress conditions and demonstrate the importance of maintaining the 3'UTR sequence of cyclins untouched during the tagging process.	[Ballega, Elisabet; Carballar, Reyes; Samper, Barbara; Ricco, Natalia; Ribeiro, Mariana P.; Bru, Samuel; Jimenez, Javier; Clotet, Josep] Univ Int Catalunya, Fac Med & Hlth Sci, Dept Basic Sci, Barcelona, Spain	Universitat Internacional de Catalunya (UIC)	Jimenez, J; Clotet, J (corresponding author), Univ Int Catalunya, Fac Med & Hlth Sci, Dept Basic Sci, Barcelona, Spain.	jjimenez@uic.es; jclotet@uic.cat	Clotet, Josep/ABC-8727-2020; Clotet, Josep/AAF-2618-2019; Jiménez, Javier/ABE-1795-2020	Clotet, Josep/0000-0001-5462-8598; Jiménez, Javier/0000-0002-0402-4427; Ribeiro, Mariana/0000-0001-5258-7921	Generalitat de Catalunya; Spanish Government (MINECO) [BFU 2013-44189-P, PGC2018-096597-B-I00]; Spanish Government [PGC2018-096597-B-I00]	Generalitat de Catalunya(Generalitat de Catalunya); Spanish Government (MINECO)(Spanish Government); Spanish Government(Spanish GovernmentEuropean Commission)	RC was awarded with a Generalitat de Catalunya grant. JC received a grant from the Spanish Government (MINECO Grant Ref: BFU 2013-44189-P and PGC2018-096597-B-I00). JJ received a grant from the Spanish Government (PGC2018-096597-B-I00). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adrover MA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002204; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Andrews B, 1998, TRENDS GENET, V14, P66, DOI 10.1016/S0168-9525(97)01322-X; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Ball DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026272; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; BENTON BK, 1993, EMBO J, V12, P5267, DOI 10.1002/j.1460-2075.1993.tb06222.x; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Brachmann CB, 1998, YEAST, V14, P115; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; CROSS FR, 1995, CURR OPIN CELL BIOL, V7, P790, DOI 10.1016/0955-0674(95)80062-X; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; de Bruin RAM, 2008, MOL CELL BIOL, V28, P6919, DOI 10.1128/MCB.00211-08; Deshpande A, 2009, CELL CYCLE, V8, P3592, DOI 10.4161/cc.8.21.9993; Doncic A, 2011, MOL CELL, V43, P528, DOI 10.1016/j.molcel.2011.06.025; Doonan JH, 2009, MOL BIOTECHNOL, V42, P14, DOI 10.1007/s12033-008-9126-8; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Flick K, 1998, MOL CELL BIOL, V18, P2492, DOI 10.1128/MCB.18.5.2492; Flory MR, 2006, PROTEOMICS, V6, P6146, DOI 10.1002/pmic.200600159; Geissler R, 2016, RNA BIOL, V13, P1075, DOI 10.1080/15476286.2016.1225645; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonzalez-Novo A, 2015, MOL CELL BIOL, V35, P1606, DOI 10.1128/MCB.01279-14; GORDON CN, 1977, J BACTERIOL, V129, P97, DOI 10.1128/JB.129.1.97-100.1977; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; Ho B, 2018, CELL SYST; Horak Christine E, 2002, Funct Integr Genomics, V2, P171; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; JACKSON RJ, 1993, CELL, V74, P9, DOI 10.1016/0092-8674(93)90290-7; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jimenez Javier, 2013, Int J Biochem Mol Biol, V4, P140; Johnson A, 2013, CURR OPIN CELL BIOL, V25, P717, DOI 10.1016/j.ceb.2013.07.010; Juanes MA, 2017, METHODS MOL BIOL, V1505, P19, DOI 10.1007/978-1-4939-6502-1_2; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; Levine K, 1996, MOL CELL BIOL, V16, P6794; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Li XR, 1999, J BIOL CHEM, V274, P24220, DOI 10.1074/jbc.274.34.24220; Liu J, 2000, MOL BIOL EVOL, V17, P1061, DOI 10.1093/oxfordjournals.molbev.a026387; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PINES J, 1987, EMBO J, V6, P2987, DOI 10.1002/j.1460-2075.1987.tb02604.x; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; POPOLO L, 1993, CURR GENET, V24, P382, DOI 10.1007/BF00351845; POPOLO L, 1984, P NATL ACAD SCI-BIOL, V81, P120, DOI 10.1073/pnas.81.1.120; POPOLO L, 1993, J BACTERIOL, V175, P1879, DOI 10.1128/JB.175.7.1879-1885.1993; Quilis I, 2017, FEBS OPEN BIO, V7, P74, DOI 10.1002/2211-5463.12157; Quilis I, 2012, CELL CYCLE, V11, P3117, DOI 10.4161/cc.21505; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; REED SI, 1990, P NATL ACAD SCI USA, V87, P5697, DOI 10.1073/pnas.87.15.5697; Rosebrock Adam P, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.top080630; Ruiz-Roig C, 2010, MOL MICROBIOL, V76, P1049, DOI 10.1111/j.1365-2958.2010.07167.x; Saiz-Baggetto S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183067; Sambuk E. V., 2003, Genetika, V39, P1039; Sambuk Elena V, 2011, Enzyme Res, V2011, P356093, DOI 10.4061/2011/356093; Schnerch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074379; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Slevin MK, 2007, NUCLEIC ACIDS RES, V35, P2167, DOI 10.1093/nar/gkm084; Slotta-Huspenina J, 2008, LEUKEMIA RES, V32, P79, DOI 10.1016/j.leukres.2007.05.021; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STANDART N, 1987, DEV BIOL, V124, P248, DOI 10.1016/0012-1606(87)90476-3; Stern B, 1996, TRENDS GENET, V12, P345; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Swaffer MP, 2016, CELL, V167, P1750, DOI 10.1016/j.cell.2016.11.034; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; Tarn WY, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-5; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thorburn RR, 2013, MOL BIOL CELL, V24, P1274, DOI 10.1091/mbc.E12-07-0520; Tuller T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-391; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Uhlmann F, 2011, PHILOS T R SOC B, V366, P3572, DOI 10.1098/rstb.2011.0082; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129; Zapata J, 2014, J CELL BIOL, V204, P359, DOI 10.1083/jcb.201309119; Zubarev RA, 2013, PROTEOMICS, V13, P723, DOI 10.1002/pmic.201200451	94	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218531	10.1371/journal.pone.0218531	http://dx.doi.org/10.1371/journal.pone.0218531			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237904	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000484856000023
J	Raos, BJ; Simpson, MC; Doyle, CS; Graham, ES; Unsworth, CP				Raos, Brad J.; Simpson, M. Cather; Doyle, Colin S.; Graham, E. Scott; Unsworth, Charles P.			Evaluation of parylene derivatives for use as biomaterials for human astrocyte cell patterning	PLOS ONE			English	Article							SURFACE WETTABILITY; HUMAN NEURONS; MODEL SYSTEM; NETWORKS; ADHESION; DIFFERENTIATION; PROLIFERATION; TOPOGRAPHY; POLYMER; CULTURE	Cell patterning is becoming increasingly popular in neuroscience because it allows for the control in the location and connectivity of cells. A recently developed cell patterning technology uses patterns of an organic polymer, parylene-C, on a background of SiO2. When cells are cultured on the parylene-C/SiO2 substrate they conform to the underlying parylene-C geometry. Parylene-C is, however, just one member of a family of parylene polymers that have varying chemical and physical properties. In this work, we investigate whether two commercially available mainstream parylene derivatives, parylene-D, parylene-N and a more recent parylene derivative, parylene-HT to determine if they enable higher fidelity hNT astrocyte cell patterning compared to parylene-C. We demonstrate that all parylene derivatives are compatible with the existing laser fabrication method. We then demonstrate that parylene-HT, parylene-D and parylene-N are suitable for use as an hNT astrocyte cell attractive substrate and result in an equal quality of patterning compared to parylene-C. This work supports the use of alternative parylene derivatives for applications where their different physical and chemical properties are more suitable.	[Raos, Brad J.; Unsworth, Charles P.] Univ Auckland, Dept Engn Sci, Auckland, New Zealand; [Simpson, M. Cather] Univ Auckland, Dept Chem, Auckland, New Zealand; [Simpson, M. Cather] Univ Auckland, Dept Phys, Auckland, New Zealand; [Simpson, M. Cather; Unsworth, Charles P.] MacDiarmid Inst Adv Mat & Nanotechnol, Wellington, New Zealand; [Simpson, M. Cather] Dodd Walls Ctr Photon & Quantum Technol, Dunedin, New Zealand; [Doyle, Colin S.] Univ Auckland, Dept Chem & Mat Engn, Auckland, New Zealand; [Graham, E. Scott] Univ Auckland, Dept Mol Med & Pathol, Auckland, New Zealand; [Graham, E. Scott] Univ Auckland, Ctr Brain Res, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; Victoria University Wellington; University of Auckland; University of Auckland; University of Auckland	Raos, BJ (corresponding author), Univ Auckland, Dept Engn Sci, Auckland, New Zealand.	brao003@aucklanduni.ac.nz		Raos, Brad/0000-0001-8298-1700	Royal Society of New Zealand Marsden fund [15-UOA-032]	Royal Society of New Zealand Marsden fund(Royal Society of New ZealandMarsden Fund (NZ))	Funding support was provided to CPU from The Royal Society of New Zealand Marsden fund (15-UOA-032) (Website: https://royalsociety.org.nz/what-we-do/funds-and-opportunities/marsden).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; BARR TL, 1995, J VAC SCI TECHNOL A, V13, P1239, DOI 10.1116/1.579868; Bera M, 2000, EUR POLYM J, V36, P1765, DOI 10.1016/S0014-3057(99)00259-1; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022; Delivopoulos E, 2015, COLLOID SURFACE B, V126, P169, DOI 10.1016/j.colsurfb.2014.12.020; Delivopoulos E, 2010, J BIOMED MATER RES A, V94A, P47, DOI 10.1002/jbm.a.32662; Delivopoulos E, 2009, BIOMATERIALS, V30, P2048, DOI 10.1016/j.biomaterials.2008.12.049; Dhindsa M, 2011, THIN SOLID FILMS, V519, P3346, DOI 10.1016/j.tsf.2010.12.094; Dolbier WR, 2003, J FLUORINE CHEM, V122, P97, DOI 10.1016/S0022-1139(03)00100-3; Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Goodfellow CE, 2011, J NEUROSCI RES, V89, P1685, DOI 10.1002/jnr.22692; Haile Y, 2014, J NEUROSCI RES, V92, P1187, DOI 10.1002/jnr.23399; Hill EJ, 2008, TOXICOLOGY, V249, P243, DOI 10.1016/j.tox.2008.05.014; Hill E, 2016, J PHYSIOL-LONDON, V594, P6595, DOI 10.1113/JP270658; Hill ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040579; Hoshino T, 2011, BIOTECHNOL PROGR, V28, P587, DOI [10.1002/btpr.enzmictec.2016.10.016, DOI 10.1002/BTPR.ENZMICTEC.2016.10.016]; Hughes MA, 2013, J BIOMED MATER RES A, V101, P349, DOI 10.1002/jbm.a.34329; Hughes M. A., 2014, JOVE-J VIS EXP, V85, P50929, DOI DOI 10.3791/50929; Hughes MA, 2014, J BIOMED MATER RES A, V102, P1350, DOI 10.1002/jbm.a.34813; Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3; Jia HB, 2011, NAT PROTOC, V6, P28, DOI 10.1038/nprot.2010.169; Jordan MD, 2016, BIOMATERIALS, V105, P117, DOI 10.1016/j.biomaterials.2016.08.006; Kato YX, 2009, NEUROSCI LETT, V464, P26, DOI 10.1016/j.neulet.2009.08.007; Kim BJ, 2016, POLYM ADVAN TECHNOL, V27, P564, DOI 10.1002/pat.3729; Kim MY, 2014, J MEMBRANE SCI, V452, P460, DOI 10.1016/j.memsci.2013.11.034; Liaqat U, 2017, ENZYME MICROB TECH, V97, P1, DOI 10.1016/j.enzmictec.2016.10.016; Liaqat U, 2016, APPL SURF SCI, V378, P277, DOI 10.1016/j.apsusc.2016.03.218; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Lu B, 2010, LAB CHIP, V10, P1826, DOI 10.1039/b924855b; Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109; Raos BJ, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaae1d; Raos BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21135-0; Raos BJ, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025006; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Tan CP, 2010, MATERIALS, V3, P1803, DOI 10.3390/ma3031803; Tarczyluk MA, 2013, J CEREBR BLOOD F MET, V33, P1386, DOI 10.1038/jcbfm.2013.81; Trantidou T, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/025004; Unsworth CF, 2010, J NEUROSCI METH, V194, P154, DOI 10.1016/j.jneumeth.2010.09.022; Unsworth CP, 2011, BIOMATERIALS, V32, P6541, DOI 10.1016/j.biomaterials.2011.05.041; Unsworth CR, 2011, BIOMATERIALS, V32, P2566, DOI 10.1016/j.biomaterials.2010.12.017; van Kralingen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084269; Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K; Wei L, 2010, MAT SCI ENG C-MATER, V30, P1252, DOI 10.1016/j.msec.2010.07.003; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Wright D, 2007, LAB CHIP, V7, P1272, DOI 10.1039/b706081e	50	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218850	10.1371/journal.pone.0218850	http://dx.doi.org/10.1371/journal.pone.0218850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237927	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000045
J	Stellavato, A; Pirozzi, AVA; Diana, P; Reale, S; Vassallo, V; Fusco, A; Donnarumma, G; De Rosa, M; Schiraldi, C				Stellavato, Antonietta; Pirozzi, Anna Virginia Adriana; Diana, Paola; Reale, Sabrina; Vassallo, Valentina; Fusco, Alessandra; Donnarumma, Giovanna; De Rosa, Mario; Schiraldi, Chiara			Hyaluronic acid and chondroitin sulfate, alone or in combination, efficiently counteract induced bladder cell damage and inflammation	PLOS ONE			English	Article							CYSTITIS/BLADDER PAIN SYNDROME; FACTOR-KAPPA-B; THERAPY; GLYCOSAMINOGLYCANS; SIZE	Interstitial cystitis and/or bladder pain syndrome (IC/BPS) are characterized by discomfort, abdominal pain, and pelvic pain, and they are often associated with chronic diseases. Pathological conditions related to IC/BPS can occur due to a defect in the integrity of the bladder lining. This defect has been ascribed to damage to the glycosaminoglycan (GAG) layer of the urinary epithelium. In addition, the incipient cascade of inflammation events might prompt extracellular matrix degradation. Several medical devices based on GAG instillation were proposed to re-establish epithelial integrity by GAGs binding to proteoglycans or interacting with structural urothelium. However, to date, only in vitro studies have investigated the GAG, hyaluronic acid (HA). In the present study, TNF alpha treatment was used to mimic IC/BPS-induced damage in bladder cells in an in vitro model. Highly purified fermentative HA and pharmaceutical grade bovine chondroitin sulfate (CSb), alone or in combination, were evaluated for the ability to counteract bladder cell damage. We evaluated NF-kappa B with western blots, and we analyzed interleukin 6 and 8 expression at the transcriptional and protein levels with quantitative RT-PCR, western blotting, and ELISA. We also evaluated the expression of an antibacterial peptide, human beta-defensin-2. We confirmed our results in a 3D bladder epithelium model. Our results demonstrated that inflammatory status was reduced in the presence of HA, CSb, and the combination of both (HA/CSb 1.6%/2% w/v). This result suggested that these GAGs might be suitable for treating IC/BPS. All the assayed biomarkers showed that HA/CSb treatment modulated cells towards a more physiological status. Finally, we compared two commercial products suggested for the IC/BPS treatments and found that the product with more Ca++, showed enhanced anti-inflammatory activity and provided superior mucoadhesivity.	[Stellavato, Antonietta; Pirozzi, Anna Virginia Adriana; Diana, Paola; Reale, Sabrina; Vassallo, Valentina; De Rosa, Mario; Schiraldi, Chiara] Univ Campania Luigi Vanvitelli, Sect Biotechnol Med Histol & Mol Biol, Dept Expt Med, Naples, Italy; [Fusco, Alessandra; Donnarumma, Giovanna] Univ Campania Luigi Vanvitelli, Sect Microbiol & Clin Microbiol, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Stellavato, A; Schiraldi, C (corresponding author), Univ Campania Luigi Vanvitelli, Sect Biotechnol Med Histol & Mol Biol, Dept Expt Med, Naples, Italy.	antonietta.stellavato@unicampania.it; chiara.schiraldi@unicampania.it	Donnarumma, Giovanna/AAG-8102-2019; Fusco, Alessandra/ABH-6663-2020; Vassallo, Valentina/AAC-7742-2021	Vassallo, Valentina/0000-0001-6891-9724; De Rosa, Mario/0000-0002-2976-0818; STELLAVATO, Antonietta/0000-0003-1635-2724	University of Campania "Luigi Vanvitelli"; italian Ministry of education [PON03PE_0060_7]	University of Campania "Luigi Vanvitelli"; italian Ministry of education	Most of the authors are employed at The University of Campania "Luigi Vanvitelli" that is a government public institution. Also phD students receive their grants from the University. Bioteknet sustained short term grant for graduated collaborators. The research is within the scope of the italian Ministry of education financed project PON03PE_0060_7 to CS.	Abdel-Mageed AB, 1998, J UROLOGY, V160, P2000, DOI 10.1016/S0022-5347(01)62224-9; Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Baroni A, 2009, PEPTIDES, V30, P267, DOI 10.1016/j.peptides.2008.11.001; Batler RA, 2002, J UROLOGY, V168, P819, DOI 10.1016/S0022-5347(05)64750-7; Cervigni M, 2008, INT UROGYNECOL J, V19, P943, DOI 10.1007/s00192-008-0572-4; Cervigni M, 2012, INT UROGYNECOL J, V23, P1187, DOI 10.1007/s00192-012-1742-y; Cervigni M, 2017, NEUROUROL URODYNAM, V36, P1178, DOI 10.1002/nau.23091; Cervigni M, 2015, TRANSL ANDROL UROL, V4, P638, DOI 10.3978/j.issn.2223-4683.2015.11.04; Cobo ER, 2013, PATHOGENS, V2, P177, DOI 10.3390/pathogens2010177; D'Agostino A, 2017, CARBOHYD POLYM, V157, P21, DOI 10.1016/j.carbpol.2016.07.125; De Vita D, 2012, INT UROGYNECOL J, V23, P1707, DOI 10.1007/s00192-012-1794-z; Giberti C, 2013, THER ADV UROL, V5, P175, DOI 10.1177/1756287213490052; Gribbon P, 2000, BIOCHEM J, V350, P329, DOI 10.1042/0264-6021:3500329; Gulpinar O, 2014, CUAJ-CAN UROL ASSOC, V8, pE610, DOI 10.5489/cuaj.2036; Hang L, 1998, J UROLOGY, V159, P2185, DOI 10.1016/S0022-5347(01)63303-2; HASSAN EE, 1990, PHARMACEUT RES, V7, P491, DOI 10.1023/A:1015812615635; La Gatta A, 2010, ANAL BIOCHEM, V404, P21, DOI 10.1016/j.ab.2010.04.014; Lai H, 2015, UROLOGY, V85, P1454, DOI 10.1016/j.urology.2015.03.007; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lazzeri M, 2016, THER ADV UROL, V8, P91, DOI 10.1177/1756287215621234; Nickel JC, 2009, BJU INT, V103, P56, DOI 10.1111/j.1464-410X.2008.08028.x; Oechsner M, 1999, EUR J PHARM BIOPHARM, V47, P113, DOI 10.1016/S0939-6411(98)00070-8; Porru D, 2012, INT UROGYNECOL J, V23, P1193, DOI 10.1007/s00192-011-1546-5; Restaino OF, 2017, ANAL CHIM ACTA, V958, P59, DOI 10.1016/j.aca.2016.12.005; Rodhe N, 2009, SCAND J PRIM HEALTH, V27, P74, DOI 10.1080/02813430902757634; Rooney P, 2015, ACTA BIOMATER, V19, P66, DOI 10.1016/j.actbio.2015.02.030; Salonia A., 2016, UROLOGIA; Salzillo R, 2016, CARBOHYD POLYM, V153, P275, DOI 10.1016/j.carbpol.2016.07.106; Stellavato A, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8481243; Stellavato A, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0663-2; Stellavato A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163510; Uccello-Barretta G, 2010, INT J PHARMACEUT, V395, P122, DOI 10.1016/j.ijpharm.2010.05.031; Vastano V, 2016, ADV EXP MED BIOL, V897, P33, DOI 10.1007/5584_2015_5009; Vykhovanets EV, 2012, J UROLOGY, V187, P330, DOI 10.1016/j.juro.2011.09.007; Wyndaele JJJ, 2019, NEUROUROL URODYNAM, V38, P535, DOI 10.1002/nau.23900	35	16	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218475	10.1371/journal.pone.0218475	http://dx.doi.org/10.1371/journal.pone.0218475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237905	Green Submitted, Green Published, gold			2022-12-26	WOS:000484856000021
J	Wu, CY; Yu, HS; Chai, CY; Wen, YH; Wu, SS; Chang, YP; Lin, CHR; Tsai, JH				Wu, Ching-Ying; Yu, Hsin-Su; Chai, Chee-Yin; Wen, Yen-Hsia; Wu, Shihn-Sheng; Chang, Yang-Pei; Lin, Chun-Hung Richard; Tsai, Jui-Hsiu			Increased ischemic stroke risk in patients with Behcet's disease: A nationwide population-based cohort study	PLOS ONE			English	Article							DAGGER-ETS DISEASE; PREVALENCE; INVOLVEMENT; THICKNESS	Background Behcet's disease (BD) is a recurrent, multisystemic, inflammatory disorder that mainly affects blood vessels. Because recurrent inflammation of blood vessels in the brain plays a crucial role in the development of ischemic stroke, we hypothesized that patients with BD might have an elevated risk of ischemic stroke. This potential association has been suggested in a few case reports, but not epidemiological studies. Hence, the present study aimed to examine the relation between BD and subsequent ischemic stroke in Taiwan using a nationwide, population-based database. Methods To establish a study cohort, the longitudinal data of 306 patients newly diagnosed with BD during 2000-2010 were extracted from the National Health Insurance Research Database, Taiwan. For comparison of ischemic stroke incidence, a control cohort of 1224 subjects without BD was established using a frequency-matched ratio of 1: 4 for age, sex, and preexisting comorbidities. Results During the 10-year follow-up, 13 (4.2%) patients with BD and 20 (1.6%) control subjects experienced ischemic stroke. Kaplan-Meier analysis revealed the higher prevalence of ischemic stroke in the BD group (log-rank test, p = 0.001). After adjusting for comorbidities and demographic characteristics, Cox regression analysis revealed that patients with BD had a 2.77-fold risk of ischemic stroke (95% confidence interval, 1.38-5.57) compared to control subjects. Conclusions Patients with BD have an elevated risk of ischemic stroke. Hence, BD may affect the vascular system in the brain, resulting in a stroke event.	[Wu, Ching-Ying] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Wu, Ching-Ying; Yu, Hsin-Su; Chai, Chee-Yin] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wu, Ching-Ying] Chang Gung Univ Sci & Technol, Dept Cosmet Sci, Coll Human Ecol, Taoyuan, Taiwan; [Yu, Hsin-Su] Kaohsiung Med Univ Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Yu, Hsin-Su] Kaohsiung Med Univ, Grad Inst Clin Med, Fac Med, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Wen, Yen-Hsia; Wu, Shihn-Sheng] Kaohsiung Med Univ, Sch Pharm, Coll Pharm, Kaohsiung, Taiwan; [Chang, Yang-Pei] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lin, Chun-Hung Richard] Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung, Taiwan; [Tsai, Jui-Hsiu] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Psychiat, Chiayi, Taiwan; [Tsai, Jui-Hsiu] Taiwan Natl Hlth Res Inst, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan; [Tsai, Jui-Hsiu] Kaohsiung Med Univ, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Chang Gung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; National Sun Yat Sen University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University	Yu, HS (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.; Yu, HS (corresponding author), Kaohsiung Med Univ Hosp, Dept Dermatol, Kaohsiung, Taiwan.; Yu, HS (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Fac Med, Kaohsiung, Taiwan.; Lin, CHR (corresponding author), Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung, Taiwan.; Tsai, JH (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Psychiat, Chiayi, Taiwan.; Tsai, JH (corresponding author), Taiwan Natl Hlth Res Inst, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan.; Tsai, JH (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.	yup.kmu@gmail.com; lin@cse.nsysu.edu.tw; u105803001@kmu.edu.tw		Chang, Yang-Pei/0000-0002-1021-2643; Wu, Ching-Ying/0000-0002-3645-5117; Wu, Shihn-Sheng/0000-0002-7175-442X; Tsai, Jui-Hsiu/0000-0001-7335-4131; Chai, Chee-Yin/0000-0003-0486-9742; Wen, yen-hsia/0000-0002-4168-5857				Akman-Demir G, 1999, BRAIN, V122, P2171, DOI 10.1093/brain/122.11.2171; Alan S, 2004, ANGIOLOGY, V55, P413, DOI 10.1177/000331970405500408; Azizlerli G, 2003, INT J DERMATOL, V42, P803, DOI 10.1046/j.1365-4362.2003.01893.x; Berteau F, 2018, AUTOIMMUN REV, V17, P809, DOI 10.1016/j.autrev.2018.02.012; Biniwale Nishit, 2017, J Assoc Physicians India, V65, P89; BOYSEN G, 1988, STROKE, V19, P1345, DOI 10.1161/01.STR.19.11.1345; Caprio FZ, 2019, MED CLIN N AM, V103, P295, DOI 10.1016/j.mcna.2018.10.001; Chen HJ, 2006, STROKE, V37, P1060, DOI 10.1161/01.STR.0000206458.58142.f3; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiu CC, 2012, INTERNAL MED, V51, P17, DOI 10.2169/internalmedicine.51.6154; Davatchi F, 2010, CLIN RHEUMATOL, V29, P823, DOI 10.1007/s10067-010-1430-6; Donmez A, 2005, THROMB RES, V115, P287, DOI 10.1016/j.thromres.2004.09.010; Emmi G, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0047-z; Faezi ST, 2014, RHEUMATOL INT, V34, P1581, DOI 10.1007/s00296-014-3011-5; Farah S, 1998, J NEUROL NEUROSUR PS, V64, P382, DOI 10.1136/jnnp.64.3.382; Fei YY, 2013, CLIN RHEUMATOL, V32, P845, DOI 10.1007/s10067-013-2205-7; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Galeone Massimiliano, 2012, Patholog Res Int, V2012, P595380, DOI 10.1155/2012/595380; Gul A, 2015, SEMIN IMMUNOPATHOL, V37, P413, DOI 10.1007/s00281-015-0502-8; Hart CL, 2000, AM J PUBLIC HEALTH, V90, P1788, DOI 10.2105/AJPH.90.11.1788; Hedayatfar Alireza, 2013, J Ophthalmic Vis Res, V8, P291; Hosaka A, 2014, INT ANGIOL, V33, P419; Hsieh FI, 2014, J STROKE, V16, P59, DOI 10.5853/jos.2014.16.2.59; HU HH, 1992, STROKE, V23, P1237, DOI 10.1161/01.STR.23.9.1237; Ismail AM, 2013, BRIT J HOSP MED, V74, P592, DOI 10.12968/hmed.2013.74.10.592; Jakovljevic D, 2001, STROKE, V32, P1492, DOI 10.1161/01.STR.32.7.1492; Kaido T, 2012, ASIAN PAC J ALLERGY, V30, P239; Kappen JH, 2015, NETH J MED, V73, P471; Koike Yuka, 2015, Rinsho Shinkeigaku, V55, P428, DOI 10.5692/clinicalneurol.cn-000682; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; La Regina Micaela, 2010, Open Cardiovasc Med J, V4, P71, DOI 10.2174/1874192401004020071; Lee SK, 2011, J KOREAN NEUROSURG S, V50, P68, DOI 10.3340/jkns.2011.50.1.68; Leu HB, 2011, ATHEROSCLEROSIS, V214, P101, DOI 10.1016/j.atherosclerosis.2010.10.010; Li LQ, 2018, INTERACT CARDIOV TH, V27, P461, DOI 10.1093/icvts/ivy098; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Lin YH, 2018, OPHTHAL EPIDEMIOL, V25, P323, DOI 10.1080/09286586.2018.1469157; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; MODAN B, 1992, STROKE, V23, P1230, DOI 10.1161/01.STR.23.9.1230; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Owlia MB, 2012, ISRN PHARM, V2012, DOI DOI 10.5402/2012/760484; Radenkovic M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/252158; Saadoun D, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-20; Seyahi E, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.026; Takeuchi M, 2015, J AUTOIMMUN, V64, P137, DOI 10.1016/j.jaut.2015.08.013; Tursen Umit, 2012, Patholog Res Int, V2012, P493015, DOI 10.1155/2012/493015; Wu XH, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000263; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Yoshimura S, 2015, J STROKE CEREBROVASC, V24, pE237, DOI 10.1016/j.jstrokecerebrovasdis.2015.05.012; Zeidan MJ, 2016, AUTOIMMUN HIGHLIGHTS, V7, DOI 10.1007/s13317-016-0074-1	49	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218652	10.1371/journal.pone.0218652	http://dx.doi.org/10.1371/journal.pone.0218652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3BT	31237911	Green Published, Green Submitted, gold			2022-12-26	WOS:000484856000031
J	Ferreira, D; Bueno, JSS; Regitano, LCD; de Alencar, MM; Alves, RR; Meirelles, SLC				Ferreira Filho, Diogenes; de Sousa Bueno Filho, Julio Silvio; de Almeida Regitano, Luciana Correia; de Alencar, Mauricio Mello; Alves, Rosiana Rodrigues; Conceicao Meirelles, Sarah Laguna			Tournaments between markers as a strategy to enhance genomic predictions	PLOS ONE			English	Article							BAYESIAN LASSO; REGRESSION; SELECTION	Analysis of a large number of markers is crucial in both genome-wide association studies (GWAS) and genome-wide selection (GWS). However there are two methodological issues that restrict statistical analysis: high dimensionality (p >> n) and multicollinearity. Although there are methodologies that can be used to fit models for data with high dimensionality (eg, the Bayesian Lasso), a big problem that can occurs in this cases is that the predictive ability of the model should perform well for the individuals used to fit the model, but should not perform well for other individuals, restricting the applicability of the model. This problem can be circumvent by applying some selection methodology to reduce the number of markers (but keeping the markers associated with the phenotypic trait) before adjusting a model to predict GBVs. We revisit a tournament-based strategy between marker samples, where each sample has good statistical properties for estimation: n>p and low collinearity. Such tournaments are elaborated using multiple linear regression to eliminate markers. This method is adapted from previous works found in the literature. We used simulated data as well as real data derived from a study with SNPs in beef cattle. Tournament strategies not only circumvent the p >> n issue, but also minimize spurious associations. For real data, when we selected a few more than 20 markers, we obtained correlations greater than 0.70 between predicted Genomic Breeding Values (GBVs) and phenotypes in validation groups of a cross-validation scheme; and when we selected a larger number of markers (more than 100), the correlations exceeded 0.90, showing the efficiency in identifying relevant SNPs (or segregations) for both GWAS and GWS. In the simulation study, we obtained similar results.	[Ferreira Filho, Diogenes] Univ Fed Rural Rio De Janeiro, Dept Ciencias Econ & Exatas, Tres Rios, RJ, Brazil; [de Sousa Bueno Filho, Julio Silvio] Univ Fed Lavras, Dept Estat, Lavras, MG, Brazil; [de Almeida Regitano, Luciana Correia; de Alencar, Mauricio Mello] Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil; [Alves, Rosiana Rodrigues] Embrapa Pesca & Aquicultura, Palmas, Tocantins, Brazil; [Conceicao Meirelles, Sarah Laguna] Univ Fed Lavras, Dept Zootecnia, Lavras, MG, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal de Lavras; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Lavras	Meirelles, SLC (corresponding author), Univ Fed Lavras, Dept Zootecnia, Lavras, MG, Brazil.	sarah@dzo.ufla.br	Laguna Conceição Meirelles, Sarah/HDN-5656-2022; Meirelles, Sarah/AAL-4591-2020; Bueno Filho, Julio Silvio de Sousa/W-8903-2019; Regitano, Luciana/C-7002-2012	Meirelles, Sarah/0000-0002-3331-2495; Bueno Filho, Julio Silvio de Sousa/0000-0002-3243-0959; Regitano, Luciana/0000-0001-9242-8351; Alencar, Mauricio/0000-0002-6102-663X	Coordenacao de Aperfeicoamento de Pessoal de Ni vel Superior (CAPES) [5285-11-9, PROEX 676/2018]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Coordenacao de Aperfeicoamento de Pessoal de Ni vel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	DFF would like to thank the Coordenacao de Aperfeicoamento de Pessoal de Ni vel Superior (CAPES) (Grantee no. 5285-11-9) for providing a scholarship and for funding this study through the Programa de Excelencia (PROEX 676/2018). We also express our thanks to the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) for providing a scholarship.	Chen ZH, 2009, SCI CHINA SER A, V52, P1327, DOI 10.1007/s11425-009-0089-4; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Legarra A, 2011, GENET RES, V93, P77, DOI 10.1017/S0016672310000534; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Li ZT, 2012, THEOR APPL GENET, V125, P419, DOI 10.1007/s00122-012-1892-9; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2007, J ANIM BREED GENET, V124, P321, DOI 10.1111/j.1439-0388.2007.00708.x; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; R Core Team, 2014, R A LANGUAGE AND ENV; Resende M.D.V., 2008, PESQUISA FLORESTAL B, V56, P63; Resende MDVd, 2012, SELECAOGENOMICA AMPL; Silva FF, 2013, ARQ BRAS MED VET ZOO, V65, P1519, DOI 10.1590/S0102-09352013000500033; Silva FF, 2011, LIVEST SCI, V142, P310, DOI 10.1016/j.livsci.2011.09.010; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589	15	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0217283	10.1371/journal.pone.0217283	http://dx.doi.org/10.1371/journal.pone.0217283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233512	Green Submitted, gold, Green Published			2022-12-26	WOS:000484896700007
J	Garcia-Canadilla, P; de Vries, T; Gonzalez-Tendero, A; Bonnin, A; Gratacos, E; Crispi, F; Bijnens, B; Zhang, C				Garcia-Canadilla, Patricia; de Vries, Tom; Gonzalez-Tendero, Anna; Bonnin, Anne; Gratacos, Eduard; Crispi, Fatima; Bijnens, Bart; Zhang, Chong			Structural coronary artery remodelling in the rabbit fetus as a result of intrauterine growth restriction	PLOS ONE			English	Article							BLOOD-FLOW; CHRONIC HYPOXEMIA; HEART; VESSELS; LIFE	Intrauterine growth restriction (IUGR) is a fetal condition that affects up to 10% of all pregnancies and is associated with cardiovascular structural and functional remodelling that persists postnatally. Some studies have reported an increase in myocardial coronary blood flow in severe IUGR fetuses which has been directly associated to the dilatation of the coronary arteries. However, a direct measurement of the coronaries' lumen diameter in IUGR has not been reported before. The aim of this paper is to perform, for the first time, a quantitative analysis of the effects of IUGR in cardiac geometry and coronary vessel size in a well-known rabbit model of IUGR using synchrotron-based X-ray Phase Contrast Tomography Imaging (X-PCI). Eight rabbit fetal hearts were imaged non-destructively with X-PCI. 3D reconstructions of the coronary arterial tree were obtained after semi-automatic image segmentation. Different morphometric features including vessel lumen diameter of the three main coronaries were automatically quantified. IUGR fetuses had more globular hearts and dilated coronary arteries as compared to controls. We have quantitatively shown that IUGR leads to structural coronary vascular tree remodelling and enlargement as an adaptation mechanism in response to an adverse environment of restricted oxygen and nutrients and increased perfusion pressure.	[Garcia-Canadilla, Patricia; Bijnens, Bart; Zhang, Chong] Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain; [de Vries, Tom] Tech Univ Eindhoven, Med Image Anal, Eindhoven, Netherlands; [Gonzalez-Tendero, Anna; Gratacos, Eduard; Crispi, Fatima] Univ Barcelona, BCNatal Fetal Med Res Ctr, Hosp Clin, Barcelona, Spain; [Gonzalez-Tendero, Anna; Gratacos, Eduard; Crispi, Fatima] Univ Barcelona, Hosp St Joan de Deu, Barcelona, Spain; [Gonzalez-Tendero, Anna; Gratacos, Eduard; Crispi, Fatima] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Bonnin, Anne] European Synchrotron Radiat Facil, Grenoble, France; [Bonnin, Anne] Paul Scherrer Inst, Villigen, Switzerland; [Gratacos, Eduard; Crispi, Fatima] Ctr Biomed Res Rare Dis CIBER ER, Madrid, Spain; [Gratacos, Eduard] Inst Recerca St Joan Deu, Esplugas de Llobregat, Spain; [Bijnens, Bart] Inst Catalana Invest & Estudios Avanzados ICREA, Barcelona, Spain	Pompeu Fabra University; Eindhoven University of Technology; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; European Synchrotron Radiation Facility (ESRF); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; ICREA	Garcia-Canadilla, P (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain.	patricia.garciac@upf.edu	Gratacos, Eduard/AAR-4939-2020; BONNIN, Anne/J-3633-2014; Garcia-Canadilla, Patricia/D-8085-2014; Bijnens, Bart/AAE-7186-2021	Gratacos, Eduard/0000-0002-7405-7224; BONNIN, Anne/0000-0001-5537-8682; Garcia-Canadilla, Patricia/0000-0002-0223-1617; Bijnens, Bart/0000-0003-3130-6937	Spanish Ministry of Economy and Competitiveness [TIN2014-52923-R, MDM-2015-0502]; Caixa Foundation (Spain); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [928, 2016FI_B01184]; Instituto de Salud Carlos III, Plan Nacional de I+D+I [PI14/00226, PI15/00130, INT16/00168]; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER) "Otra manera de hacer Europa" (Spain)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Caixa Foundation (Spain); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Salud Carlos III, Plan Nacional de I+D+I(Instituto de Salud Carlos III); ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER) "Otra manera de hacer Europa" (Spain)	This study was partially supported by the Spanish Ministry of Economy and Competitiveness (grant TIN2014-52923-R to BB; Maria de Maeztu Units of Excellence Programme - MDM-2015-0502); la Caixa Foundation (Spain); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya (2014 SGR grant no 928, 2016FI_B01184); Instituto de Salud Carlos III (PI14/00226 to FC, PI15/00130 to EG and INT16/00168 to FC) as part of the Plan Nacional de I+D+I and co-funded by ISCIII-Subdireccion General de Evaluacion; the Fondo Europeo de Desarrollo Regional (FEDER) "Otra manera de hacer Europa" (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry M, 2007, ARCH DIS CHILD-FETAL, V92, pF62, DOI 10.1136/adc.2005.082297; Anrep GV, 1929, J PHYSIOL-LONDON, V67, P87, DOI 10.1113/jphysiol.1929.sp002555; Babuccu O, 2011, SURG SCI, V2, P204, DOI DOI 10.4236/SS.2011; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Baschat AA, 2003, ULTRASOUND OBST GYN, V21, P426, DOI 10.1002/uog.82; Baschat AA, 2002, ULTRASOUND OBST GYN, V20, P405, DOI 10.1046/j.1469-0705.2002.00798.x; Botting KJ, 2018, AM J PHYSIOL-REG I, V315, pR48, DOI 10.1152/ajpregu.00180.2017; Botting KJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000531; Bubb KJ, 2007, J PHYSIOL-LONDON, V578, P871, DOI 10.1113/jphysiol.2006.121160; Chaoui R, 2004, ACTA PAEDIATR, V93, P6, DOI 10.1080/08035320410022767; Chaoui R, 1996, ULTRASOUND OBST GYN, V7, P5, DOI 10.1046/j.1469-0705.1996.07010005.x; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; de Vries T, 2018, VESSEL SELECTOR MEVI; de Vries T, 2018, ILASTIK PREPROCESSIN; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Garcia-Canadilla P, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003667; Gembruch U, 1996, ULTRASOUND OBST GYN, V7, P10, DOI 10.1046/j.1469-0705.1996.07010010.x; Gonzalez-Tendero A, 2017, EUR HEART J-CARD IMG, V18, P732, DOI 10.1093/ehjci/jew314; Gratacos E, 2013, FETAL DIAGN THER, V33, P141, DOI 10.1159/000351157; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Jiang BY, 2006, PEDIATRICS, V117, pE257, DOI 10.1542/peds.2005-1325; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Luria O, 2012, MED ENG PHYS, V34, P364, DOI 10.1016/j.medengphy.2011.07.032; Mirone A, 2014, NUCL INSTRUM METH B, V324, P41, DOI 10.1016/j.nimb.2013.09.030; Poudel R, 2015, AM J PHYSIOL-REG I, V308, pR151, DOI 10.1152/ajpregu.00036.2014; Radulescu L, 2013, J Med Life, V6, P38; RELLER MD, 1992, AM J PHYSIOL, V263, pH1327, DOI 10.1152/ajpheart.1992.263.4.H1327; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; Sakamoto S, 2013, AM J CARDIOL, V111, P1420, DOI 10.1016/j.amjcard.2013.01.290; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schipke J, 2017, HISTOCHEM CELL BIOL, V148, P557, DOI 10.1007/s00418-017-1587-z; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Straehle CN, 2011, LECT NOTES COMPUT SC, V6891, P653, DOI 10.1007/978-3-642-23623-5_82; Vranas S, 2017, J DEV ORIG HLTH DIS, V8, P618, DOI 10.1017/S2040174417000381; Wang KCW, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12270; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]; Zhu MY, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.004	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218192	10.1371/journal.pone.0218192	http://dx.doi.org/10.1371/journal.pone.0218192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226127	Green Published, Green Submitted, gold			2022-12-26	WOS:000484894700010
J	Zhang, YF; Xu, K; Liu, YC; Erokwu, BO; Zhao, P; Flask, CA; Ramos-Estebanez, C; Farr, GW; LaManna, JC; Boron, WF; Yu, X				Zhang, Yifan; Xu, Kui; Liu, Yuchi; Erokwu, Bernadette O.; Zhao, Pan; Flask, Chris A.; Ramos-Estebanez, Ciro; Farr, George W.; LaManna, Joseph C.; Boron, Walter F.; Yu, Xin			Increased cerebral vascularization and decreased water exchange across the blood-brain barrier in aquaporin-4 knockout mice	PLOS ONE			English	Article							INTRAVENOUS (H2O)-O-15; DELETION; FLOW; IMPLEMENTATION; PHENOTYPE; DIFFUSION; EDEMA; FLUID; TIME	Aquaporin-4 (AQP4) plays an important role in regulating water exchange across the blood-brain barrier (BBB) and brain-cerebrospinal fluid interface. Studies on AQP-4 knockout mice (AQP4-KO) have reported considerable protection from brain edema induced by acute water intoxication and ischemic stroke, identifying AQP4 as a potential target for therapeutic interventions. However, the long-term effects of chronic AQP4 suppression are yet to be elucidated. In the current study, we evaluated the physiological and structural changes in adult AQP4-KO mice using magnetic resonance imaging (MRI) and immunohistochemical analysis. Water exchange across BBB was assessed by tracking an intravenous bolus injection of oxygen-17 (O-17) water ((H2O)-O-17) using O-17-MRI. Cerebral blood flow (CBF) was quantified using arterial spin-labeling (ASL) MRI. Capillary density was determined by immunohisto-chemical staining for glucose transporter-1 (GLUT1). Compared to wildtype control mice, AQP4-KO mice showed a significant reduction in peak and steady-state (H2O)-O-17 uptake despite unaltered CBF. Interestingly, a 22% increase in cortical capillary density was observed in AQP4-KO mice. These results suggest that increased cerebral vascularization may be an adaptive response to chronic reduction in water exchange across BBB in AQP4-KO mice.	[Zhang, Yifan; Liu, Yuchi; Flask, Chris A.; Yu, Xin] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Zhang, Yifan; Erokwu, Bernadette O.; Flask, Chris A.; Yu, Xin] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA; [Xu, Kui; Zhao, Pan; Farr, George W.; LaManna, Joseph C.; Boron, Walter F.; Yu, Xin] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Flask, Chris A.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Ramos-Estebanez, Ciro] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Farr, George W.] Aeromics LLC, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Zhang, YF; Yu, X (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.; Zhang, YF; Yu, X (corresponding author), Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA.; Yu, X (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	yxz137@case.edu; xin.yu@case.edu	Boron, Walter/ABI-1564-2020	Flask, Chris/0000-0002-1066-333X; LIU, YUCHI/0000-0003-3533-1697	National Institute of Health [R21 HL126215, R01 EB23704]; Office of Naval Research [N00014-16-1-2535, N00014-15-1-2060]; Aeromics, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL126215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB023704] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); Aeromics, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the National Institute of Health (R21 HL126215 to XY and R01 EB23704 to XY) and the Office of Naval Research (N00014-16-1-2535 and N00014-15-1-2060 to WFB). Aeromics, LLC, provided support in the form of salaries for GWF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JE, 1997, JMRI-J MAGN RESON IM, V7, P716, DOI 10.1002/jmri.1880070418; Bohn KA, 2016, J NEUROSCI METH, V270, P124, DOI 10.1016/j.jneumeth.2016.06.012; Boron WF, 2010, EXP PHYSIOL, V95, P1107, DOI 10.1113/expphysiol.2010.055244; Dobre MC, 2007, MAGN RESON IMAGING, V25, P733, DOI 10.1016/j.mri.2006.10.020; Eilert-Olsen M, 2012, GLIA, V60, P432, DOI 10.1002/glia.22277; Friscourt F, 2018, J NEUROSCI RES, V96, P177, DOI 10.1002/jnr.24155; Gao Y, 2014, NMR BIOMED, V27, P996, DOI 10.1002/nbm.3143; Goodnough CL, 2014, NEUROIMAGE, V102, P809, DOI 10.1016/j.neuroimage.2014.08.053; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; HERSCOVITCH P, 1987, J CEREBR BLOOD F MET, V7, P527, DOI 10.1038/jcbfm.1987.102; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; Igarashi H, 2014, NEUROREPORT, V25, P39, DOI 10.1097/WNR.0000000000000042; Igarashi H, 2013, NEUROREPORT, V24, P324, DOI 10.1097/WNR.0b013e32835fc827; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Ohene Y, 2019, NEUROIMAGE, V188, P515, DOI 10.1016/j.neuroimage.2018.12.026; Patching SG, 2017, MOL NEUROBIOL, V54, P1046, DOI 10.1007/s12035-015-9672-6; Pell GS, 1999, MAGN RESON MED, V41, P829, DOI 10.1002/(SICI)1522-2594(199904)41:4<829::AID-MRM24>3.0.CO;2-U; RAICHLE ME, 1983, J NUCL MED, V24, P790; Rodriguez-Grande B, 2018, J NEUROSCI RES, V96, P207, DOI 10.1002/jnr.24077; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Thrane AS, 2013, J CEREBR BLOOD F MET, V33, P996, DOI 10.1038/jcbfm.2013.63; Tsekos NV, 1998, MAGNET RESON MED, V39, P564, DOI 10.1002/mrm.1910390409; Tsipis CP, 2014, METHODS MOL BIOL, V1135, P69, DOI 10.1007/978-1-4939-0320-7_6; Verkman AS, 2000, EXP PHYSIOL, V85, p233S, DOI 10.1111/j.1469-445X.2000.tb00028.x; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; Yao XM, 2015, NEUROSCI LETT, V584, P368, DOI 10.1016/j.neulet.2014.10.040; Zhang J, 2019, MAGN RESON MED, V81, P140, DOI 10.1002/mrm.27357	32	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218415	10.1371/journal.pone.0218415	http://dx.doi.org/10.1371/journal.pone.0218415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220136	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500045
J	Dassanayake, RP; Falkenberg, SM; Nicholson, EM; Briggs, RE; Tatum, FM; Sharma, VK; Reinhardt, TA				Dassanayake, Rohana P.; Falkenberg, Shollie M.; Nicholson, Eric M.; Briggs, Robert E.; Tatum, Fred M.; Sharma, Vijay K.; Reinhardt, Timothy A.			Synthetic bovine NK-lysin-derived peptide (bNK2A) does not require intra-chain disulfide bonds for bactericidal activity	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; GRANULYSIN	Bovine NK-lysins are cationic antimicrobial proteins found predominantly in the cytosolic granules of T lymphocytes and NK-cells. NK-lysin-derived peptides show antimicrobial activity against both Gram positive and Gram negative bacteria. Mature NK-lysin protein has six well-conserved cysteine residues. This study was performed to assess whether synthetic bovine NK-lysin-derived peptide (bNK2A) forms disulfide bonds and whether disulfide bonds were essential for bNK2A antimicrobial activity. Two 30-mer bNK2A peptides were synthesized: one with two original cysteines and an analog with cysteines substituted with two serines. Mass spectrometry revealed lack of disulfide bonds in original peptide while CD spectrophotometry showed both peptides have similar a-helical structures. Since both peptides were equally inhibitory to Histophilus somni, disulfide bonds appeared dispensable for synthetic bNK2A peptide antibacterial activity.	[Dassanayake, Rohana P.; Falkenberg, Shollie M.; Briggs, Robert E.; Tatum, Fred M.; Reinhardt, Timothy A.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [Nicholson, Eric M.] ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Sharma, Vijay K.] ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Dassanayake, RP (corresponding author), ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA.	rohana.dassanayake@ars.usda.gov	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509	USDA/ARS National Animal Disease Center [5030-32000-116-00D]	USDA/ARS National Animal Disease Center	This research was conducted at a USDA research facility and all funding was provided through internal USDA research dollars. This project is an intramural project of the USDA/ARS National Animal Disease Center (5030-32000-116-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1995, EMBO J, V14, P1615, DOI 10.1002/j.1460-2075.1995.tb07150.x; Andersson M, 1996, J BIOL CHEM, V271, P10116, DOI 10.1074/jbc.271.17.10116; Chen JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158882; Chen JF, 2015, P NATL ACAD SCI USA, V112, pE7223, DOI 10.1073/pnas.1519374113; Dassanayake RP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197677; Dassanayake RP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183610; Endsley JJ, 2004, J IMMUNOL, V173, P2607, DOI 10.4049/jimmunol.173.4.2607; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gelhaus C, 2008, ANTIMICROB AGENTS CH, V52, P1713, DOI 10.1128/AAC.01342-07; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; LEIPPE M, 1992, EMBO J, V11, P3501, DOI 10.1002/j.1460-2075.1992.tb05432.x; Ma B, 2016, ANTIMICROB AGENTS CH, V60, P4283, DOI 10.1128/AAC.00041-16; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; MUNFORD RS, 1995, J LIPID RES, V36, P1653; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Pena SV, 1997, J IMMUNOL, V158, P2680; Sordillo LM, 2005, J DAIRY SCI, V88, P1378, DOI 10.3168/jds.S0022-0302(05)72805-8; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Wang Z, 2000, J IMMUNOL, V165, P1486, DOI 10.4049/jimmunol.165.3.1486; YAMASHITA T, 1995, BBA-GEN SUBJECTS, V1243, P295, DOI 10.1016/0304-4165(94)00139-O	20	1	1	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218507	10.1371/journal.pone.0218507	http://dx.doi.org/10.1371/journal.pone.0218507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216348	Green Submitted, Green Published, gold			2022-12-26	WOS:000482885300049
J	Kang, MJ; Kim, SY; Kwon, EB; Jo, YH; Lee, MK; Lee, HS; Moon, DO; Kim, MO				Kang, Myung-Ji; Kim, Soo-Yeon; Kwon, Eun-Bin; Jo, Yang Hee; Lee, Mi Kyeong; Lee, Hyun-Sun; Moon, Dong-Oh; Kim, Mun-Ock			Derrone induces autophagic cell death through induction of ROS and ERK in A549 cells	PLOS ONE			English	Article							LUNG-CANCER; CUDRANIA-COCHINCHINENSIS; SIGNALING PATHWAY; APOPTOSIS; INHIBITION; XANTHONES; CHEMOTHERAPY; FLAVONOIDS; ERLOTINIB; FRUITS	We studied the effect of derrone (DR), one of the major compounds of unripe fruits of Cudrania tricuspidata, on cancer cell death. DR inhibited cell growth of various cancer cells, and that was partially associated with apoptosis in A549 cells. DR showed the autophagic features, such as the conversion of LC3-I to LC3-II, the formation of autophagosome and the downregulation of SQSTM1/p62 (p62). The treatment of autophagy inhibitor reversed DR-mediated cell death, suggesting that DR induces autophagic cell death. The increase of cytoplasmic Ca2+ and ROS by DR treatment significantly influences the formation of autophagosomes; however, only ROS scavengers significantly rescued the reduced cell viability. Additional results revealed that treatment of DR induces sustained phosphorylation of ERK and the inhibition of ERK phosphorylation using U0126 (ERK inhibitor) markedly attenuated DR-induced cell death. Overall, these results suggest that DR induces autophagic cell death through intracellular ROS and sustained ERK phosphorylation in A549 cells.	[Kang, Myung-Ji; Kim, Soo-Yeon; Kwon, Eun-Bin; Jo, Yang Hee; Lee, Hyun-Sun; Kim, Mun-Ock] KRIBB, Nat Med Res Ctr, Cheongju, Chungbuk, South Korea; [Kang, Myung-Ji; Kwon, Eun-Bin; Jo, Yang Hee; Lee, Mi Kyeong] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Moon, Dong-Oh] Daegu Univ, Dept Biol Educ, Gyongsan, Gyeongsangbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Daegu University	Kim, MO (corresponding author), KRIBB, Nat Med Res Ctr, Cheongju, Chungbuk, South Korea.	mokim@kribb.re.kr			KRIBB Research Initiative Program - Ministry of Science ICT (MSIT) of Republic of Korea; National Research Foundation of Korea (NRF) - Korean government [NRF-2017R1D1A1B03031653]	KRIBB Research Initiative Program - Ministry of Science ICT (MSIT) of Republic of Korea; National Research Foundation of Korea (NRF) - Korean government	This work was supported by a KRIBB Research Initiative Program funded by the Ministry of Science ICT (MSIT) of Republic of Korea. This work was also supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (NRF-2017R1D1A1B03031653).	Becker A, 2010, J THORAC ONCOL, V5, P1477, DOI 10.1097/JTO.0b013e3181e981d9; Cagnol S, 2006, APOPTOSIS, V11, P337, DOI 10.1007/s10495-006-4065-y; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; CHANG CH, 1994, J ETHNOPHARMACOL, V44, P79, DOI 10.1016/0378-8741(94)90072-8; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fukai T, 2003, J NAT PROD, V66, P1118, DOI 10.1021/np030024u; Fulda S, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00128; Greenhalgh J, 2015, HEALTH TECHNOL ASSES, V19, pI, DOI 10.3310/hta19470; Han XH, 2005, ARCH PHARM RES, V28, P1324, DOI 10.1007/BF02977895; Han XH, 2009, J NAT PROD, V72, P164, DOI 10.1021/np800418j; Jiang K, 2012, INT J MOL MED, V30, P302, DOI 10.3892/ijmm.2012.989; Jo YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172069; Kania E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00140; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Lee BW, 2005, BIOORG MED CHEM LETT, V15, P5548, DOI 10.1016/j.bmcl.2005.08.099; Lee ER, 2005, J BIOL CHEM, V280, P31498, DOI 10.1074/jbc.M505537200; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lu Q, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.344; Lv LX, 2017, ONCOTARGET, V8, P26992, DOI 10.18632/oncotarget.15935; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Martin P, 2006, BIOCHEM BIOPH RES CO, V350, P803, DOI 10.1016/j.bbrc.2006.09.126; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Matsunaga Yoshiko, 2005, Journal of Toxicological Sciences, V30, P135, DOI 10.2131/jts.30.135; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Park KH, 2006, BIOORG MED CHEM LETT, V16, P5580, DOI 10.1016/j.bmcl.2006.08.032; Puigmule M, 2009, NEPHROL DIAL TRANSPL, V24, P2672, DOI 10.1093/ndt/gfp149; Sheng JY, 2018, AM J CANCER RES, V8, P354; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shimizu S, 2014, INT J MOL SCI, V15, P3145, DOI 10.3390/ijms15023145; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Sivaprasad U, 2008, J CELL MOL MED, V12, P1265, DOI 10.1111/j.1582-4934.2008.00282.x; Song J, 2012, CHEM-BIOL INTERACT, V199, P9, DOI 10.1016/j.cbi.2012.05.005; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Thun MJ, 2006, JNCI-J NATL CANCER I, V98, P691, DOI 10.1093/jnci/djj187; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Yang G, 2018, CHEM-BIOL INTERACT, V288, P24, DOI 10.1016/j.cbi.2018.03.018; Yang ZY, 2017, INT J CANCER, V140, P2805, DOI 10.1002/ijc.30691; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yuan RYK, 2017, ANN NY ACAD SCI, V1401, P19, DOI 10.1111/nyas.13387; Zou YS, 2004, BIOORGAN MED CHEM, V12, P1947, DOI 10.1016/j.bmc.2004.01.030	45	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218659	10.1371/journal.pone.0218659	http://dx.doi.org/10.1371/journal.pone.0218659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216334	Green Submitted, Green Published, gold			2022-12-26	WOS:000482885300067
J	Zhao, L; Gao, XP; Zhuang, JG; Wallen, M; Leng, SG; Xu, FD				Zhao, Lei; Gao, Xiuping; Zhuang, Jianguo; Wallen, Morgan; Leng, Shuguang; Xu, Fadi			Prolongation of bronchopulmonary C-fiber-mediated apnea by prenatal nicotinic exposure in rat pups: role of 5-HT3 receptors	FASEB JOURNAL			English	Article						sudden infant death syndrome; vagal sensory neurons; cardiovascular activity; TRPV1	PULMONARY NEUROEPITHELIAL BODIES; SEROTONERGIC SYNAPTIC FUNCTION; INFANT-DEATH-SYNDROME; CIGARETTE-SMOKING; CALCIUM TRANSIENT; SUBUNIT ALTERS; BRAIN-STEM; RESPONSES; MEMBRANE; HYPOXIA	Prenatal nicotinic exposure (PNE) reportedly sensitizes bronchopulmonary C-fibers (PCFs) and prolongs PCF-mediated apnea in rat pups, contributing to the pathogenesis of sudden infant death syndrome. Serotonin, or 5-hydroxytryptamine (5-HT), induces apnea via acting on 5-HT receptor 3 (5-HT3R) in PCFs, and among the 5-HT3R subunits, 5-HT3B is responsible for shortening the decay time of 5-HT3R-mediated currents. We examined whether PNE would promote pulmonary 5-HT secretion and prolong the apnea mediated by 5-HT(3)Rs in PCFs via affecting the 5-HT3B subunit. To this end, the following variables were compared between the control and PNE rat pups: 1) the 5-HT content in bronchoalveolar lavage fluid, 2) the apneic response to the right atrial bolus injection of phenylbiguanide (a 5-HT3R agonist) before and after PCF inactivation, 3) 5-HT3R currents and the stimulus threshold of the action currents of vagal pulmonary C-neurons, and 4) the immunoreactivity (IR) and mRNA expression of 5-HT3A and 5-HT3B in these neurons. Our results showed that PNE up-regulated the pulmonary 5-HT concentration and strengthened the PCF 5-HT3R-mediated apnea. PNE significantly facilitated neural excitability by shortening the decay time of 5-HT3R currents, lowering the stimulus threshold, and increasing 5-HT3B IR. In summary, PNE prolongs the apnea mediated by 5-HT(3)Rs in PCFs, likely by increasing 5-HT3B subunits to enhance the excitability of 5-HT3 channels.-Zhao, L., Gao, X., Zhuang, J., Wallen, M., Leng, S., Xu, F. Prolongation of bronchopulmonary C-fiber-mediated apnea by prenatal nicotinic exposure in rat pups: role of 5-HT3 receptors.	[Zhao, Lei; Gao, Xiuping; Zhuang, Jianguo; Leng, Shuguang; Xu, Fadi] Lovelace Resp Res Inst, Pathophysiol Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA; [Wallen, Morgan] Univ Tennessee, Dept Arts & Sci, Knoxville, TN USA	Lovelace Respiratory Research Institute; University of Tennessee System; University of Tennessee Knoxville	Xu, FD (corresponding author), Lovelace Resp Res Inst, Pathophysiol Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	fxu@lrri.org			U.S. National Institutes of Health (NIH), National Heart, Lung and Blood Institute [HL-107462, HL-119683]	U.S. National Institutes of Health (NIH), National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Ellen Blake for editing. This study was supported in part by U.S. National Institutes of Health (NIH), National Heart, Lung and Blood Institute Grants HL-107462 and HL-119683 (to F.X.). The authors declare no conflicts of interest.	Adams EJ, 1998, PEDIATRICS, V102, P1445, DOI 10.1542/peds.102.6.1445; ASHLEY CC, 1970, J PHYSIOL-LONDON, V209, P105, DOI 10.1113/jphysiol.1970.sp009158; Ballanyi Klaus, 2004, Current Neuropharmacology, V2, P221, DOI 10.2174/1570159043476828; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; Bodineau L, 2004, RESP PHYSIOL NEUROBI, V141, P47, DOI 10.1016/j.resp.2004.03.007; Campos M, 2009, CLIN EXP PHARMACOL P, V36, P1205, DOI 10.1111/j.1440-1681.2009.05214.x; CUTZ E, 1993, ANAT RECORD, V236, P41, DOI 10.1002/ar.1092360109; Das P, 2003, MOL BRAIN RES, V119, P207, DOI 10.1016/j.molbrainres.2003.09.003; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Dutta A, 2010, ACTA PHYSIOL, V200, P87, DOI 10.1111/j.1748-1716.2010.02105.x; Fanburg BL, 1997, AM J PHYSIOL-LUNG C, V272, pL795, DOI 10.1152/ajplung.1997.272.5.L795; Feetham CH, 2015, BRIT J PHARMACOL, V172, P1753, DOI 10.1111/bph.13023; Fewell JE, 2001, RESP PHYSIOL, V127, P61, DOI 10.1016/S0034-5687(01)00232-8; Froen TF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e52; Fu XW, 2009, ADV EXP MED BIOL, V648, P439, DOI 10.1007/978-90-481-2259-2_50; Fuller DD, 2002, J PHYSIOL-LONDON, V538, P947, DOI 10.1113/jphysiol.2001.012908; Gao XP, 2017, FASEB J, V31, P4325, DOI 10.1096/fj.201700163R; Gdovin MJ, 2010, ETHNIC DIS, V20, pS1; Goda Yukiko, 1993, Hokkaido Journal of Medical Science, V68, P29; Gu QH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00065; Hafstrom O, 2002, AM J RESP CRIT CARE, V166, P1544, DOI 10.1164/rccm.200204-289OC; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hapfelmeier G, 2003, BIOPHYS J, V84, P1720, DOI 10.1016/S0006-3495(03)74980-7; Harper RM, 2000, RESP PHYSIOL, V119, P123, DOI 10.1016/S0034-5687(99)00107-3; Haynes RL, 2017, P NATL ACAD SCI USA, V114, P7695, DOI 10.1073/pnas.1617374114; Hong JL, 1997, J PHYSIOL-LONDON, V500, P319, DOI 10.1113/jphysiol.1997.sp022023; Hu YM, 2010, AM J PHYSIOL-LUNG C, V299, pL483, DOI 10.1152/ajplung.00111.2010; ISAAC PF, 1972, NATURE, V236, P308, DOI 10.1038/236308a0; Jiang X, 2015, CELL PHYSIOL BIOCHEM, V37, P1712, DOI 10.1159/000438536; JOHNSON DE, 1989, AM REV RESPIR DIS, V140, P1807, DOI 10.1164/ajrccm/140.6.1807; Kalra R, 2002, J PHARMACOL EXP THER, V302, P935, DOI 10.1124/jpet.302.3.935; Lee LY, 2013, PULM PHARMACOL THER, V26, P491, DOI 10.1016/j.pupt.2013.03.010; Lee LY, 2003, ANAT REC PART A, V270A, P17, DOI 10.1002/ar.a.10005; Lee LY, 2001, RESP PHYSIOL, V125, P47, DOI 10.1016/S0034-5687(00)00204-8; Lin YJ, 2013, J APPL PHYSIOL, V114, P361, DOI 10.1152/japplphysiol.00977.2012; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Livermore S, 2015, AM J PHYSIOL-LUNG C, V308, pL807, DOI 10.1152/ajplung.00208.2014; Loyd DR, 2011, PAIN, V152, P2267, DOI 10.1016/j.pain.2011.06.002; Morales M, 2002, J NEUROSCI, V22, P6732; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; PETSCHE U, 1983, BRAIN RES, V265, P233, DOI 10.1016/0006-8993(83)90337-2; Potenzieri C, 2012, J PHYSIOL-LONDON, V590, P5449, DOI 10.1113/jphysiol.2012.237115; Schuller HM, 2003, ANAT REC PART A, V270A, P51, DOI 10.1002/ar.a.10019; Shea AK, 2008, NICOTINE TOB RES, V10, P267, DOI 10.1080/14622200701825908; Slotkin TA, 2007, NEUROPSYCHOPHARMACOL, V32, P1082, DOI 10.1038/sj.npp.1301231; Slotkin TA, 2015, BRAIN RES BULL, V111, P84, DOI 10.1016/j.brainresbull.2015.01.003; Slotkin TA, 2011, NEUROTOXICOL TERATOL, V33, P431, DOI 10.1016/j.ntt.2011.02.001; Stephan-Blanchard E, 2013, RESP PHYSIOL NEUROBI, V185, P110, DOI 10.1016/j.resp.2012.06.023; Stephenson R, 2001, J PHYSIOL-LONDON, V536, P225, DOI 10.1111/j.1469-7793.2001.00225.x; Stewart A, 2003, NEUROPHARMACOLOGY, V44, P214, DOI 10.1016/S0028-3908(02)00376-3; TASAKI I, 1955, J GEN PHYSIOL, V39, P211, DOI 10.1085/jgp.39.2.211; Wang C, 2017, ARTERIOSCL THROM VAS, V37, P53, DOI 10.1161/ATVBAHA.116.307264; Warshaviak DT, 2011, BBA-BIOMEMBRANES, V1808, P2608, DOI 10.1016/j.bbamem.2011.06.010; Weigand LA, 2009, J PHYSIOL-LONDON, V587, P3355, DOI 10.1113/jphysiol.2009.173054; Xu F, 2003, J APPL PHYSIOL, V94, P1446, DOI 10.1152/japplphysiol.00767.2002; Xu J, 2008, AM J PHYSIOL-LUNG C, V295, pL162, DOI 10.1152/ajplung.00282.2007; Zhang ZX, 2013, NEUROSCI LETT, V552, P1, DOI 10.1016/j.neulet.2013.07.024; Zhang ZX, 2012, RESP PHYSIOL NEUROBI, V183, P211, DOI 10.1016/j.resp.2012.06.032; Zhao L, 2016, TOXICOL APPL PHARM, V303, P58, DOI 10.1016/j.taap.2016.05.008; Zhao L, 2016, TOXICOL APPL PHARM, V290, P107, DOI 10.1016/j.taap.2015.10.023; Zhuang J., 2014, FASEB J, V28, P713; Zhuang JG, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12023; Zhuang JG, 2015, AM J PHYSIOL-LUNG C, V308, pL922, DOI 10.1152/ajplung.00241.2014	64	2	2	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10731	10741		10.1096/fj.201900279RR	http://dx.doi.org/10.1096/fj.201900279RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31251077	Bronze, Green Published			2022-12-26	WOS:000489166300013
J	Duval, R; Bui, LC; Mathieu, C; Nian, Q; Berthelet, J; Xu, XM; Haddad, I; Vinh, J; Duprey, JM; Busi, F; Guidez, F; Chomienne, C; Rodrigues-Lima, F				Duval, Romain; Bui, Linh-Chi; Mathieu, Cecile; Nian, Qing; Berthelet, Jeremy; Xu, Ximing; Haddad, Iman; Vinh, Joelle; Duprey, Jean-Marie; Busi, Florent; Guidez, Fabien; Chomienne, Christine; Rodrigues-Lima, Fernando			Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carcinogenesis; tyrosine-protein phosphatase (tyrosine phosphatase); enzyme inactivation; leukemia; cell signaling; covalent adduct; metabolic activation; benzene; carcinogen; bioactivation; enzyme inhibition; leukemogenesis; cancer; protein tyrosine phosphatase non-receptor type 2 (PTPN2)	TOPOISOMERASE-II INHIBITION; TC-PTP; IN-VITRO; DNA CLEAVAGE; CELL; LEUKEMIA; TRANSCRIPTION; INACTIVATION; ALPHA; 1B	Protein tyrosine phosphatase, nonreceptor type 2 (PTPN2) is mainly expressed in hematopoietic cells, where it negatively regulates growth factor and cytokine signaling. PTPN2 is an important regulator of hematopoiesis and immune/inflammatory responses, as evidenced by loss-of-function mutations of PTPN2 in leukemia and lymphoma and knockout mice studies. Benzene is an environmental chemical that causes hematological malignancies, and its hematotoxicity arises from its bioactivation in the bone marrow to electrophilic metabolites, notably 1,4-benzoquinone, a major hematotoxic benzene metabolite. Although the molecular bases for benzene-induced leukemia are not well-understood, it has been suggested that benzene metabolites alter topoisomerases II function and thereby significantly contribute to leukemogenesis. However, several studies indicate that benzene and its hematotoxic metabolites may also promote the leukemogenic process by reacting with other targets and pathways. Interestingly, alterations of cell-signaling pathways, such as Janus kinase (JAK)/signal transducer and activator of transcription (STAT), have been proposed to contribute to benzene-induced malignant blood diseases. We show here that 1,4-benzoquinone directly impairs PTPN2 activity. Mechanistic and kinetic experiments with purified human PTPN2 indicated that this impairment results from the irreversible formation (k(inact) = 645 m(-1)s(-1)) of a covalent 1,4-benzoquinone adduct at the catalytic cysteine residue of the enzyme. Accordingly, cell experiments revealed that 1,4-benzoquinone exposure irreversibly inhibits cellular PTPN2 and concomitantly increases tyrosine phosphorylation of STAT1 and expression of STAT1-regulated genes. Our results provide molecular and cellular evidence that 1,4-benzoquinone covalently modifies key signaling enzymes, implicating it in benzene-induced malignant blood diseases.	[Duval, Romain; Bui, Linh-Chi; Mathieu, Cecile; Nian, Qing; Berthelet, Jeremy; Duprey, Jean-Marie; Busi, Florent; Rodrigues-Lima, Fernando] Univ Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France; [Xu, Ximing] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Chinese Minist Educ, Qingdao 266003, Shandong, Peoples R China; [Haddad, Iman; Vinh, Joelle] PSL Univ, CNRS, ESPCI Paris, USR 3149, F-75005 Paris, France; [Guidez, Fabien; Chomienne, Christine] Univ Paris, Inst Rech St Louis, UMRS 1131, INSERM, F-75010 Paris, France; [Chomienne, Christine] Hop St Louis, AP HP, Serv Biol Cellulaire, F-75010 Paris, France; [Duval, Romain] Univ Paris, INSERM, BIGR, UMRS 1134, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Ocean University of China; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rodrigues-Lima, F (corresponding author), Univ Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.		Guidez, Fabien/B-3750-2009; Vinh, Joelle/K-1347-2015	Vinh, Joelle/0000-0001-7184-2668; Duval, Romain/0000-0002-5785-0685; Guidez, Fabien/0000-0003-1380-4473	University Paris Diderot, CNRS, INSERM; Plan Cancer AAP Environnement et Cancer 2013; Region Ile de France (Hors DIM 2012); University Paris Diderot (Ecole Doctorale BioSPC); China Scholarship Council (CSC); Region Ile de France (Canceropole 2015)	University Paris Diderot, CNRS, INSERM; Plan Cancer AAP Environnement et Cancer 2013; Region Ile de France (Hors DIM 2012); University Paris Diderot (Ecole Doctorale BioSPC); China Scholarship Council (CSC)(China Scholarship Council); Region Ile de France (Canceropole 2015)	This work was supported by University Paris Diderot, CNRS, INSERM, and Plan Cancer AAP Environnement et Cancer 2013 (to C.C. and F.R.-L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Ph.D. fellowships from Region Ile de France (Hors DIM 2012 and Canceropole 2015).; Supported by a Ph.D. fellowship from University Paris Diderot (Ecole Doctorale BioSPC). Present address: Dept. of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.; Supported by a Ph.D. fellowship from the China Scholarship Council (CSC).	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Bender RP, 2007, BIOCHEMISTRY-US, V46, P2856, DOI 10.1021/bi062017l; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bohmer F, 2013, FEBS J, V280, P413, DOI 10.1111/j.1742-4658.2012.08655.x; Bohmer Frank-D, 2014, JAKSTAT, V3, pe28087, DOI 10.4161/jkst.28087; Bolton JL, 2017, CHEM RES TOXICOL, V30, P13, DOI 10.1021/acs.chemrestox.6b00256; Bourdeau A, 2007, BLOOD, V109, P4220, DOI 10.1182/blood-2006-08-044370; Copeland R. A., 2005, EVALUATION ENZYME IN, P214; Dorritie Kathleen A., 2014, Advances in Biological Regulation, V56, P30, DOI 10.1016/j.jbior.2014.05.004; Duval R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10750; Eastmond DA, 2005, CHEM-BIOL INTERACT, V153, P207, DOI 10.1016/j.cbi.2005.03.024; Eastmond DA, 2014, MUTAT RES-REV MUTAT, V761, P40, DOI 10.1016/j.mrrev.2014.04.001; Frantz CE, 1996, ENVIRON HEALTH PERSP, V104, P1319, DOI 10.2307/3433183; Goldstein BD, 2011, HUM EXP TOXICOL, V30, P725, DOI 10.1177/0960327110381682; Greim H, 2014, ANN NY ACAD SCI, V1310, P7, DOI 10.1111/nyas.12362; Gross SA, 2018, CRIT REV TOXICOL, V48, P217, DOI 10.1080/10408444.2017.1401581; Gurzov EN, 2014, CELL METAB, V20, P85, DOI 10.1016/j.cmet.2014.05.011; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; Kleppe M, 2011, HAEMATOL-HEMATOL J, V96, P1723, DOI 10.3324/haematol.2011.041921; Kleppe M, 2011, BLOOD, V117, P7090, DOI 10.1182/blood-2010-10-314286; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Klotz LO, 2014, MOLECULES, V19, P14902, DOI 10.3390/molecules190914902; KOLACHANA P, 1993, CANCER RES, V53, P1023; Li YT, 2016, FREE RADICAL BIO MED, V97, P148, DOI 10.1016/j.freeradbiomed.2016.05.019; Li ZG, 2017, J IMMUNOL, V198, P1865, DOI 10.4049/jimmunol.1601336; Lindsey RH, 2005, CHEM RES TOXICOL, V18, P761, DOI 10.1021/tx049659z; Lindsey RH, 2004, BIOCHEMISTRY-US, V43, P7563, DOI 10.1021/bi049756r; Loomis D, 2017, LANCET ONCOL, V18, P1574, DOI 10.1016/S1470-2045(17)30832-X; Mazzei L, 2016, DALTON T, V45, P5455, DOI 10.1039/c6dt00652c; Mbiya W, 2013, CHEM RES TOXICOL, V26, P112, DOI 10.1021/tx300417z; McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546; Meek B, 2010, BLOOD, V115, P261, DOI 10.1182/blood-2009-05-223990; Minciullo PL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/937987; Mondrala S, 2010, CHEM-BIOL INTERACT, V184, P259, DOI 10.1016/j.cbi.2009.12.023; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Nishiyama-Fujita Y, 2013, LEUKEMIA RES, V37, P1150, DOI 10.1016/j.leukres.2013.05.008; O'Shea KM, 2015, ANN CLIN LAB SCI, V45, P487; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; PAZ MA, 1991, J BIOL CHEM, V266, P689; Pike KA, 2016, CYTOKINE, V82, P52, DOI 10.1016/j.cyto.2015.12.025; Poullet P, 2007, PROTEOMICS, V7, P2553, DOI 10.1002/pmic.200600784; Rappaport SM, 2005, CHEM-BIOL INTERACT, V153, P103, DOI 10.1016/j.cbi.2005.03.014; Reardon C, 2007, J IMMUNOL, V178, P4284, DOI 10.4049/jimmunol.178.7.4284; Rodriguez F, 2005, P NATL ACAD SCI USA, V102, P4718, DOI 10.1073/pnas.0501074102; Ruiz-Ramos R, 2005, TOXICOLOGY, V209, P279, DOI 10.1016/j.tox.2004.12.035; Sakamoto S, 2010, HYBRIDOMA, V29, P481, DOI 10.1089/hyb.2010.0052; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P41, DOI 10.4137/GRSB.S11433; Sauer E, 2018, ENVIRON RES, V166, P91, DOI 10.1016/j.envres.2018.05.029; Seiner DR, 2007, CHEM RES TOXICOL, V20, P1315, DOI 10.1021/tx700213s; Smith MT, 2011, CHEM-BIOL INTERACT, V192, P155, DOI 10.1016/j.cbi.2011.02.010; Snyder R, 2012, INT J ENV RES PUB HE, V9, P2875, DOI 10.3390/ijerph9082875; Tapper MA, 2000, TOXICOL SCI, V55, P327, DOI 10.1093/toxsci/55.2.327; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Verrax F, 2005, FREE RADICAL RES, V39, P649, DOI 10.1080/10715760500097906; Wang LP, 2012, CHEM RES TOXICOL, V25, P1303, DOI 10.1021/tx3001169; Wang QP, 2004, BIOCHEMISTRY-US, V43, P4294, DOI 10.1021/bi035986e; Whysner J, 2004, MUTAT RES-REV MUTAT, V566, P99, DOI 10.1016/S1383-5742(03)00053-X; Wiede F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036703; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zhang LP, 2010, CHEM-BIOL INTERACT, V184, P86, DOI 10.1016/j.cbi.2009.12.011; Zhou Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140013	66	12	12	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12483	12494		10.1074/jbc.RA119.008666	http://dx.doi.org/10.1074/jbc.RA119.008666			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248982	Green Published, hybrid			2022-12-26	WOS:000484402700019
J	Peffer, S; Goncalves, D; Morano, KA				Peffer, Sara; Goncalves, Davi; Morano, Kevin A.			Regulation of the Hsf1-dependent transcriptome via conserved bipartite contacts with Hsp70 promotes survival in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat shock factor protein 1 (HSF1); heat shock protein (HSP); proteostasis; Saccharomyces cerevisiae; stress response; cell stress; gene regulation; heat shock response; Hsp70; protein chaperone; transcription factor	HEAT-SHOCK FACTOR; SACCHAROMYCES-CEREVISIAE; TRANSACTIVATION DOMAIN; GENE-EXPRESSION; FACTOR CONTAINS; STRESS; BINDING; ACTIVATION; PHOSPHORYLATION; FACTOR-1	Protein homeostasis and cellular fitness in the presence of proteotoxic stress is promoted by heat shock factor 1 (Hsf1), which controls basal and stress-induced expression of molecular chaperones and other targets. The major heat shock proteins and molecular chaperones Hsp70 and Hsp90, in turn, participate in a negative feedback loop that ensures appropriate coordination of the heat shock response with environmental conditions. Features of this regulatory circuit in the budding yeast Saccharomyces cerevisiae have been recently defined, most notably regarding direct interaction between Hsf1 and the constitutively expressed Hsp70 protein Ssa1. Here, we sought to further examine the Ssa1/Hsf1 regulation. We found that Ssa1 interacts independently with both the previously defined CE2 site in the Hsf1 C-terminal transcriptional activation domain and with an additional site that we identified within the N-terminal activation domain. Consistent with both sites bearing a recognition signature for Hsp70, we demonstrate that Ssa1 contacts Hsf1 via its substrate-binding domain and that abolishing either regulatory site results in loss of Ssa1 interaction. Removing Hsp70 regulation of Hsf1 globally dysregulated Hsf1 transcriptional activity, with synergistic effects on both gene expression and cellular fitness when both sites are disrupted together. Finally, we report that Hsp70 interacts with both transcriptional activation domains of Hsf1 in the related yeast Lachancea kluyveri. Our findings indicate that Hsf1 transcriptional activity is tightly regulated to ensure cellular fitness and that a general and conserved Hsp70-HSF1 feedback loop regulates cellular proteostasis in yeast.	[Peffer, Sara; Goncalves, Davi; Morano, Kevin A.] Univ Texas Houston, Dept Microbiol & Mol Genet, McGovern Med Sch Houston, Houston, TX 77030 USA; [Peffer, Sara] MD Anderson UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Morano, KA (corresponding author), Univ Texas Houston, Dept Microbiol & Mol Genet, McGovern Med Sch Houston, Houston, TX 77030 USA.	kevin.a.morano@uth.tmc.edu		Peffer, Sara/0000-0003-3788-5044	National Institutes of Health [R01GM127287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM127287. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ausubel F. M., 2003, CURRENT PROTOCOLS IN; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Budzynski MA, 2015, MOL CELL BIOL, V35, P2530, DOI 10.1128/MCB.00816-14; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chowdhary S, 2019, CELL REP, V26, P18, DOI 10.1016/j.celrep.2018.12.034; Chowdhary S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00292-17; Cotto JJ, 1996, J BIOL CHEM, V271, P3355; CRAIG EA, 1984, CELL, V38, P841, DOI 10.1016/0092-8674(84)90279-4; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Harris N, 2001, MOL GENET GENOMICS, V265, P258, DOI 10.1007/s004380000409; Hashikawa N, 2004, MOL CELL BIOL, V24, P3648, DOI 10.1128/MCB.24.9.3648-3659.2004; Hashikawa N, 2007, J BIOL CHEM, V282, P10333, DOI 10.1074/jbc.M609708200; JAKOBSEN BK, 1988, MOL CELL BIOL, V8, P5040, DOI 10.1128/MCB.8.11.5040; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Krakowiak J, 2018, ELIFE, V7, DOI 10.7554/eLife.31668; Leach MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11704; Leach MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032467; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Marshall AN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003376; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Morano KA, 1999, MOL CELL BIOL, V19, P402; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Neef DW, 2014, CELL REP, V9, P955, DOI 10.1016/j.celrep.2014.09.056; NIETOSOTELO J, 1990, CELL, V62, P807, DOI 10.1016/0092-8674(90)90124-W; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pincus D, 2018, MOL BIOL CELL, V29, P3168, DOI 10.1091/mbc.E18-06-0353; Rienzo A, 2012, YEAST, V29, P219, DOI 10.1002/yea.2905; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakurai H, 2007, J BIOL CHEM, V282, P13334, DOI 10.1074/jbc.M611801200; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; Solis EJ, 2016, MOL CELL, V63, P60, DOI 10.1016/j.molcel.2016.05.014; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Van Durme J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000475; Verghese J, 2012, EUKARYOT CELL, V11, P1003, DOI 10.1128/EC.00146-12; Wang YY, 2012, MOL BIOL CELL, V23, P3290, DOI 10.1091/mbc.E12-06-0447; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	53	26	28	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12191	12202		10.1074/jbc.RA119.008822	http://dx.doi.org/10.1074/jbc.RA119.008822			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31239354	hybrid, Green Published			2022-12-26	WOS:000484284500022
J	Warmack, RA; Shawa, H; Liu, K; Lopez, K; Loo, JA; Horwitz, J; Clarke, SG				Warmack, Rebeccah A.; Shawa, Harrison; Liu, Kate; Lopez, Katia; Loo, Joseph A.; Horwitz, Joseph; Clarke, Steven G.			The l-isoaspartate modification within protein fragments in the aging lens can promote protein aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lens; post-translational modification (PTM); aging; protein degradation; protein aggregation; L-isoaspartate	MOLECULAR-WEIGHT PROTEIN; AGE-RELATED-CHANGES; ALPHA-A CRYSTALLIN; GAMMA-S-CRYSTALLIN; EYE LENS; POSTTRANSLATIONAL MODIFICATIONS; ASPARTYL RESIDUES; DEAMIDATION; IDENTIFICATION; CATARACT	Transparency in the lens is accomplished by the dense packing and short-range order interactions of the crystallin proteins in fiber cells lacking organelles. These features are accompanied by a lack of protein turnover, leaving lens proteins susceptible to a number of damaging modifications and aggregation. The loss of lens transparency is attributed in part to such aggregation during aging. Among the damaging post-translational modifications that accumulate in long-lived proteins, isomerization at aspartate residues has been shown to be extensive throughout the crystallins. In this study of the human lens, we localize the accumulation of l-isoaspartate within water-soluble protein extracts primarily to crystallin peptides in high-molecular weight aggregates and show with MS that these peptides are from a variety of crystallins. To investigate the consequences of aspartate isomerization, we investigated two alpha A crystallin peptides (52)LFRTVLDSGISEVR(65) and (89)VQDDFVEIH(98), identified within this study, with the l-isoaspartate modification introduced at Asp(58) and Asp(91), respectively. Importantly, whereas both peptides modestly increase protein precipitation, the native (52)LFRTVLDSGISEVR(65) peptide shows higher aggregation propensity. In contrast, the introduction of l-isoaspartate within a previously identified anti-chaperone peptide from water-insoluble aggregates, alpha A crystallin (SDRDKFVIFL)-S-66(isoAsp)VKHF80, results in enhanced amyloid formation in vitro. The modification of this peptide also increases aggregation of the lens chaperone alpha B crystallin. These findings may represent multiple pathways within the lens wherein the isomerization of aspartate residues in crystallin peptides differentially results in peptides associating with water-soluble or water-insoluble aggregates. Here the eye lens serves as a model for the cleavage and modification of long-lived proteins within other aging tissues.	[Warmack, Rebeccah A.; Shawa, Harrison; Liu, Kate; Lopez, Katia; Loo, Joseph A.; Horwitz, Joseph; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr, Los Angeles, CA 90095 USA; [Warmack, Rebeccah A.; Shawa, Harrison; Liu, Kate; Lopez, Katia; Loo, Joseph A.; Clarke, Steven G.] Univ Calif Los Angeles, Mol Biol Inst, 607 Charles E Young Dr, Los Angeles, CA 90095 USA; [Horwitz, Joseph] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr, Los Angeles, CA 90095 USA.; Clarke, SG (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, 607 Charles E Young Dr, Los Angeles, CA 90095 USA.	Clarke@mbi.ucla.edu		Clarke, Steven/0000-0002-7303-6632	National Science Foundation [MCB-1714569]; UCLA Academic Senate Faculty Research Program; Life Extension Foundation, Inc.; Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center; NATIONAL EYE INSTITUTE [R01EY008313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); UCLA Academic Senate Faculty Research Program; Life Extension Foundation, Inc.; Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Science Foundation (MCB-1714569), the UCLA Academic Senate Faculty Research Program, the Life Extension Foundation, Inc., and the Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center (to S.G.C.). The authors declare that they have no conflicts of interest with the contents of this article. The dataset containing amino acid sequences of all identified crystallin protein fragments from this publication is available in the MassIVE database under accession code MSV000084028. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ajaz MS, 1997, J BIOL CHEM, V272, P11250; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Chondrogianni N, 2014, MOL ASPECTS MED, V35, P1, DOI 10.1016/j.mam.2012.09.001; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Forrester J. V., 2016, EYE BASIC SCI PRACTI, P102; Fujii N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.399972; Fujii N, 2016, BBA-GEN SUBJECTS, V1860, P183, DOI 10.1016/j.bbagen.2015.08.001; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Harding JJ, 1984, EYE B, V1b, P207; Harrington V, 2007, MOL VIS, V13, P1680; Harrington V, 2004, MOL VIS, V10, P476; Hooi MYS, 2013, EXP EYE RES, V106, P34, DOI 10.1016/j.exer.2012.10.013; Hooi MYS, 2012, INVEST OPHTH VIS SCI, V53, P3554, DOI 10.1167/iovs.11-9085; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lampi KJ, 2014, PROG BIOPHYS MOL BIO, V115, P21, DOI 10.1016/j.pbiomolbio.2014.02.004; Lampi KJ, 2002, MOL VIS, V8, P359; LI LK, 1986, CURR EYE RES, V5, P127, DOI 10.3109/02713688609015101; Liu M, 2012, ANAL CHEM, V84, P1056, DOI 10.1021/ac202652z; LOWENSON JD, 1992, J BIOL CHEM, V267, P5985; Lyon YA, 2019, J BIOL CHEM, V294, P7546, DOI 10.1074/jbc.RA118.007052; Lyon YA, 2018, EXP EYE RES, V171, P131, DOI 10.1016/j.exer.2018.03.018; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; MCFADDEN PN, 1986, MECH AGEING DEV, V34, P91, DOI 10.1016/0047-6374(86)90107-7; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; Ni WQ, 2010, ANAL CHEM, V82, P7485, DOI 10.1021/ac101806e; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; Raju M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044077; Ray Nicholas J, 2015, Biophys Rev, V7, P353, DOI 10.1007/s12551-015-0176-4; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; ROY D, 1976, EXP EYE RES, V22, P273, DOI 10.1016/0014-4835(76)90055-5; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senthilkumar R, 2002, J BIOL CHEM, V277, P39136, DOI 10.1074/jbc.M204684200; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Srivastava OP, 2003, MOL VIS, V9, P110; SRIVASTAVA OP, 1988, EXP EYE RES, V47, P525, DOI 10.1016/0014-4835(88)90092-9; Srivastava OP, 1996, CURR EYE RES, V15, P511, DOI 10.3109/02713689609000762; Takata T, 2006, BIOCHEM BIOPH RES CO, V344, P263, DOI 10.1016/j.bbrc.2006.03.126; Takata T, 2016, FEBS J, V283, P850, DOI 10.1111/febs.13635; TAKEMOTO LJ, 1995, CURR EYE RES, V14, P837, DOI 10.3109/02713689508995806; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Thorne C. J. R., 1978, TECHNIQUES PROTEIN E, P2; Truscott RJW, 2007, PROTEIN MISFOLDING A; Truscott RJW, 2016, BBA-GEN SUBJECTS, V1860, P192, DOI 10.1016/j.bbagen.2015.08.016; Truscott RJW, 2012, EXP EYE RES, V99, P48, DOI 10.1016/j.exer.2012.04.002; VANKLEEF FSM, 1976, EUR J BIOCHEM, V66, P477; VOORTER CEM, 1988, J BIOL CHEM, V263, P19020; Wenk M, 2000, BIOPHYS CHEM, V86, P95, DOI 10.1016/S0301-4622(00)00161-7; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; YVON M, 1989, INT J PEPT PROT RES, V34, P166; Zhu XJ, 2018, J CELL MOL MED, V22, P1118, DOI 10.1111/jcmm.13363	59	11	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12203	12219		10.1074/jbc.RA119.009052	http://dx.doi.org/10.1074/jbc.RA119.009052			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31239355	Green Published, hybrid			2022-12-26	WOS:000484284500023
J	Zhu, YF; Xie, MX; Meng, ZY; Leung, LK; Chan, FL; Hu, X; Chi, KW; Liu, CL; Yao, XQ				Zhu, Yifei; Xie, Mingxu; Meng, Zhaoyue; Leung, Lai-Kwok; Chan, Franky Leung; Hu, Xin; Chi, Kaiwen; Liu, Cuiling; Yao, Xiaoqiang			Knockdown of TM9SF4 boosts ER stress to trigger cell death of chemoresistant breast cancer cells	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MULTIDRUG-RESISTANCE; PROTEIN; ADHESION; PROLIFERATION	Drug resistance is one of the major obstacles to breast cancer therapy. However, the mechanisms of how cancer cells develop chemoresistance are still not fully understood. In the present study, we found that expression of TM9SF4 proteins was much higher in adriamycin (ADM)-resistant breast cancer cells MCF-7/ADM than in its parental line wild-type breast cancer cells MCF-7/WT. shRNA-mediated knockdown of TM9SF4 preferentially reduced cell growth and triggered cell death in chemoresistant MCF-7/ADM cells compared with MCF-7/WT cells. Knockdown of TM9SF4 also reduced cell growth and triggered cell death in chemoresistant MDA-MB-231/GEM cells. Mechanistic studies showed that TM9SF4 knockdown increased protein misfolding and elevated endoplasmic reticulum (ER) stress level in MCF-7/ADM cells, as indicated by aggresome formation and upregulated expression of ER stress markers, the effect of which was reversed by a small molecule chaperone 4-phenybutyric acid. In an athymic nude mouse model of ADM-resistant human breast xenograft tumor, knockdown of TM9SF4 decreased the growth of tumor xenografts. In chemoresistant breast cancer patients, chemotherapy increased the expression of TM9SF4 proteins in breast tumor samples. Taken together, these results uncovered a novel role of TM9SF4 proteins in alleviating ER stress and protecting chemoresistant breast cancer cells from apoptotic/necrotic cell death. These results highlight a possible strategy of targeting TM9SF4 to overcome breast cancer chemoresistance.	[Zhu, Yifei; Xie, Mingxu; Meng, Zhaoyue; Chan, Franky Leung; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Zhu, Yifei; Xie, Mingxu; Meng, Zhaoyue; Chan, Franky Leung; Yao, Xiaoqiang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Zhu, Yifei] Jiangnan Univ, Wuxi Sch Med, Wuxi, Jiangsu, Peoples R China; [Leung, Lai-Kwok] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China; [Hu, Xin] Fudan Univ, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai Canc Ctr, Shanghai, Peoples R China; [Chi, Kaiwen; Liu, Cuiling] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Jiangnan University; Chinese University of Hong Kong; Fudan University; Peking University	Yao, XQ (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China.; Yao, XQ (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk	Yao, Xiaoqiang/I-5413-2016; Leung, Lai K/E-6314-2011	Yao, Xiaoqiang/0000-0002-0687-8186; Leung, Lai K/0000-0002-7781-3099	Hong Kong Research Grant Committee [AoE/M-05/12, GRF/14118516, RIF/R4005-18F]; Hong Kong Innovation and Technology Fund [ITF/096/18, PiH/230/18, PiH/049/19]	Hong Kong Research Grant Committee(Hong Kong Research Grants Council); Hong Kong Innovation and Technology Fund	This work was supported by grants from Hong Kong Research Grant Committee [AoE/M-05/12, GRF/14118516, RIF/R4005-18F] and Hong Kong Innovation and Technology Fund [ITF/096/18, PiH/230/18 and PiH/049/19].	Benghezal M, 2003, MOL BIOL CELL, V14, P2890, DOI 10.1091/mbc.E02-11-0724; Bergeret E, 2008, J CELL SCI, V121, P3325, DOI 10.1242/jcs.030163; Borst P, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120066; Chang HY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.504; Chen JA, 2011, CANCER LETT, V300, P48, DOI 10.1016/j.canlet.2010.09.005; Corboy Michael J., 2005, V301, P305; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Daniel C, 2013, BBA-MOL BASIS DIS, V1832, P606, DOI 10.1016/j.bbadis.2013.01.020; Fais S, 2012, TRENDS MOL MED, V18, P4, DOI 10.1016/j.molmed.2011.09.001; Goda K, 2009, CURR CANCER DRUG TAR, V9, P281, DOI 10.2174/156800909788166493; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Iliopoulos D, 2007, CLIN CANCER RES, V13, P268, DOI 10.1158/1078-0432.CCR-06-2038; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lebeau P, 2017, J BIOL CHEM, V292, P1510, DOI 10.1074/jbc.M116.744235; Lozupone F, 2015, ONCOGENE, V34, P5163, DOI 10.1038/onc.2014.437; Lozupone F, 2009, EMBO REP, V10, P1348, DOI 10.1038/embor.2009.236; Ma X, 2012, P NATL ACAD SCI USA, V109, P16282, DOI 10.1073/pnas.1202989109; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Ogston KN, 2003, BREAST, V12, P320, DOI 10.1016/S0960-9776(03)00106-1; Paolillo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126968; Park J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15730; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Salaroglio IC, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0657-0; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sun L, 2018, CELL DEATH DIFFER, V25, P368, DOI 10.1038/cdd.2017.166; Tavera-Mendoza LE, 2017, LAB ANIM-UK, V51, P85, DOI 10.1177/0023677216640706; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Ye FG, 2015, CANCER RES, V75, P1504, DOI 10.1158/0008-5472.CAN-14-2341	35	14	16	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2019	38	29					5778	5791		10.1038/s41388-019-0846-y	http://dx.doi.org/10.1038/s41388-019-0846-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IQ4WS	31249383				2022-12-26	WOS:000480752800003
J	Huang, YY; Chiu, MJ; Yen, RF; Tsai, CL; Hsieh, HY; Chiu, CH; Wu, CH; Hsin, LW; Tzen, KY; Cheng, CY; Ma, KH; Shiue, CY				Huang, Ya-Yao; Chiu, Ming-Jang; Yen, Ruoh-Fang; Tsai, Chia-Ling; Hsieh, Hao-Yu; Chiu, Ching-Hung; Wu, Chi-Han; Hsin, Ling-Wei; Tzen, Kai-Yuan; Cheng, Cheng-Yi; Ma, Kuo-Hsing; Shiue, Chyng-Yann			An one-pot two-step automated synthesis of [F-18]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PET TRACER F-18-AV-1451; PYRIDINE N-OXIDES; RADIATION-DOSIMETRY; TAU PATHOLOGY; IN-VIVO; ALZHEIMERS-DISEASE; RADIOSYNTHESIS; LIGAND; BODY	[F-18]T807 is a potent tau protein imaging agent. In order to fulfill the demand from preclinical and clinical studies, we developed an automated one-pot two-step synthesis of this potent tau imaging agent and studied its stability, and dosimetry in mice and monkeys. We also conducted a preliminary study of this imaging agent in humans. Using this one-pot two-step method, the radiochemical yield (RCY) of [F-18]T807 was 20.5 +/- 6.1% (n = 15) at the end of bombardment (EOB) in a synthesis time of 70 +/- 5 min. The chemical and radiochemical purities were >90% and the specific activities were 151 +/- 52 GBq/pmol. The quality of [F-18]T807 synthesized by this method met the U.S. Pharmacopoeia (USP) criteria. The stability test showed that the [F-18]T807 injection was stable at room temperature for up to 4 h after the end of synthesis (EOS). The estimated effective dose of the [F-18]T807 injection extrapolated from monkeys was 19 pSv/MBq (n = 2), while the estimated effective doses of the [F-18]T807 injection extrapolated from fasted and non-fasted mice were 123 +/- 27 (n = 3) and 94 +/- 19 (n = 4) pSv/MBq, respectively. This one-pot two-step automated method produced the [F-18] T807 injection with high reproducibility and high quality. PET imaging and radiation dosimetry evaluation in mice and Formosan rock monkeys suggested that the [F-18]T807 injection synthesized by this method is suitable for use in human PET imaging studies. Thus, this method could fulfill the demand for the [F-18]T807 injection in both preclinical and clinical studies of tauopathies, especially for nearby study sites without cyclotrons.	[Huang, Ya-Yao; Yen, Ruoh-Fang; Tsai, Chia-Ling; Chiu, Ching-Hung; Tzen, Kai-Yuan; Shiue, Chyng-Yann] Natl Taiwan Univ Hosp, Dept Nucl Med, PET Ctr, Taipei, Taiwan; [Chiu, Ming-Jang; Yen, Ruoh-Fang; Wu, Chi-Han; Hsin, Ling-Wei; Tzen, Kai-Yuan; Shiue, Chyng-Yann] Natl Taiwan Univ, Mol Imaging Ctr, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Inst Brain & Mind Sci, Coll Med, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Dept Psychol, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Biomed Engn & Bioinformat, Taipei, Taiwan; [Yen, Ruoh-Fang] Natl Taiwan Univ, Dept Radiol, Coll Med, Taipei, Taiwan; [Hsieh, Hao-Yu; Hsin, Ling-Wei] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Cheng, Cheng-Yi; Shiue, Chyng-Yann] Triserv Gen Hosp, Dept Nucl Med, PET Ctr, Taipei, Taiwan; [Ma, Kuo-Hsing] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Tri-Service General Hospital; National Defense Medical Center	Huang, YY; Shiue, CY (corresponding author), Natl Taiwan Univ Hosp, Dept Nucl Med, PET Ctr, Taipei, Taiwan.; Shiue, CY (corresponding author), Natl Taiwan Univ, Mol Imaging Ctr, Taipei, Taiwan.; Shiue, CY (corresponding author), Triserv Gen Hosp, Dept Nucl Med, PET Ctr, Taipei, Taiwan.	careyyh@ntuh.gov.tw; shiue@ntuh.gov.tw	Huang, Ya-Yao/AAR-9221-2020; Chiu, Ming-Jang/AAR-3940-2020	Huang, Ya-Yao/0000-0002-3460-7922; Chiu, Ming-Jang/0000-0002-4158-4423; YEN, RUOH-FANG/0000-0003-1648-6482; TZEN, KAI-YUAN/0000-0002-5657-8579	National Taiwan University Hospital [NTUH 108-A133, NTUH 108-S4177]; Ministry of Science and Technology [MOST 108-2321-B-002-002, MOST 107-2314-B-002-MY2]	National Taiwan University Hospital(National Taiwan University); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by National Taiwan University Hospital (NTUH 108-A133 and NTUH 108-S4177) and Ministry of Science and Technology (MOST 108-2321-B-002-002 and MOST 107-2314-B-002-MY2).	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Barret O, 2017, J NUCL MED, V58, P1124, DOI 10.2967/jnumed.116.182881; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger MJ, 2004, NUCL MED BIOL, V31, P1097, DOI 10.1016/j.nucmedbio.2004.09.002; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bramoulle Y, 2015, J LABELLED COMPD RAD, V58, pS178; Brier MR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2362; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Choi JY, 2018, J NUCL MED, V59, P117, DOI 10.2967/jnumed.117.195248; Choi JY, 2016, MOL IMAGING BIOL, V18, P479, DOI 10.1007/s11307-015-0924-7; Coakeley S, 2017, J CEREBR BLOOD F MET, V37, P3150, DOI 10.1177/0271678X16683695; CUPP CJ, 1981, J MED PRIMATOL, V10, P110; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; FAN KH, 2015, J LABELLED COMPD RAD, V58, pS22; Fodero-Tavoletti MT, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt240; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fooden Jack, 2006, Fieldiana Zoology, P1; Gao MZ, 2015, BIOORG MED CHEM LETT, V25, P2953, DOI 10.1016/j.bmcl.2015.05.035; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Golla SSV, 2017, MOL IMAGING BIOL, V19, P963, DOI 10.1007/s11307-017-1080-z; Hansen AK, 2016, BRAIN, V139, P2039, DOI 10.1093/brain/aww098; Herzog H, 2008, EUR J NUCL MED MOL I, V35, P1499, DOI 10.1007/s00259-008-0753-x; Honer M, 2018, J NUCL MED, V59, P675, DOI 10.2967/jnumed.117.196741; Horchler CL, 2015, J LABELLED COMPD RAD, V58, pS262; Hostetler ED, 2016, J NUCL MED, V57, P1599, DOI 10.2967/jnumed.115.171678; Huang YY, 2010, EUR J NUCL MED MOL I, V37, P545, DOI 10.1007/s00259-009-1281-z; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huang YE, 2015, J NUCL MED, V56; ICRP, 1996, ICRP PUBL, V73; International Commission on Radiation Protection (ICRP), 1996, ANN ICRP, V26; James OG, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00038; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Kuwabara H, 2015, 9 HUM AM IM M; Kuwabara H, 2018, J NUCL MED, V59, P1877, DOI 10.2967/jnumed.118.214437; Li Y, 2015, J NUCL MED, V56, P270, DOI 10.2967/jnumed.114.149229; Liang SH, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00025; Lucke D, 2016, CHEM-EUR J, V22, P4206, DOI 10.1002/chem.201504457; Maccioni RB, 2010, ARCH MED RES, V41, P226, DOI 10.1016/j.arcmed.2010.03.007; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Mouri Toshio, 2000, Primate Research, V16, P87; Mueller A, 2017, J NUCL MED, V58; Nagren K, 2010, EUR J NUCL MED MOL I, V37, P1575, DOI 10.1007/s00259-009-1301-z; Okamura N, 2014, EUR J NUCL MED MOL I, V41, pS260; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Pascual B, 2016, NEUROLOGY, V86, P487, DOI 10.1212/WNL.0000000000002340; Quiroz YT, 2018, JAMA NEUROL, V75, P548, DOI 10.1001/jamaneurol.2017.4907; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Salabert AS, 2017, APPL RADIAT ISOTOPES, V128, P101, DOI 10.1016/j.apradiso.2017.06.032; Scholl M, 2017, BRAIN, V140, P2286, DOI 10.1093/brain/awx171; Schwarz AJ, 2016, BRAIN, V139, P1539, DOI 10.1093/brain/aww023; Shcherbinin S, 2016, J NUCL MED, V57, P1535, DOI 10.2967/jnumed.115.170027; Shoup TM, 2013, J LABELLED COMPD RAD, V56, P736, DOI 10.1002/jlcr.3098; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stabin MG, 2005, J NUCL MED, V46, P1023; Stabin MG, 1999, APPL RADIAT ISOTOPES, V50, P73, DOI 10.1016/S0969-8043(98)00023-2; Szardenings AK, 2012, IMAGING AGENTS DETEC; Tipre DN, 2004, NUCL MED COMMUN, V25, P81, DOI 10.1097/00006231-200401000-00012; Tzen KY, 2014, ACS CHEM NEUROSCI, V5, P830, DOI 10.1021/cn500101j; Vallabhajosula S, 2011, SEMIN NUCL MED, V41, P283, DOI 10.1053/j.semnuclmed.2011.02.005; Villemagne VL, 2014, EUR J NUCL MED MOL I, V41, P816, DOI 10.1007/s00259-013-2681-7; Villemagne VL, 2012, FUTUR NEUROL, V7, P409, DOI 10.2217/FNL.12.34; Whitwell JL, 2017, MOVEMENT DISORD, V32, P124, DOI 10.1002/mds.26834; Wong DF, 2018, J NUCL MED, V59, P1869, DOI 10.2967/jnumed.118.209916; Wong DF, 2015, 9 HUM AM IM M; Xia CJ, 2017, JAMA NEUROL, V74, P427, DOI 10.1001/jamaneurol.2016.5755; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Xiong H, 2015, J LABELLED COMPD RAD, V58, pS215; Xiong H, 2015, ORG LETT, V17, P3726, DOI 10.1021/acs.orglett.5b01703; Zanotti-Fregonara P, 2013, EUR J NUCL MED MOL I, V40, P1781, DOI 10.1007/s00259-013-2512-x; Zhang W, 2012, J ALZHEIMERS DIS, V31, P601, DOI 10.3233/JAD-2012-120712	76	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0217384	10.1371/journal.pone.0217384	http://dx.doi.org/10.1371/journal.pone.0217384			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260447	Green Published, Green Submitted, gold			2022-12-26	WOS:000484918700009
J	Kuensaen, C; Chomdej, S; Kongdang, P; Sirikaew, N; Jaitham, R; Thonghoi, S; Ongchai, S				Kuensaen, Chakkrapong; Chomdej, Siriwadee; Kongdang, Patiwat; Sirikaew, Nutnicha; Jaitham, Rungnaree; Thonghoi, Supitcha; Ongchai, Siriwan			LL-37 alone and in combination with IL17A enhances proinflammatory cytokine expression in parallel with hyaluronan metabolism in human synovial sarcoma cell line SW982-A step toward understanding the development of inflammatory arthritis	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; RHEUMATOID-ARTHRITIS; ANGIOGENIC OLIGOSACCHARIDES; APOPTOSIS; OSTEOARTHRITIS; SYNOVIOCYTES; FIBROBLASTS; ACTIVATION; AUTOIMMUNE	LL-37 is the only human cathelicidin-family host defense peptide and has been reported to interact with invading pathogens causing inflammation at various body sites. Recent studies showed high levels of LL-37 in the synovial-lining membrane of patients with rheumatoid arthritis, a common type of inflammatory arthritis. The present study aims to investigate the role of LL-37 on mechanisms associated with pathogenesis of inflammatory arthritis. The effects of LL-37 on the expression of proinflammatory cytokines, hyaluronan (HA) metabolism-related genes, cell death-related pathways, and cell invasion were investigated in SW982, a human synovial sarcoma cell line. Time-course measurements of proinflammatory cytokines and mediators showed that LL-37 significantly induced IL6 and IL17A mRNA levels at early time points (3-6 hr). HA-metabolism-related genes (i.e., HA synthase 2 (HAS2), HAS3, hyaluronidase 1 (HYAL1), HYAL2, and CD44) were co-expressed in parallel. In combination, LL-37 and IL17A significantly enhanced PTGS2, TNF, and HAS3 gene expression concomitantly with the elevation of their respective products, PGE2, TNF, and HA. Cell invasion rates and FN1 gene expression were also significantly enhanced. However, LL-37 alone or combined with IL17A did not affect cell mortality or cell cycle. Treatment of SW982 cells with both LL-37 and IL17A significantly enhanced IKK and p65 phosphorylation. These findings suggest that the chronic production of a high level of LL-37 may synchronize with its downstream proinflammatory cytokines, especially IL17A, contributing to the co-operative enhancement of pathogenesis mechanisms of inflammatory arthritis, such as high production of proinflammatory cytokines and mediators together with the activation of HA-metabolism-associated genes and cell invasion.	[Kuensaen, Chakkrapong; Chomdej, Siriwadee] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand; [Kongdang, Patiwat; Sirikaew, Nutnicha; Jaitham, Rungnaree; Thonghoi, Supitcha; Ongchai, Siriwan] Chiang Mai Univ, Dept Biochem, Thailand Excellence Ctr Tissue Engn & Stem Cells, Fac Med, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University	Ongchai, S (corresponding author), Chiang Mai Univ, Dept Biochem, Thailand Excellence Ctr Tissue Engn & Stem Cells, Fac Med, Chiang Mai, Thailand.	ongchai.submission@gmail.com	Kongdang, Patiwat/AGC-0520-2022	Kuensaen, Chakkrapong/0000-0003-2117-677X; Kongdang, Patiwat/0000-0002-4075-0362; Ongchai, Siriwan/0000-0002-3472-5128	National Research Council of Thailand [256108A1040053]; Science Achievement Scholarship of Thailand; Higher Education Commission; Department of Biology, Faculty of Science, Chiang Mai University, Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Science Achievement Scholarship of Thailand; Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Department of Biology, Faculty of Science, Chiang Mai University, Thailand	This work was supported by the National Research Council of Thailand (grant number 256108A1040053) to SC. CK was supported by the Science Achievement Scholarship of Thailand, the Higher Education Commission, and the Department of Biology, Faculty of Science, Chiang Mai University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos IE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2936; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bax M, 2011, IMMUNOGENETICS, V63, P459, DOI 10.1007/s00251-011-0528-6; Boink MA, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/3078194; Boissier MC, 2012, J AUTOIMMUN, V39, P222, DOI 10.1016/j.jaut.2012.05.021; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Chang JH, 2014, INDIAN J MED RES, V139, P117; Chotjumlong P, 2013, J INNATE IMMUN, V5, P72, DOI 10.1159/000342928; Cyphert Jaime M, 2015, Int J Cell Biol, V2015, P563818, DOI 10.1155/2015/563818; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Dhawan SS, 2008, CURR ATHEROSCLER REP, V10, P128, DOI 10.1007/s11883-008-0019-x; Di Nardo A, 2007, J IMMUNOL, V178, P1829, DOI 10.4049/jimmunol.178.3.1829; Dragon S, 2008, MOL IMMUNOL, V45, P160, DOI 10.1016/j.molimm.2007.04.027; Frasca L, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.02363, 10.3389/fimmu.2018.01936]; Frasca L, 2012, CURR PHARM BIOTECHNO, V13, P1882, DOI 10.2174/138920112802273155; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; HONDA A, 1993, BIOCHEM J, V292, P497, DOI 10.1042/bj2920497; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jovanovic DV, 2000, ARTHRITIS RHEUM-US, V43, P1134, DOI 10.1002/1529-0131(200005)43:5<1134::AID-ANR24>3.0.CO;2-#; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; Kasai S, 2012, BLOOD; Khansai M, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-2035-2; Kienhofer D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115474; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Mader JS, 2009, MOL CANCER RES, V7, P689, DOI 10.1158/1541-7786.MCR-08-0274; Mateen S, 2016, CLIN CHIM ACTA, V455, P161, DOI 10.1016/j.cca.2016.02.010; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Morioka Y, 2008, J IMMUNOL, V181, P3915, DOI 10.4049/jimmunol.181.6.3915; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Neregard P, 2012, ANN RHEUM DIS, V71, pA12, DOI 10.1136/annrheumdis-2011-201230.26; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Pothacharoen P, 2006, OSTEOARTHR CARTILAGE, V14, P299, DOI 10.1016/j.joca.2005.10.005; ROONEY P, 1993, J CELL SCI, V105, P213; Safa A. R., 2012, Experimental Oncology, V34, P176; Safa Ahmad R, 2013, J Carcinog Mutagen, VSuppl 6; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Shimizu M, 2003, J RHEUMATOL, V30, P1164; Srirangan S, 2010, THER ADV MUSCULOSKEL, V2, P247, DOI 10.1177/1759720X10378372; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stuhlmeier KM, 2008, J BIOL CHEM, V283, P16781, DOI 10.1074/jbc.M801669200; Takahashi T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22409-3; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Viriyakhasem N, 2014, IN VITRO CELL DEV-AN, V50, P787, DOI 10.1007/s11626-014-9777-7; Wang W, 2017, EXP THER MED, V14, P499, DOI 10.3892/etm.2017.4546; Yi WZ, 2016, ONCOL REP, V36, P3145, DOI 10.3892/or.2016.5177; Yoshida M, 2004, ARTHRITIS RES THER, V6, pR514, DOI 10.1186/ar1223; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu FL, 2011, CLIN IMMUNOL, V141, P152, DOI 10.1016/j.clim.2011.07.003	54	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218736	10.1371/journal.pone.0218736	http://dx.doi.org/10.1371/journal.pone.0218736			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260471	gold, Green Published, Green Submitted			2022-12-26	WOS:000484918700020
J	Ye, F; Xu, HY; Yin, HD; Zhao, XL; Li, DY; Zhu, Q; Wang, Y				Ye, Fei; Xu, Hengyong; Yin, Huadong; Zhao, Xiaoling; Li, Diyan; Zhu, Qing; Wang, Yan			The role of BMP6 in the proliferation and differentiation of chicken cartilage cells	PLOS ONE			English	Article							DEVELOPING CONDYLAR CARTILAGE; STEM-CELLS; INDIAN HEDGEHOG; CHONDROGENIC DIFFERENTIATION; MANDIBULAR CONDYLE; GROWTH-HORMONE; II COLLAGENS; RECEPTOR; PROTEIN; LOCALIZATION	Previous studies have indicated that bone morphogenetic protein (BMP) 6 may play an important role in skeletal system development and progression. However, the mechanism underlying the effects of BMP6 in cartilage cell proliferation and differentiation remains unknown. In this study, cartilage cells were isolated from shanks of chicken embryos and treated with different concentrations of Growth Hormone. Cell proliferation potential was assessed using real-time polymerase chain reaction (RT-PCR), western blotting and CCK-8 assays in vitro. The results showed that at 48 h, the Collagen Iland BMP6 expression levels in 50 ng/pl GH-treated cartilage cells were significantly higher than in groups treated with 100 ng/pl or 200 ng/pl GH. We further observed that knockdown of BMP6 in cartilage cells led to significantly decreased expression mRNAs and proteins of Collagen Iland Collagen X. Moreover, the suppression of BMP6 expression by a specific siRNA led to significantly decreased expression mRNA levels of IGF1R, JAK2, PKC, PTH, IHH and PTHrP and decreased protein levels of PKC, IHH and PTHrP. Taken together, our data suggest that BMP6 may play a critical role in chicken cartilage cell proliferation and differentiation through the regulation of IGF1, JAK2, PKC, PTH, and IHH-PTHrP signaling pathways.	[Ye, Fei; Xu, Hengyong; Yin, Huadong; Zhao, Xiaoling; Li, Diyan; Zhu, Qing; Wang, Yan] Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Wang, Y (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China.	as519723614@163.com			project of Sichuan Science and Technology Department [2019YJ0513]; China Agricultural Research System [CARS-41]; 13th Five year Plan for Breeding Program in Sichuan [2016NYZ0050]	project of Sichuan Science and Technology Department; China Agricultural Research System; 13th Five year Plan for Breeding Program in Sichuan	This work was financially supported by the project of Sichuan Science and Technology Department (2019YJ0513), the China Agricultural Research System (CARS-41) and the 13th Five year Plan for Breeding Program in Sichuan (2016NYZ0050).	Aida Y, 2012, CELL BIOL INT, V36, P367, DOI 10.1042/CBI20110150; Aigner T, 1998, CALCIFIED TISSUE INT, V63, P263, DOI 10.1007/s002239900524; Aref-Eshghi E, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0788-x; Boyan BD, 2004, STEROIDS, V69, P591, DOI 10.1016/j.steroids.2004.05.008; Choi S, 2013, INT J ORAL SCI, V5, P7, DOI 10.1038/ijos.2013.19; Ciarmatori S, 2007, J MOL ENDOCRINOL, V38, P493, DOI 10.1677/jme.1.02179; Cook SD, 1996, CLIN ORTHOP RELAT R, P29, DOI 10.1097/00003086-199603000-00005; Cui C, 2017, BRAZ J POULTRY SCI, V19, P673, DOI 10.1590/1806-9061-2017-0555; de Mara CS, 2013, RHEUMATOL INT, V33, P121, DOI 10.1007/s00296-011-2328-6; Dos Santos C, 2004, NAT GENET, V36, P720, DOI 10.1038/ng1379; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Estes BT, 2006, ARTHRITIS RHEUM-US, V54, P1222, DOI 10.1002/art.21779; FARNUM CE, 1989, J ORTHOPAED RES, V7, P654, DOI 10.1002/jor.1100070505; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Fukada K, 1999, J ANAT, V195, P321, DOI 10.1046/j.1469-7580.1999.19530321.x; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Joung YH, 2013, MOL MED REP, V8, P891, DOI 10.3892/mmr.2013.1593; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kasukawa Y, 2002, J BONE MINER RES, V17, P1579, DOI 10.1359/jbmr.2002.17.9.1579; Kayabasi GK, 2013, J BIOMED MATER RES A, V101, P1353, DOI 10.1002/jbm.a.34430; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Li CH, 2012, INT J MED SCI, V9, P862, DOI 10.7150/ijms.5027; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Liu YF, 2013, STAT INTERFACE, V6, P1; LUDER HU, 1988, AM J ANAT, V182, P197, DOI 10.1002/aja.1001820302; LYONS KM, 1989, GENE DEV, V3, P1657, DOI 10.1101/gad.3.11.1657; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; MIZOGUCHI I, 1992, ACTA ANAT, V144, P59; MIZOGUCHI I, 1990, HISTOCHEMISTRY, V93, P593, DOI 10.1007/BF00272201; Nakajima T, 2008, J RADIAT RES, V49, P1, DOI 10.1269/jrr.07053; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; OHASHI N, 1997, J BONE MINER METAB, V15, P77; Qiu T, 2015, J BONE MINER RES, V30, P309, DOI 10.1002/jbmr.2327; SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206; Sheu SY, 2012, CHINESE MED J-PEKING, V125, P3646, DOI 10.3760/cma.j.issn.0366-6999.2012.20.009; Shibata S, 1997, J ANAT, V191, P561, DOI 10.1046/j.1469-7580.1997.19140561.x; Siebuhr AS, 2015, ANN RHEUM DIS, V74, P919, DOI 10.1136/annrheumdis-2015-eular.5415; SILBERMANN M, 1990, J ANAT, V170, P11; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; Uyama Y, 2004, DIFFERENTIATION, V72, P32, DOI 10.1111/j.1432-0436.2004.07201001.x; van Beuningen HM, 2014, TISSUE ENG PT A, V20, P2243, DOI [10.1089/ten.tea.2013.0553, 10.1089/ten.TEA.2013.0553]; Visnapuu V, 2000, J CRAN GENET DEV BIO, V20, P144; Volk SW, 1998, J BONE MINER RES, V13, P1521, DOI 10.1359/jbmr.1998.13.10.1521; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Vukicevic S, 2009, CYTOKINE GROWTH F R, V20, P441, DOI 10.1016/j.cytogfr.2009.10.020; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Yammani RR, 2009, ARTHRITIS RHEUM, V60, P792, DOI 10.1002/art.24295; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	49	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0204384	10.1371/journal.pone.0204384	http://dx.doi.org/10.1371/journal.pone.0204384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260450	gold, Green Published, Green Submitted			2022-12-26	WOS:000484918700001
J	Parriault, MC; Chaponnay, A; Cropet, C; About, V; Pastre, A; Perusseau-Lambert, R; Nacher, M; Huber, F				Parriault, Marie-Claire; Chaponnay, Amandine; Cropet, Claire; About, Vincent; Pastre, Agathe; Perusseau-Lambert, Roch; Nacher, Mathieu; Huber, Florence			Penile implants and other high risk practices in French Guiana's correctional facility: A cause for concern	PLOS ONE			English	Article							ARTIFICIAL-NODULES; SELF-MUTILATION; HIV; HEPATITIS; MEN; SEX	Background Prisoners in French Guiana, a French territory located in South America, have a HIV and hepatitis B prevalence of 4%. Body modifications such as penile implants, tattoos, and body piercings are common among detainees, increasing the risk of blood-borne virus transmission. Methods We conducted a cross-sectional randomised survey in which the primary objective was to estimate the prevalence of high risk 'bloody practices' ( penile implants, tattoos, body piercings) in French Guiana's only correctional facility. The secondary objective was to describe the risk factors for penile implants, the procedures and motivations for insertion, the reported complications, their risk factors and adverse impact on condom use. Results Of the 221 male inmates interviewed, 19% had tattoos or body piercings while incarcerated, and 68% had penile implants, of which, 85% had been inserted inside the correctional facility. Addictive behaviors such as cannabis use and alcohol addiction ( positive AUDIT-C score), early age at first sexual intercourse, and the number of incarcerations correlated positively with having inserted one or more penile implants while incarcerated. In contrast, having reported previous psychiatric hospitalizations and having a high knowledge score for HIV/ AIDS and sexually transmitted infections ( STIs) were negatively correlated with the insertion of penile implants while incarcerated. Penile implants were inserted in poor hygienic conditions, usually using the sharp lid of a canned food container, with 18% of early complications, mostly haemorrhage and edema. Condom use was negatively impacted for 52% of men with penile implants. Conclusions Our results highlight the need for prevention interventions which should aim at increasing knowledge levels and at implementing comprehensive risk-reduction measures.	[Parriault, Marie-Claire; Cropet, Claire; Nacher, Mathieu] Cayenne Gen Hosp, CIC INSERM, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana, France; [Chaponnay, Amandine; Nacher, Mathieu; Huber, Florence] Cayenne Gen Hosp, COREVIH, Cayenne, French Guiana, France; [About, Vincent; Pastre, Agathe] UCSA, Cayenne Gen Hosp, Cayenne, French Guiana, France; [Perusseau-Lambert, Roch] Assoc Guyanaise Reduct Risques, Cayenne, French Guiana, France; [Nacher, Mathieu] Univ French Guiana, Cayenne, French Guiana, France; [Huber, Florence] Reseau Kikiwi, Cayenne, French Guiana, French Guiana	Institut National de la Sante et de la Recherche Medicale (Inserm)	Parriault, MC (corresponding author), Cayenne Gen Hosp, CIC INSERM, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana, France.	marie-claire.parriault@ch-cayenne.fr	nacher, mathieu/AAH-4796-2021	nacher, mathieu/0000-0001-9397-3204; Huber, Florence/0000-0002-4340-0106	Regional Health Agency of French Guiana	Regional Health Agency of French Guiana	This study was funded by the Regional Health Agency of French Guiana (https://www.guyane.ars.sante.fr/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiona TC, 2010, AM J INFECT CONTROL, V38, P121, DOI 10.1016/j.ajic.2009.06.006; About V, 2014, RAPPORT ANN ACTIVITE; About V, 2015, ANN DERMATOL VENER, V142, pS585; Amon J., 2000, BEHAV SURVEILLANCE S; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Beyrer C, 2003, AIDS BEHAV, V7, P153, DOI 10.1023/A:1023946324822; Black DW, 2007, COMPR PSYCHIAT, V48, P400, DOI 10.1016/j.comppsych.2007.04.006; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Burton SRF, 1883, KAMA SUTRA VATSYAYAN; Chaponnay A, 2015, CONNAISSANCES ATTITU; Delorme C, 1999, REV EPIDEMIOL SANTE, V47, P229; Djajakusumah TS, 2000, SEX TRANSM DIS, V27, P152, DOI 10.1097/00007435-200003000-00006; Dolan K, 2016, LANCET, V388, P1089, DOI 10.1016/S0140-6736(16)30466-4; Fischer N, 2010, J SEX MED, V7, P3565, DOI 10.1111/j.1743-6109.2009.01659.x; Halfen S, 2014, HABITANTS ANTILLES G; Hellard ME, 2007, AM J INFECT CONTROL, V35, P477, DOI 10.1016/j.ajic.2006.08.002; Huber F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175740; Hudak SJ, 2012, J SEX MED, V9, P632, DOI 10.1111/j.1743-6109.2011.02551.x; Jafari S, 2012, CAN J PUBLIC HEALTH, V103, P207, DOI 10.1007/BF03403814; Jalink M, 2016, BMJ CASE REP, V2016; Klingelschmidt J, 2017, AIDS CARE, V29, P689, DOI 10.1080/09540121.2016.1234680; Levin Kate Ann, 2006, Evid Based Dent, V7, P24, DOI 10.1038/sj.ebd.6400375; LIEB K, 2004, LANCET, V364, P453, DOI DOI 10.1016/S0140-6736(04)16770-6; Loue Sana, 2002, J Immigr Health, V4, P117, DOI 10.1023/A:1014506811197; Michel L, 2011, B EPIDEMIOLOGIQUE HE, V39, P25; MILLER FT, 1993, AM J DRUG ALCOHOL AB, V19, P491, DOI 10.3109/00952999309001637; Murty O P, 2008, J Forensic Leg Med, V15, P96, DOI 10.1016/j.jflm.2007.01.005; Nacher M, 2006, AM J TROP MED HYG, V74, P915, DOI 10.4269/ajtmh.2006.74.915; Nacher M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204808; Nacher M, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1742-7; Parriault M-C, 2017, INT J STD AIDS; Parriault MC, 2016, AIDS CARE, V28, P1600, DOI 10.1080/09540121.2016.1191607; Rothschild MA, 1997, INT J LEGAL MED, V110, P88, DOI 10.1007/s004140050037; Samuel MC, 2001, EPIDEMIOL INFECT, V127, P475, DOI 10.1017/S0950268801006197; Sante Mdl, 2010, PLAN ACTIONS STRATEG, P86; Semaille C, 2013, Euro Surveill, V18, DOI 10.2807/1560-7917.ES2013.18.28.20524; SEROUR F, 1993, SEX TRANSM DIS, V20, P192, DOI 10.1097/00007435-199307000-00002; Stankov O, 2009, J SEX MED, V6, P1543, DOI 10.1111/j.1743-6109.2009.01230.x; Teixeira T, 2014, J SURG CASE REP, DOI 10.1093/jscr/rju126; Thomson N, 2008, SEX TRANSM INFECT, V84, P195, DOI 10.1136/sti.2007.028530; TSUNENARI S, 1981, AM J FOREN MED PATH, V2, P203, DOI 10.1097/00000433-198109000-00003; VIRKKUNEN M, 1976, ACTA PSYCHIAT SCAND, V54, P347, DOI 10.1111/j.1600-0447.1976.tb00130.x; Yap L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053065	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218992	10.1371/journal.pone.0218992	http://dx.doi.org/10.1371/journal.pone.0218992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3XM	31251774	gold, Green Published, Green Submitted			2022-12-26	WOS:000484915000032
J	Roman, MO; Stokes, EC; Shrestha, R; Wang, ZS; Schultz, L; Carlo, EAS; Sun, QS; Bell, J; Molthan, A; Kalb, V; Ji, CY; Seto, KC; McClain, SN; Enenkel, M				Roman, Miguel O.; Stokes, Eleanor C.; Shrestha, Ranjay; Wang, Zhuosen; Schultz, Lori; Carlo, Edil A. Sepulveda; Sun, Qingsong; Bell, Jordan; Molthan, Andrew; Kalb, Virginia; Ji, Chuanyi; Seto, Karen C.; McClain, Shanna N.; Enenkel, Markus			Satellite-based assessment of electricity restoration efforts in Puerto Rico after Hurricane Maria	PLOS ONE			English	Article							NIGHTTIME; OPENSTREETMAP; VULNERABILITY; DISASTERS; POVERTY; FUTURE	A real-time understanding of the distribution and duration of power outages after a major disaster is a precursor to minimizing their harmful consequences. Here, we develop an approach for using daily satellite nighttime lights data to create spatially disaggregated power outage estimates, tracking electricity restoration efforts after disasters strike. In contrast to existing utility data, these estimates are independent, open, and publicly-available, consistently measured across regions that may be serviced by several different power companies, and inclusive of distributed power supply ( off-grid systems). We apply the methodology in Puerto Rico following Hurricane Maria, which caused the longest blackout in US history. Within all of the island's settlements, we track outages and recovery times, and link these measures to census-based demographic characteristics of residents. Our results show an 80% decrease in lights, in total, immediately after Hurricane Maria. During the recovery, a disproportionate share of long-duration power failures (> 120 days) occurred in rural municipalities ( 41% of rural municipalities vs. 29% of urban municipalities), and in the northern and eastern districts. Unexpectedly, we also identify large disparities in electricity recovery between neighborhoods within the same urban area, based primarily on the density of housing. For many urban areas, poor residents, the most vulnerable to increased mortality and morbidity risks from power losses, shouldered the longest outages because they lived in less dense, detached housing where electricity restoration lagged. The approach developed in this study demonstrates the potential of satellite-based estimates of power recovery to improve the real-time monitoring of disaster impacts, globally, at a spatial resolution that is actionable for the disaster response community.	[Roman, Miguel O.] Univ Space Res Assoc, Earth Space Inst, Columbia, MD USA; [Stokes, Eleanor C.; Shrestha, Ranjay; Wang, Zhuosen; Sun, Qingsong; Kalb, Virginia] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Stokes, Eleanor C.; Wang, Zhuosen] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Shrestha, Ranjay; Carlo, Edil A. Sepulveda; Sun, Qingsong] Sci Syst & Applicat Inc, Lanham, MD USA; [Schultz, Lori; Bell, Jordan; Molthan, Andrew] NASA, Marshall Space Flight Ctr, Earth Sci Branch, Huntsville, AL USA; [Schultz, Lori; Bell, Jordan] Univ Alabama Huntsville, Earth Syst Sci Ctr, Huntsville, AL USA; [Carlo, Edil A. Sepulveda] NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD USA; [Ji, Chuanyi] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Seto, Karen C.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [McClain, Shanna N.] NASA Headquarters, Disasters Program, Washington, DC USA; [Enenkel, Markus] Harvard Humanitarian Initiat, Cambridge, MA USA	Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Science Systems and Applications Inc; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Alabama System; University of Alabama Huntsville; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Georgia; Georgia Institute of Technology; Yale University; National Aeronautics & Space Administration (NASA); Harvard University	Stokes, EC (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.; Stokes, EC (corresponding author), Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA.	eleanor.stokes@nasa.gov	Wang, Zhuosen/HCI-3669-2022; Seto, Karen C./C-2722-2008; Roman, Miguel/D-4764-2012	Seto, Karen C./0000-0002-4928-2446; Stokes, Eleanor C./0000-0002-0204-8847; Roman, Miguel/0000-0003-3953-319X; Bell, Jordan/0000-0001-7463-2973	NASA [NNH16ZDA001N-GEO16-0055, NNH17ZDA001N-TASNPP17-0007]	NASA(National Aeronautics & Space Administration (NASA))	M.O.R, E.C.S, Z.W, V.K, and R.S. received funding from NASA's Applied Sciences program, NASA's Earth Science Data and Information Systems (ESDIS) project, and the NASA's Terra/Aqua/Suomi-NPP program, which supported our project under the following RTOP grants: NNH16ZDA001N-GEO16-0055, NNH17ZDA001N-TASNPP17-0007. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Alstone P, 2015, NAT CLIM CHANGE, V5, P305, DOI 10.1038/nclimate2512; [Anonymous], [No title captured]; Bacon Jean, 2011, Dependable and Historic Computing. Essays Dedicated to Brian Randell on the Occasion of his 75th Birthday, P93, DOI 10.1007/978-3-642-24541-1_9; Bennett MM, 2017, REMOTE SENS ENVIRON, V192, P176, DOI 10.1016/j.rse.2017.01.005; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; Cao CY, 2013, IEEE GEOSCI REMOTE S, V10, P1582, DOI 10.1109/LGRS.2013.2262258; Chen P.-C., 2014, INT C EL DISTR CIRED; Ciepluch B., 2010, P 9 INT S SPAT ACC A, P337; Claverie M., 2017, HARMONIZED LANDSAT 8; Cole TA, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9030286; Correa S, 2018, E-ENERGY'18: PROCEEDINGS OF THE 9TH ACM INTERNATIONAL CONFERENCE ON FUTURE ENERGY SYSTEMS, P75, DOI 10.1145/3208903.3208942; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Department of Energy, 2018, HURR NAT MAR IRM HAR; Department of Energy, 2017, QUADR EN REV 2 INST; Department of Homeland Security, 2017, POW OUT INC ANN RESP; Dora C, 2015, LANCET, V385, P380, DOI 10.1016/S0140-6736(14)60605-X; EIA, FORM EIA 861 DET DAT, P201; Elvidge C., 1998, REMOTE SENSING CHANG, P123; Executive Office of the President, 2013, EC BEN INCR EL GRID; Fadaeenejad M, 2014, RENEW SUST ENERG REV, V29, P828, DOI 10.1016/j.rser.2013.08.072; Girres JF, 2010, T GIS, V14, P435, DOI 10.1111/j.1467-9671.2010.01203.x; Haklay M, 2010, ENVIRON PLANN B, V37, P682, DOI 10.1068/b35097; Haklay M, 2008, IEEE PERVAS COMPUT, V7, P12, DOI 10.1109/MPRV.2008.80; Hochstenbach C, 2018, URBAN GEOGR, V39, P26, DOI 10.1080/02723638.2016.1276718; Houser T, 2017, AM BIGGEST BLACKOUT; Howell AJ, 2014, J URBAN AFF, V36, P79, DOI 10.1111/juaf.12030; Huang QX, 2014, REMOTE SENS-BASEL, V6, P6844, DOI 10.3390/rs6086844; Ji CY, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2016.52; Jiang QY, 2013, IEEE T POWER SYST, V28, P3380, DOI 10.1109/TPWRS.2013.2244104; Johnson RS, 2013, ATMOS MEAS TECH, V6, P1245, DOI 10.5194/amt-6-1245-2013; Kahn ME, 2005, REV ECON STAT, V87, P271, DOI 10.1162/0034653053970339; Kassakian JG, 2017, FUTURE ELECT GRID IN; Kavanagh L, 2016, ANN AM ASSOC GEOGR, V106, P1286, DOI 10.1080/24694452.2016.1213156; Khan SI, 2018, J SOCIAL SCI RES, V4, P184; Kishore N, 2018, NEW ENGL J MED, V379, P162, DOI [10.1056/NEJMsa1803972, 10.1056/nejmsa1803972]; Klinger Chaamala, 2014, PLoS Curr, V6, DOI 10.1371/currents.dis.04eb1dc5e73dd1377e05a10e9edde673; Kneebone E, 2013, CONFRONTING SUBURBAN POVERTY IN AMERICA, P1; Kohiyama M, 2004, INT J REMOTE SENS, V25, P2015, DOI 10.1080/01431160310001595033; LaCommare KH, 2018, ENERGY, V153, P1038, DOI 10.1016/j.energy.2018.04.082; Larsen PH, 2018, ENERGY, V147, P1256, DOI 10.1016/j.energy.2017.12.081; Levin N, 2017, REMOTE SENS ENVIRON, V190, P366, DOI 10.1016/j.rse.2017.01.006; Lorincz K, 2004, IEEE PERVAS COMPUT, V3, P16, DOI 10.1109/MPRV.2004.18; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Milken Institute School of Public Health George Washington University, 2018, ASC EST EXC MORT HUR; Miller SD, 2013, REMOTE SENS-BASEL, V5, P6717, DOI 10.3390/rs5126717; Miller SD, 2009, IEEE T GEOSCI REMOTE, V47, P2316, DOI 10.1109/TGRS.2009.2012696; Molthan Andrew, 2013, Eos, Transactions American Geophysical Union, V94, P53; Murray N., 2017, URBAN DISASTER RISK; O'Rourke T., 2007, BRIDGE WASHINGTON NA, V37, P22, DOI DOI 10.1109/TIGA.1967.4180765; Outage Data Initiative, 2018, EFF MAN CRIT UT EV O; PARK SK, 1983, COMPUT VISION GRAPH, V23, P258, DOI 10.1016/0734-189X(83)90026-9; Roger J., 2016, SUOMI NPP VIIRS SURF; Roman MO, 2018, REMOTE SENS ENVIRON, V210, P113, DOI 10.1016/j.rse.2018.03.017; Roman MO, 2015, EARTHS FUTURE, V3, P182, DOI 10.1002/2014EF000285; Roy DP, 2010, REMOTE SENS ENVIRON, V114, P35, DOI 10.1016/j.rse.2009.08.011; Rubin O, 2012, B LAT AM RES, V31, P19, DOI 10.1111/j.1470-9856.2011.00607.x; Santiago L, 2017, PUERTO RICOS LEADERS; Song XP, 2016, REMOTE SENS ENVIRON, V175, P1, DOI 10.1016/j.rse.2015.12.027; Stokes EC, 2018, P NATL ACAD SCI USA, V115, pE9773, DOI 10.1073/pnas.1807563115; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; UN AGECC, 2010, EN SUST FUT SECR GEN, P44; UNISDR, 2017, TECHN GUID MON REP P; United States Census Bureau / American FactFinder, 2017, B19013 MED HOUS INC; United States Census Bureau / American FactFinder, 2017, B25001 HOUS UN 2013; United States Census Bureau / American FactFinder, 2017, B11006 HOUS PRES PEO; United States Department of Energy, 2008, SMARTGRID INTRO SMAR; United States Energy Information Administration, 2018, ANN EL POW IND REP; World T, 2017, FLUOR COMPL HIGH PRI; Zhang QL, 2015, REMOTE SENS-BASEL, V7, P11887, DOI 10.3390/rs70911887; Zhang QL, 2011, REMOTE SENS ENVIRON, V115, P2320, DOI 10.1016/j.rse.2011.04.032; Zhao XZ, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10101526	71	69	70	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218883	10.1371/journal.pone.0218883	http://dx.doi.org/10.1371/journal.pone.0218883			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3XM	31251791	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000028
J	Full, KM; Moran, K; Carlson, J; Godbole, S; Natarajan, L; Hipp, A; Glanz, K; Mitchell, J; Laden, F; James, P; Kerr, J				Full, Kelsie M.; Moran, Kevin; Carlson, Jordan; Godbole, Suneeta; Natarajan, Loki; Hipp, Aaron; Glanz, Karen; Mitchell, Jonathan; Laden, Francine; James, Peter; Kerr, Jacqueline			Latent profile analysis of accelerometer-measured sleep, physical activity, and sedentary time and differences in health characteristics in adult women	PLOS ONE			English	Article							BEHAVIOR; DURATION; METAANALYSIS; DISPARITIES; OUTCOMES	Objectives Independently, physical activity (PA), sedentary behavior (SB), and sleep are related to the development and progression of chronic diseases. Less is known about how rest-activity behaviors cluster within individuals and how rest-activity behavior profiles relate to health. In this study we aimed to investigate if adult women cluster into profiles based on how they accumulate rest-activity behavior (including accelerometer-measured PA, SB, and sleep), and if participant characteristics and health outcomes differ by profile membership. Methods A convenience sample of 372 women (mean age 55.38 + 10.16) were recruited from four US cities. Participants wore ActiGraph GT3X+ accelerometers on the hip and wrist for a week. Total daily minutes in moderate-to-vigorous PA (MVPA) and percentage of wear-time spent in SB was estimated from the hip device. Total sleep time (hours/minutes) and sleep efficiency (% of in bed time asleep) were estimated from the wrist device. Latent profile analysis (LPA) was performed to identify clusters of participants based on accumulation of the four rest-activity variables. Adjusted ANOVAs were conducted to explore differences in demographic characteristics and health outcomes across profiles. Results Rest-activity variables clustered to form five behavior profiles: Moderately Active Poor Sleepers (7%), Highly Actives (9%), Inactives (41%), Moderately Actives (28%), and Actives (15%). The Moderately Active Poor Sleepers (profile 1) had the lowest proportion of whites (35% vs 78-91%, p<.001) and college graduates (28% vs 68-90%, p=.004). Health outcomes did not vary significantly across all rest-activity profiles. Conclusions In this sample, women clustered within daily rest-activity behavior profiles. Identifying 24-hour behavior profiles can inform intervention population targets and innovative behavioral goals of multiple health behavior interventions.	[Full, Kelsie M.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Full, Kelsie M.; Godbole, Suneeta; Natarajan, Loki; Kerr, Jacqueline] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Moran, Kevin] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Carlson, Jordan] Childrens Mercy Hosp, Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO 64108 USA; [Hipp, Aaron] North Carolina State Univ, Dept Pk Recreat & Tourism Management, Raleigh, NC 27695 USA; [Glanz, Karen] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Glanz, Karen] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Mitchell, Jonathan] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Laden, Francine; James, Peter] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Laden, Francine; James, Peter] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Laden, Francine; James, Peter] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Laden, Francine; James, Peter] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; Northwestern University; Feinberg School of Medicine; Children's Mercy Hospital; University of North Carolina; North Carolina State University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Full, KM (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.; Full, KM (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	fullx003@umn.edu		Full, Kelsie/0000-0002-6264-0228; Hipp, J. Aaron/0000-0002-2394-7112	National Cancer Institute U54 collaboration [U54 CA116850, U54 CA155496, U54 CA155626, U54 CA155435, U54 CA155850]; National Cancer Institute [R00 CA201542, K01HL123612, F32CA162847]; NATIONAL CANCER INSTITUTE [U54CA155496, R00CA201542] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL123612] Funding Source: NIH RePORTER	National Cancer Institute U54 collaboration; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Cancer Institute U54 collaboration: U54 CA116850 XTREC coordinating center (PI Mark Thornquist); U54 CA155496 WUSTL (PI Graham Colditz); U54 CA155626 Harvard (PI Frank Hu); U54 CA155435 UCSD (Ruth Patterson); U54 CA155850 Penn (PI Kathryn Schmitz) and also the National Cancer Institute: R00 CA201542 (Peter James), K01HL123612 and F32CA162847 (Jonathan Mitchell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhajah TA, 2012, AM J PREV MED, V43, P298, DOI 10.1016/j.amepre.2012.05.027; Ancoli-Israel S, 2015, BEHAV SLEEP MED, V13, pS4, DOI 10.1080/15402002.2015.1046356; Baldwin CM, 2010, J CLIN SLEEP MED, V6, P176; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; Borner KB, 2018, J TRANSPORT HLTH; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Choi L, 2012, MED SCI SPORT EXER, V44, P2009, DOI 10.1249/MSS.0b013e318258cb36; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Collins C, 2010, POST-TRANSITIONAL JUSTICE: HUMAN RIGHTS TRIALS IN CHILE AND EL SALVADOR, P149; Drake CL, 2003, DEPRESS ANXIETY, V18, P163, DOI 10.1002/da.10151; Dumuid D, 2018, PEDIATR OBES, V13, P111, DOI 10.1111/ijpo.12196; Dunstan DW, 2011, CURR OPIN CARDIOL, V26, P412, DOI 10.1097/HCO.0b013e3283496605; Farnsworth JL, 2015, J PHYS ACT HEALTH, V12, P1567, DOI 10.1123/jpah.2014-0251; Full KM, 2018, SLEEP HLTH; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Jackson CL, 2015, ANNU REV PUBL HEALTH, V36, P417, DOI 10.1146/annurev-publhealth-031914-122838; Kerr J, 2017, MED SCI SPORT EXER, V49, P617, DOI 10.1249/MSS.0000000000001124; Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Marshall SJ, 2007, MED SCI SPORT EXER, V39, P44, DOI 10.1249/01.mss.0000239401.16381.37; Marshall SJ, 2002, PEDIATR EXERC SCI, V14, P401, DOI 10.1123/pes.14.4.401; McAloney K, 2013, PREV MED, V56, P365, DOI 10.1016/j.ypmed.2013.03.002; Neighbors CJ, 2008, AM J PUBLIC HEALTH, V98, P1460, DOI 10.2105/AJPH.2006.096982; Omorou AY, 2016, J PUBLIC HEALTH-UK, V38, P483, DOI 10.1093/pubmed/fdv080; Owen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444; Patterson RE, 2013, CANCER CAUSE CONTROL, V24, P695, DOI 10.1007/s10552-013-0150-z; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Prince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wennman H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-82	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218595	10.1371/journal.pone.0218595	http://dx.doi.org/10.1371/journal.pone.0218595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247051	gold, Green Published, Green Submitted			2022-12-26	WOS:000484911900031
J	Liu, ZP; Jiao, XY; Lu, SH; Zhu, CL; Zhai, YM; Guo, WH				Liu, Zhipeng; Jiao, Xiyun; Lu, Shenghan; Zhu, Chengli; Zhai, Yaming; Guo, Weihua			Effects of winter irrigation on soil salinity and jujube growth in arid regions	PLOS ONE			English	Article							MULCHED DRIP IRRIGATION; ARAL SEA BASIN; SHALLOW GROUNDWATER; TARIM BASIN; WATER; COTTON; XINJIANG; SALT; TEMPERATURES; DYNAMICS	The considerably high evapotranspiration and the low leaching fraction of the soil in arid regions are likely the primary causes of the enhanced soil salinity in such regions. Winter irrigation has proven to be very effective for promoting the leaching of salts from the rooting-zone. In this study, we investigated the effects of different irrigation methods (flood irrigation and drip irrigation) and winter irrigation quotas (450, 1350, 2250, 3150, 4050, and 4950 m(3)/hm(2)) on soil salinity and plant growth in an arid region. The sum of ECe in the 0-100 cm soil layer was 56.26-29.32 ms/cm under flood irrigation, 61.37-17.90 ms/cm under drip irrigation, and 64.13 ms/cm under no irrigation. The survival rates of jujube trees reached 65% and 77%, respectively, for drip irrigation and flood irrigation with a quota of 2250 m(3)/hm(2). Furthermore, at irrigation quotas in excess of 3150 m(3)/hm(2) the ground diameter and height of jujube trees were significantly greater than those observed under nonwinter irrigation and several other winter irrigation treatments. These findings indicated that winter irrigation significantly reduced soil salinity, changed the soil salt distribution, created a good environment for the growth of jujube trees and improved the survival rate of young jujube trees, especially under winter drip irrigation with a quota of 3150 m(3)/hm(2). In addition, 1-year-old jujube trees emerging in spring may benefit from an ECe lower than 5 ms/cm.	[Liu, Zhipeng; Jiao, Xiyun; Lu, Shenghan; Zhu, Chengli; Zhai, Yaming; Guo, Weihua] Hohai Univ, Coll Agr Engn, Nanjing, Jiangsu, Peoples R China; [Liu, Zhipeng; Jiao, Xiyun] Hohai Univ, State Key Lab Hydrology Water Resources & Hydraul, Nanjing, Jiangsu, Peoples R China	Hohai University; Hohai University	Zhu, CL (corresponding author), Hohai Univ, Coll Agr Engn, Nanjing, Jiangsu, Peoples R China.	clz@hhu.edu.cn	liu, zhipeng/HCI-3638-2022; LIU, ZHIPENG/GWQ-5972-2022	Liu, Zhipeng/0000-0003-1337-045X	National Key Research Program [2016YFC0400208]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [SJKY19_0521]; Fundamental Research Funds for the Central Universities [2019B67914]	National Key Research Program; Postgraduate Research & Practice Innovation Program of Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Key Research Program (2016YFC0400208), Postgraduate Research & Practice Innovation Program of Jiangsu Province (SJKY19_0521), and the Fundamental Research Funds for the Central Universities (2019B67914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Aslam M, 2017, INT J AGRIC BIOL, V19, P470, DOI [10.17957/IJAB/15.0308, 10.17957/ijab/15.0308]; Bing H, 2015, ENVIRON EARTH SCI, V74, P675, DOI 10.1007/s12665-015-4072-9; Burt CM, 2005, T ASAE, V48, P2115, DOI 10.13031/2013.20097; Chen HR, 2018, J COASTAL RES, P55, DOI 10.2112/SI82-007.1; Chen WP, 2010, AGR WATER MANAGE, V97, P2001, DOI 10.1016/j.agwat.2010.03.008; Chen Z, 2019, AGR WATER MANAGE, V218, P8, DOI 10.1016/j.agwat.2019.03.020; Forkutsa I, 2009, IRRIGATION SCI, V27, P319, DOI 10.1007/s00271-009-0149-0; Forkutsa I, 2009, IRRIGATION SCI, V27, P331, DOI 10.1007/s00271-009-0148-1; Gui DW, 2010, PLANT SOIL ENVIRON, V56, P348, DOI 10.17221/54/2009-PSE; Han CL, 2018, APPL SOIL ECOL, V124, P211, DOI 10.1016/j.apsoil.2017.11.012; Hu H, 2015, J HYDRAULIC ENG, V9, P1037; Huang Y, 2012, AGR WATER MANAGE, V107, P74, DOI 10.1016/j.agwat.2012.01.012; Li XW, 2016, J HYDROL, V538, P677, DOI 10.1016/j.jhydrol.2016.04.045; Liu MX, 2013, IRRIGATION SCI, V31, P675, DOI 10.1007/s00271-012-0343-3; Lukas S, 2014, SOIL BIOL BIOCHEM, V77, P141, DOI 10.1016/j.soilbio.2014.06.023; Ma LH, 2013, PLANT SOIL, V373, P995, DOI 10.1007/s11104-013-1880-0; Maqbool MA, 2017, PLANT BREEDING, V136, P300, DOI 10.1111/pbr.12477; Shao LW, 2011, J SOIL WATER CONSERV, V66, P104, DOI 10.2489/jswc.66.2.104; Shen YJ, 2013, AGR WATER MANAGE, V128, P55, DOI 10.1016/j.agwat.2013.06.014; VANSCHILFGAARDE J, 1994, AGR WATER MANAGE, V25, P203, DOI 10.1016/0378-3774(94)90061-2; Vu HM, 2017, J EXP BIOL, V220, P2726, DOI 10.1242/jeb.161331; Wang RS, 2011, AGR WATER MANAGE, V100, P58, DOI 10.1016/j.agwat.2011.08.005; Wang YG, 2008, ENVIRON MONIT ASSESS, V140, P291, DOI 10.1007/s10661-007-9867-z; Wang ZH, 2019, AGR WATER MANAGE, V213, P477, DOI 10.1016/j.agwat.2018.10.036; Yang PN, 2016, WATER-SUI, V8, DOI 10.3390/w8020047; Zhang Z, 2014, J ARID ENVIRON, V104, P23, DOI 10.1016/j.jaridenv.2014.01.012; Zhao Bo, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P139; Zhong RS, 2016, IRRIG DRAIN, V65, P461, DOI 10.1002/ird.2015	29	8	8	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218622	10.1371/journal.pone.0218622	http://dx.doi.org/10.1371/journal.pone.0218622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242237	Green Published, gold, Green Submitted			2022-12-26	WOS:000482883600040
J	Lyke, MM; Di Fiore, A; Fierer, N; Madden, AA; Lambert, JE				Lyke, Martha M.; Di Fiore, Anthony; Fierer, Noah; Madden, Anne A.; Lambert, Joanna E.			Metagenomic analyses reveal previously unrecognized variation in the diets of sympatric Old World monkey species	PLOS ONE			English	Article							SAGUINUS-MYSTAX; PREY; INSECTIVORY; DNA; CHIMPANZEES; SEQUENCES; BEHAVIOR; PRIMATE; FOREST	Insectivory, or the consumption of insects and other arthropods, is a significant yet cryptic component of omnivorous primate diets. Here, we used high-throughput DNA sequencing to identify arthropods from fecal DNA and assess variation in insectivory by closely-related sympatric primates. We identified arthropod prey taxa and tested the hypothesis that variation in insectivory facilitates niche differentiation and coexistence among closely-related species with high dietary overlap. We collected 233 fecal samples from redtail (Cercopithecus ascanius; n = 118) and blue monkeys (C. mitis; n = 115) and used a CO1 metabarcoding approach to identify arthropod DNA in each fecal sample. Arthropod DNA was detected in 99% of samples (N = 223 samples), and a total of 68 families (15 orders) were identified. Redtails consumed arthropods from 54 families, of which 12 (21.8%) were absent from blue monkey samples. Blue monkeys consumed arthropods from 56 families, of which 14 (24.6%) were absent from redtail samples. For both species, >97% of taxa present belonged to four orders (Araneae, Diptera, Hymenoptera, Lepidoptera). Redtail samples contained more Lepidoptera taxa (p<0.05), while blue monkey samples contained more Araneae (p<0.05). Blue monkeys consumed a greater diversity of arthropod taxa than redtail monkeys (p<0.05); however, the average number of arthropod families present per fecal sample was greater in the redtail monkey samples (p<0.05). These results indicate that while overlap exists in the arthropod portion of their diets, 20-25% of taxa consumed are unique to each group. Our findings suggest that variation in arthropod intake may help decrease dietary niche overlap and hence facilitate coexistence of closely-related primate species.	[Lyke, Martha M.] Univ Texas San Antonio, Dept Anthropol, San Antonio, TX 78249 USA; [Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Madden, Anne A.] North Carolina State Univ, Dept Appl Ecol, Raleigh, NC USA; [Lambert, Joanna E.] Univ Colorado, Dept Environm Studies, Boulder, CO 80309 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Austin; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of North Carolina; North Carolina State University; University of Colorado System; University of Colorado Boulder	Lyke, MM (corresponding author), Univ Texas San Antonio, Dept Anthropol, San Antonio, TX 78249 USA.	marthalyke@gmail.com	Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020	Madden, Anne/0000-0002-7263-5713; Lyke, Martha/0000-0002-6677-3415	National Science Foundation, Doctoral Dissertation Research Improvement Grant [1540337]; Sigma Xi [G201503151206894]; UTSA Department of Anthropology	National Science Foundation, Doctoral Dissertation Research Improvement Grant(National Science Foundation (NSF)); Sigma Xi; UTSA Department of Anthropology	Funding was provided by the National Science Foundation, Doctoral Dissertation Research Improvement Grant (1540337) to MML, Sigma Xi, Grants-in-Aid of Research (G201503151206894) to MML, and the UTSA Department of Anthropology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Bryer MAH, 2015, INT J PRIMATOL, V36, P839, DOI 10.1007/s10764-015-9857-x; Bryer MAH, 2013, BEHAVIOUR, V150, P277, DOI 10.1163/1568539X-00003049; Butynski Thomas M., 2002, P3; Butynski TM, 1990, ECOL MONOGR, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chapman CA, 2000, AM J PRIMATOL, V50, P169, DOI 10.1002/(SICI)1098-2345(200003)50:3&lt;169::AID-AJP1&gt;3.0.CO;2-P; Chapman Colin A., 2002, P325; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265; COLWELL RK, 2000, ESTIMATES 6 0 STAT E; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; CORDS M, 1986, J ANIM ECOL, V55, P811, DOI 10.2307/4418; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Deblauwe I, 2008, AM J PHYS ANTHROPOL, V135, P42, DOI 10.1002/ajpa.20703; Di Fiore A, 2004, INT J PRIMATOL, V25, P767, DOI 10.1023/B:IJOP.0000029122.99458.26; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Feeroz M, 2012, J PRIMATOL, V1, P2; FLEAGLE J G, 1981, Primates, V22, P361, DOI 10.1007/BF02381576; FRAZAO E, 1991, PRIMATES, V32, P243, DOI 10.1007/BF02381182; GANZHORN JU, 1988, OECOLOGIA, V75, P436, DOI 10.1007/BF00376949; Gursky S, 2000, INT J PRIMATOL, V21, P477, DOI 10.1023/A:1005444020059; Hamad I, 2014, SCI REPORTS, V4; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HARCOURT CS, 1986, PRIMATES, V27, P41, DOI 10.1007/BF02382521; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hladik C.M., 1979, P307; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Isbell LA, 1998, AM J PRIMATOL, V45, P381, DOI 10.1002/(SICI)1098-2345(1998)45:4<381::AID-AJP5>3.3.CO;2-2; Kay RF, 1984, USE ANATOMICAL FEATU; Kumara H.N., 2000, Primate Report, V58, P57; Lambert Joanna E., 2002, P309; Madden AA, 2016, MOL ECOLOGY; Mallott E, 2014, AM J PHYS ANTHR; Mallott EK, 2017, AM J PHYS ANTHROPOL, V162, P241, DOI 10.1002/ajpa.23113; McGrew WC, 2014, J HUMAN EVOLUTION; McGrew William C., 2001, P160; Moreno-Black G., 1978, PRIMATES, V19, P215; Nadjafzadeh MN, 2008, AM J PHYS ANTHROPOL, V135, P56, DOI 10.1002/ajpa.20704; Nekaris KAI, 2003, INT J PRIMATOL, V24, P33, DOI 10.1023/A:1021442411455; Picker M., 2004, FIELD GUIDE INSECTS; Pickett SB, 2012, AM J PRIMATOL, V74, P622, DOI 10.1002/ajp.22014; Raboy BE, 2004, AM J PRIMATOL, V63, P1, DOI 10.1002/ajp.20032; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Razgour O, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.49; Resende Briseida D., 2003, Neotropical Primates, V11, P103; Rode KD, 2006, BIOTROPICA, V38, P625, DOI 10.1111/j.1744-7429.2006.00183.x; Rothman JM, 2014, J HUMAN EVOLUTION; Rudran R., 1978, P483; Smith AC, 2000, J ZOOL, V251, P315, DOI 10.1017/S0952836900007056; SRIVASTAVA A, 1991, PRIMATES, V32, P237, DOI 10.1007/BF02381181; Stone AI, 2007, AM J PRIMATOL, V69, P142, DOI 10.1002/ajp.20335; STRUHSAKER T. T., 1997, ECOLOGY AFRICAN RAIN; Struhsaker TT, 1978, RECENT ADV PRIMATOL, V1, P225; Tashiro Y, 2006, PRIMATES, V47, P170, DOI 10.1007/s10329-005-0160-x; Tokeshi M., 2009, SPECIES COEXISTENCE; Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Xu CCY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142503; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	62	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218245	10.1371/journal.pone.0218245	http://dx.doi.org/10.1371/journal.pone.0218245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242204	Green Submitted, Green Published, gold			2022-12-26	WOS:000482883600025
J	Rahman, A; Akbar, D; Rolfe, J; Nguyen, J				Rahman, Azad; Akbar, Delwar; Rolfe, John; Nguyen, Julie			Developing a population wide cost estimating framework and methods for technological intervention enabling ageing in place: An Australian case	PLOS ONE			English	Article							OLDER-PEOPLE; HEALTH-CARE; HOME-CARE; MOBILE; INFORMATION; BENEFIT; MODEL	Purpose Ageing in place is one of the greatest desires of elderly people. Assistive digital technologies could potentially delay the institutionalization of the elderly people and allow them ageing in place. This study develops a population-wide cost estimating framework for adopting digital technologies that can improve the quality of life of elderly people through examining an Australian region. Methods We developed a five-stage cost estimation framework, which involved progressive forecasting of elderly population and direct cost estimation methods. The forecasting and cost estimation models have been set for a 10-year period because the prediction accuracy from cross-sectional data is better in the short to medium term compared to the long-term. For cost estimation, we categorised the ageing population on the basis of the number of chronic diseases that they have contracted. Costs of assistive technologies were collected from open sources. The model has been tested in the Fitzroy and Central West, a regional area of Queensland in Australia. A stakeholder panel discussion in a workshop format was used to validate the appropriateness of the proposed framework and the study findings. Results This study identified eight common chronic diseases with different comorbidity patterns in Australia. We also identified the required assistive technologies to assist patients with chronic diseases. This study estimated that annual per capita cost for technological intervention could range from AUD 4,169 to AUD 7,551 on the basis of different price margins of the technologies. Conclusion The approach of categorising the aged cohorts on the basis of the number of chronic diseases helps estimate population-wide costs compared to using single technology intervention costs for a particular chronic disease cohort. The cost estimation framework and the method developed in this study can assist the government to estimate costs for ageing-in-place programs.	[Rahman, Azad; Akbar, Delwar; Rolfe, John] Cent Queensland Univ, Sch Business & Law, Rockhampton, Qld, Australia; [Nguyen, Julie] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia	Central Queensland University; Central Queensland University	Rahman, A (corresponding author), Cent Queensland Univ, Sch Business & Law, Rockhampton, Qld, Australia.	a.rahman2@cqu.edu.au	; Rolfe, John/O-2945-2017	Rahman, Azad/0000-0002-5285-6009; nguyen, Julie/0000-0003-1018-0079; Rolfe, John/0000-0001-7659-7040	Regional Development Australia - Fitzroy and Central West (RDA-FCW) [RSH4755]	Regional Development Australia - Fitzroy and Central West (RDA-FCW)	This research project is funded by Regional Development Australia - Fitzroy and Central West (RDA-FCW) Grant number: RSH4755 (https://rdafcw.com.au/) to DA, JR, AR, JN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aged Care Financing Authority (ACFA), 2018, 6 REP FUND FIN AG CA; Aged Care Sector Committee, 2016, AG CAR ROADM; AIHW, 2016, EV CHRON DIS RISK FA; Akiyama M, 2017, INT J MED INFORM, V104, P1, DOI 10.1016/j.ijmedinf.2017.04.017; [Anonymous], 2013, AG AUSTR PREP FUT; Australian Bureau of Statistics, 2015, DIS AG CAR SUMM FIND; Australian Bureau of Statstics (ABS), 2018, AUSTR DEM STAT; Australian Institute of Health and Welfare (AIHW), AG CAR SERV LIST 30; Benefield LE, 2014, NURS CLIN N AM, V49, P123, DOI 10.1016/j.cnur.2014.02.001; Caley M, 2011, J PUBLIC HEALTH-UK, V33, P117, DOI 10.1093/pubmed/fdq044; Cameron JW, 2003, 9 AUD GEN VIC; Cook DJ, 2006, J UNIVERS COMPUT SCI, V12, P15; Dang S, 2009, TELEMED J E-HEALTH, V15, P783, DOI 10.1089/tmj.2009.0028; Elragal A, 2012, ORG INTEGRATION ENTE, P117; Khosravi P, 2016, INT J MED INFORM, V85, P17, DOI 10.1016/j.ijmedinf.2015.05.014; Kidholm K, 2012, INT J TECHNOL ASSESS, V28, P44, DOI 10.1017/S0266462311000638; Kim KI, 2017, EXP GERONTOL, V88, P25, DOI 10.1016/j.exger.2016.11.013; Kok L, 2015, EUR J HEALTH ECON, V16, P119, DOI 10.1007/s10198-013-0557-1; Kulvik M, 2015, APPL RADIAT ISOTOPES, V106, P3, DOI 10.1016/j.apradiso.2015.08.021; Kuo MH, 2016, HEALTH POLICY TECHN, V5, P131, DOI 10.1016/j.hlpt.2016.02.004; Lehoux P, 2018, SOC SCI MED, V211, P330, DOI 10.1016/j.socscimed.2018.06.038; Magnusson L, 2005, J ADV NURS, V51, P645, DOI 10.1111/j.1365-2648.2005.03541.x; Malwade S, 2018, COMPUT METH PROG BIO, V161, P233, DOI 10.1016/j.cmpb.2018.04.026; Murphy C, 2017, 8 AUD GEN WA; Queensland Government Statistician's Office (QGSO), 2018, QUEENSL TREAS QUEENS; Queiros A, 2017, PROCEDIA COMPUT SCI, V121, P206, DOI 10.1016/j.procs.2017.11.028; Rantz MJ, 2013, J AM MED DIR ASSOC, V14, P386, DOI 10.1016/j.jamda.2013.02.018; Rioux L, 2011, J ENVIRON PSYCHOL, V31, P158, DOI 10.1016/j.jenvp.2010.12.001; Schaffer JL, 2018, J ARTHROPLASTY, V33, P2345, DOI 10.1016/j.arth.2018.04.017; Schorr AV, 2018, ARCH GERONTOL GERIAT, V77, P196, DOI 10.1016/j.archger.2018.04.009; United Nations, 2015, STESASERA390 UN; van Hoof J, 2011, INT J MED INFORM, V80, P310, DOI 10.1016/j.ijmedinf.2011.02.010; Yusif S, 2016, INT J MED INFORM, V94, P112, DOI 10.1016/j.ijmedinf.2016.07.004	33	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218448	10.1371/journal.pone.0218448	http://dx.doi.org/10.1371/journal.pone.0218448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242208	Green Submitted, Green Published, gold			2022-12-26	WOS:000482883600031
J	Miguel, V; Villarreal, MA; Garcia, DA				Miguel, Virginia; Villarreal, Marcos A.; Garcia, Daniel A.			Effects of gabergic phenols on the dynamic and structure of lipid bilayers: A molecular dynamic simulation approach	PLOS ONE			English	Article							LATERAL PRESSURE PROFILE; GABA(A) RECEPTOR; GENERAL-ANESTHETICS; GABAERGIC PHENOLS; THERMODYNAMICS; PROPOFOL; MECHANISM; MEMBRANES; ALCOHOLS; BINDING	gamma-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the vertebrate and invertebrate nervous system. GABA(A) receptors are activated by GABA and their agonists, and modulated by a wide variety of recognized drugs, including barbiturates, anesthetics, and benzodiazepines. The phenols propofol, thymol, chlorothymol, carvacrol and eugenol act as positive allosteric modulators on GABA(A)-R receptor. These GABAergic phenols interact with the lipid membrane, therefore, their anesthetic activity could be the combined result of their specific activity (with receptor proteins) as well as nonspecific interactions (with surrounding lipid molecules) modulating the supramolecular organization of the receptor environment. Therefore, we aimed to contribute to a description of the molecular events that occur at the membrane level as part of the mechanism of general anesthesia, using a molecular dynamic simulation approach. Equilibrium molecular dynamics simulations indicate that the presence of GABAergic phenols in a DPPC bilayer orders lipid acyl chains for carbons near the interface and their effect is not significant at the bilayer center. Phenols interacts with the polar interface of phospholipid bilayer, particularly forming hydrogen bonds with the glycerol and phosphate group. Also, potential of mean force calculations using umbrella sampling show that propofol partition is mainly enthalpic driven at the polar region and entropic driven at the hydrocarbon chains. Finally, potential of mean force indicates that propofol partition into a gel DPPC phase is not favorable. Our in silico results were positively contrasted with previous experimental data.	[Miguel, Virginia; Garcia, Daniel A.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Dept Quim, Catedra Quim Biol, Cordoba, Argentina; [Miguel, Virginia; Garcia, Daniel A.] Univ Nacl Cordoba, Inst Invest Biol & Tecnol, Consejo Nacl Invest Cient & Tecn, Cordoba, Argentina; [Villarreal, Marcos A.] Univ Nacl Cordoba, Inst Invest Fis Quim Cordoba, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Quim,Dept Quim Teor & Computac, Cordoba, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Miguel, V; Garcia, DA (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Dept Quim, Catedra Quim Biol, Cordoba, Argentina.; Miguel, V; Garcia, DA (corresponding author), Univ Nacl Cordoba, Inst Invest Biol & Tecnol, Consejo Nacl Invest Cient & Tecn, Cordoba, Argentina.	virgimiguel@gmail.com; dagarcia@unc.edu.ar		Garcia, Daniel/0000-0001-5282-2557; Miguel, Virginia/0000-0002-5651-6386	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220130100075CO]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2017-1392]; Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba [411/18]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT))	This study was supported by PIP 11220130100075CO. Consejo Nacional de Investigaciones Cientificas y Tecnicas (https://www.conicet.gov.ar/); PICT 2017-1392, Agencia Nacional de Promocion Cientifica y Tecnologica (https://www.argentina.gob.ar/ciencia/agencia); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (411/18). (https://www.unc.edu.ar/ciencia-y-tecnologia/), all to DAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahri MA, 2007, BIOPHYS CHEM, V129, P82, DOI 10.1016/j.bpc.2007.05.011; BARRY JA, 1994, BIOCHEMISTRY-US, V33, P8082, DOI 10.1021/bi00192a013; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; Cantor RS, 1997, BIOCHEMISTRY-US, V36, P2339, DOI 10.1021/bi9627323; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frangopol PT, 2001, COLLOID SURFACE B, V22, P3, DOI 10.1016/S0927-7765(01)00153-9; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Garcia DA, 2006, NEUROPHARMACOLOGY, V50, P25, DOI 10.1016/j.neuropharm.2005.07.009; Graesboll K, 2014, BIOPHYS J, V106, P2143, DOI 10.1016/j.bpj.2014.04.014; Grasshoff C, 2005, CURR OPIN ANESTHESIO, V18, P386, DOI 10.1097/01.aco.0000174961.90135.dc; GRUNER SM, 1991, ANN NY ACAD SCI, V625, P685, DOI 10.1111/j.1749-6632.1991.tb33902.x; Hansen AH, 2013, CHEM PHYS LIPIDS, V175, P84, DOI 10.1016/j.chemphyslip.2013.08.002; Heimburg T, 2007, BIOPHYS J, V92, P3159, DOI 10.1529/biophysj.106.099754; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koenig BW, 2005, J PHYS CHEM B, V109, P7540, DOI 10.1021/jp044980b; Kondela T, 2017, MOLECULES, V22, DOI 10.3390/molecules22122078; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Leon I, 2012, PHYS CHEM CHEM PHYS, V14, P4398, DOI 10.1039/c2cp23583h; MacCallum JL, 2006, J AM CHEM SOC, V128, P125, DOI 10.1021/ja0535099; Miguel V, 2018, BBA-BIOMEMBRANES, V1860, P1563, DOI 10.1016/j.bbamem.2018.05.012; Miguel V, 2016, BBA-BIOMEMBRANES, V1858, P38, DOI 10.1016/j.bbamem.2015.10.008; Mohammadi B, 2001, EUR J PHARMACOL, V421, P85, DOI 10.1016/S0014-2999(01)01033-0; Overton C. E., 1901, STUDIEN NARKOSE ZUGL; Pytel M, 2006, BRIT J PHARMACOL, V148, P413, DOI 10.1038/sj.bjp.0706747; Pham QD, 2015, LANGMUIR, V31, P11067, DOI 10.1021/acs.langmuir.5b00856; REINER G, 2013, J BIOMATERIALS NANOB, V4, P28, DOI DOI 10.4236/JBNB.2013.43A004; Reiner GN, 2013, CELL BIOCHEM BIOPHYS, V67, P515, DOI 10.1007/s12013-013-9537-4; Reiner GN, 2013, COLLOID SURFACE B, V101, P61, DOI 10.1016/j.colsurfb.2012.06.004; Reiner GN, 2009, J PHARMACEUT BIOMED, V49, P686, DOI 10.1016/j.jpba.2008.12.040; Rinaldi A, 2014, EMBO REP, V15, P1113, DOI 10.15252/embr.201439593; Rowe ES, 1998, BIOCHEMISTRY-US, V37, P2430, DOI 10.1021/bi9721602; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Sogaard R, 2006, BIOCHEMISTRY-US, V45, P13118, DOI 10.1021/bi060734+; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Trandum C, 2000, BIOPHYS J, V78, P2486, DOI 10.1016/S0006-3495(00)76793-2; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Westh P, 1999, BBA-BIOMEMBRANES, V1421, P261, DOI 10.1016/S0005-2736(99)00130-3	41	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218042	10.1371/journal.pone.0218042	http://dx.doi.org/10.1371/journal.pone.0218042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237897	gold, Green Published			2022-12-26	WOS:000484856000013
J	Caut, S; Francois, V; Bacques, M; Guiral, D; Lemaire, J; Lepoint, G; Marquis, O; Sturaro, N				Caut, Stephane; Francois, Vincent; Bacques, Matthieu; Guiral, Daniel; Lemaire, Jeremy; Lepoint, Gilles; Marquis, Olivier; Sturaro, Nicolas			The dark side of the black caiman: Shedding light on species dietary ecology and movement in Agami Pond, French Guiana	PLOS ONE			English	Article							MELANOSUCHUS-NIGER; STABLE-ISOTOPES; ANAVILHANAS ARCHIPELAGO; CENTRAL AMAZONIA; CONSERVATION; POPULATION; CROCODILUS; DELTA-N-15; DELTA-C-13; DYNAMICS	The black caiman is one of the largest neotropical top predators, which means that it could play a structuring role within swamp ecosystems. However, because of the difficulties inherent to studying black caimans, data are sorely lacking on many aspects of their general biology, natural history, and ecology, especially in French Guiana. We conducted a detailed study of the Agami Pond black caiman population using a multidisciplinary approach. The aim was to better understand the species' dietary ecology and movements in the pond, and thus its functional role in pond system. We gathered natural history data, tracked caiman movements using satellite transmitters, and characterized feeding ecology via stable isotope analysis. Our study was carried out over three sampling periods and spanned both wet and dry seasons, which differ in their hydrological and ecological conditions. Our results show that black caiman abundance and age demographics differed between seasons in Agami Pond. In the dry season, Agami Pond is one of the only areas within the marsh to hold water. It thus contains large quantities of different fish species, which form the basis of the black caiman's diet. Caiman body size, a proxy for age class, was around 1.5 meters. During the wet season, which corresponds to the breeding period for migratory birds (e.g., Agami herons), adult black caimans are present in Agami Pond. Adults were most abundant in the inundated forest. There, most individuals measured up to 2 meters. They also exhibited a particular "predatory" behavior near bird nests, preying on fallen chicks and adults. Juveniles and subadults were present during both seasons in the pond's open waters. These behavioral observations were backed up by stable isotope analysis, which revealed ontogenetic variation in the caiman's isotopic values. This isotopic variation reflected variation in diet that likely reduced intraspecific competition between adults and young. The telemetry and microchip data show that different age classes had different movement patterns and that seasonal variation in the pond may influence caiman prey availability and reproductive behavior. The new information gathered should help predict this species' responses to potential ecosystem disturbance (e.g., water pollution, habitat destruction) and inform the development of an effective conservation plan that involves locals and wildlife officials.	[Caut, Stephane] CSIC, Dept Etol & Conservac Biodiversidad, Estn Biol Donana, Seville, Spain; [Caut, Stephane; Bacques, Matthieu] ANIMAVEG Conservat, Villejuif, France; [Francois, Vincent] Alligator Bay, Beauvoir Sur Niort, France; [Guiral, Daniel] Aix Marseille Univ, IMBE Inst Mediterraneen Biodiversite & Ecol Marin, IRD, Marseille, France; [Lemaire, Jeremy] Univ La Rochelle, CNRS, UMR 7372, CEBC, Villiers En Bois, France; [Lepoint, Gilles; Sturaro, Nicolas] Univ Liege, UR FOCUS, Lab Oceanol, Liege, Belgium; [Marquis, Olivier] MNHN, Paris, France; [Marquis, Olivier] Parc Zool Paris, Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; University of Liege; Museum National d'Histoire Naturelle (MNHN)	Caut, S (corresponding author), CSIC, Dept Etol & Conservac Biodiversidad, Estn Biol Donana, Seville, Spain.; Caut, S (corresponding author), ANIMAVEG Conservat, Villejuif, France.	stephanecaut@gmail.com	Lemaire, Jérémy/ABF-5607-2020; Lepoint, Gilles/I-1130-2014	Lemaire, Jérémy/0000-0002-1095-9544; Lepoint, Gilles/0000-0003-4375-0357; STURARO, Nicolas/0000-0002-7225-0880	Consejo Superior de Investigaciones Cientificas (CSIC); Estacion Biologica de Donana; Paris Zoological Park; Fonds de Dotation pour la Biodiversity; Lacoste; National Geographic Society/Waitt Grants Program [W269-13]; La Ferme aux Crocodiles Zoological Park	Consejo Superior de Investigaciones Cientificas (CSIC); Estacion Biologica de Donana; Paris Zoological Park; Fonds de Dotation pour la Biodiversity; Lacoste; National Geographic Society/Waitt Grants Program(National Geographic Society); La Ferme aux Crocodiles Zoological Park	This work was supported by Consejo Superior de Investigaciones Cientificas (CSIC) research contracts to SC and the Estacion Biologica de Donana; Paris Zoological Park; Fonds de Dotation pour la Biodiversity and the private company Lacoste; the National Geographic Society/Waitt Grants Program (#W269-13 to SC); and La Ferme aux Crocodiles Zoological Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera X, 2008, REV BIOL TROP, V56, P909; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2016, ARGOS USERS MANUAL; Baker CJ, 2019, OECOLOGIA, V189, P891, DOI 10.1007/s00442-019-04382-4; Boggs ASP, 2016, GEN COMP ENDOCR, V226, P5, DOI 10.1016/j.ygcen.2015.12.006; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Boussuges A, 2001, ANN FR ANESTH, V20, P300; Brazaitis P, 1989, P WORK M CROC SPEC G, P119; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Campbell HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062127; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2013, BIOL OPEN, V2, P629, DOI 10.1242/bio.20134945; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; CITES, 2007, CONV COMM INT FAUN F; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Da Silveira R, 1997, J HERPETOL, V31, P514; Da Silveira R, 1999, J HERPETOL, V33, P181; Da Silveira R, 1999, BIOL CONSERV, V88, P103, DOI 10.1016/S0006-3207(98)00084-6; Da Silveira Ronis, 2002, P61; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; de Thoisy B, 2003, CSG NEWSLETTER, V22, P17; de Thoisy B, 2006, BIOL CONSERV, V133, P474, DOI 10.1016/j.biocon.2006.07.009; Debenay JP, 2004, MAR GEOL, V208, P295, DOI 10.1016/j.margeo.2004.04.013; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; GARRICK LD, 1977, AM ZOOL, V17, P225; Guiral D, 2007, ANN LIMNOL-INT J LIM, V43, P147, DOI 10.1051/limn:2007009; GUIRAL D., 2012, GUYANE OCEANE; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Horna JV, 2001, ECOTROPICA, V7, P1; Huchzermeyer F.W., 2003, CROCODILES BIOL HUSB; Hurpeau, 2015, AGAMI HERON CONSERVA; Kay WR, 2004, WILDLIFE RES, V31, P495, DOI 10.1071/WR04037; Laverty TM, 2013, HERPETOLOGICA, V69, P91, DOI 10.1655/HERPETOLOGICA-D-12-00031; MAGNUSSON WE, 1987, J HERPETOL, V21, P85, DOI 10.2307/1564468; Marques TS, 2013, ISOT ENVIRON HEALT S, V49, P325, DOI 10.1080/10256016.2013.835309; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Muniz FL, 2011, AMPHIBIA-REPTILIA, V32, P428, DOI 10.1163/017353711X587741; Ouboter PE, 1999, IUCN SSC CROCODILE S, V19, P13; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Plotkin MJ, 1983, ADV HERPETOLOGY EVOL; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Radloff FGT, 2012, ISOT ENVIRON HEALT S, V48, P439, DOI 10.1080/10256016.2012.667808; Read MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000949; REBELO GH, 1983, BIOL CONSERV, V26, P95, DOI 10.1016/0006-3207(83)90060-5; Ron SR, 1998, J HERPETOL, V32, P320, DOI 10.2307/1565444; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Rosenblatt AE, 2013, PHYSIOL BIOCHEM ZOOL, V86, P137, DOI 10.1086/668295; Rosenblatt AE, 2011, J ANIM ECOL, V80, P786, DOI 10.1111/j.1365-2656.2011.01830.x; Ross P, 1998, CROCODILES ACTION PL; Silveira R, 2003, CROCODILE SPEC GROUP, V22, P16; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; Thomas Bindi, 2010, Northern Territory Naturalist, V22, P60; Thorbjarnarson J., 2010, CROCODILES STATUS SU, P29; Villamarin F, 2017, FRESHWATER BIOL, P1; Villamarin F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19918-6; Wallace KM, 2008, J HERPETOL, V42, P361, DOI 10.1670/07-1071.1; Ward EJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00190.1; Wheatley PV, 2012, MAR ECOL PROG SER, V447, P211, DOI 10.3354/meps09503; Woodborne S, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00170.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	63	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0217239	10.1371/journal.pone.0217239	http://dx.doi.org/10.1371/journal.pone.0217239			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233530	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700006
J	Jarrard, WE; Schultz, A; Etheridge, T; Damodaran, S; Allen, GO; Jarrard, D; Yang, B				Jarrard, William E.; Schultz, Adam; Etheridge, Tyler; Damodaran, Shivashankar; Allen, Glenn O.; Jarrard, David; Yang, Bing			Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection	PLOS ONE			English	Article							DNA-METHYLATION; EXPRESSION; CARCINOMA; DIAGNOSIS; ANTIGEN; CELLS	Background Prostate cancer (PC) is a multifocal disease. DNA methylation alterations are not restricted to the immediate peritumor environment, but spatially widespread in the adjacent and distant histologically normal prostate tissues. In the current study, we utilized high-throughput methylation arrays to identify epigenetic changes in the urine from men with and without cancer. Design, setting, and participants DNA urine samples were enriched for methylated fragments using MBD methyl-binding antibodies and applied to high density CytoScanHD arrays. Significant loci were validated using quantitative pyrosequencing and binary logistic regression modeling applied to urine sample analyses in a training (n = 83) and validation approach (n = 84). Methylation alterations in prostate tissues using pyrosequencing at the PLA2G16 locus were examined in 38 histologically normal specimens from men with (TA, n = 26) and without (NTA, n = 12) cancer and correlated to gene expression. Results Methylation microarrays identified 3,986 loci showing significantly altered methylation in the urine samples from patients with PC compared to those without (TA vs NTA; p<0.01). These loci were then compared against subjects with their prostates removed to exclude non-prostate cell markers yielding 196 significant regions. Multiple CpGs adjacent to PLA2G16 CpG island showed increased methylation in TA compared to NTA (p<0.01) in a large validation study of urine samples. The predictive accuracy of PLA2G16 methylation at CG2 showed the highest predictive value at 0.8 (odds ratio, 1.37; 95% confidence interval, 1.16-1.62; p<0.001). Using a probability cutoff of 0.065, the sensitivity and specificity of the multivariate model was 92% and 35%. When histologically normal prostate tissues/biopsies from patients with PC (TA) were compared to subjects without cancer, significant hypermethylation of PLA2G16 was noted (odds ratio, 1.35; 95% confidence interval, 1.071.71; p = 0.01). Conclusion PLA2G16 methylation defines an extensive field defect in histologically normal prostate tissue associated with PC. PLA2G16 methylation in urine and prostate tissues can detect the presence of PC.	[Jarrard, William E.; Schultz, Adam; Jarrard, David] Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI USA; [Etheridge, Tyler; Damodaran, Shivashankar; Allen, Glenn O.; Jarrard, David; Yang, Bing] Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yang, B (corresponding author), Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	yangb@urology.wisc.edu			University of Wisconsin foundation of Prostate Cancer Research; Nast, Clack and Cullen families'; University of Wisconsin [D2P-131-PRJ89HM]	University of Wisconsin foundation of Prostate Cancer Research; Nast, Clack and Cullen families'; University of Wisconsin	This work was supported by University of Wisconsin foundation of Prostate Cancer Research. The Nast, Clack and Cullen families' funding. This work was also supported by University of Wisconsin D2P-131-PRJ89HM.	Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; BOLOGNA M, 1988, EUR UROL, V14, P474; Crawford ED, 2012, J UROLOGY, V188, P1726, DOI 10.1016/j.juro.2012.07.023; Fujita K, 2009, HUM PATHOL, V40, P924, DOI 10.1016/j.humpath.2009.01.004; Geybels MS, 2015, PROSTATE, V75, P1941, DOI 10.1002/pros.23093; Korzeniewski N, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.09.015; KOSS LG, 1985, ACTA CYTOL, V29, P810; Li L, 2016, ONCOTARGET, V7, P18021, DOI 10.18632/oncotarget.7694; Luo JH, 2013, AM J PATHOL, V182, P2028, DOI 10.1016/j.ajpath.2013.02.040; Truong M, 2013, J UROLOGY, V189, P422, DOI 10.1016/j.juro.2012.04.143; Merdan S, 2015, CANCER-AM CANCER SOC, V121, P4071, DOI 10.1002/cncr.29611; Minciu R, 2016, CLIN LAB, V62, P1183, DOI 10.7754/Clin.Lab.2015.151019; Nazarenko I, 2006, AM J PATHOL, V169, P1427, DOI 10.2353/ajpath.2006.051341; Ploussard G, 2010, NAT REV UROL, V7, P101, DOI 10.1038/nrurol.2009.261; Schulz WA, 2009, SEMIN CANCER BIOL, V19, P172, DOI 10.1016/j.semcancer.2009.02.006; SHARIFI R, 1983, UROLOGY, V21, P417, DOI 10.1016/0090-4295(83)90170-X; Sriuranpong V, 2004, CLIN CANCER RES, V10, P4944, DOI 10.1158/1078-0432.CCR-03-0757; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Tomlins SA, 2016, EUR UROL, V70, P45, DOI 10.1016/j.eururo.2015.04.039; Truong M, 2012, BRIT J CANCER, V107, P100, DOI 10.1038/bjc.2012.216; Truong M, 2013, J UROLOGY, V189, P2335, DOI 10.1016/j.juro.2012.11.074; Van Neste L, 2016, PROSTATE, V76, P1078, DOI 10.1002/pros.23191; Yanatatsaneejit P, 2008, ORAL ONCOL, V44, P400, DOI 10.1016/j.oraloncology.2007.05.008; Yang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088052; Yang B, 2013, NEOPLASIA, V15, P399, DOI 10.1593/neo.13280; Yang XL, 2017, J THORAC DIS, V9, P1002, DOI 10.21037/jtd.2017.03.108; Zhao F, 2017, J UROLOGY, V197, P335, DOI 10.1016/j.juro.2016.08.081	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218950	10.1371/journal.pone.0218950	http://dx.doi.org/10.1371/journal.pone.0218950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233548	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700053
J	Shao, QQ; Yang, T; Huang, H; Majumder, T; Khot, BA; Khouzani, MM; Alarmanazi, F; Gore, YK; Liu, GF				Shao, Qiangqiang; Yang, Tao; Huang, Huai; Majumder, Tanushree; Khot, Bhakti Ajit; Khouzani, Mohammad Masoudian; Alarmanazi, Farrah; Gore, Yasmin K.; Liu, Guofa			Disease-associated mutations in human TUBB3 disturb netrin repulsive signaling	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; MICROTUBULE DYNAMICS; COLORECTAL-CANCER; AXON GUIDANCE; SENSORY AXONS; GROWTH; DCC; PROTEIN; RECEPTOR; DSCAM	Missense mutations in the human TUBB3 gene cause a variety of neurological disorders associated with defects in axon guidance and neuronal migration, but the underlying molecular mechanisms are not well understood. Recent studies have shown that direct coupling of dynamic TUBB3 in microtubules with netrin receptors is required for netrin-1-mediated axon guidance, and the interaction of netrin-1 repulsive receptor UNC5C with TUBB3 is involved in netrin-1 mediated axonal repulsion. Here, we report that TUBB3 mutations perturb netrin-1/UNC5C repulsive signaling in the developing nervous system. Among twelve mutants reported in previous studies, five of them show significantly reduced interaction with UNC5C in comparison to the wild-type TUBB3. TUBB3 mutants R262C and R62Q exhibit decreased subcellular colocalization with UNC5C in the peripheral area of the growth cone of primary mouse neurons. Netrin-1 reduces the colocalization of UNC5C with wildtype TUBB3, but not TUBB3 mutants R262C or R62Q, in the growth cone. Results from the in vitro cosedimentation assay indicate that netrin-1 inhibits cosedimentation of UNC5C with polymerized microtubules in primary mouse neurons expressing the wild-type TUBB3, but not R262C or R62Q. Expression of either R262C or R62Q not only blocks netrin-1-induced growth cone collapse and axonal repulsion of primary EGL cells in vitro, but also results in axon projections defects of chicken dorsal root ganglion neurons in ovo. Our study reveals that human TUBB3 mutations specifically perturb netrin-1/UNC5C-mediated repulsion.	[Shao, Qiangqiang; Yang, Tao; Huang, Huai; Majumder, Tanushree; Khot, Bhakti Ajit; Khouzani, Mohammad Masoudian; Alarmanazi, Farrah; Gore, Yasmin K.; Liu, Guofa] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Liu, GF (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	Guofa.Liu@utoledo.edu	Shao, Qiangqiang/GXZ-6789-2022	Shao, Qiangqiang/0000-0002-0674-1868; Liu, Guofa/0000-0003-1464-1493	National Institute of Health [HD-080512]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institute of Health, HD-080512. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jamel Chelly for TUBB3 mutants (G82R, T178M, E205K, and M388V). This work was supported by the National Institute of Health.	Abdollahi MR, 2009, AM J HUM GENET, V85, P737, DOI 10.1016/j.ajhg.2009.10.007; Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Buck KB, 2002, J NEUROSCI, V22, P9358; Burgess RW, 2006, J NEUROSCI, V26, P5756, DOI 10.1523/JNEUROSCI.0736-06.2006; Challacombe JF, 1997, J NEUROSCI, V17, P3085; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Cushion TD, 2013, BRAIN, V136, P536, DOI 10.1093/brain/aws338; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Finger JH, 2002, J NEUROSCI, V22, P10346; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Guerrini R, 2012, EUR J HUM GENET, V20, P995, DOI 10.1038/ejhg.2012.21; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huang H, 2015, NEUROSCIENCE, V293, P109, DOI 10.1016/j.neuroscience.2015.02.042; Huang HL, 2018, ACCIDENT ANAL PREV, V111, P56, DOI 10.1016/j.aap.2017.11.024; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kennedy TE, 2006, J NEUROSCI, V26, P8866, DOI 10.1523/JNEUROSCI.5191-05.2006; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Kumar RA, 2010, HUM MOL GENET, V19, P2817, DOI 10.1093/hmg/ddq182; Lasser M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00165; Lee AC, 2008, DEV NEUROBIOL, V68, P1363, DOI 10.1002/dneu.20662; Lei WL, 2012, CELL RES, V22, P954, DOI 10.1038/cr.2012.40; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Liu GF, 2014, NEUROSCI BULL, V30, P569, DOI 10.1007/s12264-014-1444-6; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Masuda T, 2008, J NEUROSCI, V28, P10380, DOI 10.1523/JNEUROSCI.1926-08.2008; Masuda T, 2009, CELL ADHES MIGR, V3, P171, DOI 10.4161/cam.3.2.7837; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Purohit AA, 2012, J BIOL CHEM, V287, P27126, DOI 10.1074/jbc.M112.340174; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Qu C, 2013, J CELL SCI, V126, P3070, DOI 10.1242/jcs.122184; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; Shao QQ, 2017, J NEUROSCI, V37, P5620, DOI 10.1523/JNEUROSCI.2617-16.2017; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Srivatsa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4708; Stoeckli E, 2009, EMBO REP, V10, P326, DOI 10.1038/embor.2009.47; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Ti SC, 2016, DEV CELL, V37, P72, DOI 10.1016/j.devcel.2016.03.003; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Watanabe K, 2006, DEVELOPMENT, V133, P1379, DOI 10.1242/dev.02312; Whitman MC, 2016, AM J MED GENET A, V170, P297, DOI 10.1002/ajmg.a.37362; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022	58	6	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218811	10.1371/journal.pone.0218811	http://dx.doi.org/10.1371/journal.pone.0218811			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226147	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700044
J	Zong, D; Gan, PH; Zhou, AP; Li, JY; Xie, ZL; Duan, AA; He, CZ				Zong, Dan; Gan, Peihua; Zhou, Anpei; Li, Jinyu; Xie, Zhongli; Duan, Anan; He, Chengzhong			Comparative analysis of the complete chloroplast genomes of seven Populus species: Insights into alternative female parents of Populus tomentosa	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SEQUENCE; DNA; MARKERS; EVOLUTION; SOFTWARE; ANGIOSPERMS; DIVERGENCE; SALICACEAE; CULTIVARS	Populus tomentosa, of section Populus, is distributed mainly in northern China. This species has high resistance to many diseases and insects, and it plays key roles in shelterbelts and urban afforestation in northern China. It has long been suspected to be a hybrid, but its parents remain unknown. In the present study, we report four newly sequenced complete cp genomes from section Populus and comparative genomic analyses of these new sequences and three published cp genome sequences. The seven cp genomes ranged from 155,853 bp (P. tremula var. davidiana) to 156,746 bp (P. adenopoda) in length, and their gene orders, gene numbers and GC contents were similar. We analyzed SNPs, indels, SSRs and repeats among the seven cp genomes, and eight small inversions were detected in the ndhC-trnV, rbcL-accD, petA-psbJ, trnW-trnP, rpl16-rps3, trnL-ycf15, ycf15-trnL, and ndhF-trnL intergenic regions. Furthermore, seven divergent regions (trnH-psbA, matK, psbM-psbD, ndhC-trnV, ycf1, ndhF-ccsA and ccsA-ndhD) were found in more highly variable regions. The phylogenetic tree reveals that P. tomentosa is closely related to P. alba and P. alba var. pyramidalis. Hence, P. alba was involved in the formation of P. tomentosa.	[Zong, Dan; Gan, Peihua; Zhou, Anpei; Li, Jinyu; Xie, Zhongli; Duan, Anan; He, Chengzhong] Southwest Forestry Univ, Key Lab Forest Genet & Tree Improvement & Propaga, Kunming, Yunnan, Peoples R China; [Zong, Dan; Gan, Peihua; Zhou, Anpei; Li, Jinyu; Xie, Zhongli; Duan, Anan; He, Chengzhong] Southwest Forestry Univ, State Forestry Adm, Key Lab Biodivers Conservat Southwest China, Kunming, Yunnan, Peoples R China; [Duan, Anan; He, Chengzhong] Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilizat Sou, Minist Educ, Kunming, Yunnan, Peoples R China	Southwest Forestry University - China; Southwest Forestry University - China; Southwest Forestry University - China	He, CZ (corresponding author), Southwest Forestry Univ, Key Lab Forest Genet & Tree Improvement & Propaga, Kunming, Yunnan, Peoples R China.; He, CZ (corresponding author), Southwest Forestry Univ, State Forestry Adm, Key Lab Biodivers Conservat Southwest China, Kunming, Yunnan, Peoples R China.; He, CZ (corresponding author), Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilizat Sou, Minist Educ, Kunming, Yunnan, Peoples R China.	hecz@swfu.edu.cn		Zhou, Anpei/0000-0001-8162-367X	National Natural Science Foundation of China [31860219, 31360184]; Forestry Public Benefit Research Program [201104076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Forestry Public Benefit Research Program	This study was supported by grants from the National Natural Science Foundation of China (31860219; 31360184) and the Forestry Public Benefit Research Program (201104076).	Catalano SA, 2009, CLADISTICS, V25, P93, DOI 10.1111/j.1096-0031.2008.00236.x; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; Bartkowiak S., 1958, ARBORETUM KORNICKIE, V3, P221; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Cervera MT, 2005, THEOR APPL GENET, V111, P1440, DOI 10.1007/s00122-005-0076-2; Chen ZK, 2016, INT J GRID HIGH PERF, V8, P1, DOI 10.4018/IJGHPC.2016070101; Choi MN, 2016, MITOCHONDRIAL DNA B, V1, P674, DOI 10.1080/23802359.2016.1219634; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dickmann D. I, 1983, RHODORA, V19, P10; Dong WP, 2016, PEERJ, V4, DOI 10.7717/peerj.2699; Dong WP, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0138-z; Eckenwalder J. E, 1977, THESIS; Eckenwalder James E., 1996, P7; ECKENWALDER JE, 1977, J ARNOLD ARBORETUM, V58, P193, DOI 10.5962/bhl.part.29239; [范李强 Fan Liqiang], 2018, [四川大学学报. 自然科学版, Journal of Sichuan University. Natural Science Edition], V55, P165; Fang C.F., 1999, FLORA CHINA, P139; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Grover CE, 2008, MOL BIOL EVOL, V25, P1415, DOI 10.1093/molbev/msn085; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; Han XM, 2017, MITOCHONDRIAL DNA B, V2, P932, DOI 10.1080/23802359.2017.1413291; He C.Z., 2005, THESIS; He LX, 2012, AASRI PROC, V1, P344, DOI 10.1016/j.aasri.2012.06.053; Huang DI, 2014, NEW PHYTOL, V204, P693, DOI 10.1111/nph.12956; Huang J, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120340; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kang XiangYang, 1999, Journal of Beijing Forestry University, V21, P6; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaur S, 2015, CRIT REV FOOD SCI, V55, P41, DOI 10.1080/10408398.2011.646363; Kersten B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147209; Kim KJ, 2005, MOL CELLS, V19, P104; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Li KuanYu, 1997, Acta Phytotaxonomica Sinica, V35, P24; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058747; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Okumura S, 2006, J ARID LAND STUDIES, V15, P506; PALMER JD, 1987, CURR GENET, V11, P275, DOI 10.1007/BF00355401; Qian J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057067, DOI 10.1371/JOURNAL.PONE.0057067]; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg MS, 2003, MOL BIOL EVOL, V20, P988, DOI 10.1093/molbev/msg113; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; Simmons MP, 2001, SYST BIOL, V50, P454, DOI 10.1080/106351501300318049; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stettler R.F., 1996, BIOL POPULUS ITS IMP; Suo ZL, 2012, PLANT CELL REP, V31, P2199, DOI 10.1007/s00299-012-1330-0; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Wan XQ, 2013, PLANT SYST EVOL, V299, P57, DOI 10.1007/s00606-012-0702-9; Wang DS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41320-z; Wang DS, 2015, BIOCHEM SYST ECOL, V63, P212, DOI 10.1016/j.bse.2015.09.020; Wang DS, 2016, MOL PHYLOGENY SECTIO; Wang TJ, 2016, CONSERV GENET RESOUR, V8, P435, DOI 10.1007/s12686-016-0590-3; Wang Y. Z, 2007, FLORA CHINA; Wang Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00280; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; XU C, 2017, FRONT PLANT SCI, V8; Yang JB, 2014, MOL ECOL RESOUR, V14, P1024, DOI 10.1111/1755-0998.12251; Yang YC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00959; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; Yin Jian, 2006, THESIS; Zhang D, 2007, SILVAE GENET, V56, P27, DOI 10.1515/sg-2007-0004; Zhang D, 2004, THEOR APPL GENET, V108, P657, DOI 10.1007/s00122-003-1478-7; ZHANG J, 1991, Forest Research, V4, P86; Zhang QJ, 2016, MITOCHONDRIAL DNA A, V27, P721, DOI 10.3109/19401736.2014.913159; Zhang T., 1995, J NW FORESTRY COLL, V10, P43; Zhang YJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00306; [赵静静 Zhao Jingjing], 2010, [食品与生物技术学报, Journal of Food Science and Biotechnology], V29, P755; Zheng H, 2016, CONSERV GENETICS RES, V8, P1; Zhu Z.T., 1992, J BEIJING FOR UNIV, V14, P1; Zuo LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171264	80	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218455	10.1371/journal.pone.0218455	http://dx.doi.org/10.1371/journal.pone.0218455			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216332	Green Published, Green Submitted, gold			2022-12-26	WOS:000482885300044
J	Kamaliddin, C; Rombaut, D; Guillochon, E; Royo, J; Ezinmegnon, S; Agbota, G; Huguet, S; Guemouri, S; Peirera, C; Coppee, R; Broussard, C; Alao, JM; Aubouy, A; Guillonneau, F; Deloron, P; Bertin, GI				Kamaliddin, Claire; Rombaut, David; Guillochon, Emilie; Royo, Jade; Ezinmegnon, Sem; Agbota, Gino; Huguet, Stephanie; Guemouri, Sayeh; Peirera, Celine; Coppee, Romain; Broussard, Cedric; Alao, Jules M.; Aubouy, Agnes; Guillonneau, Francois; Deloron, Philippe; Bertin, Gwladys I.			From genomic to LC-MS/MS evidence: Analysis of PfEMP1 in Benin malaria cases	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; SEQUENCE DIVERSITY; BINDING PFEMP1; EPCR-BINDING; DOMAIN; IDENTIFICATION; EXPRESSION; RECEPTOR; FAMILY; ALGORITHM	Background PfEMP1 is the major protein from parasitic origin involved in the pathophysiology of severe malaria, and PfEMP1 domain subtypes are associated with the infection outcome. In addition, PfEMP1 variability is endless and current publicly available protein repositories do not reflect the high diversity of the sequences of PfEMP1 proteins. The identification of PfEMP1 protein sequences expressed with samples remains challenging. The aim of our study is to identify the different PfEMP1 proteins variants expressed within patient samples, and therefore identify PfEMP1 proteins domains expressed by patients presenting uncomplicated malaria or severe malaria in malaria endemic setting in Cotonou, Benin. Methods We performed a multi-omic approach to decipher PfEMP1 expression at the patient's level in different clinical settings. Using a combination of whole genome sequencing approach and RNA sequencing, we were able to identify new PfEMP1 sequences and created a new custom protein database. This database was used for protein identification in mass spectrometry analysis. Results The differential expression analysis of RNAsequencing data shows an increased expression of the var domains transcripts DBL alpha 1.7, DBL alpha 1.1, DBL alpha 2 and DBL beta 12 in samples from patients suffering from Cerebral Malaria compared to Uncomplicated Malaria. Our approach allowed us to attribute PfEMP1 sequences to each sample and identify new peptides associated to PfEMP1 proteins in mass spectrometry. Conclusion We highlighted the diversity of the PfEMP1 sequences from field sample compared to reference sequences repositories and confirmed the validity of our approach. These findings should contribute to further vaccine development strategies based on PfEMP1 proteins.	[Kamaliddin, Claire; Ezinmegnon, Sem; Agbota, Gino; Guemouri, Sayeh; Peirera, Celine; Coppee, Romain; Deloron, Philippe; Bertin, Gwladys I.] Univ Paris, IRD, MERIT, UMR 261, Paris, France; [Rombaut, David; Broussard, Cedric; Guillonneau, Francois] Univ Paris, 3p5 Prote Facil, Paris, France; [Guillochon, Emilie] Inovarion, Paris, France; [Royo, Jade; Aubouy, Agnes] Paul Sabatier Toulouse III Univ, IRD, PHARMADEV, UMR 152, Toulouse, France; [Ezinmegnon, Sem; Agbota, Gino] Ctr Rech & Etud Paludisme Associe Grossesse & Enf, Cotonou, Benin; [Huguet, Stephanie] Univ Paris Saclay, Univ Evry, Univ Paris Sud, CNRS,INRA,Inst Plant Sci Paris Saclay IPS2, Gif Sur Yvette, France; [Huguet, Stephanie] Univ Paris Diderot, CNRS, INRA, Inst Plant Sci Paris Saclay IPS2,Sorbonne Paris C, Gif Sur Yvette, France; [Alao, Jules M.] CHU MEL, Pediat Dept, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Bertin, GI (corresponding author), Univ Paris, IRD, MERIT, UMR 261, Paris, France.	gwladys.bertin@ird.fr	Aubouy, Agnes/J-7792-2015; Kamaliddin, Claire/ABD-1836-2021	Aubouy, Agnes/0000-0003-2265-4972; Kamaliddin, Claire/0000-0001-8198-6235; Bertin, Gwladys/0000-0002-2218-9591; Coppee, Romain/0000-0002-3024-5928; Broussard, Cedric/0000-0001-9508-2341; Rombaut, David/0000-0001-8910-0945; Guillonneau, Francois/0000-0003-1484-4696	Merieux Research Grant; Laboratoire d'Excellence GR-Ex, Paris, France [ANR-11-LABX-0051 - ANR-11-IDEX-0005-02]; NeuroCM project [ANR-17-CE17-0001]; LabEx Saclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]; MTCI Doctoral School (Paris Descartes University) [ED 563]; European Regional Development Fund (FEDER); Canceropo Ile-de-France; Merieux Research; Inovarion (Paris, France)	Merieux Research Grant; Laboratoire d'Excellence GR-Ex, Paris, France; NeuroCM project; LabEx Saclay Plant Sciences-SPS; MTCI Doctoral School (Paris Descartes University); European Regional Development Fund (FEDER)(European Commission); Canceropo Ile-de-France; Merieux Research; Inovarion (Paris, France)	This study was funded by Merieux Research Grant to GIB (http://www.institut-merieux.com/fr/accueil/); Laboratoire d'Excellence GR-Ex, Paris, France, reference ANR-11-LABX-0051 - ANR-11-IDEX-0005-02 to PD and FG; NeuroCM project, that is funded by ANR-17-CE17-0001, to PD and GIB; LabEx Saclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS) to the POPS platform (SH); PhD Scholarship from French Minister of Research through MTCI Doctoral School (ED 563, Paris Descartes University) awarded to CK. The European Regional Development Fund (FEDER) and Canceropo Ile-de-France provided a grant to the 3P5 group (DR, CB, FG) to purchase the Orbitrap. Funder Merieux Research was involved in the decision to publish. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Inovarion (Paris, France https://www.inovarion.com/) provided support in the form of salary to EG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Argy N, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.10.012; Avril M, 2016, MBIO, V7, DOI 10.1128/mBio.00615-16; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bengtsson A, 2013, J IMMUNOL, V190, P240, DOI 10.4049/jimmunol.1202578; Bertin GI, 2016, SCI REP-UK, V6, DOI 10.1038/srep26773; Bertin GI, 2013, J INFECT DIS, V208, P1987, DOI 10.1093/infdis/jit377; Bertin GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068368; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bull PC, 2016, PARASITOLOGY, V143, P171, DOI 10.1017/S0031182015001274; Carrington E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21591-8; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Dara A, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0422-4; Gautier EF, 2018, BLOOD ADV, V2, P2646, DOI 10.1182/bloodadvances.2018023515; Gautier EF, 2016, CELL REP, V16, P1470, DOI 10.1016/j.celrep.2016.06.085; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HESS DC, 1994, NEUROSCI LETT, V168, P201, DOI 10.1016/0304-3940(94)90450-2; Hviid L, 2018, EXPERT REV VACCINES; Jespersen JS, 2016, EMBO MOL MED, V8, P839, DOI 10.15252/emmm.201606188; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kessler A, 2017, CELL HOST MICROBE, V22, P601, DOI 10.1016/j.chom.2017.09.009; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lau CKY, 2015, CELL HOST MICROBE, V17, P118, DOI 10.1016/j.chom.2014.11.007; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Lennartz F, 2017, CELL HOST MICROBE, V21, P403, DOI 10.1016/j.chom.2017.02.009; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madkhali AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111518; Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mkumbaye SI, 2017, INFECT IMMUN, V85, DOI [10.1128/iai.00841-16, 10.1128/IAI.00841-16]; Ndam NT, 2017, J INFECT DIS, V215, P1918, DOI 10.1093/infdis/jix230; OTTO TD, 2018, WELLCOME OPEN RES, V3, DOI DOI 10.1038/S41598-018-21591-8; Ponts Nadia, 2012, Methods Mol Biol, V883, P59, DOI 10.1007/978-1-61779-839-9_4; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Smith JD, 2014, MOL BIOCHEM PARASIT, V195, P82, DOI 10.1016/j.molbiopara.2014.07.006; Smith JD, 2013, CELL MICROBIOL, V15, P1976, DOI 10.1111/cmi.12183; Storm J, EMBO MOL MED, pe9164; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tessem SK, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00485-17, 10.1128/iai.00485-17]; Tonkin-Hill GQ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004328; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Wahlgren M, 2017, NAT REV MICROBIOL	52	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218012	10.1371/journal.pone.0218012	http://dx.doi.org/10.1371/journal.pone.0218012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251748	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000008
J	Hou, CC; Chen, Y; Huang, XL; Huang, QH; Li, MZ; Tan, XY				Hou, Changchun; Chen, Yan; Huang, Xiaolin; Huang, Qinghua; Li, Mengze; Tan, Xiaoyu			miR-19 targets PTEN and mediates high mobility group protein B1(HMGB1)-induced proliferation and migration of human airway smooth muscle cells	PLOS ONE			English	Article							GROUP BOX-1; ASTHMA; INFLAMMATION; HMGB1; INNATE; GROWTH; CANCER	Background The abnormal proliferation and migration of airway smooth muscle (ASM) cells contributes to airway remodeling during asthma. MiR-19a has been demonstrated to promote cell proliferation and angiogenesis of several cancer types by regulating the PTEN/PI3K/AKT pathway. Our previous study has shown that High-mobility group box protein 1 (HMGB1) is involved in the pathogenesis of airway remodeling using a mouse model of chronic asthma. However, the effects of HMGB1 on proliferation and migration of ASM cells and its underlying mechanisms remain unknown. Methods Human ASM cells were obtained by primary explant techniques. MiR-19a expression was evaluated using qRT-PCR. Cell proliferation and migration were evaluated by the CCK-8 and the transwell migration assays, respectively. Transfection studies of ASM cells were performed to identify the underlying mechanisms. Results HMGB1 stimulated ASM cell proliferation and migration in a dose-dependent manner. The expression levels of miR-19a and the PTEN and AKT signaling proteins were also modulated by HMGB1. Functional studies indicated that overexpression of miR-19a enhanced the proliferation and migration of ASM cells, whereas inhibition of miR-19a decreased the proliferation and migration of ASM cells. Western blot analysis demonstrated that miR-19a negatively regulated PTEN expression and positively regulated p-AKT expression. MiR-19 only regulates the proliferation of HASM cells induced by HMGB1, but not PDGF, EGF, TGF-beta 1. Furthermore, we demonstrated that miR-19 contributed to the promoting effects of HMGB1 on ASM cells by targeting PTEN 3'-UTR. Conclusion Our results demonstrated that HMGB1 induced proliferation and migration of ASM cells via the miR-19a/PTEN/AKT axis and provided direct evidence on the role of HMGB1 in ASM cells proliferation in vitro. The present study further indicated that miR-19a may be explored as a potential novel therapeutic target to reverse proliferation and migration of ASM cells.	[Hou, Changchun; Chen, Yan; Tan, Xiaoyu] Guangxi Med Univ, Affiliated Hosp 2, Dept Resp Med, Nanning, Peoples R China; [Huang, Xiaolin] Guangxi Med Univ, Affiliated Hosp 2, Dept Intens Care Unit, Nanning, Peoples R China; [Huang, Qinghua; Li, Mengze] Guangxi Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Hou, CC (corresponding author), Guangxi Med Univ, Affiliated Hosp 2, Dept Resp Med, Nanning, Peoples R China.	houchangchun305@163.com	Li, Mengze/ABE-9949-2020	Li, Mengze/0000-0003-0620-6301	National natural science foundation of China [81600020]; natural science foundation of GuangXi [2016GXNSFBA380100]	National natural science foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of GuangXi(National Natural Science Foundation of Guangxi Province)	National natural science foundation of China (No: 81600020). The funders had no role in study design, http://www.nsfc.gov.cn/english/site_1/, data collection and analysis, decision to publish, or preparation of the manuscript. The natural science foundation of GuangXi (No: 2016GXNSFBA380100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova E, 2016, J ALLERGY CLIN IMMUN, V137, P58, DOI 10.1016/j.jaci.2015.05.031; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Bianchi ME, 2017, IMMUNOL REV, V280, P74, DOI 10.1111/imr.12601; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chen TJ, 2018, AM J PHYSIOL-LUNG C, V315, pL149, DOI 10.1152/ajplung.00137.2017; Chen TJ, 2015, AM J RESP CRIT CARE, V191, P678, DOI 10.1164/rccm.201405-0941OC; Chen YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18815; Deshpande DA, 2015, DRUG DEVELOP RES, V76, P286, DOI 10.1002/ddr.21267; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Dileepan M, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0107-0; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fuziwara CS, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00064; Goncharova EA, 2010, AM J PHYSIOL-LUNG C, V299, pL25, DOI 10.1152/ajplung.00228.2009; Haj-Salem I, 2015, ALLERGY, V70, P212, DOI 10.1111/all.12551; Halayko AJ, 2006, CURR DRUG TARGETS, V7, P525, DOI 10.2174/138945006776818728; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Homer RJ, 2005, PHYSIOLOGY, V20, P28, DOI 10.1152/physiol.00035.2004; Hou CC, 2015, CELL MOL IMMUNOL, V12, P409, DOI 10.1038/cmi.2014.60; Hou CC, 2011, MOL MED, V17, P807, DOI 10.2119/molmed.2010.00173; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Liu Y, 2015, EXP LUNG RES, V41, P535, DOI 10.3109/01902148.2015.1090501; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Prakash YS, 2016, AM J PHYSIOL-LUNG C, V311, pL1113, DOI 10.1152/ajplung.00370.2016; Saglani S, 2015, EUR RESPIR J, V46, P1796, DOI 10.1183/13993003.01196-2014; Simpson LJ, 2014, NAT IMMUNOL, V15, P1162, DOI 10.1038/ni.3026; Singh PB, 2017, J EXP MED, V214, P3627, DOI 10.1084/jem.20170545; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Wang HL, 2014, INT J CLIN EXP PATHO, V7, P3836; Zabini D, 2015, J CELL MOL MED, V19, P1151, DOI 10.1111/jcmm.12519	33	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219081	10.1371/journal.pone.0219081	http://dx.doi.org/10.1371/journal.pone.0219081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247032	Green Submitted, Green Published, gold			2022-12-26	WOS:000484911900075
J	Riso, EM; Toplaan, L; Viira, P; Vaiksaar, S; Jurimae, J				Riso, Eva-Maria; Toplaan, Lisette; Viira, Piret; Vaiksaar, Sille; Jurimae, Jaak			Physical fitness and physical activity of 6-7-year-old children according to weight status and sports participation	PLOS ONE			English	Article							PRESCHOOL-AGE CHILDREN; BODY-COMPOSITION; SEDENTARY TIME; ACTIVITY INTENSITY; ORGANIZED SPORTS; AEROBIC FITNESS; TEST BATTERY; OVERWEIGHT; ASSOCIATIONS; OBESITY	Background The aim of this study was to investigate physical fitness and physical activity (PA) of 6-7-year- old children just before entering school according to their sports club (SC) participation and weight status, and to examine possible associations of their body mass index, fat mass and fat-free mass with physical fitness and PA. Methods A total of 256 preschoolers aged 6 to 7 years participated in the study. Physical fitness was assessed using PREFIT test battery and objective PA by 7 day accelerometry. Body composition was estimated using two skinfold thickness parameters. SC participation and parental data were assessed by questionnaires. Results Children participating in SC had higher moderate-to-vigorous PA, vigorous PA and cardiorespiratory fitness than children not participating in SC. Overweight children had lower results in cardiorespiratory fitness and all weight-bearing fitness tests, and better results in handgrip strength test in comparison with normal weight children. Significant associations were found between body composition indices and physical fitness tests. PA level was associated with fat-free mass and physical fitness but not with fatness indices. Conclusions Weight-status and body composition together with PA level were associated with physical fitness level. The differences in physical fitness based more upon weight status than SC participation among 6-7-years old children.	[Riso, Eva-Maria; Toplaan, Lisette; Viira, Piret; Vaiksaar, Sille; Jurimae, Jaak] Univ Tartu, Inst Sports Sci & Physiotherapy, Fac Med, Tartu, Estonia	University of Tartu	Riso, EM (corresponding author), Univ Tartu, Inst Sports Sci & Physiotherapy, Fac Med, Tartu, Estonia.	eva-maria.riso@ut.ee			Estonian Ministry of Education and Science [IUT 20-58]	Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia)	Jaak Jurimae received funding from IUT 20-58 grant from the Estonian Ministry of Education and Science.	Agha-Alinejad H, 2015, J RES MED SCI, V20, P334; Ara I, 2004, INT J OBESITY, V28, P1585, DOI 10.1038/sj.ijo.0802754; Artero EG, 2010, SCAND J MED SCI SPOR, V20, P418, DOI 10.1111/j.1600-0838.2009.00959.x; Cadenas-Sanchez C, 2016, J SCI MED SPORT, V19, P910, DOI 10.1016/j.jsams.2016.02.003; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Collings PJ, 2017, SPORTS MED, V47, P769, DOI 10.1007/s40279-016-0606-x; Collings PJ, 2013, AM J CLIN NUTR, V97, P1020, DOI 10.3945/ajcn.112.045088; Ebenegger V, 2012, OBESITY FACTS, V5, P23, DOI 10.1159/000336603; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Graf C, 2011, EPMA J, V2, P261, DOI 10.1007/s13167-011-0091-0; Henriksson P, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080473; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Jones RA, 2009, INT J PEDIATR OBES, V4, P54, DOI 10.1080/17477160802199984; Jouret B, 2007, AM J CLIN NUTR, V85, P1643, DOI 10.1093/ajcn/85.6.1643; Kobel S, 2015, PUBLIC HEALTH, V129, P237, DOI 10.1016/j.puhe.2014.12.002; Konstabel K, 2014, INT J OBESITY, V38, pS135, DOI 10.1038/ijo.2014.144; Leppanen MH, 2016, INT J OBESITY, V40, P1126, DOI 10.1038/ijo.2016.54; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Marill KA, 2004, ACAD EMERG MED, V11, P87, DOI 10.1197/S1069-6563(03)00600-6; Marques A, 2016, J SCI MED SPORT, V19, P154, DOI 10.1016/j.jsams.2015.02.007; Martinez-Tellez B, 2016, PEDIATR OBES, V11, P468, DOI 10.1111/ijpo.12088; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Moliner-Urdiales D, 2010, EUR J APPL PHYSIOL, V109, P1119, DOI 10.1007/s00421-010-1457-z; Niederer I, 2012, RES Q EXERCISE SPORT, V83, P12, DOI 10.1080/02701367.2012.10599820; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2015, SPORTS MED, V45, P533, DOI 10.1007/s40279-014-0281-8; Riso EM, 2019, ACTA PAEDIATR, V108, P1624, DOI 10.1111/apa.14750; Riso EM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5406-9; Riso EM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3000-6; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Silva P, 2017, EUR J SPORT SCI, V17, P208, DOI 10.1080/17461391.2016.1226389; Sirard JR, 2008, PEDIATR EXERC SCI, V20, P198, DOI 10.1123/pes.20.2.198; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Tokmakidis SP, 2006, EUR J PEDIATR, V165, P867, DOI 10.1007/s00431-006-0176-2; Vaitkeviciute D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107759; Willig AL, 2011, OBESITY, V19, P2222, DOI 10.1038/oby.2011.109; World Health Organization, 2015, PUBLIC HLTH IMPLICAT; Zahner L, 2009, MED SCI SPORT EXER, V41, P344, DOI 10.1249/MSS.0b013e318186d843	39	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218901	10.1371/journal.pone.0218901	http://dx.doi.org/10.1371/journal.pone.0218901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237932	gold, Green Submitted, Green Published			2022-12-26	WOS:000484856000048
J	Peck, DT; Seeley, TD				Peck, David Thomas; Seeley, Thomas Dyer			Mite bombs or robber lures? The roles of drifting and robbing in Varroa destructor transmission from collapsing honey bee colonies to their neighbors	PLOS ONE			English	Article							MESOSTIGMATA VARROIDAE; INVASION; POPULATION; EVOLUTION; INCREASE	When honey bee colonies collapse from high infestations of Varroa mites, neighboring colonies often experience surges in their mite populations. Collapsing colonies, often called "mite bombs", seem to pass their mites to neighboring colonies. This can happen by mite-infested workers from the collapsing colonies drifting into the neighboring colonies, or by mite-free workers from the neighboring colonies robbing out the collapsing colonies, or both. To study inter-colony mite transmission, we positioned six nearly mite-free colonies of black-colored bees around a cluster of three mite-laden colonies of yellow-colored bees. We then monitored the movement of bees between the black-bee and yellow-bee colonies before, during, and after mite-induced collapse of the yellow-bee colonies. Throughout the experiment, we monitored each colony's mite level. We found that large numbers of mites spread to the black-bee colonies (in both nearby and distant hives) when the yellow-bee colonies collapsed from high mite infestations and became targets of robbing by the black-bee colonies. We conclude that "robber lures" is a better term than "mite bombs" for describing colonies that are succumbing to high mite loads and are exuding mites to neighboring colonies.	[Peck, David Thomas; Seeley, Thomas Dyer] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Peck, DT (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	dtp36@cornell.edu		Peck, David/0000-0002-4650-6811	Honeybee Capital	Honeybee Capital	This work was supported in part by a grant to TDS from Katherine Collins, of Honeybee Capital (honeybeecapital. org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Cale GH., 1946, HIVE HONEYBEE, P214; Cervo R, 2014, J EXP BIOL, V217, P2998, DOI 10.1242/jeb.099978; DeGrandi-Hoffman G, 2017, ENVIRON ENTOMOL, V46, P737, DOI 10.1093/ee/nvx077; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.01; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Ewald PW, 2004, INFECT DIS CLIN N AM, V18, P1, DOI 10.1016/S0891-5520(03)00099-0; Fraser HM, 1947, P ANN REP ACC YEAR 1, P23; FREE JB, 1954, BEHAVIOUR, V7, P233; Frey E, 2014, J ECON ENTOMOL, V107, P508, DOI 10.1603/EC13381; Frey E, 2011, J APICULT RES, V50, P138, DOI 10.3896/IBRA.1.50.2.05; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Garrido C, 2003, APIDOLOGIE, V34, P535, DOI 10.1051/apido:2003041; Goodwin RM, 2006, J APICULT RES, V45, P155, DOI 10.1080/00218839.2006.11101335; GREATTI M, 1992, EXP APPL ACAROL, V16, P279, DOI 10.1007/BF01218569; JAY S C, 1966, Journal of Apicultural Research, V5, P137; JAY S. CAMERON, 1965, J APICUL RES, V4, P167; Kevan PG, 2006, AM BEE J, V146, P694; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Kuenen LPS, 1997, J INSECT BEHAV, V10, P213, DOI 10.1007/BF02765554; Loftus JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150362; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mortensen AN, 2018, PARASITOL RES, V117, P3337, DOI 10.1007/s00436-018-6035-z; Oliver R., 2018, AM BEE J, V158, P297; Peck DT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167798; Pfeiffer KJ, 1998, INSECT SOC, V45, P151, DOI 10.1007/s000400050076; SAKOFSKI F, 1990, APIDOLOGIE, V21, P547, DOI 10.1051/apido:19900608; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Seeley TD, 2015, APIDOLOGIE, V46, P716, DOI 10.1007/s13592-015-0361-2; Seeley TD, 2015, APIDOLOGIE, V46, P654, DOI 10.1007/s13592-015-0355-0; von Buttel-Reepen H., 1900, GLEANINGS BEE CULT, V20, p[1, 223]	31	40	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218392	10.1371/journal.pone.0218392	http://dx.doi.org/10.1371/journal.pone.0218392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226130	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700016
J	Mancini, V; Tommasin, D; Li, YL; Reeves, J; Baets, R; Greenwald, S; Segers, P				Mancini, Viviana; Tommasin, Daniela; Li, Yanlu; Reeves, Jonathan; Baets, Roel; Greenwald, Steve; Segers, Patrick		CARDIS Consortium	Detecting carotid stenosis from skin vibrations using Laser Doppler Vibrometry - An in vitro proof-of-concept	PLOS ONE			English	Article							DIRECT NUMERICAL-SIMULATION; ARTERY STENOSIS; TURBULENCE INTENSITY; FLOW; PREVALENCE; DISEASE	Early detection of asymptomatic carotid stenosis may help identifying individuals at risk of stroke. We explore a new method based on laser Doppler vibrometry (LDV) which could allow the non-contact detection of stenosis from neck skin vibrations due to stenosis-induced flow disturbances. Experimental fluid dynamical tests were performed with water on a severely stenosed patient-specific carotid bifurcation model. Measurements were taken under various physiological flow regimes both in a compliant and stiff-walled version of the model, at 1 to 4 diameters downstream from the stenosis. An inter-arterial pressure catheter was positioned as reference. Increasing flow led to corresponding increase in power spectral density (PSD) of pressure and LDV recordings in the 0-500 Hz range. The stiff model lead to higher PSD. PSD of the LDV signal was less dependent on the downstream measurement location than pressure. The strength of the association between PSD and flow level, model material and measuring location was highest in the 0-50 Hz range, however useful information was found up to 200 Hz. This proof-of-concept suggests that LDV has the potential to detect stenosis-induced disturbed flow. Further computational and clinical validation studies are ongoing to assess the sensitivity and specificity of the technique for clinical screening.	[Mancini, Viviana; Tommasin, Daniela; Segers, Patrick] Univ Ghent, BioMMeda, Ghent, Belgium; [Li, Yanlu; Baets, Roel] Univ Ghent, Dept Informat Technol, Ghent, Belgium; [Reeves, Jonathan; Greenwald, Steve] Queen Mary Univ London, Blizard Inst, London, England; [Reeves, Jonathan] Barts Hlth NHS Trust, Clin Phys, London, England	Ghent University; Ghent University; University of London; Queen Mary University London; Barts Health NHS Trust	Mancini, V (corresponding author), Univ Ghent, BioMMeda, Ghent, Belgium.	viviana.mancini@ugent.be	Segers, Patrick/AAA-7844-2020	Segers, Patrick/0000-0003-3870-3409; Greenwald, Stephen/0000-0002-8471-7070; Reeves, Jonathan/0000-0001-9339-6777; Viviana, Mancini/0000-0003-4775-6115; Li, Yanlu/0000-0003-3440-1972	EU H2020 [644798]	EU H2020	The study was supported within the context of the Early stage CARdio Vascular Disease Detection with Integrated Silicon Photonics (CARDIS) project, funded by an EU H2020 644798 grant to RB. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was done within the context of the Early stage CARdio Vascular Disease Detection with Integrated Silicon Photonics (CARDIS) project, funded by an EU H2020 644798 grant. We gratefully acknowledge the contribution of the entire consortium and the teams behind the development and construction of the multi-beam LDV prototype.	AHMED SA, 1983, J BIOMECH, V16, P505, DOI 10.1016/0021-9290(83)90065-9; Beach KW, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-39; COLGAN MP, 1988, J VASC SURG, V8, P674, DOI 10.1067/mva.1988.avs0080674; De Melis M, 2008, AM J HYPERTENS, V21, P1280, DOI 10.1038/ajh.2008.280; de Weerd M, 2010, STROKE, V41, P1294, DOI 10.1161/STROKEAHA.110.581058; de Weerd M, 2009, STROKE, V40, P1105, DOI 10.1161/STROKEAHA.108.532218; EHN, 2017, EUR CARD DIS STAT 20, P192; Groen HC, 2010, J BIOMECH, V43, P2332, DOI 10.1016/j.jbiomech.2010.04.039; Heinzel G., 2002, TECHNICAL REPORT, P1; Iannaccone F, 2014, INT J ARTIF ORGANS, V37, P928, DOI 10.5301/ijao.5000379; Kefayati S, 2014, J BIOMECH, V47, P253, DOI 10.1016/j.jbiomech.2013.09.007; KHALIFA AMA, 1981, J BIOMECH, V14, P279, DOI 10.1016/0021-9290(81)90038-5; Lanzino G, 2009, MAYO CLIN PROC, V84, P362, DOI 10.1016/S0025-6196(11)60546-6; Lee SE, 2008, J BIOMECH, V41, P2551, DOI 10.1016/j.jbiomech.2008.03.038; Li Y., 2013, MINIATURIZED LASER D; Li YL, 2018, OPT EXPRESS, V26, P3638, DOI 10.1364/OE.26.003638; Li YL, 2013, BIOMED OPT EXPRESS, V4, P1229, DOI 10.1364/BOE.4.001229; Likittanasombut P, 2006, J NEUROIMAGING, V16, P34, DOI 10.1177/1051228405001523; Mancini V, 2019, CARDIOVASC ENG TECHN, V10, P277, DOI 10.1007/s13239-019-00410-9; Moomaw CJ, 2013, NEUROEPIDEMIOLOGY, V40, P36, DOI [10.1159/000341410, DOI 10.1159/000341410]; Morbiducci U, 2007, ANN BIOMED ENG, V35, P45, DOI 10.1007/s10439-006-9202-9; OBRIEN PC, 1988, MAYO CLIN PROC, V63, P1043, DOI 10.1016/S0025-6196(12)64922-2; PRATI P, 1992, STROKE, V23, P1705, DOI 10.1161/01.STR.23.12.1705; Raman G, 2012, AHRQ TECHNOL ASSESS, V1, P1; Rothwell PM, 1994, AM HEAR ASS, P2435; Sandercock PAG, 2002, PRACT NEUROL, V2, P221, DOI DOI 10.1046/j.1474-7766.2002.00078.x; Scalise L, 2008, PROC SPIE, V7098, DOI 10.1117/12.803011; Touze E, 2006, STROKE, V37, P2904, DOI 10.1161/01.STR.0000248764.51601.bb; UEMATSU S, 1983, STROKE, V14, P256, DOI 10.1161/01.STR.14.2.256; Valen-Sendstad K, 2014, J BIOMECH, V47, P3210, DOI 10.1016/j.jbiomech.2014.04.018; Varghese SS, 2007, J FLUID MECH, V582, P281, DOI 10.1017/S0022112007005836; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wong EY, 2013, EUR RADIOL, V23, P1720, DOI 10.1007/s00330-012-2741-6	33	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218317	10.1371/journal.pone.0218317	http://dx.doi.org/10.1371/journal.pone.0218317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220141	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500034
J	Manuwald, U; Schoffer, O; Hegewald, J; Grosse, J; Kugler, J; Kapellen, TM; Kiess, W; Rothe, U				Manuwald, Ulf; Schoffer, Olaf; Hegewald, Janice; Grosse, Johann; Kugler, Joachim; Kapellen, Thomas Michael; Kiess, Wieland; Rothe, Ulrike			Ketoacidosis at onset of type 1 diabetes in children up to 14 years of age and the changes over a period of 18 years in Saxony, Eastern-Germany: A population based register study	PLOS ONE			English	Article							DIAGNOSIS; RISK; ASSOCIATION; ADOLESCENTS; PREVALENCE; GENOTYPES; MELLITUS	Objective The aim of this study was to examine the incidence trends of type 1 diabetes diagnosed with ketoacidosis in Saxony, Germany from 1999 to 2016. Methods The population based Childhood Diabetes Registry of Saxony comprising valid data for all children aged 0-14 years diagnosed with type 1 diabetes from1999 to 2016 were used for the analyses. Direct age-standardized incidence rates were calculated and the effects of age, sex, calendar year, home districts and family history of any types of diabetes on the incidence were modelled using Poisson regression. Trend analyses for standard rate ratios of children with moderate and severe diabetic ketoacidosis versus children with type 1 diabetes with non-diabetic ketoacidosis were performed using join point regression. Results The rate of ketoacidosis at the time of the type 1 diabetes diagnosis was high with 35.2% during the entire observation period in Saxony. The Poisson regression analysis indicated a statistically significant increased occurrence of diabetic ketoacidosis for younger age-groups, but no statistically significant differences between boys and girls. The join point trend analyses show that the proportion of severe and moderate ketoacidosis is increasing disproportionally to the increase in incidence of type 1 diabetes over the years. Conclusion Due to the observed increasing incidence of diabetes as well of diabetic ketoacidosis, an educational prevention campaign is needed in Saxony as soon as possible to aid pediatricians, general physicians as well as general public to identify the early signs of type 1 diabetes.	[Manuwald, Ulf; Kugler, Joachim; Rothe, Ulrike] Tech Univ Dresden, Fac Med Carl Gustav Carus, Hlth Sci Publ Hlth, Dresden, Germany; [Schoffer, Olaf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany; [Hegewald, Janice] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst & Policlin Occupat & Social Med, Dresden, Germany; [Hegewald, Janice] Tech Univ Chemnitz, Inst Sociol, Chemnitz, Germany; [Grosse, Johann] Sachs Landesvereinigung Gesundheitsforderung eV, Saxonian Network Hlth Promot, Dresden, Germany; [Kapellen, Thomas Michael; Kiess, Wieland] Univ Leipzig, Dept Women & Child Hlth, Ctr Pediat Res, Hosp Children & Adolescents, Leipzig, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Chemnitz; Leipzig University	Manuwald, U (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Hlth Sci Publ Hlth, Dresden, Germany.	Ulf.Manuwald@tu-dresden.de	Schoffer, Olaf/R-1841-2016	Schoffer, Olaf/0000-0001-6922-7148; Hegewald, Janice/0000-0003-3388-161X; Prof. Rothe, Ulrike/0000-0001-9779-7260	Open Access Publication Funds of the SLUB/TU Dresden	Open Access Publication Funds of the SLUB/TU Dresden	We acknowledge support by the Open Access Publication Funds of the SLUB/TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanani NMK, 2016, SCI WORLD J, V2016, DOI [10.1155/2016/6736029, DOI 10.1155/2016/6736029]; Andersen MLM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064632; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bendas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132716; Bodin J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/208947; Boyle P, 1991, CANC REGISTRATION PR, V95; Breslow N E, 1987, IARC Sci Publ, P1; Cardwell CR, 2012, DIABETES CARE, V35, P2215, DOI 10.2337/dc12-0438; Cardwell CR, 2005, DIABETIC MED, V22, P200, DOI 10.1111/j.1464-5491.2005.01369.x; Cohen AK, 2018, J PUBLIC HEALTH-HEID, V26, P235, DOI 10.1007/s10389-017-0857-5; Galler A, 2010, HORM RES PAEDIAT, V74, P285, DOI 10.1159/000303141; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Grosse J, 2018, HORM METAB RES, V50, P209, DOI 10.1055/s-0044-102090; Gulden E, 2015, CLIN IMMUNOL, V159, P143, DOI 10.1016/j.clim.2015.05.013; Hathout EH, 2006, PEDIATR DIABETES, V7, P81, DOI 10.1111/j.1399-543X.2006.00150.x; Hekkala A, 2007, DIABETES CARE, V30, P861, DOI 10.2337/dc06-2281; Hekkala A, 2011, EUR J ENDOCRINOL, V165, P813, DOI 10.1530/EJE-11-0376; Hermann R, 2003, DIABETOLOGIA, V46, P588, DOI 10.1007/s00125-003-1076-x; Hommel A, 2018, HORM METAB RES, V50, P44, DOI 10.1055/s-0043-120921; Jefferies C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10358; Kukko M, 2004, DIABETES CARE, V27, P676, DOI 10.2337/diacare.27.3.676; Larsson HE, 2011, DIABETES CARE, V34, P2347, DOI 10.2337/dc11-1026; Manuwald U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183665; Mohr SB, 2008, DIABETOLOGIA, V51, P1391, DOI 10.1007/s00125-008-1061-5; Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Rewers A, 2015, JAMA-J AM MED ASSOC, V313, P1570, DOI 10.1001/jama.2015.1414; Samuelsson U, 2005, DIABETES RES CLIN PR, V68, P49, DOI 10.1016/j.diabres.2004.08.002; Ucar A, 2013, J PEDIATR ENDOCR MET, V26, P1059, DOI 10.1515/jpem-2013-0060; Usher-Smith JA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4092; Vukovic R, 2018, EUR J PEDIATR, V177, P1155, DOI 10.1007/s00431-018-3172-4; Wojcik M, 2015, EUR J PEDIATR, V174, P1319, DOI 10.1007/s00431-015-2537-1; Wolfsdorf JI, 2018, PEDIATR DIABETES, V19, P155, DOI 10.1111/pedi.12701	33	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218807	10.1371/journal.pone.0218807	http://dx.doi.org/10.1371/journal.pone.0218807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220176	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500092
J	Pearce, TL; Wilson, CR; Gent, DH; Scott, JB				Pearce, Tamieka Lee; Wilson, Calum Rae; Gent, David Hugh; Scott, Jason Barry			Multiple mutations across the succinate dehydrogenase gene complex are associated with boscalid resistance in Didymella tanaceti in pyrethrum	PLOS ONE			English	Article							RAY BLIGHT DISEASE; BOTRYTIS-CINEREA; ALTERNARIA-ALTERNATA; MOLECULAR CHARACTERIZATION; SDHI FUNGICIDES; IRON-SULFUR; SCLEROTINIA-SCLEROTIORUM; INHIBITING FUNGICIDES; ZYMOSEPTORIA-TRITICI; TAN SPOT	Failures in control of tan spot of pyrethrum, caused by Didymella tanaceti, has been associated with decreased sensitivity within the pathogen population to the succinate dehydrogenase inhibitor (SDHI) fungicide boscalid. Sequencing the SdhB, SdhC, and SdhD subunits of isolates with resistant and sensitive phenotypes identified 15 mutations, resulting in three amino acid substitutions in the SdhB (H277Y/R, I279V), six in the SdhC (S73P, G79R, H134R, H134Q, S135R and combined H134Q/S135R), and two in the SdhD (D112E, H122R). In vitro testing of their boscalid response and estimation of resistance factors (RF) identified isolates with wild-type (WT) Sdh genotypes were sensitive to boscalid. Isolates with SdhB-I279V, SdhC-H134Q and SdhD-D112E exhibited moderate resistance phenotypes (10 >= RF < 100) and isolates with SdhC-H134R exhibited very high resistance phenotypes (RF >= 1000). All other substitutions were associated with high resistance phenotypes (100 >= RF < 1000). High-resolution melt assays were designed and used to estimate the frequencies of substitutions in four field populations (n = 774) collected in August (pre-boscalid application) and November (post-boscalid application) 2012. The SdhB-H277Y, SdhC-H134R and SdhB-H277R genotypes were most frequently observed across populations at 56.7, 19.0, and 10.3%, respectively. In August 92.9% of D. tanaceti contained a substitution associated with decreased sensitivity. Following boscalid application, this increased to 98.9%, with no WT isolates detected in three fields. Overlaying previously obtained microsatellite and mating-type data revealed that all ten recurrent substitutions were associated with multiple genotypes. Thus, boscalid insensitivity in D. tanaceti appears widespread and not associated with clonal spread of a limited pool of individuals.	[Pearce, Tamieka Lee; Scott, Jason Barry] Univ Tasmania, Tasmanian Inst Agr, Hort Ctr, Burnie, Tas, Australia; [Wilson, Calum Rae] Univ Tasmania, Tasmanian Inst Agr, Hort Ctr, Sandy Bay, Tas, Australia; [Gent, David Hugh] USDA ARS, Forage Seed & Cereal Res Unit, Corvallis, OR USA	University of Tasmania; University of Tasmania; United States Department of Agriculture (USDA)	Pearce, TL (corresponding author), Univ Tasmania, Tasmanian Inst Agr, Hort Ctr, Burnie, Tas, Australia.	Tamieka.Pearce@utas.edu.au	Scott, Jason B/C-2395-2014; Scott, Jason B/D-4553-2011	Scott, Jason B/0000-0001-9443-4384; Scott, Jason B/0000-0001-9443-4384; Gent, David/0000-0001-9529-9831; Pearce, Tamieka/0000-0001-7611-2322; Wilson, Calum/0000-0001-5434-3816	Australian Government through Australian Research Council; Botanical Resources Australia Pty. Ltd (ARC Linkage Project) [LP130100739]	Australian Government through Australian Research Council(Australian Research Council); Botanical Resources Australia Pty. Ltd (ARC Linkage Project)	Funding for this research was provided by the Australian Government through Australian Research Council with contribution from Botanical Resources Australia Pty. Ltd (ARC Linkage Project LP130100739), https://www.arc.gov.au/, to F. Hay, C. Wilson, S. Pethybridge and D. Gent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2016, 60 GERM CROP PROT C; [Anonymous], 2021, LANG ENV STAT COMP; Avenot HF, 2008, PHYTOPATHOLOGY, V98, P736, DOI 10.1094/PHYTO-98-6-0736; Avenot HF, 2014, PLANT DIS, V98, P197, DOI 10.1094/PDIS-04-13-0459-RE; Avenot HF, 2007, PLANT DIS, V91, P1345, DOI 10.1094/PDIS-91-10-1345; Avenot HF, 2012, PEST MANAG SCI, V68, P645, DOI 10.1002/ps.2311; Avenot HF, 2010, CROP PROT, V29, P643, DOI 10.1016/j.cropro.2010.02.019; Bot BM, 2016, R PACK NPLR N PAR LO; Brent K. J., 1998, FUNGICIDE RESISTANCE; Casida JE, 1995, PYRETHRUM FLOWER PRO; Chatzidimopoulos M, 2014, PLANT PATHOL, V63, P1336, DOI 10.1111/ppa.12210; De Miccolis A. R., 2014, PEST MANAG SCI, V70, P1884, DOI [10.1002/ps.3748, DOI 10.1002/PS.3748]; Deising HB, 2008, BRAZ J MICROBIOL, V39, P286, DOI [10.1590/S1517-83822008000200017, 10.1590/S1517-838220080002000017]; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Fan Z, 2015, PLANT DIS, V99, P1744, DOI 10.1094/PDIS-03-15-0354-RE; Fernandez-Ortuno D, 2017, PLANT DIS; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Glattli A., 2009, Association Francaise de Protection des Plantes, 9eme conference international sur les maladies des plantes, Tours, France, 8 et 9 Decembre 2009, P670; Gudmestad NC, 2013, PLANT DIS, V97, P952, DOI 10.1094/PDIS-12-12-1176-RE; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hay FS, 2015, PLANT DIS, V99, P1227, DOI 10.1094/PDIS-12-14-1357-RE; Heick TM, 2017, CROP PROT, V99, P108, DOI 10.1016/j.cropro.2017.05.009; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Huang SB, 2013, CURR OPIN PLANT BIOL, V16, P344, DOI 10.1016/j.pbi.2013.02.007; Jones SJ, 2011, NEW ZEAL J CROP HORT, V39, P203, DOI 10.1080/01140671.2011.563425; Jutsum AR, 1998, PESTIC SCI, V54, P435, DOI 10.1002/(SICI)1096-9063(199812)54:4&lt;435::AID-PS844&gt;3.0.CO;2-K; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khater H. F., 2012, Pharmacologia, V3, P641; Knapova G, 2002, PLANT PATHOL, V51, P641, DOI 10.1046/j.1365-3059.2002.00750.x; Laleve A, 2014, FUNGAL GENET BIOL, V67, P24, DOI 10.1016/j.fgb.2014.03.006; Laleve A, 2014, ENVIRON MICROBIOL, V16, P2253, DOI 10.1111/1462-2920.12282; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Leroux P, 2013, PEST MANAG SCI, V69, P15, DOI 10.1002/ps.3408; Leroux P, 2010, APPL ENVIRON MICROB, V76, P6615, DOI 10.1128/AEM.00931-10; Li L, 2020, PEST MANAG SCI, V76, P236, DOI 10.1002/ps.5502; Lichtemberg P, 2018, CALIF AGR, V72, P170, DOI 10.3733/ca.2018a0022; Mallik I, 2014, PHYTOPATHOLOGY, V104, P40, DOI 10.1094/PHYTO-02-13-0041-R; Matheron ME, 2004, PLANT DIS, V88, P665, DOI 10.1094/PDIS.2004.88.6.665; Miyamoto T, 2010, PLANT PATHOL, V59, P873, DOI 10.1111/j.1365-3059.2010.02321.x; Mondal SN, 2005, PLANT DIS, V89, P1186, DOI 10.1094/PD-89-1186; Pearce TL, 2016, PLANT PATHOL, V65, P1170, DOI 10.1111/ppa.12493; Pearce TL, 2019, PHYTOPATHOLOGY, V109, P155, DOI 10.1094/PHYTO-08-17-0280-R; Pearce TL, 2016, PHYTOPATHOLOGY, V106, P1521, DOI 10.1094/PHYTO-01-16-0038-R; Pethybridge SJ, 2008, PLANT PATHOL, V57, P1058, DOI 10.1111/j.1365-3059.2008.01896.x; Pethybridge SJ, 2008, PLANT DIS, V92, P1260, DOI 10.1094/PDIS-92-9-1260; Pethybridge SJ, 2008, PLANT DIS, V92, P887, DOI 10.1094/PDIS-92-6-0887; Pethybridge SJ, 2007, PLANT DIS, V91, P1116, DOI 10.1094/PDIS-91-9-1116; Pethybridge SJ, 2006, PLANT DIS, V90, P891, DOI 10.1094/PD-90-0891; Pethybridge SJ, 2013, PLANT DIS, V97, P1431, DOI 10.1094/PDIS-11-12-1102-RE; Pethybridge SJ, 1998, AUSTRALAS PLANT PATH, V27, P45, DOI 10.1071/AP98004; Popko JT, 2018, PLANT DIS, V102, P2625, DOI 10.1094/PDIS-12-17-2025-RE; Rehfus A, 2018, PLANT PATHOL, V67, P175, DOI 10.1111/ppa.12715; Rehfus A, 2016, PEST MANAG SCI, V72, P1977, DOI 10.1002/ps.4244; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; Samaras A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01815; Scalliet G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035429; Scott J, 2017, PLANT DIS; Shrestha SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177220; Sierotzki H., 2011, Modern fungicides and antifungal compounds VI. 16th International Reinhardsbrunn Symposium, Friedrichroda, Germany, April 25-29, 2010, P179; Sierotzki H, 2013, PHYTOPATHOLOGY, V103, P880, DOI 10.1094/PHYTO-01-13-0009-RVW; Skinner T, 1998, CURR GENET, V34, P393, DOI 10.1007/s002940050412; Stammler G, 2007, P 16 INT PLANT PROT; Stevenson K, 2008, APS CENT M JUL 26 30; Thomas A, 2012, PLANT DIS, V96, P979, DOI 10.1094/PDIS-09-11-0744-RE; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaghefi N, 2012, AUSTRALAS PLANT PATH, V41, P675, DOI 10.1007/s13313-012-0161-3; Vaghefi N, 2015, PHYTOPATHOLOGY, V105, P358, DOI 10.1094/PHYTO-08-14-0212-R; Vega B, 2015, PLANT DIS, V99, P231, DOI 10.1094/PDIS-04-14-0374-RE; Vega B, 2012, PLANT DIS, V96, P1262, DOI 10.1094/PDIS-12-11-1037-RE; Veloukas T, 2013, PLANT DIS, V97, P118, DOI 10.1094/PDIS-03-12-0322-RE; Veloukas T, 2011, PLANT DIS, V95, P1302, DOI 10.1094/PDIS-04-11-0317; Venables W. N., 2002, STAT COMPLEMENTS MOD; Weber RWS, 2011, PLANT DIS, V95, P1263, DOI 10.1094/PDIS-03-11-0209; Yamashita M, 2018, PEST MANAG SCI, V74, P672, DOI 10.1002/ps.4761; Yang JH, 2015, PLANT DIS, V99, P65, DOI 10.1094/PDIS-04-14-0387-RE; Yin YN, 2011, PHYTOPATHOLOGY, V101, P986, DOI 10.1094/PHYTO-01-11-0016	77	9	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218569	10.1371/journal.pone.0218569	http://dx.doi.org/10.1371/journal.pone.0218569			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220147	Green Published, gold, Green Accepted			2022-12-26	WOS:000484893500067
J	Shum, M; Houde, VP; Bellemare, V; Moreira, RJ; Bellmann, K; St-Pierre, P; Viollet, B; Foretz, M; Marette, A				Shum, Michael; Houde, Vanessa P.; Bellemare, Vicky; Moreira, Rafael Junges; Bellmann, Kerstin; St-Pierre, Philippe; Viollet, Benoit; Foretz, Marc; Marette, Andre			Inhibition of mitochondrial complex 1 by the S6K1 inhibitor PF-4708671 partly contributes to its glucose metabolic effects in muscle and liver cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; obesity; mechanistic target of rapamycin (mTOR); glucose metabolism; gluconeogenesis; AMPK-activated protein kinase (AMPK); glucose homeostasis; mitochondrial complex I; p70 S6 kinase (S6K1); PF-4708671	SKELETAL-MUSCLE; INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; AS160 PHOSPHORYLATION; AMINO-ACID; AMPK; ACTIVATION; RAPAMYCIN; KINASE; PATHWAY	mTOR complex 1 (mTORC1) and p70 S6 kinase (S6K1) are both involved in the development of obesity-linked insulin resistance. Recently, we showed that the S6K1 inhibitor PF-4708671 (PF) increases insulin sensitivity. However, we also reported that PF can increase glucose metabolism even in the absence of insulin in muscle and hepatic cells. Here we further explored the potential mechanisms by which PF increases glucose metabolism in muscle and liver cells independent of insulin. Time course experiments revealed that PF induces AMP-activated protein kinase (AMPK) activation before inhibiting S6K1. However, PF-induced glucose uptake was not prevented in primary muscle cells from AMPK alpha 1/2 double KO (dKO) mice. Moreover, PF-mediated suppression of hepatic glucose production was maintained in hepatocytes derived from AMPK alpha 1/2-dKO mice. Remarkably, PF could still reduce glucose production and activate AMPK in hepatocytes from S6K1/2 dKO mice. Mechanistically, bioenergetics experiments revealed that PF reduces mitochondrial complex I activity in both muscle and hepatic cells. The stimulatory effect of PF on glucose uptake was partially reduced by expression of the Saccharomyces cerevisiae NADH:ubiquinone oxidoreductase in L6 cells. These results indicate that PF-mediated S6K1 inhibition is not required for its effect on insulin-independent glucose metabolism and AMPK activation. We conclude that, although PF rapidly activates AMPK, its ability to acutely increase glucose uptake and suppress glucose production does not require AMPK activation. Unexpectedly, PF rapidly inhibits mitochondrial complex I activity, a mechanism that partially underlies PF's effect on glucose metabolism.	[Shum, Michael; Houde, Vanessa P.; Bellemare, Vicky; Moreira, Rafael Junges; Bellmann, Kerstin; St-Pierre, Philippe; Marette, Andre] Univ Laval, Quebec Heart & Lung Inst, Dept Med, Quebec City, PQ G1V 4G5, Canada; [Viollet, Benoit; Foretz, Marc] INSERM, Inst Cochin, U1016, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR8104, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France	Laval University; Quebec Heart & Lung Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Marette, A (corresponding author), Hop Laval, Quebec Heart & Lung Inst, Dept Med, Pavillon Marguerite dYouville,Room Y4308, Ste Foy, PQ G1V 4G5, Canada.	andre.marette@criucpq.ulaval.ca	FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Moreira, Rafael/0000-0002-7796-4233; Marette, Andre/0000-0003-3950-5973; Houde, Vanessa P./0000-0003-1932-805X; Shum, Michael/0000-0001-8784-9928	Canadian Institutes of Health Research Foundation [143247]; Region Ile-de-France (CORDDIM); Societe Francophone du Diabete; Fondation pour le Recherche Medicale [DEQ20150934718]; Cardiometabolic Health, Diabetes, and Obesity Research Network	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Region Ile-de-France (CORDDIM)(Region Ile-de-France); Societe Francophone du Diabete; Fondation pour le Recherche Medicale(Fondation pour la Recherche Medicale); Cardiometabolic Health, Diabetes, and Obesity Research Network	This work was funded by Canadian Institutes of Health Research Foundation Grant 143247, a grant from the Cardiometabolic Health, Diabetes, and Obesity Research Network (to A.M.), and grants from Region Ile-de-France (CORDDIM), Societe Francophone du Diabete, and Fondation pour le Recherche Medicale (DEQ20150934718) (to M.F. and B.V.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Deshmukh A, 2009, CELL MOL LIFE SCI, V66, P1457, DOI 10.1007/s00018-009-8818-y; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Hasenour CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170382; Hou WL, 2018, J CELL MOL MED, V22, P1316, DOI 10.1111/jcmm.13432; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kjobsted R, 2018, FASEB J, V32, P1741, DOI 10.1096/fj.201700442R; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shum M, 2016, DIABETOLOGIA, V59, P592, DOI 10.1007/s00125-015-3839-6; Treebak JT, 2007, AM J PHYSIOL-ENDOC M, V292, pE715, DOI 10.1152/ajpendo.00380.2006; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vainer GW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107364; Villani LA, 2016, MOL METAB, V5, P1048, DOI 10.1016/j.molmet.2016.08.014; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242	36	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12250	12260		10.1074/jbc.RA119.008488	http://dx.doi.org/10.1074/jbc.RA119.008488			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31243102	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000484284500026
J	Weinmann, AE; Goldstein, ST; Triantaphyllou, MV; Langer, MR				Weinmann, Anna E.; Goldstein, Susan T.; Triantaphyllou, Maria V.; Langer, Martin R.			Effects of sampling site, season, and substrate on foraminiferal assemblages grown from propagule banks from lagoon sediments of Corfu Island (Greece, Ionian Sea)	PLOS ONE			English	Article							BENTHIC FORAMINIFERA; LIFE-CYCLE; EPIPHYTIC FORAMINIFERA; COASTAL ENVIRONMENTS; BIOTIC INDEX; NEW-ZEALAND; COLONIZATION; DISPERSAL; DYNAMICS; GULF	Foraminiferal propagule banks occur in fine sediment fractions that contain small individuals of benthic foraminifera. These sediments include locally sourced juveniles and propagules, as well as allochthonous propagules that have dispersed from surrounding areas. Such propagules can remain viable even under unfavorable local conditions. When exposed to more favorable conditions, they may grow to adult stages. Accordingly, during environmental changes, propagule banks have the potential to function as species pools and allow quick assemblage reactions. The propagule method was designed to study responses of foraminiferal assemblages by exposing propagule banks to controlled conditions in the laboratory, an approach that is applicable to a variety of ecological questions. Therefore it is important to understand the nature and dynamics of propagule banks, including local and seasonal influences. To obtain insights into the composition of local propagule banks, we studied experimentally grown assemblages from two shallow-water lagoons on Corfu Island in western Greece, and compared the results with in situ assemblages. We sampled in spring and autumn of 2017 and experimental treatments included the use of different substrates in our experiments to account for potential effects on assemblage compositions. Results revealed that sediments from each lagoon contained a distinct propagule bank. We found abundant allochthonous taxa among specimens grown in all experimental treatments, indicating dispersal of propagules, and possibly also juveniles, from adjacent regions into both lagoons. The time of sampling had a significant effect on experimental assemblages, indicating that the composition of propagule banks can vary throughout the year. However, no significant differences were found in assemblages grown in different substrata, suggesting a stronger influence of water variables ( e. g., temperature or salinity) on assemblage compositions. Moreover, the experimental set-ups favored small, fast-growing, sediment-dwelling species tolerant of relatively high organic content. Our findings highlight the potential of propagule banks as species pools and will help to refine and improve future applications of the method.	[Weinmann, Anna E.; Langer, Martin R.] Rhein Friedrich Wilhelms Univ Bonn, Inst Geowissensch & Meteorol, Abt Palaontol, Bonn, Germany; [Goldstein, Susan T.] Univ Georgia, Dept Geol, Athens, GA 30602 USA; [Triantaphyllou, Maria V.] Natl & Kapodistrian Univ Athens, Fac Geol & Geoenvironm, Athens, Greece	University of Bonn; University System of Georgia; University of Georgia; National & Kapodistrian University of Athens	Weinmann, AE (corresponding author), Rhein Friedrich Wilhelms Univ Bonn, Inst Geowissensch & Meteorol, Abt Palaontol, Bonn, Germany.	a.weinmann@uni-bonn.de	Triantaphyllou, Maria/AAL-7877-2021; Weinmann, Anna E./AAS-7145-2021	Triantaphyllou, Maria/0000-0001-7508-7508; Weinmann, Anna E./0000-0002-7999-0486	Deutsche Forschungsgemeinschaft (DFG) [WE 5340/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding for this study was provided by a grant from the Deutsche Forschungsgemeinschaft (DFG) to AEW (WE 5340/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello Giuseppe, 2006, Bollettino della Societa Paleontologica Italiana, V45, P1; AlmogiLabin A, 1995, MAR MICROPALEONTOL, V26, P153, DOI 10.1016/0377-8398(95)00013-5; Alve E, 2003, LIMNOL OCEANOGR, V48, P2163, DOI 10.4319/lo.2003.48.6.2163; Alve E, 2002, J MICROPALAEONTOL, V21, P95, DOI 10.1144/jm.21.1.95; Alve E, APPROACHES STUDY LIV; Alve E, 2016, MAR MICROPALEONTOL, V122, P1, DOI 10.1016/j.marmicro.2015.11.001; Alve E, 2010, J SEA RES, V63, P36, DOI 10.1016/j.seares.2009.09.003; BANNER FT, 1985, J FORAMIN RES, V15, P159, DOI 10.2113/gsjfr.15.3.159; BARMAWIDJAJA DM, 1992, J FORAMIN RES, V22, P297, DOI 10.2113/gsjfr.22.4.297; Barras C, 2014, ECOL INDIC, V36, P719, DOI 10.1016/j.ecolind.2013.09.028; Benito X, 2016, ESTUAR COAST SHELF S, V180, P97, DOI 10.1016/j.ecss.2016.06.001; Berkeley A, 2007, EARTH-SCI REV, V83, P205, DOI 10.1016/j.earscirev.2007.04.003; BOLTOVSKOY E, 1969, contributions from the cushman foundation for foraminiferal research, V20, P87; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Bouchet VMP, 2007, J FORAMIN RES, V37, P204, DOI 10.2113/gsjfr.37.3.204; Burkett AM, 2016, DEEP-SEA RES PT I, V117, P39, DOI 10.1016/j.dsr.2016.08.011; BUZAS MA, 1994, SCIENCE, V264, P1439, DOI 10.1126/science.264.5164.1439; Buzas MA, 2002, J FORAMIN RES, V32, P68, DOI 10.2113/0320068; Carnahan EA, 2009, MAR POLLUT BULL, V59, P221, DOI 10.1016/j.marpolbul.2009.08.008; Cherif O.H., 1970, THESIS; Cimerman F., 1991, MEDITERRANEAN FORAMI, V30; Culver SJ, 2012, J FORAMIN RES, V42, P109, DOI 10.2113/gsjfr.42.2.109; DAVAUD E, 1995, J SEDIMENT RES A, V65, P136; Debenay JP, 2015, MAR POLLUT BULL, V93, P103, DOI 10.1016/j.marpolbul.2015.02.009; Debenay JP, 2009, J FORAMIN RES, V39, P249, DOI 10.2113/gsjfr.39.4.249; Debenay JP, 2006, ESTUAR COAST SHELF S, V67, P181, DOI 10.1016/j.ecss.2005.11.014; Debenay JP, 2005, J FORAMIN RES, V35, P327, DOI 10.2113/35.4.327; Debenay JP, 2000, T GEOBIOL, V15, P39; Debenay JP, 1998, MAR MICROPALEONTOL, V35, P67, DOI 10.1016/S0377-8398(98)00011-5; Dimiza Margarita D., 2016, Revue de Micropaleontologie, V59, P19, DOI 10.1016/j.revmic.2015.10.002; Dimiza MD, 2016, ECOL INDIC, V60, P611, DOI 10.1016/j.ecolind.2015.07.030; du Chatelet EA, 2017, MICROPALEONTOLOGY, V63, P257; Duffield CJ, 2014, J FORAMIN RES, V44, P416, DOI 10.2113/gsjfr.44.4.416; Duffield CJ, 2015, MAR MICROPALEONTOL, V120, P20, DOI 10.1016/j.marmicro.2015.08.002; Fajemila Olugbenga T., 2016, Revue de Micropaleontologie, V59, P397, DOI 10.1016/j.revmic.2016.09.002; Favry A, 1997, OCEANOL ACTA, V20, P387; Ferrarin C, 2014, GEOPHYS RES LETT, V41, P5935, DOI 10.1002/2014GL060843; Finger KL, 2018, AQUAT INVASIONS, V13, P17, DOI 10.3391/ai.2018.13.1.03; Fischer P, 2016, QUATERN INT, V401, P4, DOI 10.1016/j.quaint.2015.07.019; Frezza Virgilio, 2005, Bollettino della Societa Paleontologica Italiana, V44, P155; Frontalini F, 2013, ACTA PROTOZOOL, V52, P147, DOI 10.4467/16890027AP.13.0014.1111; Fujita K, 2004, J FORAMIN RES, V34, P169, DOI 10.2113/34.3.169; Goldstein ST, 2011, MAR ECOL PROG SER, V437, P1, DOI 10.3354/meps09296; Guy-Haim T, 2017, LIMNOL OCEANOGR LETT, V2, P80, DOI 10.1002/lol2.10039; Hallock P, 2003, ENVIRON MONIT ASSESS, V81, P221, DOI 10.1023/A:1021337310386; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hart M. B., 2016, GEOSCIENCE S W ENGLA, V14, P39; Hayek LAC, 2013, J FORAMIN RES, V43, P305, DOI 10.2113/gsjfr.43.3.305; Hayward BW, 1996, J FORAMIN RES, V26, P150, DOI 10.2113/gsjfr.26.2.150; HAYWARD BW, 1994, MICROPALEONTOLOGY, V40, P185, DOI 10.2307/1485816; Hottinger L., 1993, RECENT FORAMINIFERID; Jorissen F, 2018, MAR MICROPALEONTOL, V140, P33, DOI 10.1016/j.marmicro.2017.12.006; Koukousioura O, 2012, QUATERN INT, V261, P105, DOI 10.1016/j.quaint.2011.07.004; Langer MR, 2006, MICROPALEONTOLOGY, V52, P343, DOI 10.2113/gsmicropal.52.4.343; Langer MR, 2016, NEUES JAHRB GEOL P-A, V281, P327, DOI 10.1127/njgpa/2016/0602; Langer MR, 2016, BIOL INVASIONS, V18, P1335, DOI 10.1007/s10530-016-1070-0; LANGER MR, 1993, MAR MICROPALEONTOL, V20, P235, DOI 10.1016/0377-8398(93)90035-V; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Mateu-Vicens G, 2010, J FORAMIN RES, V40, P134, DOI 10.2113/gsjfr.40.2.134; Meric E, 2004, Benthic Foraminifera of Eastern Aegean Sea (Turkey) systematics and autoecology, V18; Milker Y, 2012, PALAEONTOL ELECTRON, V15; Morvan J, 2006, MAR MICROPALEONTOL, V61, P131, DOI 10.1016/j.marmicro.2006.05.009; Mouanga GH, 2018, THESIS U BONN GERMAN; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; MURRAY JW, 1982, J FORAMIN RES, V12, P51, DOI 10.2113/gsjfr.12.1.51; Murray JW, 2000, J FORAMIN RES, V30, P66, DOI 10.2113/0300066; Murray JW, 2000, J FORAMIN RES, V30, P177, DOI 10.2113/0300177; Myers EH, 1938, P NATL ACAD SCI USA, V24, P10, DOI 10.1073/pnas.24.1.10; Naeher S, 2012, BIOGEOSCIENCES, V9, P5081, DOI 10.5194/bg-9-5081-2012; Ribes T, 2000, J FORAMIN RES, V30, P192, DOI 10.2113/0300192; Ross BJ, 2016, J FORAMIN RES, V46, P358, DOI 10.2113/gsjfr.46.4.358; Ruckert-Hilbig A., 1983, TUBINGER MIKROPALAON, V1, P1; Schmidt C, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2998-4; Schonfeld J, 2007, MAR MICROPALEONTOL, V65, P78, DOI 10.1016/j.marmicro.2007.06.003; Schonfeld J, 2018, J MICROPALAEONTOL, V37, P383, DOI 10.5194/jm-37-383-2018; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; Triantaphyllou MV, 2012, J FORAMIN RES, V42, P143, DOI 10.2113/gsjfr.42.2.143; Weinmann AE, 2017, J FORAMIN RES, V47, P325, DOI 10.2113/gsjfr.47.4.325; Weinmann AE, 2016, MAR ECOL-EVOL PERSP, V37, P891, DOI 10.1111/maec.12368; WELTJE G, 1993, GEOLOGY, V21, P307, DOI 10.1130/0091-7613(1993)021<0307:AIPORI>2.3.CO;2	80	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219015	10.1371/journal.pone.0219015	http://dx.doi.org/10.1371/journal.pone.0219015			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251773	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000036
J	Izquierdo, L; Mellon, G; Buchaillet, C; Fac, C; Soutiere, MP; Pallier, C; Dulioust, A; Roque-Afonso, AM				Izquierdo, Laure; Mellon, Guillaume; Buchaillet, Celine; Fac, Catherine; Soutiere, Marie-Pierre; Pallier, Coralie; Dulioust, Anne; Roque-Afonso, Anne-Marie			Prevalence of hepatitis E virus and reassessment of HIV and other hepatitis virus seroprevalences among French prison inmates	PLOS ONE			English	Article							INFECTIONS; FRANCE	Background Prison inmates are considered a high-risk population for blood-borne and enterically transmitted infections before and during their imprisonment. Hepatitis E virus (HEV) prevalence is unknown among French inmates, whereas a reassessment of human immunodeficiency virus (HIV), hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) prevalences is required to describe the epidemiologic evolution in this high-risk population. Methods A prospective survey was conducted from June to December 2017 in Fresnes prison, a penitentiary center with 2,581 inmates. In addition to HIV, HAV, HBV and HCV testing, which is offered to all patients at admission, we systematically offered HEV screening. Retrospective serological data for HIV, HBV and HCV, collected annually from 2014 to 2017, were also used to assess evolution. Results In 2017, 1,093 inmates were screened for HEV, HIV, HAV, HBV and HCV. Prevalences in this population were 8.2%, 1.3%, 62.7%, 1.9% and 2.9%, respectively. HEV seroprevalence increased with age (p<0.0001) and was higher among Eastern Europe born inmates (p<0.0001). Between 2014 and 2017, HIV seroprevalence remained steady, while a decrease in HBV and HCV seroprevalence was observed. Conclusions Compared to the reported prevalence in French blood donors, HEV seroprevalence was remarkably low in French inmates. HIV, HAV, HBV and HCV prevalences among prisoners were higher than reported in the general population.	[Izquierdo, Laure; Soutiere, Marie-Pierre; Pallier, Coralie; Roque-Afonso, Anne-Marie] Hop Paul Brousse, AP HP, Virol, Villejuif, France; [Izquierdo, Laure; Roque-Afonso, Anne-Marie] INSERM U1193, Villejuif, France; [Izquierdo, Laure; Roque-Afonso, Anne-Marie] Univ Paris Sud, Le Kremlin Bicetre, France; [Mellon, Guillaume; Dulioust, Anne] Med Etab Publ Natl Sante Fresnes EPSNF, Fresnes, France; [Mellon, Guillaume] Hop St Louis, AP HP, Malad Infectieuses & Trop, Paris, France; [Buchaillet, Celine; Fac, Catherine] Ctr Hosp Univ Bicetre, Ctr Penitentiaire Fresnes, UCSA, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Mellon, G (corresponding author), Med Etab Publ Natl Sante Fresnes EPSNF, Fresnes, France.; Mellon, G (corresponding author), Hop St Louis, AP HP, Malad Infectieuses & Trop, Paris, France.	gmellon@mgh.harvard.edu	Roque-Afonso, Anne-Marie/AAF-9706-2021; Mellon, Guillaume/GOE-5391-2022					Marques NMD, 2011, BRAZ J INFECT DIS, V15, P272, DOI 10.1016/S1413-8670(11)70188-X; Daniel Dhumeaux, 2016, PRISE CHARGE THERAPE; Direction de l'Administration Penitentiaire, STAT MENS PERS ECR D; Dolan K, 2016, LANCET, V388, P1089, DOI 10.1016/S0140-6736(16)30466-4; Falla AM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2988-x; Gough E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-777; Hartl J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080211; Jacomet C, 2016, EUR J PUBLIC HEALTH, V26, P122, DOI 10.1093/eurpub/ckv183; Mansuy JM, 2016, HEPATOLOGY, V63, P1145, DOI 10.1002/hep.28436; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; Michel L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2421-y; Morice Y, 2001, J GEN VIROL, V82, P1001, DOI 10.1099/0022-1317-82-5-1001; MORLAT P, 2017, PRISE CHARGE MED PER; Rapicetta M, 2013, INFECTION, V41, P69, DOI 10.1007/s15010-012-0385-8; Roux P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005694; Semaille C, 2013, Euro Surveill, V18, DOI 10.2807/1560-7917.ES2013.18.28.20524; Zuin M, 2017, EUR J CLIN MICROBIOL, V36, P479, DOI 10.1007/s10096-016-2821-7	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218482	10.1371/journal.pone.0218482	http://dx.doi.org/10.1371/journal.pone.0218482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242210	gold, Green Published, Green Submitted			2022-12-26	WOS:000482883600032
J	Mazanderani, AH; Motaze, NV; McCarthy, K; Suchard, M; du Plessis, NM				Mazanderani, Ahmad Haeri; Motaze, Nkengafac Villyen; McCarthy, Kerrigan; Suchard, Melinda; du Plessis, Nicolette Marie			Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015	PLOS ONE			English	Article							EPIDEMIOLOGY; VACCINATION; INFECTION	Introduction South Africa is considered highly endemic for hepatitis A virus (HAV) although few seroprevalence studies have been conducted over the past two decades. The World Health Organization recommends integrating HAV vaccination into national childhood immunization schedules where there is transition from high to intermediate endemicity. As a means of gauging age-specific rates of infection, we report HAV seroprevalence rates among specimens tested for HAV serology within South Africas public health sector from 2005-2015. Materials and methods Hepatitis A serology results (Anti-HAV IgM, IgG and total antibody) from 2005-2015 were extracted from South Africas National Health Laboratory Services Corporate Data Warehouse (NHLS CDW), the central data repository of all laboratory test-sets within the public health sector. Results were extracted according to test-set, result, date of testing, health facility, name, surname, age, and sex. Anti-HAV IgG results were merged with total antibody results to reflect anti-HAV seroprevalence. Testing volume, positivity rates and age-specific anti-HAV seroprevalence rates by year and geographic distribution are described. Results and discussion A total of 501 083 HAV IgM results were retrieved, of which 16 423 (3.3%) were positive, 484 259 (96.6%) negative and 401 (0.1%) equivocal; and 34 710 HAV total antibody/IgG tests of which 30 675 (88.4%) were positive, 4 020 (11.6%) negative and 15 equivocal. Whereas IgM positivity was highest among the 1-4 year age group (33.5%) and lowest among patients >45 years (<0.5%), total antibody positivity ranged from its lowest level of 52.7% in the 1-4 year age group increasing to levels of >90% only after 25 years of age. Conclusion Anti-HAV total antibody testing within the South African public health sector demonstrates seroprevalence rates reach levels >90% only in adulthood, suggesting South Africa could be in transition from high to intermediate endemicity. Prospective studies with geographically representative sampling are required to confirm these findings and evaluate provincial and urban/rural heterogeneity.	[Mazanderani, Ahmad Haeri] Ctr HIV & STIs, Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Mazanderani, Ahmad Haeri] Univ Pretoria, Fac Hlth Sci, Dept Med Virol, Pretoria, South Africa; [Motaze, Nkengafac Villyen; Suchard, Melinda] Natl Inst Communicable Dis, Ctr Vaccines & Immunol, Natl Hlth Lab Serv, Johannesburg, South Africa; [Motaze, Nkengafac Villyen] Stellenbosch Univ, Dept Global Hlth, Cape Town, South Africa; [McCarthy, Kerrigan] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Outbreak Response Unit, Johannesburg, South Africa; [Suchard, Melinda] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Chem Pathol, Johannesburg, South Africa; [du Plessis, Nicolette Marie] Univ Pretoria, Fac Hlth Sci, Kalafong Prov Tertiary Hosp, Dept Paediat, Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Stellenbosch University; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Pretoria	Mazanderani, AH (corresponding author), Ctr HIV & STIs, Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.; Mazanderani, AH (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Med Virol, Pretoria, South Africa.	ahmadh@nicd.ac.za		Haeri Mazanderani, Ahmad/0000-0001-7644-153X; Suchard, Melinda Shelley/0000-0002-6978-4654; McCarthy, Kerrigan/0000-0001-8958-9795				Franco E, 2012, WORLD J HEPATOL, V4, P68, DOI 10.4254/wjh.v4.i3.68; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jacobsen KH, 2005, INT J EPIDEMIOL, V34, P600, DOI 10.1093/ije/dyi062; Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857; Lehohla P., 2015, 03 18 07 GHS SERIES; MacLeod W., 2015, ANAL BIG DATA BETTER; MARTIN DJ, 1994, T ROY SOC TROP MED H, V88, P288, DOI 10.1016/0035-9203(94)90080-9; Ozbek OA, 2004, J EVAL CLIN PRACT, V10, P519, DOI 10.1111/j.1365-2753.2003.00447.x; Rosenthal P, 2003, HEPATOLOGY, V37, P44, DOI 10.1053/jhep.2003.50016; SATHAR MA, 1994, J MED VIROL, V44, P9, DOI 10.1002/jmv.1890440104; Schoub BD, 1999, S AFR MED J, V89, P1074; Sherman GG, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010701; van Walraven C, 2002, J EVAL CLIN PRACT, V8, P327, DOI 10.1046/j.1365-2753.2002.00336.x; WHO, 2012, WEEKLY EPIDEMIOLOGIC, V87, P261; Wolfe S, 2015, EPIDEMIOLOGY PREVENT; World Health Organization, 2011, IMMUNOLOGICAL BASIS	16	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0216033	10.1371/journal.pone.0216033	http://dx.doi.org/10.1371/journal.pone.0216033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242191	Green Published, gold, Green Submitted			2022-12-26	WOS:000482883600006
J	Bouchard, C; Boudko, DY; Jiang, RHY				Bouchard, Christelle; Boudko, Dmitri Y.; Jiang, Rays H. Y.			A SLC6 transporter cloned from the lion's mane jellyfish (Cnidaria, Scyphozoa) is expressed in neurons	PLOS ONE			English	Article							MOTOR-NERVE NET; AMINO-ACID TRANSPORTERS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; SYSTEM; IDENTIFICATION; SYNAPSES; FAMILY; ORGANIZATION; COELENTERATA	In the course of recent comparative genomic studies conducted on nervous systems across the phylogeny, current thinking is leaning in favor of more heterogeneity among nervous systems than what was initially expected. The isolation and characterization of molecular components that constitute the cnidarian neuron is not only of interest to the physiologist but also, on a larger scale, to those who study the evolution of nervous systems. Understanding the function of those ancient neurons involves the identification of neurotransmitters and their precursors, the description of nutrients used by neurons for metabolic purposes and the identification of integral membrane proteins that bind to those compounds. Using a molecular cloning strategy targeting membrane proteins that are known to be present in all forms of life, we isolated a member of the solute carrier family 6 from the scyphozoan jellyfish Cyanea capillata. The phylogenetic analysis suggested that the new transporter sequence belongs to an ancestral group of the nutrient amino acid transporter subfamily and is part of a cluster of cnidarian sequences which may translocate the same substrate. We found that the jellyfish transporter is expressed in neurons of the motor nerve net of the animal. To this end, we established an in situ hybridization protocol for the tissues of C. capillata and developed a specific antibody to the jellyfish transporter. Finally, we showed that the gene that codes for the jellyfish transporter also expresses a long non-coding RNA. We hope that this research will contribute to studies that seek to understand what constitutes a neuron in species that belong to an ancient phylum.	[Bouchard, Christelle] Univ S Florida, Coll Sci & Math, Sarasota, FL 34243 USA; [Boudko, Dmitri Y.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Physiol & Biophys, N Chicago, IL USA; [Jiang, Rays H. Y.] Univ S Florida, USF Genom Program, Coll Publ Hlth, Global & Planetary Hlth, Tampa, FL USA	State University System of Florida; University of South Florida; Chicago Medical School; Rosalind Franklin University Medical & Science; State University System of Florida; University of South Florida	Bouchard, C (corresponding author), Univ S Florida, Coll Sci & Math, Sarasota, FL 34243 USA.	bouchardc@usf.edu		Bouchard, Christelle/0000-0002-0044-984X	National Science Foundation [IOS1021769]	National Science Foundation(National Science Foundation (NSF))	The research was partly supported by a National Science Foundation grant IOS1021769, awarded to Peter Anderson, who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; ANDERSON PAV, 1985, J NEUROPHYSIOL, V53, P821, DOI 10.1152/jn.1985.53.3.821; ANDERSON PAV, 1989, J NEUROBIOL, V20, P435, DOI 10.1002/neu.480200513; ANDERSON PAV, 1983, J NEUROPHYSIOL, V50, P671, DOI 10.1152/jn.1983.50.3.671; ANDERSON PAV, 1981, J MORPHOL, V170, P383, DOI 10.1002/jmor.1051700309; ANDERSON PAV, 1984, BIOL BULL-US, V166, P396, DOI 10.2307/1541225; Anderson PAV, 2009, INVERTEBR NEUROSCI, V9, P167, DOI 10.1007/s10158-009-0095-9; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Apte S, 1996, ENDOCYT CELL RES, V11, P129; BARZANSKY B, 1974, AM ZOOL, V14, P575; Basyuk E, 2000, Nucleic Acids Res, V28, pE46, DOI 10.1093/nar/28.10.e46; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Boudko D.Y., 2010, P171; Boudko DY, 2012, J INSECT PHYSIOL, V58, P433, DOI 10.1016/j.jinsphys.2011.12.018; Boudko DY, 2010, EPITHELIAL TRANSPORT PHYSIOLOGY, P379, DOI 10.1007/978-1-60327-229-2_16; Boudko DY, 2005, P NATL ACAD SCI USA, V102, P1360, DOI 10.1073/pnas.0405183101; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Bullock T., 1965, STRUCTURE FUNCTION N; CARLBERG M, 1995, BIOL BULL-US, V188, P78, DOI 10.2307/1542069; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Fairweather SJ, 2015, J BIOL CHEM, V290, P24308, DOI 10.1074/jbc.M115.648519; Farmer MK, 2000, GENOMICS, V70, P241, DOI 10.1006/geno.2000.6387; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hagglund MGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058651; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; HORRIDGE A, 1954, Q J MICROSC SCI, V95, P85; HORRIDGE GA, 1962, Q J MICROSC SCI, V103, P531; Jeziorski MC, 1998, J BIOL CHEM, V273, P22792, DOI 10.1074/jbc.273.35.22792; Jezzini SH, 2005, J NEUROSCI METH, V149, P15, DOI 10.1016/j.jneumeth.2005.05.007; Kinjo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082410; Kowalczuk S, 2005, BIOCHEM J, V386, P417, DOI 10.1042/BJ20050100; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leontovich AA, 2000, DEVELOPMENT, V127, P907; Li RF, 2016, J PROTEOMICS, V148, P57, DOI 10.1016/j.jprot.2016.07.023; Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125001; Luque JM, 1996, EUR J NEUROSCI, V8, P127, DOI 10.1111/j.1460-9568.1996.tb01173.x; Masson J, 1996, RECEPTOR CHANNEL, V4, P227; MASSON J, 1995, J NEUROSCI RES, V42, P423, DOI 10.1002/jnr.490420317; Meleshkevitch EA, 2006, J EXP BIOL, V209, P3183, DOI 10.1242/jeb.02374; Meleshkevitch EA, 2009, J EXP BIOL, V212, P1559, DOI 10.1242/jeb.027383; Moroz LL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0041; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; PASSANO LM, 1982, ELECTRICAL CONDUCTIO, P149; PATTON ML, 1972, AM ZOOL, V12, pR35; Plickert G, 1997, DEV GENES EVOL, V207, P362, DOI 10.1007/s004270050124; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ptitsyn A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138006; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rashid F, 2016, GENOM PROTEOM BIOINF, V14, P73, DOI 10.1016/j.gpb.2016.03.005; Ripps H, 2012, MOL VIS, V18, P2673; Rocha J, 2011, MAR DRUGS, V9, P1860, DOI 10.3390/md9101860; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Ryan JF, 2014, ZOOLOGY, V117, P225, DOI 10.1016/j.zool.2014.06.001; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Satterlie RA, 2014, BIOL BULL-US, V226, P29, DOI 10.1086/BBLv226n1p29; SAUVAGEAU M, 2013, ELIFE, V2, P74122, DOI DOI 10.1002/DNEU.22555; SCHLICHTER D, 1978, MAR BIOL, V45, P97, DOI 10.1007/BF00390545; SCHWAB WE, 1980, AM ZOOL, V20, P941; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Singer D, 2009, J BIOL CHEM, V284, P19953, DOI 10.1074/jbc.M109.011171; Takanaga H, 2005, BIOCHEM BIOPH RES CO, V337, P892, DOI 10.1016/j.bbrc.2005.09.128; Takanaga H, 2005, J BIOL CHEM, V280, P8974, DOI 10.1074/jbc.M413027200; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Weiler A, 2017, NEUROBIOL DIS, V107, P15, DOI 10.1016/j.nbd.2017.02.008; Westfall JA, 1996, J NEUROCYTOL, V25, P735, DOI 10.1007/BF02284838; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zaia KA, 2009, J BIOL CHEM, V284, P8439, DOI 10.1074/jbc.M806407200	75	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218806	10.1371/journal.pone.0218806	http://dx.doi.org/10.1371/journal.pone.0218806			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233570	gold, Green Published, Green Submitted			2022-12-26	WOS:000484896700041
J	Monteiro, KJL; Calegar, DA; Santos, JP; Bacelar, PAA; Coronato-Nunes, B; Reis, ERC; Boia, MN; Carvalho-Costa, FA; Jaeger, LH				Monteiro, Kerla J. L.; Calegar, Deiviane A.; Santos, Jessica P.; Bacelar, Polyanna A. A.; Coronato-Nunes, Beatriz; Reis, Elis Regina C.; Boia, Marcio N.; Carvalho-Costa, Filipe A.; Jaeger, Lauren H.			Genetic diversity of Ascaris spp. infecting humans and pigs in distinct Brazilian regions, as revealed by mitochondrial DNA	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SUUM; LUMBRICOIDES; TRANSMISSION; VARIABILITY	In this study, we assessed the genetic diversity of Ascaris lumbricoides / Ascaris suum circulating in humans and pigs, exploring potential zoonotic cycles in endemic areas in Brazil. We carried out cross-sectional surveys in four municipalities: Santa Isabel do Rio Negro (SIRN-AM) (n = 328); Nossa Senhora de Nazare (NSN-PI) and Teresina (TER-PI) (n = 605 and n = 297, respectively); and Cachoeiras de Macacu (CAM-RJ) (n = 543). We also studied 61 fecal samples/adult worms obtained from pigs (n = 53 in NSN-PI and n = 8 in TER-PI). A similar to 450 bp fragment of the Ascaris cytochrome c oxidase subunit 1 (cox1) and similar to 400 bp of the NADH dehydrogenase subunit 1 (nad1) were amplified and sequenced. Maximum-likeli-hood (ML) tree and Median-joining (MJ) haplotype network analyses were performed. We also performed scanning electron micrographs of adult specimens. Positivity rates were 93/328 (28.4%) in SIRN-AM, 6/297 (2.0%) in TER-PI, 0/605 (0%) in NSN-PI, and 6/543 (1.1%) in CAM-RJ. In NSN-PI it reached 11/53 (20.7%) in pigs. The MJ network based on cox1 locus (383 bp) revealed three main clusters, one centered around haplotypes H01/H28/H32 and the other around H07/H11. The cox1 haplotypes had a heterogeneous distribution, showing no pattern by geographic region, and high haplotype diversity. The ML trees based on cox1 and nad1 loci showed a similar topology with each other, and with the haplotype networks. Three distinct clusters were observed. Sequences of cox1 and nad1 from humans and animals were distributed throughout the tree and it was not possible to differentiate specimens of human and swine origin. Ascaris populations obtained from humans and swine in different Brazilian regions are not discriminable through the genetic markers used, which indicates the potential for zoonotic transmission and the need for better control of these infections in swine herds, mainly when created in a peridomestic environment.	[Monteiro, Kerla J. L.; Calegar, Deiviane A.; Santos, Jessica P.; Bacelar, Polyanna A. A.; Coronato-Nunes, Beatriz; Reis, Elis Regina C.; Carvalho-Costa, Filipe A.; Jaeger, Lauren H.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil; [Monteiro, Kerla J. L.; Santos, Jessica P.; Bacelar, Polyanna A. A.; Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz Piaui, Escritorio Tecn Reg, Teresina, Piaui, Brazil; [Boia, Marcio N.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, RJ, Brazil; [Jaeger, Lauren H.] Univ Fed Juiz de Fora, Dept Ciencias Farmaceut, Juiz De Fora, MG, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Juiz de Fora	Jaeger, LH (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.; Jaeger, LH (corresponding author), Univ Fed Juiz de Fora, Dept Ciencias Farmaceut, Juiz De Fora, MG, Brazil.	laurenhj@hotmail.com	Jaeger, Lauren Hubert/GVU-0797-2022	Jaeger, Lauren H./0000-0001-8031-7742; SANTOS, JESSICA/0000-0002-1639-517X	Oswaldo Cruz Foundation (Fiocruz); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)	Oswaldo Cruz Foundation (Fiocruz); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Oswaldo Cruz Foundation (Fiocruz) and the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES) to KJLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; [Anonymous], 2016, GUIA PRATICO OPERACI; ANSEL M, 1973, International Journal for Parasitology, V3, P317, DOI 10.1016/0020-7519(73)90109-4; Ascunce MS, 2013, AM J PHYS ANTHROPOL, V152, P118, DOI 10.1002/ajpa.22336; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Belew S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004057; Bendall RP, 2011, EMERG INFECT DIS, V17, P1964, DOI 10.3201/eid1710.101826; Betson M, 2014, J INFECT DIS, V210, P932, DOI 10.1093/infdis/jiu193; Betson M, 2012, T ROY SOC TROP MED H, V106, P75, DOI 10.1016/j.trstmh.2011.10.011; Betson M, 2011, T ROY SOC TROP MED H, V105, P370, DOI 10.1016/j.trstmh.2011.04.009; Blouin B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006688; Boes J, 1998, VET PARASITOL, V75, P181, DOI 10.1016/S0304-4017(97)00197-0; Bronzan RN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006551; Brooker SJ, 2015, LANCET INFECT DIS, V15, P941, DOI 10.1016/S1473-3099(15)70042-3; Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003; Chelladurai JJ, 2017, J INFECT DIS, V215, P131, DOI 10.1093/infdis/jiw507; Criscione CD, 2007, P ROY SOC B-BIOL SCI, V274, P2669, DOI 10.1098/rspb.2007.0877; Alves EBD, 2016, J INFECT DIS, V213, P1355, DOI 10.1093/infdis/jiw027; Dutto M, 2013, CENT EUR J PUBL HEAL, V21, P224, DOI 10.21101/cejph.a3798; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farrell SH, 2018, CLIN INFECT DIS, V66, pS253, DOI 10.1093/cid/ciy002; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Iniguez AM, 2012, T ROY SOC TROP MED H, V106, P604, DOI 10.1016/j.trstmh.2012.06.009; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; Leles D, 2010, PARASITOL INT, V59, P93, DOI 10.1016/j.parint.2009.10.001; Leles D, 2009, VET PARASITOL, V163, P167, DOI 10.1016/j.vetpar.2009.03.050; Monteiro KJL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860024, 10.1590/s1678-9946201860024]; Liu GH, 2012, GENE, V492, P110, DOI 10.1016/j.gene.2011.10.043; Andrade AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000655; Miller LA, 2015, EMERG INFECT DIS, V21, P332, DOI 10.3201/eid2102.140048; Moncayo AL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021319; Monteiro KJL, 2020, J HELMINTHOL, V94, DOI 10.1017/S0022149X18001013; Nejsum P, 2012, J HELMINTHOL, V86, P148, DOI 10.1017/S0022149X12000193; Nejsuma P, 2017, INFECT GENET EVOL, V48, P4, DOI 10.1016/j.meegid.2016.12.003; Peng WD, 2005, ELECTROPHORESIS, V26, P4317, DOI 10.1002/elps.200500276; Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Sadaow L, 2018, PARASITOL RES, V117, P2427, DOI 10.1007/s00436-018-5931-6; Soe MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004855; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Umetsu S, 2014, WORLD J GASTROENTERO, V20, P14058, DOI 10.3748/wjg.v20.i38.14058	42	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218867	10.1371/journal.pone.0218867	http://dx.doi.org/10.1371/journal.pone.0218867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233550	gold, Green Submitted, Green Published			2022-12-26	WOS:000484896700047
J	Wang, L; Wu, YZ; Zhuang, LJ; Chen, XF; Min, HY; Song, SY; Liang, Q; Li, AD; Gao, Q				Wang, Lei; Wu, Yongzheng; Zhuang, Lingjia; Chen, Xiufang; Min, Haiyan; Song, Shiyu; Liang, Qiao; Li, An-Dong; Gao, Qian			Puerarin prevents high-fat diet-induced obesity by enriching Akkermansia muciniphila in the gut microbiota of mice	PLOS ONE			English	Article							RNA; DISEASE; TRANSPLANTATION; METABOLISM; EXPRESSION; DIVERSITY; SEQUENCES; CAPACITY; GLUCOSE; MARKER	Growing evidence indicates that the gut microbiota plays a significant role in the pathophysiological processes of obesity and its related metabolic symptoms in the host. Puerarin, an active ingredient in the root of Pueraria lobate has been suggested to have a potent antiobesity effect. Herein, we tested whether this effect of puerarin is associated with changes in the gut microbiota. In addition to reducing body weight, inflammation, and insulin resistance, puerarin administration significantly altered the composition of the gut microbiota. Notably, puerarin treatment greatly increased the abundance of Akkermansia muciniphila, a mucin-degrading bacterium known to be beneficial for host metabolism and significantly downregulated in high-fat diet-fed mice. Further experiments revealed that puerarin increased intestinal expression levels of Muc2 and Reg3g and protected intestinal barrier function (normal permeability) by increasing the expression of ZO-1 and occludin in vivo and in vitro. These data suggest that puerarin's enriching effect on A. muciniphila is mediated, at least in part, by a host cellular response to protect the host from diet-induced metabolic disorders and other diseases.	[Wang, Lei; Wu, Yongzheng; Zhuang, Lingjia; Chen, Xiufang; Min, Haiyan; Song, Shiyu; Liang, Qiao; Li, An-Dong; Gao, Qian] Nanjing Univ, Med Sch, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; Nanjing Univ, Med Sch, Ctr Translat Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Li, AD; Gao, Q (corresponding author), Nanjing Univ, Med Sch, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.	liandong@nju.edu.cn; qian_gao@nju.edu.cn	Song, Shiyu/AAO-5023-2021	Song, Shiyu/0000-0001-8438-2277	National Natural Science Foundation of China [81570775]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge the financial support of the Key Project from the National Natural Science Foundation of China (81570775).	Anderson JW, 2001, OBES RES, V9, p326S, DOI 10.1038/oby.2001.138; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Balamurugan R, 2010, BRIT J NUTR, V103, P335, DOI 10.1017/S0007114509992182; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; CHANG SK, 1994, GASTROENTEROLOGY, V107, P28, DOI 10.1016/0016-5085(94)90057-4; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gentile CL, 2018, SCIENCE, V362, P776, DOI 10.1126/science.aau5812; Hanninen A, 2018, GUT, V67, P1445, DOI 10.1136/gutjnl-2017-314508; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hsu FL, 2003, J NAT PROD, V66, P788, DOI 10.1021/np0203887; Jijon HB, 2018, MUCOSAL IMMUNOL, V11, P703, DOI 10.1038/mi.2017.91; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Jung HW, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010033; Juul FE, 2018, NEW ENGL J MED, V378, P2535, DOI 10.1056/NEJMc1803103; Kelly CR, 2015, GASTROENTEROLOGY, V149, P1644; Kerr D, 2002, LANCET, V360, P1249, DOI 10.1016/S0140-6736(02)11250-5; Kim J, 2012, FREE RADICAL BIO MED, V53, P357, DOI 10.1016/j.freeradbiomed.2012.04.030; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Luo CF, 2011, INT J PHARMACEUT, V410, P138, DOI 10.1016/j.ijpharm.2011.02.064; McIntire MG, 2011, AM J SURG PATHOL, V35, P1007, DOI 10.1097/PAS.0b013e318218940d; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Prasain JK, 2012, PHYTOMEDICINE, V20, P17, DOI 10.1016/j.phymed.2012.09.017; Rahman K, 2016, GASTROENTEROLOGY, V151, P733, DOI 10.1053/j.gastro.2016.06.022; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Strom JO, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-39; Tan CX, 2017, AM J CHINESE MED, V45, P1169, DOI 10.1142/S0192415X17500641; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Teng Y, 2009, MOL BIOL REP, V36, P1129, DOI 10.1007/s11033-008-9288-2; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Wallace TC, 2011, NUTR REV, V69, P392, DOI 10.1111/j.1753-4887.2011.00402.x; Winer DA, 2016, CELL METAB, V23, P413, DOI 10.1016/j.cmet.2016.01.003; Xie W, 2011, DIABETES OBES METAB, V13, P289, DOI 10.1111/j.1463-1326.2010.01336.x; Xu J, 2015, ISME J, V9, P552, DOI 10.1038/ismej.2014.177; Yang Y, 2016, NEUROREPORT, V27, P124, DOI 10.1097/WNR.0000000000000509; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008; Zhou YX, 2014, PHYTOTHER RES, V28, P961, DOI 10.1002/ptr.5083	55	39	41	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218490	10.1371/journal.pone.0218490	http://dx.doi.org/10.1371/journal.pone.0218490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233515	Green Submitted, gold, Green Published			2022-12-26	WOS:000484896700022
J	Aboshady, HM; Mandonnet, N; Stear, MJ; Arquet, R; Bederina, M; Sarry, J; Tosser-Klopp, G; Klopp, C; Johansson, AM; Jonas, E; Bambou, JC				Aboshady, Hadeer M.; Mandonnet, Nathalie; Stear, Michael J.; Arquet, Remy; Bederina, Malia; Sarry, Julien; Tosser-Klopp, Gwenola; Klopp, Christophe; Johansson, Anna M.; Jonas, Elisabeth; Bambou, Jean-Christophe			Transcriptome variation in response to gastrointestinal nematode infection in goats	PLOS ONE			English	Article							HAEMONCHUS-CONTORTUS INFECTION; FECAL EGG COUNT; TELADORSAGIA-CIRCUMCINCTA; ANTHELMINTIC RESISTANCE; PARASITE RESISTANCE; GENE-EXPRESSION; SHEEP; IGA; IDENTIFICATION; EOSINOPHILIA	Gastrointestinal nematodes (GIN) are a major constraint for small ruminant production. Due to the rise of anthelmintic resistance throughout the world, alternative control strategies are needed. The development of GIN resistance breeding programs is a promising strategy. However, a better understanding of the mechanisms underlying genetic resistance might lead to more effective breeding programmes. In this study, we compare transcriptome profiling of abomasal mucosa and lymph node tissues from non-infected, resistant and susceptible infected Creole goats using RNA-sequencing. A total of 24 kids, 12 susceptible and 12 GIN resistant based on the estimated breeding value, were infected twice with 10,000 L3 Haemonchus contortus. Physiological and parasitological parameters were monitored during infection. Seven weeks after the second infection, extreme kids (n = 6 resistant and 6 susceptible), chosen on the basis of the fecal egg counts (FEC), and 3 uninfected control animals were slaughtered. Susceptible kids had significantly higher FEC compared with resistant kids during the second infection with no differences in worm burden, male and female worm count or establishment rate. A higher number of differentially expressed genes (DEG) were identified in infected compared with non-infected animals in both abomasal mucosa (792 DEG) and lymph nodes (1726 DEG). There were fewer DEG in resistant versus susceptible groups (342 and 450 DEG, in abomasal mucosa and lymph nodes respectively). 'Cell cycle' and 'cell death and survival' were the main identified networks in mucosal tissue when comparing infected versus non-infected kids. Antigen processing and presentation of peptide antigen via major histocompatibility complex class I were in the top biological functions for the DEG identified in lymph nodes. The TGF beta 1 gene was one of the top 5 upstream DEG in mucosal tissue. Our results are one of the fist investigating differences in the expression profile induced by GIN infection in goats.	[Aboshady, Hadeer M.] AgroParisTech, Paris, France; [Aboshady, Hadeer M.; Johansson, Anna M.; Jonas, Elisabeth] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Aboshady, Hadeer M.; Mandonnet, Nathalie; Bederina, Malia; Bambou, Jean-Christophe] INRA, URZ, Petit Bourg, Guadeloupe, France; [Aboshady, Hadeer M.] Cairo Univ, Dept Anim Prod, Fac Agr, Cairo, Egypt; [Stear, Michael J.] La Trobe Univ, Dept Anim Plant & Soil Sci, AgriBio, Ctr AgriBiosci, Melbourne, Vic, Australia; [Arquet, Remy] INRA, PTEA, Petit Bourg, Guadeloupe, France; [Sarry, Julien; Tosser-Klopp, Gwenola] Univ Toulouse, ENVT, INPT, GenPhySE,INRA, Castanet Tolosan, France; [Klopp, Christophe] INRA, Plateforme Bioinformat Toulouse, Midi Pyrenees UBIA, Castanet Tolosan, France	AgroParisTech; Swedish University of Agricultural Sciences; INRAE; Egyptian Knowledge Bank (EKB); Cairo University; La Trobe University; INRAE; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE	Bambou, JC (corresponding author), INRA, URZ, Petit Bourg, Guadeloupe, France.	jean-christophe.bambou@inra.fr	Klopp, Christophe/J-3164-2019; Stear, Michael/AAG-6329-2020; Jonas, Elisabeth/F-1764-2017	Klopp, Christophe/0000-0001-7126-5477; Stear, Michael/0000-0001-5054-1348; Johansson, Anna M/0000-0002-9762-0497; Aboshady, Hadeer/0000-0002-1514-8839; Jonas, Elisabeth/0000-0003-4950-2549	Project MALIN (La Region Guadeloupe and Fonds Europeens FEDER); project European Graduate School in Animal Breeding and Genetics (EGS-ABG, Erasmus Mundus); division of animal genetics of INRA	Project MALIN (La Region Guadeloupe and Fonds Europeens FEDER); project European Graduate School in Animal Breeding and Genetics (EGS-ABG, Erasmus Mundus); division of animal genetics of INRA	This study was funded by the Project MALIN (La Region Guadeloupe and Fonds Europeens FEDER). H.M.A. was supported by a doctoral fellowship from the project European Graduate School in Animal Breeding and Genetics (EGS-ABG, Erasmus Mundus) and the division of animal genetics of INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/JOURNAL.PONE.0132555; Coutinho RMA, 2015, SMALL RUMINANT RES, V123, P173, DOI 10.1016/j.smallrumres.2014.10.002; Amarante AFT, 1999, VET PARASITOL, V80, P311, DOI 10.1016/S0304-4017(98)00229-5; Amarante AFT, 2005, VET PARASITOL, V128, P99, DOI 10.1016/j.vetpar.2004.11.021; Andronicos N, 2010, INT J PARASITOL, V40, P417, DOI 10.1016/j.ijpara.2009.09.007; AUMONT G, 1997, 7294 ATP CIRADMIPA; Bambou JC, 2013, BIOMED RES INT, V2013, P9; Bambou JC, 2008, VET PARASITOL, V158, P311, DOI 10.1016/j.vetpar.2008.09.020; Bhuiyan AA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040751; Bishop SC, 2012, ANIMAL, V6, P741, DOI 10.1017/S1751731111000681; Bisset SA, 1996, VET PARASITOL, V61, P249, DOI 10.1016/0304-4017(95)00836-5; Davies G, 2004, M EAAP BLED SLOV 5 9; DAWKINS HJS, 1989, INT J PARASITOL, V19, P199, DOI 10.1016/0020-7519(89)90008-8; de la Chevrotiere C, 2012, VET PARASITOL, V186, P337, DOI 10.1016/j.vetpar.2011.11.071; Diez-Tascon C, 2005, PHYSIOL GENOMICS, V21, P59, DOI 10.1152/physiolgenomics.00257.2004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolinska M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0233-4; Dorny P, 1998, RES VET SCI, V65, P259, DOI 10.1016/S0034-5288(98)90153-9; DOUCH PGC, 1995, LIVEST PROD SCI, V41, P121, DOI 10.1016/0301-6226(94)00046-A; Castillo JAF, 2011, VET PARASITOL, V177, P339, DOI 10.1016/j.vetpar.2010.11.056; Gauly M, 2002, VET PARASITOL, V106, P55, DOI 10.1016/S0304-4017(02)00028-6; Geurden T, 2014, VET PARASITOL, V201, P59, DOI 10.1016/j.vetpar.2014.01.016; Gossner A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-68; Henderson NG, 2006, VET IMMUNOL IMMUNOP, V112, P62, DOI 10.1016/j.vetimm.2006.03.012; Hoste H, 2008, PARASITE IMMUNOL, V30, P79, DOI 10.1111/j.1365-3024.2007.00987.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keane OM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-42; Keane OM, 2007, PHYSIOL GENOMICS, V30, P253, DOI 10.1152/physiolgenomics.00273.2006; Knight PA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-78; Lacroux C, 2006, VET RES, V37, P607, DOI 10.1051/vetres:2006022; Li RW, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacKinnon KM, 2010, PARASITE IMMUNOL, V32, P484, DOI 10.1111/j.1365-3024.2010.01211.x; MacKinnon KM, 2009, VET IMMUNOL IMMUNOP, V130, P210, DOI 10.1016/j.vetimm.2009.02.013; McBean D, 2016, VET PARASITOL, V229, P1, DOI 10.1016/j.vetpar.2016.08.027; Mcrae KM, 2016, VET PARASITOL, V224, P96, DOI 10.1016/j.vetpar.2016.05.014; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Papadopoulos E, 2008, SMALL RUMINANT RES, V76, P99, DOI 10.1016/j.smallrumres.2007.12.012; POMROY WE, 1986, NEW ZEAL VET J, V34, P36, DOI 10.1080/00480169.1986.35272; Rowe A, 2008, VET PARASITOL, V154, P71, DOI 10.1016/j.vetpar.2008.02.014; Silva MVB, 2012, ANIM GENET, V43, P63, DOI 10.1111/j.1365-2052.2011.02202.x; Stear MJ, 2009, PARASITE IMMUNOL, V31, P274, DOI 10.1111/j.1365-3024.2009.01105.x; Stear MJ, 1995, PARASITE IMMUNOL, V17, P643, DOI 10.1111/j.1365-3024.1995.tb01010.x; Stear MJ, 2002, PARASITOLOGY, V124, P553, DOI 10.1017/S0031182002001580; Strain SAJ, 2002, PARASITOLOGY, V124, P545, DOI 10.1017/S0031182002001531; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang YJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2368-1; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	52	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218719	10.1371/journal.pone.0218719	http://dx.doi.org/10.1371/journal.pone.0218719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220166	gold, Green Published, Green Submitted			2022-12-26	WOS:000484893500086
J	Chimura, M; Yamada, S; Taniguchi, Y; Yasaka, Y; Kawai, H				Chimura, Misato; Yamada, Shinichiro; Taniguchi, Yasuyo; Yasaka, Yoshinori; Kawai, Hiroya			Late gadolinium enhancement on cardiac magnetic resonance combined with I-123-metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); PROGNOSTIC VALUE; HEART-FAILURE; SYMPATHETIC INNERVATION; VENTRICULAR-ARRHYTHMIAS; MYOCARDIAL FIBROSIS; MIBG; DEATH	Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is limited in its ability to detect diffuse interstitial fibrosis, which is commonly found in idiopathic dilated cardiomyopathy (DCM). On the other hand, Washout rate (WR) by cardiac I-123-metaiodobenzylguanidine (I-123-MIBG) scintigraphy which evaluates cardiac sympathetic nervous function, is a useful tool for predicting the prognosis in DCM. We investigated the predictive value of the combination of two different types of examinations, LGE on CMR and WR by I-123-MIBG scintigraphy for outcomes in DCM compared with LGE alone. One-hundred forty-eight DCM patients underwent CMR and I-123-MIBG scintigraphy. Patients were divided into 4 groups according to the presence or absence of LGE and WR cut-off value of 45% for predicting prognosis based on receiver operating characteristic curve analysis. Cardiac deaths, re-hospitalization for heart failure, implantation of a left ventricular assist device, and life-threatening ventricular arrhythmias were defined as clinical events. Forty-two DCM patients reached the clinical events during the median follow-up for 9.1 years (interquartile range, 8.0-9.2 years). Multivariable Cox regression analysis identified WR >= 45%+LGE positive group as an independent predictor of cardiac events (HR 3.18, 95% CI 1.36-7.45, p = 0.008). Notably, there was no significance in the cardiac event-free survival rate between the WR<45%+LGE positive and WR >= 45%+LGE negative groups (p = 0.89). The combination of WR by I-123-MIBG scintigraphy and LGE on CMR, which evaluate different type of cardiac deterioration, serves as a stronger predictor of long-term outcomes in DCM patients than LGE alone.	[Chimura, Misato; Yamada, Shinichiro; Taniguchi, Yasuyo; Yasaka, Yoshinori; Kawai, Hiroya] Himeji Cardiovasc Ctr, Himeji, Hyogo, Japan		Chimura, M (corresponding author), Himeji Cardiovasc Ctr, Himeji, Hyogo, Japan.	mstogncmr@gmail.com	Chimura, Misato/AAP-5916-2021					Akutsu Y, 2009, J NUCL MED, V50, P61, DOI 10.2967/jnumed.108.055194; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Boogers MJ, 2010, J AM COLL CARDIOL, V55, P2769, DOI 10.1016/j.jacc.2009.12.066; Di Marco A, 2017, JACC-HEART FAIL, V5, P28, DOI 10.1016/j.jchf.2016.09.017; Imamura Y, 2002, ANN NUCL MED, V16, P387, DOI 10.1007/BF02990076; IMAMURA Y, 1995, J AM COLL CARDIOL, V26, P1594, DOI 10.1016/0735-1097(95)00374-6; Imamura Y, 2001, JPN CIRC J, V65, P155, DOI 10.1253/jcj.65.155; Kawaguchi T, 2006, J MED INVESTIG, V53, P95, DOI 10.2152/jmi.53.95; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kuruvilla S, 2014, CIRC-CARDIOVASC IMAG, V7, P250, DOI 10.1161/CIRCIMAGING.113.001144; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Mahrholdt H, 2002, CIRCULATION, V106, P2322, DOI 10.1161/01.CIR.0000036368.63317.1C; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; MERLET P, 1992, J NUCL MED, V33, P471; Merlet P, 1999, J NUCL MED, V40, P917; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Miranda SM, 2013, ARQ BRAS CARDIOL, V101, P4, DOI 10.5935/abc.20130111; Momose M, 2011, ANN NUCL MED, V25, P419, DOI 10.1007/s12149-011-0479-x; Nakata T, 1998, J NUCL CARDIOL, V5, P579, DOI 10.1016/S1071-3581(98)90112-X; Nakata T, 2013, JACC-CARDIOVASC IMAG, V6, P772, DOI 10.1016/j.jcmg.2013.02.007; Ohshima S, 2013, EUR J NUCL MED MOL I, V40, P262, DOI 10.1007/s00259-012-2256-z; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Ruperez M, 2003, CIRCULATION, V108, P1499, DOI 10.1161/01.CIR.0000089129.51288.BA; Sanderson JE, 2001, HEART, V86, P701, DOI 10.1136/heart.86.6.701; Schalla S, 2010, EUR J HEART FAIL, V12, P227, DOI 10.1093/eurjhf/hfq004; SCHOFER J, 1988, J AM COLL CARDIOL, V12, P1252, DOI 10.1016/0735-1097(88)92608-3; Verberne HJ, 2008, EUR HEART J, V29, P1147, DOI 10.1093/eurheartj/ehn113; Yagi H, 2012, INT HEART J, V53, P282, DOI 10.1536/ihj.53.282	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0217865	10.1371/journal.pone.0217865	http://dx.doi.org/10.1371/journal.pone.0217865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220100	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500016
J	Kersten, E; Dammeier, S; Ajana, S; Groenewoud, JMM; Codrea, M; Klose, F; Lechanteur, YT; Fauser, S; Ueffing, M; Delcourt, C; Hoyng, CB; de Jong, EK; den Hollander, AI; Arango-Gonzalez, B; Arndt, V; Bhatia, V; Bhattacharya, SS; Biarnes, M; Borrell, A; Buhren, S; Calado, SM; Colijn, JM; Cougnard-Gregoire, A; de Jong, E; De la Cerda, B; Diaz-Corrales, FJ; Diether, S; Emri, E; Endermann, T; Ferraro, L; Garcia, M; Heesterbeek, TJ; Honisch, S; Iacone, R; Kilger, E; Klaver, CCW; Langen, H; Lengyel, I; Luthert, P; Maugeais, C; Meester-Smoor, M; Merle, B; Mones, J; Nogoceke, E; Peto, T; Pool, F; Rodriguez, E; Bartz-Schmidt, KU; van Leeuwen, EM; Verzijden, T; Zumbansen, M				Kersten, Eveline; Dammeier, Sascha; Ajana, Soufiane; Groenewoud, Joannes M. M.; Codrea, Marius; Klose, Franziska; Lechanteur, Yara T.; Fauser, Sascha; Ueffing, Marius; Delcourt, Cecile; Hoyng, Carel B.; de Jong, Eiko K.; den Hollander, Anneke I.; Arango-Gonzalez, Blanca; Arndt, Verena; Bhatia, Vaibhav; Bhattacharya, Shomi S.; Biarnes, Marc; Borrell, Anna; Buhren, Sebastian; Calado, Sofia M.; Colijn, Johanna M.; Cougnard-Gregoire, Audrey; de Jong, Eiko; De la Cerda, Berta; Diaz-Corrales, F. J.; Diether, Sigrid; Emri, Eszter; Endermann, Tanja; Ferraro, Lucia; Garcia, Miriam; Heesterbeek, Thomas J.; Honisch, Sabina; Iacone, Roberto; Kilger, Ellen; Klaver, Caroline C. W.; Langen, Hanno; Lengyel, Imre; Luthert, Phil; Maugeais, Cyrille; Meester-Smoor, Magda; Merle, Benedicte; Mones, Jordi; Nogoceke, Everson; Peto, Tunde; Pool, Fran; Rodriguez, Eduardo; Bartz-Schmidt, Karl Ulrich; van Leeuwen, Elisabeth M.; Verzijden, Timo; Zumbansen, Markus		Eye-Risk Consortium	Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway	PLOS ONE			English	Article							SYSTEMIC COMPLEMENT ACTIVATION; PREVALENCE	Age-related macular degeneration (AMD) is a common, progressive multifactorial vision-threatening disease and many genetic and environmental risk factors have been identified. The risk of AMD is influenced by lifestyle and diet, which may be reflected by an altered metabolic profile. Therefore, measurements of metabolites could identify biomarkers for AMD, and could aid in identifying high-risk individuals. Hypothesis-free technologies such as metabolomics have a great potential to uncover biomarkers or pathways that contribute to disease pathophysiology. To date, only a limited number of metabolomic studies have been performed in AMD. Here, we aim to contribute to the discovery of novel biomarkers and metabolic pathways for AMD using a targeted metabolomics approach of 188 metabolites. This study focuses on non-advanced AMD, since there is a need for biomarkers for the early stages of disease before severe visual loss has occurred. Targeted metabolomics was performed in 72 patients with early or intermediate AMD and 72 control individuals, and metabolites predictive for AMD were identified by a sparse partial least squares discriminant analysis. In our cohort, we identified four metabolite variables that were most predictive for early and intermediate stages of AMD. Increased glutamine and phosphatidylcholine diacyl C28:1 levels were detected in non-advanced AMD cases compared to controls, while the rate of glutaminolysis and the glutamine to glutamate ratio were reduced in non-advanced AMD. The association of glutamine with non-advanced AMD corroborates a recent report demonstrating an elevated glutamine level in early AMD using a different metabolomics technique. In conclusion, this study indicates that metabolomics is a suitable method for the discovery of biomarker candidates for AMD. In the future, larger metabolomics studies could add to the discovery of novel biomarkers in yet unknown AMD pathways and expand our insights in AMD pathophysiology.	[Kersten, Eveline; Lechanteur, Yara T.; Hoyng, Carel B.; de Jong, Eiko K.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Ophthalmol, Nijmegen, Netherlands; [Dammeier, Sascha; Klose, Franziska; Ueffing, Marius] Univ Tubingen, Core Facil Med Bioanalyt, Inst Ophthalm Res, Tubingen, Germany; [Ajana, Soufiane; Delcourt, Cecile] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, LEHA Team,UMR 1219, Bordeaux, France; [Groenewoud, Joannes M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, Nijmegen, Netherlands; [Codrea, Marius] Univ Tubingen, Quantitat Biol Ctr, Tubingen, Germany; [Fauser, Sascha] F Hoffmann La Roche & Cie AG, Basel, Switzerland; [Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Radboud University Nijmegen; Eberhard Karls University of Tubingen; Roche Holding; University of Cologne; Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Ophthalmol, Nijmegen, Netherlands.; den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands.	Anneke.denhollander@radboudumc.nl	Calado, Sofia M./K-2202-2016; Arango-Gonzalez, Blanca/AAR-7427-2021; Lehtimäki, Terho/AAD-1094-2022; Ajana, Soufiane/AAH-5181-2021; Kersten, Eveline/P-8173-2015; Groenewoud, Hans JMM/R-3588-2017; COUGNARD-GREGOIRE, Audrey/T-4443-2019; Lechanteur, Yara/ABB-6875-2020; Merle, Benedicte MJ/F-1247-2015; Lengyel, Imre/B-5217-2009; Delcourt, Cecile/I-2627-2013	Calado, Sofia M./0000-0001-5509-4145; Arango-Gonzalez, Blanca/0000-0002-9045-182X; Lehtimäki, Terho/0000-0002-2555-4427; Groenewoud, Hans JMM/0000-0002-4974-150X; COUGNARD-GREGOIRE, Audrey/0000-0002-1494-5764; Lechanteur, Yara/0000-0003-0951-4625; Merle, Benedicte MJ/0000-0003-1332-0954; Lengyel, Imre/0000-0001-7467-2174; Delcourt, Cecile/0000-0002-2099-0481; Mones, Jordi/0000-0003-3685-2160	European Union's Horizon 2020 research and innovation programme [634479]	European Union's Horizon 2020 research and innovation programme	This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 634479 (EYE-RISK). La Roche AG provided support in the form of salary for S.F., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of S.F. are articulated in the 'author contributions' section.	Aledo JC, 2004, BIOESSAYS, V26, P778, DOI 10.1002/bies.20063; Burgess S, 2017, OPHTHALMOLOGY, V124, P1165, DOI 10.1016/j.ophtha.2017.03.042; Calder PC, 1999, AMINO ACIDS, V17, P227, DOI 10.1007/BF01366922; Camelo S, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/532487; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Carayol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135437; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Cheung CMG, 2017, J LIPID RES, V58, P1785, DOI 10.1194/jlr.M073684; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Colijn JM, 2019, OPHTHALMOLOGY, V126, P393, DOI 10.1016/j.ophtha.2018.09.045; Colijn JM, 2017, OPHTHALMOLOGY, V124, P1753, DOI 10.1016/j.ophtha.2017.05.035; Cougnard-Gregoire A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090973; Eandi CM, 2016, EUR J PHARMACOL, V787, P78, DOI 10.1016/j.ejphar.2016.03.002; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Ghanizadeh A, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/536521; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Jove M, 2014, FASEB J, V28, P5163, DOI 10.1096/fj.14-253187; Kersten E, 2018, SURV OPHTHALMOL, V63, P9, DOI 10.1016/j.survophthal.2017.05.003; Kohler I, 2017, EUR J PHARM SCI, V109, pS15, DOI 10.1016/j.ejps.2017.05.018; Kosmides Alyssa K., 2013, Critical Reviews in Biomedical Engineering, V41, P205; Lains I, 2019, PROG RETIN EYE RES, V69, P57, DOI 10.1016/j.preteyeres.2018.11.002; Lains I, 2018, OPHTHALMOLOGY, V125, P245, DOI 10.1016/j.ophtha.2017.08.008; Lains I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177749; Lauwen S, 2017, INVEST OPHTH VIS SCI, V58, pBIO88, DOI 10.1167/iovs.17-21809; Leibowitz A, 2012, INT J MOL SCI, V13, P10041, DOI 10.3390/ijms130810041; Luo D, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0555-7; Ma DWL, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.27; Merle BMJ, 2019, OPHTHALMOLOGY, V126, P381, DOI 10.1016/j.ophtha.2018.08.006; Mitchell P, 2018, LANCET, V392, P1147, DOI 10.1016/S0140-6736(18)31550-2; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Ozerova IN, 2007, B EXP BIOL MED+, V143, P320, DOI 10.1007/s10517-007-0100-4; Paun CC, 2015, INVEST OPHTH VIS SCI, V56, P7766, DOI 10.1167/iovs.15-17035; Ristau T, 2014, INVEST OPHTH VIS SCI, V55, P210, DOI 10.1167/iovs.13-13248; Rodriguez-Cuenca S, 2017, PROG LIPID RES, V66, P14, DOI 10.1016/j.plipres.2017.01.002; Saunier V, 2018, JAMA OPHTHALMOL, V136, P473, DOI 10.1001/jamaophthalmol.2018.0504; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Wang YF, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100663; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1	39	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218457	10.1371/journal.pone.0218457	http://dx.doi.org/10.1371/journal.pone.0218457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220133	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500051
J	Vita, RSB; Menezes, NL; Pellegrini, MOO; Melo-De-Pinna, GFA				Vita, Ricardo S. B.; Menezes, Nanuza L.; Pellegrini, Marco O. O.; Melo-de-Pinna, Gladys F. A.			A new interpretation on vascular architecture of the cauline system in Commelinaceae (Commelinales)	PLOS ONE			English	Article							INTERCALARY; SECTIONS; ANATOMY; STEM	The vascular system of monocotyledons, including Commelinaceae, has been studied since the 19th century, but to date, the proposed vascular architecture models consist of schematic representations partially based on the authors' interpretation. One of the greatest difficulties in studying these systems is the large number of vascular bundles and the complexity of their connections, especially in the monocotyledons which have a nodal vascular plexus. In this study, shoot apex samples of 14 species of Commelinaceae were submitted to three-dimensional analyses (confocal microscopy, X-ray microtomography, graphic vectorization, and whole-mount diaphanization), as well as conventional techniques in plant anatomy. Based on the results, a previously unreported category of bundles is described in Commelinaceae for the first time, as well as the fact that peripheral bundles are not interrupted or end blindly in the periphery of the pith, as previously thought. With this new interpretation of the vascular architecture, three patterns of nodal vascular plexus are proposed: 1) in the first pattern the internal nodal vascular plexus (IVP) forms a continuous cylinder and does not connect to the external nodal vascular plexus (EVP); 2) the IVP forms a cylinder divided into two columns and does not connect to the EVP and 3) the IVP forms a cylinder connected to the EVP. The first description of central bundles in the Commelinaceae might suggests their existence in closely related groups, such as the remaining four families of Commelinales (i.e., Haemodoraceae, Hanguanaceae, Philydraceae, and Pontederiaceae), and even in other distantly related groups of monocotyledons.	[Vita, Ricardo S. B.; Menezes, Nanuza L.; Pellegrini, Marco O. O.; Melo-de-Pinna, Gladys F. A.] Univ Sao Paulo, Biosci Inst, Dept Bot, Sao Paulo, Brazil	Universidade de Sao Paulo	Melo-De-Pinna, GFA (corresponding author), Univ Sao Paulo, Biosci Inst, Dept Bot, Sao Paulo, Brazil.	gfmpinna@usp.br	Pellegrini, Marco Octávio de Oliveira/L-3283-2014	Pellegrini, Marco Octávio de Oliveira/0000-0002-8783-1362; Melo-de-Pinna, Gladys/0000-0003-4924-8755	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2015/15158-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [300810/2016-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Proc. 2015/15158-4), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Process 300810/2016-4) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber A, 1925, MONOCOTYLEDONS MORPH; Arduim, 1997, MANUAL BASICO METODO; Arnott H., 1959, TURTOX NEWS, V37, P192, DOI DOI 10.1021/CEN-V037N009.P192; Beck CB., 2010, INTRO PLANT STRUCTUR, DOI [10.1017/CBO9780511844683, DOI 10.1017/CBO9780511844683]; BROUWER R, 1953, ACTA BOT NEERL, V2, P66; BRUNDRETT MC, 1988, PROTOPLASMA, V146, P133, DOI 10.1007/BF01405922; Cattai MB, 2010, AN ACAD BRAS CIENC, V82, P653, DOI 10.1590/S0001-37652010000300013; CRIVELLATO E, 1990, Z MIKROSK ANAT FORSC, V104, P769; CUTLER HUGH C., 1948, ANN MISSOURI BOT GARD, V35, P301, DOI 10.2307/2394695; De Bary A., 1884, COMP ANATOMY VEGETAT; Esau K, 1943, HILGARDIA, V15, P325; Esau K., 1977, ANATOMY SEED PLANTS; Evert RF., 2006, ESAUS PLANT ANATOMY, V3, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Fahn A., 1982, LEAF ANATOMY, V3, P208; FISHER JB, 1976, AM J BOT, V63, P510, DOI 10.2307/2441815; FISHER JB, 1970, AM J BOT, V57, P691, DOI 10.2307/2441293; FISHER JB, 1973, Q REV BIOL, V48, P291, DOI 10.1086/407591; Gomes VF, 2009, BRAZ ARCH BIOL TECHN, V52, P1473, DOI 10.1590/S1516-89132009000600019; GREGORY M, 1989, ISRAEL J BOT, V38, P125; Guillard A., 1878, ANN SCI NAT BOT 6, V5, P1; Haberlandt G., 1914, PHYSL PLANT ANATOMY; HEYSER W, 1970, Flora (Jena), V159, P286; ImageVis3D CIBC, 2015, INT VIS SOFTW LARG S; Jeffrey E.C., 1917, ANATOMY WOODY PLANTS, DOI 10.5962/bhl.title.17178; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Kumazawa M., 1946, BOT MAG TOKYO, V59, P42; Luque R., 1996, ACTA BOT BRAS, V10, P199, DOI [DOI 10.1590/S0102-33061996000200001, 10.1590/s0102-33061996000200001]; Menezes N.L., 1971, CIENCIA CULTURA, V23, P389; Nageli C, 1868, BEITRAGE WISSENSCHAF; Pasternak T, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0094-2; Plowman AB, 1906, ANN BOT-LONDON, V20, P1; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Scott LI, 1925, VELL J LINN SOC BOT, V47, P1, DOI [10.1111/j.1095-8339.1925.tb00500.x, DOI 10.1111/J.1095-8339.1925.TB00500.X]; Sharman BC, 1942, ANN BOT-LONDON, V6, P245, DOI 10.1093/oxfordjournals.aob.a088407; Staedler YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075295; Stevens WC, 1911, PLANT ANATOMY STANDP; VanTieghem MP., 1867, B SOC BOT FRANCE, V14, P240; von Mohl H., 1845, VERMISCHTE SCHRIFTEN; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; ZIMMERMANN MH, 1968, AM J BOT, V55, P1100, DOI 10.2307/2440478; ZIMMERMANN MH, 1972, BOT GAZ, V133, P141, DOI 10.1086/336628	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218383	10.1371/journal.pone.0218383	http://dx.doi.org/10.1371/journal.pone.0218383			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220117	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500042
J	Vu, V; Hangasky, JA; Detomasi, TC; Henry, SJW; Ngo, ST; Span, EA; Marletta, MA				Vu, Van V.; Hangasky, John A.; Detomasi, Tyler C.; Henry, Skylar J. W.; Son Tung Ngo; Span, Elise A.; Marletta, Michael A.			Substrate selectivity in starch polysaccharide monooxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; polysaccharide; metalloprotein; copper; copper monooxygenase; amylose; auxiliary activity (AA) enzyme; oxygenase; polysaccharide monooxygenase; starch	CARBOHYDRATE-BINDING MODULES; HELICAL MOLECULAR-STRUCTURE; OXIDATIVE CLEAVAGE; AUTOMATED DOCKING; PACKING ANALYSIS; CELLULOSE; CELLOBIOHYDROLASE; DEGRADATION; DISCOVERY; ENZYMES	Degradation of polysaccharides is central to numerous biological and industrial processes. Starch-active polysaccharide monooxygenases (AA13 PMOs) oxidatively degrade starch and can potentially be used with industrial amylases to convert starch into a fermentable carbohydrate. The oxidative activities of the starch-active PMOs from the fungi Neurospora crassa and Myceliophthora thermophila, NcAA13 and MtAA13, respectively, on three different starch substrates are reported here. Using high-performance anion-exchange chromatography coupled with pulsed amperometry detection, we observed that both enzymes have significantly higher oxidative activity on amylose than on amylopectin and cornstarch. Analysis of the product distribution revealed that NcAA13 and MtAA13 more frequently oxidize glycosidic linkages separated by multiples of a helical turn consisting of six glucose units on the same amylose helix. Docking studies identified important residues that are involved in amylose binding and suggest that the shallow groove that spans the active-site surface of AA13 PMOs favors the binding of helical amylose substrates over nonhelical substrates. Truncations of NcAA13 that removed its native carbohydrate-binding module resulted in diminished binding to amylose, but truncated NcAA13 still favored amylose oxidation over other starch substrates. These findings establish that AA13 PMOs preferentially bind and oxidize the helical starch substrate amylose. Moreover, the product distributions of these two enzymes suggest a unique interaction with starch substrates.	[Vu, Van V.] Nguyen Tat Thanh Univ, Nguyen Tat Thanh Hitech Inst, Ho Chi Minh City 70000, Vietnam; [Hangasky, John A.; Marletta, Michael A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Detomasi, Tyler C.; Marletta, Michael A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Henry, Skylar J. W.; Marletta, Michael A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Span, Elise A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Son Tung Ngo] Ton Duc Thang Univ, Lab Theoret & Computat Biophys, Ho Chi Minh City 758307, Vietnam; [Son Tung Ngo] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City 758307, Vietnam	Nguyen Tat Thanh University (NTTU); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Ton Duc Thang University; Ton Duc Thang University	Vu, V (corresponding author), Nguyen Tat Thanh Univ, Nguyen Tat Thanh Hitech Inst, Ho Chi Minh City 70000, Vietnam.; Marletta, MA (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Marletta, MA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Marletta, MA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	vanvu@ntt.edu.vn; marletta@berkeley.edu	Ngo, Son Tung/F-8964-2013; Vu, Van/B-2098-2010	Ngo, Son Tung/0000-0003-1034-1768; Vu, Van/0000-0003-0009-6703; Hangasky, John/0000-0002-8386-3922; Detomasi, Tyler/0000-0003-4390-108X	National Science Foundation [1565770]; Vietnam National Foundation for Science and Technology Development Grant [106-NN.02-2016.33]	National Science Foundation(National Science Foundation (NSF)); Vietnam National Foundation for Science and Technology Development Grant	This research was funded by National Science Foundation Grant 1565770 and Vietnam National Foundation for Science and Technology Development Grant 106-NN.02-2016.33. The authors declare that they have no conflicts of interest with the contents of this article.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; BERRY CS, 1986, J CEREAL SCI, V4, P301, DOI 10.1016/S0733-5210(86)80034-0; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Buleon A, 1997, MACROMOLECULES, V30, P3952, DOI 10.1021/ma970136q; Caffalette CA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08646-8; Courtade G, 2018, J BIOL CHEM, V293, P13006, DOI 10.1074/jbc.RA118.004269; Couturier M, 2018, NAT CHEM BIOL, V14, P306, DOI [10.1038/nchembio.2558, 10.1038/NCHEMBIO.2558]; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeLano W. L., 2012, THE PYMOL MOLECULAR; Eibinger M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01028-y; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Filiatrault-Chastel C, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1394-y; Forsberg Z, 2016, J BIOL CHEM, V291, P7300, DOI 10.1074/jbc.M115.700161; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; Hangasky JA, 2019, TRENDS CHEM, V1, P198, DOI 10.1016/j.trechm.2019.01.007; Hangasky JA, 2018, P NATL ACAD SCI USA, V115, P4915, DOI 10.1073/pnas.1801153115; Hemsworth GR, 2015, TRENDS BIOTECHNOL, V33, P747, DOI 10.1016/j.tibtech.2015.09.006; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kruer-Zerhusen N, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0925-7; Liu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189479; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Loose JSM, 2018, BIOCHEMISTRY-US, V57, P4114, DOI 10.1021/acs.biochem.8b00484; Moller MS, 2016, CELL MOL LIFE SCI, V73, P2619, DOI 10.1007/s00018-016-2241-y; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mutahir Z, 2018, FEBS LETT, V592, P2562, DOI 10.1002/1873-3468.13189; Nekiunaite L, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0604-0; Nekiunaite L, 2016, FEBS LETT, V590, P2737, DOI 10.1002/1873-3468.12293; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Sarkar A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-302; SARKO A, 1978, STARKE, V30, P73, DOI 10.1002/star.19780300302; SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Tandrup T, 2018, BIOCHEM SOC T, V46, P1431, DOI 10.1042/BST20170549; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vamadevan V, 2015, STARCH-STARKE, V67, P55, DOI 10.1002/star.201400188; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Vu VV, 2016, CELL MOL LIFE SCI, V73, P2809, DOI 10.1007/s00018-016-2251-9; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Wang SJ, 2015, COMPR REV FOOD SCI F, V14, P568, DOI 10.1111/1541-4337.12143; WU HCH, 1978, CARBOHYD RES, V61, P7; WU HCH, 1978, CARBOHYD RES, V61, P27; Xu GB, 2018, BIORESOURCE TECHNOL, V265, P558, DOI 10.1016/j.biortech.2018.05.086	68	17	17	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12157	12166		10.1074/jbc.RA119.009509	http://dx.doi.org/10.1074/jbc.RA119.009509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31235519	hybrid, Green Published			2022-12-26	WOS:000484284500019
J	Crawford, NT; McIntyre, AJ; McCormick, A; D'Costa, ZC; Buckley, NE; Mullan, PB				Crawford, N. T.; McIntyre, A. J.; McCormick, A.; D'Costa, Z. C.; Buckley, N. E.; Mullan, P. B.			TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; HISTONE H3; EXPRESSION; METHYLATION; MECHANISM; GROWTH; G9A; PROGRESSION; SENESCENCE; BYPASS	Early Growth Response 1 (EGR1) is a stress response transcription factor with multiple tumour suppressor roles in breast tissue, whose expression is often lost in breast cancers. We have previously shown that the breast cancer oncogene TBX2 (T-BOX2) interacts with EGR1 to co-repress EGR1-target genes including the breast tumour suppressor NDRG1. Here, we show the mechanistic basis of this TBX2 repression complex. We show that siRNA knockdown of TBX2, EGR1, Heterochromatin Protein 1 (HP1) isoforms and the generic HP1-associated corepressor protein KAP1 all resulted in growth inhibition of TBX2-expressing breast cancer cells. We show that TBX2 interacts with HP1 through a conserved HP1-binding motif in its N-terminus, which in turn leads to the recruitment of KAP1 and other associated proteins. Mutation of the TBX2 HP1 binding domain abrogates the TBX2-HP1 interaction and loss of repression of target genes such as NDRG1. Chromatin-immunoprecipitation (ChIP) assays showed that TBX2 establishes a repressive chromatin mark, specifically H3K9me3, around the NDRG1 proximal promoter coincident with the recruitment of the DNA methyltransferase DNMT3B and histone methyltransferase (HMT) complex components (G9A, Enhancer of Zeste 2 (EZH2) and Suppressor of Zeste 12 (SUZ12)). Knockdown of G9A, EZH2 or SUZ12 resulted in upregulation of TBX2/EGR1 co-regulated targets accompanied by a dramatic inhibition of cell proliferation. We show that a generic inhibitor of HMT activity, DzNep, phenocopies expression of an inducible dominant negative TBX2. Knockdown of TBX2, KAP1 or HP1 inhibited NDRG1 promoter decoration specifically with the H3K9me3 repression mark. Correspondingly, treatment with a G9A inhibitor effectively reversed TBX2 repression of NDRG1 and synergistically downregulated cell proliferation following TBX2 functional inhibition. These data demonstrate that TBX2 promotes suppression of normal growth control mechanisms through recruitment of a large repression complex to EGR1-responsive promoters leading to the uncontrolled proliferation of breast cancer cells.	[Crawford, N. T.; McIntyre, A. J.; McCormick, A.; D'Costa, Z. C.; Buckley, N. E.; Mullan, P. B.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Mullan, PB (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland.	p.mullan@qub.ac.uk		Crawford, Nyree/0000-0003-2258-4687; Buckley, Niamh/0000-0001-9326-8513; McIntyre, Alexander/0000-0002-8411-2581	Breast Cancer Campaign; NEC; AMCI; AMCC; ZCD'C; NEB; PBM	Breast Cancer Campaign; NEC; AMCI; AMCC; ZCD'C; NEB; PBM	Special thanks to Dr James Murray (Trinity College Dublin) for the kind gift of sheep anti-human NDRG1 antibody and Professor Max Costa (University of New York) for NDRG1 promoter luciferase constructs. This work was supported by grants from the Breast Cancer Campaign and Breast Cancer Now (NEC, AMCI, AMCC, ZCD'C, NEB, PBM).	Abrahams A, 2010, IUBMB LIFE, V62, P92, DOI 10.1002/iub.275; Adem C, 2004, GENE CHROMOSOME CANC, V41, P1, DOI 10.1002/gcc.20057; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barlund M, 2000, CANCER RES, V60, P5340; Buckley NE, 2007, MOL CANCER RES, V5, P261, DOI 10.1158/1541-7786.MCR-06-0250; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; de Belle I, 1999, ONCOGENE, V18, P3633, DOI 10.1038/sj.onc.1202696; de la Cruz CC, 2007, CHROMOSOME RES, V15, P2007, DOI 10.1007/s10577-007-1126-1; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Granit RZ, 2013, ONCOGENE, V32, P3886, DOI 10.1038/onc.2012.390; Hartman ZC, 2013, CANCER RES, V73, P3470, DOI 10.1158/0008-5472.CAN-12-4524-T; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Ismail A, 2009, CANCER LETT, V278, P230, DOI 10.1016/j.canlet.2009.01.006; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Krones-Herzig A, 2003, P NATL ACAD SCI USA, V100, P3233, DOI 10.1073/pnas.2628034100; Kwon SH, 2010, GENE DEV, V24, P2133, DOI 10.1101/gad.1959110; Li YH, 2002, P NATL ACAD SCI USA, V99, P16462, DOI 10.1073/pnas.162371699; Martin N, 2012, EMBO J, V31, P95, DOI 10.1038/emboj.2011.370; Moore HM, 2013, BREAST CANCER RES TR, V138, P741, DOI 10.1007/s10549-013-2498-x; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Purcell DJ, 2012, J CELL BIOCHEM, V113, P2406, DOI 10.1002/jcb.24114; Redmond KL, 2010, ONCOGENE, V29, P3252, DOI 10.1038/onc.2010.84; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Roylance R, 1999, CANCER RES, V59, P1433; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sinclair CS, 2002, CANCER RES, V62, P3587; Tirkkonen M, 1997, CANCER RES, V57, P1222; Vance KW, 2010, MOL BIOL CELL, V21, P2770, DOI 10.1091/mbc.E09-12-1029; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vormer TL, 2008, MOL CELL BIOL, V28, P7263, DOI 10.1128/MCB.00313-08; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041355; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Yu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051239	38	24	25	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2019	38	31					5971	5986		10.1038/s41388-019-0853-z	http://dx.doi.org/10.1038/s41388-019-0853-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3GE	31253870	Green Accepted			2022-12-26	WOS:000482740000005
J	Liu, WY; Woolbright, BL; Pirani, K; Didde, R; Abbott, E; Kaushik, G; Martin, P; Hamilton-Reeves, J; Taylor, JA; Holzbeierlein, JM; Anant, S; Lee, EK				Liu, Weiya; Woolbright, Benjamin L.; Pirani, Karim; Didde, Ryan; Abbott, Erika; Kaushik, Gaurav; Martin, Paige; Hamilton-Reeves, Jill; Taylor, John A., III; Holzbeierlein, Jeffrey M.; Anant, Shrikant; Lee, Eugene K.			Tumor M2-PK: A novel urine marker of bladder cancer	PLOS ONE			English	Article							M2 PYRUVATE-KINASE; M2-PYRUVATE KINASE; GLYCOLYSIS; DIAGNOSIS; SHIKONIN; M-2	Purpose Bladder cancer is a "Warburg-like" tumor characterized by a reliance on aerobic glycolysis and expression of pyruvate kinase M2 (PKM2). PKM2 oscillates between an active tetramer and an inactive dimer. We aim to further characterize PKM2, in particular PKM2 dimer, as a urinary biomarker of bladder cancer and a potential target for treatment. Methods HTB-9, HTB-5, and UM-UC3 bladder cancer cells were assessed for proliferation under differential glucose levels using the hexosaminidase assay. Western blot and Blue-native analysis was performed for protein expression of PKM2. Shikonin, an herb that is known to bind and inhibit PKM2, was utilized to determine if PKM2 has a role in glucose usage and cellular proliferation in bladder cancer cells by caspase activity assay. Institutional review board approval was obtained to collect healthy control and bladder cancer patient urine samples. The ScheBo M2-PK EDTA Plasma Test was performed on urine samples to assess urine Tumor M2-PK values. Results The three bladder cancer cell lines tested all demonstrate statistically significant increases in proliferation when exposed to higher level of glucose (200mg/dL). Similarly, low doses of glucose (25mg/dL) result in reduced proliferation. Increased cell growth in higher glucose concentration correlated with up-regulation of PKM2 protein expression. Shikonin, a PKM2 inhibitor, reduced cell proliferation and switched PKM2 isoforms from the dimer to tetramer. Lastly, dimer PKM2 (Tumor-M2PK) levels were assessed in the urine samples from bladder cancer (Bca) patients and healthy controls. Tumor M2-PK significantly correlated with the presence of BCa in our subjects. Conclusions Our studies demonstrate the potential of PKM2, specifically the dimer (Tumor-M2PK) as a target of drug therapy and as a urinary marker for bladder cancer.	[Liu, Weiya; Woolbright, Benjamin L.; Pirani, Karim; Didde, Ryan; Abbott, Erika; Martin, Paige; Hamilton-Reeves, Jill; Taylor, John A., III; Holzbeierlein, Jeffrey M.; Lee, Eugene K.] Univ Kansas, Med Ctr, Dept Urol, Kansas City, KS 66103 USA; [Kaushik, Gaurav; Anant, Shrikant] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Lee, EK (corresponding author), Univ Kansas, Med Ctr, Dept Urol, Kansas City, KS 66103 USA.	elee@kumc.edu	Anant, Shrikant/AAF-8020-2020	Didde, Ryan/0000-0002-7032-2174	American Cancer Society [IRG-09-062-05]; Frontiers Pilot and Collaborative Studies Funding Program [UL1RR033179]; Urology Foundation; NATIONAL CANCER INSTITUTE [R01CA190291] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Frontiers Pilot and Collaborative Studies Funding Program; Urology Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by American Cancer Society Institutional Research Grant (IRG-09-062-05 to EKL); Frontiers Pilot and Collaborative Studies Funding Program (UL1 TR000001 to EKL, formerly UL1RR033179); Urology Foundation Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Bluemlein K, 2011, ONCOTARGET, V2, P393; Chang SS, 2016, J UROLOGY, V196, P1021, DOI 10.1016/j.juro.2016.06.049; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Conde VR, 2015, EXP CELL RES, V335, P91, DOI 10.1016/j.yexcr.2015.04.007; Davis R, 2012, J UROLOGY, V188, P2473, DOI 10.1016/j.juro.2012.09.078; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Eigenbrodt E, 1997, ANTICANCER RES, V17, P3153; Guin S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju062; Hardt PD, 2004, BRIT J CANCER, V91, P980, DOI 10.1038/sj.bjc.6602033; KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4; Li WF, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0118-1; Massari F, 2016, CANCER TREAT REV, V45, P46, DOI 10.1016/j.ctrv.2016.03.005; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2001, BIOCHEM J, V356, P247, DOI 10.1042/0264-6021:3560247; Roigas J, 2001, TUMOR BIOL, V22, P282, DOI 10.1159/000050628; Schneider J, 2002, ANTICANCER RES, V22, P311; Subramaniam D, 2008, CANCER RES, V68, P1962, DOI 10.1158/0008-5472.CAN-07-6011; van Rhijn BWG, 2005, EUR UROL, V47, P736, DOI 10.1016/j.eururo.2005.03.014; Ventrucci M, 2004, DIGEST DIS SCI, V49, P1149, DOI 10.1023/B:DDAS.0000037803.32013.aa; Wang X, 2017, SCI REP-UK, V7, DOI 10.1038/srep45983; Wang YL, 2015, CANCER BIOL THER, V16, P839, DOI 10.1080/15384047.2015.1030551; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wechsel HW, 1999, ANTICANCER RES, V19, P2583; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yeh CC, 2007, IN VIVO, V21, P1011; Zhou HP, 2016, ONCOTARGET, V7, P23947, DOI 10.18632/oncotarget.8114	28	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218737	10.1371/journal.pone.0218737	http://dx.doi.org/10.1371/journal.pone.0218737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246990	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900036
J	Mihaila, D; Donegan, J; Barns, S; LaRocca, D; Du, Q; Zheng, D; Vidal, M; Neville, C; Uhlig, R; Middleton, FA				Mihaila, Dragos; Donegan, Jordan; Barns, Sarah; LaRocca, Daria; Du, Qian; Zheng, Danny; Vidal, Michael; Neville, Christopher; Uhlig, Richard; Middleton, Frank A.			The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function	PLOS ONE			English	Article							GLAND NEEDLE-BIOPSY; GUT-MICROBIOTA; ALPHA-SYNUCLEIN; L-DOPA; BRAIN; METAANALYSIS; DYSFUNCTION; MICROORGANISMS; PATHOGENESIS; AXIS	Changes in the function and microbiome of the upper and lower gastrointestinal tract have been documented in Parkinson's disease (PD), although most studies have examined merely fecal microbiome profiles and patients with advanced disease states. In the present study we sought to identify sensitive and specific biomarkers of changes in the oral microbiome of early stage PD through shotgun metatranscriptomic profiling. We recruited 48 PD subjects and 36 age- and gender-matched healthy controls. Subjects completed detailed assessments of motor, cognitive, balance, autonomic and chemosensory (smell and taste) functions to determine their disease stage. We also obtained a saliva sample for profiling of microbial RNA and host mRNA using next generation sequencing. We found no differences in overall alpha and beta diversity between subject groups. However, changes in specific microbial taxa were observed, including primarily bacteria, but also yeast and phage. Nearly half of our findings were consistent with prior studies in the field obtained through profiling of fecal samples, with others representing highly novel candidates for detection of early stage PD. Testing of the diagnostic utility of the microbiome data revealed potentially robust performance with as few as 11 taxonomic features achieving a cross-validated area under the ROC curve of 0.90 and overall accuracy of 84.5%. Bioinformatic analysis of 167 different metabolic pathways supported shifts in a small set of distinct pathways involved in amino acid and energy metabolism among the organisms comprising the oral microbiome. In parallel with the microbial analysis, we also examined the evidence for changes in human salivary mRNAs in the same subjects. This revealed significant changes in a set of 9 host mRNAs, several of which mapped to various brain functions and showed correlations with some of the significantly changed microbial taxa. Unexpectedly, we also observed robust correlations between many of the microbiota and functional measures, including those reflecting cognition, balance, and disease duration. These results suggest that the oral microbiome may represent a highly-accessible and informative microenvironment that offers new insights in the pathophysiology of early stage PD.	[Mihaila, Dragos] SUNY Upstate Med Univ, Dept Neurol, Syracuse, NY 13210 USA; [Donegan, Jordan; Barns, Sarah; LaRocca, Daria; Du, Qian; Zheng, Danny; Vidal, Michael; Middleton, Frank A.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Barns, Sarah; Du, Qian; Uhlig, Richard] Quadrant Biosci Inc, Syracuse, NY USA; [Neville, Christopher] SUNY Upstate Med Univ, Dept Dept Phys Therapy Educ, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA.	middletf@upstate.edu		Middleton, Frank/0000-0002-3107-7188; Zheng, Danny/0000-0001-9665-0144	Quadrant Biosciences, Inc.	Quadrant Biosciences, Inc.	FM, DM, and CN received a pilot award from Quadrant Biosciences, Inc. (www.quadrantbiosciences.com) to support the research in this report. The funders had no role in study design, data analysis, or initial writing of the manuscript, but did assist with data collection (preparation of software and administrative support), and helped proofread and edit the final version of the manuscript.	Adler CH, 2016, MOVEMENT DISORD, V31, P250, DOI 10.1002/mds.26476; Adler CH, 2014, NEUROLOGY, V82, P858, DOI 10.1212/WNL.0000000000000204; Ainsworth D, 2017, NUCLEIC ACIDS RES, V45, P1649, DOI 10.1093/nar/gkw1248; [Anonymous], 2015, Aust Prescr, V38, P139; [Anonymous], 2017, MR INT J ENG TECHNOL, V9, P39, DOI DOI 10.1007/s12520-016-0414-0; Bayliss J, 2011, GUT HORMONES RESTRIC; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cox LM, 2018, NEUROTHERAPEUTICS, V15, P135, DOI 10.1007/s13311-017-0598-8; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Degtyarev VV, 2014, J CONSTR STEEL RES, V94, P163, DOI 10.1016/j.jcsr.2013.10.004; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Dokun AO, 2013, AM J PHYSIOL-HEART C, V304, pH1085; Domingo Aloysius, 2018, Handb Clin Neurol, V147, P211, DOI 10.1016/B978-0-444-63233-3.00014-2; FENG ZB, 2016, CURRENT PROTOCOLS BI, V59, DOI DOI 10.1002/CPBI.11; Field Tiffany, 2012, Complement Ther Clin Pract, V18, P54, DOI 10.1016/j.ctcp.2011.04.002; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Gerhardt S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060708; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Gough EK, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0089-2; Greene JG, 2011, J PARKINSON DIS, V1, P137, DOI 10.3233/JPD-2011-11033; Guven T, 2013, CLIN INFECT DIS, V56, P1407, DOI 10.1093/cid/cit072; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Hill-Burns EM, 2017, MOVEMENT DISORD, V32, P739, DOI 10.1002/mds.26942; Hong JY, 2015, J MOV DISORD, V8, P21, DOI 10.14802/jmd.14029; Hopfner F, 2017, BRAIN RES, V1667, P41, DOI 10.1016/j.brainres.2017.04.019; Jin K, 2013, J INFECT DEV COUNTR, V7, P1008, DOI 10.3855/jidc.3025; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Klingelhoefer L, 2015, NAT REV NEUROL, V11, P625, DOI 10.1038/nrneurol.2015.197; Kunze WA, 2009, J CELL MOL MED, V13, P2261, DOI 10.1111/j.1582-4934.2009.00686.x; Lastovica A.J., 2014, FAMILY CAMPYLOBACTER, P307, DOI [10.1007/978-3-642-39044-9_274, DOI 10.1007/978-3-642-39044-9_274, DOI 10.1007/978-3-642-3904]; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Li W, 2017, SCI CHINA LIFE SCI, V60, P1223, DOI 10.1007/s11427-016-9001-4; Liu ZW, 2017, AM J EPIDEMIOL, V185, P538, DOI 10.1093/aje/kww146; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586; Martinez-Martin P, 2015, PARKINSONISM RELAT D, V21, P50, DOI 10.1016/j.parkreldis.2014.10.026; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Min Y, 1999, IMMUNOLOGY, V96, P10; MOLINS A, 1987, J NEUROL NEUROSUR PS, V50, P1707, DOI 10.1136/jnnp.50.12.1707-a; Morley JF, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-017-0039-8; Mulak A, 2015, WORLD J GASTROENTERO, V21, P10609, DOI 10.3748/wjg.v21.i37.10609; Neville C, 2015, MED DEVICES-EVID RES, V8, P447, DOI 10.2147/MDER.S91719; NILSSON B, 1979, ACTA ODONTOL SCAND, V37, P235, DOI 10.3109/00016357909027585; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Ochoa-Cortes F, 2016, INFLAMM BOWEL DIS, V22, P433, DOI 10.1097/MIB.0000000000000667; Oshima K, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00485-15; Paillusson S, 2013, J NEUROCHEM, V125, P512, DOI 10.1111/jnc.12131; Pellegrini C, 2016, NEUROGASTROENT MOTIL, V28, P1781, DOI 10.1111/nmo.12933; Pereira PAB, 2017, PARKINSONISM RELAT D, V38, P61, DOI 10.1016/j.parkreldis.2017.02.026; Petrov VA, 2017, B EXP BIOL MED+, V162, P734, DOI 10.1007/s10517-017-3700-7; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schwebke JR, 2014, J INFECT DIS, V210, P338, DOI 10.1093/infdis/jiu089; Souza CD, 2019, J MOTOR BEHAV, V51, P212, DOI 10.1080/00222895.2018.1458279; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Surwase SN, 2011, AMINO ACIDS, V41, P495, DOI 10.1007/s00726-010-0768-z; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; Unger MM, 2011, J NEUROL, V258, P982, DOI 10.1007/s00415-010-5864-1; Van Maele-Fabry G, 2012, ENVIRON INT, V46, P30, DOI 10.1016/j.envint.2012.05.004; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Visser M, 2004, MOVEMENT DISORD, V19, P1306, DOI 10.1002/mds.20153; Warden Clara, 2016, J Clin Mov Disord, V3, P5, DOI 10.1186/s40734-016-0033-z; Welsh M, 2003, MOVEMENT DISORD, V18, P637, DOI 10.1002/mds.10424; Xu D, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/684758; Yu SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00262-0; 2013, NEUROLOGY S3, V80, pS20	75	37	39	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218252	10.1371/journal.pone.0218252	http://dx.doi.org/10.1371/journal.pone.0218252			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IL9PR	31247001	Green Published, Green Submitted, gold			2022-12-26	WOS:000477617100001
J	Mo, PKH; Lau, JTF; Xin, MQ; Fong, VWI				Mo, Phoenix K. H.; Lau, Joseph T. F.; Xin, Meiqi; Fong, Vivian W. I.			Understanding the barriers and factors to HIV testing intention of women engaging in compensated dating in Hong Kong: The application of the extended Theory of Planned Behavior	PLOS ONE			English	Article							FEMALE SEX WORKERS; SEXUALLY-TRANSMITTED INFECTIONS; EMPOWERING PROCESSES; SEEKING BEHAVIOR; HEALTH-PROBLEMS; HELP-SEEKING; SELF-STIGMA; CONDOM USE; PREVALENCE; SERVICES	Background Women engaging in compensated dating is one of the at risk group of HIV infection due to multiple sexual partnerships and risky sexual practices. The present study examined the prevalence of HIV testing behavior and intention, and identified factors associated with HIV testing intention among women engaging in compensated dating in Hong Kong. Factors from the Theory of Planned Behaviors and the role of various types of barriers to HIV testing were also explored. Methods An anonymous, cross-sectional survey was conducted online. Target participants were women who have engaged in compensated dating and provided sex services to clients. Participants were recruited via three sources, including i) online outreaching, ii) referral made by NGOs, and iii) referral made by participants. A total of 183 participants completed the study. Results Respectively 29.7% and 18.6% have taken up HIV testing and showed intention to take up HIV testing in the future year. Results from the multiple hierarchical regression model showed that having ever received HIV testing (beta = 0.44, p < .001), attitudes towards HIV testing (beta = 0.22, p < .01), subjective norm (beta = 0.18, p < .05), perceived behavioral control (beta = 0.18, p < .01) and perceived discrimination from health care workers (beta = -0.24, p < .05) significantly predicted intention to take up HIV testing. Conclusion The present study demonstrates the applicability of extended TPB in HIV testing intention among women engaging in compensated dating. Interventions to promote HIV testing among this group are greatly warranted.	[Mo, Phoenix K. H.; Lau, Joseph T. F.; Xin, Meiqi; Fong, Vivian W. I.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China	Chinese University of Hong Kong	Mo, PKH (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.	phoenix.mo@cuhk.edu.hk; jlau@cuhk.edu.hk; meiqixin@link.cuhk.edu.hk; Vivian.fong@cuhk.edu.hk	Mo, Phoenix K.H./K-2853-2013	Mo, Phoenix K.H./0000-0001-9822-5424; XIN, Meiqi/0000-0002-8636-4918; Fong, Vivian Wai In/0000-0001-8356-3615	Commissioned Health and Medical Research Fund of Food and Health Bureau of HKSAR Government [CU-16-C15]	Commissioned Health and Medical Research Fund of Food and Health Bureau of HKSAR Government	This study is supported by the Commissioned Health and Medical Research Fund of Food and Health Bureau of HKSAR Government, Reference number: CU-16-C15 (https://rfs1.fhb.gov.hk/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html) to PKHM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abamecha F, 2013, J MULTIDISCIP HEALTH, V6, P399, DOI 10.2147/JMDH.S49339; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 2002, CONSTRUCTING TPB QUE; Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142; Ayodele O, 2017, AM J HEALTH BEHAV, V41, P147, DOI [10.5993/ajhb.41.2.5, 10.5993/AJHB.41.2.5]; Baker LM, 2004, WOMEN HEALTH, V39, P83, DOI 10.1300/J013v39n02_06; Bandura A., 1986, SOCIAL FDN THOUGHT A; Beattie TSH, 2012, J EPIDEMIOLOGY CO S2, V66; Caritas Youth and Community Service, 2010, ANN SEX HLTH SURV FE; Cheung CK, 2016, J ADOLESCENCE, V52, P124, DOI 10.1016/j.adolescence.2016.07.011; Chu SC., 2014, THESIS, DOI [10.5353/th_b5204906, DOI 10.5353/TH_B5204906]; Codd RT, 2003, J SOC CLIN PSYCHOL, V22, P168, DOI 10.1521/jscp.22.2.168.22877; Cooke R, 2016, HLTH PSYCHOL REV, V10; Courneya KS, 2008, MED SCI SPORT EXER, V40, P1180, DOI 10.1249/MSS.0b013e318168da45; El-Bassel N, 2001, AIDS PATIENT CARE ST, V15, P41, DOI 10.1089/108729101460092; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Global Network of Sex Work Projects (NSWP), 2016, POL BRIEF YOUNG SEX; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Hong Y, 2010, J TRANSCULT NURS, V21, P29, DOI 10.1177/1043659609349063; Kakoko DC, 2006, SOC SCI MED, V63, P991, DOI 10.1016/j.socscimed.2006.02.016; Kong MH, 2003, ASIAN J WOMEN STUD, V9, P67; Kurtz SP, 2005, J HEALTH CARE POOR U, V16, P345, DOI 10.1353/hpu.2005.0038; Lam B, 2014, YOUNG SEX WORKERS HO; Lau JTF, 2007, AIDS CARE, V19, P721, DOI 10.1080/09540120601084373; Lee TY, 2013, J PEDIATR ADOL GYNEC, V26, pS42, DOI 10.1016/j.jpag.2013.03.014; Li JCM, 2015, INT J OFFENDER THER, V59, P588, DOI 10.1177/0306624X13516285; Li MHT, 2015, JACOBS J EPIDEMIOLOG, V1; Lin CY, 2018, PREGNANCY HYPERTENS, V12, P84, DOI 10.1016/j.preghy.2018.04.001; Lin CY, 2017, EPILEPSY BEHAV, V68, P123, DOI 10.1016/j.yebeh.2017.01.010; Menozzi D, 2015, NUTRIENTS, V7, P7633, DOI 10.3390/nu7095357; Mo PKH, 2012, PSYCHOL HEALTH, V27, P445, DOI 10.1080/08870446.2011.592981; Mo PKH, 2010, COMPUT HUM BEHAV, V26, P1183, DOI 10.1016/j.chb.2010.03.028; Mo PKH, 2009, SOC PSYCH PSYCH EPID, V44, P675, DOI 10.1007/s00127-008-0484-0; Ngo AD, 2007, AIDS CARE, V19, P878, DOI 10.1080/09540120601163078; Roxburgh A, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-24; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Special Preventive Programme Centre for Health Protection DoH, 2010, CRISP COMM BAS RISK; Surratt HL, 2014, J HEALTH CARE POOR U, V25, P1360, DOI 10.1353/hpu.2014.0113; Surratt HL, 2012, AIDS CARE, V24, P553, DOI 10.1080/09540121.2011.630342; Ueno C., 2003, INTERASIA CULTURAL S, V4, DOI 10.1080/1464937032000113060; Vogel DL, 2007, J COUNS PSYCHOL, V54, P40, DOI 10.1037/0022-0167.54.1.40; Wang C, 2007, SEX TRANSM INFECT, V83, P534, DOI 10.1136/sti.2007.027151; Wong WCW, 2011, J TRAVEL MED, V18, P1, DOI 10.1111/j.1708-8305.2010.00453.x; World Health Organization, 2011, GLOB HLTH SECT STRAT; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e; Yang Memorial Methodist Social Service, 2009, THE PHENOMENA OF COM	47	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0213920	10.1371/journal.pone.0213920	http://dx.doi.org/10.1371/journal.pone.0213920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3WH	31246969	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900005
J	Pischke, SE; Hestenes, S; Johansen, HT; Fure, H; Bugge, JF; Espinoza, A; Skulstad, H; Edvardsen, T; Fosse, E; Mollnes, TE; Halvorsen, PS; Nielsen, EW				Pischke, Soeren Erik; Hestenes, Siv; Johansen, Harald Thidemann; Fure, Hilde; Bugge, Jan Frederik; Espinoza, Andreas; Skulstad, Helge; Edvardsen, Thor; Fosse, Erik; Mollnes, Tom Eirik; Halvorsen, Per Steinar; Nielsen, Erik Waage			Sepsis causes right ventricular myocardial inflammation independent of pulmonary hypertension in a porcine sepsis model	PLOS ONE			English	Article							SEPTIC SHOCK; CATHEPSIN-L; CARDIAC DYSFUNCTION; INHIBITION; LEGUMAIN; HEART; SYSTEM	Introduction Right ventricular (RV) myocardial dysfunction is a common feature in septic shock. It can worsen outcome, but the etiology is poorly understood. Pulmonary artery hypertension (PAH) plays a part in the pathogenesis of the right heart dysfunction in sepsis but its importance is unknown. In pigs, PAH in sepsis is substantial and the translational value of porcine sepsis models therefore questioned. We hypothesized that porcine sepsis causes a myocardial inflammatory response which leads to myocardial dysfunction independent of PAH. Materials and methods Sepsis was induced by Escherichia coli-infusion in 10 pigs resulting in PAH and increased right ventricular pressure (RVP). The same degree of RVP was achieved by external pulmonary artery banding (PAB) in a consecutive series of 6 animals. Results Sepsis, but not PAB, led to increase in endothelial damage marker PAI-1 and cytokines TNF and IL-6 (all p<0.05) in plasma. In myocardium, TNF and IL-6 were significantly elevated in sepsis, TNF in both ventricles and IL-6 mostly in RV, while IL-1 beta, IL-18 and C5a were significantly higher in RV compared to LV after PAB (all p<0.05). Myocardial mRNA levels of IL-1 beta, IL-6, IL-18, IP-10, E-selectin and PAI-1 were significantly elevated in RV and LV during sepsis compared to PAB, while Caspase-1 was decreased in septic compared to PAB animals (all p<0.05). Cathepsin L activity was increased in RV by PAB, while sepsis inhibited this response. Escherichia coli-induced sepsis caused myocardial inflammation independent of PAH. Conclusion Prominent PAH should therefore not exclude porcine sepsis models to further our understanding of human sepsis.	[Pischke, Soeren Erik; Mollnes, Tom Eirik; Nielsen, Erik Waage] Univ Oslo, Dept Immunol, Oslo, Norway; [Pischke, Soeren Erik; Mollnes, Tom Eirik; Nielsen, Erik Waage] Oslo Univ Hosp, Oslo, Norway; [Pischke, Soeren Erik; Bugge, Jan Frederik; Espinoza, Andreas; Nielsen, Erik Waage] Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Anaesthesiol, Oslo, Norway; [Pischke, Soeren Erik; Bugge, Jan Frederik; Espinoza, Andreas; Skulstad, Helge; Edvardsen, Thor; Fosse, Erik; Mollnes, Tom Eirik; Halvorsen, Per Steinar; Nielsen, Erik Waage] Univ Oslo, Fac Med, Oslo, Norway; [Hestenes, Siv; Fosse, Erik; Halvorsen, Per Steinar] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Hestenes, Siv] Vestre Viken Baerum Hosp, Dept Anaesthesia Intens Care & Emergency Med, Baerum, Norway; [Johansen, Harald Thidemann] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Fure, Hilde; Mollnes, Tom Eirik; Nielsen, Erik Waage] Nordland Hosp, Res Lab, Bodo, Norway; [Fure, Hilde; Mollnes, Tom Eirik; Nielsen, Erik Waage] Univ Tromso, KG Jebsen TREC, Fac Hlth Sci, Tromso, Norway; [Skulstad, Helge; Edvardsen, Thor] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway; [Skulstad, Helge; Edvardsen, Thor] Univ Oslo, Oslo, Norway; [Mollnes, Tom Eirik] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Trondheim, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU)	Nielsen, EW (corresponding author), Univ Oslo, Dept Immunol, Oslo, Norway.; Nielsen, EW (corresponding author), Oslo Univ Hosp, Oslo, Norway.; Nielsen, EW (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.; Nielsen, EW (corresponding author), Nordland Hosp, Res Lab, Bodo, Norway.; Nielsen, EW (corresponding author), Univ Tromso, KG Jebsen TREC, Fac Hlth Sci, Tromso, Norway.	erik.waage.nielsen@gmail.com	Pischke, Soeren Erik/AAX-9676-2021; Mollnes, Tom/ABI-5183-2020; Edvardsen, Thor/F-4079-2012	Pischke, Soeren Erik/0000-0003-2543-3251; Edvardsen, Thor/0000-0002-3800-765X; Espinoza, Andreas/0000-0002-6230-3088	Norwegian Research Council; Norwegian Council for Cardiovascular Diseases; Norwegian Council on Cardiovascular Disease; Odd Fellow Foundation; Simon Fougner Hartmann Family Fund; European Community [602699]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Council for Cardiovascular Diseases; Norwegian Council on Cardiovascular Disease; Odd Fellow Foundation; Simon Fougner Hartmann Family Fund; European Community(European Commission)	SEP was supported by a grant from the Norwegian Research Council. SH was supported by a grant from the Norwegian Council for Cardiovascular Diseases (PhD grant). TEM was supported by grants from The Norwegian Council on Cardiovascular Disease, The Odd Fellow Foundation, The Simon Fougner Hartmann Family Fund and the European Community's Seventh Framework Programme under grant agreement no 602699 (DIREKT).	Aneman A, 2016, INTENS CARE MED, V42, P2073, DOI 10.1007/s00134-016-4503-4; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chen N, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12487; Cheng XW, 2012, CIRCULATION, V125, P1551, DOI 10.1161/CIRCULATIONAHA.111.066712; Dall E, 2016, BIOCHIMIE, V122, P126, DOI 10.1016/j.biochi.2015.09.022; Davani EY, 2006, CARDIOVASC RES, V72, P134, DOI 10.1016/j.cardiores.2006.06.029; DHAINAUT JF, 1988, INTENS CARE MED, V14, P488, DOI 10.1007/BF00256967; Furian T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.017; Giamarellos-Bourboulis EJ, 2011, CRIT CARE, V15, DOI 10.1186/cc9974; Goldfarb RD, 2005, SHOCK, V24, P75, DOI 10.1097/01.shk.0000191337.01036.b7; Hestenes SM, 2014, CRIT CARE MED, V42, pE432, DOI 10.1097/CCM.0000000000000310; Hobai IA, 2015, SHOCK, V43, P3, DOI 10.1097/SHK.0000000000000261; Hoeper MM, 2011, AM J RESP CRIT CARE, V184, P1114, DOI 10.1164/rccm.201104-0662CI; Huang SJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12741; Jarkovska D, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00726; Johansen HT, 1999, ANAL BIOCHEM, V273, P278, DOI 10.1006/abio.1999.4221; Kato T, 2004, SHOCK, V21, P329, DOI 10.1097/00024382-200404000-00007; KAZARIAN KK, 1994, SHOCK, V1, P201, DOI 10.1097/00024382-199403000-00008; KIMCHI A, 1984, J AM COLL CARDIOL, V4, P945, DOI 10.1016/S0735-1097(84)80055-8; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Lappegard KT, 2006, PACE, V29, P753, DOI 10.1111/j.1540-8159.2006.00430.x; Lappegard KT, 2014, MOL IMMUNOL, V61, P126, DOI 10.1016/j.molimm.2014.06.036; Mair KH, 2014, DEV COMP IMMUNOL, V45, P321, DOI 10.1016/j.dci.2014.03.022; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Matsumoto H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32275-8; Mehra S, 2017, MOL CELL BIOCHEM, V428, P139, DOI 10.1007/s11010-016-2924-6; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Miller G, 2011, FASEB J, V25, P1606, DOI 10.1096/fj.10-172312; MITSUO T, 1992, CRIT CARE MED, V20, P630, DOI 10.1097/00003246-199205000-00014; Mollnes TE, 2002, BLOOD, V100, P1869; Oliveira GHM, 2006, AM J CARDIOL, V97, P1626, DOI 10.1016/j.amjcard.2005.12.056; Orde SR, 2014, CRIT CARE, V18, DOI 10.1186/cc13987; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Schuetz P, 2011, SHOCK, V36, P104, DOI 10.1097/SHK.0b013e31821e4e04; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sun M, 2011, CARDIOVASC RES, V89, P374, DOI 10.1093/cvr/cvq328; Tang QZ, 2009, J MOL MED, V87, P249, DOI 10.1007/s00109-008-0423-2; Thorgersen EB, 2013, INFECT IMMUN, V81, P3173, DOI 10.1128/IAI.00390-13; Thorgersen EB, 2010, FASEB J, V24, P712, DOI 10.1096/fj.09-140798; Tipoe TL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01218; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Vieillard-Baron A, 2008, CRIT CARE MED, V36, P1701, DOI 10.1097/CCM.0b013e318174db05; WERLE B, 1995, BIOL CHEM H-S, V376, P157, DOI 10.1515/bchm3.1995.376.3.157; WINKLER GC, 1988, AM J ANAT, V181, P217, DOI 10.1002/aja.1001810302; Zaky A, 2014, SHOCK, V41, P12, DOI 10.1097/SHK.0000000000000065	45	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218624	10.1371/journal.pone.0218624	http://dx.doi.org/10.1371/journal.pone.0218624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247004	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900033
J	Bedggood, P; Metha, A				Bedggood, Phillip; Metha, Andrew			Mapping flow velocity in the human retinal capillary network with pixel intensity cross correlation	PLOS ONE			English	Article							PARAFOVEAL CAPILLARIES; BLOOD-FLOW; MOTION	We present a new method for determining cellular velocity in the smallest retinal vascular networks as visualized with adaptive optics. The method operates by comparing the intensity profile of each movie pixel with that of every other pixel, after shifting in time by one frame. The time-shifted pixel which most resembles the reference pixel is deemed to be a 'source' or ;destination' of flow information for that pixel. Velocity in the transverse direction is then calculated by dividing the spatial displacement between the two pixels by the inter-frame period. We call this method pixel intensity cross-correlation, or "PIX". Here we compare measurements derived from PIX to two other state-of-the-art algorithms (particle image velocimetry and the spatiotemporal kymograph), as well as to manually tracked cell data. The examples chosen highlight the potential of the new algorithm to substantially improve spatial and temporal resolution, resilience to noise and aliasing, and assessment of network flow properties compared with existing methods.	[Bedggood, Phillip; Metha, Andrew] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia	University of Melbourne	Bedggood, P (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia.	pabedg@unimelb.edu.au	Metha, Andrew/H-2401-2015	Metha, Andrew/0000-0003-2997-4362; Bedggood, Phillip/0000-0001-5144-3694	Australian Research Council [DP180103393]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Discovery Project DP180103393 (https://www.arc.gov.au/) to AM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedggood P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174617; Bedggood P, 2014, OPT LETT, V39, P610, DOI 10.1364/OL.39.000610; Bedggood Phillip, 2012, Biomed Opt Express, V3, P3264, DOI 10.1364/BOE.3.003264; Burns SA, 2014, BIOMED OPT EXPRESS, V5, P961, DOI 10.1364/BOE.5.000961; Chui TYP, 2012, OPTOMETRY VISION SCI, V89, P602, DOI 10.1097/OPX.0b013e3182504227; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; de Castro A, 2016, OPT LETT, V41, P1881, DOI 10.1364/OL.41.001881; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Delori FC, 2007, J OPT SOC AM A, V24, P1250, DOI 10.1364/JOSAA.24.001250; Duan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162621; Gu BY, 2018, BIOMED OPT EXPRESS, V9, DOI 10.1364/BOE.9.003653; Guevara-Torres A, 2016, BIOMED OPT EXPRESS, V7, P4228, DOI 10.1364/BOE.7.004228; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Jerman T, 2015, MED IMAGING 2015 IMA; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Martin JA, 2009, EXP EYE RES, V88, P356, DOI 10.1016/j.exer.2008.07.008; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P635, DOI 10.1038/jcbfm.2013.18; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; SCHALLEK J, 2013, INVEST OPHTH VIS SCI, V54, P37585; Tam J, 2011, INVEST OPHTH VIS SCI, V52, P9257, DOI 10.1167/iovs.11-8481; Tam J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548880; Tam J, 2010, INVEST OPHTH VIS SCI, V51, P1691, DOI 10.1167/iovs.09-4483; Uji A, 2012, INVEST OPHTH VIS SCI, V53, P171, DOI 10.1167/iovs.11-8192; WOLF S, 1994, HYPERTENSION, V23, P464, DOI 10.1161/01.HYP.23.4.464; Zhong ZY, 2008, OPT EXPRESS, V16, P12746, DOI 10.1364/OE.16.012746	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218918	10.1371/journal.pone.0218918	http://dx.doi.org/10.1371/journal.pone.0218918			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237930	Green Published, gold			2022-12-26	WOS:000484856000050
J	Sekhar, S; Windes, P; Fan, XZ; Tafti, DK				Sekhar, Susheel; Windes, Peter; Fan, Xiaozhou; Tafti, Danesh K.			Canonical description of wing kinematics and dynamics for a straight flying insectivorous bat (Hipposideros pratti)	PLOS ONE			English	Article							LEADING-EDGE VORTICES; HEAT-TRANSFER; AERODYNAMIC PERFORMANCE; FLIGHT; LIFT; VORTEX; DEFORMATION; FLEXIBILITY; SIMULATION; FLOW	Bats, with highly articulated wings, are some of the most agile flyers in nature. A novel three-dimensional geometric decomposition framework is developed to reduce the complex kinematics of a bat wing into physical movements used to describe flapping flight: namely flapping, stroke plane deviation and pitching, together with cambering and flexion. The decomposition is combined with aerodynamic simulations to investigate the cumulative effect of each motion on force production, and their primary contribution to the unsteady vortex dynamics. For the nearly straight and level flight of Hipposideros pratti, results show that the flapping motion by itself induced a moderate drag and lift. Stroke plane deviation increased lift, and nullified the drag. With the inclusion of the pitching motion into the kinematics, lift production further increased by a factor of more than 2.5, and exhibited a positive net thrust by virtue of the favorable wing orientation during the upstroke. The primary contribution of cambering, which included a maximum chord line displacement of approximate to 40% standard mean chord, was the stabilization of the leading edge vortex during the downstroke. This increased mean lift by about 35% at the expense of net thrust. Flexion was perhaps the most complex motion with maximum displacements of 75% standard mean chord. This was instrumental in reducing the negative lift during the upstroke by preventing the formation of strong leading edge vortices. The aerodynamic effective angle of attack emerged as a heuristic parameter to describe lift and net thrust production across movements.	[Sekhar, Susheel; Windes, Peter; Fan, Xiaozhou; Tafti, Danesh K.] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Tafti, DK (corresponding author), Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA.	dtafti@exchange.vt.edu		Windes, Peter/0000-0002-6059-5128; Sekhar, Susheel/0000-0003-0952-5092	NSF CBET [1510797]; VT ICTAS/BIST Center	NSF CBET(National Science Foundation (NSF)); VT ICTAS/BIST Center	The financial support of the NSF CBET Grant No. 1510797 to DKT and support from VT ICTAS/BIST Center is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono H., 2010, 48 AIAA AER SCI M IN, P1, DOI [10.2514/6.2010-554, DOI 10.2514/6.2010-554]; Bender M, 2019, NONLINEAR DYNAM, V95, P217, DOI 10.1007/s11071-018-4560-z; Bender MJ, 2015, AIAA MOD SIM TECHN C, DOI [10.2514/6.2015-1806, DOI 10.2514/6.2015-1806]; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Cheney JA, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/2/025007; Cheng X, 2016, SCI REP-UK, V6, DOI 10.1038/srep25706; CHONG MS, 1990, PHYS FLUIDS A-FLUID, V2, P765, DOI 10.1063/1.857730; Chung SJ, 2010, J GUID CONTROL DYNAM, V33, P440, DOI 10.2514/1.45311; Curet Oscar M, 2013, J R Soc Interface, V10, P20120940, DOI 10.1098/rsif.2012.0940; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Fan X, 2018, 2018 AIAA MOD SIM TE, DOI [10.2514/6.2018-2155, DOI 10.2514/6.2018-2155]; Fung YC, 2008, AN INTRODUCTION TO T; Gerdes JW, 2012, J MECH ROBOT, V4, DOI 10.1115/1.4005525; Gopalakrishnan P., 2008, UNSTEADY AERODYNAMIC; Gopalakrishnan P, 2010, AIAA J, V48, P865, DOI 10.2514/1.39957; He L, 2018, POWDER TECHNOL, V335, P409, DOI 10.1016/j.powtec.2018.05.031; He L, 2017, INT J HEAT MASS TRAN, V114, P324, DOI 10.1016/j.ijheatmasstransfer.2017.06.068; Hedenstrom A, 2015, J EXP BIOL, V218, P653, DOI 10.1242/jeb.031203; Hedenstrom A, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/1/015001; Hubel TY, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0385; Hubel TY, 2010, J EXP BIOL, V213, P3427, DOI 10.1242/jeb.043257; Kang CK, 2011, J FLUID MECH, V689, P32, DOI 10.1017/jfm.2011.428; Lentink D, 2009, FLYING INSECTS AND ROBOTS, P185, DOI 10.1007/978-3-540-89393-6_14; Lentink D, 2009, J EXP BIOL, V212, P2691, DOI 10.1242/jeb.022251; Lentink D, 2009, J EXP BIOL, V212, P2705, DOI 10.1242/jeb.022269; Lin YS, 2017, IEEE WINT CONF APPL, P418, DOI 10.1109/WACV.2017.53; Lucas KN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4293; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Maeda M, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170307; MAXWORTHY T, 1981, ANNU REV FLUID MECH, V13, P329, DOI 10.1146/annurev.fl.13.010181.001553; Mountcastle AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0531; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Nagendra K, 2014, J COMPUT PHYS, V267, P225, DOI 10.1016/j.jcp.2014.02.045; Nakata T, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/045002; Nakata T, 2012, J COMPUT PHYS, V231, P1822, DOI 10.1016/j.jcp.2011.11.005; Nakata T, 2012, P ROY SOC B-BIOL SCI, V279, P722, DOI 10.1098/rspb.2011.1023; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Pivkin IV, 2005, LECT NOTES COMPUT SC, V3515, P689; Ramezani A, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aal2505; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Shyy W, 2007, AIAA J, V45, P2817, DOI 10.2514/1.33205; Shyy W, 2009, AIAA J, V47, P289, DOI 10.2514/1.41732; SRIDHAR S, 2015, BIOINSPIR BIOMIM, V10, DOI DOI 10.1088/1748-3190/10/3/036007; Svoboda T, 2005, PRESENCE-VIRTUAL AUG, V14, P407, DOI 10.1162/105474605774785325; Tafti D.K., 2001, P ASME FLUIDS ENG DI, V256, P347; Tafti DK, 2011, INT SER DEV HEAT TRA, P217; Tian XD, 2006, BIOINSPIR BIOMIM, V1, pS10, DOI 10.1088/1748-3182/1/4/S02; Le TQ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0312; Viswanath K, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4864297; Viswanath K, 2014, 52 AER SCI M, DOI [10.2514/6.2014-0220, DOI 10.2514/6.2014-0220]; Viswanath K, 2013, AIAA J, V51, P145, DOI 10.2514/1.J051675; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; Wang SZ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0821; Wang SZ, 2015, THEOR APPL MECH LETT, V5, P5, DOI 10.1016/j.taml.2015.01.006; WEISFOGH T, 1973, J EXP BIOL, V59, P169; Windes P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207613; Wolf M, 2010, J EXP BIOL, V213, P2142, DOI 10.1242/jeb.029777; Wu P, 2010, AIAA J, V48, P2111, DOI 10.2514/1.J050310; Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928; Zheng LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053060	62	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218672	10.1371/journal.pone.0218672	http://dx.doi.org/10.1371/journal.pone.0218672			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237912	Green Published, Green Submitted, gold			2022-12-26	WOS:000484856000032
J	Thorsteinsdottir, L; Jonsdottir, S; Stefansdottir, SB; Andresdottir, V; Wagner, B; Marti, E; Torsteinsdottir, S; Svansson, V				Thorsteinsdottir, Lilja; Jonsdottir, Sigriour; Stefansdottir, Sara Bjork; Andresdottir, Valgerdur; Wagner, Bettina; Marti, Eliane; Torsteinsdottir, Sigurbjorg; Svansson, Vilhjalmur			The effect of maternal immunity on the equine gammaherpesvirus type 2 and 5 viral load and antibody response	PLOS ONE			English	Article							MULTINODULAR PULMONARY-FIBROSIS; HERPESVIRUS TYPE-2; RESPIRATORY-DISEASE; NASAL SWABS; FOALS; HORSE; INFECTION; EHV-2; PREVALENCE; VIRUSES	Two types of gammaherpesviruses (gamma EHV) are known to infect horses, EHV-2 and EHV-5. Foals become infected early in life, probably via the upper respiratory tract, despite maternal antibodies. In this study, we analyzed samples from a herd of mares and their foals. The foals were followed from birth to 22 months of age and the dams during the first 6 months postpartum. Blood and nasal swab samples were taken regularly for evaluation of antibody responses, virus isolation and viral load by qPCR. EHV-2 was isolated on day 5, and EHV-5 on day 12, earlier than previously reported. gamma EHV specific antibodies were not detectable in serum of foals before colostrum intake but peaked a few days after colostrum. Overall, EHV-2 viral load peaked in nasal swab at three to four months of age, paralleled with decline in maternal antibodies, but EHV-5 viral load did not peak until month 12. Maternal antibodies had a notable effect on the viral load and induction of endogenous antibody production. Foals were grouped in two groups depending on the mare's gamma EHV specific total IgG levels in serum at birth, group-high and group-low. Group-high had higher levels of maternal gamma EHV specific total IgG and IgG4/7 for the first 3 months, but when the endogenous production had superseded maternal antibodies, group-low was higher. The maternal antibodies had an effect on the gamma EHV viral load. Group-low peaked in EHV-2 viral load one month earlier than group-high. These effects were more evident for EHV-5, as there were seven months between the viral load peaks for the groups. The study provides information on how maternal antibody transfer affects gamma EHV shedding and antibody production in offspring. It also extends our knowledge on the occurrence of EHV-2 and EHV-5 infection in foals during the first two years of life.	[Thorsteinsdottir, Lilja; Jonsdottir, Sigriour; Stefansdottir, Sara Bjork; Andresdottir, Valgerdur; Torsteinsdottir, Sigurbjorg; Svansson, Vilhjalmur] Univ Iceland, Biomed Ctr, Inst Expt Pathol, Reykjavik, Iceland; [Jonsdottir, Sigriour; Marti, Eliane] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland; [Wagner, Bettina] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	University of Iceland; University of Bern; Cornell University	Thorsteinsdottir, L (corresponding author), Univ Iceland, Biomed Ctr, Inst Expt Pathol, Reykjavik, Iceland.	liljatho@hi.is		Stefansdottir, Sara Bjork/0000-0001-9560-7574; Jonsdottir, Sigridur/0000-0001-5562-7650; Jonsdottir, Sigridur/0000-0003-2576-9599; Thorsteinsdottir, Lilja/0000-0003-2410-2960; Wagner, Bettina/0000-0003-2370-6324	Icelandic Research Fund [130446]; Developmental Fund for Icelandic Horse Breeding [10190951]; Icelandic Horse Conservation Fund [10190942]	Icelandic Research Fund; Developmental Fund for Icelandic Horse Breeding; Icelandic Horse Conservation Fund	This work was supported by: The Icelandic Research Fund (VS, 130446), The Developmental Fund for Icelandic Horse Breeding (VS, 10190951), The Icelandic Horse Conservation Fund (VS, 10190942).	AGIUS CT, 1994, J GEN VIROL, V75, P2707, DOI 10.1099/0022-1317-75-10-2707; Back H, 2015, VET MICROBIOL, V179, P142, DOI 10.1016/j.vetmic.2015.06.002; BAIRD AN, 1987, J EQUINE VET SCI, V7, P124, DOI 10.1016/S0737-0806(87)80019-9; Bell SA, 2006, VET MICROBIOL, V116, P249, DOI 10.1016/j.vetmic.2006.05.002; Bjornsdottir S, 2017, MBIO, V8, DOI 10.1128/mBio.00826-17; BLAKESLEE JR, 1975, CAN J MICROBIOL, V21, P1940, DOI 10.1139/m75-281; Borchers K, 2006, VET MICROBIOL, V118, P260, DOI 10.1016/j.vetmic.2006.07.024; Brault SA, 2011, VET MICROBIOL, V147, P253, DOI 10.1016/j.vetmic.2010.06.031; Brault SA, 2010, VET IMMUNOL IMMUNOP, V137, P136, DOI 10.1016/j.vetimm.2010.05.010; BROWNING GF, 1987, J CLIN MICROBIOL, V25, P13, DOI 10.1128/JCM.25.1.13-16.1987; COLLINSON PN, 1994, J AM VET MED ASSOC, V205, P329; Craig Maria I, 2005, BMC Vet Res, V1, P9, DOI 10.1186/1746-6148-1-9; Dowdall SMJ, 2002, VET PARASITOL, V106, P225, DOI 10.1016/S0304-4017(02)00085-7; Drummer HE, 1996, ARCH VIROL, V141, P495, DOI 10.1007/BF01718313; Dunowska M, 1999, NEW ZEAL VET J, V47, P44, DOI 10.1080/00480169.1999.36109; Dunowska M, 2011, VET MICROBIOL, V152, P176, DOI 10.1016/j.vetmic.2011.04.017; Dunowska M, 2002, NEW ZEAL VET J, V50, P132, DOI 10.1080/00480169.2002.36299; Dunowska M, 2002, NEW ZEAL VET J, V50, P140, DOI 10.1080/00480169.2002.36300; Dynon K, 2007, AUST VET J, V85, P46, DOI 10.1111/j.1751-0813.2006.00096.x; Fortier G, 2013, VET J, V197, P492, DOI 10.1016/j.tvjl.2012.12.027; Franchini M, 1997, VIROLOGY, V238, P8, DOI 10.1006/viro.1997.8825; FU ZF, 1986, NEW ZEAL VET J, V34, P152, DOI 10.1080/00480169.1986.35331; Galosi CM, 2005, J VET DIAGN INVEST, V17, P500, DOI 10.1177/104063870501700520; Goodman LB, 2012, CLIN VACCINE IMMUNOL, V19, P235, DOI 10.1128/CVI.05522-11; Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649; Hartley CA, 2013, VET MICROBIOL, V167, P86, DOI 10.1016/j.vetmic.2013.05.031; Herder V, 2012, VET MICROBIOL, V155, P420, DOI 10.1016/j.vetmic.2011.09.020; Holznagel DL, 2003, EQUINE VET J, V35, P620, DOI 10.2746/042516403775467153; Hue ES, 2014, J VIROL METHODS, V198, P18, DOI 10.1016/j.jviromet.2013.12.008; Hussey GS, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-23; Jeffcott L B, 1974, Equine Vet J, V6, P109, DOI 10.1111/j.2042-3306.1974.tb03942.x; Jonsdottir S, 2018, VET IMMUNOL IMMUNOP, V201, P32, DOI 10.1016/j.vetimm.2018.05.005; Jonsdottir S, 2015, VET IMMUNOL IMMUNOP, V166, P8, DOI 10.1016/j.vetimm.2015.05.002; Kershaw O, 2001, VIRUS RES, V80, P93, DOI 10.1016/S0168-1702(01)00299-4; Korosue K, 2012, J VET MED SCI, V74, P1387, DOI 10.1292/jvms.11-0470; Leon A, 2008, VET MICROBIOL, V126, P20, DOI 10.1016/j.vetmic.2007.06.019; Lewis MJ, 2008, MOL IMMUNOL, V45, P818, DOI 10.1016/j.molimm.2007.06.158; Lopez AM, 2002, CLIN DIAGN LAB IMMUN, V9, P1270, DOI 10.1128/CDLI.9.6.1270-1276.2002; Marenzoni ML, 2013, VET RES COMMUN, V37, P311, DOI 10.1007/s11259-013-9578-6; Marenzoni ML, 2011, J VET DIAGN INVEST, V23, P802, DOI 10.1177/1040638711407890; Marenzoni ML, 2010, VET RES COMMUN, V34, P703, DOI 10.1007/s11259-010-9443-9; Marti E, 2009, VET IMMUNOL IMMUNOP, V127, P203, DOI 10.1016/j.vetimm.2008.10.316; Mekuria ZH, 2017, J GEN VIROL, V98, P461, DOI 10.1099/jgv.0.000668; Mizukoshi F, 2002, VET IMMUNOL IMMUNOP, V88, P97, DOI 10.1016/S0165-2427(02)00130-7; Murray MJ, 1996, EQUINE VET J, V28, P432, DOI 10.1111/j.2042-3306.1996.tb01614.x; Muscat KE, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00224; Nelson KM, 1998, VACCINE, V16, P1306, DOI 10.1016/S0264-410X(98)00009-7; Nordengrahn A, 2002, VET RES, V33, P251, DOI 10.1051/vetres:2002013; Nordengrahn A, 1996, VET MICROBIOL, V51, P55, DOI 10.1016/0378-1135(96)00032-6; Nordengrahn A, 2001, J VET DIAGN INVEST, V13, P389, DOI 10.1177/104063870101300504; Padalino B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194272; Perkins GA, 2015, EQUINE VET J, V47, P267, DOI 10.1111/evj.12387; PLUMMER G, 1973, INFECT IMMUN, V8, P621, DOI 10.1128/IAI.8.4.621-627.1973; REUBEL GH, 1995, ARCH VIROL, V140, P1049, DOI 10.1007/BF01315414; ROIZMANN B, 1992, ARCH VIROL, V123, P425, DOI 10.1007/BF01317276; Rushton JO, 2013, VET MICROBIOL, V164, P139, DOI 10.1016/j.vetmic.2013.01.035; Sheoran AS, 1998, VET IMMUNOL IMMUNOP, V62, P153, DOI 10.1016/S0165-2427(97)00162-1; Sheoran AS, 2000, AM J VET RES, V61, P1099, DOI 10.2460/ajvr.2000.61.1099; SHERMAN J, 1977, J CLIN MICROBIOL, V5, P285; Stasiak K, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1018-3; STUDDERT MJ, 1974, CORNELL VET, V64, P94; Svansson V, 2009, VET MICROBIOL, V137, P363, DOI 10.1016/j.vetmic.2009.01.020; Thorsteinsdottir L, 2016, IN VITRO CELL DEV-AN, V52, P872, DOI 10.1007/s11626-016-0046-9; Thorsteinsdottir L, 2013, RES VET SCI, V94, P170, DOI 10.1016/j.rvsc.2012.07.011; Thorsteinsdottir L, 2010, J VET DIAGN INVEST, V22, P420, DOI 10.1177/104063871002200313; Torfason EG, 2008, RES VET SCI, V85, P605, DOI 10.1016/j.rvsc.2008.01.003; Van Cleemput J, 2019, VET RES, V50, DOI 10.1186/s13567-019-0630-6; Wagner B, 2006, VET IMMUNOL IMMUNOP, V110, P269, DOI 10.1016/j.vetimm.2005.10.007; Wagner B, 2004, J IMMUNOL, V173, P3230, DOI 10.4049/jimmunol.173.5.3230; Wang L, 2007, VET MICROBIOL, V121, P18, DOI 10.1016/j.vetmic.2006.11.009; WILKS CR, 1974, AUST VET J, V50, P438, DOI 10.1111/j.1751-0813.1974.tb06866.x; Willey S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-16; Williams KJ, 2007, VET PATHOL, V44, P849, DOI 10.1354/vp.44-6-849; Wong DM, 2008, JAVMA-J AM VET MED A, V232, P898, DOI 10.2460/javma.232.6.898	74	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218576	10.1371/journal.pone.0218576	http://dx.doi.org/10.1371/journal.pone.0218576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226153	Green Published, gold			2022-12-26	WOS:000484894700023
J	Vidakovics, MLAP; Ure, AE; Arrias, PN; Romanowski, V; Gomez, RM				Perez Vidakovics, Maria Laura A.; Ure, Agustin E.; Arrias, Paula N.; Romanowski, Victor; Gomez, Ricardo M.			Junin virus induces autophagy in human A549 cells	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; MONITORING AUTOPHAGY; ARENAVIRUS; REPLICATION; INFECTION; MACHINERY; PATHWAY; COMPLEX; INVOLVEMENT; ACTIVATION	Autophagy, a highly regulated degradative process that promotes cellular homeostasis, is increasingly recognised as a fundamental component of the cellular response against viral infection. In this study, we investigated the role of autophagy during Junin virus (JUNV) multiplication using human A549 cells. We found that JUNV infection induces an increment of the LC3-II/LC3-I ratio, an accumulation of punctate pattern in RFP-LC3-transfected cells and the colocalisation of viral nucleoprotein and LC3 protein, suggesting autophagosome formation. JUNV infection also induced the degradation of the autophagy receptor p62, suggesting that complete autophagic flux was triggered. In addition, we showed that inhibition of autophagy with bafilomycin A1 or 3-methyladenine significantly reduces viral multiplication. Moreover, viral yield was increased when autophagy was induced using rapamycin. Furthermore, JUNV infection induced the colocalisation of p62, ATG16, RAB5, RAB7A and LAMP1 with the autophagosomal LC3 protein. That suggests that phagosomes undergo the maturation process during viral infection. Finally, we demonstrated that siRNA experiments targeting essential autophagy genes (ATG5, ATG7 and Beclin 1) reduce viral protein synthesis and viral yield. Overall, our results indicate that JUNV activates host autophagy machinery enhancing its multiplication.	[Perez Vidakovics, Maria Laura A.; Ure, Agustin E.; Arrias, Paula N.; Romanowski, Victor; Gomez, Ricardo M.] Univ Nacl La Plata, CONICET, Inst Biotecnol & Biol Mol, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Vidakovics, MLAP (corresponding author), Univ Nacl La Plata, CONICET, Inst Biotecnol & Biol Mol, La Plata, Buenos Aires, Argentina.	marialaura.perezvidakovics@biol.unlp.edu.ar	Gomez, Ricardo M/AAG-9555-2019; Ure, Agustín Enrique/AAG-9078-2021	Gomez, Ricardo M/0000-0002-4001-519X; Ure, Agustín Enrique/0000-0001-6494-2003; Romanowski, Victor/0000-0001-6378-7929; Arrias, Paula Nazarena/0000-0001-5668-768X; Perez Vidakovics, Maria Laura Anabella/0000-0003-4283-812X	National Agency for the Promotion of Science and Technology (Argentina) [PICT 2014-1492, PICT 2014-3499, PICT 2016-2022]; International Society for Infectious Diseases (ISID); National Scientific and Technical Research Council (Argentina) [PIP 0680]	National Agency for the Promotion of Science and Technology (Argentina)(ANPCyT); International Society for Infectious Diseases (ISID); National Scientific and Technical Research Council (Argentina)	This work was supported by research grants PICT 2014-1492 (MLAPV), PICT 2014-3499 (AEU), PICT 2016-2022 (VR) from the National Agency for the Promotion of Science and Technology (Argentina, www.argentina.gob.ar/ciencia/agencia); a grant from the International Society for Infectious Diseases (ISID, www.isid.org) to MLAPV, and PIP 0680 (VR) from the National Scientific and Technical Research Council (Argentina, www.conicet.gov.ar).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoldi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095197; Autophagy Jackson W., 2014, INFECT IMMUNE RESPON, DOI [10.1002/9781118677551, DOI 10.1002/9781118677551]; Baird NL, 2012, J VIROL, V86, P11301, DOI 10.1128/JVI.01635-12; Berryman S, 2012, J VIROL, V86, P12940, DOI 10.1128/JVI.00846-12; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brunetti JE, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040199; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Castilla V, 2001, ARCH VIROL, V146, P251, DOI 10.1007/s007050170173; Crawford SE, 2012, P NATL ACAD SCI USA, V109, pE3405, DOI 10.1073/pnas.1216539109; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; Rodriguez ME, 2014, J GEN VIROL, V95, P799, DOI 10.1099/vir.0.061242-0; Fahmy AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40351; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Gomez RM, 2003, THROMB HAEMOSTASIS, V90, P326, DOI 10.1160/TH02-09-0043; Groseth A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001137; Martinez MG, 2008, VIRUS RES, V138, P17, DOI 10.1016/j.virusres.2008.08.004; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim JH, 2014, EXP CELL RES, V327, P340, DOI 10.1016/j.yexcr.2014.08.001; King BR, 2017, J GEN VIROL, V98, P2454, DOI 10.1099/jgv.0.000930; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; LEVIS SC, 1985, J INTERFERON RES, V5, P383, DOI 10.1089/jir.1985.5.383; Linero FN, 2009, VIRUS RES, V145, P166, DOI 10.1016/j.virusres.2009.07.004; Martinez MG, 2013, BIOCHEM BIOPH RES CO, V441, P612, DOI 10.1016/j.bbrc.2013.10.106; Martinez MG, 2007, J GEN VIROL, V88, P1776, DOI 10.1099/vir.0.82808-0; Martinez M. Guadalupe, 2009, Biotechnology Journal, V4, P866, DOI 10.1002/biot.200800357; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munz C, 2011, VIRUSES-BASEL, V3, P1166, DOI 10.3390/v3071166; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Nakatogawa H, 2013, ESSAYS BIOCHEM, V55, P39, DOI [10.1042/bse0550039, 10.1042/BSE0550039]; National Institute of Allergy and Infectious Diseases, 2018, NIAID EM INF DIS PAT; Orvedahl A, 2008, AUTOPHAGY, V4, P280, DOI 10.4161/auto.5289; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Radoshitzky SR, 2015, ARCH VIROL, V160, P1851, DOI 10.1007/s00705-015-2418-y; Richards AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003046; Romanowski V, 2017, HUMAN VIROLOGY LATIN, P195, DOI [10.1007/978-3-319-54567-7_10, DOI 10.1007/978-3-319-54567-7_10]; Salvato M.S., 2012, VIRUS TAXONOMY, P715; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharifi MN, 2015, METHODS MOL BIOL, V1292, P129, DOI 10.1007/978-1-4939-2522-3_10; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Sridharan Savitha, 2011, Cancers (Basel), V3, P2630, DOI 10.3390/cancers3022630; Sun MX, 2012, AUTOPHAGY, V8, P1434, DOI 10.4161/auto.21159; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Tortorici MA, 2001, VIRUS RES, V73, P41, DOI 10.1016/S0168-1702(00)00222-7; Vela EM, 2008, ARCH VIROL, V153, P1391, DOI 10.1007/s00705-008-0129-3; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yordy B, 2013, INT IMMUNOL, V25, P1, DOI 10.1093/intimm/dxs101; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06; York J, 2009, J VIROL, V83, P4121, DOI 10.1128/JVI.02410-08; Zhou DJ, 2012, J INFECT DIS, V205, P1258, DOI 10.1093/infdis/jis187; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406; Zinchuk V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01365	77	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218730	10.1371/journal.pone.0218730	http://dx.doi.org/10.1371/journal.pone.0218730			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216340	Green Published, gold, Green Submitted			2022-12-26	WOS:000482885300068
J	Schultz, F; Swiatlowska, P; Alvarez-Laviada, A; Sanchez-Alonso, JL; Song, QQ; de Vries, AAF; Pijnappels, DA; Ongstad, E; Braga, VMM; Entcheva, E; Gourdie, RG; Miragoli, M; Gorelik, J				Schultz, Francisca; Swiatlowska, Pamela; Alvarez-Laviada, Anita; Sanchez-Alonso, Jose L.; Song, Qianqian; de Vries, Antoine A. F.; Pijnappels, Daniel A.; Ongstad, Emily; Braga, Vania M. M.; Entcheva, Emilia; Gourdie, Robert G.; Miragoli, Michele; Gorelik, Julia			Cardiomyocyte-myofibroblast contact dynamism is modulated by connexin-43	FASEB JOURNAL			English	Article						heart failure; myocardial infarction; Cx43; heterocellular coupling	CARDIAC ELECTRICAL-ACTIVITY; VENTRICULAR MYOCYTES; GAP-JUNCTIONS; FIBROBLASTS; CONDUCTION; EXPRESSION; PROTEIN; ACTIN; TRAFFICKING; FIBROSIS	Healthy cardiomyocytes are electrically coupled at the intercalated discs by gap junctions. In infarcted hearts, adverse gap-junctional remodeling occurs in the border zone, where cardiomyocytes are chemically and electrically influenced by myofibroblasts. The physical movement of these contacts remains unquantified. Using scanning ion conductance microscopy, we show that intercellular contacts between cardiomyocytes and myofibroblasts are highly dynamic, mainly owing to the edge dynamics (lamellipodia) of the myofibroblasts. Decreasing the amount of functional connexin-43 (Cx43) at the membrane through Cx43 silencing, suppression of Cx43 trafficking, or hypoxia-induced Cx43 internalization attenuates heterocellular contact dynamism. However, we found decreased dynamism and stabilized membrane contacts when cellular coupling was strengthened using 4-phenylbutyrate (4PB). Fluorescent-dye transfer between cells showed that the extent of functional coupling between the 2 cell types correlated with contact dynamism. Intercellular calcein transfer from myofibroblasts to cardiomyocytes is reduced after myofibroblast-specific Cx43 down-regulation. Conversely, 4PB-treated myofibroblasts increased their functional coupling to cardiomyocytes. Consistent with lamellipodia-mediated contacts, latrunculin-B decreases dynamism, lowers physical communication between heterocellular pairs, and reduces Cx43 intensity in contact regions. Our data show that heterocellular cardiomyocyte-myofibroblast contacts exhibit high dynamism. Therefore, Cx43 is a potential target for prevention of aberrant cardiomyocyte coupling and myofibroblast proliferation in the infarct border zone.-Schultz, F., Swiatlowska, P., Alvarez-Laviada, A., Sanchez-Alonso, J. L., Song, Q., de Vries, A. A. F., Pijnappels, D. A., Ongstad, E., Braga, V. M. M., Entcheva, E., Gourdie, R. G., Miragoli, M., Gorelik, J. Cardiomyocyte-myofibroblast contact dynamism is modulated by connexin-43.	[Schultz, Francisca; Swiatlowska, Pamela; Alvarez-Laviada, Anita; Sanchez-Alonso, Jose L.; Song, Qianqian; Gorelik, Julia] Imperial Coll London, Natl Heart & Lung Inst, London, England; [de Vries, Antoine A. F.; Pijnappels, Daniel A.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Ongstad, Emily; Gourdie, Robert G.] Virginia Tech, Caril Res Inst, Ctr Heart & Regenerat Med, Roanoke, VA USA; [Braga, Vania M. M.] Imperial Coll London, Dept Resp Sci, Fac Med, Natl Heart & Lung Inst, London, England; [Entcheva, Emilia] George Washington Univ, Dept Biomed Engn, Washington, DC USA; [Miragoli, Michele] Humanitas Clin & Res Ctr, Milan, Italy; [Miragoli, Michele] Univ Parma, Dept Med & Surg, Via Gramsci 14, I-43124 Parma, Italy	Imperial College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Virginia Polytechnic Institute & State University; Imperial College London; George Washington University; University of Parma; University Hospital of Parma	Miragoli, M (corresponding author), Univ Parma, Dept Med & Surg, Via Gramsci 14, I-43124 Parma, Italy.; Gorelik, J (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Imperial Ctr Translat & Expt Med, 4th Floor,Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	michele.miragoli@unipr.it; j.gorelik@imperial.ac.uk	Miragoli, Michele/K-6418-2016; song, qianqian/GXH-5161-2022; Pijnappels, Daniël/AAA-2304-2022; de Vries, Antoine/ABG-5787-2021; Pijnappels, Daniël/GLN-2810-2022	Miragoli, Michele/0000-0002-4058-4368; Pijnappels, Daniël/0000-0001-6731-4125; Sanchez Alonso-Mardones, Jose Luis/0000-0003-2942-0079; Braga, Vania/0000-0003-0546-7163; Gorelik, Julia/0000-0003-1148-9158; Schultz, Francisca/0000-0002-8923-2128	British Heart Foundation [RG/17/13/33173]; Medical Research Council [MR/L006855/1]; National Heart, Lung, and Blood Institute (NHLBI), U.S. National Institutes of Health [1R01HL141855-01]; Heart Research UK; Italian Ministry of Education, Universities and Research (FFABR-MIUR-2017); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141855] Funding Source: NIH RePORTER; BBSRC [BB/D019400/1, BB/M022617/1] Funding Source: UKRI; MRC [MR/L006855/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung, and Blood Institute (NHLBI), U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Heart Research UK; Italian Ministry of Education, Universities and Research (FFABR-MIUR-2017); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank P. O'Gara (Imperial College London, London, United Kingdom) for the assistance with the isolation of adult rat ventricular fibroblasts and M. Sikkel (Imperial College London, London) and C. Mansfield (Imperial College London, London) for generating rat models of myocardial infarction. This work was supported by British Heart Foundation (RG/17/13/33173 to J.G.), Medical Research Council (MR/L006855/1 to J.G.), National Heart, Lung, and Blood Institute (NHLBI), U.S. National Institutes of Health Grant-1R01HL141855-01 (to R.G., J.G. and A.A.-L.), Heart Research UK, and by Italian Ministry of Education, Universities and Research (FFABR-MIUR-2017 to M.M.). M.M. and J.G. jointly supervised this work. The authors declare no conflicts of interest.	Aasen T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051296; Alvarez-Maubecin V, 2000, J NEUROSCI, V20, P4091; Askar SF, 2012, CARDIOVASC RES, V93, P434, DOI 10.1093/cvr/cvr351; Asklund T, 2004, EUR J CANCER, V40, P1073, DOI 10.1016/j.ejca.2003.11.034; Biernacka A, 2011, AGING DIS, V2, P158; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Connolly A, 2015, IEEE T BIO-MED ENG, V62, P2251, DOI 10.1109/TBME.2015.2421296; Danon A, 2010, GEN PHYSIOL BIOPHYS, V29, P222, DOI 10.4149/gpb_2010_03_222; FOO ITH, 1992, LAB INVEST, V67, P727; Froes MM, 1999, P NATL ACAD SCI USA, V96, P7541, DOI 10.1073/pnas.96.13.7541; Fu HY, 2016, CIRC RES, V118, P798, DOI 10.1161/CIRCRESAHA.115.307604; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Gokhale TA, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006276; Gorelik J, 2006, CARDIOVASC RES, V72, P422, DOI 10.1016/j.cardiores.2006.09.009; Gourdie RG, 2016, NAT REV DRUG DISCOV, V15, P620, DOI 10.1038/nrd.2016.89; Haefliger JA, 2004, CARDIOVASC RES, V62, P345, DOI 10.1016/j.cardiores.2003.11.015; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hubbard ML, 2012, EUROPACE, V14, pV3, DOI 10.1093/europace/eus267; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Jia ZH, 2012, BIOPHYS J, V102, P1294, DOI 10.1016/j.bpj.2012.02.034; Jiang B, 2016, CIRCULATION, V134; Johnstone SR, 2012, J MEMBRANE BIOL, V245, P319, DOI 10.1007/s00232-012-9453-3; Kohl P, 2014, J MOL CELL CARDIOL, V70, P37, DOI 10.1016/j.yjmcc.2013.12.024; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Lefroy DC, 1998, AM J CARDIOL, V82, P444, DOI 10.1016/S0002-9149(98)00359-2; Lewis CJ, 2004, BRIT J PHARMACOL, V141, P813, DOI 10.1038/sj.bjp.0705668; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Mahoney VM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26744; Mahoney VM, 2016, PROG BIOPHYS MOL BIO, V120, P128, DOI 10.1016/j.pbiomolbio.2015.12.006; Majumder R, 2016, SCI REP-UK, V6, DOI 10.1038/srep24334; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Miragoli M, 2011, J R SOC INTERFACE, V8, P913, DOI 10.1098/rsif.2010.0597; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; O'Quinn MP, 2011, CIRC RES, V108, P704, DOI 10.1161/CIRCRESAHA.110.235747; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Pogoda K, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0099-3; Rhee S, 2009, EXP MOL MED, V41, P858, DOI 10.3858/emm.2009.41.12.096; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Rhett JM, 2012, HEART RHYTHM, V9, P619, DOI 10.1016/j.hrthm.2011.10.003; Roell W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25147-8; Rohr S, 2009, HEART RHYTHM, V6, P848, DOI 10.1016/j.hrthm.2009.02.038; Rosker C, 2011, CIRC RES, V109, P1120, DOI 10.1161/CIRCRESAHA.111.244798; Rubart M, 2018, CARDIOVASC RES, V114, P389, DOI 10.1093/cvr/cvx163; Rutherford SL, 2012, CIRC RES, V111, P301, DOI 10.1161/CIRCRESAHA.111.260943; Sacan A, 2008, BIOINFORMATICS, V24, P1647, DOI 10.1093/bioinformatics/btn247; Salvarani N, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004567; Schultz F, 2016, PROG BIOPHYS MOL BIO, V120, P149, DOI 10.1016/j.pbiomolbio.2016.01.003; Shinde AV, 2014, J MOL CELL CARDIOL, V70, P74, DOI 10.1016/j.yjmcc.2013.11.015; Smyth JW, 2012, CIRC RES, V110, P978, DOI 10.1161/CIRCRESAHA.111.257964; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Takatori O, 2017, J CARDIOVASC PHARM T, V22, P283, DOI 10.1177/1074248416679308; TAKENSKWAK BR, 1992, AM J PHYSIOL, V262, pC1531, DOI 10.1152/ajpcell.1992.262.6.C1531; Thompson SA, 2014, J MOL CELL CARDIOL, V68, P29, DOI 10.1016/j.yjmcc.2013.12.025; Thompson SA, 2011, CIRCULATION, V123, P2083, DOI 10.1161/CIRCULATIONAHA.110.015057; Truskey George A, 2010, Int J High Throughput Screen, V2010, P171; van Veen TAB, 2001, CARDIOVASC RES, V51, P217, DOI 10.1016/S0008-6363(01)00324-8; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Zhang Y, 2008, CELL COMMUN ADHES, V15, P289, DOI 10.1080/15419060802198736	63	14	14	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10453	10468		10.1096/fj.201802740RR	http://dx.doi.org/10.1096/fj.201802740RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31253057	Green Published, Bronze			2022-12-26	WOS:000482214200058
J	Wang, Y; Wang, S; Nie, XY; Yang, KL; Xu, P; Wang, XN; Liu, MX; Yang, YS; Chen, Z; Wang, SH				Wang, Yu; Wang, Sen; Nie, Xinyi; Yang, Kunlong; Xu, Peng; Wang, Xiuna; Liu, Mengxin; Yang, Yongshuai; Chen, Zhuo; Wang, Shihua			Molecular and structural basis of nucleoside diphosphate kinase-mediated regulation of spore and sclerotia development in the fungus Aspergillus flavus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspergillus; inhibitor; crystal structure; developmental factor; sporulation; recombinant protein expression; pathology; protein kinase; microbiology; fungi; Aspergillus flavus; azidothymidine (AZT); nucleoside diphosphate kinase (NDK); sclerotium; spore	X-RAY STRUCTURE; CRYSTAL-STRUCTURE; AFLATOXIN BIOSYNTHESIS; GENE; DIPHOSPHOKINASE; CONTRIBUTES; INHIBITION; NDK; PURIFICATION; EXPRESSION	The fundamental biological function of nucleoside diphosphate kinase (NDK) is to catalyze the reversible exchange of the gamma-phosphate between nucleoside triphosphate (NTP) and nucleoside diphosphate (NDP). This kinase also has functions that extend beyond its canonically defined enzymatic role as a phosphotransferase. However, the role of NDK in filamentous fungi, especially in Aspergillus flavus (A. flavus), is not yet known. Here we report that A. flavus has two NDK-encoding gene copies as assessed by qPCR. Using gene-knockout and complementation experiments, we found that AfNDK regulates spore and sclerotia development and is involved in plant virulence as assessed in corn and peanut seed-based assays. An antifungal test with the inhibitor azidothymidine suppressed AfNDK activity in vitro and prevented spore production and sclerotia formation in A. flavus, confirming AfNDK's regulatory functions. Crystallographic analysis of AfNDK, coupled with site-directed mutagenesis experiments, revealed three residues (Arg-104, His-117, and Asp-120) as key sites that contribute to spore and sclerotia development. These results not only enrich our knowledge of the regulatory role of this important protein in A. flavus, but also provide insights into the prevention of A. flavus infection in plants and seeds, as well as into the structural features relevant for future antifungal drug development.	[Wang, Yu; Wang, Sen; Nie, Xinyi; Yang, Kunlong; Wang, Xiuna; Liu, Mengxin; Yang, Yongshuai; Chen, Zhuo; Wang, Shihua] Fujian Agr & Forestry Univ, Key Lab Pathogen Fungi & Mycotoxins Fujian Prov, Key Lab Biopesticide & Chem Biol, Educ Minist, Fuzhou 350002, Fujian, Peoples R China; [Wang, Yu; Wang, Sen; Nie, Xinyi; Yang, Kunlong; Wang, Xiuna; Liu, Mengxin; Yang, Yongshuai; Chen, Zhuo; Wang, Shihua] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou 350002, Fujian, Peoples R China; [Xu, Peng; Yang, Yongshuai; Chen, Zhuo] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Xu, Peng; Yang, Yongshuai; Chen, Zhuo] Chinese Acad Sci, Fujian Inst Res Struct Matter, CAS Key Lab, Fuzhou 350002, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Wang, SH (corresponding author), Fujian Agr & Forestry Univ, Key Lab Pathogen Fungi & Mycotoxins Fujian Prov, Key Lab Biopesticide & Chem Biol, Educ Minist, Fuzhou 350002, Fujian, Peoples R China.; Wang, SH (corresponding author), Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou 350002, Fujian, Peoples R China.	wshyyl@sina.com	Kunlong, Yang/AHB-2840-2022; Chen, Zhuo/A-6144-2011	Yang, Kunlong/0000-0002-9246-101X; Wang, Yu/0000-0002-0542-3390; Chen, Zhuo/0000-0002-6351-8689	National Natural Science Foundation of China [31772105]; Natural Science Foundation of Fujian Province, China [2017J05043, 2018J07002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	This work was supported by National Natural Science Foundation of China Grant 31772105 and Natural Science Foundation of Fujian Province, China, Grants 2017J05043 and 2018J07002. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari A, 2004, ENVIRON INT, V29, P1071, DOI 10.1016/S0160-4120(03)00103-X; AGARWAL RP, 1971, J BIOL CHEM, V246, P2258; Amare MG, 2014, FUNGAL GENET BIOL, V66, P11, DOI 10.1016/j.fgb.2014.02.008; Anciaux K, 1997, FEBS LETT, V400, P75, DOI 10.1016/S0014-5793(96)01358-0; [Anonymous], 2012, PYMOL MOL GRAPHICS S; Arai S, 2012, PROTEIN SCI, V21, P498, DOI 10.1002/pro.2032; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; Boissan M, 2014, SCIENCE, V344, P1510, DOI 10.1126/science.1253768; BROOK I, 1987, JAMA-J AM MED ASSOC, V258, P1517, DOI 10.1001/jama.258.11.1517; BURNIE JP, 1991, J CLIN MICROBIOL, V29, P2099, DOI 10.1128/JCM.29.10.2099-2106.1991; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Chang PK, 2010, J MICROBIOL METH, V81, P240, DOI 10.1016/j.mimet.2010.03.010; Chen CJ, 2003, J STRUCT BIOL, V142, P247, DOI 10.1016/S1047-8477(03)00014-5; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; CHENG YC, 1971, BIOCHEMISTRY-US, V10, P2139; CHIADMI M, 1993, STRUCTURE, V1, P283, DOI 10.1016/0969-2126(93)90016-A; Chopra P, 2003, EUR J BIOCHEM, V270, P625, DOI 10.1046/j.1432-1033.2003.03402.x; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; ELWELL LP, 1987, ANTIMICROB AGENTS CH, V31, P274, DOI 10.1128/AAC.31.2.274; Fasoyin OE, 2018, FUNGAL GENET BIOL, V115, P41, DOI 10.1016/j.fgb.2018.04.008; FUKUCHI T, 1993, GENE, V129, P141; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Gomez DE, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00113; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Heinemann S, 2004, J HOSP INFECT, V57, P149, DOI 10.1016/j.jhin.2004.02.007; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Hu YL, 2018, TOXINS, V10, DOI 10.3390/toxins10070301; Im YJ, 2004, J MOL BIOL, V343, P659, DOI 10.1016/j.jmb.2004.08.054; IZUMIYA H, 1995, J BIOL CHEM, V270, P27859, DOI 10.1074/jbc.270.46.27859; Kim YJ, 2014, INFECT IMMUN, V82, P3252, DOI 10.1128/IAI.02007-14; Klich MA, 2007, MOL PLANT PATHOL, V8, P713, DOI 10.1111/J.1364-3703.2007.00436.X; Kolli BK, 2008, MOL BIOCHEM PARASIT, V158, P163, DOI 10.1016/j.molbiopara.2007.12.010; Krishnamurthy YL, 2006, LETT APPL MICROBIOL, V43, P469, DOI 10.1111/j.1472-765X.2006.02011.x; Krishnan S, 2009, MYCOSES, V52, P206, DOI 10.1111/j.1439-0507.2008.01642.x; Ladner JE, 1999, ACTA CRYSTALLOGR D, V55, P1127, DOI 10.1107/S0907444999002528; Lee B, 2006, MOL GENET GENOMICS, V275, P9, DOI 10.1007/s00438-005-0044-1; Lee MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28874; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; Lin XR, 2003, EUKARYOT CELL, V2, P1169, DOI 10.1128/EC.2.6.1169-1177.2003; Ma Lijiang, 2014, Curr Protoc Hum Genet, V80, DOI 10.1002/0471142905.hg0721s80; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mishra AK, 2017, J COMPUT AID MOL DES, V31, P547, DOI 10.1007/s10822-017-0022-9; Morera S, 1995, STRUCTURE, V3, P1307, DOI 10.1016/S0969-2126(01)00268-4; MOURAD N, 1966, J BIOL CHEM, V241, P271; Moynie L, 2007, PROTEINS, V67, P755, DOI 10.1002/prot.21316; Neeld D, 2014, MICROBIOL-SGM, V160, P1417, DOI 10.1099/mic.0.078139-0; Nie XY, 2016, J AGR FOOD CHEM, V64, P6772, DOI 10.1021/acs.jafc.6b02199; Ogura Y, 1999, EUR J BIOCHEM, V266, P709, DOI 10.1046/j.1432-1327.1999.00783.x; Ogura Y, 2001, J BIOL CHEM, V276, P21228, DOI 10.1074/jbc.M011381200; Okumura Y, 2004, J MED MICROBIOL, V53, P351, DOI 10.1099/jmm.0.05248-0; Okumura Yoshiyuki, 2008, Nihon Ishinkin Gakkai Zasshi, V49, P87, DOI 10.3314/jjmm.49.87; Pedelacq JD, 2005, PROTEIN SCI, V14, P2562, DOI 10.1110/ps.051664205; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Qian L, 2014, PROTEIN EXPRES PURIF, V103, P48, DOI 10.1016/j.pep.2014.08.014; Ren SL, 2018, MOL CELL PROTEOMICS, V17, P457, DOI [10.1074/mcp.RA117.000393, 10.1074/mcp.ra117.000393]; Runa F, 2015, FUNGAL GENET BIOL, V84, P62, DOI 10.1016/j.fgb.2015.09.003; SAEKI T, 1975, J ANTIBIOT, V28, P974, DOI 10.7164/antibiotics.28.974; SAMPOL E, 1995, BRIT J CLIN PHARMACO, V40, P83, DOI 10.1111/j.1365-2125.1995.tb04540.x; Schirrmeister BE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-177; Souza TACB, 2011, MOL BIOSYST, V7, P2189, DOI 10.1039/c0mb00307g; STRELKOV SV, 1995, J MOL BIOL, V249, P665, DOI 10.1006/jmbi.1995.0327; Sun Q, 2016, APPL MICROBIOL BIOT, V100, P1355, DOI 10.1007/s00253-015-7159-z; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Valenti D, 1999, FEBS LETT, V444, P291, DOI 10.1016/S0014-5793(99)00071-X; Vieira PS, 2017, BIOCHEM BIOPH RES CO, V488, P461, DOI 10.1016/j.bbrc.2017.05.048; Vieira PS, 2015, J STRUCT BIOL, V192, P336, DOI 10.1016/j.jsb.2015.09.009; Vlatkovic N, 2015, N-S ARCH PHARMACOL, V388, P175, DOI 10.1007/s00210-014-1062-5; Wang S, 2016, CHINESE J STRUC CHEM, V35, P1708, DOI 10.14102/j.cnki.0254-5861.2011-1278; WILLIAMS RL, 1993, J MOL BIOL, V234, P1230, DOI 10.1006/jmbi.1993.1673; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wu HC, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7238; Yang KL, 2017, FUNGAL GENET BIOL, V101, P7, DOI 10.1016/j.fgb.2017.02.004; Yang KL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23259; Zhang DP, 2018, BMC BIOTECHNOL, V18, DOI 10.1186/s12896-018-0436-z; Zhang F, 2018, CURR GENET, V64, P1335, DOI 10.1007/s00294-018-0851-7; Zhang F, 2016, TOXINS, V8, DOI 10.3390/toxins8070202	80	18	19	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12415	12431		10.1074/jbc.RA119.007505	http://dx.doi.org/10.1074/jbc.RA119.007505			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31243100	hybrid, Green Published			2022-12-26	WOS:000484402700014
J	Jannat, A; Khan, M; Shabbir, M; Badshah, Y				Jannat, Arooma; Khan, Maryam; Shabbir, Maria; Badshah, Yasmin			Expression of suppressor of cytokine signaling 3 (SOCS3) and interleukin-6 (-174-G/C) polymorphism in atopic conditions	PLOS ONE			English	Article							FC-EPSILON-RI; TH2 CYTOKINE; IL-6 LEVELS; MAST-CELLS; ASSOCIATION; BASOPHILS; GENE; IGE; ASTHMA; G/C	Hypersensitivity of the immune system is caused by elevated immunoglobulin E (IgE) levels in the serum, in response to a discrete allergen leading to allergic reactions. IgE-mediated inflammation is regulated by the cascade of defense related signaling molecules including interleukin-6 (IL-6) that plays pivotal role in the survival and maturation of mast cells during an allergic reaction. IL-6 mediated defense responses are tightly regulated by Suppressor of Cytokine Signaling 3 (SOCS3), an inhibitory molecules of Janus Kinase-Signal Transducers and Activators of Transcription (JAK-STAT) signaling, in a negative feedback mechanism. The given study focuses on the assessment of crosstalk between SOCS3 and IL-6 to unravel the molecular significance of SOCS3 and IL-6 in the diagnosis and prognosis of allergy. The expression study of SOCS3 through real-time PCR analysis revealed, a 5.9 mean fold increase in SOCS3 expression in atopic cases in comparison to control cases. Moreover, IL-6 has, also, been found significantly enhanced in the serum level of atopic cases (26.4 pg/ml) as compared to control cases (3.686 pg/ml). Female population was found to be at a higher risk to develop atopic condition than male population as females exhibited higher expression of both SOCS3 and IL-6 than males. Furthermore, the polymorphic study of IL-6 promoter region (IL-6 174-G/C) in atopic population has reasserted the importance of SOCS3 and IL-6 in the diagnosis and prognosis of allergy. Expression of SOCS3 and IL-6 serum levels were found to be highly correlated. Therefore establishing the role of IL-6 (-174-G/C) polymorphism on the expression of SOCS3 and IL-6 in atopic cases. Notably, the study established SOCS3 and IL-6 as potential targets for the diagnosis/prognosis of allergy and for the development of reliable therapeutic strategies to control atopic conditions in the near future.	[Jannat, Arooma; Khan, Maryam; Shabbir, Maria; Badshah, Yasmin] NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Badshah, Y (corresponding author), NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad, Pakistan.	yasmeenb_1982@yahoo.com	b, yasmin/AAP-1261-2021; Shabbir, Maria/AAA-5414-2019	b, yasmin/0000-0002-7136-8828; Shabbir, Maria/0000-0002-5685-3059; Jannat, Arooma/0000-0002-8719-7920; Khan, Maryam/0000-0001-6103-1415	National University of Sciences and Technology (NUST)	National University of Sciences and Technology (NUST)	The study was supported by National University of Sciences and Technology (NUST) as a part of student research fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasandagutti ML, 2014, GENET TEST MOL BIOMA, V18, P804, DOI 10.1089/gtmb.2014.0193; Badshah Y, 2018, J INTERF CYTOK RES, V38, P559, DOI 10.1089/jir.2018.0081; BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; Berings M, 2018, CLIN EXP ALLERGY; Brockow K, 2005, CLIN IMMUNOL, V115, P216, DOI 10.1016/j.clim.2005.01.011; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Charrad R, 2016, IMMUNOBIOLOGY, V221, P182, DOI 10.1016/j.imbio.2015.09.009; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; Cho SH, 2015, AM J RESP CELL MOL, V53, P601, DOI 10.1165/rcmb.2015-0207RC; Desai A, 2016, J ALLERGY CLIN IMMUN, V137, P1863, DOI 10.1016/j.jaci.2015.09.059; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Gibbs BF, 1996, EUR J IMMUNOL, V26, P2493, DOI 10.1002/eji.1830261033; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Haan S., 2016, FRONT BIOSCI-LANDMRK, V8, P189, DOI DOI 10.2741/E760; JOHNS MB, 1989, ANAL BIOCHEM, V180, P276, DOI 10.1016/0003-2697(89)90430-2; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Kasperska-Zajac A, 2011, CLIN EXP ALLERGY, V41, P1386, DOI 10.1111/j.1365-2222.2011.03789.x; Kim TH, 2012, INT ARCH ALLERGY IMM, V158, P387, DOI 10.1159/000333103; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Komyod W, 2007, MOL CANCER RES, V5, P271, DOI 10.1158/1541-7786.MCR-06-0274; Kosugi EM, 2013, RHINOLOGY, V51, P70, DOI [10.4193/Rhin12.166, 10.4193/Rhino12.166]; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Li HM, 1996, J IMMUNOL, V156, P4833; Li HY, 2018, INFLAMMATION, V41, P914, DOI 10.1007/s10753-018-0746-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayado A, 2016, LEUKEMIA, V30, P124, DOI 10.1038/leu.2015.176; MCKENZIE RC, 1990, J INVEST DERMATOL, V95, pS105, DOI 10.1111/1523-1747.ep12874955; Morjaria JB, 2011, THORAX, V66, P537, DOI 10.1136/thx.2010.136523; Naik SP, 2017, J ASTHMA, V54, P584, DOI 10.1080/02770903.2016.1244828; Nieters A, 2004, CLIN EXP ALLERGY, V34, P346, DOI 10.1111/j.1365-2222.2004.01889.x; Ochensberger B, 1996, BLOOD, V88, P3028, DOI 10.1182/blood.V88.8.3028.bloodjournal8883028; Zafra MP, 2015, INT J MOL SCI, V16, P5434, DOI 10.3390/ijms16035434; Zafra MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091996; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; Pumphrey RSH, 1999, CLIN EXP ALLERGY, V29, P1256, DOI 10.1046/j.1365-2222.1999.00588.x; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Settin A, 2008, INDIAN J PEDIATR, V75, P1019, DOI 10.1007/s12098-008-0161-z; Simms D., 1993, FOCUS, V15, P532, DOI DOI 10.1016/0003-267061)80041-X; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Uto-Konomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040343; Xiang S, 2013, J HUAZHONG U SCI-MED, V33, P615, DOI 10.1007/s11596-013-1168-x; Yin YL, 2015, HUM IMMUNOL, V76, P775, DOI 10.1016/j.humimm.2015.09.037; Yousefzadeh H, 2017, REP BIOCHEM MOL BIOL, V6, P102; Yu CR, 2003, J BIOL CHEM, V278, P29752, DOI 10.1074/jbc.M300489200; Zhao CY, 2018, INT ARCH ALLERGY IMM, V175, P209, DOI 10.1159/000486857	50	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219084	10.1371/journal.pone.0219084	http://dx.doi.org/10.1371/journal.pone.0219084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251775	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000042
J	Vetrano, M; Ranieri, D; Nanni, M; Pavan, A; Malisan, F; Vulpiani, MC; Visco, V				Vetrano, Mario; Ranieri, Danilo; Nanni, Monica; Pavan, Antonio; Malisan, Florence; Vulpiani, Maria Chiara; Visco, Vincenzo			Hyaluronic Acid (HA), Platelet-Rich Plasm and Extracorporeal Shock Wave Therapy (ESWT) promote human chondrocyte regeneration in vitro and ESWT-mediated increase of CD44 expression enhances their susceptibility to HA treatment	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SPLICING VARIANT; KNEE; OSTEOARTHRITIS; SENESCENCE; INFLAMMATION; REPAIR; PAIN	Novel strategies have been proposed for articular cartilage damage occurring during osteoarthritis ( OA) and -among these-Extracorporeal Shock Wave Therapy ( ESWT), intra-articular injections of Platelet-Rich Plasma ( PRP) or Hyaluronic Acid ( HA) revealed encouraging results. To investigate the possible mechanisms responsible for those clinical benefits, we established primary cultures of human chondrocytes derived from cartilage explants and measured the in vitro effects of ESW, PRP and HA therapies. After molecular/morphological cell characterization, we assessed those effects on the functional activities of the chondrocyte cell cultures, at the protein and molecular levels. ESWT significantly prevented the progressive dedifferentiation that spontaneously occurs during prolonged chondrocyte culture. We then attested the efficiency of all such treatments to stimulate the expression of markers of chondrogenic potential such as SOX9 and COL2A, to increase the Ki67 proliferation index as well as to antagonize the traditional marker of chondrosenescence p16INK4a ( known as Cdkn2a). Furthermore, all our samples showed an ESW- and HA-mediated enhancement of migratory and anti-inflammatory activity onto the cytokine-rich environment characterizing OA. Taken together, those results suggest a regenerative effect of such therapies on primary human chondrocytes in vitro. Moreover, we also show for the first time that ESW treatment induces the surface expression of major hyaluronan cell receptor CD44 allowing the increase of COL2A/COL1A ratio upon HA administration. Therefore, this work suggests that ESW-induced CD44 overexpression enhances the in vitro cell susceptibility of human chondrocytes to HA, presumably favouring the repair of degenerated cartilage.	[Vetrano, Mario; Vulpiani, Maria Chiara] Sapienza Univ Rome, Fac Med & Psychol, Dept Surg & Med Sci & Translat Med, Rome, Italy; [Vetrano, Mario; Pavan, Antonio; Vulpiani, Maria Chiara; Visco, Vincenzo] StAndrea Univ Hosp, Rome, Italy; [Ranieri, Danilo; Nanni, Monica; Pavan, Antonio; Visco, Vincenzo] Sapienza Univ Rome, Fac Med & Psychol, Dept Clin & Mol Med, Rome, Italy; [Malisan, Florence] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University of Rome Tor Vergata	Visco, V (corresponding author), StAndrea Univ Hosp, Rome, Italy.; Visco, V (corresponding author), Sapienza Univ Rome, Fac Med & Psychol, Dept Clin & Mol Med, Rome, Italy.	vincenzo.visco1@uniroma1.it	Vetrano, Mario/ABE-5885-2020	Vetrano, Mario/0000-0002-8680-4004; MALISAN, FLORENCE/0000-0002-0213-9407; NANNI, MONICA/0000-0001-5706-0053				Abate M, 2017, INT J IMMUNOPATH PH, V30, P89, DOI 10.1177/0394632016689275; Alessio N, 2018, AGING-US, V10, P1575, DOI 10.18632/aging.101493; Altman RD, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0775-z; Andia I, 2018, SPORTS MED ARTHROSC, V26, P59, DOI 10.1097/JSA.0000000000000191; Andia I, 2018, EXPERT OPIN BIOL TH, V18, P785, DOI 10.1080/14712598.2018.1492541; Andia I, 2013, NAT REV RHEUMATOL, V9, P721, DOI 10.1038/nrrheum.2013.141; Ashraf S, 2016, OSTEOARTHR CARTILAGE, V24, P196, DOI 10.1016/j.joca.2015.07.008; Avenoso A, 2018, ARCH BIOCHEM BIOPHYS, V640, P75, DOI 10.1016/j.abb.2018.01.007; Avitabile D, 2014, CELL MOL LIFE SCI, V71, P2547, DOI 10.1007/s00018-013-1503-1; Balaji S, 2017, FASEB J, V31, P868, DOI 10.1096/fj.201600856R; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Bergholt NL, 2018, J BIOMED MATER RES A, V106, P2805, DOI 10.1002/jbm.a.36467; Boehme KA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082282; Caldwell KL, 2015, OSTEOARTHR CARTILAGE, V23, P351, DOI 10.1016/j.joca.2014.11.004; Chan DD, 2015, OSTEOARTHR CARTILAGE, V23, P1879, DOI 10.1016/j.joca.2015.06.021; Cowman MK, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00261; Duan L, 2015, AM J TRANSL RES, V7, P194; Giusti I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/630870; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Guan YJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12752; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Hopper N, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0709-z; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Lee JK, 2017, ANN REHABIL MED-ARM, V41, P828, DOI 10.5535/arm.2017.41.5.828; Leone L, 2016, ONCOTARGET, V7, P6410, DOI 10.18632/oncotarget.7064; Leone L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049759; Luo N, 2014, ARTHRITIS RHEUMATOL, V66, P1547, DOI 10.1002/art.38388; Maffulli N, 2017, BRIT MED BULL, V124, P91, DOI 10.1093/bmb/ldx042; Maldonado M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/284873; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Muller S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1026-x; Murata R, 2007, OSTEOARTHR CARTILAGE, V15, P1275, DOI 10.1016/j.joca.2007.04.001; Nazempour A, 2016, ANN BIOMED ENG, V44, P1325, DOI 10.1007/s10439-016-1575-9; Ochiai N, 2007, OSTEOARTHR CARTILAGE, V15, P1093, DOI 10.1016/j.joca.2007.03.011; Ohno-Nakahara M, 2004, J BIOCHEM, V135, P567, DOI 10.1093/jb/mvh069; Quero L, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4274; Ranieri D, 2016, ONCOTARGET, V7, P5440, DOI 10.18632/oncotarget.6706; Sirin DY, 2018, EXP THER MED, V15, P4205, DOI 10.3892/etm.2018.5943; Tibesku CO, 2006, ANN RHEUM DIS, V65, P105, DOI 10.1136/ard.2004.034694; Varela-Eirin M, 2018, AGEING RES REV, V42, P56, DOI 10.1016/j.arr.2017.12.006; Vetrano M, 2013, AM J SPORT MED, V41, P795, DOI 10.1177/0363546513475345; Vetrano M, 2011, KNEE SURG SPORT TR A, V19, P2159, DOI 10.1007/s00167-011-1534-9; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wang Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050975; Widera D, 2009, STEM CELLS, V27, P1899, DOI 10.1002/stem.104; Zhang FJ, 2013, RHEUMATOL INT, V33, P79, DOI 10.1007/s00296-011-2339-3	48	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218740	10.1371/journal.pone.0218740	http://dx.doi.org/10.1371/journal.pone.0218740			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251756	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000018
J	Lin, DY; Lin, ZP; Cao, JW; Velmurugan, R; Ward, ES; Ober, RJ				Lin, Dongyun; Lin, Zhiping; Cao, Jiuwen; Velmurugan, Ramraj; Ward, E. Sally; Ober, Raimund J.			A two-stage method for automated detection of ring-like endosomes in fluorescent microscopy images	PLOS ONE			English	Article							SUBCELLULAR LOCATION; LIVE CELLS; PATTERNS	Endosomes are subcellular organelles which serve as important transport compartments in eukaryotic cells. Fluorescence microscopy is a widely applied technology to study endosomes at the subcellular level. In general, a microscopy image can contain a large number of organelles and endosomes in particular. Detecting and annotating endosomes in fluorescence microscopy images is a critical part in the study of subcellular trafficking processes. Such annotation is usually performed by human inspection, which is time-consuming and prone to inaccuracy if carried out by inexperienced analysts. This paper proposes a two-stage method for automated detection of ring-like endosomes. The method consists of a localization stage cascaded by an identification stage. Given a test microscopy image, the localization stage generates a voting-map by locally comparing the query endosome patches and the test image based on a bag-of-words model. Using the voting-map, a number of candidate patches of endosomes are determined. Subsequently, in the identification stage, a support vector machine (SVM) is trained using the endosome patches and the background pattern patches. Each of the candidate patches is classified by the SVM to rule out those patches of endosome-like background patterns. The performance of the proposed method is evaluated with real microscopy images of human myeloid endothelial cells. It is shown that the proposed method significantly outperforms several state-of-the-art competing methods using multiple performance metrics.	[Lin, Dongyun; Lin, Zhiping] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore; [Cao, Jiuwen] Hangzhou Dianzi Univ, Key Lab IOT & Informat Fus Technol Zhejiang, Hangzhou, Zhejiang, Peoples R China; [Velmurugan, Ramraj; Ober, Raimund J.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Ward, E. Sally; Ober, Raimund J.] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA; [Ward, E. Sally] Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA; [Ward, E. Sally; Ober, Raimund J.] Univ Southampton, Canc Sci Unit, Ctr Canc Immunol, Fac Med, Southampton, Hants, England	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Hangzhou Dianzi University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Southampton	Lin, ZP (corresponding author), Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore.	EZPLIN@ntu.edu.sg	Lin, Zhiping/AAF-2719-2020	Lin, Zhiping/0000-0002-1587-1226	National Institutes of Health [R01GM085575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (R01GM085575), to RJO (https://www.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Calderon CP, 2014, MOLECULES, V19, P18381, DOI 10.3390/molecules191118381; Cao JW, 2016, MULTIMED TOOLS APPL, V75, P2839, DOI 10.1007/s11042-014-2424-1; Coelho LP, 2010, BIOINFORMATICS, V26, pi7, DOI 10.1093/bioinformatics/btq220; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Devanaboyina SC, 2013, MABS-AUSTIN, V5, P851, DOI 10.4161/mabs.26389; Dollar P, 2012, IEEE T PATTERN ANAL, V34, P743, DOI 10.1109/TPAMI.2011.155; Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4; Gan Z, 2009, TRAFFIC, V10, P600, DOI 10.1111/j.1600-0854.2009.00887.x; Hu Y, 2010, BIOINFORMATICS, V26, P1630, DOI 10.1093/bioinformatics/btq239; Jiang S, 2007, CYTOM PART A, V71A, P563, DOI 10.1002/cyto.a.20404; Johnson GR, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004614; Kuang ZZ, 2017, 2017 IEEE THIRD INTERNATIONAL CONFERENCE ON MULTIMEDIA BIG DATA (BIGMM 2017), P197, DOI 10.1109/BigMM.2017.70; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Loy G, 2003, IEEE T PATTERN ANAL, V25, P959, DOI 10.1109/TPAMI.2003.1217601; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Murphy RF, 2003, J VLSI SIG PROC SYST, V35, P311, DOI 10.1023/B:VLSI.0000003028.71666.44; Ozaki Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211347; Ram S, 2016, IEEE T MED IMAGING, V35, P1753, DOI 10.1109/TMI.2016.2527740; Satpathy A, 2014, IEEE T IMAGE PROCESS, V24, P1953, DOI 10.1109/TIP.2014.2310123; Shariff A, 2010, CYTOM PART A, V77A, P457, DOI 10.1002/cyto.a.20854; Shen XH, 2014, IEEE T PATTERN ANAL, V36, P1229, DOI 10.1109/TPAMI.2013.237; Shimahara Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212619; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Smal I, 2010, IEEE T MED IMAGING, V29, P282, DOI 10.1109/TMI.2009.2025127; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wang J., 2010, COMPUTER VISION PATT, DOI DOI 10.1109/CVPR.2010.5540018	30	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218931	10.1371/journal.pone.0218931	http://dx.doi.org/10.1371/journal.pone.0218931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246999	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900053
J	Broseghini, M; Ceccolini, C; Della Volpe, C; Siboni, S				Broseghini, Marica; Ceccolini, Clara; Della Volpe, Claudio; Siboni, Stefano			The Notched Stick, an ancient vibrot example	PLOS ONE			English	Article							RATCHET	An intriguing simple toy, commonly known as the Notched Stick, is discussed as an example of a "vibrot", a device designed and built to yield conversion of mechanical vibrations into a rotational motion. The toy, that can be briefly described as a propeller fixed on a stick by means of a nail and free to rotate around it, is investigated from both an experimental and a numerical point of view, under various conditions and settings, to investigate the basic working principles of the device. The conversion efficiency from vibration to rotational motion turns out to be very small, or even not detectable at all, whenever the propeller is tightly connected to the stick nail and perfectly axisymmetrical with respect to the nail axis; the small effects possibly observed can be ascribed to friction forces. In contrast, the device succeeds in converting vibrations into rotations when the propeller center of mass is not aligned with the nail axis, a condition occurring when either the nail-propeller coupling is not tight or the propeller is not completely axisymmetrical relative to the nail axis. The propeller rotation may be induced by a process of parametric resonance for purely vertical oscillations of the nail, by ordinary resonance if the nail only oscillates horizontally or, finally, by a combination of both processes when nail oscillations take place in an intermediate direction. Parametric resonance explains the onset of rotations also when the weight of the propeller is negligible. In contrast with what is commonly claimed in the literature, the possible elliptical motion of the nail, due to a composition of two harmonic motions of the same frequency imposed along orthogonal directions, seems unnecessary to determine the propeller rotation.	[Broseghini, Marica; Ceccolini, Clara; Della Volpe, Claudio; Siboni, Stefano] Univ Trento, Dept Civil Environm & Mech Engn DICAM, Trento, Italy	University of Trento	Della Volpe, C (corresponding author), Univ Trento, Dept Civil Environm & Mech Engn DICAM, Trento, Italy.	claudio.dellavolpe@unitn.it						Altshuler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067838; Arnold V.I., 1989, MATH METHODS CLASSIC; Aubrecht G. J.  II, 1982, Physics Teacher, V20, P614, DOI 10.1119/1.2341165; Bauchau OA, 2006, COMPUT METHOD APPL M, V195, P6909, DOI 10.1016/j.cma.2005.08.013; Bradski G, 2000, DR DOBBS J, V25, P120; CAUGHEY TK, 1960, AM J PHYS, V28, P104; de Jalon J.G., 1994, KINEMATIC DYNAMIC SI; Della Volpe C, 2002, COLLOID SURFACE A, V206, P47, DOI 10.1016/S0927-7757(02)00072-9; Della Volpe C, 2006, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 4, P79; Flores P, 2016, CONTACT FORCE MODELS; Gilardi G, 2002, MECH MACH THEORY, V37, P1213, DOI 10.1016/S0094-114X(02)00045-9; Goldsmith W., 2001, IMPACT THEORY PHYS B; Harada A, 2005, P DYN DES C, DOI [10.1299/jsmedmc.2005._222-1, DOI 10.1299/JSMEDMC.2005._222-1]; HILBER HM, 1977, EARTHQUAKE ENG STRUC, V5, P283, DOI 10.1002/eqe.4290050306; Laird ER, 1955, AM J PHYS, V23, P472, DOI [10.1119/1.1953047, DOI 10.1119/1.1953047]; Leonard RW, 1937, AM J PHYS, V5, P175, DOI [10.1119/1.1991220, DOI 10.1119/1.1991220]; Liu YX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010020; Miller JS, 1955, AM J PHYS, V23, P176, DOI [10.1119/1.1933939, DOI 10.1119/1.1933939]; Negrut D, 2007, J COMPUT NONLIN DYN, V2, P73, DOI 10.1115/1.2389231; Norden B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.011110; Norden B, 2002, APPL PHYS LETT, V80, P2601, DOI 10.1063/1.1468900; Petri PA, 2001, THESIS; SATONOBU J, 1995, JPN J APPL PHYS 1, V34, P2745, DOI 10.1143/JJAP.34.2745; Scarnati JT, 1992, SCI ACTIVITIES CLASS, V29, P30, DOI [10.1080/00368121.1992.10113024, DOI 10.1080/00368121.1992.10113024]; Schilchting HJ, 1988, PHYS DIDAKTIK, V16, P238; Scholz C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03154-7; Scholz C, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/12/123001; Scott GD, 1956, AM J PHYS, V24, P464, DOI [10.1119/1.1934275, DOI 10.1119/1.1934275]; Torres H, 2016, REV CUB FIS, V33, P39; Welch S. S., 1973, Physics Teacher, V11, DOI 10.1119/1.2350008; Workamp M, 2018, SOFT MATTER, V14, P5572, DOI 10.1039/c8sm00402a; Yoshitake Y, 2012, T JAPAN SOC MECH E C, V78, P2760	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218666	10.1371/journal.pone.0218666	http://dx.doi.org/10.1371/journal.pone.0218666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242233	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600044
J	Ortiz-Rodriguez, JM; Ortega-Ferrusola, C; Gil, MC; Martin-Cano, FE; Gaitskell-Phillips, G; Rodriguez-Martinez, H; Hinrichs, K; Alvarez-Barrientos, A; Roman, A; Pena, FJ				Ortiz-Rodriguez, Jose M.; Ortega-Ferrusola, Cristina; Gil, Maria C.; Martin-Cano, Francisco E.; Gaitskell-Phillips, Gemma; Rodriguez-Martinez, Heriberto; Hinrichs, Katrin; Alvarez-Barrientos, Alberto; Roman, Angel; Pena, Fernando J.			Transcriptome analysis reveals that fertilization with cryopreserved sperm downregulates genes relevant for early embryo development in the horse	PLOS ONE			English	Article							STALLION SPERMATOZOA; LIPID-PEROXIDATION; DNA-DAMAGE; SEMEN; GENOME; ACTIVATION; RNAS; OVULATION; QUALITY; IMPACT	Artificial insemination with cryopreserved spermatozoa is a major assisted reproductive technology in many species. In horses, as in humans, insemination with cryopreserved sperm is associated with lower pregnancy rates than those for fresh sperm, however, direct effects of sperm cryopreservation on the development of resulting embryos are largely unexplored. The aim of this study was to investigate differences in gene expression between embryos resulting from fertilization with fresh or cryopreserved sperm. Embryos were obtained at 8, 10 or 12 days after ovulation from mares inseminated post-ovulation on successive cycles with either fresh sperm or frozen-thawed sperm from the same stallion, providing matched embryo pairs at each day. RNA was isolated from two matched pairs (4 embryos) for each day, and cDNA libraries were built and sequenced. Significant differences in transcripts per kilobase million (TPM) were determined using (i) genes for which the expression difference between treatments was higher than 99% of that in the random case (P < 0.01), and (ii) genes for which the fold change was >= 2, to avoid expression bias in selection of the candidate genes. Molecular pathways were explored using the DAVID webserver, followed by network analyses using STRING, with a threshold of 0.700 for positive interactions. The transcriptional profile of embryos obtained with frozen-thawed sperm differed significantly from that for embryos derived from fresh sperm on all days, showing significant down-regulation of genes involved in biological pathways related to oxidative phosphorylation, DNA binding, DNA replication, and immune response. Many genes with reduced expression were orthologs of genes known to be embryonic lethal in mice. This study, for the first time, provides evidence of altered transcription in embryos resulting from fertilization with cryopreserved spermatozoa in any species. As sperm cryopreservation is commonly used in many species, including human, the effect of this intervention on expression of developmentally important genes in resulting embryos warrants attention.	[Ortiz-Rodriguez, Jose M.; Ortega-Ferrusola, Cristina; Gil, Maria C.; Martin-Cano, Francisco E.; Gaitskell-Phillips, Gemma; Pena, Fernando J.] Univ Extremadura, Lab Equine Reprod & Equine Spermatol, Vet Teaching Hosp, Caceres, Spain; [Rodriguez-Martinez, Heriberto] Linkoping Univ, Dept Clin & Expt Med, Fac Med & Hlth Sci, Linkoping, Sweden; [Hinrichs, Katrin] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Alvarez-Barrientos, Alberto] Univ Extremadura, STAB, Badajoz, Spain; [Roman, Angel] Univ Extremadura, Dept Biochem & Mol Biol, Badajoz, Spain	Universidad de Extremadura; Linkoping University; Texas A&M University System; Texas A&M University College Station; Universidad de Extremadura; Universidad de Extremadura	Pena, FJ (corresponding author), Univ Extremadura, Lab Equine Reprod & Equine Spermatol, Vet Teaching Hosp, Caceres, Spain.	fjuanpvega@unex.es	Peña, Fernando J/D-8450-2012; Ortega-Ferrusola, Cristina/AGI-8478-2022; Ortiz-Rodríguez, Jose Manuel/AAP-2305-2021; Cano, Francisco Eduardo Martín/W-8892-2019; Gaitskell-Phillips, Gemma/AAB-5919-2020; Cano, Francisco Eduardo Martín/K-1112-2014; Rodriguez-Martinez, Heriberto/G-2675-2012	Peña, Fernando J/0000-0002-1311-2947; Ortega-Ferrusola, Cristina/0000-0002-7698-8735; Ortiz-Rodríguez, Jose Manuel/0000-0002-3248-6493; Cano, Francisco Eduardo Martín/0000-0003-4971-4883; Gaitskell-Phillips, Gemma/0000-0003-4308-7903; Cano, Francisco Eduardo Martín/0000-0003-4971-4883; Rodriguez-Martinez, Heriberto/0000-0002-5194-2124; Hinrichs, Katrin/0000-0002-8581-3814	Ministerio de Economia y Competitividad-FEDER, Madrid, Spain [AGL2017-83149-R]; Junta de Extremadura-FEDER [IB16030, GR18008]; Swedish Research council VR [521-2011-6553]; Swedish Research council FORMAS, Stockholm [2017-00946]; Valhondo Calaaf Foundation, Caceres, Spain	Ministerio de Economia y Competitividad-FEDER, Madrid, Spain; Junta de Extremadura-FEDER; Swedish Research council VR(Swedish Research Council); Swedish Research council FORMAS, Stockholm(Swedish Research Council Formas); Valhondo Calaaf Foundation, Caceres, Spain	FJP received financial support for this study from the Ministerio de Economia y Competitividad-FEDER, Madrid, Spain, grant AGL2017-83149-R. FJP also received support from the Junta de Extremadura-FEDER (IB16030 and GR18008). HRM received support from the Swedish Research councils VR, (Grant 521-2011-6553) and FORMAS (Grant 2017-00946), Stockholm. JMOR holds a Predoctoral grant from the Valhondo Calaaf Foundation, Caceres, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurich C, 2016, THERIOGENOLOGY, V86, P1347, DOI 10.1016/j.theriogenology.2016.04.077; Banrezes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029388; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Bouckenheimer J, 2017, HUM REPROD UPDATE, V23, P19, DOI 10.1093/humupd/dmw035; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Burruel V, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110981; Camillo F, 2014, ANIM REPROD SCI, V151, P56, DOI 10.1016/j.anireprosci.2014.09.011; Chen Q, 2016, NAT REV GENET, V17, P733, DOI 10.1038/nrg.2016.106; Cuervo-Arango J, 2009, THERIOGENOLOGY, V71, P1267, DOI 10.1016/j.theriogenology.2008.12.020; Dearing CG, 2017, CRYOBIOLOGY, V79, P9, DOI 10.1016/j.cryobiol.2017.10.003; Feng ZH, 2003, BIOCHEMISTRY-US, V42, P7848, DOI 10.1021/bi034431g; Fernandez-Gonzalez R, 2008, BIOL REPROD, V78, P761, DOI 10.1095/biolreprod.107.065623; Fujimoto S, 2004, DEV BIOL, V274, P370, DOI 10.1016/j.ydbio.2004.07.025; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Iqbal K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113928; Jiang XP, 2017, ASIAN J ANDROL, V19, P404, DOI 10.4103/1008-682X.178488; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jodar M, 2013, HUM REPROD UPDATE, V19, P604, DOI 10.1093/humupd/dmt031; Kopeika J, 2015, HUM REPROD UPDATE, V21, P209, DOI 10.1093/humupd/dmu063; Lane M, 2001, MOL REPROD DEV, V59, P33, DOI 10.1002/mrd.1004; Lu YG, 2017, AQUAT TOXICOL, V191, P189, DOI 10.1016/j.aquatox.2017.08.008; Munoz PM, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.139444; Munoz PM, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132878; Rodriguez AM, 2011, ANIM REPROD SCI, V127, P78, DOI 10.1016/j.anireprosci.2011.07.009; Ferrusola CO, 2017, ANDROLOGY-US, V5, P1174, DOI 10.1111/andr.12419; Ferrusola CO, 2009, REPRODUCTION, V138, P55, DOI [10.1530/REP-08-0484, 10.1530/RFP-08-0484]; Ortega-Ferrusola C, 2017, REPRODUCTION, V153, P293, DOI 10.1530/REP-16-0539; Ozil JP, 2001, DEVELOPMENT, V128, P917; Panzani D, 2014, THERIOGENOLOGY, V82, P807, DOI 10.1016/j.theriogenology.2014.06.020; Pena FJ, 2015, REPROD DOMEST ANIM, V50, P529, DOI 10.1111/rda.12551; Pena FJ, 2011, THERIOGENOLOGY, V76, P1177, DOI 10.1016/j.theriogenology.2011.06.023; Davila MP, 2016, REPRODUCTION, V152, P683, DOI 10.1530/REP-16-0409; Davila MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138777; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Sendler E, 2013, NUCLEIC ACIDS RES, V41, P4104, DOI 10.1093/nar/gkt132; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Teperek M, 2016, GENOME RES, V26, P1034, DOI 10.1101/gr.201541.115; Thomson LK, 2009, HUM REPROD, V24, P2061, DOI 10.1093/humrep/dep214; Timme-Laragy AR, 2018, SEMIN CELL DEV BIOL, V80, P17, DOI 10.1016/j.semcdb.2017.09.019; Valcarce DG, 2013, ANDROLOGY-US, V1, P723, DOI 10.1111/j.2047-2927.2013.00116.x; Valcarce DG, 2013, CRYOBIOLOGY, V67, P84, DOI 10.1016/j.cryobiol.2013.05.007; Wei X, 2015, FREE RADICAL RES, V49, P905, DOI 10.3109/10715762.2015.1040009; Zeng CG, 2014, CRYOBIOLOGY, V69, P119, DOI 10.1016/j.cryobiol.2014.06.003	43	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0213420	10.1371/journal.pone.0213420	http://dx.doi.org/10.1371/journal.pone.0213420			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237882	Green Submitted, gold, Green Published			2022-12-26	WOS:000484856000004
J	Fernandez, MD; Montes-Martinez, A; Pineiro-Lamas, M; Regueira-Mendez, C; Takkouche, B				del Mar Fernandez, Maria; Montes-Martinez, Agustin; Pineiro-Lamas, Maria; Regueira-Mendez, Carlos; Takkouche, Bahi			Tobacco consumption and premenstrual syndrome: A case-control study	PLOS ONE			English	Article							CIGARETTE-SMOKING; VALIDATION; SYMPTOMS; STEROIDS; HEALTH; WOMEN	Objective To assess whether tobacco smoking is associated with Premenstrual Syndrome (PMS) and its most severe form, Premenstrual Dysphoric Disorder (PMDD). Design Case-control study with incident cases using the Spanish public healthcare system. Setting 3 major public hospitals and one family counseling and planning center. Population Women consulting for troubles related to menstruation and for other motives such as screening for uterine cancer, contraception counseling or desire for pregnancy. Methods Logistic regression. Main outcome measures Odds Ratios of PMS and PMDD. Results 285 incident PMS cases and 285 age-matched controls on the one hand, and 88 incident PMDD cases and 176 controls on the other hand participated in the study. The odds of premenstrual disorders was higher in current smokers compared with never smokers: Odds Ratio (OR) = 1.78, 95% Confidence Interval (CI): 1.20-2.63 for PMS and OR = 2.92, 95% CI: 1.55-5.50 for PMDD. For PMS, women who smoke 1 to 5 cigarettes/day presented an OR = 2.82, 95% CI: 1.57-5.06 and those who smoke more than 15 cigarettes/day an OR = 2.52, 95% CI: 0.99-6.40. Compared to non-smokers, current and ex-smokers who smoked < 3 pack-years presented an OR = 1.79, 95% CI: 1.04-3.08 for PMS, and an OR = 3.06, 95% CI: 1.27-7.35 for PMDD. Smokers of 3 to 8 pack-years presented an OR = 2.34, 95% CI: 1.33-4.13 for PMS and OR = 3.56, 95% CI: 1.55-8.17 for PMDD. These results were confirmed by the exposure-effect curve obtained from a cubic spline model. Conclusions This study shows that smokers are more likely to develop PMS and PMDD.	[del Mar Fernandez, Maria; Montes-Martinez, Agustin; Pineiro-Lamas, Maria; Regueira-Mendez, Carlos; Takkouche, Bahi] Univ Santiago de Compostela, Dept Prevent Med, Santiago De Compostela, Spain; [Montes-Martinez, Agustin; Pineiro-Lamas, Maria; Regueira-Mendez, Carlos; Takkouche, Bahi] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Takkouche, B (corresponding author), Univ Santiago de Compostela, Dept Prevent Med, Santiago De Compostela, Spain.; Takkouche, B (corresponding author), Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain.	bahi.takkouche@usc.es	/AAD-1740-2020	Pineiro-Lamas, Maria/0000-0003-3655-100X; Takkouche, Bahi/0000-0002-0739-2241; Montes Martinez, Agustin/0000-0003-0474-8393	Regional Ministry of Education, Universities and Vocational Training (Conselleria de Educacion, Universidades y Formacion Profesional), Santiago de Compostela, Spain [ED431C 2018/20]	Regional Ministry of Education, Universities and Vocational Training (Conselleria de Educacion, Universidades y Formacion Profesional), Santiago de Compostela, Spain	The authors received no specific funding for this work. The Department of Preventive Medicine of the University of Santiago de Compostela receives funding from the Regional Ministry of Education, Universities and Vocational Training (Conselleria de Educacion, Universidades y Formacion Profesional), Santiago de Compostela, Spain. (Grant ED431C 2018/20).	American Psychiatric Association, 2014, DIAGNOSTIC AND STATI; Bertone-Johnson ER, 2008, AM J EPIDEMIOL, V168, P938, DOI 10.1093/aje/kwn194; Borenstein JE, 2003, J REPROD MED, V48, P515; Browne TK, 2015, J BIOETHIC INQ, V12, P313, DOI 10.1007/s11673-014-9567-7; Cohen S., 1995, STRATEGIES MEASURING, P3; Deuster PA, 1999, ARCH FAM MED, V8, P122, DOI 10.1001/archfami.8.2.122; Direkvand-Moghadam A, 2014, J CLIN DIAGN RES, V8, P106, DOI 10.7860/JCDR/2014/8024.4021; Duskova M, 2012, PHYSIOL RES, V61, P97, DOI 10.33549/physiolres.932164; Futterman LA, 2006, J REPROD MED, V51, P349; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Karaoulanis S, 2015, EUR NEUROPSYCHOPHARM, V25, pS401, DOI 10.1016/S0924-977X(15)30529-0; Knaapen L, 2008, STUD HIST PHI PART C, V39, P120, DOI 10.1016/j.shpsc.2007.12.009; Kritz-Silverstein D, 1999, J WOMEN HEALTH GEN-B, V8, P1185, DOI 10.1089/jwh.1.1999.8.1185; Latthe P, 2006, BMJ-BRIT MED J, V332, P749, DOI 10.1136/bmj.38748.697465.55; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Masho SW, 2005, J PSYCHOSOM OBST GYN, V26, P33, DOI 10.1080/01443610400023049; O'Brien PMS, 2011, ARCH WOMEN MENT HLTH, V14, P13, DOI 10.1007/s00737-010-0201-3; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Rapkin Andrea J, 2012, Menopause Int, V18, P52, DOI 10.1258/mi.2012.012014; Rapkin Andrea J, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P157, DOI 10.1586/erp.09.14; Rendu F, 2011, INT J ENV RES PUB HE, V8, P136, DOI 10.3390/ijerph8010136; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P130; Sakai H, 2011, J OBSTET GYNAECOL RE, V37, P325, DOI 10.1111/j.1447-0756.2010.01353.x; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Steiner M, 2003, Arch Womens Ment Health, V6, P203, DOI 10.1007/s00737-003-0018-4; Sternfeld B, 2002, OBSTET GYNECOL, V99, P1014, DOI 10.1016/S0029-7844(02)01958-0; Strine TW, 2005, J WOMENS HEALTH, V14, P316, DOI 10.1089/jwh.2005.14.316; U.S. Department of Health and Human Services, 2001, WOM SMOK REP SURG GE; US Department of Health and Human Services, 1988, DHSS PUBL, VCDC 88-8406, P14; Vilain C., 1987, EVALUATION MONITORIN; YLIKORKALA O, 1979, BRIT J OBSTET GYNAEC, V86, P648, DOI 10.1111/j.1471-0528.1979.tb10829.x; 2010, GEND WOM TOB EP, P1	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218794	10.1371/journal.pone.0218794	http://dx.doi.org/10.1371/journal.pone.0218794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226148	Green Published, Green Submitted, gold			2022-12-26	WOS:000484894700042
J	Khalilpourfarshbafi, M; Murugan, DD; Sattar, MZA; Sucedaram, Y; Abdullah, NA				Khalilpourfarshbafi, Manizheh; Murugan, Dharmani Devi; Sattar, Munavvar Zubaid Abdul; Sucedaram, Yamuna; Abdullah, Nor Azizan			Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; PEROXISOME-PROLIFERATOR; LIPID-METABOLISM; ADIPOSE-TISSUE; ADIPONECTIN; RESISTANCE; PROTEIN; EXPRESSION; BIOLOGY	The increased prevalence of obesity and associated insulin resistance calls for effective therapeutic treatment of metabolic diseases. The current PPAR gamma-targeting antidiabetic drugs have undesirable side effects. The present study investigated the anti-diabetic and anti-obesity effects of withaferin A (WFA) in diet-induced obese (DIO) C57BL/6J mice and also the anti-adipogenic effect of WFA in differentiating 3T3-F442A cells. DIO mice were treated with WFA (6 mg/kg) or rosiglitazone (10 mg/kg) for 8 weeks. At the end of the treatment period, metabolic profile, liver function and inflammatory parameters were obtained. Expression of selective genes controlling insulin signaling, inflammation, adipogenesis, energy expenditure and PPAR gamma phosphorylation-regulated genes in epididymal fats were analyzed. Furthermore, the anti-adipogenic effect of WFA was evaluated in 3T3-F442A cell line. WFA treatment prevented weight gain without affecting food or caloric intake in DIO mice. WFA-treated group also exhibited lower epididymal and mesenteric fat pad mass, an improvement in lipid profile and hepatic steatosis and a reduction in serum inflammatory cytokines. Insulin resistance was reduced as shown by an improvement in glucose and insulin tolerance and serum adiponectin. WFA treatment upregulated selective insulin signaling (insr, irs1, slc2a4 and pi3k) and PPAR gamma phosphorylation-regulated (car3, selenbp1, aplp2, txnip, and adipoq) genes, downregulated inflammatory (tnf-alpha and il-6) genes and altered energy expenditure controlling (tph2 and adrb3) genes. In 3T3-F442A cell line, withaferin A inhibited adipogenesis as indicated by a decrease in lipid accumulation in differentiating adi-pocytes and protein expression of PPAR gamma and C/EBP alpha. The effect of rosiglitazone on physiological and lipid profiles, insulin resistance, some genes expression and differentiating adipocytes were markedly different. Our data suggest that WFA is a promising therapeutic agent for both diabetes and obesity.	[Khalilpourfarshbafi, Manizheh; Murugan, Dharmani Devi; Sucedaram, Yamuna; Abdullah, Nor Azizan] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia; [Sattar, Munavvar Zubaid Abdul] MAHSA Univ, Fac Pharm, Jenjarom, Malaysia	Universiti Malaya; Mahsa University	Abdullah, NA (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia.	azizan@ummc.edu.my	MURUGAN, DHARMANI DEVI/B-8436-2010	MURUGAN, DHARMANI DEVI/0000-0002-1345-0292	Fundamental Research Grant (FRGS) from the Ministry of Education, Malaysia [FP006-2017A]; University of Malaya Research Fund Special Assistance [BKS007-2017]	Fundamental Research Grant (FRGS) from the Ministry of Education, Malaysia; University of Malaya Research Fund Special Assistance	This work was supported by the Fundamental Research Grant (FRGS Grant No: FP006-2017A) from the Ministry of Education, Malaysia awarded to N.A.A, and the University of Malaya Research Fund Special Assistance (BKS007-2017) awarded to N.A.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Andersson D, 2009, INT J OBESITY, V33, P662, DOI 10.1038/ijo.2009.54; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887; Batumalaie K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27236; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Boden G, 2009, DIABETES, V58, P518, DOI 10.2337/db08-1746; Choi I, 2006, BIOFACTORS, V26, P273, DOI 10.1002/biof.5520260405; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi MS, 2015, BRIT J NUTR, V113, P867, DOI 10.1017/S0007114515000100; Eisinger K, 2014, INT J MOL SCI, V15, P2991, DOI 10.3390/ijms15022991; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hajiaghaalipour F, 2015, INT J BIOL SCI, V11, P508, DOI 10.7150/ijbs.11241; Heyninck K, 2014, BIOCHEM PHARMACOL, V91, P501, DOI 10.1016/j.bcp.2014.08.004; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hutley LJ, 2003, EUR J CLIN INVEST, V33, P574, DOI 10.1046/j.1365-2362.2003.01178.x; Inafuku M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-124; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Khalilpourfarshbafi M, 2019, EUR J NUTR, V58, P5, DOI 10.1007/s00394-018-1663-8; Kurylowicz A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0395-2; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Lee J, 2009, OBESITY, V17, P226, DOI 10.1038/oby.2008.472; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Leonardini A, 2009, PPAR RES, V2009, DOI 10.1155/2009/818945; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; MacLaren R, 2008, J LIPID RES, V49, P308, DOI 10.1194/jlr.M700199-JLR200; Miller MR, 2012, J CLIN ENDOCR METAB, V97, P3285, DOI 10.1210/jc.2012-1318; Montague CT, 1998, DIABETES, V47, P1384, DOI 10.2337/diabetes.47.9.1384; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; NAOWABOOT J, 2015, J MED ASS THAI S3, V98, pS; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Okamoto S, 2016, CANCER SCI, V107, P1302, DOI 10.1111/cas.12988; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Park HS, 2009, BIOFACTORS, V35, P373, DOI 10.1002/biof.38; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	52	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218792	10.1371/journal.pone.0218792	http://dx.doi.org/10.1371/journal.pone.0218792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226166	Green Submitted, Green Published, gold			2022-12-26	WOS:000484894700041
J	Favreau, B; Denis, M; Ployet, R; Mounet, F; da Silva, HP; Franceschini, L; Laclau, JP; Labate, C; Carrer, H				Favreau, Benedicte; Denis, Marie; Ployet, Raphael; Mounet, Fabien; da Silva, Hana Peireira; Franceschini, Livia; Laclau, Jean-Paul; Labate, Carlos; Carrer, Helaine			Distinct leaf transcriptomic response of water deficient Eucalyptus grandis submitted to potassium and sodium fertilization	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNELS; GENE FAMILY; DROUGHT STRESS; ARABIDOPSIS-THALIANA; EXPRESSION ANALYSIS; OSMOTIC ADJUSTMENT; ENHANCES DROUGHT; SALT TOLERANCE; K+ HOMEOSTASIS; PLANT-GROWTH	While potassium fertilization increases growth yield in Brazilian eucalyptus plantations, it could also increase water requirements, making trees more vulnerable to drought. Sodium fertilization, which has been shown to promote eucalyptus growth compared to K-deficient trees, could partially mitigate this adverse effect of potassium. However, little is known about the influence of K and Na fertilization on the tree metabolic response to water deficit. The aim of the present study was thus to analyze the transcriptome of leaves sampled from Eucalyptus grandis trees subjected to 37% rainfall reduction, and fertilized with potassium (K), sodium (Na), compared to control trees (C). The multifactorial experiment was set up in a field with a throughfall exclusion system. Transcriptomic analysis was performed on leaves from two-year-old trees, and data analyzed using multifactorial statistical analysis and weighted gene co-expression network analysis (WGCNA). Significant sets of genes were seen to respond to rainfall reduction, in interaction with K or Na fertilization, or to fertilization only (regardless of the water supply regime). The genes were involved in stress signaling, primary and secondary metabolism, secondary cell wall formation and photosynthetic activity. Our focus on key genes related to cation transporters and aquaporins highlighted specific regulation of ion homeostasis, and plant adjustment to water deficit. While water availability significantly affects the transcriptomic response of eucalyptus species, this study points out that the transcriptomic response is highly dependent on the fertilization regime. Our study is based on the first large-scale field trial in a tropical region, specifically designed to study the interaction between water availability and nutrition in eucalyptus. To our knowledge, this is the first global transcriptomic analysis to compare the influence of K and Na fertilization on tree adaptive traits in water deficit conditions.	[Favreau, Benedicte; Denis, Marie] CIRAD, UMR AGAP, Montpellier, France; [Favreau, Benedicte; Denis, Marie] Univ Montpellier, AGAP, CIRAD, INRA,Montpellier SupAgro, Montpellier, France; [Ployet, Raphael; Mounet, Fabien] Univ Toulouse, CNRS, UPS, Lab Rech Sci Vegetales, Castanet Tolosan, France; [da Silva, Hana Peireira; Franceschini, Livia; Labate, Carlos] Univ Sao Paulo, Dept Genet, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil; [Laclau, Jean-Paul] CIRAD, UMR Eco&Sols, Montpellier, France; [Carrer, Helaine] Univ Sao Paulo, Dept Biol Sci, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil	CIRAD; Universite de Montpellier; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universidade de Sao Paulo; Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universidade de Sao Paulo	Favreau, B (corresponding author), CIRAD, UMR AGAP, Montpellier, France.; Favreau, B (corresponding author), Univ Montpellier, AGAP, CIRAD, INRA,Montpellier SupAgro, Montpellier, France.	benedicte.favreau@cirad.fr	Laclau, Jean-Paul/D-8285-2012; Carrer, Helaine/C-3159-2012; Mounet, Fabien/F-3614-2011; Benedicte, Favreau/A-4604-2010; Labate, Carlos Alberto/L-2183-2015	Laclau, Jean-Paul/0000-0002-2506-214X; Carrer, Helaine/0000-0002-9329-1841; Mounet, Fabien/0000-0001-6632-3070; Benedicte, Favreau/0000-0003-2786-9374; Labate, Carlos Alberto/0000-0001-7309-1300; Ployet, Raphael/0000-0003-4809-5988	Agropolis Capes [1302-003]; CNPq [444793/2014-3]; CIBA	Agropolis Capes; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CIBA	This work was supported by: Agropolis Capes No 1302-003 to BF, MD, RP, and FM, http://www.agropolis-fondation.fr/CAPES; CNPq 444793/2014-3 to BF and HC, http://www.cnpq.br/; CIBA to BF, MD, RP, and FM, https://www.ciba-network.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Agropolis Capes No 1302-003 and Universal CNPq No 444793/2014-3 and CIBA. Thanks to Julie Petit, Julie Leclercq and Pascal Montoro for their help in reviewing the manuscript.	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Ahmad I, 2016, J EXP BOT, V67, P2689, DOI 10.1093/jxb/erw103; Ahn SJ, 2004, PLANT PHYSIOL, V134, P1135, DOI 10.1104/pp.103.034660; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anschutz U, 2014, J PLANT PHYSIOL, V171, P670, DOI 10.1016/j.jplph.2014.01.009; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Assaha DVM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00509; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Battie-Laclau P, 2014, NEW PHYTOL, V203, P401, DOI 10.1111/nph.12810; Battie-Laclau P, 2014, PLANT CELL ENVIRON, V37, P70, DOI 10.1111/pce.12131; Battie-Laclau P, 2013, PLANT SOIL, V371, P19, DOI 10.1007/s11104-013-1663-7; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; Booth TH, 2013, FOREST ECOL MANAG, V301, P28, DOI 10.1016/j.foreco.2012.04.004; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Cakmak I, 2005, J PLANT NUTR SOIL SC, V168, P521, DOI 10.1002/jpln.200420485; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Cheng NH, 2005, PLANT PHYSIOL, V138, P2048, DOI 10.1104/pp.105.061218; Chin K, 2013, PLANT PHYSIOL, V163, P611, DOI 10.1104/pp.113.225680; Chiu JC, 2002, MOL BIOL EVOL, V19, P1066, DOI 10.1093/oxfordjournals.molbev.a004165; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Coopman RE, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue2-fulltext-9; D'Auria JC, 2005, CURR OPIN PLANT BIOL, V8, P308, DOI 10.1016/j.pbi.2005.03.012; Das A, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6020021; Demidchik V, 2002, PLANT J, V32, P799, DOI 10.1046/j.1365-313X.2002.01467.x; Demidchik V, 2007, NEW PHYTOL, V175, P387, DOI 10.1111/j.1469-8137.2007.02128.x; De Leon JLD, 2010, CEREAL RES COMMUN, V38, P15, DOI 10.1556/CRC.38.2010.1.2; Epron D, 2012, TREE PHYSIOL, V32, P667, DOI 10.1093/treephys/tpr107; Erel R, 2014, TREE PHYSIOL, V34, P1102, DOI 10.1093/treephys/tpu081; Fairbairn DJ, 2000, PLANT MOL BIOL, V43, P515, DOI 10.1023/A:1006496402463; Fernando VCD, 2016, ABIOTIC AND BIOTIC STRESS IN PLANTS - RECENT ADVANCES AND FUTURE PERSPECTIVES, P507, DOI 10.5772/61957; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fuller T, 2011, SPR HBK COMPU STAT, P369, DOI 10.1007/978-3-642-16345-6_18; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Gattward JN, 2012, PHYSIOL PLANTARUM, V146, P350, DOI 10.1111/j.1399-3054.2012.01621.x; Gerardeaux E, 2010, ENVIRON EXP BOT, V67, P451, DOI 10.1016/j.envexpbot.2009.09.008; Ghan R, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1043-1; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Goncalves JLM, 2008, SOUTH FORESTS, V70, P105, DOI 10.2989/SOUTH.FOR.2008.70.2.6.534; Grattapaglia D, 2008, NEW PHYTOL, V179, P911, DOI 10.1111/j.1469-8137.2008.02503.x; Gu RS, 2004, TREE PHYSIOL, V24, P265, DOI 10.1093/treephys/24.3.265; Hafsi C, 2014, ACTA PHYSIOL PLANT, V36, P1055, DOI 10.1007/s11738-014-1491-2; Hasanuzzaman M, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1054-y; Heinen RB, 2014, PLANT MOL BIOL, V86, P335, DOI 10.1007/s11103-014-0232-7; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Hopper DW, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0804-6; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Huang CJ, 2014, PLANT PHYSIOL BIOCH, V76, P86, DOI 10.1016/j.plaphy.2013.12.021; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hura T, 2016, J PLANT PHYSIOL, V202, P1, DOI 10.1016/j.jplph.2016.06.018; Intergovernmental Panel on Climate C, 2014, CLIMATE CHANGE 2013; Isayenkov S, 2011, PLANT SIGNAL BEHAV, V6, P1201, DOI 10.4161/psb.6.8.15808; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Isserlin Ruth, 2014, F1000Res, V3, P141, DOI 10.12688/f1000research.4536.1; Jarzyniak KM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00687; JESCHKE WD, 1977, Z PFLANZENPHYSIOL, V84, P247; Kaddour R, 2009, CR BIOL, V332, P784, DOI 10.1016/j.crvi.2009.05.003; Kerstiens G, 2002, NEW PHYTOL, V153, P509, DOI 10.1046/j.0028-646X.2001.00330.x; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Kosma DK., 2007, ADV MOL BREEDING DRO, P91, DOI DOI 10.1007/978-1-4020-5578-2_5; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Kronzucker HJ, 2013, PLANT SOIL, V369, P1, DOI 10.1007/s11104-013-1801-2; Kucera Mike, 2016, F1000Res, V5, P1717; Kugler A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-140; Laclau JP, 2010, FOREST ECOL MANAG, V259, P1771, DOI 10.1016/j.foreco.2009.06.010; Laclau JP, 2009, TREE PHYSIOL, V29, P111, DOI 10.1093/treephys/tpn010; Lacombe B, 2001, SCIENCE, V292, P1486, DOI 10.1126/science.292.5521.1486b; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; LINDHAUER MG, 1990, Z PFLANZ BODENKUNDE, V153, P25, DOI 10.1002/jpln.19901530107; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu ZF, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1201-5; Ma W, 2006, PLANT PHYSIOL BIOCH, V44, P494, DOI 10.1016/j.plaphy.2006.08.007; Maathuis FJM, 2003, PLANT J, V35, P675, DOI 10.1046/j.1365-313X.2003.01839.x; Maathuis FJM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00467; MacRobbie EAC, 2006, J MEMBRANE BIOL, V210, P131, DOI 10.1007/s00232-005-0851-7; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Maser P, 2002, PLANT SOIL, V247, P43, DOI 10.1023/A:1021159130729; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Mengel K, 2004, ANN BOT, V93, P479, DOI [10.1093/aob/mch063, DOI 10.1093/AOB/MCH063]; Merchant A, 2007, ANN BOT-LONDON, V100, P1507, DOI 10.1093/aob/mcm234; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; Muller M, 2014, PLANT J, V78, P646, DOI 10.1111/tpj.12501; Mulligan MK, 2017, METHODS MOL BIOL, V1488, P75, DOI 10.1007/978-1-4939-6427-7_4; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NUNES MA, 1984, J EXP BOT, V35, P322, DOI 10.1093/jxb/35.3.322; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Osakabe Y, 2013, PLANT CELL, V25, P609, DOI 10.1105/tpc.112.105700; Peuke AD, 2002, J EXP BOT, V53, P241, DOI 10.1093/jexbot/53.367.241; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Pratelli R, 2014, J EXP BOT, V65, P5535, DOI 10.1093/jxb/eru320; Pruthvi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111152; Pyo YJ, 2010, PLANT PHYSIOL, V153, P863, DOI 10.1104/pp.110.154369; RABE E, 1990, J HORTIC SCI BIOTECH, V65, P231; Ramirez V, 2009, PLANT J, V58, P578, DOI 10.1111/j.1365-313X.2009.03804.x; Almeida JCR, 2010, FOREST ECOL MANAG, V259, P1786, DOI 10.1016/j.foreco.2009.08.032; Re DA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-150; Rengasamy P, 2010, FUNCT PLANT BIOL, V37, P613, DOI 10.1071/FP09249; Rohart F., 2017, BIORXIV, DOI [10.1101/108597, DOI 10.1101/108597]; Roy BC, 2017, J BIOMOL STRUCT DYN, V35, P2454, DOI 10.1080/07391102.2016.1222968; Roy S, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1117723; Saand MA, 2015, DNA RES, V22, P471, DOI 10.1093/dnares/dsv029; Schroeder JI, 2003, P NATL ACAD SCI USA, V100, P4976, DOI 10.1073/pnas.1031801100; Sette JCR, 2009, REV FLORESTA, V39, P535, DOI DOI 10.5380/RF.V39I3.15353; Shabala S, 2003, ANN BOT-LONDON, V92, P627, DOI 10.1093/aob/mcg191; Shabala S, 2014, PHYSIOL PLANTARUM, V151, P257, DOI 10.1111/ppl.12165; Shabala SN, 2002, PLANT PHYSIOL, V129, P290, DOI 10.1104/pp.020005; Shankar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070321; Shih HW, 2015, CURR BIOL, V25, P3119, DOI 10.1016/j.cub.2015.10.025; Singh SK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00991; Sircar S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00256; Smart LB, 2001, PLANT CELL PHYSIOL, V42, P686, DOI 10.1093/pcp/pce085; Stevanato P, 2013, INT SUGAR J, V115, P800; Subbarao GV, 1999, J PLANT NUTR, V22, P1745, DOI 10.1080/01904169909365751; Subbarao GV, 2000, J PLANT NUTR, V23, P1449, DOI 10.1080/01904160009382114; Subbarao GV, 2003, CRIT REV PLANT SCI, V22, P391, DOI 10.1080/07352680390243495; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Thumma BR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-364; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wakeel A, 2011, CRIT REV PLANT SCI, V30, P401, DOI 10.1080/07352689.2011.587728; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039856; Wang M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081229; Wang TB, 1998, PLANT PHYSIOL, V118, P651, DOI 10.1104/pp.118.2.651; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153; Wang YG, 2017, J PLANT RES, V130, P1079, DOI 10.1007/s10265-017-0964-y; Wang YQ, 2017, P NATL ACAD SCI USA, V114, P5047, DOI 10.1073/pnas.1618557114; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; Watkinson JI, 2003, PLANT PHYSIOL, V133, P1702, DOI 10.1104/pp.103.026914; Wei JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069737; Wisniewski N, 2013, J HEART LUNG TRANSPL, V32, pS223, DOI 10.1016/j.healun.2013.01.565; Wu JX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154330; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yildirim K, 2017, PLANT PHYSIOL BIOCH, V115, P183, DOI 10.1016/j.plaphy.2017.03.020; Yu YQ, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1085275; Zahoor R, 2017, J PLANT PHYSIOL, V215, P30, DOI 10.1016/j.jplph.2017.05.001; Zahoor R, 2017, ENVIRON EXP BOT, V137, P73, DOI 10.1016/j.envexpbot.2017.02.002; Zargar SM, 2017, J PROTEOMICS, V169, P233, DOI 10.1016/j.jprot.2017.04.010; Zeng Ying, 2002, Plant Molecular Biology Reporter, V20, P417, DOI 10.1007/BF02772130; Zhao X, 2011, J PLANT PHYSIOL, V168, P903, DOI 10.1016/j.jplph.2010.11.024; Zheng YH, 2012, PLANT PHYSIOL BIOCH, V52, P169, DOI 10.1016/j.plaphy.2012.01.007; Zorb C, 2014, J PLANT PHYSIOL, V171, P656, DOI 10.1016/j.jplph.2013.08.008	161	10	10	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218528	10.1371/journal.pone.0218528	http://dx.doi.org/10.1371/journal.pone.0218528			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220144	gold, Green Published, Green Submitted			2022-12-26	WOS:000484893500060
J	Fontes, RBV; Baptista, JS; Rabbani, SR; Traynelis, VC; Liberti, EA				Fontes, Ricardo B. V.; Baptista, Josemberg S.; Rabbani, Said R.; Traynelis, Vincent C.; Liberti, Edson A.			Normal aging in human lumbar discs: An ultrastructural comparison	PLOS ONE			English	Article							INTERVERTEBRAL DISCS; ANULUS FIBROSUS; GLOBAL BURDEN; BACK-PAIN; DEGENERATION; ARCHITECTURE; DISABILITY; DISEASE; FIBERS; MATRIX	The normal aging of the extracellular matrix and collagen content of the human lumbar intervertebral disc (IVD) remains relatively unknown despite vast amounts of basic science research, partly because of the use of inadequate surrogates for a truly normal, human IVD. Our objective in this study was to describe and compare the morphology and ultrastructure of lumbar IVDs in 2 groups of young (G1-<35 years) and elderly (G2->65 years). Thirty L4-5 and L5-S1 discs per group were obtained during autopsies of presumably-asymptomatic individuals and analyzed with magnetic resonance imaging (MRI), a morphological grading scale, light microscopy, scanning electron microscopy (SEM) and immunohistochemistry (IHC) for collagen types I, II, III, IV, V, VI, IX and X. As expected, a mild to moderate degree of degeneration was present in G1 discs and significantly more advanced in G2. The extracellular matrix of G2 discs was significantly more compact with an increase of cartilaginous features such as large chondrocyte clusters. Elastic fibers were abundant in G1 specimens and their presence correlated more with age than with degeneration grade, being very rare in G2. SEM demonstrated persistence of basic structural characteristics such as denser lamellae with Sharpey-type insertions into the endplates despite advanced age or degeneration grades. Immunohistochemistry revealed type II collagen to be the most abundant type followed by collagen IV. All collagen types were detected in every disc sector except for type X collagen. Statistical analysis demonstrated a general decrease in collagen expression from G1 to G2 with an annular- and another nuclear-specific pattern. These results suggest modifications of IVD morphology do not differ between the anterior or posterior annulus but are more advanced or happen earlier in the posterior areas of the disc. This study finally describes the process of extracellular matrix modification during disc degeneration in an unselected, general population and demonstrates it is similar to the same process in the cervical spine as published previously.	[Fontes, Ricardo B. V.; Traynelis, Vincent C.] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA; [Baptista, Josemberg S.] Univ Fed Espirito Santo, Lab Appl Morphol LEMA, Vitoria, ES, Brazil; [Rabbani, Said R.] Univ Sao Paulo, Inst Fis, Dept Gen Phys, Sao Paulo, SP, Brazil; [Liberti, Edson A.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Anat, Sao Paulo, SP, Brazil	Rush University; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade de Sao Paulo	Baptista, JS (corresponding author), Univ Fed Espirito Santo, Lab Appl Morphol LEMA, Vitoria, ES, Brazil.	josemberg.baptista@ufes.br	da Silva Baptista, Josemberg/D-7597-2013	da Silva Baptista, Josemberg/0000-0003-0514-8170	Cervical Spine Research Society; CAPES/DS scholarship	Cervical Spine Research Society; CAPES/DS scholarship	This study was funded by a Resident Research Grant from the Cervical Spine Research Society (to RBVF). Partial financial support was also obtained through a CAPES/DS scholarship (to RBVF).	Baptista J. S., 2013, Journal of Morphological Sciences, V30, P33; Brayda-Bruno M, 2014, EUR SPINE J, V23, pS315, DOI 10.1007/s00586-013-2960-9; BUCKWALTER JA, 1976, J BONE JOINT SURG AM, V58, P73, DOI 10.2106/00004623-197658010-00013; Cheng KK, 2014, SPINE J, V14, P522, DOI 10.1016/j.spinee.2013.06.089; Cloyd JM, 2007, SPINE, V32, P1826, DOI 10.1097/BRS.0b013e3181132a9d; CORNAH MS, 1970, J ANAT, V107, P351; COVENTRY MB, 1945, J BONE JOINT SURG, V27, P105; de Oliveira F, 2009, J ANAT, V214, P388, DOI 10.1111/j.1469-7580.2009.01047.x; Fontes RBD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139283; Fontes RBV, 2006, NEUROSURGERY, V58, P978, DOI 10.1227/01.NEU.0000210224.54816.40; Francois R J, 1982, Spine (Phila Pa 1976), V7, P522, DOI 10.1097/00007632-198209000-00022; FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506; Goodrich James Tait, 2004, Neurosurg Focus, V16, pE2; Harrington R, 2003, SOC HIST MED, V16, P209, DOI 10.1093/shm/16.2.209; Holguin N, 2014, J APPL PHYSIOL, V116, P1551, DOI 10.1152/japplphysiol.01322.2013; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hristova GI, 2011, J ORTHOP RES, V29, P1888, DOI 10.1002/jor.21456; INOUE H, 1981, SPINE, V6, P139, DOI 10.1097/00007632-198103000-00006; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Leboeuf-Yde C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-39; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Longo G, 2006, EUR SPINE J, V15, P1845, DOI 10.1007/s00586-005-0035-2; Luschka H, 1858, HALBEGELENKE MENSCHL; Marketos SG, 1999, SPINE, V24, P2358, DOI 10.1097/00007632-199911150-00012; Matsumoto M, 2013, EUR SPINE J, V22, P708, DOI 10.1007/s00586-012-2500-z; Montes GS, 1996, CELL BIOL INT, V20, P15, DOI 10.1006/cbir.1996.0004; Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001; Nosikova YS, 2012, J ANAT, V221, P577, DOI 10.1111/j.1469-7580.2012.01537.x; Paietta RC, 2013, J STRUCT BIOL, V184, P310, DOI 10.1016/j.jsb.2013.08.011; Phillips KLE, 2013, ANN RHEUM DIS, V72, P1860, DOI 10.1136/annrheumdis-2012-202266; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schmorl G, 1968, GESUNDE KRANKE WIRBE, V5; Showalter BL, 2012, SPINE, V37, pE900, DOI 10.1097/BRS.0b013e31824d911c; Singh K, 2005, SPINE J, V5, P267, DOI DOI 10.1016/J.SPINEE.2005.02.016; Smith LJ, 2009, EUR SPINE J, V18, P439, DOI 10.1007/s00586-009-0918-8; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang F, 2018, OSTEOARTHR CARTILAGE, V26, P1274, DOI 10.1016/j.joca.2018.05.022	38	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218121	10.1371/journal.pone.0218121	http://dx.doi.org/10.1371/journal.pone.0218121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220091	gold, Green Submitted, Green Published			2022-12-26	WOS:000484893500023
J	Marencakova, J; Price, C; Maly, T; Zahalka, F; Nester, C				Marencakova, Jitka; Price, Carina; Maly, Tomas; Zahalka, Frantisek; Nester, Christopher			How do novice and improver walkers move in their home environments? An open-sourced infant's gait video analysis	PLOS ONE			English	Article							INDEPENDENT WALKING; TODDLERS; COORDINATION; STRATEGIES; LOCOMOTION; PATTERNS; CHILDREN; STEPS	Objective Natural independent walking mostly occurs during infant's everyday explorations of their home environment. Gait characteristics of infant walkers at different developmental stages exist in literature, however, data has been only collected in laboratory environments, which may reduce gait variability, therefore mask differences between developmental stages of natural gait. The aim of the study was to provide the first data set of temporal and functional gait characteristics of novice and improver infant walkers in familiar environment conditions in their home. We hypothesised that familiar environment conditions may effectively demonstrate natural gait characteristics and real differences in gait variables differing between 2 groups of developing infant walkers. Methods In a cross-sectional design; we used open-source videos of infants in their home environments: twenty videos of 10 novice (5 girls, 5 boys, 7-12 months) and 10 improver (4 girls, 6 boys, 8-13 months) walkers were chosen from an open-source website. 2-D video gait analysis was undertaken for these parameters: falls frequency, frequency of stops, gait cadence, and time of stance phase, swing phase, and double support. Between groups comparison for novice versus improver was investigated by Mann-Whitney U tests (p <= 0.05) with determination of effect size of Pearson r correlation. Results Statistically significant differences between groups with large effect sizes were found for these parameters: falls frequency (p = 0.01, r = 0.56); cadence (p = 0.01, r = 0.57); stance phase duration of right leg (p < 0.01, r = 0.63); stance phase duration of left leg (p = 0.01, r = 0.56); and double support phase duration (p < 0.01, r = 0.69). Novices scored higher in comparison with improver walkers in all the parameters except cadence. Conclusions This study presents the first data set of functional and temporal gait parameters of novice and improver infant walkers in their home environments. As an addition to recent research, novice infants walk with lower cadence and higher falls frequency, stance phase time and double support in their familiar environments. With increasing experiences, infant's cadence increases while the other parameters decrease.	[Marencakova, Jitka; Maly, Tomas; Zahalka, Frantisek] Charles Univ Prague, Fac Phys Educ & Sport, Sport Res Ctr, Prague, Czech Republic; [Price, Carina; Nester, Christopher] Univ Salford, Sch Hlth & Soc, Res Ctr Hlth Sci, Salford, Lancs, England	Charles University Prague; University of Salford	Marencakova, J (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Sport Res Ctr, Prague, Czech Republic.	marencakova.jitka@seznam.cz	Marenčáková, Jitka/D-9406-2017; Maly, Tomas/R-1147-2017; Maly, Tomas/AAK-2224-2021; Zahalka, Frantisek/M-6238-2017	Marenčáková, Jitka/0000-0003-1981-818X; Maly, Tomas/0000-0001-5439-6766; Maly, Tomas/0000-0001-5439-6766; Price, Carina/0000-0002-5633-1250; Nester, christopher/0000-0003-1688-320X; Zahalka, Frantisek/0000-0001-9972-7637	Czech Republic - Ministry of Education, Youth and Sports [CZ.02.2.69/0.0/0.0/16_027/0008495]	Czech Republic - Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by Czech Republic - Ministry of Education, Youth and Sports CZ.02.2.69/0.0/0.0/16_027/0008495. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph KE, 2012, PSYCHOL SCI, V23, P1387, DOI 10.1177/0956797612446346; Adolph KE, 2003, CHILD DEV, V74, P475, DOI 10.1111/1467-8624.7402011; Bertsch C, 2004, GAIT POSTURE, V19, P235, DOI 10.1016/S0966-6362(03)00064-X; Bisi MC, 2015, GAIT POSTURE, V41, P574, DOI 10.1016/j.gaitpost.2014.11.017; Bosch K, 2010, GAIT POSTURE, V32, P564, DOI 10.1016/j.gaitpost.2010.08.003; BRIL B, 1992, J MOTOR BEHAV, V24, P105, DOI 10.1080/00222895.1992.9941606; Cheron G, 2001, EXP BRAIN RES, V137, P455, DOI 10.1007/s002210000663; CLARK JE, 1993, CHILD DEV, V64, P1143, DOI 10.1111/j.1467-8624.1993.tb04192.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cole WG, 2016, DEV PSYCHOBIOL, V58, P341, DOI 10.1002/dev.21374; Dominici N, 2010, J NEUROPHYSIOL, V103, P1673, DOI 10.1152/jn.00945.2009; Figueiredo PRP, 2013, BRAZ J PHYS THER, V17, P359, DOI [10.1590/S1413-35552013005000105, 10.1590/S1413-35552012005000105]; FORSSBERG H, 1985, EXP BRAIN RES, V57, P480; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gardiner J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165287; Hallemans A, 2003, FOOT ANKLE INT, V24, P444, DOI 10.1177/107110070302400513; Hallemans A, 2006, GAIT POSTURE, V24, P270, DOI 10.1016/j.gaitpost.2005.10.003; Ivanenko YP, 2005, J NEUROPHYSIOL, V94, P754, DOI 10.1152/jn.00088.2004; Ivanenko YP, 2007, EXERC SPORT SCI REV, V35, P67; Korff T, 2012, PAEDIAT BIOMECHANICS; Lacquaniti F, 2002, ARCH ITAL BIOL, V140, P263; Ledebt A, 2000, INFANT BEHAV DEV, V23, P79, DOI 10.1016/S0163-6383(00)00027-8; Looper J, 2013, GAIT POSTURE, V37, P631, DOI 10.1016/j.gaitpost.2012.09.009; Owen E., 2016, PHYS THERAPY CHILDRE; Sundermier L, 2001, EXP BRAIN RES, V136, P340, DOI 10.1007/s002210000579; Sutherland D, 1997, GAIT POSTURE, V6, P163, DOI 10.1016/S0966-6362(97)00029-5	26	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218665	10.1371/journal.pone.0218665	http://dx.doi.org/10.1371/journal.pone.0218665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220161	gold, Green Published, Green Submitted			2022-12-26	WOS:000484893500079
J	Bjune, K; Wierod, L; Naderi, S				Bjune, Katrine; Wierod, Lene; Naderi, Soheil			Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms	PLOS ONE			English	Article							GENE-EXPRESSION; ALLOSTERIC INHIBITOR; BINDING; ACTIVATION; PROTEIN; CANCER; MK-2206; STRESS; IDENTIFICATION; STABILIZATION	Protein kinase B (AKT) is a serine/threonine kinase that functions as an important downstream effector of phosphoinositide 3-kinase. We have recently shown that MK-2206 and triciribine, two highly selective AKT inhibitors increase the level of low density lipoprotein receptor (LDLR) mRNA which leads to increased amount of cell-surface LDLRs. However, whereas MK-2206 induces transcription of the LDLR gene, triciribine stabilizes LDLR mRNA, raising the possibility that the two inhibitors may actually affect other kinases than AKT. In this study, we aimed to ascertain the role of AKT in regulation of LDLR mRNA expression by examining the effect of five additional AKT inhibitors on LDLR mRNA levels. Here we show that in cultured HepG2 cells, AKT inhibitors ARQ-092, AKT inhibitor VIII, perifosine, AT7867 and CCT128930 increase LDLR mRNA levels by inducing the activity of LDLR promoter. CCT128930 also increased the stability of LDLR mRNA. To study the role of AKT isoforms on LDLR mRNA levels, we examined the effect of siRNA-mediated knockdown of AKT1 or AKT2 on LDLR promoter activity and LDLR mRNA stability. Whereas knockdown of either AKT1 or AKT2 led to upregulation of LDLR promoter activity, only knockdown of AKT2 had a stabilizing effect on LDLR mRNA. Taken together, these results provide strong evidence for involvement of AKT in regulation of LDLR mRNA expression, and point towards the AKT isoform specificity for upregulation of LDLR mRNA expression.	[Bjune, Katrine; Wierod, Lene; Naderi, Soheil] Oslo Univ Hosp, Dept Med Genet, Unit Cardiac & Cardiovasc Genet, Oslo, Norway	University of Oslo	Bjune, K (corresponding author), Oslo Univ Hosp, Dept Med Genet, Unit Cardiac & Cardiovasc Genet, Oslo, Norway.	kabjun@ous-hf.no		Bjune, Katrine/0000-0002-2303-0216	Nasjonalforeningen for folkehelsen [2013.ST054]	Nasjonalforeningen for folkehelsen	Katrine Bjune's PhD was funded by Nasjonalforeningen for folkehelsen Grant number 2013.ST054 (https://nasjonalforeningen.no/).The sponsor did not play any role in the study disign, data collection or analysis, the decision to publish nor the preparation of the manuscript.	Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bellacosa A, 2004, CANCER BIOL THER, V3, P268, DOI 10.4161/cbt.3.3.703; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Bjune K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34237-6; Bjune K, 2018, ATHEROSCLEROSIS, V276, P28, DOI 10.1016/j.atherosclerosis.2018.07.009; Blumenberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102466; Brown MS, 2018, ANNU REV BIOCHEM, V87, P783, DOI 10.1146/annurev-biochem-062917-011852; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Goldstein J.L., 2001, METABOLIC MOL BASES, V11, P2863; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grimshaw KM, 2010, MOL CANCER THER, V9, P1100, DOI 10.1158/1535-7163.MCT-09-0986; Gupta A, 2010, ADV THER, V27, P348, DOI 10.1007/s12325-010-0033-6; Holla OL, 2010, MOL GENET METAB, V99, P149, DOI 10.1016/j.ymgme.2009.09.012; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Hudis C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3577; Iacovides DC, 2013, MOL CELL PROTEOMICS, V12, P3210, DOI 10.1074/mcp.M112.023119; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Myers AL, 2015, ONCOTARGET, V6, P25897, DOI 10.18632/oncotarget.4532; Oh J, 2005, J CELL BIOCHEM, V96, P786, DOI 10.1002/jcb.20551; Pak YK, 1996, J LIPID RES, V37, P985; Pinton G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036856; Ramanathan RK, 2015, CANCER-AM CANCER SOC, V121, P2193, DOI 10.1002/cncr.29363; Richardson PG, 2012, EXPERT OPIN DRUG MET, V8, P623, DOI 10.1517/17425255.2012.681376; Saura C, 2017, CANCER DISCOV, V7, P102, DOI 10.1158/2159-8290.CD-16-0512; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Tan SX, 2011, BIOCHEM J, V435, P539, DOI 10.1042/BJ20110040; Varret M, 2008, CLIN GENET, V73, P1, DOI 10.1111/j.1399-0004.2007.00915.x; Vivanco I, 2014, ELIFE, V3, DOI 10.7554/eLife.03751; Wilson GM, 1998, J LIPID RES, V39, P1025; Yan L, 2009, CANCER RES, V69; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yap TA, 2014, CLIN CANCER RES, V20, P5672, DOI 10.1158/1078-0432.CCR-14-0868; Yap TA, 2011, MOL CANCER THER, V10, P360, DOI 10.1158/1535-7163.MCT-10-0760; Yashiro T, 2011, BIOCHEM BIOPH RES CO, V409, P155, DOI 10.1016/j.bbrc.2011.04.006; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140479; Zhang SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169585; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218537	10.1371/journal.pone.0218537	http://dx.doi.org/10.1371/journal.pone.0218537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216345	Green Published, Green Submitted, gold			2022-12-26	WOS:000482885300054
J	Lee, JY; Mehrazarin, S; Alshaikh, A; Kim, S; Chen, W; Lux, R; Gwack, Y; Kim, RH; Kang, MK				Lee, Jae Young; Mehrazarin, Shebli; Alshaikh, Abdullah; Kim, Sol; Chen, Wei; Lux, Renate; Gwack, Yousang; Kim, Reuben H.; Kang, Mo K.			Histone Lys demethylase KDM3C demonstrates anti-inflammatory effects by suppressing NF-kappa B signaling and osteoclastogenesis	FASEB JOURNAL			English	Article						epigenetics; histone methylation; oral inflammation; JMJD1C; periodontitis	PORPHYROMONAS-GINGIVALIS; GENE-EXPRESSION; BONE-RESORPTION; PERIODONTITIS; METHYLATION; H3; INTERLEUKIN-1; INHIBITION; COMPLEXES; ALPHA	Histone Lys-specific demethylases (KDMs) play a key role in many biological processes through epigenetic mechanisms. However, the role of KDMs in inflammatory responses to oral bacterial infection is poorly understood. Here, we show a novel regulatory role of KDM3C in inflammatory responses to oral bacterial infection. KDM3C expression is transiently suppressed in human and mouse macrophages exposed to LPS from Porphyromonas gingivalis (Pg LPS). Loss of KDM3C in both human and mouse macrophages led to notable induction of proinflammatory cytokines in response to Pg LPS stimulation. Also, KDM3C depletion led to strong induction of p65 phosphorylation and accelerated nuclear translocation in cells exposed to Pg LPS. Kdm3C knockout (KO) in mice led to increased alveolar bone destruction upon induction of experimental periodontitis or pulp exposure compared with those of the wild-type (WT) littermates. The Kdm3C KO mice also revealed an increased number of osteoclasts juxtaposed to the bony lesions. We also confirmed enhanced osteoclastogenesis by bone marrow-derived macrophages isolated from the Kdm3C KO compared with the WT controls. These findings suggest an anti-inflammatory function of KDM3C in regulating the inflammatory responses against oral bacterial infection through suppression of NF-kappa B signaling and osteoclastogenesis.-Lee, J. Y., Mehrazarin, S., Alshaikh, A., Kim, S., Chen, W., Lux, R., Gwack, Y., Kim, R. H., Kang, M. K. Histone Lys demethylase KDM3C demonstrates anti-inflammatory effects by suppressing NF-kappa B signaling and osteoclastogenesis.	[Lee, Jae Young; Mehrazarin, Shebli; Alshaikh, Abdullah; Kim, Sol; Chen, Wei; Kim, Reuben H.; Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Div Constitut & Regenerat Sci, Shapiro Family Lab Viral Oncol & Aging Res, Los Angeles, CA 90024 USA; [Lee, Jae Young; Chen, Wei; Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Div Constitut & Regenerat Sci, Sect Endodont, Los Angeles, CA 90024 USA; [Lux, Renate] Univ Calif Los Angeles, Sch Dent, Div Constitut & Regenerat Sci, Sect Periodont, Los Angeles, CA 90024 USA; [Gwack, Yousang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kang, MK (corresponding author), Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Room 43-007,10833 Conte Ave, Los Angeles, CA 90095 USA.	mkang@dentistry.ucla.edu			U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research [R21DE028269, R56DE024593, R03DE024259]; American Association of Endodontists Foundation; Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE024259, R21DE028269] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research; American Association of Endodontists Foundation; Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in part, by grants from the U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research (R21DE028269, R56DE024593, and R03DE024259) and a grant from the American Association of Endodontists Foundation. M.K.K. is also supported by the Jack A. Weichman Endowed Fund. The authors declare no conflicts of interest.	Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Demmer RT, 2008, J PERIODONTOL, V79, P2112, DOI [10.1902/jop.2008.080139, 10.1902/jop.2008.080139 ]; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Ea CK, 2012, J BIOL CHEM, V287, P31207, DOI 10.1074/jbc.M112.365601; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Haddad JJE, 2001, BIOCHEM J, V355, P29, DOI 10.1042/bj3550029; He Y, 2017, J ENDODONT, V43, P90, DOI 10.1016/j.joen.2016.09.003; Izawa A, 2014, INFECT IMMUN, V82, P1904, DOI 10.1128/IAI.01618-13; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kajikawa T, 2017, J CLIN PERIODONTOL, V44, P472, DOI 10.1111/jcpe.12707; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kim KC, 2003, CANCER RES, V63, P7619; Kuroki S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108597; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lam RS, 2014, J IMMUNOL, V193, P2349, DOI 10.4049/jimmunol.1400853; Lee HT, 2014, INFLAMM RES, V63, P389, DOI 10.1007/s00011-014-0711-y; Leveillard Thierry, 1993, Gene Expression, V3, P135; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MUNDY GR, 1993, J CELL BIOCHEM, V53, P296, DOI 10.1002/jcb.240530405; Nakajima R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163466; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091083; Oz HS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/754857; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; PFEILSCHIFTER J, 1989, J BONE MINER RES, V4, P113, DOI 10.1002/jbmr.5650040116; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Santos-Barriopedro I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02586-x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Suuronen T, 2003, J NEUROCHEM, V87, P407, DOI 10.1046/j.1471-4159.2003.02004.x; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; To M, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0588-8; van't Hof RJ, 2017, BONE, V99, P69, DOI 10.1016/j.bone.2017.03.051; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Xiao F, 2017, STEM CELL REP, V9, P927, DOI 10.1016/j.stemcr.2017.07.013; Yoza BK, 2011, CYTOKINE, V53, P145, DOI 10.1016/j.cyto.2010.10.007; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	49	13	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10515	10527		10.1096/fj.201900154RR	http://dx.doi.org/10.1096/fj.201900154RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31251083	Green Published			2022-12-26	WOS:000482214200063
J	Liu, J; Dong, S; Wang, H; Li, L; Ye, QM; Li, YH; Miao, JX; Jhiang, S; Zhao, J; Zhao, YT				Liu, Jia; Dong, Su; Wang, Heather; Li, Lian; Ye, Qinmao; Li, Yanhui; Miao, Jiaxing; Jhiang, Sissy; Zhao, Jing; Zhao, Yutong			Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively	FASEB JOURNAL			English	Article						TTF1; ubiquitination; HECW1; FBXL19; different cell types	FACTOR-I; UBIQUITIN LIGASES; GENE; PULMONARY; PROTEIN; DIFFERENTIATION; EXPRESSION; PAX8; RECEPTOR; TTF-1	Thyroid transcription factor 1 (TTF1) regulates the tissue-specific expression of genes. However, the molecular regulation of TTF1 in thyroid normal and carcinoma cells has not been revealed. Here we identify 2 distinct ubiquitin E3 ligases that are responsible for TTF1 degradation in normal thyroid cells and carcinoma cells, respectively. Phorbol myristate acetate induced TTF1 protein degradation in the ubiquitin-proteasome system in both HTori3 thyroid follicular epithelial cells and follicular thyroid carcinoma 133 (FTC133) cells. Lysine 151 residue was identified as a ubiquitin acceptor site within TTF1 in both cell types. Overexpression of E3 ubiquitin protein ligase 1 containing HECT, C2, and WW domain (HECW1) induced TTF1 degradation and ubiquitination in Htori3 cells but not in FTC133 cells. Overexpression of ubiquitin E3 ligase subunit FBXL19 increased TTF1 ubiquitination and degradation in FTC133 cells, but it had no effect on TTF1 levels in Htori3 cells. Overexpression of TTF1 increased thyroglobulin and sodium/iodide symporter mRNA levels, cell migration, and proliferation in HTori3 cells, whereas the effects were reversed by the overexpression of HECW1. This study reveals an undiscovered molecular mechanism by which TTF1 ubiquitination and degradation is regulated by different E3 ligases in thyroid normal and tumor cells.-Liu, J., Dong, S., Wang, H., Li, L., Ye, Q., Li, Y., Miao, J., Jhiang, S., Zhao, J., Zhao, Y. Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.	[Liu, Jia] Jilin Univ, Hosp 1, Dept Thyroid Surg, Changchun, Jilin, Peoples R China; [Dong, Su; Li, Yanhui] Jilin Univ, Hosp 1, Dept Anesthesia, Changchun, Jilin, Peoples R China; [Liu, Jia; Dong, Su; Wang, Heather; Li, Lian; Ye, Qinmao; Li, Yanhui; Miao, Jiaxing; Jhiang, Sissy; Zhao, Jing; Zhao, Yutong] Ohio State Univ, Dept Physiol & Cell Biol, 333 10th Ave,Graves Hall 2166E, Columbus, OH 43065 USA	Jilin University; Jilin University; University System of Ohio; Ohio State University	Zhao, YT (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, 333 10th Ave,Graves Hall 2166E, Columbus, OH 43065 USA.	yutong.zhao@osumc.edu			U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01GM115389]; NIH National Heart, Lung, and Blood Institute [HL136294, HL131665]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136294, R01HL131665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115389] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01GM115389 (to J.Z.) and NIH National Heart, Lung, and Blood Institute Grants HL136294 and HL131665 (to Y.Z.). The authors declare no conflicts of interest.	Afrasiabi E, 2008, MOL CELL ENDOCRINOL, V292, P26, DOI 10.1016/j.mce.2008.04.018; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Cai JT, 2018, PROTEIN CELL, V9, P754, DOI 10.1007/s13238-017-0486-3; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Dong S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-76; Gong T, 2018, TRENDS BIOCHEM SCI, V43, P685, DOI 10.1016/j.tibs.2018.06.008; Huang HB, 2017, J CELL BIOCHEM, V118, P3444, DOI 10.1002/jcb.26001; Jendrzejewski J, 2016, THYROID, V26, P1276, DOI 10.1089/thy.2015.0665; Katoh R, 2000, HUM PATHOL, V31, P386, DOI 10.1016/S0046-8177(00)80255-5; Kaufmann O, 2000, HISTOPATHOLOGY, V36, P8; Keijzer R, 2001, DEVELOPMENT, V128, P503; Kenny SL, 2012, AM J SURG PATHOL, V36, P799, DOI 10.1097/PAS.0b013e31824a72c6; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kimura S, 1996, TRENDS ENDOCRIN MET, V7, P247, DOI 10.1016/S1043-2760(96)00115-4; Kiryluk K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006609; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Li Y, 2013, STEM CELLS DEV, V22, P1433, DOI 10.1089/scd.2012.0620; Liu Z, 2017, ONCOGENE, V36, P3740, DOI 10.1038/onc.2016.524; Lonigro R, 2001, J BIOL CHEM, V276, P47807, DOI 10.1074/jbc.M107692200; Lopez-Campistrous A, 2016, EBIOMEDICINE, V12, P86, DOI 10.1016/j.ebiom.2016.09.007; Ma RS, 2013, THYROID, V23, P385, DOI 10.1089/thy.2012.0644; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958; Missero C, 2000, MOL CELL BIOL, V20, P2783, DOI 10.1128/MCB.20.8.2783-2793.2000; Mithoe SC, 2018, CURR OPIN PLANT BIOL, V45, P162, DOI 10.1016/j.pbi.2018.07.008; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Mu D, 2012, CANCER GENE THER, V19, P402, DOI 10.1038/cgt.2012.13; Nettore IC, 2013, J ENDOCRINOL INVEST, V36, P654, DOI 10.3275/8973; Pelizzoi R, 2008, INT J DEV BIOL, V52, P55, DOI 10.1387/ijdb.062196rp; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Plantinga TS, 2014, J CLIN ENDOCR METAB, V99, pE1368, DOI 10.1210/jc.2014-1171; Pohlenz J, 2002, J CLIN INVEST, V109, P469, DOI 10.1172/JCI200214192; Postiglione MP, 2002, P NATL ACAD SCI USA, V99, P15462, DOI 10.1073/pnas.242328999; Schwingshackl A, 2017, AM J PHYSIOL-LUNG C, V313, pL1030, DOI 10.1152/ajplung.00121.2017; Shimura H, 2001, CANCER RES, V61, P3640; Shinada K, 2011, BIOCHEM BIOPH RES CO, V404, P143, DOI 10.1016/j.bbrc.2010.11.082; Shinohara H, 2018, THYROID, V28, P1071, DOI 10.1089/thy.2017.0481; Son HY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15966; Steiner F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071093; Wei JX, 2018, FASEB J, V32, P4284, DOI 10.1096/fj.201701069R; Wei JX, 2013, BBA-MOL CELL RES, V1833, P2757, DOI 10.1016/j.bbamcr.2013.07.005; Weissferdt A, 2013, MODERN PATHOL, V26, P1554, DOI 10.1038/modpathol.2013.111; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139; Zhao J, 2013, FASEB J, V27, P2611, DOI 10.1096/fj.12-223099; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	50	8	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10538	10550		10.1096/fj.201900415R	http://dx.doi.org/10.1096/fj.201900415R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31238008	Green Published, Bronze			2022-12-26	WOS:000482214200065
J	Pilgaard, T; Hagelund, L; Stallknecht, SE; Jensen, HH; Esbensen, BA				Pilgaard, Trine; Hagelund, Lise; Stallknecht, Sandra Elkjaer; Jensen, Henrik Holm; Esbensen, Bente Appel			Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis - Results of a cross-sectional study	PLOS ONE			English	Article							FUNCTIONAL ASSESSMENT; GENERAL-POPULATION; DISEASE-ACTIVITY; ASSOCIATION; SCALE	Background Despite improvements in treatment for rheumatoid arthritis ( RA), psoriatic arthritis ( PsA) and spondyloarthritis ( axSpA), several key unmet needs remain, such as fatigue. The objective of this study was to describe the severity of fatigue, disease characteristics and socioeconomic factors in people with RA, PsA and axSpA. Methods The study was designed as a cross-sectional survey collecting patient characteristics such as disease characteristics, socioeconomic factors and fatigue in people with RA, PsA and axSpA in Denmark. Respondents were consecutively recruited for the study over a six-month period in 2018 via routine visits to outpatient rheumatology clinics. Study nurses collected information on diagnosis, current disease-related treatment and disease activity from medical journals. People were invited to complete a questionnaire related to socioeconomic factors and containing the FACIT-Fatigue subscale. Descriptive statistics were analyzed using SAS. Results We invited 633 people to participate, and 488 ( 77%) completed the questionnaire. Women constituted 62% of respondents, and the mean age was 53.5 years. Respondents had on average been diagnosed between 11 and 15 years ago. Overall, 79% had no changes to their disease-related treatment during the past year, and the average disease activity as indicated by DAS28 for RA and PsA was 2.48 and 2.36, respectively, and BASDAI for axSpA was 28.40. Fatigue was present in all three diagnoses ( mean: 34.31). The mean fatigue score varied from respondents answering that they suffered from no or little fatigue ( mean: 45.48) to extreme fatigue ( mean: 10.11). Analyses demonstrated that the respondents were not considerably different from nonrespondents, and the study population is considered representative compared with Danish RA and axSpA patients in the Danish National Rheumatology Registry, the DANBIO database. Conclusion We found that the majority of the study population were fatigued ( 61%). They had low disease activity and few disease-related treatment changes.	[Pilgaard, Trine; Hagelund, Lise] Pfizer Denmark AS, Ballerup, Denmark; [Stallknecht, Sandra Elkjaer; Jensen, Henrik Holm] Incentive, Holte, Denmark; [Esbensen, Bente Appel] Rigshosp, Ctr Head & Orthopaed, Ctr Rheumatol & Spine Dis, Copenhagen Ctr Arthrit Res, Glostrup, Denmark; [Esbensen, Bente Appel] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	Pfizer; Rigshospitalet; University of Copenhagen	Stallknecht, SE (corresponding author), Incentive, Holte, Denmark.	ses@incentive.dk		Stallknecht, Sandra Elkjaer/0000-0002-1721-3665; Pilgaard, Trine/0000-0002-1771-956X	Pfizer Denmark	Pfizer Denmark(Pfizer)	This nonpharmacological work was funded by Pfizer Denmark, which is a commercial company. TP and LH are employees of Pfizer Denmark. Incentive was a paid vendor and is also a commercial company. SES and HHJ are employees of Incentive. The funder provided support in the form of salaries for authors TP and LH. The founder also provided consultation fees for authors SES and HHJ of Incentive during the conduct of the study and consultation fees outside the submitted work. BAE is an employee of Rigshospitalet and University of Copenhagen and reports research grant for data collection and personal fees for lead investigator consultancy on the protocol development from the funder during the conduct of the study. In addition, BAE has received research grants and personal consultancy fees from the funder outside the submitted work. The specific roles of all authors are articulated in the 'author contributions' section.	Basu N, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0662-y; Bechman K, 2018, J RHEUMATOL, V45, P1515, DOI 10.3899/jrheum.171375; BELZA BL, 1995, J RHEUMATOL, V22, P639; Bianchi WA, 2014, MOD RHEUMATOL, V24, P980, DOI 10.3109/14397595.2014.906049; Bruce B, 2003, J RHEUMATOL, V30, P167; Cella D, 2005, J RHEUMATOL, V32, P811; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Chandran V, 2007, ANN RHEUM DIS, V66, P936, DOI 10.1136/ard.2006.065763; Diniz LR, 2017, REV BRAS REUMATOL, V57, P431, DOI 10.1016/j.rbre.2017.05.004; Espahbodi S, 2017, CLIN EXP RHEUMATOL, V35, P571; FACIT, 2018, QUESTIONNAIRES; Feldthusen C, 2013, CLIN RHEUMATOL, V32, P557, DOI 10.1007/s10067-012-2133-y; Fieo RA, 2014, ASSESSMENT, V21, P706, DOI 10.1177/1073191114541143; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Gossec L, 2016, JOINT BONE SPINE, V83, P427, DOI 10.1016/j.jbspin.2015.07.012; Gudu T, 2016, JOINT BONE SPINE, V83, P439, DOI 10.1016/j.jbspin.2015.07.017; Hewlett S, 2007, ARTHRIT RHEUM-ARTHR, V57, P429, DOI 10.1002/art.22611; Hewlett S, 2011, RHEUMATOLOGY, V50, P1004, DOI 10.1093/rheumatology/keq282; Husted JA, 2009, ANN RHEUM DIS, V68, P1553, DOI 10.1136/ard.2008.098202; Katz P, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0649-5; Liu JT, 2014, WORLD J ORTHOP, V5, P537, DOI 10.5312/wjo.v5.i4.537; Lopez-Medina C, 2016, J RHEUMATOL, V43, P751, DOI 10.3899/jrheum.150832; Loppenthin K, 2015, RHEUMATOL INT, V35, P1655, DOI 10.1007/s00296-015-3274-5; Madsen SG, 2016, SCAND J RHEUMATOL, V45, P255, DOI 10.3109/03009742.2015.1095943; Meincke R., 2017, PATIENTS NUMBERS DAN; Michelsen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123582; Montan I, 2018, VALUE HEALTH, V21, P1313, DOI 10.1016/j.jval.2018.03.013; Nikolaus S, 2013, ARTHRIT CARE RES, V65, P1128, DOI 10.1002/acr.21949; Nordin A, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0167-6; O'Connell K., 2016, WHAT CAUSES FATIGUE; Pedersen OBV, 2008, ANN RHEUM DIS, V67, P1422, DOI 10.1136/ard.2007.082172; PINALS RS, 1981, ARTHRITIS RHEUM, V24, P1308, DOI 10.1002/art.1780241012; Pollard LC, 2006, RHEUMATOLOGY, V45, P885, DOI 10.1093/rheumatology/kel021; Repping-Wuts H, 2009, RHEUMATOLOGY, V48, P207, DOI 10.1093/rheumatology/ken399; Repping-Wuts H, 2007, J CLIN NURS, V16, P377, DOI 10.1111/j.1365-2702.2007.02082.x; Schwarz R, 2003, ONKOLOGIE, V26, P140, DOI 10.1159/000069834; Singh H, 2014, JCR-J CLIN RHEUMATOL, V20, P87, DOI 10.1097/RHU.0000000000000073; SORENSEN K, 1973, DAN MED BULL, V20, P86; Stebbings SM, 2014, CLIN RHEUMATOL, V33, P1467, DOI 10.1007/s10067-013-2445-6; Stolwijk C, 2015, ARTHRITIS CARE RES, V68; The Danish Council for the Use of Expensive Hospital Medicines (RADS), 2016, BAGGR BIOL SYNT TARG; Watt T, 2000, J EPIDEMIOL COMMUN H, V54, P827, DOI 10.1136/jech.54.11.827; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79; WHO, 2016, CHRON RHEUM COND; Wolfe F, 1996, J RHEUMATOL, V23, P1407	45	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218831	10.1371/journal.pone.0218831	http://dx.doi.org/10.1371/journal.pone.0218831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251785	Green Submitted, gold, Green Published			2022-12-26	WOS:000484915000026
J	Saninjuk, K; Romsang, A; Duang-nkern, J; Vattanaviboon, P; Mongkolsuk, S				Saninjuk, Kritsakorn; Romsang, Adisak; Duang-nkern, Jintana; Vattanaviboon, Paiboon; Mongkolsuk, Skorn			Transcriptional regulation of the Pseudomonas aeruginosa iron-sulfur cluster assembly pathway by binding of IscR to multiple sites	PLOS ONE			English	Article							GENE-EXPRESSION; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; OXIDATIVE STRESS; DNA-BINDING; SUF OPERON; BIOGENESIS; PROTEINS; SUSCEPTIBILITY; PATHOGENICITY	Iron-sulfur ([ Fe-S]) cluster proteins have essential functions in many biological processes. [ Fe-S] homeostasis is crucial for bacterial survival under a wide range of environmental conditions. IscR is a global transcriptional regulator in Pseudomonas aeruginosa; it has been shown to regulate genes involved in [ Fe-S] cluster biosynthesis, iron homeostasis, resistance to oxidants, and pathogenicity. Many aspects of the IscR transcriptional regulatory mechanism differ from those of other well-studied systems. This study demonstrates the mechanisms of IscR Type-1 binding to its target sites that mediate the repression of gene expression at the isc operon, nfuA, and tpx. The analysis of IscR binding to multiple binding sites in the promoter region of the isc operon reveals that IscR first binds to the high-affinity site B followed by binding to the low-affinity site A. The results of in vitro IscR binding assays and in vivo analysis of IscR-mediated repression of gene expression support the role of site B as the primary site, while site A has only a minor role in the efficiency of IscR repression of gene expression. Ligation of an [ Fe-S] cluster to IscR is required for the binding of IscR to target sites and in vivo repression and stress-induced gene expression. Analysis of Type-1 sites in many bacteria, including P. aeruginosa, indicates that the first and the last three AT-rich bases were among the most highly conserved bases within all analyzed Type-1 sites. Herein, we first propose the putative sequence of P. aeruginosa IscR Type-1 binding motif as 5' AWWSSYRMNNWWWTNNNWSGGNYWW3'. This can benefit further studies in the identification of novel genes under the IscR regulon and the regulatory mechanism model of P. aeruginosa IscR as it contributes to the roles of an [ Fe-S] cluster in several biologically important cellular activities.	[Saninjuk, Kritsakorn; Romsang, Adisak; Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand; [Romsang, Adisak; Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Ctr Emerging Bacterial Infect, Bangkok, Thailand; [Duang-nkern, Jintana; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Vattanaviboon, Paiboon] Chulabhorn Royal Acad, Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand; [Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Minist Educ, Ctr Excellence Environm Hlth & Toxicol, EHT, Bangkok, Thailand	Mahidol University; Mahidol University; Chulabhorn Research Institute; Chulabhorn Graduate Institute; Chulabhorn Royal Academy	Mongkolsuk, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Mahidol Univ, Fac Sci, Ctr Emerging Bacterial Infect, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Minist Educ, Ctr Excellence Environm Hlth & Toxicol, EHT, Bangkok, Thailand.	skorn@cri.or.th	Romsang, Adisak/H-7142-2014; Saninjuk, Kritsakorn/V-1916-2019; Romsang, Adisak/K-2630-2019	Romsang, Adisak/0000-0002-5339-5443; Saninjuk, Kritsakorn/0000-0002-7511-2985; Romsang, Adisak/0000-0002-5339-5443	Mahidol University; Faculty of Science, Mahidol University; Chulabhorn Research Institute; Royal Golden Jubilee Ph.D. Scholarship from Thailand Research Fund [PHD/0047/2557]	Mahidol University; Faculty of Science, Mahidol University; Chulabhorn Research Institute; Royal Golden Jubilee Ph.D. Scholarship from Thailand Research Fund	This work was supported by grants from the Mahidol University (https://www.mahidol.ac.th) to the Center for Emerging Bacterial Infections (EBI), and the Central Instrument Facility (CIF grant) of the Faculty of Science, Mahidol University (https://science.mahidol.ac.th), and Chulabhorn Research Institute (http://www.cri.or.th/en/index.php). K.S. was supported by the Royal Golden Jubilee Ph.D. Scholarship (PHD/0047/2557) from Thailand Research Fund (http://rgj.trf.or.th/eng/rgje11.asp) with S. M. as K. S.' s mentor. A. R. was supported by the grant from Mahidol University (https://www.mahidol.ac.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Parts of this work are from K. S. dissertation submitted for a Ph.D. degree from Mahidol University.	Andre G, 2017, RES MICROBIOL, V168, P345, DOI 10.1016/j.resmic.2016.03.002; Boonma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172071; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Crack JC, 2014, BIOCHEM J, V463, P83, DOI 10.1042/BJ20140169; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daung-nkern J, 2010, J ANTIMICROB CHEMOTH, V65, P1831, DOI 10.1093/jac/dkq194; de Bruijn F. J, 2016, STRESS ENV REGULATIO, P1090; Dokpikul T, 2016, APPL ENVIRON MICROB, V82, P4732, DOI 10.1128/AEM.01262-16; Fuangthong M, 2015, MICROBIOL RES, V170, P139, DOI 10.1016/j.micres.2014.08.004; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; Kimura S, 2015, BBA-MOL CELL RES, V1853, P1272, DOI 10.1016/j.bbamcr.2014.12.010; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Lin CN, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-84; Lin TH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01984; Lushchak OV, 2014, REDOX REP, V19, P8, DOI 10.1179/1351000213Y.0000000073; Miller HK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004194; Nesbit AD, 2012, J BACTERIOL, V194, P6892, DOI 10.1128/JB.01757-12; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Outten FW, 2015, BBA-MOL CELL RES, V1853, P1464, DOI 10.1016/j.bbamcr.2014.11.001; Panmanee W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189066; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Quenee L, 2005, BIOTECHNIQUES, V38, P63, DOI 10.2144/05381ST01; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Rincon-Enriquez G, 2008, MOL MICROBIOL, V67, P1257, DOI 10.1111/j.1365-2958.2008.06118.x; Roche B, 2013, BBA-BIOENERGETICS, V1827, P923, DOI 10.1016/j.bbabio.2013.05.001; Romsang A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202151; Romsang A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30368-y; Romsang A, 2015, INT J ANTIMICROB AG, V45, P314, DOI 10.1016/j.ijantimicag.2014.10.024; Romsang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086763; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; Sambrook J., 2001, MOL CLONING LAB MANU; Santos JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1101, DOI 10.1016/j.bbapap.2015.01.010; Santos JA, 2014, P NATL ACAD SCI USA, V111, pE2251, DOI 10.1073/pnas.1322728111; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; Tanaka N, 2016, MOL MICROBIOL, V99, P835, DOI 10.1111/mmi.13271; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wongsaroj L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205815; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x	45	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218385	10.1371/journal.pone.0218385	http://dx.doi.org/10.1371/journal.pone.0218385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251744	gold, Green Published, Green Submitted			2022-12-26	WOS:000484915000010
J	Christensen, LM; Sule, P; Strain, M; Cirillo, JD				Christensen, Lanette M.; Sule, Preeti; Strain, Madison; Cirillo, Jeffrey D.			Legionella pneumophila p45 element influences host cell entry and sensitivity to sodium	PLOS ONE			English	Article							IV SECRETION SYSTEM; INTRACELLULAR GROWTH; LEGIONNAIRES-DISEASE; VIRULENCE SYSTEM; POTABLE WATER; IDENTIFICATION; GENE; MECHANISMS; SEQUENCE; STRAINS	Legionella pneumophila are environmental bacteria found ubiquitously in both natural and man-made water reservoirs, sometimes as constituents of biofilm communities, but mostly intracellularly within protozoal hosts. In the event that Legionella become aerosolized in water droplets and inhaled by humans, they can cause a potentially fatal form of pneumonia called Legionnaires' disease. Strains of L. pneumophila have highly plastic genomes that harbor numerous inter- and intra-genomic elements, enhancing their ability to live under diverse environmental conditions. One such mobile genomic element, p45 carries similar to 45 kbp of genes, including the Lvh (Legionella Vir homolog) type IVa secretion system. This element was evaluated for its contribution to L. pneumophila environmental resilience and virulence-related characteristics by comparing clinically isolated strain Philadelphia-1 that carries p45, Lp01 that lacks p45, and Lp01 with p45 reintroduced, Lp01(+p45). We found that the p45 element impacts host cell entry and resistance to sodium, both virulence-related characteristics in Legionella species.	[Christensen, Lanette M.; Sule, Preeti; Strain, Madison; Cirillo, Jeffrey D.] Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, Coll Med, Hlth Sci Ctr, Bryan, TX 77807 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Cirillo, JD (corresponding author), Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, Coll Med, Hlth Sci Ctr, Bryan, TX 77807 USA.	jdcirillo@tamu.edu	Cirillo, Jeffrey/L-4286-2019	Cirillo, Jeffrey/0000-0003-3058-2702	National Institutes of Health [AI40165]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (https://www.nih.gov/) grant AI40165 to JDC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ralph Isberg and Michele Swanson for providing bacterial strains. We recognize the technical and theoretical contributions made to this project by the late Suat L.G. Cirillo. This work was supported by National Institutes of Health grant AI40165.	Abbott ZD, 2015, MBIO, V6, DOI 10.1128/mBio.00595-15; Andrews HL, 1998, INFECT IMMUN, V66, P950, DOI 10.1128/IAI.66.3.950-958.1998; ARNOW PM, 1982, J INFECT DIS, V146, P460, DOI 10.1093/infdis/146.4.460; Bachman MA, 2001, MOL MICROBIOL, V40, P1201, DOI 10.1046/j.1365-2958.2001.02465.x; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bozue JA, 1996, INFECT IMMUN, V64, P668, DOI 10.1128/IAI.64.2.668-673.1996; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Christensen LM, 2019, J INFECT DIS; Cirillo JD, 1999, TRENDS MICROBIOL, V7, P96, DOI 10.1016/S0966-842X(99)01456-0; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; CIRILLO JD, 1994, INFECT IMMUN, V62, P3254, DOI 10.1128/IAI.62.8.3254-3261.1994; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; Cirillo SLG, 2002, MICROBIOL-SGM, V148, P1667, DOI 10.1099/00221287-148-6-1667; Cirillo SLG, 2001, INFECT IMMUN, V69, P508, DOI 10.1128/IAI.69.1.508-517.2001; Doleans A, 2004, J CLIN MICROBIOL, V42, P458, DOI 10.1128/JCM.42.1.458-460.2004; Doleans-Jordheim A, 2006, MICROBIOL-SGM, V152, P3561, DOI 10.1099/mic.0.29227-0; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; HENKE M, 1986, ISRAEL J MED SCI, V22, P690; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; HSU SC, 1984, APPL ENVIRON MICROB, V48, P830, DOI 10.1128/AEM.48.4.830-832.1984; Jayakumar D, 2012, INFECT IMMUN, V80, P4143, DOI 10.1128/IAI.00598-12; Ji P, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0406-7; Juhas M, 2007, J BACTERIOL, V189, P761, DOI 10.1128/JB.01327-06; Kozak-Muiznieks NA, 2018, INFECT GENET EVOL, V59, P172, DOI 10.1016/j.meegid.2018.02.008; Lautner M, 2013, J BACTERIOL, V195, P1583, DOI 10.1128/JB.01739-12; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; MEENHORST PL, 1985, J INFECT DIS, V152, P356, DOI 10.1093/infdis/152.2.356; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Qin T, 2014, APPL ENVIRON MICROB, V80, P2150, DOI 10.1128/AEM.03844-13; Rao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064129; Ridenour DA, 2003, INFECT IMMUN, V71, P6256, DOI 10.1128/IAI.71.11.6256-6263.2003; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Samrakandi MM, 2002, J CLIN MICROBIOL, V40, P1352, DOI 10.1128/JCM.40.4.1352-1362.2002; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; SHANDS KN, 1985, JAMA-J AM MED ASSOC, V253, P1412, DOI 10.1001/jama.253.10.1412; Vogel JP, 1996, ANN NY ACAD SCI, V797, P271, DOI 10.1111/j.1749-6632.1996.tb52975.x; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Wee BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082221; WIATER LA, 1994, MOL MICROBIOL, V11, P641; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087	49	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218941	10.1371/journal.pone.0218941	http://dx.doi.org/10.1371/journal.pone.0218941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246988	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900054
J	Crespo-Piazuelo, D; Criado-Mesas, L; Revilla, M; Castello, A; Fernandez, AI; Folch, JM; Ballester, M				Crespo-Piazuelo, Daniel; Criado-Mesas, Lourdes; Revilla, Manuel; Castello, Anna; Fernandez, Ana I.; Folch, Josep M.; Ballester, Maria			Indel detection from Whole Genome Sequencing data and association with lipid metabolism in pigs	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; MEAT QUALITY; LONGISSIMUS-DORSI; PROTEIN-12 CTRP12; SKELETAL-MUSCLE; INSERTION; DELETION; PATTERNS; OBESITY; DIVERGENCE	The selection in commercial swine breeds for meat-production efficiency has been increasing among the past decades, reducing the intramuscular fat content, which has changed the sensorial and technological properties of pork. Through processes of natural adaptation and selective breeding, the accumulation of mutations has driven the genetic divergence between pig breeds. The most common and well-studied mutations are single-nucleotide polymorphisms (SNPs). However, insertions and deletions (indels) usually represents a fifth part of the detected mutations and should also be considered for animal breeding. In the present study, three different programs (Dindel, SAMtools mpileup, and GATK) were used to detect indels from Whole Genome Sequencing data of Iberian boars and Landrace sows. A total of 1,928,746 indels were found in common with the three programs. The VEP tool predicted that 1,289 indels may have a high impact on protein sequence and function. Ten indels inside genes related with lipid metabolism were genotyped in pigs from three different backcrosses with Iberian origin, obtaining different allelic frequencies on each backcross. Genome-Wide Association Studies performed in the Longissimus dorsi muscle found an association between an indel located in the C1q and TNF related 12 (C1QTNF12) gene and the amount of eicosadienoic acid (C20:2(n-6)).	[Crespo-Piazuelo, Daniel; Criado-Mesas, Lourdes; Revilla, Manuel; Castello, Anna; Folch, Josep M.] CSIC IRTA UAB UB Consortium, Plant & Anim Genom, CRAG, Bellaterra, Spain; [Crespo-Piazuelo, Daniel; Revilla, Manuel; Castello, Anna; Folch, Josep M.] UAB, Dept Ciencia Anim & Dels Aliments, Fac Vet, Bellaterra, Spain; [Fernandez, Ana I.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain; [Ballester, Maria] IRTA, Dept Genet & Millora Anim, Caldes De Montbui, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Autonomous University of Barcelona; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); IRTA	Crespo-Piazuelo, D (corresponding author), CSIC IRTA UAB UB Consortium, Plant & Anim Genom, CRAG, Bellaterra, Spain.; Crespo-Piazuelo, D (corresponding author), UAB, Dept Ciencia Anim & Dels Aliments, Fac Vet, Bellaterra, Spain.	daniel.crespo@cragenomica.es	Fernández, Ana Isabel/J-3265-2012; Crespo-Piazuelo, Daniel/K-2280-2015; Revilla, Manuel/U-9033-2018; Farré, Anna Castelló/K-9637-2015; Ballester, Maria/E-7201-2016; Folch, Josep M/I-4738-2015	Fernández, Ana Isabel/0000-0002-1509-5191; Crespo-Piazuelo, Daniel/0000-0001-7896-2507; Revilla, Manuel/0000-0002-0164-9317; Farré, Anna Castelló/0000-0001-8497-6251; Ballester, Maria/0000-0002-5413-4640; Folch, Josep M/0000-0003-3689-1303	Ministerio de Economia y Competitividad (MINECO); Fondo Europeo de Desarrollo Regional (FEDER) [AGL2014-56369-C2-2-R, AGL2017-82641-R]; "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya [ECO/1788/2014]; FPI [AGL2014-56369-C2]; FI-DGR [ECO/1639/2013]; Spanish Ministry of Economy and Competitiveness [RYC-2013-12573]; Spanish Ministry of Economy and Competitiveness for the "Severo Ochoa Programme for Centres of Excellence in RD" 2016-2019 [SEV-2015-0533]; CERCA Programme/Generalitat de Catalunya	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya; FPI(Spanish Government); FI-DGR; Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness for the "Severo Ochoa Programme for Centres of Excellence in RD" 2016-2019; CERCA Programme/Generalitat de Catalunya	This work was funded by the Ministerio de Economia y Competitividad (MINECO) and the Fondo Europeo de Desarrollo Regional (FEDER) projects AGL2014-56369-C2-2-R and AGL2017-82641-R. DCP was funded by a "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya (ECO/1788/2014). LCM was funded with a FPI grant from the AGL2014-56369-C2 project. MR was also funded by a FI-DGR (ECO/1639/2013). MB was financially supported by a "Ramon y Cajal" contract (RYC-2013-12573) from the Spanish Ministry of Economy and Competitiveness. We acknowledge the support of the Spanish Ministry of Economy and Competitiveness for the "Severo Ochoa Programme for Centres of Excellence in R&D" 2016-2019 (SEV-2015-0533) grant awarded to the Centre for Research in Agricultural Genomics and the CERCA Programme/Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Andrews S., 2010, FASTQC QUALITY CONTR; Anzai T, 2003, P NATL ACAD SCI USA, V100, P7708, DOI 10.1073/pnas.1230533100; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; CAMERON ND, 1991, MEAT SCI, V29, P295, DOI 10.1016/0309-1740(91)90009-F; CAMERON ND, 1990, LIVEST PROD SCI, V26, P119, DOI 10.1016/0301-6226(90)90061-A; Casellas J, 2010, J ANIM SCI, V88, P2246, DOI 10.2527/jas.2009-2205; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chen L, 2014, J GENET GENOMICS, V41, P653, DOI 10.1016/j.jgg.2014.10.001; Chen Z, 2014, P NATL ACAD SCI USA, V111, P7367, DOI 10.1073/pnas.1406511111; Cheverud JM, 2010, J LIPID RES, V51, P907, DOI 10.1194/jlr.M900128; Chico Y, 2000, BBA-MOL BASIS DIS, V1502, P380, DOI 10.1016/S0925-4439(00)00062-4; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dawson E, 2001, GENOME RES, V11, P170, DOI 10.1101/gr.156901; DEJONG WW, 1981, NATURE, V290, P157, DOI 10.1038/290157a0; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Estevez M, 2003, MEAT SCI, V64, P499, DOI 10.1016/S0309-1740(02)00228-0; Fan YH, 2007, CURR GENOMICS, V8, P370, DOI 10.2174/138920207783406479; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; Gealekman O, 2014, J BIOL CHEM, V289, P18327, DOI 10.1074/jbc.M113.545798; Hellmann J, 2016, DIABETES, V65, P2268, DOI 10.2337/db15-1689; Huang TY, 2017, AM J PHYSIOL-ENDOC M; Kang HM, 2015, GENOMICS, V106, P286, DOI 10.1016/j.ygeno.2015.08.002; KARLSSON A, 1993, J ANIM SCI, V71, P930, DOI 10.2527/1993.714930x; Lagarde M, 2013, MOL NUTR FOOD RES, V57, P1347, DOI 10.1002/mnfr.201200828; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindholm-Perry AK, 2017, ANIM GENET; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Michas G, 2014, ATHEROSCLEROSIS, V234, P320, DOI 10.1016/j.atherosclerosis.2014.03.013; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Molnar J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-761; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Neuman JA, 2013, BRIEF BIOINFORM, V14, P46, DOI 10.1093/bib/bbs013; Ntawubizi M, 2010, J ANIM SCI, V88, P1286, DOI 10.2527/jas.2009-2355; Ophir R, 1997, GENE, V205, P191, DOI 10.1016/S0378-1119(97)00398-3; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ren ZQ, 2012, MOL BIOL REP, V39, P1419, DOI 10.1007/s11033-011-0876-1; Revilla M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177014; Saini RK, 2018, LIFE SCI, V203, P255, DOI 10.1016/j.lfs.2018.04.049; Sambrook J, 1989, MOL CLONING LAB MANU, pE3; Sano T, 2015, OBESITY, V23, P1460, DOI 10.1002/oby.21127; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Serra X, 1998, LIVEST PROD SCI, V56, P215, DOI 10.1016/S0301-6226(98)00151-1; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Walder K, 2002, INT J OBESITY, V26, P442, DOI 10.1038/sj.ijo.0801946; Wang Z, 2017, ANIM GENET, V48, P38, DOI 10.1111/age.12465; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Wei ZK, 2012, J BIOL CHEM, V287, P35804, DOI 10.1074/jbc.M112.365965; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wood JD, 1999, P NUTR SOC, V58, P363, DOI 10.1017/S0029665199000488; Zang L, 2016, GENE, V576, P729, DOI 10.1016/j.gene.2015.09.047; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	64	2	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218862	10.1371/journal.pone.0218862	http://dx.doi.org/10.1371/journal.pone.0218862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246983	gold, Green Published, Green Submitted			2022-12-26	WOS:000484911900045
J	Oppermann, H; Faust, H; Yamanishi, U; Meixensberger, J; Gaunitz, F				Oppermann, Henry; Faust, Helene; Yamanishi, Ulrike; Meixensberger, Juergen; Gaunitz, Frank			Carnosine inhibits glioblastoma growth independent from PI3K/Akt/mTOR signaling	PLOS ONE			English	Article							CELL-GROWTH; PROLIFERATION; METABOLISM; INDUCTION; THERAPY	Glioblastoma is a high-grade glioma with poor prognosis even after surgery and standard therapy. Here, we asked whether carnosine (beta-alanyl-L-histidine), a naturally occurring dipeptide, exert its anti-neoplastic effect on glioblastoma cells via PI3K/Akt/mTOR signaling. Therefore, glioblastoma cells from the lines U87 and T98G were exposed to carnosine, to the mTOR inhibitor rapamycin and to the PI3K inhibitor Ly-294,002. Pyruvate dehydrogenase kinase (PDK4) expression, known to be a target of PI3K/Akt/mTOR, and which is also affected by carnosine, was analyzed by RT-qPCR, and reporter gene assays with the human PDK4 promoter were performed. Cell viability was assessed by cell-based assays and mTOR and Akt phosphorylation by Western blotting. Rapamycin and Ly-294,002 increased PDK4 mRNA expression in both cell lines but significance was only reached in U87. Carnosine significantly increased expression in both lines. A significant combinatorial effect of carnosine was only detected in U87 when the dipeptide was combined with Ly294,002. Reporter gene assays revealed no specific effect of carnosine on the human PDK4 promoter, whereas both inhibitors increased reporter gene expression. Rapamycin reduced phosphorylation of mTOR, and Ly-294,002 that of Akt. A significant reduction of Akt phosphorylation was observed in the presence of carnosine in U87 but not in T98G, and carnosine had no effect on mTOR phosphorylation. Cell viability as determined by ATP in cell lysates was reduced only in the presence of carnosine. We conclude that carnosine's anti-neoplastic effect is independent from PI3K/Akt/mTOR signaling. As the dipeptide reduced viability in tumor cells that do not respond to PI3K or mTOR inhibitors, it appears to be worth to further investigate the mechanisms by which carnosine exerts its anti-tumor effect and to consider it for therapy, especially as it is a naturally occurring compound that has already been used for the treatment of other diseases without indication of side-effects.	[Oppermann, Henry; Faust, Helene; Yamanishi, Ulrike; Meixensberger, Juergen; Gaunitz, Frank] Univ Klinikum Leipzig AoR, Klin & Poliklin Neurochirurg, Leipzig, Germany	Leipzig University	Gaunitz, F (corresponding author), Univ Klinikum Leipzig AoR, Klin & Poliklin Neurochirurg, Leipzig, Germany.	Frank.Gaunitz@medizin.uni-leipzig.de	Gaunitz, Frank/A-2641-2008	Oppermann, Henry/0000-0001-9216-5918; Gaunitz, Frank/0000-0001-6628-0605	German Research Foundation (DFG); Leipzig University	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	This work was supported from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; Baraniuk James Nicholas, 2013, Glob J Health Sci, V5, P69, DOI 10.5539/gjhs.v5n3p69; Boldyrev A, 2008, REJUV RES, V11, P821, DOI 10.1089/rej.2008.0716; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Braun S, 2012, CANCER BIOL THER, V13, P487, DOI 10.4161/cbt.19591; Bush NAO, 2017, NEUROSURG REV, V40, P1, DOI 10.1007/s10143-016-0709-8; Chez MG, 2002, J CHILD NEUROL, V17, P833, DOI 10.1177/08830738020170111501; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Devyatov A. A., 2018, Biomeditsinskaya Khimiya, V64, P344, DOI 10.18097/PBMC20186404344; Ditte Z, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-358; Gaunitz F, 2003, ASSAY DRUG DEV TECHN, V1, P469, DOI 10.1089/154065803322163786; Gulewitsch W, 1900, BER DTSCH CHEM GES, V33, P1902, DOI 10.1002/cber.19000330275; Hipkiss AR, 2011, MOL ASPECTS MED, V32, P267, DOI 10.1016/j.mam.2011.10.004; Horii Y, 2012, NEUROSCI LETT, V510, P1, DOI 10.1016/j.neulet.2011.12.058; Iovine B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096755; Iovine B, 2012, CANCER LETT, V315, P122, DOI 10.1016/j.canlet.2011.07.021; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Kulebyakin K, 2012, AMINO ACIDS, V43, P91, DOI 10.1007/s00726-011-1135-4; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Letzien U, 2014, AMINO ACIDS, V46, P1009, DOI 10.1007/s00726-014-1664-8; Li XM, 2016, ONCOTARGET, V7, P33440, DOI [10.18632/oncotarget.7961, 10.18632/oncotarget.6497]; MANNION AF, 1992, EUR J APPL PHYSIOL O, V64, P47, DOI 10.1007/BF00376439; Metallo CM, 2010, GENE DEV, V24, P2717, DOI 10.1101/gad.2010510; Nakamura JL, 2005, J NEURO-ONCOL, V71, P215, DOI 10.1007/s11060-004-1718-y; Nan Y, 2017, J CANCER RES CLIN, V143, P1477, DOI 10.1007/s00432-017-2415-5; Oppermann H, 2019, AMINO ACIDS, V51, P761, DOI 10.1007/s00726-019-02713-6; Oppermann H, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0611-2; Oppermann H, 2019, AMINO ACIDS, V51, P61, DOI 10.1007/s00726-018-2619-2; Oppermann H, 2016, ONCOTARGET, V7, P85848, DOI 10.18632/oncotarget.13039; Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P1, DOI 10.1093/neuonc/noy131; Renner C, 2008, INT J PEPT RES THER, V14, P127, DOI 10.1007/s10989-007-9121-0; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2; Shen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104632; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vanderson DB, 2014, FREE RADICAL BIO MED, V75, pS27, DOI 10.1016/j.freeradbiomed.2014.10.751; Wang JP, 2013, BRAIN RES, V1507, P125, DOI 10.1016/j.brainres.2013.02.032; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yudushkin I, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020067; Zhang ZW, 2014, J CANCER, V5, P382, DOI 10.7150/jca.8024; Zhao HF, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0670-3	40	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218972	10.1371/journal.pone.0218972	http://dx.doi.org/10.1371/journal.pone.0218972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247000	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900059
J	Rehan, M				Rehan, Mohd			Anticancer compound XL765 as PI3K/mTOR dual inhibitor: A structural insight into the inhibitory mechanism using computational approaches	PLOS ONE			English	Article							PIK3CA GENE; PI3K PATHWAY; PHOSPHOINOSITIDE 3-KINASES; MOLECULAR DOCKING; SCORING FUNCTIONS; MTOR INHIBITORS; HIGH-FREQUENCY; CANCER; GROWTH; RAPAMYCIN	The PI3K-AKT-mTOR pathway is often a commonly disrupted pathway in human cancer and, therefore, it is widely exploited for cancer therapy. The inhibitors for the important proteins of the pathway including PI3K and mTOR have been increasingly designed. The dual inhibitors targeting PI3K and mTOR both have proven to be more effective than those targeting single protein only. An orally-active compound XL765 is well established as PI3K/mTOR dual inhibitor and have shown in vitro and in vivo anticancer activity against a variety of cancer types and is undergoing clinical trials. The present study explored the exact binding pose and the the interactive forces holding XL765 within the active sites of PI3K. and mTOR using molecular docking analyses. The XL765 interacting residues of both the proteins were delineated and the degree of participation in binding was estimated by various methods. In the process, among the interacting residues of PI3K., the Lys-890 and the Met-953 were recognized as the key residues involved in XL765 binding. While, in mTOR case, the Trp-2239 was recognized as the key residue playing role in the XL765 binding. In order to explore the better inhibitors, the study also generated combinatorial chemical library by modifying the scaffold considered from XL765. The virtual screening of the generated compound library led to identification of six novel promising compounds proposed as PI3K/mTOR dual inhibitors. Thus, the present work will through light on the drug inhibitory mechanism of XL765 for PI3K and mTOR, and will also assist in designing novel efficacious drug candidates.	[Rehan, Mohd] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Rehan, Mohd] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rehan, M (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.; Rehan, M (corresponding author), King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia.	mrehan786@gmail.com	Rehan, Mohd/H-9835-2012	Rehan, Mohd/0000-0003-4898-6043	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [D-91-141-1437]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (D-91-1411437). The author, therefore, acknowledges with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (D-91-141-1437). The author, therefore, gratefully acknowledges the DSR technical and financial support.	Agarwal R, 2010, CURR OPIN INVEST DR, V11, P615; Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cheng HM, 2013, ACS MED CHEM LETT, V4, P91, DOI 10.1021/ml300309h; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dai CX, 2013, ENDOCRINOLOGY, V154, P1247, DOI 10.1210/en.2012-1908; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Ghadimi MP, 2012, MOL CANCER THER, V11, P1758, DOI 10.1158/1535-7163.MCT-12-0015; Ghosh KS, 2009, BIOPOLYMERS, V91, P737, DOI 10.1002/bip.21220; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hubbard S. J., 1993, TECHNICAL REPORT; Jamal MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087309; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Laird AD, 2007, AACR M ABSTR, V2007, P8250; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Li DD, 2018, J MOL GRAPH MODEL, V79, P81, DOI 10.1016/j.jmgm.2017.11.003; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu YN, 2013, MINI-REV MED CHEM, V13, P2047, DOI 10.2174/13895575113136660105; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; LoRusso P, 2009, J CLIN ONCOL, V27, p15s; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Molckovsky A, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-20; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philp AJ, 2001, CANCER RES, V61, P7426; Pires DEV, 2015, J MED CHEM, V58, P4066, DOI 10.1021/acs.jmedchem.5b00104; Prasad G, 2011, NEURO-ONCOLOGY, V13, P384, DOI 10.1093/neuonc/noq193; Rehan M, 2019, J CELL BIOCHEM, V120, P1328, DOI 10.1002/jcb.27100; Rehan M, 2017, J CELL BIOCHEM, V118, P4558, DOI 10.1002/jcb.26117; Rehan M, 2015, J MOL GRAPH MODEL, V62, P226, DOI 10.1016/j.jmgm.2015.10.005; Rehan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109705; Sabbah DA, 2010, J CHEM INF MODEL, V50, P1887, DOI 10.1021/ci1002679; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Stewart W., 2014, WORLD CANC REPORT 20; Tanneeru K, 2012, J MOL MODEL, V18, P1611, DOI 10.1007/s00894-011-1184-3; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zhang YJ, 2011, DRUG DISCOV TODAY, V16, P325, DOI 10.1016/j.drudis.2011.02.008; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	65	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219180	10.1371/journal.pone.0219180	http://dx.doi.org/10.1371/journal.pone.0219180			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247018	gold, Green Published, Green Submitted			2022-12-26	WOS:000484911900084
J	Damanka, SA; Agbemabiese, CA; Dennis, FE; Lartey, BL; Adiku, TK; Enweronu-Laryea, CC; Armah, GE				Damanka, Susan Afua; Agbemabiese, Chantal Ama; Dennis, Francis Ekow; Lartey, Belinda Larteley; Adiku, Theophilus Korku; Enweronu-Laryea, Christabel Chika; Armah, George Enyimah			Genetic analysis of Ghanaian G1P[8] and G9P[8] rotavirus A strains reveals the impact of P[8] VP4 gene polymorphism on P-genotyping	PLOS ONE			English	Article							VIRUS VARIATION RESOURCE; MOLECULAR EPIDEMIOLOGY; CHILDREN; DIVERSITY; EMERGENCE; DIARRHEA; G9; CONSTELLATIONS; IDENTIFICATION; REPLACEMENT	The World Health Organisation rotavirus surveillance networks have documented and shown eclectic geographic and temporal diversity in circulating G- and P-genotypes identified in children <5 years of age. To effectively monitor vaccine performance and effectiveness, robust molecular and phylogenetic techniques are essential to detect novel strain variants that might emerge due to vaccine pressure. This study inferred the phylogenetic history of the VP7 and VP4 genes of previously non-typeable strains and provided insight into the diversity of P[8] VP4 sequences which impacted the outcome of our routine VP4 genotyping method. Near-full-length VP7 gene and the VP8* fragment of the VP4 gene were obtained by Sanger sequencing and genotypes were determined using RotaC v2.0 web-based genotyping tool. The genotypes of the 57 rotavirus-positive samples with sufficient stool was determined. Forty-eight of the 57 (84.2%) had the P[8] specificity, of which 43 (89.6%) were characterized as P[8] a subtype and 5 (10.4%) as the rare OP354-like subtype. The VP7 gene of 27 samples were successfully sequenced and their G- genotypes confirmed as G1 (18/27) and G9 (9/27). Phylogenetic analysis of the P[8] a sequences placed them in subcluster IIIc within lineage III together with contemporary G1P[8], G3P[8], G8P[8], and G9P[8] strains detected globally from 2006-2016. The G1 VP7 sequences of the study strains formed a monophyletic cluster with African G1P[8] strains, previously detected in Ghana and Mali during the RotaTeq vaccine trial as well as Togo. The G9 VP7 sequences of the study strains formed a monophyletic cluster with contemporary African G9 sequences from neighbouring Burkina Faso within the major sub-cluster of lineage III. Mutations identified in the primer binding region of the VP8* sequence of the Ghanaian P[8] a strains may have resulted in the genotyping failure since the newly designed primer successfully genotyped the previously non-typeable P[8] strains. In summary, the G1, G9, and P[8] a sequences were highly similar to contemporary African strains at the lineage level. The study also resolved the methodological challenges of the standard genotyping techniques and highlighted the need for regular evaluation of the multiplex PCR-typing method especially in the post-vaccination era. The study further highlights the need for regions to start using sequencing data from local rotavirus strains to design and update genotyping primers.	[Damanka, Susan Afua; Agbemabiese, Chantal Ama; Dennis, Francis Ekow; Lartey, Belinda Larteley; Armah, George Enyimah] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Accra, Ghana; [Adiku, Theophilus Korku] Univ Hlth & Allied Sci, Sch Basic & Biomed Sci, Ho, Ghana; [Enweronu-Laryea, Christabel Chika] Univ Ghana, Coll Hlth Sci, Korle Bu Teaching Hosp, Dept Child Hlth, Accra, Ghana	University of Ghana; University of Ghana	Damanka, SA (corresponding author), Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Accra, Ghana.	sdamanka@noguchi.ug.edu.gh		Enweronu-Laryea, Christabel/0000-0001-9346-5365; Agbemabiese, Chantal/0000-0003-1862-9408				Afrad MH, 2014, INFECT GENET EVOL, V28, P214, DOI 10.1016/j.meegid.2014.10.002; Arista S, 2006, J VIROL, V80, P10724, DOI 10.1128/JVI.00340-06; Armah GE, 2001, J MED VIROL, V63, P67, DOI 10.1002/1096-9071(200101)63:1&lt;67::AID-JMV1010&gt;3.0.CO;2-T; Armah GE, 2003, J CLIN MICROBIOL, V41, P2317, DOI 10.1128/JCM.41.6.2317-2322.2003; Asmah RH, 2001, J CLIN MICROBIOL, V39, P1981, DOI 10.1128/JCM.39.5.1981-1984.2001; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Binka E, 2012, PAEDIAT INFECT DIS J, V30, P718; Binka FN, 2003, TROP MED INT HEALTH, V8, P840, DOI 10.1046/j.1365-3156.2003.01097.x; Brister JR, 2014, NUCLEIC ACIDS RES, V42, pD660, DOI 10.1093/nar/gkt1268; Castello AA, 2006, J CLIN MICROBIOL, V44, P2046, DOI 10.1128/JCM.02436-05; Cunliffe NA, 2001, J CLIN MICROBIOL, V39, P836, DOI 10.1128/JCM.39.3.836-843.2001; Damanka S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0643-y; Damanka S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0523-5; Das S, 2003, J CLIN MICROBIOL, V41, P2760, DOI 10.1128/JCM.41.6.2760-2762.2003; Delogu R, 2015, J MED VIROL, V87, P1292, DOI 10.1002/jmv.24180; Do LP, 2016, ARCH VIROL, V161, P833, DOI 10.1007/s00705-015-2706-6; Doan YH, 2015, INFECT GENET EVOL, V34, P423, DOI 10.1016/j.meegid.2015.05.026; Enweronu-Laryea CC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-287; Enweronu-Laryea CC, 2012, J INFECT DEV COUNTR, V6, P148, DOI 10.3855/jidc.1667; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065; Heylen E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14658; Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P898; KOBAYASHI N, 1989, ARCH VIROL, V109, P11, DOI 10.1007/BF01310514; Lartey Belinda L, 2018, Vaccine, V36, P7238, DOI 10.1016/j.vaccine.2018.01.010; Luchs A, 2016, ACTA TROP, V156, P87, DOI 10.1016/j.actatropica.2015.12.008; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Mayindou G, 2016, J MED VIROL, V88, P596, DOI 10.1002/jmv.24382; Mijatovic-Rustempasic S, 2014, INFECT GENET EVOL, V21, P214, DOI 10.1016/j.meegid.2013.11.004; Nagashima S, 2009, ARCH VIROL, V154, P1223, DOI 10.1007/s00705-009-0436-3; Nakagomi T, 2017, ARCH VIROL, V162, P213, DOI 10.1007/s00705-016-3103-5; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Pietsch C, 2009, EMERG INFECT DIS, V15, P1512, DOI 10.3201/eid1509.090497; Pun SB, 2007, EMERG INFECT DIS, V13, P482, DOI 10.3201/eid1303.061367; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Roczo-Farkas S, 2018, J INFECT DIS, V218, P546, DOI 10.1093/infdis/jiy197; Sai LT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-302; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Silva PA, 2008, J MED VIROL, V80, P1790, DOI 10.1002/jmv.21231; Simmonds MK, 2008, J CLIN VIROL, V42, P368, DOI 10.1016/j.jcv.2008.02.011; STEELE AD, 1987, J CLIN MICROBIOL, V25, P2384, DOI 10.1128/JCM.25.12.2384-2387.1987; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Troeger C, 2018, JAMA PEDIATR, V172, P958, DOI 10.1001/jamapediatrics.2018.1960	48	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218790	10.1371/journal.pone.0218790	http://dx.doi.org/10.1371/journal.pone.0218790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242245	Green Submitted, gold, Green Published			2022-12-26	WOS:000482883600055
J	Fontana, M; Tavoni, M; Vantini, S				Fontana, Matteo; Tavoni, Massimo; Vantini, Simone			Functional Data Analysis of high-frequency load curves reveals drivers of residential electricity consumption	PLOS ONE			English	Article							BIG DATA; ENERGY; FEEDBACK; DEMAND; DETERMINANTS; PROVIDE; MODELS	Smart energy meters generate real time, high frequency data which can foster demand management and response of consumers and firms, with potential private and social benefits. However, proper statistical techniques are needed to make sense of this large amount of data and translate them into usable recommendations. Here, we apply Functional Data Analysis (FDA), a novel branch of Statistics that analyses functions-to identify drivers of residential electricity load curves. We evaluate a real time feedback intervention which involved about 1000 Italian households for a period of three years. Results of the FDA modelling reveal, for the first time, daytime-indexed patterns of residential electricity consumption which depend on the ownership of specific clusters of electrical appliances and an overall reduction of consumption after the introduction of real time feedback, unrelated to appliance ownership characteristics.	[Fontana, Matteo; Tavoni, Massimo] Politecn Milan, Dept Management Econ & Ind Engn, Milan, Italy; [Vantini, Simone] Politecn Milan, MOX Dept Math, Milan, Italy; [Tavoni, Massimo] RFF CMCC European Inst Econ & Environm, Milan, Italy	Polytechnic University of Milan; Polytechnic University of Milan	Fontana, M (corresponding author), Politecn Milan, Dept Management Econ & Ind Engn, Milan, Italy.	matteo.fontana@polimi.it			European Research Council, ERC [336155]	European Research Council, ERC(European Research Council (ERC))	Matteo Fontana and Massimo Tavoni acknowledge financial support from the European Research Council, ERC grant agreement no 336155 - project COBHAM "The role of consumer behaviour and heterogeneity in the integrated assessment of energy and climate policies." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Abramowicz K, 2018, SCAND J STAT, V45, P1036, DOI 10.1111/sjos.12333; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Antoch J, 2008, CONTRIB STAT, P23, DOI 10.1007/978-3-7908-2062-1_4; Armel KC, 2013, ENERG POLICY, V52, P213, DOI 10.1016/j.enpol.2012.08.062; Attari SZ, 2014, DOES INFORM FEEDBACK; Ayres I., 2012, J LAW ECON ORGAN; Bradley P, 2016, ENERG POLICY, V98, P108, DOI 10.1016/j.enpol.2016.07.022; Canale A, 2016, INT J FORECASTING, V32, P1340, DOI 10.1016/j.ijforecast.2016.05.002; Costa DL, 2013, J EUR ECON ASSOC, V11, P680, DOI 10.1111/jeea.12011; Cuevas A, 2014, J STAT PLAN INFER, V147, P1, DOI 10.1016/j.jspi.2013.04.002; Darby S, 2006, REV DEFRA LIT METERI; Darby SJ, 2012, ENERG POLICY, V49, P759, DOI 10.1016/j.enpol.2012.07.026; Delmas MA, 2014, J ENVIRON ECON MANAG, V67, P353, DOI 10.1016/j.jeem.2013.12.009; Delmas MA, 2013, ENERG POLICY, V61, P729, DOI 10.1016/j.enpol.2013.05.109; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Faruqui A, 2010, ENERGY, V35, P1598, DOI 10.1016/j.energy.2009.07.042; Ferraro PJ, 2013, RESOUR ENERGY ECON, V35, P356, DOI 10.1016/j.reseneeco.2013.04.001; Ferraty F, 2011, OXFORD HDB FUNCTIONA; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Horvath L., 2012, SPRINGER SERIES STAT, DOI [10.1007/978-1-4614-3655-3, DOI 10.1007/978-1-4614-3655-3]; Houde S, 2013, ENERG J, V34, P87, DOI 10.5547/01956574.34.1.4; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Jessoe K, 2012, KNOWLEDGE IS LESS PO; Jones RV, 2016, ENERG BUILDINGS, V117, P71, DOI 10.1016/j.enbuild.2016.02.020; Kavousian A, 2013, ENERGY, V55, P184, DOI 10.1016/j.energy.2013.03.086; Kwac J, 2013, IEEE INT CONF BIG DA; Lenzi A, 2017, ENVIRONMETRICS, V28, DOI 10.1002/env.2414; Liebl D, 2013, ANN APPL STAT, V7, P1562, DOI 10.1214/13-AOAS652; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; McKerracher C, 2013, ENERG EFFIC, V6, P387, DOI 10.1007/s12053-012-9169-3; Pini A, 2017, J NONPARAMETR STAT, V29, P407, DOI 10.1080/10485252.2017.1306627; Ramsay J., 2005, SPRINGER SERIES STAT, DOI [10.1007/b98888, DOI 10.1007/B98888]; Rice JA, 2001, BIOMETRICS, V57, P253, DOI 10.1111/j.0006-341X.2001.00253.x; Schintler LA, 2014, REV POLICY RES, V31, P343, DOI 10.1111/ropr.12079; Schliessbach J, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/785613; Schultz PW, 2015, ENERGY, V90, P351, DOI 10.1016/j.energy.2015.06.130; Stern PC, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2016.43; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Vilar JM, 2012, INT J ELEC POWER, V39, P48, DOI 10.1016/j.ijepes.2012.01.004; Wang JL, 2016, ANNU REV STAT APPL, V3, P257, DOI 10.1146/annurev-statistics-041715-033624; Yao F, 2005, J AM STAT ASSOC, V100, P577, DOI 10.1198/016214504000001745	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218702	10.1371/journal.pone.0218702	http://dx.doi.org/10.1371/journal.pone.0218702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3BT	31237923	Green Submitted, Green Published, gold			2022-12-26	WOS:000484856000034
J	Khan, S; Taning, CNT; Bonneure, E; Mangelinckx, S; Smagghe, G; Ahmad, R; Fatima, N; Asif, M; Shah, MM				Khan, Saira; Taning, Clauvis Nji Tizi; Bonneure, Elias; Mangelinckx, Sven; Smagghe, Guy; Ahmad, Raza; Fatima, Nighat; Asif, Muhammad; Shah, Mohammad Maroof			Bioactivity-guided isolation of rosmarinic acid as the principle bioactive compound from the butanol extract of Isodon rugosus against the pea aphid, Acyrthosiphon pisum	PLOS ONE			English	Article							BOTANICAL INSECTICIDES; PLECTRANTHOIC ACID; TRITERPENOIDS; DETERRENTS; MANAGEMENT; DIPTERA; PLANTS; RACES	Aphids are agricultural pest insects that transmit viruses and cause feeding damage on a global scale. Current pest control practices involving the excessive use of synthetic insecticides over many years have resulted in aphid resistance to a number of pesticides. In nature, plants produce secondary metabolites during their interaction with insects and these metabolites can act as toxicants, antifeedants, anti-oviposition agents and deterrents towards the insects. In a previous study, we demonstrated that the butanol fraction from a crude methanolic extract of an important plant species, Isodon rugosus showed strong insecticidal activity against the pea aphid, Acyrthosiphon pisum. To further explore this finding, the current study aimed to exploit a bioactivity-guided strategy to isolate and identify the active compound in the butanol fraction of I. rugosus. As such, reversed-phase flash chromatography, acidic extraction and different spectroscopic techniques were used to isolate and identify the new compound, rosmarinic acid, as the bioactive compound in I. rugosus. Insecticidal potential of rosmarinic acid against A. pisum was evaluated using standard protocols and the data obtained was analyzed using qualitative and quantitative statistical approaches. Considering that a very low concentration of this compound (LC90 = 5.4 ppm) causes significant mortality in A. pisum within 24 h, rosmarinic acid could be exploited as a potent insecticide against this important pest insect. Furthermore, I. rugosus is already used for medicinal purposes and rosmarinic acid is known to reduce genotoxic effects induced by chemicals, hence it is expected to be safer compared to the current conventional pesticides. While this study highlights the potential of I. rugosus as a possible biopesticide source against A. pisum, it also provides the basis for further exploration and development of formulations for effective field application.	[Khan, Saira; Ahmad, Raza; Shah, Mohammad Maroof] COMSATS Univ Islamabad, Dept Biotechnol, Abbottabad Campus, Abbottabad, Pakistan; [Khan, Saira; Taning, Clauvis Nji Tizi; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Plants & Crops, Ghent, Belgium; [Khan, Saira; Bonneure, Elias; Mangelinckx, Sven] Univ Ghent, Fac Biosci Engn, Dept Green Chem & Technol, Ghent, Belgium; [Fatima, Nighat] COMSATS Univ Islamabad, Dept Pharm, Abbottabad Campus, Abbottabad, Pakistan; [Asif, Muhammad] COMSATS Univ Islamabad, Dept Management Sci, Abbottabad Campus, Abbottabad, Pakistan	COMSATS University Islamabad (CUI); Ghent University; Ghent University; COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI)	Shah, MM (corresponding author), COMSATS Univ Islamabad, Dept Biotechnol, Abbottabad Campus, Abbottabad, Pakistan.; Smagghe, G (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Plants & Crops, Ghent, Belgium.	guy.smagghe@ugent.be; mmshah@cuiatd.edu.pk	Smagghe, Guy/AAE-8914-2019; Asif, Muhammad/ABA-1874-2021; Taning, Clauvis NJi Tizi/AAO-7485-2021	Smagghe, Guy/0000-0001-8334-3313; Taning, Clauvis NJi Tizi/0000-0002-7597-1261; Mangelinckx, Sven/0000-0002-9349-880X; Shah, Mohammad Maroof/0000-0002-7489-1059; Bonneure, Eli/0000-0002-4478-0403	Higher Education Commission, Pakistan (IRSIP)	Higher Education Commission, Pakistan (IRSIP)	This work was supported by the Higher Education Commission, Pakistan (IRSIP) to SK (http://www.hec.gov.pk/english/pages/home.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdur Rauf, 2012, World Applied Sciences Journal, V20, P540; Ajmal S.A., 2012, INT RES J PHARM, V3, P164; Akhtar Y, 2004, J APPL ENTOMOL, V128, P32, DOI 10.1046/j.1439-0418.2003.00806.x; Akhtar Y, 2010, J AGR FOOD CHEM, V58, P4983, DOI 10.1021/jf9045123; AlJabr AM, 2017, MOLECULES, V22, DOI 10.3390/molecules22010169; Archer TL, 1999, J ECON ENTOMOL, V92, P794, DOI 10.1093/jee/92.4.794; Baek MY, 2013, J KOREAN SOC APPL BI, V56, P135, DOI 10.1007/s13765-013-3013-0; Basukriadi A, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu106; Carrillo L, 2011, TRANSGENIC RES, V20, P305, DOI 10.1007/s11248-010-9417-2; Chakraborty D, 2007, INDIAN J EXP BIOL, V45, P744; Chermenskaya TD, 2012, IND CROP PROD, V36, P122, DOI 10.1016/j.indcrop.2011.08.010; Dapkevicius A, 2002, J NAT PROD, V65, P892, DOI 10.1021/np010636j; De Feo V, 2009, J PLANT INTERACT, V4, P119, DOI 10.1080/17429140802503343; De Geyter E, 2012, PEST MANAG SCI, V68, P164, DOI 10.1002/ps.2235; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; Giner M, 2013, IND CROP PROD, V47, P63, DOI 10.1016/j.indcrop.2013.02.019; Hyun HB, 2015, J KOREAN SOC APPL BI, V58, P715, DOI 10.1007/s13765-015-0097-8; Ikbal C, 2019, J PEST SCI, V92, P971, DOI 10.1007/s10340-019-01089-6; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Janbaz KH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-71; Jaouannet M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00663; Khan S, 2017, PHYTOPARASITICA, V45, P113, DOI 10.1007/s12600-017-0569-y; Khan S, 2016, TURK ENTOMOL DERG-TU, V40, P445, DOI 10.16970/ted.47318; Kim SK, 2011, J AGR FOOD CHEM, V59, P934, DOI 10.1021/jf104027x; Nachman RJ, 2012, PEPTIDES, V34, P266, DOI 10.1016/j.peptides.2011.11.009; Ng JCK, 2004, MOL PLANT PATHOL, V5, P505, DOI [10.1111/j.1364-3703.2004.00240.x, 10.1111/J.1364-3703.2004.00240.X]; Pavela R, 2008, PARASITOL RES, V102, P555, DOI 10.1007/s00436-007-0821-3; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Rauf A., 2013, J MED PLANTS, V2, P001; Rauf A, 2012, MIDDLE E J MED PLANT, V1, P41; RAZDAN TK, 1982, TETRAHEDRON, V38, P991, DOI 10.1016/0040-4020(82)85077-1; RAZDAN TK, 1982, PHYTOCHEMISTRY, V21, P409, DOI 10.1016/S0031-9422(00)95277-4; Regnault-Roger C, 2004, J STORED PROD RES, V40, P395, DOI 10.1016/S0022-474X(03)00031-6; Sadeghi A, 2009, CAN ENTOMOL, V141, P95, DOI [10.4039/n08-060, 10.4039/N08-060]; Sher Z, 2011, PAK J BOT, V43, P1445; Smagghe G, 2010, PEPTIDES, V31, P498, DOI 10.1016/j.peptides.2009.07.001; Sparks TC, 2015, PESTIC BIOCHEM PHYS, V121, P122, DOI 10.1016/j.pestbp.2014.11.014; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; Sylvester E.S., 1989, World Crop Pests, V2C, P65; Torkey H. M., 2009, Australian Journal of Basic and Applied Sciences, V3, P4060; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Via S, 1996, EVOLUTION, V50, P163, DOI 10.1111/j.1558-5646.1996.tb04483.x; Zapata N, 2016, CHIL J AGR RES, V76, P188, DOI 10.4067/S0718-58392016000200008	44	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0215048	10.1371/journal.pone.0215048	http://dx.doi.org/10.1371/journal.pone.0215048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233534	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700002
J	Salic, K; Kleemann, R; Wilkins-Port, C; McNulty, J; Verschuren, L; Palmer, M				Salic, Kanita; Kleemann, Robert; Wilkins-Port, Cynthia; McNulty, John; Verschuren, Lars; Palmer, Melissa			Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of nonalcoholic steatohepatitis in Ldlr-/-.Leiden mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CHOLESTEROL 7-ALPHA-HYDROXYLASE; AMERICAN ASSOCIATION; GLUCOSE-METABOLISM; NUCLEAR RECEPTOR; GUT MICROBIOTA; PROGRESSION; EXCRETION; FIBROSIS; OBESITY	Interruption of bile acid recirculation through inhibition of the apical sodium-dependent bile acid transporter (ASBT) is a promising strategy to alleviate hepatic cholesterol accumulation in non-alcoholic steatohepatitis (NASH), and improve the metabolic aspects of the disease. Potential disease-attenuating effects of the ASBT inhibitor volixibat (5, 15, and 30 mg/kg) were investigated in high-fat diet (HFD)-fed Ldlr-/-.Leiden mice over 24 weeks. Plasma and fecal bile acid levels, plasma insulin, lipids, and liver enzymes were monitored. Final analyses included liver histology, intrahepatic lipids, mesenteric white adipose tissue mass, and liver gene profiling. Consistent with its mechanism of action, volixibat significantly increased the total amount of bile acid in feces. At the highest dose, volixibat significantly attenuated the HFD-induced increase in hepatocyte hypertrophy, hepatic triglyceride and cholesteryl ester levels, and mesenteric white adipose tissue deposition. Non-alcoholic fatty liver disease activity score (NAS) was significantly lower in volixibat-treated mice than in the HFD controls. Gene profiling showed that volixibat reversed the inhibitory effect of the HFD on metabolic master regulators, including peroxisome proliferator-activated receptor-gamma coactivator-1 beta, insulin receptor, and sterol regulatory element-binding transcription factor 2. Volixibat may have beneficial effects on physiological and metabolic aspects of NASH pathophysiology.	[Salic, Kanita; Kleemann, Robert] TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Wilkins-Port, Cynthia; McNulty, John; Palmer, Melissa] Shire LLC, Cambridge, MA 02138 USA; [Verschuren, Lars] TNO, Dept Microbiol & Syst Biol, Zeist, Netherlands; [Wilkins-Port, Cynthia] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Wake Forest University	Palmer, M (corresponding author), Shire LLC, Cambridge, MA 02138 USA.	melissa.palmer@takeda.com		Palmer, Melissa/0000-0002-8745-6865	Takeda; Shire Development LLC; Shire International GmbH	Takeda(Takeda Pharmaceutical Company Ltd); Shire Development LLC; Shire International GmbH	This study was funded by Shire Development LLC, now part of Takeda. Volixibat was a Shire investigational medical product at time of study. Volixibat is now owned by Mirum Pharmaceuticals. TNO received funding from Shire Development LLC for designing and conducting this study and for analyzing and reporting the results.; We thank Wim van Duyvenvoorde, Martien P. M. Caspers and Dr Aswin L. Menke for their technical support. We thank Dr K. Dodd from Oxford PharmaGenesis, Oxford, UK for writing assistance, funded by Shire International GmbH.	Aharoni-Simon M, 2011, LAB INVEST, V91, P1018, DOI 10.1038/labinvest.2011.55; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Arab JP, 2017, HEPATOLOGY, V65, P350, DOI 10.1002/hep.28709; Arguello G, 2015, BBA-MOL BASIS DIS, V1852, P1765, DOI 10.1016/j.bbadis.2015.05.015; Athyros VG, 2017, CURR PHARM DESIGN, V23, P1477, DOI 10.2174/1381612823666170125154257; ATTILI AF, 1986, MED HYPOTHESES, V19, P57, DOI 10.1016/0306-9877(86)90137-4; Banini B., 2016, AM COLL GASTR ANN SC; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Bhat BG, 2003, J LIPID RES, V44, P1614, DOI 10.1194/jlr.M200469-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobeldijk I, 2008, J CHROMATOGR B, V871, P306, DOI 10.1016/j.jchromb.2008.05.008; Brodosi L, 2016, ANN HEPATOL, V15, P673, DOI 10.5604/16652681.1212318; Brunt EM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.80; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chiang John Y L, 2017, Liver Res, V1, P3, DOI 10.1016/j.livres.2017.05.001; Dominguez N, 2004, HEPATOLOGY, V40, P820, DOI DOI 10.1002/HEP.1840400411; Dongiovanni P, 2015, J HEPATOL, V63, P705, DOI 10.1016/j.jhep.2015.05.006; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ferslew BC, 2015, DIGEST DIS SCI, V60, P3318, DOI 10.1007/s10620-015-3776-8; Galman C, 2003, J LIPID RES, V44, P859, DOI 10.1194/jlr.D200043-JLR200; Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002; Handa P, 2014, HEPATOLOGY, V60, P133, DOI 10.1002/hep.26946; Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399; Huff MW, 2002, ARTERIOSCL THROM VAS, V22, P1884, DOI 10.1161/01.ATV.0000035390.87288.26; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003; Klaassen CD, 2015, DRUG METAB DISPOS, V43, P1505, DOI 10.1124/dmd.115.065698; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Lew JL, 2004, J BIOL CHEM, V279, P8856, DOI 10.1074/jbc.M306422200; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Liang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075290; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Milic S, 2014, WORLD J GASTROENTERO, V20, P9330, DOI 10.3748/wjg.v20.i28.9330; Morrison MC, 2016, INT J OBESITY, V40, P1416, DOI 10.1038/ijo.2016.74; Morrison MC, 2018, HEPATOL COMMUN, V2, P1513, DOI 10.1002/hep4.1270; Morrison MC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00132; Mulder P, 2016, INT J OBESITY, V40, P675, DOI 10.1038/ijo.2015.226; Musso G, 2013, PROG LIPID RES, V52, P175, DOI 10.1016/j.plipres.2012.11.002; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; PALMER M, 1990, GASTROENTEROLOGY, V99, P1408, DOI 10.1016/0016-5085(90)91169-7; Palmer M, 2016, HEPATOLOGY, V64, p574A; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Post SM, 2003, ARTERIOSCL THROM VAS, V23, P892, DOI 10.1161/01.ATV.0000067702.22390.20; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; Rao A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4823; Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Siddiqui MS, 2015, CLIN GASTROENTEROL H, V13, P1000, DOI 10.1016/j.cgh.2014.10.008; Siebers N, 2018, EUR J DRUG METAB PH, V43, P91, DOI 10.1007/s13318-017-0429-7; Simoes ICM, 2018, INT J BIOCHEM CELL B, V95, P93, DOI 10.1016/j.biocel.2017.12.019; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Tiessen R, 2014, HEPATOLOGY, V60, p629A; Tiessen RG, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-017-0736-0; van Koppen A, 2018, CELL MOL GASTROENTER, V5, P83, DOI 10.1016/j.jcmgh.2017.10.001; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Xie GX, 2016, INT J CANCER, V139, P1764, DOI 10.1002/ijc.30219; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	74	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218459	10.1371/journal.pone.0218459	http://dx.doi.org/10.1371/journal.pone.0218459			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233523	Green Published, Green Submitted, gold			2022-12-26	WOS:000484896700019
J	Sens, F; Normand, G; Fournier, T; Della-Schiava, N; Luong, S; Pelletier, C; Robinson, P; Lemoine, S; Rouviere, O; Juillard, L				Sens, Florence; Normand, Gabrielle; Fournier, Thomas; Della-Schiava, Nellie; Luong, Stephane; Pelletier, Caroline; Robinson, Philip; Lemoine, Sandrine; Rouviere, Olivier; Juillard, Laurent			Blood pressure decreases after revascularization in atherosclerotic renal artery disease: A cohort study based on a multidisciplinary meeting	PLOS ONE			English	Article							DUPLEX ULTRASOUND; TASK-FORCE; STENOSIS; MANAGEMENT; GUIDELINES; DOPPLER	Background In atherosclerotic renal artery disease, the benefit of revascularization is controversial. A clinical decision-making process based on a multidisciplinary meeting was formalized in the Lyon university hospital. Objectives To investigate whether this decisional process ensured a clinical benefit to patients assigned to renal revascularization. Methods Single-centre retrospective cohort study, including patients diagnosed from April 2013 to February 2015 with an atherosclerotic renal artery disease with a peak systolic velocity >180cm/s. For each patient, the decision taken in multidisciplinary meeting (medical treatment or revacularization) was compared to the one guided by international guidelines. Blood pressure values, number of antihypertensive medications, presence of an uncontrolled or resistant hypertension, and glomerular filtration rate at one-year follow-up were compared to baseline values. Safety data were collected. Results Forty-nine patients were included: 26 (53%) were assigned to a medical treatment and 23 (47%) to a renal revascularization. Therapeutic decision was in accordance with the 2013 American Health Association guidelines and with the 2017 European Society of Cardiology guidelines for 78% and 22% of patients who underwent revascularization, respectively. Patients assigned to revascularization presented a significant decrease in systolic blood pressure (-23 +/- 34mmHg, p = 0.007), diastolic blood pressure (-12 +/- 18mmHg, p = 0.007), number of antihypertensive medications (-1.00 +/- 1.03, p = 0.001), and number of uncontrolled or resistant hypertension (p = 0.022 and 0.031) at one-year follow-up. Those parameters were not modified among patients assigned to medical treatment alone. There was no grade 3 adverse event. Conclusion Based on a multidisciplinary selection of revascularization indications, patients on whom a renal revascularization was performed exhibited a significant improvement of blood pressure control parameters with no severe adverse events.	[Sens, Florence; Normand, Gabrielle; Fournier, Thomas; Pelletier, Caroline; Lemoine, Sandrine; Juillard, Laurent] Hosp Civils Lyon, Edouard Herriot Hosp, Dept Nephrol, Lyon, France; [Sens, Florence; Normand, Gabrielle; Pelletier, Caroline; Lemoine, Sandrine; Rouviere, Olivier; Juillard, Laurent] Lyon 1 Claude Bernard Univ, Villeurbanne, France; [Sens, Florence; Lemoine, Sandrine; Juillard, Laurent] FCRIN INI CRCT, Nancy, France; [Della-Schiava, Nellie] Hosp Civils Lyon, Edouard Herriot Hosp, Dept Vasc Surg, Lyon, France; [Luong, Stephane; Rouviere, Olivier] Hosp Civils Lyon, Edouard Herriot Hosp, Dept Urinary & Vasc Imaging, Lyon, France; [Robinson, Philip] Hosp Civils Lyon, Direct Rech Clin & Innovat, Lyon, France	CHU Lyon; CHU Lyon; CHU Lyon; CHU Lyon	Sens, F (corresponding author), Hosp Civils Lyon, Edouard Herriot Hosp, Dept Nephrol, Lyon, France.; Sens, F (corresponding author), Lyon 1 Claude Bernard Univ, Villeurbanne, France.; Sens, F (corresponding author), FCRIN INI CRCT, Nancy, France.	florence.sens@chu-lyon.fr	Lemoine, Sandrine/AAL-4365-2021; Carmen, Team3/Y-7384-2019; Rouviere, Olivier/O-8150-2017	Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; Rouviere, Olivier/0000-0002-0030-478X				Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Anderson JL, 2013, CIRCULATION, V127, P1425, DOI 10.1161/CIR.0b013e31828b82aa; Bax L, 2009, ANN INTERN MED, V150, P840, DOI 10.7326/0003-4819-150-12-200906160-00119; Best O, 2013, INTERN MED J, V43, P912, DOI 10.1111/imj.12203; Cheung CM, 2007, NEPHRON CLIN PRACT, V107, pC35, DOI 10.1159/000107552; Coen Giorgio, 2004, BMC Nephrol, V5, P15, DOI 10.1186/1471-2369-5-15; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; de Leeuw PW, 2013, JAMA-J AM MED ASSOC, V309, P663, DOI 10.1001/jama.2012.194145; Drieghe B, 2008, EUR HEART J, V29, P517, DOI 10.1093/eurheartj/ehm631; EUROPEAN S, 2011, EUR HEART J, V32, P2851, DOI DOI 10.1093/; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Gupta R, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0894-2; Hackam DG, 2007, HYPERTENSION, V50, P998, DOI 10.1161/HYPERTENSIONAHA.107.097345; Hansen KJ, 2002, J VASC SURG, V36, P443, DOI 10.1067/mva.2002.127351; Herrmann SMS, 2016, CLIN J AM SOC NEPHRO, V11, P458, DOI 10.2215/CJN.03620415; HOFFMANN U, 1991, KIDNEY INT, V39, P1232, DOI 10.1038/ki.1991.156; HTTPS, HYPERTENSIONAHA, P60943, DOI DOI 10.1161/HYPERTENSI0NAHA.107.097345; HTTPS, 2011, HYPERTENSIONAHA, V6736, P60943, DOI DOI 10.1161/HYPERTENSI0NAHA.107.097345; HTTPS, HYPERTENSIONAHA, P60943, DOI DOI 10.1161/HYPERTENSI0NAHA.107.097345; Jenks S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002944.pub2; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Miralles M, 1996, J VASC SURG, V23, P428, DOI 10.1016/S0741-5214(96)80007-3; Mohan IV, 2015, EUR J VASC ENDOVASC, V49, P465, DOI 10.1016/j.ejvs.2014.12.026; Murphy TP, 2016, HYPERTENSION, V68, P1145, DOI 10.1161/HYPERTENSIONAHA.116.07744; OLIN JW, 1995, ANN INTERN MED, V122, P833, DOI 10.7326/0003-4819-122-11-199506010-00004; ONUKWUGHA E, 2000, J ONCOL PRACT, V155, P60943, DOI DOI 10.1200/J0P.2015.004200; Parikh SA, 2014, CATHETER CARDIO INTE, V84, P1163, DOI 10.1002/ccd.25559; Radermacher J, 2002, J NEPHROL, V15, pS69; Raman G, 2016, ANN INTERN MED, V165, P635, DOI 10.7326/M16-1053; Ritchie J, 2014, CURR OPIN NEPHROL HY, V23, P525, DOI 10.1097/MNH.0000000000000059; Safian RD, 2001, NEW ENGL J MED, V344, P431, DOI 10.1056/NEJM200102083440607; Sharma G, 2010, ARCH INTERN MED, V170, P363, DOI 10.1001/archinternmed.2009.553; Textor SC, 2016, CLIN J AM SOC NEPHRO, V11, P1125, DOI 10.2215/CJN.04640416; VASSALLO D, 2017, DIAL, P23, DOI DOI 10.1002/14651858.CD002944.PUB2; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; ANN INTERN MED, P840, DOI DOI 10.7326/0003-4819-150-12-200906160-00119; J ONCOL PRACT FEVR, P155, DOI DOI 10.1200/JOP.2015.004200	39	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218788	10.1371/journal.pone.0218788	http://dx.doi.org/10.1371/journal.pone.0218788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233539	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700039
J	Gregorio, SF; Ruiz-Jarabo, I; Carvalho, EM; Fuentes, J				Gregorio, Silvia F.; Ruiz-Jarabo, Ignacio; Carvalho, Edison M.; Fuentes, Juan			Increased intestinal carbonate precipitate abundance in the sea bream (Sparus aurata L.) in response to ocean acidification	PLOS ONE			English	Article							MARINE TELEOST INTESTINE; ACID-BASE-BALANCE; BICARBONATE SECRETION; WATER-ABSORPTION; HCO3-SECRETION; ESOPHAGEAL DESALINATION; FUNDULUS-HETEROCLITUS; ANION-EXCHANGE; FISH INTESTINE; ION-TRANSPORT	Marine fish contribute to the carbon cycle by producing mineralized intestinal precipitates generated as by-products of their osmoregulation. Here we aimed at characterizing the control of epithelial bicarbonate secretion and intestinal precipitate presence in the gilthead sea bream in response to predicted near future increases of environmental CO2. Our results demonstrate that hypercapnia (950 and 1800 mu atm CO2) elicits higher intestine epithelial HCO3- secretion ex vivo and a subsequent parallel increase of intestinal precipitate presence in vivo when compared to present values (440 mu atm CO2). Intestinal gene expression analysis in response to environmental hypercapnia revealed the up-regulation of transporters involved in the intestinal bicarbonate secretion cascade such as the basolateral sodium bicarbonate co-transporter slc4a4, and the apical anion transporters slc26a3 and slc26a6 of sea bream. In addition, other genes involved in intestinal ion uptake linked to water absorption such as the apical nkcc2 and aquaporin 1b expression, indicating that hypercapnia influences different levels of intestinal physiology. Taken together the current results are consistent with an intestinal physiological response leading to higher bicarbonate secretion in the intestine of the sea bream paralleled by increased luminal carbonate precipitate abundance and the main related transporters in response to ocean acidification.	[Gregorio, Silvia F.; Ruiz-Jarabo, Ignacio; Carvalho, Edison M.; Fuentes, Juan] Univ Algarve, Ctr Marine Sci CCMar, Campus Gambelas, Faro, Portugal; [Ruiz-Jarabo, Ignacio] Univ Cadiz, Dept Biol, Fac Marine & Environm Sci, Inst Univ Invest Marina INMAR,CEI MAR, Cadiz, Spain; [Carvalho, Edison M.] Univ Zurich, DMMD, Zurich, Switzerland	Universidade do Algarve; Universidad de Cadiz; University of Zurich	Fuentes, J (corresponding author), Univ Algarve, Ctr Marine Sci CCMar, Campus Gambelas, Faro, Portugal.	jfuentes@ualg.pt	Fuentes, Juan/I-6663-2013; Ruiz-Jarabo, I./AAA-6194-2020; Gregório, Sílvia/G-1618-2018	Fuentes, Juan/0000-0003-0430-8734; Gregório, Sílvia/0000-0002-6648-5122; Carvalho, Edison SM/0000-0002-4970-9278; Ruiz-Jarabo, Ignacio/0000-0002-3918-0921	European Social Funds through the Portuguese National Science Foundation (FCT) [SFRH/BD/113363/2015, PTDC/MAR-BIO/3034/2014]; Portuguese Foundation for Science and Technology (FCT) [UID/Multi/04326/2019]; Ministry of Science and Higher Education	European Social Funds through the Portuguese National Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was partially supported by the Ministry of Science and Higher Education and European Social Funds through the Portuguese National Science Foundation (FCT) by studentship SFRH/BD/113363/2015 to SFG and by Project PTDC/MAR-BIO/3034/2014 to JF. Centre for Marine Sciences (CCMAR) is supported by national funds from the Portuguese Foundation for Science and Technology (FCT) through project UID/Multi/04326/2019.	Martos-Sitcha JA, 2013, GEN COMP ENDOCR, V193, P221, DOI 10.1016/j.ygcen.2013.07.017; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carvalho ESM, 2015, GEN COMP ENDOCR, V213, P24, DOI 10.1016/j.ygcen.2014.12.011; Carvalho ESM, 2012, J COMP PHYSIOL B, V182, P1069, DOI 10.1007/s00360-012-0685-4; Chang MH, 2012, AM J PHYSIOL-CELL PH, V302, pC1083, DOI 10.1152/ajpcell.00233.2011; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Esbaugh AJ, 2014, COMP BIOCHEM PHYS A, V171, P57, DOI 10.1016/j.cbpa.2014.02.012; Esbaugh AJ, 2012, J COMP PHYSIOL B, V182, P921, DOI 10.1007/s00360-012-0668-5; Ferlazzo A, 2012, J EXP BIOL, V215, P3836, DOI 10.1242/jeb.074906; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Fuentes J., 1997, P135; Fuentes J, 2007, AM J PHYSIOL-REG I, V293, pR956, DOI 10.1152/ajpregu.00111.2007; Fuentes J, 2010, GEN COMP ENDOCR, V168, P95, DOI 10.1016/j.ygcen.2010.04.005; Fuentes J, 2010, AM J PHYSIOL-REG I, V299, pR150, DOI 10.1152/ajpregu.00378.2009; Genz J, 2008, J EXP BIOL, V211, P2327, DOI 10.1242/jeb.016832; Genz J, 2011, COMP BIOCHEM PHYS A, V160, P156, DOI 10.1016/j.cbpa.2011.05.027; Genz J, 2011, AM J PHYSIOL-REG I, V300, pR895, DOI 10.1152/ajpregu.00299.2010; Genz J, 2011, COMP BIOCHEM PHYS A, V159, P150, DOI 10.1016/j.cbpa.2011.02.011; Gregorio SF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041072; Gregorio SF, 2014, J EXP BIOL, V217, P1555, DOI 10.1242/jeb.098517; Gregorio SF, 2013, J EXP BIOL, V216, P470, DOI 10.1242/jeb.073742; Grosell M, 2006, AM J PHYSIOL-REG I, V291, pR1145, DOI 10.1152/ajpregu.00818.2005; Grosell M, 2005, AM J PHYSIOL-REG I, V288, pR936, DOI 10.1152/ajpregu.00684.2003; Grosell M, 2011, ACTA PHYSIOL, V202, P421, DOI 10.1111/j.1748-1716.2010.02241.x; Grosell M, 2009, J EXP BIOL, V212, P1940, DOI 10.1242/jeb.026856; Grosell M, 2009, J EXP BIOL, V212, P1684, DOI 10.1242/jeb.027730; Grosell M, 2007, COMP BIOCHEM PHYS A, V148, P14, DOI 10.1016/j.cbpa.2006.10.017; Grosell M, 2006, J EXP BIOL, V209, P2813, DOI 10.1242/jeb.02345; Guffey S, 2011, AM J PHYSIOL-REG I, V301, pR1682, DOI 10.1152/ajpregu.00059.2011; Heuer RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34480; Heuer RM, 2016, PHYSIOL BIOCHEM ZOOL, V89, P402, DOI 10.1086/688235; Heuer RM, 2014, AM J PHYSIOL-REG I, V307, pR1061, DOI 10.1152/ajpregu.00064.2014; Heuer RM, 2012, PHYSIOL BIOCHEM ZOOL, V85, P450, DOI 10.1086/667617; HIRANO T, 1976, P NATL ACAD SCI USA, V73, P1348, DOI 10.1073/pnas.73.4.1348; IPCC, 2013, INT PAN CLIM CHANG C; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kurita Y, 2008, AM J PHYSIOL-REG I, V294, pR1402, DOI 10.1152/ajpregu.00759.2007; LORETZ CA, 1995, FISH PHYSIOL, V14, P25, DOI DOI 10.1016/S1546-5098(08)60241-1; Mackenzie CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099712; Marquez L, 2014, COMP BIOCHEM PHYS A, V167, P52, DOI 10.1016/j.cbpa.2013.10.016; Martos-Sitcha JA, 2015, J EXP BIOL, V218, P684, DOI 10.1242/jeb.114546; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Michaelidis B, 2007, MAR BIOL, V150, P1417, DOI 10.1007/s00227-006-0436-8; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; MUSCH MW, 1982, NATURE, V300, P351, DOI 10.1038/300351a0; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PARMELEE JT, 1983, AM J PHYSIOL, V245, pR888, DOI 10.1152/ajpregu.1983.245.6.R888; Perry CT, 2011, P NATL ACAD SCI USA, V108, P3865, DOI 10.1073/pnas.1015895108; Perry SF, 2010, J COMP PHYSIOL B, V180, P1213, DOI 10.1007/s00360-010-0492-8; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Raldua D, 2008, AM J PHYSIOL-REG I, V294, pR993, DOI 10.1152/ajpregu.00695.2007; ROBBINS LL, 2010, US GEOL SURV OPEN FI, V2010, P17, DOI DOI 10.3133/OFR20101280; Ruhr IM, 2016, AJP REGUL INTEGR COM, V311; Salter MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00787-4; Salter MA, 2012, SEDIMENTOLOGY, V59, P2172, DOI 10.1111/j.1365-3091.2012.01339.x; Smith HW, 1930, AM J PHYSIOL, V93, P480, DOI 10.1152/ajplegacy.1930.93.2.480; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Speers AE, 2016, ECOL ECON, V128, P33, DOI 10.1016/j.ecolecon.2016.04.012; Taylor JR, 2010, J EXP BIOL, V213, P459, DOI 10.1242/jeb.029363; Tresguerres M, 2010, AM J PHYSIOL-REG I, V299, pR62, DOI 10.1152/ajpregu.00761.2009; WALSH PJ, 1991, LIMNOL OCEANOGR, V36, P1227, DOI 10.4319/lo.1991.36.6.1227; Whittamore JM, 2012, J COMP PHYSIOL B, V182, P1, DOI 10.1007/s00360-011-0601-3; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972; Wilson RW, 2003, BBA-BIOMEMBRANES, V1618, P163, DOI 10.1016/j.bbamem.2003.09.014; Wilson RW, 2002, BBA-BIOMEMBRANES, V1566, P182, DOI 10.1016/S0005-2736(02)00600-4; Wilson RW, 1996, J EXP BIOL, V199, P2331; Wood CM, 2012, J EXP BIOL, V215, P508, DOI 10.1242/jeb.060004; Woosley RJ, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007599; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124	72	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218473	10.1371/journal.pone.0218473	http://dx.doi.org/10.1371/journal.pone.0218473			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226164	Green Published, Green Submitted, gold			2022-12-26	WOS:000484894700020
J	McKee, ML; Royer, DL; Poulos, HM				McKee, Melissa L.; Royer, Dana L.; Poulos, Helen M.			Experimental evidence for species-dependent responses in leaf shape to temperature: Implications for paleoclimate inference	PLOS ONE			English	Article							MARGIN ANALYSIS; CLIMATE; LEAVES; CONSTRAINTS; PLASTICITY; INSIGHTS; GRADIENT; SIZE	In many woody dicot plant species, colder temperatures correlate with a greater degree of leaf dissection and with larger and more abundant leaf teeth (the serrated edges along margins). The measurement of site-mean characteristics of leaf size and shape (physiognomy), including leaf dissection and tooth morphology, has been an important paleoclimate tool for over a century. These physiognomic-based climate proxies require that all woody dicot plants at a site, regardless of species, change their leaf shape rapidly and predictably in response to temperature. Here we experimentally test these assumptions by growing five woody species in growth cabinets under two temperatures (17 and 25 degrees C). In keeping with global site-based patterns, plants tend to develop more dissected leaves with more abundant and larger leaf teeth in the cool treatment. Overall, this upholds the assumption that leaf shape responds in a particular direction to temperature change. The assumption that leaf shape variables respond to temperature in the same way regardless of species did not hold because the responses varied by species. Leaf physiognomic models for inferring paleoclimate should take into account these species-specific responses.	[McKee, Melissa L.; Royer, Dana L.] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA; [Poulos, Helen M.] Wesleyan Univ, Coll Environm, Middletown, CT USA	Wesleyan University; Wesleyan University	Royer, DL (corresponding author), Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA.	droyer@wesleyan.edu		Royer, Dana/0000-0003-0976-953X				[Anonymous], 2017, EMMEANS ESTIMATED MA; Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; Chitwood DH, 2016, PLANT PHYSIOL, V170, P1480, DOI 10.1104/pp.15.01825; Edwards EJ, 2016, AM J BOT, V103, P975, DOI 10.3732/ajb.1600129; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1179, DOI 10.1111/j.1365-3040.2005.01354.x; Givnish TJ, 2017, AM J BOT, V104, P354, DOI 10.3732/ajb.1600287; Glade-Vargas N, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01073; Greenwood DR, 2004, PALAIOS, V19, P129, DOI 10.1669/0883-1351(2004)019<0129:PEULAI>2.0.CO;2; Hinojosa LF, 2011, GLOBAL ECOL BIOGEOGR, V20, P380, DOI 10.1111/j.1466-8238.2010.00595.x; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Li SF, 2016, PALAEOGEOGR PALAEOCL, V442, P1, DOI 10.1016/j.palaeo.2015.11.005; Li YQ, 2016, GLOBAL ECOL BIOGEOGR, V25, P1401, DOI 10.1111/geb.12498; Little SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015161; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; R Development Core Team, 2018, LANG ENV STAT COMP V; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049559; Royer DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007653; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wolfe J.A., 1993, US GEOLOGICAL SURVEY, V2040, P1, DOI DOI 10.3133/B2040; Wolfe JA, 1979, US GEOLOGICAL SURVEY, V1106, P1, DOI DOI 10.3133/PP1106; Yang J, 2015, GLOBAL ECOL BIOGEOGR, V24, P1113, DOI 10.1111/geb.12334	25	12	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218884	10.1371/journal.pone.0218884	http://dx.doi.org/10.1371/journal.pone.0218884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226157	Green Submitted, gold, Green Published			2022-12-26	WOS:000484894700048
J	Monsees, H; Suhl, J; Paul, M; Kloas, W; Dannehl, D; Wurtz, S				Monsees, Hendrik; Suhl, Johanna; Paul, Maurice; Kloas, Werner; Dannehl, Dennis; Wuertz, Sven			Lettuce (Lactuca sativa, variety Salanova) production in decoupled aquaponic systems: Same yield and similar quality as in conventional hydroponic systems but drastically reduced greenhouse gas emissions by saving inorganic fertilizer	PLOS ONE			English	Article							RECIRCULATING AQUACULTURE SYSTEMS; NITRATE; GROWTH; SULFUR; WATER; BACTERIA; SUSTAINABILITY; IDENTIFICATION; ACCUMULATION; POLYPHENOLS	Decoupled aquaponic systems have the potential to become one of the most effective sustainable production systems for the combined production of animal protein and plant crops. Here, recirculating aquaculture systems for fish production are combined with hydroponics for soilless plant production thereby recycling dissolved nutrients derived from metabolism of the fish. The aim of the present study was to characterize hydroponic lettuce production using conventional nutrient solution in comparison with decoupled aquaponics using the nutrient rich fish water as basis for the nutrient solution being supplemented by missing nutrients. In addition, one aquaponic treatment became disinfected in order to assess any occurring advantage of the aquaponics derived fish water. For evaluation the temperature, electrical conductivity, pH, and the mineral composition of the nutrient solution, as well as colony forming units in the fish water were monitored. Additionally, plant growth (fresh and dry weight, number and area of leaves) and quality parameters of lettuce leaves (nitrate, mineral content, phenolic compounds) were examined. Carbon sources and microorganisms derived from fish water seem to have neither beneficial nor detrimental effects on plant growth in this study. Except for some differences in the mineral content of the lettuce leaves, all other quality parameters were not significantly different. The use of aquaponic fish water saved 62.8% mineral fertilizer and fully substituted the required water for the nutrient solution in comparison to the control. Additionally, the reduced fertilizer demand using decoupled aquaponics can contribute to reduce greenhouse gas emissions of an annual lettuce production site per ha by 72% due to saving the energy for fertilizer production. This study clearly demonstrates the huge potential of the innovative approach of decoupled aquaponics to foster the transformation of our conventional agriculture towards sustainable production systems saving resources and minimizing emissions.	[Monsees, Hendrik; Suhl, Johanna; Paul, Maurice; Kloas, Werner; Wuertz, Sven] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Suhl, Johanna; Dannehl, Dennis] Humboldt Univ, Albrecht Daniel Thaer Inst Agr & Hort Sci, Div Biosyst Engn, Fac Life Sci, Berlin, Germany; [Kloas, Werner] Humboldt Univ, Fac Life Sci, Inst Biol, Dept Endocrinol, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin; Humboldt University of Berlin	Monsees, H (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany.	h.monsees@igb-berlin.de		Monsees, Hendrik/0000-0003-2935-1106	European Union's Seventh Framework Programme for research, technological development and demonstration [619137]; Leibniz Association's Open Access Publishing Fund	European Union's Seventh Framework Programme for research, technological development and demonstration; Leibniz Association's Open Access Publishing Fund	This work has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration (https://ec.europa.eu/research/fp7/index_en.cfm) under grant agreement no 619137 (HM and JS). The Leibniz Association's Open Access Publishing Fund provided the funding for this open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adani F, 1998, J PLANT NUTR, V21, P561, DOI 10.1080/01904169809365424; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anjana, 2007, AGRON SUSTAIN DEV, V27, P45, DOI 10.1051/agro:2006021; [Anonymous], 2015, PROZESSORIENTIERTE B; Barbosa GL, 2015, INT J ENV RES PUB HE, V12, P6879, DOI 10.3390/ijerph120606879; Becker C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142867; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Boudet AM, 2007, PHYTOCHEMISTRY, V68, P2722, DOI 10.1016/j.phytochem.2007.06.012; Coolong TW, 2003, J PLANT NUTR, V26, P949, DOI 10.1081/PLN-120020067; Cowie A., 2004, IEA BIOENERGY, V38, P1; Dannehl D, 2015, J APPL BOT FOOD QUAL, V88, P68, DOI 10.5073/JABFQ.2015.088.010; Dannehl D, 2014, POLYPHENOLS IN PLANTS: ISOLATION, PURIFICATION AND EXTRACT PREPARATION, P3, DOI 10.1016/B978-0-12-397934-6.00001-2; Dannehl D, 2012, FOOD CHEM, V131, P239, DOI 10.1016/j.foodchem.2011.08.069; DATKO AH, 1978, PLANT PHYSIOL, V62, P629, DOI 10.1104/pp.62.4.629; Delaide B, 2016, WATER-SUI, V8, DOI 10.3390/w8100467; Demsar J, 2003, AGROCHIMICA, V47, P112; DuPont MS, 2000, J AGR FOOD CHEM, V48, P3957, DOI 10.1021/jf0002387; Economakis C, 1996, 2 INT S IRR HORT CRO, P449; Ehret DL, 2001, AGRONOMIE, V21, P323, DOI 10.1051/agro:2001127; Fageria VD, 2001, J PLANT NUTR, V24, P1269, DOI 10.1081/PLN-100106981; Falk KL, 2007, PLANT BIOLOGY, V9, P573, DOI 10.1055/s-2007-965431; FAO, 2017, AQUASTAT DAT AQUASTA; Forster N, 2015, J AGR FOOD CHEM, V63, P2852, DOI 10.1021/jf506174v; Goddek S, 2016, WATER-SUI, V8, DOI 10.3390/w8070303; Goddek S, 2015, SUSTAINABILITY-BASEL, V7, P4199, DOI 10.3390/su7044199; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gunes A, 1995, AGROCHIMICA, V39, P326; Hambly AC, 2015, WATER RES, V83, P112, DOI 10.1016/j.watres.2015.06.037; Hawkesford M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P135, DOI 10.1016/B978-0-12-384905-2.00006-6; HOCHMUTH G, 2004, PLANT TISSUE ANAL IN; Hochmuth G., 2001, FLORIDA GREENHOUSE V; ISO, 1995, 10694 ISO; [ISO] International Organization for Standardization, 1998, 13878 ISO; Jenssen T. K., 2003, ENERGY CONSUMPTION G, P509; Junge R, 2017, WATER-SUI, V9, DOI 10.3390/w9030182; Kloas W, 2015, AQUACULT ENV INTERAC, V7, P179, DOI 10.3354/aei00146; Konstantopoulou E, 2010, SCI HORTIC-AMSTERDAM, V125, P93, DOI 10.1016/j.scienta.2010.03.003; Leonard N, 2002, AQUACULT ENG, V26, P111, DOI 10.1016/S0144-8609(02)00008-0; Leonard N, 2000, AQUACULT ENG, V22, P109, DOI 10.1016/S0144-8609(00)00035-2; Llorach R, 2008, FOOD CHEM, V108, P1028, DOI 10.1016/j.foodchem.2007.11.032; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; MacCarthy P, 2001, SOIL SCI, V166, P738, DOI 10.1097/00010694-200111000-00003; Madigan MT, 2017, BROCK BIOL MICROORGA, DOI [10.3390/microorganisms5020034, DOI 10.3390/MICROORGANISMS5020034]; Martins CIM, 2010, AQUACULT ENG, V43, P83, DOI 10.1016/j.aquaeng.2010.09.002; Mattson N.S., 2014, INSID GROW BALL PUBL, V2014, P16; McCall D, 1998, J HORTIC SCI BIOTECH, V73, P698, DOI 10.1080/14620316.1998.11511036; Merino L, 2006, FOOD ADDIT CONTAM A, V23, P1283, DOI 10.1080/02652030600930543; Monsees H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183056; Mulabagal V, 2010, FOOD CHEM, V118, P300, DOI 10.1016/j.foodchem.2009.04.119; Nazaryuk VM, 2002, RUSS J ECOL+, V33, P392, DOI 10.1023/A:1020995329784; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Pantanella E, 2015, ACTA HORTIC, V1062, P71, DOI 10.17660/ActaHortic.2015.1062.8; Radi M, 2003, AGRONOMIE, V23, P737, DOI 10.1051/agro:2003052; Rakocy J. E., 2006, SRAC Publication - Southern Regional Aquaculture Center, P1; Ribas-Agusti A, 2011, PHYTOCHEM ANALYSIS, V22, P555, DOI 10.1002/pca.1318; Savvas D, 2007, AGR WATER MANAGE, V91, P102, DOI 10.1016/j.agwat.2007.05.001; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Schiavon M, 2010, J CHEM ECOL, V36, P662, DOI 10.1007/s10886-010-9790-6; Snyder RG, 2016, GREENHOUSE TOMATO HD; Sugita H, 2005, AQUACULTURE, V243, P403, DOI 10.1016/j.aquaculture.2004.09.028; Suhl J, 2018, AQUACULT ENG, V82, P63, DOI 10.1016/j.aquaeng.2018.06.008; Suhl J, 2016, AGR WATER MANAGE, V178, P335, DOI 10.1016/j.agwat.2016.10.013; Theunissen J, 2010, INT J PHYS SCI, V5, P1964; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Timmons MB., 2010, RECIRCULATING AQUACU; Tyson RV, 2011, HORTTECHNOLOGY, V21, P6, DOI 10.21273/HORTTECH.21.1.6; *UBA, 2017, UMW LANDW; Ultee A, 2004, J APPL MICROBIOL, V96, P560, DOI 10.1111/j.1365-2672.2004.02174.x; van Rijn J, 2013, AQUACULT ENG, V53, P49, DOI 10.1016/j.aquaeng.2012.11.010; Villarroel M, 2016, WATER-SUI, V8, DOI 10.3390/w8100468; Waechter-Kristensen B., 1999, Acta Horticulturae, P197; Yamin G, 2017, WATER RES, V108, P412, DOI 10.1016/j.watres.2016.11.028; Zekki H, 1996, J AM SOC HORTIC SCI, V121, P1082, DOI 10.21273/JASHS.121.6.1082	74	18	18	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218368	10.1371/journal.pone.0218368	http://dx.doi.org/10.1371/journal.pone.0218368			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220125	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500040
J	Tripathi, P; Behera, MD; Roy, PS				Tripathi, Poonam; Behera, Mukunda Dev; Roy, Partha Sarathi			Spatial heterogeneity of climate explains plant richness distribution at the regional scale in India	PLOS ONE			English	Article							SPECIES RICHNESS; EVOLUTIONARY SPEED; NON-STATIONARITY; DIVERSITY; PATTERNS; WATER; ENVIRONMENT; ENERGY; BIODIVERSITY; GRADIENTS	Introduction Knowledge of species richness patterns and their relation with climate is required to develop various forest management actions including habitat management, biodiversity and risk assessment, restoration and ecosystem modelling. In practice, the pattern of the data might not be spatially constant and cannot be well addressed by ordinary least square (OLS) regression. This study uses GWR to deal with spatial non-stationarity and to identify the spatial correlation between the plant richness distribution and the climate variables (i.e., the temperature and precipitation) in a 1 degrees grid in different biogeographic zones of India. Methodology We utilized the species richness data collected using 0.04 ha nested quadrats in an Indian study. The data from this national study, titled 'Biodiversity Characterization at Landscape Level', were aggregated at the 1 degrees grid level and adjudged for sampling sufficiency. The performances of OLS and GWR models were compared in terms of the coefficient of determination (R-2) and the corrected Akaike Information Criterion (AICc). Results and discussion A comparative study of the R-2 and AICc values of the models showed that all the GWR models performed better compared with the analogous OLS models. The climate variables were found to significantly influence the distribution of plant richness in India. The minimum precipitation (Pmin) consistently dominated individually (R-2 = 0.69; AICc = 2608) and in combinations. Among the shared models, the one with a combination of Pmin and Tmin had the best model fits (R-2 = 0.72 and AICc = 2619), and variation partitioning revealed that the influence of these parameters on the species richness distribution was dominant in the arid and the semi-arid zones and in the Deccan peninsula zone. Conclusion The shift in climate variables and their power to explain the species richness of biogeographic zones suggests that the climate-diversity relationships of plants species vary spatially. In particular, the dominant influence of Tmin and Pmin could be closely linked to the climate tolerance hypothesis (CTH). We found that the climate variables had a significant influence in defining species richness patterns in India; however, various other environmental and non-environmental (edaphic, topographic and anthropogenic) variables need to be integrated in the models to understand climate-species richness relationships better at a finer scale.	[Tripathi, Poonam; Behera, Mukunda Dev] Indian Inst Technol, Ctr Oceans Rivers Atmosphere & Land Sci CORAL, Kharagpur, W Bengal, India; [Roy, Partha Sarathi] Int Crops Res Inst Semi Arid Trop, Innovat Syst Dry Lands, Syst Anal Climate Smart Agr, Hyderabad, India; [Tripathi, Poonam] Int Ctr Integrated Mt Dev, Kathmandu, Nepal	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Tripathi, P (corresponding author), Indian Inst Technol, Ctr Oceans Rivers Atmosphere & Land Sci CORAL, Kharagpur, W Bengal, India.; Tripathi, P (corresponding author), Int Ctr Integrated Mt Dev, Kathmandu, Nepal.	tripathy.poonam@gmail.com		Behera, Mukunda/0000-0002-9976-6270; tripathi, poonam/0000-0003-1534-4650				Brodribb T, 1998, FUNCT ECOL, V12, P465, DOI 10.1046/j.1365-2435.1998.00213.x; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Da Silva Cassemiro FADS, 2007, GLOBAL ECOL BIOGEOGR, V16, P820, DOI 10.1111/j.1466-8238.2007.00332.x; Davidar P, 2005, J BIOGEOGR, V32, P493, DOI 10.1111/j.1365-2699.2005.01165.x; Eiserhardt WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027027; Evans KL, 2008, J ANIM ECOL, V77, P395, DOI 10.1111/j.1365-2656.2007.01332.x; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Foody GM, 2004, GLOBAL ECOL BIOGEOGR, V13, P315, DOI 10.1111/j.1466-822X.2004.00097.x; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gillman LN, 2014, J BIOGEOGR, V41, P39, DOI 10.1111/jbi.12173; Goldie X, 2010, P ROY SOC B-BIOL SCI, V277, P2645, DOI 10.1098/rspb.2010.0439; Grace JB, 2011, ECOLOGY, V92, P108, DOI 10.1890/09-2137.1; Graves GR, 2005, P NATL ACAD SCI USA, V102, P7871, DOI 10.1073/pnas.0500424102; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2012, J BIOGEOGR, V39, P1, DOI 10.1111/j.1365-2699.2011.02637.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Holmgren M, 2007, J BIOGEOGR, V34, P1100, DOI 10.1111/j.1365-2699.2006.01683.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jiang ZH, 2016, COMMUNITY ECOL, V17, P17, DOI 10.1556/168.2016.17.1.3; Kleidon A, 2000, GLOB CHANGE BIOL, V6, P507, DOI 10.1046/j.1365-2486.2000.00332.x; Kumar Vinod, 2009, Journal of Applied and Natural Science, V1, P117; Li LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066450; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; MacArthur R.H., 1972, pvii; Mantilla-Contreras J, 2012, J PLANT ECOL, V5, P249, DOI 10.1093/jpe/rtr031; Martin-Queller E, 2011, J VEG SCI, V22, P238, DOI 10.1111/j.1654-1103.2010.01242.x; Menon S, 1997, CURR SCI INDIA, V73, P134; Miller JA, 2011, INT J GEOGR INF SCI, V25, P423, DOI 10.1080/13658816.2010.518147; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Montoya D, 2007, ECOGRAPHY, V30, P173, DOI 10.1111/j.0906-7590.2007.04873.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; Osborne PE, 2007, DIVERS DISTRIB, V13, P313, DOI 10.1111/j.1472-4642.2007.00344.x; Pandit MK, 2012, CONSERV BIOL, V26, P1061, DOI 10.1111/j.1523-1739.2012.01918.x; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Robertson TR, 2010, OECOLOGIA, V162, P185, DOI 10.1007/s00442-009-1449-z; Rodgers W.A., 1988, PLANNING WILDLIFE PR; Roy PS, 2013, CURR SCI INDIA, V105, P774; Roy P. S., 2012, Proceedings of the National Academy of Sciences India. Section B, Biological Sciences, V82, P261; Roy P.S, 2012, BIODIVERSITY CHARACT; Svenning JC, 2009, ECOGRAPHY, V32, P13, DOI 10.1111/j.1600-0587.2008.05732.x; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Tripathi P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173774; Vazquez-Rivera H, 2015, GLOBAL ECOL BIOGEOGR, V24, P97, DOI 10.1111/geb.12232; Wang ZH, 2012, ECOGRAPHY, V35, P1124, DOI 10.1111/j.1600-0587.2011.06781.x; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wilson TB, 1998, J ARID ENVIRON, V38, P541, DOI 10.1006/jare.1998.0362; Wohlgemuth T, 2008, PLANT BIOSYST, V142, P604, DOI 10.1080/11263500802410975; Wright David H., 1993, P66; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; WRIGHT SJ, 1992, TRENDS ECOL EVOL, V7, P260, DOI 10.1016/0169-5347(92)90171-7; Xu XT, 2016, J BIOGEOGR, V43, P279, DOI 10.1111/jbi.12620	60	12	14	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218322	10.1371/journal.pone.0218322	http://dx.doi.org/10.1371/journal.pone.0218322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220130	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500036
J	Chen, JC; Kuroki, S; Someda, M; Yonehara, S				Chen, Jiancheng; Kuroki, Shunsuke; Someda, Masataka; Yonehara, Shin			Interferon-gamma induces the cell surface exposure of phosphatidylserine by activating the protein MLKL in the absence of caspase-8 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caspase; cell death; interferon; necrosis (necrotic death); phosphatidylserine; receptor-interacting protein (RIP); interferon-gamma; MLKL; necroptosis; RIPK3	MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; APOPTOTIC CELLS; DEATH; NECROSIS; PHOSPHORYLATION; NECROPTOSIS; EXPRESSION; IDENTIFICATION; DOWNSTREAM	Phosphatidylserine (PS), an anionic phospholipid enriched in the inner leaflet of the plasma membrane, is exposed to the outer leaflet during apoptosis. PS exposure was recently shown to be induced during tumor necrosis factor-induced necroptosis. We herein demonstrated that interferon (IFN)-gamma induced necroptosis in Caspase-8-knockout mouse-derived embryonic fibroblasts (C8KO MEFs), as well as in WT MEFs co-treated with the pan-caspase inhibitor, z-VAD-fmk. PS exposure and necroptosis were significant after 6- and 24-h treatments with IFN-gamma, respectively. To elucidate the molecular mechanisms underlying IFN-gamma-induced PS exposure, we generated C8KO MEF-derived cell lines without the expression of RIPK3 (receptor-interacting protein kinase 3), an essential molecule in tumor necrosis factor-induced necroptosis, and IFN-gamma-induced PS exposure and necrotic cell death were shown to be specifically inhibited by the loss of RIPK3 expression. Furthermore, the down-regulated expression of MLKL (mixed lineage kinase domain-like protein), a key molecule for inducing membrane rupture downstream of RIPK3 in necroptosis, abolished IFN-gamma-induced PS exposure in C8KO MEFs. In human colorectal adenocarcinoma-derived HT29 cells, PS exposure and necroptosis were similarly induced by treatment with IFN-gamma in the presence of Smac mimetics and z-VAD-fmk. The removal of IFN-gamma from PS-exposing MEFs after a 6-h treatment completely inhibited necroptotic cell death but not the subsequent increase in the number of PS-exposing cells. Therefore, PS exposure mediated by RIPK3-activated MLKL oligomers was induced by a treatment with IFN-gamma for a significant interval of time before the induction of necroptosis by membrane rupture.	[Chen, Jiancheng; Kuroki, Shunsuke; Someda, Masataka; Yonehara, Shin] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Chen, Jiancheng; Someda, Masataka; Yonehara, Shin] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Kuroki, Shunsuke] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; Osaka University	Yonehara, S (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Yoshida Shimoadachi Cho 46-29, Kyoto 6068501, Japan.	yonehara.shin.8s@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15H01376]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (homeostatic regulation by various types of cell death) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15H01376 to S.Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Balachandran S, 2013, J INTERF CYTOK RES, V33, P171, DOI 10.1089/jir.2012.0087; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cekay MJ, 2017, CANCER LETT, V410, P228, DOI 10.1016/j.canlet.2017.09.002; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dondelinger Y, 2016, TRENDS CELL BIOL, V26, P721, DOI 10.1016/j.tcb.2016.06.004; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Liu SZ, 2017, P NATL ACAD SCI USA, V114, pE7450, DOI 10.1073/pnas.1707531114; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.200424930; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; Ousingsawat J, 2017, CELL MOL LIFE SCI, V74, P173, DOI 10.1007/s00018-016-2338-3; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takahashi S, 2013, INT IMMUNOL, V25, P287, DOI 10.1093/intimm/dxs109; Tanzer MC, 2017, CELL DEATH DIFFER, V24, P481, DOI 10.1038/cdd.2016.147; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Toda S, 2012, MOL CELL BIOL, V32, P118, DOI 10.1128/MCB.05993-11; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang HB, 2017, P NATL ACAD SCI USA, V114, P11944, DOI 10.1073/pnas.1715742114; Yoon S, 2017, IMMUNITY, V47, P51, DOI 10.1016/j.immuni.2017.06.001; Zargarian S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002711	42	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11994	12006		10.1074/jbc.RA118.007161	http://dx.doi.org/10.1074/jbc.RA118.007161			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217278	hybrid, Green Published			2022-12-26	WOS:000484284500006
J	Fishman, B; Daniel, S; Koren, G; Lunenfeld, E; Levy, A				Fishman, Boris; Daniel, Sharon; Koren, Gideon; Lunenfeld, Eitan; Levy, Amalie			Pregnancy outcome following opioid exposure: A cohort study	PLOS ONE			English	Article							RISK; DRUG; MEDICATIONS; CONSUMPTION; ANOMALIES	Introduction Opioids constitute a cornerstone of pain relief treatment. However, opioid safety during pregnancy has not been well established. Recent studies reported an association between in utero opioid exposure and spina bifida. Methods In order to further evaluate the association of opioids exposure during pregnancy with adverse pregnancy outcomes, we conducted a large historical cohort by linking four data-bases: medications dispensations, births, pregnancy terminations for medical reasons and infant hospitalizations during the years of 1999-2009. Confounders that were controlled for included maternal age, ethnicity, maternal diabetes, smoking status, parity, obesity, year and folic acid intake. A secondary analysis for total major malformations and for spina bifida was performed using propensity score matching for first trimester exposure. Results Of the 101,586 women included in the study, 3003 were dispensed opioids during the first trimester. Intrauterine exposure to opioids was not associated with overall major malformations (adjusted odds ratio (aOR) 0.97, 95% CI 0.83-1.13), cardiovascular malformations (aOR = 0.89, 95% CI 0.70-1.13) other malformations by systems or spina bifida in particular. However, the risk for spina bifida among newborns and abortuses who were exposed to codeine was four times higher than that of the unexposed (aOR = 4.42, 95% CI 1.60-12.23). This association remained significant in a secondary analysis using propensity score matching. Third trimester exposure to opioids was not associated with low birth weight (aOR = 1.08, 95% CI 0.77-1.52), perinatal death (aOR = 1.38, 95% CI 0.64-2.99) and other adverse pregnancy outcomes. Conclusions These findings suggest that opioids exposure (as a homogenous group) is not a significant risk factor for overall major malformations. Exposure to codeine during the first trimester was found to be associated with increased risk of spina bifida. However, this finding was based on a small number of cases and need to be verified in future work.	[Fishman, Boris; Daniel, Sharon; Levy, Amalie] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel; [Daniel, Sharon] Soroka Med Ctr, Dept Pediat, Beer Sheva, Israel; [Koren, Gideon; Lunenfeld, Eitan] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Koren, Gideon] Motherisk Israel, Tel Aviv, Israel; [Koren, Gideon] Maccabi Hlth Serv, Tel Aviv, Israel; [Lunenfeld, Eitan] Soroka Med Ctr, Dept Obstet & Gynecol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Levy, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel.	lamaha@bgu.ac.il	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875; Daniel, Sharon/0000-0003-1820-9278				Ailes EC, 2015, MMWR-MORBID MORTAL W, V64, P2008; Briggs G. G, 2011, DRUGS IN PREGNANCY A; Broussard CS, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.039; Brunton L., 2011, GOODMAN GILMANS PHAR; Correa-Villasenor A, 2003, BIRTH DEFECTS RES A, V67, P617, DOI 10.1002/bdra.10111; De Jong van den Berg L T, 1999, Teratology, V60, P33; de Jonge L, 2015, DRUG SAFETY, V38, P737, DOI 10.1007/s40264-015-0302-z; DeCastro J., 1991, REGIONAL OPIOID ANAL; Glinianaia SV, 2008, HUM REPROD, V23, P1306, DOI 10.1093/humrep/den104; Handal M, 2011, EUR J CLIN PHARMACOL, V67, P953, DOI 10.1007/s00228-011-1030-7; Huang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29938; ICDC, 2010, HLTH STAT ISR 2010; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; KALLEN B, 1989, EUR J EPIDEMIOL, V5, P31, DOI 10.1007/BF00145041; Kallen B, 2013, PHARMACEUTICALS, V6, P1221, DOI 10.3390/ph6101221; KIRBY ML, 1980, BRAIN RES, V202, P143, DOI 10.1016/0006-8993(80)90649-6; Kotecha MK, 2013, ANAESTHESIA, V68, P1210, DOI 10.1111/anae.12450; Lev B, 2011, HLTH BEHAV PREVENTIO; Levy A, 2012, J CLIN PHARMACOL, V52, P78, DOI 10.1177/0091270010390806; Matok I, 2009, BRIT J CLIN PHARMACO, V68, P956, DOI 10.1111/j.1365-2125.2009.03544.x; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Nasiraei-Moghadam S, 2005, DEV BRAIN RES, V159, P12, DOI 10.1016/j.devbrainres.2005.06.012; Nasiraei-Moghadam S, 2010, J MOL NEUROSCI, V41, P156, DOI 10.1007/s12031-009-9312-6; Nezvalova-Henriksen K, 2011, EUR J CLIN PHARMACOL, V67, P1253, DOI 10.1007/s00228-011-1069-5; Ponizovsky AM, 2011, EUR J CLIN PHARMACOL, V67, P165, DOI 10.1007/s00228-010-0932-0; Rasmussen SA, 2003, BIRTH DEFECTS RES A, V67, P193, DOI 10.1002/bdra.10012; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Rynn L, 2008, UPDATE OVERALL PREVA; SHAW GM, 1992, EUR J EPIDEMIOL, V8, P757, DOI 10.1007/BF00145398; Shaw GM, 1998, TERATOLOGY, V57, P1; Sheiner E, 1998, EUR J OBSTET GYN R B, V76, P141, DOI 10.1016/S0301-2115(97)00178-4; Sheiner E, 1999, INT J GYNECOL OBSTET, V64, P227, DOI 10.1016/S0020-7292(98)00166-0; Vrijheid M, 2000, ARCH DIS CHILD, V82, P349, DOI 10.1136/adc.82.5.349; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Yazdy MM, 2013, OBSTET GYNECOL, V122, P838, DOI 10.1097/AOG.0b013e3182a6643c; Yu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111056; Zagon IS, 2002, BRAIN RES REV, V38, P351, DOI 10.1016/S0165-0173(01)00160-6; Zagon IS, 1999, BRAIN RES, V839, P313, DOI 10.1016/S0006-8993(99)01753-9	38	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219061	10.1371/journal.pone.0219061	http://dx.doi.org/10.1371/journal.pone.0219061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260464	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700028
J	Baral, K; Rotwein, P				Baral, Kabita; Rotwein, Peter			The insulin-like growth factor 2 gene in mammals: Organizational complexity within a conserved locus	PLOS ONE			English	Article							GROWTH-FACTOR-II; IGF-II; IMPRINTED GENES; SKELETAL-MUSCLE; INSULIN; MOUSE; H19; EXPRESSION; ENHANCER; METHYLATION	The secreted protein, insulin-like growth factor 2 (IGF2), plays a central role in fetal and prenatal growth and development, and is regulated at the genetic level by parental imprinting, being expressed predominantly from the paternally derived chromosome in mice and humans. Here, IGF2/Igf2 and its locus has been examined in 19 mammals from 13 orders spanning similar to 166 million years of evolutionary development. By using human or mouse DNA segments as queries in genome analyses, and by assessing gene expression using RNA-sequencing libraries, more complexity was identified within IGF2/Igf2 than was annotated previously. Multiple potential 5' non-coding exons were mapped in most mammals and are presumably linked to distinct IGF2/Igf2 promoters, as shown for several species by interrogating RNA-sequencing libraries. DNA similarity was highest in IGF2/Igf2 coding exons; yet, even though the mature IGF2 protein was conserved, versions of 67 or 70 residues are produced secondary to species-specific maintenance of alternative RNA splicing at a variable intron-exon junction. Adjacent H19 was more divergent than IGF2/Igf2, as expected in a gene for a noncoding RNA, and was identified in only 10/19 species. These results show that common features, including those defining IGF2/Igf2 coding and several non-coding exons, were likely present at the onset of the mammalian radiation, but that others, such as a putative imprinting control region 5' to H19 and potential enhancer elements 3' to H19, diversified with speciation. This study also demonstrates that careful analysis of genomic and gene expression repositories can provide new insights into gene structure and regulation.	[Baral, Kabita] Univ Texas El Paso, Coll Sci, Grad Sch, El Paso, TX 79968 USA; [Rotwein, Peter] Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Mol & Translat Med, El Paso, TX 79905 USA	University of Texas System; University of Texas El Paso	Rotwein, P (corresponding author), Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Mol & Translat Med, El Paso, TX 79905 USA.	peter.rotwein@ttuhsc.edu		Rotwein, Peter/0000-0002-9505-1817	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK042748]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK042748 to PR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Alzhanov D, 2016, PHYSIOL GENOMICS, V48, P167, DOI 10.1152/physiolgenomics.00095.2015; Alzhanov DT, 2010, J BIOL CHEM, V285, P38969, DOI 10.1074/jbc.M110.160986; Asher RJ, 2009, BIOESSAYS, V31, P853, DOI 10.1002/bies.200900053; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Bartolomei MS, 2008, NAT GENET, V40, P932, DOI 10.1038/ng0808-932; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLUNDELL TL, 1980, NATURE, V287, P781, DOI 10.1038/287781a0; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cassidy FC, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.164517; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Eggermann Thomas, 2010, Pediatr Endocrinol Rev, V8, P86; Eun B, 2013, NUCLEIC ACIDS RES, V41, P8126, DOI 10.1093/nar/gkt597; Eun B, 2013, NUCLEIC ACIDS RES, V41, P817, DOI 10.1093/nar/gks1182; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; HAMPTON B, 1989, J BIOL CHEM, V264, P19155; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; JANSEN M, 1985, FEBS LETT, V179, P243, DOI 10.1016/0014-5793(85)80527-5; Kadakia R, 2016, HORM RES PAEDIAT, V85, P75, DOI 10.1159/000443500; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Katsanis N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1107-9; Kitsiou-Tzeli S, 2017, CURR OPIN ENDOCRINOL, V24, P43, DOI 10.1097/MED.0000000000000305; LEE JE, 1990, DEVELOPMENT, V110, P151; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu L, 2017, P NATL ACAD SCI USA, V114, pE7282, DOI 10.1073/pnas.1616744114; Livingstone C, 2014, CLIN ENDOCRINOL, V80, P773, DOI 10.1111/cen.12446; Livingstone C, 2013, ENDOCR-RELAT CANCER, V20, pR321, DOI 10.1530/ERC-13-0231; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Manolio TA, 2017, CELL, V169, P6, DOI 10.1016/j.cell.2017.03.005; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Nikolaev SI, 2007, P NATL ACAD SCI USA, V104, P20443, DOI 10.1073/pnas.0705658104; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Quintana-Murci L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1093-y; Rodenburg RJT, 1997, MOL ENDOCRINOL, V11, P237, DOI 10.1210/me.11.2.237; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; Rotwein P, 2018, J BIOL CHEM, V293, P15912, DOI 10.1074/jbc.RA118.004861; Rotwein P, 2018, PHYSIOL GENOMICS, V50, P425, DOI 10.1152/physiolgenomics.00030.2018; Rotwein P, 2018, J BIOL CHEM, V293, P4324, DOI 10.1074/jbc.RA117.001573; Rotwein P, 2017, J BIOL CHEM, V292, P19608, DOI 10.1074/jbc.AAC117.000854; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; SUSSENBACH JS, 1993, ADV EXP MED BIOL, V343, P63; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; Tucci V, 2019, CELL, V176, P952, DOI 10.1016/j.cell.2019.01.043; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Ward MC, 2017, NATURE, V550, P190, DOI 10.1038/550190a; Weiner J, 2006, FEBS J, V273, P2037, DOI 10.1111/j.1742-4658.2006.05220.x; Wilkins JF, 2016, BIOESSAYS, V38, P482, DOI 10.1002/bies.201500198; Wit JM, 2011, ENDOCR DEV, V21, P30, DOI 10.1159/000328119; Xue C, 2016, GENOME RES, V26, P1651, DOI 10.1101/gr.204255.116; YOOWARREN H, 1988, MOL CELL BIOL, V8, P4707, DOI 10.1128/MCB.8.11.4707; Younis S, 2018, P NATL ACAD SCI USA, V115, pE2048, DOI 10.1073/pnas.1719278115	66	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219155	10.1371/journal.pone.0219155	http://dx.doi.org/10.1371/journal.pone.0219155			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251794	Green Submitted, gold, Green Published			2022-12-26	WOS:000484915000047
J	Hernaez, A; Soria-Florido, MT; Schroder, H; Ros, E; Pinto, X; Estruch, R; Salas-Salvado, J; Corella, D; Aros, F; Serra-Majem, L; Martinez-Gonzalez, MA; Fiol, M; Lapetra, J; Elosua, R; Lamuela-Raventos, RM; Fito, M				Hernaez, Alvaro; Trinidad Soria-Florido, Maria; Schroder, Helmut; Ros, Emilio; Pinto, Xavier; Estruch, Ramon; Salas-Salvado, Jordi; Corella, Dolores; Aros, Fernando; Serra-Majem, Lluis; Angel Martinez-Gonzalez, Miguel; Fiol, Miquel; Lapetra, Jose; Elosua, Roberto; Maria Lamuela-Raventos, Rosa; Fito, Montserrat			Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX CAPACITY; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; THERAPEUTIC TARGET; ATHEROSCLEROSIS; MEN; DYSLIPIDEMIA; CONFORMATION; PREDICTOR	Background High-density lipoprotein (HDL) functionality and low-density lipoprotein (LDL) atherogenic traits can describe the role of both particles on cardiovascular diseases more accurately than HDL- or LDL-cholesterol levels. However, it is unclear how these lipoprotein properties are particularly affected by different cardiovascular risk factors. Objective To determine which lipoprotein properties are associated with greater cardiovascular risk scores and each cardiovascular risk factor. Methods In two cross-sectional baseline samples of PREDIMED trial volunteers, we assessed the associations of HDL functionality (N = 296) and LDL atherogenicity traits (N = 210) with: 1) the 10-year predicted coronary risk (according to the Framingham-REGICOR score), and 2) classical cardiovascular risk factors. Results Greater cardiovascular risk scores were associated with low cholesterol efflux values; oxidized, triglyceride-rich, small HDL particles; and small LDLs with low resistance against oxidation (P-trend<0.05, all). After adjusting for the rest of risk factors; 1) type-2 diabetic individuals presented smaller and more oxidized LDLs (P<0.026, all); 2) dyslipidemic participants had smaller HDLs with an impaired capacity to metabolize cholesterol (P<0.035, all); 3) high body mass index values were associated to lower HDL and LDL size and a lower HDL capacity to esterify cholesterol (P<0.037, all); 4) men presented a greater HDL oxidation and lower HDL vasodilatory capacity (P<0.046, all); and 5) greater ages were related to small, oxidized, cytotoxic LDL particles (P<0.037, all). Conclusions Dysfunctional HDL and atherogenic LDL particles are present in high cardiovascular risk patients. Dyslipidemia and male sex are predominantly linked to HDL dysfunctionality, whilst diabetes and advanced age are associated with LDL atherogenicity.	[Hernaez, Alvaro; Ros, Emilio; Estruch, Ramon] August Pi i Sunyer Biomed Res Inst IDIBAPS, Cardiovasc Risk Nutr & Aging Res Unit, Barcelona, Spain; [Hernaez, Alvaro] Univ Ramon Llull, Blanquerna Sch Life Sci, Barcelona, Spain; [Hernaez, Alvaro; Ros, Emilio; Pinto, Xavier; Estruch, Ramon; Salas-Salvado, Jordi; Corella, Dolores; Aros, Fernando; Angel Martinez-Gonzalez, Miguel; Fiol, Miquel; Lapetra, Jose; Maria Lamuela-Raventos, Rosa; Fito, Montserrat] Inst Salud Carlos III ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Trinidad Soria-Florido, Maria; Schroder, Helmut; Fito, Montserrat] Hosp del Mar Med Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp, Barcelona, Spain; [Trinidad Soria-Florido, Maria] Univ Barcelona, PhD Program Food Sci & Nutr, Barcelona, Spain; [Schroder, Helmut] ISCIII, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Ros, Emilio] Hosp Clin Barcelona, Lipid Clin Endocrinol & Nutr Serv, Barcelona, Spain; [Pinto, Xavier] Hosp Univ Bellvitge, Internal Med Serv, Lipids & Vasc Risk Unit, Lhospitalet De Llobregat, Spain; [Estruch, Ramon] Hosp Clin Barcelona, Internal Med Serv, Barcelona, Spain; [Salas-Salvado, Jordi] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Univ St Joan, Human Nutr Unit, Reus, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med, Valencia, Spain; [Aros, Fernando] Hosp Univ Alava, Dept Cardiol, Vitoria, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci, Las Palmas Gran Canaria, Spain; [Angel Martinez-Gonzalez, Miguel] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Angel Martinez-Gonzalez, Miguel] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Fiol, Miquel] Hosp Son Espases, Balearic Islands Hlth Res Inst, Palma De Mallorca, Spain; [Lapetra, Jose] Distrito Sanitario Atencion Primaria Sevilla, Dept Family Med, Res Unit, Seville, Spain; [Elosua, Roberto] Hosp del Mar Med Res Inst IMIM, Cardiovasc Epidemiol & Genet, REGICOR Res Grp, Barcelona, Spain; [Elosua, Roberto] ISCIII, CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain; [Maria Lamuela-Raventos, Rosa] Univ Barcelona, Fac Pharm, Dept Nutr & Bromatol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Ramon Llull; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinic de Barcelona; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Valencia; University Hospital of Araba; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; University of Navarra; Harvard University; Harvard T.H. Chan School of Public Health; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; University of Barcelona	Fito, M (corresponding author), Inst Salud Carlos III ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain.; Fito, M (corresponding author), Hosp del Mar Med Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp, Barcelona, Spain.	mfito@imim.es	Pintó, Xavier/AGI-4297-2022; Salas-Salvado, Jordi/C-7229-2017; Hernaez, Alvaro/GXF-3337-2022; Fiol, Miguel/F-6793-2016; Florido, María Trinidad Soria/ABA-2522-2020; Schroder, Helmut/G-2586-2015; Estruch, Ramon/AAZ-3723-2020; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Raventos, Rosa M Lamuela/F-3986-2016; Hernaez, Alvaro/AAH-4192-2019	Pintó, Xavier/0000-0002-2216-2444; Salas-Salvado, Jordi/0000-0003-2700-7459; Fiol, Miguel/0000-0002-5370-1391; Florido, María Trinidad Soria/0000-0002-5625-9033; Schroder, Helmut/0000-0003-2231-5081; Hernaez, Alvaro/0000-0001-8593-1477; ELOSUA, ROBERTO/0000-0001-8235-0095	Agencia de Gestio d'Ajuts Universitaris i de Recerca [2017 SGR 222, 2015 FI_B 01042]; Fundacio La Marato de TV3 [201512.31]; Instituto de Salud Carlos III [CB06/03/0028, PI15/00047, CD17/00122, CES12/025]	Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Fundacio La Marato de TV3; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by: Agencia de Gestio d'Ajuts Universitaris i de Recerca (2017 SGR 222), Fundacio La Marato de TV3 (201512.31), and Instituto de Salud Carlos III (CB06/03/0028 and PI15/00047). A.H. was funded by Instituto de Salud Carlos III (CD17/00122), M.-T.S.-F. was supported by Agencia de Gestio d'Ajuts Universitaris i de Recerca (2015 FI_B 01042), and M. Fito was supported by Instituto de Salud Carlos III (CES12/025). CIBERs of Pathophysiology of Obesity and Nutrition (CIBEROBN) and Cardiovascular Diseases (CIBERCV) are initiatives of the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Aoki T, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-4; AVIRAM M, 1988, J BIOL CHEM, V263, P16842; Besler C, 2012, EMBO MOL MED, V4, P251, DOI 10.1002/emmm.201200224; BONNEFONTROUSSELOT D, 1995, BBA-LIPID LIPID MET, V1255, P23, DOI 10.1016/0005-2760(94)00211-G; Carvalho LSF, 2014, ATHEROSCLEROSIS, V237, P840, DOI 10.1016/j.atherosclerosis.2014.10.103; Cole TG, 2013, CLIN CHEM, V59, P752, DOI 10.1373/clinchem.2012.196733; Curtiss LK, 2000, BIOCHEMISTRY-US, V39, P5712, DOI 10.1021/bi992902m; Dullaart RPF, 2010, ATHEROSCLEROSIS, V208, P537, DOI 10.1016/j.atherosclerosis.2009.07.042; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Ferrara A, 1997, CIRCULATION, V96, P37; Ganjali S, 2018, DRUG DISCOV TODAY, V23, P171, DOI 10.1016/j.drudis.2017.09.014; Gomez M, 2014, ATHEROSCLEROSIS, V232, P134, DOI 10.1016/j.atherosclerosis.2013.10.026; Haidari M, 2001, CLIN CHEM, V47, P1234; Hemaez A, 2017, CIRCULATION, V135, P633, DOI [10.1161/CIRCULATIONAHA.116.023712, DOI 10.1161/CIRCULATIONAHA.116.023712]; Hermsdorff HHM, 2014, EUR J PREV CARDIOL, V21, P884, DOI 10.1177/2047487312472420; Hernaez A, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601015; Hernaez A, 2015, J NUTR, V145, P1692, DOI 10.3945/jn.115.211557; Hernaez A, 2014, ARTERIOSCL THROM VAS, V34, P2115, DOI 10.1161/ATVBAHA.114.303374; Hoogeveen RC, 2014, ARTERIOSCL THROM VAS, V34, P1069, DOI 10.1161/ATVBAHA.114.303284; Jacobson TA, 2011, INT J CLIN PRACT, V65, P82, DOI 10.1111/j.1742-1241.2010.02547.x; Johnson JL, 2004, ATHEROSCLEROSIS, V176, P371, DOI 10.1016/j.atherosclerosis.2004.05.018; Johnston N, 2006, INT J CARDIOL, V113, P167, DOI 10.1016/j.ijcard.2005.11.006; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Kresanov P, 2013, FREE RADICAL BIO MED, V65, P1284, DOI 10.1016/j.freeradbiomed.2013.09.023; KUNITAKE ST, 1990, J BIOL CHEM, V265, P20739; Kunutsor SK, 2016, ATHEROSCLEROSIS, V245, P143, DOI 10.1016/j.atherosclerosis.2015.12.021; Mabuchi H, 2014, MOL CELLS, V37, P777, DOI 10.14348/molcells.2014.0265; Marrugat J, 2007, J EPIDEMIOL COMMUN H, V61, P40, DOI 10.1136/jech.2005.038505; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Phillips CM, 2015, ATHEROSCLEROSIS, V242, P399, DOI 10.1016/j.atherosclerosis.2015.07.040; Pirillo A, 2013, CARDIOLOGY, V124, P116, DOI 10.1159/000346463; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; Sobenin IA, 1996, DIABETES, V45, pS35, DOI 10.2337/diab.45.3.S35; SPARKS DL, 1995, J BIOL CHEM, V270, P26910, DOI 10.1074/jbc.270.45.26910; Tang WHW, 2011, CIRC-HEART FAIL, V4, P59, DOI 10.1161/CIRCHEARTFAILURE.110.958348; Taskinen MR, 2015, ATHEROSCLEROSIS, V239, P483, DOI 10.1016/j.atherosclerosis.2015.01.039; Wagner AM, 2002, ACTA DIABETOL, V39, P215, DOI 10.1007/s005920200037; WILSON PWF, 1990, AM J CARDIOL, V66, pA7, DOI 10.1016/0002-9149(90)90562-F	44	25	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218533	10.1371/journal.pone.0218533	http://dx.doi.org/10.1371/journal.pone.0218533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246976	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900027
J	Amador, MDM; Arevalo-Rodriguez, M; Duran, EM; Reyes, JCM; Martin, CS				Moreno Amador, Maria de Lourdes; Arevalo-Rodriguez, Miguel; Mellado Duran, Encarnacion; Martinez Reyes, Juan Carlos; Sousa Martin, Carolina			A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides	PLOS ONE			English	Article							PROLINE-SPECIFIC ENDOPEPTIDASE; SP-NOV.; DNA HYBRIDIZATION; WHEAT ALLERGY; FREE DIET; ENZYME; PURIFICATION; ENDOPROTEASE; ACID; BEER	Gluten is a complex of proteins present in barley, wheat, rye and several varieties of oats that triggers celiac disease in genetically predisposed subjects. Gluten is notoriously difficult to digest by mammalian proteolytic enzymes and therefore, proline-rich digestion-resistant peptides contain multiple immunogenic epitopes. Prolyl endopeptidases (PEP) hydrolyse internal proline residues on the carboxyl side of peptides and have been proposed for food gluten detoxification and as oral enzyme supplementation for celiacs. The aim of this study was to identify new gluten-degrading microbial enzymes with the potential to reduce gluten immunogenicity by neutralizing its antigenic epitopes. Using a gluten-degrading colony screening approach, a bacterial isolate (2RA3) displaying the highest glutenase activity was selected, characterized and its genome completely sequenced. The identification through 16S rDNA gene sequencing showed a 99,1% similarity to Chryseobacterium taeanense. Hydrolysis of gluten immunogenic peptides (GIP) was further monitored, over a 48-hour period, by colony encapsulation in gliadin-containing microspheres, followed by detection with the G12 anti-GIP monoclonal antibody. Glutenase activity was detected in the extracellular medium of 2RA3 cultures, where gel electrophoresis and gliadin zymography revealed the presence of a similar to 50 kDa gluten-degrading enzyme. Nano-ESI-Q-TOF of the excised active band identified 7 peptides contained in the protein product predicted for an open reading frame (ORF) in the 2RA3 genome. Based on sequence similarity to the PEP family, the new enzyme was named PEP 2RA3. The PEP 2RA3 coding sequence was PCR-amplified from C. taeanense 2RA3, cloned and expressed in Escherichia coli as a C-terminally His-tagged recombinant protein and purified by Ni-NTA affinity chromatography. The recombinant protein, with predicted molecular mass and isoelectric point of 78.95 kDa and 6.8, respectively, shows PEP activity with standard chromogenic substrates, works optimally at pH 8.0 and 30 degrees C and remains stable at pH 6.0 and 50 degrees C, indicating a potential use in gluten-containing food process applications. The ability of the recombinant enzyme to degrade GIP in beer into smaller peptides was confirmed.	[Moreno Amador, Maria de Lourdes; Mellado Duran, Encarnacion; Sousa Martin, Carolina] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain; [Arevalo-Rodriguez, Miguel; Martinez Reyes, Juan Carlos] Biomedal SL, Seville, Spain	University of Sevilla	Martin, CS (corresponding author), Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain.	csoumar@us.es	MELLADO, ENCARNACIÓN/K-8665-2014; de Lourdes Moreno Amador, María/H-5836-2012	MELLADO, ENCARNACIÓN/0000-0002-7135-1428; de Lourdes Moreno Amador, María/0000-0002-7490-2037	Ministry of Science and Innovation [AGL2009-09069]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	A project of the Ministry of Science and Innovation (AGL2009-09069 to CSM) supported this work financially. Authors employed by Biomedal S. L. played a role in the study design and analysis of certain experiments. The specific roles of these authors are articulated in the 'author contributions' section.	Akeroyd M, 2016, J AM SOC BREW CHEM, V74, P91, DOI 10.1094/ASBCJ-2016-2300-01; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Capiralla H, 2002, PROCESS BIOCHEM, V38, P571, DOI 10.1016/S0032-9592(02)00180-2; Cebolla A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121927; Ciacci C, 2015, UNITED EUR GASTROENT, V3, P121, DOI 10.1177/2050640614559263; Colgrave ML, 2017, J AGR FOOD CHEM, V65, P9715, DOI 10.1021/acs.jafc.7b03742; Comino I, 2016, AM J GASTROENTEROL, V111, P1456, DOI 10.1038/ajg.2016.439; Comino I, 2013, J SCI FOOD AGR, V93, P933, DOI 10.1002/jsfa.5830; Comino I, 2012, MOL NUTR FOOD RES, V56, P1697, DOI 10.1002/mnfr.201200358; Moreno MD, 2017, GUT, V66, P250, DOI 10.1136/gutjnl-2015-310148; DELEY J, 1970, EUR J BIOCHEM, V12, P133; Deora NS, 2015, FOOD SCI TECHNOL INT, V21, P364, DOI 10.1177/1082013214538984; Ehren J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006313; Elli L, 2015, WORLD J GASTROENTERO, V21, P7110, DOI 10.3748/wjg.v21.i23.7110; Enany S, 2014, J INFECT PUBLIC HEAL, V7, P296, DOI 10.1016/j.jiph.2014.02.002; Fiedler KL, 2018, ANAL CHEM, V90, P2111, DOI 10.1021/acs.analchem.7b04371; GARCIA MT, 1987, INT J SYST BACTERIOL, V37, P251, DOI 10.1099/00207713-37-3-251; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Helmerhorst EJ, 2014, PROC SPIE, V9112, DOI 10.1117/12.2058730; Helmerhorst EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013264; HUSS VAR, 1983, SYST APPL MICROBIOL, V4, P184, DOI 10.1016/S0723-2020(83)80048-4; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Kabashima T, 1998, ARCH BIOCHEM BIOPHYS, V358, P141, DOI 10.1006/abbi.1998.0836; KANATANI A, 1993, J BIOCHEM, V113, P790, DOI 10.1093/oxfordjournals.jbchem.a124120; Kang C, 2014, J IND MICROBIOL BIOT, V41, P49, DOI 10.1007/s10295-013-1378-z; Khosla C, 2017, ACS CHEM BIOL, V12, P1455, DOI 10.1021/acschembio.6b01155; Kohli A, 2012, PHYSIOL PLANTARUM, V145, P165, DOI 10.1111/j.1399-3054.2012.01573.x; Konig J, 2018, EXPERT REV GASTROENT, V12, P531, DOI 10.1080/17474124.2018.1473762; Krishnareddy S, 2017, THER ADV GASTROENTER, V10, P473, DOI 10.1177/1756283X17690991; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez M, 2005, J AGR FOOD CHEM, V53, P7944, DOI 10.1021/jf0506535; Lundin KEA, 2014, CURR OPIN GASTROEN, V30, P154, DOI 10.1097/MOG.0000000000000041; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; Marquez MC, 2008, INT J SYST EVOL MICR, V58, P1922, DOI 10.1099/ijs.0.65813-0; Mika N, 2015, APPL MICROBIOL BIOT, V99, P7837, DOI 10.1007/s00253-015-6838-0; Mitea C, 2008, GUT, V57, P25, DOI 10.1136/gut.2006.111609; Ortiz C, 2017, REV CHIL PEDIATR-CHI, V88, P417, DOI 10.4067/S0370-41062017000300017; Oyama H, 1997, J FERMENT BIOENG, V84, P538, DOI 10.1016/S0922-338X(97)81908-3; Park MS, 2006, INT J SYST EVOL MICR, V56, P433, DOI 10.1099/ijs.0.63825-0; QUESADA E, 1984, INT J SYST BACTERIOL, V34, P287, DOI 10.1099/00207713-34-3-287; Rea D, 2006, CELL BIOCHEM BIOPHYS, V44, P349, DOI 10.1385/CBB:44:3:349; Real A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100917; Rodrigues M, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0740-z; Rosell CM, 2014, J CEREAL SCI, V59, P354, DOI 10.1016/j.jcs.2013.10.001; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shen FT, 2005, INT J SYST EVOL MICR, V55, P1301, DOI 10.1099/ijs.0.63514-0; Shetty R, 2017, ENZYME MICROB TECH, V107, P57, DOI 10.1016/j.enzmictec.2017.08.002; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; Suano A, 2016, FOOD CHEM, V205, P36, DOI [10.1016/j.foodchem.2016.02.066, DOI 10.1016/J.FOODCHEM.2016.02.066]; SZWAJCERDEY E, 1992, J BACTERIOL, V174, P2454, DOI 10.1128/jb.174.8.2454-2459.1992; Tai CJ, 2006, INT J SYST EVOL MICR, V56, P1771, DOI 10.1099/ijs.0.64294-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tye-Din JA, 2010, CLIN IMMUNOL, V134, P289, DOI 10.1016/j.clim.2009.11.001; van Landschoot A., 2011, CEREVISIA, V36, P93, DOI [10.1016/j.cervis.2011.09.001, DOI 10.1016/J.CERVIS.2011.09.001]; VENTOSA A, 1982, J GEN MICROBIOL, V128, P1959; Verhoeckx KCM, 2015, FOOD CHEM TOXICOL, V80, P223, DOI 10.1016/j.fct.2015.03.005; WAYNE LG, 1988, ZBL BAKT-INT J MED M, V268, P433; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; YOSHIMOTO T, 1980, J BIOL CHEM, V255, P4786	62	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218346	10.1371/journal.pone.0218346	http://dx.doi.org/10.1371/journal.pone.0218346			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246975	gold, Green Submitted, Green Published			2022-12-26	WOS:000484911900018
J	Sarkar, J; Milani, B; Kim, E; An, S; Kwon, J; Jain, S				Sarkar, Joy; Milani, Behrad; Kim, Eunjae; An, Seungwon; Kwon, Jieun; Jain, Sandeep			Corneal nerve healing after in situ laser nerve transection	PLOS ONE			English	Article							INNERVATION; RECOVERY; LASIK; PRK	Purpose We have previously reported that lamellar dissection of the cornea transects stromal nerves, and that regenerating neurites form a dense net along the surgical plane. In these experiments, we have disrupted the stromal nerve trunks in situ, without incising the cornea, to determine the regeneration events in the absence of a surgical plane. Methods Thy1-YFP mice were anesthetized and in vivo images of the corneal nerves were obtained with a wide-field stereofluorescent microscope. A far infrared XYRCOS Laser attached to 20X objective of an upright microscope was used to perform in situ transection of the stromal nerves. 3 types of laser transections were performed (n = 5/group): (i) point transection (a single cut); (ii) segmental transection (two cuts enclosing a segment of nerve trunk); and (iii) annular transection (cuts on all nerve trunks crossing the perimeter of a 0.8 mm diameter circular area centered on the corneal apex). Mice were imaged sequentially for 4 weeks thereafter to assess nerve degeneration (disappearance or weakening of original fluorescence intensity) or regeneration (appearance of new fluorescent fronds). Beta-3-tubulin immunostaining was performed on corneal whole-mounts to demonstrate nerve disruption. Results The pattern of stromal nerves in corneas of the same mouse and in corneas of littermates was dissimilar. Two distinct patterns were observed, often within the same cornea: (i) interconnected trunks that spanned limbus to limbus; or (ii) dichotomously branching trunks that terminate at the corneal apex. Point transections did not cause degeneration of proximal or distal segment in interconnected trunks, but resulted in degeneration of distal segment of branching trunks. In segmental transections, the nerve segment enclosed within the two laser cuts degenerated. Lack of beta-3 tubulin staining at transection site confirmed nerve transection. In interconnected trunks, at 4 weeks, a hyperfluorescent plaque filled the gap created by the transection. In annular transections, some nerve trunks degenerated, while others regained or retained fluorescence. Conclusions Interconnected stromal nerves in murine corneas do not degenerate after in situ point transection and show evidence of healing at the site of disruption. Presence or absence of a surgical plane influences corneal nerve regeneration after transection.	[Sarkar, Joy; Milani, Behrad; Kim, Eunjae; An, Seungwon; Kwon, Jieun; Jain, Sandeep] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jain, S (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	jains@uic.edu		Sarkar, Joy/0000-0001-6074-6507	National Eye Institute (NEI) [R01EY023656]; NEI [P30EY001792]; Research to Prevent Blindness; Midwest Eye Banks; NATIONAL EYE INSTITUTE [R13EY027189, P30EY001792, R01EY023656, R01EY024966] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Midwest Eye Banks; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (NEI) Grant R01EY023656 (SJ), NEI core grant P30EY001792, Midwest Eye Banks (SJ), and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Belmonte C, 1997, PROG RETIN EYE RES, V16, P117, DOI 10.1016/S1350-9462(96)00027-4; Belmonte C, 2011, ADLERS PHYSL EYE, P363; BEUERMAN RW, 1980, EXP NEUROL, V69, P196, DOI 10.1016/0014-4886(80)90154-5; Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616; Chao C, 2014, OCUL SURF, V12, P32, DOI 10.1016/j.jtos.2013.09.001; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Dastjerdi Mohammad H, 2009, Int Ophthalmol Clin, V49, P11, DOI 10.1097/IIO.0b013e31819242c9; Dohlman Thomas H, 2016, Int Ophthalmol Clin, V56, P101, DOI 10.1097/IIO.0000000000000104; Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015; Erie Jay C, 2003, Trans Am Ophthalmol Soc, V101, P293; Erie JC, 2005, AM J OPHTHALMOL, V140, P1059, DOI 10.1016/j.ajo.2005.07.027; Heigle TJ, 1996, CORNEA, V15, P135, DOI 10.1097/00003226-199603000-00005; LELE PP, 1959, EXP NEUROL, V1, P334, DOI 10.1016/0014-4886(59)90025-1; LELE PP, 1956, BRAIN, V79, P119, DOI 10.1093/brain/79.1.119; Marfurt CF, 2010, ENCY EYE, V1; Moilanen JAO, 2008, BRIT J OPHTHALMOL, V92, P1397, DOI 10.1136/bjo.2007.126821; Moilanen JAO, 2003, INVEST OPHTH VIS SCI, V44, P1064, DOI 10.1167/iovs.02-0247; Namavari A, 2012, INVEST OPHTH VIS SCI, V53, P732, DOI 10.1167/iovs.11-8445; Namavari A, 2011, INVEST OPHTH VIS SCI, V52, P8025, DOI 10.1167/iovs.11-8332; National Institutes of Health: National Eye Institute, NEI WORKSH OC PAIN S; Niederer RL, 2007, INVEST OPHTH VIS SCI, V48, P621, DOI 10.1167/iovs.06-0538; Nishida T, 2012, JPN J OPHTHALMOL, V56, P20, DOI 10.1007/s10384-011-0105-4; Sarkar J, 2012, INVEST OPHTH VIS SCI, V53, P1792, DOI 10.1167/iovs.11-8775; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Shriver LP, 2006, AM J PATHOL, V169, P999, DOI 10.2353/ajpath.2006.050791; Wilson SE, 2001, OPHTHALMOLOGY, V108, P1082, DOI 10.1016/S0161-6420(01)00587-5	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218879	10.1371/journal.pone.0218879	http://dx.doi.org/10.1371/journal.pone.0218879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246989	gold, Green Submitted, Green Published			2022-12-26	WOS:000484911900049
J	Tang, WH; Ranganathan, N; Shahrezaei, V; Larrouy-Maumus, G				Tang, Wenhao; Ranganathan, Nisha; Shahrezaei, Vahid; Larrouy-Maumus, Gerald			MALDI-TOF mass spectrometry on intact bacteria combined with a refined analysis framework allows accurate classification of MSSA and MRSA	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; BIOMARKER DISCOVERY; IDENTIFICATION; SELECTION	Fast and reliable detection coupled with accurate data-processing and analysis of antibiotic-resistant bacteria is essential in clinical settings. In this study, we use MALDI-TOF on intact cells combined with a refined analysis framework to demonstrate discrimination between methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus. By combining supervised and unsupervised machine learning methods, we firstly show that the mass spectroscopy data contains strong signal for the clustering of MSSA and MRSA. Then we concentrate on applying supervised learning to extract and verify the important features. A new workflow is proposed that allows for extracting a fixed set of reference peaks so that any new data can be aligned to it and hence consistent feature matrices can be obtained. Also note that by doing so we are able to examine the robustness of the important features that have been found. We also show that appropriate size of the benchmark data, appropriate alignment of the testing data and use of an optimal set of features via feature selection results in prediction accuracy over 90%. In summary, as proof-of-principle, our integrated experimental and bioinformatics study suggests a novel intact cell MALDI-TOF to be of great promise for fast and reliable detection of MRSA strains.	[Tang, Wenhao; Shahrezaei, Vahid] Imperial Coll London, Dept Math, London, England; [Ranganathan, Nisha] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Dept Med, Fac Med, London, England; [Larrouy-Maumus, Gerald] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, Fac Nat Sci, London, England	Imperial College London; Imperial College London; Imperial College London	Shahrezaei, V (corresponding author), Imperial Coll London, Dept Math, London, England.; Larrouy-Maumus, G (corresponding author), Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, Fac Nat Sci, London, England.	v.shahrezaei@imperial.ac.uk; g.larrouy-maumus@imperial.ac.uk	Tang, Wenhao/ABF-1011-2021	Shahrezaei, Vahid/0000-0002-4013-5458	Department of Life Sciences in the Faculty of Natural Sciences Imperial College London, UK; Department of Mathematics, AMMP PhD scholarship; MRC-Confidence in Concept grant [105603/Z/14/Z]; MRC [MR/P028225/1, MC_PC_15028] Funding Source: UKRI	Department of Life Sciences in the Faculty of Natural Sciences Imperial College London, UK; Department of Mathematics, AMMP PhD scholarship; MRC-Confidence in Concept grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Department of Life Sciences in the Faculty of Natural Sciences Imperial College London, UK, and MRC-Confidence in Concept grant number 105603/Z/14/Z supported this work (https://mrc.ukri.org/). WT is supported by a Department of Mathematics, AMMP PhD scholarship.	BERNARDO K, IDENTIFICATION, P6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CONRAD TOF, 2017, BMC BIOINFORMATICS, V18, DOI DOI 10.1016/J.MIMET.2005.04.015; Drake RR, 2011, J MASS SPECTROM, V46, P1223, DOI 10.1002/jms.2008; Du ZM, 2002, ANAL CHEM, V74, P5487, DOI 10.1021/ac020109k; Edwards-Jones V, 2000, J MED MICROBIOL, V49, P295, DOI 10.1099/0022-1317-49-3-295; GIBB S, 2012, ARXIV PREPRINT ARXIV, DOI DOI 10.1016/J.JASMS.2004.03.008; Gibb S, 2015, BIOINFORMATICS, V31, P3156, DOI 10.1093/bioinformatics/btv334; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hansen ME, 2004, J AM SOC MASS SPECTR, V15, P1173, DOI 10.1016/j.jasms.2004.03.008; He QP, 2011, CANCER INFORM, V10, P65, DOI 10.4137/CIN.S6358; Jackson KA, 2005, J MICROBIOL METH, V62, P273, DOI 10.1016/j.mimet.2005.04.015; KEY M, 2012, BMC BIOINFORMATI S16, V13, DOI DOI 10.4137/CIN.S6358; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Lu JJ, 2012, ANAL CHEM, V84, P5685, DOI 10.1021/ac300855z; Luteijn JM, 2011, CLIN MICROBIOL INFEC, V17, P146, DOI 10.1111/j.1469-0691.2010.03202.x; Pournajaf Abazar, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS293, DOI 10.12980/APJTB.4.2014C423; Sauget M, 2017, TRENDS MICROBIOL, V25, P447, DOI 10.1016/j.tim.2016.12.006; SPECTROMETRY, 2002, PROTEOMICS, V2, P747; SPECTROMETRY, PROTEOMICS; TEAM RCR, 2013, R A LANGUAGE AND ENV, DOI DOI 10.1007/S00253-011-3783-4; Tibshirani R, 2004, BIOINFORMATICS, V20, P3034, DOI 10.1093/bioinformatics/bth357; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; WU Y, 2006, STATISTICAL METHODS, DOI DOI 10.1186/1471-2105-13-S16-S10; Yasui Y, 2003, BIOSTATISTICS, V4, P449, DOI 10.1093/biostatistics/4.3.449	25	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218951	10.1371/journal.pone.0218951	http://dx.doi.org/10.1371/journal.pone.0218951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247021	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900056
J	May, M; Beauchemin, M; Vary, C; Barlow, D; Houseknecht, KL				May, Meghan; Beauchemin, Megan; Vary, Calvin; Barlow, Deborah; Houseknecht, Karen L.			The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; TRABECULAR BONE LOSS; ATYPICAL ANTIPSYCHOTICS; 2ND-GENERATION ANTIPSYCHOTICS; TNF-ALPHA; SCHIZOPHRENIA; DOPAMINE; RECEPTOR; CYTOKINE; PATHOGENESIS	Atypical antipsychotic medications such as risperidone are widely prescribed for diverse psychiatric indications including schizophrenia, bipolar disorder and depression. These medications have complex pharmacology and are associated with significant endocrine and metabolic side effects. This class of medications also carries FDA black box warnings due to increased risk of death in elderly patients. Clinical reports indicate that patients treated with these medications are more susceptible to infections; however, the underlying mechanisms/pharmacology are unclear. We have previously reported that risperidone and it's active metabolite distributes to the bone marrow in clinically relevant concentrations in preclinical species, leading us to hypothesize that the hematopoietic system may be impacted by these medications. To test this hypothesis, using proteomic and cytokine array technology, we evaluated the expression of genes involved in inflammatory and immune function following short term (5 days) and longer term (4 weeks) treatment in healthy animals. We report that low-dose risperidone treatment results in global immunosuppression in mice, observed following 5 days of dosing and exacerbated with longer term drug treatment (4 weeks). These data are consistent with increased susceptibility to infection in patients administered these medications and have profound implications for the increasing off-label prescribing to vulnerable patient populations including children and the elderly.	[May, Meghan; Beauchemin, Megan; Barlow, Deborah; Houseknecht, Karen L.] Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA; [Vary, Calvin] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA	University of New England - Maine; Maine Medical Center	Houseknecht, KL (corresponding author), Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.	khouseknecht@une.edu			National Institutes of Health (NIH.gov) including NIDDK [DK095143]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121301] Funding Source: NIH RePORTER	National Institutes of Health (NIH.gov) including NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by grants from the National Institutes of Health (NIH.gov) including NIDDK award number DK095143 to KLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amin MM, 2013, CLIN PSYCHOPHARM NEU, V11, P144, DOI 10.9758/cpn.2013.11.3.144; Allers K, 2017, INT CLIN PSYCHOPHARM, V32, P213, DOI 10.1097/YIC.0000000000000173; Ballard C, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.06.021; Barker KA, 2015, J AM MED DIR ASSOC, V16, P832, DOI 10.1016/j.jamda.2015.05.015; Calarge CA, 2009, J CHILD ADOL PSYCHOP, V19, P101, DOI 10.1089/cap.2008.007; Capuzzi E, 2017, NEUROSCI BIOBEHAV R, V77, P122, DOI 10.1016/j.neubiorev.2017.03.003; Castagnini LA, 2010, J PEDIATR-US, V156, P498, DOI 10.1016/j.jpeds.2009.10.013; Chen ML, 2012, INT IMMUNOPHARMACOL, V12, P197, DOI 10.1016/j.intimp.2011.11.011; de la Chapelle A, 1977, Hum Genet, V37, P183; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Drzyzga L, 2006, BRAIN BEHAV IMMUN, V20, P532, DOI 10.1016/j.bbi.2006.02.002; Erbagci AB, 2001, MEDIAT INFLAMM, V10, P109, DOI 10.1080/09629350120072761; Gaughran F, 2002, INT REV NEUROBIOL, V52, P275; GILLET LC, 2012, MOL CELL PROTEOMICS, V6, pO111, DOI DOI 10.1074/MCP.0111; Gray A., 2016, PHARM J, V296, DOI [10.1211/PJ.2016.20200305, DOI 10.1211/PJ.2016.20200305]; Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x; Henig O, 2017, INFECT DIS CLIN N AM, V31, P689, DOI 10.1016/j.idc.2017.07.015; Houseknecht KL, 2007, NEUROPSYCHOPHARMACOL, V32, P289, DOI 10.1038/sj.npp.1301209; Jensen NH, 2010, THESCIENTIFICWORLDJO, V10, P1870, DOI 10.1100/tsw.2010.180; Jump RLP, 2018, J AM GERIATR SOC, V66, P789, DOI 10.1111/jgs.15248; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim HM, 2011, PSYCHIAT SERV, V62, P1207, DOI 10.1176/ps.62.10.pss6210_1207; Kroken RA, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00753; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P1109, DOI 10.1001/jama.2013.276603; Liperoti R, 2007, J CLIN PSYCHIAT, V68, P929, DOI 10.4088/JCP.v68n0616; Magro F, 2006, DIGEST DIS SCI, V51, P2039, DOI 10.1007/s10620-006-9168-3; Magro F, 2004, ACTA PHYSIOL SCAND, V180, P379, DOI 10.1111/j.1365-201X.2004.01260.x; Magro F, 2002, DIGEST DIS SCI, V47, P216, DOI 10.1023/A:1013256629600; Majumdar S, 2018, SCAND J IMMUNOL, V87, P4, DOI 10.1111/sji.12618; Manfredi G, 2013, GEN HOSP PSYCHIAT, V35, DOI 10.1016/j.genhosppsych.2012.03.009; Mauri MC, 2014, EXCLI J, V13, P1163; Melnikov M, 2016, J NEUROIMMUNOL, V292, P97, DOI 10.1016/j.jneuroim.2016.01.020; Morrison M, 2017, CURR DRUG SAF; Motyl KJ, 2017, BONE, V103, P168, DOI 10.1016/j.bone.2017.07.008; Motyl KJ, 2015, ENDOCRINOLOGY, V156, P2374, DOI 10.1210/en.2015-1099; Motyl KJ, 2012, BONE, V50, P490, DOI 10.1016/j.bone.2011.08.005; Olfson M, 2012, ARCH GEN PSYCHIAT, V69, P1247, DOI 10.1001/archgenpsychiatry.2012.647; Park JH, 2019, J MOL MED BERL; Patel JK, 2009, SCHIZOPHR RES, V111, P9, DOI 10.1016/j.schres.2009.03.025; Ralph SJ, 2018, J ALZHEIMERS DIS REP, V2, P1, DOI 10.3233/ADR-170042; Rath B, 2017, EXPERT REV ANTI-INFE, V15, P545, DOI 10.1080/14787210.2017.1295847; Ray WA, 2019, JAMA PSYCHIAT, V76, P162, DOI 10.1001/jamapsychiatry.2018.3421; Regue M, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0431-8; Rettenbacher MA, 2010, PHARMACOPSYCHIATRY, V43, P41, DOI 10.1055/s-0030-1249071; Reynolds GP, 2011, THER ADV PSYCHOPHARM, V1, P197, DOI 10.1177/2045125311430112; Rigler SK, 2013, J AM GERIATR SOC, V61, P715, DOI 10.1111/jgs.12216; Romeo B, 2018, INT J NEUROPSYCHOPH, V21, P828, DOI 10.1093/ijnp/pyy062; Schafer M, 2001, NERVENARZT, V72, P872, DOI 10.1007/s001150170022; Schoenichen C, 2019, FRONT BIOSCI, V24, P514; Schuld A, 2004, NERVENARZT, V75, P215, DOI 10.1007/s00115-003-1599-x; SENN HJ, 1977, LANCET, V1, P547; Sluys M, 2004, EUR PSYCHIAT, V19, P117, DOI 10.1016/j.eurpsy.2003.03.009; Sohn M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003784; Solmi M, 2017, CNS SPECTRUMS, V22, P415, DOI 10.1017/S1092852916000638; Tolstanova G, 2015, DIGEST DIS SCI, V60, P2963, DOI 10.1007/s10620-015-3698-5; Tsuchida Y, 2011, GUT, V60, P638, DOI 10.1136/gut.2010.227546; van Strien AM, 2018, J CLIN PSYCHOPHARM, V38, P296, DOI 10.1097/JCP.0000000000000895; Vidal P. M., 2019, J NEUROIMMUNE PHARM; World Health Organization, 2018, SCHIZOPHRENIA; Xiang YQ, 2017, EUR NEUROPSYCHOPHARM, V27, P8, DOI 10.1016/j.euroneuro.2016.11.012; Zhou K, 2017, BEST PRACT RES CL GA, V31, P311, DOI 10.1016/j.bpg.2017.06.002	61	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218937	10.1371/journal.pone.0218937	http://dx.doi.org/10.1371/journal.pone.0218937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242264	Green Submitted, gold, Green Published			2022-12-26	WOS:000482883600068
J	Ndizeye, Z; Broeck, DV; Lebelo, RL; Bogers, J; Benoy, I; Van Geertruyden, JP				Ndizeye, Zacharie; Broeck, Davy Vanden; Lebelo, Ramokone Lisbeth; Bogers, Johannes; Benoy, Ina; Van Geertruyden, Jean-Pierre			Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; RISK HUMAN-PAPILLOMAVIRUS; NEGATIVE WOMEN; AS04-ADJUVANTED VACCINE; DOUBLE-BLIND; HPV-DNA; IMMUNODEFICIENCY; INFECTION; METAANALYSIS; POPULATION	Background Human papillomaviruses are the most important causative agents for invasive cervical cancer development. HPV type-specific vaccination and HPV cervical cancer screening methods are being widely recommended to control the disease but the epidemiology of the circulating HPV types may vary locally. The circulating HPV-strains have never been assessed in Burundi. This study determined the prevalence and genotype-specific distribution of HPV in four different strata in Burundi: HIV-infected or non-infected and women living in rural or urban areas. Implications for HPV diagnosis and vaccine implementation was discussed. Methods Four cross-sectional surveys were conducted in Burundi (2013 in a rural area and 2016 in urban area) among HIV-infected and uninfected women living in rural and urban areas. Liquid-Based Cytology (LBC) and HPV genotyping were performed and risk factors for HPV infection and cervical pre-cancer lesions were determined using logistic regression model. Results HPV prevalence was very high in urban area with significant differences between HIV-positive and negative women (p<0.0001). In fact, 45.7% of HIV-positive participants were infected with any HPV type and all were infected with at least one HR/pHR-HPV type. Among the HIV-negative participants, 13.4% were HPV-infected, of whom, only four women (2.7%) were infected with HR/pHR-HPV types. In rural area, HPV infection did not significantly differ between HIV-positive and negative women (30.0% and 31.3% respectively; p = 0.80). In urban area, multiple infections with HR/pHR-HPV types were detected in 13.9% and 2.7% among HIV-positive and negative women respectively (p<0.0001), whereas in rural area, multiple infections with HR/pHR-HPV types were detected in 4.7% and 3.3% of HIV-positive and negative women respectively (p = 0.56). The most prevalent HR/pHR-HPV types in HIV-positive women living in urban area were HPV 52, 51, 56, 18 and 16 types. In HIV-negative women living in urban area, the most prevalent HR/pHR-HPV types were HPV 66, 67, 18, 45 and 39 types. In HIV-positive women living in rural area, the most prevalent HR/pHR-HPV types were HPV 66, 16, 18 and 33 types. In HIV-negative women living in rural area, the most prevalent HR/pHR-HPV types were HPV 16, 66, 18, 35 and 45 types. Independent risk factors associated with cervical lesions were HPV and HIV infections. Conclusions There is a high burden of HR and pHR-HPV infections, in particular among HIV-infected women living in urban area. The study points out the need to introduce a comprehensive cervical cancer control programme adapted to the context. This study shows that the nona-valent vaccine covers most of the HR/pHR-HPV infections in rural and urban areas among HIV-infected and uninfected women.	[Ndizeye, Zacharie] Univ Burundi, Dept Community Med, Fac Med, Bujumbura, Burundi; [Ndizeye, Zacharie; Van Geertruyden, Jean-Pierre] Univ Antwerp, Global Hlth Inst, Fac Med & Hlth Sci, Antwerp, Belgium; [Broeck, Davy Vanden; Bogers, Johannes] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium; [Broeck, Davy Vanden; Bogers, Johannes; Benoy, Ina] AML Sonic Healthcare, Lab Mol Pathol, Antwerp, Belgium; [Broeck, Davy Vanden; Bogers, Johannes; Benoy, Ina] Natl Reference Ctr HPV, Brussels, Belgium; [Lebelo, Ramokone Lisbeth] Sefako Makgatho Hlth Sci Univ, Dept Virol, Pretoria, South Africa; [Bogers, Johannes; Benoy, Ina] Univ Antwerp, AMBIOR, Lab Cell Biol & Histol, Antwerp, Belgium	University of Antwerp; Ghent University; Sefako Makgatho Health Sciences University; University of Antwerp	Ndizeye, Z (corresponding author), Univ Burundi, Dept Community Med, Fac Med, Bujumbura, Burundi.; Ndizeye, Z (corresponding author), Univ Antwerp, Global Hlth Inst, Fac Med & Hlth Sci, Antwerp, Belgium.	zndizeye@gmail.com	Ndizeye, Zacharie/A-4085-2019; Lebelo, Ramokone Lisbeth/AAA-3259-2022; Benoy, Ina HH/E-3623-2017; Van geertruyden, Jean-Pierre/K-6425-2014	Lebelo, Ramokone Lisbeth/0000-0002-9365-514X; Benoy, Ina HH/0000-0002-1975-6516; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; NDIZEYE, Zacharie/0000-0002-3235-9494	IUC-VLIRUOS/UB; University of Burundi [ZIUS2017AP022]	IUC-VLIRUOS/UB; University of Burundi	This study was funded by the IUC-VLIRUOS/UB, an Institutional University Cooperation between Belgian Universities and the University of Burundi, ZIUS2017AP022. URL: https://www.vliruos.be/en/projects/project/22?pid=3609.	Arbyn M, 2015, CLIN MICROBIOL INFEC, V21, P817, DOI 10.1016/j.cmi.2015.04.015; Baay MFD, 2004, J MED VIROL, V73, P481, DOI 10.1002/jmv.20115; Bruni L B-RL, 2017, SUMMARY REPORT 2016; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Coutlee F, 2006, J CLIN MICROBIOL, V44, P1998, DOI 10.1128/JCM.00104-06; Dartell M, 2012, SEX TRANSM DIS, V39, P201, DOI 10.1097/OLQ.0b013e31823b50ad; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; De Vuyst H, 2010, CANCER CAUSE CONTROL, V21, P2309, DOI 10.1007/s10552-010-9645-z; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Gravitt Patti E, 2012, Open Virol J, V6, P198, DOI 10.2174/1874357901206010198; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Halec G, 2014, J PATHOL, V234, P441, DOI 10.1002/path.4405; Halec G, 2013, INT J CANCER, V132, P63, DOI 10.1002/ijc.27605; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, BIOL AG B; Kelly H, 2018, LANCET HIV, V5, pE45, DOI 10.1016/S2352-3018(17)30149-2; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Maseko FC, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26282; Mbulawa ZZA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190166; McDonald AC, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00048; Micalessi IM, 2012, CLIN CHEM LAB MED, V50, P655, DOI [10.1515/CCLM.2011.835, 10.1515/cclm.2011.835]; Minist?re ? la Pr?sidence charg? de la Bonne Gouvernance et du Plan [Burundi] (MPBGP) M de la S Publique et de la Lutte contre le Sida [Burundi] et ICF (MSPLS) I de S et d'?tudes ? du (ISTEEBU) B, 2017, TROISIEME ENQUETE DE, P679; Ministere de la Sante Publique et de la Lutte contre le SIDA, 2013, PLAN INTR VACC VIR P; Minkoff H, 1998, AM J OBSTET GYNECOL, V178, P982, DOI 10.1016/S0002-9378(98)70535-6; Mukanyangezi MF, 2018, HIV MED, V19, P152, DOI 10.1111/hiv.12564; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N., 1993, Boletin de la Oficina Sanitaria Panamericana, V115, P301; MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513; MUNOZ N, 1994, MUTAT RES, V305, P293, DOI 10.1016/0027-5107(94)90249-6; Ndizeye Z, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0321-5; Nelson AM, 2016, J CLIN ONCOL, V34, P20, DOI 10.1200/JCO.2015.61.9767; Ngabo F, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1539-6; Peters K, 2019, LONG TERM CROSS REAC; Poljak M., 2018, INT J MOL SCI, V19; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Rebolj M, 2016, J CLIN MICROBIOL, V54, P2669, DOI 10.1128/JCM.01321-16; Reddy D, 2015, INT J STD AIDS, V26, P379, DOI 10.1177/0956462414539149; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith-McCune KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010094; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Wheeler CM, 2016, LANCET INFECT DIS, V16, P1154, DOI 10.1016/S1473-3099(16)30120-7; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	50	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0209303	10.1371/journal.pone.0209303	http://dx.doi.org/10.1371/journal.pone.0209303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237894	Green Published, Green Submitted, gold			2022-12-26	WOS:000484856000002
J	Ren, JD; Sun, CS; Chen, L; Hu, JH; Huang, XT; Liu, XL; Lu, LZ				Ren, Jindong; Sun, Changsen; Chen, Li; Hu, Jianhong; Huang, Xuetao; Liu, Xiaolin; Lu, Lizhi			Exploring differentially expressed key genes related to development of follicle by RNA-seq in Peking ducks (Anas Platyrhynchos)	PLOS ONE			English	Article							HORMONE; STEROIDOGENESIS; OVARY; CELL	Duck follicles enter different reproductive phases throughout life, and follicle gene expression patterns differ according to these phases. In particular, differentially expressed genes and related to development of follicle (mRNAs) play an important role to explore the key genes in this process; however, the expression profiles of these genes remain unclear. In this study, transcriptome sequencing was used to investigate the expression levels of duck ovarian genes, and comparative transcriptional analysis was carried out to identify differential genes, and cluster them into groups and function identification. The results showed differential expression of 593 coding genes between young and laying ducks, and of 518 coding genes between laying and old ducks. In further GO analysis, 35 genes from the comparison between old ducks and laying ducks have significant been changed involved in hormones related to follicle development. They include up-regulated genes StAR, CYP17, EPOX, 3 beta-HSD, CYP1B1 CYP19A1 and down-regulated genes SR-B1 in laying ducks hormone synthesis than old ducks. Among which EPOX is a key gene for time special highly expression during egg laying stage, and other key regulatory genes' highly expression showed in young and laying stage, and lower expression showing with follicular development stopping. Therefore, EPOX is a key regulator for duck follicle development in laying period, its expression level increase 100 times higher than in youth and decrease 98% than stop laying period in duck life cycle.	[Ren, Jindong; Sun, Changsen] Taizhou Univ, Sch Life Sci, Taizhou, Zhejiang, Peoples R China; [Chen, Li; Huang, Xuetao; Lu, Lizhi] Zhejiang Acad Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Hu, Jianhong; Liu, Xiaolin] Northwest Agr & Forestry Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Taizhou University; Zhejiang Academy of Agricultural Sciences; Northwest A&F University - China	Lu, LZ (corresponding author), Zhejiang Acad Agr Sci, Hangzhou, Zhejiang, Peoples R China.; Liu, XL (corresponding author), Northwest Agr & Forestry Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	Liuxiaolin@nwafu.edu.cn; Lulizhibox@163.com			Earmarked Fund for National Waterfowl-industry Technology Research System [CARS-43-2, CARS-42-2]; Zhejiang Major Scientific and Technological Project of Agricultural (livestock's) Breeding [2016C02054-13]	Earmarked Fund for National Waterfowl-industry Technology Research System; Zhejiang Major Scientific and Technological Project of Agricultural (livestock's) Breeding	This work was supported by Earmarked Fund for National Waterfowl-industry Technology Research System CARS-43-2 Pro, to Lizhi Lu; Earmarked Fund for National Waterfowl-industry Technology Research System CARS-42-2 Pro, to Xiaolin Liu; and Zhejiang Major Scientific and Technological Project of Agricultural (livestock's) Breeding 2016C02054-13 Pro, to Lizhi Lu.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], [No title captured]; Correia E, 2016, INT J DEV BIOL, V60, P71, DOI 10.1387/ijdb.150365jb; Craig ZR, 2011, REPRODUCTION, V142, P633, DOI 10.1530/REP-11-0136; Diaz FJ, 2011, MOL REPROD DEV, V78, P212, DOI 10.1002/mrd.21288; Frye C A, 2009, Minerva Ginecol, V61, P541; Hector Rincon-Arano, 2009, J CELL BIOCHEM, V108, P675, DOI [10.1002/jcb.22304, DOI 10.1002/JCB.22304]; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Johnson AL, 2009, GEN COMP ENDOCR, V163, P12, DOI 10.1016/j.ygcen.2008.11.012; Johnson AL, 2014, TURK J VET ANIM SCI, V38, P660, DOI 10.3906/vet-1405-6; Johnson PA, 2008, BIOL REPROD, V78, P13, DOI 10.1095/biolreprod.107.061879; Joseph NT, 2013, GEN COMP ENDOCR, V190, P134, DOI 10.1016/j.ygcen.2013.05.018; Kosonsiriluk S, 2013, GEN COMP ENDOCR, V190, P149, DOI 10.1016/j.ygcen.2013.02.015; Kundu MC, 2012, GEN COMP ENDOCR, V179, P47, DOI 10.1016/j.ygcen.2012.07.025; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lu LZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0652-y; Ma JX, 1998, GENOMICS, V49, P152, DOI 10.1006/geno.1998.5235; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Minoru Kanehisa, 2018, NUCLEIC ACIDS RES; Nakane Y, 2010, CELL TISSUE RES, V342, P341, DOI 10.1007/s00441-010-1073-6; Nilsson EE, 2014, REPRODUCTION, V147, P865, DOI 10.1530/REP-14-0005; Nimz M, 2009, DOMEST ANIM ENDOCRIN, V37, P45, DOI 10.1016/j.domaniend.2009.02.002; RICHARDS JS, 1976, ENDOCRINOLOGY, V99, P1562, DOI 10.1210/endo-99-6-1562; Seo KS, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-139; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vosko AM, 2007, GEN COMP ENDOCR, V152, P165, DOI 10.1016/j.ygcen.2007.04.018; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Yang YJ, 2017, GENETICS, V205, P1551, DOI 10.1534/genetics.116.199133; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094; Yuan W, 1998, DOMEST ANIM ENDOCRIN, V15, P55, DOI 10.1016/S0739-7240(97)00062-3	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0209061	10.1371/journal.pone.0209061	http://dx.doi.org/10.1371/journal.pone.0209061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237879	Green Submitted, Green Published, gold			2022-12-26	WOS:000484856000001
J	Ocenar, J; Arizala, D; Boluk, G; Dhakal, U; Gunarathne, S; Paudel, S; Dobhal, S; Arif, M				Ocenar, Jordie; Arizala, Dario; Boluk, Gamze; Dhakal, Upasana; Gunarathne, Samudra; Paudel, Sujan; Dobhal, Shefali; Arif, Mohammad			Development of a robust, field-deployable loop-mediated isothermal amplification (LAMP) assay for specific detection of potato pathogen Dickeya dianthicola targeting a unique genomic region	PLOS ONE			English	Article							ERWINIA-CHRYSANTHEMI; SOFT-ROT; DIAGNOSIS; BLACKLEG; SOLANI	Destructive maceration, a wide host range, and longevity in non-plant substrates has established Dickeya dianthicola (blackleg of potato) as a significant threat to potato industries worldwide. To protect these businesses, a specific and sensitive point-of-care D. dianthicola detection tool is necessary. We have developed a loop-mediated isothermal amplification (LAMP) assay for specific, sensitive, and rapid detection of D. dianthicola, which can be streamlined for point-of-care use. The developed LAMP assay targets a unique gene, alcohol dehydrogenase, of D. dianthicola. Assay specificity was assessed using strains present in inclusivity (16 D. dianthicola strains) and exclusivity panels (56 closely related, potato pathogenic, and other bacterial strains). Amplification with strains of inclusivity panel occurred, and cross-reactivity with non-target DNA was not observed. The limit of detection (LOD) was 10 CFU/ml when dilutions were made before isolating the genomic DNA; however, LOD was determined as 1 pg using 10-fold serially diluted D. dianthicola genomic DNA. Similar LOD of 1 pg was observed when serially diluted target genomic DNA was mixed with host genomic DNA. LOD (1 pg) was also calculated with 10-fold serially diluted synthetic DNA fragments containing primer target sites. Naturally and artificially inoculated plant samples were used for field adaptability tests with the field-deployable Optigene Plant Material Lysis Kit and a heat block (65 degrees C); the results were obtained within 20 minutes. Despite the lack of method precision, no false positives or false negatives were observed. Therefore, with prepared reactions and a steady heat source, this assay can be used for rapid point-of-care detection, which is imperative for quarantine, eradication, disease management, and border protection.	[Ocenar, Jordie; Arizala, Dario; Boluk, Gamze; Dhakal, Upasana; Gunarathne, Samudra; Paudel, Sujan; Dobhal, Shefali; Arif, Mohammad] Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA; [Ocenar, Jordie] State Hawaii, Dept Agr, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa	Arif, M (corresponding author), Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	arif@hawaii.edu		Arif, Mohammad/0000-0002-5887-2050	USDA National Institute of Food and Agriculture, Hatch project [9038H]; Department of Plant and Environmental Protection Sciences teaching funds; National Science Foundation grant support (NSF-CSBR) [DBI-1561663]	USDA National Institute of Food and Agriculture, Hatch project; Department of Plant and Environmental Protection Sciences teaching funds; National Science Foundation grant support (NSF-CSBR)	This work was supported by the USDA National Institute of Food and Agriculture, Hatch project 9038H, managed by the College of Tropical Agriculture and Human Resources. The strains were revived and maintained by National Science Foundation grant support (NSF-CSBR grant no. DBI-1561663). The study was also partially supported by the Department of Plant and Environmental Protection Sciences teaching funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34275-0; Arif M, 2013, APPL ENVIRON MICROB, V79, P2312, DOI 10.1128/AEM.03239-12; Arif M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129810; Buhlmann A, 2013, J MICROBIOL METH, V92, P332, DOI 10.1016/j.mimet.2012.12.017; Chao YC, 2006, PLANT DIS, V90, P1358, DOI 10.1094/PD-90-1358A; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Czajkowski R, 2013, PLANT PATHOL, V62, P597, DOI 10.1111/j.1365-3059.2012.02664.x; Czajkowski R, 2011, PLANT PATHOL, V60, P999, DOI 10.1111/j.1365-3059.2011.02470.x; Diallo S, 2009, EUR J PLANT PATHOL, V125, P349, DOI 10.1007/s10658-009-9477-4; Dobhal S, 2019, J APPL MICROBIOL, V126, P388, DOI 10.1111/jam.14128; EFSA Panel on Plant Health, 2013, EFSA Journal, V11, P3072; FAO, 2016, PROD CHERR TOP 10 PR; Fujimoto T, 2018, J GEN PLANT PATHOL, V84, P124, DOI 10.1007/s10327-018-0772-9; Hodgetts J, 2011, B INSECTOLOGY S, V64; Hong M, 2012, WORLD J MICROB BIOT, V28, P523, DOI 10.1007/s11274-011-0843-y; Lan WW, 2013, J GEN PLANT PATHOL, V79, P182, DOI 10.1007/s10327-013-0440-z; Langlois PA, 2017, PHYTOPATHOLOGY, V107, P519, DOI 10.1094/PHYTO-08-16-0286-R; Larrea-Sarmiento A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32295-4; Laurila J, 2010, EUR J PLANT PATHOL, V126, P249, DOI 10.1007/s10658-009-9537-9; Lenarcic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096027; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Nair A, 2017, COMMERCIAL POTATO PR; Nassar A, 1996, APPL ENVIRON MICROB, V62, P2228, DOI 10.1128/AEM.62.7.2228-2235.1996; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Obidiegwu JE, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00542; Parida M, 2008, REV MED VIROL, V18, P407, DOI 10.1002/rmv.593; Parkinson N, 2015, EUR J PLANT PATHOL, V141, P63, DOI 10.1007/s10658-014-0523-5; Potrykus M, 2014, ANN APPL BIOL, V165, P474, DOI 10.1111/aab.12156; Pritchard L, 2013, PLANT PATHOL, V62, P587, DOI 10.1111/j.1365-3059.2012.02678.x; Safenkova IV, 2017, ANAL BIOANAL CHEM, V409, P1915, DOI 10.1007/s00216-016-0140-6; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Schneider KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018496; Thiessen LD, 2018, PEERJ, V6, DOI 10.7717/peerj.4639; Toth I, 2014, INVESTIGATING BIOL A, P87; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; van der Wolf JM, 2014, EUR J PLANT PATHOL, V138, P695, DOI 10.1007/s10658-013-0343-z; van der Wolf Jan M., 2007, P595; Yasuhara-Bell J, 2017, PHYTOPATHOLOGY, V107, P1339, DOI 10.1094/PHYTO-04-17-0160-R; Yasuhara-Bell J, 2016, MOL PLANT PATHOL, V17, P1499, DOI 10.1111/mpp.12378	41	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218868	10.1371/journal.pone.0218868	http://dx.doi.org/10.1371/journal.pone.0218868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233546	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700048
J	Wang, HW; Ahmad, M; Jadayel, R; Najjar, F; Lagace, D; Leenen, FHH				Wang, Hong-Wei; Ahmad, Monir; Jadayel, Rami; Najjar, Fatimah; Lagace, Diane; Leenen, Frans H. H.			Inhibition of inflammation by minocycline improves heart failure and depression-like behaviour in rats after myocardial infarction	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTORS; SYMPATHETIC HYPERACTIVITY; BRAIN; MICROGLIA; NEUROINFLAMMATION; DYSFUNCTION; ACTIVATION; EXCITATION; APOPTOSIS; ISCHEMIA	Rationale Patients with heart failure have an increased incidence of depression. Central and peripheral inflammation play a major role in the pathophysiology of both heart failure and depression. Aim Minocycline is an antibiotic that inhibits microglia activation and release of pro-inflammatory cytokines. We assessed effects of minocycline on extent of heart failure and depression at 2 and 8 weeks post myocardial infarction. Methods/Results Male Wistar rats were randomly divided into 3 groups: (i) sham + vehicle; (ii) MI + vehicle; and (iii) MI + minocycline with n/group of 8, 9 and 9 at 2 weeks, and 10, 16, 8 at weeks, respectively. Oral minocycline (50 mg/kg/day) or vehicle started 2 days before surgery. Depression-like behaviour was assessed with sucrose preference and forced swim tests, and cardiac function with echo and hemodynamics. After myocardial infarction, microglia activation and plasma/brain pro-inflammatory cytokines increased, which were mostly prevented by minocycline. At 8 weeks, cardiac dysfunction was attenuated by minocycline: infarct size (MI + Vehicle 29 +/- 1, MI + Min 23 +/- 1%), ejection fraction (Sham 80 +/- 1, MI + Vehicle 48 +/- 2, MI + Min 58 +/- 2%) and end diastolic pressure (Sham 3.2 +/- 0.3, MI + Vehicle 18.2 +/- 1.1, MI + Min 8.5 +/- 0.9 mm Hg). Depression-like behaviour was significantly improved by minocycline in sucrose preference test (% Sucrose Intake: Sham 96 +/- 1, MI + Vehicle 78 +/- 2, MI + Min 87 +/- 2) and forced swim test (% Immobile: Sham 40 +/- 4, MI + Vehicle 61 +/- 3, MI + Min 37 +/- 6). Conclusion Rats post myocardial infarction develop systemic inflammation, heart failure and depression-like behaviour that are all attenuated by minocycline. Targeting (neuro) inflammation may represent new therapeutic strategy for patients with heart failure and depression.	[Wang, Hong-Wei; Ahmad, Monir; Jadayel, Rami; Najjar, Fatimah; Leenen, Frans H. H.] Univ Ottawa Heart Inst, Brain & Heart Res Grp, Ottawa, ON, Canada; [Lagace, Diane] Univ Ottawa, Dept Cellular & Mol Med, Neurosci Res Program, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa	Leenen, FHH (corresponding author), Univ Ottawa Heart Inst, Brain & Heart Res Grp, Ottawa, ON, Canada.	fleenen@ottawaheart.ca			University of Ottawa, Heart Institute [4571]; Canadian Institutes of Health Research [FRN: MOP-136923]; Pfizer Canada; University of Ottawa Heart Institute Foundation	University of Ottawa, Heart Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer Canada(Pfizer); University of Ottawa Heart Institute Foundation	This study was supported by Grant #4571 from the University of Ottawa, Heart Institute; and Operating Grant #FRN: MOP-136923 from the Canadian Institutes of Health Research. F.H.H.L received funding.; Frans Leenen holds the Pfizer Chair in Hypertension Research, an endowed chair supported by Pfizer Canada, University of Ottawa Heart Institute Foundation and Canadian Institutes of Health Research.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Angermann CE, 2016, JAMA-J AM MED ASSOC, V315, P2683, DOI 10.1001/jama.2016.7635; Arakawa S, 2012, PHARMACOL BIOCHEM BE, V100, P601, DOI 10.1016/j.pbb.2011.09.008; Bah TM, 2011, BEHAV PHARMACOL, V22, P779, DOI 10.1097/FBP.0b013e32834d1385; Biancardi VC, 2016, AM J PHYSIOL-HEART C, V310, pH404, DOI 10.1152/ajpheart.00247.2015; Dadsetan S, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00106; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Dworak M, 2014, AUTON NEUROSCI-BASIC, V185, P43, DOI 10.1016/j.autneu.2014.03.007; Dworak M, 2012, AUTON NEUROSCI-BASIC, V169, P70, DOI 10.1016/j.autneu.2012.04.004; Felder RB, 2010, EXP PHYSIOL, V95, P19, DOI 10.1113/expphysiol.2008.045948; Francis J, 2004, AM J PHYSIOL-HEART C, V286, pH2264, DOI 10.1152/ajpheart.01072.2003; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frey A, 2014, FRONT BEHAV NEUROSCI, V376, P1; Goldstein BI, 2015, CIRCULATION, V132, P965, DOI 10.1161/CIR.0000000000000229; Grippo AJ, 2003, AM J PHYSIOL-REG I, V284, pR666, DOI 10.1152/ajpregu.00430.2002; Guy R, 2012, POSTMYOCARDIAL INFAR; Hinwood M, 2012, CEREB CORTEX, V22, P1442, DOI 10.1093/cercor/bhr229; Hovens IB, 2016, BRAIN BEHAV IMMUN, V54, P178, DOI 10.1016/j.bbi.2016.02.003; Hu XR, 2010, EUR J PHARMACOL, V638, P84, DOI 10.1016/j.ejphar.2010.03.059; Huang BS, 2005, AM J PHYSIOL-HEART C, V288, pH2491, DOI 10.1152/ajpheart.00840.2004; Jani BD, 2016, PLOS ONE, V10, P1371; Kang YM, 2008, AM J PHYSIOL-HEART C, V295, pH227, DOI 10.1152/ajpheart.01157.2007; Keilhoff G, 2011, RESUSCITATION, V82, P341, DOI 10.1016/j.resuscitation.2010.11.011; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Lee HW, 2017, EXP PHYSIOL, V102, P314, DOI 10.1113/EP086049; Leenen FHH, 1999, AM J PHYSIOL-HEART C, V276, pH317, DOI 10.1152/ajpheart.1999.276.1.H317; Leenen FHH, 2007, CIRC RES, V101, P221, DOI 10.1161/CIRCRESAHA.107.158261; Leonard Brian E., 2010, Current Immunology Reviews, V6, P205; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Moraska AR, 2013, CIRC-HEART FAIL, V6, P387, DOI 10.1161/CIRCHEARTFAILURE.112.000118; Najjar F, 2018, AM J PHYSIOL-HEART C, V315, pH1159, DOI 10.1152/ajpheart.00615.2017; Neigh GN, 2009, STROKE, V40, P3601, DOI 10.1161/STROKEAHA.109.564146; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Paxinos G, 2005, RAT BRAIN STEROTAXIC, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Pradhu SD, 2016, CIRC RES, V119, P91, DOI [10.1161/CIRCRESAHA.116.303577, DOI 10.1161/CIRCRESAHA.116.303577]; Rafatian N, 2014, AM J PHYSIOL-REG I, V307, pR879, DOI 10.1152/ajpregu.00075.2014; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Santisteban MM, 2015, CIRC RES, V117, P178, DOI 10.1161/CIRCRESAHA.117.305853; Shi P, 2010, HYPERTENSION, V56, P297, DOI 10.1161/HYPERTENSIONAHA.110.150409; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Spinelli S, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00215; SPRIGGS DR, 1988, J NATL CANCER I, V80, P1039, DOI 10.1093/jnci/80.13.1039; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; Toda S, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00188; Wann BP, 2009, J PSYCHOPHARMACOL, V23, P451, DOI 10.1177/0269881108089820; Willner P, 2013, NEUROSCI BIOBEHAV R, V37, P2331, DOI 10.1016/j.neubiorev.2012.12.007; Wilson RS, 2014, NEUROLOGY, V83, P702, DOI 10.1212/WNL.0000000000000715; Yu Y, 2017, AM J PHYSIOL-HEART C, V313, pH744, DOI 10.1152/ajpheart.00280.2017; Yu Y, 2012, HYPERTENSION, V59, P477, DOI 10.1161/HYPERTENSIONAHA.111.182345	52	13	13	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0217437	10.1371/journal.pone.0217437	http://dx.doi.org/10.1371/journal.pone.0217437			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233508	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700008
J	Ganesan, A; Kashima, Y; Kiat, JE; Dar-Nimrod, I				Ganesan, Asha; Kashima, Yoshihisa; Kiat, John Emmanuel; Dar-Nimrod, Ilan			Transmission of disorder and etiological information: Effects on health knowledge recollection and health-related cognition	PLOS ONE			English	Article							MENTAL-DISORDERS; SOCIAL DISTANCE; SUSCEPTIBILITY; COMMUNICATION; EXPLANATIONS; PERCEPTIONS; EVOLUTION; DISCOVERY; JUDGMENTS; ATTITUDES	Biased transmission of health knowledge has far-reaching effects on information reproduction and health-related cognitions. We examined whether transmissions of different types of disorder and etiological information influence recollections of health knowledge and evaluations of patients, by simulating the digital transmission of information. Transmission chains of four non-interacting persons (i.e., four generations) were formed. The first generation read three vignettes describing fictitious patients with one of three disorders (physiological, psychological, culture-bound) uniquely paired with one of three etiologies (genetic, environmental, unknown etiology). Next, they evaluated patients' well-being, rated desired social distance, and recalled the vignettes. These written recollections replaced the original vignettes for a second-generation of participants, whose recollections were used for the third generation and so on. The framing of disorders affected recollections of etiology, in which culture-bound framings resulted in the poorest recall of etiologies. Participants also perceived the culture-bound disorder as the least serious but desired the most social distance from patients diagnosed with it, when compared to other disorders. The study showed that health information is selectively attended to and reproduced, possibly affected by perceived self-relevance. Faulty recollections and framing of disorders affect health cognitions, potentially instigating biased transmission of disorder- and patient-related narratives.	[Ganesan, Asha; Dar-Nimrod, Ilan] Univ Sydney, Sch Psychol, Fac Sci, Camperdown, NSW, Australia; [Kashima, Yoshihisa] Univ Melbourne, Fac Med Dent & Hlth Sci, Sch Psychol Sci, Melbourne, Vic, Australia; [Kiat, John Emmanuel] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Dar-Nimrod, Ilan] Univ Sydney, Charles Perkins Ctr, Camperdown, NSW, Australia	University of Sydney; University of Melbourne; University of California System; University of California Davis; University of Sydney	Ganesan, A (corresponding author), Univ Sydney, Sch Psychol, Fac Sci, Camperdown, NSW, Australia.	asha.ganesan12@gmail.com	Dar-Nimrod, Ilan/AAX-2441-2020	Dar-Nimrod, Ilan/0000-0003-2308-3673; Kiat, John/0000-0002-4256-9524; Ganesan, Asha/0000-0002-8626-5565	Templeton Foundation	Templeton Foundation	This research is funded by The Templeton Foundation funding to the Genetics and Human Agency Initiative received by IDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00636; Beall AT, 2016, PSYCHOL SCI, V27, P595, DOI 10.1177/0956797616628861; Betton V, 2015, BRIT J PSYCHIAT, V206, P443, DOI 10.1192/bjp.bp.114.152835; Bogardus ES, 1933, SOCIOL SOC RES, V17, P265; Broesch J, 2014, HUM NATURE-INT BIOS, V25, P181, DOI 10.1007/s12110-014-9196-1; Brogan A, 2009, BRIT J HEALTH PSYCH, V14, P35, DOI 10.1348/135910708X292788; Cheung BY, 2014, SOC PERSONAL PSYCHOL, V8, P626, DOI 10.1111/spc3.12138; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dar-Nimrod I, 2018, PUBLIC HEALTH GENOM, V21, P133, DOI 10.1159/000496381; Dar-Nimrod I, 2014, NEW GENET SOC, V33, P400, DOI 10.1080/14636778.2014.951993; Dar-Nimrod I, 2014, APPETITE, V81, P269, DOI 10.1016/j.appet.2014.06.109; Dar-Nimrod I, 2013, GENET MED, V15, P132, DOI 10.1038/gim.2012.111; Dar-Nimrod I, 2011, PSYCHOL BULL, V137, P800, DOI 10.1037/a0021860; Diesendruck G, 2013, CHILD DEV, V84, P1906, DOI 10.1111/cdev.12108; Dovidio JF, 2012, AM J PUBLIC HEALTH, V102, P945, DOI 10.2105/AJPH.2011.300601; Engel C, 2015, PERSPECT PSYCHOL SCI, V10, P361, DOI 10.1177/1745691615577865; Evans DGR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0442-6; Green EGT, 2008, BRIT J SOC PSYCHOL, V47, P497, DOI 10.1348/014466607X248912; Hamamura T, 2010, EVOL PSYCHOL-US, V8, P506; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Haslam N, 2015, CURR DIR PSYCHOL SCI, V24, P399, DOI 10.1177/0963721415588082; Heine SJ, 2017, ADV EXP SOC PSYCHOL, V55, P137, DOI 10.1016/bs.aesp.2016.10.003; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 2010, P ROY SOC B-BIOL SCI, V277, P3715, DOI 10.1098/rspb.2010.1191; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; Jayaratne TE, 2006, GROUP PROCESS INTERG, V9, P77, DOI 10.1177/1368430206059863; Jolie A., 2013, NEW YORK TIMES, V14, P2013; Jorm AF, 2009, AUST NZ J PSYCHIAT, V43, P183, DOI 10.1080/00048670802653349; Kerath SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-114; Kim HS, 2015, J COMMUN, V65, P512, DOI 10.1111/jcom.12160; Kim NS, 2016, J EXP PSYCHOL-APPL, V22, P39, DOI 10.1037/xap0000070; Kim NS, 2009, MEM COGNITION, V37, P744, DOI 10.3758/MC.37.6.744; Kim NS, 2002, J EXP PSYCHOL GEN, V131, P451, DOI 10.1037//0096-3445.131.4.451; Kimel SY, 2016, PERS SOC PSYCHOL B, V42, P688, DOI 10.1177/0146167216642196; Krippendorff K., 2013, CONTENT ANAL INTRO I; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lebowitz MS, 2014, P NATL ACAD SCI USA, V111, P17786, DOI 10.1073/pnas.1414058111; Lee TL, 2014, J EXP SOC PSYCHOL, V54, P68, DOI 10.1016/j.jesp.2014.04.006; Legare CH, 2017, P NATL ACAD SCI USA, V114, P7877, DOI 10.1073/pnas.1620743114; Liberman Z, 2017, TRENDS COGN SCI, V21, P556, DOI 10.1016/j.tics.2017.04.004; Lowstuter KJ, 2008, GENET MED, V10, P691, DOI [10.1097/GIM.0b013e3181837246, 10.1097GIM.0b013e3181837246]; Major B, 2013, HEALTH PSYCHOL, V32, P514, DOI 10.1037/a0030358; Mesoudi A, 2008, PHILOS T R SOC B, V363, P3489, DOI 10.1098/rstb.2008.0129; Mesoudi A, 2006, BRIT J PSYCHOL, V97, P405, DOI 10.1348/000712605X85871; Mills L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08678-4; Murray DR, 2012, EUR J SOC PSYCHOL, V42, P180, DOI 10.1002/ejsp.863; O'Connor C, 2012, NEURON, V74, P220, DOI 10.1016/j.neuron.2012.04.004; OYEYEMI SO, 2014, BMJ-BRIT MED J, V349, pG6178, DOI [DOI 10.1136/BMJ.G6178, 10.1136/bmj.g6178]; Parrott R, 2012, J HEALTH COMMUN, V17, P762, DOI 10.1080/10810730.2012.677301; Penner LA, 2010, J EXP SOC PSYCHOL, V46, P436, DOI 10.1016/j.jesp.2009.11.004; Phelan J.C., 2011, PSYCHIAT REHABILITAT, V6, P159, DOI [DOI 10.1080/10973430208408431, 10.1080/10973430208408431]; Phelan JC, 2005, J HEALTH SOC BEHAV, V46, P307, DOI 10.1177/002214650504600401; Richerson PJ, 1999, HUM NATURE-INT BIOS, V10, P253, DOI 10.1007/s12110-999-1004-y; SAS Institute. Inc., 2017, SAS 9 4; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Short SE, 2015, CURR OPIN PSYCHOL, V5, P78, DOI 10.1016/j.copsyc.2015.05.002; Swami V, 2009, BRIT J HEALTH PSYCH, V14, P519, DOI 10.1348/135910708X370781; Taber JM, 2017, SOC SCI MED, V190, P101, DOI 10.1016/j.socscimed.2017.08.010; Townsend AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088006; Van Bavel JJ, 2012, PERS SOC PSYCHOL B, V38, P1566, DOI 10.1177/0146167212455829; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Whiten A, 2016, CURR OPIN PSYCHOL, V8, P15, DOI 10.1016/j.copsyc.2015.09.002; Williams JJ, 2010, COGNITIVE SCI, V34, P776, DOI 10.1111/j.1551-6709.2010.01113.x; Williams MJ, 2008, J PERS SOC PSYCHOL, V94, P1033, DOI 10.1037/0022-3514.94.6.1033; Yopchick JE, 2009, MEM COGNITION, V37, P29, DOI 10.3758/MC.37.1.29	66	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218703	10.1371/journal.pone.0218703	http://dx.doi.org/10.1371/journal.pone.0218703			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226156	Green Submitted, gold, Green Published			2022-12-26	WOS:000484894700033
J	Koury, J; Ramirez, A; Xie, C; Harb, J; Dong, C; Maki, C; Ramos, T; Izadyar, F; Clark, D; Drechsler, Y; Kaur, G; Hao, JJ				Koury, Jeffrey; Ramirez, Ana; Xie, Chen; Harb, Jerry; Dong, Charli; Maki, Chad; Ramos, Tom; Izadyar, Fari; Clark, David; Drechsler, Yvonne; Kaur, Gagandeep; Hao, Jijun			Phosphodiesterase 4D, miR-203 and selected cytokines in the peripheral blood are associated with canine atopic dermatitis	PLOS ONE			English	Article							POTENTIAL TOPICAL TREATMENT; ACVD TASK-FORCE; GENE TRANSCRIPTS; PDE4 INHIBITOR; ADULT PATIENTS; SKIN; EFFICACY; PSORIASIS; CHILDREN; SAFETY	Canine Atopic Dermatitis (AD) is a common complex and multifactorial disease involving immune dysregulation, genetic predisposition, skin barrier defects, environmental factors and allergic sensitization. To date, diagnosis of canine AD relies on a combination of patient history, clinical examination, allergy testing and response to diet trials/therapies with no reliable biomarkers available to distinguish AD from other diseases with similar clinical presentations. A handful of studies to identify potential biomarkers in the peripheral blood of AD dogs and healthy controls have been performed with some showing inconsistent and contradictory results. In this study, we, for the first time, report statistically significant increases in expression of phosphodiesterase 4D (PDE4D) gene in peripheral blood mononuclear cells (PBMCs) and miR-203 in plasma from AD dogs compared to healthy controls. In addition, we report a statistically non-significant change of the CD4(+)/CD8(+) ratio, a dramatic decrease of three gene markers (PIAS1, RORA and SH2B1) as well as a panel of differential expression of cytokines in AD dogs in comparison to the healthy controls. Our study provides important insight into the complexities of canine AD, and further studies to verify the specificity of these findings for canine AD at a larger-scale are warranted.	[Koury, Jeffrey; Harb, Jerry; Hao, Jijun] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA; [Ramirez, Ana] Calif State Polytech Univ Pomona, Coll Sci, Pomona, CA 91768 USA; [Xie, Chen; Clark, David; Drechsler, Yvonne; Kaur, Gagandeep; Hao, Jijun] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA; [Dong, Charli] Anim Dermatol Clin, Pasadena, CA USA; [Maki, Chad; Ramos, Tom; Izadyar, Fari] VetCell Therapeut, Santa Ana, CA USA	Western University of Health Sciences; California State University System; California State Polytechnic University Pomona; Western University of Health Sciences	Hao, JJ (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA.; Kaur, G; Hao, JJ (corresponding author), Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA.	gkaur@westernu.edu; jhao@westernu.edu		Harb, Jerry/0000-0001-5457-6564; Koury, Jeffrey/0000-0002-7368-4891	Western University of Health Sciences; VetCell Therapeutics	Western University of Health Sciences; VetCell Therapeutics	This work was supported by the intramural grant of Western University of Health Sciences to JH and the grant from VetCell Therapeutics to JH and GK. CM, TR, and FI are employees of VetCell Therapeutics and received funding in the form of salaries. The specific roles of these authors are articulated in the 'Author Contributions'. The funders provided support in the form of study reagents and were involved in study design and preparation of the manuscript.	Ahluwalia J, 2017, DRUGS, V77, P1389, DOI 10.1007/s40265-017-0784-3; Akama T, 2009, BIOORG MED CHEM LETT, V19, P2129, DOI 10.1016/j.bmcl.2009.03.007; Baumer W, 2007, VET DERMATOL, V18, P107, DOI 10.1111/j.1365-3164.2007.00576.x; Beccati M, 2016, VET DERMATOL, V27, P17, DOI 10.1111/vde.12277; Bieber T, 2012, ALLERGY, V67, P1475, DOI 10.1111/all.12049; Bruno O, 2009, J MED CHEM, V52, P6546, DOI 10.1021/jm900977c; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; DeBoer DJ, 2001, VET IMMUNOL IMMUNOP, V81, P271, DOI 10.1016/S0165-2427(01)00312-9; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Fedenko Elena S, 2011, Self Nonself, V2, P120; Ferrer L, 1999, VET REC, V145, P191, DOI 10.1136/vr.145.7.191; Fraser MA, 2003, VET REC, V152, P159, DOI 10.1136/vr.152.6.159; Furue M, 2014, J DERMATOL, V41, P577, DOI 10.1111/1346-8138.12534; Gonzales AJ, 2013, VET DERMATOL, V24, P48, DOI 10.1111/j.1365-3164.2012.01098.x; Hensel P, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0515-5; HILL PB, 1995, VET IMMUNOL IMMUNOP, V44, P105, DOI 10.1016/0165-2427(94)05298-7; Hillier A, 2001, VET IMMUNOL IMMUNOP, V81, P147, DOI 10.1016/S0165-2427(01)00296-3; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Jassies-van der Lee A, 2014, VET DERMATOL, V25, P456, DOI 10.1111/vde.12140; Kim S, 2011, ANN DERMATOL, V23, P468, DOI 10.5021/ad.2011.23.4.468; Lv YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Majewska A, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0805-6; Marsella Rosanna, 2017, Vet Sci, V4, DOI 10.3390/vetsci4030037; Marsella R, 2018, VET DERMATOL, V29, DOI 10.1111/vde.12500; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; McCandless EE, 2014, VET IMMUNOL IMMUNOP, V157, P42, DOI 10.1016/j.vetimm.2013.10.017; Nazarian R, 2009, CURR OPIN INVEST DR, V10, P1236; Nemoto O, 2016, J DERMATOL, V43, P881, DOI 10.1111/1346-8138.13231; Nuttall TJ, 2002, CLIN EXP ALLERGY, V32, P789, DOI 10.1046/j.1365-2222.2002.01356.x; OHNO T, 1988, TOHOKU J EXP MED, V154, P157, DOI 10.1620/tjem.154.157; Olivry T, 1999, EXP DERMATOL, V8, P204, DOI 10.1111/j.1600-0625.1999.tb00372.x; Olivry T, 2016, J INVEST DERMATOL, V136, P1961, DOI 10.1016/j.jid.2016.05.117; Paller AS, 2016, J AM ACAD DERMATOL, V75, P494, DOI 10.1016/j.jaad.2016.05.046; Pender MP, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/189096; Raap U, 2012, PEDIAT ALLERG IMM-UK, V23, P285, DOI 10.1111/j.1399-3038.2011.01241.x; Samrao A, 2012, ARCH DERMATOL, V148, P890, DOI 10.1001/archdermatol.2012.812; Santoro D, 2015, VET DERMATOL, V26, DOI 10.1111/vde.12197; Santoro D, 2016, J INVEST DERMATOL, V136, P1087, DOI 10.1016/j.jid.2016.03.015; Schlotter YM, 2011, VET IMMUNOL IMMUNOP, V143, P20, DOI 10.1016/j.vetimm.2011.05.025; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Tarpataki N, 2012, VET DERMATOL S1, V23, P58, DOI [10.1111/j.1365-3164.2012.01059.x.abstract, DOI 10.1111/J.1365-3164.2012.01059.X.ABSTRACT]; Taszkun I, 2013, B VET I PULAWY, V57, P365, DOI 10.2478/bvip-2013-0063; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Veremeyko T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00050; Volf EM, 2012, J DRUGS DERMATOL, V11, P341; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Williams CH, 2015, CELL REP, V11, P43, DOI 10.1016/j.celrep.2015.03.001; Wittmann M, 2013, DERMATOLOGY THER, V3, P1, DOI 10.1007/s13555-013-0023-0; Xie C, 2018, J PHARMACEUT BIOMED, V153, P37, DOI 10.1016/j.jpba.2018.01.009; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	53	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218670	10.1371/journal.pone.0218670	http://dx.doi.org/10.1371/journal.pone.0218670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226136	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700029
J	Almeida, JL; Dakic, A; Kindig, K; Kone, M; Letham, DLD; Langdon, S; Peat, R; Holding-Pillai, J; Hall, EM; Ladd, M; Shaffer, MD; Berg, H; Li, J; Wigger, G; Lund, S; Steffen, CR; Fransway, BB; Geraghty, B; Natoli, M; Bauer, B; Gollin, SM; Lewis, DW; Reid, Y				Almeida, Jamie L.; Dakic, Aleksandra; Kindig, Karin; Kone, Maikan; Letham, Deborah L. D.; Langdon, Scott; Peat, Ruth; Holding-Pillai, Jayamalini; Hall, Erin M.; Ladd, Mark; Shaffer, Megan D.; Berg, Heath; Li, Jinliang; Wigger, Georges; Lund, Steve; Steffen, Carolyn R.; Fransway, Barbara B.; Geraghty, Bob; Natoli, Manuela; Bauer, Beth; Gollin, Susanne M.; Lewis, Dale W.; Reid, Yvonne			Interlaboratory study to validate a STR profiling method for intraspecies identification of mouse cell lines	PLOS ONE			English	Article							CULTURE; AUTHENTICATION	The Consortium for Mouse Cell Line Authentication was formed to validate Short Tandem Repeat (STR) markers for intraspecies identification of mouse cell lines. The STR profiling method is a multiplex polymerase chain reaction (PCR) assay comprised of primers targeting 19 mouse STR markers and two human STR markers (for interspecies contamination screening). The goals of the Consortium were to perform an interlaboratory study to-(1) validate the mouse STR markers to uniquely identify mouse cell lines (intraspecies identification), (2) to provide a public database of mouse cell lines with the National Institute of Standards and Technology (NIST)-validated mouse STR profiles, and (3) to publish the results of the interlaboratory study. The interlaboratory study was an international effort that consisted of 12 participating laboratories representing institutions from academia, industry, biological resource centers, and government. The study was based on 50 of the most commonly used mouse cell lines obtained from the American Type Culture Collection (ATCC). Of the 50 mouse cell lines, 18 had unique STR profiles that were 100% concordant (match) among all Consortium laboratory members, and the remaining 32 cell lines had discordance that was resolved readily and led to improvement of the assay. The discordance was due to low signal and interpretation issues involving artifacts and genotyping errors. Although the total number of discordant STR profiles was relatively high in this study, the percent of labs agreeing on allele calls among the discordant samples was above 92%. The STR profiles, including electropherogram images, for NIST-validated mouse cell lines will be published on the NCBI BioSample Database (https://www.ncbi.nlm.nih.gov/biosample/). Overall, the interlaboratory study showed that the multiplex PCR method using 18 of the 19 mouse STR markers is capable of discriminating at the intraspecies level between mouse cell lines. Further studies are ongoing to refine the assay including (1) development of an allelic ladder for improving the accuracy of allele calling and (2) integration of stutter filters to identify true stutter.	[Almeida, Jamie L.; Reid, Yvonne] NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA; [Dakic, Aleksandra; Kindig, Karin; Kone, Maikan] ATCC, Stand Resource Ctr, Manassas, VA USA; [Letham, Deborah L. D.] Charles River Labs, Malvern, PA USA; [Langdon, Scott] Duke Univ, Durham, NC USA; [Peat, Ruth; Holding-Pillai, Jayamalini] Francis Crick Inst, Cell Serv, London, England; [Hall, Erin M.; Ladd, Mark; Shaffer, Megan D.] Genet Cell Line Testing, Burlington, NC USA; [Berg, Heath] IDEXX BioAnalyt, Columbia, MO USA; [Li, Jinliang] Laragen Inc, Culver City, CA USA; [Wigger, Georges] Microsynth AG, Balgach, Switzerland; [Lund, Steve] NIST, Stat Engn Div, Gaithersburg, MD 20899 USA; [Steffen, Carolyn R.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Fransway, Barbara B.] Univ Arizona, Genet Core, Genet Core Lab, Tucson, AZ USA; [Geraghty, Bob; Natoli, Manuela] Univ Cambridge, Cambridge Inst, Canc Res UK, Cambridge, England; [Bauer, Beth] Univ Maryland, College Pk, MD 20742 USA; [Gollin, Susanne M.; Lewis, Dale W.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA	National Institute of Standards & Technology (NIST) - USA; Duke University; Francis Crick Institute; National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; University of Arizona; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Almeida, JL (corresponding author), NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA.	jamie.almeida@nist.gov						Almeida JL, 2014, CYTOTECHNOLOGY, V66, P133, DOI 10.1007/s10616-013-9545-7; Almeida JL, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-102; [Anonymous], 2015, ASN00032015 ANSIATCC; [Anonymous], 2011, ASN00022011 ANSIATCC; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Butler JM, 2005, FORENSIC DNA TYPING; Capes-Davis A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002477; Capes-Davis A, 2013, INT J CANCER, V132, P2510, DOI 10.1002/ijc.27931; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Fong C K, 1994, Clin Diagn Virol, V2, P95, DOI 10.1016/0928-0197(94)90042-6; Freedman LP, 2015, BIOTECHNIQUES, V59, P189, DOI 10.2144/000114344; Freedman LP, 2015, NAT METHODS, V12, P493, DOI 10.1038/nmeth.3403; HAUGE XY, 1993, HUM MOL GENET, V2, P411, DOI 10.1093/hmg/2.4.411; Hill CR, 2009, J FORENSIC SCI, V54, P1008, DOI 10.1111/j.1556-4029.2009.01110.x; Hollander M., 1973, NONPARAMETRIC STAT M; Horbach SPJM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186281; Lazaruk K, 2001, FORENSIC SCI INT, V119, P1, DOI 10.1016/S0379-0738(00)00388-1; Moretti TR, 2001, J FORENSIC SCI, V46, P647; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; Tratar UL, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00268; Walsh PS, 1996, NUCLEIC ACIDS RES, V24, P2807, DOI 10.1093/nar/24.14.2807; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510	24	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218412	10.1371/journal.pone.0218412	http://dx.doi.org/10.1371/journal.pone.0218412			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220119	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500044
J	Contaifer, D; Buckley, LF; Wohlford, G; Kumar, NG; Morriss, JM; Ranasinghe, AD; Carbone, S; Canada, JM; Trankle, C; Abbate, A; Tassell, BW; Wijesinghe, DS				Contaifer, Daniel, Jr.; Buckley, Leo F.; Wohlford, George; Kumar, Naren G.; Morriss, Joshua M.; Ranasinghe, Asanga D.; Carbone, Salvatore; Canada, Justin M.; Trankle, Cory; Abbate, Antonio; Van Tassell, Benjamin W.; Wijesinghe, Dayanjan S.			Metabolic modulation predicts heart failure tests performance	PLOS ONE			English	Article							CARDIAC METABOLISM; PROGNOSTIC VALUE; URIC-ACID; BIOMARKERS; DISEASE; PLASMA; CYSTEINE; PROTEIN; STRESS; STROKE	The metabolic changes that accompany changes in Cardiopulmonary testing (CPET) and heart failure biomarkers (HFbio) are not well known. We undertook metabolomic and lipidomic phenotyping of a cohort of heart failure (HF) patients and utilized Multiple Regression Analysis (MRA) to identify associations to CPET and HFBio test performance (peak oxygen consumption (Peak VO2), oxygen uptake efficiency slope (OUES), exercise duration, and minute ventilation-carbon dioxide production slope (VE/VCO2 slope), as well as the established HF biomarkers of inflammation C-reactive protein (CRP), beta-galactoside-binding protein (galectin-3), and N-terminal prohormone of brain natriuretic peptide (NT-proBNP)). A cohort of 49 patients with a left ventricular ejection fraction < 50%, predominantly males African American, presenting a high frequency of diabetes, hyperlipidemia, and hypertension were used in the study. MRA revealed that metabolic models for VE/VCO2 and Peak VO2 were the most fitted models, and the highest predictors' coefficients were from Acylcarnitine C18:2, palmitic acid, citric acid, asparagine, and 3-hydroxybutiric acid. Metabolic Pathway Analysis (MetPA) used predictors to identify the most relevant metabolic pathways associated to the study, aminoacyl-tRNA and amino acid biosynthesis, amino acid metabolism, nitrogen metabolism, pantothenate and CoA biosynthesis, sphingolipid and glycerolipid metabolism, fatty acid biosynthesis, glutathione metabolism, and pentose phosphate pathway (PPP). Metabolite Set Enrichment Analysis (MSEA) found associations of our findings with pre-existing biological knowledge from studies of human plasma metabolism as brain dysfunction and enzyme deficiencies associated with lactic acidosis. Our results indicate a profile of oxidative stress, lactic acidosis, and metabolic syndrome coupled with mitochondria dysfunction in patients with HF tests poor performance. The insights resulting from this study coincides with what has previously been discussed in existing literature thereby supporting the validity of our findings while at the same time characterizing the metabolic underpinning of CPET and HFBio.	[Contaifer, Daniel, Jr.; Buckley, Leo F.; Wohlford, George; Kumar, Naren G.; Morriss, Joshua M.; Van Tassell, Benjamin W.; Wijesinghe, Dayanjan S.] Virginia Commonwealth Univ, Sch Pharm, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23284 USA; [Kumar, Naren G.] Virginia Commonwealth Univ, Sch Med, Dept Microbiol, Richmond, VA USA; [Ranasinghe, Asanga D.] Amarillo Coll, Dept Phys & Biol Sci, Amarillo, TX USA; [Carbone, Salvatore; Canada, Justin M.; Trankle, Cory; Abbate, Antonio] Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA USA; [Abbate, Antonio] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA USA; [Wijesinghe, Dayanjan S.] Virginia Commonwealth Univ, Da Vinci Ctr, Richmond, VA 23284 USA; [Wijesinghe, Dayanjan S.] Virginia Commonwealth Univ, Sch Pharm, ISB3D, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Tassell, BW; Wijesinghe, DS (corresponding author), Virginia Commonwealth Univ, Sch Pharm, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23284 USA.; Wijesinghe, DS (corresponding author), Virginia Commonwealth Univ, Da Vinci Ctr, Richmond, VA 23284 USA.; Wijesinghe, DS (corresponding author), Virginia Commonwealth Univ, Sch Pharm, ISB3D, Richmond, VA 23284 USA.	bvantassell@vcu.edu; wijesingheds@vcu.edu	Wohlford, George/AAH-2838-2019; Abbate, Antonio/G-8805-2016; Kumar, Naren Gajenthra/AFH-3198-2022; Carbone, Salvatore/J-2830-2019	Abbate, Antonio/0000-0002-1930-785X; Carbone, Salvatore/0000-0002-8163-0527; Contaifer Junior, Daniel/0000-0002-3165-4192; Wohlford, George/0000-0002-5670-7916	National Institutes of Health [HD087198, HL117026]; Heart Failure Society of America; SCIEX	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart Failure Society of America; SCIEX	Research reported in this publication was supported by research grants from National Institutes of Health under grant numbers HD087198 (to DSW), HL117026 (to BVT, AA) and from the Heart Failure Society of America (to LFB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work also received support via a Young Investigator Award from SCIEX for clinical lipidomic research (DSW).	Ahmad T, 2016, J AM COLL CARDIOL, V67, P291, DOI 10.1016/j.jacc.2015.10.079; Albouaini K, 2007, HEART, V93, P1285, DOI 10.1136/hrt.2007.121558; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Aquilani R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111251; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Bahrmann P, 2016, EUR HEART J-ACUTE CA, V5, P568, DOI 10.1177/2048872615612455; Bao XP, 2007, CIRCULATION, V116, P1024, DOI 10.1161/CIRCULATIONAHA.107.696005; Campbell K, 2016, ANTIOXID REDOX SIGN, V24, P543, DOI 10.1089/ars.2015.6516; Cheng ML, 2015, J AM COLL CARDIOL, V65, P1509, DOI 10.1016/j.jacc.2015.02.018; Coutinho TD, 2007, AM J HYPERTENS, V20, P83, DOI 10.1016/j.amjhyper.2006.06.015; de Carvalho LP, 2018, JACC-BASIC TRANSL SC, V3, P163, DOI 10.1016/j.jacbts.2017.12.005; De Chiara B, 2012, SCI WORLD J, DOI 10.1100/2012/303654; Dewey CM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003101; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dona AC, 2016, EUR J PREV CARDIOL, V23, P1578, DOI 10.1177/2047487316645469; Dou L, 2015, J AM SOC NEPHROL, V26, P876, DOI 10.1681/ASN.2013121283; Dunlay Shannon M, 2014, Curr Heart Fail Rep, V11, P404, DOI 10.1007/s11897-014-0220-x; El-Khairy L, 2001, CIRCULATION, V103, P2544; Fiehn Oliver, 2016, Curr Protoc Mol Biol, V114, DOI 10.1002/0471142727.mb3004s114; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Giorgi C, 2010, ANTIOXID REDOX SIGN, V13, P1051, DOI 10.1089/ars.2009.2825; Grant Chris M, 2008, J Biol, V7, P1, DOI 10.1186/jbiol63; Imamura F, 2013, CIRCULATION, V127, P1512, DOI 10.1161/CIRCULATIONAHA.112.001197; Iqbal N, 2012, CARDIOVASC DIAGN THE, V2, P147, DOI 10.3978/j.issn.2223-3652.2012.06.03; Kortmann W, 2008, 5 OXOPROLINE CAUSE H, V66, P4; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; LANDAAS S, 1977, CLIN CHIM ACTA, V78, P489, DOI 10.1016/0009-8981(77)90082-1; Le Lay S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/908539; Lee GR, 2017, PRACT LAB MED, V9, P1, DOI 10.1016/j.plabm.2017.06.001; Lee HC, 2012, MOL BIOL CELL, V23, P4689, DOI 10.1091/mbc.E12-09-0673; Lommi J, 1997, J INTERN MED, V242, P231, DOI 10.1046/j.1365-2796.1997.00187.x; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; Malhotra R, 2016, JACC-HEART FAIL, V4, P607, DOI 10.1016/j.jchf.2016.03.022; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Miller WL, 2016, ESC HEART FAIL, V3, P3, DOI 10.1002/ehf2.12071; Mohorko N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/418681; Mueller-Hennessen M, 2017, ESC HEART FAIL, V4, P178, DOI 10.1002/ehf2.12133; Nadruz W, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006000; Nettleton JA, 2017, ANN NUTR METAB, V70, P26, DOI 10.1159/000455681; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Reis A, 2012, BBA-BIOMEMBRANES, V1818, P2374, DOI 10.1016/j.bbamem.2012.02.002; Riedel O, 2018, CLIN RES CARDIOL, V107, P487, DOI 10.1007/s00392-018-1210-x; SAEZ G, 1982, BIOCHIM BIOPHYS ACTA, V719, P24, DOI 10.1016/0304-4165(82)90302-6; SARGENT JR, 1994, MED HYPOTHESES, V42, P237, DOI 10.1016/0306-9877(94)90122-8; Sorokina N, 2007, CIRCULATION, V115, P2033, DOI 10.1161/CIRCULATIONAHA.106.668665; Stanley WC, 2001, EUR HEART J SUPPL, V3, pO2, DOI 10.1016/S1520-765X(01)90147-6; Stephenson FA, 2006, BIOCHEM SOC T, V34, P877, DOI 10.1042/BST0340877; Sun HP, 2016, CIRCULATION, V133, P2038, DOI 10.1161/CIRCULATIONAHA.115.020226; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; van der Pol A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam8574; Van Tassell BW, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004373; Vimercati C, 2014, AM J PHYSIOL-HEART C, V306, pH709, DOI 10.1152/ajpheart.00783.2013; Wang J, 2013, MOL BIOSYST, V9, P2618, DOI 10.1039/c3mb70227h; Wu D, 2014, INT J MOL MED, V34, P1706, DOI 10.3892/ijmm.2014.1942; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Zordoky BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124844	57	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218153	10.1371/journal.pone.0218153	http://dx.doi.org/10.1371/journal.pone.0218153			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220103	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500025
J	Coorey, G; Peiris, D; Usherwood, T; Neubeck, L; Mulley, J; Redfern, J				Coorey, Genevieve; Peiris, David; Usherwood, Tim; Neubeck, Lis; Mulley, John; Redfern, Julie			Persuasive design features within a consumer-focused eHealth intervention integrated with the electronic health record: A mixed methods study of effectiveness and acceptability	PLOS ONE			English	Article							PERSONAL HEALTH; CARDIOVASCULAR-DISEASE; LIFE-STYLE; TECHNOLOGY; SERVICES; PEOPLE; TOOLS; OLDER; RISK	Introduction eHealth strategies targeting health-related behaviour often incorporate persuasive software design. To further engage patients with their overall health management, consumer-facing web portals may be integrated with data from one or more care providers. This study aimed to explore effectiveness for healthier behaviour of persuasive design characteristics within a web application integrated with the primary health care electronic record; also patient and general practitioner (GP) preferences for future integrated records. Methods Mixed methods study within the Consumer Navigation of Electronic Cardiovascular Tools randomised controlled trial. Participants were patients with moderate-high risk of cardiovascular disease, and their GPs. Survey and web analytic data were analysed with descriptive statistics. Interview and focus group transcripts were recorded, transcribed, coded and analysed for themes. Results Surveys (n = 397) received from patients indicated improved medication adherence (31.8%); improved mental health and well-being (40%); higher physical activity (47%); and healthier eating (61%). Users of the interactive features reported benefiting from personalised cardiovascular disease risk score (73%); goal tracking (69%); risk factor self-monitoring (52%) and receipt of motivational health tips (54%). Focus group and interview participants (n = 55) described customisations that would increase portal appeal and relevance, including more provider interaction. Of the GP survey respondents (n = 38), 74% reported increased patient attendance and engagement with their care. For future integrated portals, 94% of GPs were in favour and key themes among interviewees (n = 17) related to design optimisation, impact on workflow and data security. Conclusion Intervention features reflecting the persuasive design categories of Primary Task support, Dialogue support and System Credibility support facilitated healthier lifestyle behaviour. Patients valued customisable functions and greater patient-provider interactivity. GPs identified system challenges but saw advantages for patients and the health care relationship. Future studies could further elucidate the persuasive design principles that are at play and which may promote adoption of EHR-integrated consumer portals.	[Coorey, Genevieve] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Coorey, Genevieve; Peiris, David; Mulley, John] George Inst Global Hlth, Sydney, NSW, Australia; [Peiris, David] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Usherwood, Tim; Redfern, Julie] Univ Sydney, Fac Med & Hlth, Dept Gen Practice, Sydney, NSW, Australia; [Neubeck, Lis] Edinburgh Napier Univ, Sch Hlth & Social Care, Edinburgh, Midlothian, Scotland	University of Sydney; George Institute for Global Health; University of Sydney; University of New South Wales Sydney; University of Sydney; Edinburgh Napier University	Coorey, G (corresponding author), Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Sydney, NSW, Australia.; Coorey, G (corresponding author), George Inst Global Hlth, Sydney, NSW, Australia.	gcoorey@georgeinstitute.org.au	Coorey/AAM-1503-2021; Neubeck, Lis/AAL-2192-2020; Redfern, Julie/AAM-8617-2020	Neubeck, Lis/0000-0001-5852-1034; Redfern, Julie/0000-0001-8707-5563; Peiris, David/0000-0002-6898-3870	Australian National Health and Medical Research Council (NHMRC) [1047508]; Health Professional Scholarship from the National Heart Foundation of Australia [101544]; NHMRC Career Development Fellowship [1143904, 1143538]; Heart Foundation Future Leader Fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Health Professional Scholarship from the National Heart Foundation of Australia; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation Future Leader Fellowship	The Consumer Navigation of Electronic Cardiovascular Tools RCT was funded by the Australian National Health and Medical Research Council, https://nhmrc.gov.au/(NHMRC Grant ID 1047508). GC is supported by a Health Professional Scholarship (ID 101544) from the National Heart Foundation of Australia, https://www.heartfoundation.org.au/. DP is supported by an NHMRC Career Development Fellowship (ID 1143904) and a Heart Foundation Future Leader Fellowship. JR is funded by a NHMRC Career Development Fellowship [ID 1143538]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalbers T, 2011, AGEING RES REV, V10, P487, DOI 10.1016/j.arr.2011.05.001; Adler AJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011851.pub2; [Anonymous], 2009, CAIS, DOI [10.17705/1CAIS.02428, DOI 10.17705/1CAIS.02428]; [Anonymous], 2015, PERSPECT HEAL INF MA; Antypas K, 2014, J MED INTERNET RES, V16, P78, DOI 10.2196/jmir.3132; Baer D, 2011, J ONCOL PRACT, V7, P230, DOI 10.1200/JOP.2011.000323; Bartlett Yvonne Kiera, 2017, J Med Internet Res, V19, pe124, DOI 10.2196/jmir.6616; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chatterjee S, 2009, J AM MED INFORM ASSN, V16, P171, DOI 10.1197/jamia.M2859; Chow CK, 2015, JAMA-J AM MED ASSOC, V314, P1255, DOI 10.1001/jama.2015.10945; Coorey GM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014353; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Davis S, 2017, J AM MED INFORM ASSN, V24, P857, DOI 10.1093/jamia/ocw172; Davis S, 2017, STUD HEALTH TECHNOL, V234, P75, DOI 10.3233/978-1-61499-742-9-75; Day Karen, 2012, Stud Health Technol Inform, V178, P39; Detmer D, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-45; Fogg B., 2009, P 4 INT C PERS TECHN; Fogg B. J., 2003, PERSUASIVE TECHNOLOG, P89; Fylan F, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3254-z; Gardner B, 2015, HEALTH PSYCHOL REV, V9, P277, DOI 10.1080/17437199.2013.876238; Glynn L, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0333-7; Greenhalgh T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5814; Irizarry T, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4255; Karppinen P, 2018, J BIOMED INFORM, V84, P82, DOI 10.1016/j.jbi.2018.06.012; Kerns JW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002931; Krist AH, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-73; Langrial Sitwat, 2012, Persuasive Technology. Design for Health and Safety. Proceedings 7th International Conference, PERSUASIVE 2012, P256, DOI 10.1007/978-3-642-31037-9_23; Lehto T, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1559; Logue Melanie D, 2012, Inform Prim Care, V20, P151; Lupton D, 2016, ECON SOC, V45, P101, DOI 10.1080/03085147.2016.1143726; Matthews J, 2016, J MED SYST, V40, DOI 10.1007/s10916-015-0425-x; Mold F, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.7858; Mold F, 2015, BRIT J GEN PRACT, V65, pE141, DOI 10.3399/bjgp15X683941; Moll J, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9492; Neubeck L, 2016, INT J MED INFORM, V96, P24, DOI 10.1016/j.ijmedinf.2016.01.009; Nohr C, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2482-y; O'Connor S, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0359-3; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Palmer MJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012675.pub2; Pearce C, 2014, J AM MED INFORM ASSN, V21, P707, DOI 10.1136/amiajnl-2013-002068; Pietrzak E, 2014, J CARDIOPULM REHABIL, V34, P303, DOI 10.1097/HCR.0000000000000063; Portz JD, 2016, HEALTH TECHNOL-GER, V6, P89, DOI 10.1007/s12553-016-0130-x; Price M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0159-1; Redfern J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004523; Salvi D, 2018, J TELEMED TELECARE, V24, P303, DOI 10.1177/1357633X17697501; Storm V, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5147; Taha J, 2013, PSYCHOL AGING, V28, P1124, DOI 10.1037/a0033911; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wildeboer G, 2016, INT J MED INFORM, V96, P71, DOI 10.1016/j.ijmedinf.2016.04.005; Woods SS, 2013, J MED INTERNET RES, V15, P182, DOI 10.2196/jmir.2356	51	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218447	10.1371/journal.pone.0218447	http://dx.doi.org/10.1371/journal.pone.0218447			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220127	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500049
J	Krebs, J; Hillenbrand, A; Tsagogiorgas, C; Patry, C; Tonshoff, B; Yard, B; Beck, G; Rafat, N				Krebs, Joerg; Hillenbrand, Alexander; Tsagogiorgas, Charalambos; Patry, Christian; Toenshoff, Burkhard; Yard, Benito; Beck, Grietje; Rafat, Neysan			Intravenous delivery of granulocyte-macrophage colony stimulating factor impairs survival in lipopolysaccharide-induced sepsis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ACUTE LUNG INJURY; G-CSF; CYTOKINE PRODUCTION; STEM-CELLS; MOBILIZATION; SEVERITY	Background Cell-based therapies with bone marrow-derived progenitor cells (BMDPC) lead to an improved clinical outcome in animal sepsis models. In the present study we evaluated the ability of granulocyte macrophage-colony stimulating factor (GM-CSF) to mobilize BMDPC in a lipopolysaccharide (LPS)-induced sepsis model and thereby its potential as a novel treatment strategy. Methods Male Wistar rats received LPS (25 mu g/kg/h for 4 days) intravenously and were subsequently treated with GM-CSF 12.5 mu g/kg (0h, 24h, 48h, 72h). As control groups, rats were infused with sodium chloride or GM-CSF only. Clinical and laboratory parameters, proinflammatory plasma cytokines as well as BMDPC counts were analyzed. Cytokine release by isolated peripheral blood mononuclear cells from rat spleen upon incubation with LPS, GM-CSF and a combination of both were investigated in vitro. Results In vivo, rats receiving both LPS and GM-CSF, showed a reduced weight loss and increased mobilization of BMDPC. At the same time, this regime resulted in an increased release of proinflammatory cytokines (IL-6, IL-8) and a significantly increased mortality. In vitro, the combination of LPS and GM-CSF showed a significantly increased IL-6 release upon incubation compared to incubation with LPS or GM-CSF alone. Conclusions GM-CSF did not have a beneficial effect on the clinical course in our LPS-induced sepsis model. It synergistically promoted inflammation with LPS and probably thereby impaired survival.	[Krebs, Joerg; Hillenbrand, Alexander; Tsagogiorgas, Charalambos] Heidelberg Univ, Univ Hosp Mannheim, Dept Anaesthesiol & Crit Care Med, Heidelberg, Germany; [Patry, Christian; Toenshoff, Burkhard; Rafat, Neysan] Heidelberg Univ, Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany; [Yard, Benito] Heidelberg Univ, Univ Hosp Mannheim, Dept Med 5, Heidelberg, Germany; [Beck, Grietje] Helios Dr Horst Schmidt Clin, Dept Anaesthesiol, Wiesbaden, Germany; [Rafat, Neysan] Heidelberg Univ, Univ Childrens Hosp Mannheim, Dept Neonatol, Heidelberg, Germany; [Rafat, Neysan] BIHE, Dept Pharmaceut Sci, Tehran, Iran	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Rafat, N (corresponding author), Heidelberg Univ, Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany.; Rafat, N (corresponding author), Heidelberg Univ, Univ Childrens Hosp Mannheim, Dept Neonatol, Heidelberg, Germany.; Rafat, N (corresponding author), BIHE, Dept Pharmaceut Sci, Tehran, Iran.	Neysan.Rafat@umm.de	Krebs, Joerg/AHD-7504-2022	Krebs, Joerg/0000-0003-3037-0144; Rafat, Neysan/0000-0003-2035-8598	German Research Foundation (DFG); Postdoc-Program of the University of Heidelberg	German Research Foundation (DFG)(German Research Foundation (DFG)); Postdoc-Program of the University of Heidelberg	This study was supported by a research grant from the German Research Foundation (DFG) (G. B.). N. R. was supported by a research scholarship from the Postdoc-Program of the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2000, EUR RESPIR J, V15, P895, DOI 10.1034/j.1399-3003.2000.15e14.x; Asakura E, 1996, IMMUNOBIOLOGY, V195, P300, DOI 10.1016/S0171-2985(96)80047-7; Basu S, 1997, J IMMUNOL, V159, P1412; Bergamini A, 2000, IMMUNOLOGY, V101, P254, DOI 10.1046/j.1365-2567.2000.00117.x; BERMUDEZ L E, 1990, Cytokine, V2, P287, DOI 10.1016/1043-4666(90)90030-W; BO L, 2011, CRIT CARE, V15, P1, DOI DOI 10.1161/01.CIR.00000097001.79750.78; BRISSETTE WH, 1995, CYTOKINE, V7, P291, DOI 10.1006/cyto.1995.0035; Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC; CAIRO MS, 1990, PEDIATR RES, V27, P612, DOI 10.1203/00006450-199006000-00016; CARR R, 2003, COCHRANE DB SYST REV, P7431; Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.0000097001.79750.78; Gao M, 2012, INFLAMM RES, V61, P889, DOI 10.1007/s00011-012-0481-3; Gazitt Y, 2002, CURR OPIN HEMATOL, V9, P190, DOI 10.1097/00062752-200205000-00003; Goodman ER, 1999, ARCH SURG-CHICAGO, V134, P1049, DOI 10.1001/archsurg.134.10.1049; Hierholzer C, 1997, ARCH ORTHOP TRAUM SU, V116, P173, DOI 10.1007/BF00426067; Hierholzer C, 1998, J LEUKOCYTE BIOL, V63, P169, DOI 10.1002/jlb.63.2.169; Hierholzer C, 1997, AM J PHYSIOL-LUNG C, V273, pL1058, DOI 10.1152/ajplung.1997.273.5.L1058; HTTPS, CCM, P7431, DOI DOI 10.1186/CC10031; HTTPS, 1995, CCM, V35, P7431; HTTPS, 1997, CCM, V273, P5; HTTPS, CCM, P7431, DOI DOI 10.1165/RCMB.2011-0132TR; HTTPS, CCM, P7431; KHAMENEH H, 2011, PLOS ONE, V6, P9580; Lee JW, 2013, AM J RESP CRIT CARE, V187, P751, DOI 10.1164/rccm.201206-0990OC; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; MARLOW N, 2013, ARCH DIS CHILD-FETAL, V98, pF4, DOI DOI 10.1097/SHK.0B013E3181673543; Matute-Bello G, 2000, CRIT CARE MED, V28, P1, DOI 10.1097/00003246-200001000-00001; MEDINA RJ, 2010, BMC MED GENOMICS, V3, P7431, DOI DOI 10.1038/NM1182; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Mutunga M, 2001, AM J RESP CRIT CARE, V163, P195, DOI 10.1164/ajrccm.163.1.9912036; Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3; RAFAT N, 2014, J PULM RESP MED, V4, P2, DOI DOI 10.1186/1756-0500-7-613; RAFAT N, 2014, BMC RES NOTES, V7, P7431, DOI DOI 10.1164/RCCM.200410-1325OC; Rafat N, 2007, CRIT CARE MED, V35, P1677, DOI 10.1097/01.CCM.0000269034.86817.59; Rafat N, 2013, AM J RESP CELL MOL, V48, P399, DOI 10.1165/rcmb.2011-0132TR; Richardson MR, 2011, J MOL CELL CARDIOL, V50, P266, DOI 10.1016/j.yjmcc.2010.07.009; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Song Fei, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P294; Spight D, 2008, SHOCK, V30, P434, DOI 10.1097/SHK.0b013e3181673543; Spitzer G, 1997, BONE MARROW TRANSPL, V20, P921, DOI 10.1038/sj.bmt.1700999; TIEGS G, 1994, J CLIN INVEST, V93, P2616, DOI 10.1172/JCI117274; TODA H, 1994, BLOOD, V83, P2893, DOI 10.1182/blood.V83.10.2893.2893; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; VERHOEF G, 1991, AM J HEMATOL, V36, P285, DOI 10.1002/ajh.2830360413; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288	46	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218602	10.1371/journal.pone.0218602	http://dx.doi.org/10.1371/journal.pone.0218602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220157	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500072
J	Karrer, D; Ruhl, M				Karrer, Dominik; Ruehl, Martin			A new lipoxygenase from the agaric fungus Agrocybe aegerita: Biochemical characterization and kinetic properties	PLOS ONE			English	Article							LINOLEIC-ACID; MANGANESE LIPOXYGENASE; FATTY-ACIDS; 1-OCTEN-3-OL; PURIFICATION; DETERMINANT	Oxylipins are metabolites with a variety of biological functions. However, the biosynthetic pathway is widely unknown. It is considered that the first step is the oxygenation of polyunsaturated fatty acids like linoleic acid. Therefore, a lipoxygenase (LOX) from the edible basidiomycete Agrocybe aegerita was investigated. The AaeLOX4 was heterologously expressed in E. coli and purified via affinity chromatography and gel filtration. Biochemical properties and kinetic parameters of the purified AaeLOX4 were determined with linoleic acid and linolenic acid as substrates. The obtained K-m, v(max) and k(cat) values for linoleic acid were 295.5 mu M, 16.5 mu M. min(-1). mg(-1) and 103.9 s(-1), respectively. For linolenic acid K-m, v(max) and k(cat) values of 634.2 mu M, 19.5 mu M. min(-1). mg(-1) and 18.3 s(-1) were calculated. Maximum activities were observed at pH 7.5 and 25 degrees C. The main product of linoleic acid conversion was identified with normal-phase HPLC. This analysis revealed an explicit production of 13-hydroperoxy-9,11-octadecadienoic acid (13-HPOD). The experimental regio specificity is underpinned by the amino acid residues W384, F450, R594 and V635 considered relevant for regio specificity in LOX. In conclusion, HPLC-analysis and alignments revealed that AaeLOX4 is a 13-LOX.	[Karrer, Dominik; Ruehl, Martin] Justus Liebig Univ Giessen, Inst Food Chem & Food Biotechnol, Giessen, Hesse, Germany; [Ruehl, Martin] Fraunhofer Inst Mol Biol & Appl Ecol, IME Business Area Bioresources, Giessen, Hesse, Germany	Justus Liebig University Giessen; Fraunhofer Gesellschaft	Ruhl, M (corresponding author), Justus Liebig Univ Giessen, Inst Food Chem & Food Biotechnol, Giessen, Hesse, Germany.; Ruhl, M (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol, IME Business Area Bioresources, Giessen, Hesse, Germany.	martin.ruehl@uni-giessen.de	Rühl, Martin/V-4740-2019	Rühl, Martin/0000-0001-8274-8175	Deutsche Forschungsgemeinschaft [RU 2137/1]; Hessen State Ministry of Higher Education, Research and the Arts	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hessen State Ministry of Higher Education, Research and the Arts	The grant RU 2137/1 from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/) was awarded to MR. DK and MR used facilities of the LOEWE Center for Insect Biotechnology & Bioresources financed by the Hessen State Ministry of Higher Education, Research and the Arts (http://www.proloewe.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JU, 2018, BBA-MOL CELL BIOL L, V1863, P823, DOI 10.1016/j.bbalip.2018.04.014; An JU, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02543-8; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Andreou AZ, 2009, LIPIDS, V44, P207, DOI 10.1007/s11745-008-3264-4; ASSAF S, 1995, J AGR FOOD CHEM, V43, P2173, DOI 10.1021/jf00056a040; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Cao S, 2016, PLOS ONE, V11, P4; Gupta DK, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4430-y; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; Hornung E, 2008, PHYTOCHEMISTRY, V69, P2774, DOI 10.1016/j.phytochem.2008.09.006; Kleofas V., 2014, NAT RESOUR, V05, P233, DOI [10.4236/NR.2014.56022, DOI 10.4236/NR.2014.56022]; Kock JLF, 1998, FEBS LETT, V427, P345, DOI 10.1016/S0014-5793(98)00406-2; Kuribayashi T, 2002, J AGR FOOD CHEM, V50, P1247, DOI 10.1021/jf0112217; Lee IG, 2019, GREEN CHEM, V21, P3172, DOI 10.1039/c9gc01031a; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Oliw EH, 2011, BBA-MOL CELL BIOL L, V1811, P138, DOI 10.1016/j.bbalip.2010.12.002; Pinto MD, 2003, J AGR FOOD CHEM, V51, P1653, DOI 10.1021/jf025818d; Plagemann I, 2013, J MOL CATAL B-ENZYM, V87, P99, DOI 10.1016/j.molcatb.2012.11.004; Rapior S, 1998, CRYPTOGAMIE MYCOL, V19, P15; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Wadman MW, 2005, LIPIDS, V40, P1163, DOI 10.1007/s11745-005-1481-2; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P18, DOI 10.1016/0005-2760(84)90292-3; WURZENBERGER M, 1982, Z LEBENSM UNTERS FOR, V175, P186, DOI 10.1007/BF01139769; WURZENBERGER M, 1984, ACTA BIOCH BIOPH SIN, V795, P163	27	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218625	10.1371/journal.pone.0218625	http://dx.doi.org/10.1371/journal.pone.0218625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216342	gold, Green Published, Green Submitted			2022-12-26	WOS:000482885300065
J	Bhat, SP; Gangalum, RK; Kim, D; Mangul, S; Kashyap, RK; Zhou, XK; Elashoff, D				Bhat, Suraj P.; Gangalum, Rajendra K.; Kim, Dongjae; Mangul, Serghei; Kashyap, Raj K.; Zhou, Xinkai; Elashoff, David			Transcriptional profiling of single fiber cells in a transgenic paradigm of an inherited childhood cataract reveals absence of molecular heterogeneity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallin; lens; cataract; vision; transcription; gene expression; crystallin gene expression; genetic cataract; lens; single cells; spatial transcriptomics	LAMELLAR CATARACT; LENS DEVELOPMENT; HSF4; ALPHA; EXPRESSION; CRYSTALLINS; EYE; DIVERSITY; MUTATION; GROWTH	Our recent single-cell transcriptomic analysis has demonstrated that heterogeneous transcriptional activity attends molecular transition from the nascent to terminally differentiated fiber cells in the developing mouse lens. To understand the role of transcriptional heterogeneity in terminal differentiation and the functional phenotype (transparency) of this tissue, here we present a single-cell analysis of the developing lens, in a transgenic paradigm of an inherited pathology, known as the lamellar cataract. Cataracts hinder transmission of light into the eye. Lamellar cataract is the most prevalent bilateral childhood cataract. In this disease of early infancy, initially, the opacities remain confined to a few fiber cells, thus presenting an opportunity to investigate early molecular events that lead to cataractogenesis. We used a previously established paradigm that faithfully recapitulates this disease in transgenic mice. About 500 single fiber cells, manually isolated from a 2-day-old transgenic lens were interrogated individually for the expression of all known 17 crystallins and 78 other relevant genes using a Biomark HD (Fluidigm). We find that fiber cells from spatially and developmentally discrete regions of the transgenic (cataract) lens show remarkable absence of the heterogeneity of gene expression. Importantly, the molecular variability of cortical fiber cells, the hallmark of the WT lens, is absent in the transgenic cataract, suggesting absence of specific cell-type(s). Interestingly, we find a repetitive pattern of gene activity in progressive states of differentiation in the transgenic lens. This molecular dysfunction portends pathology much before the physical manifestations of the disease.	[Bhat, Suraj P.; Gangalum, Rajendra K.; Kim, Dongjae; Kashyap, Raj K.] Univ Calif Los Angeles, Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA; [Bhat, Suraj P.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Bhat, Suraj P.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Mangul, Serghei] Univ Calif Los Angeles, Dept Comp Sci & Human Genet, Los Angeles, CA 90095 USA; [Zhou, Xinkai; Elashoff, David] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bhat, SP (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.; Bhat, SP (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA.; Bhat, SP (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	bhat@jsei.ucla.edu	huang, dezhi/ABC-6566-2021; Gangalum, Rajendra K/H-1369-2013	Bhat, Suraj P/0000-0003-4707-5870; Gangalum, Rajendra K/0000-0002-8746-0266; Kim, Dongjae/0000-0002-4911-5656	National Institutes of Health [1R01EY024929]; Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY024929, P30EY000331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant 1R01EY024929 (to S.P.B.) and by the Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund and by a Research to Prevent Blindness, Inc. unrestricted grant to the Department of Ophthalmology at UCLA. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bassnett S, 2017, PROG RETIN EYE RES, V60, P181, DOI 10.1016/j.preteyeres.2017.04.001; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat SP, 2003, PROG DRUG RES, V60, P205; Bhat SP, 2001, BIOSCIENCE REP, V21, P537, DOI 10.1023/A:1017952128502; Birkenfeld J, 2013, VISION RES, V86, P27, DOI 10.1016/j.visres.2013.04.004; Brennan LA, 2018, EXP EYE RES, V174, P173, DOI 10.1016/j.exer.2018.06.003; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Buenrostro JD, 2018, CELL, V173, P1535, DOI 10.1016/j.cell.2018.03.074; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Enoki Y, 2010, BBA-MOL BASIS DIS, V1802, P749, DOI 10.1016/j.bbadis.2010.06.001; Falls HF, 1943, ARCH OPHTHALMOL-CHIC, V29, P210, DOI 10.1001/archopht.1943.00880140056002; Forster JE, 2006, OPHTHAL PHYSL OPT, V26, P372, DOI 10.1111/j.1475-1313.2006.00370.x; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Gangalum RK, 2018, ISCIENCE, V10, P66, DOI 10.1016/j.isci.2018.11.024; Gangalum RK, 2014, INVEST OPHTH VIS SCI, V55, P7227, DOI 10.1167/iovs.14-14594; Gao M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.478; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Iribarren R, 2015, PROG RETIN EYE RES, V47, P86, DOI 10.1016/j.preteyeres.2015.02.002; Javadiyan Shari, 2016, BMC Res Notes, V9, P83, DOI 10.1186/s13104-016-1890-0; Jing Z, 2014, HUM MUTAT, V35, P1068, DOI 10.1002/humu.22610; Jing Z, 2013, CELL STRESS CHAPERON, V18, P377, DOI 10.1007/s12192-012-0386-7; Lein E, 2017, SCIENCE, V358, P64, DOI 10.1126/science.aan6827; Mahendiran K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05195; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; Mou LS, 2010, INVEST OPHTH VIS SCI, V51, P396, DOI 10.1167/iovs.09-3772; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; PIERSCIONEK B, 1987, VISION RES, V27, P1539, DOI 10.1016/0042-6989(87)90162-3; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shi XH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-10; Skelly DA, 2018, CELL REP, V22, P600, DOI 10.1016/j.celrep.2017.12.072; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Somasundaram T, 2000, J BIOL CHEM, V275, P17154, DOI 10.1074/jbc.M000304200; Somasundaram T, 2004, J BIOL CHEM, V279, P44497, DOI 10.1074/jbc.M405813200; Srivastava SK, 1997, INVEST OPHTH VIS SCI, V38, P2300; Symmons O, 2016, MOL CELL, V62, P788, DOI 10.1016/j.molcel.2016.05.023; Tan DWM, 2013, DEVELOPMENT, V140, P1433, DOI 10.1242/dev.087551; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Zhao HY, 2011, J MOL BIOL, V411, P680, DOI 10.1016/j.jmb.2011.06.007; Zhao WJ, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0066-3	45	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13530	13544		10.1074/jbc.RA119.008853	http://dx.doi.org/10.1074/jbc.RA119.008853			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31243103	Green Published, hybrid			2022-12-26	WOS:000486418600002
J	Xian, YF; Ip, SP; Li, HQ; Qu, C; Su, ZR; Chen, JN; Lin, ZX				Xian, Yan-Fang; Ip, Siu-Po; Li, Hui-Qin; Qu, Chang; Su, Zi-Ren; Chen, Jian-Nan; Lin, Zhi-Xiu			Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3 beta signaling pathway	FASEB JOURNAL			English	Article						Chinese medicine; depression; behavioral tests; mechanism	UNPREDICTABLE MILD STRESS; NERVE GROWTH-FACTOR; EXTINCTION-INDUCED DESPAIR; FORCED SWIMMING TEST; UNCARIA-SINENSIS; HPA AXIS; BRAIN; DEPRESSION; MODEL; BDNF	Isorhynchophylline (IRN), an oxindole alkaloid isolated from Uncaria rhynchophylla, elicited distinct antidepressant-like activity in mice. The present study aimed to investigate the antidepressant-like effects of IRN in chronic unpredictable mild stress (CUMS)-induced depressive-like behaviors in mice and to illustrate its possible mechanisms of action. The mice were subjected to CUMS for 6 wk and administered with IRN (20 or 40 mg/kg) daily by oral gavage for 3 wk. The PI3K/protein kinase B (Akt) inhibitor and glycogen synthase kinase-3 beta (GSK-3 beta) inhibitors were used to determine the involvement of the PI3K/Akt/GSK-3 beta pathway in the antidepressant-like effects of IRN in the mice. The results showed that CUMS caused depression-like behaviors in the mice, such as behavioral despair by the forced swim test (FST) and anhedonia by the sucrose preference test. In addition, CUMS could significantly reduce the levels of nerve growth factor and brain-derived neurotrophic factor but markedly increase the release of TNF-alpha and IL-6 in the hippocampus and cerebral cortex of the mice. Western blotting analysis showed that CUMS markedly suppressed the levels of phosphorylated GSK-3 beta (Ser9) and phosphorylated Akt (Ser473) but significantly enhanced the translocation of NF-kappa B p65 from cytosol to nuclei in the hippocampus and cerebral cortex of the mice. CUMS could also significantly increase the NF-kappa B binding activity in the hippocampus and cerebral cortex of the mice, whereas IRN treatment could significantly reverse the behavioral and biochemical changes induced by CUMS in the mice. Moreover, the antidepressant-like effect of IRN was completely abolished by the PI3K/Akt inhibitor. Combination treatment with IRN and GSK-3 beta inhibitors in the mice exerted a synergistic anti-immobility action in the FST. The results of mechanistic investigations indicated that the antidepressant-like action of IRN was mediated, at least in part, by enhancing neurotrophins and attenuating neuroinflammation via modulating the PI3K/Akt/GSK-3 beta pathway.-Xian, Y.-F., Ip, S.-P., Li, H.-Q., Qu, C., Su, Z.-R., Chen, J.-N., Lin, Z.-X. Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3 beta signaling pathway.	[Xian, Yan-Fang; Ip, Siu-Po; Li, Hui-Qin; Qu, Chang; Lin, Zhi-Xiu] Chinese Univ Hong Kong, Sch Chinese Med, Fac Med, Hong Kong, Peoples R China; [Xian, Yan-Fang; Ip, Siu-Po; Lin, Zhi-Xiu] Chinese Univ Hong Kong, Brain Res Ctr, Sch Chinese Med, Fac Med, Hong Kong, Peoples R China; [Lin, Zhi-Xiu] Chinese Univ Hong Kong, Hong Kong Inst Integrat Med, Hong Kong, Peoples R China; [Su, Zi-Ren; Chen, Jian-Nan] Guangzhou Univ Chinese Med, Guangdong Prov Key Lab New Drug Dev & Res Chinese, Math Engn Acad Chinese Med, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Guangzhou University of Chinese Medicine	Xian, YF; Lin, ZX (corresponding author), Chinese Univ Hong Kong, Sch Chinese Med, Fac Med, Shatin, Hong Kong, Peoples R China.	lisaxian@cuhk.edu.hk; linzx@cuhk.edu.hk	Ip, Paul/M-8831-2014; Lin, Zhi-Xiu/H-2807-2016; Xian, Yan-Fang/AAA-6876-2020	Ip, Paul/0000-0001-8657-6585; 	General Research Fund from the Research Grants Council of Hong Kong [14110814]; Chinese University of Hong Kong (CUHK) [2015.1.081, 2017.076]	General Research Fund from the Research Grants Council of Hong Kong; Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong)	This work was supported by the General Research Fund from the Research Grants Council of Hong Kong (14110814) and The Chinese University of Hong Kong (CUHK) Direct Grants 2015.1.081 and 2017.076. The authors declare no conflicts of interest.	Angelucci F, 2003, INT J NEUROPSYCHOPH, V6, P225, DOI 10.1017/S1461145703003468; Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Basterzi AD, 2009, PROG NEURO-PSYCHOPH, V33, P281, DOI 10.1016/j.pnpbp.2008.11.016; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Budni J, 2012, J PSYCHOPHARMACOL, V26, P714, DOI 10.1177/0269881111424456; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Chourbaji S, 2005, BEHAV BRAIN RES, V164, P100, DOI 10.1016/j.bbr.2005.06.003; Chourbaji S, 2012, NEUROSCIENCE, V220, P267, DOI 10.1016/j.neuroscience.2012.06.016; Christensen NL, 1997, ECOSYSTEM FUNCTION AND HUMAN ACTIVITIES, P1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cunha MP, 2016, MOL NEUROBIOL, V53, P2954, DOI 10.1007/s12035-015-9192-4; Dwivedi Y, 2005, BIOL PSYCHIAT, V58, P315, DOI 10.1016/j.biopsych.2005.04.014; Farooq RK, 2012, BEHAV BRAIN RES, V231, P130, DOI 10.1016/j.bbr.2012.03.020; Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002; Fuchs E, 2004, EUR NEUROPSYCHOPHARM, V14, pS481, DOI 10.1016/j.euroneuro.2004.09.002; Givens CJ, 2016, NURS CLIN N AM, V51, P309, DOI 10.1016/j.cnur.2016.01.013; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Han TK, 2015, METAB BRAIN DIS, V30, P711, DOI 10.1007/s11011-014-9624-2; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hellweg R, 2002, MOL PSYCHIATR, V7, P604, DOI 10.1038/sj.mp.4001042; Hirschfeld Robert M A, 2012, J Clin Psychiatry, V73 Suppl 1, P5, DOI 10.4088/JCP.11096su1c.01; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huston JP, 2009, J NEURAL TRANSM, V116, P1029, DOI 10.1007/s00702-009-0210-4; Iwata M, 2013, BRAIN BEHAV IMMUN, V31, P105, DOI 10.1016/j.bbi.2012.12.008; Jiang H, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.43; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; KANATANI H, 1985, J PHARM PHARMACOL, V37, P401, DOI 10.1111/j.2042-7158.1985.tb03023.x; Kang TH, 2004, LIFE SCI, V76, P331, DOI 10.1016/j.lfs.2004.08.012; Karege F, 2007, BIOL PSYCHIAT, V61, P240, DOI 10.1016/j.biopsych.2006.04.036; Kaster MP, 2012, NEUROPHARMACOLOGY, V62, P419, DOI 10.1016/j.neuropharm.2011.08.018; Kingeter LM, 2010, CELL SIGNAL, V22, P9, DOI 10.1016/j.cellsig.2009.09.033; Kitagishi Yasuko, 2012, Depress Res Treat, V2012, P752563, DOI 10.1155/2012/752563; Koprdova R, 2016, NEUROENDOCRINOL LETT, V37, P103; Lang UE, 2004, STRESS, V7, P39, DOI 10.1080/10253890310001638145; Lang UE, 2004, NEUROPSYCHOPHARMACOL, V29, P795, DOI 10.1038/sj.npp.1300382; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Li S, 2007, LIFE SCI, V80, P1373, DOI 10.1016/j.lfs.2006.12.027; Lu JH, 2012, AUTOPHAGY, V8, P98, DOI 10.4161/auto.8.1.18313; Ludka FK, 2016, J PSYCHIATR RES, V82, P50, DOI 10.1016/j.jpsychires.2016.07.004; Luo DD, 2008, BRAIN RES BULL, V77, P8, DOI 10.1016/j.brainresbull.2008.05.010; Manji H K, 2001, Psychopharmacol Bull, V35, P5; Mao QQ, 2009, PROG NEURO-PSYCHOPH, V33, P1211, DOI 10.1016/j.pnpbp.2009.07.002; Matrisciano F, 2008, J PSYCHIATR RES, V43, P247, DOI 10.1016/j.jpsychires.2008.03.014; Matsumoto K, 2005, EUR J PHARMACOL, V517, P191, DOI 10.1016/j.ejphar.2005.05.015; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0; Rodrigues ALS, 1996, PHARMACOL TOXICOL, V79, P150, DOI 10.1111/j.1600-0773.1996.tb00259.x; Rosa AO, 2008, PROG NEURO-PSYCHOPH, V32, P1549, DOI 10.1016/j.pnpbp.2008.05.020; Shi HS, 2012, NEUROPSYCHOPHARMACOL, V37, P2671, DOI 10.1038/npp.2012.131; Shimada Y, 1999, J PHARM PHARMACOL, V51, P715, DOI 10.1211/0022357991772853; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Thakare VN, 2018, J PSYCHOPHARMACOL, V32, P223, DOI 10.1177/0269881117742666; Topic B, 2008, NEUROBIOL LEARN MEM, V90, P519, DOI 10.1016/j.nlm.2008.06.011; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; World Health Organization (WHO), 2017, DEPRESSION; Xian YF, 2017, NEUROCHEM RES, V42, P678, DOI 10.1007/s11064-016-2124-5; Xian YF, 2014, J ALZHEIMERS DIS, V39, P331, DOI 10.3233/JAD-131457; Xian YF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/163057; Xian YF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/802625; Xian YF, 2012, CELL MOL NEUROBIOL, V32, P353, DOI 10.1007/s10571-011-9763-5; Xie H, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0747-8; Yang XH, 2017, NEUROPSYCH DIS TREAT, V13, P2727, DOI 10.2147/NDT.S150028; Yuan D, 2009, INT IMMUNOPHARMACOL, V9, P1549, DOI 10.1016/j.intimp.2009.09.010; Zheng H, 2006, BEHAV BRAIN RES, V168, P47, DOI 10.1016/j.bbr.2005.10.007	70	27	30	5	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10393	10408		10.1096/fj.201802743RR	http://dx.doi.org/10.1096/fj.201802743RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31233346				2022-12-26	WOS:000482214200054
J	Yang, GL; Han, ZY; Xiong, JH; Wang, SZ; Wei, HJ; Qin, TT; Xiao, HY; Liu, Y; Xu, LX; Qi, JW; Zhang, ZS; Jiang, RC; Zhang, JN; Li, LY				Yang, Gui-Li; Han, Zhenying; Xiong, Jianhua; Wang, Shizhao; Wei, Huijie; Qin, Ting-Ting; Xiao, Huaiyuan; Liu, Ye; Xu, Li-Xia; Qi, Jian-Wei; Zhang, Zhi-Song; Jiang, Rongcai; Zhang, Jianning; Li, Lu-Yuan			Inhibition of intracranial hemangioma growth and hemorrhage by TNFSF15	FASEB JOURNAL			English	Article						hemangioblastoma; TNF superfamily; VEGF	ENDOTHELIAL-CELLS; UP-REGULATION; EXPRESSION; SUPPRESSES; VEGF; ACTIVATION; MICROGLIA; ANGIOGENESIS; MACROPHAGES; ISOFORMS	Hemangioblastoma (HB) is an abnormal intracranial buildup of blood vessels that exhibit a great potential for hemorrhage. Surgical options are limited, and few medications are available for treatment. We show here by immunohistochemical analysis that HB lesions display highly increased levels of VEGF expression and macrophage/microglia infiltration compared with those in normal brain tissues. In the meantime, TNF superfamily 15 (TNFSF15) (also known as vascular endothelial growth inhibitor), an antiangiogenic cytokine, is highly expressed in normal brain blood vessels but diminished in HB lesions. We set up a brain hemangioma model by using mouse bEnd.3 cells of a T antigen-transformed endothelial cell line that produce a large amount of VEGF. When implanted in mouse brains, these cells form lesions that closely resemble the pathologic characteristics of HB. Retroviral infection of bEnd.3 cells with TNFSF15 leads to inhibition of VEGF production and retardation of hemangioma formation. Similar results are obtained when wild-type bEnd.3 cells are implanted in the brains of transgenic mice overexpressing TNFSF15. Additionally, TNFSF15 treatment results in enhanced pericyte coverage of the blood vessels in the lesions together with reduced inflammatory cell infiltration and decreased hemorrhage. These findings indicate that the ability of TNFSF15 to counterbalance the abnormally highly angiogenic and inflammatory potential of the microenvironment of HB is of therapeutic value for the treatment of this disease.-Yang, G.-L., Han, Z., Xiong, J., Wang, S., Wei, H., Qin, T.-T., Xiao, H., Liu, Y., Xu, L.-X., Qi, J.-W., Zhang, Z.-S., Jiang, R., Zhang, J., Li, L.-Y. Inhibition of intracranial hemangioma growth and hemorrhage by TNFSF15.	[Yang, Gui-Li; Han, Zhenying; Xiong, Jianhua; Wang, Shizhao; Wei, Huijie; Liu, Ye; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Key Lab Postneuroinjury Repair & Regenerat Cent N, Minist Educ, Tianjin Neurol Inst,Gen Hosp, Tianjin, Peoples R China; [Qin, Ting-Ting; Xiao, Huaiyuan] Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Canc Inst & Hosp,Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Xu, Li-Xia; Qi, Jian-Wei; Zhang, Zhi-Song; Li, Lu-Yuan] Nankai Univ, Coll Pharm, Tianjin Key Lab Mol Drug Res, State Key Lab Med Chem Biol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Nankai University	Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, 154 Shan St, Tianjin 300052, Peoples R China.; Li, LY (corresponding author), Nankai Univ, 94 Weijin Rd,New Life Sci Bldg A307, Tianjin 300071, Peoples R China.	jnzhang@tmu.edu.cn; liluyuan@nankai.edu.cn	Xu, Lixia/CAJ-5305-2022	Xu, Lixia/0000-0002-1843-0127	Natural Science Foundation of China [81874167, 81330029, 81501069, 81502173, 81601039, 81802296]; Municipal Science and Technology Commission [15ZXLCSY00060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Science and Technology Commission	This study is supported in part by the Natural Science Foundation of China (Grants 81874167, 81330029, 81501069, 81502173, 81601039, and 81802296) and the Municipal Science and Technology Commission (15ZXLCSY00060). The authors declare no conflicts of interest.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Cheng SY, 1997, P NATL ACAD SCI USA, V94, P12081, DOI 10.1073/pnas.94.22.12081; Chew LJ, 2002, FASEB J, V16, P742, DOI 10.1096/fj.01-0757fje; Christoffersson G, 2012, BLOOD, V120, P4653, DOI 10.1182/blood-2012-04-421040; Conway Kevin P, 2007, Int Wound J, V4, P55, DOI 10.1111/j.1742-481X.2006.00295.x; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Deng HT, 2017, FEBS OPEN BIO, V7, P108, DOI 10.1002/2211-5463.12171; Deng WM, 2012, ANGIOGENESIS, V15, P71, DOI 10.1007/s10456-011-9244-y; Eyo UB, 2013, J NEUROIMMUNE PHARM, V8, P494, DOI 10.1007/s11481-013-9434-z; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; HO KL, 1987, ACTA NEUROPATHOL, V74, P345, DOI 10.1007/BF00687211; Hou W, 2005, CLIN CANCER RES, V11, P5595, DOI 10.1158/1078-0432.CCR-05-0384; Huang JZ, 2003, P NATL ACAD SCI USA, V100, P7785, DOI 10.1073/pnas.1432908100; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liang PH, 2011, ANGIOGENESIS, V14, P61, DOI 10.1007/s10456-010-9195-8; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; MORII K, 1993, BIOCHEM BIOPH RES CO, V194, P749, DOI 10.1006/bbrc.1993.1885; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Muramatsu R, 2014, NEUROSCI RES, V81-82, P38, DOI 10.1016/j.neures.2014.01.007; Park S, 2012, HISTOL HISTOPATHOL, V27, P975, DOI 10.14670/HH-27.975; Parr Christian, 2006, Angiogenesis, V9, P73, DOI 10.1007/s10456-006-9033-1; Qi JW, 2013, P NATL ACAD SCI USA, V110, P13863, DOI 10.1073/pnas.1304529110; Qin TT, 2015, J PATHOL, V237, P307, DOI 10.1002/path.4577; Rockenfeller R, 2017, J THEOR BIOL, V431, P11, DOI 10.1016/j.jtbi.2017.07.023; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; SHEIBANI N, 1995, P NATL ACAD SCI USA, V92, P6788, DOI 10.1073/pnas.92.15.6788; Takano S, 1996, CANCER RES, V56, P2185; Tian F, 2007, J IMMUNOL, V179, P3742, DOI 10.4049/jimmunol.179.6.3742; Tian F, 2009, BLOOD, V113, P5352, DOI 10.1182/blood-2008-08-173773; WIZIGMANNVOOS S, 1995, CANCER RES, V55, P1358; Yang GL, 2017, FASEB J, V31, P2001, DOI 10.1096/fj.201600800R; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181; Zhang K, 2016, ONCOTARGET, V7, P69436, DOI 10.18632/oncotarget.11683; Zhang N, 2010, ANTICANCER RES, V30, P87; Zhao Q, 2018, APPL IMMUNOHISTO M M, V26, P727, DOI 10.1097/PAI.0000000000000517; Zhou J, 2011, ONCOGENE, V30, P1892, DOI 10.1038/onc.2010.575	40	2	3	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10505	10514		10.1096/fj.201802758RRR	http://dx.doi.org/10.1096/fj.201802758RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31242765	Bronze			2022-12-26	WOS:000482214200062
J	Eguchi, S; Takefuji, M; Sakaguchi, T; Ishihama, S; Mori, Y; Tsuda, T; Takikawa, T; Yoshida, T; Ohashi, K; Shimizu, Y; Hayashida, R; Kondo, K; Bando, YK; Ouchi, N; Murohara, T				Eguchi, Shunsuke; Takefuji, Mikito; Sakaguchi, Teruhiro; Ishihama, Sohta; Mori, Yu; Tsuda, Takuma; Takikawa, Tomonobu; Yoshida, Tatsuya; Ohashi, Koji; Shimizu, Yuuki; Hayashida, Ryo; Kondo, Kazuhisa; Bando, Yasuko K.; Ouchi, Noriyuki; Murohara, Toyoaki			Cardiomyocytes capture stem cell-derived, anti-apoptotic microRNA-214 via clathrin-mediated endocytosis in acute myocardial infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); endocytosis; cardiomyocyte; clathrin; extracellular vesicles; myocardial infarction; ischemia; heart health; microRNA-214; paracrine signaling	CARDIAC MYOCYTES; HEART-FAILURE; EXOSOMES; PHOSPHORYLATION; INFLAMMATION; PROTEIN-2; OVERLOAD; PROTECTS; THERAPY; RUPTURE	Extracellular vesicles (EVs) have emerged as key mediators of intercellular communication that have the potential to improve cardiac function when used in cell-based therapy. However, the means by which cardiomyocytes respond to EVs remains unclear. Here, we sought to clarify the role of exosomes in improving cardiac function by investigating the effect of cardiomyocyte endocytosis of exosomes from mesenchymal stem cells on acute myocardial infarction (MI). Exposing cardiomyocytes to the culture supernatant of adipose-derived regenerative cells (ADRCs) prevented cardiomyocyte cell damage under hypoxia in vitro. In vivo, the injection of ADRCs into the heart simultaneous with coronary artery ligation decreased overall cardiac infarct area and prevented cardiac rupture after acute MI. Quantitative RT-PCR-based analysis of the expression of 35 known anti-apoptotic and secreted microRNAs (miRNAs) in ADRCs revealed that ADRCs express several of these miRNAs, among which miR-214 was the most abundant. Of note, miR-214 silencing in ADRCs significantly impaired the anti-apoptotic effects of the ADRC treatment on cardiomyocytes in vitro and in vivo. To examine cardiomyocyte endocytosis of exosomes, we cultured the cardiomyocytes with ADRC-derived exosomes labeled with the fluorescent dye PKH67 and found that hypoxic culture conditions increased the levels of the labeled exosomes in cardiomyocytes. Chlorpromazine, an inhibitor of clathrin-mediated endocytosis, significantly suppressed the ADRC-induced decrease of hypoxia-damaged cardiomyocytes and also decreased hypoxia-induced cardiomyocyte capture of both labeled EVs and extracellular miR-214 secreted from ADRCs. Our results indicate that clathrin-mediated endocytosis in cardiomyocytes plays a critical role in their uptake of circulating, exosome-associated miRNAs that inhibit apoptosis.	[Eguchi, Shunsuke; Takefuji, Mikito; Sakaguchi, Teruhiro; Ishihama, Sohta; Mori, Yu; Tsuda, Takuma; Takikawa, Tomonobu; Yoshida, Tatsuya; Ohashi, Koji; Shimizu, Yuuki; Hayashida, Ryo; Kondo, Kazuhisa; Bando, Yasuko K.; Ouchi, Noriyuki; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan	Nagoya University	Takefuji, M; Murohara, T (corresponding author), Nagoya Univ, Dept Cardiol, Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	takefuji@med.nagoya-u.ac.jp; murohara@med.nagoya-u.ac.jp	Bando, Yasuko K./M-4831-2014	Bando, Yasuko K./0000-0003-4166-6784; Shimizu, Yuuki/0000-0003-3103-1160	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. T.).	Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Anzai T, 2013, CIRC J, V77, P580, DOI 10.1253/circj.CJ-13-0013; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Barile L, 2017, EUR HEART J, V38, P1372, DOI 10.1093/eurheartj/ehw304; Boon RA, 2015, NAT REV CARDIOL, V12, P135, DOI 10.1038/nrcardio.2014.207; Chen ZP, 2006, AM J RESP CELL MOL, V35, P127, DOI 10.1165/rcmb.2006-0044OC; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Gao XM, 2010, INT J CARDIOL, V143, P20, DOI 10.1016/j.ijcard.2009.01.019; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gray WD, 2015, CIRC RES, V116, P255, DOI 10.1161/CIRCRESAHA.116.304360; Gyongyosi M, 2018, CIRC RES, V123, P301, DOI 10.1161/CIRCRESAHA.117.311302; Gyongyosi M, 2016, CIRC RES, V118, P1254, DOI 10.1161/CIRCRESAHA.115.307347; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Korf-Klingebiel M, 2011, CIRCULATION, V123, P504, DOI 10.1161/CIRCULATIONAHA.110.989665; Li YQ, 2014, P NATL ACAD SCI USA, V111, P13511, DOI 10.1073/pnas.1411295111; Lu F, 2007, J MOL CELL CARDIOL, V43, P535, DOI 10.1016/j.yjmcc.2007.06.011; Lv GW, 2014, J CELL BIOCHEM, V115, P93, DOI 10.1002/jcb.24636; Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001; Mettlen M, 2018, ANNU REV BIOCHEM, V87, P871, DOI 10.1146/annurev-biochem-062917-012644; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Sahoo S, 2014, CIRC RES, V114, P333, DOI 10.1161/CIRCRESAHA.114.300639; Shukla S, 2017, EUR J CELL BIOL, V96, P728, DOI 10.1016/j.ejcb.2017.09.002; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Suzuki E, 2016, WORLD J STEM CELLS, V8, P297, DOI 10.4252/wjsc.v8.i9.297; Takefuji M, 2012, CIRCULATION, V126, P1972, DOI 10.1161/CIRCULATIONAHA.112.109256; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang Y, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4971261; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zampetaki A, 2012, CIRC RES, V110, P508, DOI 10.1161/CIRCRESAHA.111.247445; Zipes DP, 2019, BRAUNWALDS HEART DIS, V11th	43	35	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11665	11674		10.1074/jbc.RA119.007537	http://dx.doi.org/10.1074/jbc.RA119.007537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31217281	Green Published, hybrid			2022-12-26	WOS:000486127800002
J	Grosso, J; Baldo, D; Cardozo, D; Kolenc, F; Borteiro, C; de Oliveira, MIR; Bonino, MF; Barrasso, DA; Candioti, FV				Grosso, Jimena; Baldo, Diego; Cardozo, Dario; Kolenc, Francisco; Borteiro, Claudio; de Oliveira, Marianna I. R.; Bonino, Marcelo F.; Barrasso, Diego A.; Vera Candioti, Florencia			Early ontogeny and sequence heterochronies in Leiuperinae frogs (Anura: Leptodactylidae)	PLOS ONE			English	Article							PLEURODEMA-THAUL ANURA; LARVAL DEVELOPMENT; PSEUDOPALUDICOLA ANURA; EMBRYONIC-DEVELOPMENT; PHYLOGENETIC ANALYSIS; REPRODUCTIVE-BIOLOGY; ADVERTISEMENT CALL; ATLANTIC FOREST; ORAL-APPARATUS; SPADEFOOT TOAD	The study of early development in Neotropical Leiuperinae frogs (Anura, Leptodactylidae) has been addressed by several works in recent times. However, a comparative developmental approach under a phylogenetic context was not available. Herein we analyzed the morphological and ontogenetic diversity of embryos belonging to 22 species of the three largest genera in Leiuperinae. We find that in most cases, variations fit with the phylogeny at the inter-and intrageneric levels. Embryo kyphosis and whitish color are synapomorphies for the clade grouping Physalaemus and Engystomops. The presence of a third lower tooth row on the oral disc is plesiomorphic for Leiuperinae, only changing in derived clades. The configurations and developmental trajectories of the lower lip are exceptionally diverse. The developmental sequences optimized on the phylogenetic tree recover an early differentiated first lower tooth row a synapomorphy of Pseudopaludicola and Physalaemus, and an early differentiated second row as synapomorphy of Pleurodema. On the other hand, few features are highly conserved in the subfamily, such as the adhesive glands universally present in a type-C configuration. Our results also suggest that the morphology and ontogeny of embryos is in some cases associated to the environment where they develop. A large body size, poorly developed transient respiratory structures, large yolk provision and delayed development of the digestive tract occur convergently in embryos inhabiting cold, oxygenated environments. Embryos that develop in warmer water bodies in xeric environments show more complex and persistent transient respiratory structures and an early onset of hind limbs development. Our survey highlights that morphology and early development of anurans can be a valuable source of information for phylogenetic studies, and provide fundamental bases to explore and discuss how evolutionary changes can be shaped by environmental conditions.	[Grosso, Jimena; Vera Candioti, Florencia] FML, CONICET, Unidad Ejecutora Lillo, San Miguel De Tucuman, Argentina; [Baldo, Diego; Cardozo, Dario] Consejo Nacl Invest Cient & Tecn, IBS, Lab Genet Evolut, Misiones, Argentina; [Kolenc, Francisco; Borteiro, Claudio] Museo Nacl Hist Nat, Secc Herpetol, Montevideo, Uruguay; [de Oliveira, Marianna I. R.] Univ Fed Bahia, Programa Posgrad Biodiversidade & Evolucao PPGBio, Salvador, BA, Brazil; [Barrasso, Diego A.] Consejo Nacl Invest Cient & Tecn, IDEAus, Inst Diversidad & Evoluc Austral, Chubut, Argentina; [Barrasso, Diego A.] UNPSJB, Fac Ciencias Nat & Ciencias Salud, Chubut, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal da Bahia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Grosso, J (corresponding author), FML, CONICET, Unidad Ejecutora Lillo, San Miguel De Tucuman, Argentina.	jime.grosso@gmail.com	Cardozo, Dario/H-7118-2019	Cardozo, Dario/0000-0003-0612-2458; Barrasso, Diego/0000-0003-3474-5505; Grosso, Jimena/0000-0002-1897-6621	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Agencia Nacional de Promocion Cientifica y Tecnologica, Universidad Nacional de Tucuman (Argentina) [PICT 2012/2315, 2014/2035, 2014/1343, 2014/1930, 2015/2381, 2015/0813, 2015/0820, 2016/4066, 2017/2437, PIP 112201101/00875, CIUNT-G430]; Sistema Nacional de Investigadores (Uruguay) [SNI 3073-018]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Agencia Nacional de Promocion Cientifica y Tecnologica, Universidad Nacional de Tucuman (Argentina); Sistema Nacional de Investigadores (Uruguay)	This research is supported by funds of Consejo Nacional de Investigaciones Cientificas y Tecnicas, Agencia Nacional de Promocion Cientifica y Tecnologica, Universidad Nacional de Tucuman (Argentina) (PICT 2012/2315, 2014/2035, 2014/1343, 2014/1930, 2015/2381, 2015/0813, 2015/0820, 2016/4066, 2017/2437, PIP 112201101/00875, and CIUNT-G430), and Sistema Nacional de Investigadores (Uruguay) (SNI 3073-018). Authors who received funding are JG, FVC, DB, DAB, CB and FK.	Albecker MA, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0222-0; Alcala A.C, 1962, COPEIA, V1962, P679; Valetti JA, 2014, REV BIOL TROP, V62, P173, DOI 10.15517/rbt.v62i1.7763; Altig R, 2007, HERPETOL CONSERV BIO, V2, P71; Andrade Cahuenas BC, 2015, THESIS; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Baldo J, 1997, CUAD HERPETOL, V11, P69; Barrasso DA, 2012, HERPETOLOGICA, V68, P48, DOI 10.1655/HERPETOLOGICA-D-11-00028.1; BARRIO A, 1977, Physis Seccion C los Continentes y los Organismos Terrestres, V37, P311; BARRIO AVELINO, 1945, REV ARGENTINA ZOOGEOGR, V5, P37; BARRIO AVELINO, 1964, ACTA ZOOL LILLOANA, V20, P285; Brown DD, 2005, THYROID, V15, P815, DOI 10.1089/thy.2005.15.815; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Buchholz DR, 2002, COPEIA, P180, DOI 10.1643/0045-8511(2002)002[0180:EPODIS]2.0.CO;2; Busse K., 1971, INVESTIGACIONES ZOOL, V15, P5; Cei JM, 1980, MONITORE ZOOLOGICO I, V2, P609; Chipman AD, 1999, EVOL DEV, V1, P49; Vieira WLD, 2009, BIODIVERS CONSERV, V18, P55, DOI 10.1007/s10531-008-9434-0; de Andrade FS, 2016, SALAMANDRA, V52, P107; de Sa RO, 2014, S AM J HERPETOL, V9, pS1, DOI 10.2994/SAJH-D-13-00022.1; del Pino EM, 2007, P NATL ACAD SCI USA, V104, P11882, DOI 10.1073/pnas.0705092104; Denver RJ, 1998, GEN COMP ENDOCR, V110, P326, DOI 10.1006/gcen.1998.7082; Desnitskiy Alexey G., 2012, Russian Journal of Herpetology, V19, P221; Diaz N., 1986, Anales del Museo de Historia Natural de Valparaiso, V17, P65; Diaz-Paez H, 2001, AMPHIBIA-REPTILIA, V22, P431, DOI 10.1163/15685380152770390; Downie JR, 2006, HERPETOL J, V16, P77; DOWNIE JR, 1984, COPEIA, P778, DOI 10.2307/1445168; Elinson RP, 2012, WIRES DEV BIOL, V1, P345, DOI 10.1002/wdev.23; Fabrezi M, 2016, EVODEVO, V7, DOI 10.1186/s13227-016-0043-9; Fabrezi M, 2008, ZOOL J LINN SOC-LOND, V154, P752, DOI 10.1111/j.1096-3642.2008.00420.x; Faivovich J, 2012, CLADISTICS, V28, P460, DOI 10.1111/j.1096-0031.2012.00406.x; Ferraro DP, 2016, SALAMANDRA, V52, P48; FORMAS J R, 1976, Journal of Herpetology, V10, P221, DOI 10.2307/1562983; Fouquet A, 2013, MOL PHYLOGENET EVOL, V67, P445, DOI 10.1016/j.ympev.2013.02.009; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR, AMPHIBIAN SPECIES WO; Gallardo J. M., 1968, Ciencia e Investigacion, V24, P411; Giaretta AA, 2009, J NAT HIST, V43, P995, DOI 10.1080/00222930802702456; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Gómez M.L., 2016, Rev. vet., V27, P21; Gosner K. L., 1960, Herpetologica, V16, P183; Grenat PR, 2011, BIOLOGIA, V66, P1148, DOI 10.2478/s11756-011-0124-0; Grosso JR, 2017, ZOOL ANZ, V266, P35, DOI 10.1016/j.jcz.2016.10.005; Haas A, 1999, ZOOMORPHOLOGY, V119, P23, DOI 10.1007/s004350050078; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Haddad CFB, 1998, J HERPETOL, V32, P557, DOI 10.2307/1565210; Hall John A., 1997, Herpetological Monographs, V11, P124, DOI 10.2307/1467009; Halloy M, 2000, COPEIA, P606, DOI 10.1643/0045-8511(2000)000[0606:OSSIPB]2.0.CO;2; Harrison LB, 2008, SYST BIOL, V57, P378, DOI 10.1080/10635150802164421; Hodl W., 1992, Amphibia-Reptilia, V13, P263, DOI 10.1163/156853892X00472; HULSE AC, 1979, J HERPETOL, V13, P153, DOI 10.2307/1563921; Jeffery JE, 2005, SYST BIOL, V54, P230, DOI 10.1080/10635150590923227; Jetz W, 2018, NAT ECOL EVOL, V2, P850, DOI 10.1038/s41559-018-0515-5; Salica MJ, 2011, SALAMANDRA, V47, P144; Kehr Arturo I., 2005, Herpetological Review, V36, P250; Kokubum MND, 2005, J NAT HIST, V39, P1745, DOI 10.1080/00222930400021515; Lavilla EO, 1992, SERIE DIVULGACION AS, P1; Len-Ochoa J., 1969, B SOC BIOL CONCEPCIO, V42, P355; Lourenco LB, 2015, MOL PHYLOGENET EVOL, V92, P204, DOI 10.1016/j.ympev.2015.06.011; Lynch JD, 2011, CALDASIA, V33, P235; Maneyro R, 2008, IHERINGIA SER ZOOL, V98, P210, DOI 10.1590/S0073-47212008000200007; Moncada MC, 2011, THESIS; Acosta GN, 2017, HERPETOL J, V27, P121; Noble G. K., 1931, Copeia Ann Arbor, V1931, P97, DOI 10.2307/1437329; NOBLE G. K., 1927, ANN NEW YORK ACAD SCI, V30, P31, DOI 10.1111/j.1749-6632.1927.tb55359.x; Nokhbatolfoghahai A, 2007, TISSUE CELL, V39, P225, DOI 10.1016/j.tice.2007.04.003; Nokhbatolfoghahai M, 2008, J MORPHOL, V269, P1197, DOI 10.1002/jmor.10655; Nokhbatolfoghahai M, 2006, J MORPHOL, V267, P1248, DOI 10.1002/jmor.10469; Nokhbatolfoghahai M, 2005, J MORPHOL, V263, P270, DOI 10.1002/jmor.10305; Nokhbatolfoghahai M, 2005, J NAT HIST, V39, P887, DOI 10.1080/00222930400002937; Nokhbatolfoghahai M, 2015, PHYLLOMEDUSA, V14, P3, DOI 10.11606/issn.2316-9079.v14i1p3-17; Otero MA, 2013, ZOOTAXA, V3635, P498, DOI 10.11646/zootaxa.3635.4.11; PEIXOTO O L, 1982, Revista Brasileira de Biologia, V42, P631; Pereda J., 1964, ARCHIVE EXPT BIOL ME, V1, P141; Pupin NC, 2010, HERPETOL J, V20, P147; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; R Core Team, 2021, R LANGUAGE ENV STAT; Romero-Carvajal A, 2009, DEV DYNAM, V238, P1444, DOI 10.1002/dvdy.21952; RUIBAL R, 1988, COPEIA, P591; Ryan MJ, 1996, EVOLUTION, V50, P2435, DOI 10.1111/j.1558-5646.1996.tb03630.x; SCHLUTER A, 1990, STUD NEOTROP FAUNA E, V25, P49, DOI 10.1080/01650529009360801; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Sousa JGG, 2015, ACTA HERPETOL, V10, P129; SZARSKI H, 1964, EVOLUTION, V18, P118, DOI 10.1111/j.1558-5646.1964.tb01576.x; THIBAUDEAU DG, 1988, J MORPHOL, V197, P63, DOI 10.1002/jmor.1051970106; Tlibaudeau G, 1999, TADPOLES, P170; UCHIYAMA M, 1992, CELL TISSUE RES, V267, P35, DOI 10.1007/BF00318689; Ultsch GR, 1999, HYDROBIOLOGIA, V416, P149, DOI 10.1023/A:1003867504821; Valetti JA, 2009, ZOOTAXA, P1; Veiga-Menoncello ACP, 2014, ZOOL SCR, V43, P261, DOI 10.1111/zsc.12048; Candioti FV, 2017, J HERPETOL, V51, P119, DOI 10.1670/15-127; Candioti FV, 2016, HERPETOL MONOGR, V30, P79, DOI 10.1655/HERPMONOGRAPHS-D-16-00004.1; Candioti FV, 2011, BIOL J LINN SOC, V104, P330, DOI 10.1111/j.1095-8312.2011.01727.x; Candioti MFV, 2011, ACTA ZOOL-STOCKHOLM, V92, P27, DOI 10.1111/j.1463-6395.2010.00448.x; Vieira WLDS, 2008, IHERINGIA SER ZOOL, V98, P266, DOI 10.1590/S0073-47212008000200016; Warkentin KM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P557, DOI 10.1086/317751; Warkentin KM, 1999, BIOL J LINN SOC, V68, P443, DOI 10.1006/bijl.1999.0325; WARKENTIN KM, 1992, COPEIA, P725, DOI 10.2307/1446148; Wassersug RJ, 2001, COMP BIOCHEM PHYS A, V131, P183, DOI 10.1016/S1095-6433(01)00468-8; Weigandt M, 2004, AMPHIBIA-REPTILIA, V25, P429; Wen L, 2017, ENDOCRINOLOGY, V158, P1985, DOI 10.1210/en.2016-1953; Zeng C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096637	103	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218733	10.1371/journal.pone.0218733	http://dx.doi.org/10.1371/journal.pone.0218733			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246982	Green Published, gold			2022-12-26	WOS:000484911900035
J	Jung, SY; Mancuso, N; Papp, J; Sobel, E; Zhang, ZF				Jung, Su Yon; Mancuso, Nicholas; Papp, Jeanette; Sobel, Eric; Zhang, Zuo-Feng			Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization	PLOS ONE			English	Article							POLYMORPHISM; ASSOCIATION; GLUCOSE; OBESITY	Purpose The role of insulin resistance (IR) in developing postmenopausal breast cancer has not been thoroughly resolved and may be confounded by lifestyle factors such as obesity. We examined whether genetically determined IR is causally associated with breast cancer risk. Methods We conducted Mendelian randomization (MR) analyses using individual-level data from our previous meta-analysis of a genome-wide association study (GWAS) (n = 11,109 non-Hispanic white postmenopausal women). Four single-nucleotide polymorphisms were associated with fasting glucose (FG), 2 with fasting insulin (FI), and 6 with homeostatic model assessment-IR (HOMA-IR) but were not associated with obesity. We used this GWAS to employ hazard ratios (HRs) for breast cancer risk by adjusting for potential confounding factors. Results No direct association was observed between comprising 12 IR genetic instruments and breast cancer risk (HR = 0.93, 95% CI: 0.76-1.14). In phenotype-specific analysis, genetically elevated FG was associated with reduced risk for breast cancer (main contributor of this MR-effect estimate: G6PC2 rs13431652; HR = 0.59, 95% CI: 0.35-0.99). Genetically driven FI and HOMA-IR were not significantly associated. Stratification analyses by body mass index, exercise, and dietary fat intake with combined phenotypes showed that genetically elevated IR was associated with greater breast cancer risk in overall obesity and inactive subgroups (single contributor: MTRR/LOC729506 rs13188458; HR = 2.21, 95% CI: 1.03-4.75). Conclusions We found complex evidence for causal association between IR and risk of breast cancer, which may support the potential value of intervention trials to lower IR and reduce breast cancer risk.	[Jung, Su Yon] Univ Calif Los Angeles, Sch Nursing, Translat Sci Sect, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Mancuso, Nicholas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Papp, Jeanette; Sobel, Eric] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Zhang, Zuo-Feng] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Jung, SY (corresponding author), Univ Calif Los Angeles, Sch Nursing, Translat Sci Sect, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA.	sjung@sonnet.ucla.edu	Mancuso, Nicholas/GLQ-8627-2022	Zhang, Zuo-Feng/0000-0002-4669-3995; Jung, Su Yon/0000-0002-0513-1830	National Institute of Nursing Research of the National Institutes of Health [K01NR017852]; National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NATIONAL INSTITUTE OF NURSING RESEARCH [K01NR017852] Funding Source: NIH RePORTER	National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by the National Institute of Nursing Research of the National Institutes of Health under Award Number K01NR017852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Institute of Nursing Research of the National Institutes of Health under Award Number K01NR017852. Part of the data for this project was provided by the WHI program, which is funded by the National Heart, Lung, and Blood Institute, the National Institutes of Health, and the U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap through dbGaP accession (phs000200.v11.p3).	Ahmad OS, 2017, J BONE MINER RES, V32, P1072, DOI 10.1002/jbmr.3063; Aksoy-Sagirli P, 2017, GENET TEST MOL BIOMA, V21, P428, DOI 10.1089/gtmb.2017.0062; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Boyle P, 2013, EUR J NUTR, V52, P1533, DOI 10.1007/s00394-012-0460-z; Bronsveld HK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170084; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Clayton PE, 2011, NAT REV ENDOCRINOL, V7, P11, DOI 10.1038/nrendo.2010.171; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Hernandez AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099317; Jung SY, 2018, CANC PREV RES PHILA; Kabat GC, 2009, INT J CANCER, V125, P2704, DOI 10.1002/ijc.24609; Key TJ, 2011, STEROIDS, V76, P812, DOI 10.1016/j.steroids.2011.02.029; Kirkpatrick CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011053; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Merino J, 2017, DIABETES CARE, V40, P687, DOI 10.2337/dc16-2625; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Ruan Y, 2012, ENDOCR J, V59, P601, DOI 10.1507/endocrj.EJ11-0387; Shu X, 2018, INT J EPIDEMIOL; Sieri S, 2012, INT J CANCER, V130, P921, DOI 10.1002/ijc.26071; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Steele AM, 2014, JAMA-J AM MED ASSOC, V311, P279, DOI 10.1001/jama.2013.283980; Wiens BL, 2013, J BIOPHARM STAT, V23, P1403, DOI 10.1080/10543406.2013.834920; Wu PP, 2015, J BUON, V20, P918; Zhang HT, 2013, TUMOR BIOL, V34, P2929, DOI 10.1007/s13277-013-0855-3; Zhi X., 2016, INT J ENV RES PUBLIC, V13	33	6	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218917	10.1371/journal.pone.0218917	http://dx.doi.org/10.1371/journal.pone.0218917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246991	gold, Green Submitted, Green Published			2022-12-26	WOS:000484911900051
J	Potabattula, R; Dittrich, M; Schorsch, M; Hahn, T; Haaf, T; El Hajj, N				Potabattula, Ramya; Dittrich, Marcus; Schorsch, Martin; Hahn, Thomas; Haaf, Thomas; El Hajj, Nady			Male obesity effects on sperm and next-generation cord blood DNA methylation	PLOS ONE			English	Article							BODY-MASS INDEX; EPIGENOME-WIDE ASSOCIATION; BMI; INHERITANCE; EPIGENETICS; EXPRESSION; NUTRITION; PREGNANCY; PATTERNS; NEWBORNS	The prevalence of metabolic disorders, in particular obesity has dramatically increased worldwide. Genetic variants explain only a minor part of the obesity epidemic induced by physical inactivity and over-nutrition. Epidemiological studies in humans and animal models indicate that epigenetic changes associated with adverse parental and/or intrauterine factors may contribute to the missing heritability of metabolic disorders. Possible adverse paternal effects are likely transmitted by sperm to the next-generation. To investigate this hypothesis, we have systematically analyzed the effects of male body mass index (BMI) on sperm epigenome and its association with next-generation fetal cord blood (FCB) DNA methylation. Methylation levels of maternally imprinted (PEG1, PEG4, PEG5, and PEG10), paternally imprinted (H19-IG DMR, IGF2-DMR0, and MEG3-IG DMR) regions, and obesity-related non-imprinted HIF3A gene were quantified by bisulphite pyrosequencing in sperm samples of 294 human donors undergoing in vitro fertilization or intracytoplasmic sperm injection, and in 113 FCBs of the resulting offspring. Multivariable regression analyses revealed that MEG3 intergenic differentially methylated region (IG DMR) showed positive correlation between sperm methylation and donor's BMI. A gender-specific correlation between paternal BMI and FCB methylation was observed for MEG3-IG DMR, HIF3A, and IGF2-DMR0. The former two genes displayed same directional nominal association (as sperm) between paternal BMI and FCB methylation in male offspring. Hypomethylation of IGF2-DMR0 with increased paternal BMI was observed in FCBs from female offsprings. Our results suggest that male obesity is nominally associated with modification of sperm DNA methylome in humans, which may affect the epigenome of the next-generation. Nevertheless, it is important to note that none of the associated p-values survived multiple testing adjustments. Future work should test the effect of associated methylation aberrations in the offspring as DNA methylation was shown to control expression and/or imprint establishment across the studied genes.	[Potabattula, Ramya; Dittrich, Marcus; Haaf, Thomas; El Hajj, Nady] Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany; [Schorsch, Martin; Hahn, Thomas] Fertil Ctr, Wiesbaden, Germany; [El Hajj, Nady] Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar	University of Wurzburg; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Potabattula, R; El Hajj, N (corresponding author), Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany.; El Hajj, N (corresponding author), Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar.	ramya.potabattula@uni-wuerzburg.de; nady.elhajj@uni-wuerzburg.de		El Hajj, Nady/0000-0003-3420-8531; Potabattula, Ramya/0000-0002-2858-8104	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation [EL 742/1-1]; European Union (ERAofART)	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation(German Research Foundation (DFG)); European Union (ERAofART)	R.P. was supported by a fellowship of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. This study was supported by the German Research Foundation (grant EL 742/1-1 to N.E.H.) and the European Union (ERAofART to T.Hf.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsem S, 2016, HUM MOL GENET, V25, P4996, DOI 10.1093/hmg/ddw328; Bygren LO, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-12; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chen YP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030437, 10.1371/journal.pone.0046512, 10.1371/journal.pone.0036329]; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Demerath EW, 2015, HUM MOL GENET, V24, P4464, DOI 10.1093/hmg/ddv161; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Donkin I, 2016, CELL METAB, V23, P369, DOI 10.1016/j.cmet.2015.11.004; El Hajj N, 2011, SEX DEV, V5, P60, DOI 10.1159/000323806; El Hajj N, 2014, REPRODUCTION, V148, pR111, DOI 10.1530/REP-14-0334; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Freeman E, 2012, INT J OBESITY, V36, P12, DOI 10.1038/ijo.2011.198; Huypens P, 2016, NAT GENET, V48, P497, DOI 10.1038/ng.3527; Joubert BR, 2016, AM J HUM GENET, V98, P680, DOI 10.1016/j.ajhg.2016.02.019; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Kuhnen P, 2016, CELL METAB, V24, P502, DOI 10.1016/j.cmet.2016.08.001; Li Z, 2017, MOL CELL BIOCHEM, V433, P51, DOI 10.1007/s11010-017-3015-z; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mendelson MM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002215; Moore T, 1996, Rev Reprod, V1, P73, DOI 10.1530/ror.0.0010073; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pan H, 2015, EPIGENOMICS-UK, V7, P937, DOI 10.2217/epi.15.45; Peters J, 2014, NAT REV GENET, V15, P517, DOI 10.1038/nrg3766; Pfeiffer S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27969; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Richmond RC, 2016, DIABETES, V65, P1231, DOI 10.2337/db15-0996; Ronn T, 2015, HUM MOL GENET, V24, P3792, DOI 10.1093/hmg/ddv124; Sharma U, 2017, CELL METAB, V25, P544, DOI 10.1016/j.cmet.2017.02.003; Sharp GC, 2017, HUM MOL GENET, V26, P4067, DOI 10.1093/hmg/ddx290; Sontag LB, 2006, J THEOR BIOL, V242, P890, DOI 10.1016/j.jtbi.2006.05.012; Soubry A, 2015, INT J OBESITY, V39, P650, DOI 10.1038/ijo.2013.193; Soubry A, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0217-2; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; van Vliet-Ostaptchouk Jana V, 2012, Curr Nutr Rep, V1, P184; Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	43	24	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218615	10.1371/journal.pone.0218615	http://dx.doi.org/10.1371/journal.pone.0218615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246962	Green Submitted, Green Published, gold			2022-12-26	WOS:000484911900032
J	Roe, K; Giordano, D; Young, LB; Draves, KE; Holder, U; Suthar, MS; Gale, M; Clark, EA				Roe, Kelsey; Giordano, Daniela; Young, Lucy B.; Draves, Kevin E.; Holder, Ursula; Suthar, Mehul S.; Gale, Michael, Jr.; Clark, Edward A.			Dendritic cell-associated MAVS is required to control West Nile virus replication and ensuing humoral immune responses	PLOS ONE			English	Article							RIG-I; FOLLICULAR HELPER; INTERFERONS; INFECTION; ALPHA/BETA; PROTECTION; LINEAGE; ROLES	Mitochondrial antiviral signaling protein (MAVS) is a critical innate immune signaling protein that directs the actions of the RIG-I-like receptor (RLR) signaling pathway of RNA virus recognition and initiation of anti-viral immunity against West Nile virus (WNV). In the absence of MAVS, mice die more rapidly after infection with the pathogenic WNV-Texas (TX) strain, but also produce elevated WNV-specific IgG concomitant with increased viral burden. Here we investigated whether there was a B cell intrinsic role for MAVS during the development of protective humoral immunity following WNV infection. MAVS(-/-) mice survived infection from the non-pathogenic WNV-Madagascar (MAD) strain, with limited signs of disease. Compared to wildtype (WT) controls, WNV-MAD-infected MAVS(-/-) mice had elevated serum neutralizing antibodies, splenic germinal center B cells, plasma cells and effector T cells. We found that when rechallenged with the normally lethal WNV-TX, MAVS(-/-) mice previously infected with WNV-MAD were protected from disease. Thus, protective humoral and cellular immune responses can be generated in absence of MAVS. Mice with a conditional deletion of MAVS only in CD11c(+) dendritic cells phenocopied MAVS whole body knockout mice in their humoral responses to WNV-MAD, displaying elevated virus titers and neutralizing antibodies. Conversely, a B cell-specific deletion of MAVS had no effect on immune responses to WNV-MAD compared to WT controls. Thus, MAVS in dendritic cells is required to control WNV replication and thereby regulate downstream humoral immune responses.	[Roe, Kelsey; Giordano, Daniela; Young, Lucy B.; Draves, Kevin E.; Holder, Ursula; Gale, Michael, Jr.; Clark, Edward A.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Suthar, Mehul S.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA USA; [Suthar, Mehul S.] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA USA; [Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA; [Roe, Kelsey] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; Emory University; Emory University; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Roe, K; Clark, EA (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Roe, K (corresponding author), Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA.	Kelsey.Roe@seattlechildrens.org; eaclark@uw.edu		Giordano, Daniela/0000-0001-8362-7017	National Institutes of Health [AI83019, AI52203, AI104002, AI100625]; Cell and Analysis Flow Cytometry and Imaging Core in the Department of Immunology at the University of Washington; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell and Analysis Flow Cytometry and Imaging Core in the Department of Immunology at the University of Washington; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (https://www.nih.gov/). AI83019 and AI52203 awarded to EAC and AI104002 and AI100625 awarded to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Michael Diamond and Larissa Thankjay for helping with the MAVS<SUP>fl/fl</SUP> mice. This research was supported by the Cell and Analysis Flow Cytometry and Imaging Core in the Department of Immunology at the University of Washington.	Austin SK, 2014, VIRUSES-BASEL, V6, P1015, DOI 10.3390/v6031015; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Giordano D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006743; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hussmann KL, 2014, ARCH VIROL, V159, P3113, DOI 10.1007/s00705-014-2176-2; Jogdand GM, 2016, FRONT IMMUNOL, P7, DOI [10.3389/fimmu.2016.00007, DOI 10.3389/FIMMU.2016.00007]; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Kobiyama K, 2009, J IMMUNOL, V182, P1593, DOI 10.4049/jimmunol.182.3.1593; Kulkarni RR, 2014, J VIROL, V88, P13990, DOI 10.1128/JVI.02273-14; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Linke S, 2007, J VIROL METHODS, V146, P355, DOI 10.1016/j.jviromet.2007.05.021; Liu Y, 2014, CELL MOL IMMUNOL, V11, P49, DOI [10.1038/cmi.2013.40, 10.1038/cmi.2014.83]; Loetsch C, 2017, CELL REP, V21, P1624, DOI 10.1016/j.celrep.2017.10.044; Luo HL, 2017, J VIROL, V91, DOI 10.1128/JVI.02097-16; Ma DL, 2009, ANTIVIR RES, V83, P53, DOI 10.1016/j.antiviral.2009.03.006; Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086; Price GE, 2000, J VIROL, V74, P3996, DOI 10.1128/JVI.74.9.3996-4003.2000; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Suthar MS, 2012, J VIROL, V86, P7704, DOI 10.1128/JVI.00401-12; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Teijaro JR, 2016, CURR OPIN VIROL, V16, P31, DOI 10.1016/j.coviro.2016.01.001; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Zevini A, 2017, TRENDS IMMUNOL, V38, P194, DOI 10.1016/j.it.2016.12.004; Zhao JC, 2016, J VIROL, V90, P7098, DOI 10.1128/JVI.00707-16	37	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218928	10.1371/journal.pone.0218928	http://dx.doi.org/10.1371/journal.pone.0218928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242236	gold, Green Published, Green Submitted			2022-12-26	WOS:000482883600066
J	Moyson, S; Town, RM; Vissenberg, K; Blust, R				Moyson, Sofie; Town, Raewyn M.; Vissenberg, Kris; Blust, Ronny			The effect of metal mixture composition on toxicity to C. elegans at individual and population levels	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIFE-HISTORY TRAITS; HEAVY-METALS; CADMIUM TOXICITY; ZINC; SOIL; COPPER; TEMPERATURE; STRESS; GROWTH	The toxicity of zinc (Zn), copper (Cu), and cadmium (Cd) to the nematode Caenorhabditis elegans was characterised under single metal and mixture scenarios at different organisational levels. The effects on population size and body length were investigated at two concentrations corresponding to the 24 h LC5 and LC20 levels. Metal toxicity was dependent on metal concentration, exposure time and mixture composition. Populations exposed to LC20 levels of Cd, ZnCu, CuCd and ZnCuCd plummeted, while for all LC5 concentrations, population size continued to increase, albeit that single metals were less harmful than mixtures. Combinations of the LC20 concentration of Cd with a range of Zn concentrations showed concentration dependent mitigating effects on population size and antagonistic effects on mortality. By combining effects at different organisational levels, more insight into metal toxicity was obtained. Metal effects were more evident on population size than on body length or mortality, suggesting that population size could be considered as a sensitive endpoint. Furthermore, our observations of ZnCd mixture effects at the individual and population levels are consistent with literature data on the dose-dependent expression of the cdf2 gene, which is involved in mediation of Zn and Cd toxicity.	[Moyson, Sofie; Town, Raewyn M.; Blust, Ronny] Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res SPHERE, Antwerp, Belgium; [Vissenberg, Kris] Univ Antwerp, Dept Biol, Integrated Mol Plant Physiol Res, Antwerp, Belgium; [Vissenberg, Kris] Univ Appl Sci Crete, Plant Biochem & Biotechnol Lab, Technol Educ Inst, Dept Agr,Sch Agr Food & Nutr, Iraklion, Crete, Greece	University of Antwerp; University of Antwerp; Hellenic Mediterranean University	Town, RM (corresponding author), Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res SPHERE, Antwerp, Belgium.	raewyn.town@uantwerpen.be	Town, Raewyn M/H-7507-2014; Vissenberg, Kris/L-2303-2017	Town, Raewyn M/0000-0001-9505-1465; Vissenberg, Kris/0000-0003-0292-2095	University of Antwerp's Research Fund (BOF); Belgian Science Policy Office (BELSPO) Interuniversity Attraction Pole AquaStress [P7/31]; National Institutes of Health Office of Infrastructure programs	University of Antwerp's Research Fund (BOF); Belgian Science Policy Office (BELSPO) Interuniversity Attraction Pole AquaStress; National Institutes of Health Office of Infrastructure programs	RB received funding from the University of Antwerp's Research Fund (BOF) www.uantwerpen.be, and the Belgian Science Policy Office (BELSPO) Interuniversity Attraction Pole AquaStress (research project P7/31) www.belspo.be.The nematode strain used in this study was provided by the Caenorhabditis Genetic Center, which is funded by the National Institutes of Health Office of Infrastructure programs. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez OA, 2005, FUNCT ECOL, V19, P656, DOI 10.1111/j.1365-2435.2005.01012.x; Anderson GL, 2004, ENVIRON TOXICOL CHEM, V23, P1235, DOI 10.1897/03-264; ATTAR EN, 1982, ARCH ENVIRON CON TOX, V11, P291; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; BRENNER S, 1974, GENETICS, V77, P71; Calabrese EJ, 2001, CRIT REV TOXICOL, V31, P353, DOI 10.1080/20014091111730; Calafato S, 2008, TOXICOL SCI, V106, P384, DOI 10.1093/toxsci/kfn180; Cedergreen N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0140277; Chen JD, 2013, ECOTOX ENVIRON SAFE, V94, P73, DOI 10.1016/j.ecoenv.2013.04.026; Chu KW, 2002, AQUAT TOXICOL, V61, P53, DOI 10.1016/S0166-445X(02)00017-6; Chun H, 2017, J BIOL CHEM, V292, P1, DOI 10.1074/jbc.M116.760876; Cremazy A, 2018, ENVIRON SCI TECHNOL, V52, P5979, DOI 10.1021/acs.est.7b06554; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; Dew WA, 2016, AQUAT TOXICOL, V172, P86, DOI 10.1016/j.aquatox.2015.12.018; Dhawan R, 2000, ENVIRON TOXICOL CHEM, V19, P3061, DOI [10.1897/1551-5028(2000)019&lt;3061:ACOMIL&gt;2.0.CO;2, 10.1002/etc.5620191228]; Dietrich N, 2016, ARCH BIOCHEM BIOPHYS, V611, P120, DOI 10.1016/j.abb.2016.05.021; Dutilleul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116214; ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals), 2001, 80 ECETOC; EISLER R, 1977, B ENVIRON CONTAM TOX, V17, P137, DOI 10.1007/BF01685540; Fueser H, 2018, ECOTOX ENVIRON SAFE, V156, P255, DOI 10.1016/j.ecoenv.2018.03.037; Harvey SC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-15; HEMELRAAD J, 1987, Archives of Environmental Contamination and Toxicology, V16, P95; Heugens EHW, 2006, ENVIRON TOXICOL CHEM, V25, P1399, DOI 10.1897/05-294R.1; Hoss S, 2011, ENVIRON SCI TECHNOL, V45, P10219, DOI 10.1021/es2027136; Hoss S, 2009, ECOTOX ENVIRON SAFE, V72, P1811, DOI 10.1016/j.ecoenv.2009.07.003; Hoss S, 2001, ENVIRON TOXICOL CHEM, V20, P2794, DOI [10.1897/1551-5028(2001)020&lt;2794:TOCTCE&gt;2.0.CO;2, 10.1002/etc.5620201219]; Jonker MJ, 2004, ENVIRON TOXICOL CHEM, V23, P480, DOI 10.1897/03-29; Kammenga JE, 2001, ECOL APPL, V11, P226, DOI 10.1890/1051-0761(2001)011[0226:SLHSTS]2.0.CO;2; Khanna N, 1997, ARCH ENVIRON CON TOX, V32, P110, DOI 10.1007/s002449900162; Korthals GW, 2000, ECOTOXICOLOGY, V9, P219, DOI 10.1023/A:1008950905983; Kumar J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153513; Lagido C, 2009, TOXICOL SCI, V109, P88, DOI 10.1093/toxsci/kfp058; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lira VF, 2011, MAR ENVIRON RES, V72, P151, DOI 10.1016/j.marenvres.2011.07.003; Lu CL, 2018, ENVIRON SCI POLLUT R, V25, P15378, DOI 10.1007/s11356-018-1752-5; Margerit A, 2015, ECOTOX ENVIRON SAFE, V118, P139, DOI 10.1016/j.ecoenv.2015.04.023; Martinez-Finley EJ, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/895236; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Meyer JS, 2015, ENVIRON TOXICOL CHEM, V34, P726, DOI 10.1002/etc.2792; Moyson S, 2018, ENVIRON TOXICOL CHEM, V37, P145, DOI 10.1002/etc.3937; NIEBOER E, 1980, ENVIRON POLLUT B, V1, P3, DOI 10.1016/0143-148X(80)90017-8; Norhave NJ, 2012, ENVIRON TOXICOL CHEM, V31, P787, DOI 10.1002/etc.1746; Nys C, 2017, ENVIRON SCI TECHNOL, V51, P4615, DOI 10.1021/acs.est.6b05688; Perez E, 2017, ENVIRON TOXICOL CHEM, V36, P2739, DOI 10.1002/etc.3830; POPHAM JD, 1979, ENVIRON RES, V20, P183, DOI 10.1016/0013-9351(79)90096-3; Power RS, 1999, ARCH ENVIRON CON TOX, V37, P503, DOI 10.1007/s002449900545; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; Roh HC, 2015, NUCLEIC ACIDS RES, V43, P803, DOI 10.1093/nar/gku1360; Shaw JR, 2006, ENVIRON TOXICOL CHEM, V25, P182, DOI 10.1897/05-243R.1; Song SJ, 2014, ARCH ENVIRON CON TOX, V66, P390, DOI 10.1007/s00244-013-9991-4; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Wang JJ, 2018, ECOTOX ENVIRON SAFE, V162, P160, DOI 10.1016/j.ecoenv.2018.06.051; Wang YB, 2014, J THERM BIOL, V41, P16, DOI 10.1016/j.jtherbio.2014.02.007; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Xin Y, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0145838, 10.1371/journal.pone.0160613]; Yu ZY, 2017, ECOTOX ENVIRON SAFE, V135, P312, DOI 10.1016/j.ecoenv.2016.10.017	58	8	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218929	10.1371/journal.pone.0218929	http://dx.doi.org/10.1371/journal.pone.0218929			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237916	gold, Green Published, Green Submitted			2022-12-26	WOS:000484856000052
J	Adelborg, K; Nicolaisen, SK; Hasvold, P; Palaka, E; Pedersen, L; Thomsen, RW				Adelborg, Kasper; Nicolaisen, Sia Kromann; Hasvold, Pal; Palaka, Eirini; Pedersen, Lars; Thomsen, Reimar Wernich			Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients-A population-based cohort study	PLOS ONE			English	Article								Understanding predictors and trajectories of increased potassium may inform testing and treatment of hyperkalemia. We examined predictors for repeated hyperkalemia among patients after first-time renin angiotensin system inhibitor (RASi) prescription, chronic kidney disease (CKD), or chronic heart failure (CHF); and we also examined potassium trajectories in these patients after their first hyperkalemia event. We used Danish population-based registries to identify all patients with first-time RASi prescription, incident CKD, or incident CHF (2000-2012). For patients with a first hyperkalemia event, potassium trajectories over the following 6 months were examined. The predictors associated with repeated hyperkalemia were assessed, with repeated hyperkalemia defined as a potassium test >5.0 mmol/L after the first event within 6 months. Overall 262,375 first-time RASi users, 157,283 incident CKD patients, and 14,600 incident CHF patients were included. Of patients with a first hyperkalemia event, repeated hyperkalemia within 6 months occurred in 37% of RASi users, 40% with CKD, and 49% of patients with CHF. Predictors included severe hyperkalemia, low eGFR, diabetes, and spironolactone use. In all cohorts, the median potassium levels declined over 2-4 weeks after a hyperkalemia event for the first time, but reverted to levels higher than before the initial hyperkalemia event in those who had repeated hyperkalemia. Following hyperkalemia, discontinuation of RASi and spironolactone was common in the RASi and CHF cohorts. Repeated hyperkalemia was common among the explored cohorts. The first hyperkalemia event was an indicator of increased median potassium levels. Predictors may identify patients likely to benefit from intensified monitoring and intervention.	[Adelborg, Kasper; Nicolaisen, Sia Kromann; Pedersen, Lars; Thomsen, Reimar Wernich] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Hasvold, Pal] AstraZeneca Nord, Dept Med, Oslo, Norway; [Palaka, Eirini] AstraZeneca, Global Payer Evidence, Cambridge, England	Aarhus University; AstraZeneca	Adelborg, K (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	kade@clin.au.dk		Thomsen, Reimar/0000-0001-9135-3474; Adelborg, Kasper/0000-0001-5639-7252	AstraZeneca; Program for Clinical Research Infrastructure (PROCRIN)	AstraZeneca(AstraZeneca); Program for Clinical Research Infrastructure (PROCRIN)	This work was supported by an institutional research grant from AstraZeneca to Aarhus University and by the Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation. While AstraZeneca was involved in the study's concept, it was designed and conducted by the coauthors from Aarhus University. The funder provided support in the form of salaries for authors (P.H and E.P), but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the aforementioned authors are articulated in the 'author contributions' section.	Betts KA, 2018, CURR MED RES OPIN, V34, P971, DOI 10.1080/03007995.2018.1433141; Chubak J, 2012, J CLIN EPIDEMIOL, V65, P343, DOI 10.1016/j.jclinepi.2011.09.002; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Evans Kimberley J, 2005, J Intensive Care Med, V20, P272, DOI 10.1177/0885066605278969; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Grann Anne Fia, 2011, Clin Epidemiol, V3, P133, DOI 10.2147/CLEP.S17901; Ingelfinger JR, 2015, NEW ENGL J MED, V372, P275, DOI 10.1056/NEJMe1414112; Kovesdy CP, 2015, AM J MED, V128, P1281, DOI 10.1016/j.amjmed.2015.05.040; Krogager ML, 2015, EUR HEART J-CARD PHA, V1, P245, DOI 10.1093/ehjcvp/pvv026; Raebel MA, 2010, J GEN INTERN MED, V25, P326, DOI 10.1007/s11606-009-1228-x; SCHMIDT M, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J791; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Thomsen RW, 2018, DIABETIC MED, V35, P1051, DOI 10.1111/dme.13687; Thomsen RW, 2018, NEPHROL DIAL TRANSPL, V33, P1610, DOI 10.1093/ndt/gfx312; Thomsen RW, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008912	16	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218739	10.1371/journal.pone.0218739	http://dx.doi.org/10.1371/journal.pone.0218739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226134	Green Submitted, Green Published, gold			2022-12-26	WOS:000484894700039
J	Jayasekera, J; Onukwugha, E; Cadham, C; Harrington, D; Tom, S; Pradel, F; Naslund, M				Jayasekera, Jinani; Onukwugha, Eberechukwu; Cadham, Christopher; Harrington, Donna; Tom, Sarah; Pradel, Francoise; Naslund, Michael			An ecological approach to monitor geographic disparities in cancer outcomes	PLOS ONE			English	Article							AREA SOCIOECONOMIC-STATUS; BREAST-CANCER; HEALTH DISPARITIES; PROSTATE-CANCER; MORTALITY; STAGE; US; INEQUALITIES; DEPRIVATION; LEVEL	Background Area-level indices are widely used to assess the impact of socio-environmental characteristics on cancer outcomes. While area-level measures of socioeconomic status (SES) have been previously used in cancer settings, fewer studies have focused on evaluating the impact of area-level health services supply (HSS) characteristics on cancer outcomes. Moreover, there is significant variation in the methods and constructs used to create area-level indices. Methods In this study, we introduced a psychometrically-induced, reproducible approach to develop area-level HSS and SES indices. We assessed the utility of these indices in detecting the effects of area-level characteristics on prostate, breast, and lung cancer incidence and stage at diagnosis in the US. The information on county-level SES and HSS characteristics were extracted from US Census, County Business Patterns data and Area Health Resource Files. The Surveillance, Epidemiology, and End Results database was used to identify individuals diagnosed with cancer from 2010 to 2012. SES and HSS indices were developed and linked to 3-year age-adjusted cancer incidence rates. SES and HSS indices empirically summarized the level of employment, education, poverty and income, and the availability of health care facilities and health professionals within counties. Results SES and HSS models demonstrated good fit (TLI = 0.98 and 0.96, respectively) and internal consistency (alpha = 0.85 and 0.95, respectively). Increasing SES and HSS were associated with increasing prostate and breast cancer and decreasing lung cancer incidence rates. The results varied by stage at diagnosis and race. Conclusion Composite county-level measures of SES and HSS were effective in ranking counties and detecting gradients in cancer incidence and stage at diagnosis. Thus, these measures provide valuable tools for monitoring geographic disparities in cancer outcomes.	[Jayasekera, Jinani; Cadham, Christopher] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Onukwugha, Eberechukwu; Pradel, Francoise] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Harrington, Donna] Univ Maryland, Sch Social Work, 525 W Redwood St, Baltimore, MD 21201 USA; [Tom, Sarah] Columbia Univ, Dept Neurol, Div Neurol Clin Outcomes Res & Populat Sci NeuroC, New York, NY USA; [Naslund, Michael] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	Georgetown University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Columbia University; University System of Maryland; University of Maryland Baltimore	Jayasekera, J (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	jcj74@georgetown.edu		Jayasekera, Jinani/0000-0001-9212-7225; Cadham, Christopher/0000-0001-9531-2733	Georgetown-Lombardi American Cancer Society Young Investigator Award [ACS IRG 92-152-20]; Cancer Prevention Research Fellowship - American Society of Preventive Oncology and Breast Cancer Research Foundation [ASPO-17-001]; NATIONAL INSTITUTE ON AGING [K01AG050723] Funding Source: NIH RePORTER	Georgetown-Lombardi American Cancer Society Young Investigator Award(American Cancer Society); Cancer Prevention Research Fellowship - American Society of Preventive Oncology and Breast Cancer Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work received support from the Georgetown-Lombardi American Cancer Society Young Investigator Award (ACS IRG 92-152-20) (JJ) and the Cancer Prevention Research Fellowship sponsored by the American Society of Preventive Oncology and Breast Cancer Research Foundation (ASPO-17-001) (JJ). URL: https://www.cancer.org/; https://www.bcrf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2010, J GEN INTERN MED, V25, P1164, DOI 10.1007/s11606-010-1457-z; [Anonymous], SURV RES PROGR; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Butler DC, 2013, HEALTH SERV RES, V48, P539, DOI 10.1111/j.1475-6773.2012.01449.x; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Cabrera-Nguyen P., 2010, J SOC SOC WORK RES, V1, P99, DOI [DOI 10.5243/JSSWR.2010.8, 10.5243/jsswr.2010.8]; Campbell RJ, 2003, FAM MED, V35, P60; Cheng I, 2009, CANCER CAUSE CONTROL, V20, P1431, DOI 10.1007/s10552-009-9369-0; Coughlin Steven S, 2009, Open Health Serv Policy J, V2, P45; Crabbe JCF, 2015, AM J PUBLIC HEALTH, V105, pE64, DOI 10.2105/AJPH.2015.302640; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DAYAL HH, 1982, J CHRON DIS, V35, P675, DOI 10.1016/0021-9681(82)90020-0; de Souza JA, 2016, J CLIN ONCOL, V34, P6, DOI 10.1200/JCO.2015.62.2860; DeFranco EA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-316; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Ellis AR, 2009, PSYCHIAT SERV, V60, P1315, DOI 10.1176/ps.2009.60.10.1315; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Grauman DJ, 2000, J NATL CANCER I, V92, P534, DOI 10.1093/jnci/92.7.534; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jayasekera J, 2016, VALUE HEALTH, V19, pA98, DOI 10.1016/j.jval.2016.03.1709; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Keegan THM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-603; Klassen AC, 2006, AM J PREV MED, V30, pS7, DOI 10.1016/j.amepre.2005.09.004; Kline R.B., 2011, PRINCIPLES PRACTICE; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Liu LH, 1998, CANCER CAUSE CONTROL, V9, P369, DOI 10.1023/A:1008811432436; MacKinnon JA, 2007, CANCER EPIDEM BIOMAR, V16, P756, DOI 10.1158/1055-9965.EPI-06-0392; Major JM, 2012, CANCER CAUSE CONTROL, V23, P1185, DOI 10.1007/s10552-012-9988-8; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; Mobley LR, 2012, HEALTH PLACE, V18, P978, DOI 10.1016/j.healthplace.2012.06.009; National Cancer Institute's, SURV EP END RES SEER; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Onukwugha E, 2018, VALUE HEALTH, V21, pS136, DOI 10.1016/j.jval.2018.04.912; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Pruitt SL, 2009, CANCER EPIDEM BIOMAR, V18, P2579, DOI 10.1158/1055-9965.EPI-09-0135; Robert SA, 2004, EPIDEMIOLOGY, V15, P442, DOI 10.1097/01.ede.0000129512.61698.03; Roetzheim RG, 2000, J AM ACAD DERMATOL, V43, P211, DOI 10.1067/mjd.2000.106242; Rubin MS, 2014, SOC SCI MED, V100, P54, DOI 10.1016/j.socscimed.2013.10.026; Saldana-Ruiz N, 2013, AM J PUBLIC HEALTH, V103, P99, DOI 10.2105/AJPH.2012.300743; Salkind N., 2010, ENCY RES DESIGN, VVolume 1, DOI DOI 10.4135/9781412961288; Shen Y, 2005, JNCI-J NATL CANCER I, V97, P1195, DOI 10.1093/jnci/dji239; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Singh GP, 2011, J NEUROSURG ANESTH, V23, P170, DOI [10.1097/ANA.0b013e31820a0937, 10.1186/1029-242X-2011-35]; Statistics NCfH, 1998, US SOC STAT HLTH CHA; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Yabroff KR, 2003, SOC SCI MED, V57, P2265, DOI 10.1016/S0277-9536(03)00100-X; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516; Yu MD, 2014, CANCER CAUSE CONTROL, V25, P81, DOI 10.1007/s10552-013-0310-1	52	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218712	10.1371/journal.pone.0218712	http://dx.doi.org/10.1371/journal.pone.0218712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226140	Green Published, Green Submitted, gold			2022-12-26	WOS:000484894700034
J	Rasch, A; Naujokat, H; Wang, FL; Seekamp, A; Fuchs, S; Kluter, T				Rasch, Alexander; Naujokat, Hendrik; Wang, Fanlu; Seekamp, Andreas; Fuchs, Sabine; Klueter, Tim			Evaluation of bone allograft processing methods: Impact on decellularization efficacy, biocompatibility and mesenchymal stem cell functionality	PLOS ONE			English	Article							IN-VITRO; BOVINE BONE; ALKALINE-PHOSPHATASE; GRAFT; MARROW; DIFFERENTIATION; SCAFFOLDS; APOPTOSIS; MATRICES	In an ever-aging society the demand for bone-defect filling grafts continues to gain in importance. While autologous grafting still prevails as the gold standard, allografts and xenografts present viable alternatives with promising results. Physiochemical properties of a graft strongly depend on the processing method such as the decellularization protocol. In addition, the physiochemical characteristics are critical factors for a successful integration of the graft after the implantation and might influence mesenchymal stem cell function in therapeutic approaches combining grafts and autologous mesenchymal stem cells (MSCs). Several decellularization methods have been proposed, however it still remains unclear which method results in favorable physiochemical properties or might be preferred in stem cell applications. In the first part of this study we compared two decellularization approaches resulting in chemically processed allografts (CPAs) or sonication-based processed allografts (SPAs). Each decellularization approach was compared for its decellularization efficacy and its influence on the grafts' surface texture and composition. In the second part of this study biocompatibility of grafts was assessed by testing the effect of extraction medium on MSC viability and comparing them to commercially available allografts and xenografts. Additionally, grafts' performance in terms of MSC functionality was assessed by reseeding with MSCs pre-differentiated in osteogenic medium and determining cell adhesion, proliferation, as well as alkaline phosphatase (ALP) activity and the degree of mineralization. In summary, results indicate a more effective decellularization for the SPA approach in comparison to the CPA approach. Even though SPA extracts induced a decrease in MSC viability, MSC performance after reseeding was comparable to commercially available grafts based on DNA quantification, alkaline phosphatase activity and quantification of mineralization. Commercial Tutoplast allografts showed overall the best effects on MSC functionality as indicated by extraction biocompatibility testing as well as by comparing proliferation and osteogenic differentiation.	[Rasch, Alexander; Naujokat, Hendrik; Wang, Fanlu; Seekamp, Andreas; Fuchs, Sabine; Klueter, Tim] Univ Med Ctr Schleswig Holstein, Expt Trauma Surg, Dept Trauma & Orthoped Surg, Campus Kiel, Kiel, Germany; [Naujokat, Hendrik] Univ Med Ctr Schleswig Holstein, Dept Oral & Maxillofacial Surg, Campus Kiel, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Fuchs, S (corresponding author), Univ Med Ctr Schleswig Holstein, Expt Trauma Surg, Dept Trauma & Orthoped Surg, Campus Kiel, Kiel, Germany.	Sabine.Fuchs@uksh.de						Bauer TW, 2000, CLIN ORTHOP RELAT R, P10; Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9; Bernhardt A, 2011, CLIN ORAL IMPLAN RES, V22, P651, DOI 10.1111/j.1600-0501.2010.02015.x; Boskey Adele L, 2013, Bonekey Rep, V2, P447, DOI 10.1038/bonekey.2013.181; Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Curtis EM, 2016, BONE, V87, P19, DOI 10.1016/j.bone.2016.03.006; Cypher T J, 1996, J Foot Ankle Surg, V35, P413; d'Aquino R, 2011, EUR CELLS MATER, V21, P304, DOI 10.22203/eCM.v021a23; Deijkers RLM, 1999, J BONE JOINT SURG BR, V81B, P538, DOI 10.1302/0301-620X.81B3.9265; Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039; Desterro Fernanda de Paula do, 2014, Braz. Dent. J., V25, P282, DOI 10.1590/0103-6440201300067; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gao C, 2013, EUR CELLS MATER, V26, P195, DOI 10.22203/eCM.v026a14; Golub E.E., 2007, ROLE ALKALINE PHOSPH; Griesemer A, 2014, IMMUNOL REV, V258, P241, DOI 10.1111/imr.12152; Haarhaus M, 2017, NAT REV NEPHROL, V13, P429, DOI 10.1038/nrneph.2017.60; Harris CT, 2004, J BIOMED MATER RES A, V68A, P747, DOI 10.1002/jbm.a.20107; Homma Y, 2013, INJURY, V44, pS46, DOI 10.1016/S0020-1383(13)70011-1; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Jin Y, 2017, RSC ADV, V7, P13010, DOI 10.1039/c7ra01008g; Kolbe M, 2011, TISSUE ENG PT A, V17, P2199, DOI [10.1089/ten.TEA.2010.0474, 10.1089/ten.tea.2010.0474]; Kwon Seong Gyu, 2018, Biomater Res, V22, P36, DOI 10.1186/s40824-018-0148-4; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; La Noce M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030217; Li DX, 2015, PHOTOMED LASER SURG, V33, P330, DOI 10.1089/pho.2015.3903; Lin X, 2018, OSTEOARTHR CARTILAGE, V26, P433, DOI 10.1016/j.joca.2017.12.001; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Liu Q, 2011, CLIN ORAL IMPLAN RES, V22, P1259, DOI 10.1111/j.1600-0501.2010.02100.x; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Mebarki M, 2017, ACTA BIOMATER, V59, P94, DOI 10.1016/j.actbio.2017.06.018; Moon KN, 2015, IMPLANT DENT, V24, P101, DOI 10.1097/ID.0000000000000185; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Mylonas Dimitrios, 2007, J Prosthodont, V16, P421, DOI 10.1111/j.1532-849X.2007.00218.x; Oryan A, 2018, CELL TISSUE RES, V374, P63, DOI 10.1007/s00441-018-2837-7; Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127; Pong M, 2006, ULTRASONICS, V45, P133, DOI 10.1016/j.ultras.2006.07.021; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142; Saulacic N, 2015, CLIN ORAL IMPLAN RES, V26, P383, DOI 10.1111/clr.12357; Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017; Sharma U, 2014, INDIAN J CLIN BIOCHE, V29, P269, DOI 10.1007/s12291-013-0408-y; Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Smith CA, 2015, J TISSUE ENG REGEN M, V9, P595, DOI 10.1002/term.1934; Smith CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177416; Somaiah C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145068; Sundaram J, 2003, BIOPHYS J, V84, P3087, DOI 10.1016/S0006-3495(03)70034-4; Traini T, 2008, J PERIODONTOL, V79, P1232, DOI [10.1902/jop.2008.070504, 10.1902/jop.2008.070504 ]; United States Bone and Joint Initiative, 2014, BURD MUSC DIS US BMU; Vastel L, 2004, BIOMATERIALS, V25, P2105, DOI 10.1016/j.biomaterials.2003.08.067; Wang FL, 2017, MAR DRUGS, V15, DOI 10.3390/md15060186; Wiese A, 2010, ORTHOP CLIN N AM, V41, P1, DOI 10.1016/j.ocl.2009.07.003; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Wiltfang J, 2016, TISSUE ENG PART C-ME, V22, P740, DOI [10.1089/ten.TEC.2015.0501, 10.1089/ten.tec.2015.0501]; Worth A, 2005, CLIN ORAL IMPLAN RES, V16, P379, DOI 10.1111/j.1600-0501.2005.01113.x; Zou LJ, 2013, SCI REP-UK, V3, DOI [10.1038/srep02243, 10.1038/srep03108]	60	14	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218404	10.1371/journal.pone.0218404	http://dx.doi.org/10.1371/journal.pone.0218404			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220118	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500043
J	Yang, M; Liang, ZR; Yang, ML; Jia, YJ; Yang, GY; He, YR; Li, XR; Gu, HF; Zheng, HT; Zhu, ZM; Li, L				Yang, Min; Liang, Zerong; Yang, Mengliu; Jia, Yanjun; Yang, Gangyi; He, Yirui; Li, Xinrun; Gu, Harvest F.; Zheng, Hongting; Zhu, Zhiming; Li, Ling			Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism	FASEB JOURNAL			English	Article						BMP9; metabolism; insulin resistance; cytokine	ELEMENT-BINDING PROTEIN; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; CELLS; DIFFERENTIATION; EXPRESSION; BMP-9; CYTOKINE; PROMOTER; SREBP-1C	Bone morphogenetic protein (BMP)-9 has been reported to regulate energy balance in vivo. However, the mechanisms underlying BMP9-mediated regulation of energy balance remain incompletely understood. Here, we investigated the role of BMP9 in energy metabolism. In the current study, we found that hepatic BMP9 expression was down-regulated in insulin resistance (IR) mice and in patients who are diabetic. In mice fed a high-fat diet (HFD), the overexpression of hepatic BMP9 improved glucose tolerance and IR. The expression of gluconeogenic genes was down-regulated, whereas the level of insulin signaling molecule phosphorylation was increased in the livers of Adenovirus-BMP9-treated mice and glucosamine-treated hepatocytes. Furthermore, BMP9 overexpression ameliorated triglyceride accumulation and inhibited the expression of lipogenic genes in both human hepatocellular carcinoma HepG2 cells treated with a fatty acid mixture as well as the livers of HFD-fed mice. In hepatocytes isolated from sterol regulatory element-binding protein (SREBP)-1c knockout mice, the effects of BMP9 were ablated. Mechanistically, BMP9 inhibited SREBP-1c expression through the inhibition of liver X receptor response element 1 activity in the SREBP-1c promoter. Taken together, our results show that BMP9 is an important regulator of hepatic glucose and lipid metabolism.-Yang, M., Liang, Z., Yang, M., Jia, Y., Yang, G., He, Y., Li, X., Gu, H. F., Zheng, H., Zhu, Z., Li, L. Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism.	[Yang, Min; Li, Ling] Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Key Lab Diagnost Med,Minist Educ, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China; [Liang, Zerong; Yang, Mengliu; Jia, Yanjun; Yang, Gangyi; He, Yirui; Li, Xinrun] Chongqing Med Univ, Chongqing Clin Res Ctr Geriatr, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China; [Gu, Harvest F.] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Zheng, Hongting] Third Mil Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China; [Zhu, Zhiming] Third Mil Med Univ, Chongqing Inst Hypertens, Daping Hosp, Dept Hypertens & Endocrinol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Karolinska Institutet; Karolinska University Hospital; Army Medical University; Army Medical University	Li, L (corresponding author), Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Key Lab Diagnost Med,Minist Educ, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	liling@cqmu.edu.cn		Li, Ling/0000-0002-0087-3034	National Natural Science Foundation [81873658, 81570752, 81500666, 81670755]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation (81873658, 81570752, 81500666, and 81670755). The authors declare no conflicts of interest.	AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Caperuto LC, 2008, ENDOCRINOLOGY, V149, P6326, DOI 10.1210/en.2008-0655; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Herrera B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069535; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Kuo MMC, 2014, BIOMATERIALS, V35, P3172, DOI 10.1016/j.biomaterials.2013.12.063; Lee J, 2015, MOL CELL ENDOCRINOL, V414, P148, DOI 10.1016/j.mce.2015.07.031; Li L, 2011, MOL MED, V17, P1168, DOI 10.2119/molmed.2011.00051; Luo Y, 2017, CLIN SCI, V131, P239, DOI 10.1042/CS20160543; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Sottile V, 2000, FEBS LETT, V475, P201, DOI 10.1016/S0014-5793(00)01655-0; Tang JX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.555; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tobin JF, 2006, DRUG DISCOV TODAY, V11, P405, DOI 10.1016/j.drudis.2006.03.016; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vella A, 2009, DIABETES, V58, P2168, DOI 10.2337/db09-0318; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Xiao F, 2014, DIABETES, V63, P2631, DOI 10.2337/db13-1689; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Yang ML, 2014, FEBS J, V281, P3193, DOI 10.1111/febs.12853; Yuan L, 2015, INT J OBESITY, V39, P949, DOI 10.1038/ijo.2015.5; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188	34	25	25	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10077	10088		10.1096/fj.201802544RR	http://dx.doi.org/10.1096/fj.201802544RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31237775	Bronze			2022-12-26	WOS:000482214200029
J	Blahut, M; Wise, CE; Bruno, MR; Dong, G; Makris, TM; Frantom, PA; Dunkle, JA; Outten, FW				Blahut, Matthew; Wise, Courtney E.; Bruno, Michael R.; Dong, Guangchao; Makris, Thomas M.; Frantom, Patrick A.; Dunkle, Jack A.; Outten, F. Wayne			Direct observation of intermediates in the SufS cysteine desulfurase reaction reveals functional roles of conserved active-site residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; iron-sulfur protein; pre-steady-state kinetics; enzyme catalysis; enzyme mechanism; cysteine desulfurase; cysteine sulfur bond cleavage; PLP; PLP-dependent sulfur abstraction; SufS	FE-S CLUSTER; ESCHERICHIA-COLI COUNTERPART; LYASE C-DES; SELENOCYSTEINE LYASE; QUINONOID INTERMEDIATE; GENE CLONING; SULFUR; MECHANISM; PROTEIN; BIOGENESIS	Iron-sulfur (Fe-S) clusters are necessary for the proper functioning of numerous metalloproteins. Fe-S cluster (Isc) and sulfur utilization factor (Suf) pathways are the key biosynthetic routes responsible for generating these Fe-S cluster prosthetic groups in Escherichia coli. Although Isc dominates under normal conditions, Suf takes over during periods of iron depletion and oxidative stress. Sulfur acquisition via these systems relies on the ability to remove sulfur from free cysteine using a cysteine desulfurase mechanism. In the Suf pathway, the dimeric SufS protein uses the cofactor pyridoxal 5 '-phosphate (PLP) to abstract sulfur from free cysteine, resulting in the production of alanine and persulfide. Despite much progress, the stepwise mechanism by which this PLP-dependent enzyme operates remains unclear. Here, using rapid-mixing kinetics in conjunction with X-ray crystallography, we analyzed the pre-steady-state kinetics of this process while assigning early intermediates of the mechanism. We employed H123A and C364A SufS variants to trap Cys-aldimine and Cys-ketimine intermediates of the cysteine desulfurase reaction, enabling direct observations of these intermediates and associated conformational changes of the SufS active site. Of note, we propose that Cys-364 is essential for positioning the Cys-aldimine for C alpha deprotonation, His-123 acts to protonate the Ala-enamine intermediate, and Arg-56 facilitates catalysis by hydrogen bonding with the sulfhydryl of Cys-aldimine. Our results, along with previous SufS structural findings, suggest a detailed model of the SufS-catalyzed reaction from Cys binding to C-S bond cleavage and indicate that Arg-56, His-123, and Cys-364 are critical SufS residues in this C-S bond cleavage pathway.	[Blahut, Matthew; Wise, Courtney E.; Dong, Guangchao; Makris, Thomas M.; Outten, F. Wayne] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Bruno, Michael R.; Frantom, Patrick A.; Dunkle, Jack A.] Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA	University of South Carolina System; University of South Carolina Columbia; University of Alabama System; University of Alabama Tuscaloosa	Outten, FW (corresponding author), Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.; Dunkle, JA (corresponding author), Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA.	jadunkle@ua.edu; woutten@sc.edu	Dunkle, Jack/ABB-9713-2020; Frantom, Patrick/GQB-1040-2022	Dunkle, Jack/0000-0001-6252-0587; Outten, Franklin/0000-0002-9095-0194; Wise, Courtney/0000-0002-8712-9039; Makris, Thomas/0000-0001-7927-620X	National Institutes of Health NIGMS Grant [GM112919]; University of South Carolina Office of Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112919] Funding Source: NIH RePORTER	National Institutes of Health NIGMS Grant; University of South Carolina Office of Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant GM112919 (to F. W. O. and P. A. F.) and in part by a grant from the University of South Carolina Office of Research (to T. M. M. and F. W. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht AG, 2011, FEBS LETT, V585, P465, DOI 10.1016/j.febslet.2011.01.005; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Black KA, 2015, BBA-MOL CELL RES, V1853, P1470, DOI 10.1016/j.bbamcr.2014.10.018; Blauenburg B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158749; Campanini B, 2006, J BIOL CHEM, V281, P38769, DOI 10.1074/jbc.M607098200; Dai YY, 2015, BIOCHEMISTRY-US, V54, P4824, DOI 10.1021/acs.biochem.5b00663; Dai YY, 2012, FEBS LETT, V586, P4016, DOI 10.1016/j.febslet.2012.10.001; Dunkle JA, 2019, BIOCHEMISTRY-US, V58, P687, DOI 10.1021/acs.biochem.8b01122; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Hirayama A, 2015, CHEMBIOCHEM, V16, P2484, DOI 10.1002/cbic.201500426; Kaiser JT, 2003, J BIOL CHEM, V278, P357, DOI 10.1074/jbc.M209862200; Karsten WE, 2009, BBA-GEN SUBJECTS, V1790, P575, DOI 10.1016/j.bbagen.2009.02.012; Kim D, 2018, BIOCHEMISTRY-US, V57, P5210, DOI 10.1021/acs.biochem.7b01275; Kim S, 2013, J BIOL CHEM, V288, P27172, DOI 10.1074/jbc.M113.480277; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Liang J, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00004; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Omi R, 2010, J BIOL CHEM, V285, P12133, DOI 10.1074/jbc.M109.084475; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Phillips RS, 2011, BBA-PROTEINS PROTEOM, V1814, P1481, DOI 10.1016/j.bbapap.2010.12.003; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Selbach BP, 2013, BIOCHEMISTRY-US, V52, P4089, DOI 10.1021/bi4001479; Singh H, 2013, J BIOL CHEM, V288, P36189, DOI 10.1074/jbc.M113.525709; Soniya K, 2018, J COMPUT CHEM, V39, P1629, DOI 10.1002/jcc.25338; Sun SX, 1999, BIOCHEMISTRY-US, V38, P4058, DOI 10.1021/bi982924t; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; Trotter V, 2009, MOL MICROBIOL, V74, P1527, DOI 10.1111/j.1365-2958.2009.06954.x; Van Hoewyk D, 2007, P NATL ACAD SCI USA, V104, P5686, DOI 10.1073/pnas.0700774104; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zhou XZ, 1999, BIOCHEMISTRY-US, V38, P311, DOI 10.1021/bi981455s	44	17	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12444	12458		10.1074/jbc.RA119.009471	http://dx.doi.org/10.1074/jbc.RA119.009471			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248989	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000484402700016
J	Wang, JL; Zielewicz, L; Grewer, C				Wang, Jiali; Zielewicz, Laura; Grewer, Christof			A K+/Na+ co-binding state: Simultaneous versus competitive binding of K+ and Na+ to glutamate transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; neurotransmitter transport; electrophysiology; kinetics; potassium transport	AMINO-ACID TRANSPORTER; GLIAL-CELLS; NA+/CA2+ EXCHANGER; ION-EXCHANGE; ASPARTATE; MECHANISM; SODIUM; POTASSIUM; SUBSTRATE; RESIDUE	Plasma membrane-associated glutamate transporters play a key role in signaling by the major excitatory neurotransmitter glutamate. Uphill glutamate uptake into cells is energetically driven by coupling to co-transport of three Na+ ions. In exchange, one K+ ion is counter-transported. Currently accepted transport mechanisms assume that Na+ and K+ effects are exclusive, resulting from competition of these cations at the binding level. Here, we used electrophysiological analysis to test the effects of K+ and Na+ on neuronal glutamate transporter excitatory amino acid carrier 1 (EAAC1; the rat homologue of human excitatory amino acid transporter 3 (EAAT3)). Unexpectedly, extracellular K+ application to EAAC1 induced anion current, but only in the presence of Na+. This result could be explained with a K+/Na+ co-binding state in which the two cations simultaneously bind to the transporter. We obtained further evidence for this co-binding state, and its anion conductance, by analyzing transient currents when Na+ was exchanged for K+ and effects of the [K+]/[Na+] ratio on glutamate affinity. Interestingly, we observed the K+/Na+ co-binding state not only in EAAC1 but also in the subtypes EAAT1 and -2, which, unlike EAAC1, conducted anions in response to K+ only. We incorporated these experimental findings in a revised transport mechanism, including the K+/Na+ co-binding state and the ability of K+ to activate anion current. Overall, these results suggest that differentiation between Na+ and K+ does not occur at the binding level but is conferred by coupling of cation binding to conformational changes. These findings have implications also for other exchangers.	[Wang, Jiali; Zielewicz, Laura; Grewer, Christof] Binghamton Univ, Dept Chem, 4400 Vestal Pkwy East, Binghamton, NY 13902 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Grewer, C (corresponding author), Binghamton Univ, Dept Chem, 4400 Vestal Pkwy East, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu		wang, jiali/0000-0002-9520-8140	National Science Foundation [1515028]; United States-Israel Binational Science Foundation [2007051]	National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by National Science Foundation Grant 1515028 (to C.G.) and United States-Israel Binational Science Foundation Grant 2007051 (to C.G. and Baruch Kanner). The authors declare that they have no conflicts of interest with the contents of this article.	AMATO A, 1994, J PHYSIOL-LONDON, V479, P371, DOI 10.1113/jphysiol.1994.sp020302; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Cater RJ, 2014, BIOPHYS J, V107, P621, DOI 10.1016/j.bpj.2014.05.046; Cheng MH, 2017, ELIFE, V6, DOI 10.7554/eLife.25850; Divito CB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00150; Fahlke C, 2016, PFLUG ARCH EUR J PHY, V468, P491, DOI 10.1007/s00424-015-1768-3; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2012, J BIOL CHEM, V287, P26921, DOI 10.1074/jbc.M112.364059; Heinzelmann G, 2014, BIOPHYS J, V106, P2675, DOI 10.1016/j.bpj.2014.05.010; Heinzelmann G, 2011, BIOPHYS J, V101, P2380, DOI 10.1016/j.bpj.2011.10.010; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Liao J, 2016, NAT STRUCT MOL BIOL, V23, P590, DOI 10.1038/nsmb.3230; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; Marinelli F, 2014, P NATL ACAD SCI USA, V111, pE5354, DOI 10.1073/pnas.1415751111; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; REEVES JP, 1983, J BIOL CHEM, V258, P3178; Setiadi J, 2015, BIOMOLECULES, V5, P3067, DOI 10.3390/biom5043067; Shlosman I, 2018, J GEN PHYSIOL, V150, P51, DOI 10.1085/jgp.201711897; Sibille J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004137; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wang JL, 2018, J PHYS CHEM B, V122, P28, DOI 10.1021/acs.jpcb.7b09059; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104; Zielewicz L, 2019, ACS CHEM BIOL, V14, P1002, DOI 10.1021/acschembio.9b00194	48	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12180	12190		10.1074/jbc.RA119.009421	http://dx.doi.org/10.1074/jbc.RA119.009421			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31235523	hybrid, Green Published			2022-12-26	WOS:000484284500021
J	Pissaia, JF; Guanaes, BKD; Kintopp, CCD; Correr, GM; da Cunha, LF; Gonzaga, CC				Pissaia, Janes Francio; de Almeida Guanaes, Brunna Katyuscia; de Almeida Kintopp, Cibele Candida; Correr, Gisele Maria; da Cunha, Leonardo Fernandes; Gonzaga, Carla Castiglia			Color stability of ceramic veneers as a function of resin cement curing mode and shade: 3-year follow-up	PLOS ONE			English	Article							LAMINATE VENEERS; FINAL COLOR; OPACITY; COMPOSITES; EFFICIENCY; THICKNESS; SYSTEM	The influence of curing mode and shade of resin cements on the color stability of minimum thickness ceramic veneers after a three-year storage time in distilled water was evaluated in this study. Ninety-six 0.5-mm-thick feldspathic ceramic veneers (Mark II) were luted onto resin composite substrates (Filtek Z350 XT, shade A2E) with two light-cured (NX3 Light cure and AllCem Veneer) and dual-cured resin cements (NX3 dual-cure and AllCem) in various shades. The specimens were stored in distilled water at 37 degrees C. Color measurements were performed with a spectrophotometer at the following times: 1 h and 24h; 7, 30, and 180 days; and 1, 2, and 3 years. Data for color difference (Delta E-ab) light-cured and dual-cured resin cements were analyzed by two-way ANOVA with repeated measures and Tukey's test (alpha = 0.05). For the light-cured cements, the Delta E-ab values were as follows: NX3-Yellow (2.37 +/- 1.35) = ACV-A1 (2.40 +/- 1.21) = ACV-Trans (2.52 +/- 1.46) = ACV-E-Bleach M (2.56 +/- 1.42) = NX3-White (2.69 +/- 1.49) = NX3-Clear (2.98 +/- 1.68). The lowest Delta E values were found for 1 h (0.61 +/- 0.36)(a), followed by 24 h (1.15 +/- 0.55)(b) and 30 days (2.48 +/- 1.11)(c). One year, 180 days, and 2 and 3 years presented higher Delta E-ab values (3.34 +/- 0.94, 3.52 +/- 1.04, 3.52 +/- 0.95 and 3.55 +/- 1.14, respectively)(d). For the dual-cured cements, the Delta E-ab values varied as follows: NX3-Clear (2.32 +/- 1.24)(a) = NX3-Yellow (2.37 +/- 1.32)(a) = NX3-White (2.76 +/- 1.43)(a) < AC-Trans (3.77 +/- 1.91)(b) = AC-A3 (4.13 +/- 2.11)(b) < AC-Al (5.38 +/- 2.92)(c). Considering time, the lowest Delta E-ab values were found for 1 h (0.48 +/- 0.25)(a), followed by 24 h (2.13 +/- 0.83)(b), 30 days (3.54 +/- 1.31)(c), and 180 days (3,70 +/- 1.73)(c). The follow-up times of 1 (4.43 +/- 2.15)(d), 2 (5.02 +/- 1.74)(e), and 3 years (4.90 +/- 2.12)(e) presented higher Delta E-ab values. This study demonstrated that light-cured resin cements were less susceptible to color change than dual-cured cements. After 2 years of follow-up, all cements presented Delta E-ab values above the acceptability threshold.	[Pissaia, Janes Francio; de Almeida Guanaes, Brunna Katyuscia; de Almeida Kintopp, Cibele Candida; Correr, Gisele Maria; da Cunha, Leonardo Fernandes; Gonzaga, Carla Castiglia] Univ Posit, Sch Hlth Sci, Grad Program Dent, Curitiba, Parana, Brazil		Gonzaga, CC (corresponding author), Univ Posit, Sch Hlth Sci, Grad Program Dent, Curitiba, Parana, Brazil.	carlacgonzaga2@gmail.com	Gonzaga, Carla Castiglia/K-2997-2012; Cunha, Leonardo/ABA-6762-2020; Correr, Gisele/AAQ-2007-2020	Gonzaga, Carla Castiglia/0000-0001-6374-1605; Correr, Gisele/0000-0002-5032-0948	Centro de Pesquisa da Universidade Positivo [47954]	Centro de Pesquisa da Universidade Positivo	This research project from Centro de Pesquisa da Universidade Positivo was funded with public resources obtained through the "Public Call 09/2016 Institutional Program for Basic and Applied Research" - Fundacao Araucaria/Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior do Parana (SETI) - under protocol number 47954 to CCG.	Almeida JR, 2015, J PROSTHET DENT, V114, P272, DOI 10.1016/j.prosdent.2015.01.008; Alqahtani MQ, 2012, DENT MATER J, V31, P354, DOI 10.4012/dmj.2011-268; Archegas LRP, 2012, OPER DENT, V37, P281, DOI 10.2341/11-134-L; Braga RR, 2002, J ORAL REHABIL, V29, P257, DOI 10.1046/j.1365-2842.2002.00821.x; Chen XD, 2015, J PROSTHODONT RES, V59, P172, DOI 10.1016/j.jpor.2015.03.001; Cilli R, 2012, J DENT, V40, P1144, DOI 10.1016/j.jdent.2012.09.012; Marchionatti AME, 2017, J PROSTHET DENT, V118, P604, DOI 10.1016/j.prosdent.2016.11.013; Garcia Lucas da Fonseca Roberti, 2013, Gen Dent, V61, pe1; Ghavam M, 2010, OPER DENT, V35, P605, DOI 10.2341/09-161-L; Gracis S, 2015, INT J PROSTHODONT, V28, P227, DOI 10.11607/ijp.4244; Kelly JR, 2011, AUST DENT J, V56, P84, DOI 10.1111/j.1834-7819.2010.01299.x; Kilinc E, 2011, J DENT, V39, pE30, DOI 10.1016/j.jdent.2011.01.005; Calgaro PAM, 2014, AM J DENT, V27, P191; Calgaro PAM, 2013, BRAZ ORAL RES, V27, P403, DOI 10.1590/S1806-83242013000500004; Archegas LRP, 2011, J DENT, V39, P804, DOI 10.1016/j.jdent.2011.08.013; Pires-De-Souza FDP, 2009, J PROSTHET DENT, V101, P13, DOI 10.1016/S0022-3913(08)60282-6; Paravina RD, 2015, J ESTHET RESTOR DENT, V27, pS1, DOI 10.1111/jerd.12149; Perroni AP, 2018, DENT MATER, V34, P1610, DOI 10.1016/j.dental.2018.08.298; Perroni AP, 2017, J PROSTHET DENT, V118, P611, DOI 10.1016/j.prosdent.2016.12.010; Pissaia Janes Francio, 2015, Braz. J. Oral Sci., V14, P272, DOI 10.1590/1677-3225v14n4a04; Santerre JP, 2001, CRIT REV ORAL BIOL M, V12, P136, DOI 10.1177/10454411010120020401; Schneider LFJ, 2012, DENT MATER, V28, P392, DOI 10.1016/j.dental.2011.11.014; Silami Francisca Daniele Jardilino, 2016, Braz. Dent. J., V27, P95, DOI 10.1590/0103-6440201600348; Smith Darrell S., 2011, General Dentistry, V59, P390; The International Commission on Illumination, 2018, CO TECHN REP COL; Turgu S, 2013, J PROSTHET DENT, V109, P179, DOI 10.1016/S0022-3913(13)60039-6; Turgut S, 2011, J DENT, V39, pE57, DOI 10.1016/j.jdent.2011.11.006; Ural C, 2016, J ORAL SCI, V58, P157, DOI 10.2334/josnusd.15-0619	28	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219183	10.1371/journal.pone.0219183	http://dx.doi.org/10.1371/journal.pone.0219183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260461	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700041
J	Zhang, LJ; Sun, XB; Si, JY; Li, GZ; Cao, L				Zhang, Lijing; Sun, Xiaobo; Si, Jianyong; Li, Guangzhi; Cao, Li			Umbelliprenin isolated from Ferula sinkiangensis inhibits tumor growth and migration through the disturbance of Wnt signaling pathway in gastric cancer	PLOS ONE			English	Article							COLON-CANCER; APOPTOSIS; CELLS; RECURRENCE; SURVIVAL; CATENIN	The traditional herb medicine Ferula sinkiangensis K.M. Shen (F. sinkiangensis) has been used to treat stomach disorders in Xinjiang District for centuries. Umbelliprenin is the effective component isolated from F. sinkiangensis which is particularly found in plants of the family Ferula. We previously reported the promising effects of Umbelliprenin against gastric cancer cells, but its anti-migration effect remained unknown. Here we investigated the anti migration effect and mechanism of Umbelliprenin in human gastric cancer cells. In SRB assay, Umbelliprenin showed cytotoxic activities in the gastric cancer cell lines AGS and BGC-823 in a dose-and-time-dependent manner, while it showed lower cytotoxic activity in the normal gastric epithelium cell line GES-1. During transwell, scratch and colony assays, the migration of tumor cells was inhibited by Umbelliprenin treatment. In gelatin zymography assay, Umbelliprenin could inhibit the expression of MMP2 and MMP9 in tumor cells The expression levels of the Wnt-associated signaling pathway proteins were analyzed with western blots, and the results showed that Umbelliprenin decreased the expression levels of proteins of the Wnt signalling pathway, such as Wnt-2, beta-catenin, GSK-3 beta, p-GSK-3 beta, Survivin and c-myc. The translocation of 8-catenin to the nucleus was also inhibited by Umbelliprenin treatment. In TCF reporter assay, the transcriptional activity of T-cell factor/ lymphoid enhancer factor (TCF/LEF) was decreased after Umbelliprenin treatment. The in vivo results suggested that Umbelliprenin induced little to no harm in the lung, heart and kidney. Overall, these data provided evidence that Umbelliprenin may inhibit the growth, invasion and migration of gastric cancer cells by disturbing the Wnt signaling pathway.	[Zhang, Lijing; Sun, Xiaobo; Si, Jianyong; Li, Guangzhi; Cao, Li] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Zhang, Lijing; Sun, Xiaobo; Si, Jianyong; Li, Guangzhi; Cao, Li] Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Lijing] CAAS, Inst Food Sci & Technol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Agricultural Sciences; Institute of Food Science & Technology, CAAS	Cao, L (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.; Cao, L (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	lcao@implad.ac.cn			National Natural Science Foundation of China [81460661, 81460586]; Ministry of Science and Technology of the People's Republic of China; Major Scientific and Technological Special Project for "Significant New Drugs Formulation" [2012ZX09501001004, 2012ZX09301-002-001-026]; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Major Scientific and Technological Special Project for "Significant New Drugs Formulation"; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical Sciences	This work was supported by the National Natural Science Foundation of China (No. 81460661 and No. 81460586), the Ministry of Science and Technology of the People's Republic of China, and the Major Scientific and Technological Special Project for "Significant New Drugs Formulation" (Grant No. 2012ZX09501001004 and 2012ZX09301-002-001-026). This work was also supported by the Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical Sciences.	Bohle B, 2010, SURGERY, V147, P120, DOI 10.1016/j.surg.2009.06.035; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chiurillo MA, 2015, WORLD J EXP MED, V5, P84, DOI [10.5493/wjem.v5.i2.84, DOI 10.5493/wjem.v5.i2.84, DOI 10.5493/WJEM.V5.I2.84]; Cho EJ, 2016, CLIN CHIM ACTA, V452, P149, DOI 10.1016/j.cca.2015.11.015; Climent M, 2016, EJSO-EUR J SURG ONC, V42, P132, DOI 10.1016/j.ejso.2015.08.163; Dakeng S, 2012, J CELL BIOCHEM, V113, P49, DOI 10.1002/jcb.23326; Dong GZ, 2015, J FUNCT FOODS, V18, P47, DOI 10.1016/j.jff.2015.06.059; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Gholami O, 2013, IRAN J PHARM RES, V12, P371; Haghighi F, 2014, DARU, V22, DOI 10.1186/2008-2231-22-3; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kim JH, 2015, J SURG RES, V198, P80, DOI 10.1016/j.jss.2015.05.046; Luo J, 1999, CANCER RES, V59, P3552; Mousavi SH, 2015, AVICENNA J PHYTOMEDI, V5, P520; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Roviello G, 2016, TUMOR BIOL, V37, P127, DOI 10.1007/s13277-015-4408-9; Tang LL, 2014, CHEM-BIOL INTERACT, V222, P7, DOI 10.1016/j.cbi.2014.08.004; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; Yang J, 2013, COCHRANE DB SYST REV, V4; Yin CY, 2014, WORLD J GASTROENTERO, V20, P17426, DOI 10.3748/wjg.v20.i46.17426; Zeng HM, 2015, INT J CANCER, V136, P1921, DOI 10.1002/ijc.29227; Zhang J, 2014, NAT PRODUCT BIOPROSP, V4, P135, DOI 10.1007/s13659-014-0016-4; Zhang LJ, 2015, RSC ADV, V5, P91006, DOI 10.1039/c5ra11335k; Zheng RS, 2016, CANCER LETT, V370, P33, DOI 10.1016/j.canlet.2015.10.003; Ziai SA, 2012, IRAN J PHARM RES, V11, P653	25	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0207169	10.1371/journal.pone.0207169	http://dx.doi.org/10.1371/journal.pone.0207169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260453	Green Submitted, Green Published, gold			2022-12-26	WOS:000484918700003
J	Wen, YF; Wong, HM; McGrath, CP				Wen, Yi Feng; Wong, Hai Ming; McGrath, Colman P.			Developmental shape changes in facial morphology: Geometric morphometric analyses based on a prospective, population-based, Chinese cohort in Hong Kong	PLOS ONE			English	Article							LOGARITHMIC TRANSFORMATION; FLUCTUATING ASYMMETRY; ONTOGENY; GROWTH; SIZE; ALLOMETRY	Background Thorough understanding of developmental changes of human facial shape is lacking. The present study aimed to evaluate developmental shape changes of facial morphology based on a prospective, population-representative, Chinese cohort in Hong Kong. Methods A population-representative sample of Chinese in Hong Kong was followed. Serial facial images of over 260 participants were obtained at age 12, 15, and 18 years. Facial landmarks were digitized and the corresponding coordinates were submitted for Generalized Procrustes Analysis. The resultant Procrustes shape coordinates, which captured shape information encoded by the facial landmarks, were then used for statistical shape analyses. Results Small but significant developmental changes in mean facial shape were observed ( p < 0.0001 for all pairwise comparisons). Significant age-related changes in the magnitude of variance of facial shape were also observed ( p < 0.05). Phenotypic growth trajectories representing developmental shape changes were similar in size ( p > 0.05) between sexes but differed in direction ( p < 0.05) in shape space and trajectory shape ( p < 0.05). The magnitude of shape differences between sexes remained constant from 12 to 18 years. Results of frontal facial shape analyses after removing the effect of allometry were similar to results obtained before removal of allometry. For lateral facial configurations, allometric trajectories among the age-by-sex groups were similar in slope ( p > 0.05) but varied in directions in the multidimensional shape space. Conclusions Our findings suggested significant age-related changes in facial shape and provided a dynamic view of developmental changes in sexual dimorphism of facial shape. Allometry contributed minimally to developmental changes in frontal facial shape. In addition, the allometric trajectories for lateral facial configurations were similar in rate of shape change but differed in their directions in shape space.	[Wen, Yi Feng] Xi An Jiao Tong Univ, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Shaanxi, Peoples R China; [Wen, Yi Feng] Xi An Jiao Tong Univ, Coll Stomatol, Clin Res Ctr Shaanxi Prov Dent & Maxillofacial Di, Xian, Shaanxi, Peoples R China; [Wong, Hai Ming] Univ Hong Kong, Fac Dent, Paediat Dent, Hong Kong, Peoples R China; [McGrath, Colman P.] Univ Hong Kong, Dent Publ Hlth, Fac Dent, Hong Kong, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Hong Kong; University of Hong Kong	Wong, HM (corresponding author), Univ Hong Kong, Fac Dent, Paediat Dent, Hong Kong, Peoples R China.	wonghmg@hku.hk	Wen, Yi Feng/ABT-7086-2022	Wen, Yi Feng/0000-0002-5950-9456; Wong, Hai Ming/0000-0003-3411-6442	Research Grants Council of the Hong Kong Special Administrative Region, China [17103718]; Hai Ming Wong	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Hai Ming Wong	The work described in this paper was fully supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. 17103718), URL: http://www.ugc.edu.hk/eng/rgc/.The funding recipient was Hai Ming Wong.	Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Adams DC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-216; Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Bulygina E, 2006, AM J PHYS ANTHROPOL, V131, P432, DOI 10.1002/ajpa.20317; Claes P, 2018, NAT GENET, V50, P414, DOI 10.1038/s41588-018-0057-4; Collyer ML, 2015, HEREDITY, V115, P357, DOI 10.1038/hdy.2014.75; Cvijanovic M, 2014, EVOL DEV, V16, P306, DOI 10.1111/ede.12093; Djordjevic J, 2013, ORTHOD CRANIOFAC RES, V16, P146, DOI 10.1111/ocr.12012; Ercan, 2013, TURK KLIN J MED SCI, V33, P184, DOI 10.5336/medsci.2012-30150; Falconer D, 1995, INTRO QUANTITATIVE G, V19, P1; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fischer-Rousseau L, 2009, EVOL DEV, V11, P740, DOI 10.1111/j.1525-142X.2009.00381.x; FOOTE M, 1988, EVOLUTION, V42, P396, DOI 10.1111/j.1558-5646.1988.tb04143.x; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; FORMBY WA, 1994, AM J ORTHOD DENTOFAC, V105, P464, DOI 10.1016/S0889-5406(94)70007-9; Gazi-Coklica V, 1997, EUR J ORTHODONT, V19, P681, DOI 10.1093/ejo/19.6.681; Gingerich PD, 2000, J THEOR BIOL, V204, P201, DOI 10.1006/jtbi.2000.2008; Hallgrimsson B, 1999, INT J PRIMATOL, V20, P121, DOI 10.1023/A:1020540418554; Jayaraman J, 2013, AM J HUM BIOL, V25, P329, DOI 10.1002/ajhb.22370; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Kleinbaum D., 2013, APPL REGRESSION ANAL; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; Larson JR, 2018, AM J PHYS ANTHROPOL, V165, P327, DOI 10.1002/ajpa.23356; Mascaro J, 2014, BIOL J LINN SOC, V111, P230, DOI 10.1111/bij.12177; Mellion ZJ, 2013, AM J ORTHOD DENTOFAC, V143, P845, DOI 10.1016/j.ajodo.2013.01.019; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Naini FB, 2011, FACIAL AESTHETICS CO; NONAKA K, 1984, J CRAN GENET DEV BIO, V4, P271; Oksanen J., 2015, VEGAN PACKAGE COMMUN; Palestis BG, 2016, SYMMETRY-BASEL, V8, DOI 10.3390/sym8110123; Pound N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1639; PRICE T, 1991, EVOLUTION, V45, P518, DOI 10.1111/j.1558-5646.1991.tb04327.x; RISKA B, 1984, GENETICS, V107, P79; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Toma AM, 2012, EUR J ORTHODONT, V34, P655, DOI 10.1093/ejo/cjr106; Vahdettin L, 2012, J OROFAC ORTHOP, V73, P440, DOI 10.1007/s00056-012-0099-7; Wellens HLL, 2013, J ANAT, V222, P397, DOI 10.1111/joa.12027; Wen YF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186598; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588; You QL, 1999, EUR J ORTHODONT, V21, P717, DOI 10.1093/ejo/21.6.717; Zelditch M. L., 2012, PRACTICAL COMPANION; Zelditch ML, 2016, EVOL BIOL, P1	50	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218542	10.1371/journal.pone.0218542	http://dx.doi.org/10.1371/journal.pone.0218542			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3XM	31252428	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000013
J	Zeiger, JS; Silvers, WS; Fleegler, EM; Zeiger, RS				Zeiger, Joanna S.; Silvers, William S.; Fleegler, Edward M.; Zeiger, Robert S.			Cannabis use in active athletes: Behaviors related to subjective effects	PLOS ONE			English	Article							CLUSTER-ANALYSIS; PAIN MANAGEMENT; MARIJUANA; TOBACCO; SUGGESTIONS; PERFORMANCE; PREVALENCE; EXERCISE; EFFICACY; ALCOHOL	Cannabis use has not been well characterized in athletes. Studies primarily examine problematic use or its categorization by anti-doping bodies as a banned substance. Patterns of use, reasons for use, and responses to cannabis consumption have not been studied in a community-based sample of adult athletes. The Athlete PEACE Survey examined cannabis use patterns and subjective effects to cannabis in a community-based cohort of adult athletes. We used mainly social media and email blasts to recruit and SurveyGizmo to collect data. 1,161 ( 91.1%) of the 1,274 athletes taking the survey completed it. Current cannabis use was evaluated by asking "In the past two weeks, have you used marijuana ( including THC and/or CBD)?" and cannabis type used was assessed by asking "What do you primarily use THC, CBD, or both?". Cannabis benefits and adverse effects ( i.e. subjective effects) and patterns of use were reported. 302 athletes ( 26%) currently use cannabis of whom 301 had complete data for cluster analysis. Cluster analysis was used to determine cannabis user phenotypes and exploratory factor analysis ( EFA) was used to create subjective effects factors. Associations between cannabis user phenotype clusters and the subjective effects factors were explored using multivariate analysis. Cluster analysis identified three statistically distinct cannabis user phenotypes: ( 1) older athletes who primarily use medical CBD, ( 2) mixed age athletes who use cannabis mainly recreationally with both THC and CBD use, and ( 3) mixed age athletes who used cannabis the longest with primary THC and CBD use. EFA showed three subjective effects factors: ( 1) Well-being, ( 2) Calm, and ( 3) Adverse. Mean positive subjective were higher than mean adverse subjective effects ( p<0.001). The cluster using THC and CBD showed the highest mean scores for all three subjective effects factors ( p<0.001). Athletes who use a combination of THC and CBD exhibited the most benefit to well-being and calm with minimal adverse effects. Our methodology can be used to develop real-world evidence to inform future use of medical cannabis products.	[Zeiger, Joanna S.; Silvers, William S.; Fleegler, Edward M.; Zeiger, Robert S.] Canna Res Grp, Boulder, CO 80302 USA; [Silvers, William S.] Univ Colorado, Sch Med, Aurora, CO USA; [Fleegler, Edward M.] To Life Peace LLC, Wheat Ridge, CO USA; [Zeiger, Robert S.] Kaiser Permanente Southern Calif, San Diego, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente	Zeiger, JS (corresponding author), Canna Res Grp, Boulder, CO 80302 USA.	joanna@cannaresearchgroup.net		Zeiger, Joanna/0000-0002-2421-2206				Agrawal A, 2014, ADDICTION, V109, P663, DOI 10.1111/add.12449; Ambrose KR, 2015, BEST PRACT RES CL RH, V29, P120, DOI 10.1016/j.berh.2015.04.022; [Anonymous], 2017, 2017 NATL RUNNER SUR; Aviram J, 2017, Pain Physician, V20, pE755; Bacher J., 2004, SPSS TWOSTEP CLUSTER; Berman JS, 2004, PAIN, V112, P299, DOI 10.1016/j.pain.2004.09.013; Bhatnagar R., 2014, AM J ED RES, V2, P683, DOI [10.12691/education-2-8-18, DOI 10.12691/EDUCATION-2-8-18, 10.12691/ education- 2-8-18]; Blackwell DL, 2008, STATE VARIATION M 20; Boehnke KF, 2019, ANN INTERN MED, V170, P118, DOI 10.7326/M18-2972; Bousquet PJ, 2015, INT ARCH ALLERGY IMM, V166, P231, DOI 10.1159/000381339; Brisola-Santos MB, 2016, AM J ADDICTION, V25, P518, DOI 10.1111/ajad.12425; Bryan AD, 2018, DOES CANNABIS USE FA, P48; Cook PF., 2010, PERFORM MANOVA SPSS; Corroon J, 2018, CANNABIS CANNABINOID, V3, P152, DOI 10.1089/can.2018.0006; Curran HV, 2002, PSYCHOPHARMACOLOGY, V164, P61, DOI 10.1007/s00213-002-1169-0; Dietrich A, 2004, BRIT J SPORT MED, V38, P536, DOI 10.1136/bjsm.2004.011718; Dolnicar S, 2014, J TRAVEL RES, V53, P296, DOI 10.1177/0047287513496475; Ehlert K. M., 2017, P AM SOC ENGG ED C A, P1; Fiz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018440; Geneen LJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011279.pub3; Gillman AS, 2015, SPORTS MED, V45, P1357, DOI 10.1007/s40279-015-0362-3; Goldenberg M, 2017, DRUG ALCOHOL DEPEN, V174, P80, DOI 10.1016/j.drugalcdep.2016.12.030; Green B, 2003, DRUG ALCOHOL REV, V22, P453, DOI 10.1080/09595230310001613976; Hainline B, 2017, BRIT J SPORT MED, V51, P1245, DOI 10.1136/bjsports-2017-097884; Hainline B, 2017, BRIT J SPORT MED, V51, P1259, DOI 10.1136/bjsports-2017-097890; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed., P785; Hair J.F., 2014, 7 EDITION MULTIVARIA, Vseventh; Haroutounian S, 2016, CLIN J PAIN, V32, P1036, DOI 10.1097/AJP.0000000000000364; Haug NA, 2017, ADDICT BEHAV, V72, P14, DOI 10.1016/j.addbeh.2017.03.006; Heishman SJ, PHARM BIOCH BEHAV, V37; Henry D, 2015, PREV SCI, V16, P1007, DOI 10.1007/s11121-015-0561-z; Hill KP, 2017, CANNABIS CANNABINOID, V2, P96, DOI 10.1089/can.2017.0017; Huestis MA, 2011, SPORTS MED, V41, P949, DOI 10.2165/11591430-000000000-00000; Kline P., 2000, HDB PSYCHOL TESTING; Lin LA, 2016, ADDICT BEHAV, V61, P99, DOI 10.1016/j.addbeh.2016.05.015; Morean ME, 2019, ADDICT BEHAV, V93, P233, DOI 10.1016/j.addbeh.2019.02.003; Parker R, 2017, SOUTH AFR J PHYSIOTH, V73, DOI 10.4102/sajp.v73i1.323; Peretti-Watel P, 2003, ADDICTION; Polaski AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210418; Primack BA, 2012, J AM COLL HEALTH, V60, P374, DOI 10.1080/07448481.2012.663840; PUNJ G, 1983, J MARKETING RES, V20, P134, DOI 10.2307/3151680; Rice SM, 2016, SPORTS MED, V46, P1333, DOI 10.1007/s40279-016-0492-2; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Russo E.B., 2013, COMPREHENSIVE TREATM, P181, DOI [10.1007/978-1-4614-1560-2_18, DOI 10.1007/978-1-4614-1560-2_18]; Russo EB, 2011, BRIT J PHARMACOL, V163, P1344, DOI 10.1111/j.1476-5381.2011.01238.x; Scherrer JF, 2009, DRUG ALCOHOL DEPEN, V105, P76, DOI 10.1016/j.drugalcdep.2009.06.014; Schilling L, LICIT ILLICIT SUBSTA, DOI [10.1186/s13011-017-0128-z, DOI 10.1186/S13011-017-0128-Z]; Schwope DM, 2012, J ANAL TOXICOL, V36, P405, DOI 10.1093/jat/bks044; Shuer ML, 1997, WESTERN J MED, V166, P104; Stith SS, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00916; Stockings E, 2018, PAIN, V159, P1932, DOI 10.1097/j.pain.0000000000001293; The Official Website-USA Cycling, 2018, ACT MEMB REP; Trompeter K, 2018, GER J SPORT MED Z SP, V7-8, P240; USA Triathlon, 2016, US TRIATHL MEMB REP, P1; Vigil JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187795; Wade DT, 2003, CLIN REHABIL, V17, P21, DOI 10.1191/0269215503cr581oa; Ware MA, 2018, CLIN J SPORT MED, V28, P480, DOI 10.1097/JSM.0000000000000650; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Williams B., 2010, AUSTRALAS J PARAMED, V8; Windgassen S, 2018, J MENT HEALTH, V27, P94, DOI 10.1080/09638237.2018.1437615; Zeiger JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193071; Zeiger JS, 2012, DRUG ALCOHOL DEPEN, V123, pS52, DOI 10.1016/j.drugalcdep.2012.02.014; Zeiger JS, 2010, DRUG ALCOHOL DEPEN, V109, P161, DOI 10.1016/j.drugalcdep.2009.12.026; Zhornitsky S, 2012, PHARMACEUTICALS, V5, P529, DOI 10.3390/ph5050529	64	23	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218998	10.1371/journal.pone.0218998	http://dx.doi.org/10.1371/journal.pone.0218998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3XM	31251769	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000033
J	Johnston, JA; Nelson, DR; Zhang, LM; Curtis, SE; Voelker, JR; Wetterau, JR				Johnston, Joseph A.; Nelson, David R.; Zhang, Limin; Curtis, Sarah E.; Voelker, James R.; Wetterau, John R.			Estimating the distribution of a novel clinical biomarker (FGF-23) in the US population using findings from a regional research registry	PLOS ONE			English	Article							GROWTH-FACTOR 23; CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; MORTALITY; FACTOR-23; RISK; ABNORMALITIES; PREVALENCE; PHOSPHATE; FAILURE	Evidence of involvement of novel biomarkers in disease pathogenesis from research cohorts often precedes an understanding of their distributions in broader populations. This study aimed to estimate the distribution of fibroblast growth factor 23 (FGF-23), an endocrine hormone that helps to regulate serum phosphate levels, in the overall US population and in important subgroups. We used a predictive model generated using data from the Framingham Health Study to estimate FGF-23 values for adults in the US National Health and Nutrition Examination Survey and the size of patient subgroups with levels of FGF-23 above selected thresholds. To assess the face validity of our FGF-23 estimates, we examined the relationship between estimated FGF-23 and cardiovascular and all-cause mortality within NHANES using Kaplan-Meier estimates and Cox proportional-hazards regression models and compared it to that observed in Framingham. Estimated FGF-23 values from NHANES were lower (median [interquartile range] 47.4 [35.8, 64.0] vs. 67.0 [54.0, 85.0] RU/mL) than the observed FGF-23 values from the Framingham cohort. Age- and sex-adjusted 10-year all-cause mortality was significantly higher (hazard ratio 2.43 [95% confidence interval: 1.42, 4.16]) for subjects with estimated FGF-23 levels in the highest versus lowest quartile. Estimating the distribution of biomarker values in the general population by applying predictive equations from smaller research cohorts is feasible and can inform drug research decision making.	[Johnston, Joseph A.; Nelson, David R.; Zhang, Limin; Curtis, Sarah E.] Eli Lilly & Co, Global Patient Outcomes & Real World Evidence, Indianapolis, IN 46285 USA; [Voelker, James R.; Wetterau, John R.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Johnston, JA (corresponding author), Eli Lilly & Co, Global Patient Outcomes & Real World Evidence, Indianapolis, IN 46285 USA.	johnstonja@lilly.com		Nelson, David/0000-0002-3240-0725; Johnston, Joseph/0000-0003-3913-9256	Eli Lilly and Co	Eli Lilly and Co(Eli Lilly)	This study was funded by Eli Lilly and Co (https://www.lilly.com/).Eli Lilly provided financial support in the form of salaries for JJ, DN, LZ, SC, JV and JW. The specific roles of these authors are articulated in the author contributions. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JR, 2014, CLIN J AM SOC NEPHRO, V9, P239, DOI 10.2215/CJN.05830513; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; CDC, 2014, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2018, NAT HLTH NUTR EX SUR; Evenepoel P, 2014, SEMIN NEPHROL, V34, P151, DOI 10.1016/j.semnephrol.2014.02.007; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fleming TR, 2012, STAT MED, V31, P2973, DOI 10.1002/sim.5403; Gradman AH, 2006, PROG CARDIOVASC DIS, V48, P326, DOI 10.1016/j.pcad.2006.02.001; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Haring R, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003486; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; LEAVERTON PE, 1987, J CHRON DIS, V40, P775, DOI 10.1016/0021-9681(87)90129-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lloyd-Jones DM, 2001, ARCH INTERN MED, V161, P949, DOI 10.1001/archinte.161.7.949; National Center for Health Statistics, 2013, NCHS 2011 LINK MORT; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Qin ZX, 2017, ATHEROSCLEROSIS, V261, P1, DOI 10.1016/j.atherosclerosis.2017.03.042; Quan SF, 1997, SLEEP, V20, P1077; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Rossaint J, 2016, J CLIN INVEST, V126, P962, DOI 10.1172/JCI83470; Ryan TP, 2007, AM J MED, V120, P981, DOI 10.1016/j.amjmed.2007.05.012; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Scialla JJ, 2013, KIDNEY INT, V83, P1159, DOI 10.1038/ki.2013.3; Silswal N, 2014, AM J PHYSIOL-ENDOC M, V307, pE426, DOI 10.1152/ajpendo.00264.2014; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Smith ER, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02709-w; Smith ER, 2014, CLIN J AM SOC NEPHRO, V9, P1283, DOI 10.2215/CJN.10941013; Toth PP, 2012, J CLIN LIPIDOL, V6, P325, DOI 10.1016/j.jacl.2012.05.002; von Jeinsen B, 2019, ESC HEART FAIL, V6, P536, DOI 10.1002/ehf2.12416	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218435	10.1371/journal.pone.0218435	http://dx.doi.org/10.1371/journal.pone.0218435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246994	Green Submitted, gold, Green Published			2022-12-26	WOS:000484911900024
J	Kang, HJ; Chu, KB; Lee, DH; Lee, SH; Park, BR; Kim, MC; Kang, SM; Quan, FS				Kang, Hae-Ji; Chu, Ki-Back; Lee, Dong-Hun; Lee, Su-Hwa; Park, Bo Ryoung; Kim, Min-Chul; Kang, Sang-Moo; Quan, Fu-Shi			Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs	PLOS ONE			English	Article							CROSS-PROTECTION; IMMUNITY; H5N1; CONFER; CHALLENGE; INFECTION; BROADER; CELLS	Despite the ability to induce a broad range of cross protection, M2e5x virus-like particles (VLPs) alone provide limited vaccine efficacy and confer low efficacy of protection against highly pathogenic avian influenza virus (HPAIV) infection in chickens. Avian influenza hemagglutinin (HA) has been a major antigenic target that enhances humoral immunity, but the efficacy of avian HA-based vaccines against HPAIV needs to be further improved. In this study, we evaluated the vaccine efficacy induced by combination of conserved tandem repeat M2e5x VLPs and HA VLPs against an avian influenza virus. We found that combinatorial vaccine elicited higher levels of reassortant H5N1 (rgH5N1) virus-specific IgG, IgG1, IgG2a and IgA antibody responses compared to M2e5x VLPs in sera and lungs of mice. Combinatorial VLPs vaccination induced higher levels of CD8(+) T cell and germinal center B cell responses in lung and spleen compared to M2e5x VLPs. Combinatorial VLPs vaccination showed significantly reduced inflammatory responses and lung viral loads upon rgH5N1 virus challenge infection, resulting in less body weight loss compared to M2e5x VLPs alone. These results indicate that immune responses to both M2e and HA might provide a strategy of vaccination inducing enhanced protection against avian influenza virus.	[Kang, Hae-Ji; Chu, Ki-Back; Lee, Dong-Hun; Lee, Su-Hwa] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Park, Bo Ryoung; Kim, Min-Chul; Kang, Sang-Moo] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA; [Quan, Fu-Shi] Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul, South Korea; [Quan, Fu-Shi] Kyung Hee Univ, Med Res Ctr Bioreact React Oxygen Species, Seoul, South Korea; [Quan, Fu-Shi] Kyung Hee Univ, Inst Biomed Sci, Sch Med, Grad Sch, Seoul, South Korea	Kyung Hee University; University System of Georgia; Georgia State University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Quan, FS (corresponding author), Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul, South Korea.; Quan, FS (corresponding author), Kyung Hee Univ, Med Res Ctr Bioreact React Oxygen Species, Seoul, South Korea.; Quan, FS (corresponding author), Kyung Hee Univ, Inst Biomed Sci, Sch Med, Grad Sch, Seoul, South Korea.	fsquan@khu.ac.kr			Cooperative Research Program for Agriculture Science & Technology Development Rural Development Administration, Republic of Korea [PJ01320501]; National Research Foundation of Korea [2018R1A6A1A03025124]; Foundation for the National Institutes of Health [AI093772, AI105170, AI134132]	Cooperative Research Program for Agriculture Science & Technology Development Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grants from the Cooperative Research Program for Agriculture Science & Technology Development Rural Development Administration, Republic of Korea (Project No. PJ01320501), and National Research Foundation of Korea (2018R1A6A1A03025124), and Foundation for the National Institutes of Health (AI093772, AI105170, and AI134132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Chen H, 2009, REV SCI TECH OIE, V28, P267, DOI 10.20506/rst.28.1.1860; Chu KB, 2014, PARASITE IMMUNOL, V36, P522, DOI 10.1111/pim.12125; Flach CF, 2011, INFECT IMMUN, V79, P879, DOI 10.1128/IAI.00756-10; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Hemann EA, 2013, J IMMUNOL, V191, P2486, DOI 10.4049/jimmunol.1300954; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Kapczynski DR, 2016, VACCINE, V34, P1575, DOI 10.1016/j.vaccine.2016.02.011; Kim KH, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6040066; Kim MC, 2014, VACCINE, V32, P5824, DOI 10.1016/j.vaccine.2014.08.030; Kim MC, 2014, MOL THER, V22, P1364, DOI 10.1038/mt.2014.33; Kim MC, 2013, ANTIVIR RES, V99, P328, DOI 10.1016/j.antiviral.2013.06.010; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; Lee GJ, 2016, VACCINE, V34, P3764, DOI 10.1016/j.vaccine.2016.06.011; Lee SH, 2018, VACCINE, V36, P5692, DOI 10.1016/j.vaccine.2018.08.016; Lee SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175644; Lee YT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190868; Lee YN, 2016, J IMMUNOL, V196, P2637, DOI 10.4049/jimmunol.1501637; Oh YK, 2015, IMMUNE NETW, V15, P161, DOI 10.4110/in.2015.15.3.161; Poe JC, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122430; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Quan FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009161; Song BM, 2016, VACCINE, V34, P678, DOI 10.1016/j.vaccine.2015.11.074; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song JM, 2010, VIROLOGY, V405, P165, DOI 10.1016/j.virol.2010.05.034; Tarigan S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190947; Van Reeth K, 2002, VIRAL IMMUNOL, V15, P583, DOI 10.1089/088282402320914520; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	30	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0216871	10.1371/journal.pone.0216871	http://dx.doi.org/10.1371/journal.pone.0216871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246961	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900007
J	Van der Fels-Klerx, HJ; Vermeulen, LC; Gavai, AK; Liu, C				Van der Fels-Klerx, H. J.; Vermeulen, L. C.; Gavai, A. K.; Liu, C.			Climate change impacts on aflatoxin B-1 in maize and aflatoxin M-1 in milk: A case study of maize grown in Eastern Europe and imported to the Netherlands	PLOS ONE			English	Article							WATER ACTIVITY; CARRY-OVER; COWS; MODEL; CONTAMINATION; TEMPERATURE; FEED; PH	Various models and datasets related to aflatoxins in the maize and dairy production chain have been developed and used but they have not yet been linked with each other. This study aimed to investigate the impacts of climate change on aflatoxin B-1 production in maize and its consequences on aflatoxin M-1 contamination in dairy cow's milk, using a full chain modelling approach. To this end, available models and input data were chained together in a modelling framework. As a case study, we focused on maize grown in Eastern Europe and imported to the Netherlands to be fed-as part of dairy cows' compound feed-to dairy cows in the Netherlands. Three different climate models, one aflatoxin B-1 prediction model and five different carryover models were used. For this particular case study of East European maize, most of the calculations suggest an increase (up to 50%) of maximum mean aflatoxin M1 in milk by 2030, except for one climate (DMI) model suggesting a decrease. Results from all combinations of carryover and climate models suggest a similar or slight increase (up to 0.6%) of the chance of finding aflatoxin M-1 in milk above the EC limit of 0.05 mu g/kg by 2030. Results varied mainly with the climate model data and carryover model considered. The model framework infrastructure is flexible so that forecasting models for other mycotoxins or other food safety hazards as well as other production chains, together with necessary input databases, can easily be included as well. This modelling framework for the first time links datasets and models related to aflatoxin B-1 in maize and related aflatoxin M-1 the dairy production chain to obtain a unique predictive methodology based on Monte Carlo simulation. Such an integrated approach with scenario analysis provides possibilities for policy makers and risk managers to study the effects of changes in the beginning of the chain on the end product.	[Van der Fels-Klerx, H. J.; Vermeulen, L. C.; Gavai, A. K.; Liu, C.] Wageningen Univ & Res, Wageningen Food Safety Res, Wageningen, Netherlands	Wageningen University & Research	Van der Fels-Klerx, HJ (corresponding author), Wageningen Univ & Res, Wageningen Food Safety Res, Wageningen, Netherlands.	Ine.vanderfels@wur.nl	/GOP-0313-2022	/0000-0002-4738-190X; Vermeulen, Lucie/0000-0002-8403-2442	Netherlands Ministry of Agriculture, Nature and Food Quality (LNV) through the KB program [KB-33-001-004]	Netherlands Ministry of Agriculture, Nature and Food Quality (LNV) through the KB program	All authors received funding for this study from the Netherlands Ministry of Agriculture, Nature and Food Quality (LNV) through the KB program KB-33-001-004. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson D, 2004, CAN J PLANT SCI, V84, P1189, DOI 10.4141/P03-188; Alonso V, 2017, J APPL MICROBIOL, V122, P1048, DOI 10.1111/jam.13395; APPLEBAUM RS, 1982, J FOOD PROTECT, V45, P752, DOI 10.4315/0362-028X-45.8.752; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Battilani P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24328; Battilani P, 2013, COMPUT ELECTRON AGR, V94, P38, DOI 10.1016/j.compag.2013.03.005; Battilani P., 2012, EFSA SUPPORTING PUBL, V9, P1, DOI DOI 10.2903/sp.efsa.2012.EN-223; Battilani P, 2012, EFSA SUPP PUBL, V9; Britzi M, 2013, TOXINS, V5, P173, DOI 10.3390/toxins5010173; Chauhan Y, 2015, FIELD CROP RES, V178, P91, DOI 10.1016/j.fcr.2015.03.024; Chen P, 2014, IOP C SER EARTH ENV, V17, DOI 10.1088/1755-1315/17/1/012053; Collins M, 2011, CLIM DYNAM, V36, P1737, DOI 10.1007/s00382-010-0808-0; de Jong J, 2016, LANDKAART MONITORING; de Rijk TC, 2015, WORLD MYCOTOXIN J, V8, P641, DOI 10.3920/WMJ2015.1903; Dosio A, 2012, J GEOPHYS RES, V117, P1; Duveiller G, 2017, THEOR APPL CLIMATOL, V127, P573, DOI 10.1007/s00704-015-1650-4; EFSA, 2004, EFSA J, V89, P1, DOI [10.2903/j.efsa.2004.89, DOI 10.2903/J.EFSA.2004.89]; European Commission, 2006, EUROPEAN COMMISSION; IARC, 2012, LYON FR INT AGENCY R, V100F, P224; Jaeger EB, 2008, METEOROL Z, V17, P349, DOI 10.1127/0941-2948/2008/0301; Kosegarten CE, 2017, INT J FOOD MICROBIOL, V240, P115, DOI 10.1016/j.ijfoodmicro.2016.04.024; Masoero F, 2007, ANIMAL, V1, P1344, DOI 10.1017/S1751731107000663; Medina A, 2017, INT J FOOD MICROBIOL, V256, P36, DOI 10.1016/j.ijfoodmicro.2017.05.020; Micale F, 2004, METHODOLOGY MARS CRO, V1; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Paterson RRM, 2017, INT J ENV RES PUB HE, V14, DOI [10.3390/ijerph14020199, :10.3390/ijerph14020199]; Prandini A, 2009, FOOD CHEM TOXICOL, V47, P984, DOI 10.1016/j.fct.2007.10.005; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Statistiek CBvd, 2018, CBS STATLINE GOEDERE; Supit I., 2003, UPDATED SYSTEM DESCR; Valero P, 2009, UNIVERSITY SCIENCE AND MATHEMATICS EDUCATION IN TRANSITION, P1, DOI 10.1007/978-0-387-09829-6_1; Van der Fels-Klerx HJ, 2016, WORLD MYCOTOXIN J, V9, P717, DOI 10.3920/WMJ2016.2066; van der Fels-Klerx HJ, 2016, TOXINS, V8, DOI 10.3390/toxins8100290; Van Der Fels-Klerx HJ, 2010, FOOD ADDIT CONTAM A, V27, P636, DOI 10.1080/19440040903571762; van der Linden P., 2009, ENSEMBLES CLIMATE CH; Van Eijkeren JCH, 2006, FOOD ADDIT CONTAM A, V23, P833, DOI 10.1080/02652030600779890; VELDMAN A, 1992, ANIM PROD, V55, P163, DOI 10.1017/S0003356100037417	38	30	30	8	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218956	10.1371/journal.pone.0218956	http://dx.doi.org/10.1371/journal.pone.0218956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247003	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900057
J	Luan, CW; Chang, JJ; Hsu, CM; Tsai, MS; Chang, GH; Huang, EI; Fang, KH; Lin, MH; Liu, CY; Yang, YH; Tsai, YT				Luan, Chih-Wei; Chang, Jung-Jung; Hsu, Cheng-Ming; Tsai, Ming-Shao; Chang, Geng-He; Huang, Ethan I.; Fang, Ku-Hao; Lin, Meng-Hung; Liu, Chia-Yen; Yang, Yao-Hsu; Tsai, Yao-Te			Risk of sudden sensorineural hearing loss in patients with dysrhythmia: A nationwide population-based cohort study	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; LYMPHOCYTE RATIO; NEUTROPHIL/LYMPHOCYTE RATIO; AUTONOMIC REGULATION; ATHEROSCLEROSIS; ASSOCIATION; HYPOTENSION; NEUTROPHIL; DISEASE; ARRHYTHMIAS	Objective Whether dysrhythmia is a risk factor of sudden sensorineural hearing loss (SSNHL) remains unclear. In this study, we aimed to investigate the risk of developing SSNHL among patients with dysrhythmia in different age and gender groups by using population-based data in Taiwan. Methods We conducted a matched cohort study by analyzing data between January 2000 and December 2013 obtained from the Taiwan National Health Insurance Research Database. 41,842 newly diagnosed dysrhythmia patients and 83,684 comparison subjects without dysrhythmia were selected from claims. The incidence of sudden sensorineural hearing loss at the end of 2013 was determined in both groups. Univariate and multivariate logistic regression analyses were used to investigate the risk of SSNHL among patients with dysrhythmia. Results The incidence of SSNHL was 1.30-fold higher in the dysrhythmia group compared with the control group (53.2 versus 40.9 per 100,000 person-years), and using Cox proportional hazard regressions, the adjusted hazard ratio (HR) was 1.40 (95% confidence interval [CI], 1.15-1.70). Gender-stratified analysis revealed a significantly higher risk of SSNHL in patients with dysrhythmia than in those without dysrhythmia for both men and women (HR = 1.34, 95% CI = 1.02-1.76, P = 0.039, HR = 1.35, 95% CI = 1.02-1.78, P = 0.035, respectively). Age-stratified analysis revealed remarkable associations between dysrhythmia and SSNHL among those aged less than 40 years and more than 65 years (HR = 2.18, 95% CI = 1.03-4.64, P = 0.043 and HR = 1.54, 95% CI = 1.14-2.09, P = 0.006, respectively). Conclusions Our findings support dysrhythmia as an independent risk factor for SSNHL. Based on the study results, clinicians managing patients with dysrhythmia should be aware of the increased risk of developing SSNHL, especially among patients aged <40 and >65 years, and counsel patients to seek medical advice immediately if they experience any acute change in their hearing ability.	[Luan, Chih-Wei; Hsu, Cheng-Ming; Tsai, Ming-Shao; Chang, Geng-He; Huang, Ethan I.; Tsai, Yao-Te] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chiayi, Taiwan; [Chang, Jung-Jung] Chang Gung Mem Hosp, Div Cardiol, Chiayi, Taiwan; [Fang, Ku-Hao] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Linkou, Taiwan; [Lin, Meng-Hung; Liu, Chia-Yen] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tsai, YT (corresponding author), Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chiayi, Taiwan.	yaote1215@gmail.com	Tsai, Ming-Shao/B-3187-2017; Lin, Meng-Hung/AAJ-5470-2020; Lin, Meng-Hung/F-5730-2010; Yang, Yao-Hsu/A-3450-2019	Tsai, Ming-Shao/0000-0002-9314-5940; Lin, Meng-Hung/0000-0002-8594-3360; Lin, Meng-Hung/0000-0002-8594-3360; Yang, Yao-Hsu/0000-0002-8080-0504; Fang, Ku-Hao/0000-0002-1458-5041; Luan, Chih Wei/0000-0002-4855-8156; Hsu, Cheng-Ming/0000-0003-3792-3784	Health Information and Epidemiology Laboratory [CLRPG6G0042]; Chang Gung Memorial Hospital, Chiayi Branch; Central Bureau of the NHI; Department of Health	Health Information and Epidemiology Laboratory; Chang Gung Memorial Hospital, Chiayi Branch; Central Bureau of the NHI; Department of Health	The authors would like to thank the Health Information and Epidemiology Laboratory (CLRPG6G0042 to Y-HY) for comments and assistance in data analysis. This study was supported by a grant from Chang Gung Memorial Hospital, Chiayi Branch, and based on the NHIRD provided by the Central Bureau of the NHI and the Department of Health and managed by the National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, INDIAN J OTOLARYNGOL, V65, pS614, DOI 10.1007/s12070-013-0630-1; Agmon Y, 2001, MAYO CLIN PROC, V76, P252, DOI 10.4065/76.3.252; Al-Khatib SM, 2018, HEART RHYTHM, V15, pE190, DOI 10.1016/j.hrthm.2017.10.035; Alexander TH, 2013, OTOL NEUROTOL, V34, P1586, DOI 10.1097/MAO.0000000000000222; Andersen K, 2013, EUR HEART J, V34, P3624, DOI 10.1093/eurheartj/eht188; Aydin M, 2016, ANATOL J CARDIOL, V16, P29, DOI 10.5152/akd.2015.5927; Capaccio P, 2007, LARYNGOSCOPE, V117, P547, DOI 10.1097/MLG.0b013e31802f3c6a; CARRASCO VN, 1990, ARCH OTOLARYNGOL, V116, P411; CHAKKO S, 1989, CLIN CARDIOL, V12, P525, DOI 10.1002/clc.4960120910; Chang CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135417; Chau JK, 2010, LARYNGOSCOPE, V120, P1011, DOI 10.1002/lary.20873; Chiu HY, 2015, J AM ACAD DERMATOL, V73, P429, DOI 10.1016/j.jaad.2015.06.023; Chung SD, 2014, JAMA OTOLARYNGOL, V140, P417, DOI 10.1001/jamaoto.2014.75; Dahlin AA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007403; da Silva RMFL, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0639-0; Fischer ME, 2015, ATHEROSCLEROSIS, V238, P344, DOI 10.1016/j.atherosclerosis.2014.12.031; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Gattringer T, 2012, ARCH NEUROL-CHICAGO, V69, P1508, DOI 10.1001/archneurol.2012.346; Gode S, 2018, J INT ADV OTOL, V14, P44, DOI 10.5152/iao.2017.2780; Gul F, 2017, EUR ARCH OTO-RHINO-L, V274, P1301, DOI 10.1007/s00405-016-4301-1; HALLBERG OE, 1957, JAMA-J AM MED ASSOC, V165, P1649, DOI 10.1001/jama.1957.02980310001001; Kallinen J, 1997, ANN OTO RHINOL LARYN, V106, P22, DOI 10.1177/000348949710600104; Kim C, 2016, HEARING RES, V331, P144, DOI 10.1016/j.heares.2015.09.003; Kuhn M, 2011, TRENDS AMPLIF, V15, P91, DOI 10.1177/1084713811408349; Larsen BS, 2015, J AM COLL CARDIOL, V66, P232, DOI 10.1016/j.jacc.2015.05.018; Lazarini Paulo Roberto, 2006, Rev. Bras. Otorrinolaringol., V72, P554, DOI 10.1590/S0034-72992006000400019; Lazzerini PE, 2017, EUR HEART J, V38, P1717, DOI 10.1093/eurheartj/ehw208; Lin C, 2013, JAMA OTOLARYNGOL, V139, P251, DOI 10.1001/jamaoto.2013.1709; Lin C, 2013, LARYNGOSCOPE, V123, P767, DOI 10.1002/lary.23669; Lin C, 2013, AUDIOL NEURO-OTOL, V18, P95, DOI 10.1159/000345512; Lin SW, 2012, OTOL NEUROTOL, V33, P1482, DOI 10.1097/MAO.0b013e318271397a; Marcucci R, 2005, J THROMB HAEMOST, V3, P929, DOI 10.1111/j.1538-7836.2005.01310.x; Masuda M, 2012, OTOL NEUROTOL, V33, P1142, DOI 10.1097/MAO.0b013e3182635417; Menke J, 2010, AM J CARDIOL, V105, P502, DOI 10.1016/j.amjcard.2009.10.018; Mosnier I, 2011, AUDIOL NEURO-OTOL, V16, P55, DOI 10.1159/000312640; Ozler GS, 2014, J CRANIOFAC SURG, V25, pE260, DOI 10.1097/SCS.0000000000000565; Passamonti SM, 2015, THROMB RES, V135, P508, DOI 10.1016/j.thromres.2015.01.001; Pirodda A, 2004, J LARYNGOL OTOL, V118, P941, DOI 10.1258/0022215042790664; Pirodda A, 1997, AUDIOLOGY, V36, P98; Pirodda A, 2001, ARCH OTOLARYNGOL, V127, P1049, DOI 10.1001/archotol.127.9.1049; Rajati Mohsen, 2016, Iran J Otorhinolaryngol, V28, P189; Reiss M, 2014, ENT-EAR NOSE THROAT, V93, P318, DOI 10.1177/014556131409300809; Schulz S, 2013, IEEE ENG MED BIO, P3933, DOI 10.1109/EMBC.2013.6610405; Schulz S, 2014, OTOL NEUROTOL, V35, P1720, DOI 10.1097/MAO.0000000000000622; Schulz S, 2013, AUTON NEUROSCI-BASIC, V178, P9, DOI 10.1016/j.autneu.2013.02.009; Seo YJ, 2015, AURIS NASUS LARYNX, V42, P438, DOI 10.1016/j.anl.2015.04.011; Seo YJ, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/702807; Shao QM, 2015, ARCH MED RES, V46, P199, DOI 10.1016/j.arcmed.2015.03.011; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Ulu S, 2013, OTOL NEUROTOL, V34, P1400, DOI 10.1097/MAO.0b013e31829b57df; Umesawa M, 2017, ACTA OTO-LARYNGOL, V137, pS17, DOI 10.1080/00016489.2017.1297898; Violi F, 2016, J AM HEART ASSOC, V5, P5; Violi Francesco, 2014, J Atr Fibrillation, V7, P1112, DOI 10.4022/jafib.1112; Wei BPC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003998.pub3; Willeit K, 2014, ATHEROSCLEROSIS, V233, P679, DOI 10.1016/j.atherosclerosis.2013.11.082; Wu CS, 2006, AUDIOL NEURO-OTOL, V11, P151, DOI 10.1159/000091198; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yalta T, 2018, ANGIOLOGY, V69, P288, DOI 10.1177/0003319717709380; Yang YH, 2015, J HEPATOL, V63, P1111, DOI 10.1016/j.jhep.2015.07.006; Yeh MC, 2015, J CLIN ENDOCR METAB, V100, P2413, DOI 10.1210/jc.2014-4316; Yen YC, 2015, AM J CLIN DERMATOL, V16, P213, DOI 10.1007/s40257-015-0117-9; Yen YC, 2015, JAMA OTOLARYNGOL, V141, P429, DOI 10.1001/jamaoto.2015.102	62	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218964	10.1371/journal.pone.0218964	http://dx.doi.org/10.1371/journal.pone.0218964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242251	Green Submitted, Green Published, gold			2022-12-26	WOS:000482883600073
J	Senanayake, S; Mahesh, PKB; Gunawardena, N; Graves, N; Kularatna, S				Senanayake, Sameera; Mahesh, P. K. B.; Gunawardena, Nalika; Graves, Nicholas; Kularatna, Sanjeewa			Validity and internal consistency of EQ-5D-3L quality of life tool among pre-dialysis patients with chronic kidney disease in Sri Lanka, a lower middle-income country	PLOS ONE			English	Article							RELIABILITY; OUTCOMES; STROKE; SCALE	Objective EQ-5D-3L is a generic QOL tool used mainly in economic evaluations. Burden of Chronic Kidney Disease (CKD) is rising in Sri Lanka. Assessing the validity of generic QOL tools creates new opportunities of their utilization among patients with CKD. Methods A cross-sectional study was conducted among 1036 CKD patients, selected using the simple random sampling technique. The validity was tested with six a-priori hypotheses. These included construct validity assessments, evaluating convergent validity and performing known group comparisons. EQ-5D-3L, Short Form-36 (SF-36) were used to assess QOL. Center for Epidemiological Studies Depression Scale (CES-D-20) and General Health Questionnaire-12 (GHQ-12) were used to assess the presence of depression and psychological distress respectively. Internal consistency of the whole tool and when each item is removed was assessed by Cronbach alpha. Results The response rate was 99.2%. Majority of participants were males (n = 646,62.4%) in the age category of 4160 (n = 530; 51.2%). Most were in either stage 4 or 5 of CKD (n = 646,75.1%). The summary measures of SF-36, positively and significantly correlated with the EQ-5D-3L index and VAS scores (p<0.001). EQ-5D-3L QOL scores were significantly different between the group with depression and without as measured by CES-D-20 (p<0.001). Assessed using GHQ-12, similar significance was detected between the group with psychological distress and without (p<0.001). The Cronbach alpha was 0.834 and when each item was removed, ranged from 0.782 to 0.832. Conclusion EQ-5D-3L is a valid generic QOL tool with satisfactory internal consistency to be used among CKD patients in the pre-dialysis stage.	[Senanayake, Sameera; Graves, Nicholas; Kularatna, Sanjeewa] Queensland Univ Technol, Australian Ctr Hlth Serv Innovat, Brisbane, Qld, Australia; [Senanayake, Sameera; Mahesh, P. K. B.] Minist Hlth, Colombo, Sri Lanka; [Mahesh, P. K. B.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Gunawardena, Nalika] WHO, Colombo, Sri Lanka	Queensland University of Technology (QUT); University of Melbourne; World Health Organization	Senanayake, S (corresponding author), Queensland Univ Technol, Australian Ctr Hlth Serv Innovat, Brisbane, Qld, Australia.; Senanayake, S (corresponding author), Minist Hlth, Colombo, Sri Lanka.	samerajayan.senanayake@hdr.qut.edu.au	Mahesh, PKB/K-2205-2019; Senanayake, Sameera/K-2966-2019	Mahesh, PKB/0000-0002-9037-5142; Senanayake, Sameera/0000-0002-5606-2046; Kularatna, Sanjeewa/0000-0001-5650-154X; Graves, Nicholas/0000-0002-5559-3267	Ministry of Health, Sri Lanka [MRI/40/2015]	Ministry of Health, Sri Lanka	The study was funded by the Ministry of Health, Sri Lanka [MRI/40/2015] to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysena H, 2014, J POSTGRAD I MED; Abramson JH, 1999, SURVEY METHODS COMMU, V5th; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Cohen J., 1992, PSYCHOL B; De Silva V, 2014, CEYLON MED J; Fayers P.M., 2007, QUALITY LIFE ASSESSM, P20071; Frendl DM, 2014, MED CARE, V52, P439, DOI 10.1097/MLR.000000000000010311; Gifford FJ, 2017, KIDNEY INT REP, V2, P282, DOI 10.1016/j.ekir.2016.11.003; Gunawardena N.S., 2003, J COLL COMMUNITY PHY, V8, P18, DOI DOI 10.4038/JCCPSL.V8I1.8302; Hart A, 2001, BRIT MED J, V323, P391, DOI 10.1136/bmj.323.7309.391; Kim H, 2016, STEM CELLS INT, V2016, P1, DOI DOI 10.1155/2016/1927534; Kimberlin CL, 2008, AM J HEALTH-SYST PH, V65, P2276, DOI 10.2146/ajhp070364; Kotecha D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165790; Kularatna S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108434; Lin XJ, 2013, TZU CHI MED J, V25, P8, DOI 10.1016/j.tcmj.2012.09.002; Mahesh PKB, 2018, NEUROL SCI, V39, P287, DOI 10.1007/s10072-017-3172-6; Mahesh PKB, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0687-y; Mahesh PKB, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0730-9; Mallawarachchi DSV, 2007, QUALITY LIFE STROKE; Muller AE, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0163-x; Navaratne KV, 2010, HNP DISCUSS PAP, V1, P1; Neuen BL, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000380; Paiva CE, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-8; Rajapakse S, 2016, INT J OCCUP ENV HEAL, V22, P259, DOI 10.1080/10773525.2016.1203097; Reenen MV, 2015, EQ 5D 3L USER GUIDE; Richardson J, 2014, PATIENT, V7, P85, DOI 10.1007/s40271-013-0036-x; Senanayake S, 2018, J PSYCHOSOM RES, V112, P25, DOI 10.1016/j.jpsychores.2018.06.009; Senanayake S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0638-y; Sink CA, 2006, PROFESSIONAL SCH COU, P401, DOI DOI 10.5330/PRSC.9.4.283746K664204023; Swank JM, 2017, MEAS EVAL COUNS DEV, V50, P270, DOI 10.1080/07481756.2017.1339562; Thompson David R, 2003, Health Qual Life Outcomes, V1, P42, DOI 10.1186/1477-7525-1-42; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware JE, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0483-x; Watson JC, 2015, COUNSELING ASSESSMEN; Wells GA, 2011, J RHEUMATOL, V38, P2, DOI 10.3899/jrheum.110906; Wijetunge S, 2015, Indian J Nephrol, V25, P274, DOI 10.4103/0971-4065.145095	36	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0211604	10.1371/journal.pone.0211604	http://dx.doi.org/10.1371/journal.pone.0211604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242189	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600002
J	Damena, D; Tolosa, S; Hailemariam, M; Zewude, A; Worku, A; Mekonnen, B; Mohammed, T; Admasu, A; Chimusa, ER; Mihret, A; Abebe, T; Ameni, G				Damena, Delesa; Tolosa, Samuel; Hailemariam, Milkessa; Zewude, Aboma; Worku, Adane; Mekonnen, Biruk; Mohammed, Temesgen; Admasu, Addisu; Chimusa, Emile R.; Mihret, Adane; Abebe, Tamrat; Ameni, Gobena			Genetic diversity and drug susceptibility profiles of Mycobacterium tuberculosis obtained from Saint Peter's TB specialized Hospital, Ethiopia	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS; EXOGENOUS REINFECTION; IDENTIFICATION; GENOTYPE; COMPLEX; REGION	Background Tuberculosis (TB) is one of the major public health problems in Ethiopia. Data on genetic diversity and resistance profile of circulating TB strains is critical for informing the national TB control program. Methods A cross-sectional study was conducted on 213 smear positive pulmonary TB patients between 2015 and 2016. Sputum samples were cultured on LJ media following the Petroff's method. Region of difference-9 (RD9)-deletion typing and spoligo-typing were performed for molecular analysis of M. tuberculosis at species and strain levels, respectively. Drug sensitivity and mutation patterns of the isolates were assessed by the conventional indirect proportion method and molecular line probe assays (LPAs), respectively. Data were analyzed using statistical package for social sciences (SPSS) software version 20. Results Spoligo-typing of 150 M. tuberculosis isolates led to 57 different patterns of which 25 were new strains. The majority (71.6%) of the isolates were grouped in to 17 clusters consisting 2 to 24 isolates. The majority of the strains belonged to Euro-American lineage and the predominant spoligotypes were SIT 37 and SIT 149. MDR-TB was detected in 5.2% and 20.3% of new and retreatment cases, respectively. Two MDR-TB isolates exhibited additional resistance to one of the second line anti-TB drugs. Common gene mutations including S531L, S315T1 and M306V were detected in RIF, INH and EMB resistant strains, respectively. Conclusions The identification of several new strains, higher proportion of MDR-TB and higher clustering rate in this study, warrants the need for re-enforcement of the national TB control program. The detection of common gene mutations in the majority drug resistant strains might suggest the feasibility of LPAs for rapid screening of drug resistant M. tuberculosis strains in Ethiopia.	[Damena, Delesa; Mekonnen, Biruk; Mihret, Adane; Abebe, Tamrat] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Microbiol & Parasitol, Addis Ababa, Ethiopia; [Damena, Delesa; Tolosa, Samuel; Hailemariam, Milkessa; Zewude, Aboma; Worku, Adane; Mohammed, Temesgen; Ameni, Gobena] Aklilu Lemma Inst Pathobiol, Coll Hlth Sci, Addis Ababa, Ethiopia; [Damena, Delesa; Chimusa, Emile R.] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Pathol, Div Human Genet, Cape Town, South Africa; [Admasu, Addisu] St Peters TB Specialized Hosp, Addis Ababa, Ethiopia; [Mihret, Adane] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	Addis Ababa University; University of Cape Town	Damena, D (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Microbiol & Parasitol, Addis Ababa, Ethiopia.; Damena, D (corresponding author), Aklilu Lemma Inst Pathobiol, Coll Hlth Sci, Addis Ababa, Ethiopia.; Damena, D (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Dept Pathol, Div Human Genet, Cape Town, South Africa.	damenadelesa@gmail.com	zewude, Aboma/AAE-3970-2021; Damena, Delesa/AAG-3107-2019; Ameni, Gobena/AAR-4201-2020; Emile Rugamika, Chimusa/T-3048-2017	zewude, Aboma/0000-0001-6087-0129; Ameni, Gobena/0000-0003-3987-0671; Emile Rugamika, Chimusa/0000-0001-8846-2047; Mohammed, Temesgen/0000-0001-8727-8707; Mihret, Adane/0000-0003-3183-4772	DELTAS Africa Initiative; Addis Ababa University; St. Peter's TB specialized Hospital; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER	DELTAS Africa Initiative; Addis Ababa University; St. Peter's TB specialized Hospital; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	We would like to thank the DELTAS Africa Initiative, Addis Ababa University and St. Peter's TB specialized Hospital for their financial and technical supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agonafir M, 2010, INT J TUBERC LUNG D, V14, P1259; Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; [Anonymous], 2013, EXPL PAT PART RED HL; Barnard M., 2012, MOL DETECTION DRUG R; Bekele Y, 2012, TUBERC RES TREAT, V2012, DOI [10.1155/2012/892079, DOI 10.1155/2012/892079]; Belay M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238532; Bhanu NV, 2002, TUBERCULOSIS, V82, P105, DOI 10.1054/tube.2002.0332; Biadglegne F, 2013, INT J MED SCI, V10, P1589, DOI 10.7150/ijms.6806; Bruchfeld J, 2002, SCAND J INFECT DIS, V34, P331, DOI 10.1080/00365540110080025; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cuevas-Cordoba B, 2015, ANTIMICROB AGENTS CH, V59, P5455, DOI 10.1128/AAC.00117-15; Diriba B, 2013, INT J TUBERC LUNG D, V17, P246, DOI 10.5588/ijtld.12.0195; Eldin GSS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-219; Eyob G, 2004, INT J TUBERC LUNG D, V8, P1388; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Garedew L, 2013, INT J TUBERC LUNG D, V17, P1076, DOI 10.5588/ijtld.12.0854; Githui WA, 2004, INT J TUBERC LUNG D, V8, P352; Hirpa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-782; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Mihret A, 2012, AFR HEALTH SCI, V12, P339, DOI 10.4314/ahs.v12i3.15; Ministry of Health of Ethiopia, 2013, TUB LEPR TB HIV PREV; Ogaro TD, 2012, AFR J HLTH SCI, V20, P82; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Omer ZB, 2016, INT J MYCOBACT, V5, P475, DOI 10.1016/j.ijmyco.2016.06.005; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Tessema B, 2012, INT J TUBERC LUNG D, V16, P805, DOI 10.5588/ijtld.11.0522; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; van Klingeren B, 2007, J CLIN MICROBIOL, V45, P2662, DOI 10.1128/JCM.00244-07; Wedajo W, 2014, BMC RES NOTES, V7, P1, DOI [10.1186/1756-0500-7-1, DOI 10.1186/1756-0500-7-1]; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2013, GUID SURV DRUG RES T; Yadav R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060785; Yimer SA, 2012, APMIS, V120, P503, DOI 10.1111/j.1600-0463.2011.02861.x	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218545	10.1371/journal.pone.0218545	http://dx.doi.org/10.1371/journal.pone.0218545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233535	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700023
J	Kehrberger, S; Holzschuh, A				Kehrberger, Sandra; Holzschuh, Andrea			Warmer temperatures advance flowering in a spring plant more strongly than emergence of two solitary spring bee species	PLOS ONE			English	Article							OSMIA-CORNUTA HYMENOPTERA; POLLINATOR INTERACTIONS; PHENOLOGICAL SYNCHRONY; SEED PRODUCTION; CLIMATE-CHANGE; MASON BEE; FEMALES; COMPETITION; DISRUPTION; EVOLUTION	Climate warming has the potential to disrupt plant-pollinator interactions or to increase competition of co-flowering plants for pollinators, due to species-specific phenological responses to temperature. However, studies focusing on the effect of temperature on solitary bee emergence and the flowering onset of their food plants under natural conditions are still rare. We studied the effect of temperature on the phenology of the two spring bees Osmia cornuta and Osmia bicornis, by placing bee cocoons on eleven grasslands differing in mean site temperature. On seven grasslands, we additionally studied the effect of temperature on the phenology of the red-list plant Pulsatilla vulgaris, which was the first flowering plant, and of co-flowering plants with later flowering. With a warming of 0.1 degrees C, the abundance-weighted mean emergence of O. cornuta males advanced by 0.4 days. Females of both species did not shift their emergence. Warmer temperatures advanced the abundance-weighted mean flowering of P. vulgaris by 1.3 days per 0.1 degrees C increase, but did not shift flowering onset of co-flowering plants. Competition for pollinators between P. vulgaris and co-flowering plants does not increase within the studied temperature range. We demonstrate that temperature advances plant flowering more strongly than bee emergence suggesting an increased risk of pollinator limitation for the first flowers of P. vulgaris.	[Kehrberger, Sandra; Holzschuh, Andrea] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, Wurzburg, Germany	University of Wurzburg	Kehrberger, S (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, Wurzburg, Germany.	sandra.kehrberger@uni-wuerzburg.de		Holzschuh, Andrea/0000-0002-5235-4746; Kehrberger, Sandra/0000-0001-5345-1866	German Research Foundation (DFG) [SFB 1047]; University of Wuerzburg; German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; German Research Foundation (DFG)(German Research Foundation (DFG))	Funding was provided to AH by the German Research Foundation (DFG), collaborative research centre SFB 1047 'Insect timing'. Additional funding for Open Access Publishing was provided by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JJ, 2014, J ASIA-PAC ENTOMOL, V17, P901, DOI 10.1016/j.aspen.2014.10.002; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arroyo MTK, 2013, NEW PHYTOL, V200, P1260, DOI 10.1111/nph.12443; Bartomeus I, 2013, ECOL LETT, V16, P1331, DOI 10.1111/ele.12170; Bartomeus I, 2011, P NATL ACAD SCI USA, V108, P20645, DOI 10.1073/pnas.1115559108; Bell JM, 2005, ECOLOGY, V86, P762, DOI 10.1890/04-0694; Benadi G, 2014, J ANIM ECOL, V83, P639, DOI 10.1111/1365-2656.12158; Bosch J, 2004, APIDOLOGIE, V35, P469, DOI 10.1051/apido:2004035; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; CaraDonna PJ, 2014, P NATL ACAD SCI USA, V111, P4916, DOI 10.1073/pnas.1323073111; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; FAGERSTROM T, 1982, OECOLOGIA, V52, P164, DOI 10.1007/BF00363830; Forrest JRK, 2011, ECOL MONOGR, V81, P469, DOI 10.1890/10-1885.1; Frund J, 2013, OECOLOGIA, V173, P1639, DOI 10.1007/s00442-013-2729-1; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gordo O, 2005, OECOLOGIA, V146, P484, DOI 10.1007/s00442-005-0240-z; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Kemp WP, 2001, ANN ENTOMOL SOC AM, V94, P244, DOI 10.1603/0013-8746(2001)094[0244:PTADIT]2.0.CO;2; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Kratochwil A., 1988, FLORA, V18, P261, DOI DOI 10.1016/S0367-2530(17)30370-5; Kudo G, 2004, ECOL RES, V19, P255, DOI 10.1111/j.1440-1703.2003.00630.x; Kudo G, 2013, ECOLOGY, V94, P2311, DOI 10.1890/12-2003.1; LUDWIG G., 1996, ROTE LISTE PFLANZEN; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; MOSQUIN T, 1971, OIKOS, V22, P398, DOI 10.2307/3543864; Ne'eman G, 2006, J INSECT BEHAV, V19, P383, DOI 10.1007/s10905-006-9030-7; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Olliff-Yang RL, 2018, AOB PLANTS, V10, DOI 10.1093/aobpla/ply040; Ovaskainen O, 2013, P NATL ACAD SCI USA, V110, P13434, DOI 10.1073/pnas.1305533110; Pauw A, 2013, TRENDS ECOL EVOL, V28, P30, DOI 10.1016/j.tree.2012.07.019; Pyke GH, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1267; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Robbirt KM, 2014, CURR BIOL, V24, P2845, DOI 10.1016/j.cub.2014.10.033; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Schenk M, 2018, J ANIM ECOL, V87, P139, DOI 10.1111/1365-2656.12694; Scheuerer M., 2003, BAYER LANDESAMT UMWE, V165, P1; Sedivy C, 2011, FUNCT ECOL, V25, P718, DOI 10.1111/j.1365-2435.2010.01828.x; Seidemann K, 1999, J INSECT BEHAV, V12, P13, DOI 10.1023/A:1020920929613; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Theobald EJ, 2017, ECOLOGY, V98, P2799, DOI [10.1002/ecy.1996, 10.1002/]; van Asch M, 2007, ANNU REV ENTOMOL, V52, P37, DOI 10.1146/annurev.ento.52.110405.091418; Vicens N, 2000, ENVIRON ENTOMOL, V29, P69, DOI 10.1603/0046-225X-29.1.69; WELLS TCE, 1971, J ECOL, V59, P275, DOI 10.2307/2258467; Westrich P, 1989, WILDBIENEN BADEN WUR; White J, 2009, J ECON ENTOMOL, V102, P2026, DOI 10.1603/029.102.0602	50	26	26	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218824	10.1371/journal.pone.0218824	http://dx.doi.org/10.1371/journal.pone.0218824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233540	gold, Green Published, Green Submitted			2022-12-26	WOS:000484896700045
J	Khazneh, E; Qaddumi, J; Hamdan, Z; Qudaimat, F; Sbitany, A; Jebrin, K; Sawalmeh, O; Abuiram, Y; Shraim, M				Khazneh, Emad; Qaddumi, Jamal; Hamdan, Zakaria; Qudaimat, Falasteen; Sbitany, Asmaa; Jebrin, Kamel; Sawalmeh, Osama; Abuiram, Yousef; Shraim, Mujahed			The effects of Ramadan fasting on clinical and biochemical markers among hemodialysis patients: A prospective cohort study	PLOS ONE			English	Article							ISLAMIC MONTH; PARAMETERS; GLUCOSE; WEIGHT	Background Ramadan fasting is compulsory for all healthy adult Muslims. Although sick people are exempted from Ramadan fasting, some patients such as hemodialysis patients prefer to fast during Ramadan. The effect of Ramadan fasting on clinical outcomes and biochemical markers among hemodialysis patients is not clear. The aim of this study was to examine the effects of daily Ramadan fasting and partial Ramadan fasting on key biochemical and clinical markers among hemodialysis patients as compared to hemodialysis patients who chose not to fast during Ramadan. Methods A prospective cohort study of 269 end stage renal disease patients were recruited from the hemodialysis unit in An-Najah National University Hospital, Nablus, Palestine. The participants were divided into three cohorts based on their plans for fasting during Ramadan in May 2018; Ramadan fasting group (RFG), Ramadan partial fasting group (RPFG) and Ramadan not-fasting group (RNFG). Key clinical and biochemical markers were measured before, during and after Ramadan. Results After adjustment for diabetic and hypertension status and other sociodemographic variables, RFG had higher mean inter-dialytic weight gain (IDWG) by 0.62 kg than RNFG (95% confidence interval (CI) 0.26, 0.99). RPFG also had slight increase in mean IDWG than RNFG by 0.35 kg (95% CI 0.11, 0.60). Additionally, RFG and RPFG had significant increase in mean serum potassium as compared to RNFG. Diabetes was independently associated with increased IDWG by 0.48 kg (0.25, 0.72). Diabetes and hypertension were associated with some independent changes in biochemical markers, but these were clinically negligible. Conclusion Our findings suggest that Ramadan fasting (fully or partially) is tolerable by hemodialysis patients and is not associated with important clinical complications. However, these patients should be made aware of the potential risk of fluid overload and hyperkalemia, if they decide to fast during Ramadan. Thus, they should be closely monitored and instructed to adhere to their dietary and fluid intake allowances. Further prospective cohort studies with comprehensive dietary measures and information on adverse clinical outcomes may provide more evidence about the tolerability and safety of Ramadan fasting by hemodialysis patients.	[Khazneh, Emad; Hamdan, Zakaria; Jebrin, Kamel; Abuiram, Yousef] An Najah Natl Univ, An Najah Natl Univ Hosp, Dept Nephrol, Nablus, Palestine; [Qaddumi, Jamal] An Najah Natl Univ, Fac Med & Hlth Sci, Dept Publ Hlth, Nablus, Palestine; [Qudaimat, Falasteen; Sbitany, Asmaa] An Najah Natl Univ, Fac Med & Hlth Sci, Dept Med, Nablus, Palestine; [Sawalmeh, Osama] An Najah Natl Univ, An Najah Natl Univ Hosp, Dept Internal Med, Nablus, Palestine; [Shraim, Mujahed] Qatar Univ, Dept Publ Hlth, Coll Hlth Sci, Doha, Qatar	An Najah National University; An Najah National University; An Najah National University; An Najah National University; Qatar University	Shraim, M (corresponding author), Qatar Univ, Dept Publ Hlth, Coll Hlth Sci, Doha, Qatar.	mshraim@qu.edu.qa	Shraim, Mujahed/AAD-4647-2020; Qaddumi, Jamal A.S./AAF-9553-2020	Shraim, Mujahed/0000-0001-7972-8210; Sawalmeh, Osama/0000-0002-5733-2589; KHAZNEH, Emad/0000-0001-6803-1848	Qatar National Library	Qatar National Library(Qatar National Research Fund (QNRF))	The publication of this article was funded by the Qatar National Library. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AH, 1998, AM J NEPHROL, V18, P101, DOI 10.1159/000013316; Adnan WAHWM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114262; Al Suwaidi J, 2005, SAUDI MED J, V26, P1579; Al Wakeel JS, 2014, IRAN J KIDNEY DIS, V8, P321; Alkandari JR, 2012, J SPORT SCI, V30, pS9, DOI 10.1080/02640414.2012.698298; ALKHADER AA, 1991, SAUDI MED J, V12, P30; Alshamsi S, 2016, HEMODIAL INT, V20, P270, DOI 10.1111/hdi.12369; Azizi F, 2002, ANN SAUDI MED, V22, P186, DOI 10.5144/0256-4947.2002.186; Azizi F, 2010, ANN NUTR METAB, V56, P273, DOI 10.1159/000295848; CHEAH SH, 1990, BRIT J NUTR, V63, P329, DOI 10.1079/BJN19900119; DUMBAULD SL, 1983, KIDNEY INT, V24, P222, DOI 10.1038/ki.1983.147; Einollahi B, 2017, IRAN J KIDNEY DIS, V11, P168; GIFFORD JD, 1989, KIDNEY INT, V35, P90, DOI 10.1038/ki.1989.12; Imtiaz S, 2015, JCPSP-J COLL PHYSICI, V25, P189, DOI 03.2015/JCPSP.189192; Imtiaz S, 2016, IRAN J KIDNEY DIS, V10, P75; KORDY MT, 1991, ANN SAUDI MED, V11, P23, DOI 10.5144/0256-4947.1991.23; Kul S, 2014, J RELIG HEALTH, V53, P929, DOI 10.1007/s10943-013-9687-0; LAAJAM MA, 1990, E AFR MED J, V67, P732; Matter YE, 2018, J EGYPTIAN SOC NEPHR, V18, P1; Megahed AF, 2019, SAUDI J KIDNEY DIS T, V30, P339, DOI 10.4103/1319-2442.256841; Miladipour AH, 2012, IRAN J KIDNEY DIS, V6, P33; NOMANI MZ, 1989, AM J CLIN NUTR, V49, P1141, DOI 10.1093/ajcn/49.6.1141; Palestinian Health Information Center, 2017, HLTH ANN REP PAL 201; PRENTICE AM, 1983, HUM NUTR-CLIN NUTR, V37, P283; RASHED AH, 1992, BRIT MED J, V304, P521, DOI 10.1136/bmj.304.6826.521; Sliman NA, 1998, NUTR REP INT, V38, P1299; Sung JM, 2006, NEPHROL DIAL TRANSPL, V21, P2521, DOI 10.1093/ndt/gfl236; Trepanowski JF, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-57	28	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218745	10.1371/journal.pone.0218745	http://dx.doi.org/10.1371/journal.pone.0218745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233556	Green Published, Green Submitted, gold			2022-12-26	WOS:000484896700036
J	Spaunhorst, DJ; Todd, JR; Hale, AL				Spaunhorst, Douglas J.; Todd, James R.; Hale, Anna L.			Sugarcane cultivar response to glyphosate and trinexapac-ethyl ripeners in Louisiana	PLOS ONE			English	Article							REGISTRATION	Sugarcane ripening in Louisiana is necessary to ensure adequate sucrose levels in early-season harvested sugarcane. The response of nine sugarcane cultivar's yield components to glyphosate and trinexapac-ethyl ripeners was determined in field trials. Glyphosate (210 g ae ha(-1)) and trinexapac-ethyl (200 g ai ha(-1)) treatments failed to increase sucrose yields more than non-ripened sugarcane. Sugarcane ripened with glyphosate or trinexapac-ethyl increased theoretical recoverable sucrose (TRS) 4 to 12% more than non-ripened sugarcane in seven out of nine cultivars, but greater TRS values were counterpoised by lower sugarcane stalk weight. An unintentional consequence of reduced late-season vegetative growth may benefit growers by allowing them to harvest more sugarcane hectares to meet their daily load quota and exposes fewer hectares to a freeze event. The cultivars HoCP 00-950, Ho 09-804, and HoCP 09-840 were not responsive to glyphosate or trinexapac-ethyl ripeners and should not be treated. A delayed harvest from 28 to 49 days after treatment (DAT) coincided with greater TRS values and 17% more sucrose yield.	[Spaunhorst, Douglas J.; Todd, James R.; Hale, Anna L.] ARS, USDA, Sugarcane Res Unit, Houma, LA 70360 USA	United States Department of Agriculture (USDA)	Spaunhorst, DJ (corresponding author), ARS, USDA, Sugarcane Res Unit, Houma, LA 70360 USA.	Douglas.Spaunhorst@usda.gov			American Sugar Cane League, Inc., of the USA; USDA-ARS Sugarcane Research Unit	American Sugar Cane League, Inc., of the USA; USDA-ARS Sugarcane Research Unit	This research was partially funded through the American Sugar Cane League, Inc., of the USA and the USDA-ARS Sugarcane Research Unit. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alexander A.G., 1973, SUGARCANE PHYSL; Bischoff KP, 2009, J PLANT REGIST, V3, P241, DOI 10.3198/jpr2009.04.0210crc; Carbonari CA, 2014, AJPS, V5, P3585, DOI DOI 10.4236/AJPS.2014.524374; Chen J.C., 1993, CANE SUGAR HDB MANUA; Clements HF, HAWAII PLANT REC, V44, P201; Dalley CD, 2010, WEED SCI, V58, P329, DOI 10.1614/WS-D-09-00001.1; de Almeida Silva M., 2012, CROP MANAGEMENT CASE, V1; Donaldson R. A., 1982, Proceedings of the 56th Annual Congress of the South African Sugar Technologists' Association, P122; DUSKY JA, 1986, J PLANT GROWTH REGUL, V4, P225, DOI 10.1007/BF02266960; Eggleston G, 2004, FOOD CHEM, V87, P119, DOI 10.1016/j.foodchem.2003.11.004; Gravois KA, 2011, J PLANT REGIST, V5, P191, DOI 10.3198/jpr2010.04.0194crc; Gravois KA, 2010, J PLANT REGIST, V4, P183, DOI 10.3198/jpr2009.10.0638crc; GRAVOIS KA, 1992, CROP SCI, V32, P62, DOI 10.2135/cropsci1992.0011183X003200010014x; Hasan MF, 2003, PAK J BIOL SCI, V6, P1151; LEGENDRE BL, 1975, CROP SCI, V15, P349, DOI 10.2135/cropsci1975.0011183X001500030020x; Millhollon R. W., 1996, Journal - American Society of Sugar Cane Technologists, V16, P7; Morgan T, 2007, AUST J AGR RES, V58, P233, DOI 10.1071/AR06018; Nascentes RF, 2018, PEST MANAG SCI, V74, P1197, DOI 10.1002/ps.4606; Orgeron A. J., 2017, Journal - American Society of Sugar Cane Technologists, V37, P13; Orgeron A. J., 2016, Journal - American Society of Sugar Cane Technologists, V36, P1; Orgeron AJ, 2017, SUGARCANE RIPENER RE, P1; RICHARD EP, 1991, WEED SCI, V39, P73, DOI 10.1017/S0043174500057908; Richard EP Jr, 2009, J AM SOC SUGAR CANE, V29, P81; Richardson WB, 2017, LOW COST EDGE COMPUT, P1; Solomon S., 2000, Sugar Tech, V2, P1, DOI 10.1007/BF02945738; Tew TL, 2009, J PLANT REGIST, V3, P42, DOI 10.3198/jpr2008.07.0430crc; Tew TL, 2005, CROP SCI, V45, P785, DOI 10.2135/cropsci2005.0785a; Todd JR, 2018, J PLANT REGIST, V12, P324, DOI 10.3198/jpr2017.10.0069crc; Todd JR, 2018, J PLANT REGIST; van Heerden PDR, 2015, FIELD CROP RES, V181, P69, DOI 10.1016/j.fcr.2015.06.013; Viator RP, 2011, INT SUGAR J, V113, P66; Viator RP, 2008, AGRON J, V100, P1769, DOI 10.2134/agronj2008.0147	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218656	10.1371/journal.pone.0218656	http://dx.doi.org/10.1371/journal.pone.0218656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220169	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500078
J	Shehadeh, A; Bruck-Haimson, R; Saidemberg, D; Zacharia, A; Herzberg, S; Ben-Meir, A; Moussaieff, A				Shehadeh, Alaa; Bruck-Haimson, Reut; Saidemberg, Daniel; Zacharia, Anish; Herzberg, Shmuel; Ben-Meir, Assaf; Moussaieff, Arieh			A shift in follicular fluid from triacylglycerols to membrane lipids is associated with positive pregnancy outcome	FASEB JOURNAL			English	Article						In vitro fertilization (IVF); lipidomics; phospholipids; sphingolipids; vitamin D	VITAMIN-D LEVELS; CELL-FUNCTION; OOCYTE; EXTRACTION; WOMEN; PHOSPHOLIPIDS; BIOMARKERS; RESISTANCE; STEROLS; LESSONS	Follicular fluid (FF) is a liquid that surrounds the ovum. Its metabolite and, specifically, its lipid content have been associated with oocyte development. To characterize possible association between the lipid composition of FF and the outcome of pregnancy, we carried out a lipidomics study and compared the abundance of lipids from FF of patients with positive and negative outcomes. We found a differential lipid network wiring in positive-outcome FF, with a significant decrease (similar to 2 fold; P < 0.001) in triacylglycerol levels and higher accumulation (10-50%; P < 0.001) of membrane lipids groups (phospholipids and sphingolipids). In addition to this major metabolic alteration, other lipid groups such as cholesteryl esters showed lower levels in positive-outcome patients, whereas derivatives of vitamin D were highly accumulated in positive-outcome FF, supporting previous studies that associate vitamin D levels in FF to pregnancy outcome. Our data also point to specific lipid species with a differential accumulation pattern in positive-outcome FF that predicted pregnancy in a receiver operating characteristic analysis. Altogether, our results suggest that FF lipid network is associated with the oocyte development, with possible implications in diagnostics and treatment.-Shehadeh, A., Bruck-Haimson, R., Saidemberg, D., Zacharia. A., Herzberg, S., Ben-Meir, A., Moussaieff, A. A shift in follicular fluid from triacylglycerols to membrane lipids is associated with positive pregnancy outcome.	[Shehadeh, Alaa; Bruck-Haimson, Reut; Saidemberg, Daniel; Zacharia, Anish; Moussaieff, Arieh] Hebrew Univ Jerusalem, Inst Drug Res, Jerusalem, Israel; [Herzberg, Shmuel; Ben-Meir, Assaf] Hebrew Univ Jerusalem, Hadassah Med Ctr, IVF Unit, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Moussaieff, A (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Hadassah Kerem, IL-91120 Jerusalem, Israel.	ariehm@ekmd.huji.ac.il		Moussaieff, Arieh/0000-0003-1289-4737				Anifandis GM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-91; Antunes RA, 2018, REPROD BIOMED ONLINE, V36, P277, DOI 10.1016/j.rbmo.2017.12.010; Baltsen M, 1999, BIOMED CHROMATOGR, V13, P382, DOI 10.1002/(SICI)1099-0801(199910)13:6<382::AID-BMC896>3.0.CO;2-D; Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1; BILLIAR TR, 1988, SURGERY, V104, P343; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927; BYSKOV AG, 1995, NATURE, V374, P559, DOI 10.1038/374559a0; Cataldi T, 2013, HUM FERTIL, V16, P269, DOI 10.3109/14647273.2013.852255; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Ciepiela P, 2018, J ASSIST REPROD GEN, V35, P1265, DOI 10.1007/s10815-018-1179-4; Fayezi S, 2014, J OBSTET GYNAECOL, V34, P259, DOI 10.3109/01443615.2013.851657; Gonzalez MB, 2018, J REPROD IMMUNOL, V130, P25, DOI 10.1016/j.jri.2018.08.005; Gu L, 2015, CELL MOL LIFE SCI, V72, P251, DOI 10.1007/s00018-014-1739-4; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Irani M, 2014, FERTIL STERIL, V102, P460, DOI 10.1016/j.fertnstert.2014.04.046; Jungheim ES, 2010, AM J OBSTET GYNECOL, V203, P525, DOI 10.1016/j.ajog.2010.06.043; Karavani G, 2017, FERTIL STERIL, V107, P1159, DOI 10.1016/j.fertnstert.2017.01.023; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Liu LY, 2019, J STEROID BIOCHEM, V185, P142, DOI 10.1016/j.jsbmb.2018.08.008; Los DA, 2013, PHOTOSYNTH RES, V116, P489, DOI 10.1007/s11120-013-9823-4; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; Nandi S, 2007, DEV GROWTH DIFFER, V49, P61, DOI [10.1111/j.1440-169x.2007.00901.x, 10.1111/j.1440-169X.2007.00901.x]; O'Gorman A, 2013, REPRODUCTION, V146, P389, DOI 10.1530/REP-13-0184; Ozkan S, 2010, FERTIL STERIL, V94, P1314, DOI 10.1016/j.fertnstert.2009.05.019; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Reis A, 2013, J LIPID RES, V54, P1812, DOI 10.1194/jlr.M034330; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0; Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8; Rudick B, 2012, HUM REPROD, V27, P3321, DOI 10.1093/humrep/des280; Rudick BJ, 2014, FERTIL STERIL, V101, P447, DOI 10.1016/j.fertnstert.2013.10.008; RYAN DP, 1992, J ANIM SCI, V70, P3505, DOI 10.2527/1992.70113505x; Schneider H, 2010, INT J MOL SCI, V11, P4149, DOI 10.3390/ijms11104149; Valckx SDM, 2012, HUM REPROD, V27, P3531, DOI 10.1093/humrep/des350; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van Montfoort APA, 2014, J REPROD IMMUNOL, V104, P32, DOI 10.1016/j.jri.2014.04.003; Wallace M, 2012, FERTIL STERIL, V97, P1078, DOI 10.1016/j.fertnstert.2012.01.122; Wu LLY, 2012, REPROD FERT DEVELOP, V24, P29, DOI 10.1071/RD11904; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; Yang X, 2012, FERTIL STERIL, V97, P1438, DOI 10.1016/j.fertnstert.2012.02.034	41	3	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10291	10299		10.1096/fj.201900318RR	http://dx.doi.org/10.1096/fj.201900318RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31219705				2022-12-26	WOS:000482214200046
J	Sheng, L; Chen, MM; Cai, KS; Song, Y; Yu, DS; Zhang, H; Xu, GX				Sheng, Liang; Chen, Mingming; Cai, Keshu; Song, Yu; Yu, Dongsheng; Zhang, Hui; Xu, Guangxu			Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice	FASEB JOURNAL			English	Article						Alzheimer's disease; microglia; synaptic plasticity; cognitive impairment	MYELOID CELLS 2; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; MOUSE MODEL; DEFICIENCY; RECEPTOR; VARIANTS; INFLAMMATION; PROGRESSION; CLEARANCE	Triggering receptor expressed in myeloid cells (TREM)2 is a genetic high-risk factor for sporadic Alzheimer's disease (AD) and is considered a potential target for AD diagnosis and therapy, although its role in the different stages of AD remains controversial. We generated an embryonic deletion of Trem2 (whole body deletion) and induced hippocampal- and cortical-specific knockdown of microglial Trem2 at different stages of the AD process in amyloid precursor protein/Psen1 mice by adeno-associated virus (AAV) infection. AAV infection induced microglial Trem2 overexpression in the hippocampus of wild-type (WT) and thymus cell antigen 1-enhanced green fluorescent protein mice. Mice were subjected to ethological and pathologic tests. Whole body genetic deletion of Trem2 exerted different electrophysiological outcomes between different AD pathologic stages, which results from a complex integration of synaptic loss and amyloid aggregation. Interestingly, knockdown of Trem2 at the early-middle stage of AD (2-6 mo) prevents synaptic loss through directly inhibiting microglial phagocytosis, whereas knockdown of Trem2 at the middle-late stage of AD (6-10 mo) accelerates synaptic dysfunction because of more severe amyloid deposition caused by the depression of microglial phagocytosis. Additionally, hippocampal overexpression of Trem2 in WT mice results in significant synaptic impairment. Here, with transgenic technology and electrophysiological assay, we revealed that TREM2 up-regulation promotes microglial phagocytosis equally against synapse and amyloid plaques and eventually results in different outcomes. During the early-middle pathologic stage, TREM2 enhancing microglial phagocytosis mainly causes synaptic loss. However, TREM2 up-regulating microglial phagocytosis gradually supports a positive role when amyloid deposition occupies the leading position at the middle-late pathologic stage. In this study, we highlighted that TREM2 triggers synaptic loss during AD pathology development.-Sheng, L., Chen, M., Cai, K., Song, Y., Yu, D., Zhang, H., Xu, G. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.	[Sheng, Liang; Yu, Dongsheng] Nanjing Med Univ, Sch Basic Med Sci, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Song, Yu; Zhang, Hui] Xinxiang Med Univ, Pharm Coll, Xinxiang, Henan, Peoples R China; [Chen, Mingming] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing, Jiangsu, Peoples R China; [Cai, Keshu; Xu, Guangxu] Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Xinxiang Medical University; China Pharmaceutical University; Nanjing Medical University	Xu, GX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	xuguangxu1@126.com		Chen, Mingming/0000-0002-9702-103X	National Natural Science Foundation of China [81770862]; Psychology and Neuroscience, Xinxiang Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Psychology and Neuroscience, Xinxiang Medical University	This work was supported by grants from the National Natural Science Foundation of China (81770862) and the support project for the disciplinary group of Psychology and Neuroscience, Xinxiang Medical University (to L.S.). The authors declare no conflicts of interest.	Bateman R, 2015, LANCET NEUROL, V14, P4, DOI 10.1016/S1474-4422(14)70301-1; Bellenguez C, 2017, NEUROBIOL AGING, V59, DOI 10.1016/j.neurobiolaging.2017.07.001; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Chen MK, 2018, JAMA NEUROL, V75, P1215, DOI 10.1001/jamaneurol.2018.1836; Chen MM, 2017, J NUTR BIOCHEM, V46, P57, DOI 10.1016/j.jnutbio.2017.04.006; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Gispert JD, 2016, ALZHEIMERS DEMENT, V12, P1259, DOI 10.1016/j.jalz.2016.06.005; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Guerreiro R, 2013, CELL, V155, P968, DOI 10.1016/j.cell.2013.10.037; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Henjum K, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0182-1; Irwin D, 2017, LANCET NEUROL, V16, P55, DOI 10.1016/S1474-4422(16)30291-5; Jay TR, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0197-5; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jiang T, 2014, NEUROBIOL AGING, V35, P1243, DOI 10.1016/j.neurobiolaging.2013.11.026; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kester MI, 2015, JAMA NEUROL, V72, P1275, DOI 10.1001/jamaneurol.2015.1867; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Ma L, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0137-9; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; Medina DX, 2014, NEUROBIOL AGING, V35, P79, DOI 10.1016/j.neurobiolaging.2013.07.006; Mehta D, 2017, EXPERT OPIN INV DRUG, V26, P735, DOI 10.1080/13543784.2017.1323868; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Paolicelli RC, 2017, NEURON, V95, P297, DOI 10.1016/j.neuron.2017.05.037; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Scheff SW, 2015, J ALZHEIMERS DIS, V43, P1073, DOI 10.3233/JAD-141518; Scheff SW, 2011, J ALZHEIMERS DIS, V24, P547, DOI 10.3233/JAD-2011-101782; Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Spangenberg EE, 2017, BRAIN BEHAV IMMUN, V61, P1, DOI 10.1016/j.bbi.2016.07.003; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Suarez-Calvet M, 2016, EMBO MOL MED, V8, P466, DOI 10.15252/emmm.201506123; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tan CC, 2014, J ALZHEIMERS DIS, V42, P1051, DOI 10.3233/JAD-140843; Tarawneh R, 2015, JAMA NEUROL, V72, P656, DOI 10.1001/jamaneurol.2015.0202; Upadhaya AR, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-77; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Xiang XY, 2016, EMBO MOL MED, V8, P992, DOI 10.15252/emmm.201606370; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zheng HH, 2016, NEUROBIOL AGING, V42, P132, DOI 10.1016/j.neurobiolaging.2016.03.004	54	24	26	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10425	10442		10.1096/fj.201900527R	http://dx.doi.org/10.1096/fj.201900527R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31219699				2022-12-26	WOS:000482214200056
J	Wang, YF; Zhao, WJ; Shi, JX; Wang, JC; Hao, J; Pang, XW; Huang, XJ; Chen, XP; Li, YZ; Jin, R; Ge, Q				Wang, Yifan; Zhao, Weijia; Shi, Junxiu; Wang, Jiachi; Hao, Jie; Pang, Xuewen; Huang, Xiaojun; Chen, Xiaoping; Li, Yongzhi; Jin, Rong; Ge, Qing			Intestinal microbiota contributes to altered glucose metabolism in simulated microgravity mouse model	FASEB JOURNAL			English	Article						glucose intolerance; hind limb unloading; endotoxemia	INSULIN-RESISTANCE; AKKERMANSIA-MUCINIPHILA; GUT MICROBIOME; ENDOTOXEMIA; HOMEOSTASIS; PHYSIOLOGY; MISSIONS; OBESITY; SYSTEM	Exposure to space environment induces alterations in glucose and lipid metabolism that contribute to muscular atrophy, bone loss, and cardiovascular disorders. Intestinal microbiota is also changed, but its impact on spaceflight-related metabolic disorder is not clear. We investigated the relationship between glucose metabolic changes and gut dysbiosis in a hind limb-unloading (HU) mouse model, a well-accepted ground-based spaceflight analog. Impaired body weight gain, glucose intolerance, and peripheral insulin resistance were found in 2-4-wk HU mice. Reduced abundance of gut Bifidobacterium spp. and Akkermansia muciniphila was observed within 3 d of HU. The ground-based control (Ctrl) mice that were cohoused with HU mice showed similar patterns of dysbiosis and metabolic changes. Compared with the Ctrls, higher levels of plasma LPS-binding protein and altered transcription of Tnfa and glucose metabolism-related genes in the liver were observed in HU mice. The supplementation of Bifidobacterium spp. suppressed endotoxemia and liver inflammation and improved glucose tolerance in HU mice. The results indicate a close relationship between dysbiosis and altered glucose metabolism in the HU model and also emphasize the importance of evaluating intestinal microbiota in astronauts and its effect on glucose metabolism.-Wang, Y., Zhao, W., Shi, J., Wang, J., Hao, J., Pang, X., Huang, X., Chen, X., Li, Y., Jin, R., Ge, Q. Intestinal microbiota contributes to altered glucose metabolism in simulated microgravity mouse model.	[Wang, Yifan; Zhao, Weijia; Wang, Jiachi; Hao, Jie; Pang, Xuewen; Jin, Rong; Ge, Qing] Peking Univ, NHC Key Lab Med Immunol, Sch Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Shi, Junxiu] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Cell Biol, Shenyang, Liaoning, Peoples R China; [Shi, Junxiu] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang, Liaoning, Peoples R China; [Huang, Xiaojun] Peking Univ Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China; [Huang, Xiaojun] Inst Hematol, Beijing, Peoples R China; [Chen, Xiaoping; Li, Yongzhi] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Ge, Qing] Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing, Peoples R China	Peking University; China Medical University; China Medical University; Peking University	Jin, R; Ge, Q (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Immunol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	jinrong@bjmu.edu.cn; qingge@bjmu.edu.cn	Shi, Junxiu/GXH-8588-2022; Huang, Xiao-Jun/HIK-3759-2022	Huang, Xiao-Jun/0000-0002-2145-6643	National Key Research and Development Program of China [2017YFA0104500]; National Natural Science Foundation of China [81471525, 31671244, 31872734, 31872733]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621001]; Beijing Natural Science Foundation [7172114]; Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2018PT31039]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences	The authors wish to thank Prof. Xiaoyan Qiu (Peking University) for critical comments and helpful discussions. This work was supported by grants from the National Key Research and Development Program of China (2017YFA0104500), the National Natural Science Foundation of China (81471525, 31671244, 31872734, Q.G., 31872733, R.J.), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001), Beijing Natural Science Foundation (7172114, R.J.), the Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2018PT31039). The authors declare no conflicts of interest.	Alibegovic AC, 2009, DIABETES, V58, P2749, DOI 10.2337/db09-0369; AMIDON GL, 1991, J CLIN PHARMACOL, V31, P968, DOI 10.1002/j.1552-4604.1991.tb03658.x; Anselm V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081763; Barzegari A, 2012, FUTURE MICROBIOL, V7, P571, DOI [10.2217/FMB.12.37, 10.2217/fmb.12.37]; Bederman IR, 2013, EXP PHYSIOL, V98, P278, DOI 10.1113/expphysiol.2012.067074; Bergouignan A, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.29; Bienso RS, 2012, DIABETES, V61, P1090, DOI 10.2337/db11-0884; Botta M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041197; BROWN LR, 1976, J AM DENT ASSOC, V93, P357, DOI 10.14219/jada.archive.1976.0502; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723; Chopra V, 2006, J TOXICOL ENV HEAL A, V69, P1345, DOI 10.1080/15287390500361792; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; De Abreu S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00799; De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013; Egawa T, 2015, AM J PHYSIOL-ENDOC M, V309, pE651, DOI 10.1152/ajpendo.00165.2015; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Faraj TA, 2017, INT REV IMMUNOL, V36, P125, DOI 10.1080/08830185.2017.1280483; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Globus RK, 2016, J APPL PHYSIOL, V120, P1196, DOI 10.1152/japplphysiol.00997.2015; Gubern C, 2006, DIABETES, V55, P216, DOI 10.2337/diabetes.55.1.216; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; Heer M, 2014, SCI WORLD J, DOI 10.1155/2014/803083; Hughson RL, 2016, AM J PHYSIOL-HEART C, V310, pH628, DOI 10.1152/ajpheart.00802.2015; Ilyin VK, 2005, ACTA ASTRONAUT, V56, P839, DOI 10.1016/j.actaastro.2005.01.009; Jin ML, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00729; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kikuchi K, 2018, BIOCHEM BIOPH RES CO, V501, P1041, DOI 10.1016/j.bbrc.2018.05.105; Li PP, 2015, FASEB J, V29, P3263, DOI 10.1096/fj.15-271700; LIZKO NN, 1991, ACTA ASTRONAUT, V23, P163, DOI 10.1016/0094-5765(91)90115-L; Macho L, 2003, ADV SPACE RES, V31, P1605, DOI 10.1016/S0273-1177(03)00097-8; Mardanov AV, 2013, ACTA NATURAE, V5, P116, DOI 10.32607/20758251-2013-5-3-116-125; Maurel DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158381; McKenzie C, 2017, IMMUNOL REV, V278, P277, DOI 10.1111/imr.12556; Merrill A., 1985, J APPL PHYSIOL, V73, P142; Mithieux G, 2018, GUT, V67, P1373, DOI 10.1136/gutjnl-2017-315732; Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P240, DOI 10.1038/ijo.2009.242; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Rabot S, 2000, DIGEST DIS SCI, V45, P1687, DOI 10.1023/A:1005508532629; Ritchie LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125792; Rivera CA, 2003, J APPL PHYSIOL, V95, P1656, DOI 10.1152/japplphysiol.00302.2003; Shi JX, 2017, FASEB J, V31, P3695, DOI 10.1096/fj.201700034R; Sittipo P, 2018, J MICROBIOL, V56, P154, DOI 10.1007/s12275-018-7548-y; SMIRNOV KV, 1987, NAHRUNG, V31, P563; Somova LA, 2005, ADV SPACE RES-SERIES, V35, P1621, DOI 10.1016/j.asr.2004.12.046; Stein TP, 2005, J NUTR, V135, p1824S, DOI 10.1093/jn/135.7.1824S; STEIN TP, 1994, AVIAT SPACE ENVIR MD, V65, P1091; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; VERNIKOSDANELLIS J, 1976, AVIAT SPACE ENVIR MD, V47, P583; Yang YT, 2018, MOL MED REP, V17, P2313, DOI 10.3892/mmr.2017.8109	54	17	19	6	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10140	10151		10.1096/fj.201900238RR	http://dx.doi.org/10.1096/fj.201900238RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31238017				2022-12-26	WOS:000482214200034
J	Trotta, E				Trotta, Edoardo			RNA polymerase II (RNAP II)-associated factors are recruited to tRNA loci, revealing that RNAP II- and RNAP III-mediated transcriptions overlap in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase II; RNA polymerase III; transfer RNA (tRNA); precursor tRNA (pre-tRNA); gene silencing; chromatin immunoprecipitation (ChiP); RNA-binding protein; transcriptomics; gene regulation; genome-wide transcription	NUCLEOLAR LOCALIZATION; BINDING PROTEIN; MULTIPLE ROLES; NAB2 FUNCTIONS; MOD5 PROTEIN; GENE; NUCLEAR; WIDE; SPT6; IDENTIFICATION	In yeast (Saccharomyces cerevisiae), the synthesis of tRNAs by RNA polymerase III (RNAP III) down-regulates the transcription of the nearby RNAP II-transcribed genes by a mechanism that is poorly understood. To clarify the basis of this tRNA gene-mediated (TGM) silencing, here, conducting a bioinformatics analysis of available ChIP-chip and ChIP-sequencing genomic data from yeast, we investigated whether the RNAP III transcriptional machinery can recruit protein factors required for RNAP II transcription. An analysis of 46 genome-wide protein-density profiles revealed that 12 factors normally implicated in RNAP II-mediated gene transcription are more enriched at tRNA than at mRNA loci. These 12 factors typically have RNA-binding properties, participate in the termination stage of the RNAP II transcription, and preferentially localize to the tRNA loci by a mechanism that apparently is based on the RNAP III transcription level. The factors included two kinases of RNAP II (Bur1 and Ctk1), a histone demethylase (Jhd2), and a mutated form of a nucleosome-remodeling factor (Spt6) that have never been reported to be recruited to tRNA loci. Moreover, we show that the expression levels of RNAP II-transcribed genes downstream of tRNA loci correlate with the distance from the tRNA gene by a mechanism that depends on their orientation. These results are consistent with the notion that pre-tRNAs recruit RNAP II-associated factors, thereby reducing the availability of these factors for RNAP II transcription and contributing, at least in part, to the TGM-silencing mechanism.	[Trotta, Edoardo] CNR, Inst Translat Pharmacol, Via Fosso Cavaliere 100, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Trotta, E (corresponding author), CNR, Inst Translat Pharmacol, Via Fosso Cavaliere 100, I-00133 Rome, Italy.	edoardo.trotta@ift.cnr.it	Trotta, Edoardo/AAW-4697-2020	Trotta, Edoardo/0000-0002-1417-9238				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baejen C, 2014, MOL CELL, V55, P745, DOI 10.1016/j.molcel.2014.08.005; Baranello L, 2016, CHROMOSOME RES, V24, P175, DOI 10.1007/s10577-015-9509-1; Battaglia S, 2017, ELIFE, V6, DOI 10.7554/eLife.25637; Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; Blair LP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501662; Bolton EC, 2003, GENOME RES, V13, P254, DOI 10.1101/gr.612203; Burugula BB, 2014, MOL CELL BIOL, V34, P4115, DOI 10.1128/MCB.00695-14; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; DeGennaro CM, 2013, MOL CELL BIOL, V33, P4779, DOI 10.1128/MCB.01068-13; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Gard S, 2009, J CELL BIOL, V187, P455, DOI 10.1083/jcb.200906075; Gonzalez-Aguilera C, 2011, MOL BIOL CELL, V22, P2729, DOI 10.1091/mbc.E11-01-0055; Good PD, 2013, GENE, V526, P7, DOI 10.1016/j.gene.2013.05.016; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Jamonnak N, 2011, RNA, V17, P2011, DOI 10.1261/rna.2840711; Johnson SA, 2011, NAT STRUCT MOL BIOL, V18, P1164, DOI 10.1038/nsmb.2126; Kendall A, 2000, P NATL ACAD SCI USA, V97, P13108, DOI 10.1073/pnas.240454997; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; KINSEY PT, 1991, NUCLEIC ACIDS RES, V19, P1317, DOI 10.1093/nar/19.6.1317; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003914; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Murawski Marcin, 1994, Acta Biochimica Polonica, V41, P441; Pai DA, 2014, RNA, V20, P644, DOI 10.1261/rna.040444.113; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Perales R, 2013, EMBO J, V32, P2645, DOI 10.1038/emboj.2013.194; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Pratt-Hyatt M, 2013, P NATL ACAD SCI USA, V110, pE3081, DOI 10.1073/pnas.1219946110; Read DF, 2017, FEBS LETT, V591, P1601, DOI 10.1002/1873-3468.12627; Reuter LM, 2015, GENE DEV, V29, P1565, DOI 10.1101/gad.266205.115; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sdano MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28723; Smaldino PJ, 2015, GENE, V556, P13, DOI 10.1016/j.gene.2014.09.049; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Tokuda N, 2017, BIOPHYS J, V112, P491, DOI 10.1016/j.bpj.2016.11.3201; Tolerico LH, 1999, GENETICS, V151, P57; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Waldminghaus T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-414; Wang L, 2005, J BIOL CHEM, V280, P8637, DOI 10.1074/jbc.C500017200; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Yuen KC, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007118	58	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12349	12358		10.1074/jbc.RA119.008529	http://dx.doi.org/10.1074/jbc.RA119.008529			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31235518	Green Published, hybrid			2022-12-26	WOS:000484402700008
J	Guo, Y; Zhang, XJ; Xu, QB; Gong, FX; Shi, XQ; Li, CK; Huang, R; Nie, FY; Zhu, W; Li, JJ; Tang, JB; Li, RT; Zhang, LM; Chen, LX; Ma, RLZ				Guo, Yu; Zhang, Xiaojuan; Xu, Quanbin; Gong, Fuxing; Shi, Xiaoqian; Li, Chaokun; Huang, Rui; Nie, Fangyuan; Zhu, Wen; Li, Jiujie; Tang, Junbo; Li, Runting; Zhang, Limeng; Chen, Longxin; Ma, Runlin Z.			Human Papillomavirus 16 oncoprotein E7 retards mitotic progression by blocking Mps1-MAP4 signaling cascade	ONCOGENE			English	Article							MICROTUBULES; MAP4; MPS1; NEOPLASIA; TUBULIN; EXPRESSION; STABILITY; INFECTION; CELLS	Human epithelial cells can be infected by more than 200 types of human papilloma viruses (HPVs), and persistent HPV infections lead to cervical cancer or other deadly cancers. It has been established that mitotic progression is critical for HPV16 infection, but the underlying mechanism remains unknown. Here, we report that oncoprotein E7 of HPV16 but not HPV18 retards mitotic progression in host cell by direct binding to the C terminus of Microtubule-Associated Protein 4 (MAP4). MAP4 is a novel bona fide target of HPV16E7 protein which binds and recruits the latter to spindle microtubule in mitosis. HPV16E7 protein promotes MAP4 stability by inhibiting MAP4 phosphorylation- mediated degradation to increase the stability of microtubule polymerization and cause an extend mitotic progression. We further uncovered that Mps1 is a kinase of MAP4, and E7MAP4 binding blocks Mps1 phosphorylation of MAP4, thereby interrupting phosphorylation-dependent MAP4 degradation. Mutations of MAP4 at T927ES928E partially abolished E7-binding capacity and rescued mitotic progression in host cells. In conclusion, our study reveals a molecular mechanism by which HPV16E7 perturbs host mitotic progression by interfering Mps1MAP4 signaling cascade, which results in an extended infection window and may facilitate the persistent HPV16 infection.	[Guo, Yu; Gong, Fuxing; Shi, Xiaoqian; Li, Chaokun; Huang, Rui; Nie, Fangyuan; Zhu, Wen; Li, Jiujie; Ma, Runlin Z.] Univ Chinese Acad Sci, Sch Life Sci, Beijing 100049, Peoples R China; [Guo, Yu; Zhang, Xiaojuan; Gong, Fuxing; Shi, Xiaoqian; Li, Chaokun; Huang, Rui; Nie, Fangyuan; Ma, Runlin Z.] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Xu, Quanbin] Univ Colorado, Dept Biochem, Boulder, CO 80309 USA; [Tang, Junbo] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Li, Runting; Zhang, Limeng; Chen, Longxin; Ma, Runlin Z.] Zhengzhou Normal Univ, Zhengzhou City Key Lab Mol Biol, Zhengzhou 450044, Henan, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Colorado System; University of Colorado Boulder; China Agricultural University; Zhengzhou Normal University	Ma, RLZ (corresponding author), Univ Chinese Acad Sci, Sch Life Sci, Beijing 100049, Peoples R China.; Ma, RLZ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Ma, RLZ (corresponding author), Zhengzhou Normal Univ, Zhengzhou City Key Lab Mol Biol, Zhengzhou 450044, Henan, Peoples R China.	rlma@genetics.ac.cn	gong, fuxing/GXF-5949-2022; Chen, Longxin/HGD-3900-2022	Xu, Quanbin/0000-0002-2833-9773; Li, Chaokun/0000-0001-9037-488X	National Basic Research Program of China [2014CB138505]; National Natural Science Foundation of China [81871130]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from National Basic Research Program of China (2014CB138505) and National Natural Science Foundation of China (81871130).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Bosch FX, 2002, VIRUS RES, V89, P183, DOI 10.1016/S0168-1702(02)00187-9; Burger MPM, 1997, INT J GYNECOL PATHOL, V16, P10, DOI 10.1097/00004347-199701000-00002; DiGiuseppe S, 2016, P NATL ACAD SCI USA, V113, P6289, DOI 10.1073/pnas.1600638113; Dou Z, 2003, CELL RES, V13, P443, DOI 10.1038/sj.cr.7290186; Frisch M, 1999, LANCET, V354, P1442, DOI 10.1016/S0140-6736(99)92824-6; Gallo DE, 2012, VIROLOGY, V422, P13, DOI 10.1016/j.virol.2011.09.015; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; Holmfeldt P, 2003, J CELL SCI, V116, P3701, DOI 10.1242/jcs.00685; Holmfeldt P, 2002, CURR BIOL, V12, P1034, DOI 10.1016/S0960-9822(02)00897-7; Jiang YY, 2016, ONCOGENE, V35, P4846, DOI 10.1038/onc.2016.17; Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; Maciejowski J, 2017, DEV CELL, V41, P143, DOI 10.1016/j.devcel.2017.03.025; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Espinosa AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055975; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mirabello L, 2017, CELL, V170, P1164, DOI 10.1016/j.cell.2017.08.001; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ou Y, 2014, UROL ONCOL, V32, P21; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pyeon D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000318; Shaw R, 2011, BRIT J ORAL MAX SURG, V49, P423, DOI 10.1016/j.bjoms.2010.06.023; STEINMANN KE, 1994, ONCOGENE, V9, P387; Takahashi M, 2003, AM J PHYSIOL-HEART C, V285, pH2072, DOI 10.1152/ajpheart.00396.2003; Thomas LK, 2014, EUR J CANCER, V50, P85, DOI 10.1016/j.ejca.2013.08.022; WEST RR, 1991, J BIOL CHEM, V266, P21886; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Zahnleiter D, 2015, HUM MUTAT, V36, P87, DOI 10.1002/humu.22711	32	3	5	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2019	38	31					5959	5970		10.1038/s41388-019-0851-1	http://dx.doi.org/10.1038/s41388-019-0851-1			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3GE	31253867				2022-12-26	WOS:000482740000004
J	Tripathi, A; Kumar, B; Sagi, SSK				Tripathi, Ankit; Kumar, Bhuvnesh; Sagi, Sarada S. K.			Prophylactic efficacy of Quercetin in ameliorating the hypoxia induced vascular leakage in lungs of rats	PLOS ONE			English	Article							ALTITUDE PULMONARY-EDEMA; ADHESION MOLECULE-1 EXPRESSION; KAPPA-B; OXIDATIVE STRESS; GLUTATHIONE SYNTHESIS; ALDEHYDIC PRODUCTS; EPITHELIAL-CELLS; INDUCIBLE FACTOR; INFLAMMATION; ANTIOXIDANT	The objective of the study was to find out the prophylactic efficacy of Quercetin in ameliorating the hypoxia induced vascular leakage in lungs of rats. Male SD rats received different doses of quercetin@ 25mg, 50mg, 100mg and 200mg/Kg BW, 1h prior to hypobaric hypoxia exposure (7,620m, for 6h). Quercetin 50 mg/kg BW supplemented orally 1h prior to hypoxia exposure was considered to be the optimum dose, due to significant reduction (p< 0.001) in lung water content and lung transvascular leakage compared to control (hypoxia, 6h). Further, biochemical analysis (ROS, MDA, GSH, GPx, LDH, and albumin) and differential expressions of proteins (IKK-alpha/beta, NFB, Nrf-2, TNF-alpha, ICAM-1, VCAM, P-selectin, Hif-1 alpha, VEGF, TNF-alpha, TGF-beta, INF-gamma and IL-4) were determined by western blotting and ELISA. Changes in lung parenchyma were assessed by histopathology. Quercetin (50 mg/kg BW) prophylaxis under hypoxia showed significant reduction in oxidative stress (ROS and MDA), concomitant increase in antioxidants (GSH, GPx and SOD) followed by decreased LDH and albumin extravasation in BAL fluid over hypoxia. Quercetin prophylaxis significantly down regulated hypoxia induced increase in IKK alpha/beta and NFB expressions leading to reduction in the levels of pro-inflammatory cytokines (TNF-alpha and INF-gamma) followed by up regulation of anti-inflammatory cytokines (IL-4 and INF-gamma) in lungs. Further, hypoxia mediated increase in HIF-1 alpha was stabilized and VEGF levels in lungs were significantly down regulated by quercetin supplementation, leading to reduction in vascular leakage in lungs of rats under hypoxia. However, Quercetin has also enacted as Nrf-2 activator which significantly boosted up the synthesis of GSH under hypoxic condition compared to hypoxia. Histopathological observations further confirmed that quercetin preconditioning has an inhibitory effect on progression of oxidative stress and inflammation via attenuation of NF kappa B and stabilization HIF-1 alpha in lungs of rats under hypoxia. These studies indicated that quercetin prophylaxis abrogates the possibility of hypobaric hypoxia induced pulmonary edema in rats.	[Tripathi, Ankit; Kumar, Bhuvnesh; Sagi, Sarada S. K.] Def Inst Physiol & Allied Sci, Nutr Div, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Sagi, SSK (corresponding author), Def Inst Physiol & Allied Sci, Nutr Div, Delhi, India.	s9510003@gmail.com			DIPAS/DRDO, Ministry of Defence, Government of India	DIPAS/DRDO, Ministry of Defence, Government of India	The study was funded under the project entitled "Improving performance under different operational environments using suitable interventions". Project No.-DIP-265, DIPAS/DRDO, Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749; Araneda OF, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/856918; Bakonyi T, 2004, J SPORT SCI MED, V3, P64; Bao DK, 2017, MOLECULES, V22, DOI 10.3390/molecules22071122; Bartsch P, 2003, SWISS MED WKLY, V133, P377; Bhagat R, 2011, RESP PHYSIOL NEUROBI, V178, P329, DOI 10.1016/j.resp.2011.07.005; Bhutada P, 2010, NEUROBIOL LEARN MEM, V94, P293, DOI 10.1016/j.nlm.2010.06.008; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; BRANNAN TS, 1980, BRAIN RES, V200, P474, DOI 10.1016/0006-8993(80)90936-1; Carpenter TC, 2005, AM J PHYSIOL-LUNG C, V289, pL1075, DOI 10.1152/ajplung.00251.2005; Carpenter TC, 2001, AM J PHYSIOL-LUNG C, V281, pL941, DOI 10.1152/ajplung.2001.281.4.L941; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Chin JE, 1997, AM J PHYSIOL-LUNG C, V272, pL219, DOI 10.1152/ajplung.1997.272.2.L219; COUDON WL, 1976, CHEST, V69, P112, DOI 10.1378/chest.69.1.112; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dias AS, 2005, J NUTR, V135, P2299, DOI 10.1093/jn/135.10.2299; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Egan TM, 2004, ANN THORAC SURG, V77, P1048, DOI 10.1016/j.athoracsur.2003.08.023; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1982, BIOCHEM J, V208, P129, DOI 10.1042/bj2080129; Fingar VH, 1997, MICROVASC RES, V54, P135, DOI 10.1006/mvre.1997.2034; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gonzalez NC, 2001, ADV EXP MED BIOL, V502, P39; Gonzalez NC, 2010, ADV EXP MED BIOL, V662, P27, DOI 10.1007/978-1-4419-1241-1_3; Gonzalez-Gallego J, 2007, NUTR HOSP, V22, P287; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; GUGLER R, 1975, EUR J CLIN PHARMACOL, V9, P229, DOI 10.1007/BF00614022; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Herget J, 2000, PHYSIOL RES, V49, P493; HOUSTON CS, 1960, NEW ENGL J MED, V263, P478, DOI 10.1056/NEJM196009082631003; Huey Raymond B, 2002, Integr Comp Biol, V42, P910, DOI 10.1093/icb/42.4.910; Hultgren H., 1960, Stanf. med. Bull., V18, P76; Hurtado A, 1937, REV MED PERUANA, V9, P3; INAUEN W, 1990, FREE RADICAL BIO MED, V9, P219, DOI 10.1016/0891-5849(90)90031-D; Kelly G. S., 2011, J CLIN THERAPEUTIC, V16, P172; KNIGHT JA, 1988, CLIN CHEM, V34, P2433; KOBAYASHI T, 1987, CHEST, V92, P814, DOI 10.1378/chest.92.5.814; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Lamson D W, 2000, Altern Med Rev, V5, P196; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luks AM, 2008, HIGH ALT MED BIOL, V9, P111, DOI 10.1089/ham.2008.1017; Maggiorini M, 2006, CARDIOVASC RES, V72, P41, DOI 10.1016/j.cardiores.2006.07.004; Morand C, 2000, FREE RADICAL RES, V33, P667, DOI 10.1080/10715760000301181; Paralikar Swapnil J, 2012, Indian J Occup Environ Med, V16, P59, DOI 10.4103/0019-5278.107066; Pasparakis M, 2008, MUCOSAL IMMUNOL, V1, pS54, DOI 10.1038/mi.2008.53; POLI G, 1985, BIOCHEM J, V227, P629, DOI 10.1042/bj2270629; Prasad J, 2013, HIGH ALT MED BIOL, V14, P383, DOI 10.1089/ham.2013.1014; Rahman I, 1999, J BIOL CHEM, V274, P5088, DOI 10.1074/jbc.274.8.5088; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Sarada S, 2008, EXP BIOL MED, V233, P1088, DOI 10.3181/0712-RM-337; Sarada SKS, 2014, J PULM RESP MED, V4, P2161; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Schumacker Paul T, 2011, Proc Am Thorac Soc, V8, P477, DOI 10.1513/pats.201103-032MW; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Song JA, 2010, TOX RESEARCH, V26, P203, DOI 10.5487/TR.2010.26.3.203; Srivastava A K, 1986, Prog Clin Biol Res, V213, P315; Starakis I, 2003, CURR THER RES CLIN E, V64, P367, DOI 10.1016/S0011-393X(03)00092-4; Stephen C., 2011, ALTERN MED REV, V16, P172; Stream JO, 2008, WILD ENVIRON MED, V19, P293, DOI 10.1580/07-WEME-REV-173.1; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tong QS, 2006, AM J RESP CELL MOL, V35, P444, DOI 10.1165/rcmb.2005-0424OC; Van Kampen C, 2001, VET IMMUNOL IMMUNOP, V79, P129, DOI 10.1016/S0165-2427(01)00251-3; van Patot MCT, 2008, HIGH ALT MED BIOL, V9, P289, DOI 10.1089/ham.2008.1029; Wang HC, 2000, J BIOL CHEM, V275, P8600, DOI 10.1074/jbc.275.12.8600; WEST JB, 1995, EUR RESPIR J, V8, P523; WILLHITE CC, 1982, FOOD CHEM TOXICOL, V20, P75, DOI 10.1016/S0278-6915(82)80012-4; Yang C-Y, 2005, BIOAVAILABILITY AND; Zhang SXL, 2004, J APPL PHYSIOL, V96, P392, DOI 10.1152/japplphysiol.00829.2003	75	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219075	10.1371/journal.pone.0219075	http://dx.doi.org/10.1371/journal.pone.0219075			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251771	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000041
J	Aufrecht, JA; Fowlkes, JD; Bible, AN; Morrell-Falvey, J; Doktycz, MJ; Retterer, ST				Aufrecht, Jayde A.; Fowlkes, Jason D.; Bible, Amber N.; Morrell-Falvey, Jennifer; Doktycz, Mitchel J.; Retterer, Scott T.			Pore-scale hydrodynamics influence the spatial evolution of bacterial biofilms in a microfluidic porous network	PLOS ONE			English	Article							TRANSPORT; RHIZOSPHERE; GROWTH; MEDIA; FLOW; HETEROGENEITY; CULTIVATION; CHEMOTAXIS; MIGRATION; RESPONSES	Bacteria occupy heterogeneous environments, attaching and growing within pores in materials, living hosts, and matrices like soil. Systems that permit high-resolution visualization of dynamic bacterial processes within the physical confines of a realistic and tractable porous media environment are rare. Here we use microfluidics to replicate the grain shape and packing density of natural sands in a 2D platform to study the flow-induced spatial evolution of bacterial biofilms underground. We discover that initial bacterial dispersal and grain attachment is influenced by bacterial transport across pore space velocity gradients, a phenomenon otherwise known as rheotaxis. We find that gravity-driven flow conditions activate different bacterial cell-clustering phenotypes depending on the strain's ability to product extracellular polymeric substances (EPS). A wildtype, biofilm-producing bacteria formed compact, multicellular patches while an EPS-defective mutant displayed a linked-cell phenotype in the presence of flow. These phenotypes subsequently influenced the overall spatial distribution of cells across the porous media network as colonies grew and altered the fluid dynamics of their microenvironment.	[Aufrecht, Jayde A.; Morrell-Falvey, Jennifer; Doktycz, Mitchel J.; Retterer, Scott T.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA; [Aufrecht, Jayde A.; Morrell-Falvey, Jennifer; Doktycz, Mitchel J.; Retterer, Scott T.] Univ Tennessee, Bredesen Ctr, Knoxville, TN 37996 USA; [Fowlkes, Jason D.; Doktycz, Mitchel J.; Retterer, Scott T.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37830 USA; [Bible, Amber N.] Univ Tennessee, Biochem & Cellular & Mol Biol, Knoxville, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Tennessee System; University of Tennessee Knoxville	Retterer, ST (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA.; Retterer, ST (corresponding author), Univ Tennessee, Bredesen Ctr, Knoxville, TN 37996 USA.; Retterer, ST (corresponding author), Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37830 USA.	rettererst@ornl.gov	Fowlkes, Jason D/Q-2738-2015; Aufrecht, Jayde/HGT-9643-2022; Retterer, Scott/A-5256-2011; Morrell-Falvey, Jennifer/A-6615-2011	Fowlkes, Jason D/0000-0002-6295-5115; Retterer, Scott/0000-0001-8534-1979; Aufrecht, Jayde/0000-0002-7102-980X; Webb, Amber/0000-0002-7431-0533; Morrell-Falvey, Jennifer/0000-0002-9362-7528	U.S. Department of Energy [DE-AC0500OR22725]; Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area; NSF [DGE-1452154]; Department of Energy	U.S. Department of Energy(United States Department of Energy (DOE)); Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE))	This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC0500OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-publicaccess-plan).This work was supported in part by the Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area (http://pmi.ornl.gov).The fabrication of the microfluidic platforms was carried out in the Nanofabrication Research Laboratory at the Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility. JAA is supported by an NSF graduate research fellowship DGE-1452154.; This work was supported in part by the Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area (http://pmi.ornl.gov).The fabrication of the microfluidic platforms was carried out in the Nanofabrication Research Laboratory at the Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility. JAA is supported by an NSF graduate research fellowship DGE-1452154	Alami Y, 2000, APPL ENVIRON MICROB, V66, P3393, DOI 10.1128/AEM.66.8.3393-3398.2000; Alsharif G, 2015, P NATL ACAD SCI USA, V112, DOI [10.1073/pnas.1417910112, DOI 10.1073/PNAS.1417910112]; Aufrecht JA, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201800048; Bible AN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00491; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Bradford SA, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004805; Brown SD, 2012, J BACTERIOL, V194, P5991, DOI 10.1128/JB.01243-12; Carman PC, 1937, T I CHEM ENG-LOND, V15, P150; Chaudhary K, 2013, WATER RESOUR RES, V49, P1149, DOI 10.1002/wrcr.20099; Coyte KZ, 2016, P NATL ACAD SCI; CUNNINGHAM AB, 1991, ENVIRON SCI TECHNOL, V25, P1305, DOI 10.1021/es00019a013; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Deng JZ, 2015, SOIL BIOL BIOCHEM, V83, P116, DOI 10.1016/j.soilbio.2014.12.006; Downie C, 2014, NEW HORIZON ENV POLI, P1, DOI 10.4337/9781783472116; Drescher K, 2013, P NATL ACAD SCI USA, V110, P4345, DOI 10.1073/pnas.1300321110; Ferrari A, 2015, WATER RESOUR RES, V51, P1381, DOI 10.1002/2014WR016384; Ford RM, 2007, ADV WATER RESOUR, V30, P1608, DOI 10.1016/j.advwatres.2006.05.019; Franklin R., 2007, SPATIAL DISTRIBUTION; Ginn TR, 2002, ADV WATER RESOUR, V25, P1017, DOI 10.1016/S0309-1708(02)00046-5; Gunda NSK, 2011, LAB CHIP, V11, P3785, DOI 10.1039/c1lc20556k; Hassanpourfard M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13070; Helmuth JA, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-11, DOI 10.1186/1471-2105-11-11]; Hunt RJ, 2017, HYDROGEOL J, V25, P921, DOI 10.1007/s10040-016-1502-z; Jones DL, 2008, PLANT SOIL, V312, P1, DOI 10.1007/s11104-008-9774-2; Karimi A, 2015, LAB CHIP, V15, P23, DOI 10.1039/c4lc01095g; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kumar A, 2013, MICROFLUID NANOFLUID, V14, P895, DOI 10.1007/s10404-012-1120-6; Langlotz C, 2011, PHYSIOL MOL PLANT P, V75, P163, DOI 10.1016/j.pmpp.2011.04.001; Long T, 2009, ENVIRON SCI TECHNOL, V43, P1546, DOI 10.1021/es802558j; Markov D, 2010, JOVE, V39; Mollon G, 2012, GRANUL MATTER, V14, P621, DOI 10.1007/s10035-012-0356-x; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; Nivedita D, 2007, MODELING 3 DIMENSION, P148; Nunan N, 2003, FEMS MICROBIOL ECOL, V44, P203, DOI 10.1016/S0168-6496(03)00027-8; O'Donnell AG, 2007, NAT REV MICROBIOL, V5, P689, DOI 10.1038/nrmicro1714; Or D, 2007, ADV WATER RESOUR, V30, P1505, DOI 10.1016/j.advwatres.2006.05.025; Persat A, 2017, CURR OPIN MICROBIOL, V36, P1, DOI 10.1016/j.mib.2016.12.002; Persat A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4824; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Raynaud X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087217; Rusconi R, 2015, CURR OPIN MICROBIOL, V25, P1, DOI 10.1016/j.mib.2015.03.003; Rusconi R, 2014, ANNU REV BIOPHYS, V43, P65, DOI 10.1146/annurev-biophys-051013-022916; Rusconi R, 2014, NAT PHYS, V10, P212, DOI 10.1038/NPHYS2883; Rusconi R, 2010, J R SOC INTERFACE, V7, P1293, DOI 10.1098/rsif.2010.0096; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sherwood JL, 2003, ENVIRON SCI TECHNOL, V37, P781, DOI 10.1021/es011210u; Shivanandan A, 2013, BMC BIOINFORMATICS, V14, DOI [10.1186/1471-2105-14-14, DOI 10.1186/1471-2105-14-14]; Singh R, 2012, ENVIRON SCI TECHNOL, V46, P3188, DOI 10.1021/es203614y; Son K, 2015, NAT REV MICROBIOL, V13, P761, DOI 10.1038/nrmicro3567; Strathmann M, 2005, MICROBIOLOGY, V71, P4801, DOI [10.1128/AEM.71.8.4801, DOI 10.1128/AEM.71.8.4801]; Valiei A, 2012, LAB CHIP, V12, P5133, DOI 10.1039/c2lc40815e; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wu MJ, 2012, LAB CHIP, V12, P253, DOI 10.1039/c1lc20838a; Yawata Y, 2016, J BACTERIOL, V198, P2589, DOI 10.1128/JB.00118-16; Zhang CY, 2010, ENVIRON SCI TECHNOL, V44, P3085, DOI 10.1021/es903396h; Zhang GD, 2013, 16TH EUROMICRO CONFERENCE ON DIGITAL SYSTEM DESIGN (DSD 2013), P3, DOI 10.1109/DSD.2013.11	59	26	26	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218316	10.1371/journal.pone.0218316	http://dx.doi.org/10.1371/journal.pone.0218316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246972	gold, Green Published, Green Submitted			2022-12-26	WOS:000484911900017
J	Heissel, S; Frederiksen, SJ; Bunkenborg, J; Hojrup, P				Heissel, Soren; Frederiksen, Sigurd J.; Bunkenborg, Jakob; Hojrup, Peter			RESEARCH ARTICLE Enhanced trypsin on a budget: Stabilization, purification and high-temperature application of inexpensive commercial trypsin for proteomics applications	PLOS ONE			English	Article							MASS-SPECTROMETRY; BOVINE TRYPSIN; PEPTIDES	Trypsin is by far the most commonly used protease in proteomics. Even though the amount of protease used in each experiment is very small, digestion of large amounts of protein prior to enrichment can be rather costly. The price of commercial trypsin is highly dependent on the quality of the enzyme, which is determined by its purity, activity, and chemical modifications. In this study we evaluated several strategies for improving the quality of crude trypsin by reductive methylation and affinity purification. We present a protocol applicable to most proteomics laboratories for obtaining a highly stable and pure trypsin preparation using reductive methylation and purification by benzamidine-sepharose. The entire workflow can be performed within a day and yields similar to 4 mg per batch but is completely scalable. The methylated product was benchmarked against sequencing grade trypsin from Promega and they were found to be comparable for one hour digestions at elevated temperatures, where residual chymotryptic activity was found to be negligible.	[Heissel, Soren; Frederiksen, Sigurd J.; Hojrup, Peter] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark; [Bunkenborg, Jakob] Alphalyse AS, Odense SO, Denmark; [Heissel, Soren] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA	University of Southern Denmark; Rockefeller University	Hojrup, P (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark.	php@bmb.sdu.dk	Højrup, Peter/ABG-8477-2020	Hojrup, Peter/0000-0002-7838-6180; Heissel, Soren/0000-0003-2692-5602; Bunkenborg, Jakob/0000-0002-2908-9323	Innovation Fund Denmark [34-214-1]	Innovation Fund Denmark	PH was awarded a grant from Innovation Fund Denmark (34-214-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alphalyse A/S provided support in the form of salary for JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by Innovation Fund Denmark (grant number 34-214-1). The authors thank the Villum Center for Bioanalytical Sciences for providing access to the mass spectrometers. A special thanks to Sergey Kovalchuk for supplying the HeLa lysate and Martin R. Madsen for assisting in the creation of various R-scripts.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; ASGEIRSSON B, 1991, COMP BIOCHEM PHYS B, V99, P327, DOI 10.1016/0305-0491(91)90050-N; Bunkenborg J, 2013, J PROTEOME RES, V12, P3631, DOI 10.1021/pr4001465; Capelo JL, 2009, ANAL CHIM ACTA, V650, P151, DOI 10.1016/j.aca.2009.07.034; Carpenter FH, 1967, METHOD ENZYMOL, V11, P237, DOI DOI 10.1016/S0076-6879(67)11028-8; Chamrad I, 2011, J PROTEOMICS, V74, P948, DOI 10.1016/j.jprot.2011.02.011; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Hojrup P, 2015, METHODS MOL BIOL, V1348, P65, DOI 10.1007/978-1-4939-2999-3_8; Keil B., 1992, SPECIFICITY PROTEOLY, V331, P201, DOI DOI 10.1007/978-3-642-48380-6; KEILDLOUHA V, 1971, FEBS LETT, V16, P291, DOI 10.1016/0014-5793(71)80373-3; LABOUESSE J, 1967, EUR J BIOCHEM, V2, P215, DOI 10.1111/j.1432-1033.1967.tb00127.x; MARSHALL JJ, 1975, ARCH BIOCHEM BIOPHYS, V167, P777, DOI 10.1016/0003-9861(75)90525-1; Mitterer A, 2011, Patent No. [EP1456228 B1, 1456228]; NUREDDIN A, 1975, BIOCHEM J, V147, P71, DOI 10.1042/bj1470071; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Picotti P, 2007, MOL CELL PROTEOMICS, V6, P1589, DOI 10.1074/mcp.M700029-MCP200; R Core Team, 2016, R A LANGUAGE AND ENV; RAM JS, 1954, ARCH BIOCHEM BIOPHYS, V52, P464; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; Sato S, 2004, TETRAHEDRON, V60, P7899, DOI 10.1016/j.tet.2004.06.045; Schittmayer M, 2016, J PROTEOME RES, V15, P1222, DOI 10.1021/acs.jproteome.5b01105; Sebela M, 2006, PROTEOMICS, V6, P2959, DOI 10.1002/pmic.200500576; SMITH RL, 1969, J BIOL CHEM, V244, P4704; STARK GR, 1960, J BIOL CHEM, V235, P3177; Tabb DL, 2004, ANAL CHEM, V76, P1243, DOI 10.1021/ac0351163; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Wilson-Grady JT, 2013, METHODS, V61, P277, DOI 10.1016/j.ymeth.2013.03.031; Wu FL, 2016, RAPID COMMUN MASS SP, V30, P1059, DOI 10.1002/rcm.7535	30	17	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218374	10.1371/journal.pone.0218374	http://dx.doi.org/10.1371/journal.pone.0218374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246970	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900022
J	Kluz, M; Nieznanska, H; Dec, R; Dziecielewski, I; Nizynski, B; Scibisz, G; Pulawski, W; Staszczak, G; Klein, E; Smalc-Koziorowska, J; Dzwolak, W				Kluz, Michal; Nieznanska, Hanna; Dec, Robert; Dziecielewski, Igor; Nizynski, Bartosz; Scibisz, Grzegorz; Pulawski, Wojciech; Staszczak, Grzegorz; Klein, Ewelina; Smalc-Koziorowska, Julita; Dzwolak, Wojciech			Revisiting the conformational state of albumin conjugated to gold nanoclusters: A self-assembly pathway to giant superstructures unraveled	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; AMYLOID FIBRILS; PROTEIN; BSA; FLUORESCENCE; PH; AGGREGATION; DYNAMICS	Bovine serum albumin (BSA) is often employed as a proteinaceous component for synthesis of luminescent protein-stabilized gold nanoclusters (AuNC): intriguing systems with many potential applications. Typically, the formation of BSA-AuNC conjugate occurs under strongly alkaline conditions. Due to the sheer complexity of intertwined chemical and structural transitions taking place upon BSA-AuNC formation, the state of albumin enveloping AuNCs remains poorly characterized. Here, we study the conformational properties of BSA bound to AuNCs using an array of biophysical tools including vibrational spectroscopy, circular dichroism, fluorescence spectroscopy and trypsin digestion. The alkaline conditions of BSA-AuNC self-assembly appear to be primary responsible for the profound irreversible disruption of tertiary contacts, partial unfolding of native alpha-helices, hydrolysis of disulfide bonds and the protein becoming vulnerable to trypsin digestion. Further unfolding of BSA-AuNC by guanidinium hydrochloride (GdnHCl) is fully reversible equally in terms of albumin's secondary structure and conjugate's luminescent properties. This suggests that binding to AuNCs traps the albumin molecule in a state that is both partly disordered and refractory to irreversible misfolding. Indeed, when BSA-AuNC is subjected to conditions favoring self-association of BSA into amyloid-like fibrils, the buildup of non-native beta-sheet conformation is less pronounced than in a control experiment with unmodified BSA. Unexpectedly, BSA-AuNC reveals a tendency to self-assemble into giant twisted superstructures of micrometer lengths detectable with transmission electron microscopy (TEM), a property absent in unmodified BSA. The process is accompanied by ordering of bound AuNCs into elongated streaks and simultaneous decrease in fluorescence intensity. The newly discovered self-association pathway appears to be specifically accessible to protein molecules with a certain restriction on structural dynamics which in the case of BSA-AuNC arises from binding to metal nanoclusters. Our results have been discussed in the context of mechanisms of protein misfolding and applications of BSA-AuNC.	[Kluz, Michal; Dec, Robert; Dziecielewski, Igor; Pulawski, Wojciech; Staszczak, Grzegorz; Klein, Ewelina; Smalc-Koziorowska, Julita; Dzwolak, Wojciech] Polish Acad Sci, Inst High Pressure Phys, Warsaw, Poland; [Nieznanska, Hanna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Dec, Robert; Nizynski, Bartosz; Scibisz, Grzegorz; Dzwolak, Wojciech] Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, Warsaw, Poland	Polish Academy of Sciences; Institute of High Pressure Physics of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Warsaw	Dzwolak, W (corresponding author), Polish Acad Sci, Inst High Pressure Phys, Warsaw, Poland.; Dzwolak, W (corresponding author), Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, Warsaw, Poland.	wdzwolak@unipress.waw.pl	Smalc-Koziorowska, Julita/ABB-6185-2021	Smalc-Koziorowska, Julita/0000-0002-1460-7861; Staszczak, Grzegorz/0000-0001-7630-2556; Dzwolak, Wojciech/0000-0002-1407-1497; Nieznanska, Hanna/0000-0001-7055-5018; Pulawski, Wojciech/0000-0002-4837-1148	National Science Centre of Poland [UMO-2017/25/B/ST5/02599]; EU Structural Funds: Centre of Advanced Technology BIM-Equipment purchase for the Laboratory of Biological and Medical Imaging	National Science Centre of Poland(National Science Centre, Poland); EU Structural Funds: Centre of Advanced Technology BIM-Equipment purchase for the Laboratory of Biological and Medical Imaging	This work was supported with a grant from the National Science Centre of Poland (https://www.ncn.gov.pl/), grant no. UMO-2017/25/B/ST5/02599 awarded to WD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Matylda Waclawska for her kind help with comparative SDS-PAGE analysis of enzymatic digestion products of BSA-AuNC and BSA-Alk. This work was supported by the National Science Centre of Poland, grant no. UMO-2017/25/B/ST5/02599 awarded to W.D. TEM studies were performed using equipment installed in the Nencki Institute within the project sponsored by the EU Structural Funds: Centre of Advanced Technology BIM-Equipment purchase for the Laboratory of Biological and Medical Imaging. The authors would like to thank Henryk Bilski for technical assistance during TEM studies.	Amdursky N, 2012, ACCOUNTS CHEM RES, V45, P1548, DOI 10.1021/ar300053p; ANDERSSO.LO, 1969, BIOCHIM BIOPHYS ACTA, V192, P534, DOI 10.1016/0304-4165(69)90406-1; AOKI K, 1973, BIOCHIM BIOPHYS ACTA, V328, P323, DOI 10.1016/0005-2795(73)90265-1; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bhattacharya M, 2011, J FLUORESC, V21, P1083, DOI 10.1007/s10895-010-0781-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cao XL, 2013, VIB SPECTROSC, V65, P186, DOI 10.1016/j.vibspec.2013.01.004; Chall S, 2017, LANGMUIR, V33, P12120, DOI 10.1021/acs.langmuir.7b01789; Chib R, 2015, J LUMIN, V168, P62, DOI 10.1016/j.jlumin.2015.07.030; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dixon JM, 2018, J AM CHEM SOC, V140, P2265, DOI 10.1021/jacs.7b11712; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fulara A, 2011, J PHYS CHEM B, V115, P11010, DOI 10.1021/jp206271e; Goormaghtigh E, PHYSICOCHEMICAL METH, V23; Grohn F, 2000, MACROMOLECULES, V33, P6042, DOI 10.1021/ma000149v; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Hsu YC, 2019, MOLECULES, V24, DOI 10.3390/molecules24081630; Hu LZ, 2012, BIOSENS BIOELECTRON, V32, P297, DOI 10.1016/j.bios.2011.12.007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin RC, 2010, NANOSCALE, V2, P343, DOI 10.1039/b9nr00160c; Knowles TPJ, 2016, ADV MATER, V28, P6546, DOI 10.1002/adma.201505961; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Krebs MRH, 2004, P NATL ACAD SCI USA, V101, P14420, DOI 10.1073/pnas.0405933101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li CX, 2012, NAT NANOTECHNOL, V7, P421, DOI [10.1038/nnano.2012.62, 10.1038/NNANO.2012.62]; Lin CAJ, 2009, ACS NANO, V3, P395, DOI 10.1021/nn800632j; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Liu GY, 2012, GOLD BULL, V45, P69, DOI 10.1007/s13404-012-0049-6; Liu YL, 2010, ADV FUNCT MATER, V20, P951, DOI 10.1002/adfm.200902062; Loksztejn A, 2010, J MOL BIOL, V395, P643, DOI 10.1016/j.jmb.2009.10.065; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; MALATEST.L, 1965, CHEM COMMUN, P212, DOI 10.1039/c19650000212; Merlot AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00299; Nystrom G, 2016, ADV MATER, V28, P472, DOI 10.1002/adma.201503465; Oh E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35538; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Raut S, 2014, METHODS APPL FLUORES, V2, DOI 10.1088/2050-6120/2/3/035004; Raut SL, 2013, CHEM PHYS LETT, V561, P74, DOI 10.1016/j.cplett.2013.01.028; Rombouts I, 2015, SCI REP-UK, V5, DOI 10.1038/srep12210; Russell BA, 2016, J MATER CHEM B, V4, P6876, DOI 10.1039/c6tb01827k; Russell BA, 2015, PHYS CHEM CHEM PHYS, V17, P21935, DOI 10.1039/c5cp02380g; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sen P, 2008, EUR BIOPHYS J BIOPHY, V37, P1303, DOI 10.1007/s00249-008-0335-7; Shang L, 2011, NANO TODAY, V6, P401, DOI 10.1016/j.nantod.2011.06.004; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Su L, 2015, J PHYS CHEM C, V119, P12065, DOI 10.1021/acs.jpcc.5b03224; Usov I, 2013, FARADAY DISCUSS, V166, P151, DOI 10.1039/c3fd00083d; VANWART HE, 1973, P NATL ACAD SCI USA, V70, P2619, DOI 10.1073/pnas.70.9.2619; Vetri V, 2015, FEBS LETT, V589, P2448, DOI 10.1016/j.febslet.2015.07.006; Wen XM, 2012, J PHYS CHEM C, V116, P19032, DOI 10.1021/jp305902w; Wu ZK, 2010, NANO LETT, V10, P2568, DOI 10.1021/nl101225f; Xie JP, 2009, J AM CHEM SOC, V131, P888, DOI 10.1021/ja806804u; Yan L, 2012, J MATER CHEM, V22, P1000, DOI 10.1039/c1jm13457d; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	58	7	7	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218975	10.1371/journal.pone.0218975	http://dx.doi.org/10.1371/journal.pone.0218975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247048	Green Submitted, Green Published, gold			2022-12-26	WOS:000484911900061
J	Lee, SH; Park, MS; Song, YB; Park, J; Kim, J; Lee, SM; Lee, YT				Lee, Seung-Hwa; Park, Myung Soo; Song, Young Bin; Park, Jungchan; Kim, Jaeyoun; Lee, Sangmin Maria; Lee, Young Tak			Perioperative myocardial injury in revascularized coronary patients who undergo noncardiac surgery	PLOS ONE			English	Article							SENSITIVITY CARDIAC TROPONIN; INFARCTION; MORTALITY; ASSOCIATION	Background Whether high-sensitivity cardiac troponin elevation during the perioperative period is associated with poor clinical outcome in revascularized coronary patients who undergo noncardiac surgery remains unclear. We investigated the effects of perioperative troponin elevation on the long-term clinical outcomes of patients with a history of coronary revascularization. Methods We analyzed patients whose pre-or postoperative high-sensitivity cardiac troponin I (hscTnI) assay results were available. Patients were divided into two groups according to hscTnI levels. The patient groups were analyzed separately according to whether hs-cTnI was assessed preoperatively or postoperatively. The primary outcome was all-cause death during the follow-up period. Results Median follow-up duration was 25 months (interquartile range 11-50). In the propensity-matched analysis, the risk of all-cause death during follow-up was higher in the group with elevated hs-cTnI group than in the normal group (12.7% vs 6.3%; hazard ratio [HR], 2.67; 95% confidential interval [CI], 1.04-6.82; p = 0.04). In the propensity-matched analysis of preoperative hs-cTnI levels, we found no significant difference between the groups in the rate of all-cause death (12.9% vs. 11.9%; HR, 1.06; 95% CI, 0.45-2.50; p = 0.89). In the postoperative propensity-matched analysis, all-cause death was higher in patients with elevated hs-cTnI than in those with normal levels (14.9% vs. 5.9%; HR, 2.80; 95% CI, 1.01-7.77; p = 0.048). Conclusion In revascularized coronary patients who underwent noncardiac surgery, postoperative (but not preoperative) hs-cTnI elevation was associated with all-cause death during follow-up. Larger datasets are needed to support this finding.	[Lee, Seung-Hwa; Song, Young Bin] Sungkyunkwan Univ, Heart Stroke & Vasc Inst, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Park, Myung Soo] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Med, Sch Med, Hwasung, South Korea; [Park, Jungchan; Kim, Jaeyoun; Lee, Sangmin Maria] Sungkyunkwan Univ, Dept Anesthesiol & Pain Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Lee, Young Tak] Sungkyunkwan Univ, Dept Thorac & Cardiovasc Surg, Samsung Med Ctr, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Song, YB (corresponding author), Sungkyunkwan Univ, Heart Stroke & Vasc Inst, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea.	youngbin.song@gmail.com		Lee, Seung Hwa/0000-0001-5508-7519; Song, Young Bin/0000-0003-3986-9152				Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Baron T, 2015, HEART, V101, P101, DOI 10.1136/heartjnl-2014-306093; Beckman JA, 2013, CIRCULATION, V127, P2253, DOI 10.1161/CIRCULATIONAHA.113.003195; Brush JE, 2016, J AM COLL CARDIOL, V68, P2365, DOI 10.1016/j.jacc.2016.08.066; Devereaux PJ, 2017, JAMA-J AM MED ASSOC, V317, P1642, DOI 10.1001/jama.2017.4360; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Ford I, 2016, J AM COLL CARDIOL, V68, P2719, DOI 10.1016/j.jacc.2016.10.020; Gillmann HJ, 2014, CRIT CARE MED, V42, P1498, DOI 10.1097/CCM.0000000000000249; Haider DG, 2017, INT J CARDIOL, V228, P779, DOI 10.1016/j.ijcard.2016.10.043; Hammadah M, 2018, JACC-CARDIOVASC IMAG, V11, P603, DOI 10.1016/j.jcmg.2016.11.021; Kristensen SD, 2014, EUR HEART J, V35, P2344, DOI 10.1093/eurheartj/ehu285; Landesberg G, 2009, CIRCULATION, V119, P2936, DOI 10.1161/CIRCULATIONAHA.108.828228; Mahajan VS, 2011, CIRCULATION, V124, P2350, DOI 10.1161/CIRCULATIONAHA.111.023697; Maile MD, 2016, ANESTH ANALG, V123, P135, DOI 10.1213/ANE.0000000000001309; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Park J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177838; Park KC, 2017, CARDIOVASC RES, V113, P1708, DOI 10.1093/cvr/cvx183; Potter JM, 2017, CLIN BIOCHEM, V50, P105, DOI 10.1016/j.clinbiochem.2016.10.011; Puelacher C, 2018, CIRCULATION, V137, P1221, DOI 10.1161/CIRCULATIONAHA.117.030114; Sandoval Y, 2016, AM J MED, V129, P354, DOI 10.1016/j.amjmed.2015.12.005; Sessler DI, 2016, ANESTH ANALG, V123, P359, DOI 10.1213/ANE.0000000000001450; Stein GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084285; van der Linden N, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005703; van Waes JAR, 2013, CIRCULATION, V127, P2264, DOI 10.1161/CIRCULATIONAHA.113.002128; Zimmerman AM, 2016, J AM COLL SURGEONS, V223, P381, DOI 10.1016/j.jamcollsurg.2016.04.043	29	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219043	10.1371/journal.pone.0219043	http://dx.doi.org/10.1371/journal.pone.0219043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247014	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900068
J	Vanderzande, S; Howard, NP; Cai, LC; Linge, CD; Antanaviciute, L; Bink, MCAM; Kruisselbrink, JW; Bassil, N; Gasic, K; Iezzoni, A; Van de Weg, E; Peace, C				Vanderzande, Stijn; Howard, Nicholas P.; Cai, Lichun; Linge, Cassia Da Silva; Antanaviciute, Laima; Bink, Marco C. A. M.; Kruisselbrink, Johannes W.; Bassil, Nahla; Gasic, Ksenija; Iezzoni, Amy; Van de Weg, Eric; Peace, Cameron			High-quality, genome-wide SNP genotypic data for pedigreed germplasm of the diploid outbreeding species apple, peach, and sweet cherry through a common workflow	PLOS ONE			English	Article							FAMILY-BASED ANALYSIS; HIGH-DENSITY; ERRORS; IDENTIFICATION; CONSEQUENCES; ASSOCIATIONS; POPULATION; VALIDATION; CULTIVARS; IMPACT	High-quality genotypic data is a requirement for many genetic analyses. For any crop, errors in genotype calls, phasing of markers, linkage maps, pedigree records, and unnoticed variation in ploidy levels can lead to spurious marker-locus-trait associations and incorrect origin assignment of alleles to individuals. High-throughput genotyping requires automated scoring, as manual inspection of thousands of scored loci is too time-consuming. However, automated SNP scoring can result in errors that should be corrected to ensure recorded genotypic data are accurate and thereby ensure confidence in downstream genetic analyses. To enable quick identification of errors in a large genotypic data set, we have developed a comprehensive workflow. This multiple-step workflow is based on inheritance principles and on removal of markers and individuals that do not follow these principles, as demonstrated here for apple, peach, and sweet cherry. Genotypic data was obtained on pedigreed germplasm using 6-9K SNP arrays for each crop and a subset of well-performing SNPs was created using ASSIsT. Use of correct (and corrected) pedigree records readily identified violations of simple inheritance principles in the genotypic data, streamlined with FlexQTL software. Retained SNPs were grouped into haploblocks to increase the information content of single alleles and reduce computational power needed in downstream genetic analyses. Haploblock borders were defined by recombination locations detected in ancestral generations of cultivars and selections. Another round of inheritance-checking was conducted, for haploblock alleles (i.e., haplotypes). High-quality genotypic data sets were created using this workflow for pedigreed collections representing the U.S. breeding germplasm of apple, peach, and sweet cherry evaluated within the RosBREED project. These data sets contain 3855, 4005, and 1617 SNPs spread over 932, 103, and 196 haploblocks in apple, peach, and sweet cherry, respectively. The highly curated phased SNP and haplotype data sets, as well as the raw iScan data, of germplasm in the apple, peach, and sweet cherry Crop Reference Sets is available through the Genome Database for Rosaceae.	[Vanderzande, Stijn; Peace, Cameron] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Howard, Nicholas P.] Univ Minnesota, Dept Hort Sci, St Paul, MN USA; [Howard, Nicholas P.] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Oldenburg, Germany; [Cai, Lichun; Iezzoni, Amy] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Linge, Cassia Da Silva; Antanaviciute, Laima; Gasic, Ksenija] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC USA; [Bink, Marco C. A. M.; Kruisselbrink, Johannes W.] Wageningen UR, Biometris, Wageningen, Netherlands; [Bink, Marco C. A. M.] Hendrix Genet, Res & Technol Ctr, Boxmeer, Netherlands; [Bassil, Nahla] USDA ARS, Natl Clonal Germplasm Repository, Corvallis, OR USA; [Van de Weg, Eric] Wageningen UR, Plant Breeding, Wageningen, Netherlands	Washington State University; University of Minnesota System; University of Minnesota Twin Cities; Carl von Ossietzky Universitat Oldenburg; Michigan State University; Clemson University; Wageningen University & Research; United States Department of Agriculture (USDA); Wageningen University & Research	Vanderzande, S (corresponding author), Washington State Univ, Dept Hort, Pullman, WA 99164 USA.	stijn.vanderzande@wsu.edu	da Silva Linge, Cassia/C-9538-2019; Van de Weg, Eric W/G-3225-2011; Gasic, Ksenija/AAN-6234-2021	da Silva Linge, Cassia/0000-0003-4760-1359; Van de Weg, Eric W/0000-0002-9443-5974; Gasic, Ksenija/0000-0003-4391-5262	USDA-NIFA-Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae" [2009-51181-05808]; USDA-NIFA-Specialty Crop Research Initiative project, "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars" [2014-51181-22378]; USDA NIFA Hatch projects [0211277, 1014919]; EU [265582]	USDA-NIFA-Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae"; USDA-NIFA-Specialty Crop Research Initiative project, "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars"; USDA NIFA Hatch projects; EU(European Commission)	This project was co-funded by the USDA-NIFA-Specialty Crop Research Initiative projects, "RosBREED: Enabling marker-assisted breeding in Rosaceae" (2009-51181-05808), "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars" (2014-51181-22378), USDA NIFA Hatch projects 0211277 and 1014919, and the FruitBreedomics project No 265582: "Integrated approach for increasing breeding efficiency in fruit tree crops" that was cofunded by the EU seventh Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Allard A, 2016, J EXP BOT, V67, P2875, DOI 10.1093/jxb/erw130; Anciro A, 2018, THEOR APPL GENET, V131, P2167, DOI 10.1007/s00122-018-3145-z; Bassil NV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1310-1; Bianco L, 2016, PLANT J, V86, P62, DOI 10.1111/tpj.13145; Bianco L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110377; Boursiquot J.M., 2013, P 9 INT S GRAP PHYS, P123; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; BUETOW KH, 1991, AM J HUM GENET, V49, P985; Cai LC, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0689-6; Chagne D, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0920-8; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Cheung CYK, 2014, GENET EPIDEMIOL, V38, P291, DOI 10.1002/gepi.21806; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Di Guardo M, 2015, ASSIST AUTOMATIC SNP; Di Guardo M, 2017, J EXP BOT, V68, P1451, DOI 10.1093/jxb/erx017; Di Guardo M, 2015, BIOINFORMATICS, V31, P3873, DOI 10.1093/bioinformatics/btv446; Di Pierro EA, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.57; Durand JB, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00858; Evans KM, 2011, MOL BREEDING, V28, P535, DOI 10.1007/s11032-010-9502-5; Fresnedo-Ramirez J, 2015, ACTA HORTIC, V1084, P249, DOI 10.17660/ActaHortic.2015.1084.35; Fresnedo-Ramirez J, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0985-z; Goldstein DR, 1997, HUM HERED, V47, P86, DOI 10.1159/000154396; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Guo Y, 2014, NAT PROTOC, V9, P2643, DOI 10.1038/nprot.2014.174; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Hernandez Mora J. R., 2017, Acta Horticulturae, P405; Mora JRH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3783-6; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Howard NP, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.3; Iezzoni A., 2017, Acta Horticulturae, P115, DOI [10.17660/actahortic.2017.1172.20, 10.17660/ActaHortic.2017.1172.20]; Iezzoni A., 2016, Acta Horticulturae, P1; Iezzoni A, 2010, ACTA HORTIC, V859, P389; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kirk KM, 2002, EUR J HUM GENET, V10, P616, DOI 10.1038/sj.ejhg.5200855; Klagges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054743; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036674; Lacombe T, 2013, THEOR APPL GENET, V126, P401, DOI 10.1007/s00122-012-1988-2; Larsen B, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-016-1087-7; Lassois L, 2016, PLANT MOL BIOL REP, V34, P827, DOI 10.1007/s11105-015-0966-7; Laurens F, 2012, ACTA HORTIC, V929, P95; Laurens F., 2010, J FRUIT SCI, V27, P102; Laurens F, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0016-3; Linge CD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207724; Mangandi J, 2017, G3-GENES GENOM GENET, V7, P1707, DOI 10.1534/g3.117.042119; Namjou B, 2009, ARTHRITIS RHEUM-US, V60, P1085, DOI 10.1002/art.24387; Okie WR, 1998, HANDBOOK OF PEACH AN; Peace C, 2019, HORTICULTURE RES; Peace CP, 2014, TREE GENET GENOMES, V10, P1679, DOI 10.1007/s11295-014-0788-z; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Pikunova A, 2014, TREE GENET GENOMES, V10, P261, DOI 10.1007/s11295-013-0679-8; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasheed A, 2017, MOL PLANT, V10, P1047, DOI 10.1016/j.molp.2017.06.008; Roach JA, 2016, THEOR APPL GENET, V129, P1191, DOI 10.1007/s00122-016-2695-1; Rosyara UR, 2014, J AM SOC HORTIC SCI, V139, P148, DOI 10.21273/JASHS.139.2.148; Scorza R., 1996, FRUIT BREEDING TREE, P325; Terwilliger JD, 1990, AM J HUM GENET S, V47, pA201; Troggio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067407; van de Weg E, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-017-0755-0; Vanderzande S, 2019, DEV INITIAL ASSESSME; Vanderzande S, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1206-0; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3606-9; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Verma S, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1324-y; Voorrips RE, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0539-y; Vouillamoz JF, 2006, HEREDITY, V97, P102, DOI 10.1038/sj.hdy.6800842; Xu XY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0240-6; YOUNG ND, 1989, THEOR APPL GENET, V77, P95, DOI 10.1007/BF00292322	72	45	46	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0210928	10.1371/journal.pone.0210928	http://dx.doi.org/10.1371/journal.pone.0210928			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246947	gold, Green Submitted, Green Published			2022-12-26	WOS:000484911900002
J	Caramenti, M; Lafortuna, CL; Mugellini, E; Abou Khaled, O; Bresciani, JP; Dubois, A				Caramenti, Martina; Lafortuna, Claudio L.; Mugellini, Elena; Abou Khaled, Omar; Bresciani, Jean-Pierre; Dubois, Amandine			Regular physical activity modulates perceived visual speed when running in treadmill-mediated virtual environments	PLOS ONE			English	Article							HUMAN LOCOMOTION; PERCEPTION; WALKING; CALIBRATION; ADAPTATION; KINEMATICS; DIFFERENCE; CHILDREN; DISTANCE; LENGTH	In virtual reality, visual speed is usually underestimated relative to locomotor speed. Here we investigated how physical activity and fitness affect perceived visual speed when running in a treadmill-mediated virtual environment. Thirty healthy participants (ten sedentary individuals, ten team sport players and ten expert runners) ran on a treadmill at two different speeds (8, 12km/h) in front of a moving virtual scene. Participants were asked to match the speed of the visual scene to their running speed (i.e. treadmill speed), indicating for each trial whether the scene was moving slower or faster than the treadmill. The speed of the visual scene was adjusted according to the participant's response using a staircase until visual and running speeds were perceived as equivalent. More sedentary participants underestimated visual speed relative to their actual running speed. Specifically, visual speed had to exceed running speed to be perceived as equivalent. The underestimation of visual speed was speed-dependent, and it was significantly larger for sedentary participants than for team sports players and expert runners. The volume of physical activity per week was found to be the best predictor of visual speed perception for both running speeds, while the perceived effort constituted a good predictor only at 8km/h. Physical fitness, on the other hand turned out to be a poor predictor of visual speed perception. Therefore, in order to enhance users' engagement and their adherence to physical activity programs, the development of "personalized" treadmill-mediated virtual environments should take into account users' personal characteristics to provide the most natural and engaging feedback possible.	[Caramenti, Martina; Bresciani, Jean-Pierre; Dubois, Amandine] Univ Fribourg, Dept Neurosci & Movement Sci, Fribourg, Switzerland; [Caramenti, Martina; Lafortuna, Claudio L.] CNR, Ist Bioimmagini & Fisiol Mol, Lab Biomeccan Franco Saibene, Milan, Italy; [Caramenti, Martina; Mugellini, Elena; Abou Khaled, Omar] Univ Appl Sci & Arts Western Switzerland, HumanTech Inst, Fribourg, Switzerland; [Bresciani, Jean-Pierre] Univ Grenoble Alpes, LPNC Grenoble, Grenoble, France	University of Fribourg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Caramenti, M (corresponding author), Univ Fribourg, Dept Neurosci & Movement Sci, Fribourg, Switzerland.; Caramenti, M (corresponding author), CNR, Ist Bioimmagini & Fisiol Mol, Lab Biomeccan Franco Saibene, Milan, Italy.; Caramenti, M (corresponding author), Univ Appl Sci & Arts Western Switzerland, HumanTech Inst, Fribourg, Switzerland.	martina.caramenti@unifr.ch	Caramenti, Martina/H-7426-2018; Caramenti, Martina/N-4755-2019; KHALED, Omar ABOU/O-6389-2019	Caramenti, Martina/0000-0002-3345-0994; Caramenti, Martina/0000-0002-3345-0994; KHALED, Omar ABOU/0000-0002-0178-9037; Lafortuna, Claudio/0000-0002-8625-7653; Bresciani, Jean-Pierre/0000-0002-7242-5433				Abernethy B, 2002, GAIT POSTURE, V15, P256, DOI 10.1016/S0966-6362(01)00195-3; Adolph KE, 1997, MONOGR SOC RES CHILD, V62, pR5; Banton T, 2005, PRESENCE-TELEOP VIRT, V14, P394, DOI 10.1162/105474605774785262; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Bingham GP, 2014, J EXP PSYCHOL HUMAN, V40, P61, DOI 10.1037/a0033458; Bingham GP, 1998, J EXP PSYCHOL HUMAN, V24, P145, DOI 10.1037/0096-1523.24.1.145; Bingham GP, 1999, J EXP PSYCHOL HUMAN, V25, P1331; Bredin J, 2005, EXP BRAIN RES, V167, P670, DOI 10.1007/s00221-005-0251-3; Caramenti M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195781; Christenson GN, 1988, J AM OPTOMETRIC ASS; Coon JT, 2011, ENVIRON SCI TECHNOL, V45, P1761, DOI 10.1021/es102947t; CORLETT JT, 1985, PERCEPTION, V14, P257, DOI 10.1068/p140257; Dal U, 2010, GAIT POSTURE, V31, P366, DOI 10.1016/j.gaitpost.2010.01.006; Durgin FH, 2005, ELECT IMAGING 2005; Durgin FH, 2007, ACM T APPL PERCEPT, V4, DOI [10.1145/1227134.1227139, 10.1145/1227134/1227139]; Durgin FH, 2009, CURR DIR PSYCHOL SCI, V18, P43, DOI 10.1111/j.1467-8721.2009.01603.x; ELLIOTT BC, 1976, MED SCI SPORT EXER, V8, P84; Franchak JM, 2010, VISION RES, V50, P2758, DOI 10.1016/j.visres.2010.09.019; Gibson J.J., 1986, ECOLOGICAL APPROACH; GIBSON JJ, 1958, BRIT J PSYCHOL, V49, P182, DOI 10.1111/j.2044-8295.1958.tb00656.x; Graff C, 2014, J MATH PSYCHOL, V60, P82, DOI 10.1016/j.jmp.2014.02.001; GRIEVE DW, 1966, ERGONOMICS, V9, P379, DOI 10.1080/00140136608964399; HULT RE, 1986, PERCEPT MOTOR SKILL, V63, P163, DOI 10.2466/pms.1986.63.1.163; Ijsselsteijn WA, 2006, PRESENCE-TELEOP VIRT, V15, P688, DOI 10.1162/pres.15.6.688; ISHIGAKI H, 1993, PERCEPT MOTOR SKILL, V77, P835, DOI 10.2466/pms.1993.77.3.835; Jacobs A, 2005, J EXP PSYCHOL HUMAN, V31, P157, DOI 10.1037/0096-1523.31.1.157; Kassler L., 2010, P 7 S APPL PERC GRAP; Kemeny A, 2003, TRENDS COGN SCI, V7, P31, DOI 10.1016/S1364-6613(02)00011-6; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; Kong PW, 2012, GAIT POSTURE, V36, P46, DOI 10.1016/j.gaitpost.2012.01.001; Kong PW, 2009, SPORT BIOMECH, V8, P52, DOI 10.1080/14763140802629990; Kunz BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054446; Lavcanska V, 2005, HUM MOVEMENT SCI, V24, P544, DOI 10.1016/j.humov.2005.08.001; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; Marsh AP, 2006, MED SCI SPORT EXER, V38, P1157, DOI 10.1249/01.mss.0000222844.81638.35; Mohler BJ, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1227134/1227138; Monte AD, 1973, TREADMILL USED TRAIN, P359; NELSON RC, 1972, MED SCI SPORT EXER, V4, P233, DOI 10.1249/00005768-197200440-00029; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; Powell W., 2011, 3 IEEE VR 2011 WORKS; Pretto P, 2012, ELIFE, V1, DOI 10.7554/eLife.00031; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Prokop T, 1997, EXP BRAIN RES, V114, P63, DOI 10.1007/PL00005624; Redding GM, 1997, J MOTOR BEHAV, V29, P119, DOI 10.1080/00222899709600827; RIESER JJ, 1995, J EXP PSYCHOL HUMAN, V21, P480, DOI 10.1037/0096-1523.21.3.480; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Sanchez-Lopez J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091112; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; Sekiya N, 1996, J HUM MOVEMENT STUD, V30, P241; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; van Andel S, 2017, HUM MOVEMENT SCI, V51, P59, DOI 10.1016/j.humov.2016.11.004; Wank V, 1998, INT J SPORTS MED, V19, P455, DOI 10.1055/s-2007-971944; White SC, 1998, MED SCI SPORT EXER, V30, P1537, DOI 10.1097/00005768-199810000-00011; Williams EL, 2015, J SCI MED SPORT, V18, P486, DOI 10.1016/j.jsams.2014.07.003	56	6	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0219017	10.1371/journal.pone.0219017	http://dx.doi.org/10.1371/journal.pone.0219017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242254	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600075
J	Li, CC; Wang, LX; Li, JL; Gao, CL; Luo, YQ; Ren, LL				Li, Chengcheng; Wang, Lixiang; Li, Jiale; Gao, Chenglong; Luo, Youqing; Ren, Lili			Thermal survival limits of larvae and adults of Sirex noctilio (Hymenoptera: Siricidae) in China	PLOS ONE			English	Article							AMYLOSTEREUM-AREOLATUM; POTENTIAL DISTRIBUTION; FUNGAL SYMBIONT; BODY-SIZE; WOODWASP; PEST	Temperature can be a major factor for the distribution of insects, especially among invasive insects. Sirex noctilio (Hymenoptera: Siricidae) has invaded many regions in China, causing enormous ecological and economic losses. We aimed to explore the trend and potential of diffusion by researching the thermal survival limits of S. noctilio. We measured the supercooling point (SCP), critical thermal temperature (CTmax), high lethal temperature (HLT) and low lethal temperature (LLT) for S. noctilio population in China and assessed life stage-related variation in thermal tolerance. Moreover, we determined the temperature tolerance range of S. noctilio and identified the temperature parameters for its potential invasive distribution risk analysis. The SCP of adults was -11.78 +/- 0.67 (mean +/- SEM), the CTmax was 37.67 +/- 0.54, and those of larvae were -20.77 +/- 0.44 and 40.53 +/- 0.27, respectively. The LLT increased with exposure time, and the HLT was generally near 43 degrees C. S. noctilio adults can tolerate higher temperatures than larvae, and the larvae showed high resistance to cold temperature. We calculated several temperature indexes based on our results, such as the lower temperature threshold (DV0) at -2.7 degrees C, the upper temperature threshold (DV3) at 31 degrees C, the temperature threshold for both heat stress (TTHS) at 35 degrees C and cold stress (TTCS) at -32.5 degrees C. We observed that, S. noctilio was not resistant to high temperatures, its CTmax is slightly lower than the lethal temperature, and the adults were more tolerant than larvae. Our next goal was to combine the temperature tolerance of symbiotic fungi, information on climate change and the current distribution of this species to predict its potential global distribution.	[Li, Chengcheng; Wang, Lixiang; Li, Jiale; Gao, Chenglong; Luo, Youqing; Ren, Lili] Beijing Forestry Univ, Sch Forestry, Sino France Joint Lab Invas Forest Pests Eurasia, Beijing, Peoples R China	Beijing Forestry University	Luo, YQ; Ren, LL (corresponding author), Beijing Forestry Univ, Sch Forestry, Sino France Joint Lab Invas Forest Pests Eurasia, Beijing, Peoples R China.	youqingluo@126.com; lily_ren@bjfu.edu.cn	li, jia/GVT-7587-2022		Beijing's Science and Technology Planning Project [Z171100001417005]; National Key R & D Program of China [2018YFC1200400]; National Natural Science Foundation of China [31500529]	Beijing's Science and Technology Planning Project; National Key R & D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work received support from Beijing's Science and Technology Planning Project (Z171100001417005)"; National Key R & D Program of China "2018YFC1200400"; National Natural Science Foundation of China (31500529).	[Anonymous], 2018, ROUT INT HANDB; Bale JS, 2010, INSECT OVERWINTERING; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Chung KS, 2001, HYDROBIOLOGIA, V462, P253, DOI 10.1023/A:1013158904036; Feng YQ, 2014, ENVIRON ENTOMOL, V43, P1419, DOI 10.1603/EN13352; Ge XZ, 2019, PEST MANAG SCI, V75, P160, DOI 10.1002/ps.5083; Goulet H, 2011, SIREX WOODWASP ITS F; Hahn DA, 2008, ENVIRON ENTOMOL, V37, P1074, DOI 10.1603/0046-225X(2008)37[1074:BSBNCR]2.0.CO;2; Halbritter DA, 2018, J INSECT PHYSIOL, V107, P204, DOI 10.1016/j.jinsphys.2018.03.005; Heinrich EC, 2017, J THERM BIOL, V69, P267, DOI 10.1016/j.jtherbio.2017.08.009; Hoebeke E, 2005, SIREX NOCTILIO DISCO; Hu JT, 2014, J INSECT PHYSIOL, V67, P105, DOI 10.1016/j.jinsphys.2014.06.009; Hurley BP, 2008, BIOL CONTROL, V45, P450, DOI 10.1016/j.biocontrol.2008.02.010; Iede ET, 1998, P C TRAIN CONTR SIR; JAMIESON J, 1957, NZ J FOR, V1, P32; KING JM, 1966, AUST J BOT, V14, P25, DOI 10.1071/BT9660025; Kirk A. A., 1974, Australian Forestry, V37, P126; Kitching RL, 1981, SOME AUSTR CASE HIST; Lee Jr R. E., 2010, LOW TEMPERATURE BIOL; Li ChengCheng, 2019, Journal of Northeast Forestry University, V47, P112; Li DP, 2015, J ECON ENTOMOL, V108, P1136, DOI 10.1093/jee/tov072; Li X, 2019, PEST MANAG SCI, V75, P215, DOI 10.1002/ps.5092; Ma G, 2012, J INSECT PHYSIOL, V58, P1456, DOI 10.1016/j.jinsphys.2012.08.012; MADDEN JL, 1981, AUST J ZOOL, V29, P493, DOI 10.1071/ZO9810493; Madden JL, 1988, SIREX AUSTRALASIA; Makarieva AM, 2005, OIKOS, V111, P425, DOI 10.1111/j.1600-0706.2005.14095.x; Morgan FD, 1966, T ROYSOCNZ; Nahrung HF, 2017, AUSTRAL ENTOMOL, V56, P148, DOI 10.1111/aen.12217; Pieterse W, 2017, J INSECT PHYSIOL, V98, P1, DOI 10.1016/j.jinsphys.2016.11.004; Rwomushana I, 2010, J APPL ENTOMOL, V132, P832; Sibilia CD, 2018, J INSECT SCI, V18, DOI 10.1093/jisesa/iey066; Sinclair BJ, 2015, J THERM BIOL, V53, P180, DOI 10.1016/j.jtherbio.2015.11.003; Stroganova V.K.., 1968, ROGOKHVOSTY SIBIRI; Sun XT, 2016, J ECON ENTOMOL, V109, P1424, DOI 10.1093/jee/tow060; Tribe GD, 1995, AFR ENTOMOL, V3, P215; UVAROV B. P., 1931, TRANS ENT SOC [LONDON], V79, P1; Lantschner MV, 2014, BIOL INVASIONS, V16, P329, DOI 10.1007/s10530-013-0521-0	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218888	10.1371/journal.pone.0218888	http://dx.doi.org/10.1371/journal.pone.0218888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242259	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600061
J	Baecker, A; Kim, S; Risch, HA; Nuckols, TK; Wu, BU; Hendifar, AE; Pandol, SJ; Pisegna, JR; Jeon, CY				Baecker, Aileen; Kim, Sungjin; Risch, Harvey A.; Nuckols, Teryl K.; Wu, Bechien U.; Hendifar, Andrew E.; Pandol, Stephen J.; Pisegna, Joseph R.; Jeon, Christie Y.			Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data	PLOS ONE			English	Article							POOLED ANALYSIS; EPIDEMIOLOGY; METAANALYSIS; POPULATION; DIAGNOSIS	Background and objective Early detection methods for pancreatic cancer are lacking. We aimed to develop a prediction model for pancreatic cancer based on changes in health captured by healthcare claims data. Methods We conducted a case-control study on 29,646 Medicare-enrolled patients aged 68 years and above with pancreatic ductal adenocarcinoma (PDAC) reported to the Surveillance Epidemiology an End Results (SEER) tumor registries program in 2004-2011 and 88,938 age and sex-matched controls. We developed a prediction model using multivariable logistic regression on Medicare claims for 16 risk factors and pre-diagnostic symptoms of PDAC present within 15 months prior to PDAC diagnosis. Claims within 3 months of PDAC diagnosis were excluded in sensitivity analyses. We evaluated the discriminatory power of the model with the area under the receiver operating curve (AUC) and performed cross-validation by bootstrapping. Results The prediction model on all cases and controls reached AUC of 0.68. Excluding the final 3 months of claims lowered the AUC to 0.58. Among new-onset diabetes patients, the prediction model reached AUC of 0.73, which decreased to 0.63 when claims from the final 3 months were excluded. Performance measures of the prediction models was confirmed by internal validation using the bootstrap method. Conclusion Models based on healthcare claims for clinical risk factors, symptoms and signs of pancreatic cancer are limited in classifying those who go on to diagnosis of pancreatic cancer and those who do not, especially when excluding claims that immediately precede the diagnosis of PDAC.	[Baecker, Aileen; Jeon, Christie Y.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Kim, Sungjin; Nuckols, Teryl K.; Hendifar, Andrew E.; Pandol, Stephen J.; Jeon, Christie Y.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Risch, Harvey A.] Yale Sch Publ Hlth, New Haven, CT USA; [Wu, Bechien U.] Kaiser Permanente Southern Calif, Res & Evaluat, Pasadena, CA USA; [Pisegna, Joseph R.; Jeon, Christie Y.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Yale University; Kaiser Permanente; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Jeon, CY (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.; Jeon, CY (corresponding author), Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.; Jeon, CY (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.	christie.jeon@cshs.org	Scott, Teryl Nuckols/AAH-9711-2021	Jeon, Christie/0000-0002-5739-2477	 [R21CA220073];  [U01DK108314]; NATIONAL CANCER INSTITUTE [R21CA220073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK108314] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CYJ, SK, HAR, TKN, and SJP are supported in part by R21CA220073. CYJ, BUW, JP, SJP are supported in part by U01DK108314.	Alsamarrai A, 2014, CLIN GASTROENTEROL H, V12, P1635, DOI 10.1016/j.cgh.2014.01.038; American Cancer Society, 2016, CANC FACTS FIGURES 2; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Bosetti C, 2014, ANN ONCOL, V25, P2065, DOI 10.1093/annonc/mdu276; Boursi B, 2017, GASTROENTEROLOGY, V152, P840, DOI 10.1053/j.gastro.2016.11.046; Chari ST, 2005, GASTROENTEROLOGY, V129, P504, DOI 10.1053/j.gastro.2005.05.007; Cylus Jonathan, 2015, Health Syst Transit, V17, P1; Division of Cancer Control and Population Sciences NCI, 2018, SURV EP END RES SEER; Duell EJ, 2012, ANN ONCOL, V23, P2964, DOI 10.1093/annonc/mds140; Engels EA, 2011, AM J EPIDEMIOL, V174, P860, DOI 10.1093/aje/kwr146; Hardin JW, 2003, GEN ESTIMATING EQUAT, Vxiii; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE, 2001, REGRESSION MODELING, Vxxii; Hebert PL, 2005, HEALTH SERV RES, V40, P517, DOI 10.1111/j.1475-6773.2005.0e371.x; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Keane MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005720; Klein AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072311; Lucenteforte E, 2012, ANN ONCOL, V23, P374, DOI 10.1093/annonc/mdr120; Olson SH, 2016, PANCREAS, V45, P986, DOI 10.1097/MPA.0000000000000590; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Risch HA, 2019, JNCI-J NATL CANCER I, V111, P1, DOI 10.1093/jnci/djy093; Risch HA, 2015, AM J EPIDEMIOL, V182, P26, DOI 10.1093/aje/kwv026; Schulte A, 2016, CANCER EPIDEMIOL, V45, P145, DOI 10.1016/j.canep.2016.10.005; Scott TL, 2002, MED CARE, V40, P395, DOI 10.1097/00005650-200205000-00005; SEER Program (National Cancer Institute (U. S.)), 2016, SEER STAT FACT SHEET; Sharma A, 2018, GASTROENTEROLOGY, V155, P730, DOI 10.1053/j.gastro.2018.05.023; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Stapley S, 2012, BRIT J CANCER, V106, P1940, DOI 10.1038/bjc.2012.190; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Warren JL, 2002, MED CARE, V40, P55; Warren Joan L, 2002, Med Care, V40, pIV; Wolff RF, 2019, ANN INTERN MED, V170, P51, DOI 10.7326/M18-1376; Yamashita T, 2007, COMMUN STAT-THEOR M, V36, P2395, DOI 10.1080/03610920701215639; Yu A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146473	38	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218580	10.1371/journal.pone.0218580	http://dx.doi.org/10.1371/journal.pone.0218580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237889	gold, Green Published, Green Submitted			2022-12-26	WOS:000484856000026
J	Kotsias, F; Bucafusco, D; Nunez, DA; Borisovsky, LAL; Rodriguez, M; Bratanich, AC				Kotsias, Fiorella; Bucafusco, Danilo; Anabel Nunez, Denise; Lago Borisovsky, Lucia Antonella; Rodriguez, Mariana; Cristina Bratanich, Ana			Genomic characterization of canine circovirus associated with fatal disease in dogs in South America	PLOS ONE			English	Article							PORCINE CIRCOVIRUS; PARVOVIRUS; TYPE-2; PHYLOGENIES; COINFECTION; INFECTIONS; EVOLUTION; SEQUENCE; HISTORY; VIRUS	Canine circovirus (CanineCV) was detected, together with canine parvovirus (CPV), in samples from an outbreak of fatal gastroenteritis in dogs in Argentina. We obtained the full-length genome of this recently discovered virus by overlapping PCR, designated strain UBA-Baires. Sequence analysis revealed a highly conserved genome but also showed several unique mutations in amino acids from the capsid protein that have not been previously reported. Phylogenetic analysis shows that this strain is more closely related to European strains than to viruses detected in North America or Asia. Although the pathogenic role of CanineCV in dogs is still unclear, this study highlights the importance of CanineCV as a coinfecting virus in disease development. To our knowledge, this is the first report of the involvement of CanineCV in severe clinical disease in dogs in South America. Our results expand our information on the geographical extent of this virus and contribute to the understanding of its role in disease.	[Kotsias, Fiorella; Bucafusco, Danilo; Anabel Nunez, Denise; Lago Borisovsky, Lucia Antonella; Cristina Bratanich, Ana] Univ Buenos Aires, Fac Ciencias Vet, Catedra Virol, Buenos Aires, DF, Argentina; [Kotsias, Fiorella; Cristina Bratanich, Ana] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Prod Anim INPA, Buenos Aires, DF, Argentina; [Bucafusco, Danilo] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Rodriguez, Mariana] DVM, Private Practice, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bratanich, AC (corresponding author), Univ Buenos Aires, Fac Ciencias Vet, Catedra Virol, Buenos Aires, DF, Argentina.; Bratanich, AC (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Prod Anim INPA, Buenos Aires, DF, Argentina.	abratanich@fvet.uba.ar	Bucafusco, Danilo/AFQ-4876-2022	Bucafusco, Danilo/0000-0002-2844-7475				Allan GM, 1999, J COMP PATHOL, V121, P1, DOI 10.1053/jcpa.1998.0295; Allan G, 2012, VIRUS RES, V164, P4, DOI 10.1016/j.virusres.2011.09.013; Anderson A, 2017, VET REC, V180, P542, DOI 10.1136/vr.103926; Breitbart M, 2017, J GEN VIROL, V98, P1997, DOI 10.1099/jgv.0.000871; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; Correa-Fiz F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33849-2; Decaro N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105909; Dowgier G, 2017, VET MICROBIOL, V204, P54, DOI 10.1016/j.vetmic.2017.04.007; Ellis JA, 2000, J VET DIAGN INVEST, V12, P21, DOI 10.1177/104063870001200104; Franzo G, 2016, SCI REP-UK, V6, DOI 10.1038/srep39458; Gentil M, 2017, TIERAERZTL PRAX K H, V45, P89, DOI 10.15654/TPK-160701; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hsu HS, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0722-8; Kapoor A, 2012, J VIROL, V86, P7018, DOI 10.1128/JVI.00791-12; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Li LL, 2013, EMERG INFECT DIS, V19, P534, DOI 10.3201/eid1904.121390; Opriessnig T, 2012, VIRUS RES, V164, P20, DOI 10.1016/j.virusres.2011.09.014; Pesavento PA, 2014, VET PATHOL, V51, P478, DOI 10.1177/0300985813511129; Piewbang C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25936-1; Segales J, 2013, VET MICROBIOL, V165, P13, DOI 10.1016/j.vetmic.2012.12.033; Sun W., 2019, CHINA VIRUS RES, V259, P85, DOI DOI 10.1016/j.virusres.2018.10.021; Thaiwong T, 2016, VET PATHOL, V53, P1204, DOI 10.1177/0300985816646430; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weber MN, 2018, VIROLOGY, V525, P192, DOI 10.1016/j.virol.2018.09.023; Zaccaria G, 2016, VIROLOGY, V490, P69, DOI 10.1016/j.virol.2016.01.007	27	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218735	10.1371/journal.pone.0218735	http://dx.doi.org/10.1371/journal.pone.0218735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237902	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000037
J	Schaller, D; Hagenow, S; Stark, H; Wolberd, G				Schaller, David; Hagenow, Stefanie; Stark, Holger; Wolberd, Gerhard			Ligand-guided homology modeling drives identification of novel histamine H3 receptor ligands	PLOS ONE			English	Article							PROTEIN STRUCTURES; ANTAGONISTS; DISCOVERY; STRATEGIES; COMPLEX; BINDING; SEARCH; POTENT; AMIDES	In this study, we report a ligand-guided homology modeling approach allowing the analysis of relevant binding site residue conformations and the identification of two novel histamine H-3 receptor ligands with binding affinity in the nanomolar range. The newly developed method is based on exploiting an essential charge interaction characteristic for aminergic G-protein coupled receptors for ranking 3D receptor models appropriate for the discovery of novel compounds through virtual screening.	[Schaller, David; Wolberd, Gerhard] Free Univ Berlin, Inst Pharm, Mol Design Lab, Pharmaceut & Med Chem, Berlin, Germany; [Hagenow, Stefanie; Stark, Holger] Heinrich Heine Univ Dusseldorf, Fac Math & Nat Sci, Dept Pharm, Inst Pharmaceut & Med Chem, Dusseldorf, Nordrhein Westf, Germany	Free University of Berlin; Heinrich Heine University Dusseldorf	Wolberd, G (corresponding author), Free Univ Berlin, Inst Pharm, Mol Design Lab, Pharmaceut & Med Chem, Berlin, Germany.	gerhard.wolber@fu-berlin.de	Wolber, Gerhard/ABD-4955-2020; Stark, Holger/A-4235-2009; Wolber, Gerhard/C-7133-2008	Wolber, Gerhard/0000-0002-5344-0048; Stark, Holger/0000-0003-3336-1710; Wolber, Gerhard/0000-0002-5344-0048; Schaller, David/0000-0002-1881-4518	Elsa-Neumann-Foundation in Berlin	Elsa-Neumann-Foundation in Berlin	This work was funded by the Elsa-Neumann-Foundation in Berlin to DS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson JT, 2010, BIOORG MED CHEM LETT, V20, P6246, DOI 10.1016/j.bmcl.2010.08.099; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Becknell NC, 2011, BIOORG MED CHEM LETT, V21, P7076, DOI 10.1016/j.bmcl.2011.09.091; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Berlin M, 2011, J MED CHEM, V54, P26, DOI 10.1021/jm100064d; Berlin M, 2010, BIOORG MED CHEM LETT, V20, P2359, DOI 10.1016/j.bmcl.2010.01.121; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Bruysters M, 2004, EUR J PHARMACOL, V487, P55, DOI 10.1016/j.ejphar.2004.01.028; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cole JC, 2005, VIRTUAL SCREENING IN DRUG DISCOVERY, P379; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Freyd T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173889; Gao ZL, 2013, BIOORG MED CHEM LETT, V23, P3416, DOI 10.1016/j.bmcl.2013.03.080; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khanfar MA, 2018, BIOORGAN MED CHEM, V26, P4034, DOI 10.1016/j.bmc.2018.06.028; Khanfar MA, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00201; Kiss R, 2016, EXPERT OPIN DRUG DIS, V11, P1165, DOI 10.1080/17460441.2016.1245288; Kolaczkowski M, 2013, J CHEM INF MODEL, V53, P638, DOI 10.1021/ci300413h; Kooistra AJ, 2013, BRIT J PHARMACOL, V170, P101, DOI 10.1111/bph.12248; Kottke T, 2011, EUR J PHARMACOL, V654, P200, DOI 10.1016/j.ejphar.2010.12.033; Lavecchia A, 2013, CURR MED CHEM, V20, P2839, DOI 10.2174/09298673113209990001; Letavic MA, 2010, BIOORG MED CHEM LETT, V20, P4210, DOI 10.1016/j.bmcl.2010.05.041; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Michino M, 2015, PHARMACOL REV, V67, P198, DOI 10.1124/pr.114.009944; MOGUILEVSKY N, 1995, J RECEPT SIGNAL TR R, V15, P91, DOI 10.3109/10799899509045210; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Nikolic K, 2015, J TAIWAN INST CHEM E, V46, P15, DOI 10.1016/j.jtice.2014.09.017; Pavlov D., 2011, J CHEM-NY, V3, P4, DOI [DOI 10.1186/1758-2946-3-S1-P4, 10.1186/1758-2946-3-S1-P4]; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Ragland DA, 2017, J CHEM THEORY COMPUT, V13, P5671, DOI 10.1021/acs.jctc.7b00601; Ripphausen P, 2010, J MED CHEM, V53, P8461, DOI 10.1021/jm101020z; Rodriguez D, 2014, J CHEM INF MODEL, V54, P2004, DOI 10.1021/ci5002235; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schaller D, 2017, ACS MED CHEM LETT, V8, P648, DOI 10.1021/acsmedchemlett.7b00118; Schmidt T, 2014, DRUG DISCOV TODAY, V19, P890, DOI 10.1016/j.drudis.2013.10.027; Schneider G, 1999, ANGEW CHEM INT EDIT, V38, P2894, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Thal DM, 2016, NATURE, V531, P335, DOI 10.1038/nature17188; Thorsen TS, 2014, STRUCTURE, V22, P1657, DOI 10.1016/j.str.2014.08.022; Uveges AJ, 2002, J PHARMACOL EXP THER, V301, P451, DOI 10.1124/jpet.301.2.451; Wager TT, 2011, J MED CHEM, V54, P7602, DOI 10.1021/jm200939b; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Watanabe M, 2006, J MED CHEM, V49, P5587, DOI 10.1021/jm0603318; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Zaragoza F, 2005, J MED CHEM, V48, P306, DOI 10.1021/jm040873u	54	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218820	10.1371/journal.pone.0218820	http://dx.doi.org/10.1371/journal.pone.0218820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237914	Green Published, Green Submitted, gold			2022-12-26	WOS:000484856000043
J	Griffin, BR; You, ZY; Holmen, J; SooHoo, M; Gist, KM; Colbert, JF; Chonchol, M; Faubel, S; Jovanovich, A				Griffin, Benjamin R.; You, Zhiying; Holmen, John; SooHoo, Megan; Gist, Katja M.; Colbert, James F.; Chonchol, Michel; Faubel, Sarah; Jovanovich, Anna			Incident infection following acute kidney injury with recovery to baseline creatinine: A propensity score matched analysis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; LONG-TERM RISK; MORTALITY; DIALYSIS; CONSEQUENCES; EPIDEMIOLOGY; ASSOCIATION; DYSFUNCTION; DISEASE	Background Severe acute kidney injury (AKI) is associated with subsequent infection. Whether AKI followed by a return to baseline creatinine is associated with incident infection is unknown. Objective We hypothesized that risk of both short and long term infection would be higher among patients with AKI and return to baseline creatinine than in propensity score matched peers without AKI in the year following a non-infectious hospital admission. Design Retrospective, propensity score matched cohort study. Participants We identified 494 patients who were hospitalized between January 1, 1999 and December 31, 2009 and had AKI followed by return to baseline creatinine. These were propensity score matched to controls without AKI. Main Measures The predictor variable was AKI defined by International Classification of Diseases, Ninth Revision (ICD-9) codes and by the Kidney Disease Improving Global Outcomes definition, with return to baseline creatinine defined as a decrease in serum creatinine level to within 10% of the baseline value within 7 days of hospital discharge. The outcome variable was incident infection defined by ICD-9 code within 1 year of hospital discharge. Results AKI followed by return to baseline creatinine was associated with a 4.5-fold increased odds ratio for infection (odds ratio 4.53 [95% CI, 2.43-8.45]; p<0.0001) within 30 days following discharge. The association between AKI and subsequent infection remained significant at 31-60 days and 91 to 365 days but not during 61-90 days following discharge. Conclusion Among patients from an integrated health care delivery system, non-infectious AKI followed by return to baseline creatinine was associated with an increased odds ratio for infection in the year following discharge.	[Griffin, Benjamin R.; You, Zhiying; Chonchol, Michel; Faubel, Sarah; Jovanovich, Anna] Univ Colorado Denver, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO 80204 USA; [Holmen, John] Intermt Healthcare Syst, Salt Lake City, UT USA; [SooHoo, Megan; Gist, Katja M.] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA; [Colbert, James F.] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA; [Faubel, Sarah; Jovanovich, Anna] VA Eastern Colorado Hlth Care Syst, Renal Sect, Denver, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Jovanovich, A (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO 80204 USA.; Jovanovich, A (corresponding author), VA Eastern Colorado Hlth Care Syst, Renal Sect, Denver, CO 80045 USA.	Anna.Jovanovich@ucdenver.edu		Griffin, Benjamin/0000-0001-8599-5462	NIH T32 program [5T32DK007135-43]; Veterans Administration [CDA 5IK2CX001030-03]; Intermountain Healthcare System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG061144] Funding Source: NIH RePORTER	NIH T32 program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); Intermountain Healthcare System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	BG is supported by NIH T32 program 5T32DK007135-43. AJ is supported by Veterans Administration CDA 5IK2CX001030-03. JH is supported by the Intermountain Healthcare System. The funder, Intermountain Healthcare System, provides support in the form of salary for author, JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2017, INTEMOUNTAIN HELPING; Bates DW, 2001, CLIN INFECT DIS, V32, P686, DOI 10.1086/319211; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Brown JR, 2016, AM J NEPHROL, V43, P261, DOI 10.1159/000445846; Chao CT, 2014, J CANCER RES CLIN, V140, P613, DOI 10.1007/s00432-014-1600-z; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chawla LS, 2014, CLIN J AM SOC NEPHRO, V9, P448, DOI 10.2215/CJN.02440213; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2007, AM J KIDNEY DIS, V50, P712, DOI 10.1053/j.ajkd.2007.07.018; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Dalrymple LS, 2008, CLIN J AM SOC NEPHRO, V3, P1487, DOI 10.2215/CJN.01290308; Doyle JF, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1353-y; Faubel S, 2016, ADV CHRONIC KIDNEY D, V23, P179, DOI 10.1053/j.ackd.2016.02.007; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hoste EAJ, 2004, J AM SOC NEPHROL, V15, P454, DOI 10.1097/01.ASN.0000110182.14608.0C; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Lai TS, 2013, CRIT CARE, V17, DOI 10.1186/cc13054; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Mehta RL, 2011, INTENS CARE MED, V37, P241, DOI 10.1007/s00134-010-2089-9; Palant CE, 2017, CURR OPIN ANESTHESIO, V30, P100, DOI 10.1097/ACO.0000000000000428; Parr SK, 2016, ADV CHRONIC KIDNEY D, V23, P186, DOI 10.1053/j.ackd.2016.01.014; Reynvoet E, 2009, CRIT CARE MED, V37, P2203, DOI 10.1097/CCM.0b013e3181a03961; Silver SA, 2015, NEPHRON, V131, P43, DOI 10.1159/000438871; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thakar CV, 2003, KIDNEY INT, V64, P239, DOI 10.1046/j.1523-1755.2003.00040.x; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Walser M, 1998, AM J KIDNEY DIS, V32, P23, DOI 10.1053/ajkd.1998.v32.pm9669420; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wang WJ, 2014, J BONE MINER RES, V29, P676, DOI 10.1002/jbmr.2061; Wu VC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000933; Wu VC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/365186; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Wu VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069556	38	10	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0217935	10.1371/journal.pone.0217935	http://dx.doi.org/10.1371/journal.pone.0217935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233518	gold, Green Published, Green Submitted			2022-12-26	WOS:000484896700009
J	Hardison, DR; Holland, WC; Currier, RD; Kirkpatrick, B; Stumpf, R; Fanara, T; Burris, D; Reich, A; Kirkpatrick, GJ; Litaker, RW				Hardison, D. Ransom; Holland, William C.; Currier, Robert D.; Kirkpatrick, Barbara; Stumpf, Richard; Fanara, Tracy; Burris, Devin; Reich, Andrew; Kirkpatrick, Gary J.; Litaker, R. Wayne			HABscope: A tool for use by citizen scientists to facilitate early warning of respiratory irritation caused by toxic blooms of Karenia brevis	PLOS ONE			English	Article							FLORIDA RED TIDE; HUMAN HEALTH; PYRODINIUM-BAHAMENSE; PTYCHODISCUS-BREVIS; BREVETOXINS; SAXITOXIN; EXPOSURE; SYSTEM	Blooms of the toxic microalga Karenia brevis occur seasonally in Florida, Texas and other portions of the Gulf of Mexico. Brevetoxins produced during Karenia blooms can cause neurotoxic shellfish poisoning in humans, massive fish kills, and the death of marine mammals and birds. Brevetoxin-containing aerosols are an additional problem, having a severe impact on beachgoers, triggering coughing, eye and throat irritation in healthy individuals, and more serious respiratory distress in those with asthma or other breathing disorders. The blooms and associated aerosol impacts are patchy in nature, often affecting one beach but having no impact on an adjacent beach. To provide timely information to visitors about which beaches are low-risk, we developed HABscope; a low cost (similar to$400) microscope system that can be used in the field by citizen scientists with cell phones to enumerate K. brevis cell concentrations in the water along each beach. The HABscope system operates by capturing short videos of collected water samples and uploading them to a central server for rapid enumeration of K. brevis cells using calibrated recognition software. The HABscope has a detection threshold of about 100,000 cells, which is the point when respiratory risk becomes evident. Higher concentrations are reliably estimated up to 10 million cells L-1. When deployed by volunteer citizen scientists, the HABscope consistently distinguished low, medium, and high concentrations of cells in the water. The volunteers were able to collect data on most days during a severe bloom. This indicates that the HABscope can provide an effective capability to significantly increase the sampling coverage during Karenia brevis blooms.	[Hardison, D. Ransom; Holland, William C.; Litaker, R. Wayne] NOAA, Natl Ocean Serv, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC 28516 USA; [Currier, Robert D.; Kirkpatrick, Barbara] Texas A&M Univ, Dept Oceanog, Gulf Mexico Coastal Ocean Observing Syst, College Stn, TX 77843 USA; [Stumpf, Richard] NOAA, Ctr Coastal Management & Assessment, Silver Spring, MD USA; [Fanara, Tracy; Burris, Devin; Kirkpatrick, Gary J.] Mote Marine Lab & Aquarium, Sarasota, FL USA; [Reich, Andrew] Florida Dept Hlth, Publ Hlth Toxicol Sect, Tallahassee, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Texas A&M University System; Texas A&M University College Station; National Oceanic Atmospheric Admin (NOAA) - USA; Mote Marine Laboratory & Aquarium; Florida Department of Health	Hardison, DR (corresponding author), NOAA, Natl Ocean Serv, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC 28516 USA.	rance.hardison@noaa.gov	Litaker, Richard Wayne/AAH-2036-2021	Litaker, Richard Wayne/0000-0001-6293-8000	NASA Research Opportunities in Space and Earth Science (ROSES) [NNH15AB23INRA: NN13ZDA001N]	NASA Research Opportunities in Space and Earth Science (ROSES)	RS and BK received funding for the project from NASA Research Opportunities in Space and Earth Science (ROSES) grant: NNH15AB23INRA: NN13ZDA001N, https://science.nasa.gov/researchers/sara/grant-solicitations/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAI S, 1982, J ALLERGY CLIN IMMUN, V69, P418, DOI 10.1016/0091-6749(82)90116-6; ASAI S, 1984, J ALLERGY CLIN IMMUN, V73, P824, DOI 10.1016/0091-6749(84)90454-8; Backer LC, 2003, HARMFUL ALGAE, V2, P19, DOI 10.1016/S1568-9883(03)00005-2; BADEN DG, 1982, TOXICON, V20, P929, DOI 10.1016/0041-0101(82)90081-2; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Currier RD, 2009, OCEANS-IEEE, P2508; Edler L, 2010, MICROSCOPIC MOL METH, V110; Fleming LE, 2005, ENVIRON HEALTH PERSP, V113, P650, DOI 10.1289/ehp.7500; Fleming LE, 2007, CHEST, V131, P187, DOI 10.1378/chest.06-1830; Fleming LE, 2011, HARMFUL ALGAE, V10, P224, DOI 10.1016/j.hal.2010.08.006; FRANZ DR, 1989, TOXICON, V27, P647, DOI 10.1016/0041-0101(89)90015-9; HARADA T, 1982, B JPN SOC SCI FISH, V48, P821; Hoagland P, 2014, ENVIRON INT, V68, P144, DOI 10.1016/j.envint.2014.03.016; Hoagland P, 2009, ENVIRON HEALTH PERSP, V117, P1239, DOI 10.1289/ehp.0900645; Kirkpatrick B, 2008, SCI TOTAL ENVIRON, V402, P1, DOI 10.1016/j.scitotenv.2008.03.032; Kirkpatrick B, 2010, HARMFUL ALGAE, V9, P186, DOI 10.1016/j.hal.2009.09.003; Landsberg JH, 2006, ENVIRON HEALTH PERSP, V114, P1502, DOI 10.1289/ehp.8998; Milian A, 2007, J ASTHMA, V44, P583, DOI 10.1080/02770900701539251; Morgan KL, 2009, HARMFUL ALGAE, V8, P212, DOI 10.1016/j.hal.2008.05.002; National Center for Health Statistics, 2015, HLTH US 2014 SPEC FE; Newson SE, 2017, BIOL CONSERV, V215, P61, DOI 10.1016/j.biocon.2017.09.004; Nierenberg K, 2011, HARMFUL ALGAE, V10, P374, DOI 10.1016/j.hal.2011.01.004; POLI MA, 1986, MOL PHARMACOL, V30, P129; Seegers BN, 2018, OPT EXPRESS, V26, P7404, DOI 10.1364/OE.26.007404; Stumpf RP, 2009, J MARINE SYST, V76, P151, DOI 10.1016/j.jmarsys.2008.05.016; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Voigt GL., 2011, HEMATOLOGY TECHNIQUE; Watkins SM, 2008, MAR DRUGS, V6, P431, DOI 10.3390/md20080021; Wiersma YF, 2010, AVIAN CONSERV ECOL, V5	30	8	8	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218489	10.1371/journal.pone.0218489	http://dx.doi.org/10.1371/journal.pone.0218489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220134	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500054
J	Kenyon, JJ; Arbatsky, NP; Shneider, MM; Popova, AV; Dmitrenok, AS; Kasimova, AA; Shashkov, AS; Hall, RM; Knirel, YA				Kenyon, Johanna J.; Arbatsky, Nikolay P.; Shneider, Mikhail M.; Popova, Anastasiya V.; Dmitrenok, Andrei S.; Kasimova, Anastasiya A.; Shashkov, Alexander S.; Hall, Ruth M.; Knirel, Yuriy A.			The K46 and K5 capsular polysaccharides produced by Acinetobacter baumannii NIPH 329 and SDF have related structures and the side-chain non-ulosonic acids are 4-O-acetylated by phage-encoded O-acetyltransferases	PLOS ONE			English	Article							GENE-CLUSTER; ANTIGEN; UNIT; GLUCOSYLATION; BIOSYNTHESIS	Acinetobacter baumannii isolate NIPH 329 carries a novel capsular polysaccharide (CPS) gene cluster, designated KL46, that is closely related to the KL5 locus in A. baumannii isolate SDF but includes genes for synthesis of 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-non-2-ulosonic (di-N-acetylpseudaminic) acid (Pse5Ac7Ac) instead of the corresponding D-glycero-D-galacto isomer (di-N-acetyllegionaminic acid) (Leg5Ac7Ac). In agreement with the genetic content of KL46, chemical studies of the K46 CPS produced by NIPH 329 revealed a branched tetrasaccharide repeat (K unit) with an overall structure the same as K5 from SDF but with (a) over cap -Pse5Ac7Ac replacing alpha-Leg5Ac7Ac. As for K5, the K46 unit begins with D-GalpNAc and includes alpha-D-GlcpNAc-(1 -> 3)-D-GalpNAc and alpha-D-Galp-(1 -> 6)-D-GlcpNAc linkages, formed by Gtr14 and Gtr15 glycosyltransferases, respectively. The Gtr94(K46) glycosyltransferase, which is related to Gtr13(K5), links Pse5Ac7Ac to D-Galp in the growing K unit via a (a) over cap-(2 -> 6) linkage. Nearly identical Wzy enzymes connect the K46 and K5 units via a alpha-D-GalpNAc-(1 -> 3)-alpha-D-Galp linkage to form closely related CPSs. Both Pse5Ac7Ac in K46 and Leg5Ac7Ac in K5 are acetylated at O4 but no acetyltransferase gene is present in KL46 or KL5. Related acetyltransferases were found encoded in the NIPH 329 and SDF genomes, but not in other strains carrying an unacetylated Pse or Leg derivative in the CPS. The genes encoding the acetyltransferases were in different putative phage genomes. However, related acetyltransferases were rare among the > 3000 publically available genome sequences.	[Kenyon, Johanna J.] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Arbatsky, Nikolay P.; Dmitrenok, Andrei S.; Kasimova, Anastasiya A.; Shashkov, Alexander S.; Knirel, Yuriy A.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia; [Shneider, Mikhail M.] Russian Acad Sci, MM Shemyakin & YA Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Popova, Anastasiya V.] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia; [Popova, Anastasiya V.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia; [Kasimova, Anastasiya A.] DI Mendeleev Univ Chem Technol Russia, Russian Acad Sci, Higher Chem Coll, Moscow, Russia; [Hall, Ruth M.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	Queensland University of Technology (QUT); Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; Mendeleev University of Chemical Technology of Russia; Russian Academy of Sciences; University of Sydney	Kenyon, JJ (corresponding author), Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.	johanna.kenyon@qut.edu.au	Kenyon, Johanna J/AAA-3622-2022; Shneider, Mikhail/AAL-6817-2020; Dmitrenok, Andrey/T-6169-2018; Kasimova, Anastasia/AAG-7516-2021	Kenyon, Johanna J/0000-0002-1487-6105; Shneider, Mikhail/0000-0002-3768-3541; Dmitrenok, Andrey/0000-0003-3736-0459; Kasimova, Anastasiya/0000-0002-6685-4098	Russian Science Foundation [19-14-00273]; Australian Research Council (ARC) DECRA fellowship [180101563]	Russian Science Foundation(Russian Science Foundation (RSF)); Australian Research Council (ARC) DECRA fellowship(Australian Research Council)	This work was financially supported by the Russian Science Foundation (project No. 19-14-00273) to YAK and an Australian Research Council (ARC) DECRA fellowship 180101563 to JJK.	Arbatsky NP, 2019, RUSS CHEM B+, V68, P163, DOI 10.1007/s11172-019-2432-4; Arbatsky NP, 2016, RUSS CHEM B+, V65, P588, DOI 10.1007/s11172-016-1342-y; Arbatsky NP, 2018, INT J BIOL MACROMOL, V117, P1195, DOI 10.1016/j.ijbiomac.2018.06.029; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; Haseley SR, 1997, EUR J BIOCHEM, V250, P617, DOI 10.1111/j.1432-1033.1997.0617a.x; Kasimova AA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P831, DOI 10.1134/S0006297918070064; Kasimova AA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P483, DOI 10.1134/S0006297917040101; Kasimova AA, 2018, GLYCOBIOLOGY, V28, P876, DOI 10.1093/glycob/cwy074; Kenyon JJ, 2019, INT J BIOL MACROMOL, V128, P101, DOI 10.1016/j.ijbiomac.2019.01.080; Kenyon JJ, 2017, CARBOHYD RES, V452, P149, DOI 10.1016/j.carres.2017.10.005; Kenyon JJ, 2017, INT J BIOL MACROMOL, V103, P648, DOI 10.1016/j.ijbiomac.2017.05.082; Kenyon JJ, 2017, MICROBIOL-SGM, V163, P355, DOI 10.1099/mic.0.000430; Kenyon JJ, 2016, CARBOHYD RES, V434, P12, DOI 10.1016/j.carres.2016.07.016; Kenyon JJ, 2016, MICROBIOL-SGM, V162, P1479, DOI 10.1099/mic.0.000313; Kenyon JJ, 2015, CARBOHYD RES, V409, P30, DOI 10.1016/j.carres.2015.03.016; Kenyon JJ, 2014, GLYCOBIOLOGY, V24, P554, DOI 10.1093/glycob/cwu024; Kenyon JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062160; Knirel YA, 2003, ADV CARBOHYD CHEM BI, V58, P371, DOI 10.1016/S0065-2318(03)58007-6; LIPKIND GM, 1988, CARBOHYD RES, V181, P1, DOI 10.1016/0008-6215(88)84018-7; Nemec A, 1999, J MED MICROBIOL, V48, P287, DOI 10.1099/00222615-48-3-287; Perichon B, 2014, ANTIMICROB AGENTS CH, V58, P936, DOI 10.1128/AAC.01261-13; SASAKI T, 1974, J BIOL CHEM, V249, P761; Senchenkova SN, 2019, CARBOHYD RES, V479, P1, DOI 10.1016/j.carres.2019.04.008; Senchenkova SN, 2015, CARBOHYD RES, V407, P154, DOI 10.1016/j.carres.2015.02.006; Senchenkova SN, 2014, CARBOHYD RES, V391, P89, DOI 10.1016/j.carres.2014.04.002; Shashkov AS, 2015, RUSS CHEM B+, V64, P1196, DOI 10.1007/s11172-015-1000-9; Shashkov AS, 2018, MICROBIOL-SGM, V164, P1289, DOI 10.1099/mic.0.000710; Shashkov AS, 2017, CARBOHYD RES, V448, P28, DOI 10.1016/j.carres.2017.05.017; Shashkov AS, 2016, GLYCOBIOLOGY, V26, P501, DOI 10.1093/glycob/cwv168; Taylor VL, 2013, J BACTERIOL, V195, P4735, DOI 10.1128/JB.00903-13; VERMA NK, 1991, MOL MICROBIOL, V5, P71, DOI 10.1111/j.1365-2958.1991.tb01827.x; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; World Health Organisation, 2017, GLOB PRIOR LIST ANT; WRIGHT A, 1971, J BACTERIOL, V105, P927, DOI 10.1128/JB.105.3.927-936.1971	36	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218461	10.1371/journal.pone.0218461	http://dx.doi.org/10.1371/journal.pone.0218461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220143	gold, Green Published, Green Submitted			2022-12-26	WOS:000484893500052
J	Ndungu, K; Thungu, D; Wamwiri, F; Mireji, P; Ngae, G; Gitonga, P; Mulinge, J; Auma, J; Thuita, J				Ndungu, Kariuki; Thungu, Daniel; Wamwiri, Florence; Mireji, Paul; Ngae, Geoffrey; Gitonga, Purity; Mulinge, James; Auma, Joanna; Thuita, John			Route of inoculation influences Trypanosoma congolense and Trypanosoma brucei brucei virulence in Swiss white mice	PLOS ONE			English	Article							AFRICAN TRYPANOSOMES; INTRAMUSCULAR INJECTION; SUSCEPTIBILITY; RESISTANCE; GAMMA	Experiments on infections caused by trypanosomes are widely performed in Swiss white mice through various inoculation routes. To better understand the effect of route of trypanosome inoculation on disease outcomes in this model, we characterised the virulence of two isolates, Trypanosoma brucei KETRI 2710 and T. congolense KETRI 2765 in Swiss white mice. For each of the isolates, five routes of parasite inoculation, namely intraperitoneal (IP), subcutaneous (SC), intramuscular (IM) intradermal (ID) and intravenous (IV) were compared using groups (n = 6) of mice, with each mouse receiving 1x10(4) trypanosomes. We subsequently assessed impact of the routes on disease indices that included pre-patent period (PP), parasitaemia levels, Packed Cell Volume (PCV), bodyweight changes and survival time. Pre-patent period for IP inoculated mice was a mean +/- SE of 3.8 +/- 0.2 and 6.5 +/- 0.0 for the T brucei and T. congolense isolates respectively; the PP for mice groups inoculated using other routes were not significantly different(p>0.05) irrespective of route of inoculation and species of trypanosomes. With ID and IP routes, parasitaemia was significantly higher in T. brucei and significantly lower in T. congolense infected mice and the progression to peak parasitaemia routes showed no significant different between the routes of either species of trypanosome. The IM and ID routes in T. congolense inoculations, and IP and IV in T. b. brucei induced the fastest and slowest parasitaemia progressions respectively. There were significant differences in rates of reduction of PCV with time post infection in mice infected by the two species and which was more pronounced in sc and ip injected mice. No significant differences in mice body weight changes and survivorship was observed between the routes of inoculation. Inoculation route therefore appears to be a critical determinant of pathogenicity of Trypanosoma congolense and Trypanosoma brucei brucei in murine mouse model of African trypanosomiasis.	[Ndungu, Kariuki; Thungu, Daniel; Wamwiri, Florence; Mireji, Paul; Gitonga, Purity; Auma, Joanna] Kenya Agr & Livestock Res Org, Biotechnol Res Inst, Kikuyu, Kenya; [Mireji, Paul] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Ngae, Geoffrey] Kenya Agr & Livestock Res Org, Food Crops Res Inst, Nairobi, Kenya; [Mulinge, James] Kenya Methodist Univ, Nairobi, Kenya; [Thuita, John] Meru Univ Sci & Technol, Meru, Kenya	Kenya Medical Research Institute; Kenya Methodist University	Ndungu, K (corresponding author), Kenya Agr & Livestock Res Org, Biotechnol Res Inst, Kikuyu, Kenya.	kariukindungu36@yahoo.com	Mireji, Paul/M-3830-2019	Mireji, Paul/0000-0002-7965-2428	Kenya Government	Kenya Government	The study was supported by the Kenya Government.	ASH LS, 1989, J MED ENTOMOL, V26, P133, DOI 10.1093/jmedent/26.3.133; Bengaly Z, 2002, VET PARASITOL, V105, P111, DOI 10.1016/S0304-4017(01)00609-4; Coustou V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000618; D'Archivio S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001976; Das RG, 2007, LAB ANIM-UK, V41, P312, DOI 10.1258/002367707781282802; Eunice MM, 2009, EVOLUTION DIAGNOSTIC; Giordani F, 2016, PARASITOLOGY, V143, P1862, DOI 10.1017/S0031182016001268; Gitonga PK, 2017, ONDERSTEPOORT J VET, V84, DOI 10.4102/ojvr.v84i1.1412; Groman EV, 2004, CONTEMP TOP LAB ANIM, V43, P35; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Hertz CJ, 1998, J IMMUNOL, V161, P6775; IKEDE B O, 1977, Acta Tropica, V34, P53; Janelle J, 2009, INFECT GENET EVOL, V9, P1260, DOI 10.1016/j.meegid.2009.08.007; Kamidi CM, 2018, PARASITOLOGY, V145, P1235, DOI 10.1017/S0031182017002359; Kariuki C, 2015, AFR J LAB MED, V4, DOI 10.4102/ajlm.v4i1.137; Karori SM, 2008, PARASITOL INT, V57, P325, DOI 10.1016/j.parint.2008.02.003; Magez S, 2006, J INFECT DIS, V193, P1575, DOI 10.1086/503808; Magez S, 2011, PARASITE IMMUNOL, V33, P423, DOI 10.1111/j.1365-3024.2011.01293.x; Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412; Masumu J, 2009, VET PARASITOL, V163, P127, DOI 10.1016/j.vetpar.2009.04.006; Menezes AD, 2018, BRAZ J CARDIOV SURG, V33, P82, DOI 10.21470/1678-9741-2017-0134; Moore ES, 2017, J AM ASSOC LAB ANIM, V56, P307; Morton DB, 2001, LAB ANIM-UK, V35, P1, DOI 10.1258/0023677011911345; N'Djetchi MK, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005993; Noyes HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005170; Oladele S, 2008, INT J POULTRY SCI, V7; Padiyar Bharathi, 2018, Int J Clin Pediatr Dent, V11, P299, DOI 10.5005/jp-journals-10005-1530; Paidpally V, 2014, AJR AM J ROENTGENOL, V203; PETANA W. B., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P382, DOI 10.1016/0035-9203(63)90104-4; RASMUSSEN F, 1978, VET SCI COMMUN, V2, P173, DOI 10.1007/BF02291447; SALOGA J, 1993, J CLIN INVEST, V91, P133, DOI 10.1172/JCI116162; SONES KR, 1992, ACTA TROP, V51, P213, DOI 10.1016/0001-706X(92)90039-Z; Svendsen O, 2006, BASIC CLIN PHARMACOL, V99, P58, DOI 10.1111/j.1742-7843.2006.pto_327.x; Thuita JK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000238; Toukam CMW, 2011, PARASITE, V18, P295, DOI 10.1051/parasite/2011184295; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wei GJ, 2011, J INFECT DIS, V203, P418, DOI 10.1093/infdis/jiq051; Wolfensohn S., 1994, HDB LAB ANIMAL MANAG, P143	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218441	10.1371/journal.pone.0218441	http://dx.doi.org/10.1371/journal.pone.0218441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220132	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500048
J	Sun, FF; Abreu-Rodriguez, I; Ye, S; Gay, S; Distler, O; Neidhart, M; Karouzakis, E				Sun, Fangfang; Abreu-Rodriguez, Irene; Ye, Shuang; Gay, Steffen; Distler, Oliver; Neidhart, Michel; Karouzakis, Emmanuel			TET1 is an important transcriptional activator of TNF alpha expression in macrophages	PLOS ONE			English	Article							GENE-EXPRESSION; DNA; INFLAMMATION; ENZYMES	Activation of macrophages and overexpression of TNF alpha is associated with the pathogenesis of chronic inflammatory diseases. However, the mechanisms leading to TNF alpha overexpression are still unknown. 5-methylocytosine (5-mC) is an epigenetic modification that is associated with silenced genes. Recent studies showed that it is converted to 5-hydroxylmethylocytosine (5-hmC) and reactivates gene expression through the action of the family of Ten-Eleven-Translocation (TET1-3) enzymes. In this study, we show that 5-hmC levels are increased globally and specifically in the TNF alpha promoter during the differentiation of monocytes to macrophages. In addition, the levels of 5-hmC are increased upon LPS stimulation of macrophages. Furthermore, CRIPSR stable knockout of TET1 decreases the expression of TNF alpha and other pro-inflammatory cytokines. In conclusion, we showed that TET1 contributes to the activation of macrophages possibly through regulation of 5-hydroxymethylation in the promoter of pro-inflammatory cytokine genes. The TET1 enzyme could be a promising therapeutic target to inhibit the persistent inflammation caused by macrophages in chronic inflammatory diseases.	[Sun, Fangfang; Abreu-Rodriguez, Irene; Gay, Steffen; Distler, Oliver; Neidhart, Michel; Karouzakis, Emmanuel] Univ Zurich, Univ Hosp Zurich, Ctr Expt Rheumatol, Dept Rheumatol, Zurich, Switzerland; [Sun, Fangfang; Ye, Shuang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Rheumatol, South Campus, Shanghai, Peoples R China	University of Zurich; University Zurich Hospital; Shanghai Jiao Tong University	Karouzakis, E (corresponding author), Univ Zurich, Univ Hosp Zurich, Ctr Expt Rheumatol, Dept Rheumatol, Zurich, Switzerland.	Emmanuel.karouzakis@usz.ch	Sun, Fangfang/AER-6324-2022; Distler, Oliver/AAE-6225-2019	Sun, Fangfang/0000-0003-2570-4576; Distler, Oliver/0000-0002-0546-8310; Neidhart, Michel/0000-0002-9656-5967; Karouzakis, Emmanuel/0000-0001-7650-9653	European Union's Horizon 2020 European Institute of Innovation and Technology research and innovation programme [667837]; Swiss federal Commission for Scholarships for foreign Students (FCS)	European Union's Horizon 2020 European Institute of Innovation and Technology research and innovation programme; Swiss federal Commission for Scholarships for foreign Students (FCS)	This project has received funding from the European Union's Horizon 2020 European Institute of Innovation and Technology research and innovation programme under grant agreement No 667837 which support the consumables and the salary of EK. In addition, FS salary was supported by a Swiss federal Commission for Scholarships for foreign Students (FCS).	Albers J, 2015, J CLIN INVEST, V125, P1603, DOI 10.1172/JCI79743; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Klug M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r46; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Schmidt SV, 2016, CELL RES, V26, P151, DOI 10.1038/cr.2016.1; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Tekpli X, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0070-8; Tsagaratou A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00220; Tsagaratou A, 2017, NAT IMMUNOL, V18, P45, DOI 10.1038/ni.3630; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Wallner S, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0079-z; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yue XJ, 2016, J EXP MED, V213, P377, DOI 10.1084/jem.20151438; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; 2014, ADV GEN SCI KEEP UP, P1	23	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218551	10.1371/journal.pone.0218551	http://dx.doi.org/10.1371/journal.pone.0218551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5EM	31216336	gold, Green Published, Green Submitted			2022-12-26	WOS:000482885300055
J	Hendricson, A; Umlauf, S; Choi, JY; Thekkiniath, J; Surovtseva, YV; Fuller, KK; Reynolds, TB; Voelker, DR; Ben Mamoun, C				Hendricson, Adam; Umlauf, Sheila; Choi, Jae-Yeon; Thekkiniath, Jose; Surovtseva, Yulia, V; Fuller, Kevin K.; Reynolds, Todd B.; Voelker, Dennis R.; Ben Mamoun, Choukri			High-throughput screening for phosphatidylserine decarboxylase inhibitors using a distyrylbenzene-bis-aldehyde (DSB-3)-based fluorescence assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylethanolamine; phosphatidylserine; phosphatidylserine decarboxylase; plasmodium; high-throughput screening (HTS); Candida albicans; Plasmodium knowlesi; Plasmodium falciparum; enzyme; parasitic disease; antimicrobial agent; phospholipids	MODULATES LIPID-METABOLISM; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; TUMOR-SUPPRESSOR; MEMBRANE-LIPIDS; PHOSPHATIDYLETHANOLAMINE; YEAST; GENE; COMPLEMENTATION; IDENTIFICATION	Phosphatidylserine decarboxylases (PSDs) catalyze the decarboxylation of phosphatidylserine to generate phosphatidylethanolamine, a critical step in phospholipid metabolism in both prokaryotes and eukaryotes. Most PSDs are membrane-bound, and classical radioisotope-based assays for determining their activity in vitro are not suitable for high-throughput drug screening. The finding that the PkPSD from Plasmodium knowlesi can be purified in a soluble and active form and the recent development of a fluorescence-based distyrylbenzene-bis-aldehyde (DSB-3) assay to measure PSD activity in vitro have laid the groundwork for screening chemical libraries for PSD inhibitors. Using this assay, here we conducted a high-throughput screen of a structurally diverse 130,858-compound library against PkPSD. Further characterization of the hits identified in this screening yielded five PkPSD inhibitors with IC50 values ranging from 3.1 to 42.3 mu m. Lead compounds were evaluated against the pathogenic yeast Candida albicans in the absence or presence of exogenous ethanolamine, and YU253467 and YU254403 were identified as inhibiting both native C. albicans PSD mitochondrial activity and C. albicans growth, with an MIC50 of 22.5 and 15 mu g/ml without ethanolamine and an MIC50 of 75 and 60 mu g/ml with ethanolamine, respectively. Together, these results provide the first proof of principle for the application of DSB-3-based fluorescent readouts in high-throughput screening for PSD inhibitors. The data set the stage for future analyses to identify more selective and potent PSD inhibitors with antimicrobial or antitumor activities.	[Hendricson, Adam; Umlauf, Sheila; Surovtseva, Yulia, V] Yale Ctr Mol Discovery, West Haven, CT 06516 USA; [Choi, Jae-Yeon; Voelker, Dennis R.] Natl Jewish Hlth, Basic Sci Sect, Dept Med, Denver, CO 80206 USA; [Thekkiniath, Jose; Ben Mamoun, Choukri] Yale Sch Med, Dept Internal Med, Sect Infect Dis, TAC-S469C,300 Cedar St, New Haven, CT 06520 USA; [Fuller, Kevin K.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Fuller, Kevin K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Reynolds, Todd B.] Univ Tennessee, Coll Arts & Sci, Dept Microbiol, Knoxville, TN 37996 USA	National Jewish Health; Yale University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Tennessee System; University of Tennessee Knoxville	Ben Mamoun, C (corresponding author), Yale Sch Med, Dept Internal Med, Sect Infect Dis, TAC-S469C,300 Cedar St, New Haven, CT 06520 USA.	choukri.benmamoun@yale.edu		Reynolds, Todd/0000-0002-2867-7182	PITCH program of the Connecticut Bioscience Innovation Fund; National Institutes of Health [AI097218, GM110506, AI123321, R43AI136118, GM104485]; Bill and Melinda Gates Foundation [OPP1021571]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123321, R01AI097218] Funding Source: NIH RePORTER	PITCH program of the Connecticut Bioscience Innovation Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the PITCH program of the Connecticut Bioscience Innovation Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants AI097218 and GM104485.; Supported by National Institutes of Health Grants AI097218, GM110506, AI123321, and R43AI136118 and Bill and Melinda Gates Foundation Grant OPP1021571.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Baunaure F, 2004, MOL MICROBIOL, V51, P33, DOI 10.1046/j.1365-2958.2003.03822.x; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Chen YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18610-5; Choi JY, 2018, J BIOL CHEM, V293, P1493, DOI 10.1074/jbc.RA117.000525; Choi JY, 2016, MOL MICROBIOL, V99, P999, DOI 10.1111/mmi.13280; Choi JY, 2015, J BIOL CHEM, V290, P10972, DOI 10.1074/jbc.M115.642413; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Davis SE, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00815-17, 10.1128/iai.00815-17]; Eriksson O, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00396; Forbes CD, 2007, J BIOMOL SCREEN, V12, P628, DOI 10.1177/1087057107301320; Friedman JR, 2018, DEV CELL, V44, P261, DOI 10.1016/j.devcel.2017.11.023; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; KANFER J, 1964, J BIOL CHEM, V239, P1720; Keckesova Z, 2017, NATURE, V543, P681, DOI 10.1038/nature21408; KUGE O, 1991, J BIOL CHEM, V266, P6370; MILLER MA, 1986, J BIOL CHEM, V261, P9753; Nerlich A, 2007, PLANT PHYSIOL, V144, P904, DOI 10.1104/pp.107.095414; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Rontein D, 2003, PLANT PHYSIOL, V132, P1678, DOI 10.1104/pp.103.023242; Short DPG, 2013, FUNGAL GENET BIOL, V53, P59, DOI 10.1016/j.fgb.2013.01.004; TOBIAS LD, 1979, LIPIDS, V14, P181, DOI 10.1007/BF02533870; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669	32	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12146	12156		10.1074/jbc.RA119.007766	http://dx.doi.org/10.1074/jbc.RA119.007766			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31227523	Green Published, hybrid			2022-12-26	WOS:000484284500018
J	Nahle, S; Pasquin, S; Laplante, V; Rousseau, F; Sharma, M; Gauchat, JF				Nahle, Sarah; Pasquin, Sarah; Laplante, Veronique; Rousseau, Francois; Sharma, Mukut; Gauchat, Jean-Francois			Cardiotrophin-like cytokine (CLCF1) modulates mesenchymal stem cell osteoblastic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; cytokine; mesenchymal stem cells (MSCs); osteoblast; osteoporosis; cardiotrophin-like cytokine (CLCF1)	CILIARY NEUROTROPHIC FACTOR; STUVE-WIEDEMANN-SYNDROME; MARROW STROMAL CELLS; TERM-FOLLOW-UP; FACTOR-RECEPTOR; STIMULATING FACTOR-3; SIGNALING PATHWAYS; MICE LACKING; IN-VITRO; BONE	Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into adipocytes, chondrocytes, or osteocytes. MSCs secrete an array of cytokines and express the LIFR beta (leukemia inhibitory factor receptor) chain on their surface. Mutations in the gene coding for LIFR beta lead to a syndrome with altered bone metabolism. LIFR beta is one of the signaling receptor chains for cardiotrophin-like cytokine (CLCF1), a neurotrophic factor known to modulate B and myeloid cell functions. We investigated its effect on MSCs induced to differentiate into osteocytes in vitro. Our results indicate that CLCF1 binds mouse MSCs, triggers STAT1 and -3 phosphorylation, inhibits the up-regulation of master genes involved in the control of osteogenesis, and markedly prevents osteoblast generation and mineralization. This suggests that CLCF1 could be a target for therapeutic intervention with agents such as cytokine traps or blocking mAbs in bone diseases such as osteoporosis.	[Nahle, Sarah; Pasquin, Sarah; Laplante, Veronique; Gauchat, Jean-Francois] Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ H3T 1J4, Canada; [Rousseau, Francois] Novimmune SA, CH-1228 Plan Les Ouates, Switzerland; [Sharma, Mukut] Kansas City Vet Affairs Med Ctr, Renal Div, Kansas City, MO 64128 USA	Universite de Montreal; NovImmune SA	Gauchat, JF (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ H3T 1J4, Canada.	jf.gauchat@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP-57832, PTJ 159654]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-57832 and PTJ 159654 (to J.-F.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; Askmyr M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15529; Chen C, 2012, J CELL BIOCHEM, V113, P3672, DOI 10.1002/jcb.24240; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Dagoneau N, 2004, AM J HUM GENET, V74, P298, DOI 10.1086/381715; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Gaspar IM, 2008, AM J MED GENET A, V146A, P1748, DOI 10.1002/ajmg.a.32325; Ge JR, 2018, CHIN J INTEGR MED, V24, P415, DOI 10.1007/s11655-016-2744-2; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hahn AF, 2010, J NEUROL SCI, V293, P68, DOI 10.1016/j.jns.2010.02.028; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Heo JS, 2017, INT J MOL MED, V40, P1486, DOI 10.3892/ijmm.2017.3142; Honda Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03420; Huang S, 2015, J ORTHOP TRANSL, V3, P26, DOI 10.1016/j.jot.2014.07.005; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Jung C, 2010, CLIN GENET, V77, P266, DOI 10.1111/j.1399-0004.2009.01314.x; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Larsen JV, 2016, MOL CELL BIOL, V36, P1272, DOI 10.1128/MCB.00917-15; Larsen JV, 2010, MOL CELL BIOL, V30, P4175, DOI 10.1128/MCB.00274-10; Lelievre E, 2001, J BIOL CHEM, V276, P22476, DOI 10.1074/jbc.M101681200; Maeda S, 2002, J CELL PHYSIOL, V193, P73, DOI 10.1002/jcp.10151; McGregor NE, 2010, CALCIFIED TISSUE INT, V86, P261, DOI 10.1007/s00223-010-9337-4; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pasquin S, 2018, J IMMUNOL, V201, P2462, DOI 10.4049/jimmunol.1800733; Pasquin S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22400-y; Pasquin S, 2016, CYTOKINE, V82, P122, DOI 10.1016/j.cyto.2015.12.019; Perret D, 2004, J BIOL CHEM, V279, P43961, DOI 10.1074/jbc.M407686200; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Senaldi G, 2002, J IMMUNOL, V168, P5690, DOI 10.4049/jimmunol.168.11.5690; Shi Y, 1999, BIOCHEM BIOPH RES CO, V262, P132, DOI 10.1006/bbrc.1999.1181; SIFFERT RS, 1951, J EXP MED, V93, P415, DOI 10.1084/jem.93.5.415; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Tormo AJ, 2012, CYTOKINE, V60, P653, DOI 10.1016/j.cyto.2012.08.014; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zou X, 2009, VET PATHOL, V46, P514, DOI 10.1354/vp.08-VP-0239-B-BC	42	11	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11952	11959		10.1074/jbc.AC119.008361	http://dx.doi.org/10.1074/jbc.AC119.008361			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31248987	Green Published, hybrid			2022-12-26	WOS:000484284500001
J	Thompson, J; Johansen, R; Dunbar, J; Munsky, B				Thompson, Jaron; Johansen, Renee; Dunbar, John; Munsky, Brian			Machine learning to predict microbial community functions: An analysis of dissolved organic carbon from litter decomposition	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; ASSEMBLAGES	Microbial communities are ubiquitous and often influence macroscopic properties of the ecosystems they inhabit. However, deciphering the functional relationship between specific microbes and ecosystem properties is an ongoing challenge owing to the complexity of the communities. This challenge can be addressed, in part, by integrating the advances in DNA sequencing technology with computational approaches like machine learning. Although machine learning techniques have been applied to microbiome data, use of these techniques remains rare, and user-friendly platforms to implement such techniques are not widely available. We developed a tool that implements neural network and random forest models to perform regression and feature selection tasks on microbiome data. In this study, we applied the tool to analyze soil microbiome (16S rRNA gene profiles) and dissolved organic carbon (DOC) data from a 44-day plant litter decomposition experiment. The micro biome data includes 1709 total bacterial operational taxonomic units (OTU) from 300+ microcosms. Regression analysis of predicted and actual DOC for a held-out test set of 51 samples yield Pearson's correlation coefficients of.636 and.676 for neural network and random forest approaches, respectively. Important taxa identified by the machine learning techniques are compared to results from a standard tool (indicator species analysis) widely used by microbial ecologists. Of 1709 bacterial taxa, indicator species analysis identified 285 taxa as significant determinants of DOC concentration. Of the top 285 ranked features determined by machine learning methods, a subset of 86 taxa are common to all feature selection techniques. Using this subset of features, prediction results for random permutations of the data set are at least equally accurate compared to predictions determined using the entire feature set. Our results suggest that integration of multiple methods can aid identification of a robust subset of taxa within complex communities that may drive specific functional outcomes of interest.	[Thompson, Jaron; Munsky, Brian] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA; [Munsky, Brian] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA; [Johansen, Renee; Dunbar, John] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	Colorado State University; Colorado State University; United States Department of Energy (DOE); Los Alamos National Laboratory	Munsky, B (corresponding author), Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.; Munsky, B (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.	brian.munsky@colostate.edu	; Munsky, Brian/A-1947-2016	Johansen, Renee/0000-0002-9529-5408; Munsky, Brian/0000-0001-6147-7329	U.S. Department of Energy Office of Biological and Environmental Research, Genomic Science program [F255LANL2018]; National Institute of General Medical Sciences of the National Institutes of Health [R35GM124747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124747] Funding Source: NIH RePORTER	U.S. Department of Energy Office of Biological and Environmental Research, Genomic Science program(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JT, RJ, JD and BM were supported by grant F255LANL2018 from the U.S. Department of Energy Office of Biological and Environmental Research, Genomic Science program (https://genomicscience.energy.gov/). BM and JT were supported by award number R35GM124747 from the National Institute of General Medical Sciences of the National Institutes of Health (https.//www.nigms niltgov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JT, RJ, JD and BM were supported by grant F255LANL2018 from the U.S. Department of Energy Office of Biological and Environmental Research, Genomic Science program. BM and JT were supported under award number R35GM124747 from the National Institute of General Medical Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop Christopher M., 2006, PATTERN RECOGNITION; Bokulich Nicholas A, 2018, J Open Res Softw, V3, DOI 10.21105/joss.00934; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Breiman L., 2017, CLASSIFICATION REGRE; Challita N, 2016, 2016 IEEE INTERNATIONAL MULTIDISCIPLINARY CONFERENCE ON ENGINEERING TECHNOLOGY (IMCET), P81, DOI 10.1109/IMCET.2016.7777431; Chang HX, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00519; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Feng YQ, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2085, DOI 10.1109/ICMLC.2003.1259848; Johansen R, 2019, MICROBIAL COMMUNITY; Johnson HR, 2016, PLOS ONE, V11, P1; Kilinc N, 2018, CONTEMP GEOGR LEIS T, P234; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Larsen PE, 2012, NAT METHODS, V9, P621, DOI [10.1038/NMETH.1975, 10.1038/nmeth.1975]; Li HZ, 2015, ANNU REV STAT APPL, V2, P73, DOI 10.1146/annurev-statistics-010814-020351; Li Y, 2015, DEEP FEATURE SELECTI; Liang C, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.105; Liu ZQ, 2011, BIOINFORMATICS, V27, P3242, DOI 10.1093/bioinformatics/btr547; Noble PA, 2007, ECOL MODEL, V203, P87, DOI 10.1016/j.ecolmodel.2005.06.013; Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Riehle K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S11; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Statnikov A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-11; Theano Development Team, 2016, ARXIV160502688; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994	29	46	47	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0215502	10.1371/journal.pone.0215502	http://dx.doi.org/10.1371/journal.pone.0215502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260460	Green Published, Green Submitted, gold			2022-12-26	WOS:000484918700007
J	Ludwisiak, K; Podgorski, M; Biernacka, K; Stefanczyk, L; Olewnik, L; Majos, A; Polguj, M				Ludwisiak, Kamil; Podgorski, Michal; Biernacka, Katarzyna; Stefanczyk, Ludomir; Olewnik, Lukasz; Majos, Agata; Polguj, Michal			Variation in the morphology of spinous processes in the cervical spine - An objective and parametric assessment based on CT study	PLOS ONE			English	Article							RACE	Background Typically, cervical vertebrae display bifid spinous processes. Nevertheless, this feature may vary both between subjects and even within the vertebrae of the same individual. Although such variation can be important in archaeological research, anthropological studies and forensic medicine, it has not so far been the subject of any detailed studies. Material and methods An analysis of 200 cervical spine CT examinations was performed. The morphology of the spinous process was evaluated, and new anthropometric parameters were selected to allow a more precise quantitative analysis of the degree of bifidity. Results The spinous process base (i.e. the part of the spinous process which was not bifid) was significantly longer in CII and CVII than in the other vertebrae. The spinous process branches (bifid elements) were significantly longer in CVI and CVII than in the other vertebrae. The angle between the branches was significantly sharper in CII and CVII than in CIII-CVI, on the right side, and CIII-CV, on the left side. On the right side, the branching coefficient (degree of branch development) was significantly higher for CII and significantly lower for CVI-CVII than for the other vertebrae. On the left side, the coefficient was significantly higher for CII and CIV, and significantly lower for CVI-CVII, compared to the other vertebrae. Conclusion Our findings highlight new objective parameters of morphological variability in the spinous processes of the cervical spine. They can form the basis of a new detailed differentiation of vertebrae and can represent an independent determinant of anatomical variability in the cervical spine.	[Ludwisiak, Kamil; Majos, Agata] Med Univ Lodz, Dept Diagnost Imaging, Cent Clin Hosp, Lodz, Poland; [Podgorski, Michal; Biernacka, Katarzyna] Polish Mothers Mem Hosp, Res Inst, Dept Diagnost Imaging, Lodz, Poland; [Stefanczyk, Ludomir] Med Univ Lodz, Dept Radiol & Diagnost Imaging, Lodz, Poland; [Olewnik, Lukasz] Med Univ Lodz, Dept Normal & Clin Anat, Interfac Dept Anat & Histol, Lodz, Poland; [Polguj, Michal] Med Univ Lodz, Dept Angiol, Interfac Dept Anat & Histol, Lodz, Poland	Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; Medical University Lodz; Medical University Lodz; Medical University Lodz	Polguj, M (corresponding author), Med Univ Lodz, Dept Angiol, Interfac Dept Anat & Histol, Lodz, Poland.	michal.polguj@umed.lodz.pl	Majos, Agata Joanna/S-9916-2016	Polguj, Michal/0000-0003-4146-4998; Podgorski, Michal/0000-0003-4513-0602; Biernacka-Racicot, Katarzyna/0000-0001-6550-446X; Olewnik, Lukasz/0000-0002-6414-9504; Majos, Agata/0000-0002-4141-0191				Allbrook DB, 1955, AM J PHYS ANTHROP-NE, V13, P489, DOI 10.1002/ajpa.1330130309; Anas IY, 2010, INT J BIOMED HLTH SC, V6, P63; BRACE CL, 1995, J FORENSIC SCI, V40, P171; Cramer G, 2013, CLIN ANATOMY SPINE S, V5, P68; Cramer GD, 1995, BASIC CLIN ANATOMY S; Cunningham D J, 1886, J Anat Physiol, V20, P637; Duray SM, 1999, J FORENSIC SCI, V44, P937; Greiner TM, 2017, CLIN ANAT, V30, P894, DOI 10.1002/ca.22948; Keats T, 2001, ATLAS NORMAL ROENTGE, P270; Keats T, 2012, ATLAS NORMAL ROENTGE, P168; KENNEDY KAR, 1995, J FORENSIC SCI, V40, P797; Kocabiyik N, 2017, FOLIA MORPHOL, V76, P440, DOI 10.5603/FM.a2017.0010; Lang J., 1993, CLIN ANATOMY CERVICA; Otsudo T, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9835846; Rathbun T, 1984, HUMAN INDENTIFICATIO; SAUER NJ, 1992, SOC SCI MED, V34, P107, DOI 10.1016/0277-9536(92)90086-6; Schultz A. H., 1961, pUnpaginated; Shore LR, 1931, J ANAT, V65, P482; Singh B, 2014, INT J BIOMED RES, V5, P576, DOI [10.7439/ijbr.v5i9.779, DOI 10.7439/IJBR.V5I9.779]; Cho W, 2012, GLOB SPINE J, V2, P99, DOI 10.1055/s-0032-1319776; Zhang L, 2018, EXP THER MED, V16, P511, DOI 10.3892/etm.2018.6245	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218885	10.1371/journal.pone.0218885	http://dx.doi.org/10.1371/journal.pone.0218885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246998	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900050
J	Tyukin, IY; Iudin, D; Iudin, F; Tyukina, T; Kazantsev, V; Mukhina, I; Gorban, AN				Tyukin, Ivan Y.; Iudin, Dmitriy; Iudin, Feodor; Tyukina, Tatiana; Kazantsev, Victor; Mukhina, Irina; Gorban, Alexander N.			Simple model of complex dynamics of activity patterns in developing networks of neuronal cultures	PLOS ONE			English	Article							CRITICALITY; ADAPTATION; EVOLUTION; AVALANCHES; BIFURCATIONS; MECHANISMS; STRESS; GROWTH	Living neuronal networks in dissociated neuronal cultures are widely known for their ability to generate highly robust spatiotemporal activity patterns in various experimental conditions. Such patterns are often treated as neuronal avalanches that satisfy the power scaling law and thereby exemplify self-organized criticality in living systems. A crucial question is how these patterns can be explained and modeled in a way that is biologically meaningful, mathematically tractable and yet broad enough to account for neuronal heterogeneity and complexity. Here we derive and analyse a simple network model that may constitute a response to this question. Our derivations are based on few basic phenomenological observations concerning the input-output behavior of an isolated neuron. A distinctive feature of the model is that at the simplest level of description it comprises of only two variables, the network activity variable and an exogenous variable corresponding to energy needed to sustain the activity, and few parameters such as network connectivity and efficacy of signal transmission. The efficacy of signal transmission is modulated by the phenomenological energy variable. Strikingly, this simple model is already capable of explaining emergence of network spikes and bursts in developing neuronal cultures. The model behavior and predictions are consistent with published experimental evidence on cultured neurons. At the larger, cellular automata scale, introduction of the energy-dependent regulatory mechanism results in the overall model behavior that can be characterized as balancing on the edge of the network percolation transition. Network activity in this state shows population bursts satisfying the scaling avalanche conditions. This network state is self-sustainable and represents energetic balance between global network-wide processes and spontaneous activity of individual elements.	[Tyukin, Ivan Y.; Iudin, Dmitriy; Iudin, Feodor; Kazantsev, Victor; Mukhina, Irina; Gorban, Alexander N.] Nizhnii Novgorod State Univ, Nizhnii Novgorod, Russia; [Iudin, Dmitriy; Kazantsev, Victor] RAS, Inst Appl Phys, Nizhnii Novgorod, Russia; [Tyukin, Ivan Y.] St Petersburg State Electrotech Univ LETI, St Petersburg, Russia; [Tyukin, Ivan Y.; Tyukina, Tatiana; Gorban, Alexander N.] Univ Leicester, Leicester, Leics, England	Lobachevsky State University of Nizhni Novgorod; Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; Saint Petersburg State Electrotechnical University; University of Leicester	Tyukin, IY (corresponding author), Nizhnii Novgorod State Univ, Nizhnii Novgorod, Russia.; Tyukin, IY (corresponding author), St Petersburg State Electrotech Univ LETI, St Petersburg, Russia.; Tyukin, IY (corresponding author), Univ Leicester, Leicester, Leics, England.	I.Tyukin@le.ac.uk	Gorban, Alexander N/D-7310-2011; Tyukin, Ivan/Q-6747-2019; Kazantsev, Victor B/L-1424-2013	Gorban, Alexander N/0000-0001-6224-1430; Tyukin, Ivan/0000-0002-7359-7966; Kazantsev, Viktor/0000-0002-2881-6648; Tyukina, Tatiana/0000-0002-4440-3771	Ministry of Science and Higher Education of the Russian Federation [14, Y26.31.0022]; Ministry of Science and Higher Education of Russian Federation [14, Y26.31.0022]	Ministry of Science and Higher Education of the Russian Federation; Ministry of Science and Higher Education of Russian Federation	This work was supported by Ministry of Science and Higher Education of the Russian Federation (Project No. 14. Y26.31.0022).; The work was supported by the Ministry of Science and Higher Education of Russian Federation (Project No. 14. Y26.31.0022).	Abbott LF, 2007, PROG BRAIN RES, V165, P13, DOI 10.1016/S0079-6123(06)65002-4; Bak P., 1997, NATURE WORKS SCI SEL; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Bornholdt S, 2000, PHYS REV LETT, V84, P6114, DOI 10.1103/PhysRevLett.84.6114; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Censi F, 2011, IEEE T BIO-MED ENG, V58, P2943, DOI 10.1109/TBME.2011.2150747; Christensen K, 1998, PHYS REV LETT, V81, P2380, DOI 10.1103/PhysRevLett.81.2380; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Girardi-Schappo M, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.042415; Gong P, 2004, EUROPHYS LETT, V67, P328, DOI 10.1209/epl/i2003-10287-7; Gong P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.018302; Gorban AN, 2009, MATH MODEL NAT PHENO, V4, P1, DOI 10.1051/mmnp/20094601; Gorban AN, 2016, J THEOR BIOL, V405, P127, DOI 10.1016/j.jtbi.2015.12.017; Gorban AN, 2010, PHYSICA A, V389, P3193, DOI 10.1016/j.physa.2010.03.035; GORBAN AN, 1981, DOKL AKAD NAUK SSSR+, V261, P1050; Gorban AN, 2004, ELECT J DIFFER EQ; Gritsun TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043352; Huang JC, 2018, J MATH ANAL APPL, V464, P201, DOI 10.1016/j.jmaa.2018.03.074; Iudin DI, 2015, COMMUN NONLINEAR SCI, V20, P861, DOI 10.1016/j.cnsns.2014.06.031; Iudin DI, 2012, APPL MATH COMPUT, V218, P8099, DOI 10.1016/j.amc.2011.11.044; Iudin DI, 2013, FRACTALS SIMPLE COMP; Iudin FD, 2015, JETP LETT+, V101, P271, DOI 10.1134/S0021364015040074; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Masquelier T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075824; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Okujeni S, 2017, J NEUROSCI, V37, P3972, DOI 10.1523/JNEUROSCI.2552-16.2017; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Pimashkin A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00046; Quintanilla JA, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051115; Selye H, 1938, AM J PHYSIOL, V123, P758, DOI 10.1152/ajplegacy.1938.123.3.758; Selye H, 1938, NATURE, V141, P926, DOI 10.1038/141926a0; SHANTE VKS, 1971, ADV PHYS, V20, P325, DOI 10.1080/00018737100101261; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Steur E, 2016, IFAC PAPERSONLINE, V49, P62, DOI 10.1016/j.ifacol.2016.07.981; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; Tsodyks M, 2000, J NEUROSCI, V20; Tyukin IY, 2018, SUPPLEMENTARY MAT SI; Vedunova MV, 2014, B EXP BIOL MED+, V156, P461, DOI 10.1007/s10517-014-2374-7; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, DATASET EXTREMELY RI; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8	53	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218304	10.1371/journal.pone.0218304	http://dx.doi.org/10.1371/journal.pone.0218304			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246978	Green Published, gold, Green Submitted			2022-12-26	WOS:000484911900016
J	Borowsky, R; Luk, A; Kim, RS				Borowsky, Richard; Luk, Alissa; Kim, Rebecca S.			Sperm swimming behaviors are correlated with sperm haploid genetic variability in the Mexican tetra, Astyanax mexicanus	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; BOAR SPERM; SPERMATOZOA; MOUSE; RNA	The diploid genotypes of males are widely thought to determine sperm phenotypes, yet recent work shows that the haploid genetics of the individual sperm cell also contributes significantly. We tested seven sperm phenotypes, flagellar length and six behaviors, looking for correlations between genetic and phenotypic variability. While flagellar length appears to be controlled by the diploid genotype of the source, variation in three of the behavioral phenotypes, linearity, wobble, and progression are significantly correlated with the heterozygosity of the male producer. Because males that are more genetically variable produce a sperm set that is more diverse in its haploid genotypes, we suggest that the correlations may reflect significant haploid genetic control of sperm swimming behaviors.	[Borowsky, Richard; Luk, Alissa] NYU, Dept Biol, New York, NY 10003 USA; [Kim, Rebecca S.] NYU, Dept Environm Med, Langone Ctr, 550 1St Ave, New York, NY 10016 USA	New York University; New York University	Borowsky, R (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.	rborowsky@nyu.edu			National Science Foundation (IOS) [1525047]	National Science Foundation (IOS)(National Science Foundation (NSF))	This study was funded by National Science Foundation (IOS) through award #1525047 (https://www.nsf.gov/div/index.jsp?div=IOS) to RB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavioon G, 2017, P NATL ACAD SCI USA, V114, P8053, DOI 10.1073/pnas.1705601114; Garcia-Vazquez FA, 2015, J REPROD DEVELOP, V61, P407, DOI 10.1262/jrd.2014-170; Garcia-Vazquez FA, 2015, THERIOGENOLOGY, V84, P566, DOI 10.1016/j.theriogenology.2015.04.011; Auger J, 2016, HUM REPROD, V31, P10, DOI 10.1093/humrep/dev251; Borowsky R, 2009, ASTYANAX MEXICANUS B, P469; Borowsky R, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0538-z; Borowsky R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079903; Bradic M, 2013, MOL BIOL EVOL, V30, P2383, DOI 10.1093/molbev/mst136; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Gilbert I, 2007, REPRODUCTION, V133, P1073, DOI 10.1530/REP-06-0292; HOLM S, 1979, SCAND J STAT, V6, P65; HUDSON RR, 1992, GENETICS, V132, P583; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Immler S, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1040; Johnston RJ, 2010, ANNU REV CELL DEV BI, V26, P689, DOI 10.1146/annurev-cellbio-100109-104113; Johnston RJ, 2010, CELL, V140, P610, DOI 10.1016/j.cell.2010.02.018; KIERSZENBAUM AL, 1975, J CELL BIOL, V65, P258, DOI 10.1083/jcb.65.2.258; Koziol K, 2015, POL J VET SCI, V18, P565, DOI 10.1515/pjvs-2015-0073; McPherson FJ, 2014, ANIM REPROD SCI, V151, P28, DOI 10.1016/j.anireprosci.2014.09.021; Mitchell R.W., 1977, MEXICAN EYELESS CHAR; MONESI V, 1965, EXP CELL RES, V39, P197, DOI 10.1016/0014-4827(65)90023-6; Opatova P, 2016, ECOL EVOL, V6, P295, DOI 10.1002/ece3.1868; ORIDO Y, 1988, J MORPHOL, V196, P333, DOI 10.1002/jmor.1051960306; Pitnick S, 2009, P ROY SOC B-BIOL SCI, V276, P4029, DOI 10.1098/rspb.2009.1208; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Sivinsky J., 1984, SPERM COMPETITION EV, P86; Stewart KA, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0601-8; Vibranovski MD, 2010, GENETICS, V186, P431, DOI 10.1534/genetics.110.118919; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wilson-Leedy J. G., 2006, COMPUTER ASSISTED SP; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218538	10.1371/journal.pone.0218538	http://dx.doi.org/10.1371/journal.pone.0218538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242252	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600036
J	Niriayo, YL; Ibrahim, S; Kassa, TD; Asgedom, SW; Atey, TM; Gidey, K; Demoz, GT; Kahsay, D				Niriayo, Yirga Legesse; Ibrahim, Seid; Kassa, Tesfaye Dessale; Asgedom, Solomon Weldegebreal; Atey, Tesfay Mahari; Gidey, Kidu; Demoz, Gebre Teklemariam; Kahsay, Desalegn			Practice and predictors of self-care behaviors among ambulatory patients with hypertension in Ethiopia	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; HEALTH-CARE; AFRICAN-AMERICANS; ILLNESS BELIEFS; PREVALENCE; MANAGEMENT; ADHERENCE; ACCESS; RISK	Background Despite the benefits of evidence-based self-care behaviors in the management of hypertension, hypertensive patients have low rate of adherence to the recommended self-care behaviors. Studies related to self-care behaviors among hypertensive patients are limited in Ethiopia. Objective To assess the rate of adherence to self-care behaviors and associated factors among hypertensive patients. Method A cross-sectional study was conducted at the cardiac clinic of Ayder comprehensive specialized hospital among ambulatory hypertensive patients. Self-care behaviors were assessed using an adopted Hypertension Self-Care Activity Level Effects (H-SCALE). Data were collected through patient interview and review of medical records. Binary logistic regression analysis was performed to identify predictors of self-care behaviors. Result A total of 276 patients were included in the study. The majority of the participants were nonsmokers (89.9%) and alcohol abstainers (68.8%). Less than half of the participants were adherent to the prescribed antihypertensive medications (48.2%) and recommended physical activity level (44.9%). Moreover, only 21.45% and 29% were adherent to weight management and low salt diet recommendations, respectively. Our finding indicated that rural resident (adjusted odds ratio [AOR]: 0.45, 95% confidence interval [CI]: 0.21-0.97), comorbidity (AOR: 0.16, 95% CI: 0.08-0.31), and negative medication belief (AOR: 0.25, 95% CI: 0.14-0.46) were significantly associated with medication adherence. Female sex (AOR: 0.46, 95% CI: 0.23-0.92), old age (AOR: 0.19, 95% CI: 0.06-0.60) and lack of knowledge on self-care behaviors (AOR: 0.13, 95% CI: 0.03-0.57) were significantly associated with adherence to weight management. Female sex (AOR: 1.97, 95% CI: 1.03-3.75) and lack of knowledge on self-care (AOR: 0.07, 95% CI: 0.03-0.16) were significantly associated with adherence to alcohol abstinence. Female sex (AOR: 6.33, 95% CI: 1.80-22.31) and khat chewing (AOR: 0.08, 95% CI: 0.03-0.24) were significantly associated with non-smoking behavior. There was also a significant association between female sex and physical activity (AOR: 0.22, 95% CI: 0.12-0.40). Conclusion The rate of adherence to self-care behaviors particularly weight management, low salt intake, physical exercise, and medication intake was low in our study. Elders, females, khat chewers, rural residents, and patients with negative medication belief, comorbidity, and inadequate knowledge of SCBs were less adherent to self-care behaviors compared to their counterparts. Therefore, health care providers should pay more emphasis to patients at risk of having low self-care behaviors.	[Niriayo, Yirga Legesse; Ibrahim, Seid; Kassa, Tesfaye Dessale; Asgedom, Solomon Weldegebreal; Atey, Tesfay Mahari; Gidey, Kidu; Kahsay, Desalegn] Mekelle Univ, Coll Hlth Sci, Sch Pharm, Dept Clin Pharm, Mekelle, Tigray, Ethiopia; [Demoz, Gebre Teklemariam] Aksum Univ, Coll Hlth Sci, Dept Pharm, Clin Pharm & Pharm Practice Unit, Aksum, Tigray, Ethiopia	Mekelle University	Niriayo, YL (corresponding author), Mekelle Univ, Coll Hlth Sci, Sch Pharm, Dept Clin Pharm, Mekelle, Tigray, Ethiopia.	yirga.pharma@gmail.com	Demoz, Gebre Teklemariam/K-6986-2019	Demoz, Gebre Teklemariam/0000-0002-2534-821X; Gidey, kidu/0000-0002-7363-1327; Atey, Tesfay Mehari/0000-0002-6483-2258; Niriayo, yirga/0000-0002-6943-753X				Adisa R, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0934-x; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Al-Sutari MM, 2017, INT J EVID-BASED HEA, V15, P178, DOI 10.1097/XEB.0000000000000108; Alhalaiqa F, 2017, TURK J MED SCI, V47, P273, DOI 10.3906/sag-1508-18; Alsanosy RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065504; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Ambaw AD, 2012, BMC PUBLIC HEALTH, V12, P1471; Asmah EE, 2017, AM J HEALTH EDUC, V48, P374, DOI 10.1080/19325037.2017.1358120; Beigi MAB, 2014, INT CARDIOVASC RES J, V8, P94; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Boima V, 2015, INT J HYPERTENS, V2015, DOI 10.1155/2015/205716; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Bradley E, 2011, INT J QUAL HEALTH C, V23, P222, DOI 10.1093/intqhc/mzr013; Buda Eyasu Siyum, 2017, Clin Hypertens, V23, P26, DOI 10.1186/s40885-017-0081-1; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; de Vijver SV, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.38.3100; Douglas K, 2018, NIGERIAN J MED, V27, P234; Egenasi C, 2015, S AFR FAM PRACT, V57, P326, DOI 10.1080/20786190.2015.1078152; Elbur A.I., 2015, INT J PHARM PHARM SC, V7, P168; Erku DA, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6987636; Flynn SJ, 2013, PATIENT PREFER ADHER, V7, P741, DOI 10.2147/PPA.S46517; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Gelaw Y, 2004, ETHIOP J HEALTH DEV, V18, P179; Girma F, 2014, J HYPERTENS, V3, P1, DOI DOI 10.4172/2167-1095.1000174; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; Gupta S, 2016, ASIAN J MULTIDISCIPL, V4, P2348; Hacihasanoglu R, 2011, J CLIN NURS, V20, P692, DOI 10.1111/j.1365-2702.2010.03534.x; Hekler EB, 2008, J BEHAV MED, V31, P391, DOI 10.1007/s10865-008-9165-4; Heymann AD, 2011, ISR MED ASSOC J, V13, P553; Hien HA, 2018, INT J HYPERTENS, V2018, DOI 10.1155/2018/6326984; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Hu H, 2013, INT J ANTENN PROPAG, V2013, DOI 10.1155/2013/416096; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Khanam MA, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25028; Kibret KT, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0014-z; Kressin NR, 2010, CIRC-CARDIOVASC QUAL, V3, P173, DOI 10.1161/CIRCOUTCOMES.109.860841; Kumar PN, 2010, INT J BIOL MED RES, V1, P248; Lee E, 2017, CONTEMP NURSE, V53, P607, DOI 10.1080/10376178.2017.1368401; Liwa AC, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0437-9; Lulebo Aimee M, 2015, BMC Res Notes, V8, P526, DOI 10.1186/s13104-015-1519-8; Mallat SG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1142; McClintock H, 2017, LANCET GLOB HEALTH, V5, P18; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mohamed SF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6052-y; Mostafavi Firoozeh, 2016, Mater Sociomed, V28, P298; Motlagh SFZ, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.35805; Niriayo YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206120; Ogah OS, 2013, HEART, V99, P1390, DOI 10.1136/heartjnl-2012-303227; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Peltzer K, 2004, Curationis, V27, P15; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Pickett S, 2014, WESTERN J NURS RES, V36, P152, DOI 10.1177/0193945913491837; Reda AA, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-39; Reda AA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-213; Ross S, 2004, J HUM HYPERTENS, V18, P607, DOI 10.1038/sj.jhh.1001721; Saleem F, 2012, J YOUNG PHARM, V4, P101, DOI 10.4103/0975-1483.96624; Schrauben SJ, 2017, HEALTH PROMOT INT, V32, P475, DOI 10.1093/heapro/dav108; Sharma G., 2013, J IND ENG INT, V9, P1; Shihab HM, 2012, CIRCULATION, V126, P2983, DOI 10.1161/CIRCULATIONAHA.112.117333; Shiri Clarris, 2007, Cardiovasc J Afr, V18, P353; Strasser R, 2016, ANNU REV PUBL HEALTH, V37, P395, DOI 10.1146/annurev-publhealth-032315-021507; Teshome DF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196535; van der Hoeven M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-31; Venkatachalam J, 2015, Indian J Community Med, V40, P33, DOI 10.4103/0970-0218.149267; Warren-Findlow J, 2013, J CLIN HYPERTENS, V15, P637, DOI 10.1111/jch.12157; Warren-Findlow J, 2011, J NATL MED ASSOC, V103, P503, DOI 10.1016/S0027-9684(15)30365-5; Webber D., 2013, SELFCARE, V4, P101; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yigzaw Kebede, 2002, Ethiopian Journal of Health Development, V16, P9; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	74	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218947	10.1371/journal.pone.0218947	http://dx.doi.org/10.1371/journal.pone.0218947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242265	gold, Green Published, Green Submitted			2022-12-26	WOS:000482883600070
J	Sabry, M; Zubiak, A; Hood, SP; Simmonds, P; Arellano-Ballestero, H; Cournoyer, E; Mashar, M; Pockley, AG; Lowdell, MW				Sabry, May; Zubiak, Agnieszka; Hood, Simon P.; Simmonds, Poppy; Arellano-Ballestero, Helena; Cournoyer, Eily; Mashar, Meghavi; Pockley, A. Graham; Lowdell, Mark W.			Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures	PLOS ONE			English	Article							PERIPHERAL T-CELLS; RESTING NK CELLS; DOWN-MODULATION; GRANZYME-B; EXPRESSION; CYTOTOXICITY; NKG2D; RECEPTORS; ACTIVATION; CD16	An emerging cellular immunotherapy for cancer is based on the cytolytic activity of natural killer (NK) cells against a wide range of tumors. Although in vitro activation, or "priming," of NK cells by exposure to pro-inflammatory cytokines, such as interleukin (IL)-2, has been extensively studied, the biological consequences of NK cell activation in response to target cell interactions have not been thoroughly characterized. We investigated the consequences of co-incubation with K562, CTV-1, Daudi RPMI-8226, and MCF-7 tumor cell lines on the phenotype, cytokine expression profile, and transcriptome of human NK cells. We observe the downregulation of several activation receptors including CD16, CD62L, C-X-C chemokine receptor (CXCR)-4, natural killer group 2 member D (NKG2D), DNAX accessory molecule (DNAM)-1, and NKp46 following tumor-priming. Although this NK cell phenotype is typically associated with NK cell dysfunction in cancer, we reveal the upregulation of NK cell activation markers, such as CD69 and CD25; secretion of pro-inflammatory cytokines, including macrophage inflammatory proteins (MIP-1) alpha/beta and IL-1 beta/6/8; and overexpression of numerous genes associated with enhanced NK cell cytotoxicity and immunomodulatory functions, such as FAS, TNFSF10, MAPK11, TNF, and IFNG. Thus, it appears that tumor-mediated ligation of receptors on NK cells may induce a primed state which may or may not lead to full triggering of the lytic or cytokine secreting machinery. Key signaling molecules exclusively affected by tumor-priming include MAP2K3, MARCKSL1, STAT5A, and TNFAIP3, which are specifically associated with NK cell cytotoxicity against tumor targets. Collectively, these findings help define the phenotypic and transcriptional signature of NK cells following their encounters with tumor cells, independent of cytokine stimulation, and provide insight into tumor-specific NK cell responses to inform the transition toward harnessing the therapeutic potential of NK cells in cancer.	[Sabry, May; Zubiak, Agnieszka; Simmonds, Poppy; Arellano-Ballestero, Helena; Cournoyer, Eily; Mashar, Meghavi; Lowdell, Mark W.] UCL, Dept Haematol, London, England; [Hood, Simon P.; Pockley, A. Graham] Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham, England; [Lowdell, Mark W.] InmuneBio Inc, La Jolla, CA 92037 USA; [Hood, Simon P.] Univ Manchester, CR United Kingdom Manchester Inst, Clin & Expt Pharmacol Grp, Manchester, Lancs, England	University of London; University College London; Nottingham Trent University; University of Manchester	Lowdell, MW (corresponding author), UCL, Dept Haematol, London, England.; Lowdell, MW (corresponding author), InmuneBio Inc, La Jolla, CA 92037 USA.	m.lowdell@ucl.ac.uk	Pockley, Alan G/I-4704-2015	Pockley, Alan G/0000-0001-9593-6431; Sabry, May/0000-0003-2466-4066	UCL intellectual property development grant; INmuneBio Inc.; Novamune Ltd; Nottingham Trent University; John and Lucille van Geest Foundation; Nottingham Trent University Vice Chancellor's PhD Scholarship	UCL intellectual property development grant; INmuneBio Inc.; Novamune Ltd; Nottingham Trent University; John and Lucille van Geest Foundation; Nottingham Trent University Vice Chancellor's PhD Scholarship	This work was supported by a UCL intellectual property development grant and under research contracts from INmuneBio Inc. and Novamune Ltd to MWL. The John van Geest Cancer Research Centre, of which AGP is the Director, is core-funded by Nottingham Trent University and partially funded by the John and Lucille van Geest Foundation to Nottingham Trent University. SPH was funded by a Nottingham Trent University Vice Chancellor's PhD Scholarship to AGP.	Bottcher A, 2013, CANCER GENOM PROTEOM, V10, P197; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Casetti L, 2013, CANCER RES, V73, P2052, DOI 10.1158/0008-5472.CAN-12-3955; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Casu B, 2019, CANCERS, V11, DOI 10.3390/cancers11010075; Cavalcanti M, 1999, INT J ONCOL, V14, P361; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; CUTURI MC, 1989, J EXP MED, V169, P569, DOI 10.1084/jem.169.2.569; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Fauriat C, 2006, LEUKEMIA, V20, P732, DOI 10.1038/sj.leu.2404096; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fehniger TA, 2018, BIOL BLOOD MARROW TR, V24, P1581, DOI 10.1016/j.bbmt.2018.03.019; Foltz JA, 2018, CANCERS, V10, DOI 10.3390/cancers10110423; Gati A, 2004, INT J CANCER, V109, P393, DOI 10.1002/ijc.11730; Gillard-Bocquet M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00019; Nieto-Velazquez NG, 2016, TRANSL ONCOL, V9, P384, DOI 10.1016/j.tranon.2016.07.003; Grzywacz B, 2007, LEUKEMIA, V21, P356, DOI 10.1038/sj.leu.2404499; Healy CG, 1998, CYTOMETRY, V32, P109, DOI 10.1002/(SICI)1097-0320(19980601)32:2<109::AID-CYTO6>3.0.CO;2-G; Hodge DL, 2002, J IMMUNOL, V168, P6090, DOI 10.4049/jimmunol.168.12.6090; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jewett A, 1996, J IMMUNOL, V156, P907; JEWETT A, 1995, CELL IMMUNOL, V160, P91, DOI 10.1016/0008-8749(95)80013-9; Konjevic G, 2007, CLIN EXP METASTAS, V24, P1, DOI 10.1007/s10585-006-9043-9; Kono K, 1996, CLIN CANCER RES, V2, P1825; Kottaridis PD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123416; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Meazza R, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/861920; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; North J, 2007, J IMMUNOL, V178, P85, DOI 10.4049/jimmunol.178.1.85; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Pal M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1317411; Park KU, 2010, J IMMUNOTHER, V33, P945, DOI 10.1097/CJI.0b013e3181f71b81; Peduto L, 2009, CURR PHARM DESIGN, V15, P2282, DOI 10.2174/138161209788682415; Penack O, 2005, LEUKEMIA, V19, P835, DOI 10.1038/sj.leu.2403704; Peruzzi G, 2013, J IMMUNOL, V191, P1883, DOI 10.4049/jimmunol.1300313; Pockley AG, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0522; Quatrini L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2724; Romee R, 2013, BLOOD, V121, P3599, DOI 10.1182/blood-2012-04-425397; Sabry M, 2011, J IMMUNOL, V187, P6227, DOI 10.4049/jimmunol.1101640; Srpan K, 2018, J CELL BIOL, V217, P3267, DOI 10.1083/jcb.201712085; Wang FY, 2015, EUR J IMMUNOL, V45, P661, DOI 10.1002/eji.201444998; WARREN HS, 1995, J IMMUNOL, V154, P5144; Warren HS, 1996, J IMMUNOL, V156, P2866; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711	47	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218674	10.1371/journal.pone.0218674	http://dx.doi.org/10.1371/journal.pone.0218674			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242243	gold, Green Accepted, Green Published			2022-12-26	WOS:000482883600045
J	Suzuki, TYU; Gallego, J; Assuncao, WG; Briso, ALF; dos Santos, PH				Umeda Suzuki, Thais Yumi; Gallego, Juno; Assuncao, Wirley Goncalves; Fraga Briso, Andre Luiz; dos Santos, Paulo Henrique			Influence of silver nanoparticle solution on the mechanical properties of resin cements and intrarradicular dentin	PLOS ONE			English	Article							OUT BOND STRENGTH; FIBER POSTS; CHLORHEXIDINE APPLICATION; SODIUM-HYPOCHLORITE; CURED COMPOSITES; ROOT CANALS; DIODE-LASER; ADHESIVES; MICROTENSILE; INTERFACE	This study evaluated the influence of silver nanoparticle on mechanical properties of the components of underlying dentin and resin cement in different regions of intraradicular dentin. Ninety extracted single-rooted human teeth were used in this study. After endodontic preparation, the teeth were divided into five groups, according to the irrigating agents: distilled water, 5.25% sodium hypochlorite, 25% polyacrylic acid, 2% chlorhexidine and 23 ppm silver nanoparticles dispersion. Then, the groups were divided in 3 subgroups (n = 6) according to the technique adopted for adhesive cementation: SUA group: Scotchbond Universal Adhesive + RelyX ARC; U200 group: RelyX U200; and MCE group: MaxCem Elite. The mechanical properties of hardness and elastic modulus were measured in resin cement and underlying dentin in ultra-micro hardness tester in different thirds of radicular dentin surface. Data were subjected to ANOVA and Fisher's test (p = 0.05). In the underlying dentin, in general, there was no statistically significant difference in different thirds of intraradicular dentin according to the different solutions used. In the resin cements, higher hardness values were found, in general, for the cervical third. When silver nanoparticle solution was used, higher mechanical properties were generally obtained for resin cement for the SBU and U200 groups, with little or no changes in mechanical properties for the dentin. Silver nanoparticle application is a viable option for irrigation the intraradicular dentin previously through the cementation process of glass fiber posts. The mechanical properties are influenced by irrigant solutions used and the depth intraradical analyzed area.	[Umeda Suzuki, Thais Yumi] Fed Univ Minas Gerais UFMG, Fac Dent, Dept Restorat Dent, Belo Horizonte, MG, Brazil; [Gallego, Juno] Sao Paulo State Univ, Engn Fac Ilha Solteira, Dept Mech Engn, Ilha Solteira, SP, Brazil; [Assuncao, Wirley Goncalves; dos Santos, Paulo Henrique] Sao Paulo State Univ, Aracatuba Sch Dent, Dept Dent Mat & Prosthodont, Aracatuba, SP, Brazil; [Fraga Briso, Andre Luiz] Sao Paulo State Univ, Aracatuba Sch Dent, Dept Restorat Dent, Aracatuba, SP, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	dos Santos, PH (corresponding author), Sao Paulo State Univ, Aracatuba Sch Dent, Dept Dent Mat & Prosthodont, Aracatuba, SP, Brazil.	paulosantos@foa.unesp.br	Briso, Andre/C-2792-2012; Gallego, Juno/G-1908-2012; Santos, Paulo Henrique dos/C-8537-2012; Briso, Andre/AID-8946-2022; Briso, André/AAQ-9746-2021; Suzuki, Thais/C-9893-2016	Gallego, Juno/0000-0002-5477-8139; Santos, Paulo Henrique dos/0000-0002-4100-5153; Briso, Andre/0000-0002-6126-1760; Suzuki, Thais/0000-0003-4220-3781	Sao Paulo Research Foundation (FAPESP) - Brazil [2012/12771-9]; Sao Paulo Research Foundation (FAPESP) - Brazil research aid [2012/09721-0, 2018/07530-9]	Sao Paulo Research Foundation (FAPESP) - Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation (FAPESP) - Brazil research aid(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The student was supported by research grants form Sao Paulo Research Foundation (FAPESP) - Brazil (#2012/12771-9) and Sao Paulo Research Foundation (FAPESP) - Brazil research aid (#2012/09721-0 and 2018/07530-9).	Ahn SJ, 2009, DENT MATER, V25, P206, DOI 10.1016/j.dental.2008.06.002; Andre CB, 2015, J DENT, V43, P466, DOI 10.1016/j.jdent.2015.01.004; Ari H, 2003, J ENDODONT, V29, P248, DOI 10.1097/00004770-200304000-00004; Aslantas EE, 2014, J ENDODONT, V40, P876, DOI 10.1016/j.joen.2013.10.041; Baena E, 2012, OPER DENT, V37, P548, DOI 10.2341/11-079-L; Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053; Barcellos DC, 2011, J ADHES DENT, V13, P261, DOI 10.3290/j.jad.a19224; Leitune VCB, 2010, ORAL SURG ORAL MED O, V110, pE77, DOI 10.1016/j.tripleo.2010.04.046; Breschi L, 2010, DENT MATER, V26, P320, DOI 10.1016/j.dental.2009.11.153; Brunzel S, 2010, J ADHES DENT, V12, P143, DOI 10.3290/j.jad.a17525; Cecchin D, 2014, J ENDODONT, V40, P2045, DOI 10.1016/j.joen.2014.08.019; Cheong C, 2003, OPER DENT, V28, P747; Chou WL, 2005, POLYM ADVAN TECHNOL, V16, P600, DOI 10.1002/pat.630; Demiryurek EO, 2009, ORAL SURG ORAL MED O, V108, pE74, DOI 10.1016/j.tripleo.2009.03.047; DEWALD JP, 1987, J DENT RES, V66, P727, DOI 10.1177/00220345870660030401; Di Hipolito V, 2012, DENT MATER, V28, P495, DOI 10.1016/j.dental.2011.11.027; Nunez-Anita RE, 2014, INT J NANOMED, V9, P3999, DOI 10.2147/IJN.S63064; Ertas H, 2014, ACTA ODONTOL SCAND, V72, P783, DOI 10.3109/00016357.2014.906651; Faria-e-Silva AL, 2013, BRAZ ORAL RES, V27, P14, DOI 10.1590/S1806-83242013000100003; Ferracane J L, 1985, Dent Mater, V1, P11, DOI 10.1016/S0109-5641(85)80058-0; Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009; Ghisi Alexandre Corrêa, 2014, Braz. Dent. J., V25, P420, DOI 10.1590/0103-6440201300129; Gomes JE, 2010, J ENDODONT, V36, P1698, DOI 10.1016/j.joen.2010.07.007; Goracci C, 2004, EUR J ORAL SCI, V112, P353, DOI 10.1111/j.1600-0722.2004.00146.x; Gu XH, 2009, EUR J ORAL SCI, V117, P597, DOI 10.1111/j.1600-0722.2009.00661.x; Kasraei Shahin, 2014, Restor Dent Endod, V39, P109, DOI 10.5395/rde.2014.39.2.109; Khan M, 2014, INT J NANOMED, V9, P3551, DOI 10.2147/IJN.S61983; Kim YK, 2009, INT ENDOD J, V42, P667, DOI 10.1111/j.1365-2591.2009.01565.x; Magalhaes AP, 2016, J CLIN EXP DENT, V8, pe114, DOI [10.4317/jced.52983, DOI 10.4317/JCED.52983]; Marcelino APM, 2014, BRAZ ORAL RES, V28, P491, DOI 10.1590/1807-3107BOR-2014.vol28.0052; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; Mauricio PJBTDD, 2007, J BIOMED MATER RES B, V83B, P364, DOI 10.1002/jbm.b.30805; Monteiro DR, 2012, J PROSTHODONT, V21, P7, DOI 10.1111/j.1532-849X.2011.00772.x; Moraes RR, 2011, OPER DENT, V36, P635, DOI 10.2341/10-367-L; Nevarez-Rascon A, 2014, MATER LETT, V136, P63, DOI 10.1016/j.matlet.2014.08.005; Noronha VT, 2017, DENT MATER, V33, P1110, DOI 10.1016/j.dental.2017.07.002; Oliveira LD, 2007, ORAL SURG ORAL MED O, V104, pE125, DOI 10.1016/j.tripleo.2007.04.019; Paque F, 2006, INT ENDOD J, V39, P18, DOI 10.1111/j.1365-2591.2005.01042.x; Parikh DV, 2005, TEXT RES J, V75, P134, DOI 10.1177/004051750507500208; Passos SP, 2011, J PROSTHODONT, V20, P561, DOI [10.1111/j.1532-849X.2011.00752.x, 10.1111/j.153-849X.2011.00752.x]; Pavan S, 2010, J PROSTHET DENT, V104, P258, DOI 10.1016/S0022-3913(10)60134-5; D'Alpino PHP, 2015, J MECH BEHAV BIOMED, V46, P83, DOI 10.1016/j.jmbbm.2015.02.019; Prabhakar Ar, 2013, Int J Clin Pediatr Dent, V6, P171, DOI 10.5005/jp-journals-10005-1213; Stona P, 2013, J ADHES DENT, V15, P221, DOI 10.3290/j.jad.a29531; Suzuki TYU, 2015, J PROSTHET DENT, V113, P54, DOI 10.1016/j.prosdent.2014.07.009; Tanumiharja M, 2000, J DENT, V28, P361, DOI 10.1016/S0300-5712(00)00009-9; Tay FR, 2005, J ENDODONT, V31, P584, DOI 10.1097/01.don.0000168891.23486.de; Tay FR, 2003, J ADHES DENT, V5, P27; Teixeira CS, 2009, J ENDODONT, V35, P1034, DOI 10.1016/j.joen.2009.04.018; Tonial Daniela, 2010, Stomatologija, V12, P73; Tuncdemir AR, 2013, J ADV PROSTHODONT, V5, P457, DOI 10.4047/jap.2013.5.4.457; Viapiana R, 2012, PHOTOMED LASER SURG, V30, P102, DOI 10.1089/pho.2011.3109; Wu DM, 2014, J ENDODONT, V40, P285, DOI 10.1016/j.joen.2013.08.022; Yassen Ghaeth Hamdon, 2015, Restor Dent Endod, V40, P104, DOI 10.5395/rde.2015.40.2.104; Zhang K, 2012, DENT MATER, V28, P842, DOI 10.1016/j.dental.2012.04.027	55	16	16	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0217750	10.1371/journal.pone.0217750	http://dx.doi.org/10.1371/journal.pone.0217750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242198	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600014
J	Kang, SY; Bang, JI; Kang, KW; Lee, HY; Chung, JK				Kang, Seo Young; Bang, Ji-In; Kang, Keon Wook; Lee, Ho-young; Chung, June-Key			FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; EMISSION-TOMOGRAPHY; CANCER; EXPRESSION; PAPILLARY; MANAGEMENT; PATTERNS; F-18-FDG; TUMOR	Background In some patients with metastatic differentiated thyroid cancer, even if they had substantial of radioactive iodine (RAI) uptake, the RAI therapy response was poor. We investigated the usefulness of FDG PET/CT for the early prediction of RAI therapy response in the patients with metastatic differentiated thyroid cancer (DTC). Methods The 54 metastatic DTC patients who underwent both RAI therapy scan and FDG PET/CT at the same period were enrolled in the study. Clinical information and several parameters from RAI therapy scan and FDG PET/CT were investigated. Therapeutic response of RAI was assessed as two categories: response rate (RR) and disease control rate (DCR). Results Twenty-two patients (41%) had therapeutic response to RAI therapy, whereas 32 (59%) patients did not. There were no significant differences in age, sex, stage, histology, metastasis site, stimulated Tg or Tg-Ab, therapeutic doses, and even RAI uptake pattern among two groups. However, there was a significant negative correlation between FDG avidity of metastatic lesions and RR (OR = 0.233; p = 0.016). Although the patient group with only RAI uptake showed a significant correlation with RR (OR = 5.833; p = 0.01), the patient group with both RAI and FDG uptake did not show any significant correlation with RR. In the subgroup analysis, uptake grades of RAI or FDG was well correlated with DCR. Conclusions The patient group with FDG uptake in metastatic DTC showed poor response to RAI therapy regardless of the degree of RAI uptake. Therefore, FDG PET/CT may help us identify the patients with radioiodine refractory DTC and establish an appropriate treatment strategy in the early period.	[Kang, Seo Young; Kang, Keon Wook] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul, South Korea; [Kang, Seo Young; Bang, Ji-In] Ewha Womans Univ, Med Ctr, Dept Nucl Med, Seoul, South Korea; [Kang, Seo Young] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Lee, Ho-young] Seoul Natl Univ, Bundang Hosp, Dept Nucl Med, Seong Nam, South Korea; [Chung, June-Key] Natl Canc Ctr, Dept Nucl Med, Goyang, South Korea	Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC)	Chung, JK (corresponding author), Natl Canc Ctr, Dept Nucl Med, Goyang, South Korea.	jkchung@snu.ac.kr	Kang, Keon Wook/J-1385-2012	Kang, Keon Wook/0000-0003-2622-9017; Chung, June-Key/0000-0002-6866-8571	Ministry of Health & Welfare, Republic of Korea [HI14C1072]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Drug Development Research, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1072).	Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; CARRASCO N, 1993, BIOCHIM BIOPHYS ACTA, V1154, P65, DOI 10.1016/0304-4157(93)90017-I; Castro MR, 2001, J CLIN ENDOCR METAB, V86, P5627, DOI 10.1210/jc.86.11.5627; Chung JK, 2002, J NUCL MED, V43, P1188; Chung JK, 2014, ENDOCRINOL METAB, V29, P233, DOI 10.3803/EnM.2014.29.3.233; Chung JK, 2014, J KOREAN MED SCI, V29, P1331, DOI 10.3346/jkms.2014.29.10.1331; Duarte PS, 2018, CLIN NUCL MED, V43, P436, DOI 10.1097/RLU.0000000000002046; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; FEINE U, 1995, NUKLEARMED, V34, P127; Feine U, 1996, J NUCL MED, V37, P1468; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Kim S, 2014, NUCL MED MOLEC IMAG, V48, P91, DOI 10.1007/s13139-013-0249-x; Kurokawa T, 2004, INT J CANCER, V109, P926, DOI 10.1002/ijc.20057; MAXON HR, 1983, NEW ENGL J MED, V309, P937, DOI 10.1056/NEJM198310203091601; Min JJ, 2001, EUR J NUCL MED, V28, P639, DOI 10.1007/s002590100509; Moon SH, 2013, ENDOCR RES, V38, P77, DOI 10.3109/07435800.2012.713426; Pacini F, 2012, EXPERT REV ENDOCRINO, V7, P541, DOI [10.1586/EEM.12.36, 10.1586/eem.12.36]; Robbins RJ, 2006, J CLIN ENDOCR METAB, V91, P498, DOI 10.1210/jc.2005-1534; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Schlumberger M, 2014, LANCET DIABETES ENDO, V2, P356, DOI 10.1016/S2213-8587(13)70215-8; TOLLEFSEN HR, 1964, CANCER, V17, P1035, DOI 10.1002/1097-0142(196408)17:8<1035::AID-CNCR2820170810>3.0.CO;2-W; Vaccarella S, 2016, NEW ENGL J MED, V375, P614, DOI 10.1056/NEJMp1604412; Vaisman F, 2015, ENDOCR-RELAT CANCER, V22, pR301, DOI 10.1530/ERC-15-0300; Verburg FA, 2017, BEST PRACT RES CL EN, V31, P279, DOI 10.1016/j.beem.2017.04.010; von Falck C, 2007, EUR J NUCL MED MOL I, V34, P812, DOI 10.1007/s00259-006-0350-9; Zhang ZJ, 2007, CHINESE MED J-PEKING, V120, P125, DOI 10.1097/00029330-200701020-00010	26	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218416	10.1371/journal.pone.0218416	http://dx.doi.org/10.1371/journal.pone.0218416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237886	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000020
J	Wang, QW; Bi, SS; Sun, ML; Wang, YL; Wang, D; Yang, SB				Wang, Qiwei; Bi, Shusheng; Sun, Minglei; Wang, Yuliang; Wang, Di; Yang, Shaobao			Deep learning approach to peripheral leukocyte recognition	PLOS ONE			English	Article							BLOOD; CLASSIFICATION	Microscopic examination of peripheral blood plays an important role in the field of diagnosis and control of major diseases. Peripheral leukocyte recognition by manual requires medical technicians to observe blood smears through light microscopy, using their experience and expertise to discriminate and analyze different cells, which is time-consuming, labor-intensive and subjective. The traditional systems based on feature engineering often need to ensure successful segmentation and then manually extract certain quantitative and qualitative features for recognition but still remaining a limitation of poor robustness. The classification pipeline based on convolutional neural network is of automatic feature extraction and free of segmentation but hard to deal with multiple object recognition. In this paper, we take leukocyte recognition as object detection task and apply two remarkable object detection approaches, Single Shot Multibox Detector and An Incremental Improvement Version of You Only Look Once. To improve recognition performance, some key factors involving these object detection approaches are explored and the detection models are generated using the train set of 14,700 annotated images. Finally, we evaluate these detection models on test sets consisting of 1,120 annotated images and 7,868 labeled single object images corresponding to 11 categories of peripheral leukocytes, respectively. A best mean average precision of 93.10% and mean accuracy of 90.09% are achieved while the inference time is 53 ms per image on a NVIDIA GTX1080Ti GPU.	[Wang, Qiwei; Bi, Shusheng; Sun, Minglei; Wang, Yuliang] Beihang Univ, Sch Mech Engn & Automat, Beijing, Peoples R China; [Wang, Di; Yang, Shaobao] Beijing iCELL Med Co Ltd, Dept Technol Res, Beijing, Peoples R China	Beihang University	Bi, SS (corresponding author), Beihang Univ, Sch Mech Engn & Automat, Beijing, Peoples R China.	ssbi@buaa.edu.cn		Wang, Qiwei/0000-0001-5476-8873				Agaian S, 2014, IEEE SYST J, V8, P995, DOI 10.1109/JSYST.2014.2308452; Agrawal M, 2008, LECT NOTES COMPUT SC, V5305, P102, DOI 10.1007/978-3-540-88693-8_8; Alferez S, 2016, INT J LAB HEMATOL, V38, P209, DOI 10.1111/ijlh.12473; Alferez S, 2015, AM J CLIN PATHOL, V143, P168, DOI 10.1309/AJCP78IFSTOGZZJN; Amjad R, 2018, MICROSC RES TECHNIQ, P1; Bain BJ, 2005, NEW ENGL J MED, V353, P498, DOI 10.1056/NEJMra043442; Ceelie H, 2007, J CLIN PATHOL, V60, P72, DOI 10.1136/jcp.2005.035402; Chaira T, 2014, MICRON, V61, P1, DOI 10.1016/j.micron.2014.01.004; Choi JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189259; Dai J, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P1796, DOI 10.1109/ICIT.2016.7475036; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Durant Thomas JS, 2017, CLIN CHEM, V63, P1; Erhan D, PREPRINT; Ford J, 2013, INT J LAB HEMATOL, V35, P351, DOI 10.1111/ijlh.12082; Gallagher Patrick G, 2005, Hematology Am Soc Hematol Educ Program, P13; Girshick R, PREPRINT; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; He K., MASK R CNN; He KM, 2014, LECT NOTES COMPUT SC, V8691, P346, DOI 10.1007/978-3-319-10578-9_23; Jaroonrut P, 2015, BIOMED ENG ONLINE, P14, DOI [10.1186/s12938-015-0008-6, DOI 10.1186/S12938-015-0008-6]; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Jiang M, 2018, INT J PATTERN RECOGN, V32, DOI 10.1142/S0218001418570069; Joseph R., 2016, DARKNET OPEN SOURCE; Liang GB, 2018, IEEE ACCESS, V6, P36188, DOI 10.1109/ACCESS.2018.2846685; Liang YX, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1014-6; Liu L., DEEP LEARNING GENERI; Liu W., PREPRINT, DOI 10.26434/chemrxiv.11938173.v9; Lopez-Puigdollers D, 2019, EXPERT SYST APPL, V115, P695, DOI 10.1016/j.eswa.2018.08.029; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mathur Atin, 2013, J Pathol Inform, V4, pS15, DOI 10.4103/2153-3539.109883; MoradiAmin M, 2016, MICROSC RES TECHNIQ, V79, P908, DOI 10.1002/jemt.22718; Nazlibilek S, 2014, MEASUREMENT, V55, P58, DOI 10.1016/j.measurement.2014.04.008; Putzu L, 2014, ARTIF INTELL MED, V62, P179, DOI 10.1016/j.artmed.2014.09.002; Qin FW, 2018, COMPUT METH PROG BIO, V162, P243, DOI 10.1016/j.cmpb.2018.05.024; Ramesh N., 2012, J PATHOL INFORM, V3, DOI DOI 10.4103/2153-3539.93400; Redmon J, PREPRINT; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Rezatofighi SH, 2011, COMPUT MED IMAG GRAP, V35, P333, DOI 10.1016/j.compmedimag.2011.01.003; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Sermanet P, PREPRINT; Shahin AI, 2019, COMPUT METH PROG BIO, V168, P69, DOI 10.1016/j.cmpb.2017.11.015; Su MC, 2014, SCI WORLD J, DOI 10.1155/2014/796371; Szegedy C, 2013, ADV NEURAL INFORM PR, P2553, DOI DOI 10.5555/2999792.2999897; Tiwari P, 2018, DETECTION SUBTYPE BL, DOI [10.1016/j.cogsys.2018.08.022, DOI 10.1016/J.COGSYS.2018.08.022]; Zhao JW, 2017, MED BIOL ENG COMPUT, V55, P1287, DOI 10.1007/s11517-016-1590-x; Zou ZX, PREPRINT	46	58	61	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218808	10.1371/journal.pone.0218808	http://dx.doi.org/10.1371/journal.pone.0218808			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237896	Green Published, Green Submitted, gold			2022-12-26	WOS:000484856000041
J	Yunes, MC; Teixeira, DL; von Keyserlingk, MAG; Hotzel, MJ				Yunes, Maria Cristina; Teixeira, Dayane L.; von Keyserlingk, Marina A. G.; Hotzel, Maria J.			Is gene editing an acceptable alternative to castration in pigs?	PLOS ONE			English	Article							GENETICALLY-MODIFIED FOODS; SURGICAL CASTRATION; INFORMATION; ATTITUDES; TECHNOLOGY; PERCEPTION; PIGLETS; IMMUNOCASTRATION; KNOWLEDGE; CITIZENS	Male piglets are commonly castrated to eliminate the risk of boar taint. Surgical castration is the commonly used procedure and is known to induce pain. Gene modification targeted at eliminating boar taint in male pigs has been proposed as a possible alternative to surgical castration. The aims of this study were to explore public acceptability of this biotechnology using a mixed methods approach. Quantitative data to assess acceptability of 570 participants from southern Brazil were analysed with multinomial logistic regression models and Spearman correlations; qualitative responses of the reasons provided in support of their position were coded into themes. Just over half of the participants (56%) considered gene modification of male pigs acceptable. Acceptability was lower among participants who grew up in an agricultural environment (rho = 0.02), but was not influenced by sex, age, religion, urban or rural living, or level of education. Acceptability of gene modification of male pigs as an alternative to surgical castration was positively related to the perception of benefits (r = -0.56, rho<0.0001) and negatively related to the participant's perception of risks (r = -0.35, rho<0.0001). Acceptability was not related to knowledge of basic concepts of genetic biotechnologies (r = 0.06, rho<0.14), or to awareness of issues related to pig castration or boar taint (r = 0.03, rho<0.44), both of which were low among participants. Participants that considered gene modification of pigs acceptable justified their position using arguments that it improved animal welfare. In contrast, those that were not in favour were generally opposed to genetic modification. Unforeseen downstream consequences of using genetic modification in this manner was a major concern raised by over 80% of participants. Our findings suggest that perceived animal welfare may encourage public support of gene editing of food animals. However, potential risks of the technology need to be addressed and conveyed to the public, as many participants requested clarification of such risks as a condition for support.	[Yunes, Maria Cristina; Hotzel, Maria J.] Univ Fed Santa Catarina, Lab Etol Aplicada & Bem Estar Anim, Dept Zootecnia & Desenvolvimento Rural, Florianopolis, SC, Brazil; [Teixeira, Dayane L.] Pontificia Univ Catolica Chile, Dept Ciencias Anim, Fac Agron & Ingn Forestal, Santiago, Chile; [von Keyserlingk, Marina A. G.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada	Universidade Federal de Santa Catarina (UFSC); Pontificia Universidad Catolica de Chile; University of British Columbia	Hotzel, MJ (corresponding author), Univ Fed Santa Catarina, Lab Etol Aplicada & Bem Estar Anim, Dept Zootecnia & Desenvolvimento Rural, Florianopolis, SC, Brazil.	maria.j.hotzel@ufsc.br	Teixeira, Dayane/AAA-6807-2020; Hötzel, Maria José/H-6975-2014; Teixeira, Dayane L/H-8640-2018	Teixeira, Dayane/0000-0001-5063-7972; Hötzel, Maria José/0000-0003-1034-3202; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [311509/2015-0]; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (311509/2015-0 to MJH) and the Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEKSEJEVA I, 2014, MANAG ORG SYST RES, V71, P7; Aluwe M, 2015, RES VET SCI, V103, P80, DOI 10.1016/j.rvsc.2015.09.019; [Anonymous], 2015, BRAS QUE VOA; [Anonymous], 2017, AGR FAMILIAR REPRESE; [Anonymous], 2015, AGR FAMILIAR PRODUZ; Bee G, 2015, ANIM PROD SCI, V55, P1347, DOI 10.1071/AN15279; Behrens JH, 2009, INNOV FOOD SCI EMERG, V10, P383, DOI 10.1016/j.ifset.2009.01.001; Bruce A., 2016, FOOD FUTURES ETHICS, P513; Bruce A, 2017, TRANSGENIC RES, V26, P385, DOI 10.1007/s11248-017-0017-2; Bruce DM, 2016, FOOD FUTURES ETHICS, P518; Caplan AL, 2015, EMBO REP, V16, P1421, DOI 10.15252/embr.201541337; Cardoso CS, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7120089; Carroll D, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0812-0; Castelfranchi Y, 2013, HIST CIENC SAUDE-MAN, V20, P1163, DOI 10.1590/S0104-59702013000400005; Centro de GestAo e Estudos Estrategicos (CGEE), 2015, PERC PUBL CIENC TECN; Ciarelli Gustavo, 2009, Rev. Adm. Pública, V43, P541; CLAUS R, 1994, MEAT SCI, V38, P289, DOI 10.1016/0309-1740(94)90118-X; Costa-Font M, 2008, FOOD POLICY, V33, P99, DOI 10.1016/j.foodpol.2007.07.002; Cuite Cara L., 2005, International Journal of Biotechnology, V7, P178, DOI 10.1504/IJBT.2005.006453; Davis SR, 2017, J ANIM SCI, V95, P1788, DOI 10.2527/jas.2016.0956; De Briyne N, 2016, PORCINE HEALTH MANAG, V2, DOI 10.1186/s40813-016-0046-x; de Graeff N, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0106; Deliza R, 2003, TRENDS FOOD SCI TECH, V14, P43, DOI 10.1016/S0924-2244(02)00240-6; Demartini M., 2015, REV EPOCA; Eriksson S, 2018, J DAIRY SCI, V101, P1, DOI 10.3168/jds.2017-12962; Eurobarometer, 2002, EUR BIOT 2002; Fredriksen B, 2011, RES VET SCI, V90, P352, DOI 10.1016/j.rvsc.2010.06.018; Frewer LJ, 2002, RISK ANAL, V22, P701, DOI 10.1111/0272-4332.00062; Frewer LJ, 1997, SCI TECHNOL HUM VAL, V22, P98, DOI 10.1177/016224399702200105; Furnival AC, 2008, HIST CIENC SAUDE-MAN, V15, P277, DOI 10.1590/S0104-59702008000200003; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Gaskell G., 2003, EUROPEANS BIOTECHNOL; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Guivant JS, 2015, PATHWAY SUSTAIN, P74; Hallman W. K, 2003, PUBLIC PERCEPTIONS G; Hallman WK, 2004, RR1104007 STAT U JER; Hansen J, 2003, APPETITE, V41, P111, DOI 10.1016/S0195-6663(03)00079-5; Hoban TJ, 2004, 04E09 ESA FAO UN AGR; Hotzel MJ, 2017, J DAIRY SCI, V100, P4150, DOI 10.3168/jds.2016-11933; Hotzel MJ, 2016, J DAIRY SCI, V99, P6853, DOI 10.3168/jds.2016-11393; Huberman AM, 1994, HDB QUALITATIVE RES, P643; IBGE, 2011, SIN CENS DEM 2010 BR; James S, 2003, AUST J AGR RESOUR EC, V47, P501, DOI 10.1111/j.1467-8489.2003.t01-1-00225.x; Joffe H, 2003, BRIT J SOC PSYCHOL, V42, P55, DOI 10.1348/014466603763276126; Knight JG, 2005, J PUBLIC AFF, V5, P226, DOI 10.1002/pa.24; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Lemos Teixeira Dayane, 2018, PLoS One, V13, pe0190671, DOI 10.1371/journal.pone.0190671; Lundstrom TS, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-10; Macnaghten P., 2001, ANIMAL FUTURES PUBLI; Macnaghten P., 2015, GOVERNING AGR SUSTAI; Mancini MC, 2017, LIVEST SCI, V203, P10, DOI 10.1016/j.livsci.2017.06.012; McConnachie E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216542; Mielby H, 2013, PUBLIC UNDERST SCI, V22, P155, DOI 10.1177/0963662511430577; PATTERSON RL, 1968, J SCI FOOD AGR, V19, P31, DOI 10.1002/jsfa.2740190107; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Prunier A, 2006, ANIM WELFARE, V15, P277; Rault JL, 2011, APPL ANIM BEHAV SCI, V135, P214, DOI 10.1016/j.applanim.2011.10.017; Recombinetics, REC DNA GEN ALL END; Renn O, 2004, TOXICOL LETT, V149, P405, DOI 10.1016/j.toxlet.2003.12.051; Ribeiro TG, 2016, FOOD RES INT, V84, P120, DOI 10.1016/j.foodres.2016.03.029; Rollin BE, 1992, CREATION TRANSGENIC; Rollin BE, 2006, SCIENCE AND ETHICS, P1; Sato P, 2017, ANIMALS, V7, DOI 10.3390/ani7080064; Shriver A, ENCY FOOD AGR ETHICS; Sonstegard T, 2016, ASAP ANIMAL PRODUCTI, V2; Sul21, 2017, IND OMITE PRESENCA T; Tait-Burkard C, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1583-1; Tan W, 2012, ADV GENET, V80, P37, DOI 10.1016/B978-0-12-404742-6.00002-8; Thompson DL, 2000, ANIM REPROD SCI, V60, P459, DOI 10.1016/S0378-4320(00)00116-0; Thompson Paul B., 1998, P243; Tuyttens FAM, 2012, RES VET SCI, V92, P524, DOI 10.1016/j.rvsc.2011.02.017; Van Beirendonck S, 2013, J AGR ENVIRON ETHIC, V26, P259, DOI 10.1007/s10806-012-9378-y; Vanhonacker F, 2009, ANIM WELFARE, V18, P371; Vanhonacker F, 2008, LIVEST SCI, V116, P126, DOI 10.1016/j.livsci.2007.09.017; Ventura BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154733; Waltz E, 2017, NATURE, V548, P148, DOI 10.1038/nature.2017.22116; Weary DM, 2016, ANIMAL, V10, P309, DOI 10.1017/S1751731115001160; Whitall H., 2017, ETHICAL CHALLENGES R	78	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218176	10.1371/journal.pone.0218176	http://dx.doi.org/10.1371/journal.pone.0218176			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233520	gold, Green Published, Green Submitted			2022-12-26	WOS:000484896700012
J	Van Dyk, TR; Zhang, NH; Combs, A; Howarth, T; Whitacre, C; McAlister, S; Beebe, DW				Van Dyk, Tori R.; Zhang, Nanhua; Combs, Angela; Howarth, Taylor; Whitacre, Catharine; McAlister, Shealan; Beebe, Dean W.			Feasibility and impact on daytime sleepiness of an experimental protocol inducing variable sleep duration in adolescents	PLOS ONE			English	Article							MOOD	Although most research on sleep and adolescent health has focused on how long each youth sleeps on average, variability in sleep duration may be just as problematic. Existing findings have been inconsistent and unable to address cause-effect relationships. This study piloted an experimental protocol to induce sleep variability and explore its impact on daytime sleepiness in adolescents. Healthy adolescents aged 14-17 participated in a 3-week, at-home protocol. Sleep was monitored by sleep diaries and actigraphy. Following a run-in period to stabilize wake times (set at 6:30AM throughout the protocol), participants were randomly counterbalanced across two 5-night experimental conditions. Bedtimes were consistent at 11:00PM during the stable sleep condition (7.5-hour sleep period each night) but changed on alternating nights during the variable sleep condition (ranging from 9:30PM to 12:30AM) so that sleep duration averaged 7.5 hours across the condition with a standard deviation of 1.37 hours. Difficulty waking was assessed each morning and daytime sleepiness was assessed by end-of-condition parent-and adolescent-reports. Of the 20 participants who completed the study, 16 met the predetermined adherence definition. For those who were adherent, there were no differences in overall sleep duration between the stable and variable sleep conditions (p>.05) but adolescents had 58.6 minutes greater night-to-night variation in sleep duration in the variable condition (p < .001). Across all nights, youth reported greater difficulty waking following nights of shorter assigned sleep (p = .004) and greater overall sleepiness during the variable condition (p = .03). It is feasible to experimentally vary how long adolescents sleep on a nightly basis while holding average sleep duration constant. Such a protocol will promote tests of the acute effects of day-to-day changes in sleep duration on health.	[Van Dyk, Tori R.] Loma Linda Univ, Dept Psychol, Loma Linda, CA 92350 USA; [Zhang, Nanhua; Combs, Angela; Howarth, Taylor; Whitacre, Catharine; McAlister, Shealan; Beebe, Dean W.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Zhang, Nanhua; Beebe, Dean W.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Loma Linda University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Van Dyk, TR (corresponding author), Loma Linda Univ, Dept Psychol, Loma Linda, CA 92350 USA.	tvandyk@llu.edu		Zhang, Nanhua/0000-0001-5796-3404	Cincinnati Children's Hospital Research Foundation	Cincinnati Children's Hospital Research Foundation	Financial support was provided by a Cincinnati Children's Hospital Research Foundation grant awarded to DB and TVD. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum KT, 2014, J CHILD PSYCHOL PSYC, V55, P180, DOI 10.1111/jcpp.12125; Becker SP, 2017, SLEEP MED REV, V34, P94, DOI 10.1016/j.smrv.2016.07.004; Beebe DW, 2008, J CHILD PSYCHOL PSYC, V49, P915, DOI 10.1111/j.1469-7610.2008.01885.x; Beebe DW, 2018, CLIN J SPORT MED, V28, P395, DOI 10.1097/JSM.0000000000000454; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Fuligni AJ, 2006, J RES ADOLESCENCE, V16, P353, DOI 10.1111/j.1532-7795.2006.00498.x; Fuligni AJ, 2018, CHILD DEV, V89, pe18, DOI 10.1111/cdev.12729; He F, 2015, SLEEP MED, V16, P856, DOI 10.1016/j.sleep.2015.03.004; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P233, DOI 10.1016/j.sleh.2015.10.004; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; LeBourgeois MK, 2005, PEDIATRICS, V115, P257, DOI 10.1542/peds.2004-0815H; Lo JC, 2016, SLEEP, V39, P687, DOI 10.5665/sleep.5552; Meltzer LJ, 2015, PEDIAT SLEEP PROBLEM; National Sleep Foundation, 2006, SUMM FIND 2006 SLEEP; Owens JA, 2000, SLEEP, V23, P1043; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Van Dyk TR, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx123	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218894	10.1371/journal.pone.0218894	http://dx.doi.org/10.1371/journal.pone.0218894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226161	gold, Green Published, Green Submitted			2022-12-26	WOS:000484894700049
J	Behrendt, CE; Cosgrove, CM; Johnson, NJ; Altekruse, SF				Behrendt, Carolyn E.; Cosgrove, Candace M.; Johnson, Norman J.; Altekruse, Sean F.			Are associations between psychosocial stressors and incident lung cancer attributable to smoking?	PLOS ONE			English	Article							SOCIAL STRESS; TUMOR-GROWTH; LIFE-COURSE; MORTALITY; RISK; MEN; PROMOTES; DRINKING; EVENTS; MODEL	Purpose To learn whether reported associations between major psychosocial stressors and lung cancer are independent of smoking history. Methods Subjects were at least 25 years old and without lung cancer at enrollment in the United States Census Bureau's National Longitudinal Mortality Survey in 1995-2008. Follow-up via Surveillance Epidemiology and End Results and National Death Index continued until lung cancer diagnosis, death, or December 2011. Involuntary unemployment, widowhood, and divorce, stratified by sex, were tested for association with subsequent lung cancer using proportional hazards regression for competing risks. Smoking status, years smoked, cigarettes per day, and years since quitting were imputed when missing. Results At enrollment, subjects (n = 100,733, 47.4% male, age 49.1(+/- 15.8) years) included 17.6% current smokers, 23.5% former smokers. Of men and women, respectively, 11.3% and 15.0% were divorced/separated, 2.9% and 11.8% were widowed, and 2.9% and 2.3% were involuntarily unemployed. Ultimately, 667 subjects developed lung cancer; another 10,071 died without lung cancer. Adjusted for age, education, and ancestry, lung cancer was associated with unemployment, widowhood, and divorce/separation in men but not women. Further adjusted for years smoked, cigarettes per day, and years since quitting, none of these associations was significant in either sex. Conclusions Once smoking is accounted for, psychosocial stressors in adulthood do not independently promote lung cancer. Given their increased smoking behavior, persons experiencing stressors should be referred to effective alternatives to smoking and to support for smoking cessation.	[Behrendt, Carolyn E.] City Hope Natl Med Ctr, Biostat & Epidemiol, Informat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Cosgrove, Candace M.; Johnson, Norman J.] US Census Bur, Mortal Res Branch, Suitland, MD USA; [Altekruse, Sean F.] NCI, Surveillance Res Program, Div Canc Control & Populat Sci, Rockville, MD USA; [Altekruse, Sean F.] NHLBI, Epidemiol Branch, Prevent & Populat Sci Program, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA	City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Behrendt, CE (corresponding author), City Hope Natl Med Ctr, Biostat & Epidemiol, Informat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA.	cbehrendt@coh.org		Behrendt, Carolyn/0000-0002-7260-1433	United States Census Bureau; National Cancer Institute [P30CA033572]; National Heart, Lung and Blood Institute; National Institute on Aging; National Center for Health Statistics; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	United States Census Bureau; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Health Statistics(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded through interagency agreements between the United States Census Bureau and the following sponsors: The National Cancer Institute; National Heart, Lung and Blood Institute; National Institute on Aging; and National Center for Health Statistics. Coauthors SFA, NJJ, and CMC are employees of the Census Bureau or a sponsor agency and contributed to the study's data collection, analysis, decision to publish, and preparation of the manuscript. Lead author CEB's work to conceive and direct this analysis and draft the manuscript was performed in the City of Hope Biostatistics Core, supported in part by the National Cancer Institute under award number P30CA033572. The views expressed in this article are those of the authors and do not necessarily represent the official views of the United States Census Bureau; National Institutes of Health; or Department of Health and Human Services.	Al-Wadei HAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029915; Al-Wadei HAN, 2012, CANCER PREV RES, V5, P189, DOI 10.1158/1940-6207.CAPR-11-0177; Al-Wadei HAN, 2010, LUNG CANCER, V69, P33, DOI 10.1016/j.lungcan.2009.09.011; [Anonymous], 2018, BEHAV RES PROGRAM; [Anonymous], SMALL AR EST CANC RE; Arcaya M, 2014, SOC SCI MED, V110, P89, DOI 10.1016/j.socscimed.2014.03.034; Bergelt C, 2006, BRIT J CANCER, V95, P1579, DOI 10.1038/sj.bjc.6603471; Blanc-Lapierre A, 2017, PREV MED, V96, P28, DOI 10.1016/j.ypmed.2016.12.004; Brown DW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-20; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; COLBY JP, 1994, SOC SCI MED, V38, P373, DOI 10.1016/0277-9536(94)90407-3; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; Heikkila K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f165; Henkens K, 2008, EUR J PUBLIC HEALTH, V18, P644, DOI 10.1093/eurpub/ckn095; HOLM S, 1979, SCAND J STAT, V6, P65; Hovanec J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192999; JAHN I, 1995, SOC SCI MED, V40, P961, DOI 10.1016/0277-9536(94)00151-I; Kennedy B, 2014, CANCER CAUSE CONTROL, V25, P499, DOI 10.1007/s10552-014-0352-z; Knekt P, 1996, AM J EPIDEMIOL, V144, P1096, DOI 10.1093/oxfordjournals.aje.a008887; Lewis DR, 2009, INT J TUBERC LUNG D, V13, P1008; Li X, 2003, EUR J CANCER PREV, V12, P355, DOI 10.1097/00008469-200310000-00002; LINKINS RW, 1990, AM J EPIDEMIOL, V132, P962, DOI 10.1093/oxfordjournals.aje.a115739; LYNGE E, 1997, IARC SCI PUBL, V138, P343; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Nystedt P, 2006, SOC SCI MED, V62, P1427, DOI 10.1016/j.socscimed.2005.08.009; Schuller HM, 2000, J CANCER RES CLIN, V126, P624, DOI 10.1007/PL00008474; Song YF, 2017, CANCER RES, V77, P1611, DOI 10.1158/0008-5472.CAN-16-2143; Wu X, 2015, MOL MED REP, V12, P1405, DOI 10.3892/mmr.2015.3559; Yu D, J NATL CANC I	32	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218439	10.1371/journal.pone.0218439	http://dx.doi.org/10.1371/journal.pone.0218439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220129	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500047
J	Pan, W; Flint, J; Shenhav, L; Liu, TL; Liu, MM; Hu, B; Zhu, TS				Pan, Wei; Flint, Jonathan; Shenhav, Liat; Liu, Tianli; Liu, Mingming; Hu, Bin; Zhu, Tingshao			Re-examining the robustness of voice features in predicting depression: Compared with baseline of confounders	PLOS ONE			English	Article							HAN CHINESE WOMEN; CLINICAL DEPRESSION; FIELD TRIALS; SPEECH; EMOTION; BURDEN; CLASSIFICATION; DISORDERS; DISEASE; ONSET	A large proportion of Depression Disorder patients do not receive an effective diagnosis, which makes it necessary to find a more objective assessment to facilitate a more rapid and accurate diagnosis of depression. Speech data is easy to acquire clinically, its association with depression has been studied, although the actual predictive effect of voice features has not been examined. Thus, we do not have a general understanding of the extent to which voice features contribute to the identification of depression. In this study, we investigated the significance of the association between voice features and depression using binary logistic regression, and the actual classification effect of voice features on depression was re-examined through classification modeling. Nearly 1000 Chinese females participated in this study. Several different datasets was included as test set. We found that 4 voice features (PC1, PC6, PC17, PC24, P<0.05, corrected) made significant contribution to depression, and that the contribution effect of the voice features alone reached 35.65% (Nagelkerke's R-2). In classification modeling, voice data based model has consistently higher predicting accuracy(F-measure) than the baseline model of demographic data when tested on different datasets, even across different emotion context. F-measure of voice features alone reached 81%, consistent with existing data. These results demonstrate that voice features are effective in predicting depression and indicate that more sophisticated models based on voice features can be built to help in clinical diagnosis.	[Pan, Wei; Liu, Mingming; Zhu, Tingshao] Chinese Acad Sci, Inst Psychol, Beijing, Peoples R China; [Pan, Wei; Liu, Mingming] Univ Chinese Acad Sci, Beijing, Peoples R China; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; [Shenhav, Liat] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Liu, Tianli] Peking Univ, Inst Populat Res, Beijing, Peoples R China; [Hu, Bin] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou, Gansu, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Peking University; Lanzhou University	Zhu, TS (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing, Peoples R China.	tszhu@psych.ac.cn		Liu, Mingming/0000-0002-6965-1499; Zhu, Tingshao/0000-0003-0020-3812; Pan, Wei/0000-0001-9798-770X; Shenhav, Liat/0000-0003-1708-6050	National Basic Research Program of China [2014CB744600]	National Basic Research Program of China(National Basic Research Program of China)	The authors gratefully acknowledge the generous support from National Basic Research Program of China (2014CB744600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelin A., 2000, ISCA TUT RES WORKSH; Afshan A, 2018, INTERSPEECH, P1676, DOI 10.21437/Interspeech.2018-1399; Akobeng AK, 2016, ACTA PAEDIATR, V105, P605, DOI 10.1111/apa.13384; Alghowinem S, 2013, INT CONF ACOUST SPEE, P8022, DOI 10.1109/ICASSP.2013.6639227; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045; Bhatti MW, 2004, 2004 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL 2, PROCEEDINGS, P181; Christ SL, 2007, J GERONTOL B-PSYCHOL, V62, pS399, DOI 10.1093/geronb/62.6.S399; COKER CH, 1976, P IEEE, V64, P452, DOI 10.1109/PROC.1976.10154; Crystal D., 1976, PROSODIC SYSTEMS INT, V1; Cummins N, 2015, SPEECH COMMUN, V71, P10, DOI 10.1016/j.specom.2015.03.004; Cummins N, 2014, INT CONF ACOUST SPEE, DOI 10.1109/ICASSP.2014.6853741; Cummins N, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P3008; DARBY JK, 1977, FOLIA PHONIATR, V29, P279, DOI 10.1159/000264098; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Dobson C., 2017, SCI SCOPE, V40, P76; El Ayadi M, 2011, PATTERN RECOGN, V44, P572, DOI 10.1016/j.patcog.2010.09.020; Eyben F., 2013, P 21 ACM INT C MULT, P835, DOI 10.1145/2502081.2502224; France DJ, 2000, IEEE T BIO-MED ENG, V47, P829, DOI 10.1109/10.846676; FRICK RW, 1985, PSYCHOL BULL, V97, P412, DOI 10.1037/0033-2909.97.3.412; GOLDBERG D, 1995, EPIDEMIOL REV, V17, P182, DOI 10.1093/oxfordjournals.epirev.a036174; Guo JX, 2017, INTERSPEECH, P3712, DOI 10.21437/Interspeech.2017-430; Guo JX, 2018, SPEECH COMMUN, V105, P92, DOI 10.1016/j.specom.2018.10.004; Guo JX, 2016, INTERSPEECH, P2219, DOI 10.21437/Interspeech.2016-282; Guo JX, 2017, J ACOUST SOC AM, V141, pEL420, DOI 10.1121/1.4979841; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; LIEBERMAN P, 1962, J ACOUST SOC AM, V34, P922, DOI 10.1121/1.1918222; Liu ZY, 2015, INT CONF AFFECT, P743, DOI 10.1109/ACII.2015.7344652; Low LSA, 2011, IEEE T BIO-MED ENG, V58, P574, DOI 10.1109/TBME.2010.2091640; Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Moore E, 2008, IEEE T BIO-MED ENG, V55, P96, DOI 10.1109/TBME.2007.900562; Morales M.R., 2017, P 4 WORKSHOP COMPUTA, P1, DOI DOI 10.18653/V1/W17-3101; Mundt JC, 2007, J NEUROLINGUIST, V20, P50, DOI 10.1016/j.jneuroling.2006.04.001; MURRAY IR, 1993, J ACOUST SOC AM, V93, P1097, DOI 10.1121/1.405558; Nierenberg AA, 2001, J CLIN PSYCHIAT; Penninx BWJH, 2001, ARCH GEN PSYCHIAT, V58, P221, DOI 10.1001/archpsyc.58.3.221; Redei EE, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.66; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Scherer KR, 2000, 6 INT C SPOK LANG PR; Scherer S, 2013, INTERSPEECH, P847; Scherer S, 2014, IMAGE VISION COMPUT, V32, P648, DOI 10.1016/j.imavis.2014.06.001; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Sim J, 2018, INT J SOC RES METHOD, V21, P619, DOI 10.1080/13645579.2018.1454643; SPITZER RL, 1979, AM J PSYCHIAT, V136, P815; Sturim D, 2011, 12 ANN C INT SPEECH; Sui XY, 2017, THESIS; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Toda T, 2007, IEEE T AUDIO SPEECH, V15, P2222, DOI 10.1109/TASL.2007.907344; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Vaissiere J., 1983, PROSODY MODELS MEASU, P53, DOI DOI 10.1007/978-3-642-69103-4_5; Wang JY, 2018, LECT NOTES COMPUT SC, V10745, P433, DOI 10.1007/978-3-319-74521-3_46; Wang JY, 2017, IEEE INT C BIOINFORM, P986; Weng ST, 2015, ASIAPAC SIGN INFO PR, P152, DOI 10.1109/APSIPA.2015.7415492; WHO, 2017, DEPR OTH COMM MENT D; Yang FZ, 2014, J AFFECT DISORDERS, V157, P72, DOI 10.1016/j.jad.2014.01.004; Yang FZ, 2011, J AFFECT DISORDERS, V135, P89, DOI 10.1016/j.jad.2011.06.056; Yang L, 2016, PROCEEDINGS OF THE 6TH INTERNATIONAL WORKSHOP ON AUDIO/VISUAL EMOTION CHALLENGE (AVEC'16), P89, DOI 10.1145/2988257.2988269	63	3	4	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218172	10.1371/journal.pone.0218172	http://dx.doi.org/10.1371/journal.pone.0218172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220113	Green Submitted, Green Published, gold			2022-12-26	WOS:000484893500028
J	Sabahelzain, MM; Moukhyer, M; Dube, E; Hardan, A; van den Borne, B; Bosma, H				Sabahelzain, Majdi M.; Moukhyer, Mohamed; Dube, Eve; Hardan, Ahmed; van den Borne, Bart; Bosma, Hans			Towards a further understanding of measles vaccine hesitancy in Khartoum state, Sudan: A qualitative study	PLOS ONE			English	Article								Background Vaccine hesitancy is one of the contributors to low vaccination coverage in both developed and developing countries. Sudan is one of the countries that suffers from low measles vaccine coverage and from measles outbreaks. In order to facilitate the future development of interventions, this study aimed at exploring the opinions of Expanded Program on Immunization officers at ministries of health, WHO, UNICEF and vaccine care providers at Khartoum-based primary healthcare centers. Methods Qualitative data were collected using semi-structured interviews during the period January-March 2018. Data (i.e. quotes) were matched to the categories and the sub-categories of a framework that was developed by the WHO-SAGE Working Group called ''Determinants of Vaccine Hesitancy Matrix''. Findings The interviews were conducted with 14 participants. The majority of participants confirmed the existence of measles vaccine hesitancy in Khartoum state. They further identified various determinants that were grouped into three domains including contextual, groups and vaccination influences. The main contextual determinant as reported is the presence of people who can be qualified as "anti-vaccination". They mostly belong to particular religious and ethnic groups. Parents' beliefs about prevention and treatment from measles are the main determinants of the group influences. Attitude of the vaccine providers, measles vaccine schedule and its mode of delivery were the main vaccine related determinants. Conclusion Measles vaccine hesitancy in Sudan appears complex and highly specific to local circumstances. To better understand the magnitude and the context-specific causes of measles vaccine hesitancy and to develop adapted strategies to address them, there is clearly a further need to investigate measles vaccine hesitancy among parents.	[Sabahelzain, Majdi M.] Ahfad Univ Women, Sch Hlth Sci, Dept Publ Hlth, Omdurman, Sudan; [Sabahelzain, Majdi M.; van den Borne, Bart] Maastricht Univ, CAPHRI, Dept Hlth Promot, Maastricht, Netherlands; [Moukhyer, Mohamed] Jazan Univ, Coll Appl Med Sci, Educ Dev & Qual Unit, Jazan, Saudi Arabia; [Dube, Eve] INSPQ, Quebec City, PQ, Canada; [Hardan, Ahmed] WHO, Khartoum, Sudan; [Bosma, Hans] Maastricht Univ, CAPHRI, Dept Social Med, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Jazan University; Institut national de sante publique du Quebec (INSPQ); World Health Organization; Maastricht University; Maastricht University Medical Centre (MUMC)	Sabahelzain, MM (corresponding author), Ahfad Univ Women, Sch Hlth Sci, Dept Publ Hlth, Omdurman, Sudan.; Sabahelzain, MM (corresponding author), Maastricht Univ, CAPHRI, Dept Hlth Promot, Maastricht, Netherlands.	majdisabahelzain@gmail.com	Bosma, Hans/A-6184-2013; van den Borne, Bart/AAP-3775-2020	Sabahelzain, Majdi/0000-0002-6095-2172	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Adamo G, 2017, ANN IG MED PREV COMU, V29, P1, DOI 10.7416/ai.2017.2128; ALSHARIF J, 2019, SALAFIS IN SUDAN NON, V2012, P20, DOI DOI 10.1186/S12889-019-6706-4; [Anonymous], 2017, WHO; Brown KF, 2010, VACCINE, V28, P4235, DOI 10.1016/j.vaccine.2010.04.052; CENTERS FOR, 2011, MMWR-MORBID MORTAL W, V60, P814; D'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809; DUBE P, 2020, VACCINE, V32, P6649, DOI DOI 10.1016/J.VACCINE.2014.09.039; DUBE P, 2013, VACCINE, V8, P1763, DOI DOI 10.4161/HV.24657; DUBE P, 2016, PLOS ONE, V3, P11, DOI DOI 10.1371/JOURNAL.PONE.0156118; Federal Ministry of Health, 2012, SUDAN NATIONAL IMMUN; Giambi C, 2018, VACCINE, V36, P779, DOI 10.1016/j.vaccine.2017.12.074; HARMSEN IA, 2015, BMC PUBLIC HEALTH, V15, P7431, DOI DOI 10.1016/J.VACCINE.2010.04.052; HARMSEN IA, 2012, EPUB, V20, P7431, DOI DOI 10.1007/S10943-017-0428-7; J V, 2018, PMC, V20, P7873; J V, 2018, PMC, V14, P1945, DOI DOI 10.1098/RSTB.2012.0148; J V, PMC, P7431, DOI DOI 10.1093/EURPUB/CKU254; J V, 2005, PMC, P7431; J V, 2014, PMC, V9, P39, DOI DOI 10.1371/JOURNAL.PONE.0156118; J V, 2000, PMC, P7431; J V, 2018, PMC, V8, P7431; Karafillakis E, 2016, VACCINE, V34, P5013, DOI 10.1016/j.vaccine.2016.08.029; Korhonen T, 2015, EUR J PUBLIC HEALTH, V25, P512, DOI 10.1093/eurpub/cku254; Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037; LARSON HJ, 2016, PMC, V13, P8590, DOI DOI 10.1016/J.EBIOM.2016.08.042; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Machekanyanga Z, 2017, J RELIG HEALTH, V56, P1683, DOI 10.1007/s10943-017-0428-7; Napolitano F, 2018, HUM VACC IMMUNOTHER, V14, P1558, DOI 10.1080/21645515.2018.1463943; PADMAWATI RS, 2019, BMC PUBLIC HEALTH, V19, P7431, DOI DOI 10.1016/J.SOCSCIMED.2014.04.018; PIPES D, 2019, CONSPIRACY THEORIES, V2004, P11, DOI DOI 10.1016/J.VACCINE.2019.02.049; Pipes D, 2004, PMC; QUINN S, 2016, PLOS CURR, V29, P7431; Rosso A, 2019, VACCINE, V37, P1954, DOI 10.1016/j.vaccine.2019.02.049; Saint-Victor DS, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0148; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Taylor LE, 2014, VACCINE, V32, P3623, DOI 10.1016/j.vaccine.2014.04.085; The Vaccine Alliance, 2015, SUSTAINABLE DEVELOPM; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018	37	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0213882	10.1371/journal.pone.0213882	http://dx.doi.org/10.1371/journal.pone.0213882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220092	Green Submitted, gold, Green Published			2022-12-26	WOS:000484893500002
J	van Wees, DA; den Daas, C; Kretzschmar, MEE; Heijne, JCM				van Wees, Daphne A.; den Daas, Chantal; Kretzschmar, Mirjam E. E.; Heijne, Janneke C. M.			Who drops out and when? Predictors of non-response and loss to follow-up in a longitudinal cohort study among STI clinic visitors	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; SEXUAL-BEHAVIOR; HEALTH; BIAS; PREVALENCE; INTENTION; GOALS; HIV	Introduction Response rates in health research are declining, and low response rates could result in biased outcomes when population characteristics of participants systematically differ from the non-respondents. Few studies have examined key factors of non-response beyond demographic characteristics, such as behavioral and psychological factors. The aim of the current study was to identify predictors of non-response and loss to follow-up in a longitudinal sexual health study. Materials and methods A longitudinal cohort study (iMPaCT) was conducted from November 2016 to July 2018 among heterosexual STI clinic visitors aged 18-24 years. At four different time points in one year, data was collected on sexual behavior, psychological determinants and chlamydia infections. The national STI surveillance database provided data on demographic, behavioral and sexual health-related characteristics for non-respondents. Predictors of non-response at baseline and of loss to follow-up were identified using multivariable logistic regression analyses. Results In total, 13,658 STI clinic visitors were eligible to participate, of which 1,063 (8%) participated. Male gender, low/medium education level, young age (<= 20 years) and having a non-Dutch migration background were significant predictors of non-response at baseline. Furthermore, non-respondents at baseline were more likely to report STI-related symptoms, to have been notified by a partner, to have had condomless sex, and to have had <= 2 partners in the past six months, compared to participants. Psychological predictors of loss to follow-up differed between STI clinic regions, but low perceived importance of health at baseline was associated with loss to follow-up in all regions. The baseline chlamydia positivity rate was significantly higher in the non-respondents (17%) compared to the participants (14%), but was not a predictor of loss to follow-up. Discussion Targeted recruitment aimed at underrepresented groups in the population based on demographic, behavioral and psychological characteristics, might be necessary to decrease loss to follow-up, and to prevent non-response bias in health research.	[van Wees, Daphne A.; den Daas, Chantal; Kretzschmar, Mirjam E. E.; Heijne, Janneke C. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [den Daas, Chantal] Univ Utrecht, Fac Social & Behav Sci, Dept Interdisciplinary Social Sci, Utrecht, Netherlands; [Kretzschmar, Mirjam E. E.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University; Utrecht University Medical Center	van Wees, DA (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	daphne.van.wees@rivm.nl	; van Wees, Daphne/J-6536-2018	den Daas, Chantal/0000-0003-0955-3691; Kretzschmar, Mirjam/0000-0002-4394-7697; van Wees, Daphne/0000-0002-6562-7029	National Institute for Public Health and the Environment (RIVM) [S/113004/01/IP]	National Institute for Public Health and the Environment (RIVM)	This work was supported by the Strategic Programme (SPR) of the National Institute for Public Health and the Environment (RIVM) (project number S/113004/01/IP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2009, J APPL SOC PSYCHOL, V39, P1356, DOI 10.1111/j.1559-1816.2009.00485.x; Bauman A, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0046-y; Booker CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-249; Caldwell PHY, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000368; Carey MP, 2008, SEX TRANSM DIS, V35, P73, DOI 10.1097/OLQ.0b013e318148b4ba; Cheung KL, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4189-8; Corry NH, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0294-8; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; den Daas C, 2014, ARCH SEX BEHAV, V43, P659, DOI 10.1007/s10508-013-0183-0; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dunne MP, 1997, INT J EPIDEMIOL, V26, P844, DOI 10.1093/ije/26.4.844; Ek S, 2015, HEALTH PROMOT INT, V30, P736, DOI 10.1093/heapro/dat063; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Greenland KE, 2011, SEX TRANSM DIS, V38, P467, DOI 10.1097/OLQ.0b013e318204546e; Gustavson K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-918; Herzog SA, 2013, EPIDEMIOLOGY, V24, P854, DOI 10.1097/EDE.0b013e31829e110e; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Jorgensen MJ, 2015, SEX TRANSM INFECT, V91, P171, DOI 10.1136/sextrans-2014-051814; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; Kypri K, 2011, PREV MED, V53, P274, DOI 10.1016/j.ypmed.2011.07.017; Levine EC, 2018, ARCH SEX BEHAV, V47, P1439, DOI 10.1007/s10508-018-1178-7; Maclennan B, 2012, DRUG ALCOHOL DEPEN, V126, P189, DOI 10.1016/j.drugalcdep.2012.05.014; Meiklejohn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035527; Mindell JS, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0072-4; Moshier SJ, 2013, ADDICT BEHAV, V38, P1651, DOI 10.1016/j.addbeh.2012.09.008; Op de Coul ELM, 2012, SEX TRANSM DIS, V39, P97, DOI 10.1097/OLQ.0b013e3182383097; Powers J, 2015, J CLIN EPIDEMIOL, V68, P870, DOI 10.1016/j.jclinepi.2015.01.010; R Development Core Team, 2017, R LANG ENV STAT COMP; Rogelberg SC, 2006, PERS PSYCHOL, V59, P903, DOI 10.1111/j.1744-6570.2006.00058.x; Rosser BRS, 2016, JMIR CANCER, V2, P80, DOI 10.2196/cancer.5578; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [DOI 10.1080/14792772143000003, 10.1080/14792772143000003]; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Statistics Netherlands (CBS), 2018, PERSON WITH A DUTCH, DOI [10.1111/j.1600-0587.2012.07348.x, DOI 10.1111/J.1600-0587.2012.07348.X]; Tsadik M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016864; van Bergen J, 2005, SEX TRANSM INFECT, V81, P17, DOI 10.1136/sti.2004.010173; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; van Wees DA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3498-6; van Wees DA, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0847; Visser M, 2018, SEXUALLY TRANSMITTED; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wallander L, 2015, EUR J PUBLIC HEALTH, V25, P172, DOI 10.1093/eurpub/cku154; Warsted Morten, 2018, BMC Res Notes, V11, P123, DOI 10.1186/s13104-018-3228-6; Yancey AK, 2006, ANNU REV PUBL HEALTH, V27, P1, DOI 10.1146/annurev.publhealth.27.021405.102113	46	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2019	14	6							e0218658	10.1371/journal.pone.0218658	http://dx.doi.org/10.1371/journal.pone.0218658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5EM	31216341	Green Published, gold			2022-12-26	WOS:000482885300066
J	Hlaing, EEH; Ishihara, Y; Wang, ZY; Odagaki, N; Kamioka, H				Hlaing, Ei Ei Hsu; Ishihara, Yoshihito; Wang, Ziyi; Odagaki, Naoya; Kamioka, Hiroshi			Role of intracellular Ca2+-based mechanotransduction of human periodontal ligament fibroblasts	FASEB JOURNAL			English	Article						hPDL; intracellular calcium; SOST; sclerostin; Rankl; Opg; bone remodeling	CALCIUM OSCILLATIONS; CA2+ OSCILLATIONS; MECHANICAL-STRESS; GENE-EXPRESSION; FLUID-FLOW; BONE; WNT; OSTEOCLASTOGENESIS; SCLEROSTIN; ACTIVATION	Human periodontal ligament (hPDL) fibroblasts are thought to receive mechanical stress (MS) produced by orthodontic tooth movement, thereby regulating alveolar bone remodeling. However, the role of intracellular calcium ([Ca2+](i))-based mechanotransduction is not fully understood. We explored the MS-induced [Ca2+](i) responses both in isolated hPDL fibroblasts and in intact hPDL tissue and investigated its possible role in alveolar bone remodeling. hPDL fibroblasts were obtained from healthy donors' premolars that had been extracted for orthodontic reasons. The oscillatory [Ca2+](i) activity induced by static compressive force was measured by a live-cell Ca2+ imaging system and evaluated by several feature extraction method. The spatial pattern of cell-cell communication was investigated by Moran's I, an index of spatial autocorrelation and the gap junction (GJ) inhibitor. The Ca2+-transporting ionophore A23187 was used to further investigate the role of [Ca2+](i) up-regulation in hPDL cell behavior. hPDL fibroblasts displayed autonomous [Ca2+](i) responses. Compressive MS activated this autonomous responsive behavior with an increased percentage of responsive cells both in vitro and ex vivo. The integration, variance, maximum amplitude, waveform length, and index J in the [Ca2+](i) responses were also significantly increased, whereas the mean power frequency was attenuated in response to MS. The increased Moran's I after MS indicated that MS might affect the pattern of cell-cell communication via GJs. Similar to the findings of MS-mediated regulation, the A23187-mediated [Ca2+](i) uptake resulted in the up-regulation of receptor activator of NF-kappa B ligand (Rankl) and Sost along with increased sclerostin immunoreactivity, suggesting that [Ca2+](i) signaling networks may be involved in bone remodeling. In addition, A23187-treated hPDL fibroblasts also showed the suppression of osteogenic differentiation and mineralization. Our findings suggest that augmented MS-mediated [Ca2+](i) oscillations in hPDL fibroblasts enhance the production and release of bone regulatory signals via Rankl/Osteoprotegerin and the canonical Wnt/beta-catenin pathway as an early process in tooth movement-initiated alveolar bone remodeling.-Ei Hsu Hlaing, E., Ishihara, Y., Wang, Z., Odagaki, N., Kamioka, H. Role of intracellular Ca2+-based mechanotransduction of human periodontal ligament fibroblasts.	[Hlaing, Ei Ei Hsu; Wang, Ziyi; Kamioka, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthodont, Okayama, Japan; [Ishihara, Yoshihito; Odagaki, Naoya] Okayama Univ Hosp, Dept Orthodont, Okayama, Japan; [Wang, Ziyi] Japan Soc Promot Sci JSPS DC2, Tokyo, Japan	Okayama University; Okayama University; Japan Society for the Promotion of Science	Ishihara, Y (corresponding author), Okayama Univ Hosp, Dept Orthodont, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	ishihara@md.okayama-u.ac.jp	Hlaing, Ei Ei Hsu/ABF-3646-2020; ISHIHARA, Yoshihito/B-2345-2011; Wang, Ziyi/AAW-6082-2020	Hlaing, Ei Ei Hsu/0000-0002-5539-9499; ISHIHARA, Yoshihito/0000-0002-5999-8253; Wang, Ziyi/0000-0003-1884-8053	Japan Society for the Promotion of Science, Japan [17H04413, 19H03859]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The present work was supported by Grant-in-Aid for Scientific Research [to Y.I. (17H04413) and H.K. (19H03859)] from the Japan Society for the Promotion of Science, Japan. The authors declare no conflicts of interest.	ARORA PD, 1994, J CELL PHYSIOL, V161, P187, DOI 10.1002/jcp.1041610202; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Boccafoschi F, 2011, J CELL BIOCHEM, V112, P1403, DOI 10.1002/jcb.23056; Chowdhury RH, 2013, SENSORS-BASEL, V13, P12431, DOI 10.3390/s130912431; DAVIDOVITCH Z, 1988, DENT CLIN N AM, V32, P411; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Glogauer M, 1997, J CELL SCI, V110, P11; Godbout C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064560; Ishihara Y, 2013, BONE, V53, P204, DOI 10.1016/j.bone.2012.12.002; Ishihara Y, 2012, BONE, V50, P842, DOI 10.1016/j.bone.2012.01.021; Jing D, 2014, FASEB J, V28, P1582, DOI 10.1096/fj.13-237578; Kanzaki H, 2002, J BONE MINER RES, V17, P210, DOI 10.1359/jbmr.2002.17.2.210; Kato R, 2013, J DENT RES, V92, P635, DOI 10.1177/0022034513489992; Kawanabe N, 2010, DIFFERENTIATION, V79, P74, DOI 10.1016/j.diff.2009.10.005; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kook SH, 2011, J CELL BIOCHEM, V112, P2891, DOI 10.1002/jcb.23205; Lekic P, 1996, ANAT REC, V245, P327; Li SN, 2015, J ORTHOP RES, V33, P1008, DOI 10.1002/jor.22830; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li Y, 2011, J DENT RES, V90, P115, DOI 10.1177/0022034510385237; Manokawinchoke J, 2015, J DENT RES, V94, P983, DOI 10.1177/0022034515581372; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Meng GX, 2018, J ORTHOP RES, V36, P2039, DOI 10.1002/jor.23843; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137610; Morrell AE, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0007-x; NakagoMatsuo C, 1996, AM J ORTHOD DENTOFAC, V109, P244, DOI 10.1016/S0889-5406(96)70147-6; Nakao K, 2007, J DENT RES, V86, P623, DOI 10.1177/154405910708600708; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037, DOI 10.1152/ajpcell.1993.264.4.C1037; Nayak K., 2013, J DENT ORAL HEALTH, V1, P1; Odagaki N, 2018, J DENT RES, V97, P1374, DOI 10.1177/0022034518771331; Pavasant P, 2011, PERIODONTOL 2000, V56, P154, DOI 10.1111/j.1600-0757.2010.00374.x; Phinyomark A., 2012, COMPUTATIONAL INTELL, DOI [10.5772/50639, DOI 10.5772/50639]; RESENDEZ E, 1986, J CELL BIOL, V103, P2145, DOI 10.1083/jcb.103.6.2145; ROBERTS WE, 1982, AM J ANAT, V165, P373, DOI 10.1002/aja.1001650403; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Ruffinatti FA, 2011, J NEUROSCI METH, V199, P310, DOI 10.1016/j.jneumeth.2011.05.009; SOMJEN D, 1980, BIOCHIM BIOPHYS ACTA, V627, P91, DOI 10.1016/0304-4165(80)90126-9; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Su M, 1997, J DENT RES, V76, P1357, DOI 10.1177/00220345970760070501; Tordjmann T, 1997, EMBO J, V16, P5398, DOI 10.1093/emboj/16.17.5398; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Wescott DC, 2007, J DENT RES, V86, P1212, DOI 10.1177/154405910708601214; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wyles SP, 2016, CTS-CLIN TRANSL SCI, V9, P158, DOI 10.1111/cts.12393; Yamaguchi M, 2009, ORTHOD CRANIOFAC RES, V12, P113, DOI 10.1111/j.1601-6343.2009.01444.x; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Yellowley CE, 1997, AM J PHYSIOL-CELL PH, V273, pC30, DOI 10.1152/ajpcell.1997.273.1.C30; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105	54	11	11	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10409	10424		10.1096/fj.201900484R	http://dx.doi.org/10.1096/fj.201900484R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31238000	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000482214200055
J	Sugiura, K; Yokochi, Y; Fu, N; Fukaya, Y; Yoshida, K; Mihara, S; Hisabori, T				Sugiura, Kazunori; Yokochi, Yuichi; Fu, Nae; Fukaya, Yuki; Yoshida, Keisuke; Mihara, Shoko; Hisabori, Toru			The thioredoxin (Trx) redox state sensor protein can visualize Trx activities in the light/dark response in chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosensor; chloroplast; fluorescence; FRET); redox regulation; thioredoxin	DISULFIDE BOND FORMATION; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; THIOL MODULATION; IDENTIFICATION; RESIDUES; SYSTEM	Thiol-based redox regulation via ferredoxin-thioredoxin (Trx) reductase/Trx controls various functions in chloroplasts in response to light/dark changes. Trx is a key factor of this regulatory system, and five Trx subtypes, including 10 isoforms, have been identified as chloroplast-localized forms in Arabidopsis thaliana. These subtypes display distinct target selectivity, and, consequently, they form a complicated redox regulation network in chloroplasts. In this study, we developed a FRET-based sensor protein by combining CFP, YFP, and the N-terminal region of CP12, a redox-sensitive regulatory and Trx-targeted protein in chloroplasts. This sensor protein enabled us to monitor the redox change of chloroplast thioredoxin in vivo, and we therefore designated this protein change in redox state of Trx (CROST). Using CP12 isoforms, we successfully prepared two types of CROST sensors that displayed different affinities for two major chloroplast Trx isoforms (f-type and m-type). These sensor proteins helped unravel the real-time redox dynamics of Trx molecules in chloroplasts during the light/dark transition.	[Sugiura, Kazunori; Yokochi, Yuichi; Fu, Nae; Fukaya, Yuki; Yoshida, Keisuke; Mihara, Shoko; Hisabori, Toru] Tokyo Inst Technol, Lab Chem & Life Sci, Inst Innovat Res, Midori Ku, Nagatsuta Cho 4259, Yokohama, Kanagawa 2268503, Japan; [Yokochi, Yuichi; Fu, Nae; Yoshida, Keisuke; Mihara, Shoko; Hisabori, Toru] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Nagatsuta Cho 4259, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Lab Chem & Life Sci, Inst Innovat Res, Midori Ku, Nagatsuta Cho 4259, Yokohama, Kanagawa 2268503, Japan.; Hisabori, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Nagatsuta Cho 4259, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Mihara, Shoko/AAG-7591-2020; Yoshida, Keisuke/E-5231-2014; Hisabori, Toru/E-5205-2014	Mihara, Shoko/0000-0001-8698-9355; Yoshida, Keisuke/0000-0001-6542-6254; Hisabori, Toru/0000-0003-2046-0277	MEXT-KAKENHI [16H06556]; Dynamic Alliance for Open Innovation Bridging Human, Environment, and Materials	MEXT-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Dynamic Alliance for Open Innovation Bridging Human, Environment, and Materials	This work was supported by MEXT-KAKENHI Grant 16H06556 (to T.H.) and the Dynamic Alliance for Open Innovation Bridging Human, Environment, and Materials. The authors declare that they have no conflicts of interest with the contents of this article.	BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; BUCHANAN BB, 1991, ARCH BIOCHEM BIOPHYS, V288, P1, DOI 10.1016/0003-9861(91)90157-E; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fan YC, 2017, NAT CHEM BIOL, V13, P1045, DOI [10.1038/NCHEMBIO.2417, 10.1038/nchembio.2417]; Fan YC, 2015, ANAL CHEM, V87, P2802, DOI 10.1021/ac5041988; Fu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115318; Geck RK, 1996, J BIOL CHEM, V271, P24736, DOI 10.1074/jbc.271.40.24736; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mihara S, 2018, BIOCHEM J, V475, P1091, DOI 10.1042/BCJ20170869; Mihara S, 2017, PLANT CELL PHYSIOL, V58, P86, DOI 10.1093/pcp/pcw182; MILLS JD, 1982, BIOCHIM BIOPHYS ACTA, V679, P75, DOI 10.1016/0005-2728(82)90257-2; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; SCHEIBE R, 1981, BIOCHIM BIOPHYS ACTA, V636, P58, DOI 10.1016/0005-2728(81)90075-X; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Sugiura K, 2019, BBA-GEN SUBJECTS, V1863, P1098, DOI 10.1016/j.bbagen.2019.01.016; Sugiura K, 2015, BIOCHEM BIOPH RES CO, V457, P242, DOI 10.1016/j.bbrc.2014.12.095; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; Wenderoth I, 1997, J BIOL CHEM, V272, P26985, DOI 10.1074/jbc.272.43.26985; Yoshida K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7110153; Yoshida K, 2018, P NATL ACAD SCI USA, V115, pEB296, DOI 10.1073/pnas.1808284115; Yoshida K, 2016, P NATL ACAD SCI USA, V113, pE3967, DOI 10.1073/pnas.1604101113; Yoshida K, 2015, J BIOL CHEM, V290, P19540, DOI 10.1074/jbc.A115.647545; Yoshida K, 2014, PLANT CELL PHYSIOL, V55, P1415, DOI 10.1093/pcp/pcu066	29	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12091	12098		10.1074/jbc.RA119.007616	http://dx.doi.org/10.1074/jbc.RA119.007616			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217277	Green Published, hybrid			2022-12-26	WOS:000484284500013
J	Biro, A				Biro, Aniko			Reduced user fees for antibiotics under age 5 in Hungary: Effect on antibiotic use and imbalances in the implementation	PLOS ONE			English	Article							DRUG; CARE	Objectives In August 2016, new prescription guidelines were introduced in Hungary to reduce the copayments for antibiotics among children aged 0-4. This study aims at analysing the implementation of this policy and its effect on the use of antibiotics. Methods The analysis is based on administrative prescription records between January 2010-February 2018, covering the entire population of Hungary aged 0-7. Spatial autocorrelation indices are calculated and settlement level regression models are estimated to analyse the spatial variation in the application of the new guidelines. The effect of reduced co-payments on antibiotic use is estimated with a difference-in-differences type model: the treatment and control groups are children aged 0-4 and 5-7, respectively; the treatment and control periods are August 2016-February 2018 and January 2010-July 2016, respectively. Results The new prescription guidelines are more widely applied in settlements with higher per capita income and lower unemployment rate. Adherence to the new guidelines is spatially clustered. A 10-15% decrease in the out-of-pocket costs of antibiotics is estimated to increase the consumption of antibiotics by about 5% (95% CI: 2.63%-7.55%). Conclusions In the absence of clear enforcement mechanisms, the adoption of the new prescription guidelines is selective, contradicting the aims of the policy of making antibiotics affordable for the poor children. The results point to the possible role of physicians' information networks in the application of prescription guidelines. The use of antibiotics among children aged 0-4 is responsive to the price subsidy of antibiotics.	[Biro, Aniko] Hungarian Acad Sci, Hlth & Populat Momentum Res Grp, Inst Econ, Ctr Econ & Reg Studies, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Economic & Regional Studies	Biro, A (corresponding author), Hungarian Acad Sci, Hlth & Populat Momentum Res Grp, Inst Econ, Ctr Econ & Reg Studies, Budapest, Hungary.	biro.aniko@krtk.mta.hu	Biro, Aniko/T-9217-2019	Biro, Aniko/0000-0002-4833-4224	Momentum programme of the Hungarian Academy of Sciences [LP2018-2/2018]	Momentum programme of the Hungarian Academy of Sciences	AB was supported by the Momentum programme of the Hungarian Academy of Sciences (grant number: LP2018-2/2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Filippini M, 2012, EMPIR ECON, V42, P471, DOI 10.1007/s00181-011-0529-1; Ford EW, 2006, J AM MED INFORM ASSN, V13, P106, DOI 10.1197/jamia.M1913; FOXMAN B, 1987, J CHRON DIS, V40, P429, DOI 10.1016/0021-9681(87)90176-7; Gemmill MC, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-12; Gibson TB, 2005, AM J MANAG CARE, V11, P730; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Lexchin J, 2004, INT J HEALTH SERV, V34, P101, DOI 10.2190/4M3E-L0YF-W1TD-EKG0; Lubloy A, 2018, SOC EC, V40, P227, DOI [10.1556/204.2018.40.2.4, DOI 10.1556/204.2018.40.2.4]; Lubloy A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-469; Pisati M., 2001, STATA TECHNICAL B, V60, P21	11	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219085	10.1371/journal.pone.0219085	http://dx.doi.org/10.1371/journal.pone.0219085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251779	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000484915000043
J	Hisdal, J; Landsverk, SA; Hoff, IE; Hagen, OA; Kirkeboen, KA; Hoiseth, LO				Hisdal, Jonny; Landsverk, Svein Aslak; Hoff, Ingrid Elise; Hagen, Ove Andreas; Kirkeboen, Knut Arvid; Hoiseth, Lars Oivind			Associations between changes in precerebral blood flow and cerebral oximetry in the lower body negative pressure model of hypovolemia in healthy volunteers	PLOS ONE			English	Article							CARDIAC-OUTPUT; OXYGEN-SATURATION; VERTEBRAL ARTERIES; PERFUSION INDEX; IMPACT	Reductions in cerebral oxygen saturation (ScO2) measured by near infra-red spectroscopy have been found during compensated hypovolemia in the lower body negative pressure (LBNP)-model, which may reflect reduced cerebral blood flow. However, ScO2 may also be contaminated from extracranial (scalp) tissues, mainly supplied by the external carotid artery (ECA), and it is possible that a ScO2 reduction during hypovolemia is caused by reduced scalp, and not cerebral, blood flow. The aim of the present study was to explore the associations between blood flow in precerebral arteries and ScO2 during LBNP-induced hypovolemia. Twenty healthy volunteers were exposed to LBNP 20, 40, 60 and 80 mmHg. Blood flow in the internal carotid artery (ICA), ECA and vertebral artery (VA) was measured by Doppler ultrasound. Stroke volume for calculating cardiac output was measured by suprasternal Doppler. Associations of changes within subjects were examined using linear mixed-effects regression models. LBNP reduced cardiac output, ScO2 and ICA and ECA blood flow. Changes in flow in both ICA and ECA were associated with changes in ScO2 and cardiac output. Flow in the VA did not change during LBNP and changes in VA flow were not associated with changes in ScO2 or cardiac output. During experimental compensated hypovolemia in healthy, conscious subjects, a reduced ScO2 may thus reflect a reduction in both cerebral and extracranial blood flow.	[Hisdal, Jonny; Hoiseth, Lars Oivind] Oslo Univ Hosp, Sect Vasc Invest, Dept Vasc Surg, Div Cardiovasc & Pulm Dis, Oslo, Norway; [Hisdal, Jonny; Kirkeboen, Knut Arvid] Univ Oslo, Fac Med, Oslo, Norway; [Landsverk, Svein Aslak; Hoff, Ingrid Elise; Hagen, Ove Andreas; Kirkeboen, Knut Arvid; Hoiseth, Lars Oivind] Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Anesthesiol, Oslo, Norway; [Hoff, Ingrid Elise] Norwegian Air Ambulance Fdn, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Hoiseth, LO (corresponding author), Oslo Univ Hosp, Sect Vasc Invest, Dept Vasc Surg, Div Cardiovasc & Pulm Dis, Oslo, Norway.; Hoiseth, LO (corresponding author), Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Anesthesiol, Oslo, Norway.	lars.oivind.hoiseth@hotmail.com		Hoiseth, Lars Oivind/0000-0003-0669-8297				Bland JM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d556; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brown CM, 2003, J NEUROL SCI, V208, P71, DOI 10.1016/S0022-510X(02)00438-0; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Deegan BM, 2010, IEEE ENG MED BIO, P2505, DOI 10.1109/IEMBS.2010.5626647; DOWELL AR, 1969, J APPL PHYSIOL, V26, P352, DOI 10.1152/jappl.1969.26.3.352; Dubin A, 2000, INTENS CARE MED, V26, P1619, DOI 10.1007/s001340000669; ERIKSEN M, 1990, MED BIOL ENG COMPUT, V28, P555, DOI 10.1007/BF02442607; GARNETT AR, 1989, RESUSCITATION, V17, P55; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Hoiseth LO, 2015, CRIT CARE MED, V43, P747, DOI 10.1097/CCM.0000000000000766; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; ISSERLES SA, 1991, ANESTH ANALG, V73, P808; Johnson BD, 2014, J APPL PHYSIOL, V117, P131, DOI 10.1152/japplphysiol.00070.2014; Kay VL, 2016, AM J PHYSIOL-REG I, V310, pR375, DOI 10.1152/ajpregu.00367.2015; Lakhal K, 2017, BRIT J ANAESTH, V118, P355, DOI 10.1093/bja/aew478; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LEVINE BD, 1994, CIRCULATION, V90, P298, DOI 10.1161/01.CIR.90.1.298; Lewis NCS, 2015, CLIN SCI, V129, P169, DOI 10.1042/CS20140751; Meng LZ, 2015, ANESTHESIOLOGY, V123, P1198, DOI 10.1097/ALN.0000000000000872; Meng LZ, 2015, ANESTHESIOLOGY, V122, P196, DOI 10.1097/ALN.0000000000000506; Ogoh S, 2005, J PHYSIOL-LONDON, V569, P697, DOI 10.1113/jphysiol.2005.095836; Ogoh S, 2015, EXP PHYSIOL, V100, P259, DOI 10.1113/expphysiol.2014.083964; Sato K, 2012, EXP PHYSIOL, V97, P1272, DOI 10.1113/expphysiol.2012.064774; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P523, DOI 10.1097/00004647-199605000-00020; Sorensen H, 2014, BRIT J ANAESTH, V113, P452, DOI 10.1093/bja/aet481; Sorensen H, 2016, DAN MED J, V63; Sorensen H, 2012, ANESTHESIOLOGY, V117, P263, DOI 10.1097/ALN.0b013e3182605afe; Tymko MM, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12957; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; van Genderen ME, 2013, ANESTH ANALG, V116, P351, DOI 10.1213/ANE.0b013e318274e151	34	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0219154	10.1371/journal.pone.0219154	http://dx.doi.org/10.1371/journal.pone.0219154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251778	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000046
J	Sasaki, K; Ben Othman, M; Ferdousi, F; Yoshida, M; Watanabe, M; Tominaga, K; Isoda, H				Sasaki, Kazunori; Ben Othman, Mahmoud; Ferdousi, Farhana; Yoshida, Masaki; Watanabe, Makoto; Tominaga, Kenichi; Isoda, Hiroko			Modulation of the neurotransmitter systems through the anti-inflammatory and antidepressant-like effects of squalene from Aurantiochytrium sp.	PLOS ONE			English	Article							SEROTONERGIC NEUROTRANSMISSION; DOCOSAHEXAENOIC ACID; CHEMOKINE RECEPTORS; DEPRESSION; STRAIN; BDNF; DIFFERENTIATION; GLUTAMATE; 18W-13A; FEMALE	Although algae have been the focal point of biofuel research, studies on their biological activities have been limited. In recent years, however, the importance of algae as sources of functional ingredients has been recognized due to their health beneficial effects. In this study, we evaluated the antidepressant-like activities of ethanol extract of Aurantiochytrium sp. ( EEA) in the forced swimming test ( FST)-induced depression in ICR mice. Imipramine, a commercially available tricyclic antidepressant drug, was used as positive control. Animals were administered EEA orally for 14 consecutive days and were subjected to the locomotor activity testing. Additionally, changes in gene expression in mice brain were assessed by real-time PCR and microarray assays to understand the molecular mechanisms underlying the effect of EEA. We found that the immobility time in FST was significantly reduced in the EEA-treated mice compared to that of in the control mice. Microarray and real-time PCR results revealed that EEA treatment induced changes in several genes in mice brain associated with pro-inflammation and dopaminergic, cholinergic, glutamatergic, and serotonergic synapses. It has previously been reported that several cytokines, such as IL-6 and TNF-alpha, which mediate neuroinflammation, are also responsible for indirectly altering brain neurotransmitter levels in neuropsychiatric disorders. Therefore, the regulation of the expression of pro-inflammatory genes in EEA-administered mice brain is considered to contribute to the enhancement of neurotransmitter systems-related gene expression in our study. Moreover, our in vitro study suggested that squalene, a component produced by Aurantiochytrium, was one of the active substances in EEA. In conclusion, our study provides the first evidence that Aurantiochytrium sp. can reduce neuroinflammation that may contribute to the modulation of the neurotransmitter systems, which could underlie its antistress and antidepressant effects.	[Sasaki, Kazunori; Ben Othman, Mahmoud; Ferdousi, Farhana; Tominaga, Kenichi; Isoda, Hiroko] Univ Tsukuba, ARENA, Tsukuba, Ibaraki, Japan; [Sasaki, Kazunori; Isoda, Hiroko] Natl Inst Adv Ind Sci & Technol, Interdisciplinary Res Ctr Catalyt Chem, Tsukuba, Ibaraki, Japan; [Sasaki, Kazunori] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Yoshida, Masaki; Watanabe, Makoto] Univ Tsukuba, Algal Biomass & Energy Syst R&D Ctr ABES, Tsukuba, Ibaraki, Japan; [Yoshida, Masaki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; University of Tsukuba; University of Tsukuba	Isoda, H (corresponding author), Univ Tsukuba, ARENA, Tsukuba, Ibaraki, Japan.; Isoda, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Interdisciplinary Res Ctr Catalyt Chem, Tsukuba, Ibaraki, Japan.	isoda.hiroko.ga@u.tsukuba.ac.jp		Tominaga, Ken-ichi/0000-0002-6078-2169; Isoda, Hiroko/0000-0002-1399-9541; Ferdousi, Farhana/0000-0003-2816-9118	Japan Science and Technology Agency (JST); Technology Research Partnership for Sustainable Development (SATREPS) [JPMJSA1506]	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Technology Research Partnership for Sustainable Development (SATREPS)	This study was partially supported by the Japan Science and Technology Agency (JST) and by the Technology Research Partnership for Sustainable Development (SATREPS) grant no. JPMJSA1506 to HI.	Adzic M, 2015, BEHAV BRAIN RES, V291, P130, DOI 10.1016/j.bbr.2015.05.029; Aguilera Y, 2005, EXP EYE RES, V80, P535, DOI 10.1016/j.exer.2004.11.003; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ben Othman M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/737401; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fehling Johanna, 2007, P75, DOI 10.1016/B978-012370518-1/50007-2; Fujii T, 1998, J NEUROIMMUNOL, V82, P101, DOI 10.1016/S0165-5728(97)00195-1; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Hlavacova N, 2018, PROG NEURO-PSYCHOPH, V82, P332, DOI 10.1016/j.pnpbp.2017.07.008; Huang D, 2018, GENES DIS; Kaur K, 2017, J NEUROL SCI, V381, P308, DOI 10.1016/j.jns.2017.08.3251; Kaya K, 2011, BIOSCI BIOTECH BIOCH, V75, P2246, DOI 10.1271/bbb.110430; Kelly G S, 1999, Altern Med Rev, V4, P29; KIM JS, 1982, ARCH PSYCHIAT NERVEN, V232, P299, DOI 10.1007/BF00345492; Liao L, 2017, INT IMMUNOPHARMACOL, V49, P178, DOI 10.1016/j.intimp.2017.05.036; Maes M, 1995, J AFFECT DISORDERS, V36, P29, DOI 10.1016/0165-0327(95)00049-6; Mao LM, 2010, NEURON, V67, P679, DOI 10.1016/j.neuron.2010.08.036; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; Furlan VJM, 2017, BRAZ J MICROBIOL, V48, P359, DOI 10.1016/j.bjm.2017.01.001; MIETTINEN TA, 1994, AM J CLIN NUTR, V59, P356, DOI 10.1093/ajcn/59.2.356; Milledge JJ, 2011, REV ENVIRON SCI BIO, V10, P31, DOI 10.1007/s11157-010-9214-7; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Nakazawa A, 2012, BIORESOURCE TECHNOL, V109, P287, DOI 10.1016/j.biortech.2011.09.127; Nunes SOV, 2002, BRAZ J MED BIOL RES, V35, P581, DOI 10.1590/S0100-879X2002000500011; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; PORSOLT RD, 1978, EUR J PHARMACOL, V51, P291, DOI 10.1016/0014-2999(78)90414-4; Qi F, 2017, BIORESOURCE TECHNOL, V227, P221, DOI 10.1016/j.biortech.2016.12.011; Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1; Reichenberg A, 2001, BIOORG MED CHEM LETT, V11, P833, DOI 10.1016/S0960-894X(01)00075-0; Ren J, 2014, J BIOL CHEM, V289, P9013, DOI 10.1074/jbc.M113.515957; Revathikumar P, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0725-1; Richmond A., 2013, Handbook of microalgal culture: applied phycology and biotechnology; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sasaki K, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00900; Shabbir F, 2013, NEUROCHEM INT, V62, P324, DOI 10.1016/j.neuint.2012.12.014; Sijtsma L, 2004, APPL MICROBIOL BIOT, V64, P146, DOI 10.1007/s00253-003-1525-y; Skolnick P, 1996, PHARMACOPSYCHIATRY, V29, P23, DOI 10.1055/s-2007-979537; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; STORM HM, 1993, LIPIDS, V28, P555, DOI 10.1007/BF02536088; Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001; Stuart MJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00357; Sultana J, 2014, EUR J CLIN PHARMACOL, V70, P469, DOI 10.1007/s00228-013-1636-z; Sung M, 2018, BIORESOURCE TECHNOL, V261, P117, DOI 10.1016/j.biortech.2018.03.099; Takahashi S, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01205; Takahashi T, 2014, FEBS J, V281, P4672, DOI 10.1111/febs.12974; Toffali L, 2017, J IMMUNOL, V198, P708, DOI 10.4049/jimmunol.1600933; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Zhang XY, 2016, BRAIN BEHAV IMMUN, V51, P169, DOI 10.1016/j.bbi.2015.09.014	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218923	10.1371/journal.pone.0218923	http://dx.doi.org/10.1371/journal.pone.0218923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251788	gold, Green Published, Green Submitted			2022-12-26	WOS:000484915000030
J	Shatz, W; Hass, PE; Peer, N; Paluch, MT; Blanchette, C; Han, GH; Sandoval, W; Morando, A; Loyet, KM; Bantseev, V; Booler, H; Crowell, S; Kamath, A; Scheer, JM; Kelley, RF				Shatz, Whitney; Hass, Philip E.; Peer, Nikhil; Paluch, Maciej T.; Blanchette, Craig; Han, Guanghui; Sandoval, Wendy; Morando, Ashley; Loyet, Kelly M.; Bantseev, Vladimir; Booler, Helen; Crowell, Susan; Kamath, Amrita; Scheer, Justin M.; Kelley, Robert F.			Identification and characterization of an octameric PEG-protein conjugate system for intravitreal long-acting delivery to the back of the eye	PLOS ONE			English	Article							MACULAR DEGENERATION; PHARMACOKINETICS; RANIBIZUMAB; IMPAIRMENT; BLINDNESS	Innovative protein engineering and chemical conjugation technologies have yielded an impressive number of drug candidates in clinical development including > 80 antibody drug conjugates, > 60 bispecific antibodies, > 35 Fc-fusion proteins and > 10 immuno-cytokines. Despite these innovations, technological advances are needed to address unmet medical needs with new pharmacological mechanisms. Age-related eye diseases are among the most common causes of blindness and poor vision in the world. Many such diseases affect the back of the eye, where the inaccessibility of the site of action necessitates therapeutic delivery via intravitreal ( IVT) injection. Treatments administered via this route typically have vitreal half-lives < 10 days in humans, requiring frequent administration. Since IVT injection is burdensome to patients, there exists a strong need to develop therapeutics with prolonged residence time in the eye. We report here a strategy to increase retention of a therapeutic fragment antibody ( Fab) in the eye, using an anti-complement factor D Fab previously optimized for ocular delivery. Polyethylene glycol structures, varying in length, geometry and degree of branching, were coupled to the Fab via maleimide-activated termini. A screening strategy was developed to allow for key determinants of ocular half-life to be measured in vitro. After compound selection, a scalable process was established to enable tolerability and pharmacokinetic studies in cynomolgus monkeys, demonstrating an increase in vitreal half-life with no associated adverse events. Further, we show that the technique for compound selection, analytical characterization, and scalable production is general for a range of antibody fragments. The application of the technology has broad impact in across many therapeutic areas with the first major advancement in the treatment of an important ocular disease.	[Shatz, Whitney; Hass, Philip E.; Peer, Nikhil; Paluch, Maciej T.; Blanchette, Craig; Scheer, Justin M.] Genentech Inc, Prot Chem, San Francisco, CA 94080 USA; [Han, Guanghui; Sandoval, Wendy] Genentech Inc, Microchem Prote & Lipid, San Francisco, CA 94080 USA; [Morando, Ashley; Loyet, Kelly M.] Genentech Inc, Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Bantseev, Vladimir; Booler, Helen] Genentech Inc, Safety Assessment, San Francisco, CA 94080 USA; [Crowell, Susan; Kamath, Amrita] Genentech Inc, Preclin & Translat Pharmacokinet, San Francisco, CA 94080 USA; [Kelley, Robert F.] Genentech Inc, Drug Delivery, San Francisco, CA 94080 USA; [Peer, Nikhil] Genentech Inc, Purificat Dev, San Francisco, CA 94080 USA; [Han, Guanghui] BGI Amer, Mass Spectrometry Ctr, San Jose, CA USA; [Scheer, Justin M.] Boehringer Ingelheim GmbH & Co KG, Antibody Engn, Ridgefield, CT USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Boehringer Ingelheim	Shatz, W (corresponding author), Genentech Inc, Prot Chem, San Francisco, CA 94080 USA.	Shatz.whitney@gene.com	Loyet, Kelly/AAD-7544-2021; Han, Guanghui/N-8573-2013	Han, Guanghui/0000-0002-9893-9168; Loyet, Kelly M./0000-0002-3733-099X; Shatz-Binder, Whitney/0000-0003-2996-501X	Genentech	Genentech(Roche HoldingGenentech)	The study was funded by Genentech, which provided indirect support to the study in the form of salaries to authors: W.S., P. E.H., N.P., M.T.P., C.B., G.H., W.S., A.M., K.M.L., V.B., H.B., S.C., A.K., J.M.S., and R.F.K. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ABUCHOWSKI A, 1984, CANCER BIOCHEM BIOPH, V7, P175; Aguirre SA, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-018-2450-1; Bantseev V, 2018, J OCUL PHARMACOL TH, V34, P204, DOI 10.1089/jop.2017.0063; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Bressler NM, 2011, ARCH OPHTHALMOL-CHIC, V129, P709, DOI 10.1001/archophthalmol.2011.140; Campagne MVL, COCRYSTAL STRUCTURE, P1; CDC (Centers for Disease Control and Prevention), 2011, SEX TRANSM DIS SURV; Ehlken C, 2018, CLIN OPHTHALMOL, V12, P11, DOI 10.2147/OPTH.S151611; Gadkar K, 2015, INVEST OPHTH VIS SCI, V56, P5390, DOI 10.1167/iovs.15-17108; Ghate Deepta, 2006, Expert Opin Drug Deliv, V3, P275, DOI 10.1517/17425247.3.2.275; Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1; Haller JA, 2011, OPHTHALMOLOGY, V118, P2453, DOI 10.1016/j.ophtha.2011.05.014; Holz FG, 2018, JAMA OPHTHALMOL, V136, P666, DOI 10.1001/jamaophthalmol.2018.1544; Holz FG, 2014, OPHTHALMOLOGY, V121, P1079, DOI 10.1016/j.ophtha.2013.11.023; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Johnston RL, 2016, OPHTHALMOLOGY, V123, P2386, DOI 10.1016/j.ophtha.2016.07.037; Le KN, 2015, CPT-PHARMACOMET SYST, V4, P595, DOI 10.1002/psp4.12031; Loyet KM, 2014, J PHARMACOL EXP THER, V351, P527, DOI 10.1124/jpet.114.215921; Maurice D, 2001, J OCUL PHARMACOL TH, V17, P393, DOI 10.1089/108076801753162807; Miyake T, 2010, INVEST OPHTH VIS SCI, V51, P1606, DOI 10.1167/iovs.09-4140; Nucci ML, 1991, ADV DRUG DELIV REV; PEYMAN GA, 1975, DOC OPHTHALMOL, V39, P183, DOI 10.1007/BF00578762; Rajagopal K, 2013, J PHARM SCI-US, V102, P2655, DOI 10.1002/jps.23634; Regula JT, 2016, EMBO MOL MED, V8, P1265, DOI 10.15252/emmm.201505889; Rostron E, 2012, EYE, V26, P933, DOI 10.1038/eye.2012.61; Saylor M, 2009, ARCH OPHTHALMOL-CHIC, V127, P402, DOI 10.1001/archophthalmol.2009.9; Shatz W, 2019, EXPERT OPIN DRUG DEL, V16, P43, DOI 10.1080/17425247.2019.1553953; Shatz W, 2016, MOL PHARMACEUT, V13, P2996, DOI 10.1021/acs.molpharmaceut.6b00345; Tesar D, 2017, PROTEIN ENG INCREASE, V5, DOI [10.1080/19420862.2017.1372078, DOI 10.1080/19420862.2017.1372078]; Welp A, 2016, MAKING EYE HLTH POPU, DOI [10.17226/23471, DOI 10.17226/23471]; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Xu L, 2013, INVEST OPHTH VIS SCI, V54, P1616, DOI 10.1167/iovs.12-10260; Zarzar J, 2018, BIOPHYS CHEM, V236, P22, DOI 10.1016/j.bpc.2017.10.003; Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI 10.1021/bc700333s	34	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218613	10.1371/journal.pone.0218613	http://dx.doi.org/10.1371/journal.pone.0218613			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251757	Green Published, gold, Green Submitted			2022-12-26	WOS:000484915000015
J	Swenson, BR; Louie, T; Lin, HJ; Mendez-Giraldez, R; Below, JE; Laurie, CC; Kerr, KF; Highland, H; Thornton, TA; Ryckman, KK; Kooperberg, C; Soliman, EZ; Seyerle, AA; Guo, XQ; Taylor, KD; Yao, J; Heckbert, SR; Darbar, D; Petty, LE; McKnight, B; Cheng, S; Bello, NA; Whitsel, EA; Hanis, CL; Nalls, MA; Evans, DS; Rotter, JI; Sofer, T; Avery, CL; Sotoodehnia, N				Swenson, Brenton R.; Louie, Tin; Lin, Henry J.; Mendez-Giraldez, Raul; Below, Jennifer E.; Laurie, Cathy C.; Kerr, Kathleen F.; Highland, Heather; Thornton, Timothy A.; Ryckman, Kelli K.; Kooperberg, Charles; Soliman, Elsayed Z.; Seyerle, Amanda A.; Guo, Xiuqing; Taylor, Kent D.; Yao, Jie; Heckbert, Susan R.; Darbar, Dawood; Petty, Lauren E.; McKnight, Barbara; Cheng, Susan; Bello, Natalie A.; Whitsel, Eric A.; Hanis, Craig L.; Nalls, Mike A.; Evans, Daniel S.; Rotter, Jerome I.; Sofer, Tamar; Avery, Christy L.; Sotoodehnia, Nona			GWAS of QRS duration identifies new loci specific to Hispanic/Latino populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HEART-RATE; PR INTERVAL; CARDIAC CONDUCTION; COMMON VARIANTS; HERITABILITY; PROLONGATION; VARIABILITY; FAILURE; TRAITS	Background The electrocardiographically quantified QRS duration measures ventricular depolarization and conduction. QRS prolongation has been associated with poor heart failure prognosis and cardiovascular mortality, including sudden death. While previous genome-wide association studies ( GWAS) have identified 32 QRS SNPs across 26 loci among European, African, and Asian-descent populations, the genetics of QRS among Hispanics/Latinos has not been previously explored. Methods We performed a GWAS of QRS duration among Hispanic/Latino ancestry populations ( n = 15,124) from four studies using 1000 Genomes imputed genotype data ( adjusted for age, sex, global ancestry, clinical and study-specific covariates). Study-specific results were combined using fixed-effects, inverse variance-weighted meta-analysis. Results We identified six loci associated with QRS ( P<5x10(-8)), including two novel loci: MYOCD, a nuclear protein expressed in the heart, and SYT1, an integral membrane protein. The top SNP in the MYOCD locus, intronic SNP rs16946539, was found in Hispanics/Latinos with a minor allele frequency ( MAF) of 0.04, but is monomorphic in European and African descent populations. The most significant QRS duration association was with intronic SNP rs3922344 ( P = 1.19x10(-24)) in SCN5A/SCN10A. Three other previously identified loci, CDKN1A, VTI1A, and HAND1, also exceeded the GWAS significance threshold among Hispanics/Latinos. A total of 27 of 32 previously identified QRS duration SNPs were shown to generalize in Hispanics/Latinos. Conclusions Our QRS duration GWAS, the first in Hispanic/Latino populations, identified two new loci, underscoring the utility of extending large scale genomic studies to currently under-examined populations.	[Swenson, Brenton R.] Univ Washington, Inst Publ Hlth Genet, Seattle, WA 98195 USA; [Swenson, Brenton R.; Heckbert, Susan R.; McKnight, Barbara; Sotoodehnia, Nona] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Louie, Tin; Laurie, Cathy C.; Kerr, Kathleen F.; Thornton, Timothy A.; McKnight, Barbara] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Lin, Henry J.; Guo, Xiuqing; Taylor, Kent D.; Yao, Jie; Rotter, Jerome I.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Lin, Henry J.; Guo, Xiuqing; Taylor, Kent D.; Yao, Jie; Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Lin, Henry J.] Harbor UCLA Med Ctr, Div Med Genet, Torrance, CA 90509 USA; [Mendez-Giraldez, Raul] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Below, Jennifer E.; Petty, Lauren E.] Vanderbilt Univ, Med Ctr, Dept Med Genet, Nashville, TN USA; [Highland, Heather; Whitsel, Eric A.; Avery, Christy L.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Ryckman, Kelli K.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Ryckman, Kelli K.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Cardiol Sect, Dept Internal Med, Winston Salem, NC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Seyerle, Amanda A.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes & Policy, Chapel Hill, NC USA; [Seyerle, Amanda A.] Univ N Carolina, Carolina Hlth Informat Program, Chapel Hill, NC USA; [Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Darbar, Dawood] Univ Illinois, Div Cardiol, Chicago, IL USA; [Cheng, Susan] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Bello, Natalie A.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Bello, Natalie A.] Columbia Univ, Med Ctr, Div Cardiol, New York, NY USA; [Whitsel, Eric A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Hanis, Craig L.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Nalls, Mike A.] Data Tech Int, Glen Echo, MD USA; [Nalls, Mike A.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Evans, Daniel S.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA; [Sofer, Tamar] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Sofer, Tamar] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Avery, Christy L.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Sotoodehnia, Nona] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of Iowa; University of Iowa; Fred Hutchinson Cancer Center; Wake Forest University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cedars Sinai Medical Center; Harvard University; Brigham & Women's Hospital; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); California Pacific Medical Center; California Pacific Medical Center Research Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Swenson, BR (corresponding author), Univ Washington, Inst Publ Hlth Genet, Seattle, WA 98195 USA.; Swenson, BR; Sotoodehnia, N (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.; Sotoodehnia, N (corresponding author), Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA.	brenton.swenson@u.washington.edu; nsotoo@u.washington.edu	Below, Jennifer E/W-2179-2018; Soliman, Elsayed Z/AAD-7135-2020; Rotter, Jerome/AAY-6598-2021	Below, Jennifer E/0000-0002-1346-1872; Soliman, Elsayed Z/0000-0001-5632-8150; Bello, Natalie/0000-0003-3257-3623; Swenson, Brenton/0000-0002-4176-8273; Kerr, Kathleen/0000-0002-6438-9583; Sofer, Tamar/0000-0001-8520-8860; Cheng, Susan/0000-0002-4977-036X; Ryckman, Kelli/0000-0002-9496-4147	NIH [R01HL142302, R01HL124935, T32 HL139439, T32HL007055, HL116747, HL111089]; NHLBI [T32HL7055, T32HL07779, HL092217, HSN 26220/20054C, N02-HL-64278]; NIH/NHLBI [K23 HL136853]; Katz Foundation; Laughlin family; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233, N01-HC65234, N01-HC65235, N01-HC65236, N01-HC65237, HHSN268201300024C]; National Institute on Minority Health and Health Disparities; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research (NIDCR); National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; NIH Institution-Office of Dietary Supplements; NHLBI; National Institute of Dental and Craniofacial Research [HHSN268 201300005C AM03, MOD03]; NCATS CTSI [UL1TR000124]; NIDDK Diabetes Research Center (DRC) [DK063491]; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health [DK073541, DK020595, AI085014, DK085501, HL102830]; University of Texas Health Science Center at Houston; National Institutes of Health (NIH); CIDR is funded through a federal contract from the National Institutes of Health (NIH) [HHSN26820078209 6C]; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201600018C, HHSN26820 1600001C, HHSN268201600002C, HHSN2682 01600003C, HHSN268201600004C];  [HHSN268201500003I];  [N01-HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [UL1-TR-000040];  [UL1-TR-001079];  [UL1-TR-001420];  [UL1-TR-001881]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420, UL1TR001079, UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007374, R01HL124935, T32HL007779, T32HL007055, T32HL139439, K23HL136853, R01HL142302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Katz Foundation; Laughlin family; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Institution-Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCATS CTSI; NIDDK Diabetes Research Center (DRC); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Health Science Center at Houston; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIDR is funded through a federal contract from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	JEB is supported by NIH (R01HL142302). AAS is supported by NHLBI training grants (T32HL7055 and T32HL07779). DD is supported by NIH (R01HL124935; T32 HL139439) and NHLBI (HL092217). NAB is supported by NIH/NHLBI K23 HL136853 and the Katz Foundation. CLA is supported by NIH (T32HL007055). NS is supported by the NIH (HL116747, HL111089); and the Laughlin family. Additionally this work is indirectly supported by the funding received by each cohort study which contributed data to the analysis: Hispanic Community Health Study/Study of Latinos (HCHS/SOL): The baseline examination of HCHS/SOL was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), San Diego State University (N01-HC65237), and the Brigham and Women's Hospital (HHSN268201300024C). The following Institutes/Centers/Offices contributed to the first phase of HCHS/SOL through a transfer of funds to the National Hearth Lung and Blood Institute (NHLBI): National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, NIH Institution-Office of Dietary Supplements. The Genetic Analysis Center at University of Washington was supported by NHLBI and National Institute of Dental and Craniofacial Research contracts (HHSN268 201300005C AM03 and MOD03). Genotyping efforts were supported by NHLBI HSN 26220/20054C, NCATS CTSI grant UL1TR000124, and NIDDK Diabetes Research Center (DRC) grant DK063491. Multi-Ethnic Study of Atherosclerosis (MESA): MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, UL1-TR-001881, and DK063491. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Starr County Study: This work was supported in part by grants DK073541, DK020595, AI085014, DK085501, and HL102830 from the National Institutes of Health and funds from the University of Texas Health Science Center at Houston. Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is funded through a federal contract from the National Institutes of Health (NIH) to The Johns Hopkins University, contract number HHSN26820078209 6C. Women's Health Initiative: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts: HHSN268201600018C, HHSN26820 1600001C, HHSN268201600002C, HHSN2682 01600003C, and HHSN268201600004C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Desai AD, 2006, AM J MED, V119, P600, DOI 10.1016/j.amjmed.2005.08.028; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evans DS, 2016, HUM MOL GENET; GATZOULIS MA, 1995, CIRCULATION, V92, P231, DOI 10.1161/01.CIR.92.2.231; HAVLIK RJ, 1980, J ELECTROCARDIOL, V13, P45, DOI 10.1016/S0022-0736(80)80008-2; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Hong KW, 2014, HUM MOL GENET, V23, P6659, DOI 10.1093/hmg/ddu374; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Jeff JM, 2013, ANN HUM GENET, V77, P321, DOI 10.1111/ahg.12023; Kerr KF, 2017, HEART RHYTHM, V14, P1675, DOI 10.1016/j.hrthm.2017.06.018; Li JP, 2009, ANN NONINVAS ELECTRO, V14, P147, DOI 10.1111/j.1542-474X.2009.00289.x; Mendez-Giraldez R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17136-0; Mikhailov AT, 2016, HEART FAIL REV, V21, P783, DOI 10.1007/s10741-016-9569-0; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Mutikainen S, 2009, ANN NONINVAS ELECTRO, V14, P57, DOI 10.1111/j.1542-474X.2008.00273.x; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Romanoski CE, 2015, NATURE, V518, P314, DOI 10.1038/518314a; Russell MW, 1997, J ELECTROCARDIOL, V30, P64, DOI 10.1016/S0022-0736(98)80034-4; Sandhu R, 2004, AM J CARDIOL, V93, P244, DOI 10.1016/j.amjcard.2003.09.053; Sano M, 2014, HUM MOL GENET, V23, P6668, DOI 10.1093/hmg/ddu375; Seyerle AA, 2018, HEART, V104, P904, DOI 10.1136/heartjnl-2017-312045; Smith JG, 2009, HEART RHYTHM, V6, P634, DOI 10.1016/j.hrthm.2009.02.022; Sofer T, 2017, GENET EPIDEMIOL, V41, P251, DOI 10.1002/gepi.22029; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; van Setten J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04766-9; Wang LY, 2010, CIRC-CARDIOVASC GENE, V3, P386, DOI 10.1161/CIRCGENETICS.110.938381; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	37	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0217796	10.1371/journal.pone.0217796	http://dx.doi.org/10.1371/journal.pone.0217796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251759	Green Submitted, Green Published, gold			2022-12-26	WOS:000484915000007
J	da Silva, SG; Evenson, KR; Ekelund, U; da Silva, ICM; Domingues, MR; da Silva, BGC; Mendes, MD; Cruz, GIN; Hallal, PC				da Silva, Shana Ginar; Evenson, Kelly R.; Ekelund, Ulf; Mohsam da Silva, Inacio Crochemore; Domingues, Marlos Rodrigues; Cordeiro da Silva, Bruna Goncalves; Mendes, Marcio de Almeida; Nino Cruz, Gloria Isabel; Hallal, Pedro Curi			How many days are needed to estimate wrist-worn accelerometry-assessed physical activity during the second trimester in pregnancy?	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; VARIABILITY	Background Objective methods to measure physical activity (PA) can lead to better cross-cultural comparisons, monitoring temporal PA trends, and measuring the effect of interventions. However, when applying this technology in field-work, the accelerometer data processing is prone to methodological issues. One of the most challenging issues relates to standardizing total wear time to provide reliable data across participants. It is generally accepted that at least 4 complete days of accelerometer wear represent a week for adults. It is not known if this same assumption holds true for pregnant women. Aim We assessed the optimal number of days needed to obtain reliable estimates of overall PA and moderate-to-vigorous physical activity (MVPA) during the 2nd trimester in pregnancy using a raw triaxial wrist-worn accelerometer. Methods Cross-sectional analyses were carried out in the antenatal wave of the 2015 Pelotas (Brazil) Birth Cohort Study. Participants wore the wrist ActiGraph wGT3X-BT accelerometer for seven consecutive days. The daily average acceleration, which indicated overall PA, was measured as milli-g (mg), and time spent in MVPA (minutes/day) was analyzed in 5-minute bouts. ANOVA and Kruskal-Wallis tests were used to compare variability across days of the week. Bland-Altman plots and the Spearman-Brown Prophecy Formula were applied to determine the reliability coefficient associated with one to seven days of measurement. Results Among 2,082 pregnant women who wore the accelerometer for seven complete days, overall and MVPA were lower on Sundays compared to other days of the week. Reliability of > = 0.80 to evaluate overall PA was reached with at least three monitoring days, whereas seven days were needed to estimate reliable measures of MVPA. Conclusions Our findings indicate that obtaining one week of accelerometry in adults is appropriate for pregnant women, particularly to obtain differences on weekend days and reliably estimate overall PA and MVPA.	[da Silva, Shana Ginar; Mohsam da Silva, Inacio Crochemore; Cordeiro da Silva, Bruna Goncalves; Mendes, Marcio de Almeida; Nino Cruz, Gloria Isabel; Hallal, Pedro Curi] Univ Fed Pelotas, PostGrad Program Epidemiol, Pelotas, RS, Brazil; [da Silva, Shana Ginar] Fed Univ Fronteira Sul Passo Fundo, Sch Med, Passo Fundo, RS, Brazil; [Evenson, Kelly R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway; [Mohsam da Silva, Inacio Crochemore; Domingues, Marlos Rodrigues] Univ Fed Pelotas, PostGrad Program Phys Educ, Pelotas, RS, Brazil	Universidade Federal de Pelotas; University of North Carolina; University of North Carolina Chapel Hill; Norwegian School of Sport Sciences; Universidade Federal de Pelotas	da Silva, SG (corresponding author), Univ Fed Pelotas, PostGrad Program Epidemiol, Pelotas, RS, Brazil.; da Silva, SG (corresponding author), Fed Univ Fronteira Sul Passo Fundo, Sch Med, Passo Fundo, RS, Brazil.	sginar@gmail.com	Ekelund, Ulf/AAE-8471-2019; da Silva, Shana S/F-5883-2014; Silva, Inacio C M/L-9896-2017; Silva, Shana/AGM-8323-2022; Domingues, Marlos/A-4758-2009	Ekelund, Ulf/0000-0003-2115-9267; da Silva, Shana S/0000-0003-1504-6936; Silva, Inacio C M/0000-0001-5390-8360; Silva, Shana/0000-0003-1504-6936; de Almeida Mendes, Marcio/0000-0002-5590-5750; Domingues, Marlos/0000-0002-2503-2944; Evenson, Kelly/0000-0002-3720-5830; Nino Cruz, Gloria Isabel/0000-0002-4951-5991	Wellcome Trust [095582/z/11/z]; Brazilian National Research Council; Coordination for the Improvement of Higher Education Personnel; CAPES; CNPq [439505/2016-0]	Wellcome Trust(Wellcome TrustEuropean Commission); Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The 2015 Birth Cohort Study was funded by the Wellcome Trust (grant 095582/z/11/z to PCH), the Brazilian National Research Council and the Coordination for the Improvement of Higher Education Personnel. SGdS would like to thank CAPES and CNPq (n. 439505/2016-0) for the scholarship and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth B, 2015, PROG CARDIOVASC DIS, V57, P387, DOI 10.1016/j.pcad.2014.10.005; Baranowski T, 2000, RES Q EXERCISE SPORT, V71, pS74, DOI 10.1080/02701367.2000.11082789; Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI 10.1590/S0034-89102005000400002; Byun W, 2015, INT J ENV RES PUB HE, V12, P13148, DOI 10.3390/ijerph121013148; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; da Silva ICM, 2014, INT J EPIDEMIOL, V43, P1959, DOI 10.1093/ije/dyu203; da Silva SG, 2018, SCAND J MED SCI SPOR, V28, P1934, DOI 10.1111/sms.13083; da Silva SG, 2017, SPORTS MED, V47, P295, DOI 10.1007/s40279-016-0565-2; Dillon CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0109913; Engineering/Marketing A, 2009, ACTILIFE US MAN; Evenson KR, 2011, PREV MED, V53, P39, DOI 10.1016/j.ypmed.2011.04.014; Hallal PC, 2018, INT J EPIDEMIOL, V47, P1048, DOI 10.1093/ije/dyx219; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Hjorth MF, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-154; Kang MS, 2012, J PHYS ACT HEALTH, V9, P336, DOI 10.1123/jpah.9.3.336; Martins RC, 2017, J PHYS ACT HEALTH, V14, P208, DOI 10.1123/jpah.2015-0384; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Pedisic Z, 2015, BRIT J SPORT MED, V49, P219, DOI 10.1136/bjsports-2013-093407; Poudevigne MS, 2006, SPORTS MED, V36, P19, DOI 10.2165/00007256-200636010-00003; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; Vanhelst J, 2014, CLIN PHYSIOL FUNCT I, V34, P384, DOI 10.1111/cpf.12109; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; WHO, BMI CLASSIFICATION, DOI DOI 11/44679/INDEX.HTM; Wolff-Hughes DL, 2016, PHYSIOL MEAS, V37, P1447, DOI 10.1088/0967-3334/37/9/1447	30	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0211442	10.1371/journal.pone.0211442	http://dx.doi.org/10.1371/journal.pone.0211442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246953	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900003
J	Fusco, A; Iasevoli, L; Iosa, M; Gallotta, MC; Padua, L; Tucci, L; Antonucci, G; Baldari, C; Guidetti, L				Fusco, Augusto; Iasevoli, Luigi; Iosa, Marco; Gallotta, Maria Chiara; Padua, Luca; Tucci, Livia; Antonucci, Gabriella; Baldari, Carlo; Guidetti, Laura			Dynamic motor imagery mentally simulates uncommon real locomotion better than static motor imagery both in young adults and elderly	PLOS ONE			English	Article							TEMPORAL ACCURACY; MOVEMENT; WALKING; EXECUTION; DURATION; MECHANISMS; CHILDREN; FEATURES; CONTEXT; MODEL	A new form of Motor Imagery (MI), called dynamic Motor Imagery (dMI) has recently been proposed. The dMI adds to conventional static Motor Imagery (sMI) the presence of simultaneous actual movements partially replicating those mentally represented. In a previous research conducted on young participants, dMI showed to be temporally closer than sMI in replicating the real performance for some specific locomotor conditions. In this study, we evaluated if there is any influence of the ageing on dMI. Thirty healthy participants were enrolled: 15 young adults (27.1 +/- 3.8 y.o.) and 15 older adults (65.9 +/- 9.6y.o.). The performance time and the number of steps needed to either walk to a target (placed at 10m from participants) or to imagine walking to it, were assessed. Parameters were measured for sMI, dMI and real locomotion (RL) in three different locomotor conditions: forward walking (FW), backward walking (BW), and lateral walking (LW). Temporal performances of sMI and dMI did not differ between RL in the FW, even if significantly different to each other (p = 0.0002). No significant differences were found for dMI with respect to RL for LW (p = 0.140) and BW (p = 0.438), while sMI was significantly lower than RL in LW (p<0.001). The p-value of main effect of age on participants' temporal performances was p = 0.055. The interaction between age and other factors such as the type of locomotion (p = 0.358) or the motor condition (p = 0.614) or third level interaction (p = 0.349) were not statistically significant. Despite a slight slowdown in the performance of elderly compared to young participants, the temporal and spatial accuracy was better in dMI than sMI in both groups. Motor imagery processes may be strengthened by the feedback generated through dMI, and this effect appears to be unaffected by age.	[Fusco, Augusto] IRCCS Fdn Don Carlo Gnocchi, Milan, Italy; [Iasevoli, Luigi; Gallotta, Maria Chiara; Tucci, Livia; Guidetti, Laura] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Hlth Sci Sect, Rome, Italy; [Iasevoli, Luigi; Iosa, Marco; Antonucci, Gabriella] IRCCS Fdn Santa Lucia, Rome, Italy; [Padua, Luca] Sacred Heart Catholic Univ, Dept Geriatr Neurosci & Orthopaed, Rome, Italy; [Padua, Luca] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy; [Antonucci, Gabriella] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Baldari, Carlo] Univ eCampus, Rome, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; Foro Italico University of Rome; IRCCS Santa Lucia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Universita Ecampus	Fusco, A (corresponding author), IRCCS Fdn Don Carlo Gnocchi, Milan, Italy.	afusco@dongnocchi.it	Iosa, Marco/AAC-1693-2022; Fusco, Augusto/K-5794-2012; Padua, Luca/K-5398-2016; Iosa, Marco/B-9531-2012; ANTONUCCI, Gabriella/F-3827-2011	Fusco, Augusto/0000-0002-8528-7834; Padua, Luca/0000-0003-2570-9326; ANTONUCCI, Gabriella/0000-0003-0253-9029; Gallotta, Maria Chiara/0000-0001-5532-6380; Guidetti, Laura/0000-0002-1419-4550				Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Allali G, 2014, J GERONTOL A-BIOL, V69, P1389, DOI 10.1093/gerona/glt207; Beauchet O, 2013, J NUTR HEALTH AGING, V17, P235, DOI 10.1007/s12603-012-0394-4; Berlingeri M, 2010, EXP BRAIN RES, V205, P307, DOI 10.1007/s00221-010-2363-7; Caeyenberghs K, 2009, DEVELOPMENTAL SCI, V12, P474, DOI 10.1111/j.1467-7687.2008.00803.x; Callow N., 2006, Journal of Imagery Research in Sport and Physical Activity, V1, P2, DOI 10.2202/1932-0191.1001; Callow N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00697; Calmels C, 2001, SPORT PSYCHOL, V15, P142, DOI 10.1123/tsp.15.2.142; Calmels C, 2006, J MOTOR BEHAV, V38, P339, DOI 10.3200/JMBR.38.5.339-348; Collet C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00415; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; Debarnot U, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00280; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Kanthack TFD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149654; Fusco A, 2016, RESTOR NEUROL NEUROS, V34, P247, DOI 10.3233/RNN-150573; Fusco A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00760; Gould D., 1996, EXPLORING SPORT EXER, P25, DOI [10.1037/10186-002, DOI 10.1037/10186-002]; Guillot A, 2005, BIOL SPORT, V22, P215; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Guillot A, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-8; Harris JE, 2015, CLIN REHABIL, V29, P1092, DOI 10.1177/0269215514566248; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Holmes PS, 2001, J APPL SPORT PSYCHOL, V13, P60, DOI 10.1080/10413200109339004; Iosa M, 2012, BEHAV BRAIN RES, V226, P124, DOI 10.1016/j.bbr.2011.09.007; Iosa M, 2016, EXPERT REV MED DEVIC, V13, P641, DOI 10.1080/17434440.2016.1198694; Iosa M, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/tnhurn.2014.00859, 10.3389/fnhum.2014.00859]; Iosa M, 2013, NEUROPEDIATRICS, V44, P147, DOI 10.1055/s-0033-1336016; Ivanenko YP, 2011, HUM MOVEMENT SCI, V30, P341, DOI 10.1016/j.humov.2010.04.001; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kunz BR, 2009, J EXP PSYCHOL HUMAN, V35, P1458, DOI 10.1037/a0015786; Lee M, 2013, GAIT POSTURE, V38, P674, DOI 10.1016/j.gaitpost.2013.02.014; Louis M, 2008, J MOTOR BEHAV, V40, P117, DOI 10.3200/JMBR.40.2.117-132; Macuga KL, 2012, NEUROIMAGE, V59, P2798, DOI 10.1016/j.neuroimage.2011.09.083; Malouin F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00576; Malouin F, 2010, PHYS THER, V90, P240, DOI 10.2522/ptj.20090029; Munzert J, 2002, PERCEPT MOTOR SKILL, V94, P307, DOI 10.2466/PMS.94.1.307-318; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Papaxanthis C, 2002, EXP BRAIN RES, V143, P447, DOI 10.1007/s00221-002-1012-1; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Reed CL, 2002, MEM COGNITION, V30, P1169, DOI 10.3758/BF03213400; Saimpont A, 2012, NEUROSCIENCE, V222, P49, DOI 10.1016/j.neuroscience.2012.06.066; Saimpont A, 2013, J MOTOR BEHAV, V45, P21, DOI 10.1080/00222895.2012.740098; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; Schack T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00328; Schott N, 2007, INT J SPORT PSYCHOL, V38, P304; Schott N, 2012, EXP AGING RES, V38, P559, DOI 10.1080/0361073X.2012.726045; Sharma N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088443; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Viviani P, 2011, EXP BRAIN RES, V214, P93, DOI 10.1007/s00221-011-2809-6; Wakefield C, 2012, J SPORT PSYCHOL ACTI, V3, P1, DOI 10.1080/21520704.2011.639853; Williams SE, 2012, J SPORT EXERCISE PSY, V34, P621, DOI 10.1123/jsep.34.5.621; Zapparoli L, 2016, BEHAV BRAIN RES, V303, P137, DOI 10.1016/j.bbr.2016.01.058; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022; [No title captured]	58	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218378	10.1371/journal.pone.0218378	http://dx.doi.org/10.1371/journal.pone.0218378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242209	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600030
J	Liu, ZW; Tian, XG; Liu, WK; Xian, YT; Chen, WL; Chen, HY; Zhou, R				Liu, Zhenwei; Tian, Xingui; Liu, Wenkuan; Xian, Yuting; Chen, Weilue; Chen, Huaying; Zhou, Rong			Development of two antigen-binding fragments to a conserved linear epitope of human adenovirus and their application in immunofluorescence	PLOS ONE			English	Article							INFECTION	Detection of human adenoviruses (HAdVs) in nasopharyngeal swab samples by immunofluorescence assay (IFA) will be valuable for diagnosing HAdV infection, which is a leading cause of severe respiratory tract disease, and will help in curbing the spread of HAdV. Monoclonal antibodies employed in IFA for HAdV detection should ideally target highly conserved epitope types. Here, we describe the development of two antigen-binding fragments (Fabs) with specific reactivity to HAdV using phage antibody library technology. When tested with IFA, both Fabs recognized cells infected with several types of HAdV, some of which have been identified in epidemics globally, or associated with outbreaks of severe or fatal acute respiratory diseases. The specificity and cross-reactivity of both Fabs to HAdVs indicated that the generated Fabs could be applied in the development of IFAs to detect HAdVs. Both Fabs bound to the knob proteins, as shown by chemiluminescence enzyme immunoassay and western blot. In addition, epitope mapping showed that both Fabs recognized a conserved linear epitope among several types of HAdV. Two different Fabs recognized the same epitope, suggesting that the epitope triggered the production of at least two kinds of antibodies in the body. The generated Fabs exerted no neutralization against HAdVs. The results demonstrate that both Fabs bind to an epitope that plays no role in neutralization of HAdV.	[Liu, Zhenwei; Tian, Xingui; Liu, Wenkuan; Xian, Yuting; Chen, Weilue; Chen, Huaying; Zhou, Rong] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhou, R (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	zhourong@gird.cn	Tian, Xingui/AAF-5709-2020; Tian, Xingui/AAC-3957-2021	Tian, Xingui/0000-0001-9761-6677; zhou, rong/0000-0001-7322-3561	National Science and Technology Major Project of China [2017ZX10103011-003, 2018ZX10102001]; National Natural Science Foundation of China [31570163]; Guangzhou Science and Technology Program key projects [201803040004]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Program key projects	This study was supported by the National Science and Technology Major Project of China (2017ZX10103011-003, 2018ZX10102001), the National Natural Science Foundation of China (31570163) and Guangzhou Science and Technology Program key projects (201803040004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Jamil J, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-46; Alharbi S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-55; Arnberg N, 2012, TRENDS PHARMACOL SCI, V33, P442, DOI 10.1016/j.tips.2012.04.005; Barbas III CF, 2004, PHAGE DISPLAY LAB MA; Buckwalter SP, 2012, J CLIN MICROBIOL, V50, P766, DOI 10.1128/JCM.05629-11; Clackson T, 2004, PHAGE DISPLAY, P272; Coughlan L, 2010, VIRUSES-BASEL, V2, P2290, DOI 10.3390/v2102290; Heim A, 2003, J MED VIROL, V71, P320, DOI 10.1002/jmv.10486; Hu K, 2018, VACCINE, V36, P4287, DOI 10.1016/j.vaccine.2018.05.118; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YS, 2015, HEALTHY AGING RES, V4; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100665; Liu MX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084408, 10.1371/journal.pone.0108012, 10.1371/journal.pone.0102344]; Malasig MD, 2001, J CLIN MICROBIOL, V39, P2984, DOI 10.1128/JCM.39.8.2984-2986.2001; Rojas LJ, 2012, EPIDEMIOL INFECT, V140, P818, DOI 10.1017/S0950268811001269; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Tian XG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0197-8; Tian XG, 2014, VIRUS GENES, V49, P22, DOI 10.1007/s11262-014-1071-y; Vellinga J, 2005, J GEN VIROL, V86, P1581, DOI 10.1099/vir.0.80877-0; Wang YC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02919; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wood SR, 1997, J MED VIROL, V51, P198, DOI 10.1002/(SICI)1096-9071(199703)51:3&lt;198::AID-JMV9&gt;3.0.CO;2-1; Xue LX, 2017, APPL POWER ELECT CO, P2441, DOI 10.1109/APEC.2017.7931041; Yeung R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-11; Zhang QW, 2006, J GEN VIROL, V87, P1531, DOI 10.1099/vir.0.81515-0; Zhang QW, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.78; Zhang QW, 2012, J VIROL, V86, P7019, DOI 10.1128/JVI.00814-12	29	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0219091	10.1371/journal.pone.0219091	http://dx.doi.org/10.1371/journal.pone.0219091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242267	Green Submitted, Green Published, gold			2022-12-26	WOS:000482883600077
J	Woo, YM; Kim, S; Park, JH; Lee, NY; Kim, JW; Kim, DDH				Woo, Young Min; Kim, Sehwa; Park, Jong-Ho; Lee, Nan Young; Kim, Jong-Won; Kim, Dennis Dong Hwan			Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISM; MITOCHONDRIAL TRANSLATION; CANCER; LOCUS; DISEASE; PROTEIN; FAMILY; GROWTH	Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder. Our previous study reported novel loci as genetic markers associated with increased susceptibility to CML. The present study conducted an expression quantitative trait loci (eQTL) analysis to confirm that the single nucleotide polymorphisms (SNPs) at these loci affect the expression of candidate CML-susceptible genes. We identified that three SNPs (rs963193, rs6931104, and rs9371517) were related to the gene expression pattern of RMND1 (Required For Meiotic Nuclear Division 1 Homolog) in both granulocytes and mononuclear cells from 83 healthy donors. Furthermore, reduced expression of RMND1 expression was noted in CML patients compared with that in healthy individuals. We used the eQTL browsing tool to assess the regulatory information on the three associated significant SNPs, out of which rs6931104 showed strong evidence of regulatory effects. Chromatin immunoprecipitation (ChIP) assays demonstrated that A alleles of rs6931104 could significantly change the binding affinity of transcription factor (TF) RFX3 compared to the G alleles. Then, we performed in vitro experiments on BCR-ABL1-positive (BCR-ABL1(+)) cell lines. We found that expression of the CML-susceptible gene RMND1 is affected by the binding affinity of TF RFX3, suggesting that RFX3 plays a role in RMND1 expression. Our findings suggest potential target genes for associations of genetic susceptibility risk loci and provide further insights into the pathogenesis and mechanism of CML.	[Woo, Young Min; Kim, Sehwa; Park, Jong-Ho; Kim, Jong-Won] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Lee, Nan Young] Kyungpook Natl Univ, Chilgok Hosp, Dept Lab Med, Daegu, South Korea; [Kim, Jong-Won] Sungkyunkwan Univ, Samsung Med Ctr, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Kim, Jong-Won] Sungkyunkwan Univ, Samsung Med Ctr, Dept Lab Med & Genet, Sch Med, Seoul, South Korea; [Kim, Dennis Dong Hwan] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada	Sungkyunkwan University (SKKU); Samsung Medical Center; Kyungpook National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Kim, JW (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea.; Kim, JW (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea.; Kim, JW (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Lab Med & Genet, Sch Med, Seoul, South Korea.	kimjw@skku.edu	Kim, Dennis/AAH-8499-2019	WOO, YOUNGMIN/0000-0003-1020-4093; Kim, Jong-Won/0000-0002-0708-9242	National Research Foundation of Korea(NRF) - Korea government(MSIT) [2019R1A2C2002177]	National Research Foundation of Korea(NRF) - Korea government(MSIT)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (No. 2019R1A2C2002177).	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Boultwood J, 2010, LEUKEMIA, V24, P1139, DOI 10.1038/leu.2010.65; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Crossman LC, 2005, LEUKEMIA, V19, P1859, DOI 10.1038/sj.leu.2403935; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744; Dunbier AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001382; Dunning AM, 2016, NAT GENET, V48, P374, DOI 10.1038/ng.3521; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garcia-Diaz B, 2012, AM J HUM GENET, V91, P729, DOI 10.1016/j.ajhg.2012.08.019; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020; Jiang JF, 2014, ONCOTARGET, V5, P6168, DOI 10.18632/oncotarget.2179; Kim DH, 2011, BLOOD, V117, P6906, DOI 10.1182/blood-2011-01-329797; Kim DH, 2009, BLOOD, V113, P2517, DOI 10.1182/blood-2008-07-169110; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Ng YS, 2016, J MED GENET, V53, P768, DOI 10.1136/jmedgenet-2016-103910; Park JH, 2019, LEUKEMIA, V33, P1439, DOI 10.1038/s41375-018-0321-8; Ravn K, 2016, AM J MED GENET A, V170, P142, DOI 10.1002/ajmg.a.37399; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Yamamoto-Ibusuki M, 2015, EUR J HUM GENET, V23, P949, DOI 10.1038/ejhg.2014.219; Yoo YA, 2005, MOL CELL BIOL, V25, P6603, DOI 10.1128/MCB.25.15.6603-6616.2005; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhou XJ, 2011, PLANT PHYSIOL, V157, P1793, DOI 10.1104/pp.111.185827	39	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218968	10.1371/journal.pone.0218968	http://dx.doi.org/10.1371/journal.pone.0218968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237926	Green Submitted, gold, Green Published			2022-12-26	WOS:000484856000056
J	Mendis, HC; Ozcan, A; Santra, S; De La Fuente, L				Mendis, Hajeewaka C.; Ozcan, Ali; Santra, Swadeshmukul; De La Fuente, Leonardo			A novel Zn chelate (TSOL) that moves systemically in citrus plants inhibits growth and biofilm formation of bacterial pathogens	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; AXONOPODIS PV. CITRI; ANTIBACTERIAL ACTIVITY; ALAMAR BLUE; MYCOBACTERIUM-TUBERCULOSIS; ANTIMICROBIAL ACTIVITY; GENE-EXPRESSION; ZINC-OXIDE; DISEASE; STATE	Ternary solution (TSOL) is a novel Zn chelate-based systemic antimicrobial formulation designed for treating citrus bacterial pathogens 'Candidatus Liberibacter asiaticus' and Xanthomonas citri subsp. citri. TSOL is a component of MS3T, a novel multifunctional surface/sub-surface/systemic therapeutic formulation. Antimicrobial activity of TSOL was compared with the antimicrobial compound ZnO against X. citri subsp. citri and 'Ca. L. asiaticus' surrogate Liberibacter crescens in batch cultures. X. citri subsp. citri and L. crescens were also introduced into microfluidic chambers, and the inhibitory action of TSOL against biofilm formation was evaluated. The minimum inhibitory concentration of TSOL for both X. citri subsp. citri and L. crescens was 40ppm. TSOL was bactericidal to X. citri subsp. citri and L. crescens above 150 ppm and 200 ppm, respectively. On the contrary, ZnO was more effective as a bactericidal agent against L. crescens than X. citri subsp. citri. TSOL was more effective in controlling growth and biofilm formation of X. citri subsp. citri in batch cultures compared to ZnO. Time-lapse video imaging microscopy showed that biofilm formation of X. citri subsp. citri was inhibited in microfluidic chambers treated with 60 ppm TSOL. TSOL also inhibited further growth of already formed X. citri subsp. citri and L. crescens biofilms in microfluidic chambers. Leaf spraying of TSOL showed higher plant uptake and systemic movement in citrus (Citrus reshni) plants compared to that of ZnO, suggesting that TSOL is a promising antimicrobial compound to control vascular plant pathogens such as 'Ca. L. asiaticus'.	[Mendis, Hajeewaka C.; De La Fuente, Leonardo] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Mendis, Hajeewaka C.; Ozcan, Ali; Santra, Swadeshmukul] Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA; [Ozcan, Ali; Santra, Swadeshmukul] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA; [Santra, Swadeshmukul] Univ Cent Florida, Dept Mat Sci & Engn, Orlando, FL 32816 USA; [Santra, Swadeshmukul] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	Auburn University System; Auburn University; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	De La Fuente, L (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	lzd0005@auburn.edu	Ozcan, Ali/AAR-1045-2020; Ozcan, Ali/AAC-3457-2021; De La Fuente, Leonardo/A-2012-2013	Ozcan, Ali/0000-0001-6781-535X; Ozcan, Ali/0000-0001-6781-535X; Mendis, Hajeewaka/0000-0002-2346-9077; De La Fuente, Leonardo/0000-0002-0027-4840	USDA National Institute of Food and Agriculture Specialty Crops Research Initiative (NIFA-SCRI) [2016-70016-24828]; Citrus Research and Development Foundation [15-037C]; HATCH AAES (Alabama Agricultural Experiment Station) program	USDA National Institute of Food and Agriculture Specialty Crops Research Initiative (NIFA-SCRI); Citrus Research and Development Foundation; HATCH AAES (Alabama Agricultural Experiment Station) program	This project was funded by Agriculture and Food Research Initiative competitive grant no. 2016-70016-24828 from the USDA National Institute of Food and Agriculture Specialty Crops Research Initiative (NIFA-SCRI) awarded to SS and LD; Citrus Research and Development Foundation grant (Project No. 15-037C); and the HATCH AAES (Alabama Agricultural Experiment Station) program awarded to LD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; ALVA AK, 1995, SOIL SCI SOC AM J, V59, P481, DOI 10.2136/sssaj1995.03615995005900020031x; ANJANEYULU Y, 1986, SYN REACT INORG MET, V16, P257, DOI 10.1080/00945718608057530; [Anonymous], 2010, COPP 2 SULF MSDS AD4; [Anonymous], 2014, ZINK NITR MSDS S2590; Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081; Aubert B., 1992, P 7 INT CITR C CULT, P817; Bassanezi RB, 2011, EUR J PLANT PATHOL, V130, P577, DOI 10.1007/s10658-011-9779-1; Berhamin-Filho A, 2008, P INT RES C HANGL OR; Bloemberg GV, 2004, BACTERIAL BIOFILMS P, P141; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34; Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h; BRENNAN RF, 1991, AUST J EXP AGR, V31, P831, DOI 10.1071/EA9910831; Bueno C, 2002, PHOTOCHEM PHOTOBIOL, V76, P385; Chatterjee S, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/5/055301; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; del Campo R, 2009, FEMS MICROBIOL LETT, V298, P143, DOI 10.1111/j.1574-6968.2009.01709.x; Dutt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137134; Fagen JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084469; FDA, 2018, SUBST GEN REC SA 182; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Gordon T, 2011, COLLOID SURFACE A, V374, P1, DOI 10.1016/j.colsurfa.2010.10.015; Gottwald T.R, 2017, J CITRUS PATHOL, V4, P1; Gottwald T.R., 2007, OUTLOOKS PEST MANAG, V18, P274, DOI DOI 10.1564/18DEC09; Gottwald T S P, 2008, P INT RES C HUANGL; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; GOTTWALD TR, 1989, PHYTOPATHOLOGY, V79, P687, DOI 10.1094/Phyto-79-687; GOTTWALD TR, 1989, PHYTOPATHOLOGY, V79, P1276, DOI 10.1094/Phyto-79-1276; Graham J, 2010, P FLORIDA STATE HORT; Graham JH, 2016, PLANT DIS, V100, P2442, DOI 10.1094/PDIS-05-16-0598-RE; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Gunasekera TS, 2002, APPL ENVIRON MICROB, V68, P1988, DOI 10.1128/AEM.68.4.1988-1993.2002; Hall DG, 2007, J ECON ENTOMOL, V100, P847, DOI 10.1603/0022-0493(2007)100[847:EOAPFO]2.0.CO;2; Hall DG, 2013, HORTSCIENCE, V48, P330, DOI 10.21273/HORTSCI.48.3.330; Hao GX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01078; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hoffman MT, 2013, PHYTOPATHOLOGY, V103, P15, DOI 10.1094/PHYTO-06-12-0138-R; Hu JH, 2017, PHYTOPATHOLOGY, V107, P187; Hu JH, 2016, PHYTOPATHOLOGY, V106, P1495, DOI 10.1094/PHYTO-02-16-0114-R; Johnson EG, 2014, PLANT PATHOL, V63, P290, DOI 10.1111/ppa.12109; Kandel PP, 2016, APPL ENVIRON MICROB, V82, P5269, DOI 10.1128/AEM.01412-16; Kasemets K, 2009, TOXICOL IN VITRO, V23, P1116, DOI 10.1016/j.tiv.2009.05.015; KOGURE K, 1979, CAN J MICROBIOL, V25, P415, DOI 10.1139/m79-063; LEITE RP, 1990, CROP PROT, V9, P3, DOI 10.1016/0261-2194(90)90038-9; Leonard MT, 2012, STAND GENOMIC SCI, V7, P271, DOI 10.4056/sigs.3326772; Leong SCT, 2012, SCI WORLD J, DOI 10.1100/2012/651416; Li JY, 2014, PHYTOPATHOLOGY, V104, P134, DOI 10.1094/PHYTO-04-13-0100-R; Lin CK, 1963, ACTA PHYTOPHYLACT SI, V2, P243; Liu SW, 2019, J AGR FOOD CHEM, V67, P7157, DOI 10.1021/acs.jafc.9b02045; MACNAEIDHE FS, 1988, IRISH J AGR RES, V27, P91; Mann RS, 2012, J APPL ENTOMOL, V136, P87, DOI 10.1111/j.1439-0418.2010.01592.x; McKenzie C, 2002, ARTHROPOD MANAGEMENT, V27; Mongkolsuk S, 1997, J BACTERIOL, V179, P3950, DOI 10.1128/jb.179.12.3950-3955.1997; Monier JM, 2004, APPL ENVIRON MICROB, V70, P346, DOI 10.1128/AEM.70.1.346-355.2004; Morris CE, 2003, ANNU REV PHYTOPATHOL, V41, P429, DOI 10.1146/annurev.phyto.41.022103.134521; Naranjo E, 2019, SCI REPORTS, V9, DOI [10.1038/s41598-018-36956-2, DOI 10.1038/S41598-018-36956-2]; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ohira T, 2008, J MATER SCI-MATER M, V19, P1407, DOI 10.1007/s10856-007-3246-8; Oliver JD, 2005, J MICROBIOL, V43, P93; Oliver JD, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P277; Onagbola EO, 2011, J APPL ENTOMOL, V135, P404, DOI 10.1111/j.1439-0418.2010.01565.x; Parsek MR, 2004, J BACTERIOL, V186, P4427, DOI 10.1128/JB.186.14.4427-4440.2004; Espitia PJP, 2012, FOOD BIOPROCESS TECH, V5, P1447, DOI 10.1007/s11947-012-0797-6; Premanathan M, 2011, NANOMED-NANOTECHNOL, V7, P184, DOI 10.1016/j.nano.2010.10.001; Quarles W., 2013, IPM PRACTITIONER, V34; Raman N, 2007, J CHEM SCI, V119, P303, DOI 10.1007/s12039-007-0041-5; Raman N, 2003, P INDIAN AS-CHEM SCI, V115, P161, DOI 10.1007/BF02704255; Ramey BE, 2004, CURR OPIN MICROBIOL, V7, P602, DOI 10.1016/j.mib.2004.10.014; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324; Hippler FWR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116903; RODRIGUEZ GG, 1992, APPL ENVIRON MICROB, V58, P1801, DOI 10.1128/AEM.58.6.1801-1808.1992; Rogers M.E., 2012, ENY734 UFIFAS EDIS; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sawai J, 1998, J FERMENT BIOENG, V86, P521, DOI 10.1016/S0922-338X(98)80165-7; Sawai J, 2003, J MICROBIOL METH, V54, P177, DOI 10.1016/S0167-7012(03)00037-X; SAWAI J, 1995, J CHEM ENG JPN, V28, P288, DOI 10.1252/jcej.28.288; SCHWARZ RE, 1973, FAO PLANT PROTECT B, V21, P132; SMITH MW, 1979, J AM SOC HORTIC SCI, V104, P474; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DC, 2008, MOL CELL PROBE, V22, P139, DOI 10.1016/j.mcp.2007.12.006; Timmer LW, 1996, PLANT DIS, V80, P166, DOI 10.1094/PD-80-0166; US EPA, 1996, 3050B USEPA; Vyas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130328; Wang N, 2017, ANNU REV PHYTOPATHOL, V55, P451, DOI 10.1146/annurev-phyto-080516-035513; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Wang X, 2004, CARBOHYD POLYM, V56, P21, DOI 10.1016/j.carbpol.2003.11.007; Webb JS, 2003, CURR OPIN MICROBIOL, V6, P578, DOI 10.1016/j.mib.2003.10.014; Whidden M, 2015, B MATH BIOL, V77, P2161, DOI 10.1007/s11538-015-0115-3; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; YAJKO DM, 1995, J CLIN MICROBIOL, V33, P2324, DOI 10.1128/JCM.33.9.2324-2327.1995; Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0; Young M, 2018, J AGR FOOD CHEM, V66, P6604, DOI 10.1021/acs.jafc.7b02526; Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1; Zhang MQ, 2011, PHYTOPATHOLOGY, V101, P1097, DOI 10.1094/PHYTO-09-10-0262; ZIMMERMANN R, 1978, APPL ENVIRON MICROB, V36, P926, DOI 10.1128/AEM.36.6.926-935.1978	100	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218900	10.1371/journal.pone.0218900	http://dx.doi.org/10.1371/journal.pone.0218900			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233560	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700051
J	Song, DF; Yin, L; Wang, C; Wen, XY				Song, DaoFei; Yin, Lei; Wang, Chang; Wen, XiuYing			Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats	PLOS ONE			English	Article							SALT-INDUCIBLE KINASE; PROTEIN-KINASE; INSULIN-RESISTANCE; HEPG2 CELLS; MODEL; GLUCONEOGENESIS; STREPTOZOTOCIN; CREB; PATHWAY; TRANSCRIPTION	Aim In this study, we investigated the role and mechanism of Salt-induced kinase 1 (SIK1) in regulation of hepatic glucose and lipid metabolism in a high-fat food (HFD) and streptozocin (STZ)-induced type 2 diabetes mellitus (T2DM) rat model. Methods A diabetic rat model treated with HFD plus low-dose STZ was developed and was transduced to induce a high expression of SIK1 in vivo via a tail-vein injection of a recombinant adenoviral vector. The effects on hepatic glucogenetic and lipogenic gene expression, systemic metabolism and pathological changes were then determined. Results In T2DM rats, SIK1 expression was reduced in the liver. Overexpression of SIK1 improved hyperglycaemia, hyperlipidaemia and fatty liver, reduced the expression of cAMP-response element binding protein (CREB)-regulated transcription co-activator 2 (CRTC2), phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase), pS577 SIK1, sterol regulatory element binding-protein-1c (SREBP-1c) and its target genes, including acetylCoA carboxylase (ACC) and fatty acid synthase (FAS), and increased the expression of SIK1, pT182 SIK1 and pS171 CRTC2 in diabetic rat livers with the suppression of gluconeogenesis and lipid deposition. Conclusion SIK1 plays a crucial role in the regulation of glucose and lipid metabolism in the livers of HFD/STZ-induced T2DM rats, where it suppresses hepatic gluconeogenesis and lipogenesis by regulating the SIK1/CRTC2 and SIK1/SREBP-1c signalling pathways. Strategies to activate SIK1 kinase in liver would likely have beneficial effects in patients with T2DM and nonalcoholic fatty liver disease (NAFLD).	[Song, DaoFei; Yin, Lei; Wang, Chang] Huazhong Univ Sci & Technol, Tongji Med Coll, Liyuan Hosp, Dept Endocrinol, Wuhan, Hubei, Peoples R China; [Wen, XiuYing] Huazhong Univ Sci & Technol, Tongji Med Coll, Liyuan Hosp, Dept Tradit Chinese Med & Endocrinol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wen, XY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Liyuan Hosp, Dept Tradit Chinese Med & Endocrinol, Wuhan, Hubei, Peoples R China.	wenxyoung@hust.edu.cn		Wen, Xiuying/0000-0002-9312-0524	National Natural Science Foundation of China [NSFC81673657]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China, NSFC81673657 (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Breant B, 2006, HORM RES, V65, P98, DOI 10.1159/000091513; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Islam MS, 2007, PHARMACOLOGY, V79, P243, DOI 10.1159/000101989; Islam MS, 2009, METHOD FIND EXP CLIN, V31, P249, DOI 10.1358/mf.2009.31.4.1362513; Jiang SJ, 2015, WORLD J GASTROENTERO, V21, P7777, DOI 10.3748/wjg.v21.i25.7777; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224; Nixon M, 2016, MOL METAB, V5, P34, DOI 10.1016/j.molmet.2015.10.004; PASCOE WS, 1990, DIABETES, V39, P226, DOI 10.2337/diabetes.39.2.226; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Phillips Carrie A, 2002, Curr Diab Rep, V2, P523, DOI 10.1007/s11892-002-0123-1; Quan HY, 2012, INT J MOL MED, V29, P73, DOI 10.3892/ijmm.2011.805; Rebecca BERDEAUX, 2011, [Frontiers in Biology, 生物学前沿], V6, P231; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Wang CJ, 2009, APPL IMMUNOHISTO M M, V17, P530, DOI 10.1097/PAI.0b013e3181a13bf2; Wen XY, 2012, J ETHNOPHARMACOL, V142, P144, DOI 10.1016/j.jep.2012.04.028; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; Yu J, 2013, INT J MOL MED, V32, P151, DOI 10.3892/ijmm.2013.1377; Zhang Y, 2017, LIFE SCI, V173, P107, DOI 10.1016/j.lfs.2017.02.001	32	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0210930	10.1371/journal.pone.0210930	http://dx.doi.org/10.1371/journal.pone.0210930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233505	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700001
J	Yang, YY; Liu, ZX; Selby, CP; Sancar, A				Yang, Yanyan; Liu, Zhenxing; Selby, Christopher P.; Sancar, Aziz			Long-term, genome-wide kinetic analysis of the effect of the circadian clock and transcription on the repair of cisplatin-DNA adducts in the mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; circadian clock; DNA damage; kinetics; nucleotide excision repair; chemotherapy; chronotherapy; cisplatin; excision repair sequencing (XR-seq); transcription-coupled repair; DNA adduct	RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; MOLECULAR-MECHANISMS; ULTRAVIOLET-LIGHT; COUPLED REPAIR; DAMAGE; CANCER; INITIATION; RECOVERY; CORE	Cisplatin is the most commonly used chemotherapeutic drug for managing solid tumors. However, toxicity and the innate or acquired resistance of cancer cells to the drug limit its usefulness. Cisplatin kills cells by forming cisplatin-DNA adducts, most commonly the Pt-d(GpG) diadduct. We recently showed that, in mice, repair of this adduct 2 h following injection is controlled by two circadian programs. 1) The circadian clock controls transcription of 2000 genes in liver and, via transcription-directed repair, controls repair of the transcribed strand (TS) of these genes in a rhythmic fashion unique to each gene's phase of transcription. 2) The excision repair activity itself is controlled by the circadian clock with a single phase at which the repair of the nontranscribed strand (NTS) and the rest of the genome takes place. Here, we followed the repair kinetic for long periods genome-wide both globally and at single nucleotide resolution by the Excision Repair-sequencing (XR-seq) method to better understand cisplatin DNA damage and repair. We find that transcription-driven repair is nearly complete after 2 days, whereas weeks are required for repair of the NTS and the rest of the genome. TS repair oscillates in rhythmically expressed genes up to 2 days post injection, and in all expressed genes, we see a trend in TS repair with time from the 5 ' to 3 ' end. These findings help to understand the circadian- and transcription-dependent and -independent control of repair in response to cisplatin, and should aid in designing cisplatin chemotherapy regimens with improved therapeutic indexes.	[Yang, Yanyan; Liu, Zhenxing; Selby, Christopher P.; Sancar, Aziz] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Liu, Zhenxing/U-2062-2019; Liu, Zhenxing/HCH-6877-2022; liu, zhenxing/GWC-9542-2022	liu, zhenxing/0000-0001-8236-1931	National Institutes of Health [GM118102, ES027255]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES027255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118102 and ES027255 (to A.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Adebali O, 2017, J BIOL CHEM, V292, P18386, DOI 10.1074/jbc.C117.818807; Andrade-Lima LC, 2015, BIOMOLECULES, V5, P1600, DOI 10.3390/biom5031600; Andrade-Lima LC, 2015, NUCLEIC ACIDS RES, V43, P2744, DOI 10.1093/nar/gkv148; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bugai A, 2019, MOL CELL, V74, P254, DOI 10.1016/j.molcel.2019.01.033; Chaney SG, 1996, JNCI-J NATL CANCER I, V88, P1346, DOI 10.1093/jnci/88.19.1346; Chiou YY, 2018, J BIOL CHEM, V293, P2476, DOI 10.1074/jbc.RA117.000971; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Jiang HY, 2019, GENE DEV, V33, P705, DOI 10.1101/gad.322453.118; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; Lavigne MD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02145-4; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Ljungman M, 1999, CARCINOGENESIS, V20, P395, DOI 10.1093/carcin/20.3.395; Ngoc LV, 2017, GENE DEV, V31, P1289, DOI 10.1101/gad.303149.117; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Nojima T, 2016, NAT PROTOC, V11, P413, DOI 10.1038/nprot.2016.012; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Pines A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03484-6; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Sancar A, 2015, BIOCHEMISTRY-US, V54, P110, DOI 10.1021/bi5007354; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Tippens ND, 2018, GENE DEV, V32, P1, DOI 10.1101/gad.311605.118; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658; Yang YY, 2018, P NATL ACAD SCI USA, V115, pE4777, DOI 10.1073/pnas.1804493115; Yimit A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08290-2	49	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11960	11968		10.1074/jbc.RA119.009579	http://dx.doi.org/10.1074/jbc.RA119.009579			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217280	Green Published, hybrid			2022-12-26	WOS:000484284500002
J	Carballo-Bolanos, R; Denis, V; Huang, YY; Keshavmurthy, S; Chen, CA				Carballo-Bolanos, Rodrigo; Denis, Vianney; Huang, Ya-Yi; Keshavmurthy, Shashank; Chen, Chaolun Allen			Temporal variation and photochemical efficiency of species in Symbiodinaceae associated with coral Leptoria phrygia (Scleractinia; Merulinidae) exposed to contrasting temperature regimes	PLOS ONE			English	Article							ALGAL SYMBIONT COMMUNITIES; SEASONAL FLUCTUATIONS; PALIFERA SCLERACTINIA; OULASTREA-CRISPATA; TISSUE BIOMASS; REEF CORALS; LONG-TERM; CLADE-D; ZOOXANTHELLAE; SPECIFICITY	The Symbiodinaceae are paradoxical in that they play a fundamental role in the success of scleractinian corals, but also in their dismissal when under stress. In the past decades, the discovery of the endosymbiont's genetic and functional diversity has led people to hope that some coral species can survive bleaching events by associating with a stress-resistant symbiont that can become dominant when seawater temperatures increase. The variety of individual responses encouraged us to scrutinize each species individually to gauge its resilience to future changes. Here, we analyse the temporal variation in the Symbiodinaceae community associated with Leptoria phrygia, a common scleractinian coral from the Indo-Pacific. Coral colonies were sampled from two distant reef sites located in southern Taiwan that differ in temperature regimes, exemplifying a 'variable site' ( VS) and a 'steady site' ( SS). We investigated changes in the relative abundance of the dominant symbiont and its physiology every 3-4 months from 2016-2017. At VS, 11 of the 12 colonies were dominated by the stress-resistant Durusdinium spp. (>90% dominance) and only one colony exhibited co-dominance between Durusdinium spp. and Cladocopium spp. Every colony displayed high photochemical efficiency across all sampling periods, while showing temporal differences in symbiont density and chlorophyll a concentration. At SS, seven colonies out of 13 were dominated by Cladocopium spp., five presented co-dominance between Durusdinium spp./Cladocopium spp. and only one was dominated by Durusdinium spp. Colonies showed temporal differences in photochemical efficiency and chlorophyll a concentration during the study period. Our results suggest that VS colonies responded physiologically better to high temperature variability by associating with Durusdinium spp., while in SS there is still inter-colonial variability, a feature that might be advantageous for coping with different environmental changes.	[Carballo-Bolanos, Rodrigo; Chen, Chaolun Allen] Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei, Taiwan; [Carballo-Bolanos, Rodrigo; Chen, Chaolun Allen] Natl Taiwan Normal Univ, Taipei, Taiwan; [Carballo-Bolanos, Rodrigo; Huang, Ya-Yi; Keshavmurthy, Shashank; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Carballo-Bolanos, Rodrigo; Chen, Chaolun Allen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Denis, Vianney; Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Chen, Chaolun Allen] Tunghai Univ, Dept Life Sci, Taichung, Taiwan	Academia Sinica - Taiwan; National Taiwan Normal University; Academia Sinica - Taiwan; National Taiwan Normal University; National Taiwan University; Tunghai University	Chen, CA (corresponding author), Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei, Taiwan.; Chen, CA (corresponding author), Natl Taiwan Normal Univ, Taipei, Taiwan.; Chen, CA (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.; Chen, CA (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.; Chen, CA (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.; Chen, CA (corresponding author), Tunghai Univ, Dept Life Sci, Taichung, Taiwan.	cac@gate.sinica.edu.tw	Keshavmurthy, Shashank/C-3672-2013; Denis, Vianney/E-6868-2013	Keshavmurthy, Shashank/0000-0002-2235-9132; Denis, Vianney/0000-0002-0914-5586	Academia Sinica; National Taiwan Normal University; Ministry of Science and Technology of Taiwan [101-2621-B-001-005-MY3]; Academia Sinica [AS-104-SS-A03]	Academia Sinica(Academia Sinica - Taiwan); National Taiwan Normal University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Taiwan International Graduate Program, Biodiversity Program, Academia Sinica and National Taiwan Normal University (http://tigp-biodiv.biodiv.tw/) to RCB; 101-2621-B-001-005-MY3. Ministry of Science and Technology of Taiwan (https://www.most.gov.tw/?l=en) to CAC; AS-104-SS-A03. Academia Sinica (https://www.sinica.edu.tw/en) to CAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2013, MAR ECOL PROG SER, V479, P85, DOI 10.3354/meps10102; Bates D, 2012, LME4 LINEAR MIXED EF; Bay LK, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160322; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; Chen CA, 2003, ZOOL STUD, V42, P540; Cignoni P., 2008, 6 EUR IT CHAPT C 200, DOI 10.2312/LocalChapterEvents/ItalChap/ItalianChapConf2008/129-136; Cooper TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025536; Cunning R, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1725; Cunning R, 2017, CORAL REEFS, P1; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; Fan KL, 1991, ELSEVIER OCEANOGR SE, V54, P309; Ferrara GB, 2006, CELL MOL BIOL LETT, V11, P155, DOI 10.2478/s11658-006-0013-7; Fisher PL, 2012, CORAL REEFS, V31, P473, DOI 10.1007/s00338-011-0853-0; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hsu CM, 2012, ZOOL STUD, V51, P1343; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jan S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004887; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JOHANNES RE, 1970, LIMNOL OCEANOGR, V15, P822, DOI 10.4319/lo.1970.15.5.0822; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Kao KW, 2018, ZOOL STUD, V57, DOI 10.6620/ZS.2018.57-55; Kemp DW, 2015, CORAL REEFS, V34, P535, DOI 10.1007/s00338-015-1277-z; Kemp DW, 2014, LIMNOL OCEANOGR, V59, P788, DOI 10.4319/lo.2014.59.3.0788; Keshavmurthy S, 2014, PEERJ, V2, DOI 10.7717/peerj.327; Keshavmurthy S, 2012, MOL ECOL, V21, P4393, DOI 10.1111/j.1365-294X.2012.05704.x; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2010, P ROYAL SOC B; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Lee H.-J., 1997, J OCEANOGR, V53, P467; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Lien YT, 2007, CORAL REEFS, V26, P35, DOI 10.1007/s00338-006-0185-7; Lien YT, 2013, MAR ECOL PROG SER, V473, P163, DOI 10.3354/meps10041; McClanahan TR, 2015, MAR ECOL-EVOL PERSP, V36, P1215, DOI 10.1111/maec.12225; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; Muscatine L., 1990, P75; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Peir J-J, 2011, NUCL POWER OPERATION; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sawall Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103179; Scheufen T, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00309; Silverstein RN, 2017, J EXP BIOL, V220, P1192, DOI 10.1242/jeb.148239; Silverstein RN, 2015, GLOBAL CHANGE BIOL, V21, P236, DOI 10.1111/gcb.12706; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; Ulstrup KE, 2008, MAR ECOL PROG SER, V361, P139, DOI 10.3354/meps07360; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; Xu LJ, 2017, CORAL REEFS, V36, P477, DOI 10.1007/s00338-016-1532-y	67	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218801	10.1371/journal.pone.0218801	http://dx.doi.org/10.1371/journal.pone.0218801			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251761	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000023
J	Barocas, JA; So-Armah, K; Cheng, DM; Lioznov, D; Baum, M; Gallagher, K; Fuster, D; Gnatienko, N; Krupitsky, E; Freiberg, MS; Samet, JH				Barocas, Joshua A.; So-Armah, Kaku; Cheng, Debbie M.; Lioznov, Dmitry; Baum, Marianna; Gallagher, Kerrin; Fuster, Daniel; Gnatienko, Natalia; Krupitsky, Evgeny; Freiberg, Matthew S.; Samet, Jeffrey H.			Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naive persons with alcohol use in Russia	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; VIRUS; PROGRESSION; CIRRHOSIS; DISEASE; PREVALENCE; THERAPY; BIOPSY; HCV	Background and aims Liver disease in people living with HIV co-infected with hepatitis C virus is a source of morbidity and mortality in Russia. HIV accelerates liver fibrosis in the setting of HCV co-infection and alcohol use. Zinc deficiency is common among people living with HIV and may be a factor that facilitates the underlying mechanisms of liver fibrosis. We investigated the association between zinc deficiency and advanced liver fibrosis in a cohort of HIV/HCV co-infected persons reporting heavy drinking in Russia. Methods This is a secondary data analysis of baseline data from 204 anti-retroviral treatment naive HIV/HCV co-infected Russians with heavy drinking that were recruited into a clinical trial of zinc supplementation. The primary outcome of interest in this cross-sectional study was advanced liver fibrosis. Zinc deficiency, the main independent variable, was defined as plasma zinc <0.75 mg/L. Exploratory analyses were performed examining continuous zinc levels and fibrosis scores. Analyses were conducted using multivariable regression models adjusted for potential confounders. Results The prevalence of advanced liver fibrosis was similar for those with zinc deficiency compared to those with normal zinc levels, (27.7% vs. 23.0%, respectively). We did not detect an association between zinc deficiency and advanced liver fibrosis in the adjusted regression model (aOR: 1.28, 95% CI: 0.62-2.61, p = 0.51) nor in exploratory analyses. Conclusions In this cohort of Russians with HIV/HCV co-infection, who are anti-retroviral treatment naive and have heavy alcohol use, we did not detect an association between zinc deficiency or zinc levels and advanced liver fibrosis.	[Barocas, Joshua A.] Boston Med Ctr, Infect Dis Sect, Boston, MA 02118 USA; [Barocas, Joshua A.; So-Armah, Kaku; Samet, Jeffrey H.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Cheng, Debbie M.; Gallagher, Kerrin] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Lioznov, Dmitry; Krupitsky, Evgeny] First Pavlov State Med Univ, St Petersburg, Russia; [Lioznov, Dmitry] Smoridintsev Res Inst Influenza, St Petersburg, Russia; [Baum, Marianna] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Fuster, Daniel] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Gnatienko, Natalia] Boston Med Ctr, Gen Internal Med Sect, Boston, MA USA; [Krupitsky, Evgeny] VM Bekhterev Natl Med Res Ctr Psychiat & Neurol, St Petersburg, Russia; [Freiberg, Matthew S.] Vanderbilt Univ, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	Boston Medical Center; Boston University; Boston University; Pavlov First Saint Petersburg State Medical University; State University System of Florida; Florida International University; Hospital Germans Trias i Pujol; Boston Medical Center; V.M. Bekhterev National Research Medical Center Psychiatry & Neurology; Vanderbilt University	Barocas, JA (corresponding author), Boston Med Ctr, Infect Dis Sect, Boston, MA 02118 USA.; Barocas, JA (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	Joshua.Barocas@bmc.org	Fuster, Daniel/C-6659-2019; Krupitsky, Evgeny/M-5935-2016; Lioznov, Dmitry/J-2539-2013	Fuster, Daniel/0000-0003-1262-5860; Krupitsky, Evgeny/0000-0002-0529-4525; Lioznov, Dmitry/0000-0003-3643-7354; So-Armah, Kaku/0000-0003-1505-6384	National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health [U01AA021989, U01AA020780, U24AA020779, U24AA020778]; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [T32AI052074]; Providence/Boston Center for AIDS Research [P30AI042853]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052074, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020779, U01AA020780, U01AA021989, U24AA020778] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Providence/Boston Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health [U01AA021989, U01AA020780 to J.H.S. and M.S.F., U24AA020779 to D.M.C., U24AA020778 to J.H.S.]-https://www.niaaa.nih.gov/, and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [T32AI052074 to J.A.B.]-https://www.niaid.nih.gov/and by a 2018 supplemental grant from the Providence/Boston Center for AIDS Research [P30AI042853 to J.A.B.]-https://www.brown.edu/academics/medical/about-us/research/centers-institutes-and-programs/aids/. No funders played a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum MK, 1997, J ACQ IMMUN DEF SYND, V16, P272, DOI 10.1097/00042560-199712010-00008; Baum MK, 2000, J NUTR, V130, p1421S, DOI 10.1093/jn/130.5.1421S; BEACH RS, 1992, AIDS, V6, P701, DOI 10.1097/00002030-199207000-00013; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; CAMPS J, 1992, CLIN SCI, V83, P695, DOI 10.1042/cs0830695; Castellares C, 2008, J VIRAL HEPATITIS, V15, P165, DOI 10.1111/j.1365-2893.2007.00903.x; Crosse K, 2004, CLIN GASTROENTEROL H, V2, P463, DOI 10.1016/S1542-3565(04)00162-4; Dashti HM, 1997, NUTRITION, V13, P206; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Fairbairn NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166539; Gnatienko N, 2018, HIV CLIN TRIALS, V19, P101, DOI 10.1080/15284336.2018.1459344; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hastie T. J., 1990, GEN ADDITIVE MODELS, V43; Heimer R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S6-S12; Jones CY, 2006, JAIDS-J ACQ IMM DEF, V43, P475, DOI 10.1097/01.qai.0000243096.27029.fe; Klibansky DA, 2012, J VIRAL HEPATITIS, V19, pE184, DOI 10.1111/j.1365-2893.2011.01493.x; Kojima-Yuasa A, 2003, CHEM-BIOL INTERACT, V146, P89, DOI 10.1016/S0009-2797(03)00087-5; Konerman MA, 2014, HEPATOLOGY, V59, P767, DOI 10.1002/hep.26741; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Martinez SS, 2017, J NUTR, V147, P556, DOI 10.3945/jn.116.243832; Matsumura H, 2012, J CLIN BIOCHEM NUTR, V51, P178, DOI 10.3164/jcbn.12-11; Muga R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046810; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Omran DA, 2017, BIOL TRACE ELEM RES, V179, P1, DOI 10.1007/s12011-017-0938-x; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P357, DOI 10.1016/j.jtemb.2014.09.002; Prystupa A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060582; Rockstroh JK, 2014, CURR OPIN HIV AIDS, V9, P365, DOI 10.1097/COH.0000000000000064; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, P4; Sobell L. C., 1995, ALCOHOL TIMELINE FOL; Sterling RK, 2004, CLIN GASTROENTEROL H, V2, P469, DOI 10.1016/S1542-3565(04)00164-8; Thiele M, 2018, GASTROENTEROLOGY, V154, P1369, DOI 10.1053/j.gastro.2018.01.005; Tsui Judith I, 2016, Hepatol Med Policy, V1, DOI 10.1186/s41124-016-0020-x; United Nations Office of Drugs and Crime, 2017, GLOB OV DRUG DEM SUP; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wedemeyer H, 2015, J VIRAL HEPATITIS, V22, P1, DOI 10.1111/jvh.12371; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218852	10.1371/journal.pone.0218852	http://dx.doi.org/10.1371/journal.pone.0218852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246992	gold, Green Published			2022-12-26	WOS:000484911900044
J	Ingram, LA; Butler, AA; Walsh, LD; Brodie, MA; Lord, SR; Gandevia, SC				Ingram, Lewis A.; Butler, Annie A.; Walsh, Lee D.; Brodie, Matthew A.; Lord, Stephen R.; Gandevia, Simon C.			The upper limb Physiological Profile Assessment: Description, reliability, normative values and criterion validity	PLOS ONE			English	Article							9-HOLE PEG TEST; 2-POINT DISCRIMINATION; SENSORIMOTOR FUNCTION; RISK-FACTORS; FALLS RISK; HAND; AGE; STRENGTH; PEOPLE; TIME	A progressive decline in upper limb function is associated with ageing and disease. In this cross-sectional study we assessed the performance of 367 healthy individuals aged of 20 to 95 years across a battery of upper limb clinical tests, which we have termed the upper limb Physiological Profile Assessment (PPA). The upper limb PPA was designed to quantify the performance of the multiple physiological domains important for adequate function in the upper extremities. Included are tests of muscle strength, unilateral movement and dexterity, position sense, skin sensation, bimanual coordination, arm stability, along with a functional task. We report age and gender normative values for each test. Test-retest reliability ranged from good to excellent in all tests (intra-class correlation coefficients from 0.65 to 0.98) with the exception of position sense (0.31). Ten of the thirteen tests revealed differences in performance between males and females, twelve showed a decline in performance with increasing age, and eight discriminated between older people with and without upper limb functional impairment. Furthermore, most tests showed good external validity with respect to age, an upper limb functional test and self-reported function. This profiling approach provides a reference range for clinical groups with upper limb sensory and motor impairments and may assist in identifying undiagnosed deficits in the general population. Furthermore, the tests are sufficiently reliable to detect motor impairments in people with compromised upper limb function and evaluate the effectiveness of interventions.	[Ingram, Lewis A.; Butler, Annie A.; Brodie, Matthew A.; Lord, Stephen R.; Gandevia, Simon C.] Neurosci Res Australia, Sydney, NSW, Australia; [Ingram, Lewis A.; Butler, Annie A.; Brodie, Matthew A.; Lord, Stephen R.; Gandevia, Simon C.] Univ New South Wales, Sydney, NSW, Australia; [Walsh, Lee D.] Platypus Tech Consultants Pty Ltd, Canberra, ACT, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Lord, SR (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.; Lord, SR (corresponding author), Univ New South Wales, Sydney, NSW, Australia.	s.lord@neura.edu.au	Brodie, Matthew Andrew/HDN-0096-2022; Brodie, Matthew A D/ABG-1640-2020; Walsh, Lee/D-6184-2011; Butler, Annie/O-5645-2014	Brodie, Matthew Andrew/0000-0002-5711-3458; Brodie, Matthew A D/0000-0002-5711-3458; Ingram, Lewis/0000-0003-2741-1574; Lord, Stephen R/0000-0002-7111-8802; Walsh, Lee/0000-0002-1405-1031; Butler, Annie/0000-0002-3678-1297	Motor Impairment Program grant for the National Health and Medical Research Council (NHMRC) [1055084]	Motor Impairment Program grant for the National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Motor Impairment Program grant for the National Health and Medical Research Council (NHMRC), #1055084. The NHMRC also provided indirect support for this study in the form of salaries for AB, MB, SL, and SG. LDW is a paid employee of Platypus Technical Consultants Pty Ltd (Australia). Platypus Technical Consultants Pty Ltd (Australia) also provided indirect support for this study in the form of salary for LDW. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JJ, 1999, ERGONOMICS, V42, P327, DOI 10.1080/001401399185685; Altman D.G., 1991, PRACTICAL STATISTIC; Aoyagi K, 2001, BMC Geriatr, V1, P3, DOI 10.1186/1471-2318-1-3; ASKEW LJ, 1987, CLIN ORTHOP RELAT R, P261; Bear-Lehman J, 2003, TOP GERIATR REHABIL, V19, P127; Beaton DE, 2001, BR J HAND THER, V6, P109, DOI DOI 10.1177/175899830100600401; Bell-Krotoski J., 1995, REHABILITATION HAND; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boswell-Ruys CL, 2009, ARCH PHYS MED REHAB, V90, P1571, DOI 10.1016/j.apmr.2009.02.016; Bowden JL, 2013, AGE, V35, P1077, DOI 10.1007/s11357-012-9429-3; Brebner J. M., 1980, REACTION TIMES, P1; Brodie MAD, 2016, COMPUT METHOD BIOMEC, V19, P1339, DOI 10.1080/10255842.2016.1140747; CARLSON WS, 1979, J OCCUP ENVIRON MED, V21, P260; Chen CL, 2003, ARCH PHYS MED REHAB, V84, P1276, DOI 10.1016/S0003-9993(03)00200-4; Dane S, 2003, INT J NEUROSCI, V113, P923, DOI 10.1080/00207450390220367; Dannenbaum RM, 2002, CLIN REHABIL, V16, P630, DOI 10.1191/0269215502cr532oa; Dean CM, 2012, NEUROREHAB NEURAL RE, V26, P1046, DOI 10.1177/1545968312441711; DEDOMENICO G, 1987, EXP BRAIN RES, V65, P471, DOI 10.1007/BF00236321; DELLON AL, 1987, J HAND SURG-AM, V12A, P693, DOI 10.1016/S0363-5023(87)80049-7; Desrosiers J, 1996, J AM GERIATR SOC, V44, P974, DOI 10.1111/j.1532-5415.1996.tb01871.x; Dunn G., 1989, DESIGN ANAL RELIABIL; Field A., 2013, DISCOVERING STAT USI; Gilbertson L, 1994, BR J OCCUP THER, V57, P483; Godde B, 2018, ACTA PSYCHOL, V190, P135, DOI 10.1016/j.actpsy.2018.08.004; Grice KO, 2003, AM J OCCUP THER, V57, P570; Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9; Hanten W P, 1999, J Hand Ther, V12, P193; Hoang PD, 2014, ARCH PHYS MED REHAB, V95, P480, DOI 10.1016/j.apmr.2013.09.017; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Hunsaker FG, 2002, J BONE JOINT SURG AM, V84A, P208, DOI 10.2106/00004623-200202000-00007; Jevas S, 2001, RES Q EXERCISE SPORT, V72, pA49; Kennedy CA, 2011, DASH OUTCOME MEASURE, V3rd; Kotte Shamala H P, 2018, Shoulder Elbow, V10, P207, DOI 10.1177/1758573217748643; Kwan MMS, 2011, ARCH PHYS MED REHAB, V92, P1080, DOI 10.1016/j.apmr.2011.01.018; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Lord SR, 2016, J PHYSIOL-LONDON, V594, P4513, DOI 10.1113/JP271108; LORD SR, 1994, AGE AGEING, V23, P452, DOI 10.1093/ageing/23.6.452; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Lord SR, 1996, AGE AGEING, V25, P292, DOI 10.1093/ageing/25.4.292; LORD SR, 1991, J GERONTOL, V46, pM69, DOI 10.1093/geronj/46.3.M69; Lovie-Kitchin JE, 2015, OPHTHAL PHYSL OPT, V35, P631, DOI 10.1111/opo.12252; Luchies CW, 2002, J GERONTOL A-BIOL, V57, pM246, DOI 10.1093/gerona/57.4.M246; Lundborg G, 2004, J HAND SURG-BRIT EUR, V29B, P418, DOI 10.1016/j.jhsb.2004.02.008; Maes C, 2017, NEUROSCI BIOBEHAV R, V75, P234, DOI 10.1016/j.neubiorev.2017.01.052; Massy-Westropp Nicola M, 2011, BMC Res Notes, V4, P127, DOI 10.1186/1756-0500-4-127; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; NOBLE CE, 1964, PERCEPT MOTOR SKILL, V19, P935, DOI 10.2466/pms.1964.19.3.935; NOVAK CB, 1993, ANN PLAS SURG, V31, P495, DOI 10.1097/00000637-199312000-00003; Paul SS, 2014, NEUROREHAB NEURAL RE, V28, P282, DOI 10.1177/1545968313508470; Portney, 2019, FDN CLIN RES APPL PR; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rozental TD, 2000, ANN PLAS SURG, V44, P605, DOI 10.1097/00000637-200044060-00005; Sella GE, 2001, EURA MEDICOPHYS, V37, P161; Shumway-Cook A, 2016, MOTOR CONTROL TRANSL, V5th; Smith YA, 2000, PERCEPT MOTOR SKILL, V90, P823, DOI 10.2466/pms.2000.90.3.823; Tiedemann AC, 2007, J GERONTOL A-BIOL, V62, P1259, DOI 10.1093/gerona/62.11.1259; Tremblay F, 2005, EXP BRAIN RES, V164, P155, DOI 10.1007/s00221-005-2238-5; van Nes SI, 2008, J NEUROL NEUROSUR PS, V79, P832, DOI 10.1136/jnnp.2007.139220; VERBAKEN JH, 1986, AM J OPTOM PHYS OPT, V63, P724; Wang KJ, 2017, IEEE J BIOMED HEALTH, V21, P1479, DOI 10.1109/JBHI.2017.2677901; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001; Welford A., 1977, HDB PSYCHOL AGING, P450; Welford A.T., 1980, REACTION TIMES; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	65	13	13	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218553	10.1371/journal.pone.0218553	http://dx.doi.org/10.1371/journal.pone.0218553			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3WH	31247034	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000484911900028
J	Sorjonen, JM; Valtonen, A; Hirvisalo, E; Karhapaa, M; Lehtovaara, VJ; Lindgren, J; Marnila, P; Mooney, P; Maki, M; Siljander-Rasi, H; Tapio, M; Tuiskula-Haavisto, M; Roininen, H				Sorjonen, Jaana M.; Valtonen, Anu; Hirvisalo, Elina; Karhapaa, Maija; Lehtovaara, Vilma J.; Lindgren, Josefina; Marnila, Pertti; Mooney, Patrick; Maki, Maarit; Siljander-Rasi, Hilkka; Tapio, Miika; Tuiskula-Haavisto, Maria; Roininen, Heikki			The plant-based by-product diets for the mass-rearing of Acheta domesticus and Gryllus bimaculatus	PLOS ONE			English	Article							HOUSE CRICKET; ORTHOPTERA; GROWTH; FOOD; GRYLLIDAE; SURVIVAL; VALUES	Edible insect rearing could provide one alternative for protein production by having a smaller environmental impact than traditional livestock farming due to insects' ability to convert organic side streams. Currently, the insect rearing industry utilizes soybeans as a major source of protein in the feeds. Protein-rich by-products of food industry could be used to replace them in insect feeds, but it is not known if they also meet the insects' nutritional requirements. Our study evaluated the growth performance of two widely used edible cricket species, Acheta domesticus and Gryllus bimaculatus (Orthoptera: Gryllidae), on 18 experimental diets. The experimental diets included commercial chicken feeds and cricket diets, where soybean was partly and completely replaced with by-products from food industry: potato protein, barley mash, barley feed, compressed leftover of turnip rape and mix of broad bean and pea on three levels of protein. We found that the high- and medium-protein turnip rape and barley mash diets produced the highest yield and an increase in all performance variables. Overall, the high- and medium-protein diets produced the highest yield, growth and fastest development. Our results showed that by-products of food industry could be utilized as a part of the cricket feeds and thus advance the goals of circular economy.	[Sorjonen, Jaana M.; Valtonen, Anu; Lehtovaara, Vilma J.; Lindgren, Josefina; Mooney, Patrick; Roininen, Heikki] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Hirvisalo, Elina; Karhapaa, Maija; Marnila, Pertti; Maki, Maarit; Siljander-Rasi, Hilkka; Tapio, Miika; Tuiskula-Haavisto, Maria] Nat Resources Inst Finland, Jokioinen, Finland	University of Eastern Finland; Natural Resources Institute Finland (Luke)	Sorjonen, JM (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland.	jaanasor@uef.fi	Tapio, Miika/AAA-7043-2020	Marnila, Pertti/0000-0002-4142-9773; Sorjonen, Jaana/0000-0002-6868-9049	Ministry of Agriculture and Forestry of Finland [50629]; OLVI foundation; Finnish Food Research Foundation	Ministry of Agriculture and Forestry of Finland; OLVI foundation; Finnish Food Research Foundation	This work was financially supported by the Ministry of Agriculture and Forestry of Finland (https://mmm.fi/en/frontpage, project no 50629 to HR) and OLVI foundation's (https://www.olvisaatio.fi/) and Finnish Food Research Foundation's (https://www.etl.fi/en/etl/research-foundation.html) grants for JMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABISGOLD JD, 1987, J EXP BIOL, V129, P329; Behmer ST, 1997, J INSECT PHYSL, V45, P339; Brosowski A, 2016, BIOMASS BIOENERG, V95, P257, DOI 10.1016/j.biombioe.2016.10.017; Chapman RF, 2013, J CHEM INF MODEL, V5th; Cickova H, 2015, WASTE MANAGE, V35, P68, DOI 10.1016/j.wasman.2014.09.026; CLIFFORD CW, 1990, J APPL ENTOMOL, V109, P1, DOI 10.1111/j.1439-0418.1990.tb00012.x; Cohen AC, 2004, INSECT DIETS SCI TEC; Collavo Alberto, 2005, P519; da Silva VP, 2010, J ENVIRON MANAGE, V91, P1831, DOI 10.1016/j.jenvman.2010.04.001; Dobermann D, 2019, J INSECTS FOOD FEED, V5, P117, DOI 10.3920/JIFF2018.0024; FAO, 2017, FUT FOOD AGR TRENDS; Finke M.D., 2013, MASS PRODUCTION BENE; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Halloran A, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0392-8; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Joern A, 1997, OECOLOGIA, V112, P201, DOI 10.1007/s004420050301; Lundy ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118785; MASAKI S, 1987, EVOL BIOL, V21, P349; MCFARLANE JE, 1962, CAN J ZOOLOG, V40, P559, DOI 10.1139/z62-048; Michiels K, 2010, ARCH INSECT BIOCHEM, V73, P193, DOI 10.1002/arch.20351; Miech P, 2016, J INSECTS FOOD FEED, V2, P285, DOI 10.3920/JIFF2016.0028; NAKAGAKI BJ, 1991, J ECON ENTOMOL, V84, P891, DOI 10.1093/jee/84.3.891; Nellemann C, 2009, ENV FOOD CRISIS THE; Oonincx DGAB, 2011, ZOO BIOL, V30, P9, DOI 10.1002/zoo.20308; Oonincx DGAB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144601; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; PATTON RL, 1967, ANN ENTOMOL SOC AM, V60, P1238, DOI 10.1093/aesa/60.6.1238; Telang A, 2002, J INSECT PHYSIOL, V48, P1021, DOI 10.1016/S0022-1910(02)00190-7; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; United Nations, 2014, WAT FOOD SEC; van Huis A., 2017, INSECTS FOOD FEED PR; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1	32	18	18	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218830	10.1371/journal.pone.0218830	http://dx.doi.org/10.1371/journal.pone.0218830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246993	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900042
J	Chen, JH; Chen, Y; Yang, S; Zhong, XD; Han, X				Chen, Jianhong; Chen, Yi; Yang, Shan; Zhong, Xudong; Han, Xu			A prediction model on rockburst intensity grade based on variable weight and matter-element extension	PLOS ONE			English	Article							CLOUD MODEL	Rockburst is a common dynamic disaster in deep underground engineering. To accurately predict rockburst intensity grade, this study proposes a novel rockburst prediction model based on variable weight and matter-element extension theory. In the proposed model, variable weight theory is used to optimize the weights of prediction indexes. Matter-element extension theory and grade variable method are used to calculate the grade variable interval corresponding to the classification standard of rockburst intensity grade. The rockburst intensity grade of Engineering Rock Mass is predicted by rock burst intensity level variable and the interval. Finally, the model is tested by predicting the rockburst intensity grades of worldwide several projects. The prediction results are compared with the actual rockburst intensity grades and the prediction results of other models. The results indicate that, after using variable weight theory and grade variable method, the correct rate of prediction results of matter-element extension model is improved, and the safety of the prediction results is also enhanced. This study provides a new way to predict rock burst in underground engineering.	[Chen, Jianhong; Chen, Yi; Yang, Shan; Zhong, Xudong; Han, Xu] Cent S Univ, Sch Resource & Safety Engn, Changsha, Hunan, Peoples R China	Central South University	Yang, S (corresponding author), Cent S Univ, Sch Resource & Safety Engn, Changsha, Hunan, Peoples R China.	yangshan@csu.edu.cn			National Natural Science Foundation of China [51404305, 51374242]; graduate student free Exploration Project of Central South University [2018zzts746]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); graduate student free Exploration Project of Central South University	This study was supported by the National Natural Science Foundation of China (Grant nos. 51404305 and 51374242) to SY and JC and the graduate student free Exploration Project of Central South University (Grant nos. 2018zzts746) to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoko AC, 2013, INT J ROCK MECH MIN, V61, P86, DOI 10.1016/j.ijrmms.2013.02.010; Al Heib M, 2013, ROCK MECHANICS FOR RESOURCES, ENERGY AND ENVIRONMENT, P551; Cai MF, 2016, J ROCK MECH GEOTECH, V8, P204, DOI 10.1016/j.jrmge.2015.11.002; [蔡美峰 Cai Meifeng], 2013, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V32, P1973; Cai W., 1998, SYSTEMS ENG THEORY P, P76, DOI [10.3321/j.issn:1000-6788.1998.01.014, DOI 10.3321/J.ISSN:1000-6788.1998.01.014]; [蔡文 Cai Wen], 2013, [科学通报, Chinese Science Bulletin], V58, P1190; Chen H.J., 2008, J U S CHINA, V22, P10; Chen ZH, 1997, INT J ROCK MECH MIN, V34, P991, DOI 10.1016/S0148-9062(97)00011-9; Diederichs MS, 2018, J S AFR I MIN METALL, V118, P193, DOI 10.17159/2411-9717/2018/v118n3a1; Faradonbeh RS, 2019, ENG COMPUT-GERMANY, V35, P659, DOI 10.1007/s00366-018-0624-4; Feng XT, 2017, ENGINEERING-PRC, V3, P538, DOI 10.1016/J.ENG.2017.04.013; [高玮 Gao Wei], 2010, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V32, P874; [宫凤强 GONG Fengqiang], 2007, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V26, P1012; Guo L, 2005, IND SAFETY ENV PROTE, V31, P32; He MC, 2010, INT J ROCK MECH MIN, V47, P286, DOI 10.1016/j.ijrmms.2009.09.003; He MC, 2015, ROCK SOIL MECH, V36, P1, DOI 10.16285/j.rsm.2015.01.001; Hoek E, 1980, UNDERGROUND EXCAVATI, DOI [10.1016/0013-7952(83)90009-1, DOI 10.1016/0013-7952(83)90009-1]; Hu B.Q., 2003, J WUHAN U, V36, P79; [贾义鹏 Jia Yipeng], 2014, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V36, P1079; Jia Z.Q., 2016, CHINESE J GEOTECH EN, V38, P110; Jiang QA, 2010, B ENG GEOL ENVIRON, V69, P381, DOI 10.1007/s10064-010-0275-1; Kabwe E, 2015, OPEN J SAF SCI TECHN, V5, P104, DOI [10.4236/ojsst.2015.54013, DOI 10.4236/OJSST.2015.54013]; KUKSENKO VS, 1987, SOV MIN SCI+, V23, P6, DOI 10.1007/BF02534035; Labuz JF, 2012, ROCK MECH ROCK ENG, V45, P975, DOI 10.1007/s00603-012-0281-7; [李德清 LI De-qing], 2009, [系统工程理论与实践, Systems Engineering-Theory & Practice], V29, P127; Li Deqing, 2002, Journal of Beijing Normal University (Natural Science), V38, P455; Li H.X., 1995, FUZZY SYST MATH, V9, P1; Li N, 2018, NAT HAZARDS, V90, P197, DOI 10.1007/s11069-017-3044-7; Liu X-H., 2012, J MINING AMP SAFETY, V29, P78; Liu Z., 2008, CHIN J ROCK MECH ENG, V27, P3095; [马天辉 Ma Tianhui], 2016, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V35, P470; Mansurov V A., 1993, LAB EXPT THEIR ROLE, P745, DOI [10.1016/B978-0-08-042066-0.50038-0, DOI 10.1016/B978-0-08-042066-0.50038-0]; Mazaira A, 2015, CAN GEOTECH J, V52, P1426, DOI 10.1139/cgj-2014-0359; [裴启涛 Pei Qitao], 2013, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V32, P2088; Sharan SK, 2007, COMPUT STRUCT, V85, P1304, DOI 10.1016/j.compstruc.2006.08.084; [史智萍 Shi Zhiping], 2015, [电网技术, Power System Technology], V39, P3233; Tang XW, 2003, COMPUT MATH APPL, V45, P723, DOI 10.1016/S0898-1221(03)00032-4; [王学滨 WANG Xuebin], 2011, [四川大学学报. 工程科学版, Journal of Sichuan University. Engineering Science Edition], V43, P7; Wang YC, 2015, ROCK SOIL MECH, V36, P1189, DOI 10.16285/j.rsm.2015.04.037; Wang YC, 2010, ROCK SOIL MECH, V31, P529; [谢和平 xie Heping], 2005, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V24, P3003; Xiong X B, 2008, S 1O NAT ROCK MECH E, P403; [徐飞 Xu Fei], 2010, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V32, P718; [徐会军 Xu Huijun], 2018, [采矿与安全工程学报, Journal of Mining & Safety Engineering], V35, P112; Yang C, 2012, J GUANGDONG U TECHNO, V29, P7; Zhang B, 2017, ROCK SOIL MECH, V38, P257, DOI 10.16285/j.rsm.2017.S2.036; Zhang Jingjian, 2008, CHINESE J ROCK MECH, V27, P2035, DOI DOI 10.3321/J.ISSN:1000-6915.2008.10.010; Zhou J., 2010, J CHINA COAL SOC, V35, P22; Zhou J, 2016, J COMPUT CIVIL ENG, V30, DOI 10.1061/(ASCE)CP.1943-5487.0000553; Zhou J, 2016, T NONFERR METAL SOC, V26, P1938, DOI 10.1016/S1003-6326(16)64312-1; Zhou Jian, 2012, Journal of Coal Science and Engineering (China), V16, P144, DOI 10.1007/s12404-010-0207-5; Zhou J, 2012, SAFETY SCI, V50, P629, DOI 10.1016/j.ssci.2011.08.065; Zhou Xuan-chi, 2012, Journal of Shanghai Jiaotong University, V46, P1956; Zhu YZ., 1999, SYST ENG THEORY PRAC, V19, P116	54	5	5	19	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218525	10.1371/journal.pone.0218525	http://dx.doi.org/10.1371/journal.pone.0218525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242202	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600034
J	Mathys, DA; Mollenkopf, DF; Feicht, SM; Adams, RJ; Albers, AL; Stuever, DM; Grooters, SV; Ballash, GA; Daniels, JB; Wittum, TE				Mathys, Dimitria A.; Mollenkopf, Dixie F.; Feicht, Sydnee M.; Adams, Rachael J.; Albers, Amy L.; Stuever, David M.; Grooters, Susan V.; Ballash, Gregory A.; Daniels, Joshua B.; Wittum, Thomas E.			Carbapenemase-producing Enterobacteriaceae and Aeromonas spp. present in wastewater treatment plant effluent and nearby surface waters in the US	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; EMERGENCE; GENES; EPIDEMIOLOGY; ENVIRONMENT; INFECTION; IMPACT; KPC-2	Carbapenemase-producing bacteria (CPB) are rare, multidrug resistant organisms most commonly associated with hospitalized patients. Metropolitan wastewater treatment plants (WWTP) treat wastewater from large geographic areas which include hospitals and may serve as epidemiologic reservoirs for the maintenance or expansion of CPB that originate from hospitals and are ultimately discharged in treated effluent. However, little is known about the potential impact of these WWTP CPB on the local surface water and their risk to the public health. In addition, CPB that are present in surface water may ultimately disseminate to intensively-managed animal agriculture facilities where there is potential for amplification by extended-spectrum cephalosporins. To better understand the role of WWTPs in the dissemination of CPB in surface waters, we obtained samples of treated effluent, and both upstream and downstream nearby surface water from 50 WWTPs throughout the US. A total of 30 CPB with clinically-relevant genotypes were recovered from 15 WWTPs (30%) of which 13 (50%) serviced large metropolitan areas and 2 (8.3%) represented small rural populations (P < 0.05). Recovery of CPB was lowest among WWTPs that utilized ultraviolet radiation for primary disinfection (12%), and higher (P = 0.11) for WWTPs that used chlorination (42%) or that did not utilize disinfection (50%). We did not detect a difference in CPB recovery by sampling site, although fewer CPB were detected in upstream (8%) compared to effluent (20%) and downstream (18%) samples. Our results indicate that WWTP effluent and nearby surface waters in the US are routinely contaminated with CPB with clinically important genotypes including those producing Klebsiella pneumoniae carbapenemase (KPC) and New Delhi metallo-beta-lactamase (NDM). This is a concern for both public health and animal agriculture because introduction of CPB into intensively managed livestock populations could lead to their amplification and foodborne dissemination.	[Mathys, Dimitria A.; Mollenkopf, Dixie F.; Feicht, Sydnee M.; Adams, Rachael J.; Albers, Amy L.; Stuever, David M.; Grooters, Susan V.; Ballash, Gregory A.; Wittum, Thomas E.] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Daniels, Joshua B.] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Daniels, Joshua B.] Colorado State Univ, Ft Collins, CO 80523 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Colorado State University	Wittum, TE (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA.	wittum.1@osu.edu		Wittum, Thomas/0000-0002-9216-1308; Adams, Rachael/0000-0003-1511-3975	USDA NIFA award [2014-67005-21709]	USDA NIFA award	Funding for this project was provided by the USDA NIFA award no. 2014-67005-21709 (TEW, JBD).	ASANO T, 1988, J WATER POLLUT CON F, V60, P854; Bradford PA, 2004, CLIN INFECT DIS, V39, P55, DOI 10.1086/421495; Carattoli A., 2014, ANTIMICROBIAL AGENTS; Chagas TPG, 2011, J HOSP INFECT, V77, P281, DOI 10.1016/j.jhin.2010.10.008; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Hawken SE, 2018, CLIN INFECT DIS, V66, P460, DOI 10.1093/cid/cix934; Jia B., 2016, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1004; Kanamori H, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01516-16; Kelly AM, 2017, INT J ANTIMICROB AG, V50, P127, DOI 10.1016/j.ijantimicag.2017.03.012; Koh TH, 2015, INFECT CONT HOSP EP, V36, P619, DOI 10.1017/ice.2015.44; Larsen MV, 2014, J CLIN MICROBIOL, V52, P1529, DOI 10.1128/JCM.02981-13; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; de Araujo CFM, 2016, ANTIMICROB AGENTS CH, V60, P4380, DOI 10.1128/AAC.02753-15; Mariappan Shanthi, 2017, Int J Appl Basic Med Res, V7, P32, DOI 10.4103/2229-516X.198520; Mathers AJ, 2011, MBIO, V2, DOI 10.1128/mBio.00204-11; Moland ES, 2003, J ANTIMICROB CHEMOTH, V51, P711, DOI 10.1093/jac/dkg124; Mollenkopf DF, 2018, FOODBORNE PATHOG DIS, V15; Mollenkopf DF, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01298-16; Mollenkopf DF, 2014, FOODBORNE PATHOG DIS, V11, P920, DOI 10.1089/fpd.2014.1808; Mollenkopf DF, 2011, FOODBORNE PATHOG DIS, V8, P333, DOI 10.1089/fpd.2010.0701; Montezzi LF, 2015, INT J ANTIMICROB AG, V45, P174, DOI 10.1016/j.ijantimicag.2014.10.016; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P411, DOI 10.1111/j.1469-0691.2012.03795.x; Okamoto K, 2017, INFECT CONT HOSP EP, V38, P670, DOI 10.1017/ice.2017.62; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Peirano G, 2011, EMERG INFECT DIS, V17, P242, DOI 10.3201/eid1702.101313; Picao RC, 2013, DIAGN MICR INFEC DIS, V76, P80, DOI 10.1016/j.diagmicrobio.2013.02.001; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1662, DOI 10.1128/AAC.05850-11; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Senda K, 1996, J CLIN MICROBIOL, V34, P2909, DOI 10.1128/JCM.34.12.2909-2913.1996; Subirats J, 2017, ENVIRON SCI POLLUT R, V24, P6710, DOI 10.1007/s11356-017-8426-6; Swain B, 2014, J CLIN DIAGN RES, V8, pDD1, DOI 10.7860/JCDR/2014/9230.4703; Thaller MC, 2011, ANTIMICROB AGENTS CH, V55, P118, DOI 10.1128/AAC.01062-10; Tijet Nathalie, 2013, Antimicrob Agents Chemother, V57, P4578, DOI 10.1128/AAC.00878-13; van Duin D, 2016, VIRULENCE, V11, P1, DOI DOI 10.1080/21505594.2016.1222343; Vikram A, 2018, FOODBORNE PATHOG DIS, V15, P336, DOI [10.1089/fpd.2010.0701, DOI 10.1089/FPD.2010.0701]; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126784; Weingarten RA, 2018, MBIO, V9, DOI 10.1128/mBio.02011-17; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Wittum TE, 2012, APPL ENVIRON MICROB, V78, P7819, DOI 10.1128/AEM.01967-12; Wong MHY, 2015, J GLOB ANTIMICROB RE, V3, P109, DOI 10.1016/j.jgar.2015.03.006; Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	45	30	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218650	10.1371/journal.pone.0218650	http://dx.doi.org/10.1371/journal.pone.0218650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242271	gold, Green Submitted, Green Published			2022-12-26	WOS:000482883600042
J	Novikova, OA; Nazarkina, ZK; Cherepanova, AV; Laktionov, PP; Chelobanov, BP; Murashov, IS; Deev, RV; Pokushalov, EA; Karpenko, AA; Laktionov, PP				Novikova, Olga A.; Nazarkina, Zhanna K.; Cherepanova, Anna V.; Laktionov, Petr P.; Chelobanov, Boris P.; Murashov, Ivan S.; Deev, Roman V.; Pokushalov, Evgeny A.; Karpenko, Andrey A.; Laktionov, Pavel P.			Isolation, culturing and gene expression profiling of inner mass cells from stable and vulnerable carotid atherosclerotic plaques	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IDENTIFICATION; PROGRESSION; TRANSDIFFERENTIATION; INFLAMMATION; FIBRONECTIN; APOPTOSIS; BIOLOGY; PLASMA	The connective tissue components that form the atherosclerotic plaque body are produced by the plaque inner mass cells (PIMC), located inside the plaque. We report an approach to isolate and culture cells from the connective tissue of stable and vulnerable human atherosclerotic plaques based on elimination of non-connective tissue cells such as blood and non-plaque intima cells with a lysis buffer. The resulting plaque cells were characterized by growth capacity, morphology, transcriptome profiling and specific protein expression. Plaque cells slowly proliferated for up to three passages unaffected by the use of proliferation stimulants or changes of culture media composition. Stable plaques yielded more cells than vulnerable ones. Plaque cell cultures also contained several morphological cellular types. RNA-seq profiles of plaque cells were different from any of the cell types known to be involved in atherogenesis. The expression of the following proteins was observed in cultured plaque cells: smooth muscle cells marker alpha-SMA, macrophage marker CD14, extracellular matrix proteins aggrecan, fibronectin, neovascularisation markers VEGF-A, CD105, cellular adhesion receptor CD31 and progenitor/dedifferentiation receptor CD34. Differential expression of several notable transcripts in cells from stable and vulnerable plaques suggests the value of plaque cell culture studies for the search of plaque vulnerability markers.	[Novikova, Olga A.; Cherepanova, Anna V.; Murashov, Ivan S.; Pokushalov, Evgeny A.; Karpenko, Andrey A.; Laktionov, Pavel P.] Minist Hlth Russian Federat, E Meshalkin Natl Med Res Ctr, Novosibirsk, Russia; [Nazarkina, Zhanna K.; Cherepanova, Anna V.; Chelobanov, Boris P.; Pokushalov, Evgeny A.; Laktionov, Pavel P.] SB RAS Inst Chem Biol & Fundamental Med, Lab Mol Med, Novosibirsk, Russia; [Laktionov, Petr P.] SB RAS Inst Mol & Cellular Biol, Lab Genom, Novosibirsk, Russia; [Laktionov, Petr P.; Chelobanov, Boris P.] Novosibirsk State Univ, Novosibirsk, Russia; [Deev, Roman V.] Ryazan State Med Univ, Ryazan, Russia	Meshalkin National Medical Research Center; Ministry of Health of the Russian Federation; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Ryazan State Medical University	Cherepanova, AV (corresponding author), Minist Hlth Russian Federat, E Meshalkin Natl Med Res Ctr, Novosibirsk, Russia.; Cherepanova, AV (corresponding author), SB RAS Inst Chem Biol & Fundamental Med, Lab Mol Med, Novosibirsk, Russia.	a_cher@niboch.nsc.ru	Chelobanov, Boris P/C-1459-2017; Карпенко, Андрей/GRS-3228-2022; Deev, Roman/L-1658-2015; Abubakirova, Olga/AAH-1738-2020; Murashov, Ivan S/N-5706-2017; Karpenko, Andrei/AAH-1725-2020; Pokushalov, Evgeny/ABA-6205-2020; Pokushalov, Evgeny A/L-7993-2014; Nazarkina, Zhanna/AAE-1583-2019; Laktionov, Petr/N-7957-2015	Chelobanov, Boris P/0000-0002-2958-2580; Карпенко, Андрей/0000-0002-8064-1857; Deev, Roman/0000-0001-8389-3841; Murashov, Ivan S/0000-0002-3712-1258; Pokushalov, Evgeny A/0000-0002-2560-5167; Laktionov, Petr/0000-0003-2174-6496	Russian Science Foundation [18-15-00080]; Russian State funded budget project of ICBFM SB RAS [AAAA-A17-117020210026-2]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian State funded budget project of ICBFM SB RAS	This work was supported by the Russian Science Foundation (http://rscf.ru/en/) grant number 18-15-00080 to PPL and partially by Russian State funded budget project of ICBFM SB RAS # AAAA-A17-117020210026-2 to EAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiero M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0368-7; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Alexopoulos N, 2009, NAT REV CARDIOL, V6, P681, DOI 10.1038/nrcardio.2009.165; Atsumi T, 2014, CANCER RES, V74, P8, DOI 10.1158/0008-5472.CAN-13-2322; Ayari H, 2012, ADV MED SCI-POLAND, V57, P334, DOI 10.2478/v10039-012-0056-0; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; BENNETT MR, 1995, J CLIN INVEST, V95, P2266, DOI 10.1172/JCI117917; BENNETT S, 1994, J LEUKOCYTE BIOL, V56, P236; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bobryshev YV, 2005, J PATHOL, V205, P641, DOI 10.1002/path.1743; Bonanno E, 2000, CYTOMETRY, V39, P158, DOI 10.1002/(SICI)1097-0320(20000201)39:2<158::AID-CYTO9>3.0.CO;2-8; Bot I, 2016, ATHEROSCLEROSIS, V251, P536, DOI 10.1016/j.atherosclerosis.2016.06.053; Camare C, 2017, REDOX BIOL, V12, P18, DOI 10.1016/j.redox.2017.01.007; Chistiakov DA, 2016, EXP MOL PATHOL, V100, P409, DOI 10.1016/j.yexmp.2016.03.012; Dhume AS, 2003, J VASC SURG, V38, P155, DOI 10.1016/S0741-5214(02)75463-3; Ebert LM, 2016, ANGIOGENESIS, V19, P463, DOI 10.1007/s10456-016-9520-y; Farrokhi E, 2015, AM J MED SCI, V349, P240, DOI 10.1097/MAJ.0000000000000381; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Fornasa G, 2012, CARDIOVASC RES, V94, P30, DOI 10.1093/cvr/cvs076; Gargiulo S, 2015, AGING CELL, V14, P569, DOI 10.1111/acel.12322; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Heo KS, 2014, MOL CELLS, V37, P435, DOI [10.14348/molcells.2014.0078, 10.14348/molcells.2014.0108]; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kigawa Y, 2017, J ATHEROSCLER THROMB, V24, P1, DOI 10.5551/jat.33431; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koenen RR, 2011, EMBO MOL MED, V3, P713, DOI 10.1002/emmm.201100183; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Lau TT, 2015, TISSUE ENG PART C-ME, V21, P105, DOI [10.1089/ten.tec.2014.0159, 10.1089/ten.TEC.2014.0159]; Lavrentieva A, 2013, ADV BIOCHEM ENG BIOT, V129, P73, DOI 10.1007/10_2012_133; Lemaitre V, 2001, J CLIN INVEST, V107, P1227, DOI 10.1172/JCI9626; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovett JK, 2004, CIRCULATION, V110, P2190, DOI 10.1161/01.CIR.0000144307.82502.32; Michel JB, 2011, EUR HEART J, V32, P1977, DOI 10.1093/eurheartj/ehr054; Moore KJ, 2012, EMBO MOL MED, V4, P561, DOI 10.1002/emmm.201200238; Nachtigal P, 2012, ATHEROSCLEROSIS, V224, P4, DOI 10.1016/j.atherosclerosis.2012.03.001; Ohta R, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Pankajakshan D, 2011, EXP MOL PATHOL, V90, P280, DOI 10.1016/j.yexmp.2011.02.005; Patino WD, 2006, CIRC RES, V98, P1282, DOI 10.1161/01.RES.0000222284.48288.28; Pons J, 2003, CAN J PHYSIOL PHARM, V81, P177, DOI 10.1139/Y02-166; Proudfoot D, 2012, METHODS MOL BIOL, V806, P251, DOI 10.1007/978-1-61779-367-7_17; Qiao JH, 2015, EXP MOL PATHOL, V99, P654, DOI 10.1016/j.yexmp.2015.11.010; Ramirez RN, 2017, CELL SYST, V4, P416, DOI 10.1016/j.cels.2017.03.005; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Rosas E, 2013, CURR PHARM DESIGN, V19, P5897; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; van Gils MJ, 2012, AM J NEURORADIOL, V33, P1267, DOI 10.3174/ajnr.A2970; Virmani R, 2004, HDB VULNERABLE PLAQU, P33; Welch JR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081226, 10.1371/journal.pone.0083443, 10.1371/journal.pone.0059853]	57	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218892	10.1371/journal.pone.0218892	http://dx.doi.org/10.1371/journal.pone.0218892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242269	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600062
J	Wang, HB; Lu, J; Dolezal, J; Kulkarni, S; Zhang, WQ; Chen, A; Gorka, J; Mandel, JA; Prochownik, EV				Wang, Huabo; Lu, Jie; Dolezal, James; Kulkarni, Sucheta; Zhang, Weiqi; Chen, Angel; Gorka, Joanna; Mandel, Jordan A.; Prochownik, Edward V.			Inhibition of hepatocellular carcinoma by metabolic normalization	PLOS ONE			English	Article							FATTY-ACID; PYRUVATE-DEHYDROGENASE; OXIDATIVE STRESS; SERINE HYDROXYMETHYLTRANSFERASE; TRANSCRIPTIONAL NETWORK; LACTATE-DEHYDROGENASE; GENE-EXPRESSION; CANCER; MYC; GLUCOSE	In two different mouse liver cancer models, we recently showed that a switch from oxidative phosphorylation (Oxphos) to glycolysis (the Warburg effect) is invariably accompanied by a marked decline in fatty acid oxidation (FAO) and a reciprocal increase in the activity of pyruvate dehydrogenase (PDH), which links glycolysis to the TCA cycle. We now show that short-term implementation of either medium-chain (MC) or long-chain (LC) high fat diets (HFDs) nearly doubled the survival of mice with c-Myc oncoprotein-driven hepatocellular carcinoma (HCC). Mechanistically, HFDs forced tumors to become more reliant on fatty acids as an energy source, thus normalizing both FAO and PDH activities. More generally, both MC-and LC-HFDs partially or completely normalized the expression of 682 tumor-dys-regulated transcripts, a substantial fraction of which are involved in cell cycle control, proliferation and metabolism. That these same transcripts were responsive to HFDs in livers strongly suggested that the changes were the cause of tumor inhibition rather than its consequence. In seven different human cancer cohorts, patients with tumors containing high ratios of FAO-related: glycolysis-related transcripts had prolonged survival relative to those with low ratios. Furthermore, in 13 human cancer types, the expression patterns of transcripts encoding enzymes participating in FAO and/or cholesterol biosynthesis also correlated with significantly prolonged survival. Collectively, our results support the idea that the survival benefits of HFDs are due to a reversal of the Warburg effect and other tumor-associated metabolic and cell cycle abnormalities. They also suggest that short-term dietary manipulation, either alone or in combination with more traditional chemotherapeutic regimens, might be employed as a relatively non-toxic and cost-effective means of enhancing survival in certain cancer types.	[Wang, Huabo; Lu, Jie; Dolezal, James; Kulkarni, Sucheta; Zhang, Weiqi; Chen, Angel; Gorka, Joanna; Mandel, Jordan A.; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA 15219 USA; [Zhang, Weiqi] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Prochownik, Edward V.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Pittsburgh, PA 15219 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Liver Res Ctr, Pittsburgh, PA 15219 USA; [Dolezal, James] Univ Chicago, Pritzker Sch Med, Dept Internal Med, Chicago, IL 60637 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago	Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA 15219 USA.; Prochownik, EV (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA.; Prochownik, EV (corresponding author), Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Pittsburgh, PA 15219 USA.; Prochownik, EV (corresponding author), Univ Pittsburgh, Med Ctr, Liver Res Ctr, Pittsburgh, PA 15219 USA.	procev@chp.edu		WANG, HUABO/0000-0003-2551-3243; Dolezal, James/0000-0002-6788-7203; Prochownik, Edward/0000-0001-9666-8205; Gorka, Joanna/0000-0001-9871-7664	NIH National Cancer Institute [R01CA174713]; NATIONAL CANCER INSTITUTE [R01CA174713] Funding Source: NIH RePORTER	NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by NIH National Cancer Institute Grant R01CA174713 To E.V.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Al Hasawi N, 2014, CRIT REV ONCOL HEMAT, V92, P312, DOI 10.1016/j.critrevonc.2014.05.007; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Aminzadeh-Gohari S, 2017, ONCOTARGET, V8, P64728, DOI 10.18632/oncotarget.20041; Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1; BATENBURG JJ, 1976, J BIOL CHEM, V251, P1364; BATENBURG JJ, 1975, BIOCHEM BIOPH RES CO, V66, P533, DOI 10.1016/0006-291X(75)90543-4; Bayin NS, 2017, ONCOTARGET, V8, P64932, DOI 10.18632/oncotarget.18117; Billin AN, 2006, CURR TOP MICROBIOL, V302, P255; Bonnefont JP, 1999, MOL GENET METAB, V68, P424, DOI 10.1006/mgme.1999.2938; Bryson JM, 1996, INT J OBESITY, V20, P738; Camarero N, 2006, MOL CANCER RES, V4, P645, DOI 10.1158/1541-7786.MCR-05-0267; Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024; Chen SW, 2017, ONCOTARGET, V8, P22460, DOI 10.18632/oncotarget.13006; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Dejure FR, 2017, EMBO J, V36, P3409, DOI 10.15252/embj.201796438; Deshmukh A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0555-x; Di Stasi D, 2005, INT J CANCER, V115, P224, DOI 10.1002/ijc.20885; Diolaiti D, 2015, BBA-GENE REGUL MECH, V1849, P484, DOI 10.1016/j.bbagrm.2014.05.016; Dolezal JM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4178-z; Dolezal JM, 2017, J BIOL CHEM, V292, P10068, DOI 10.1074/jbc.M117.782052; Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856; Edmunds LR, 2014, J BIOL CHEM, V289, P25382, DOI 10.1074/jbc.M114.580662; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fu TF, 2001, ARCH BIOCHEM BIOPHYS, V393, P42, DOI 10.1006/abbi.2001.2471; Gagne LM, 2017, TRENDS CELL BIOL, V27, P738, DOI 10.1016/j.tcb.2017.06.002; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Goetzman ES, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00129; Grande S, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/3292704; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Jackson LE, 2017, CANCER RES, V77, P5795, DOI 10.1158/0008-5472.CAN-17-1325; Jenkins CM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203661; JONES PJH, 1994, ARTERIOSCLER THROMB, V14, P542, DOI 10.1161/01.ATV.14.4.542; Kulkarni S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182705; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Parekh N, 2012, ANNU REV NUTR, V32, P311, DOI 10.1146/annurev-nutr-071811-150713; Park H, 2012, MOL CARCINOGEN, V51, P869, DOI 10.1002/mc.20856; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Patra KC, 2013, ONCOTARGET, V4, P1862, DOI 10.18632/oncotarget.1563; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pischon T, 2016, RECENT RESULTS CANC, V208, P1, DOI 10.1007/978-3-319-42542-9_1; Poff A, 2019, SEMIN CANCER BIOL, V56, P135, DOI 10.1016/j.semcancer.2017.12.011; Poungvarin N, 2015, ENDOCRINOLOGY, V156, P1982, DOI 10.1210/en.2014-1666; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shen K, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040900, 10.1371/journal.pone.0049529]; Su SG, 2017, INT J BIOCHEM CELL B, V91, P53, DOI 10.1016/j.biocel.2017.08.016; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218; Wang Huabo, 2015, J Biol Methods, V2; Wang HB, 2015, ONCOTARGET, V6, P15857, DOI 10.18632/oncotarget.4327; Warner SL, 2014, FUTURE MED CHEM, V6, P1167, DOI [10.4155/FMC.14.70, 10.4155/fmc.14.70]; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wolpaw AJ, 2018, TRENDS CELL BIOL, V28, P201, DOI 10.1016/j.tcb.2017.11.006; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Zhang P, 2010, MOL ENDOCRINOL, V24, P1274, DOI 10.1210/me.2009-0437	70	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218186	10.1371/journal.pone.0218186	http://dx.doi.org/10.1371/journal.pone.0218186			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242205	Green Submitted, Green Published, gold			2022-12-26	WOS:000482883600023
J	Sheth, H; McNally, D; Santibanez-Koref, M; Burn, J				Sheth, Harsh; McNally, Daniel; Santibanez-Koref, Mauro; Burn, John			Association of stroke and bleed events in non-valvular atrial fibrillation patients with direct oral anticoagulant prescriptions in NHS England between 2013 and 2016	PLOS ONE			English	Article							WARFARIN; COMPLICATIONS; METAANALYSIS; RIVAROXABAN; PREDICTION; DABIGATRAN; CHADS(2); OUTCOMES	Prescription of direct oral anticoagulants (DOAC) compared to warfarin for treating atrial fibrillation patients have increased substantially since their introduction in the England's National Health Service. Assessment of the risk of strokes and bleeds in relation to the large-scale uptake in DOACs compared to warfarin at the clinical commissioning group (CCG) level needs to be carried out. Publicly available-aggregated, CCG level, multi-source health and prescription records data were interrogated to investigate the association between prescription rate of DOACs and stroke/bleed events during the period of 2013 to 2016. Variability of prescription rates and patient numbers across 208 CCGs were used to infer the effect of DOACs on stroke and bleed risk. Relative risk (RR) and 95% credible intervals (CI) were estimated using Markov chain Monte Carlo approach in JAGS. During the study period, the proportion of DOAC prescriptions increased at an average rate of 122% per annum. DOAC prescription was association with a 50% reduction in ischaemic (RR = 0.48, 95% CI = 0.39, 0.57) and haemorrhagic stroke (RR = 0.50, 95% CI = 0.26-0.77). In contrast, DOAC prescription reached significant association with reduction in gastrointestinal bleeds (RR = 0.86, 95% CI = 0.73-0.98) but not clinically relevant bleeds (RR = 0.95, 95% CI = 0.85-1.05). Sex stratified data showed significant association between DOAC prescription and reduction in haemorrhagic stroke risk (RR = 0.40, 95% CI = 0.28-0.52) and gastrointestinal bleeds (RR = 0.76, 95% CI = 0.63-0.93) in males only. Age stratified data suggested significant association with reduction in risk of both ischaemic and haemorrhagic strokes in patients aged 70 years and above, and reduction in risk of clinically relevant and gastrointestinal bleeds in patients aged 70-79 years only. Publicly available health and prescription data for the English population indicates reduction in stroke and bleed risk in specific age and sex sub-groups with the uptake of DOACs compared to warfarin between 2013 and 2016.	[Sheth, Harsh; McNally, Daniel; Santibanez-Koref, Mauro; Burn, John] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Sheth, Harsh] Fdn Res Genet & Endocrinol, Inst Human Genet, Ahmadabad, Gujarat, India	Newcastle University - UK	Sheth, H; Burn, J (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England.; Sheth, H (corresponding author), Fdn Res Genet & Endocrinol, Inst Human Genet, Ahmadabad, Gujarat, India.	shethharsh08@gmail.com; john.burn@newcastle.ac.uk		McNally, Daniel/0000-0002-0430-914X; Burn, John/0000-0002-9823-2322; Sheth, Harsh/0000-0001-9626-0971	Academic Health Science Network-North East and North Cumbria; Imperial College Health Partners	Academic Health Science Network-North East and North Cumbria; Imperial College Health Partners	The current study was supported by the grant received by John Burn from the Academic Health Science Network-North East and North Cumbria (https://www.ahsn-nenc.org.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Imperial College Health Partners for project support and Harvey Walsh for accessing and providing aggregate HES, QOF and THIN data.	Abraham NS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1857; Burn J, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2017-000712; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cowan C, 2013, HEART, V99, P1166, DOI 10.1136/heartjnl-2012-303472; Cowan JC, 2018, EUR HEART J, V39, P2975, DOI 10.1093/eurheartj/ehy411; Depaoli S, 2016, J EDUC BEHAV STAT, V41, P628, DOI 10.3102/1076998616664876; Evans T, 2017, ATRIAL FIBRILLATION; Fan J., 1996, MONOGRAPHS STAT APPL, V66, pxvi+341; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Green L, 2018, HAEMATOLOGICA, V103, P738, DOI 10.3324/haematol.2017.182220; Jackevicius CA, 2017, HEART, V103, P1331, DOI 10.1136/heartjnl-2016-310672; LANDEFELD CS, 1989, AM J MED, V87, P144; Lip GYH, 2013, CEREBROVASC DIS, V36, P281, DOI 10.1159/000355981; Loo SY, 2017, BRIT J CLIN PHARMACO, V83, P2096, DOI 10.1111/bcp.13299; NICE, 2014, ATR FIBR MAN; Ntaios G, 2017, STROKE, V48, P2494, DOI 10.1161/STROKEAHA.117.017549; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Vinogradova Y, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2505; Zhu WG, 2015, TEX HEART I J, V42, P6, DOI 10.14503/THIJ-14-4353	22	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218878	10.1371/journal.pone.0218878	http://dx.doi.org/10.1371/journal.pone.0218878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233554	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700049
J	Abariute, L; Lard, M; Hebisch, E; Prinz, CN				Abariute, Laura; Lard, Mercy; Hebisch, Elke; Prinz, Christelle N.			Uptake of nanowires by human lung adenocarcinoma cells	PLOS ONE			English	Article							SEMICONDUCTOR NANOWIRES; IN-VITRO; NANOPARTICLES; EFFICIENCY; DISCOVERY; TOXICITY; PLATFORM; CANCER	Semiconductor nanowires are increasingly used in optoelectronic devices. However, their effects on human health have not been assessed fully. Here, we investigate the effects of gallium phosphide nanowires on human lung adenocarcinoma cells. Four different geometries of nanowires were suspended in the cell culture for 48 hours. We show that cells internalize the nanowires and that the nanowires have no effect on cell proliferation rate, motility, viability and intracellular ROS levels. By blocking specific internalization pathways, we demonstrate that the nanowire uptake is the result of a combination of processes, requiring dynamin and actin polymerization, which suggests an internalization through macropinocytosis and phagocytosis.	[Abariute, Laura; Lard, Mercy; Hebisch, Elke; Prinz, Christelle N.] Lund Univ, Div Solid State Phys, Lund, Sweden; [Abariute, Laura; Lard, Mercy; Hebisch, Elke; Prinz, Christelle N.] Lund Univ, NanoLund, Lund, Sweden	Lund University; Lund University	Prinz, CN (corresponding author), Lund Univ, Div Solid State Phys, Lund, Sweden.; Prinz, CN (corresponding author), Lund Univ, NanoLund, Lund, Sweden.	christelle.prinz@ftf.lth.se	Lard, Mercy/AAV-6577-2021; Lard, Mercy/C-4193-2011	Lard, Mercy/0000-0001-9243-4735; Prinz, Christelle/0000-0002-1726-3275; Hebisch, Elke/0000-0002-6509-2191	PhD4Energy (FP7-REA-GA) [608153]; Crafoord Foundation; NanoLund; Swedish Research Council (VR); European Research Council (ERC-CoG NanoPokers) [682663]	PhD4Energy (FP7-REA-GA); Crafoord Foundation; NanoLund; Swedish Research Council (VR)(Swedish Research Council); European Research Council (ERC-CoG NanoPokers)	This work was financed by PhD4Energy (FP7-REA-GA 608153), the Crafoord Foundation, NanoLund, the Swedish Research Council (VR) and the European Research Council (ERC-CoG NanoPokers 682663).	Adolfsson K, 2013, NANO LETT, V13, P4728, DOI 10.1021/nl4022754; Adolfsson K, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/28/285101; Berthing T, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/41/415102; Berthing T, 2011, SMALL, V7, P640, DOI 10.1002/smll.201001642; Black LE, 2017, NANO LETT, V17, P6287, DOI 10.1021/acs.nanolett.7b02972; Bonde S, 2013, ACS APPL MATER INTER, V5, P10510, DOI 10.1021/am402070k; Borgstrom MT, 2010, NANO RES, V3, P264, DOI 10.1007/s12274-010-1029-x; Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016; Chen Y, 2011, BLOOD, V117, P6392, DOI 10.1182/blood-2010-12-322867; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Dasgupta NP, 2014, ADV MATER, V26, P2137, DOI 10.1002/adma.201305929; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; Dick KA, 2008, PROG CRYST GROWTH CH, V54, P138, DOI 10.1016/j.pcrysgrow.2008.09.001; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Gallentoft L, 2015, BIOMATERIALS, V42, P172, DOI 10.1016/j.biomaterials.2014.11.051; Heurlin M, 2012, NATURE, V492, P90, DOI 10.1038/nature11652; Horev-Azaria L, 2011, TOXICOL SCI, V122, P489, DOI 10.1093/toxsci/kfr124; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; ibidi GmbH, 2015, APPLICATION NOTE 33, P2; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; Kuhn DA, 2014, BEILSTEIN J NANOTECH, V5, P1625, DOI 10.3762/bjnano.5.174; Leonard TS, 2014, ENVIRON HEALTH INSIG, V8, P21, DOI 10.4137/EHI.S15261; Li Z, 2018, J MATER CHEM B, V6, P7042, DOI 10.1039/c8tb02049c; Li Z, 2017, NANOSCALE, V9, P19039, DOI 10.1039/c7nr06284b; Linsmeier CE, 2009, NANO LETT, V9, P4184, DOI 10.1021/nl902413x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Magnusson MH, 1999, J NANOPART RES, V1, P243, DOI 10.1023/A:1010012802415; Mattsson K, 2016, NANOTOXICOLOGY, V10, P1160, DOI 10.1080/17435390.2016.1189615; Na YR, 2013, NANO LETT, V13, P153, DOI 10.1021/nl3037068; Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399; Oracz J, 2017, NANO LETT, V17, P2652, DOI 10.1021/acs.nanolett.7b00468; Otnes G, 2017, NANO TODAY, V12, P31, DOI 10.1016/j.nantod.2016.10.007; Penner RM, 2012, ANNU REV ANAL CHEM, V5, P461, DOI 10.1146/annurev-anchem-062011-143007; Perconti P, 2016, PROC SPIE, V9755, DOI 10.1117/12.2217797; Persson H, 2015, SCI REP-UK, V5, DOI 10.1038/srep18535; Persson H, 2013, SMALL, V9, P4006, DOI 10.1002/smll.201300644; Piret G, 2015, ACS APPL MATER INTER, V7, P18944, DOI 10.1021/acsami.5b03798; Piret G, 2014, RSC ADV, V4, P27888, DOI 10.1039/c4ra04121f; Probes Molecular, 2004, J CELL MOL MED, P1, DOI [10.1111/j.1582-4934.2004.tb00255.x, DOI 10.1111/J.1582-4934.2004.TB00255.X]; Roberts JR, 2012, J NANOMATER, V2012, DOI 10.1155/2012/398302; Safi M, 2011, ACS NANO, V5, P5354, DOI 10.1021/nn201121e; Samuelson L, 2004, PHYSICA E, V25, P313, DOI 10.1016/j.physe.2004.06.030; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Selby LI, 2017, WIRES NANOMED NANOBI, V9, DOI 10.1002/wnan.1452; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Skold N, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/15/155301; Song MM, 2010, BIOMATERIALS, V31, P1509, DOI 10.1016/j.biomaterials.2009.11.034; Stearns RC, 2001, AM J RESP CELL MOL, V24, P108, DOI 10.1165/ajrcmb.24.2.4081; Wagner GR, 1997, LANCET, V349, P1311, DOI 10.1016/S0140-6736(96)07336-9; Wallentin J, 2013, SCIENCE, V339, P1057, DOI 10.1126/science.1230969; Xu AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4613; Yang JA, 2013, NANO LETT, V13, P2295, DOI 10.1021/nl400972r; Yumoto R, 2012, DRUG METAB PHARMACOK, V27, P336, DOI 10.2133/dmpk.DMPK-11-RG-127; Zhang AQ, 2016, NANOSCI TECHNOL, P15, DOI 10.1007/978-3-319-41981-7_2; Zhou Q, 2015, ANNU REV BIOMED ENG, V17, P165, DOI 10.1146/annurev-bioeng-071114-040525; Zimmerman JF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601039	56	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218122	10.1371/journal.pone.0218122	http://dx.doi.org/10.1371/journal.pone.0218122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226121	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700009
J	Loas, G; Solibieda, A; Rotsaert, M; Englert, Y				Loas, Gwenole; Solibieda, Alice; Rotsaert, Marianne; Englert, Yvon			Suicidal ideations among medical students: The role of anhedonia and type D personality	PLOS ONE			English	Article							DEPRESSION; PLEASURE; SCALE; BURNOUT; DS14	Background The relationships between hedonic deficits, type D personality and suicidal ideation were explored in a group of medical students. Methods In a cross-sectional study, 382 medical students filled out several questionnaires measuring suicide risk, depression (using the Beck Depression Inventory, i.e. BDI), type D personality (using the type D personality scale-14, i.e. DS-14) and anhedonia (using the anhedonia subscale of the BDI, the Snaith Hamilton Pleasure Scale, the Anticipatory and Consummatory subscales of the Physical Anhedonia Scale). Results State anhedonia and, in particular, recent change of state anhedonia and not trait anhedonia was significantly associated with suicidal ideation, specifically when depression was controlled for. Negative affectivity component of type D personality and anhedonia were independent predictors of suicidal ideation even when depression was controlled for. Loss of pleasure and not loss of interest was a significant predictor of suicidal ideation. Conclusions Change of state anhedonia and its component of loss of pleasure measuring dissatisfaction in life could be a risk factor of suicidal ideation in medical students. Dissatisfaction, particularly in the medical course, could be a strong predictor of suicidal ideation in medical students.	[Loas, Gwenole; Solibieda, Alice; Rotsaert, Marianne; Englert, Yvon] ULB, Clin Univ Bruxelles, Dept Psychiat, Brussels, Belgium; [Loas, Gwenole; Solibieda, Alice; Rotsaert, Marianne; Englert, Yvon] ULB, Clin Univ Bruxelles, Lab Psychiat Res ULB 266, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Loas, G (corresponding author), ULB, Clin Univ Bruxelles, Dept Psychiat, Brussels, Belgium.	gwenole.loas@erasme.ulb.ac.be		loas, gwenole/0000-0003-1719-916X; englert, yvon/0000-0002-3919-6755				Ballard ED, 2017, J AFFECT DISORDERS, V218, P195, DOI 10.1016/j.jad.2017.04.057; Batsele E, 2017, J HEALTH PSYCHOL, V22, P1075, DOI 10.1177/1359105315624499; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bianchi R, 2013, J HEALTH PSYCHOL, V18, P782, DOI 10.1177/1359105313481079; Centre de Psychologie Appliquee (CPA), 1996, VAL VERS FRANC BDI 2; Cha CB, 2018, J CHILD PSYCHOL PSYC, V59, P460, DOI 10.1111/jcpp.12831; Daghigh A, 2018, SUICIDE LIFE-THREAT; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Downs N, 2014, ACAD PSYCHIATR, V38, P547, DOI 10.1007/s40596-014-0115-x; Ducasse D, 2018, DEPRESS ANXIETY, V35, P382, DOI 10.1002/da.22709; FAWCETT J, 1990, AM J PSYCHIAT, V147, P1189; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Guihard G, 2018, ENCEPHALE, V44, P94, DOI 10.1016/j.encep.2017.10.006; Hawes M, 2018, DEPRESS ANXIETY, V35, P1218, DOI 10.1002/da.22814; Joiner TE, 2003, PSYCHIAT RES, V119, P243, DOI 10.1016/S0165-1781(03)00131-8; Kosik RO, 2017, NEUROPSYCHIATRY-LOND, V7, P09, DOI DOI 10.4172/Neuropsychiatry.1000172; Lapyte A, 2015, ANN PSYCHIAT MENTAL, V3, P8; Loas G, 1997, ENCEPHALE, V23, P454; Loas G, 2009, ANN MED-PSYCHOL, V167, P641, DOI 10.1016/j.amp.2009.09.002; Loas G., 2014, ANHEDONIA SUICIDE BE, VVolume II; Loas G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193619; Loas G, 2016, PSYCHIAT RES, V246, P296, DOI 10.1016/j.psychres.2016.09.056; Lussier A, 2015, PSYCHOL REP, V116, P855, DOI 10.2466/09.02.PR0.116k27w2; Michal M, 2010, J AFFECT DISORDERS, V125, P227, DOI 10.1016/j.jad.2010.02.108; Park YM, 2014, PSYCHIAT INVEST, V11, P232, DOI 10.4306/pi.2014.11.3.232; Pedrazza M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01238; Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; Winer ES, 2016, ARCH SUICIDE RES, V20, P265, DOI 10.1080/13811118.2015.1025119; Winer ES, 2014, PSYCHIAT RES, V218, P124, DOI 10.1016/j.psychres.2014.04.016; Winer ES, 2014, J AFFECT DISORDERS, V152, P193, DOI 10.1016/j.jad.2013.09.010; Wurm W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149913; Yoon DH, 2015, PSYCHIAT INVEST, V12, P16, DOI 10.4306/pi.2015.12.1.16	34	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0217841	10.1371/journal.pone.0217841	http://dx.doi.org/10.1371/journal.pone.0217841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226120	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700006
J	Okumura, N; Kagami, T; Watanabe, K; Kadoya, S; Sato, M; Koizumi, N				Okumura, Naoki; Kagami, Takato; Watanabe, Kyoko; Kadoya, Saori; Sato, Masakazu; Koizumi, Noriko			Feasibility of a cryopreservation of cultured human corneal endothelial cells	PLOS ONE			English	Article							ROCK INHIBITOR; IN-VITRO; TRANSPLANTATION; KERATOPLASTY; SHEET	Transparency of the cornea is essential for vision and is maintained by the corneal endothelium. Consequently, corneal endothelial decompensation arising from irreversible damage to the corneal endothelium causes severe vision impairment. Until recently, transplantation of donor corneas was the only therapeutic choice for treatment of endothelial decompensation. In 2013, we initiated clinical research into cell-based therapy involving injection of a suspension of cultured human corneal endothelial cells (HCECs), in combination with Rho kinase inhibitor, into the anterior chamber. The aim of the present study was to establish a protocol for cryopreservation of HCECs to allow large-scale commercial manufacturing of these cells. This study focused on the effects of various cryopreservation reagents on HCEC viability. Screening of several commercially available cryopreservation reagents identified Bambanker hRM as an effective agent that maintained a cell viability of 89.4% after 14 days of cryopreservation, equivalent to the cell viability of 89.2% for non-cryopreserved control cells. The use of Bambanker hRM and HCECs at a similar grade to that used clinically for cell based therapy (passage 3-5 and a cell density higher than 2000 cells/mm(2)) gave a similar cell density for cryopreserved HCECs to that of non-preserved control HCECs after 28 days of cultivation (2099 cells/mm(2) and 2111 cells/mm(2), respectively). HCECs preserved using Bambanker hRM grew in a similar fashion to non-preserved control HCECs and formed a monolayer sheet-like structure. Cryopreservation of HCECs has multiple advantages including the ability to accumulate stocks of master cells, to transport HCEC stocks, and to manufacture HCECs on demand for use in cell-based treatment of endothelial decompensation.	[Okumura, Naoki; Kagami, Takato; Watanabe, Kyoko; Kadoya, Saori; Sato, Masakazu; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan	Doshisha University	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology	Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology	This study was supported by the Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm) to KN and ON. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	America; WDEBAo, 2016, AM WDEBAO 2016 EYE B; Bourne W M, 1998, Trans Am Ophthalmol Soc, V96, P229; BOURNE WM, 1998, T AM OPHTHAL SOC, V96, P239; Eskandari N, 2018, CRYOBIOLOGY, V85, P63, DOI 10.1016/j.cryobiol.2018.10.001; Fan WX, 2009, CRYOBIOLOGY, V58, P28, DOI 10.1016/j.cryobiol.2008.10.124; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Hatou S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0286; Hongo A, 2017, INVEST OPHTH VIS SCI, V58, P3325, DOI 10.1167/iovs.16-21170; Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kinoshita S, 2018, NEW ENGL J MED, V378, P995, DOI 10.1056/NEJMoa1712770; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Marquez-Curtis LA, 2018, CRYOPRESERVATION END, P119; Marquez-Curtis LA, 2017, CRYOBIOLOGY, V77, P1, DOI 10.1016/j.cryobiol.2017.04.012; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3637, DOI 10.1167/iovs.05-0462; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Vianna LMM, 2016, ARQ BRAS OFTALMOL, V79, P37, DOI 10.5935/0004-2749.20160011; Nishida T., 2011, CORNEA, P3; Okumura N, 2017, CORNEA, V36, P1387, DOI 10.1097/ICO.0000000000001317; Okumura N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158427; Okumura N, 2015, INVEST OPHTH VIS SCI, V56, P2933, DOI 10.1167/iovs.14-15163; Okumura N, 2014, CORNEA, V33, pS37, DOI 10.1097/ICO.0000000000000229; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Price FW, 2005, J REFRACT SURG, V21, P339; Suh LH, 2007, INVEST OPHTH VIS SCI, V48, P3056, DOI 10.1167/iovs.06-0771; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1	32	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218431	10.1371/journal.pone.0218431	http://dx.doi.org/10.1371/journal.pone.0218431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226131	gold, Green Published, Green Submitted			2022-12-26	WOS:000484894700018
J	Smit, EA; Milne, AJ; Dean, RT; Weidemann, G				Smit, Eline Adrianne; Milne, Andrew J.; Dean, Roger T.; Weidemann, Gabrielle			Perception of affect in unfamiliar musical chords	PLOS ONE			English	Article							AVERAGE PITCH HEIGHT; EMOTIONAL CONNOTATIONS; CONSONANCE THEORY; INTERVAL SIZE; R PACKAGE; EXPECTATION; EXPRESSION; CONSISTENT; MELODY; MODEL	This study investigates the role of extrinsic and intrinsic predictors in the perception of affect in mostly unfamiliar musical chords from the Bohlen-Pierce microtonal tuning system. Extrinsic predictors are derived, in part, from long-term statistical regularities in music; for example, the prevalence of a chord in a corpus of music that is relevant to a participant. Conversely, intrinsic predictors make no use of long-term statistical regularities in music; for example, psychoacoustic features inherent in the music, such as roughness. Two types of affect were measured for each chord: pleasantness/unpleasantness and happiness/sadness. We modelled the data with a number of novel and well-established intrinsic predictors, namely roughness, harmonicity, spectral entropy and average pitch height; and a single extrinsic predictor, 12-TET Dissimilarity, which was estimated by the chord's smallest distance to any 12-tone equally tempered chord. Musical sophistication was modelled as a potential moderator of the above predictors. Two experiments were conducted, each using slightly different tunings of the Bohlen-Pierce musical system: a just intonation version and an equal-tempered version. It was found that, across both tunings and across both affective responses, all the tested intrinsic features and 12-TET Dissimilarity have consistent influences in the expected direction. These results contrast with much current music perception research, which tends to assume the dominance of extrinsic over intrinsic predictors. This study highlights the importance of both intrinsic characteristics of the acoustic signal itself, as well as extrinsic factors, such as 12-TET Dissimilarity, on perception of affect in music.	[Smit, Eline Adrianne; Milne, Andrew J.; Dean, Roger T.; Weidemann, Gabrielle] Western Sydney Univ, MARCS Inst Brain Behav & Dev, Milperra, NSW, Australia; [Weidemann, Gabrielle] Western Sydney Univ, Sch Social Sci & Psychol, Milperra, NSW, Australia	Western Sydney University; Western Sydney University	Smit, EA (corresponding author), Western Sydney Univ, MARCS Inst Brain Behav & Dev, Milperra, NSW, Australia.	e.smit@westernsydney.edu.au	Milne, Andrew/D-1312-2011	Milne, Andrew/0000-0002-4688-8004; Dean, Roger Thornton/0000-0002-8859-8902; Smit, Eline/0000-0003-0250-378X	MARCS Postgraduate Scholarship; MARCS Institute for Brain, Behaviour and Development, Western Sydney University; Australian Research Council [DE170100353]; Australian Government	MARCS Postgraduate Scholarship; MARCS Institute for Brain, Behaviour and Development, Western Sydney University; Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work is funded by the MARCS Postgraduate Scholarship, that was granted to Ms. Eline Smit for her PhD Candidature. The funder is the MARCS Institute for Brain, Behaviour and Development, Western Sydney University. Dr Andrew Milne is the recipient of an Australian Research Council Discovery Early Career Researcher Award (project number DE170100353) funded by the Australian Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bailes F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135082; Balkwill LL, 2004, JPN PSYCHOL RES, V46, P337, DOI 10.1111/j.1468-5584.2004.00265.x; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bohlen H., ACUSTICA, V39, P67; Bowling DL, 2015, P NATL ACAD SCI USA, V112, P11155, DOI 10.1073/pnas.1505768112; Bowling DL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00464; Burkner PC, 2018, R J, V10, P395; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; CAZDEN N, 1980, INT REV AESTHET SOC, V11, P123, DOI 10.2307/836494; Cazden N, 1945, J AESTHETICS ART CRI, V4, P3, DOI DOI 10.2307/426253; Cohen A.J., 2001, MUSIC EMOTION THEORY, P878, DOI [10.1093/acprof:oso/9780199230143.003.0031, DOI 10.1093/ACPROF:OSO/9780199230143.003.0031]; Cousineau M, 2012, P NATL ACAD SCI USA, V109, P19858, DOI 10.1073/pnas.1207989109; Crowder R. G., 1985, PSYCHOMUSICOLOGY, V5, P3, DOI DOI 10.1037/H0094203; Crowder R. G., 1984, PSYCHOMUSICOLOGY, V4, P3, DOI DOI 10.1037/H0094207; de Finetti B., 1974, THEORY PROBABILITY; DEWITT LA, 1987, PERCEPT PSYCHOPHYS, V41, P73, DOI 10.3758/BF03208216; Dubnov S, 2004, IEEE SIGNAL PROC LET, V11, P698, DOI 10.1109/LSP.2004.831663; Friedman RS, 2018, MUSIC PERCEPT, V35, P518, DOI 10.1525/MP.2018.35.4.518; Gelman A, 2015, J EDUC BEHAV STAT, V40, P530, DOI 10.3102/1076998615606113; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Gingras B, 2014, Q J EXP PSYCHOL, V67, P1428, DOI 10.1080/17470218.2013.863954; Heinlein CP, 1928, J COMP PSYCHOL, V8, P101, DOI 10.1037/h0070573; Helmholtz H., 1954, SENSATION TONES PHYS; Herff SA, 2018, Q J EXP PSYCHOL, V71, P1367, DOI 10.1177/1747021817734978; Hong Y, 2018, J NEW MUSIC RES, V47, P462, DOI 10.1080/09298215.2018.1478428; Huron D, 2012, EMPIR MUSICOL REV, V7, P103; Huron D, 2008, EMPIR MUSICOL REV, V3, P59, DOI 10.18061/1811/31940; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Johnson-Laird PN, 2012, MUSIC PERCEPT, V30, P19, DOI 10.1525/MP.2012.30.1.19; JOHNSTON JD, 1988, IEEE J SEL AREA COMM, V6, P314, DOI 10.1109/49.608; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1460, DOI 10.1121/1.1911624; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1451, DOI 10.1121/1.1911623; Kruschke J. K., 2015, DOING BAYESIAN DATA, V2nd, DOI 10.1016/B978-0-12-405888-0.00010-6; Kruschke JK, 2018, ADV METH PRACT PSYCH, V1, P270, DOI 10.1177/2515245918771304; Lahdelma I., 2017, THESIS; Lahdelma I, 2016, PSYCHOL MUSIC, V44, P37, DOI 10.1177/0305735614552006; Leung Y, 2018, J NEW MUSIC RES, V8215, P1; Leung Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203026; Loui P, 2012, TOP COGN SCI, V4, P554, DOI 10.1111/j.1756-8765.2012.01208.x; Loui P, 2010, MUSIC PERCEPT, V27, P377, DOI 10.1525/mp.2010.27.5.377; Loui P, 2009, J NEUROSCI, V29, P454, DOI 10.1523/JNEUROSCI.4503-08.2009; MAHER TF, 1980, AM J PSYCHOL, V93, P309, DOI 10.2307/1422235; Marin MM, 2015, NEUROPSYCHOLOGIA, V78, P207, DOI 10.1016/j.neuropsychologia.2015.10.004; MATHEWS MV, 1988, J ACOUST SOC AM, V84, P1214, DOI 10.1121/1.396622; McDermott JH, 2016, NATURE, V535, P547, DOI 10.1038/nature18635; McDermott JH, 2010, CURR BIOL, V20, P1035, DOI 10.1016/j.cub.2010.04.019; McLachlan N, 2013, J EXP PSYCHOL GEN, V142, P1142, DOI 10.1037/a0030830; Milne A., 2013, THESIS; Milne AJ, 2017, J MATH MUSIC, V11, P101, DOI 10.1080/17459737.2017.1395915; Milne AJ, 2016, MUSIC SCI, V20, P465, DOI 10.1177/1029864915622682; Milne AJ, 2016, J MATH MUSIC, V10, P59, DOI 10.1080/17459737.2016.1152517; Milne AJ, 2015, MUSIC PERCEPT, V32, P364, DOI 10.1525/MP.2015.32.4.364; Milne AJ, 2011, J MATH MUSIC, V5, P1, DOI 10.1080/17459737.2011.573678; Mullensiefen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101091; Oshinsky J.S., 1977, MOTIV EMOTION, V1, P331, DOI [10.1007/BF00992539, DOI 10.1007/BF00992539, 10.1007/BF009 92539]; Parncutt R., 2011, J INTERDISCIPLINARY, V5, P119, DOI [DOI 10.4407/JIMS.2011.11.002, 10.4407/jims.2011.11.002]; Parncutt R, 2019, J NEW MUSIC RES, V48, P1, DOI 10.1080/09298215.2018.1477804; Parncutt R, 2014, MUSIC SCI, V18, P324, DOI 10.1177/1029864914542842; Pearce MT, 2006, MUSIC PERCEPT, V23, P377, DOI 10.1525/mp.2006.23.5.377; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; SCHERER KR, 1995, J VOICE, V9, P235, DOI 10.1016/S0892-1997(05)80231-0; Sethares W., 2005, TUNING TIMBRE SPECTR, DOI 10.1007/b138848; Stolzenburg F, 2015, J MATH MUSIC, V9, P215, DOI 10.1080/17459737.2015.1033024; Temperley D, 2013, MUSIC PERCEPT, V30, P237, DOI 10.1525/mp.2012.30.3.237; TERHARDT E, 1982, J ACOUST SOC AM, V71, P679, DOI 10.1121/1.387544; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; van de Schoot R., 2014, EUROPEAN HLTH PSYCHO, V16, P75; VANDEGEER JP, 1962, ACTA PSYCHOL, V20, P308, DOI 10.1016/0001-6918(62)90028-8; Zhang JD, 2020, PSYCHOL MUSIC, V48, P389, DOI 10.1177/0305735618804038	72	18	18	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218570	10.1371/journal.pone.0218570	http://dx.doi.org/10.1371/journal.pone.0218570			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226170	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700022
J	Dutta, RK; Parween, F; Hossain, MS; Dhama, N; Pandey, P; Gupta, RD				Dutta, Roshan Kumar; Parween, Fauzia; Hossain, Md. Summon; Dhama, Nidhi; Pandey, Parmanand; Gupta, Rinkoo Devi			Comparative analysis of the metal-dependent structural and functional properties of mouse and human SMP30	PLOS ONE			English	Article							SENESCENCE MARKER PROTEIN-30; ENZYME; BINDING; PROLIFERATION; PURIFICATION; SPECTROSCOPY; REGUCALCIN	Senescence Marker Protein (SMP30) is a metalloenzyme that shows lactonase activity in the ascorbic acid (AA) biosynthesis pathway in non-primate mammals such as a mouse. However, AA biosynthesis does not occur in the primates including humans. Several studies have shown the role of SMP30 in maintaining calcium homeostasis in mammals. In addition, it is also reported to have promiscuous enzyme activity with an organophosphate (OP) substrate. Hence, this study aims to recombinantly express and purify the SMP30 proteins from both mouse and human, and to study their structural alterations and functional deviations in the presence of different divalent metals. For this, mouse SMP30 (MoSMP30) as well as human SMP30 (HuSMP30) were cloned in the bacterial expression vector. Proteins were overexpressed and purified from soluble fractions as well as from inclusion bodies as these proteins were expressed largely in insoluble fractions. The purified proteins were used to study the folding conformations in the presence of different divalent cations (Ca2+, Co2+, Mg2+, and Zn2+) with the help of circular dichroism (CD) spectroscopy. It was observed that both MoSMP30 and HuSMP30 acquired native folding conformations. To study the metal-binding affinity, dissociation constant (Kd values) were calculated from UV-VIS titration curve, which showed the highest affinity of MoSMP30 with Zn2+. However, HuSMP30 showed the highest affinity with Ca2+, suggesting the importance of HuSMP30 in maintaining calcium homeostasis. Enzyme kinetics were performed with gamma-Thiobutyrolactone and Demeton-S in the presence of different divalent cations. Interestingly, both the proteins showed lactonase activity in the presence of Ca2+. In addition, MoSMP30 and HuSMP30 also showed lactonase activity in the presence of Co2+ and Zn2+ respectively. Moreover, both the proteins showed OP hydrolase activities in the presence of Ca2+ as well as Zn2+, suggesting the metal-dependent promiscuous nature of SMP30.	[Dutta, Roshan Kumar; Parween, Fauzia; Hossain, Md. Summon; Dhama, Nidhi; Pandey, Parmanand; Gupta, Rinkoo Devi] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	South Asian University (SAU)	Gupta, RD (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	rdgupta@sau.ac.in	Gupta, Rinkoo Devi/AAI-9528-2021	Gupta, Rinkoo Devi/0000-0003-1156-9596; Hossain, Md. Summon/0000-0003-2870-4643	South Asian University's "Start-up Fund"; University Grants Commission (UGC), India; South Asian University	South Asian University's "Start-up Fund"; University Grants Commission (UGC), India(University Grants Commission, India); South Asian University	This work is financially supported by South Asian University's "Start-up Fund" to RDG. FP thanks University Grants Commission (UGC), India for Junior Research Fellowship. RKD and ND thank South Asian University for providing fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053706; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4; Chakraborti S, 2008, FASEB J, V22; Chakraborti S, 2010, BIOCHEMISTRY-US, V49, P3436, DOI 10.1021/bi9022297; Choi MS, 2010, BIOCHEM BIOPH RES CO, V393, P509, DOI 10.1016/j.bbrc.2010.02.036; Ditargiani RC, 2010, CHEM-BIOL INTERACT, V187, P349, DOI 10.1016/j.cbi.2010.02.021; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grzyska PK, 2010, ANAL BIOCHEM, V399, P64, DOI 10.1016/j.ab.2009.11.022; Gupta R., 2016, CHEM PROCESS, V4, P2, DOI [10.1186/s40508-016-0046-9, DOI 10.1186/S40508-016-0046-9]; Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x; KANE JF, 1988, TRENDS BIOTECHNOL, V6, P95, DOI 10.1016/0167-7799(88)90065-0; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028; Lin PH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32085; Marques R, 2014, CELL MOL LIFE SCI, V71, P93, DOI 10.1007/s00018-013-1323-3; Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274; Prier CK, 2015, J AM CHEM SOC, V137, P13992, DOI 10.1021/jacs.5b09348; Ravera S, 2015, J GEN PHYSIOL, V145, P555, DOI 10.1085/jgp.201511365; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Valasatava Y, 2018, J INORG BIOCHEM, V179, P40, DOI 10.1016/j.jinorgbio.2017.11.002; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yamaguchi M, 2005, INT J MOL MED, V15, P371; YAMAGUCHI M, 1978, CHEM PHARM BULL, V26, P1915; Yamaguchi M, 2012, INTEGR BIOL-UK, V4, P825, DOI 10.1039/c2ib20042b	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218629	10.1371/journal.pone.0218629	http://dx.doi.org/10.1371/journal.pone.0218629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220150	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500075
J	Amemiya, S; Toyoda, H; Kimura, M; Saito, H; Kobayashi, H; Ihara, K; Kamagata, K; Kawabata, R; Kato, S; Nakashimada, Y; Furuta, T; Hamamoto, S; Uozumi, N				Amemiya, Shun; Toyoda, Hayato; Kimura, Mami; Saito, Hiromi; Kobayashi, Hiroshi; Ihara, Kunio; Kamagata, Kiyoto; Kawabata, Ryuji; Kato, Setsu; Nakashimada, Yutaka; Furuta, Tadaomi; Hamamoto, Shin; Uozumi, Nobuyuki			The mechanosensitive channel YbdG from Escherichia coli has a role in adaptation to osmotic up-shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; cell biology; stress; stress response; membrane protein; mechanosensitive channel; high osmolarity; YbdG; mechanosensor; gain-of-function mutation; Escherichia coli; osmotic shock; ion channel; YbdG-I167T; signal transduction	ION-CHANNEL; HIGH-THROUGHPUT; COMPLETE SET; MSCS; EXPRESSION; GENE; K-12; INACTIVATION; ORGANIZATION; ACTIVATION	Mechanosensitive channels play an important role in the adaptation of cells to hypo-osmotic shock. Among members of this channel family in Escherichia coli, the exact function and physiological role of the mechanosensitive channel homolog YbdG remain unclear. Characterization of YbdG's physiological role has been hampered by its lack of measurable transport activity. Using a nitrosoguanidine mutagenesis-aided screen in combination with next-generation sequencing, here we isolated a mutant with a point mutation in ybdG. This mutation (resulting in a I167T change) conferred sensitivity to high osmotic stress, and the mutant cells differed from WT cells in morphology during hyperosmotic stress at alkaline pH. Interestingly, unlike the cells containing the I167T variant, a null-ybdG mutant did not exhibit this sensitivity and phenotype. Although I167T was located near the putative ion-conducting pore in a transmembrane region of YbdG, no change in ion channel activities of YbdG-I167T was detected. Of note, introduction of the WT C-terminal cytosolic region of YbdG into the I167T variant complemented the osmo-sensitive phenotype. Co-precipitation of proteins interacting with the C-terminal YbdG region led to the isolation of HldD and FbaA, whose overexpression in cells containing the YbdG-I167T variant partially rescued the osmo-sensitive phenotype. This study indicates that YbdG functions as a component of a mechanosensing system that transmits signals triggered by external osmotic changes to intracellular factors. The cellular role of YbdG uncovered here goes beyond its predicted function as an ion or solute transport protein.	[Amemiya, Shun; Toyoda, Hayato; Kimura, Mami; Hamamoto, Shin; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan; [Saito, Hiromi; Kobayashi, Hiroshi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Chiba 2608675, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Kamagata, Kiyoto] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan; [Kawabata, Ryuji] Hiroshima Univ, Sch Engn, Higashihiroshima 7398527, Japan; [Kato, Setsu; Nakashimada, Yutaka] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan; [Furuta, Tadaomi] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, B-62 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan	Tohoku University; Chiba University; Nagoya University; Tohoku University; Hiroshima University; Hiroshima University; Tokyo Institute of Technology	Uozumi, N (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan.	uozumi@tohoku.ac.jp	Furuta, Tadaomi/D-5225-2015; Kato, Setsu/AAC-1418-2019; Uozumi, Nobuyuki/AAG-3252-2019; IHARA, Kunio/D-1952-2011; Nakashimada, Yutaka/B-5493-2010	Furuta, Tadaomi/0000-0003-4568-9043; Nakashimada, Yutaka/0000-0002-7452-7433; Uozumi, Nobuyuki/0000-0003-4268-1126	Japan Society for the Promotion of Science (JSPS) [16H06558, 19K22264, 19H02880, 15K186780]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research 16H06558, 19K22264, and 19H02880 (to N.U.) and 15K186780 (to S.H.) from Japan Society for the Promotion of Science (JSPS). The authors declare that they have no conflicts of interest with the contents of this article.	Amir A, 2014, P NATL ACAD SCI USA, V111, P5778, DOI 10.1073/pnas.1317497111; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bartlett TM, 2017, CELL, V168, P172, DOI 10.1016/j.cell.2016.12.019; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Chen CM, 2013, BIOINFORMATICS, V29, P2808, DOI 10.1093/bioinformatics/btt484; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Edwards MD, 2012, CHANNELS, V6, P272, DOI 10.4161/chan.20998; Grajkowski W, 2005, BIOPHYS J, V88, P3050, DOI 10.1529/biophysj.104.053546; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Jeanguenin L, 2011, PLANT J, V67, P570, DOI 10.1111/j.1365-313X.2011.04617.x; Joloba ML, 2004, J BACTERIOL, V186, P8542, DOI 10.1128/JB.186.24.8542-8546.2004; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Kera K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00664-17; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kobayashi H, 2000, J GEN APPL MICROBIOL, V46, P235, DOI 10.2323/jgam.46.235; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Koprowski P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127029; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Li YZ, 2002, EMBO J, V21, P5323, DOI 10.1093/emboj/cdf537; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Marin K, 1998, J BACTERIOL, V180, P4843, DOI 10.1128/JB.180.18.4843-4849.1998; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; MIZUNO T, 1987, J BIOCHEM-TOKYO, V101, P387, DOI 10.1093/oxfordjournals.jbchem.a121923; Murata A, 2015, J MOL BIOL, V427, P2663, DOI 10.1016/j.jmb.2015.06.016; Nanatani K, 2015, J BACTERIOL, V197, P676, DOI 10.1128/JB.02276-14; Nanatani K, 2013, CHANNELS, V7, P238, DOI 10.4161/chan.25350; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; OHYAMA T, 1994, J BACTERIOL, V176, P4311, DOI 10.1128/jb.176.14.4311-4315.1994; Osanai T, 2005, J BIOL CHEM, V280, P34684, DOI 10.1074/jbc.M507489200; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; REED RH, 1985, FEMS MICROBIOL LETT, V28, P225, DOI 10.1016/0378-1097(85)90086-2; Rowe I, 2014, J GEN PHYSIOL, V143, P543, DOI 10.1085/jgp.201311114; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Shi HD, 2018, CELL, V172, P1294, DOI 10.1016/j.cell.2018.02.050; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Wood JM, 2015, J GEN PHYSIOL, V145, P381, DOI 10.1085/jgp.201411296; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus	55	5	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12281	12292		10.1074/jbc.RA118.007340	http://dx.doi.org/10.1074/jbc.RA118.007340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31256002	hybrid, Green Published			2022-12-26	WOS:000484402700002
J	Norleans, J; Wang, JY; Kuryatov, A; Leffler, A; Doebelin, C; Kamenecka, TM; Lindstrom, J				Norleans, Jack; Wang, Jingyi; Kuryatov, Alexander; Leffler, Abba; Doebelin, Christelle; Kamenecka, Theodore M.; Lindstrom, Jon			Discovery of an intrasubunit nicotinic acetylcholine receptor-binding site for the positive allosteric modulator Br-PBTC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); allosteric regulation; molecular docking; drug design; receptor desensitization; positive allosteric modulator	AGONIST; SUBUNIT; DOCKING; ALPHA-5; ACTIVATION; DESENSITIZATION; MECHANISM; SOFTWARE; DOMAIN	Nicotinic acetylcholine receptor (nAChR) ligands that lack agonist activity but enhance activation in the presence of an agonist are called positive allosteric modulators (PAMs). nAChR PAMs have therapeutic potential for the treatment of nicotine addiction and several neuropsychiatric disorders. PAMs need to be selectively targeted toward certain nAChR subtypes to tap this potential. We previously discovered a novel PAM, (R)-7-bromo-N-(piperidin-3-yl)benzo[b]thiophene-2-carboxamide (Br-PBTC), which selectively potentiates the opening of alpha 4 beta 2*, alpha 2 beta 2*, alpha 2 beta 4*, and (alpha 4 beta 4)(2)alpha 4 nAChRs and reactivates some of these subtypes when desensitized (* indicates the presence of other subunits). We located the Br-PBTC-binding site through mutagenesis and docking in alpha 4. The amino acids Glu-282 and Phe-286 near the extracellular domain on the third transmembrane helix were found to be crucial for Br-PBTC's PAM effect. E282Q abolishes Br-PBTC potentiation. Using (alpha 4(E282Q)beta 2)(2)alpha 5 nAChRs, we discovered that the trifluoromethylated derivatives of Br-PBTC can potentiate channel opening of alpha 5-containing nAChRs. Mutating Tyr-430 in the alpha 5 M4 domain changed alpha 5-selectivity among Br-PBTC derivatives. There are two kinds of alpha 4 subunits in alpha 4 beta 2 nAChRs. Primary alpha 4 forms an agonist-binding site with another beta 2 subunit. Accessory alpha 4 forms an agonist-binding site with another alpha 4 subunit. The pharmacological effect of Br-PBTC depends both on its own and agonists' occupancy of primary and accessory alpha 4 subunits. Br-PBTC reactivates desensitized (alpha 4 beta 2)(2)alpha 4 nAChRs. Its full efficacy requires intact Br-PBTC sites in at least one accessory and one primary alpha 4 subunit. PAM potency increases with higher occupancy of the agonist sites. Br-PBTC and its derivatives should prove useful as alpha subunit-selective nAChR PAMs.	[Norleans, Jack; Kuryatov, Alexander; Lindstrom, Jon] Univ Penn, Dept Neurosci, Perelman Sch Med, 130A John Morgan Bldg, Philadelphia, PA 19104 USA; [Wang, Jingyi] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Leffler, Abba] NYU, Sackler Inst Grad Biomed Sci, Neurosci Grad Program, Sch Med, New York, NY 10010 USA; [Doebelin, Christelle; Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Med, Scripps, FL USA; [Doebelin, Christelle; Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA	University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Austin; New York University; Scripps Research Institute	Lindstrom, J (corresponding author), Univ Penn, Dept Neurosci, Perelman Sch Med, 130A John Morgan Bldg, Philadelphia, PA 19104 USA.	jslkk@pennmedicine.upenn.edu	Wang, Jin/GYA-2019-2022; wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022; wang, jing/GVT-8700-2022		Neuroscience Department of the Perelman School of Medicine at the University of Pennsylvania; National Institutes of Health NIDA Grant [DA030929]	Neuroscience Department of the Perelman School of Medicine at the University of Pennsylvania; National Institutes of Health NIDA Grant	This work was supported by the Neuroscience Department of the Perelman School of Medicine at the University of Pennsylvania and National Institutes of Health NIDA Grant DA030929. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcaino C, 2017, J BIOL CHEM, V292, P551, DOI 10.1074/jbc.M116.751206; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnold LE, 2012, J CHILD ADOL PSYCHOP, V22, P198, DOI 10.1089/cap.2011.0056; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Carignano C, 2016, BBA-BIOMEMBRANES, V1858, P1964, DOI 10.1016/j.bbamem.2016.05.019; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Deba F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19790-4; Domville JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22150-x; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Glaab E, 2016, BRIEF BIOINFORM, V17, P352, DOI 10.1093/bib/bbv037; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Henault CM, 2015, NEUROPHARMACOLOGY, V96, P157, DOI 10.1016/j.neuropharm.2014.11.011; Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w; Jain A, 2016, J BIOL CHEM, V291, P23452, DOI 10.1074/jbc.M116.749150; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Jin Z, 2014, BIOORG MED CHEM LETT, V24, P674, DOI 10.1016/j.bmcl.2013.11.049; Kamenecka T. M., 2016, International Patent, Patent No. [PCT/US2016/033774, 2016033774]; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Mazzaferro S, 2017, J BIOL CHEM, V292, P2729, DOI 10.1074/jbc.M116.764183; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; McFedries A, 2013, CHEM BIOL, V20, P667, DOI 10.1016/j.chembiol.2013.04.008; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newcombe J, 2018, MOL PHARMACOL, V93, P128, DOI 10.1124/mol.117.110551; Pandya A, 2011, J MOL NEUROSCI, V45, P42, DOI 10.1007/s12031-011-9509-3; Paradiso KG, 2003, J PHYSIOL-LONDON, V553, P857, DOI 10.1113/jphysiol.2003.053447; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prickaerts J, 2012, NEUROPHARMACOLOGY, V62, P1099, DOI 10.1016/j.neuropharm.2011.10.024; Quadri M, 2019, MOL PHARMACOL, V95, P43, DOI 10.1124/mol.118.113340; Quik M, 2011, PHARMACOL REV, V63, P938, DOI 10.1124/pr.110.003269; Ray C, 2017, ACS CHEM BIOL, V12, P702, DOI 10.1021/acschembio.6b01117; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tuccinardi T, 2014, J CHEM INF MODEL, V54, P2980, DOI 10.1021/ci500424n; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Wang JY, 2018, BRIT J PHARMACOL, V175, P1805, DOI 10.1111/bph.13745; Wang JY, 2015, J BIOL CHEM, V290, P28834, DOI 10.1074/jbc.M115.676551; Wang JY, 2015, J BIOL CHEM, V290, P13907, DOI 10.1074/jbc.M115.646786; Wang JY, 2012, J BIOL CHEM, V287, P21957, DOI 10.1074/jbc.M112.339796; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	61	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12132	12145		10.1074/jbc.RA118.006253	http://dx.doi.org/10.1074/jbc.RA118.006253			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31221718	Green Published, hybrid			2022-12-26	WOS:000484284500017
J	De Mastro, F; Cocozza, C; Traversa, A; Savy, D; Abdelrahman, HM; Brunetti, G				De Mastro, Francesco; Cocozza, Claudio; Traversa, Andreina; Savy, Davide; Abdelrahman, Hamada M.; Brunetti, Gennaro			Influence of crop rotation, tillage and fertilization on chemical and spectroscopic characteristics of humic acids	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; MOLECULAR CHARACTERIZATION; HUMIFICATION INDEX; SUBSTANCES; DYNAMICS; MANAGEMENT; QUALITY	The changes in soil organic matter composition induced by anthropogenic factors is a topic of great interest for the soil scientists. The objective of this work was to identify possible structural changes in humic molecules caused by a 2-year rotation of durum wheat with faba bean, lasted for a decade, and conducted with different agricultural practices in a Mediterranean soil. Humic acids (HA) were extracted at three depths (0-30, 30-60 and 60-90 cm) from a Mediterranean soil subjected to different tillage (no tillage, minimum tillage and conventional tillage), crops (faba bean and wheat), and fertilization. The changes in HA quality were assessed by several chemical (ash, yield and elemental analysis) and spectroscopic techniques (solid-state 13C nuclear magnetic resonance, Fourier transform infrared and fluorescence). The results suggest that the different agronomic practices strongly affected the quality of HA. Smaller but more aromatic molecules were observed with depth, while the fertilization induced the formation of simpler and less aromatic molecules due to the enhanced decomposition processes. Under no tillage, more stable humic molecules were observed due to the less soil aeration, while under conventional tillage larger and more aromatic molecules were obtained. Compared to wheat, more aromatic and more oxidized but less complex molecules were observed after faba bean crop. The inorganic fertilization accelerates the decomposition of organic substances rather than their stabilization. At the end of each crop cycle, humic matter of different quality was isolated and this confirms the importance of the rotation practice to guarantee a diversification of the soil organic matter with time. Finally, no tillage induces the formation of more stable humic matter.	[De Mastro, Francesco; Cocozza, Claudio; Traversa, Andreina; Brunetti, Gennaro] Univ Bari, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy; [Savy, Davide] Univ Naples Federico II, Ctr Interdipartimentale Ric Risonanza Magnet Nucl, Portici, Italy; [Abdelrahman, Hamada M.] Cairo Univ, Dept Soil Sci, Fac Agr, Giza, Egypt; [Savy, Davide] Univ Liege, Gembloux Agrobio Tech, Plant Biol Lab, Gembloux, Belgium	Universita degli Studi di Bari Aldo Moro; University of Naples Federico II; Egyptian Knowledge Bank (EKB); Cairo University; University of Liege	Cocozza, C (corresponding author), Univ Bari, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy.	claudio.cocozza@uniba.it	Cocozza, Claudio/M-6020-2019; Abdelrahman, Hamada/D-2137-2009	Cocozza, Claudio/0000-0003-2246-5688; Abdelrahman, Hamada/0000-0002-6069-7239; De Mastro, Francesco/0000-0001-9130-5341; Savy, Davide/0000-0001-8059-5427				Adani F, 2006, CHEMOSPHERE, V65, P1300, DOI 10.1016/j.chemosphere.2006.04.032; Andren O, 1997, ECOL APPL, V7, P1226, DOI 10.1890/1051-0761(1997)007[1226:ITICBM]2.0.CO;2; Aziz I., 2009, ACTIVE ORGANIC MATTE; BALDOCK JA, 1995, CARBON FORMS AND FUNCTIONS IN FOREST SOILS, P89; Barancikova G, 1997, GEODERMA, V78, P251, DOI 10.1016/S0016-7061(97)00033-5; Bardy M, 2008, GEODERMA, V145, P222, DOI 10.1016/j.geoderma.2008.03.008; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Celik I, 2011, INT J PLANT PROD, V5, P237; Chefetz B, 2000, ENVIRON SCI TECHNOL, V34, P2925, DOI 10.1021/es9912877; CHEN Y, 1977, SOIL SCI SOC AM J, V41, P352, DOI 10.2136/sssaj1977.03615995004100020037x; Conte P, 1997, GEODERMA, V80, P327, DOI 10.1016/S0016-7061(97)00058-X; D'Orazio V, 2014, PLANT SOIL, V374, P473, DOI 10.1007/s11104-013-1897-4; De Mastro F, 2019, SOIL RES, V57, P365, DOI 10.1071/SR18297; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; Dick DP, 2005, GEODERMA, V124, P319, DOI 10.1016/j.geoderma.2004.05.008; Ding G, 2002, SOIL SCI SOC AM J, V66, P421, DOI 10.2136/sssaj2002.0421; Ding XL, 2011, SOIL TILL RES, V114, P43, DOI 10.1016/j.still.2011.03.008; Dong LH, 2009, GEOMICROBIOL J, V26, P484, DOI 10.1080/01490450903061085; Drosos M, 2018, LAND DEGRAD DEV, V29, P1792, DOI 10.1002/ldr.2989; Drosos M, 2014, ENVIRON SCI POLLUT R, V21, P3963, DOI 10.1007/s11356-013-2302-9; Galantini J, 2006, SOIL TILL RES, V87, P72, DOI 10.1016/j.still.2005.02.032; Kumada K., 1987, Chemistry of soil organic matter., p241pp; Lguirati A, 2005, INT BIODETER BIODEGR, V56, P8, DOI 10.1016/j.ibiod.2005.03.004; Marinari S, 2010, GEODERMA, V156, P379, DOI 10.1016/j.geoderma.2010.03.007; Miikki V, 1997, CHEMOSPHERE, V34, P1639, DOI 10.1016/S0045-6535(97)00021-0; Moussadek R., 2014, APPL ENVIRON SOIL SC, DOI [10.1155/2014/654796, DOI 10.1155/2014/654796]; Ohno T, 2002, ENVIRON SCI TECHNOL, V36, P742, DOI 10.1021/es0155276; Panettieri M, 2013, AGR ECOSYST ENVIRON, V177, P48, DOI 10.1016/j.agee.2013.05.025; Piccolo A, 2018, FUTURE OF SOIL CARBON: ITS CONSERVATION AND FORMATION, P87, DOI 10.1016/B978-0-12-811687-6.00004-3; RICE JA, 1991, ORG GEOCHEM, V17, P635, DOI 10.1016/0146-6380(91)90006-6; Savy D, 2017, ACS SUSTAIN CHEM ENG, V5, P9023, DOI 10.1021/acssuschemeng.7b01928; Savy D, 2015, MOLECULES, V20, P19958, DOI 10.3390/molecules201119671; Swift R. S., 1996, Methods of soil analysis. Part 3 - chemical methods., P1011; Segnini A, 2013, SCI AGR, V70, P321, DOI 10.1590/S0103-90162013000500006; SENESI N, 1991, SOIL SCI, V152, P259, DOI 10.1097/00010694-199110000-00004; Singer MJ, 1998, GEOMORPHOLOGY, V24, P79, DOI 10.1016/S0169-555X(97)00102-5; Spaccini R, 2007, J AGR FOOD CHEM, V55, P2293, DOI 10.1021/jf0625398; Spaccini R, 2013, J GEOCHEM EXPLOR, V129, P45, DOI 10.1016/j.gexplo.2012.10.004; Sposito G., 2008, CHEM SOILS, V2nd; Stevenson F. J., 1982, Humus chemistry, genesis, composition, reactions.; Szajdak L, 2003, ORG GEOCHEM, V34, P693, DOI 10.1016/S0146-6380(03)00024-X; Tadini AM, 2018, SCI TOTAL ENVIRON, V613, P160, DOI 10.1016/j.scitotenv.2017.09.068; Tan KH, 2014, BOOKS SOIL PLANT ENV, P1, DOI 10.1201/b17037; Traversa A, 2014, CHEMOSPHERE, V111, P184, DOI 10.1016/j.chemosphere.2014.03.063; Xing BS, 2005, PEDOSPHERE, V15, P1; Zaccone C, 2009, GEODERMA, V148, P399, DOI 10.1016/j.geoderma.2008.11.017; Zepp RG, 1995, ROLE NONLIVING ORGAN; Zhang J, 2017, AEBMR ADV ECON, V33, P1	48	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219099	10.1371/journal.pone.0219099	http://dx.doi.org/10.1371/journal.pone.0219099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247049	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900078
J	Dollat, M; Talla, C; Sokhna, C; Sarr, FD; Trape, JF; Richard, V				Dollat, Marion; Talla, Cheikh; Sokhna, Cheikh; Sarr, Fatoumata Diene; Trape, Jean-Francois; Richard, Vincent			Measuring malaria morbidity in an area of seasonal transmission: Pyrogenic parasitemia thresholds based on a 20-year follow-up study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CLINICAL MALARIA; CASE DEFINITIONS; ANTIBODY-RESPONSES; INFECTION; COMMUNITY; DIELMO	Introduction Asymptomatic carriage of P. falciparum is frequent in areas endemic for malaria and individual diagnosis of clinical malaria attacks is still difficult. We investigated the impact of changes in malaria endemicity on the diagnostic criteria for malaria attacks in an area of seasonal malaria transmission. Methods We analyzed the longitudinal data collected over 20 years from a daily survey of all inhabitants of Ndiop, a rural community in central Senegal, in a logistic regression model to investigate the relationship between the level of Plasmodium falciparum parasitemia and the risk of fever, with the aim of determining the best parasitemia thresholds for attributing to malaria a fever episode. Results A total of 34,136 observations recorded from July 1993 to December 2013 from 850 individuals aged from 1 day to 87 years were included. P. falciparum asymptomatic carriage declined from 36% to 1% between 1993 and 2013. A total of 9,819 fever episodes were associated with a positive blood film for P. falciparum. Using age-dependent parasitemia thresholds for attributing to malaria a fever episode, we recorded 6,006 malaria attacks during the study period. Parasitemia thresholds seemed to be lower during the low-to-zero transmission season and tended to decrease with changes in control policies. The number of clinical malaria attacks was overestimated for all age groups throughout the study when all fever episodes associated with P. falciparum parasitemia were defined as malaria attacks. Conclusion Pyrogenic thresholds are particularly sensitive to changes in malaria epidemiology and are therefore an interesting tool to accurately assess the burden of malaria in the context of declining transmission.	[Dollat, Marion; Talla, Cheikh; Sarr, Fatoumata Diene; Richard, Vincent] Inst Pasteur, Unite Epidemiol Malad Infect, Dakar, Senegal; [Dollat, Marion] Hop Avicenne, AP HP, Serv Malad Infect & Trop, Paris, France; [Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, Lab Paludol, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Institut de Recherche pour le Developpement (IRD)	Dollat, M (corresponding author), Inst Pasteur, Unite Epidemiol Malad Infect, Dakar, Senegal.; Dollat, M (corresponding author), Hop Avicenne, AP HP, Serv Malad Infect & Trop, Paris, France.	dollatmarion@gmail.com	Talla, Cheikh/AAZ-5134-2020	Talla, Cheikh/0000-0003-0678-1226; Vincent, RICHARD/0000-0002-6961-1753	Institut Pasteur, Ministry of research...	Institut Pasteur, Ministry of research...	The Dielmo and Ndiop Cohort was implemented by "Institut Pasteur de Dakar" and "Institut de recherche pour le developpement" through their own budget funded by different sources (Institut Pasteur, Ministry of research...) since 1990. the combination of different funding was able to maintain the follow-up activities included in the annual budget of each institution. The staff of the IRD and Pasteur Institutes of Dakar and Paris contributed to the design, healthcare, data collection, and data treatment during the 20 years of the project.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; [Anonymous], WORLD MAL REP 2017; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bouvier P, 1997, AM J EPIDEMIOL, V145, P850, DOI 10.1093/oxfordjournals.aje.a009179; BRUCECHWATT LJ, 1952, ANN TROP MED PARASIT, V46, P173, DOI 10.1080/00034983.1952.11685522; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Delley V, 2000, TROP MED INT HEALTH, V5, P404, DOI 10.1046/j.1365-3156.2000.00566.x; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Espie E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137737; Fowkes FJI, 2016, PARASITOLOGY, V143, P139, DOI 10.1017/S0031182015001249; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; McGuinness D, 1998, T ROY SOC TROP MED H, V92, P527, DOI 10.1016/S0035-9203(98)90902-6; MILLER M. J., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P152, DOI 10.1016/0035-9203(58)90036-1; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073624; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050036; Perraut R, 2000, AM J TROP MED HYG, V62, P746, DOI 10.4269/ajtmh.2000.62.746; Perraut R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179146; RICHARD A, 1988, ANN SOC BELG MED TR, V68, P317; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P435, DOI 10.1016/0035-9203(85)90054-9; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; White MT, 2014, J INFECT DIS, V210, P1115, DOI 10.1093/infdis/jiu219; WHO, 2010, BAS MAL MICR	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0217903	10.1371/journal.pone.0217903	http://dx.doi.org/10.1371/journal.pone.0217903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246965	Green Submitted, Green Published, gold			2022-12-26	WOS:000484911900009
J	Kaaniche, F; Hamed, A; Abdel-Razek, AS; Wibberg, D; Abdissa, N; El Euch, IZ; Allouche, N; Mellouli, L; Shaaban, M; Sewald, N				Kaaniche, Fatma; Hamed, Abdelaaty; Abdel-Razek, Ahmed S.; Wibberg, Daniel; Abdissa, Negera; El Euch, Imene Zendah; Allouche, Noureddine; Mellouli, Lotfi; Shaaban, Mohamed; Sewald, Nobert			Bioactive secondary metabolites from new endophytic fungus Curvularia. sp isolated from Rauwolfia macrophylla	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PLANTS; IDENTIFICATION; ERGOSTEROL; ACID	Over the last decades, endophytic fungi represent a new source of pharmacologically active secondary metabolites based on the underlying assumption that they live symbiotically within their plant host. In the present study, a new endophytic fungus was isolated from Rauwolfia macrophylla, a medicinal plant from Cameroon. The fungus showed a highest homology to Curvularia sp. based on complete nucleotide sequence data generated from the internal transcribed spacer (ITS) of ribosomal DNA region. Large scale fermentation, working-up and separation of the strain extract using different chromatographic techniques afforded three bioactive compounds: 2'-deoxyribolactone (1), hexylitaconic acid (2) and ergosterol (3). The chemical structures of compounds 1-3 were confirmed by 1 and 2D NMR spectroscopy and mass spectrometry, and comparison with corresponding literature data. Biologically, the antimicrobial, antioxidant activities and the acetylcholinesterase inhibitory of the isolated compounds were studied.	[Kaaniche, Fatma; Hamed, Abdelaaty; Abdel-Razek, Ahmed S.; El Euch, Imene Zendah; Shaaban, Mohamed; Sewald, Nobert] Bielefeld Univ, Dept Chem Organ & Bioorgan Chem, Bielefeld, Germany; [Kaaniche, Fatma; Allouche, Noureddine] Univ Sfax, Fac Sci Sfax, Organ Chem Lab, Nat Subst Team, Sfax, Tunisia; [Kaaniche, Fatma; Mellouli, Lotfi] Ctr Biotechnol Sfax Tunisia, Lab Microorganisms & Biomol, Sfax, Tunisia; [Hamed, Abdelaaty] Al Azhar Univ, Dept Chem, Fac Sci, Nasr City Cairo, Egypt; [Abdel-Razek, Ahmed S.] Natl Res Ctr, Genet Engn & Biotechnol Res Div, Microbial Chem Dept, Dokki Giza, Egypt; [Wibberg, Daniel] Bielefeld Univ, Ctr Biotechnol CeBiTec, Bielefeld, Germany; [Abdissa, Negera] Jimma Univ, Dept Chem, Jimma, Ethiopia; [Shaaban, Mohamed] Natl Res Ctr, Pharmaceut & Drug Ind Res Div, Chem Nat Cpds Dept, Dokki, Egypt	University of Bielefeld; Universite de Sfax; Faculty of Sciences Sfax; Universite de Sfax; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Bielefeld; Jimma University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Sewald, N (corresponding author), Bielefeld Univ, Dept Chem Organ & Bioorgan Chem, Bielefeld, Germany.	Norbert.sewald@uni-bielefeld.de	Sewald, Norbert/A-2541-2012; Hamed, Abdelaaty/AAE-4161-2020; Abdel-Razek, Ahmed/G-3069-2016	Sewald, Norbert/0000-0002-0309-2655; Hamed, Abdelaaty/0000-0003-4119-7447; Abdel-Razek, Ahmed/0000-0001-7123-1904	German Academic Exchange Service (DAAD); German Federal Foreign Office [57166072]; Deutsche Forschungsgemeinschaft; Bielefeld University; BMBF [031A533]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Federal Foreign Office; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University; BMBF(Federal Ministry of Education & Research (BMBF))	This research work has been financed by the German Academic Exchange Service (DAAD) with funds from the German Federal Foreign Office in the frame of the Research Training Network "Novel Cytotoxic Drugs from Extremophilic Actinomycetes" (Project ID57166072), website: https://www.daad.de/en/. The Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University support for the Article Processing Charge.; The authors are thankful to the NMR and MS Departments in Bielefeld University for the spectral measurements. We thank Prof. Dr. Bruno Lenta Ndjakou, Chemistry Department-, Yaounde University, Cameroon for donating the fungal extracts as well as Mr. Sebastian Gohlke for his assistance regarding HPLC chromatography analysis. We thank also Carmela Michalek for biological activitiy tests and Marco Wissbrock for informatic technical assistance. The bioinformatics support of the BMBF-funded project "Bielefeld-Giessen Resource Center for Microbial Bioinformatics-BiGi (Grant number 031A533)" within the German Network for Bioinformatics Infrastructure (de.NBI) is gratefully acknowledged. This research work has been financed by the German Academic Exchange Service (DAAD) with funds from the German Federal Foreign Office in the frame of the Research Training Network "Novel Cytotoxic Drugs from Extremophilic Actinomycetes" (Project ID57166072).	Abdissa N, 2017, MOLECULES, V22, DOI 10.3390/molecules22071136; Alexandre TR, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0120-0; AMER MMA, 1980, PLANTA MED, P8; Antia BS, 2011, PHYTOCHEMISTRY, V72, P816, DOI 10.1016/j.phytochem.2011.02.013; Arunpanichlert J, 2016, NAT PROD RES, V30, P46, DOI 10.1080/14786419.2015.1032282; Avinash K. S., 2015, J MYCOL, V2015, P1, DOI 10.1155/2015/185821; Brun R, 2011, FUTURE MICROBIOL, V6, P677, DOI [10.2217/FMB.11.44, 10.2217/fmb.11.44]; Chen SD, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00085; De Schutter C, 2017, J ORG CHEM, V82, P13171, DOI 10.1021/acs.joc.7b02245; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Hamed A, 2019, NAT PROD RES, V33, P3029, DOI [10.1080/14786419.2018.1512997, 10.1080/14786419.2018.1544977]; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Hidayat I., 2016, CURR RES ENV APPL MY, V6, P132, DOI [10.5943/cream/6/2/7, DOI 10.5943/CREAM/6/2/7]; Ibrahim SRM, 2018, MINI-REV MED CHEM, V18, P1110, DOI 10.2174/1389557518666180305163151; ISOGAI A, 1984, AGR BIOL CHEM TOKYO, V48, P2607; Kageyama-Yahara N, 2010, BIOL PHARM BULL, V33, P142, DOI 10.1248/bpb.33.142; Kaul S, 2012, PHYTOCHEM REV, V11, P487, DOI 10.1007/s11101-012-9260-6; Klemke C, 2004, J NAT PROD, V67, P1058, DOI 10.1021/np034061x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee NK, 2016, FOOD SCI BIOTECHNOL, V25, P1627, DOI 10.1007/s10068-016-0250-0; Lenta BN, 2007, J ETHNOPHARMACOL, V111, P8, DOI 10.1016/j.jep.2006.10.036; Lenta BN, 2016, Z NATURFORSCH B, V71, P1159, DOI 10.1515/znb-2016-0128; Liu XL, 2008, APPL MICROBIOL BIOT, V78, P241, DOI 10.1007/s00253-007-1305-1; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; Mattila P, 2002, FOOD CHEM, V76, P293, DOI 10.1016/S0308-8146(01)00275-8; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; Mondol MAM, 2017, J NAT PROD, V80, P347, DOI 10.1021/acs.jnatprod.6b00785; Nakahashi A, 2009, BIOORG MED CHEM LETT, V19, P3027, DOI 10.1016/j.bmcl.2009.04.057; Neubauer PR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196797; Okabe M, 2009, APPL MICROBIOL BIOT, V84, P597, DOI 10.1007/s00253-009-2132-3; Pal P, 2017, RSC ADV, V7, P25897, DOI 10.1039/c6ra28598h; Pitnentel IC, 2006, BRAZ ARCH BIOL TECHN, V49, P705, DOI 10.1590/S1516-89132006000600003; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salat K, 2012, BEHAV PHARMACOL, V23, P407, DOI 10.1097/FBP.0b013e3283566042; Samanthi KAU, 2015, J NATL SCI FOUND SRI, V43, P217, DOI 10.4038/jnsfsr.v43i3.7950; Sellem I, 2016, BANGL J PHARMACOL, V11, P531, DOI 10.3329/bjp.v11i2.26001; Silva FD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195874; Tarawneh AH, 2013, NAT PROD COMMUN, V8, P1285; Torres S, 2017, NAT PROD RES, V31, P473, DOI 10.1080/14786419.2016.1185717; Tsukamoto S, 2006, BIOORG MED CHEM LETT, V16, P69, DOI 10.1016/j.bmcl.2005.09.052; Witczak ZJ, 1999, CURR MED CHEM, V6, P165; Xia Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198994; Zhou L, 2010, MINI-REV MED CHEM, V10, P977, DOI 10.2174/138955710792007178	44	27	33	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0217627	10.1371/journal.pone.0217627	http://dx.doi.org/10.1371/journal.pone.0217627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247016	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900008
J	Kidd, M; Drozdov, IA; Matar, S; Gurunlian, N; Ferranti, NJ; Malczewska, A; Bennett, P; Bodei, L; Modlin, IM				Kidd, Mark; Drozdov, Ignat A.; Matar, Somer; Gurunlian, Nicole; Ferranti, Nicholas J.; Malczewska, Anna; Bennett, Philip; Bodei, Lisa; Modlin, Irvin M.			Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; POLYMERASE-CHAIN-REACTION; TIME PCR; BLOOD; TRANSCRIPTS; CANCER; EXPRESSION; CELLS; RNA; LIMITATIONS	Background Multigene-based PCR tests are time-consuming and limiting aspects of the protocol include increased risk of operator-based variation. In addition, such protocols are complex to transfer and reproduce between laboratories. Aims Evaluate the clinical utility of a pre-spotted PCR plate (PSP) for a novel multigene (n = 51) blood-based gene expression diagnostic assay for neuroendocrine tumors (NETs). Methods A pilot study (n = 44; 8 controls and 36 NETs) was undertaken to compare C-Q, normalized gene expression and algorithm-based output (NETest score). Gene expression was then evaluated between matched blood: tumor tissue samples (n = 7). Thereafter, two prospective sets (diagnostic: n = 167; clinical validation: n = 48, respectively) were evaluated for diagnostic and clinical utility value. Two independent molecular diagnostics facilities were used to assess assay reproducibility and inter-laboratory metrics. Samples were collected (per CLIA protocol) processed to mRNA and cDNA and then either run per standard assay (liquid primers) or on PSPs. Separately, matching plasma samples were analyzed for chromogranin A (CgA). Statistics included non-parametric testing, Pearson-concordance, Predictive Modeling and AUROC analyses. Results In the pilot study (n = 44), C-Q values were highly concordant (r: 0.82, p<0.0001) and normalized gene expression data significantly related (p<0.0001) (Pearson-pairwise correlation). NETest values were not different (49.7 +/- 33 standard vs. 48.5 +/- 31.5 PSP) and the overall concordance in output 96%. Predictive modelling confirmed this concordance (F1 score = 0.95). Gene expression levels were highly correlated between blood and tumor tissue (R: 0.71-0.83). In the diagnostic cohort (n = 30 controls, n = 87 non-NET controls, n = 50 NET), NETest was significantly lower (p<0.0001) in controls (11 +/- 6.5) and non-NET controls (13 +/- 18) than NETs (61 +/- 31). The AUROCs were 0.93-0.97 and the diagnostic accuracy was 90-97.5%. As a diagnostic, the PSP-NETest was significantly better than CgA (accuracy: 56%, p<0.0001). For clinical samples, the PSP generated robust and accurate (>96%) scores and was significantly better (p<0.0001) than CgA. The assay protocol was consistent (r: 0.97) and reproducible (co-efficient of variation: 1.3-4.2%) across the two facilities. Conclusion The PSP protocol for the NETest has been established and prospectively tested in clinical samples. It is highly reproducible, has similar metrics (CV, categorization by control or NET) to the standard PCR assay and generates clinically concordant (>96%) NETest results. Moreover, it functions significantly more accurately than CgA.	[Kidd, Mark; Drozdov, Ignat A.; Matar, Somer; Ferranti, Nicholas J.] Wren Labs, Branford, CT 06405 USA; [Gurunlian, Nicole; Bennett, Philip] Sarah Cannon Mol Diagnost, London, England; [Malczewska, Anna] Med Univ Silesia, Katowice, Poland; [Bodei, Lisa] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Modlin, Irvin M.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Medical University Silesia; Memorial Sloan Kettering Cancer Center; Yale University	Kidd, M (corresponding author), Wren Labs, Branford, CT 06405 USA.; Modlin, IM (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	mkidd@wrenlaboratories.com; imodlin@optoninline.net	Bodei, Lisa/AAE-9798-2020; Kidd, Mark/G-9328-2013	Malczewska, Anna/0000-0003-0321-4832; Kidd, Mark/0000-0002-1525-5167; Drozdov, Ignat/0000-0001-6727-4688	Clifton Life Sciences	Clifton Life Sciences	The study was funded by Clifton Life Sciences. They played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen FJ, 2018, CLIN CANCER RES, V24, P2182, DOI 10.1158/1078-0432.CCR-17-3378; Cwikla JB, 2015, J CLIN ENDOCR METAB, V100, pE1437, DOI 10.1210/jc.2015-2792; De la Taille A, 1999, ONCOLOGY-NY, V13, P187; de la Taille A, 1999, ONCOLOGY WILLISTON P, V13, P94; Dingemans AMC, 1997, LAB INVEST, V77, P213; Filosso PL, 2018, EUR J CARDIO-THORAC, V53, P631, DOI 10.1093/ejcts/ezx386; Gala JL, 1998, CLIN CHEM, V44, P472; Genc CG, 2018, J SURG ONCOL, V118, P37, DOI 10.1002/jso.25129; Granade TC, 2018, J VIROL METHODS, V259, P60, DOI 10.1016/j.jviromet.2018.06.001; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Henke W, 1998, INT J CANCER, V77, P164, DOI 10.1002/(SICI)1097-0215(19980703)77:1<164::AID-IJC25>3.0.CO;2-D; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Kidd M, 2017, ONCOTARGET, V9, P7182, DOI DOI 10.18632/0NC0TARGET.23820; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Kidd M, 2015, ENDOCR-RELAT CANCER, V22, P561, DOI 10.1530/ERC-15-0092; Knezevic D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-690; Lambrechts AC, 1998, ANN ONCOL, V9, P1269, DOI 10.1023/A:1008445604263; Liu E, 2018, ONCOLOGIST; Malczewska A., 2019, NEUROENDOCRINOLOGY; Malczewska A, 2019, NEUROENDOCRINOLOGY, V108, P219, DOI 10.1159/000497037; Marotta V, 2018, ENDOCR-RELAT CANCER, V25, pR11, DOI 10.1530/ERC-17-0269; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Modlin IM, 2015, AM J GASTROENTEROL, V110, P1223, DOI 10.1038/ajg.2015.160; Modlin IM, 2016, SURGERY, V159, P336, DOI 10.1016/j.surg.2015.06.056; Modlin IM, 2014, ENDOCR CONNECT, V3, DOI 10.1530/EC-14-0100; Modlin IM, 2014, CLIN CHEM LAB MED, V52, P419, DOI 10.1515/cclm-2013-0496; Modlin IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063364; Pavel M, 2016, NEUROENDOCRINOLOGY, V103, P172, DOI 10.1159/000443167; Raza A, 2012, MOL BIOL REP, V39, P7421, DOI 10.1007/s11033-012-1574-3; Rosa SF, 2016, FOOD CHEM, V201, P110, DOI 10.1016/j.foodchem.2016.01.007; Siravegna G, 2017, NAT REV CLIN ONCOL, V2, P14; Snoek J., 2012, ADV NEURAL INFORM PR, V2, P2951, DOI DOI 10.48550/ARXIV.1206.2944; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vuttariello E, 2013, MOL BIOTECHNOL, V54, P954, DOI 10.1007/s12033-012-9646-0; WU DY, 1991, DNA CELL BIOL, V10, P233, DOI 10.1089/dna.1991.10.233; You YN, 2015, SURG ONCOL, V24, P61, DOI 10.1016/j.suronc.2015.02.001; Zippelius A, 1997, J CLIN ONCOL, V15, P2701, DOI 10.1200/JCO.1997.15.7.2701; ZWEIG MH, 1993, CLIN CHEM, V39, P561	41	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218592	10.1371/journal.pone.0218592	http://dx.doi.org/10.1371/journal.pone.0218592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247038	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900030
J	Stivalet, O; Paisant, A; Belabbas, D; Omarjee, L; Le Faucheur, A; Landreau, P; Garlantezec, R; Jaquinandi, V; Liedl, DA; Wennberg, PW; Mahe, G				Stivalet, O.; Paisant, A.; Belabbas, D.; Omarjee, L.; Le Faucheur, A.; Landreau, P.; Garlantezec, R.; Jaquinandi, V.; Liedl, D. A.; Wennberg, P. W.; Mahe, G.			Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; OXYGEN-PRESSURE MEASUREMENTS; RELIABILITY; MANAGEMENT	Background The sensitivity and specificity of exercise testing have never been studied simultaneously against an objective quantification of arterial stenosis. Aims were to define the sensitivity and specificity of several exercise tests to detect peripheral artery disease (PAD), and to assess whether or not defined criteria defined in patients suspected of having a PAD show a difference dependent on the resting ABI. Methods In this prospective study, consecutive patients with exertional limb pain referred to our vascular center were included. All patients had an ABI, a treadmill exercise-oximetry test, a second treadmill test (both 10% slope; 3.2km/h speed) with post-exercise pressures, and a computed-tomography-angiography (CTA). The receiver-operating-characteristic curve was used to define a cut-off point corresponding to the best area under the curve (AUC; [CI95%]) to detect arterial stenosis >= 50% as determined by the CTA. Results Sixty-three patients (61+/-11 years-old) were included. Similar AUCs from 0.72[0.63-0.79] to 0.83[0.75-0.89] were found for the different tests in the overall population. To detect arterial stenosis >= 50%, cut-off values of ABI, post-exercise ABI, post-exercise ABI decrease, post-exercise ankle pressure decrease, and distal delta from rest oxygen pressure (DROP) index were <= 0.91, <= 0.52, >= 43%, >= 20mmHg and <=-15mmHg, respectively (p<0.01). In the subset of patients with an ABI >0.91, cut-off values of post-exercise ABI decrease (AUC = 0.67[0.53-0.78]), and DROP (AUC = 0.67[0.53-0.78]) were >= 18.5%, and <=-15mmHg respectively (p<0.05). Conclusion Resting ABI is as accurate as exercise testing in patients with exertional limb pain. Specific exercise testing cut-off values should be used in patients with normal ABI to diagnose PAD.	[Stivalet, O.; Omarjee, L.; Landreau, P.; Jaquinandi, V.; Mahe, G.] CHU Rennes, Vasc Med Unit, Rennes, France; [Stivalet, O.] CH St Malo, Vasc Med, St Malo, France; [Paisant, A.; Belabbas, D.] CHU Rennes, Dept Radiol, Rennes, France; [Omarjee, L.] CH Redon, Vasc Med Unit, Redon, France; [Le Faucheur, A.; Garlantezec, R.; Jaquinandi, V.; Mahe, G.] Univ Rennes, INSERM, CIC, Rennes, France; [Le Faucheur, A.] Ecole Normale Super, Bruz, France; [Liedl, D. A.; Wennberg, P. W.; Mahe, G.] Mayo Clin, Gonda Vasc Ctr, Rochester, MN 55905 USA	CHU Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Mayo Clinic	Mahe, G (corresponding author), CHU Rennes, Vasc Med Unit, Rennes, France.; Mahe, G (corresponding author), Univ Rennes, INSERM, CIC, Rennes, France.; Mahe, G (corresponding author), Mayo Clin, Gonda Vasc Ctr, Rochester, MN 55905 USA.	maheguillaume@yahoo.fr	ronan, Garlantezec/ABF-7638-2020; OMARJEE, Loukman/AAM-4873-2020; LE FAUCHEUR, Alexis/AAK-3232-2021; , Mahe/AAF-7983-2020	LE FAUCHEUR, Alexis/0000-0002-3688-6574; OMARJEE, Loukman/0000-0001-7766-396X				Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Abraham P, 2003, CIRCULATION, V107, P1896, DOI 10.1161/01.CIR.0000060500.60646.E0; Abraham P, 1997, AM J SPORT MED, V25, P581, DOI 10.1177/036354659702500424; Aday AW, 2016, CIRCULATION, V134; Aday AW, 2018, VASC MED; Bruneau A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062651; Chaudru S, 2016, EUR J VASC ENDOVASC, V51, P240, DOI 10.1016/j.ejvs.2015.09.005; Donnou C, 2017, VASC MED; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gardner AW, 1998, ANGIOLOGY, V49, P723; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, pE71, DOI 10.1016/j.jacc.2016.11.007; Grenon S Marlene, 2009, N Engl J Med, V361, pe40, DOI 10.1056/NEJMvcm0807012; Henni S, 2018, MICROVASC RES, V117, P44, DOI 10.1016/j.mvr.2018.01.003; Hoogeveen EK, 2008, EUR J CLIN INVEST, V38, P290, DOI 10.1111/j.1365-2362.2008.01946.x; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Koch C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004522; LAING S, 1983, BRIT J SURG, V70, P628, DOI 10.1002/bjs.1800701017; LAING SP, 1980, BRIT MED J, V280, P13, DOI 10.1136/bmj.280.6206.13; Mahe G, 2018, PRESSE MED, V47, P47, DOI 10.1016/j.lpm.2017.09.021; Mahe Guillaume, 2015, Front Cardiovasc Med, V2, P33, DOI 10.3389/fcvm.2015.00033; Mahe G, 2016, J ENDOVASC THER, V23, P233, DOI 10.1177/1526602815621757; Mahe G, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001277; Mahe G, 2015, VASC MED, V20, P251, DOI 10.1177/1358863X14567030; Ouedraogo N, 2011, PHYSIOL MEAS, V32, P181, DOI 10.1088/0967-3334/32/2/003; OURIEL K, 1982, SURGERY, V91, P686; Poulin A, 2018, ATHEROSCLEROSIS; Romano M, 2004, EUR J RADIOL, V50, P303, DOI 10.1016/S0720-048X(03)00118-9; van Langen H, 2009, VASC MED, V14, P221, DOI 10.1177/1358863X08101017; WINSOR T, 1950, AM J MED SCI, V220, P117, DOI 10.1097/00000441-195008000-00001; Xu DC, 2010, VASC MED, V15, P361, DOI 10.1177/1358863X10378376	30	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0219082	10.1371/journal.pone.0219082	http://dx.doi.org/10.1371/journal.pone.0219082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31247050	Green Published, Green Submitted, gold			2022-12-26	WOS:000484911900076
J	Vahdati, K; Bavani, ARM; Khosh-Khui, M; Fakour, P; Sarikhani, S				Vahdati, Kourosh; Bavani, Ali Reza Massah; Khosh-Khui, Morteza; Fakour, Poya; Sarikhani, Saadat			Applying the AOGCM-AR5 models to the assessments of land suitability for walnut cultivation in response to climate change: A case study of Iran	PLOS ONE			English	Article							WINTER CHILL; FRUIT; IMPACTS	Due to higher temperatures and lower water availability, climate change is likely to have a major impact on walnut production in the near future. Climate change will alter the land suitability for walnut cultivation around the world, especially in arid and semi-arid regions like Iran. Here, land suitability for the cultivation of walnut (Juglans regia L.) in Iran was determined using the GIS for present and future conditions (2020-2049) with an approach to climate change. Accordingly, data from 375 synoptic stations throughout Iran were gathered for climatic factors including average, minimum and maximum temperatures, relative humidity and chilling requirement. Also, ASTER sensors (Advanced Spaceborne Thermal Emission and Reflection Radiometer) and their data provided this research with cells that make a precision of 150 m (5 s), and the data were used for gauging geological parameters such as altitude and land slope. The electrical conductivity (EC) of soil and water were informed by the data bank of the Iranian Water Resources Management. The results of temperature simulations for the future (2020-2049) were analyzed by 21 AOGCM-AR5 models under the RCP4.5 emission scenario. In the first phase of evaluations, the maps of land suitability were constructed for present conditions by considering a network of the above-mentioned parameters. By combining these layers of information, the final map of land suitability was illustrated for walnut cultivation. In the second phase, the NEX-GDDP was used in order to determine land suitability for the future (2020-2049). The results showed that Iran currently has 582844 km(2) of land suitable for walnut cultivation. However, the future will see less suitable lands: the current area will be reduced by 6.19%, from 582844 km(2) to 546710 km(2). In general, the northern, northwestern and western margins of Iran are currently suitable for walnut cultivation. By approximation, these lands will also be major areas for prospective cultivations of walnut in the future (2020-2049), even though their current stretch will be reduced.	[Vahdati, Kourosh; Sarikhani, Saadat] Univ Tehran, Dept Hort, Coll Aburaihan, Tehran, Iran; [Bavani, Ali Reza Massah; Fakour, Poya] Univ Tehran, Dept Irrigat & Drainage, Coll Aburaihan, Tehran, Iran; [Khosh-Khui, Morteza] Shiraz Univ, Coll Agr, Dept Hort Sci, Shiraz, Iran	University of Tehran; University of Tehran; Shiraz University	Vahdati, K (corresponding author), Univ Tehran, Dept Hort, Coll Aburaihan, Tehran, Iran.	kvahdati@ut.ac.ir	Sarikhani, Saadat/V-7277-2018	Sarikhani, Saadat/0000-0001-6534-3643; Fakour, Poya/0000-0003-1011-5939; Vahdati, Kourosh/0000-0001-8458-8697; Massah Bavani, Ali Reza/0000-0002-5433-1791				Abd-Elmabod SK, 2013, GEOPH RES ABSTR, V15; AbdelRahman MAE, 2016, EGYPT J REMOTE SENS, V19, P125, DOI 10.1016/j.ejrs.2016.02.001; Ahmadi K, 2017, IRAN AGR STAT 2015 2; Alizadeh-Choobari O, 2018, CLIM DYNAM, V50, P249, DOI 10.1007/s00382-017-3602-4; [Anonymous], 2005, NUT GROWERS GUIDE CO; [Anonymous], [No title captured]; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Brown M.E., 2015, CLIMATE CHANGE GLOBA, DOI [10.7930/J0862DC7, DOI 10.7930/J0862DC7]; Dhami J., 2012, J AGROMETEOROL, V14, P464; Eccel E, 2009, INT J BIOMETEOROL, V53, P273, DOI 10.1007/s00484-009-0213-8; Falahati F, 2012, GEOGRAPHY ENV SUSTAI, V2, P54; Fallahi E, 2017, HORTSCIENCE, V52, P1145, DOI 10.21273/HORTSCI12080-17; Fazel Amiri, 2012, African Journal of Agricultural Research, V7, P89; Gao ZQ, 2018, INT CONF MEAS, P358, DOI 10.1109/ICMTMA.2018.00093; Germain, 1999, NOYER; Ghosh JK., 2012, APPL CHAOS NONLINEAR, V2, P21; Hassankhah A., 2017, INT J HORTIC SCI TEC, V4, P259, DOI DOI 10.22059/IJHST.2018.260944.249; IBP, 2015, IR CO LAWS REG HDB, V1; INC, 2018, NUTS AND DRIED FRUIT; Jones PD, 1996, INT J CLIMATOL, V16, P361, DOI [10.1002/(SICI)1097-0088(199604)16:4<361::AID-JOC53>3.0.CO;2-F, 10.1002/(SICI)1097-0088(199604)16:4&lt;361::AID-JOC53&gt;3.0.CO;2-F]; Luedeling E, 2011, PLOS ONE, V6, P20155, DOI DOI 10.1371/J0URNAL.P0NE.0020155; Luedeling E, 2012, SCI HORTIC-AMSTERDAM, V144, P218, DOI 10.1016/j.scienta.2012.07.011; Maurer EP, 2007, CLIMATIC CHANGE, V82, P309, DOI 10.1007/s10584-006-9180-9; Mesgaran MB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08066-y; Monteith JL, 2013, PRINCIPLES OF ENVIRONMENTAL PHYSICS: PLANTS, ANIMALS, AND THE ATMOSPHERE, 4TH EDITION, P1; Nisfariza Mohd N. M., 2008, Pertanika Journal of Tropical Agricultural Science, V31, P147; Ochieng J, 2016, NJAS-WAGEN J LIFE SC, V77, P71, DOI 10.1016/j.njas.2016.03.005; Qiu B.W, 2005, T CSAE, V21, P667; Ramirez F, 2015, SPRINGERBRIEFS PLANT, P31, DOI [10.1007/978-3-319-14200-5_9, DOI 10.1007/978-3-319-14200-5_9]; Ramos DE, 1997, WALNUT PRODUCTION MA, V3373; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Soleimani A, 2011, PROGR HORTICULTURE, V43, P173; Talaei AR, 2006, ACTA HORTIC, P29, DOI 10.17660/ActaHortic.2006.726.1; Teka K, 2012, MOMONA ETHIOP J SCI, V4, P64; Vahdati K, 2018, IRANIAN J HORTICULTU; Van Chuong H., 2011, J SCI HUE U, V67, P13; Wrege MS, 2010, ACTA HORTIC, V872, P31, DOI DOI 10.17660/ACTAH0RTIC.2010.872.2; Zhao XF, 2014, ADV MAT RES, V955, P3777, DOI [10.4028/www.scientific.net/AMR.955-959.3777, DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.955-959.3777]; Ziadat F.M., 2006, J J AGR SCI, V2, P372	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218725	10.1371/journal.pone.0218725	http://dx.doi.org/10.1371/journal.pone.0218725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246980	Green Submitted, Green Published, gold			2022-12-26	WOS:000484911900034
J	Durst, MA; Ratia, K; Lavie, A				Durst, Matthew A.; Ratia, Kiira; Lavie, Arnon			Identifying small molecule probes of ENTPD5 through high throughput screening	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; PROSTATE-CANCER; EXPRESSION; PTEN	Ectonucleoside Triphosphate Diphosphohydrolase 5 (ENTPD5) has been shown to be important in maintaining cellular function in cancer, and its expression is upregulated through multiple, unique pathways in certain cancers, including laryngeal, glioblastoma multiforme, breast, testicular, and prostate. ENTPD5 supports cancer growth by promoting the import of UDP- glucose, a metabolite used for protein glycosylation and hence proper glycoprotein folding, into the ER by providing the counter molecule, UMP, to the ER antiporter. Despite its cancer- supporting function, no small molecule inhibitors of ENTPD5 are commercially available, and few studies have been performed in tissue culture to understand the effects of chemical inhibition of ENTPD5. We performed a high- throughput screen (HTS) of 21,120 compounds to identify small molecule inhibitors of ENPTD5 activity. Two hits were identified, and we performed a structure activity relationship (SAR) screen around these hits. Further validation of these probes were done in an orthogonal assay and then assayed in cell culture to assess their effect on prostate cancer cell lines. Notably, treatment with the novel ENTPD5 inhibitor reduced the amount of glycoprotein produced in treated cells, consistent with the hypothesis that ENTPD5 is important for glycoprotein folding. This work serves as an important step in designing new molecular probes for ENTPD5 as well as further probing the utility of targeting ENTPD5 to combat cancer cell proliferation.	[Durst, Matthew A.; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Ratia, Kiira] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Ratia, Kiira] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Lavie, Arnon] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.; Lavie, A (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL 60612 USA.	Lavie@uic.edu		Durst, Matthew/0000-0001-9513-2361; Lavie, Arnon/0000-0001-5591-8722	American Medical Association Foundation; University of Illinois College of Medicine CCTS Pre-doctoral Education for Clinical and Translational Scientists fellowship (2016-2017)	American Medical Association Foundation; University of Illinois College of Medicine CCTS Pre-doctoral Education for Clinical and Translational Scientists fellowship (2016-2017)	This work was supported by a American Medical Association Foundation Seed Grant (2016-2017) and by the University of Illinois College of Medicine CCTS Pre-doctoral Education for Clinical and Translational Scientists fellowship (2016-2017) to MAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, THESIS; Antanasijevic A, 2016, J BIOMOL NMR, V64, P255, DOI 10.1007/s10858-016-0025-1; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Hay CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139990; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Horak P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03739; Murphy-Piedmonte DM, 2005, BBA-PROTEINS PROTEOM, V1747, P251, DOI 10.1016/j.bbapap.2004.11.017; Neel DS, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0007-0; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Picanco-Albuquerque CG, 2016, VIRCHOWS ARCH, V468, P607, DOI 10.1007/s00428-016-1904-2; Read R, 2009, VET PATHOL, V46, P491, DOI 10.1354/vp.08-VP-0201-R-AM; Segura-Pena D, 2004, J BIOL CHEM, V279, P33882, DOI 10.1074/jbc.M401989200; Sundlov JA, 2012, BIOCHEMISTRY-US, V51, P6493, DOI 10.1021/bi300934s; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Verhagen PCMS, 2006, J PATHOL, V208, P699, DOI 10.1002/path.1929; Vidotto T, 2018, MOL CYTOGENET, V11, DOI 10.1186/s13039-017-0348-y; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; Vogiatzi F, 2016, P NATL ACAD SCI USA, V113, pE8433, DOI 10.1073/pnas.1612711114; Zebisch M, 2014, J STRUCT BIOL, V185, P336, DOI 10.1016/j.jsb.2014.01.005; Zebisch M, 2012, J MOL BIOL, V415, P288, DOI 10.1016/j.jmb.2011.10.050; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	24	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0210305	10.1371/journal.pone.0210305	http://dx.doi.org/10.1371/journal.pone.0210305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242188	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600001
J	Brezzi, M; Bertisch, B; Roelens, M; Moradpour, D; Beretta-Piccoli, BT; Semmo, N; Mullhaupt, B; Semela, D; Negro, F; Keiser, O				Brezzi, Matteo; Bertisch, Barbara; Roelens, Maroussia; Moradpour, Darius; Beretta-Piccoli, Benedetta Terziroli; Semmo, Nasser; Mullhaupt, Beat; Semela, David; Negro, Francesco; Keiser, Olivia		Swiss Hepatitis C Cohort Study	Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study	PLOS ONE			English	Article							VIRUS-INFECTION; GENERAL-POPULATION; NATIONAL-HEALTH; RISK-FACTORS; EPIDEMIOLOGY; PREVALENCE; RIBAVIRIN	Late diagnosis and treatment may increase morbidity and mortality among persons with hepatitis C virus (HCV) infection. We included all participants of the Swiss Hepatitis C Cohort Study (SCCS). We used unadjusted and adjusted logistic and Cox regressions to determine the association between the geographic origin of the participants and the following outcomes: antiviral treatment status; sustained virologic response; cirrhosis at enrolment; incident cirrhosis; loss to follow-up (LTFU); and mortality. The analyses were adjusted for sex, baseline age, education, source of income, alcohol consumption, injection drug use (IDU), HCV genotype, HIV or HBV coinfection, duration of HCV infection, time since enrolment, cirrhosis, (type of) HCV treatment, and centre at enrolment. Among 5,356 persons, 1,752 (32.7%) were foreign-born. IDU was more common among Swiss- (64.1%) than foreign-born (36.6%) persons. Cirrhosis at enrolment was more frequent among foreign- than Swiss-born persons, reflecting the high frequency of cirrhosis among Italian-born persons who acquired HCV between 1950 and 1970 in Italian healthcare settings. Although antiviral treatment coverage was similar, the sustained viral response rate was increased and the mortality was lower among foreign-vs. Swiss-born persons, with the lowest mortality in persons from Asia/Oceania. LTFU was more frequent in persons from Germany, Eastern and Southern Europe, and the Americas. In conclusion, in Switzerland, a country with universal healthcare, geographic origin had no influence on hepatitis C treatment access, and the better treatment outcomes among foreign-born persons were likely explained by their lower prevalence of IDU and alcohol consumption than among Swiss-born persons.	[Brezzi, Matteo; Bertisch, Barbara; Roelens, Maroussia; Keiser, Olivia] Univ Geneva, Inst Global Hlth, Geneva, Switzerland; [Moradpour, Darius] Univ Hosp Lausanne, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Beretta-Piccoli, Benedetta Terziroli] Fdn Epatoctr Ticino, Lugano, Switzerland; [Semmo, Nasser] Univ Bern, Dept BioMed Res Hepatol, Bern, Switzerland; [Mullhaupt, Beat] Univ Hosp Zurich, Swiss Hepatopancreatobiliary Ctr, Zurich, Switzerland; [Mullhaupt, Beat] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Semela, David] Cantonal Hosp St Gallen, Div Gastroenterol & Hepatol, St Gallen, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland	University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Geneva; University of Geneva	Bertisch, B (corresponding author), Univ Geneva, Inst Global Hlth, Geneva, Switzerland.	barbara.bertisch-moellenhoff@unige.ch		Bertisch, Barbara/0000-0003-1725-4245; Terziroli Beretta-Piccoli, Benedetta/0000-0001-5004-5029	Swiss National Science Foundation [3347C0-108782/1, 33CS30-148417/1, 163878]; AbbVie; Bristol Myers Squibb; Gilead; Janssen-Cilag; MSD; Novartis; Roche Pharma Switzerland; Roche Diagnostics	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); AbbVie(AbbVie); Bristol Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; Novartis(Novartis); Roche Pharma Switzerland; Roche Diagnostics	This work was supported by Swiss National Science Foundation grants 3347C0-108782/1 and 33CS30-148417/1 to the Swiss Hepatitis C Cohort Study and unrestricted grants to the Swiss Hepatitis C Cohort Study Foundation by AbbVie, Bristol Myers Squibb, Gilead, Janssen-Cilag, MSD, Novartis, Roche Pharma Switzerland and Roche Diagnostics. OK is funded by Swiss National Science Foundation Professorship Grant Number 163878. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrea B, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14544; [Anonymous], 2014, MIGR REP 2014; Bertisch B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155464; Brunner NFL, 2015, ADDICTION MED, V17, P259; Carballo M, 2016, J FAM MED, V3, P1065; Chiaramonte M, 1996, J HEPATOL, V24, P129, DOI 10.1016/S0168-8278(96)80020-1; Cominetti F, 2015, ANAL SITUATION HEPAT; Cooper C, 2019, J HEPATOL, V70, pE328, DOI 10.1016/S0618-8278(19)30641-3; Ditah I, 2015, AM J GASTROENTEROL, V110, P1126, DOI 10.1038/ajg.2015.31; Ditah I, 2014, J HEPATOL, V60, P691, DOI 10.1016/j.jhep.2013.11.014; European Centre for Disease Prevention and Control, 2016, EP ASS HEP B C MIGR; Giudici F, 2016, J VIRAL HEPATITIS, V23, P697, DOI 10.1111/jvh.12535; Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Kanwal F, 2007, HEPATOLOGY, V46, P1741, DOI 10.1002/hep.21927; Kramer JR, 2011, AM J GASTROENTEROL, V106, P483, DOI 10.1038/ajg.2010.430; Le Lan C, 2012, J HEPATOL, V56, P334, DOI 10.1016/j.jhep.2011.05.021; Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6; Mravcik V, 2013, PATIENT PREFER ADHER, V7, P1067, DOI 10.2147/PPA.S49113; Negro F, 2019, INT LIV C VIENN; Negro F, 2014, DIGEST LIVER DIS, V46, pS158, DOI 10.1016/j.dld.2014.09.023; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Prasad L, 2007, INT J EPIDEMIOL, V36, P731, DOI 10.1093/ije/dym096; Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003; Riestra S, 2001, EUR J GASTROEN HEPAT, V13, P477, DOI 10.1097/00042737-200105000-00003; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Meer AJ, 2016, J HEPATOL, V65, pS95, DOI 10.1016/j.jhep.2016.07.039; Witteck A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13193; Wong RJ, 2018, AM J GASTROENTEROL, V113, P1329, DOI 10.1038/s41395-018-0033-8; Zahnd C, 2017, ANAL SITUATION HEPAT	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218706	10.1371/journal.pone.0218706	http://dx.doi.org/10.1371/journal.pone.0218706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233524	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000484896700030
J	Satoto, TBT; Satrisno, H; Lazuardi, L; Diptyanusa, A; Purwaningsih; Rumbiwati; Kuswati				Satoto, Tri Baskoro Tunggul; Satrisno, Hary; Lazuardi, Lutfan; Diptyanusa, Ajib; Purwaningsih; Rumbiwati; Kuswati			Insecticide resistance in Aedes aegypti: An impact from human urbanization?	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; PYRETHROID RESISTANCE; DENGUE; MUTATIONS; EVOLUTION; POPULATIONS; INDONESIA; DIPTERA; VECTOR; LARVAE	In the city of Magelang, Indonesia, the distribution of Dengue Haemorhagic Fever (DHF) cases tend to be clustered, ever changing along with human urbanization from 2014 to 2017. Although DHF cases have been less reported in the city of Magelang for the past 5 years, vector control measures by using insecticide space spraying, particularly permethrin, have been continuously performed. Current study aimed to detect kdr mutations associated with pyrethroid resistance in Ae. aegypti and to study possible association between insecticide resistance and DHF case distribution related to human urbanization. The study was a cross sectional study conducted in 3 sub-districts in the city of Magelang, Central Java, Indonesia. Eggs of Ae. aegypti collected from 195 sample households were reared and were tested for resistance to pyrethroids by using PCR. Primers AaSCF1 and AaSCR4, and primers AaSCF7 and AaSCR7 were used in detecting presence of mutation in VGSC IIS6 and IIIS6 gene, respectively. Fragments of amplified DNA were sequenced and were analyzed. Spatio-temporal using Standard Deviational Ellipse (SDE) was performed to obtain mapping of DHF case distribution trends. The total number of DHF case was 380 cases, with the most cases (158) occurred in 2015 and the least cases (66) reported in 2017. DHF case distribution was grouped into several clusters. SDE calculation demonstrated movement of DHF case in the direction to principal arterial road, suggesting link to urbanization. Gene sequencing demonstrated VGSC IIS6 gene mutation (S989P and V1016G) in Ae. aegypti collected from study areas, indicating resistance to permethrin. VGSC IIIS6 gene mutation was not found. Current study concluded that multiple kdr mutations associated with resistance to pyrethroid was detected in Ae. aegypti, and that human urbanization may have a role in the development of such resistance.	[Satoto, Tri Baskoro Tunggul] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Ctr Trop Med, Res & Dev Bldg,Jalan Persatuan, Yogyakarta, Indonesia; [Satrisno, Hary] Kapuas Dist Hlth Off, Cent Kalimantan, Indonesia; [Lazuardi, Lutfan] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Publ Hlth, Yogyakarta, Indonesia; [Diptyanusa, Ajib; Rumbiwati; Kuswati] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Parasitol, Yogyakarta, Indonesia; [Purwaningsih] Hlth Lab Cent Sulawesi, Cent Sulawesi, Indonesia	Gadjah Mada University; Gadjah Mada University; Gadjah Mada University	Satoto, TBT (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Ctr Trop Med, Res & Dev Bldg,Jalan Persatuan, Yogyakarta, Indonesia.	tribaskoro@ugm.ac.id	Diptyanusa, Ajib/AAG-3390-2019	Diptyanusa, Ajib/0000-0002-1860-0923	Magelang Health Office	Magelang Health Office	The authors are grateful for the support from Magelang Health Office and the help from all the laboratory personnel at the Laboratory of Parasitology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada.	Al Nazawi AM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2096-6; Lorono-Pino MA, 2013, AM J TROP MED HYG, V89, P385, DOI 10.4269/ajtmh.12-0772; Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Britch SC, 2010, J AM MOSQUITO CONTR, V26, P183, DOI 10.2987/09-5948.1; *CDC, 2017, SURV CONTR AED AEG A; Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014; Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060; Eder M, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0475-7; Estep AS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006544; Fahri S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002354; Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115; Fernando SD, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3113-0; Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749; Francis S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179673; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P319, DOI 10.1093/jee/70.3.319; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P653, DOI 10.1093/jee/70.5.653; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Hamid PH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189680; Hamid PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2215-4; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hidayati H, 2011, TROP BIOMED, V28, P425; Hsu JC, 2017, INT J INFECT DIS, V54, P43, DOI 10.1016/j.ijid.2016.11.008; Jeefoo P, 2011, INT J ENV RES PUB HE, V8, P51, DOI 10.3390/ijerph8010051; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948; Kawada H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003032; KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; MOH of Republic of Indonesia, 2016, DHF SIT IND; MOH of Republic of Indonesia, 2017, HLTH PROF CENTR JAV; Moncayo AC, 2004, EMERG INFECT DIS, V10, P1790, DOI 10.3201/eid1010.030846; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Nugraha, 2012, MALARIA J S1, V11, pP130, DOI [10.1186/1475-2875-11-S1-P130, DOI 10.1186/1475-2875-11-S1-P130]; Nwane P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-163; Pliego EP, 2018, J THEOR BIOL, V437, P126, DOI 10.1016/j.jtbi.2017.10.025; Polson KA, 2011, B ENTOMOL RES, V101, P435, DOI 10.1017/S0007485310000702; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; PUTRA RE, 2016, INT J MOSQ RES A, V3, P23; Rajatileka S, 2008, ACTA TROP, V108, P54, DOI 10.1016/j.actatropica.2008.08.004; Saavedra-Rodriguez K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25222-0; Saingamsook J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2416-x; Satoto TBT, 2018, ENVIRON HEALTH PREV, V23, DOI 10.1186/s12199-018-0711-6; Satrisno H, 2018, THESIS; Sombie A, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-018-0134-5; South A, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2203-y; Suwanchaichinda C, 2001, PESTIC BIOCHEM PHYS, V70, P63, DOI 10.1006/pest.2001.2544; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; Wang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118537; WHO, 2003, GUIDELINES FOR DENGU; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT; Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103	59	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218079	10.1371/journal.pone.0218079	http://dx.doi.org/10.1371/journal.pone.0218079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233517	gold, Green Submitted, Green Published			2022-12-26	WOS:000484896700011
J	Krabbe, BA; Arnan, X; Lannes, P; Bergstedt, CE; Larsen, RS; Pedersen, JS; Shik, JZ				Krabbe, Birla A.; Arnan, Xavier; Lannes, Pol; Bergstedt, Christoffer Echtvad; Larsen, Rasmus Stenbak; Pedersen, Jes Soe; Shik, Jonathan Z.			Using nutritional geometry to define the fundamental macronutrient niche of the widespread invasive ant Monomorium pharaonis	PLOS ONE			English	Article							FOOD DISTRIBUTION; ARGENTINE ANT; FIRE ANT; LABORATORY COLONIES; SOLENOPSIS-INVICTA; LIFE-SPAN; HYMENOPTERA; ESTABLISHMENT; RESOURCE; CONSEQUENCES	The emerging field of nutritional geometry (NG) provides powerful new approaches to test whether and how organisms prioritize specific nutritional blends when consuming chemically complex foods. NG approaches can thus help move beyond food-level estimates of diet breadth to predict invasive success, for instance by revealing narrow nutritional niches if broad diets are actually composed of nutritionally similar foods. We used two NG paradigms to provide different, but complementary insights into nutrient regulation strategies and test a hypothesis of extreme nutritional generalism in colony propagules of the globally distributed invasive ant Monomorium pharaonis. First, in two dimensions (protein:carbohydrates; P:C), M. pharaonis colonies consistently defended a slightly carbohydrate-biased intake target, while using a generalist equal-distance strategy of collectively overharvesting both protein and carbohydrates to reach this target when confined to imbalanced P:C diets. Second, a recently developed right-angled mixture triangle method enabled us to define the fundamental niche breadth in three dimensions (protein:carbohydrates:lipid, P:C:L). We found that colonies navigated the P:C:L landscape, in part, to mediate a tradeoff between worker survival (maximized on high-carbohydrate diets) and brood production (maximized on high-protein diets). Colonies further appeared unable to avoid this tradeoff by consuming extra lipids when the other nutrients were limiting. Colonies also did not rely on nutrient regulation inside their nests, as they did not hoard or scatter fractions of harvested diets to adjust the nutritional blends they consumed. These complementary NG approaches highlight that even the most successful invasive species with broad fundamental macronutrient niches must navigate complex multidimensional nutritional landscapes to acquire limiting macronutrients and overcome developmental constraints as small propagules.	[Krabbe, Birla A.; Lannes, Pol; Bergstedt, Christoffer Echtvad; Larsen, Rasmus Stenbak; Pedersen, Jes Soe; Shik, Jonathan Z.] Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark; [Arnan, Xavier] CREAF, Cerdanyola Del Valles, Spain	University of Copenhagen; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Shik, JZ (corresponding author), Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark.	jonathan.shik@gmail.com	Arnan, Xavier/N-7829-2013; Pedersen, Jes Soe/J-6337-2014	Arnan, Xavier/0000-0002-9904-274X; Shik, Jonathan Zvi/0000-0003-3309-7737; Pedersen, Jes Soe/0000-0002-4439-2638	Marie Curie International Incoming Fellowship [327940 INSEAME]; Spanish Ministry of Economy and Competitiveness [RYC-2015-18448]	Marie Curie International Incoming Fellowship(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by Marie Curie International Incoming Fellowship (327940 INSEAME) to JZS, and Ramon y Cajal research contract by the Spanish Ministry of Economy and Competitiveness (RYC-2015-18448) to XA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Shawn Wilder for providing advice about preparing 3-D diets and Luigi Pontieri for advice about M. pharaonis husbandry and natural history. JZS was supported by a Marie Curie International Incoming Fellowship (327940 INSEAME) hosted by Jacobus J. Boomsma at the University of Copenhagen. X.A. was supported by a Ramon y Cajal research contract by the Spanish Ministry of Economy and Competitiveness (RYC-2015-18448). All relevant archived data is provided in supplemental materials.	ALVARES LE, 1993, J APPL ENTOMOL, V116, P90, DOI 10.1111/j.1439-0418.1993.tb01171.x; Arganda S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2052; Bazazi S, 2016, ANIM BEHAV, V111, P235, DOI 10.1016/j.anbehav.2015.10.021; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Blumenthal D, 2009, P NATL ACAD SCI USA, V106, P7899, DOI 10.1073/pnas.0812607106; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Box G.E.P., 2007, RESPONSE SURFACES MI; Buczkowski G, 2009, ETHOLOGY, V115, P1091, DOI 10.1111/j.1439-0310.2009.01698.x; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Cohen A. C., 2015, INSECT DIETS SCI TEC; Coogan SCP, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2177; Cook SC, 2012, INSECT SOC, V59, P93, DOI 10.1007/s00040-011-0193-7; Cook SC, 2010, ANIM BEHAV, V79, P429, DOI 10.1016/j.anbehav.2009.11.022; da Costa RR, 2019, FUNGAL ECOL, V38, P54, DOI 10.1016/j.funeco.2018.08.009; Drake JM, 2006, BIOL INVASIONS, V8, P365, DOI 10.1007/s10530-004-8122-6; Dussutour A, 2008, INSECT SOC, V55, P329, DOI 10.1007/s00040-008-1008-3; Dussutour A, 2010, P NATL ACAD SCI USA, V107, P4607, DOI 10.1073/pnas.0912198107; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; Eow AGH, 2007, SOCIOBIOLOGY, V49, P165; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; HAACK KD, 1995, J ENTOMOL SCI, V30, P70, DOI 10.18474/0749-8004-30.1.70; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hawley J, 2016, BEHAV ECOL, V27, P245, DOI 10.1093/beheco/arv151; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Judd TM, 2006, ANN ENTOMOL SOC AM, V99, P398, DOI 10.1603/0013-8746(2006)099[0398:RBFSAF]2.0.CO;2; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; KELLER L, 1989, OECOLOGIA, V80, P236, DOI 10.1007/BF00380157; Lee KP, 2003, J INSECT PHYSIOL, V49, P1161, DOI 10.1016/j.jinsphys.2003.08.013; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lenth RV, 2009, J STAT SOFTW, V32, P1; Machovsky-Capuska GE, 2016, TRENDS ECOL EVOL, V31, P355, DOI 10.1016/j.tree.2016.02.009; MARKIN GP, 1970, INSECT SOC, V17, P127, DOI 10.1007/BF02223074; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Mooney KA, 2005, ECOLOGY, V86, P1225, DOI 10.1890/04-0938; Nash JC, 2014, J STAT SOFTW, V60, P1; Nychka D., 2015, R PACKAGE VERSION, V8, P2; Penick CA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2608; Pontieri L, 2017, J EVOLUTION BIOL, V30, P225, DOI 10.1111/jeb.13012; R Development Core Team, 2016, R LANG ENV STAT COMP; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Raubenheimer D, 2011, ECOL MONOGR, V81, P407, DOI 10.1890/10-1707.1; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Schmidt AM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-20; Senior AM, 2016, MAMM BIOL, V81, P523, DOI 10.1016/j.mambio.2016.07.001; Shik JZ, 2016, P NATL ACAD SCI USA, V113, P10121, DOI 10.1073/pnas.1606128113; Shik JZ, 2014, ANIM BEHAV, V95, P33, DOI 10.1016/j.anbehav.2014.06.008; Shik JZ, 2013, BIOL INVASIONS, V15, P829, DOI 10.1007/s10530-012-0330-x; Simpson SJ, 2012, NATURE NUTR UNIFYING; SORENSEN AA, 1981, INSECT SOC, V28, P129, DOI 10.1007/BF02223701; Sperfeld E, 2017, FUNCT ECOL, V31, P286, DOI 10.1111/1365-2435.12707; SUDD JH, 1985, ECOL ENTOMOL, V10, P89, DOI 10.1111/j.1365-2311.1985.tb00538.x; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; Tobin John E., 1994, P279; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Warbrick-Smith J, 2009, ENTOMOL EXP APPL, V132, P65, DOI 10.1111/j.1570-7458.2009.00870.x; Wetterer JK, 2010, MYRMECOL NEWS, V13, P115; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; Wright TF, 2010, ETHOL ECOL EVOL, V22, P393, DOI 10.1080/03949370.2010.505580; Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218764	10.1371/journal.pone.0218764	http://dx.doi.org/10.1371/journal.pone.0218764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220167	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500089
J	Aoi, W; Hirano, N; Lassiter, DG; Bjornholm, M; Chibalin, AV; Sakuma, K; Tanimura, Y; Mizushima, K; Takagi, T; Naito, Y; Zierath, JR; Krook, A				Aoi, Wataru; Hirano, Nariyuki; Lassiter, David G.; Bjornholm, Marie; Chibalin, Alexander V.; Sakuma, Kunihiro; Tanimura, Yuko; Mizushima, Katsura; Takagi, Tomohisa; Naito, Yuji; Zierath, Juleen R.; Krook, Anna			Secreted protein acidic and rich in cysteine (SPARC) improves glucose tolerance via AMP-activated protein kinase activation	FASEB JOURNAL			English	Article						myokine; skeletal muscle; exercise; glucose uptake	SKELETAL-MUSCLE; LIPID-METABOLISM; MITOCHONDRIAL BIOGENESIS; EXERCISE; INSULIN; EXPRESSION; SPARC/OSTEONECTIN; PHOSPHORYLATION; DIFFERENTIATION; ANGIOGENESIS	During exercise, skeletal muscles release cytokines, peptides, and metabolites that exert autocrine, paracrine, or endocrine effects on glucose homeostasis. In this study, we investigated the effects of secreted protein acidic and rich in cysteine (SPARC), an exercise-responsive myokine, on glucose metabolism in human and mouse skeletal muscle. SPARC-knockout mice showed impaired systemic metabolism and reduced phosphorylation of AMPK and protein kinase B in skeletal muscle. Treatment of SPARC-knockout mice with recombinant SPARC improved glucose tolerance and concomitantly activated AMPK in skeletal muscle. These effects were dependent on AMPK-gamma 3 because SPARC treatment enhanced skeletal muscle glucose uptake in wild-type mice but not in AMPK-gamma 3-knockout mice. SPARC strongly interacted with the voltage-dependent calcium channel, and inhibition of calcium-dependent signaling prevented SPARC-induced AMPK phosphorylation in human and mouse myotubes. Finally, chronic SPARC treatment improved systemic glucose tolerance and AMPK signaling in skeletal muscle of high-fat diet-induced obese mice, highlighting the efficacy of SPARC treatment in the management of metabolic diseases. Thus, our findings suggest that SPARC treatment mimics the effects of exercise on glucose tolerance by enhancing AMPK-dependent glucose uptake in skeletal muscle.-Aoi, W., Hirano, N., Lassiter, D. G., Bjornholm, M., Chibalin, A. V., Sakuma, K., Tanimura, Y., Mizushima, K., Takagi, T., Naito, Y., Zierath, J. R., Krook, A. Secreted protein acidic and rich in cysteine (SPARC) improves glucose tolerance via AMP-activated protein kinase activation.	[Aoi, Wataru; Hirano, Nariyuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Kyoto, Japan; [Aoi, Wataru; Zierath, Juleen R.; Krook, Anna] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Lassiter, David G.; Bjornholm, Marie; Chibalin, Alexander V.; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Sakuma, Kunihiro] Tokyo Inst Technol, Sch Environm & Soc, Inst Liberal Arts, Tokyo, Japan; [Tanimura, Yuko] Aichi Toho Univ, Fac Human, Nagoya, Aichi, Japan; [Mizushima, Katsura; Takagi, Tomohisa; Naito, Yuji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan	Kyoto Prefectural University; Karolinska Institutet; Karolinska Institutet; Tokyo Institute of Technology; Kyoto Prefectural University of Medicine	Aoi, W (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, 1-5 Hangi Cho, Kyoto 6068522, Japan.	waoi@kpu.ac.jp	Tanimura, Yuko/AAG-9023-2020	Sakuma, Kunihiro/0000-0003-1353-0150	Japan Society for the Promotion of Science (JSPS) [25282199, 17H02176]; Strategic Research Program in Diabetes at Karolinska Institutet; Swedish Research Council [2011-3550]; Swedish Diabetes Foundation [DIA2012-082, DIA2012-047]; Swedish Foundation for Strategic Research [SRL10-0027]; Diabetes Wellness Sweden; Novo Nordisk Foundation; Stockholm County Council	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Program in Diabetes at Karolinska Institutet; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Diabetes Wellness Sweden; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Stockholm County Council(Stockholm County Council)	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (B) (25282199 and 17H02176), the Strategic Research Program in Diabetes at Karolinska Institutet, the Swedish Research Council (2011-3550), the Swedish Diabetes Foundation (DIA2012-082; DIA2012-047), the Swedish Foundation for Strategic Research (SRL10-0027), Diabetes Wellness Sweden, Novo Nordisk Foundation, and the Stockholm County Council. The authors declare no conflicts of interest.	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Aoi W, 2008, BIOCHEM BIOPH RES CO, V366, P892, DOI 10.1016/j.bbrc.2007.12.019; Aoi W, 2013, GUT, V62, P882, DOI 10.1136/gutjnl-2011-300776; Aoi W, 2010, AM J PHYSIOL-ENDOC M, V298, pE799, DOI 10.1152/ajpendo.00448.2009; Barnes BR, 2005, FASEB J, V19, P773, DOI 10.1096/fj.04-3221com; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Chlenski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023880; Cho WJ, 2000, BIOCHEM BIOPH RES CO, V271, P630, DOI 10.1006/bbrc.2000.2682; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Fan WW, 2017, CELL METAB, V25, P242, DOI 10.1016/j.cmet.2016.10.022; Friedenreich C, 2006, CANCER EPIDEM BIOMAR, V15, P2398, DOI 10.1158/1055-9965.EPI-06-0595; Glund S, 2007, DIABETES, V56, P1630, DOI 10.2337/db06-1733; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jendraschak E, 1996, SEMIN CANCER BIOL, V7, P139, DOI 10.1006/scbi.1996.0019; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Kos K, 2009, DIABETES, V58, P1780, DOI 10.2337/db09-0211; Lavie CJ, 2015, CIRC RES, V117, P207, DOI 10.1161/CIRCRESAHA.117.305205; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Mansergh FC, 2007, PHYSIOL GENOMICS, V32, P64, DOI 10.1152/physiolgenomics.00151.2007; Marcinko K, 2014, EXP PHYSIOL, V99, P1581, DOI 10.1113/expphysiol.2014.082255; Massart J, 2017, DIABETES, V66, P1807, DOI 10.2337/db17-0141; MCDERMOTT JC, 1991, PFLUG ARCH EUR J PHY, V418, P301, DOI 10.1007/BF00550865; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Motamed K, 2003, J CELL BIOCHEM, V90, P408, DOI 10.1002/jcb.10645; Mudry JM, 2017, DIABETES, V66, P651, DOI 10.2337/db16-0882; Nakamura K, 2012, AGING-US, V4, P40; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Raney MA, 2008, J APPL PHYSIOL, V104, P1366, DOI 10.1152/japplphysiol.01282.2007; RICHTER EA, 1982, J CLIN INVEST, V69, P785, DOI 10.1172/JCI110517; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakuma K, 2008, ACTA NEUROPATHOL, V115, P663, DOI 10.1007/s00401-008-0371-5; Song HY, 2018, BIOCHEM BIOPH RES CO, V497, P667, DOI 10.1016/j.bbrc.2018.02.129; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Tartare-Deckert S, 2001, J BIOL CHEM, V276, P22231, DOI 10.1074/jbc.M010634200; Wall CE, 2016, J MOL ENDOCRINOL, V57, pR49, DOI 10.1530/JME-16-0073; Wang X, 2013, DIABETES, V62, P444, DOI 10.2337/db12-0244; Wei Ming, 2000, Comprehensive Therapy, V26, P176, DOI 10.1007/s12019-000-0006-9; Whitham M, 2016, NAT REV DRUG DISCOV, V15, P719, DOI 10.1038/nrd.2016.153; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	59	18	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10551	10562		10.1096/fj.201900453R	http://dx.doi.org/10.1096/fj.201900453R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31225998	Bronze			2022-12-26	WOS:000482214200066
J	Guo, SM; Zhang, R; Liu, Q; Wan, QY; Wang, YY; Yu, Y; Liu, GZ; Shen, YJ; Yu, Y; Zhang, J				Guo, Shumin; Zhang, Rui; Liu, Qian; Wan, Qiangyou; Wang, Yuanyang; Yu, Yu; Liu, Guizhu; Shen, Yujun; Yu, Ying; Zhang, Jian			2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes injury-induced vascular neointima formation in mice	FASEB JOURNAL			English	Article						vascular smooth muscle cells; proliferation; neointima formation	ARYL-HYDROCARBON RECEPTOR; SMOOTH-MUSCLE-CELL; C-JUN; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; CYCLE PROGRESSION; ACTIVATION; INHIBITION; DIFFERENTIATION; APOPTOSIS	2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an environmental pollutant that causes cardiovascular toxicity. The phenotypic transformation of vascular smooth muscle cells (VSMCs) from the contractile to the synthetic phenotype is a hallmark of vascular response to injury. However, the precise role and molecular mechanism of TCDD in vascular remodeling remains unknown. In the present study, we found that TCDD treatment promoted VSMC phenotypic transition from contractile to synthetic phenotype and exaggerated vascular neointimal hyperplasia after wire injury in mice. TCDD treatment enhanced VSMC entry into cell cycle from G0/G1 phase to S and G2/M phase. The expression of cyclin D1, cyclin-dependent kinase 4 (CDK4), and its phosphorylation were coordinately increased in response to TCDD treatment. Knocking down of aryl hydrocarbon receptor (AHR) inhibited VSMC phenotypic transition induced by TCDD and promoted S/G2 phase cell cycle arrest. TCDD treatment markedly increased oncogenic c-Jun gene expression in VSMCs. ChIP assay revealed the direct binding of AHR on the promoter of c-Jun to up-regulate the mRNA expression of c-Jun. Silencing of c-Jun gene enhanced the expression of p53 and p21, whereas attenuated the expression of CDK4 and cyclin D1 leading to the decrease in the TCDD-stimulated VSMC proliferation and synthetic phenotype transition in vitro. In vivo study showed that genetic ablation of c-Jun in VSMCs restricted injury-induced neointimal hyperplasia in TCDD-treated mice. Thus, TCDD exposure exaggerated injury-induced vascular remodeling by the activation of AHR and up-regulation of the expression of its target gene c-Jun, indicating that inhibition of AHR may be a promising prevention strategy for TCDD-associated cardiovascular diseases.-Guo, S., Zhang, R., Liu, Q., Wan, Q., Wang, Y., Yu, Y., Liu, G., Shen, Y., Yu, Y., Zhang, J. 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes injury-induced vascular neointima formation in mice.	[Guo, Shumin; Zhang, Rui; Liu, Qian; Wang, Yuanyang; Shen, Yujun; Yu, Ying; Zhang, Jian] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin, Peoples R China; [Guo, Shumin; Zhang, Rui; Liu, Qian; Wang, Yuanyang; Shen, Yujun; Yu, Ying; Zhang, Jian] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Key Lab Inflammat Biol, Tianjin, Peoples R China; [Wan, Qiangyou; Yu, Ying] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Key Lab Nutr Metab & Food Safety, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yu, Yu] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Cardiovasc, Shanghai, Peoples R China; [Liu, Guizhu] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Tianjin Medical University; Tianjin Medical University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhang, J (corresponding author), Tianjin Med Univ, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	zhangjian7@tmu.edu.cn		Yu, Yu/0000-0003-2291-0606	Ministry of Science and Technology of China [2017YFC1307402]; National Natural Science Foundation of China [81771513]; Tianjin Natural Science Foundation [17JCYBJC40700, 17JCYBJC26800]; Young Elite Scientists Sponsorship Program, Tianjin [TJSQNTJ-2018-10]; Experts Recruitment Program of Xinhua Hospital [Re-013]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); Young Elite Scientists Sponsorship Program, Tianjin; Experts Recruitment Program of Xinhua Hospital	The authors thank Dr. Lijian Hui [State Key Laboratory of Cell Biology, Chinese Academy of Sciences (CAS) Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China] for providing c-Jun<SUP>F/F</SUP> mice. This work was supported by grants from the Ministry of Science and Technology of China (2017YFC1307402), the National Natural Science Foundation of China (81771513), the Tianjin Natural Science Foundation (17JCYBJC40700, 17JCYBJC26800), Young Elite Scientists Sponsorship Program by Tianjin (TJSQNTJ-2018-10), and the Experts Recruitment Program of Xinhua Hospital (Re-013). The authors declare no conflicts of interest.	Agbor LN, 2011, BIOCHEM PHARMACOL, V82, P514, DOI 10.1016/j.bcp.2011.06.011; Al-Dhfyan A, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0636-5; Andrysik Z, 2013, ARCH TOXICOL, V87, P491, DOI 10.1007/s00204-012-0963-7; Angelos MG, 2017, BLOOD, V129, P3428, DOI 10.1182/blood-2016-07-730440; Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Bock KW, 2009, BIOL CHEM, V390, P1225, DOI 10.1515/BC.2009.138; Boucher JM, 2013, CIRC RES, V113, P975, DOI 10.1161/CIRCRESAHA.113.301272; Christen T, 2001, CIRCULATION, V103, P882, DOI 10.1161/01.CIR.103.6.882; Christen T, 1999, CIRC RES, V85, P99; Tran C, 2013, BIOCHEM PHARMACOL, V85, P753, DOI 10.1016/j.bcp.2012.12.010; Dalton T P, 2001, Cardiovasc Toxicol, V1, P285, DOI 10.1385/CT:1:4:285; Dong Li-Hua, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P119; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Harrill JA, 2015, HEPATOLOGY, V61, P548, DOI 10.1002/hep.27547; Hattori Y, 2003, CARDIOVASC RES, V58, P186, DOI 10.1016/S0008-6363(02)00855-6; Humblet O, 2008, ENVIRON HEALTH PERSP, V116, P1443, DOI 10.1289/ehp.11579; Ishimura R, 2006, TOXICOL SCI, V91, P265, DOI 10.1093/toxsci/kfj138; Kang DC, 1998, INT J ONCOL, V13, P1117; Kaplan-Albuquerque N, 2005, CIRC RES, V97, P427, DOI 10.1161/01.RES.0000179776.40216.a9; Khachigian LM, 2002, J BIOL CHEM, V277, P22985, DOI 10.1074/jbc.M200977200; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kolluri SK, 2017, ARCH TOXICOL, V91, P2497, DOI 10.1007/s00204-017-1981-2; Kopf PG, 2010, TOXICOL SCI, V117, P537, DOI 10.1093/toxsci/kfq218; Krishna SM, 2013, INT J CARDIOL, V168, P692, DOI 10.1016/j.ijcard.2013.04.139; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lanham KA, 2014, TOXICOL SCI, V141, P141, DOI 10.1093/toxsci/kfu111; Liebermann DA, 1998, INT J ONCOL, V12, P685; Liu GZ, 2018, FASEB J, V32, P5413, DOI 10.1096/fj.201800173R; Lu AK, 2015, J CLIN INVEST, V125, P1228, DOI 10.1172/JCI77656; Menyhart O, 2016, BBA-REV CANCER, V1866, P300, DOI 10.1016/j.bbcan.2016.10.002; Pelcl T, 2018, BASIC CLIN PHARMACOL, V123, P356, DOI 10.1111/bcpt.13013; Pierre S, 2011, BIOCHEM PHARMACOL, V81, P304, DOI 10.1016/j.bcp.2010.10.003; Podechard N, 2009, CARDIOVASC RES, V82, P361, DOI 10.1093/cvr/cvp007; Sany SBT, 2015, ENVIRON SCI POLLUT R, V22, P19434, DOI 10.1007/s11356-015-5597-x; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Seok SH, 2017, P NATL ACAD SCI USA, V114, P5431, DOI 10.1073/pnas.1617035114; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Sorg O, 2014, TOXICOL LETT, V230, P225, DOI 10.1016/j.toxlet.2013.10.039; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Sulentic CEW, 2011, TOXICOL SCI, V120, pS171, DOI 10.1093/toxsci/kfq324; Takahashi M, 2003, CIRCULATION, V108, P2524, DOI 10.1161/01.CIR.0000096482.02567.8C; Tellides G, 2015, CIRC RES, V116, P312, DOI 10.1161/CIRCRESAHA.116.301312; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; Villa M, 2017, EMBO J, V36, P116, DOI 10.15252/embj.201695027; Vogel Christoph F A, 2004, Cardiovasc Toxicol, V4, P363, DOI 10.1385/CT:4:4:363; Wang Q, 2013, ENVIRON HEALTH PERSP, V121, P1334, DOI 10.1289/ehp.1307297; Watson L, 2000, EUR J CLIN INVEST, V30, P11; Weissberg P L, 1995, Blood Press Suppl, V2, P68; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wu DL, 2011, ARTERIOSCL THROM VAS, V31, P1260, DOI 10.1161/ATVBAHA.110.220202; Yang XH, 2005, ONCOGENE, V24, P7869, DOI 10.1038/sj.onc.1208938; Yu Y, 2017, J CELL MOL MED, V21, P3540, DOI 10.1111/jcmm.13265; Zhang C, 2018, CARDIOVASC RES, V114, P443, DOI 10.1093/cvr/cvx236; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033; Zhang MJ, 2016, HISTOCHEM CELL BIOL, V145, P119, DOI 10.1007/s00418-015-1386-3; Zhao MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11309; Zhu ZM, 2018, HYPERTENSION, V71, P56, DOI [10.1161/HYPERTENSIONAHA.117.09848, 10.1161/HYPERTENSIONAHA.117.09944, 10.1161/HYPERTENSIONAHA.117.10527]	59	4	4	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10207	10217		10.1096/fj.201900546R	http://dx.doi.org/10.1096/fj.201900546R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31216422				2022-12-26	WOS:000482214200039
J	Wichmann, L; Dulai, JS; Marles-Wright, J; Maxeiner, S; Szczesniak, PP; Manzini, I; Althaus, M				Wichmann, Lukas; Dulai, Jasdip Singh; Marles-Wright, Jon; Maxeiner, Stephan; Szczesniak, Pawel Piotr; Manzini, Ivan; Althaus, Mike			An extracellular acidic cleft confers profound H+-sensitivity to epithelial sodium channels containing the delta-subunit in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); Xenopus; evolution; allosteric regulation; molecular evolution; delta-subunit; pH; sodium self-inhibition; tetrapod; water-to-land transition	SENSING ION CHANNELS; NA+ CHANNEL; ENAC; TOAD; ACTIVATION; RESIDUES; ASIC1; INHIBITION; EXCRETION; AFFINITY	The limited sodium availability of freshwater and terrestrial environments was a major physiological challenge during vertebrate evolution. The epithelial sodium channel (ENaC) is present in the apical membrane of sodium-absorbing vertebrate epithelia and evolved as part of a machinery for efficient sodium conservation. ENaC belongs to the degenerin/ENaC protein family and is the only member that opens without an external stimulus. We hypothesized that ENaC evolved from a proton-activated sodium channel present in ionocytes of freshwater vertebrates and therefore investigated whether such ancestral traits are present in ENaC isoforms of the aquatic pipid frog Xenopus laevis. Using whole-cell and single-channel electrophysiology of Xenopus oocytes expressing ENaC isoforms assembled from alpha beta gamma- or delta beta gamma-subunit combinations, we demonstrate that Xenopus delta beta gamma-ENaC is profoundly activated by extracellular acidification within biologically relevant ranges (pH 8.0-6.0). This effect was not observed in Xenopus alpha beta gamma-ENaC or human ENaC orthologs. We show that protons interfere with allosteric ENaC inhibition by extracellular sodium ions, thereby increasing the probability of channel opening. Using homology modeling of ENaC structure and site-directed mutagenesis, we identified a cleft region within the extracellular loop of the delta-subunit that contains several acidic amino acid residues that confer proton-sensitivity and enable allosteric inhibition by extracellular sodium ions. We propose that Xenopus delta beta gamma-ENaC can serve as a model for investigating ENaC transformation from a proton-activated toward a constitutively-active ion channel. Such transformation might have occurred during the evolution of tetrapod vertebrates to enable bulk sodium absorption during the water-to-land transition.	[Wichmann, Lukas; Dulai, Jasdip Singh; Marles-Wright, Jon; Althaus, Mike] Newcastle Univ, Sch Nat & Environm Sci, Ridley Bldg 2, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Maxeiner, Stephan] Saarland Univ, Inst Anat & Cell Biol, D-66421 Homburg, Germany; [Szczesniak, Pawel Piotr] Goethe Univ Frankfurt, Dept Med, Haematol Oncol, D-60323 Frankfurt, Germany; [Wichmann, Lukas; Manzini, Ivan] Justus Liebig Univ Giessen, Dept Anim Physiol & Mol Biomed, Inst Anim Physiol, D-35390 Giessen, Germany	Newcastle University - UK; Universitatsklinikum des Saarlandes; Goethe University Frankfurt; Justus Liebig University Giessen	Althaus, M (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Ridley Bldg 2, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	mike.althaus@newcastle.ac.uk	Maxeiner, Stephan/Y-7692-2019; Manzini, Ivan/V-4545-2019	Maxeiner, Stephan/0000-0002-4472-695X; Manzini, Ivan/0000-0002-3575-9637; Dulai, Jasdip Singh/0000-0002-6784-5214; Marles-Wright, Jon/0000-0002-9156-3284; Wichmann, Lukas/0000-0001-9808-8407				Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Assmann M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0084-2; Awayda MS, 2000, AM J PHYSIOL-CELL PH, V279, pC1896, DOI 10.1152/ajpcell.2000.279.6.C1896; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; BALINSKY JB, 1961, J EXP BIOL, V38, P695; Bayley M, 2019, PHYSIOLOGY, V34, P14, DOI 10.1152/physiol.00028.2018; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Boscardin E, 2016, BRIT J PHARMACOL, V173, P2671, DOI 10.1111/bph.13533; Chalfant ML, 1999, AM J PHYSIOL-CELL PH, V276, pC477, DOI 10.1152/ajpcell.1999.276.2.C477; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cottrell GA, 1997, J EXP BIOL, V200, P2377; Dymowska AK, 2015, J EXP BIOL, V218, P1244, DOI 10.1242/jeb.113118; Dymowska AK, 2014, AM J PHYSIOL-CELL PH, V307, pC255, DOI 10.1152/ajpcell.00398.2013; Evans BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142823; FRAZIER LW, 1971, BIOCHIM BIOPHYS ACTA, V241, P20, DOI 10.1016/0005-2736(71)90299-9; Giraldez T, 2012, AM J PHYSIOL-RENAL, V303, pF328, DOI 10.1152/ajprenal.00116.2012; Hanukoglu I, 2016, GENE, V579, P95, DOI 10.1016/j.gene.2015.12.061; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295, DOI 10.1152/ajpcell.1994.267.5.C1295; Ianevski A, 2017, BIOINFORMATICS, V33, P2413, DOI 10.1093/bioinformatics/btx162; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Kashlan OB, 2018, FASEB J, V32; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; LEAF A, 1964, AM J PHYSIOL, V207, P547, DOI 10.1152/ajplegacy.1964.207.3.547; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lynagh T, 2018, P NATL ACAD SCI USA, V115, P8430, DOI 10.1073/pnas.1806614115; MCBEAN RL, 1970, AM J PHYSIOL, V219, P1115, DOI 10.1152/ajplegacy.1970.219.4.1115; MCCLANAHAN L, 1967, COMP BIOCHEM PHYSIOL, V20, P73, DOI 10.1016/0010-406X(67)90726-8; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; PALMER LG, 1987, AM J PHYSIOL, V253, pF333, DOI 10.1152/ajprenal.1987.253.2.F333; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHOEMAKER VH, 1964, COMP BIOCHEM PHYSIOL, V13, P261, DOI 10.1016/0010-406X(64)90121-5; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEINMETZ PR, 1974, PHYSIOL REV, V54, P890, DOI 10.1152/physrev.1974.54.4.890; Studer RA, 2011, PHYSIOL GENOMICS, V43, P844, DOI 10.1152/physiolgenomics.00002.2011; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; USSING HH, 1949, ACTA PHYSIOL SCAND, V17, P1, DOI 10.1111/j.1748-1716.1949.tb00550.x; Wichmann L, 2018, J BIOL CHEM, V293, P6647, DOI 10.1074/jbc.RA118.002543; Yadav B, 2015, COMPUT STRUCT BIOTEC, V13, P504, DOI 10.1016/j.csbj.2015.09.001; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang P, 1999, BIOPHYS J, V77, P3043, DOI 10.1016/S0006-3495(99)77135-3	51	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12507	12520		10.1074/jbc.RA119.008255	http://dx.doi.org/10.1074/jbc.RA119.008255			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248986	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000484402700021
J	Mishra, S; Bernal, C; Silvano, M; Anand, S; Altaba, ARI				Mishra, Sonakshi; Bernal, Carolina; Silvano, Marianna; Anand, Santosh; Altaba, Ariel Ruiz i			The protein secretion modulator TMED9 drives CNIH4/TGF alpha/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases	ONCOGENE			English	Article							GROWTH-FACTOR-ALPHA; TGF-ALPHA; FACTOR RECEPTOR; P24 FAMILY; BETA-CATENIN; COLORECTAL-CANCER; EXOCYTIC VESICLES; CARGO RECEPTORS; PROTGF-ALPHA; TUMOR-GROWTH	How cells in primary tumors initially become pro-metastatic is not understood. A previous genome-wide RNAi screen uncovered colon cancer metastatic suppressor and WNT promoting functions of TMED3, a member of the p24 ER-to-Golgi protein secretion family. Repression of canonical WNT signaling upon knockdown (kd) of TMED3 might thus be sufficient to drive metastases. However, searching for transcriptional influences on other family members here we find that TMED3 kd leads to enhanced TMED9, that TMED9 acts downstream of TMED3 and that TMED9 kd compromises metastasis. Importantly, TMED9 pro-metastatic function is linked to but distinct from the repression of TMED3-WNT-TCF signaling. Functional rescue of the migratory deficiency of TMED9 kd cells identifies TGF alpha as a mediator of TMED9 pro-metastatic activity. Moreover, TMED9 kd compromises the biogenesis, and thus function, of TGF alpha. Analyses in three colon cancer cell types highlight a TMED9-dependent gene set that includes CNIH4, a member of the CORNICHON family of TGF alpha exporters. Our data indicate that TGFA and CNIH4, which display predictive value for disease-free survival, promote colon cancer cell metastatic behavior, and suggest that TMED9 pro-metastatic function involves the modulation of the secretion of TGF alpha ligand. Finally, TMED9/TMED3 antagonism impacts WNT-TCF and GLI signaling, where TMED9 primacy over TMED3 leads to the establishment of a positive feedback loop together with CNIH4, TGF alpha, and GLI1 that enhances metastases. We propose that primary colon cancer cells can transition between two states characterized by secretion-transcription regulatory loops gated by TMED3 and TMED9 that modulate their metastatic proclivities.	[Mishra, Sonakshi; Bernal, Carolina; Silvano, Marianna; Anand, Santosh; Altaba, Ariel Ruiz i] Univ Geneva, Dept Genet Med & Dev, Fac Med, Med Sch, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland	University of Geneva	Altaba, ARI (corresponding author), Univ Geneva, Dept Genet Med & Dev, Fac Med, Med Sch, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Ariel.RuizAltaba@unige.ch		Anand, Santosh/0000-0003-2287-0229	Swiss Government pre-doctoral grant; Swiss National Science Foundation; Swiss Cancer League; Departement d'Instruction Publique de Geneve	Swiss Government pre-doctoral grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Departement d'Instruction Publique de Geneve	We are grateful to R. Coffey for the kind gift of HA/FLAG-tagged TGFa, to all Ruiz i Altaba lab members for discussion, to M. Kuciak and A. Conod for comments on the manuscript and to I. Borges Grazina for technical help. This work was supported by a Swiss Government pre-doctoral grant to SM and by grants from the Swiss National Science Foundation and the Swiss Cancer League, and by funds from the Departement d'Instruction Publique de Geneve to ARA.	Aberger F, 2014, SEMIN CELL DEV BIOL, V33, P93, DOI 10.1016/j.semcdb.2014.05.003; Adolf A, 2018, PROTEOMIC PROFILING; Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; ALISON MR, 1993, CELL PROLIFERAT, V26, P449, DOI 10.1111/j.1365-2184.1993.tb00132.x; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Briley GP, 1997, MOL BIOL CELL, V8, P1619, DOI 10.1091/mbc.8.8.1619; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Cao Z, 2008, MOL CELL PROTEOMICS, V7, P1651, DOI 10.1074/mcp.M700155-MCP200; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; Connolly DJ, 2013, J BIOL CHEM, V288, P5616, DOI 10.1074/jbc.M112.403899; De Jong KP, 1998, HEPATOLOGY, V28, P971, DOI 10.1002/hep.510280411; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Duquet A, 2014, EMBO MOL MED, V6, P882, DOI 10.15252/emmm.201303799; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; El-Hariry I, 2001, INT J CANCER, V94, P652, DOI 10.1002/ijc.1515; Emery G, 2000, J CELL SCI, V113, P2507; Fraisier V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082223; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gregorieff A, 2015, NATURE, V526, P715, DOI 10.1038/nature15382; Gu XH, 2012, CLIN EXP MED, V12, P195, DOI 10.1007/s10238-011-0155-4; Gwak J, 2016, ONCOTARGET, V7, P48250, DOI 10.18632/oncotarget.10198; Hu TH, 2010, J BIOL CHEM, V285, P13561, DOI 10.1074/jbc.M109.075945; HUANG F, 1995, EXP CELL RES, V219, P8, DOI 10.1006/excr.1995.1198; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Jerome-Majewska LA, 2010, DEV BIOL, V341, P154, DOI 10.1016/j.ydbio.2010.02.019; Kho DH, 2009, GUT, V58, P509, DOI 10.1136/gut.2008.150938; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Lai W, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0566-z; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lau TS, 2017, ONCOGENE, V36, P3576, DOI 10.1038/onc.2016.509; Lavoie C, 1999, J CELL BIOL, V146, P285, DOI 10.1083/jcb.146.2.285; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li CX, 2004, P NATL ACAD SCI USA, V101, P5571, DOI 10.1073/pnas.0401294101; Li X, 2015, BIOCHEM BIOPH RES CO, V463, P483, DOI 10.1016/j.bbrc.2015.04.151; Liao XY, 2015, INT J MOL SCI, V16, P17655, DOI 10.3390/ijms160817655; Liaunardy-Jopeace A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005275; Liu Q, 2016, ONCOTARGET, V7, P36800, DOI 10.18632/oncotarget.9191; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MILLER W, 1985, CLIN EXP METASTAS, V3, P189, DOI 10.1007/BF01786762; Mitrovic S, 2008, MOL BIOL CELL, V19, P1976, DOI 10.1091/mbc.E07-10-0989; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Pagant S, 2015, CURR BIOL, V25, P403, DOI 10.1016/j.cub.2014.11.070; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Perez Castro C, 2007, J CELL SCI, V120, P2454, DOI 10.1242/jcs.004200; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Port F, 2011, EMBO REP, V12, P1144, DOI 10.1038/embor.2011.165; Price MA, 2011, PIGM CELL MELANOMA R, V24, P1148, DOI 10.1111/j.1755-148X.2011.00929.x; Qin W, 2014, INT J ONCOL, V45, P1225, DOI 10.3892/ijo.2014.2506; Radaelli E, 2009, HISTOL HISTOPATHOL, V24, P879, DOI 10.14670/HH-24.879; REPESH LA, 1989, INVAS METAST, V9, P192; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Riku M, 2016, ONCOTARGET, V7, P5690, DOI 10.18632/oncotarget.6788; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romagnoli M, 2014, EMBO MOL MED, V6, P278, DOI 10.1002/emmm.201303373; Ruifrok ACC, 1997, RADIAT RES, V147, P1, DOI 10.2307/3579436; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sasaki T, 2008, AM J PATHOL, V173, P205, DOI 10.2353/ajpath.2008.071147; Sauvageau E, 2014, TRAFFIC, V15, P383, DOI 10.1111/tra.12148; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Seth C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150697; Singh Bhuminder, 2016, F1000Res, V5, DOI 10.12688/f1000research.9025.1; Singh B, 2014, ANNU REV PHYSIOL, V76, P275, DOI 10.1146/annurev-physiol-021113-170406; Singovski G, 2016, J MOL CELL BIOL, V8, P157, DOI 10.1093/jmcb/mjv034; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Sukhotnik I, 2008, PEDIATR SURG INT, V24, P1303, DOI 10.1007/s00383-008-2271-0; Tada M, 2000, DEVELOPMENT, V127, P2227; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; von Karstedt S, 2015, CANCER CELL, V27, P561, DOI 10.1016/j.ccell.2015.02.014; Wajapeyee N, 2009, MOL CANCER THER, V8, P3009, DOI 10.1158/1535-7163.MCT-09-0470; Wang P, 2015, BIOCHEM BIOPH RES CO, V460, P314, DOI 10.1016/j.bbrc.2015.03.032; Wang XC, 2012, PANCREAS, V41, P10, DOI 10.1097/MPA.0b013e318223c7e4; Wang YW, 2017, ONCOTARGET, V8, P34429, DOI 10.18632/oncotarget.16260; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wong SF, 2005, CLIN THER, V27, P684, DOI 10.1016/j.clinthera.2005.06.003; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang PC, 2016, MOL BIOL CELL, V27, P1938, DOI 10.1091/mbc.E16-02-0090; Zheng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37070	106	20	20	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2019	38	29					5817	5837		10.1038/s41388-019-0845-z	http://dx.doi.org/10.1038/s41388-019-0845-z			21	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IQ4WS	31253868	Green Published, hybrid			2022-12-26	WOS:000480752800006
J	Chadha, A; Florentine, SK; Chauhan, BS; Long, B; Jayasundera, M				Chadha, Aakansha; Florentine, Singarayer K.; Chauhan, Bhagirath S.; Long, Benjamin; Jayasundera, Mithila			Influence of soil moisture regimes on growth, photosynthetic capacity, leaf biochemistry and reproductive capabilities of the invasive agronomic weed; Lactuca serriola	PLOS ONE			English	Article							WATER-USE EFFICIENCY; DROUGHT STRESS; CLIMATE-CHANGE; WHEAT PLANTS; RESPONSES; MECHANISMS; L.; TOLERANCE; SUGARS	Global temperatures are predicted to increase by 1.5-5.9 degrees C during this century, and this change is likely to impact average rainfall, with predictions that water deficit will perhaps be the most severe threat to sustainable agriculture. In this respect, invasive weeds, which have traits better adapted to drought stress than crops, add to concerns regarding crop sustainability. Lactuca serriola, an aggressive agronomic weed is thought to be a successful weed because of its ability to maintain high water use efficiency under drought conditions. In this study, experiments were conducted to examine the influence of different soil moisture regimes ( 100%, 75%, 50% and 25% water holding capacity ( WHC)) on growth, photosynthetic capacity, leaf biochemistry and reproduction of this species. Soil moisture significantly affected plant's height, stem diameter, number of leaves and biomass. The highest plant height ( 115.14 cm +/- 11.64), shoot diameter ( 9.4 mm +/- 0.18), leaf area ( 1206.5 mm(2) +/- 73.29), plant fresh weight ( 83.1 +/- 3.98) and dry weight ( 22.38 +/- 1.24) were recorded at 75% soil moisture content. A fundamental adaptation to drought was observed as plants in the 25% WHC treatment had the highest root: shoot ratio. Soluble sugars and total phenolic content were highest in the 25% WHC treatment and significantly different to 100% WHC which was a response to soil moisture stress to ameliorate the damaging effects of reactive oxygen species produced under stress conditions. Results also indicate that L. serriola can survive and produce seeds under water stress as more than 6000 seeds were produced per plant in all WHC treatments. In this study, there was no significant difference in the seed weight, number of seeds produced and their germination ability. This can have a huge impact on agricultural systems as the species can survive both under low and high soil moisture conditions. We therefore suggest that the demonstrated ability of L. serriola to complete its life cycle and produce biomass and seeds under water stressed conditions leads to the introduction of strategies that minimize weed survival while maximizing irrigation efficiency for the crop. A clear understanding of the ecological and biological characteristics of this weed will help land managers take appropriate control measures to mitigate the effect of this species on economic crop productivity.	[Chadha, Aakansha; Florentine, Singarayer K.; Long, Benjamin] Federat Univ Australia, Ctr Environm Management, Sch Life & Hlth Sci, Mt Helen, Vic, Australia; [Chauhan, Bhagirath S.] Univ Queensland, Ctr Crop Sci, QAAFI, Gatton, Qld, Australia; [Jayasundera, Mithila] RMIT Univ, Sch Sci Engn & Hlth, Bundoora, Vic, Australia	Federation University Australia; University of Queensland; Royal Melbourne Institute of Technology (RMIT)	Florentine, SK (corresponding author), Federat Univ Australia, Ctr Environm Management, Sch Life & Hlth Sci, Mt Helen, Vic, Australia.	s.florentine@federation.edu.au	Florentine, Singarayer/ABA-7740-2020; Long, Benjamin/AAV-8994-2021; Chauhan, Bhagirath/G-8892-2014	Long, Benjamin/0000-0002-3248-8851; Chadha, Aakansha/0000-0002-6237-8362; Florentine, Singarayer/0000-0002-5734-3421; Chauhan, Bhagirath/0000-0003-1540-4668				Al Hakimi A, 1995, J GENET BREED; Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Anjum F., 2003, Pakistan Journal of Agricultural Sciences, V40, P45; Bajwa AA, 2015, WEED SCI, V63, P723, DOI 10.1614/WS-D-15-00064.1; Bajwa AA, 2017, ENVIRON SCI POLLUT R, V24, P16186, DOI 10.1007/s11356-017-9176-1; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bhatt R. M., 2005, Indian Journal of Plant Physiology, V10, P54; Bohnert HJ, 2006, CURR OPIN PLANT BIOL, V9, P180, DOI 10.1016/j.pbi.2006.01.003; Chauhan BS, 2013, WEED SCI, V61, P98, DOI 10.1614/WS-D-12-00060.1; Chauhan BS, 2010, WEED SCI, V58, P132, DOI 10.1614/WS-D-09-00016.1; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Cumming, 1990, STRESS RESPONSES PLA, P241; D'Andrea L, 2017, J HERED, V108, P194, DOI 10.1093/jhered/esw078; D'Andrea L, 2009, J BIOGEOGR, V36, P1573, DOI 10.1111/j.1365-2699.2008.02060.x; D'souza MR, 2011, INDIAN J BIOTECHNOL, V10, P130; De Oliveira A.B., 2013, RESPONSES ORG WATER, P67, DOI [10.5772/54223, DOI 10.5772/54223]; Department of Environment and Energy, 2017, CLIM CHANG IMP VICT; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; FISCHER C, 1991, TREES-STRUCT FUNCT, V5, P187, DOI 10.1007/BF00227524; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Fu JM, 2001, ENVIRON EXP BOT, V45, P105, DOI 10.1016/S0098-8472(00)00084-8; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Jairus R, 2010, J STRESS PHYSL BIOCH, V6; Jaleel CA, 2008, CR BIOL, V331, P42, DOI 10.1016/j.crvi.2007.11.003; Jaleel CA, 2009, INT J AGRIC BIOL, V11, P100; Javanmardi J, 2003, FOOD CHEM, V83, P547, DOI 10.1016/S0308-8146(03)00151-1; KAMELI A, 1993, NEW PHYTOL, V125, P609, DOI 10.1111/j.1469-8137.1993.tb03910.x; Karimi M, 2015, SCI HORTIC-AMSTERDAM, V183, P93, DOI 10.1016/j.scienta.2014.11.001; Kaur S, 2016, CAN J PLANT SCI, V96, P828, DOI 10.1139/cjps-2015-0309; Kramer P.J., 1995, WATER RELATIONS PLAN; Kusaka M, 2005, PLANT SCI, V168, P1, DOI 10.1016/j.plantsci.2004.06.021; Lazar T., 2003, ANN BOT-LONDON, V91, P750, DOI DOI 10.1093/AOB/MCG079; Lee SukSoon, 2000, Korean Journal of Crop Science, V45, P108; Li SW, 2004, ACTA OECOL, V25, P17, DOI 10.1016/j.actao.2003.10.004; Manivannan P, 2007, COLLOID SURFACE B, V59, P141, DOI 10.1016/j.colsurfb.2007.05.002; Mohammadkhani N., 2008, World Applied Sciences Journal, V3, P448; Monakhova OF, 2002, APPL BIOCHEM MICRO+, V38, P373, DOI 10.1023/A:1016243424428; MORTENSEN DA, 1989, WEED SCI, V37, P76, DOI 10.1017/S0043174500055892; Norris R. F., 2003, Aspects of Applied Biology, P163; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Osawa Toshihiko, 1994, P241; Passioura J.B., 1981, ROL ROOT SYST CHAR D; PATTERSON DT, 1989, WEED SCI, V37, P658, DOI 10.1017/S0043174500072593; PATTERSON DT, 1995, WEED SCI, V43, P483, DOI 10.1017/S0043174500081510; Sarangi D, 2016, WEED SCI, V64, P42, DOI 10.1614/WS-D-15-00052.1; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Smith J, 1992, J EXP BOT, V43, P29; Steadman KJ, 2004, AUST J AGR RES, V55, P1047, DOI 10.1071/AR04083; Team R. Core, 2016, R LANG ENV STAT COMP; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Webster TM, 2008, WEED SCI, V56, P561, DOI 10.1614/WS-07-186.1; Yin CY, 2005, ENVIRON EXP BOT, V53, P315, DOI 10.1016/j.envexpbot.2004.04.007; Zhang M., 2004, P 4 INT CROP SCI C B, P252; Zimdahl R.L., 2018, FUNDAMENTALS WEED SC, DOI [10.1016/B978-0-12-811143-7.00014-7, DOI 10.1016/B978-0-12-811143-7.00014-7]	59	16	17	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218191	10.1371/journal.pone.0218191	http://dx.doi.org/10.1371/journal.pone.0218191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251746	gold, Green Published, Green Submitted			2022-12-26	WOS:000484915000009
J	McElroy, JP; Carmella, SG; Heskin, AK; Tang, MK; Murphy, SE; Reisinger, SA; Jensen, JA; Hatsukami, DK; Hecht, SS; Shields, PG				McElroy, Joseph P.; Carmella, Steven G.; Heskin, Alisa K.; Tang, Mei Kuen; Murphy, Sharon E.; Reisinger, Sarah A.; Jensen, Joni A.; Hatsukami, Dorothy K.; Hecht, Stephen S.; Shields, Peter G.			Effects of cessation of cigarette smoking on eicosanoid biomarkers of inflammation and oxidative damage	PLOS ONE			English	Article							MAJOR URINARY METABOLITE; PROSTAGLANDIN-E METABOLITE; POTENTIAL HARM; IN-VIVO; PGE-M; SMOKERS; NONSMOKERS; EXPOSURE; INCREASE; STRESS	The urinary metabolites "prostaglandin E-2 metabolite" (PGE-M) and (Z)-7-[1R, 2R, 3R, 5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid (8-iso-PGF(2 alpha)) are biomarkers of inflammation and oxidative damage, respectively, and are elevated in cigarette smokers. Relatively little is known about the effects of smoking cessation on these biomarkers. To investigate this, current cigarette smokers interested in quitting were recruited and invited to participate in a smoking cessation study where varenicline (Chantix) and brief supportive behavioral counseling were offered at each visit after baseline. Subjects returned to the clinic during the 12 week treatment phase for 9 visits post cessation on days 3, 7, 14, 21, 28, 42, 56, 70 and 84. Urine samples were collected at each visit and analyzed by liquid chromatography-tandem mass spectrometry for PGE-M, 8-iso-PGF(2 alpha), and cotinine. Cotinine values demonstrated that 15 of 38 subjects quit smoking for the entire 84 day period. Significant decreases in mean levels of PGE-M and 8-iso-PGF(2 alpha) per milligram creatinine were observed in these subjects, by 44% (p = 0.0014) and 27% (p<0.001), respectively. The results of this study demonstrate that cessation of smoking for 84 days results in modest but significant declines in urinary PGE-M and 8-iso-PGF(2 alpha) indicating reductions in systemic inflammation and oxidative damage. Given that levels were only modestly decreased, these markers are not specific to tobacco-smoke exposure. The modest declines in these biomarkers should be considered when planning studies with ex-smokers. There is a "hangover" from smoking that lasts at least 3 months.	[McElroy, Joseph P.] Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA; [Carmella, Steven G.; Heskin, Alisa K.; Tang, Mei Kuen; Murphy, Sharon E.; Jensen, Joni A.; Hatsukami, Dorothy K.; Hecht, Stephen S.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Reisinger, Sarah A.; Shields, Peter G.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Shields, PG (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.	Peter.Shields@osumc.edu	Shields, Peter G/I-1644-2012; Tang, Alexandra Mei Kuen/W-4533-2018	Tang, Alexandra Mei Kuen/0000-0002-4491-8038; Reisinger, Sarah/0000-0002-3076-5405; Shields, Peter/0000-0002-7404-217X	National Cancer Institute [N01 PC-064402]; National Cancer Institute; FDA Center for Tobacco Products [R01 CA 203851]; National Cancer Institute Cancer Center [CA-077598]; NATIONAL CANCER INSTITUTE [P30CA077598, R01CA203851] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA Center for Tobacco Products; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute through N01 PC-064402 (TobPRAC) (PGS and DKH) and by the National Cancer Institute and the FDA Center for Tobacco Products through R01 CA 203851 (SSH and DKH). Mass spectrometry was carried out in the Analytical Biochemistry Core Facility of the Masonic Cancer Center, supported in part by National Cancer Institute Cancer Center Support Grant (CA-077598). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.	Carmella SG, 2009, CHEM RES TOXICOL, V22, P734, DOI 10.1021/tx800479s; Chang CM, 2019, NICOTINE TOB RES, V21, P3, DOI 10.1093/ntr/ntx273; Chehne F, 2002, PROSTAG LEUKOTR ESS, V67, P333, DOI 10.1054/plef.2002.0438; Duffield-Lillico AJ, 2009, CANCER PREV RES, V2, P322, DOI 10.1158/1940-6207.CAPR-09-0005; Frost-Pineda K, 2011, NICOTINE TOB RES, V13, P182, DOI 10.1093/ntr/ntq235; Goettel M, 2018, CHEM RES TOXICOL, V31, P176, DOI 10.1021/acs.chemrestox.7b00276; Goettel M, 2017, J PROTEOME RES, V16, P3491, DOI 10.1021/acs.jproteome.7b00128; Gross ND, 2005, CLIN CANCER RES, V11, P6087, DOI 10.1158/1078-0432.CCR-05-0733; King CC, 2017, ARTERIOSCL THROM VAS, V37, P374, DOI [10.1161/ATVBAHA.116.308728, 10.1161/atvbaha.116.308728]; Liu JM, 2011, CANCER EPIDEM BIOMAR, V20, P1760, DOI 10.1158/1055-9965.EPI-10-0987; Lowe FJ, 2009, CLIN CHEM LAB MED, V47, P311, DOI 10.1515/CCLM.2009.069; Mah E, 2015, EXP BIOL MED, V240, P527, DOI 10.1177/1535370214556948; Milne GL, 2011, CHEM REV, V111, P5973, DOI 10.1021/cr200160h; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Murphy SE, 2014, CARCINOGENESIS, V35, P2526, DOI 10.1093/carcin/bgu191; Neale JR, 2008, J CHROMATOGR B, V871, P72, DOI 10.1016/j.jchromb.2008.06.042; Okayasu I, 2014, J CLIN LAB ANAL, V28, P32, DOI 10.1002/jcla.21640; Pilz H, 2000, THROMB RES, V99, P209, DOI 10.1016/S0049-3848(00)00249-8; Reilly M, 1996, CIRCULATION, V94, P19, DOI 10.1161/01.CIR.94.1.19; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Team RC, 2012, R LANG ENV STAT COMP; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Wang DZ, 2013, CANCER PREV RES, V6, P507, DOI 10.1158/1940-6207.CAPR-13-0153; Yan WY, 2007, J LIPID RES, V48, P1607, DOI 10.1194/jlr.M700097-JLR200	24	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218386	10.1371/journal.pone.0218386	http://dx.doi.org/10.1371/journal.pone.0218386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251764	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000011
J	Chicas-Mosier, AM; Dinges, CW; Agosto-Rivera, JL; Giray, T; Oskay, D; Abramson, CI				Chicas-Mosier, Ana M.; Dinges, Christopher W.; Agosto-Rivera, Jose L.; Giray, Tugrul; Oskay, Devrim; Abramson, Charles I.			Honey bees (Apis mellifera spp.) respond to increased aluminum exposure in their foraging choice, motility, and circadian rhythmicity	PLOS ONE			English	Article							COLONY; ACETYLCHOLINESTERASE; ACCUMULATION; DIVERSITY; SURVIVAL; BEHAVIOR; SELENIUM; IMPACT; NEONICOTINOIDS; INSECTICIDES	Aluminum is increasingly globally bioavailable with acidification from industrial emissions and poor mining practices. This bioavailability increases uptake by flora, contaminating products such as fruit, pollen, and nectar. Concentrations of aluminum in fruit and pollen have been reported between 0.05 and 670mg/L in North America. This is particularly concerning for pollinators that ingest pollen and nectar. Honey bees represent a globally present species experiencing decline in Europe and North America. Region specific decline may be a result of differential toxicity of exposure between subspecies. We find that European honey bees (Apis mellifera mellifera) may have differential toxicity as compared to two allopatric Mediterranean subspecies (Apis mellifera carnica and Apis mellifera caucasica) which showed no within subspecies exposure differences. European honey bees were then used in a laboratory experiment and exposed to aluminum in their daily water supply to mimic nectar contamination at several concentrations. After approximately 3 weeks of aluminum ingestion these bees showed significantly shorter captive longevity than controls at concentrations as low as 10.4mg/L and showed a possible hormetic response in motility. We also compared European honey bees to Africanized/European hybrid bees (Apis mellifera mellifera/scutellata hybrid) in short-term free-flight experiments. Neither the European honey bee nor the hybrid showed immediate foraging deficits in flight time, color choice, or floral manipulation after aluminum exposure. We conclude that European honey bees are at the greatest risk of aluminum related decline from chronic ingestion as compared to other subspecies and offer new methods for future use in honey bee toxicology.	[Chicas-Mosier, Ana M.; Abramson, Charles I.] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA; [Dinges, Christopher W.; Abramson, Charles I.] Oklahoma State Univ, Dept Psychol, Stillwater, OK 74078 USA; [Agosto-Rivera, Jose L.; Giray, Tugrul] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR 00931 USA; [Oskay, Devrim] Namik Kemal Univ, Dept Agr Biotechnol, Degirmenalti Campus, Tekirdag, Turkey	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Puerto Rico; University of Puerto Rico Rio Piedras; Namik Kemal University	Abramson, CI (corresponding author), Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA.; Abramson, CI (corresponding author), Oklahoma State Univ, Dept Psychol, Stillwater, OK 74078 USA.	Charles.abramson@okstate.edu	Oskay, Devrim/ABA-6576-2020	, Charles/0000-0001-8961-3089; OSKAY, DEVRIM/0000-0002-3410-2780	National Science Foundation [1144467, 2016-1560389, 2015-1545803, HRD-1612560, HRD1736019]	National Science Foundation(National Science Foundation (NSF))	This research was funded in part by National Science Foundation Programs including the Graduate Research Fellowship Program (#1144467, awarded to AMCM: https://www.nsfgrfp.org/), Research Experiences for Undergraduates (#2016-1560389, awarded to JLAR, TG, and CIA: https://www.nsf.gov/crssprgm/reu/), Partnership for International Research and Education (#2015-1545803, awarded to JLAR, TG, and CIA: https://www.nsf.gov/pire), Louis Stokes Alliance for Minority Participation Bridge to the Doctorate (#HRD-1612560, awarded to AMCM: https://www.nsf.gov/funding/pgm_ summ. jsp? pims_ id= 13646) and Centers of Research Excellence in Science and Technology: Puerto Rico Center for Environmental Neuroscience (#HRD1736019, awarded to TG: https://www.nsf.gov/awardsearch/showAward? AWD_ ID= 1736019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162347; Abramson CI, 2012, ECOTOX ENVIRON SAFE, V78, P287, DOI 10.1016/j.ecoenv.2011.11.038; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alemanno A, 2013, EUR J RISK REGUL, V4, P191, DOI 10.1017/S1867299X00003342; Andrews JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P149, DOI 10.1029/2000GB001278; ATSDR, 2017, TOX PROF AL; Barbosa WF, 2015, PEST MANAG SCI, V71, P1049, DOI 10.1002/ps.4025; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bartomeus I, 2011, P NATL ACAD SCI USA, V108, P20645, DOI 10.1073/pnas.1115559108; Bekic B, 2014, SCI PAP-SER MANAG EC, V14, P13; Bian M, 2013, CROP J, V1, P91, DOI 10.1016/j.cj.2013.08.002; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; Burden CM, 2016, ECOTOX ENVIRON SAFE, V127, P71, DOI 10.1016/j.ecoenv.2015.12.034; Cakmak I, 2010, J INSECT BEHAV, V23, P100, DOI 10.1007/s10905-009-9199-7; Cakmak I, 2009, ANIM BEHAV, V77, P1273, DOI 10.1016/j.anbehav.2009.01.032; Cardwell AS, 2018, ENVIRON TOXICOL CHEM, V37, P36, DOI 10.1002/etc.3901; Cashion MF, 1996, HORM BEHAV, V30, P280, DOI 10.1006/hbeh.1996.0034; Chen C, 2016, MOL BIOL EVOL, V33, P1337, DOI 10.1093/molbev/msw017; Chicas-Mosier AM, 2017, ECOTOX ENVIRON SAFE, V143, P80, DOI 10.1016/j.ecoenv.2017.05.008; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Craig DPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101262; Craig DPA, 2015, A NEED FOR INDIVIDUA; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Eban-Rothschild A., 2012, HONEYBEE NEUROBIOLOG, P31, DOI 10.1007/978-94-007-2099-2_3; Exley C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127665; Exley C, 2015, J TRACE ELEM MED BIO, V30, P90, DOI 10.1016/j.jtemb.2014.11.002; FEWELL JH, 1993, EXPERIENTIA, V49, P1106, DOI 10.1007/BF01929923; Galindo-Cardona A, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-65; Gauthier M, 2016, CHEMOSPHERE, V144, P848, DOI 10.1016/j.chemosphere.2015.09.057; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hill PSM, 1997, ANIM BEHAV, V54, P615, DOI 10.1006/anbe.1996.0467; Hladun KR, 2016, ENVIRON TOXICOL CHEM, V35, P322, DOI 10.1002/etc.3273; Hladun KR, 2013, ENVIRON TOXICOL CHEM, V32, P2584, DOI 10.1002/etc.2357; Hladun KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034137; Hladun KR, 2011, ENVIRON EXP BOT, V74, P90, DOI 10.1016/j.envexpbot.2011.05.003; Holzschuh A, 2010, J ANIM ECOL, V79, P491, DOI 10.1111/j.1365-2656.2009.01642.x; Hranitz JM, 2010, ALCOHOL, V44, P275, DOI 10.1016/j.alcohol.2010.02.003; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Kaizer RR, 2008, NEUROCHEM RES, V33, P2294, DOI 10.1007/s11064-008-9725-6; Kaptanoglu Buenyamin, 2007, Journal of Basic and Clinical Physiology and Pharmacology, V18, P245; Karahan A, 2015, ECOTOXICOLOGY, V24, P2017, DOI 10.1007/s10646-015-1537-2; Lee KY, 2017, INT MED J MALAYS, V16, P137; LEVINE JD, 2002, BMC NEUROSCI, V3; Meindl GA, 2013, ENVIRON POLLUT, V177, P78, DOI 10.1016/j.envpol.2013.02.017; Meixner MD, 2011, APIDOLOGIE, V42, P425, DOI 10.1007/s13592-011-0007-y; Mirza A, 2017, J TRACE ELEM MED BIO, V40, P30, DOI 10.1016/j.jtemb.2016.12.001; Moore D, 1998, BEHAV ECOL SOCIOBIOL, V43, P147, DOI 10.1007/s002650050476; Morgano MA, 2010, J AGR FOOD CHEM, V58, P6876, DOI 10.1021/jf100433p; Moron D, 2014, INSECT CONSERV DIVER, V7, P113, DOI 10.1111/icad.12040; Moron D, 2012, J APPL ECOL, V49, P118, DOI 10.1111/j.1365-2664.2011.02079.x; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Namiesnik J, 2010, CRIT REV ANAL CHEM, V40, P68, DOI 10.1080/10408340903153234; Oleksa A, 2013, APIDOLOGIE, V44, P611, DOI 10.1007/s13592-013-0212-y; Ostwald MM, 2016, J EXP BIOL, V219, P2156, DOI 10.1242/jeb.139824; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Peralta-Videa JR, 2009, INT J BIOCHEM CELL B, V41, P1665, DOI 10.1016/j.biocel.2009.03.005; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; ROBINSON GE, 1985, J INSECT PHYSIOL, V31, P277, DOI 10.1016/0022-1910(85)90003-4; Rubinos DA, 2013, ENVIRON SCI POLLUT R, V20, P7787, DOI 10.1007/s11356-013-1477-4; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Strauss U, 2015, EXP APPL ACAROL, V65, P89, DOI 10.1007/s10493-014-9842-7; van der Steen JJM, 2012, ENVIRON MONIT ASSESS, V184, P4119, DOI 10.1007/s10661-011-2248-7; Vance JT, 2009, J EXP BIOL, V212, P2604, DOI 10.1242/jeb.028100; WADDINGTON KD, 1985, J INSECT PHYSIOL, V31, P891, DOI 10.1016/0022-1910(85)90106-4; Walton A, 2016, BEHAV ECOL SOCIOBIOL, V70, P999, DOI 10.1007/s00265-016-2084-4; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Williamson SM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00013; Yellamma K, 2010, Toxicol Int, V17, P106, DOI 10.4103/0971-6580.72682	72	5	5	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2019	14	6							e0218365	10.1371/journal.pone.0218365	http://dx.doi.org/10.1371/journal.pone.0218365			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3WH	31246964	Green Submitted, Green Published, gold			2022-12-26	WOS:000484911900019
J	Hayashi, SN; Souza, PWM; Nascimento, WR; Fernandes, MEB				Hayashi, Sanae N.; Souza-Filho, Pedro Walfir M.; Nascimento, Wilson R., Jr.; Fernandes, Marcus E. B.			The effect of anthropogenic drivers on spatial patterns of mangrove land use on the Amazon coast	PLOS ONE			English	Article							FORESTS; DEFORESTATION; MANAGEMENT; CARBON; CONSERVATION; DEGRADATION; AQUACULTURE; DYNAMICS; BRAZIL; ROADS	Mangroves play an essential ecological role in the maintenance of the coastal zone and are extremely important for the socioeconomics of coastal communities. However, mangrove ecosystems are impacted by a range of anthropogenic pressures, and the loss of this habitat can be attributed primarily to the human occupation of the coastal zone. In the present study, we analyzed the spatial patterns of land use in the mangrove of the Brazilian Amazon coast, and evaluated the anthropogenic drivers of this impact, using a remote sensing approach. We mapped the road network using RapidEye images, and human settlements using global data. The results of these analyses indicate that the Brazilian Amazon coast has a low population density and low rates of anthropogenic impact in most of the coastal microregions investigated, factors that contribute to the maintenance and conservation of the region's mangrove. The study also revealed that the paved road network is one of the principal drivers of land use in the mangrove, whereas other factors, such as population density, urban centers, and the number of settlements are much less important. While the region has 2024 km of paved highways, unpaved roads (17,496 km) facilitate access to the mangrove, with approximately 90% of anthropogenic impact being recorded within a 3 km radius of these roads. While the network of paved highways is relatively reduced in extension, preventive measures are urgently required to impede any major shift in the current scenario, caused by the expansion of major development programs. The results of the study indicate that biophysical, economic, and political factors may also contribute to the reduction, stability, and development of one of the world's largest areas of mangrove forest.	[Hayashi, Sanae N.; Fernandes, Marcus E. B.] Univ Fed Para, Inst Estudos Costeiros, Lab Ecol Manguezal, Campus Braganca, Braganca, Para, Brazil; [Hayashi, Sanae N.] Univ Fed Rural Amazonia, Lab Geoproc & Educ Financeira & Ambiental, Campus Capanema, Capanema, Para, Brazil; [Souza-Filho, Pedro Walfir M.] Univ Fed Para, Inst Geociencias, Lab Analises Imagens Trop Umido, Belem, Para, Brazil; [Souza-Filho, Pedro Walfir M.; Nascimento, Wilson R., Jr.] Inst Tecnol Vale, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal Rural da Amazonia (UFRA); Universidade Federal do Para; Instituto Tecnologico Vale Desenvolvimento Sustentavel	Fernandes, MEB (corresponding author), Univ Fed Para, Inst Estudos Costeiros, Lab Ecol Manguezal, Campus Braganca, Braganca, Para, Brazil.	mebf@ufpa.br	Souza, Pedro/GZH-1275-2022; Souza-Filho, Pedro Walfir M. M./J-4958-2012	Souza-Filho, Pedro Walfir M. M./0000-0003-0252-808X; Nogueira Hayashi, Sanae/0000-0001-7249-8600	Brazilian National Council for Scientific and Technological Development (CNPq); Office of Naval Research (ONR) [N62909-14-1-N201]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Office of Naval Research (ONR)(Office of Naval Research)	Funding was provided by the Brazilian National Council for Scientific and Technological Development (CNPq) and Office of Naval Research (ONR#N62909-14-1-N201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SE, 2013, REG ENVIRON CHANGE, V13, P927, DOI 10.1007/s10113-012-0397-z; Alongi DM, 2008, FOREST ECOL MANAG, V255, P1359, DOI 10.1016/j.foreco.2007.10.051; Alongi DM, 2014, ANNU REV MAR SCI, V6, P195, DOI 10.1146/annurev-marine-010213-135020; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Barber CP, 2014, BIOL CONSERV, V177, P203, DOI 10.1016/j.biocon.2014.07.004; Barbier EB, 2003, CONTEMP ECON POLICY, V21, P418, DOI 10.1093/cep/byg022; Barbier EB, 2004, SHRIMP FARMING MANGR, DOI [10.15713/ins.mmj.3, DOI 10.15713/INS.MMJ.3]; Beymer-Farris BA, 2012, GLOBAL ENVIRON CHANG, V22, P332, DOI 10.1016/j.gloenvcha.2011.11.006; Blankespoor B, 2017, AMBIO, V46, P478, DOI 10.1007/s13280-016-0838-x; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; Brandao AO, 2006, INT J REMOTE SENS, V27, P177, DOI 10.1080/01431160500353841; Cardenas NY, 2017, INT J APPL EARTH OBS, V63, P1, DOI 10.1016/j.jag.2017.07.004; Carney J, 2014, GEOFORUM, V53, P126, DOI 10.1016/j.geoforum.2014.02.013; CATALANO D, 2018, THREATS MANGROVE FOR, V25, DOI DOI 10.1007/978-3-319-73016-5_29; Cougo MF, 2015, REMOTE SENS-BASEL, V7, P17097, DOI 10.3390/rs71215873; de Almeida LT, 2016, OCEAN COAST MANAGE, V125, P29, DOI 10.1016/j.ocecoaman.2016.03.008; de Andres M, 2018, LAND USE POLICY, V71, P121, DOI 10.1016/j.landusepol.2017.11.038; Diegues AC, 1999, OCEAN COAST MANAGE, V42, P187, DOI 10.1016/S0964-5691(98)00053-2; DINIZ Marco Túlio Mendonça, 2017, Mercator (Fortaleza), V16, pe16013, DOI 10.4215/rm2017.e16013; DNIT, 2017, RAD 2017; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Eyzaguirre IAL, 2018, COAST RES LIBR, V25, P699, DOI 10.1007/978-3-319-73016-5_31; FAO, 2007, 153 FAO, P77; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; FERNANDES M. E. B., 2007, UAKARI, V3, P55, DOI DOI 10.31420/UACARI.V3I1.19; Ferreira AC, 2016, OCEAN COAST MANAGE, V125, P38, DOI 10.1016/j.ocecoaman.2016.03.011; Giri C, 2008, J BIOGEOGR, V35, P519, DOI 10.1111/j.1365-2699.2007.01806.x; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Giri C, 2015, J ENVIRON MANAGE, V148, P101, DOI 10.1016/j.jenvman.2014.01.020; Glaser M, 2003, REG ENVIRON CHANGE, V3, P162, DOI 10.1007/s10113-003-0057-4; Guette A, 2018, APPL GEOGR, V92, P41, DOI 10.1016/j.apgeog.2018.01.012; Guimaraes AS, 2010, AQUAC RES, V41, P828, DOI 10.1111/j.1365-2109.2009.02360.x; Hadlich GM, 2010, NE BRAZIL CIAS, V29, P633; Hamilton SE, 2018, NAT CLIM CHANGE, V8, P240, DOI 10.1038/s41558-018-0090-4; Haroun R, 2018, COAST RES LIBR, V25, P589, DOI 10.1007/978-3-319-73016-5_27; Hayashi SN, 2018, THESIS; Hutchings P, 1987, ECOLOGY MANGROVES, V1, P431; IBGE, 2011, ATL GEOGR ZON COST O; ICMBio, 2018, ATL MANG BRAS, P176; Ilman M, 2016, LAND USE POLICY, V54, P448, DOI 10.1016/j.landusepol.2016.03.010; Kamal S, 2017, HYDROBIOLOGIA, V803, P121, DOI 10.1007/s10750-017-3178-3; Kristensen E, 2008, AQUAT BOT, V89, P201, DOI 10.1016/j.aquabot.2007.12.005; Krumme U, 2015, ICES J MAR SCI, V72, P939, DOI 10.1093/icesjms/fsu188; Lara RJ, 2010, ECOL STUD-ANAL SYNTH, V211, P127, DOI 10.1007/978-3-642-13457-9_8; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2015, CURR BIOL, V25, P3202, DOI 10.1016/j.cub.2015.10.046; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; LAVIEREN V., 2012, POLICY BRIEF SECURIN; Lee SY, 2016, MAR POLLUT BULL, V109, P682, DOI 10.1016/j.marpolbul.2016.01.008; Leyk S, 2018, REMOTE SENS ENVIRON, V204, P898, DOI 10.1016/j.rse.2017.08.035; Menezes Moirah Paula Machado de, 2008, Acta Amaz., V38, P403, DOI 10.1590/S0044-59672008000300004; Magris R.A., 2010, PAN-AM J AQUAT SCI, V5, P546; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; McKee, 2018, REMOTE SENSING APPL, V10, P93, DOI [10.1016/j.rsase.2018.03.002, DOI 10.1016/J.RSASE.2018.03.002]; Meng XW, 2016, ORG GEOCHEM, V98, P166, DOI 10.1016/j.orggeochem.2016.06.001; MMA, 2019, CAT IM SAT RAP MIN M; Nascimento WR, 2013, ESTUAR COAST SHELF S, V117, P83, DOI 10.1016/j.ecss.2012.10.005; Ngole-Jeme VM, 2016, J COAST CONSERV, V20, P245, DOI 10.1007/s11852-016-0435-y; Omo-Irabor OO, 2011, ENVIRON MONIT ASSESS, V178, P39, DOI 10.1007/s10661-010-1669-z; Patarasuk R, 2012, APPL GEOGR, V32, P228, DOI 10.1016/j.apgeog.2011.05.009; Perz SG, 2012, REG ENVIRON CHANGE, V12, P35, DOI 10.1007/s10113-011-0233-x; Pesaresi M., 2016, OPERATING PROCEDURE, DOI [10.2788/253582, DOI 10.2788/253582]; Pfaff A, 2007, J REGIONAL SCI, V47, P109, DOI 10.1111/j.1467-9787.2007.00502.x; Primavera JH, 2000, ECOL ECON, V35, P91, DOI 10.1016/S0921-8009(00)00170-1; Primavera JH, 2019, MANGROVE ECOSYSTEM, V2019; Queiroz L, 2013, OCEAN COAST MANAGE, V73, P54, DOI 10.1016/j.ocecoaman.2012.11.009; Rathod BL, 2015, DEGRADATION MANGROVE, V6, P1103; Richards DR, 2016, P NATL ACAD SCI USA, V113, P344, DOI 10.1073/pnas.1510272113; Rideout AJR, 2013, GLOBAL CHANGE BIOL, V19, P3493, DOI 10.1111/gcb.12176; Romanach SS, 2018, OCEAN COAST MANAGE, V154, P72, DOI 10.1016/j.ocecoaman.2018.01.009; Scherer MEG, 2016, J COASTAL RES, P690, DOI 10.2112/SI75-138.1; Schmidt Anders Jensen, 2013, Boletim Tecnico Cientifico do CEPENE, V19, P9; Seto KC, 2007, GLOBAL ENVIRON CHANG, V17, P486, DOI 10.1016/j.gloenvcha.2007.03.001; Small C, 2003, J COASTAL RES, V19, P584; Souza Filho P.W.M., 2005, REV BRAS GEOFISICA, V23, P427, DOI DOI 10.1590/S0102-261X2005000400006; Szlafsztein C, 2010, ECOL STUD-ANAL SYNTH, V211, P365, DOI 10.1007/978-3-642-13457-9_23; Szlafsztein C.F., 2009, GEST COSTEIRA INTEG, V9, P47, DOI [10.5894/rgci114, DOI 10.5894/RGCI114]; Thomas N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179302; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; van Bochove J., 2014, IMPORTANCE MANGROVES, P128	83	11	11	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0217754	10.1371/journal.pone.0217754	http://dx.doi.org/10.1371/journal.pone.0217754			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IT5DV	31242200	Green Submitted, gold, Green Published			2022-12-26	WOS:000482883600015
J	Phalke, SP; Huang, YF; Rubtsova, K; Getahun, A; Sun, DM; Reinhardt, RL; O'Brien, RL; Born, WK				Phalke, Swati Popat; Huang, Yafei; Rubtsova, Kira; Getahun, Andrew; Sun, Deming; Reinhardt, Richard L.; O'Brien, Rebecca L.; Born, Willi K.			gamma delta T cells shape memory-phenotype alpha beta T cell populations in non-immunized mice	PLOS ONE			English	Article							B-CELLS; RECEPTOR EXPRESSION; IL-4; INTERLEUKIN-4; GROWTH; IMMUNITY; FETAL; TCR; RECONSTITUTION; PRECURSORS	Size and composition of gamma delta T cell populations change dramatically with tissue location, during development, and in disease. Given the functional differentiation of gamma delta T cell subsets, such shifts might alter the impact of gamma delta T cells on the immune system. To test this concept, and to determine if gamma delta T cells can affect other immune cells prior to an immune response, we examined non-immunized mice derived from strains with different genetically induced deficiencies in gamma delta T cells, for secondary changes in their immune system. We previously saw extensive changes in pre-immune antibodies and B cell populations. Here, we report effects on alpha beta T cells. Similarly to the B cells, alpha beta T cells evidently experience the influence of gamma delta T cells at late stages of their pre-immune differentiation, as single-positive heat stable anti-gen- low thymocytes. Changes in these and in mature alpha beta T cells were most prominent with memory-phenotype cells, including both CD8+ and CD4+ populations. As previously observed with B cells, most of the effects on alpha beta T cells were dependent on IL-4. Unexpectedly, IL-4 seemed to be produced mainly by alpha beta T cells in the non-immunized mice, albeit strongly regulated by gamma delta T cells. Similarly to our findings with B cells, changes of alpha beta T cells were less pronounced in mice lacking all gamma delta T cells than in mice lacking only some, suggesting that the composition of the gamma delta T cell population determines the nature of the gamma delta-influence on the other pre-immune lymphocytes.	[Phalke, Swati Popat; Rubtsova, Kira; Reinhardt, Richard L.; O'Brien, Rebecca L.; Born, Willi K.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Huang, Yafei] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Joint Lab Stem Cell Engn & Technol Transfer, Wuhan, Hubei, Peoples R China; [Getahun, Andrew; Reinhardt, Richard L.; O'Brien, Rebecca L.; Born, Willi K.] Univ Colorado, Hlth Sci Ctr, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Sun, Deming] Univ Calif Los Angeles, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90095 USA; [Sun, Deming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Phalke, Swati Popat] Univ Libre Bruxelles, IMI, Dept Pharmacotherapy & Pharmaceut, David Vermijlen Lab, Brussels, Belgium	National Jewish Health; Huazhong University of Science & Technology; University of Colorado System; University of Colorado Anschutz Medical Campus; Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universite Libre de Bruxelles	Born, WK (corresponding author), Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA.; Born, WK (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Immunol & Microbiol, Aurora, CO 80045 USA.	bornw@njhealth.org	Phalke, Swati P/C-3188-2018	Phalke, Swati P/0000-0002-9061-0931	NIH/NIAID [1R21 AI122135-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122135] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by NIH/NIAID 1R21 AI122135-01A1 to WKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi I, 2015, BLOOD, V125, P2349, DOI 10.1182/blood-2014-09-599423; Akue AD, 2012, J IMMUNOL, V188, P2516, DOI 10.4049/jimmunol.1102213; Bank I, 2014, CLIN REV ALLERG IMMU, V47, P311, DOI 10.1007/s12016-013-8391-x; Barik S, 2017, J IMMUNOL, V199, P2767, DOI 10.4049/jimmunol.1700498; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Born W, 1999, Adv Immunol, V71, P77; Born WK, 2017, ADV IMMUNOL, V134, P1, DOI 10.1016/bs.ai.2017.01.002; Born WK, 2016, ARCH IMMUNOL THER EX, V64, P455, DOI 10.1007/s00005-016-0403-0; Born WK, 2010, J IMMUNOL, V184, P4055, DOI 10.4049/jimmunol.0903679; Born WK, 2010, IMMUNOL CELL BIOL, V88, P269, DOI 10.1038/icb.2009.105; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; Dalton JE, 2003, J IMMUNOL, V171, P6488, DOI 10.4049/jimmunol.171.12.6488; Dong P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112964; Egan CE, 2005, J IMMUNOL, V175, P8191, DOI 10.4049/jimmunol.175.12.8191; Erb KJ, 1997, J EXP MED, V185, P329, DOI 10.1084/jem.185.2.329; Finkelman FD, 1999, INT IMMUNOL, V11, P1811, DOI 10.1093/intimm/11.11.1811; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hahn YS, 2004, J IMMUNOL, V172, P2894, DOI 10.4049/jimmunol.172.5.2894; Haluszczak C, 2009, J EXPT MED; Hao JL, 2011, J IMMUNOL, V187, P4979, DOI 10.4049/jimmunol.1101389; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; HIDAKA T, 1992, CLIN EXP IMMUNOL, V89, P223; Huang YF, 2016, J IMMUNOL, V196, P217, DOI 10.4049/jimmunol.1501064; Huang YF, 2015, P NATL ACAD SCI USA, V112, pE39, DOI 10.1073/pnas.1415107111; Huang YF, 2009, J IMMUNOL, V183, P849, DOI 10.4049/jimmunol.0804104; Huang YG, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-92; Huber SA, 2000, J IMMUNOL, V165, P4174, DOI 10.4049/jimmunol.165.8.4174; Jameson SC, 2015, ADV IMMUNOL, V126, P173, DOI 10.1016/bs.ai.2014.12.001; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Kawabe T, 2018, NAT REV IMMUNOL, V18, P1, DOI 10.1038/nri.2018.12; Kedl RM, 2018, NAT REV IMMUNOL, V18, DOI 10.1038/nri.2018.13; Kelly KA, 1997, IMMUNOLOGY, V91, P65, DOI 10.1046/j.1365-2567.1997.00233.x; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; Kurzweil V, 2014, J IMMUNOL, V192, P5643, DOI 10.4049/jimmunol.1301755; Li LQ, 2004, IMMUNITY, V20, P429, DOI 10.1016/S1074-7613(04)00072-X; MANABE A, 1994, BLOOD, V83, P1731, DOI 10.1182/blood.V83.7.1731.bloodjournal8371731; Melandri D, 2018, NAT IMMUNOL, V19, P1352, DOI 10.1038/s41590-018-0253-5; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; O'Brien RL, 2007, IMMUNOL REV, V215, P77, DOI 10.1111/j.1600-065X.2006.00477.x; O'Brien RL, 2000, J IMMUNOL, V165, P6472, DOI 10.4049/jimmunol.165.11.6472; O'Brien RL, 2001, CHEM IMMUNOL, V79, P1; PALACIOS R, 1987, EMBO J, V6, P91, DOI 10.1002/j.1460-2075.1987.tb04723.x; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; PAUL WE, 1991, BLOOD, V77, P1859; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; PLUM J, 1990, J IMMUNOL, V145, P1066; RENZ H, 1991, J IMMUNOL, V146, P3049; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Rudge EU, 2002, J EXP MED, V195, P1079, DOI 10.1084/jem.20011435; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Sunaga S, 1997, J IMMUNOL, V158, P4223; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Tortola L, 2010, BLOOD, V116, P5200, DOI 10.1182/blood-2010-05-284547; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; White JT, 2017, NAT REV IMMUNOL, V17, P391, DOI 10.1038/nri.2017.34; ZLOTNIK A, 1987, P NATL ACAD SCI USA, V84, P3856, DOI 10.1073/pnas.84.11.3856	64	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218827	10.1371/journal.pone.0218827	http://dx.doi.org/10.1371/journal.pone.0218827			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237933	Green Published, Green Submitted, gold			2022-12-26	WOS:000484856000044
J	Brook, B; Harbeson, D; Amenyogbe, N; Ben-Othman, R; Kollmann, TR; Aniba, R				Brook, Byron; Harbeson, Danny; Amenyogbe, Nelly; Ben-Othman, Rym; Kollmann, Tobias R.; Aniba, Radhouane			Robust health-score based survival prediction for a neonatal mouse model of polymicrobial sepsis	PLOS ONE			English	Article							MORTALITY; SEVERITY; IMMUNITY; NEWBORN; RESPONSES; DISTINCT; INFANTS; LIFE	Infectious disease and sepsis represent a serious problem for all, but especially in early life. Much of the increase in morbidity and mortality due to infection in early life is presumed to relate to fundamental differences between neonatal and adult immunity. Mechanistic insight into the way newborns' immune systems handle infectious threats is lacking; as a result, there has only been limited success in providing effective immunomodulatory interventions to reduce infectious mortality. Given the complexity of the host-pathogen interactions, neonatal mouse models can offer potential avenues providing valuable data. However, the small size of neonatal mice hampers the ability to collect biological samples without sacrificing the animals. Further, the lack of a standardized metric to quantify newborn mouse health increases reliance on correlative biomarkers without a known relationship to 'clinical' outcome. To address this bottleneck, we developed a system that allows assessment of neonatal mouse health in a readily standardized and quantifiable manner. The resulting health scores require no special equipment or sample collection and can be assigned in less than 20 seconds. Importantly, the health scores are highly predictive of survival. A classifier built on our health score revealed a positive relationship between reduced bacterial load and survival, demonstrating how this scoring system can be used to bridge the gap between assumed relevance of biomarkers and the clinical outcome of interest. Adoption of this scoring system will not only provide a robust metric to assess health of newborn mice but will also allow for objective, prospective studies of infectious disease and possible interventions in early life.	[Brook, Byron; Harbeson, Danny; Amenyogbe, Nelly] Univ British Columbia, Dept Expt Med, Vancouver, BC, Canada; [Ben-Othman, Rym; Kollmann, Tobias R.] Univ British Columbia, Div Infect Dis, Dept Pediat, Vancouver, BC, Canada; [Aniba, Radhouane] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada; [Aniba, Radhouane] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Harbeson, D (corresponding author), Univ British Columbia, Dept Expt Med, Vancouver, BC, Canada.	dannyharbeson@gmail.com		Harbeson, Danny/0000-0002-2949-6033; Kollmann, Tobias/0000-0003-2403-9762	Canadian Institute for Health Research (CIHR); Michael Smith Foundation for Health Research Career Investigator Award	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Career Investigator Award(Michael Smith Foundation for Health Research)	This research was supported by funding from the Canadian Institute for Health Research (CIHR). T.R.K. is supported by a Michael Smith Foundation for Health Research Career Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Arakawa H, 2015, BEHAV BRAIN RES, V287, P146, DOI 10.1016/j.bbr.2015.03.040; Ashare A, 2005, AM J PHYSIOL-LUNG C, V288, pL633, DOI 10.1152/ajplung.00231.2004; Bermick JR, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0265-7; Brook B, 2019, JOVE-J VIS EXP, DOI 10.3791/58574; Brook B, 2017, SEMIN IMMUNOPATHOL, V39, P615, DOI 10.1007/s00281-017-0651-z; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Davenport EE, 2016, LANCET RESP MED, V4, P259, DOI 10.1016/S2213-2600(16)00046-1; Fleischmann-Struzek C, 2018, LANCET RESP MED, V6, P223, DOI 10.1016/S2213-2600(18)30063-8; Ghazal P, 2013, CURR OPIN INFECT DIS, V26, P213, DOI 10.1097/QCO.0b013e32835fb8bf; Goncalves MC, 2017, INFLAMMATION, V40, P1553, DOI 10.1007/s10753-017-0596-3; Gupta S, 2016, NEUROL INDIA, V64, P640, DOI 10.4103/0028-3886.185356; Harbeson D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01077; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lazic SE, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-37; Levy E, 2009, PEDIATR RES, V66, P179, DOI 10.1203/PDR.0b013e3181a9f41b; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069072; McGuill M. W., 1989, ILAR News, V31, P5; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Parasuraman S, 2010, J PHARMACOL PHARMACO, V1, P87, DOI 10.4103/0976-500X.72350; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Smith CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5649; Tomulic KL, 2017, QUAL LIFE RES, V26, P1361, DOI 10.1007/s11136-016-1457-5; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Wynn JL, 2016, CURR OPIN PEDIATR, V28, P135, DOI 10.1097/MOP.0000000000000315; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769	31	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218714	10.1371/journal.pone.0218714	http://dx.doi.org/10.1371/journal.pone.0218714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233529	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700032
J	Stankevitz, K; Schwartz, K; Hoke, T; Li, YX; Lanham, M; Mahaka, I; Mullick, S				Stankevitz, Kayla; Schwartz, Katie; Hoke, Theresa; Li, Yixuan; Lanham, Michele; Mahaka, Imelda; Mullick, Saiqa			Reaching at-risk women for PrEP delivery: What can we learn from clinical trials in sub-Saharan Africa?	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV-INFECTION; PREVENTION	Introduction ARV-based pre-exposure prophylaxis (PrEP) has the potential to avert many new HIV infections, yet little is known about how to reach women at high risk for HIV infection and motivate them to initiate PrEP. Clinical trials have succeeded in recruiting at-risk participants, evidenced by control arm HIV incidence >= 3% (defined by the World Health Organization as "substantial risk"). We examined experiences from HIV prevention trials to document recruitment strategies and identify practical, potentially effective strategies for reaching women in real-world PrEP delivery. Methods We conducted semi-structured qualitative phone interviews with 31 staff from five countries who had worked on one or more of seven ARV-based HIV prevention clinical trials. Questions explored recruitment strategies used to reach women at risk of HIV and to successfully communicate about PrEP (inclusive of oral and vaginal formulations). We structurally coded data in NVivo and analyzed codes to derive themes. We conducted results interpretation webinars with research and programmatic stakeholders to validate findings and develop recommendations. Results Clinical trial researchers employed a range of recruitment strategies to recruit at-risk women. They recommended engaging the local community and potential PrEP users via community events, meetings with gatekeepers, and use of community advisory boards; and they encouraged interpersonal communication like presentations in waiting rooms and door-to-door recruitment to address personal concerns and prevent misinformation. Participants also stressed the importance of addressing the challenges that already exist within the health system to create a more enabling environment and delivering positive messages through a variety of communication channels to normalize PrEP. Conclusions Findings from this study provide important insights into potentially effective ways for countries currently rolling out oral PrEP to reach at-risk women with information about PrEP and promote uptake.	[Stankevitz, Kayla; Schwartz, Katie; Hoke, Theresa; Li, Yixuan; Lanham, Michele] FHI 360, Durham, NC 27701 USA; [Mahaka, Imelda] Pangaea Zimbabwe AIDS Trust, Harare, Zimbabwe; [Mullick, Saiqa] Wits RHI, Johannesburg, South Africa	FHI 360	Stankevitz, K (corresponding author), FHI 360, Durham, NC 27701 USA.	kstankevitz@fhi360.org		Lanham, Michele/0000-0003-3012-5683; Stankevitz, Kayla/0000-0002-9779-7014; Mullick, Saiqa/0000-0001-7039-1949	USAID; Wits Reproductive Health and HIV Institute; AVAC [AID-OAA-A-15-00035]	USAID(United States Agency for International Development (USAID)); Wits Reproductive Health and HIV Institute; AVAC	This work was led by the OPTIONS Consortium, a program made possible by the generous assistance from the American people through the U.S. Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Financial assistance was provided by USAID (https://www.usaid.gov/) to FHI 360, the Wits Reproductive Health and HIV Institute, and AVAC under the terms of Cooperative Agreement No. AID-OAA-A-15-00035. The contents do not necessarily reflect the views of USAID or the United States Government. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was led by the OPTIONS Consortium, a program made possible by the generous assistance from the American people through the U.S. Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Financial assistance was provided by USAID to FHI 360, the Wits Reproductive Health and HIV Institute, and AVAC under the terms of Cooperative Agreement No. AID-OAA-A-15-00035. The contents do not necessarily reflect the views of USAID or the United States Government.	[Anonymous], 2015, HIV PREV STUD DOES N; [Anonymous], 2014, JAIDS-J ACQ IMM DEF, V66, P559, DOI [10.1097/qai.0000000000000275, DOI 10.1097/QAI.0000000000000275]; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Born LJ, 2012, J PUBLIC HEALTH AFR, V3, P8, DOI 10.4081/jphia.2012.e3; Calabrese SK, 2016, AIDS BEHAV, V20, P1499, DOI 10.1007/s10461-016-1318-9; Celum CL, 2015, J INT AIDS SOC, V18, P61, DOI 10.7448/IAS.18.4.20227; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Cowan FM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21101; Day S, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25174; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Do M, 2016, AIDS BEHAV, V20, P2033, DOI 10.1007/s10461-016-1402-1; Donnell D, 2014, JAIDS-J ACQ IMM DEF, V66, P340, DOI 10.1097/QAI.0000000000000172; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Elmari Briedenhann DP, 2018, CREATIVELY EMPOWERED; Haider H., 2012, CHANGING ATTITUDES B; Halcomb EJ, 2006, APPL NURS RES, V19, P38, DOI 10.1016/j.apnr.2005.06.001; Hoffman S, 2004, PERSPECT SEX REPRO H, V36, P120, DOI 10.1111/j.1931-2393.2004.tb00200.x; Hosek S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21107; Karim Q. A., 2010, SCIENCE, P1193748; Karim QA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19075; Lippman SA, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25182; MacQueen KM, 2018, J INT AIDS SOC S, V21; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mugo NR, 2016, CURR OPIN HIV AIDS, V11, P80, DOI 10.1097/COH.0000000000000224; Murnane PM, 2013, AIDS LONDON ENGLAND, V27; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Palanee-Phillips T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128857; PSI, SOC MARK EV BAS 2010, DOI 10.1007/s10461-016-1402-1; Pulerwitz J, 2016, BUILDING EVIDENCE GU, DOI DOI 10.31899/HIV7.1008; Simbayi L. C, 2014, AFRICAN NATL HIV PRE; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tolley E, 2016, QUALITATIVE METHODS, P85; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2018, FACT SHEET JUL 2018; UNAIDS, 2016, EST AIDSINFO ONL DAT; Underhill Kristen, 2010, Curr HIV/AIDS Rep, V7, P210, DOI 10.1007/s11904-010-0062-4; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; WHO, 2016, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER	40	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218556	10.1371/journal.pone.0218556	http://dx.doi.org/10.1371/journal.pone.0218556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226165	Green Published, Green Submitted, gold			2022-12-26	WOS:000484894700021
J	Arias-Del-Razo, A; Schramm, Y; Heckel, G; Saenz-Arroyo, A; Hernandez, A; Vazquez, L; Carrillo-Munoz, AI				Arias-Del-Razo, Alejandro; Schramm, Yolanda; Heckel, Gisela; Saenz-Arroyo, Andrea; Hernandez, Arturo; Vazquez, Leonardo; Carrillo-Munoz, Aldo I.			Do marine reserves increase prey for California sea lions and Pacific harbor seals?	PLOS ONE			English	Article							PHOCA-VITULINA-RICHARDII; COAST	Community marine reserves are geographical areas closed to fishing activities, implemented and enforced by the same fishermen that fish around them. Their main objective is to recover commercial stocks of fish and invertebrates. While marine reserves have proven successful in many parts of the world, their success near important marine predator colonies, such as the California sea lion (Zalophus californianus) and the Pacific harbor seal (Phoca vitulina richardii), is yet to be analyzed. In response to the concerns expressed by local fishermen about the impact of the presence of pinnipeds on their communities' marine reserves, we conducted underwater surveys around four islands in the Pacific west of the Baja California Peninsula: two without reserves (Todos Santos and San Roque); one with a recently established reserve (San Jeronimo); and, a fourth with reserves established eight years ago (Natividad). All these islands are subject to similar rates of exploitation by fishing cooperatives with exclusive rights. We estimated fish biomass and biodiversity in the seas around the islands, applying filters for potential California sea lion and harbor seal prey using known species from the literature. Generalized linear mixed models revealed that the age of the reserve has a significant positive effect on fish biomass, while the site (inside or outside of the reserve) did not, with a similar result found for the biomass of the prey of the California sea lion. Fish biodiversity was also higher around Natividad Island, while invertebrate biodiversity was higher around San Roque. These findings indicate that marine reserves increase overall fish diversity and biomass, despite the presence of top predators, even increasing the numbers of their potential prey. Community marine reserves may help to improve the resilience of marine mammals to climate-driven phenomena and maintain a healthy marine ecosystem for the benefit of both pinnipeds and fishermen.	[Arias-Del-Razo, Alejandro] Univ Americas Puebla, Dept Ciencias Quim Biol, Cholula, Mexico; [Schramm, Yolanda] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico; [Heckel, Gisela] Ctr Invest Cient & Educ Super Ensenad, Dept Biol Conservac, Ensenada, Baja California, Mexico; [Saenz-Arroyo, Andrea] Colegio Frontera Sur, Unidad San Cristobal, San Cristobal de las Casa, Chiapas, Mexico; [Hernandez, Arturo; Vazquez, Leonardo] Comunidad & Biodiversidad AC, Guaymas, Sonora, Mexico; [Carrillo-Munoz, Aldo I.] Univ Autonoma Tlaxcala, Ctr Tlaxcala Biol Conducta, Santa Maria Acuitlapilco, Tlaxcala, Mexico	Universidad Americas Puebla (UDLAP); Universidad Autonoma de Baja California; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; El Colegio de la Frontera Sur (ECOSUR)	Heckel, G (corresponding author), Ctr Invest Cient & Educ Super Ensenad, Dept Biol Conservac, Ensenada, Baja California, Mexico.	gheckel@cicese.mx	; Heckel, Gisela/K-9170-2016	Schramm, Yolanda/0000-0001-6951-4884; Heckel, Gisela/0000-0002-6003-7898; Carrillo-Munoz, Aldo-Isaac/0000-0002-4349-9919; Saenz-Arroyo, Andrea/0000-0002-5659-4608; Arias Del Razo, Alejandro/0000-0002-0422-682X	Consejo Nacional de Ciencia y Tecnologia and Secretaria de Medio Ambiente y Recursos Naturales, Mexico [2006-01-23702]	Consejo Nacional de Ciencia y Tecnologia and Secretaria de Medio Ambiente y Recursos Naturales, Mexico	YS received Grant No. 2006-01-23702 from Consejo Nacional de Ciencia y Tecnologia and Secretaria de Medio Ambiente y Recursos Naturales, Mexico, https://www.conacyt.gob.mx/, http://www.semarnat.gob.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Akaike H., 1973, P 2 INT S INF THEOR; Alaman de Regules R, 2014, HABITOS ALIMENTARIOS; [Anonymous], 2019, R LANG ENV STAT COMP; Arias-Del Razo A, 2017, AQUAT MAMM, V43, P40, DOI 10.1578/AM.43.1.2017.40; Arias-Del-Razo A., 2016, THESIS; Barlow Jay, 1994, Reports of the International Whaling Commission Special Issue, V15, P405; Camacho-Rios FJ, 2004, THESIS; Colwell R. K., 2013, ESTIMATES BIODIVERSI; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; DeLong R.L., 1991, Ecological Studies, V88, P166; Durazo-Rodriguez RP, 2015, THESIS; Elorriaga-Verplancken FR, 2013, AQUAT MAMM, V39, P415, DOI 10.1578/AM.39.4.2013.415; Espinosa de los Reyes-Ayala MG., 2007, THESIS; Fanshawe S, 2003, CONSERV BIOL, V17, P273, DOI 10.1046/j.1523-1739.2003.00432.x; Fernandez Martin EM., 2012, THESIS; Froese R, 2014, J APPL ICHTHYOL, V30, P78, DOI 10.1111/jai.12299; Froese R., 2015, FISHBASE; Gell F. R., 2002, FISHERY EFFECTS MARI, DOI 10.1016/s1386-5056(02)00038-2; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Gruber CP, 2014, THESIS; Halpern BS, 2003, ECOL APPL, V13, pS117; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Jamieson G. S., 2001, 2001142 CAN SCI ADV; Kaunda-Arara B, 2004, ENVIRON BIOL FISH, V70, P363, DOI 10.1023/B:EBFI.0000035428.59802.af; Lance MM, 2012, MAR ECOL PROG SER, V464, P257, DOI 10.3354/meps09880; Lubinsky-Jinich D, 2017, AQUAT MAMM, V43, P73, DOI 10.1578/AM.43.1.2017.73; McCay BJ, 2014, MAR POLICY, V44, P49, DOI 10.1016/j.marpol.2013.08.001; McCulloch CE, 2005, ENCY BIOSTATISTICS; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Milanes-Salinas MA, 2012, THESIS; Morales-Bojorquez E, 2008, J SHELLFISH RES, V27, P865, DOI 10.2983/0730-8000(2008)27[865:AOTDOT]2.0.CO;2; Nagendra H, 2002, APPL GEOGR, V22, P175, DOI 10.1016/S0143-6228(02)00002-4; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Shuman CS, 2010, MANUAL INTRO REEFCHE; Soule M. E., 2005, MARINE CONSERVATION; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Villasenor-Derbez JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191821; Wright BE, 2007, ECOL APPL, V17, P338, DOI 10.1890/05-1941	42	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218651	10.1371/journal.pone.0218651	http://dx.doi.org/10.1371/journal.pone.0218651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220168	gold, Green Published, Green Submitted			2022-12-26	WOS:000484893500077
J	Grustam, AS; Buyukkaramikli, N; Koymans, R; Vrijhoef, HJM; Severens, JL				Grustam, Andrija S.; Buyukkaramikli, Nasuh; Koymans, Ron; Vrijhoef, Hubertus J. M.; Severens, Johan L.			Value of information analysis in telehealth for chronic heart failure management	PLOS ONE			English	Article							COST-EFFECTIVENESS; DECISION-MAKING; ECONOMIC-EVALUATION; TELEPHONE SUPPORT; GROUP PERSPECTIVE; EXPECTED VALUE; UNCERTAINTY; CARE; MODELS; TELEMEDICINE	Objectives Value of information (VOI) analysis provides information on opportunity cost of a decision in healthcare by estimating the cost of reducing parametric uncertainty and quantifying the value of generating additional evidence. This study is an application of the VOI methodology to the problem of choosing between home telemonitoring and nurse telephone support over usual care in chronic heart failure management in the Netherlands. Methods The expected value of perfect information (EVPI) and the expected value of partially perfect information (EVPPI) analyses were based on an informal threshold of (sic)20K per quality-adjusted life-year. These VOI-analyses were applied to a probabilistic Markov model comparing the 20-year costs and effects in three interventions. The EVPPI explored the value of decision uncertainty caused by the following group of parameters: treatment-specific transition probabilities between New York Heart Association (NYHA) defined disease states, utilities associated with the disease states, number of hospitalizations and ER visits, health state specific costs, and the distribution of patients per NYHA group. We performed the analysis for two population sizes in the Netherlands-patients in all NYHA classes of severity, and patients in NYHA IV class only. Results The population EVPI for an effective population of 2,841,567 CHF patients in All NYHA classes of severity over the next 20 years is more than (sic)4.5B, implying that further research is highly cost-effective. In the NYHA IV only analysis, for the effective population of 208,003 patients over next 20 years, the population EVPI at the same informal threshold is approx. (sic)590M. The EVPPI analysis showed that the only relevant group of parameters that contribute to the overall decision uncertainty are transition probabilities, in both All NYHA and NYHA IV analyses. Conclusions Results of our VOI exercise show that the cost of uncertainty regarding the decision on reimbursement of telehealth interventions for chronic heart failure patients is high in the Netherlands, and that future research is needed, mainly on the transition probabilities.	[Grustam, Andrija S.; Buyukkaramikli, Nasuh; Severens, Johan L.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Grustam, Andrija S.; Koymans, Ron] Philips Res, Profess Hlth Solut & Serv Dept, Eindhoven, Netherlands; [Buyukkaramikli, Nasuh; Severens, Johan L.] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands; [Vrijhoef, Hubertus J. M.] Maastricht UMC, Dept Patient & Care, Maastricht, Netherlands; [Vrijhoef, Hubertus J. M.] Vrije Univ Brussels, Dept Family Med & Chron Care, Brussels, Belgium; [Vrijhoef, Hubertus J. M.] Panaxea Bv, Amsterdam, Netherlands	Erasmus University Rotterdam; Philips; Philips Research; Erasmus University Rotterdam; Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Brussel	Grustam, AS (corresponding author), Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands.; Grustam, AS (corresponding author), Philips Res, Profess Hlth Solut & Serv Dept, Eindhoven, Netherlands.	grustam@eshpm.eur.nl	Vrijhoef, Hubertus/AAR-2387-2020; Grustam, Andrija/AAL-7019-2020	Vrijhoef, Hubertus/0000-0002-5539-4671; Grustam, Andrija/0000-0002-5777-3368	Philips and Erasmus University	Philips and Erasmus University	This study was funded by Philips and Erasmus University. A. Grustam was employed by Philips during the initial phase of this research. N. Buyukkaramikli was compensated for his contribution by Erasmus University Rotterdam. R. Koymans is a regular employee at Philips. Philips, provided support in the form of salaries for authors A.G. and R.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. H. Vrijhoef is an employee of Panaxea, but has not received monetary compensation for his work from any source. Panaxea did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section J. Severens was compensated by Philips in the form of a consultancy fee paid to his institution.	Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; Anand IS, 2012, J CARD FAIL, V18, P289, DOI 10.1016/j.cardfail.2012.01.009; Bates ME, 2016, NAT NANOTECHNOL, V11, P198, DOI [10.1038/nnano.2015.249, 10.1038/NNANO.2015.249]; Bilcke J, 2011, MED DECIS MAKING, V31, P675, DOI 10.1177/0272989X11409240; Bohm M, 2016, EUR HEART J, V37, P3154, DOI 10.1093/eurheartj/ehw099; Briggs, 2006, HDB HLTH EC E; Briggs A, 2005, VALUE HEALTH, V8, P1, DOI 10.1111/j.1524-4733.2005.08101.x; Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Buyukkaramikli NC, 2019, PHARMACOECONOMICS, V37, P141, DOI 10.1007/s40273-018-0708-4; Buyukkaramikli NC, 2018, PHARMACOECONOMICS, V36, P145, DOI 10.1007/s40273-017-0581-6; Buyukkaramikli NC, 2017, PHARMACOECONOMICS, V35, P1211, DOI 10.1007/s40273-017-0528-y; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Claxton K, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8310; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K, 2016, VALUE HEALTH, V19, P885, DOI 10.1016/j.jval.2016.03.2003; Cleland JGF, 2005, J AM COLL CARDIOL, V45, P1654, DOI 10.1016/j.jacc.2005.01.050; Conraads VM, 2011, EUR HEART J, V32, P2266, DOI 10.1093/eurheartj/ehr050; Di Lenarda A, 2017, EUR HEART J SUPPL, V19, pD113, DOI 10.1093/eurheartj/sux024; Dolgin M, 1994, NOMENCLATURE CRITERI; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Galani C, 2008, VALUE HEALTH, V11, P424, DOI 10.1111/j.1524-4733.2007.00284.x; Gensini Gian Franco, 2017, Card Fail Rev, V3, P116, DOI 10.15420/cfr.2017:6:2; Gravelle H, 2001, HEALTH ECON, V10, P587, DOI 10.1002/hec.618; Griffin SC, 2011, HEALTH ECON, V20, P212, DOI 10.1002/hec.1586; Grustam AS, 2018, VALUE HEALTH, V21, P772, DOI 10.1016/j.jval.2017.11.011; Hakkaart-van Roijen L., 2015, KOSTENHANDLEIDING ME; Henderson C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1035; Hindricks G, 2014, LANCET, V384, P583, DOI 10.1016/S0140-6736(14)61176-4; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Instituut voor Medical Technology Assessment Erasmus Universiteit Rotterdam, 2010, HANDL KOST; Jackson CH, 2009, J R STAT SOC A STAT, V172, P383, DOI 10.1111/j.1467-985X.2008.00573.x; Jerant A, REDUCING COST FREQUE; Keisler Jeffrey M., 2014, Environment Systems & Decisions, V34, P3, DOI 10.1007/s10669-013-9439-4; Kim SY, 2008, PHARMACOECONOMICS, V26, P191, DOI 10.2165/00019053-200826030-00004; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Landolina M, 2012, CIRCULATION, V125, P2985, DOI 10.1161/CIRCULATIONAHA.111.088971; MANNING WG, 1996, COST EFFECTIVENESS H; McKenna C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14240; McKenna C, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13240; Ministerie van Volksgezondheid W en S, 2016, RICHTL UITV EC EV GE; Oostenbrink JB, 2008, VALUE HEALTH, V11, P1070, DOI 10.1111/j.1524-4733.2008.00389.x; Pandor A, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17320; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Ramos IC, 2017, VALUE HEALTH, V20, P1260, DOI 10.1016/j.jval.2017.05.013; Rijksinstituut voor Volksgezondheid en Milieu, 2012, HARTT EP RIS TOEK, P124; Rothery C, 2017, HEALTH ECON, V26, P109, DOI 10.1002/hec.3467; Sculpher MJ, 2016, COST EFF HLTH MED, V289; Smith RD, 2005, J HEALTH ECON, V24, P1055, DOI 10.1016/j.jhealeco.2005.02.003; Strong M, 2015, VALUE HEALTH, V18, pA725, DOI 10.1016/j.jval.2015.09.2759; Thokala P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003250; Vader JM, 2015, HDB CLIN NUTR AGING, P215; Van Hout BA, 1998, HEALTH ECON, V7, P581, DOI 10.1002/(SICI)1099-1050(1998110)7:7<581::AID-HEC380>3.0.CO;2-U; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505	57	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218083	10.1371/journal.pone.0218083	http://dx.doi.org/10.1371/journal.pone.0218083			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220101	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500019
J	Hakimi, H; Sarani, A; Takeda, M; Kaneko, O; Asada, M				Hakimi, Hassan; Sarani, Ali; Takeda, Mika; Kaneko, Osamu; Asada, Masahito			Epidemiology, risk factors, and co-infection of vector-borne pathogens in goats from Sistan and Baluchestan province, Iran	PLOS ONE			English	Article							APPARENTLY HEALTHY SHEEP; PCR-BASED DETECTION; MOLECULAR-DETECTION; BABESIA-OVIS; THEILERIA-LESTOQUARDI; TICK; INFECTION; ANAPLASMA; CATTLE; IDENTIFICATION	Several vector-borne pathogens restrict livestock farming and have significant economic impact worldwide. In endemic areas livestock are exposed to different tick species carrying various pathogens which could result in co-infection with several tick-borne pathogens in a single host. Although the co-infection of and the interaction among pathogens are critical factors to determine the disease outcome, pathogen interactions in the vector and the host are poorly understood. In this study, we surveyed the presence of Babesia ovis, Theileria ovis, Theileria lestoquardi, Anaplasma ovis, Anaplasma phagocytophilum, and Anaplasma marginale in 200 goats from 3 different districts in Sistan and Baluchestan province, Iran. Species-specific diagnostic PCRs and sequence analysis revealed that 1.5%, 12.5%, and 80% of samples were positive for T. lestoquardi, T. ovis, and A. ovis, respectively. Co-infections of goats with up to 3 pathogens were seen in 22% of the samples. We detected a significant association between T. ovis infection and age, T. ovis infection and location (Zabol), and A. ovis infection and location (Sarbaz) by multivariate logistic regression analysis. In addition, by analyzing the data with respect to Plasmodium caprae infection in these goats, a negative correlation was found between P. caprae and A. ovis infection. This study contributes to understanding the epidemiology of vector-borne pathogens and their interplay in goats.	[Hakimi, Hassan; Takeda, Mika; Kaneko, Osamu; Asada, Masahito] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki, Japan; [Sarani, Ali] Univ Zabol, Fac Vet, Dept Clin Sci, Zabol, Iran	Nagasaki University	Asada, M (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki, Japan.	masahitoasada@nagasaki-u.ac.jp	Kaneko, Osamu/AAE-3500-2019; sarani, Ali/H-6011-2018; Hakimi, Hassan/AAL-2181-2021; Hakimi, Hassan/AAF-2726-2020	Kaneko, Osamu/0000-0003-0675-8296; sarani, Ali/0000-0002-0550-9186; Hakimi, Hassan/0000-0001-6678-7393; Asada, Masahito/0000-0003-0042-6856	Japan Society for the Promotion of Science [16H05807, 16K08021, 19K06384, 16F16105]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Japan Society for the Promotion of Science (https://www.jsps.go.jp/) grants-in-Aids for Scientific Research (B), No 16H05807 to MA and OK, Scientific Research (C), No 16K08021, 19K06384 to MA, and Grant-in-Aid for JSPS Fellows, 16F16105 to OK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Paul Frank Adjou Moumouni and Xuenan Xuan from the National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine for providing positive control DNA for performing PCR. We thank Thomas J. Templeton from our institute for his critical reading of the manuscript. This work was conducted at the Joint Usage/Research Center on Tropical Disease, Institute of Tropical Medicine, Nagasaki University. HH is a recipient of the JSPS Postdoctoral Fellowship for foreign researchers from the Japan Society for the Promotion of Science.	Ahmadi-Hamedani M, 2009, IRAN J VET RES, V10, P367; Aktas M, 2006, VET PARASITOL, V140, P259, DOI 10.1016/j.vetpar.2006.04.005; Aktas M, 2005, VET PARASITOL, V133, P277, DOI 10.1016/j.vetpar.2005.05.057; Alanazi AD, 2019, TROP ANIM HEALTH PRO, V51, P89, DOI 10.1007/s11250-018-1663-y; Alessandra T, 2012, SMALL RUMINANT RES, V106, pS6, DOI 10.1016/j.smallrumres.2012.04.026; Bami MH, 2010, IRAN J VET RES, V11, P262; Berggoetz M, 2014, TICKS TICK-BORNE DIS, V5, P166, DOI 10.1016/j.ttbdis.2013.10.007; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Dib L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040007; Dunn JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115494; Haghi MM, 2017, PARASITOL RES, V116, P1101, DOI 10.1007/s00436-016-5368-8; Hasheminasab Seyed Sajjad, 2018, Annals of Parasitology, V64, P43, DOI 10.17420/ap6401.131; Hosseini-Vasoukolaei N, 2014, J ARTHROPOD-BORNE DI, V8, P204; Iqbal F, 2013, IRAN J PARASITOL, V8, P289; Izadi S, 2006, JPN J INFECT DIS, V59, P326; Kaewthamasorn M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24048-0; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lempereur L, 2017, VECTOR-BORNE ZOONOT, V17, P51, DOI 10.1089/vbz.2016.1955; Mohammadi SM, 2017, VET RES FORUM, V8, P139; Noaman Vahid, 2012, Comparative Clinical Pathology, V21, P367, DOI 10.1007/s00580-012-1438-1; Persing DH, 1997, CLIN INFECT DIS, V25, pS35, DOI 10.1086/516170; PHILLIPS RS, 1976, EXP PARASITOL, V39, P95, DOI 10.1016/0014-4894(76)90015-1; Rahbari S, 2007, PARASITOL RES, V101, pS175, DOI 10.1007/s00436-007-0692-7; Razmi GR, 2006, ANN NY ACAD SCI, V1078, P479, DOI 10.1196/annals.1374.089; Razmi G, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.635; Riaz M, 2019, J MED ENTOMOL; Saeed S, 2015, TROP BIOMED, V32, P225; Sevinc F, 2018, VET PARASITOL, V252, P143, DOI 10.1016/j.vetpar.2018.02.013; Sivakumar T, 2012, J CLIN MICROBIOL, V50, P2111, DOI 10.1128/JCM.00220-12; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Taha KM, 2011, PARASITOL RES, V109, P1525, DOI 10.1007/s00436-011-2428-y; Torina A, 2012, TICKS TICK-BORNE DIS, V3, P282, DOI 10.1016/j.ttbdis.2012.10.033; Valizadeh R., 2010, CLIMATE CHANGES STRE, P431; Walls JJ, 2000, J CLIN MICROBIOL, V38, P354; Woolhouse MEJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400026; Yaghfoori S., 2013, Archives of Razi Institute, V68, P159; Yeruham I, 1998, VET PARASITOL, V74, P153, DOI 10.1016/S0304-4017(97)00143-X; Yousefi A, 2017, ASIAN PAC J TROP BIO, V7, P455, DOI 10.1016/j.apjtb.2017.01.017; Zaeemi M, 2011, PARASITOL RES, V108, P837, DOI 10.1007/s00436-010-2119-0; Zakkyeh T, 2012, ASIAN PAC J TROP MED, V5, P29, DOI 10.1016/S1995-7645(11)60240-X; Zhou M, 2017, TICKS TICK-BORNE DIS, V8, P246, DOI 10.1016/j.ttbdis.2016.11.006	42	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218609	10.1371/journal.pone.0218609	http://dx.doi.org/10.1371/journal.pone.0218609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220153	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500073
J	Burress, H; Kellner, A; Guyette, J; Tatulian, SA; Teter, K				Burress, Helen; Kellner, Alisha; Guyette, Jessica; Tatulian, Suren A.; Teter, Ken			HSC70 and HSP90 chaperones perform complementary roles in translocation of the cholera toxin A1 subunit from the endoplasmic reticulum to the cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; heat shock protein (HSP); heat shock protein 90 (Hsp90); translocation; endoplasmic reticulum-associated protein degradation (ERAD); bacterial pathogenesis	MEMBRANE TRANSLOCATION; DEGRADATION PATHWAY; PROTEIN; HSP70; CYCLOPHILIN; CELLS; P97; IDENTIFICATION; INSTABILITY; INHIBITION	Cholera toxin (CT) travels by vesicle carriers from the cell surface to the endoplasmic reticulum (ER) where the catalytic A1 subunit of CT (CTA1) dissociates from the rest of the toxin, unfolds, and moves through a membrane-spanning translocon pore to reach the cytosol. Heat shock protein 90 (HSP90) binds to the N-terminal region of CTA1 and facilitates its ER-to-cytosol export by refolding the toxin as it emerges at the cytosolic face of the ER membrane. HSP90 also refolds some endogenous cytosolic proteins as part of a foldosome complex containing heat shock cognate 71-kDa protein (HSC70) and the HSC70/HSP90-organizing protein (HOP) linker that anchors HSP90 to HSC70. We accordingly predicted that HSC70 and HOP also function in CTA1 translocation. Inactivation of HSC70 by drug treatment disrupted CTA1 translocation to the cytosol and generated a toxin-resistant phenotype. In contrast, the depletion of HOP did not disrupt CT activity against cultured cells. HSC70 and HSP90 could bind independently to disordered CTA1, even in the absence of HOP. This indicated HSP90 and HSC70 recognize distinct regions of CTA1, which was confirmed by the identification of a YYIYVI-binding motif for HSC70 that spans residues 83-88 of the 192-amino acid CTA1 polypeptide. Refolding of disordered CTA1 occurred in the presence of HSC70 alone, indicating that HSC70 and HSP90 can each independently refold CTA1. Our work suggests a novel translocation mechanism in which sequential interactions with HSP90 and HSC70 drive the N- to C-terminal extraction of CTA1 from the ER.	[Burress, Helen; Kellner, Alisha; Guyette, Jessica; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Teter, K (corresponding author), Biomol Res Annex, 12722 Res Pkwy, Orlando, FL 32826 USA.	kteter@mail.ucf.edu		Teter, Ken/0000-0003-4176-9361	National Institutes of Health NIAID [R01AI099493]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099493] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health NIAID Grant R01AI099493 (to K.T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Burress H, 2014, J BIOL CHEM, V289, P33644, DOI 10.1074/jbc.M114.609800; Cano LQ, 2013, MOL CELL ENDOCRINOL, V369, P52, DOI 10.1016/j.mce.2013.01.023; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; CZAR MJ, 1994, J BIOL CHEM, V269, P11155; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dmochewitz L, 2011, CELL MICROBIOL, V13, P359, DOI 10.1111/j.1462-5822.2010.01539.x; Ernst K, 2017, CURR TOP MICROBIOL, V406, P163, DOI 10.1007/82_2016_14; Ernst K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02882-y; Ernst K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20301; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Haug G, 2004, INFECT IMMUN, V72, P3066, DOI 10.1128/IAI.72.5.3066-3068.2004; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Heggelund JE, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P195, DOI 10.1016/B978-0-12-800188-2.00007-0; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kaiser E, 2011, INFECT IMMUN, V79, P3913, DOI 10.1128/IAI.05372-11; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Kundel F, 2018, ACS CHEM BIOL, V13, P636, DOI 10.1021/acschembio.7b01039; Lang AE, 2014, CELL MICROBIOL, V16, P490, DOI 10.1111/cmi.12228; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Massey S, 2011, INFECT IMMUN, V79, P4739, DOI 10.1128/IAI.05503-11; McConnell E, 2007, BIOCHEM BIOPH RES CO, V355, P1087, DOI 10.1016/j.bbrc.2007.02.077; Minami Y, 1999, GENES CELLS, V4, P721, DOI 10.1046/j.1365-2443.1999.00299.x; Muanprasat C, 2013, FUTURE MED CHEM, V5, P781, DOI [10.4155/FMC.13.42, 10.4155/fmc.13.42]; Murphy JR, 2011, TOXINS, V3, P294, DOI 10.3390/toxins3030294; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Ratts R, 2003, J CELL BIOL, V160, P1139, DOI 10.1083/jcb.200210028; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schuster M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00780-x; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Tatulian Suren A, 2013, Methods Mol Biol, V974, P177, DOI 10.1007/978-1-62703-275-9_9; Taylor M., 2015, P PHYS BIOL PROT PEP, P67; Taylor M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003925; Taylor M, 2012, JOVE-J VIS EXP, DOI 10.3791/3686; Taylor M, 2011, J BIOL CHEM, V286, P22090, DOI 10.1074/jbc.M111.237966; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Tehran DA, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12647; Teter K, 2006, INFECT IMMUN, V74, P2259, DOI 10.1128/IAI.74.4.2259-2267.2006; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Teter K., 2013, MOONLIGHTING CELL ST, P323; Teter K, 2013, BIOMOLECULES, V3, P997, DOI 10.3390/biom3040997; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Williams JM, 2013, MOL BIOL CELL, V24, P785, DOI 10.1091/mbc.E12-07-0522; Winkeler A, 2003, FEBS LETT, V554, P439, DOI 10.1016/S0014-5793(03)01217-1; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	63	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12122	12131		10.1074/jbc.RA119.008568	http://dx.doi.org/10.1074/jbc.RA119.008568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31221799	hybrid, Green Published			2022-12-26	WOS:000484284500016
J	Dent, P; Booth, L; Roberts, JL; Liu, JC; Poklepovic, A; Lalani, AS; Tuveson, D; Martinez, J; Hancock, JF				Dent, Paul; Booth, Laurence; Roberts, Jane L.; Liu, Junchen; Poklepovic, Andrew; Lalani, Alshad S.; Tuveson, David; Martinez, Jennifer; Hancock, John F.			Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells	ONCOGENE			English	Article							PROTEIN-KINASE; PATHWAY; LIVER; RISK	Prior studies demonstrated that the irreversible ERBB1/2/4 inhibitor neratinib caused plasma membrane-associated mutant K-RAS to localize in intracellular vesicles, concomitant with its degradation. Herein, we discovered that neratinib interacted with the chemically distinct irreversible ERBB1/2/4 inhibitor afatinib to reduce expression of ERBB1, ERBB2, K-RAS and N-RAS; this was associated with greater-than-additive cell killing of pancreatic tumor cells. Knock down of Beclin1, ATG16L1, Rubicon or cathepsin B significantly lowered the ability of neratinib to reduce ERBB1 and K-RAS expression, and to cause tumor cell death. Knock down of ATM-AMPK suppressed vesicle formation and knock down of cathepsin B-AIF significantly reduced neratinib lethality. PKG phosphorylates K-RAS and HMG CoA reductase inhibitors reduce K-RAS farnesylation both of which remove K-RAS from the plasma membrane, abolishing its activity. Neratinib interacted with the PKG activator sildenafil and the HMG CoA reductase inhibitor atorvastatin to further reduce K-RAS expression, and to further enhance cell killing Neratinib is also a Ste20 kinase family inhibitor and in carcinoma cells, and hematopoietic cancer cells lacking ERBB1/2/4, it reduced K-RAS expression and the phosphorylation of MST1/3/4/Ezrin by similar to 30%. Neratinib increased LATS1 phosphorylation as well as that of YAP and TAZ also by similar to 30%, caused the majority of YAP to translocate into the cytosol and reduced YAP/TAZ protein levels. Neratinib lethality was enhanced by knock down of YAP. Neratinib, in a Rubicon-dependent fashion, reduced PAK1 phosphorylation and that of its substrate Merlin. Our data demonstrate that neratinib coordinately suppresses both mutant K-RAS and YAP function to kill pancreatic tumor cells.	[Dent, Paul; Booth, Laurence; Roberts, Jane L.] Virginia Commonwealth Univ, Dept Biochem, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Dent, Paul; Booth, Laurence; Roberts, Jane L.] Virginia Commonwealth Univ, Dept Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Liu, Junchen; Hancock, John F.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Poklepovic, Andrew] Virginia Commonwealth Univ, Dept Med, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Lalani, Alshad S.] Puma Biotechnol Inc, 1880 Wilshire Blvd, Los Angeles, CA 90024 USA; [Tuveson, David] Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Martinez, Jennifer] NIEHS, Inflammat & Autoimmun Grp, POB 12233, Res Triangle Pk, NC 27709 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Texas System; University of Texas Health Science Center Houston; Virginia Commonwealth University; Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dent, P (corresponding author), Virginia Commonwealth Univ, Dept Biochem, Med Coll Virginia Campus, Richmond, VA 23298 USA.; Dent, P (corresponding author), Virginia Commonwealth Univ, Dept Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	paul.dent@vcuhealth.org	Martinez, Jennifer/C-3740-2019	Martinez, Jennifer/0000-0002-3060-2518; Hancock, John/0000-0003-0542-4710; Liu, Junchen/0000-0003-2765-9780	Massey Cancer Center; Universal Inc.; Chair in Signal Transduction Research; NATIONAL CANCER INSTITUTE [R01CA192613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103286] Funding Source: NIH RePORTER	Massey Cancer Center; Universal Inc.; Chair in Signal Transduction Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for the present study was funded from philanthropic funding from Massey Cancer Center and the Universal Inc. Chair in Signal Transduction Research.	Abdel-Rahman O, 2019, CLIN TRANSL ONCOL, V21, P810, DOI 10.1007/s12094-018-1992-3; Archibugi L, 2019, DIGEST LIVER DIS, V51, P28, DOI 10.1016/j.dld.2018.09.007; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Bae SJ, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171469; Bitra A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45020; Booth L, 2019, CANCER BIOL THER, V20, P700, DOI 10.1080/15384047.2018.1551747; Booth L, 2019, J CELL PHYSIOL, V234, P4874, DOI 10.1002/jcp.27276; Booth Laurence, 2018, Oncotarget, V9, P6062, DOI 10.18632/oncotarget.23681; Booth L, 2017, ONCOTARGET, V8, P90262, DOI 10.18632/oncotarget.21660; Booth L, 2017, ONCOTARGET, V8, P16367, DOI 10.18632/oncotarget.14829; Booth L, 2016, ONCOTARGET, V7, P19620, DOI 10.18632/oncotarget.7746; Burada F, 2016, PATHOL ONCOL RES, V22, P317, DOI 10.1007/s12253-015-0006-9; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chen M, 2018, J BIOL CHEM, V293, P14455, DOI 10.1074/jbc.RA118.003279; Chen S, 2018, AGING DIS, V9, P537, DOI 10.14336/AD.2017.0702; Cho KJ, 2016, MOL CELL BIOL, V36, P3086, DOI 10.1128/MCB.00365-16; Crawford JJ, 2018, EXPERT OPIN THER PAT, V28, P867, DOI 10.1080/13543776.2018.1549226; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; E JY, 2018, CURR MED CHEM, V25, P2595, DOI 10.2174/0929867324666170412145232; Hamada T, 2018, CLIN GASTROENTEROL H, V16, P1300, DOI 10.1016/j.cgh.2018.02.022; Hergovich A, 2016, GENES-BASEL, V7, DOI 10.3390/genes7050021; Hergovich A, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-32; Hsu CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03340-7; Hsu PC, 2018, J CELL MOL MED, V22, P3073, DOI 10.1111/jcmm.13582; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kong DL, 2015, J DRUG TARGET, V23, P125, DOI 10.3109/1061186X.2014.983522; Kruspig B, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2565; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Lavoie S, 2019, ELIFE, V8, DOI 10.7554/eLife.39982; Li SX, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.38; Liu YT, 2019, ONCOL REP, V41, P1455, DOI 10.3892/or.2019.6956; Martinez J, 2018, CURR OPIN IMMUNOL, V55, P54, DOI 10.1016/j.coi.2018.09.011; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mohamed AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33852-7; Moll HP, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2301; Muniz-Feliciano L, 2017, AUTOPHAGY, V13, P2072, DOI 10.1080/15548627.2017.1380124; Nussinov R, 2016, SEMIN CELL DEV BIOL, V58, P79, DOI 10.1016/j.semcdb.2016.04.001; Park JY, 2018, MICROELECTRON ENG, V200, P1, DOI 10.1016/j.mee.2018.08.004; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; Sadabad MS, 2015, GUT, V64, P1546, DOI 10.1136/gutjnl-2014-307289; Singh H, 2018, CLIN CANCER RES, V24, P3486, DOI 10.1158/1078-0432.CCR-17-3628; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; Wang MH, 2012, INFLAMM BOWEL DIS, V18, P2277, DOI 10.1002/ibd.22931; Wang OH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152300; Waters AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aao3332; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhang Y, 2019, PANCREAS, V48, P142, DOI 10.1097/MPA.0000000000001226; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014	50	40	43	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2019	38	30					5890	5904		10.1038/s41388-019-0849-8	http://dx.doi.org/10.1038/s41388-019-0849-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3FY	31253872	Green Accepted			2022-12-26	WOS:000482739300004
J	Alger, SA; Burnham, PA; Boncristiani, HF; Brody, AK				Alger, Samantha A.; Burnham, P. Alexander; Boncristiani, Humberto F.; Brody, Alison K.			RNA virus spillover from managed honeybees (Apis mellifera) to wild bumblebees (Bombus spp.)	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; EMERGING INFECTIOUS-DISEASES; VERTICAL-TRANSMISSION; PATHOGEN SPILLOVER; BEE COLONIES; DISTANCES; IMPACTS; THREAT	The decline of many bumblebee species (Bombus spp.) has been linked to an increased prevalence of pathogens caused by spillover from managed bees. Although poorly understood, RNA viruses are suspected of moving from managed honeybees (Apis mellifera) into wild bumblebees through shared floral resources. We examined if RNA viruses spillover from managed honeybees, the extent to which viruses are replicating within bumblebees, and the role of flowers in transmission. Prevalence and active infections of deformed wing virus (DWV) were higher in bumblebees collected near apiaries and when neighboring honeybees had high infection levels. We found no DWV in bumblebees where honeybee foragers and honeybee apiaries were absent. The prevalence of black queen cell virus (BQCV) was also higher in bumblebees collected near apiaries. Furthermore, we detected viruses on 19% of flowers, all of which were collected within apiaries. Our results corroborate the hypothesis that viruses are spilling over from managed honeybees to wild bumblebees and that flowers may be an important route for transmission.	[Alger, Samantha A.; Burnham, P. Alexander; Brody, Alison K.] Univ Vermont, Biol Dept, Marsh Life Sci, Burlington, VT 05405 USA; [Boncristiani, Humberto F.] Univ Florida, Honeybee Res & Extens Lab, Entomol & Nematol Dept, Gainesville, FL USA	University of Vermont; State University System of Florida; University of Florida	Alger, SA (corresponding author), Univ Vermont, Biol Dept, Marsh Life Sci, Burlington, VT 05405 USA.	salger@uvm.edu		Alger, Samantha/0000-0001-7787-1312	National Science Foundation Graduate Research Fellowship [DGE-1451866]; Centennial Pollinator Fellowship of the Garden Club of America; Sophie Danforth Conservation Biology Fund of the Roger Williams Park Zoo; Ronald Suiter Travel Prize of the University of Vermont; Theodore Roosevelt Memorial Fund of the American Museum of Natural History; Roberto Fabri Fiahlo Research Award	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Centennial Pollinator Fellowship of the Garden Club of America; Sophie Danforth Conservation Biology Fund of the Roger Williams Park Zoo; Ronald Suiter Travel Prize of the University of Vermont; Theodore Roosevelt Memorial Fund of the American Museum of Natural History; Roberto Fabri Fiahlo Research Award	Funding was provided by a National Science Foundation Graduate Research Fellowship to SAA (DGE-1451866) (https://www.nsfgrfp.org/), the Centennial Pollinator Fellowship of the Garden Club of America to SAA (https://pollinator.org/gca-fellowship), the Sophie Danforth Conservation Biology Fund of the Roger Williams Park Zoo to SAA (https://www.rwpzoo.org/dansforthconservation-grants), the Roberto Fabri Fiahlo Research Award (https://www.uvm.edu/sites/default/files/media/Roberto_Fabri_Fialho_Award. pdf) and the Ronald Suiter Travel Prize of the University of Vermont (https://www.uvm.edu/cas/travel_ funding_ronald_suiter_prize) to SAA, and the Theodore Roosevelt Memorial Fund of the American Museum of Natural History (https://www.amnh.org/our-research/richard-gildergraduate-school/academics-and-research/fellowship-and-grant-opportunities/researchgrants-and-student-exchange-fellowships/thetheodore-roosevelt-memorial-fund) to SAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurori AC, 2016, VIRUS RES, V222, P29, DOI 10.1016/j.virusres.2016.05.024; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Graystock P, 2014, PEERJ, V2, DOI 10.7717/peerj.522; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; Hopwood J, 2013, XERCES SOC, V44; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Li JL, 2014, MBIO, V5, DOI 10.1128/mBio.00898-13; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Loope KJ, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2499; Manley R, 2015, J APPL ECOL, V52, P331, DOI 10.1111/1365-2664.12385; McArt SH, 2014, ECOL LETT, V17, P624, DOI 10.1111/ele.12257; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; McMenamin AJ, 2015, CURR OPIN INSECT SCI, V8, P121, DOI 10.1016/j.cois.2015.01.015; Meeus I, 2014, J INVERTEBR PATHOL, V121, P74, DOI 10.1016/j.jip.2014.06.012; Melathopoulos A, 2017, J INVERTEBR PATHOL, V146, P24, DOI 10.1016/j.jip.2017.04.003; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Peng WJ, 2011, APIDOLOGIE, V42, P650, DOI 10.1007/s13592-011-0061-5; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Ravoet J, 2014, J INVERTEBR PATHOL, V122, P55, DOI 10.1016/j.jip.2014.08.007; Sachman-Ruiz B, 2015, BIOL INVASIONS, V17, P2043, DOI 10.1007/s10530-015-0859-6; Schneider SS, 1997, INSECT SOC, V44, P171, DOI 10.1007/s000400050039; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Tehel A, 2016, CURR OPIN VIROL, V19, P16, DOI 10.1016/j.coviro.2016.06.006; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zhang X, 2012, J INVERTEBR PATHOL, V109, P156, DOI 10.1016/j.jip.2011.09.010	45	74	76	11	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0217822	10.1371/journal.pone.0217822	http://dx.doi.org/10.1371/journal.pone.0217822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IH3VI	31242222	Green Submitted, Green Published, gold			2022-12-26	WOS:000474420300002
J	Carl, P; Ramos, II; Segundo, MA; Schneider, RJ				Carl, Peter; Ramos, Ines I.; Segundo, Marcela A.; Schneider, Rudolf J.			Antibody conjugation to carboxyl-modified microspheres through N-hydroxysuccinimide chemistry for automated immunoassay applications: A general procedure	PLOS ONE			English	Article							PROTEIN CONJUGATION; FLUORESCENCE; LABEL; HYDROXYSULFOSUCCINIMIDE; QUANTIFICATION; IMMOBILIZATION; SURFACE; ELISA	Immunochemical techniques are the workhorse for sample enrichment and detection of a large variety of analytes. In contrast to classical microtiter plate-based assays, microparticles are a next generation solid support, as they promote automation of immunoassays using flow-based techniques. Antibody immobilization is a crucial step, as these reagents are expensive, and inefficient coupling can result in low sensitivities. This paper proposes a general procedure for efficient immobilization of antibodies onto TentaGel particles, via N-hydroxysuccinimide chemistry. The goal was the preparation of solid supports with optimum immunorecognition, while increasing the sustainability of the process. The influence of buffer composition, activation and coupling time, as well as the amount of antibody on the immobilization efficiency was investigated, resorting to fluorophore-labeled proteins and fluorescence imaging. Buffer pH and activation time are the most important parameters for efficient coupling. It is demonstrated, that the hydrolysis of N-hydroxysuccinimide esters occurs at similar rates as in solution, limiting the utilizable time for coupling. Finally, applicability of the generated material for automated affinity extraction is demonstrated on the mesofluidic platform lab-on-valve.	[Carl, Peter; Schneider, Rudolf J.] Bundesanstalt Mat Forsch & Prufung BAM, Berlin, Germany; [Carl, Peter] Humboldt Univ, Dept Chem, Berlin, Germany; [Ramos, Ines I.; Segundo, Marcela A.] Univ Porto, Fac Pharm, Dept Chem Sci, LAQV,REQUIMTE, Porto, Portugal; [Schneider, Rudolf J.] Tech Univ Berlin, Berlin, Germany	Federal Institute for Materials Research & Testing; Humboldt University of Berlin; Universidade do Porto; Technical University of Berlin	Schneider, RJ (corresponding author), Bundesanstalt Mat Forsch & Prufung BAM, Berlin, Germany.; Schneider, RJ (corresponding author), Tech Univ Berlin, Berlin, Germany.	rudolf.schneider@bam.de	Schneider, Rudolf J./AAU-9778-2021; Segundo, Marcela A/A-1009-2010; Ramos, Inês/AAC-5712-2019; Carl, Peter/AGJ-2436-2022	Schneider, Rudolf J./0000-0003-2228-1248; Segundo, Marcela A/0000-0003-2938-0214; Ramos, Inês/0000-0003-3049-0015; Carl, Peter/0000-0002-6233-8133	FCT (Fundacao para a Ciencia e a Tecnologia); POPH (Programa Operacional Potencial Humano) [SFRH/BD/97540/2013]; European Union (FEDER funds) [POCI/01/0145/FEDER/007265, POCI/01/0145/FEDER/007728]; National Funds (FCT/MEC -Ministerio da Educacao e Ciencia) [PT2020 UID/QUI/50006/2013, UID/MULTI/04378/2013]; Deutscher Akademischer Austauschdienst; Conselho de Reitores das Universidades Portuguesas under the protocol CRUP-DAAD [E-20/16]; MI ("Menschen, Ideen") program (BAM/BMWi) [Ideen_2013_90]	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); POPH (Programa Operacional Potencial Humano); European Union (FEDER funds)(European Commission); National Funds (FCT/MEC -Ministerio da Educacao e Ciencia); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Conselho de Reitores das Universidades Portuguesas under the protocol CRUP-DAAD; MI ("Menschen, Ideen") program (BAM/BMWi)	IIR was funded by FCT (Fundacao para a Ciencia e a Tecnologia, www.fct.pt) and POPH (Programa Operacional Potencial Humano) with the grant (SFRH/BD/97540/2013). This work received financial support from the European Union (FEDER funds POCI/01/0145/FEDER/007265 and POCI/01/0145/FEDER/007728; https://ec.europa.eu/regional_policy/en/funding/erdf/) and National Funds (FCT/MEC -Ministerio da Educacao e Ciencia) under the Partnership Agreements PT2020 UID/QUI/50006/2013 to MAS and UID/MULTI/04378/2013. Financial support from Deutscher Akademischer Austauschdienst (www.daad.de) and Conselho de Reitores das Universidades Portuguesas (www.crup.pt) under the protocol CRUP-DAAD (Acoes Integradas Luso-Alemas noE-20/16) to PC and RJS is also acknowledged. PC was funded by MI ("Menschen, Ideen") program (BAM/BMWi, Grant No. Ideen_2013_90). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mejia-Manzano LA, 2016, SEP SCI TECHNOL, V51, P1736, DOI 10.1080/01496395.2016.1174264; Barre A, 2017, SYNTHESIS-STUTTGART, V49, P472, DOI 10.1055/s-0036-1588607; Berlier JE, 2003, J HISTOCHEM CYTOCHEM, V51, P1699, DOI 10.1177/002215540305101214; Calisto V, 2011, CHEMOSPHERE, V84, P1708, DOI 10.1016/j.chemosphere.2011.04.072; Carroll AD, 2003, ANALYST, V128, P1157, DOI 10.1039/b302786d; Dong TT, 2017, MICROCHIM ACTA, V184, P961, DOI 10.1007/s00604-017-2081-y; Doran TM, 2014, ACS COMB SCI, V16, P259, DOI 10.1021/co500030f; EISENHUT M, 1991, J LABELLED COMPD RAD, V29, P1283, DOI 10.1002/jlcr.2580291204; Frey A, 2000, J IMMUNOL METHODS; Crevillen AG, 2007, TALANTA, V74, P342, DOI 10.1016/j.talanta.2007.10.019; Hlavacek A, 2017, MICROCHIM ACTA, V184, P4159, DOI 10.1007/s00604-017-2456-0; Janissen R, 2009, COLLOID SURFACE B, V71, P200, DOI 10.1016/j.colsurfb.2009.02.011; Klykov O, 2015, ANAL METHODS-UK, V7, P6443, DOI 10.1039/c5ay00042d; Koc K, 2015, J MOL STRUCT, V1089, P66, DOI 10.1016/j.molstruc.2015.02.038; Konry T, 2012, MICROCHIM ACTA, V176, P251, DOI 10.1007/s00604-011-0705-1; Liang R, 1996, SCIENCE, V274, P1520, DOI 10.1126/science.274.5292.1520; Lim CT, 2007, BIOSENS BIOELECTRON, V22, P1197, DOI 10.1016/j.bios.2006.06.005; Liu EY, 2016, LANGMUIR, V32, P11043, DOI 10.1021/acs.langmuir.6b02591; Markwalter CF, 2016, TALANTA, V161, P443, DOI 10.1016/j.talanta.2016.08.078; Milovanovic JR, 2013, CENT EUR J MED, V8, P383, DOI 10.2478/s11536-013-0158-5; Miro M, 2007, ANAL CHIM ACTA, V600, P46, DOI 10.1016/j.aca.2007.02.035; Murray KE, 2010, ENVIRON POLLUT, V158, P3462, DOI 10.1016/j.envpol.2010.08.009; Nojima Y, 2009, BIOL PHARM BULL, V32, P523, DOI 10.1248/bpb.32.523; Oberleitner L, 2016, ANAL METHODS-UK, V8, P6883, DOI 10.1039/c6ay01968d; Oliveira HM, 2011, TALANTA, V84, P846, DOI 10.1016/j.talanta.2011.02.011; Patel SI, 2015, CNS DRUGS, V29, P1009, DOI 10.1007/s40263-015-0289-0; Pfister D, 2015, CHEM ENG SCI, V137, P816, DOI 10.1016/j.ces.2015.07.031; Ramos II, 2018, ANAL BIOANAL CHEM, V410, P981, DOI 10.1007/s00216-017-0601-6; Sam S, 2010, LANGMUIR, V26, P809, DOI 10.1021/la902220a; Sotnikov DV, 2015, INT J MOL SCI, V16, P907, DOI 10.3390/ijms16010907; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Teste B, 2010, TALANTA, V81, P1703, DOI 10.1016/j.talanta.2010.03.027; Thomas TG, 2012, ANALYST, V137, P5358, DOI 10.1039/c2an35724k; Wang C, 2011, LANGMUIR, V27, P12058, DOI 10.1021/la202267p; Zhang HX, 2012, J RARE EARTH, V30, P1203, DOI 10.1016/S1002-0721(12)60206-3; Zhang Y, 2017, MICROCHIM ACTA, V184, P1471, DOI 10.1007/s00604-017-2116-4	36	6	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218686	10.1371/journal.pone.0218686	http://dx.doi.org/10.1371/journal.pone.0218686			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242246	Green Published, Green Submitted, gold			2022-12-26	WOS:000482883600046
J	Halczy-Kowalik, L; Drozd, A; Stachowska, E; Drozd, R; Zabski, T; Domagala, W				Halczy-Kowalik, Ludmila; Drozd, Arleta; Stachowska, Ewa; Drozd, Radoslaw; Zabski, Tomasz; Domagala, Wenancjusz			Fatty acids distribution and content in oral squamous cell carcinoma tissue and its adjacent microenvironment	PLOS ONE			English	Article							SERUM-LIPID PROFILE; BREAST-CANCER; DOCOSAHEXAENOIC ACID; PLASMA PHOSPHOLIPIDS; PROSTATE-CANCER; N-3; METABOLISM; GROWTH; RISK; SYNTHASE	Squamous cell carcinoma of the oral cavity mucosa grows under conditions of poor oxygenation and nutrient scarcity. Reprogramming of lipid biosynthesis accompanies tumor growth, but the conditions under which it occurs are not fully understood. The fatty acid content of the serum, tumor tissue and adjacent tumor microenvironment was measured by gas chromatography in 30 patients with squamous cell carcinoma grade 1-3. Twenty-five fatty acids were identified; their frequencies and percentages in each of the environments were assessed. Nineteen of the twenty-five fatty acids were found in tumor tissue, tumor adjacent tissue and blood serum. Of them, 8 were found in all thirty patients. Percentages of C16:0 and C18:1n9 were highest in the tumor, C18:1n9 and C16: 0 were highest in tumor adjacent tissue, and C16:0 and C18:0 were highest in blood serum. The frequencies and amounts of C22:1n13, C22:4n6, C22:5n3 and C24:1 in tumor adjacent tissues were higher than those in blood serum, independent of the tumor grade. The correlations between the amount of fatty acid and tumor grade were the strongest in tumor adjacent tissues. The correlations between particular fatty acids were most prevalent for grade 1+2 tumors and were strongest for grade 3 tumors. In the adjacent tumor microenvironment, lipogenesis was controlled by C22:6w3. In blood serum, C18:1trans11 limited the synthesis of long-chain fatty acids. Our research reveals intensive lipid changes in oral cavity SCC adjacent to the tumor microenvironment and blood serum of the patients. Increase in percentage of some of the FAs in the path: blood serum-tumor adjacent microenvironment-tumor, and it is dependent on tumor grade. This dependency is the most visible in the tumor adjacent environment.	[Halczy-Kowalik, Ludmila; Zabski, Tomasz] Pomeranian Med Univ, Clin Maxillofacial Surg, Szczecin, Poland; [Drozd, Arleta; Stachowska, Ewa] Pomeranian Med Univ, Dept Biochem & Human Nutr, Szczecin, Poland; [Drozd, Radoslaw] West Pomeranian Univ Technol, Dept Immunol Microbiol & Physiol Chem, Szczecin, Poland; [Domagala, Wenancjusz] Pomeranian Med Univ, Dept Pathomorphol, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University; West Pomeranian University of Technology; Pomeranian Medical University	Halczy-Kowalik, L (corresponding author), Pomeranian Med Univ, Clin Maxillofacial Surg, Szczecin, Poland.	sprpchst@pum.edu.pl	Drozd, Arleta/AAE-8033-2020; Drozd, Arleta/AGF-1128-2022; Stachowska, Ewa/G-9521-2017	Drozd, Arleta/0000-0002-5816-2040; Drozd, Arleta/0000-0002-5816-2040; Stachowska, Ewa/0000-0002-4009-1977; Drozd, Radoslaw/0000-0003-3136-4723				Abraham J, 2013, J MED DEVICES, V7, DOI 10.1115/1.4024321; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Agostini M, 2004, ORAL ONCOL, V40, P728, DOI 10.1016/j.oraloncology.2004.01.011; [Anonymous], 2014, PLOS ONE, DOI DOI 10.1371/journal.pone.0097189; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Askari M, 2015, CLIN TRANSL ONCOL, V17, P378, DOI 10.1007/s12094-014-1242-2; Azrad M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00224; Baracos VE, 2004, NUTR RES REV, V17, P177, DOI 10.1079/NRR200488; Barber MD, 2001, NUTR CANCER, V40, P118, DOI 10.1207/S15327914NC402_7; Bassett JK, 2016, CANCER CAUSE CONTROL, V27, P759, DOI 10.1007/s10552-016-0753-2; Bektas-Kayhan K., 2012, ROLE INFLAMMATION OR; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; Biswas NK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6835; Burrage LC, 2015, J PEDIAT, V169; Calder PC, 2012, MOL NUTR FOOD RES, V56, P1073, DOI 10.1002/mnfr.201100710; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Casbas-Hernandez P, 2015, CANCER EPIDEM BIOMAR, V24, P406, DOI 10.1158/1055-9965.EPI-14-0934; Cater NB, 2001, AM J CLIN NUTR, V73, P41; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; D'Eliseo D, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020015; Dallal GE, 2000, OBTAINING SUPERSCRIP; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friendly M, 2002, AM STAT, V56, P316, DOI 10.1198/000313002533; Frigolet ME, 2017, ADV NUTR, V8, p173S, DOI 10.3945/an.115.011130; Ghebremeskel K, 2000, LIPIDS, V35, P567, DOI 10.1007/s11745-000-557-3; Guo CB, 2000, BRIT J ORAL MAX SURG, V38, P506, DOI 10.1054/bjom.2000.0311; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hecker M, 2014, JPEN-PARENTER ENTER, V38, P587, DOI 10.1177/0148607113489833; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hu JF, 2011, EUR J CANCER PREV, V20, P530, DOI 10.1097/CEJ.0b013e328348fbfb; Iijima H, 2006, LIPIDS, V41, P521, DOI 10.1007/s11745-006-5000-2; Iwamoto S, 1998, NUTR CANCER, V31, P143, DOI 10.1080/01635589809514694; Jiang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11842-5; Jiang WG, 1998, CRIT REV ONCOL HEMAT, V27, P179, DOI 10.1016/S1040-8428(98)00003-1; Jones SF, 2015, CLIN CANCER RES, V21, P5434, DOI 10.1158/1078-0432.CCR-15-0126; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; Khodarahmi M, 2014, INT J PREVENTIVE MED, V5, P6; Kim JY, 2009, ANN NY ACAD SCI, V1171, P190, DOI 10.1111/j.1749-6632.2009.04897.x; Koontongkaew S, 2013, J CANCER, V4, P66, DOI 10.7150/jca.5112; Kopf PG, 2010, HYPERTENSION, V55, P547, DOI 10.1161/HYPERTENSIONAHA.109.144147; KRITCHEVSKY SB, 1992, ANNU REV NUTR, V12, P391, DOI 10.1146/annurev.nu.12.070192.002135; Kumar P, 2012, J CANCER RES THER, V8, P384, DOI 10.4103/0973-1482.103517; Kuroki Shinsuke, 2009, Kobe J Med Sci, V55, pE5; Liu JJ, 2014, NUTRIENTS, V6, P5184, DOI 10.3390/nu6115184; Lohe VK, 2010, J ORAL PATHOL MED, V39, P141, DOI 10.1111/j.1600-0714.2009.00828.x; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1566, DOI 10.1016/j.bbalip.2013.07.008; Mansara PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136542; Menendez JA, 2005, MED HYPOTHESES, V64, P342, DOI 10.1016/j.mehy.2004.07.022; Menendez JA, 2006, CURR OPIN CLIN NUTR, V9, P346, DOI 10.1097/01.mco.0000232893.21050.15; Menendez Javier A, 2016, Oncoscience, V3, P242; Morin C, 2013, PROSTAG LEUKOTR ESS, V89, P203, DOI 10.1016/j.plefa.2013.07.004; Nikolakopoulou Zacharoula, 2013, Carcinogenesis, V34, P2716, DOI 10.1093/carcin/bgt257; Palakurthi SS, 2000, CANCER RES, V60, P2919; Pappalardo G, 2015, NUTRITION, V31, P549, DOI 10.1016/j.nut.2014.12.002; Peck B, 2016, FEBS J, V283, P2767, DOI 10.1111/febs.13681; Piva MR, 2011, ONCOL LETT, V2, P1225, DOI 10.3892/ol.2011.382; Pratt VC, 2002, BRIT J CANCER, V87, P1370, DOI 10.1038/sj.bjc.6600659; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Ray U, 2018, FEBS J, V285, P432, DOI 10.1111/febs.14281; Riserus U, 2017, CURR OPIN LIPIDOL, V28, P46, DOI 10.1097/MOL.0000000000000381; Ritch CR, 2007, J UROLOGY, V177, P97, DOI 10.1016/j.juro.2006.08.105; Rose DP, 1999, INT J ONCOL, V15, P1011; Saadatian-Elahi M, 2004, INT J CANCER, V111, P584, DOI 10.1002/ijc.20284; Schonfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629; Sherubin Eugenia J, 2013, J Oral Maxillofac Pathol, V17, P4, DOI 10.4103/0973-029X.110685; Singh Simranjit, 2013, J Nat Sci Biol Med, V4, P374, DOI 10.4103/0976-9668.116994; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Troester MA, 2009, CLIN CANCER RES, V15, P7020, DOI 10.1158/1078-0432.CCR-09-1126; Tsuji M, 2003, PROSTAG LEUKOTR ESS, V68, P337, DOI 10.1016/S0952-3278(03)00025-5; Witz IP, 2009, CANCER MICROENVIRON, V2, pS9, DOI 10.1007/s12307-009-0025-8; Yang PY, 2014, CANCER LETT, V348, P1, DOI 10.1016/j.canlet.2014.03.010; Yazdi P. G., 2014, F1000 RES, DOI [10.12688/f1000research.2-256.v2, DOI 10.12688/F1000RESEARCH.2-256.V2)]; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110; Zhang PJ, 2015, INT J CLIN EXP MED, V8, P15900; Zhao J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004121	78	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218246	10.1371/journal.pone.0218246	http://dx.doi.org/10.1371/journal.pone.0218246			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242216	gold, Green Published, Green Submitted			2022-12-26	WOS:000482883600026
J	Loczenski-Brown, DM; Jones, S; Luckett, J; Daniel, Z; Brearley, MC; Ebling, FJP; Parr, T; Brameld, JM				Loczenski-Brown, David M.; Jones, Sarah; Luckett, Jeni; Daniel, Zoe; Brearley, Madelaine C.; Ebling, Francis J. P.; Parr, Tim; Brameld, John M.			Effect of adeno-associated virus (AAV)-mediated overexpression of PEPCK-M ( Pck2) on Clenbuterol-induced muscle growth	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE; ADAPTATION; GENE	We previously identified PEPCK-M (encoded by the Pck2 gene) to be highly up-regulated in skeletal muscle of pigs treated with Ractopamine, an anabolic beta-adrenergic receptor agonist. To determine whether PEPCK-M had a causative role in modulating the skeletal muscle growth response to Ractopamine, we used adeno-associated virus 1 (AAV1) to over-express Pck2 (AAV-Pck2) in murine skeletal muscle. A contralateral limb design was employed, such that each mouse served as its own control (injected with a GFP-only expressing AAV1, labelled AAV-GFP). Daily injections of Clenbuterol (1 mg/ kg for 21 days) or vehicle control were also carried out to assess the effects of AAV-Pck2 overexpression on the anabolic response to a beta-adrenergic agonist. AAV-Pck2 overexpression in leg muscles of male C57BL6/ J mice for 4 weeks (6-10 weeks of age) increased Pck2 mRNA (similar to 100-fold), protein (not quantifiable) and enzyme activity (similar to 3-fold). There was a trend (p = 0.0798) for AAV-Pck2 overexpression to reduce TA muscle weights, but there was no significant effect on muscle fibre diameters or myosin heavy chain isoform (MyHC) mRNA expression. When skeletal muscle growth was induced by daily administration of Clenbuterol (for 21 days), overexpression of AAV-Pck2 had no effect on the growth response, nor did it alter the expression of Phosphoserine Aminotransferase-1 (Psat1) or Asparagine Synthetase (Asns) mRNA or the Clenbuterol-induced decreases in MyHC IIa and IIx mRNA expression (p = 0.0065 and p = 0.0267 respectively). However AAV-Pck2 overexpression reduced TA muscle weights (p = 0.0434), particularly in the Control (vehicle treated) mice (p = 0.059 for AAV x Clenbuterol interaction) and increased the expression of Seryl-tRNA Synthetase (Sars) mRNA (p = 0.0477). Hence, contrary to the original hypothesis, AAV-Pck2 overexpression reduced TA muscle weights and did not mimic or alter the muscle hypertrophic effects of the beta-adrenergic agonist, Clenbuterol.	[Loczenski-Brown, David M.; Jones, Sarah; Daniel, Zoe; Brearley, Madelaine C.; Parr, Tim; Brameld, John M.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Luckett, Jeni] Univ Nottingham, Med Sch, Sch Med, Nottingham, England; [Ebling, Francis J. P.] Univ Nottingham, Med Sch, Sch Life Sci, Nottingham, England; [Loczenski-Brown, David M.] RenaSci Ltd, BioCity, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; Renasci Ltd	Brameld, JM (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	john.brameld@nottingham.ac.uk	Brameld, John/AAB-1745-2021	Brameld, John/0000-0003-4942-080X; Parr, Tim/0000-0003-2490-9457; Sholto, Madelaine/0000-0001-7306-9242	Biotechnology and Biological Sciences Research Council [BB/MM001385/1]; Zoetis; BBSRC [BB/M001385/1, BB/M017524/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M017524/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council [grant number BB/MM001385/1 to JMB, TP and FJPE] and by Zoetis (formerly Pfizer Animal Health). The funders were not involved in the study design, collection, analysis or interpretation of the data, nor in the writing of the manuscript.	Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brown DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28693; Brown D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34315-9; Brown DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201481; Brown DM, 2015, AGEING RES REV, V24, P263, DOI 10.1016/j.arr.2015.08.007; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hemmings KM, 2015, ANIMAL, V9, P285, DOI 10.1017/S175173111400233X; Hemmings KM, 2009, J ANIM SCI, V87, P3915, DOI 10.2527/jas.2009-2067; LEITHNER K, 2014, ONCOGENE, V34, P1, DOI DOI 10.1038/0NC.2013.570; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mendez-Lucas A, 2014, J BIOL CHEM, V289, P22090, DOI 10.1074/jbc.M114.566927; Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359; Parr T, 2016, MEAT SCI, V120, P93, DOI 10.1016/j.meatsci.2016.04.022; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; The Government Office for Science L. Foresight, 2011, FOR MIGR GLOB ENV CH; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	19	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218970	10.1371/journal.pone.0218970	http://dx.doi.org/10.1371/journal.pone.0218970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237922	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000057
J	El Hajj, A; Yen, FT; Oster, T; Malaplate, C; Pauron, L; Corbier, C; Lanhers, MC; Claudepierre, T				El Hajj, Aseel; Yen, Frances T.; Oster, Thierry; Malaplate, Catherine; Pauron, Lynn; Corbier, Catherine; Lanhers, Marie-Claire; Claudepierre, Thomas			Age-related changes in regiospecific expression of Lipolysis Stimulated Receptor (LSR) in mice brain	PLOS ONE			English	Article							LIPOPROTEIN RECEPTOR; CHOLESTEROL-METABOLISM; LIPID DROPLETS; GENE; SYNAPTOGENESIS; HYPERLIPIDEMIA; ASTROCYTES; APOE; PCR	The regulation of cholesterol, an essential brain lipid, ensures proper neuronal development and function, as demonstrated by links between perturbations of cholesterol metabolism and neurodegenerative diseases, including Alzheimer's disease. The central nervous system (CNS) acquires cholesterol via de novo synthesis, where glial cells provide cholesterol to neurons. Both lipoproteins and lipoprotein receptors are key elements in this intercellular transport, where the latter recognize, bind and endocytose cholesterol containing glia-produced lipoproteins. CNS lipoprotein receptors are like those in the periphery, among which include the ApoB, E binding lipolysis stimulated lipoprotein receptor (LSR). LSR is a multimeric protein complex that has multiple isoforms including a and alpha', which are seen as a doublet at 68 kDa, and beta at 56 kDa. While complete inactivation of murine lsr gene is embryonic lethal, studies on lsr +/- mice revealed altered brain cholesterol distribution and cognitive functions. In the present study, LSR profiling in different CNS regions revealed regiospecific expression of LSR at both RNA and protein levels. At the RNA level, the hippocampus, hypothalamus, cerebellum, and olfactory bulb, all showed high levels of total lsr compared to whole brain tissues, whereas at the protein level, only the hypothalamus, olfactory bulb, and retina showed the highest levels of total LSR. Interestingly, major regional changes in LSR expression were observed in aged mice which suggests changes in cholesterol homeostasis in specific structures in the aging brain. Immunocytostaining of primary cultures of mature murine neurons and glial cells isolated from different CNS regions showed that LSR is expressed in both neurons and glial cells. However, lsr RNA expression in the cerebellum was predominantly higher in glial cells, which was confirmed by the immunocytostaining profile of cerebellar neurons and glia. Based on this observation, we would propose that LSR in glial cells may play a key role in glia-neuron cross talk, particularly in the feedback control of cholesterol synthesis to avoid cholesterol overload in neurons and to maintain proper functioning of the brain throughout life.	[El Hajj, Aseel; Yen, Frances T.; Oster, Thierry; Malaplate, Catherine; Pauron, Lynn; Corbier, Catherine; Lanhers, Marie-Claire; Claudepierre, Thomas] Univ Lorraine, ENSAIA, UR AFPA Lab, Qualivie, Vandoeuvre Les Nancy, Lorraine, France	Universite de Lorraine	Yen, FT; Claudepierre, T (corresponding author), Univ Lorraine, ENSAIA, UR AFPA Lab, Qualivie, Vandoeuvre Les Nancy, Lorraine, France.	Frances.yen-potin@univ-lorraine.fr; Thomas.claudepierre@univ-lorraine.fr	Yen, Frances T/G-9175-2014	Yen, Frances T/0000-0001-8740-4304; Claudepierre, Thomas/0000-0001-6968-8518; El Hajj, Aseel/0000-0002-7290-491X	French Ministry of Higher Education, Research and Innovation; "Impact Biomolecules" project of the "Lorraine Universite d'Excellence" (Investissements d'avenir - ANR); Fondation Alzheimer	French Ministry of Higher Education, Research and Innovation; "Impact Biomolecules" project of the "Lorraine Universite d'Excellence" (Investissements d'avenir - ANR)(French National Research Agency (ANR)); Fondation Alzheimer	AH received a PhD fellowship from the French Ministry of Higher Education, Research and Innovation http://www.enseignementsup-recherche.gouv.fr/. The authors acknowledge support of URAFPA laboratory by the "Impact Biomolecules" project of the "Lorraine Universite d'Excellence" (Investissements d'avenir - ANR). This work was supported by the Fondation Alzheimer. The founders has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Bihain BE, 1998, CURR OPIN LIPIDOL, V9, P221, DOI 10.1097/00041433-199806000-00006; Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Chen J, 2013, BBA-MOL CELL BIOL L, V1831, P263, DOI 10.1016/j.bbalip.2012.09.007; Claudepierre T, 2003, M S-MED SCI, V19, P601, DOI 10.1051/medsci/2003195601; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; Ledesma MD, 2012, PROG LIPID RES, V51, P23, DOI 10.1016/j.plipres.2011.11.004; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fagan AM, 2000, MICROSC RES TECHNIQ, V50, P297, DOI 10.1002/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C; Fester L, 2009, HIPPOCAMPUS, V19, P692, DOI 10.1002/hipo.20548; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Herz J, 2009, CURR OPIN LIPIDOL, V20, P190, DOI 10.1097/MOL.0b013e32832d3a10; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Iwamoto N, 2014, CELL STRUCT FUNCT, V39, P1; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Mesli S, 2004, EUR J BIOCHEM, V271, P3103, DOI 10.1111/j.1432-1033.2004.04223.x; Narvekar P, 2009, DIABETES, V58, P1040, DOI 10.2337/db08-1184; Pennetta G, 2018, DEV CELL, V45, P427, DOI 10.1016/j.devcel.2018.05.002; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Quan G, 2003, DEV BRAIN RES, V146, P87, DOI 10.1016/j.devbrainres.2003.09.015; Saper CB, 2014, CURR BIOL, V24, pR1111, DOI 10.1016/j.cub.2014.10.023; Sohet F, 2015, J CELL BIOL, V208, P703, DOI 10.1083/jcb.201410131; Steinmetz CC, 2006, J PHYSIOL-LONDON, V577, P249, DOI 10.1113/jphysiol.2006.117358; Stenger C, 2012, J NEUROCHEM, V123, P467, DOI 10.1111/j.1471-4159.2012.07922.x; Sullivan EV, 2010, NEUROPSYCHOL REV, V20, P227, DOI 10.1007/s11065-010-9144-8; Turley SD, 1998, AM J PHYSIOL-ENDOC M, V274, pE1099, DOI 10.1152/ajpendo.1998.274.6.E1099; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218812	10.1371/journal.pone.0218812	http://dx.doi.org/10.1371/journal.pone.0218812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233547	Green Published, gold, Green Submitted			2022-12-26	WOS:000484896700042
J	Jin, DP; Choi, IS; Choi, BH				Jin, Dong-Pil; Choi, In-Su; Choi, Byoung-Hee			Plastid genome evolution in tribe Desmodieae (Fabaceae: Papilionoideae)	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; DNA-SEQUENCES; PHYLOGENETIC ANALYSIS; LEGUME PHYLOGENY; RPL2 INTRON; MULTIPLE; GENE; LOSSES; SUBSTITUTION; RPS16	Recent plastid genome (plastome) studies of legumes (family Fabaceae) have shown that this family has undergone multiple atypical plastome evolutions from each of the major clades. The tribe Desmodieae belongs to the Phaseoloids, an important but systematically puzzling clade within Fabaceae. In this study, we investigated the plastome evolution of Desmodieae and analyzed its phylogenetic signaling. We sequenced six complete plastomes from representative members of Desmodieae and from its putative sister Phaseoloid genus Mucuna. Those genomes contain 128 genes and range in size from 148,450 to 153,826 bp. Analyses of gene and intron content revealed similar characters among the members of Desmodieae and Mucuna. However, there were also several distinct characters identified. The loss of the rpl2 intron was a feature shared between Desmodieae and Mucuna, whereas the loss of the rps12 intron was specific to Desmodieae. Likewise, gene loss of rps16 was observed in Mucuna but not in Desmodieae. Substantial sequence variation of ycf4 was detected from all the sequenced plastomes, but pseudogenization was restricted to the genus Desmodium. Comparative analysis of gene order revealed a distinct plastome conformation of Desmodieae compared with other Phaseoloid legumes, i.e., an inversion of an approximately 1.5-kb gene cluster (trnD-GUC, trnY-GUA, and trnE-UUC). The inversion breakpoint suggests that this event was mediated by the recombination of an 11-bp repeat motif. A phylogenetic analysis based on the plastome-scale data set found the tribe Desmodieae is a highly supported monophyletic group nested within the paraphyletic Phaseoleae, as has been found in previous phylogenetic studies. Two subtribes (Desmodiinae and Lespedezinae) of Desmodieae were also supported as monophyletic groups. Within the subtribe Lespedezinae, Lespedeza is closer to Kummerowia than Campylotropis.	[Jin, Dong-Pil; Choi, In-Su; Choi, Byoung-Hee] Inha Univ, Dept Biol Sci, Incheon, South Korea; [Choi, In-Su] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	Inha University; University of Texas System; University of Texas Austin	Choi, BH (corresponding author), Inha Univ, Dept Biol Sci, Incheon, South Korea.	bhchoi@inha.ac.kr			Korea National Arboretum [KNA1-2-13, 14-2]	Korea National Arboretum	This study was supported by a scientific research fund from the Korea National Arboretum (KNA1-2-13, 14-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA S, 1985, BOT MAG TOKYO, V98, P137, DOI 10.1007/BF02488793; Amiryousefi A, 2018, BIOINFORMATICS, V34, P3030, DOI 10.1093/bioinformatics/bty220; Azani N, 2017, TAXON, V66, P44, DOI 10.12705/661.3; Bailey CD, 1997, SYST BOT, V22, P133, DOI 10.2307/2419681; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bruneau A, 2013, TAXON, V62, P217, DOI 10.12705/622.8; Choi IS, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0173766, 1]; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doyle J. J., 2000, ADV LEGUME SYSTEMATI, V9, P1; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; DOYLE JJ, 1995, SYST BOT, V20, P272, DOI 10.2307/2419496; Dugas DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16958; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan AN, 2016, MOL PHYLOGENET EVOL, V104, P44, DOI 10.1016/j.ympev.2016.08.001; Fishbein M, 2010, SYST BOT, V35, P77, DOI 10.1600/036364410790862588; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Han JE, 2010, BOT J LINN SOC, V164, P221, DOI 10.1111/j.1095-8339.2010.01084.x; Hernandez-Leon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070501; Jabbour F, 2018, MOL PHYLOGENET EVOL, V118, P108, DOI 10.1016/j.ympev.2017.09.017; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; Kajita T, 2001, SYST BOT, V26, P515; Kazakoff SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051687; Keller J, 2017, DNA RES, V24, P343, DOI 10.1093/dnares/dsx006; Kim Y, 2017, J EXP BOT, V68, P2065, DOI 10.1093/jxb/erw500; Lai M, 1997, SYST BOT, V22, P519, DOI 10.2307/2419825; Lavin M, 2001, AM J BOT, V88, P503, DOI 10.2307/2657116; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Lim CE, 2018, MITOCHONDRIAL DNA B, V3, P118, DOI 10.1080/23802359.2018.1424577; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Magee AM, 2010, GENOME RES, V20, P1700, DOI 10.1101/gr.111955.110; Martin GE, 2014, ANN BOT-LONDON, V113, P1197, DOI 10.1093/aob/mcu050; NEMOTO T, 1990, BOT MAG TOKYO, V103, P217, DOI 10.1007/BF02489627; NEMOTO T, 1988, Journal of Japanese Botany, V63, P112; Ohashi H., 1981, ADV LEGUME SYSTEMATI, V1, P292; Ohashi H., 2005, LEGUMES WORLD, P432; Ohashi Hiroyoshi, 2012, Journal of Japanese Botany, V87, P108; Roschenbleck J, 2017, GENOME BIOL EVOL, V9, P64, DOI 10.1093/gbe/evw271; Rogalski M, 2006, NUCLEIC ACIDS RES, V34, P4537, DOI 10.1093/nar/gkl634; Ruhlman TA, 2017, AM J BOT, V104, P559, DOI 10.3732/ajb.1600453; Sanderson MJ, 2015, AM J BOT, V102, P1115, DOI 10.3732/ajb.1500184; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schrire B.D, 2005, LEGUMES WORLD, P392; Schwarz EN, 2017, J MOL EVOL, V84, P187, DOI 10.1007/s00239-017-9792-x; Schwarz EN, 2015, J SYST EVOL, V53, P458, DOI 10.1111/jse.12179; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Sinn BT, 2018, AM J BOT, V105, P71, DOI 10.1002/ajb2.1001; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stefanovic S, 2009, SYST BOT, V34, P115, DOI 10.1600/036364409787602221; Ueda M, 2008, MOL BIOL EVOL, V25, P1566, DOI 10.1093/molbev/msn102; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wang YH, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00138; Wang YH, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1124-1; Weng ML, 2014, MOL BIOL EVOL, V31, P645, DOI 10.1093/molbev/mst257; Williams AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125768; Wojciechowski M.F., 2000, ADV LEGUME SYST, V9, P277; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; Wu CS, 2011, GENOME BIOL EVOL, V3, P1284, DOI 10.1093/gbe/evr095; Xu B, 2012, MOL PHYLOGENET EVOL, V62, P346, DOI 10.1016/j.ympev.2011.10.007	64	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218743	10.1371/journal.pone.0218743	http://dx.doi.org/10.1371/journal.pone.0218743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3QN	31233545	gold, Green Published, Green Submitted			2022-12-26	WOS:000484896700035
J	Cerini, F; Bologna, MA; Vignoli, L				Cerini, Francesco; Bologna, Marco A.; Vignoli, Leonardo			Dragonflies community assembly in artificial habitats: Glimpses from field and manipulative experiments	PLOS ONE			English	Article							COOCCURRENCE PATTERNS; INTRAGUILD PREDATION; COMPETITION; RULES; ASSOCIATIONS; LIMITATION; DISPERSAL; GHOST	Several factors act on community structure, so determining species composition and abundance patterns. Core processes operating at local scales, such as species-environment matching and species interactions, shape observed assemblages. Artificial habitats (simplified structure) are useful systems for assessing the main factors affecting community composition and disentangling their assembly rules. Drinking troughs (brickwork tanks for free-ranging cattle watering) are widespread in Italy and represent a suitable aquatic habitat for colonization by various aquatic organisms. Dragonflies larvae are usually found in drinking troughs and often exhibit strong species interactions and striking community assembly patterns. Our primary aim was to search for Odonata communities exhibiting non-random cooccurrence/segregation patterns in drinking troughs. We performed null-model analyses by measuring a co-occurrence index (C-score) on larval Odonata assemblages (13 species from 28 distinct troughs). Overall, we found a non-random structure for the studied dragonfly assemblages, which, given their fast generation time, must have been generated by short-term ecological processes (i.e. interspecific interactions). We thus analyzed potential competition/predation among and within ecological guilds. From the field data, we speculated that interactions within the sprawlers' guild is likely among the main drivers structuring the studied assemblages, especially the effect of intraguild predation between C. erythraea and Sympetrum spp larval stages. We then experimentally tested these interactions in laboratory and demonstrated that intraguild predation among larvae at different development stages may result in an effective exclusion/negative impact on density pattern, representing one of the processes to take into consideration when studying dragonfly assemblages.	[Cerini, Francesco; Bologna, Marco A.; Vignoli, Leonardo] Univ Roma Tre, Dipartimento Sci, Viale G Marconi, Rome, Italy	Roma Tre University	Vignoli, L (corresponding author), Univ Roma Tre, Dipartimento Sci, Viale G Marconi, Rome, Italy.	leonardo.vignoli@uniroma3.it	Vignoli, Leonardo/F-2663-2011; Cerini, Francesco/AAO-8613-2020	Vignoli, Leonardo/0000-0002-1599-092X; Cerini, Francesco/0000-0002-1367-1239; BOLOGNA, Marco Alberto/0000-0003-2498-8917	Department of Science, Roma Tre University (MIUR-Italy Dipartimenti di Eccellenza) [COMMI 314-337 LEGGE 232/2016]	Department of Science, Roma Tre University (MIUR-Italy Dipartimenti di Eccellenza)	The Grant to the Department of Science, Roma Tre University (MIUR-Italy Dipartimenti di Eccellenza, ARTICOLO 1, COMMI 314-337 LEGGE 232/2016) is gratefully acknowledged.	ANHOLT BR, 1994, OECOLOGIA, V99, P60, DOI 10.1007/BF00317083; Askew RR, 2004, THE DRAGONFLIES OF E; Beaudrot L, 2013, OECOLOGIA, V173, P1053, DOI 10.1007/s00442-013-2679-7; BENKE AC, 1978, J ANIM ECOL, V47, P335, DOI 10.2307/3787; Blois JL, 2014, ECOGRAPHY, V37, P1095, DOI 10.1111/ecog.00779; Carchini G, 2016, A KEY TO THE LARVAE; Cardillo M, 2010, GLOBAL ECOL BIOGEOGR, V19, P465, DOI 10.1111/j.1466-8238.2010.00537.x; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Corbet PS, 1999, DRAGONFLIES BEHAVIOU; Decaens T, 2008, APPL SOIL ECOL, V39, P321, DOI 10.1016/j.apsoil.2008.01.007; Diamond J.M., 1975, P342; DRAKE JA, 1990, TRENDS ECOL EVOL, V5, P159, DOI 10.1016/0169-5347(90)90223-Z; Garcia Gonzalez C, 2006, AQ CONSERV, V21, P74; GILPIN ME, 1982, OECOLOGIA, V52, P75, DOI 10.1007/BF00349014; Gotelli N., 2001, ECOSIM NULL MODELS S, V78, DOI 10.5281/zenodo.16504; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Johansson F, 2004, ECOL ENTOMOL, V29, P196, DOI 10.1111/j.0307-6946.2004.00592.x; JOHNSON DM, 1985, ECOLOGY, V66, P119, DOI 10.2307/1941312; McCauley SJ, 2006, ECOGRAPHY, V29, P585, DOI 10.1111/j.0906-7590.2006.04787.x; MERRILL R J, 1984, Odonatologica, V13, P387; MORIN PJ, 1984, ECOLOGY, V65, P1866, DOI 10.2307/1937784; Morris DW, 1999, EVOL ECOL RES, V1, P3; Osborn R., 1996, Odonatologica, V25, P49; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; RICKLEFS RE, 2000, ECOLOGY; ROBINSON JV, 1987, ECOLOGY, V68, P587, DOI 10.2307/1938464; ROBINSON JV, 1987, ECOLOGY, V68, P921, DOI 10.2307/1938363; Sanderson JG, 2009, EVOL ECOL RES, V11, P771; SCHOENER TW, 1982, AM SCI, V70, P586; Sfenthourakis S, 2006, GLOBAL ECOL BIOGEOGR, V15, P39, DOI 10.1111/j.1466-822x.2005.00192.x; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; STEYTLER NS, 1995, BIOL CONSERV, V72, P381, DOI 10.1016/0006-3207(94)00052-R; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Suutari E, 2004, OECOLOGIA, V140, P135, DOI 10.1007/s00442-004-1559-6; Ulrich W, 2008, PAIRS A FORTRAN PROG; Ulrich W, 2013, OIKOS, V122, P2, DOI 10.1111/j.1600-0706.2012.20325.x; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; VANBUSKIRK J, 1992, OIKOS, V65, P455, DOI 10.2307/3545563; Vignoli L, 2009, VIE MILIEU, V59, P47; Weiher E, 2001, ECOLOGICAL ASSEMBLY; DG	42	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0214127	10.1371/journal.pone.0214127	http://dx.doi.org/10.1371/journal.pone.0214127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226119	Green Published, Green Submitted, gold			2022-12-26	WOS:000484894700003
J	Kato, S; Yamanobe, N; Venture, G; Yoshida, E; Ganesh, G				Kato, Saki; Yamanobe, Natsuki; Venture, Gentiane; Yoshida, Eiichi; Ganesh, Gowrishankar			The where of handovers by humans: Effect of partner characteristics, distance and visual feedback	PLOS ONE			English	Article							ROBOT	Object handovers between humans are common in our daily life but the mechanisms underlying handovers are still largely unclear. A good understanding of these mechanisms is important not only for a better understanding of human social behaviors, but also for the prospect of an automatized society in which machines will need to perform similar objects exchanges with humans. In this paper, we analyzed how humans determine the location of object transfer during handovers-to determine whether they can predict the preferred handover location of a partner, the variation of this prediction in 3D space, and to examine how much of a role vision plays in the whole process. For this we developed a paradigm that allows us to compare handovers by humans with and without on-line visual feedback. Our results show that humans have the surprising ability to modulate their handover location according to partners they have just met such that the resulting handover errors are in the order of few centimeters, even in the absence of vision. The handover errors are least along the axis joining the two partners, suggesting a limited role for visual feedback in this direction. Finally, we show that the handover locations are explained very well by a linear model considering the heights, genders and social dominances of the two partners, and the distance between them. We developed separate models for the behavior of 'givers' and 'receivers' and discuss how the behavior of the same individual changes depending on his role in the handover.	[Kato, Saki; Venture, Gentiane; Yoshida, Eiichi] Tokyo Univ Agr & Technol, Grad Sch Engn, Mech Syst Engn, Tokyo, Japan; [Kato, Saki; Venture, Gentiane; Yoshida, Eiichi; Ganesh, Gowrishankar] CNRS AIST JRL Joint Robot Lab, RL UMI3218, Tsukuba, Ibaraki, Japan; [Yamanobe, Natsuki] Natl Inst Adv Ind Sci & Technol, Intelligent Syst Res Inst, Manipulat Res Grp, Tsukuba, Ibaraki, Japan; [Ganesh, Gowrishankar] Univ Montpellier, LIRMM Interact Digital Human Grp, CNRS, Montpellier, France	Tokyo University of Agriculture & Technology; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Kato, S (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Engn, Mech Syst Engn, Tokyo, Japan.; Kato, S (corresponding author), CNRS AIST JRL Joint Robot Lab, RL UMI3218, Tsukuba, Ibaraki, Japan.	saki.kato2017@gmail.com	Venture, Gentiane/E-7060-2013	Venture, Gentiane/0000-0001-7767-4765	JSPS [17H01804]; JST ERATO [JPMJER1701]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST ERATO(Japan Science & Technology Agency (JST))	This work was supported by JSPS grant in aid for research, 17H01804. GG was partially supported by JST ERATO Grant Number JPMJER1701.	Aleotti J, 2014, INT J SOC ROBOT, V6, P653, DOI 10.1007/s12369-014-0241-3; Aronson RM, 2018, ACMIEEE INT CONF HUM, P4, DOI 10.1145/3171221.3171287; Baier T, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-3, P703, DOI 10.1109/ROBIO.2006.340292; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bourgeois J, 2014, ACTA PSYCHOL, V148, P91, DOI 10.1016/j.actpsy.2014.01.008; Cakmak M, 1986, INT ROB SYST IROS 20; Chan WP, 2015, IEEE INT C INT ROBOT, P1, DOI 10.1109/IROS.2015.7353106; Chan WP, 2012, ACMIEEE INT CONF HUM, P9; Emmelmann M, 2005, IEEE VTS VEH TECHNOL, P2282; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Ganesh G., 2012, SPECIAL ISSUE ELSEVI, V61, P362; Ganesh G, NATURE COMMUNICATION; Ganesh G, 2017, NATURE COMMUNICATION; Ganesh G, 2012, IEEE INT CONF ROBOT, P3329, DOI 10.1109/ICRA.2012.6225057; Hansen C, 2017, HUMAN HUMAN HANDOVER; He WW, 2015, J HUM-ROBOT INTERACT, V4, P75, DOI 10.5898/JHRI.4.1.He; Huber M, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P107, DOI 10.1109/ROMAN.2008.4600651; Ikegami T, ENEURO0341172017, DOI [10.1523/ENEURO.0341-17, DOI 10.1523/ENEURO.0341-17]; Ikegami T, 2018, ELIFE, V7, DOI 10.7554/eLife.33392; KAJIKAWA S, 1995, IROS '95 - 1995 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS: HUMAN ROBOT INTERACTION AND COOPERATIVE ROBOTS, PROCEEDINGS, VOL 1, P193, DOI 10.1109/IROS.1995.525796; Kim J, 2004, 2 INT C AUT ROB AG, P13; Ladavas E, 1998, J COGNITIVE NEUROSCI, V10, P581, DOI 10.1162/089892998562988; Li Y., 2018, IEEE T ROBOTICS; Pellinen TK, 2009, EFFICIENT TRANSPORTATION AND PAVEMENT SYSTEMS: CHARACTERIZATION, MECHANISMS, SIMULATION, AND MODELING, P639; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Sisbot EA, 2012, IEEE T ROBOT, V28, P1045, DOI 10.1109/TRO.2012.2196303; Strabala K, 2013, J HUM-ROBOT INTERACT, V2, P112, DOI 10.5898/JHRI.2.1.Strabala; Takagi A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0054; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112	30	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0217129	10.1371/journal.pone.0217129	http://dx.doi.org/10.1371/journal.pone.0217129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226108	Green Submitted, Green Published, gold			2022-12-26	WOS:000484894700005
J	Sanvicente-Vieira, B; Rovaris, DL; Ornell, F; Sordi, A; Rothmann, LM; Niederauer, JPO; Schuch, JB; von Diemen, L; Kessler, FHP; Grassi-Oliveira, R				Sanvicente-Vieira, Breno; Rovaris, Diego Luiz; Ornell, Felipe; Sordi, Anne; Rothmann, Leonardo Melo; Ottolia Niederauer, Joao Paulo; Schuch, Jaqueline Bohrer; von Diemen, Lisia; Paim Kessler, Felix Henrique; Grassi-Oliveira, Rodrigo			Sex-based differences in multidimensional clinical assessments of early-abstinence crack cocaine users	PLOS ONE			English	Article							ADDICTION SEVERITY INDEX; CHILDHOOD-TRAUMA-QUESTIONNAIRE; GENDER-DIFFERENCES; DRUG-USE; SUBSTANCE-USE; ABUSE; WOMEN; DEPENDENCE; NEGLECT; HEALTH	Crack cocaine use disorder (CUD) has been related to sex differences. This work aimed to compare the severity of drug use and the severity of other negative related outcomes in males and females with CUD. A total of 1344 inpatients (798 males and 546 females) with crack cocaine use disorder (CUD) were evaluated by a detailed multidimensional clinical assessment, including addiction severity and trauma exposure. Linear regression predicted higher drug use severity (beta = 0.273, p < 0.001) and more problems in domains related to childcare issues (beta = 0.321), criminal involvement (beta = 0.108), work-related problems (beta = 0.281) and social support impairments (beta = 0.142) for females, all with p < 0.001. Alcohol problems were predicted to be higher in males (beta = -0.206, P < 0.001). Females had higher rates of other mental disorders, particularly trauma and stress-related disorders (OR: 3.206, CI: 2.22, 4.61). Important sex differences also emerged in trauma history and HIV infection prevalence. CUD has a more severe clinical presentation among females facing early abstinence. Sex differences in the CUD course indicate the need for consideration of sex-specific interventions and research.	[Sanvicente-Vieira, Breno; Rothmann, Leonardo Melo; Ottolia Niederauer, Joao Paulo; Grassi-Oliveira, Rodrigo] Pontificia Univ Catolica Rio Grande do Sul, Dev Cognit Neurosci Lab, Sch Hlth Sci, Porto Alegre, RS, Brazil; [Sanvicente-Vieira, Breno; Rothmann, Leonardo Melo; Ottolia Niederauer, Joao Paulo; Grassi-Oliveira, Rodrigo] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst Rio Grande Sul, Porto Alegre, RS, Brazil; [Rovaris, Diego Luiz] Univ Fed Rio Grande do Sul, Fac Med, Dept Psychiat, Porto Alegre, RS, Brazil; [Rovaris, Diego Luiz] Hosp Clin Porto Alegre, Attent Deficit Disorder Outpatient Program, Porto Alegre, RS, Brazil; [Ornell, Felipe; Sordi, Anne; Schuch, Jaqueline Bohrer; von Diemen, Lisia; Paim Kessler, Felix Henrique] Univ Fed Rio Grande do Sul, Ctr Drug & Alcohol Res, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Schuch, Jaqueline Bohrer] Pontificia Univ Catolica Rio Grande do Sul, Grad Program Biomed Gerontol, Lab Immunosenescence, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Grassi-Oliveira, R (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Dev Cognit Neurosci Lab, Sch Hlth Sci, Porto Alegre, RS, Brazil.; Grassi-Oliveira, R (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Brain Inst Rio Grande Sul, Porto Alegre, RS, Brazil.	rodrigo.grassi@pucrs.br	Rovaris, Diego/I-1133-2013; von Diemen, Lisia/D-5452-2015; ornell, felipe/AAC-8207-2019; Kessler, Felix Henrique/AAO-1722-2020; von Diemen, Lisia/GSE-1795-2022; KESSLER, FELIX HENRIQUE P/C-3798-2018; Schuch, Jaqueline Bohrer/L-1249-2015; Grassi-Oliveira, R/G-2623-2012; Sanvicente-Vieira, Breno/H-5530-2013	Rovaris, Diego/0000-0002-8910-4927; von Diemen, Lisia/0000-0001-9228-7114; ornell, felipe/0000-0002-3881-4283; KESSLER, FELIX HENRIQUE P/0000-0001-7059-2564; Schuch, Jaqueline Bohrer/0000-0002-2195-4407; Grassi-Oliveira, R/0000-0001-9911-5921; Sanvicente-Vieira, Breno/0000-0002-9922-966X; sordi, Anne/0000-0002-4629-1646	MCT/CT-Saude-DECIT/SCTIE/MS, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [466802/2014-5, 478492/2013-8]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [11/1302-7]; Secretaria Nacional de Politicas sobre Drogas (SENAD)/Ministerio da Justica [822647/2015]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]; National Institutes of Health (NIH) [R01DA044859]; Fundo de Incentivo a pesquisa (FIPE) - Hospital de Clinicas de Porto Alegre/Universidade Federal do Rio Grande do Sul [2015-0234]	MCT/CT-Saude-DECIT/SCTIE/MS, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Secretaria Nacional de Politicas sobre Drogas (SENAD)/Ministerio da Justica; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundo de Incentivo a pesquisa (FIPE) - Hospital de Clinicas de Porto Alegre/Universidade Federal do Rio Grande do Sul	This study was supported by MCT/CT-Saude-DECIT/SCTIE/MS, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [Grant number 466802/2014-5] to RG-O and [Grant number 478492/2013-8] to LVD; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [Grant number 11/1302-7]; Secretaria Nacional de Politicas sobre Drogas (SENAD)/Ministerio da Justica [Grant number 822647/2015]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [Finance Code 001] to BS-V and JBS; National Institutes of Health (NIH) [Grant number R01DA044859]; and Fundo de Incentivo a pesquisa (FIPE) - Hospital de Clinicas de Porto Alegre/Universidade Federal do Rio Grande do Sul [Grant number 2015-0234] to LVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla RR, 2014, ADDICT BEHAV, V39, P297, DOI 10.1016/j.addbeh.2013.10.019; American Psychiatric Association, 2013, DSM 5 TASK FORC DIAG, V5th; Andersen SL, 2009, NEUROSCI BIOBEHAV R, V33, P516, DOI 10.1016/j.neubiorev.2008.09.009; Becker AE, 2013, NEW ENGL J MED, V369, P66, DOI 10.1056/NEJMra1110827; Becker JB, 2016, DIALOGUES CLIN NEURO, V18, P395; Becker JB, 2017, J NEUROSCI RES, V95, P136, DOI 10.1002/jnr.23963; Becker JB, 2016, ADDICT BIOL, V21, P1052, DOI 10.1111/adb.12383; Becker JB, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-14; Beltz AM, 2015, EXP CLIN PSYCHOPHARM, V23, P247, DOI 10.1037/pha0000033; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bertoni N, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0070-x; Bobzean SAM, 2014, EXP NEUROL, V259, P64, DOI 10.1016/j.expneurol.2014.01.022; Cacciola JS, 2011, ADDICTION, V106, P1588, DOI 10.1111/j.1360-0443.2011.03482.x; Vernaglia TVC, 2017, HEALTH CARE WOMEN IN, V38, P1170, DOI 10.1080/07399332.2017.1367001; Chilcoat HD, 1998, ADDICT BEHAV, V23, P827, DOI 10.1016/S0306-4603(98)00069-0; Clayton JA, 2016, JAMA-J AM MED ASSOC, V316, P1863, DOI 10.1001/jama.2016.16405; Courtwright DT, 2012, ADDICTION, V107, P486, DOI 10.1111/j.1360-0443.2011.03723.x; Degenhardt L, 2014, DRUG ALCOHOL DEPEN, V137, P36, DOI 10.1016/j.drugalcdep.2013.12.025; Dias AC, 2011, J SUBST ABUSE TREAT, V41, P273, DOI 10.1016/j.jsat.2011.03.008; Diaz-Mesa EM, 2016, ADICCIONES, V28, P221, DOI 10.20882/adicciones.829; Edinburgh Laurel, 2006, J Sch Nurs, V22, P278, DOI 10.1622/1059-8405(2006)022[0278:GDIESA]2.0.CO;2; Evans SM, 2007, EXP CLIN PSYCHOPHARM, V15, P418, DOI 10.1037/1064-1297.15.5.418; Falck RS, 2004, J NERV MENT DIS, V192, P503, DOI 10.1097/01.nmd.0000131913.94916.d5; Fattore L, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00019; First M. B., 1997, STRUCTURED CLIN INTE; Fox HC, 2009, HARVARD REV PSYCHIAT, V17, P103, DOI 10.1080/10673220902899680; Francke ID, 2013, CHILD ABUSE NEGLECT, V37, P883, DOI 10.1016/j.chiabu.2013.04.008; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grassi-Oliveira R, 2006, REV SAUDE PUBL, V40, P249, DOI 10.1590/S0034-89102006000200010; Guimaraes RA, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1569-7; Hatsukami DK, 1996, JAMA-J AM MED ASSOC, V276, P1580; Herrmann ES, 2015, EXP CLIN PSYCHOPHARM, V23, P415, DOI 10.1037/pha0000053; Hyman SM, 2008, DRUG ALCOHOL DEPEN, V92, P208, DOI 10.1016/j.drugalcdep.2007.08.006; Imtiaz S, 2016, J SUBST USE, V21, P22, DOI 10.3109/14659891.2014.949315; Kamakura WA, 2013, ESTRATIFICACAO SOCIO; Kessler F, 2012, REV BRAS PSIQUIATR, V34, P24, DOI 10.1590/S1516-44462012000100006; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; Lejuez CW, 2007, EXP CLIN PSYCHOPHARM, V15, P165, DOI 10.1037/1064-1297.15.2.165; Marshal MP, 2008, ADDICTION, V103, P546, DOI 10.1111/j.1360-0443.2008.02149.x; Martel ML, 2018, AM J EMERG MED, V36, P18, DOI 10.1016/j.ajem.2017.06.043; McHugh RK, 2018, CLIN PSYCHOL REV, V66, P12, DOI 10.1016/j.cpr.2017.10.012; McLellan AT, 2006, AM J ADDICTION, V15, P113, DOI 10.1080/10550490500528316; Milivojevic V, 2014, HUM PSYCHOPHARM CLIN, V29, P589, DOI 10.1002/hup.2446; Minutillo Adele, 2016, Ann Ist Super Sanita, V52, P176, DOI 10.4415/ANN_16_02_08; Najavits LM, 2008, DRUG ALCOHOL DEPEN, V97, P190, DOI 10.1016/j.drugalcdep.2008.04.012; Narvaez JCM, 2014, COMPR PSYCHIAT, V55, P1369, DOI 10.1016/j.comppsych.2014.04.021; Padyab M, 2018, J DUAL DIAGN, V14, P187, DOI 10.1080/15504263.2018.1466086; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pedraz M, 2015, FRONT PSYCHIATRY, V6, DOI [10.3389/fmicb.2015.00449, 10.3389/fpsyt.2015.00017]; PIAZZA NJ, 1989, INT J ADDICT, V24, P19, DOI 10.3109/10826088909047272; Pinsky I, 2018, REV BRAS PSIQUIATR, V40, P320, DOI 10.1590/1516-4446-2017-2235; Pope SK, 2011, AM J DRUG ALCOHOL AB, V37, P491, DOI 10.3109/00952990.2011.600380; Quinones-Jenab V, 2012, ILAR J, V53, P14, DOI 10.1093/ilar.53.1.14; Scheidell JD, 2018, ADDICTION, V113, P44, DOI 10.1111/add.13921; SCHEIN S, 2013, PROBLEMS PSYCHOL 21, V6, P55; Thompson MP, 2004, AM J PUBLIC HEALTH, V94, P599, DOI 10.2105/AJPH.94.4.599; UNODOC, 2016, WORLD DRUG REP; Vergara-Moragues E, 2012, PSYCHIAT RES, V200, P734, DOI 10.1016/j.psychres.2012.07.043; Viola TW, 2016, CHILD ABUSE NEGLECT, V51, P1, DOI 10.1016/j.chiabu.2015.11.019; Viola TW, 2014, J PSYCHIATR NEUROSCI, V39, P206, DOI 10.1503/jpn.130027; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Vsevolozhskaya OA, 2016, NEUROPSYCHOPHARMACOL, V41, P869, DOI 10.1038/npp.2015.213; Wilson HW, 2009, J YOUTH ADOLESCENCE, V38, P340, DOI 10.1007/s10964-008-9331-6	64	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218334	10.1371/journal.pone.0218334	http://dx.doi.org/10.1371/journal.pone.0218334			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PT	31226126	Green Published, gold, Green Submitted			2022-12-26	WOS:000484894700013
J	Schwarz, GM; Hirtler, L				Schwarz, Gilbert M.; Hirtler, Lena			Ectopic tendons of the pectoralis minor muscle as cause for shoulder pain and motion inhibition-Explaining clinically important variabilities through phylogenesis	PLOS ONE			English	Article							ROTATOR INTERVAL; INSERTION; ANATOMY	OJECTIVE Clinical consequences of ectopic tendons of the pectoralis minor muscle (PMM) for shoulder pain and range-of-motion limitation have been demonstrated. For better understanding the existence of such ectopic tendons, a phylogenetic hypothesis is proposed. METHODS Forty-five shoulders of anatomical specimens were dissected and examined. Insertions areas of PMM were measured and occurring aberrant tendons were identified. Their relationship with the coracohumeral ligament (CHL) described and samples of the ligament were collected and histologically stained. RESULTS The prevalence of PMM variations was 37.84%. Shoulders with variations showed a statistically significant smaller coracopectoral distance (p<0.001) and larger insertion areas (p<0.003) than shoulders without. A strong negative correlation between these two variables (p<0.001, r = -0.620) was shown. CONCLUSIONS The presented results prompted the conclusion that the CHL may be in fact the remnant of the pectoralis minor tendon (PMT), which migrated from the humerus to the coracoid process through the process of phylogenetic evolution. Variations of PMTs are significantly more common than in previous studies. Imaging techniques appear to be insufficiently sensitive for reliably detecting ectopic tendons. Especially in patients experiencing shoulder pain and stiffness in whom the commoner pathologies have been ruled out the possibility of ectopic PMT should be kept in mind and ruled out.	[Schwarz, Gilbert M.] Med Univ Vienna, Dept Orthoped & Trauma Surg, Vienna, Austria; [Hirtler, Lena] Med Univ Vienna, Div Anat, Ctr Anat & Cell Biol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Hirtler, L (corresponding author), Med Univ Vienna, Div Anat, Ctr Anat & Cell Biol, Vienna, Austria.	lena.hirtler@meduniwien.ac.at	Hirtler, Lena/ABH-6385-2020	Hirtler, Lena/0000-0001-5194-9118; Schwarz, Gilbert Manuel/0000-0001-6434-0520				Bland Sutton J, 1887, LIGAMENTS THEIR NATU; Burkhart SS, 2003, ARTHROSCOPY, V19, P641, DOI 10.1016/S0749-8063(03)00389-X; Cooper D E, 1993, J Shoulder Elbow Surg, V2, P70, DOI 10.1016/1058-2746(93)90003-Y; Diogo R, 2013, BIOL REV, V88, P988, DOI 10.1111/brv.12039; Dumontier C, 1999, J SHOULDER ELB SURG, V8, P130, DOI 10.1016/S1058-2746(99)90005-8; EDELSON JG, 1991, J BONE JOINT SURG BR, V73, P150, DOI 10.1302/0301-620X.73B1.1991752; Fang-Dschau, 1937, Z F MORPHOL ANTHR, VXXXVII, P119; Goldman E., 2016, Morphologie, V100, P41, DOI 10.1016/j.morpho.2015.09.049; Higgins MA, 2012, SHOULDER ELBOW, V4, P117, DOI DOI 10.1111/j.1758-5740.2011.00168.x; Homsi C, 2003, J RADIOL, V84, P1007; Jost B, 2000, J SHOULDER ELB SURG, V9, P336, DOI 10.1067/mse.2000.106746; Kolts I, 2000, ANN ANAT, V182, P563, DOI 10.1016/S0940-9602(00)80105-3; Krause KFT, 1843, HDB MENSCHLICHEN ANA; Lambert AE, 1925, ANAT REC, V31, P193, DOI 10.1002/ar.1090310303; Lander KF, 1918, J ANAT, V52, P292; Le Double AF., 1897, TRAITE VARIATIONS SY; Lee CB, 2014, KOREAN J RADIOL, V15, P764, DOI 10.3348/kjr.2014.15.6.764; Lee SJ, 2010, SKELETAL RADIOL, V39, P1205, DOI 10.1007/s00256-010-0926-0; Leijnse JNAL, 1997, ACTA ANAT, V160, P62; Lim TK, 2015, J SHOULDER ELB SURG, V24, P848, DOI 10.1016/j.jse.2015.03.003; Moineau G, 2008, KNEE SURG SPORT TR A, V16, P869, DOI 10.1007/s00167-008-0535-9; NEER CS, 1992, CLIN ORTHOP RELAT R, P182; Rouviere H, 2002, ANATOMIE HUMAINE DES; Testut L., 1884, ANOMALIES MUSCULAIRE, DOI 10.5962/bhl.title.26341; Tubbs RS, 2005, CLIN ANAT, V18, P302, DOI 10.1002/ca.20113; Yang HF, 2009, J SHOULDER ELB SURG, V18, P305, DOI 10.1016/j.jse.2008.07.012	26	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2019	14	6							e0218715	10.1371/journal.pone.0218715	http://dx.doi.org/10.1371/journal.pone.0218715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PT	31226146	gold, Green Published, Green Submitted			2022-12-26	WOS:000484894700035
J	Sharp, JW; Hippe, DS; Nakigudde, G; Anderson, BO; Muyinda, Z; Molina, Y; Scheel, JR				Sharp, Jake W.; Hippe, Daniel S.; Nakigudde, Gertrude; Anderson, Benjamin O.; Muyinda, Zeridah; Molina, Yamile; Scheel, John R.			Modifiable patient-related barriers and their association with breast cancer detection practices among Ugandan women without a diagnosis of breast cancer	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HEALTH; ADAPTATION; SCALE; STAGE; RELIABILITY; BEHAVIORS; VALIDITY; OUTCOMES; BELIEFS	Most women with breast cancer in sub-Saharan Africa (SSA) are diagnosed with late-staged disease. The current study assesses patient-related barriers among women from a general SSA population to better understand how patient-related barriers contribute to diagnostic delays. Using convenience-based sampling, 401 Ugandan women without breast cancer were surveyed to determine how prior participation in cancer detection practices correlate with patient-related barriers to prompt diagnosis. In a predominantly poor (76%) and rural population (75%), the median age of the participants was 38. Of the women surveyed, 155 (46%) had prior exposure to breast cancer education, 92 (27%) performed breast self-examination (BSE) and 68 (20%) had undergone a recent clinical breast examination (CBE), breast ultrasound or breast biopsy. The most commonly identified barriers to prompt diagnosis were knowledge deficits regarding early diagnosis (79%), economic barriers to accessing care (68%), fear (37%) and poor social support (24%). However, only women who reported knowledge deficits-a modifiable barrier-were less likely to participate in cancer detection practices (p<0.05). Women in urban and rural areas were similarly likely to report economic barriers, knowledge deficits and/or poor social support, but rural women were less likely than urban women to have received breast cancer education and/or perform BSE (p<0.001). Women who have had prior breast cancer education (p<0.001) and/or who perform BSE (p = 0.02) were more likely to know where she can go to receive a diagnostic breast evaluation. These findings suggest that SSA countries developing early breast cancer detection programs should specifically address modifiable knowledge deficits among women less likely to achieve a diagnostic work-up to reduce diagnostic delays and improve breast cancer outcomes.	[Sharp, Jake W.; Hippe, Daniel S.; Scheel, John R.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Nakigudde, Gertrude] Uganda Womens Canc Support Org UWOCASO, Kampala, Uganda; [Anderson, Benjamin O.; Scheel, John R.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Anderson, Benjamin O.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Anderson, Benjamin O.; Scheel, John R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Muyinda, Zeridah] Mulago Hosp, Dept Radiol, Kampala, Uganda; [Molina, Yamile] Univ Illinois, Sch Publ Hlth, Community Hlth Sci Div, Chicago, IL USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mulago National Referral Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Scheel, JR (corresponding author), Univ Washington, Dept Radiol, Seattle, WA 98195 USA.; Scheel, JR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Scheel, JR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	jrs4yg@uw.edu	; Anderson, Benjamin/H-2544-2016	Scheel, John/0000-0002-0998-0098; Hippe, Daniel/0000-0003-2427-4404; Anderson, Benjamin/0000-0001-7217-7428	Radiological Society of North America; National Cancer Institute [K01CA193918]; University of Illinois Cancer Center; University of Illinois Center for Research on Women and Gender; Susan G. Komen Leadership Grant [SAC170082]; NATIONAL CANCER INSTITUTE [K01CA193918] Funding Source: NIH RePORTER	Radiological Society of North America; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Illinois Cancer Center; University of Illinois Center for Research on Women and Gender; Susan G. Komen Leadership Grant(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by The Radiological Society of North America to JRS, the National Cancer Institute grant K01CA193918 to YM, and the University of Illinois Cancer Center and Center for Research on Women and Gender to YM. Dr. Anderson received funding through the Susan G. Komen Leadership Grant SAC170082. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, WHY IS VULNERABILITY; Borrayo EA, 2009, J HEALTH PSYCHOL, V14, P944, DOI 10.1177/1359105309341203; Champion VL, 1999, RES NURS HEALTH, V22, P341, DOI 10.1002/(SICI)1098-240X(199908)22:4<341::AID-NUR8>3.0.CO;2-P; Elsie KM, 2010, PAN AFR MED J, V5; Force SPT, 2002, PHAS 1 REP VULN ASS; Gakwaya A, 2008, BRIT J CANCER, V99, P63, DOI 10.1038/sj.bjc.6604435; Gakwaya A, 2008, AFR HEALTH SCI, V8, P126; Galukande M, 2010, AFR HEALTH SCI, V10, P89; Galukande M, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0632-4; Galukande Moses, 2014, Br J Med Med Res, V4, P2599; Gozum S, 2004, CANCER NURS, V27, P491; Huaman MA, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-54; Jedy-Agba E, 2016, LANCET GLOB HEALTH, V4, pE923, DOI 10.1016/s2214-109x(16)30259-5; Kohler RE, 2017, PATIENT EDUC COUNS, V100, P167, DOI 10.1016/j.pec.2016.08.012; Koon KP, 2013, BREAST, V22, P138, DOI 10.1016/j.breast.2012.12.017; Lopez-McKee Gloria, 2011, Online J Issues Nurs, V16, P9; Matovu A, 2016, JGR, V2, P1, DOI [10.7191/jgr.2016.1021, DOI 10.7191/JGR.2016.1021]; McKenzie F, 2018, INT J CANCER, V142, P1568, DOI 10.1002/ijc.31187; Medina-Shepherd R, 2010, CANCER NURS, V33, P93, DOI 10.1097/NCC.0b013e3181c75d7b; Mikhail BI, 2001, J NURS SCHOLARSHIP, V33, P159, DOI 10.1111/j.1547-5069.2001.00159.x; Odongo J, 2015, BMC Res Notes, V8, P467, DOI 10.1186/s13104-015-1438-8; Scheel J, 2016, BREAST CANC UGANDA D; Scheel JR, 2019, ONCOLOGIST, V24, P624, DOI 10.1634/theoncologist.2017-0553; Scheel JR, 2018, CURR BREAST CANCER R, V10, P142, DOI 10.1007/s12609-018-0278-7; Scheel JR, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.2016.008748; Scheel JR, 2017, J GLOB ONCOL, V3, P105, DOI 10.1200/JGO.2015.001198; Sharma K, 2012, J ONCOL, V2012, P2012; Suarez-Perez E, 1998, P R Health Sci J, V17, P365; Taymoori P, 2009, CANCER NURS, V32, P465, DOI 10.1097/NCC.0b013e3181aaf124; Ugandan Ministry of Health, 2008, ACC US MED HOUS UG; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68; World Bank, 2016, UG POV ASS 2016 FACT; Wu TY, 2003, CANCER NURS, V26, P131, DOI 10.1097/00002820-200304000-00007; Yip CH, 2008, CANCER-AM CANCER SOC, V113, P2244, DOI 10.1002/cncr.23842	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0217938	10.1371/journal.pone.0217938	http://dx.doi.org/10.1371/journal.pone.0217938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3PH	31220096	Green Published, Green Submitted, gold			2022-12-26	WOS:000484893500017
J	Vashi, PG; Gorsuch, K; Wan, L; Hill, D; Block, C; Gupta, D				Vashi, Pankaj G.; Gorsuch, Kimberly; Wan, Li; Hill, Danielle; Block, Christel; Gupta, Digant			Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; NUTRITIONAL-STATUS; CURATIVE RESECTION; PROGNOSIS TOOL; SOLID TUMORS; PREVALENCE; IMPACT; COMPLICATIONS; VALIDITY	Background Sarcopenia, the presence of skeletal muscle mass depletion, can be objectively quantified, whereas subjective global assessment (SGA) is a widely utilized subjective instrument to assess nutritional status. Both the presence of sarcopenia and SGA-assessed malnutrition, in isolation, have been shown to be associated with worse overall survival in a wide range of cancers. However, there is no research evaluating the independent prognostic significance of both the presence of sarcopenia and malnutrition as part of the same analysis. We investigated the impact of sarcopenia on overall survival in colorectal cancer specifically controlling for malnutrition. Methods We examined a consecutive case series of 112 patients with colorectal cancer first seen at our institution between August 2012 and October 2017. Using computed tomography (CT) imaging, the cross-sectional area of muscles at the L3 vertebral level was measured and then divided by height squared to calculate skeletal muscle index (SMI). Sarcopenia was defined as SMI <= 38.5 cm(2)/m(2) for women and <= 52.4 cm(2)/m(2) for men. SGA assessments were completed within 2 weeks of CT imaging. The association of sarcopenia and malnutrition with overall survival was assessed using univariate and multivariate Cox regression analysis. Results Median age at presentation was 53.3 years. Sixty-six (58.9%) patients had metastatic disease at diagnosis. Using SMI, 46 (41.1%) patients were sarcopenic, while 66 (58.9%) were non-sarcopenic. Using SGA, 69 (61.6%) patients were assessed as well-nourished, while 43 (38.4%) were malnourished. Of 69 patients classified as well-nourished by SGA, 22 (31.9%) were sarcopenic. Similarly, of 43 patients categorized as malnourished by SGA, 19 (44.2%) were non-sarcopenic. On multivariate analysis, after adjusting for age, gender, tumor stage, BMI, treatment history and SGA, patients with sarcopenia had 3 times greater risk of mortality compared to those without sarcopenia (p = 0.001). The median survival of patients with both sarcopenia and malnutrition (n = 24) was 14.6 months (95% CI: 10.5 to 18.6) compared to the median survival of 25.9 months (95% CI: 7.8 to 44.0) in patients who were either sarcopenic or malnourished but not both (n = 41; p = 0.001). The median survival of patients who were non-sarcopenic and well nourished (n = 48; p = 0.001) was 38.6 months (95% CI: 25.6 to 51.6). Conclusions The exploratory study suggests that presence of sarcopenia supersedes the presence of malnutrition as a predictor of survival in colorectal cancer. Co-existence of sarcopenia and malnutrition is associated with worse survival in colorectal cancer compared to just one of those conditions being present. Prospective studies with large sample sizes are needed to confirm these findings.	[Vashi, Pankaj G.; Gorsuch, Kimberly; Wan, Li; Hill, Danielle; Block, Christel; Gupta, Digant] Midwestern Reg Med Ctr, CTCA, Zion, IL 60099 USA		Vashi, PG (corresponding author), Midwestern Reg Med Ctr, CTCA, Zion, IL 60099 USA.	pankaj.vashi@ctca-hope.com	GUPTA, DIGANT/ABA-9729-2020	GUPTA, DIGANT/0000-0002-1963-8886				Barao K, 2017, NUTR CLIN PRACT, V32, P658, DOI 10.1177/0884533617706894; Besley D., 2004, REGRESSION DIAGNOSTI; Boer BC, 2016, INT J COLORECTAL DIS, V31, P1117, DOI 10.1007/s00384-016-2538-1; Boutin RD, 2015, AM J ROENTGENOL, V205, pW255, DOI 10.2214/AJR.15.14635; Carvalho CS, 2017, ANN PALLIAT MED, V6, pS4, DOI 10.21037/apm.2017.03.03; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Deng CY, 2018, AM J ROENTGENOL, V210, P526, DOI 10.2214/AJR.17.18020; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Dolan RD, 2018, J CACHEXIA SARCOPENI, DOI [10.1002/jcsm.12357.:10, DOI 10.1002/JCSM.12357.:10]; Duerksen DR, 2000, NUTRITION, V16, P740, DOI 10.1016/S0899-9007(00)00398-1; Ek AC, 1996, SCAND J CARING SCI, V10, P163, DOI 10.1111/j.1471-6712.1996.tb00330.x; ENIA G, 1993, NEPHROL DIAL TRANSPL, V8, P1094; Feliciano EC, 2018, P NUTR SOC, V77, P382, DOI [10.1017/S0029665118000423, 10.1017/s0029665118000423]; Feliciano EMC, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2319; Fukushima H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115895; Go SI, 2016, SUPPORT CARE CANCER, V24, P2075, DOI 10.1007/s00520-015-2997-x; Gupta D, 2005, EUR J CLIN NUTR, V59, P35, DOI 10.1038/sj.ejcn.1602029; Gupta D, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-5; Joglekar S, 2015, J SURG ONCOL, V112, P503, DOI 10.1002/jso.24025; Jones CH, 1997, NEPHROL DIAL TRANSPL, V12, P1406, DOI 10.1093/ndt/12.7.1406; Kim HS, 2017, NUTRITION, V36, P67, DOI 10.1016/j.nut.2016.06.009; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Miyamoto Y, 2015, ANN SURG ONCOL, V22, P2663, DOI 10.1245/s10434-014-4281-6; Miyamoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129742; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Psutka SP, 2014, CANCER-AM CANCER SOC, V120, P2910, DOI 10.1002/cncr.28798; Richards CH, 2010, BRIT J CANCER, V103, P1356, DOI 10.1038/sj.bjc.6605919; Rodrigues CS, 2015, NUTRITION, V31, P1372, DOI 10.1016/j.nut.2015.06.001; Roxburgh CSD, 2011, ANN SURG ONCOL, V18, P997, DOI 10.1245/s10434-010-1410-8; Sacks GS, 2000, J AM COLL NUTR, V19, P570, DOI 10.1080/07315724.2000.10718954; Shachar SS, 2016, EUR J CANCER, V57, P58, DOI 10.1016/j.ejca.2015.12.030; Sheean PM, 2014, JPEN-PARENTER ENTER, V38, P873, DOI 10.1177/0148607113500308; Sun G, 2018, INT J COLORECTAL DIS, P10; Takeda Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195406; Tan CSY, 2015, SUPPORT CARE CANCER, V23, P385, DOI 10.1007/s00520-014-2385-y; Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495; Thoresen L, 2002, PALLIATIVE MED, V16, P33, DOI 10.1191/0269216302pm486oa	39	17	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2019	14	6							e0218761	10.1371/journal.pone.0218761	http://dx.doi.org/10.1371/journal.pone.0218761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3PH	31220163	Green Published, gold, Green Submitted			2022-12-26	WOS:000484893500088
J	Bravo-Navas, S; Yanez, L; Romon, I; Pipaon, C				Bravo-Navas, Sara; Yanez, Lucrecia; Romon, Inigo; Pipaon, Carlos			Elevated FANCA expression determines a worse prognosis in chronic lymphocytic leukemia and interferes with p53 function	FASEB JOURNAL			English	Article						CLL; ATM; NEDD8; NUB1L	BULKY LYMPHADENOPATHY; COMPLEX KARYOTYPE; CELL-CYCLE; ANEMIA; PATHWAY; PROTEIN; NEDD8; GENE; DISRUPTION; RESISTANCE	Chronic lymphocytic leukemia (CLL) is characterized by a failure in the mechanisms of apoptosis that leads to an accumulation of mature B cells in peripheral blood, bone marrow, and lymphoid organs. The molecular basis of CLL remains unknown. Certain cytogenetic and molecular markers determine a bad prognosis in CLL. Fanconi anemia complementation (FANC) proteins have been related to chromosomal instability and alterations in the mechanisms of p53 activation, control of cell cycle, and apoptosis. We investigated the role of certain FANC proteins in CLL. Our data identified a group of patients with CLL with high expression of FANCA in peripheral B-CLL cells and we established its relationship with the deletion of 11q23 and a worse prognosis. When we investigated the molecular mechanisms of this bad prognosis, we observed a reduction in the expression of 2 p53 target genes, p21 and increment Np73, in CLL primary cells transfected with FANCA. Functional studies demonstrated an impairment of p53 by FANCA. Moreover, we obtained evidence of a cooperation between FANCA and the NEDD8-interacting protein NUB1L in the destabilization of p53. For the first time, FANCA is reported as a bad prognosis marker by a mechanism other than its role in the Fanconi anemia-breast cancer DNA repair pathway.-Bravo-Navas, S., Yanez, L., Romon, i., Pipaon, C. Elevated FANCA expression determines a worse prognosis in chronic lymphocytic leukemia and interferes with p53 function.	[Bravo-Navas, Sara; Yanez, Lucrecia; Romon, Inigo; Pipaon, Carlos] Hosp Marques Valdecilla, Inst Invest Marques Valdecilla IDIVAL, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV)	Pipaon, C (corresponding author), Hosp Marques Valdecilla, Lab Hematol Mol HEMMOL, Pabellon 20,Avda Valdecilla S-N, Santander 39008, Spain.	carlos.pipaon@scsalud.es	Pipaon, Carlos/L-4922-2014; Yáñez San Segundo, Lucrecia/G-4662-2016; Romón, Iñigo/M-3497-2019	Pipaon, Carlos/0000-0002-3851-6710; Yáñez San Segundo, Lucrecia/0000-0001-9925-3048; Romón, Iñigo/0000-0003-2428-4469; Bravo Navas, Sara/0000-0002-7166-0191	Instituto de Salud Carlos III [PI17/01688]; European Development Regional Fund (FEDER)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Development Regional Fund (FEDER)	This work has been funded by Project PI17/01688 from the Instituto de Salud Carlos III, cofinanced by the European Development Regional Fund (FEDER). S.B.-N. was supported with funds obtained by L.Y. from clinical trials. pCMV-Tag2B-NUB1L was a kind gift of Dr. Hong-Yu Hu (Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China). MDM2 expression plasmid was a kind gift of Dr. Dimitris Xirodimas [Montpellier Cell Biology Research Center (CRBM), Montpellier, France]. The authors declare no conflicts of interest.	Bonacci T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169988; Buggins AGS, 2010, LEUKEMIA RES, V34, P837, DOI 10.1016/j.leukres.2010.03.011; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; Dickinson JD, 2006, LEUKEMIA LYMPHOMA, V47, P231, DOI 10.1080/10428190500254141; DUTRILLAUX B, 1982, HUM GENET, V62, P327, DOI 10.1007/BF00304549; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Molina-Estevez FJ, 2015, CURR GENE THER, V15, P550, DOI 10.2174/1566523215666150929110903; Joshi AD, 2007, CANCER GENET CYTOGEN, V172, P120, DOI 10.1016/j.cancergencyto.2006.07.010; Kao WH, 2011, J INVEST DERMATOL, V131, P2139, DOI 10.1038/jid.2011.181; Kipps TJ, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2016.96, 10.1038/nrdp.2017.8]; Liu G, 2010, ONCOGENE, V29, P2252, DOI 10.1038/onc.2009.494; Liu S, 2013, J BIOL CHEM, V288, P31339, DOI 10.1074/jbc.M113.484816; Liu ZM, 2011, MOL CANCER RES, V9, P507, DOI 10.1158/1541-7786.MCR-10-0559; Lyakhovich A, 2006, CANCER LETT, V232, P99, DOI 10.1016/j.canlet.2005.07.038; Pipaon C, 2005, FEBS LETT, V579, P4610, DOI 10.1016/j.febslet.2005.07.026; Poot M, 1996, EXP CELL RES, V222, P262, DOI 10.1006/excr.1996.0033; Reuter TY, 2003, EXP CELL RES, V289, P211, DOI 10.1016/S0014-4827(03)00261-1; Rigolin GM, 2017, BLOOD, V129, P3495, DOI 10.1182/blood-2017-03-772285; Rossi D, 2017, LEUKEMIA LYMPHOMA, V58, P1548, DOI 10.1080/10428194.2016.1250264; Sanchez-Carrera D, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150039; Sanz L, 2004, BIOCHEM BIOPH RES CO, V315, P562, DOI 10.1016/j.bbrc.2004.01.095; Soulier J, 2011, HEMATOL-AM SOC HEMAT, P492, DOI 10.1182/asheducation-2011.1.492; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Thompson PA, 2015, CANCER-AM CANCER SOC, V121, P3612, DOI 10.1002/cncr.29566; Valeri A, 2011, CLIN TRANSL ONCOL, V13, P215, DOI 10.1007/s12094-011-0645-6; van de Vrugt HJ, 2000, MAMM GENOME, V11, P326, DOI 10.1007/s003350010060; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Zenz T, 2008, BLOOD, V112, P3322, DOI 10.1182/blood-2008-04-154070; Zhu HJ, 2013, LEUKEMIA LYMPHOMA, V54, P2712, DOI 10.3109/10428194.2013.787613	35	4	4	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10477	10489		10.1096/fj.201802439RR	http://dx.doi.org/10.1096/fj.201802439RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31251079	Bronze			2022-12-26	WOS:000482214200060
J	Kang, LH; Zou, X; Zhang, GW; Xiang, J; Wang, Y; Yang, M; Chen, X; Wu, J; Guan, HJ				Kang, Lihua; Zou, Xi; Zhang, Guowei; Xiang, Jing; Wang, Yong; Yang, Mei; Chen, Xiang; Wu, Jian; Guan, Huaijin			A variant in a microRNA binding site in NEIL2 3 ' UTR confers susceptibility to age-related cataracts	FASEB JOURNAL			English	Article						ARC; DNA repair; BER pathway; SNP; hsa-miR-3912-5p	DNA-REPAIR GENES; BASE-EXCISION-REPAIR; LENS EPITHELIAL-CELLS; SINGLE NUCLEOTIDE POLYMORPHISMS; PERIPHERAL LYMPHOCYTES; MACULAR DEGENERATION; SENILE CATARACT; DAMAGE; RISK; APE1	DNA damage in lens cells is considered a critical trigger for the onset of age-related cataracts (ARCs). Among DNA repair pathways, the base excision repair (BER) pathway is responsible for mending single-strand breaks in DNA. In this case-control study with 993 ARC cases and 993 healthy controls, we genotyped 9 single-nucleotide polymorphisms (SNPs) within microRNA (miRNA) regions of 6 BER pathway genes and examined their associations with ARC susceptibility. We identified rs4639:T > C in the Nei-like DNA glycosylase 2 (NEIL2) gene as significantly associated with ARCs. Individuals carrying different rs4639 alleles had distinct NEIL2 expression in lens capsule tissues from ARC cases and controls. Bioinformatics predicts that the rs4639 T allele could disrupt hsa-miR-3912-5p binding. The results of the luciferase reporter assay were in concordance with this prediction. This study has added more evidence that SNP-modified posttranscriptional gene regulation by miRNA might be a potential pathogenic mechanism of ARCs. SNPs potentially affecting miRNA binding to the 3 ' UTR of BER pathway genes could contribute to discrepant disease susceptibility. NEIL2-rs4639T was strongly associated with a protective role in ARCs. This protective role might be fulfilled by maintaining normal expression of NEIL2 in the mediation of disrupted binding of rs4639T with hsa-miR-3912-5p. A further study to generate model systems (cell lines or animal models) with NEIL2 variants is warranted. The results provide 2 molecular targets (e.g., NEIL2 and hsa-miR-3912-5p) for intervention strategies of ARC in the future.-Kang, L., Zou, X., Zhang, G., Xiang, J., Wang, Y., Yang, M., Chen, X., Wu, J., Guan, H. A variant in a microRNA binding site in NEIL2 3 ' UTR confers susceptibility to age-related cataract.	[Kang, Lihua; Zou, Xi; Zhang, Guowei; Xiang, Jing; Wang, Yong; Yang, Mei; Wu, Jian; Guan, Huaijin] Nantong Univ, Affiliated Hosp, Eye Inst, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China; [Zou, Xi] Third Peoples Hosp Changzhou, Changzhou, Peoples R China; [Chen, Xiang] Nantong Univ, Affiliated Hosp 2, Dept Pathol, Nantong, Peoples R China	Nantong University; Nantong University	Guan, HJ (corresponding author), Nantong Univ, Affiliated Hosp, Eye Inst, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China.	guanhjeye@163.com		Wang, Yong/0000-0003-0989-9764	National Natural Science Foundation of China [81470616, 81770906, 81873676, 81500706]; Science and Technology Project of Nantong, China [YYZ17010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Nantong, China	This study was supported by the National Natural Science Foundation of China (81470616, 81770906, 81873676, and 81500706) and the Science and Technology Project of Nantong, China (YYZ17010). The authors declare no conflicts of interest.	Ates O, 2010, ACTA OPHTHALMOL, V88, P891, DOI 10.1111/j.1755-3768.2009.01583.x; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Butkiewicz D, 2001, CARCINOGENESIS, V22, P593, DOI 10.1093/carcin/22.4.593; Chan N, 2014, MOL CANCER RES, V12, P1407, DOI 10.1158/1541-7786.MCR-14-0246; Chang JR, 2011, OPHTHALMOLOGY, V118, P2113, DOI 10.1016/j.ophtha.2011.03.032; Chi XX, 2015, MOL VIS, V21, P335; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Gu SS, 2016, HUM MUTAT, V37, P1223, DOI 10.1002/humu.23073; Hu JY, 2011, OPHTHAL EPIDEMIOL, V18, P137, DOI 10.3109/09286586.2011.574335; Jiang J, 2013, INVEST OPHTH VIS SCI, V54, P932, DOI 10.1167/iovs.12-10948; Jiang SQ, 2013, AGE, V35, P2435, DOI 10.1007/s11357-013-9512-4; Khairallah M, 2015, INVEST OPHTH VIS SCI, V56, P6762, DOI 10.1167/iovs.15-17201; KLEIMAN NJ, 1993, CURR EYE RES, V12, P423, DOI 10.3109/02713689309024624; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; Knox B, 2018, ENVIRON MOL MUTAGEN, V59, P134, DOI 10.1002/em.22159; Luo MH, 2004, ANTICANCER RES, V24, P2127; Maynard S, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025130; McCarty CA, 2001, INVEST OPHTH VIS SCI, V42, P1677; Rong H, 2017, ONCOTARGET, V8, P84945, DOI 10.18632/oncotarget.17600; Sambandan S, 2017, SCIENCE, V355, P634, DOI 10.1126/science.aaf8995; Shiels A, 2015, PROG MOL BIOL TRANSL, V134, P203, DOI 10.1016/bs.pmbts.2015.05.004; Sorte K, 2011, MOL VIS, V17, P1; Su S, 2013, INVEST OPHTH VIS SCI, V54, P1201, DOI 10.1167/iovs.12-10940; Truscott RJW, 2016, BBA-GEN SUBJECTS, V1860, P192, DOI 10.1016/j.bbagen.2015.08.016; Vymetalkova V, 2017, CARCINOGENESIS, V38, P28, DOI 10.1093/carcin/bgw114; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Wang C, 2015, INT J CLIN EXP PATHO, V8, P16036; Wang Y, 2017, CELL MOL NEUROBIOL, V37, P537, DOI 10.1007/s10571-016-0393-9; Wang Y, 2017, EXP MOL PATHOL, V102, P219, DOI 10.1016/j.yexmp.2017.02.006; Wang Y, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0229-y; Wang Y, 2015, CURR EYE RES, V40, P815, DOI 10.3109/02713683.2014.957778; Wilson DM, 2011, MUTAT RES-FUND MOL M, V711, P100, DOI 10.1016/j.mrfmmm.2010.12.004; Xu BW, 2015, CURR EYE RES, V40, P378, DOI 10.3109/02713683.2014.924148; Yang X, 2010, BRIT J OPHTHALMOL, V94, P1211, DOI 10.1136/bjo.2009.165811; Zhang JF, 2014, OPHTHALMIC RES, V51, P124, DOI 10.1159/000356399; Zhang Y, 2012, OPHTHALMOLOGY, V119, P900, DOI 10.1016/j.ophtha.2011.11.004; Zou X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33071-0	41	8	8	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10469	10476		10.1096/fj.201802291R	http://dx.doi.org/10.1096/fj.201802291R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31253066				2022-12-26	WOS:000482214200059
J	Rathore, M; Girard, C; Ohanna, M; Tichet, M; Ben Jouira, R; Garcia, E; Larbret, F; Gesson, M; Audebert, S; Lacour, JP; Montaudie, H; Prod'Homme, V; Tartare-Deckert, S; Deckert, M				Rathore, M.; Girard, C.; Ohanna, M.; Tichet, M.; Ben Jouira, R.; Garcia, E.; Larbret, F.; Gesson, M.; Audebert, S.; Lacour, J. -P.; Montaudie, H.; Prod'Homme, V.; Tartare-Deckert, S.; Deckert, M.			Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-kappa B signaling pathway	ONCOGENE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; UP-REGULATION; INFLAMMATION; EXPRESSION; RESISTANCE; GROWTH; INHIBITION; PHENOTYPE; INVASION	Cutaneous melanoma is one of the most aggressive cancers characterized by a high plasticity, a propensity for metastasis, and drug resistance. Melanomas are composed of phenotypically diverse subpopulations of tumor cells with heterogeneous molecular profiles that reflect intrinsic invasive abilities. In an attempt to identify novel factors of the melanoma invasive cell state, we previously investigated the nature of the invasive secretome by using a comparative proteomic approach. Here, we have extended this analysis to show that PTX3, an acute phase inflammatory glycoprotein, is one such factor secreted by invasive melanoma to promote tumor cell invasiveness. Elevated PTX3 production was observed in the population of MITFlow invasive cells but not in the population of MITFhigh differentiated melanoma cells. Consistently, MITF knockdown increased PTX3 expression in MITFhigh proliferative and poorly invasive cells. High levels of PTX3 were found in tissues and blood of metastatic melanoma patients, and in BRAF inhibitor-resistant melanoma cells displaying a mesenchymal invasive MITFlow phenotype. Genetic silencing of PTX3 in invasive melanoma cells dramatically impaired migration and invasion in vitro and in experimental lung extravasation assay in xenografted mice. In contrast, addition of melanoma-derived or recombinant PTX3, or expression of PTX3 enhanced motility of low migratory cells. Mechanistically, autocrine production of PTX3 by melanoma cells triggered an IKIC/NF kappa B signaling pathway that promotes migration, invasion, and expression of the EMT factor TWIST1. Finally, we found that TLR4 and MYD88 knockdown inhibited PTX3-induced melanoma cell migration, suggesting that PTX3 functions through a TLR4-dependent pathway. Our work reveals that tumor-derived PTX3 contributes to melanoma cell invasion via targetable inflammation-related pathways. In addition to providing new insights into the biology of melanoma invasive behavior, this study underscores the notion that secreted PTX3 represents a potential biomarker and therapeutic target in a subpopulation of MITFlow invasive and/or refractory melanoma.	[Rathore, M.; Girard, C.; Ohanna, M.; Tichet, M.; Ben Jouira, R.; Garcia, E.; Larbret, F.; Gesson, M.; Prod'Homme, V.; Tartare-Deckert, S.; Deckert, M.] Univ Cote Azur, INSERM, C3M, Nice, France; [Rathore, M.; Girard, C.; Ohanna, M.; Larbret, F.; Prod'Homme, V.; Tartare-Deckert, S.; Deckert, M.] Equipe Labellisee Ligue Canc 2016, Nice, France; [Rathore, M.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Audebert, S.] Aix Marseille Univ, Inst Paoli Calmettes, INSERM, CNRS,CRCM, Marseille, France; [Lacour, J. -P.; Montaudie, H.] Univ Cote Azur, CHU Nice, Nice, France; [Tichet, M.] Ecole Polytech Fed Lausanne, Lab Translat Oncol, ISREC, Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Minnesota System; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Tartare-Deckert, S; Deckert, M (corresponding author), Univ Cote Azur, INSERM, C3M, Nice, France.; Tartare-Deckert, S; Deckert, M (corresponding author), Equipe Labellisee Ligue Canc 2016, Nice, France.	tartare@unice.fr; deckert@unice.fr	Ohanna, Mickael/O-5784-2016; TARTARE-DECKERT, Sophie/P-6057-2015; Prod'homme, Virginie/A-3948-2012; Deckert, Marcel/T-3566-2019; Girard, Christophe/O-8455-2016	Ohanna, Mickael/0000-0002-7751-9164; TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Prod'homme, Virginie/0000-0002-9664-4710; Deckert, Marcel/0000-0003-2094-559X; Girard, Christophe/0000-0002-4560-4479; Audebert, Stephane/0000-0002-9409-2588; Ben Jouira, Rania/0000-0001-6999-4566	Ligue Contre le Cancer; Fondation ARC; Fondation de France; French Government (National Research Agency); (ANR) through the "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; Conseil General des Alpes-Maritimes; Canceropole PACA; Region PACA; IBiSA (Infrastructures Biologie Sante et Agronomie); Institut Paoli-Calmettes	Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation ARC; Fondation de France(Fondation de France); French Government (National Research Agency); (ANR) through the "Investments for the Future" LABEX SIGNALIFE(French National Research Agency (ANR)); Conseil General des Alpes-Maritimes(Region Provence-Alpes-Cote d'Azur); Canceropole PACA(Region Grand-Est); Region PACA(Region Provence-Alpes-Cote d'Azur); IBiSA (Infrastructures Biologie Sante et Agronomie); Institut Paoli-Calmettes	We thank RS Lo and R Ballotti for melanoma cells. We acknowledge the C3M animal and imaging (Microscopy and Imaging platform Cote d'Azur, MICA) facilities. This work was supported by Ligue Contre le Cancer, Fondation ARC, Fondation de France and the French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE: program reference #ANR-11-LABX-0028-01. We also thank financial supports by Conseil General des Alpes-Maritimes, Canceropole PACA and Region PACA. MR was a recipient of a post-doctoral fellowship from Fondation ARC. The Marseille Proteomic facility (MaP; http://map.univmed.fr/) is supported by IBiSA (Infrastructures Biologie Sante et Agronomie), Canceropole PACA, Region PACA, and Institut Paoli-Calmettes.	Ahn JH, 2008, EXP DERMATOL, V17, P412, DOI 10.1111/j.1600-0625.2008.00701.x; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Bottazzi B, 2016, J HEPATOL, V64, P1416, DOI 10.1016/j.jhep.2016.02.029; Bozza S, 2014, J IMMUNOL, V193, P2340, DOI 10.4049/jimmunol.1400814; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carmo RF, 2016, J VIRAL HEPATITIS, V23, P116, DOI 10.1111/jvh.12472; Chan SH, 2017, ONCOTARGET, V8, P41364, DOI 10.18632/oncotarget.17326; Chang WC, 2015, ONCOTARGET, V6, P7741, DOI 10.18632/oncotarget.3482; Cheli Y, 2012, ONCOGENE, V31, P2461, DOI 10.1038/onc.2011.425; Choi B, 2015, ANTICANCER RES, V35, P2663; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Diamandis EP, 2011, CLIN CANCER RES, V17, P2395, DOI 10.1158/1078-0432.CCR-10-3024; Didier R, 2018, MOL CANCER THER, V17, P1416, DOI 10.1158/1535-7163.MCT-17-0919; Eiro N, 2013, ARCH DERMATOL RES, V305, P59, DOI 10.1007/s00403-012-1300-y; Fenouille N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040378; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Garlanda C, 2016, CURR OPIN IMMUNOL, V38, P39, DOI 10.1016/j.coi.2015.11.002; Giacomini A, 2018, BBA-REV CANCER, V1869, P53, DOI 10.1016/j.bbcan.2017.11.004; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Hu FQ, 2014, J BIOL REG HOMEOS AG, V28, P649; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Kondo S, 2013, BRIT J CANCER, V109, P739, DOI 10.1038/bjc.2013.348; Leali D, 2011, MOL CANCER THER, V10, P1600, DOI 10.1158/1535-7163.MCT-11-0286; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Locatelli M, 2013, J NEUROIMMUNOL, V260, P99, DOI 10.1016/j.jneuroim.2013.04.009; Magrini E, 2016, TRENDS MOL MED, V22, P497, DOI 10.1016/j.molmed.2016.04.007; Margheri F, 2009, NEOPLASIA, V11, P1106, DOI 10.1593/neo.09934; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Na YR, 2013, MELANOMA RES, V23, P434, DOI 10.1097/CMR.0000000000000021; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Obenauf AC, 2015, TRENDS CANCER, V1, P76, DOI 10.1016/j.trecan.2015.07.009; Ohanna M, 2018, GENE DEV, V32, P448, DOI 10.1101/gad.305854.117; Ravenna L, 2009, PROSTATE, V69, P1245, DOI 10.1002/pros.20966; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Ronca R, 2015, CANCER CELL, V28, P225, DOI 10.1016/j.ccell.2015.07.002; Ronca R, 2013, MOL CANCER THER, V12, P2760, DOI 10.1158/1535-7163.MCT-13-0487; Ronca R, 2013, J PATHOL, V230, P228, DOI 10.1002/path.4181; Rubino M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1333215; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Shao YP, 2015, J INVEST DERMATOL, V135, P1839, DOI 10.1038/jid.2015.91; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Takazawa Y, 2014, TOHOKU J EXP MED, V234, P57, DOI 10.1620/tjem.234.57; Thomas C, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4674; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Titz B, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.28; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tung JN, 2016, J NEURO-ONCOL, V129, P201, DOI 10.1007/s11060-016-2168-z; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Weiss MB, 2012, CANCER RES, V72, P6382, DOI 10.1158/0008-5472.CAN-12-1033; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Ying TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29385	55	42	44	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2019	38	30					5873	5889		10.1038/s41388-019-0848-9	http://dx.doi.org/10.1038/s41388-019-0848-9			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3FY	31253871	Green Published			2022-12-26	WOS:000482739300003
J	Bianco, M; Lopes, JA; Beiral, HJV; Filho, JDD; Frankenfeld, SP; Fortunato, RS; Gattass, CR; Vieyra, A; Takiya, CM				Bianco, Mario; Lopes, Jarlene A.; Beiral, Hellen J. V.; Filho, Joao D. D.; Frankenfeld, Stephan P.; Fortunato, Rodrigo S.; Gattass, Cerli R.; Vieyra, Adalberto; Takiya, Christina M.			The contralateral kidney presents with impaired mitochondrial functions and disrupted redox homeostasis after 14 days of unilateral ureteral obstruction in mice	PLOS ONE			English	Article							OXIDATIVE STRESS; COMPENSATORY HYPERTROPHY; INTERSTITIAL FIBROSIS; ACTIVATION; NRF2; PHOSPHORYLATION; PROTON; OXYGEN; CELLS; HEAT-SHOCK-PROTEIN-70	In unilateral ureteral obstruction ( UUO), both oxidative stress and mitochondrial dysfunction are related to cell death. The aim of this study has been to characterize profiles of enzyme antioxidant activities and mitochondrial functioning of the contralateral ( CL) compared to UUO and Sham ( false-operated) kidneys of Balb/c mice. Kidneys were resected 14 days after obstruction for immunohistochemical and cortical mitochondrial functioning assays. Antioxidant enzymes activities were investigated in mitochondria and cytosol. Oxygen consumption ( QO(2)) and formation of O-2 reactive species ( ROS) were assessed with pyruvate plus malate or succinate as the respiratory substrates. QO(2) decreased in CL and UUO in all states using substrates for complex II, whereas it was affected only in UUO when substrates for complex I were used. Progressive decrease in mitochondrial ROS formation-in the forward and reverse pathway at complex I-correlates well with the inhibition of QO(2) and, therefore, with decreased electron transfer at the level of complexes upstream of cytochrome c oxidase. CL and UUO transmembrane potential responses to ADP were impaired with succinate. Intense Ca2+-induced swelling was elicited in CL and UUO mitochondria. Important and selective differences exist in CL antioxidant enzymes with respect to either Sham or UUO kidneys: CL kidneys had increased mitochondrial glutathione peroxidase and cytosolic catalase activities, indicative of compensatory responses in the face of an early altered ROS homeostasis ( as detected by 4-hydroxynonenal), and of a significant tendency to apoptosis. In CL and UUO, upregulation of nuclear ( erythroid-derived 2)-like 2 transcription factor ( Nrf2), as well as of cytoplasmic and nuclear Kelch-like ECH-associated protein 1 ( Keap1) in opposition to decreased heme oxygenase-1 ( HO-1), suggest impairment of the Nrf2/Keap1/HO-1 system. It is concluded that chronic obstruction impairs mitochondrial function in CL and UUO, preferentially affecting complex II.	[Bianco, Mario; Filho, Joao D. D.] Univ Fed Rio de Janeiro, Ctr Expt Surg, Sch Med, Dept Surg,Postgrad Program Surg Sci, Rio De Janeiro, Brazil; [Lopes, Jarlene A.; Beiral, Hellen J. V.; Frankenfeld, Stephan P.; Fortunato, Rodrigo S.; Gattass, Cerli R.; Vieyra, Adalberto; Takiya, Christina M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Vieyra, Adalberto] Univ Fed Rio de Janeiro, CENABIO, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil; [Vieyra, Adalberto] Grande Rio Univ, Translat Biomed Program, Duque De Caxias, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Grande Rio	Bianco, M (corresponding author), Univ Fed Rio de Janeiro, Ctr Expt Surg, Sch Med, Dept Surg,Postgrad Program Surg Sci, Rio De Janeiro, Brazil.	biancomario1950@gmail.com	Takiya, Christina/AAU-5959-2021; Fortunato, Rodrigo/AAM-9931-2020; Frankenfeld, Stephan/AAK-4714-2021	Takiya, Christina/0000-0002-8019-628X; Bianco, Mario/0000-0002-0433-8725	Conselho Nacional de Pesquisa (Brazilian National Research Council) [485193/2012-4, 470266/2014-7, 457222/2013-1, 307605/2015-9]; Fundacao de Amparo a Pesquisa (FAPERJ) (Rio de Janeiro Research State Foundation) [E-26-102.283/2013, E-26/010.001283/2015, E-26/202.963/2017]	Conselho Nacional de Pesquisa (Brazilian National Research Council); Fundacao de Amparo a Pesquisa (FAPERJ) (Rio de Janeiro Research State Foundation)	This work was partially supported by the Conselho Nacional de Pesquisa (Brazilian National Research Council), grants no 485193/2012-4 (CMT), 470266/2014-7 (AV), 457222/2013-1 (AV), 307605/2015-9 (AV), and by Fundacao de Amparo a Pesquisa (FAPERJ) (Rio de Janeiro Research State Foundation), grants no E-26-102.283/2013 CMT), E-26/010.001283/2015 (AV), E-26/202.963/2017 (AV). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aminzadeh MA, 2013, NEPHROL DIAL TRANSPL, V28, P2038, DOI 10.1093/ndt/gft022; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Barreira AL, 2009, CELL PHYSIOL BIOCHEM, V24, P585, DOI 10.1159/000257514; Beiral HJV, 2014, CELL TRANSPLANT, V23, P207, DOI 10.3727/096368912X659862; Benipal B, 2011, BIOCHEM PHARMACOL, V81, P295, DOI 10.1016/j.bcp.2010.10.010; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; BOUMENDILPODEVIN EF, 1983, BIOCHIM BIOPHYS ACTA, V735, P86, DOI 10.1016/0005-2736(83)90263-8; CHANCE B, 1955, J BIOL CHEM, V217, P383; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Cheng C, 2003, DIABETES, V52, P2363, DOI 10.2337/diabetes.52.9.2363; CHEVALIER RL, 1990, PEDIATR NEPHROL, V4, P442, DOI 10.1007/BF00862533; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chung SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047299; Coka-Guevara S, 1999, EUR J BIOCHEM, V263, P71, DOI 10.1046/j.1432-1327.1999.00456.x; Crapo J D, 1978, Methods Enzymol, V53, P382; Diaz-Moreno I, 2018, FEBS LETT, V592, P172, DOI 10.1002/1873-3468.12959; DICKER SE, 1972, J PHYSIOL-LONDON, V220, P199, DOI 10.1113/jphysiol.1972.sp009701; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Drahota Z, 2012, J BIOENERG BIOMEMBR, V44, P309, DOI 10.1007/s10863-012-9443-2; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; FINE LG, 1989, ANNU REV PHYSIOL, V51, P19, DOI 10.1146/annurev.ph.51.030189.000315; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gamboa JL, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12780; Garcia-Roche M, 2018, REDOX BIOL, V17, P207, DOI 10.1016/j.redox.2018.03.008; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Goncalves RG, 2006, KIDNEY INT, V70, P1599, DOI 10.1038/sj.ki.5001804; Hall AM, 2007, NEPHRON PHYSIOL, V105, P1, DOI 10.1159/000096860; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Kawada N, 1999, KIDNEY INT, V56, P1004, DOI 10.1046/j.1523-1755.1999.00612.x; Kinter M, 1999, KIDNEY INT, V55, P1327, DOI 10.1046/j.1523-1755.1999.00358.x; KLEIN KL, 1981, KIDNEY INT, V20, P29, DOI 10.1038/ki.1981.100; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kowaltowski AJ, 2002, J BIOL CHEM, V277, P42802, DOI 10.1074/jbc.M207765200; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lin KC, 1998, MOL GENET METAB, V65, P303, DOI 10.1006/mgme.1998.2770; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lustgarten MS, 2012, BIOCHEM BIOPH RES CO, V422, P515, DOI 10.1016/j.bbrc.2012.05.055; MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0; Nishida H, 2014, FREE RADICAL RES, V48, P1115, DOI 10.3109/10715762.2014.915031; Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108; Ricardo SD, 1997, AM J PHYSIOL-RENAL, V272, pF789, DOI 10.1152/ajprenal.1997.272.6.F789; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Tosi MER, 2011, CELL STRESS CHAPERON, V16, P57, DOI 10.1007/s12192-010-0221-y; Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647; Shen Y, 2016, ACTA PHARMACOL SIN, V37, P637, DOI 10.1038/aps.2016.12; Sun Y, 2016, AM J PHYSIOL-RENAL, V311, pF777, DOI 10.1152/ajprenal.00215.2015; Taner T, 2015, TRANSPLANTATION, V99, P555, DOI 10.1097/TP.0000000000000356; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; VIEYRA A, 1986, J BIOL CHEM, V261, P4247; Westland R, 2014, CLIN J AM SOC NEPHRO, V9, P978, DOI 10.2215/CJN.08900813; WHITTEMB.G, 1970, PFLUG ARCH EUR J PHY, V316, P1, DOI 10.1007/BF00587893; Yeh CH, 2011, NEUROUROL URODYNAM, V30, P472, DOI 10.1002/nau.20855	62	10	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0218986	10.1371/journal.pone.0218986	http://dx.doi.org/10.1371/journal.pone.0218986			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251767	Green Published, Green Submitted, gold			2022-12-26	WOS:000484915000031
J	Hellsberg, E; Ecker, GF; Stary-Weinzinger, A; Forrest, LR				Hellsberg, Eva; Ecker, Gerhard F.; Stary-Weinzinger, Anna; Forrest, Lucy R.			A structural model of the human serotonin transporter in an outward-occluded state	PLOS ONE			English	Article							GENERAL FORCE-FIELD; X-RAY STRUCTURES; ANTIDEPRESSANT BINDING-SITE; DOPAMINE TRANSPORTER; DIVERSE ANTIDEPRESSANTS; MONOAMINE TRANSPORTERS; TRANSMEMBRANE DOMAIN; STRUCTURE VALIDATION; ALTERNATING ACCESS; BACTERIAL HOMOLOG	The human serotonin transporter hSERT facilitates the reuptake of its endogenous substrate serotonin from the synaptic cleft into presynaptic neurons after signaling. Reuptake regulates the availability of this neurotransmitter and therefore hSERT plays an important role in balancing human mood conditions. In 2016, the first 3D structures of this membrane transporter were reported in an inhibitor-bound, outward-open conformation. These structures revealed valuable information about interactions of hSERT with antidepressant drugs. Nevertheless, the question remains how serotonin facilitates the specific conformational changes that open and close pathways from the synapse and to the cytoplasm as required for transport. Here, we present a serotonin-bound homology model of hSERT in an outward-occluded state, a key intermediate in the physiological cycle, in which the interactions with the substrate are likely to be optimal. Our approach uses two template structures and includes careful refinement and comprehensive computational validation. According to microsecond-long molecular dynamics simulations, this model exhibits interactions between the gating residues in the extracellular pathway, and these interactions differ from those in an outward-open conformation of hSERT bound to serotonin. Moreover, we predict several features of this state by monitoring the intracellular gating residues, the extent of hydration, and, most importantly, protein-ligand interactions in the central binding site. The results illustrate common and distinct characteristics of these two transporter states and provide a starting point for future investigations of the transport mechanism in hSERT.	[Hellsberg, Eva; Ecker, Gerhard F.] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria; [Stary-Weinzinger, Anna] Univ Vienna, Dept Pharmacol & Toxicol, Vienna, Austria; [Forrest, Lucy R.] NINDS, Computat Struct Biol Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	University of Vienna; University of Vienna; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Forrest, LR (corresponding author), NINDS, Computat Struct Biol Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	lucy.forrest@nih.gov	Stary-Weinzinger, Anna/A-3629-2014; Forrest, Lucy/E-8113-2016	Stary-Weinzinger, Anna/0000-0002-9202-0484; Forrest, Lucy/0000-0003-1855-7985; Hellsberg, Eva/0000-0001-9913-978X	Austrian Science Fund [W1232]; Division of Intramural Research of the NIH, National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003139] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); Division of Intramural Research of the NIH, National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Austrian Science Fund, grant W1232, https://www.fwf.ac.at/en/ (to EH), and by the Division of Intramural Research of the NIH, National Institute of Neurological Disorders and Stroke, https://www.ninds.nih.gov/ (to LRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aktories K., 2013, ALLGEMEINE SPEZIELLE, P132; Anderluh A, 2014, J BIOL CHEM, V289, P4387, DOI 10.1074/jbc.M113.531632; Andersen J, 2016, ACS CHEM NEUROSCI, V7, P1406, DOI 10.1021/acschemneuro.6b00164; Andersen J, 2015, ACS CHEM NEUROSCI, V6, P1892, DOI 10.1021/acschemneuro.5b00225; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; [Anonymous], 2017, SCHROD REL 2017 4 SC; [Anonymous], 2017, SCHROD REL 2017 4 LI; [Anonymous], 2017, SCHROD REL 2017 4 MA; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Billesbolle CB, 2015, J BIOL CHEM, V290, P26725, DOI 10.1074/jbc.M115.677658; Bjerregaard H, 2015, J BIOL CHEM, V290, P7747, DOI 10.1074/jbc.M114.573477; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coleman JA, 2019, NATURE, V569, P141, DOI 10.1038/s41586-019-1135-1; Coleman JA, 2018, NAT STRUCT MOL BIOL, V25, P170, DOI 10.1038/s41594-018-0026-8; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Davis BA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23789; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Drew D, 2016, ANNU REV BIOCHEM, V85, P543, DOI 10.1146/annurev-biochem-060815-014520; Fenollar-Ferrer C, 2014, BIOCHEMISTRY-US, V53, P5444, DOI 10.1021/bi500637f; Ferraro M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166196; Field JR, 2010, J BIOL CHEM, V285, P11270, DOI 10.1074/jbc.M109.093658; Forrest LR, 2005, PROTEINS, V61, P296, DOI 10.1002/prot.20601; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Khelashvili G, 2016, BIOPHYS J, V110, p625A, DOI 10.1016/j.bpj.2015.11.3354; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Koldso H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063635; Koldso H, 2013, ACS CHEM NEUROSCI, V4, P295, DOI 10.1021/cn300148r; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kroncke BM, 2010, BIOCHEMISTRY-US, V49, P10045, DOI 10.1021/bi101148w; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeVine MV, 2018, BIOPHYS J, V114, P10, DOI 10.1016/j.bpj.2017.10.030; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; Moller IR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09675-z; Mortensen OV, 1999, MOL BRAIN RES, V71, P120, DOI 10.1016/S0169-328X(99)00178-3; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; Niello M, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.04.021; Okunola-Bakare OM, 2014, J MED CHEM, V57, P1000, DOI 10.1021/jm401754x; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Periole X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22912-7; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Ray A, 2010, BIOINFORMATICS, V26, P3067, DOI 10.1093/bioinformatics/btq581; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Saha K, 2019, PSYCHOPHARMACOLOGY, V236, P953, DOI 10.1007/s00213-018-5075-5; Saha K, 2015, NEUROPSYCHOPHARMACOL, V40, P1321, DOI 10.1038/npp.2014.325; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Seddik A, 2017, MOL INFORM, V36, DOI 10.1002/minf.201600094; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Soderhielm PC, 2015, MOL PHARMACOL, V88, P676, DOI 10.1124/mol.115.099911; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Tavoulari S, 2016, J BIOL CHEM, V291, P1456, DOI 10.1074/jbc.M115.692012; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres-Altoro MI, 2010, J BIOL CHEM, V285, P15369, DOI 10.1074/jbc.M109.088138; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Xue WW, 2018, PHYS CHEM CHEM PHYS, V20, P6606, DOI 10.1039/c7cp07869b; Xue WW, 2016, PHYS CHEM CHEM PHYS, V18, P3260, DOI 10.1039/c5cp05771j; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang FY, 2017, MOL SIMULAT, V43, P1089, DOI 10.1080/08927022.2017.1309653; Zeppelin T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005907; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; Zhang YW, 2016, P NATL ACAD SCI USA, V113, pE2776, DOI 10.1073/pnas.1603282113; Zheng GX, 2018, PHYS CHEM CHEM PHYS, V20, P29513, DOI 10.1039/c8cp06232c; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	107	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2019	14	6							e0217377	10.1371/journal.pone.0217377	http://dx.doi.org/10.1371/journal.pone.0217377			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3XM	31251747	Green Submitted, Green Published, gold			2022-12-26	WOS:000484915000006
J	Halim, H; Pinkaew, D; Chunhacha, P; Sinthujaroen, P; Thiagarajan, P; Fujise, K				Halim, Hasseri; Pinkaew, Decha; Chunhacha, Preedakorn; Sinthujaroen, Patuma; Thiagarajan, Perumal; Fujise, Ken			Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; APOE-DEFICIENT MICE; TISSUE FACTOR; MOUSE MODEL; PLATELET INHIBITION; SERUM PARAOXONASE; PLAQUE STABILITY; FACTOR-ALPHA; PHARMACOKINETICS; PHARMACODYNAMICS	Ticagrelor (TIC), a P2Y purinoceptor 12 (P2Y(12))-receptor antagonist, has been widely used to treat patients with acute coronary syndrome. Although animal studies suggest that TIC protects against atherosclerosis, it remains unknown whether it does so through its potent platelet inhibition or through other pathways. Here, we placed hypercholesterolemic Ldlr(-/-)A-pobec1(-/-) mice on a high-fat diet and treated them with either 25 mg/kg/day of clopidogrel (CLO) or 180 mg/kg/day of TIC for 16 weeks and evaluated the extent of atherosclerosis. Both treatments equally inhibited platelets as determined by ex vivo platelet aggregation assays. The extent of atherosclerosis, however, was significantly less in the TIC group than in the CLO group. Immunohistochemical staining and ELISA showed that TIC treatment was associated with less macrophage infiltration to the atherosclerotic intima and lower serum levels of CCL4, CXCL10, and TNF alpha, respectively, than CLO treatment. Treatment with TIC, but not CLO, was associated with higher serum activity and tissue level of paraoxonase- 1 (PON1), an anti-atherosclerotic molecule, suggesting that TIC might exert greater anti-atherosclerotic activity, compared with CLO, through its unique ability to induce PON1. Although further studies are needed, TIC may prove to be a viable strategy in the prevention and treatment of chronic stable human atherosclerosis.	[Halim, Hasseri; Pinkaew, Decha; Chunhacha, Preedakorn; Sinthujaroen, Patuma; Fujise, Ken] Univ Texas Med Branch, Dept Internal Med, Div Cardiol, Galveston, TX 77555 USA; [Thiagarajan, Perumal] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Fujise, Ken] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Fujise, Ken] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Halim, Hasseri] Univ Teknol MARA UiTM, Fac Pharm, Selangor Darul Ehsan, Malaysia; [Chunhacha, Preedakorn] Chulalongkorn Univ, Fac Pharmaceut Sci, Bangkok, Thailand; [Sinthujaroen, Patuma] Prince Songkla Univ, Fac Med, Hat Yai, Thailand	University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Chulalongkorn University; Prince of Songkla University	Fujise, K (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Cardiol, Galveston, TX 77555 USA.; Fujise, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Fujise, K (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.	Ken.Fujise@utmb.edu	Pinkaew, Decha/AAD-3335-2022; halim, hasseri/AAU-6272-2020	Chunhacha, Preedakorn/0000-0002-5060-7113; Halim, Hasseri/0000-0002-2983-2607; Pinkaew, Decha/0000-0001-8334-1545	AstraZeneca [P68125]; National Heart, Blood, and Lung Institute within the National Institutes of Health (NIH) [HL68024, HL117247, HL138992]; National Institute of Diabetes and Digestive and Kidney Diseases within the NIH [U2C DK059630]; American Heart Association Established Investigator Award [0540054N]; American Heart Association [7770000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138992, R01HL117247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); National Heart, Blood, and Lung Institute within the National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases within the NIH; American Heart Association Established Investigator Award(American Heart Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was supported in part by grants from AstraZeneca (P68125 to K.F.), the National Heart, Blood, and Lung Institute within the National Institutes of Health (NIH)(HL68024, HL117247, and HL138992 to K.F.), the National Institute of Diabetes and Digestive and Kidney Diseases within the NIH (U2C DK059630 to the University of Cincinnati Metabolic Diseases Institute), the American Heart Association Established Investigator Award (0540054N to K.F.), and the American Heart Association Grant-in-Aid (7770000 to K.F.). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariotti S, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0810-9; Armstrong D, 2014, J CARDIOVASC PHARM T, V19, P209, DOI 10.1177/1074248413511693; Babaev VR, 2016, ARTERIOSCL THROM VAS, V36, P1122, DOI 10.1161/ATVBAHA.116.307580; BARATH P, 1990, AM J CARDIOL, V65, P297, DOI 10.1016/0002-9149(90)90291-8; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Bonello L, 2014, J AM COLL CARDIOL, V63, P872, DOI 10.1016/j.jacc.2013.09.067; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Butler K, 2012, J CLIN PHARMACOL, V52, P1388, DOI 10.1177/0091270011415526; Butler K, 2011, J CLIN PHARMACOL, V51, P978, DOI 10.1177/0091270010379409; Butler K, 2010, BRIT J CLIN PHARMACO, V70, P65, DOI 10.1111/j.1365-2125.2010.03669.x; Campos ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12570; Canault M, 2008, J PATHOL, V214, P574, DOI 10.1002/path.2305; Cattaneo M, 2014, J AM COLL CARDIOL, V63, P2503, DOI 10.1016/j.jacc.2014.03.031; Chattopadhyay A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18701; Chen YJ, 2011, J BIOL CHEM, V286, P32575, DOI 10.1074/jbc.M110.217836; CONWAY EM, 1989, THROMB RES, V53, P231, DOI 10.1016/0049-3848(89)90098-4; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; DeRamus ML, 2017, SCI REP-UK, V7, DOI 10.1038/srep42545; Dobesh PP, 2014, PHARMACOTHERAPY, V34, P1077, DOI 10.1002/phar.1477; Du XJ, 2013, CARDIOVASC DRUG THER, V27, P485, DOI 10.1007/s10557-013-6484-7; Dutta R, 2003, ATHEROSCLEROSIS, V169, P51, DOI 10.1016/S0021-9150(03)00133-3; Eltoft A, 2018, ATHEROSCLEROSIS, V271, P1, DOI 10.1016/j.atherosclerosis.2018.02.005; Franchi F, 2015, NAT REV CARDIOL, V12, P30, DOI 10.1038/nrcardio.2014.156; Frontroth Juan Pablo, 2013, Methods Mol Biol, V992, P227, DOI 10.1007/978-1-62703-339-8_17; Gandhi C, 2012, BLOOD, V119, P2385, DOI 10.1182/blood-2011-09-376202; Gokey NG, 2011, J BIOL CHEM, V286, P29501, DOI 10.1074/jbc.M111.263509; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; Harris VM, 2015, METHODS MOL BIOL, V1312, P465, DOI 10.1007/978-1-4939-2694-7_47; Heim C, 2016, HEART VESSELS, V31, P783, DOI 10.1007/s00380-015-0696-7; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Jia LX, 2013, CARDIOVASC DRUG THER, V27, P521, DOI 10.1007/s10557-013-6471-z; Liu CL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00977-0; Liu Yang, 2012, World J Exp Med, V2, P30, DOI 10.5493/wjem.v2.i2.30; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233; Mackness M, 2013, EXPERT OPIN THER TAR, V17, P829, DOI 10.1517/14728222.2013.790367; Mallouk N, 2018, PRACT LAB MED, V11, P10, DOI 10.1016/j.plabm.2018.02.002; Mao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141464; Marmur JD, 1996, CIRCULATION, V94, P1226, DOI 10.1161/01.CIR.94.6.1226; Marsillach J, 2011, EUR J CLIN INVEST, V41, P308, DOI 10.1111/j.1365-2362.2010.02411.x; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Nylander S, 2016, BRIT J PHARMACOL, V173, P1163, DOI 10.1111/bph.13429; Ortega-Paz L, 2018, CIRCULATION, V138, P646, DOI 10.1161/CIRCULATIONAHA.118.034489; Pinkaew D, 2013, AM J PHYSIOL-HEART C, V305, pH1519, DOI 10.1152/ajpheart.00570.2013; Pinkaew D, 2012, AM J PHYSIOL-HEART C, V302, pH451, DOI 10.1152/ajpheart.00669.2011; Porto I, 2009, EXPERT OPIN INV DRUG, V18, P1317, DOI 10.1517/13543780903176415; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Preusch MR, 2016, DRUG DES DEV THER, V10, P2691, DOI 10.2147/DDDT.S105718; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Reiner MF, 2017, CARDIOVASC RES, V113, P61, DOI 10.1093/cvr/cvw233; RUS HG, 1991, ATHEROSCLEROSIS, V89, P247; RYAN WL, 1990, THROMB RES, V58, P163, DOI 10.1016/0049-3848(90)90173-A; Schwarz UR, 1999, THROMB HAEMOSTASIS, V82, P1145, DOI 10.1055/s-0037-1614344; Scofield MD, 2015, NEUROPSYCHOPHARMACOL, V40, P2526, DOI 10.1038/npp.2015.99; Segers D, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/936109; Serebruany VL, 2010, CARDIOLOGY, V117, P231, DOI 10.1159/000322789; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Storey RF, 2010, J AM COLL CARDIOL, V56, P1456, DOI 10.1016/j.jacc.2010.03.100; Sumaya Wael, 2017, Interv Cardiol Clin, V6, P49, DOI 10.1016/j.iccl.2016.08.004; Teng RL, 2014, J DRUG ASSESS, V3, P43, DOI 10.3109/21556660.2014.946604; Teng RL, 2010, DRUG METAB DISPOS, V38, P1514, DOI 10.1124/dmd.110.032250; Thomas MR, 2015, ARTERIOSCL THROM VAS, V35, P2562, DOI 10.1161/ATVBAHA.115.306528; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van der Wal AC, 1999, CARDIOVASC RES, V41, P334, DOI 10.1016/S0008-6363(98)00276-4; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296; Westrick RJ, 2001, CIRCULATION, V103, P3044, DOI 10.1161/hc2501.092492; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Xu F, 2012, CARDIOLOGY, V121, P12, DOI 10.1159/000335886; Zahno A, 2013, FREE RADICAL BIO MED, V65, P208, DOI 10.1016/j.freeradbiomed.2013.06.007; Zhai YR, 2016, DRUG CHEM TOXICOL, V39, P367, DOI 10.3109/01480545.2015.1122606	78	7	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218934	10.1371/journal.pone.0218934	http://dx.doi.org/10.1371/journal.pone.0218934			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242230	gold, Green Published, Green Submitted			2022-12-26	WOS:000482883600067
J	Mine, J; Uchida, Y; Sharshov, K; Sobolev, I; Shestopalov, A; Saito, T				Mine, Junki; Uchida, Yuko; Sharshov, Kirill; Sobolev, Ivan; Shestopalov, Alexander; Saito, Takehiko			Phylogeographic evidence for the inter- and intracontinental dissemination of avian influenza viruses via migration flyways	PLOS ONE			English	Article							WILD BIRDS; A VIRUS; MOLECULAR CHARACTERIZATION; GENETIC-CHARACTERIZATION; HEMAGGLUTININ SUBTYPE; A(H5N8) VIRUS; GLOBAL SPREAD; H5N1 VIRUSES; HONG-KONG; EVOLUTION	Genetically related highly pathogenic avian influenza viruses (HPAIVs) of H5N6 subtype caused outbreaks simultaneously in East Asia and Europe-geographically distinct regions-during winter 2017-2018. This situation prompted us to consider whether the application of phylogeographic analysis to a particular gene segment of AIVs could provide clues for understanding how AIV had been disseminated across the continent. Here, the N6 NA genes of influenza viruses isolated across the world were subjected to phylogeographic analysis to illustrate the inter-and intracontinental dissemination of AIVs. Those isolated in East Asia during winter and in Mongolia/Siberia during summer were comingled within particular clades of the phylogeographic tree. For AIVs in one clade, their dissemination in eastern Eurasia extended from Yakutia, Russia, in the north to East Asia in the south. AIVs in western Asia, Europe, and Mongolia were also comingled within other clades, indicating that Mongolia/Siberia plays an important role in the dissemination of AIVs across the Eurasian continent. Mongolia/Siberia may therefore have played a role in the simultaneous outbreaks of H5N6 HPAIVs in Europe and East Asia during the winter of 2017-2018. In addition to the long-distance intracontinental disseminations described above, intercontinental disseminations of AIVs between Eurasia and Africa and between Eurasia and North America were also observed. Integrating these results and known migration flyways suggested that the migration of wild birds and the overlap of flyways, such as that observed in Mongolia/Siberia and along the Alaskan Peninsula, contributed to the long-distance intra- and intercontinental dissemination of AIVs. These findings highlight the importance of understanding the movement of migratory birds and the dynamics of AIVs in breeding areas-especially where several migration flyways overlap-in forecasting outbreaks caused by HPAIVs.	[Mine, Junki; Uchida, Yuko; Saito, Takehiko] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Div Transboundary Anim Dis, Tsukuba, Ibaraki, Japan; [Mine, Junki; Uchida, Yuko; Saito, Takehiko] Thailand Japan Zoonot Dis Collaborat Ctr, Bangkok, Thailand; [Sharshov, Kirill; Sobolev, Ivan; Shestopalov, Alexander] Fed Res Ctr Fundamental & Translat Med, Novosibirsk, Russia; [Saito, Takehiko] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University	Saito, T (corresponding author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, Div Transboundary Anim Dis, Tsukuba, Ibaraki, Japan.; Saito, T (corresponding author), Thailand Japan Zoonot Dis Collaborat Ctr, Bangkok, Thailand.; Saito, T (corresponding author), Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan.	taksaito@affrc.go.jp	Sobolev, Ivan/AAD-4881-2020; Shestopalov, Alexander/AAO-5569-2020; Saito, Takehiko/AFM-3038-2022	Sobolev, Ivan/0000-0002-4561-6517; Mine, Junki/0000-0002-1603-8471	"Pilot program of international collaborative research (Collaborative research based on a joint call with Russia)" under "Commissioned projects for promotion of strategic international collaborative research"; Agriculture, Forestry and Fisheries Research Council; Russian Scientific Foundation [17-44-07001]; Russian Science Foundation [17-44-07001] Funding Source: Russian Science Foundation	"Pilot program of international collaborative research (Collaborative research based on a joint call with Russia)" under "Commissioned projects for promotion of strategic international collaborative research"; Agriculture, Forestry and Fisheries Research Council(Ministry of Agriculture Forestry & Fisheries - Japan); Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported in part by a research project grant from the "Pilot program of international collaborative research (Collaborative research based on a joint call with Russia)" under "Commissioned projects for promotion of strategic international collaborative research," a grant from the Agriculture, Forestry and Fisheries Research Council (JP) and a grant from the Russian Scientific Foundation (project #17-44-07001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2007, P ROY SOC B-BIOL SCI, V274, P2523, DOI 10.1098/rspb.2007.0633; BECKER WB, 1966, J HYG-CAMB, V64, P309, DOI 10.1017/S0022172400040596; Beerens N, 2018, EMERG INFECT DIS, V24, P770, DOI 10.3201/eid2404.172124; Bevins SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep28980; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Bodewes R, 2018, ADV VIRUS RES, V100, P279, DOI 10.1016/bs.aivir.2017.10.007; Boere CG, 2006, WATERBIRDS WORLD, P40; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Dusek RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092075; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hall JS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-179; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Katoh K, 2016, BIOINFORMATICS, V32, P1933, DOI 10.1093/bioinformatics/btw108; Kawaoka Y, 1998, VIRUS RES, V55, P143, DOI 10.1016/S0168-1702(98)00038-0; KAWAOKA Y, 1990, VIROLOGY, V179, P759, DOI 10.1016/0042-6822(90)90143-F; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kim YI, 2018, EUROSURVEILLANCE, V23, P8, DOI 10.2807/1560-7917.ES.2018.23.7.18-00045; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lee DH, 2015, J VIROL, V89, P6521, DOI 10.1128/JVI.00728-15; Lee EK, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0104-3; Lee YN, 2018, J VET SCI, V19, P850, DOI 10.4142/jvs.2018.19.6.850; Lewis NS, 2015, J GEN VIROL, V96, P2050, DOI 10.1099/vir.0.000155; Li SH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25291-1; Lipatov AS, 2007, EMERG INFECT DIS, V13, P539, DOI 10.3201/eid1304.061266; Lycett SJ, 2016, SCIENCE, V354, P213, DOI 10.1126/science.aaf8852; Mine J, 2019, ARCH VIROL, V164, P457, DOI 10.1007/s00705-018-4091-4; MORGAN IR, 1990, AUST VET J, V67, P125, DOI 10.1111/j.1751-0813.1990.tb07727.x; OIE, UPD AV INFL AN TYP H; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pasick J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09484; Perkins LEL, 2003, AVIAN DIS, V47, P956, DOI 10.1637/0005-2086-47.s3.956; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Selim AA, 2017, EMERG INFECT DIS, V23, P1048, DOI 10.3201/eid2306.162056; Sharshov K, 2014, VIRUS GENES, V49, P237, DOI 10.1007/s11262-014-1083-7; Shibata A, 2018, TRANSBOUND EMERG DIS, V65, P465, DOI 10.1111/tbed.12726; Shittu I, 2017, ARCH VIROL, V162, P841, DOI 10.1007/s00705-016-3149-4; Shmueli M, 2000, COMP BIOCHEM PHYS A, V125, P25, DOI 10.1016/S1095-6433(99)00162-2; Sivay MV, 2012, AVIAN DIS, V56, P456, DOI 10.1637/9868-080111-Reg.1; Takemae N, 2017, VIROLOGY, V512, P8, DOI 10.1016/j.virol.2017.08.035; Tonnessen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063270; Twabela AT, 2018, EMERG INFECT DIS, V24, P1371, DOI 10.3201/eid2407.172123; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Venkatesh D, 2018, J VIROL, V92, DOI 10.1128/JVI.00433-18; Verhagen JH, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.12.21069; Wade A, 2018, EMERG INFECT DIS, V24, P1367, DOI 10.3201/eid2407.172120; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yang L, 2017, J VIROL, V91, DOI [10.1128/JVI.02199-16, 10.1128/jvi.02199-16]; Zhou S, 2016, J GEN VIROL, V97, P2129, DOI 10.1099/jgv.0.000534; 1980, B WORLD HEALTH ORGAN, V58, P585	62	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0218506	10.1371/journal.pone.0218506	http://dx.doi.org/10.1371/journal.pone.0218506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242207	Green Published, gold, Green Submitted			2022-12-26	WOS:000482883600033
J	Mobasseri, M; Hutchinson, MC; Afshar, FJ; Pedram, M				Mobasseri, Mahyar; Hutchinson, Matthew C.; Afshar, Farahnaz Jahanshahi; Pedram, Majid			New evidence of nematode-endosymbiont bacteria coevolution based on one new and one known dagger nematode species of Xiphinema americanum-group (Nematoda, Longidoridae)	PLOS ONE			English	Article							MORPHOLOGICAL CHARACTERIZATION; CANDIDATUS-XIPHINEMATOBACTER; N. SP.; BREVICOLLUM; DORYLAIMIDA; IDENTIFICATION; PHYLOGENY; SEQUENCE; SYSTEM; NOV	Three populations of Xiphinema primum n. sp. and two populations of X. pachtaicum were recovered from natural forests and cultural regions of northern Iran. Both species belong to the X. americanum-group and were characterized by their morphological, morphometric and molecular data. The new species, which was recovered in three locations, belongs to the X. brevicolle-complex and is characterized by 2124-2981 mu m long females with a widely rounded lip region separated from the rest of the body by a depression, 103-125 mu m long odontostyle, two equally developed genital branches with endosymbiont bacteria inside the ovary, which are visible under light microscope (LM), vulva located at 51.8-58.0%, the tail is 26-37 mu m long with a bluntly rounded end and four juvenile developmental stages. It was morphologically compared with nine similar species viz. X. brevicolle, X. diffusum, X. incognitum, X. himalayense, X. luci, X. parabrevicolle, X. paramonovi, X. parataylori and X. taylori. The second species, X. pachtaicum, was recovered in two geographically distant points close to city of Amol. Molecular phylogenetic studies of the new species were performed using partial sequences of the D2-D3 expansion segments of the large subunit ribosomal RNA gene (LSU rDNA D2-D3), the internal-transcribed spacer rDNA (ITS = ITS1+5.8S+ITS2), and the mitochondrial cytochrome c oxidase I gene (COI mtDNA) regions. The Iranian population of X. pachtaicum was also phylogenetically studied based upon its LSU rDNA D2-D3 sequences. Both species were also inspected for their putative endosymbiont bacteria. Candidatus Xiphinematobacter sp. was detected from two examined populations of the new species, whereas the second endosymbiont bacterium, detected from three examined isolates of X. pachtaicum, was related to the plant and fungal endosymbionts of the family Burkholderiaceae. The phylogenetic analyses of the two endosymbiont bacteria were performed using partial sequences of 16S rDNA. In cophylogenetic analyses, significant levels of cophylogenetic signal were observed using both LSU rDNA D2-D3 and COI mtDNA markers of the host nematodes and 16S rDNA marker of the endosymbiont bacteria.	[Mobasseri, Mahyar; Pedram, Majid] Tarbiat Modares Univ, Fac Agr, Dept Plant Pathol, Tehran, Iran; [Hutchinson, Matthew C.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Afshar, Farahnaz Jahanshahi] AREEO, Iranian Res Inst Plant Protect, Tehran, Iran	Tarbiat Modares University; Princeton University	Pedram, M (corresponding author), Tarbiat Modares Univ, Fac Agr, Dept Plant Pathol, Tehran, Iran.	majid.pedram@modares.ac.ir	Afshar, Farahnaz Jahanshahi/H-5969-2017; Pedram, Majid/AAF-2834-2021	Afshar, Farahnaz Jahanshahi/0000-0001-6032-390X; Pedram, Majid/0000-0001-7640-507X; Mobasseri, Mahyar/0000-0003-0232-3922	Tarbiat Modares University; Iranian National Science Foundation (INSF)	Tarbiat Modares University; Iranian National Science Foundation (INSF)(Iran National Science Foundation (INSF))	This work was supported by Tarbiat Modares University and Iranian National Science Foundation (INSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RE, 1963, PHYTOPATHOLOGY, V53, P745; Ahmad M., 1998, Nematologia Mediterranea, V26, P131; Balbuena JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061048; Archidona-Yuste A, 2016, ZOOL J LINN SOC-LOND, V176, P231, DOI 10.1111/zoj.12316; Barsi L., 2004, Nematologia Mediterranea, V32, P101; Bianciotto V, 2003, INT J SYST EVOL MICR, V53, P121, DOI 10.1099/ijs.0.02382-0; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Cobb N. A., 1913, J Acad Sci, V3; Coomans A, 1998, FUND APPL NEMATOL, V21, P569; Coomans A, 2000, NEMATOLOGY, V2, P443, DOI 10.1163/156854100509303; Coomans A., 2001, Annalen Zoologische Wetenschappen - Koninklijk Museum voor Midden-Afrika, V287; De Grisse A.T., 1969, MEDEDELINGEN RIJKSFA, V34, P351, DOI DOI 10.1163/156854199508559; De Man JG, 1880, TIJDSCHRIFT NEDERLAN; Decraemer W, 2007, J NEMATOL, V39, P295; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EPPO, EPPO STAND; Fadaei AA, 2003, NEMATOLOGY, V5, P453, DOI 10.1163/156854103769224430; Garrity G., 2005, BERGEYS MANUAL SYSTE; Gharibzadeh F, 2018, J NEMATOL, V50, P207, DOI 10.21307/jofnem-2018-009; Guerrero P, 2007, NEMATOLOGY, V9, P515, DOI 10.1163/156854107781487251; Gutierrez-Gutierrez C, 2012, EUR J PLANT PATHOL, V134, P561, DOI 10.1007/s10658-012-0039-9; Gutierrez-Gutierrez C, 2011, EUR J PLANT PATHOL, V129, P427, DOI 10.1007/s10658-010-9705-y; HAFNER MS, 1995, PHILOS T R SOC B, V349, P77, DOI 10.1098/rstb.1995.0093; He Y, 2005, J MOL EVOL, V61, P819, DOI 10.1007/s00239-005-0102-7; He Y, 2005, NEMATOLOGY, V7, P111, DOI 10.1163/1568541054192108; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Howe DK, 2019, NEMATOLOGY, V21, P533, DOI 10.1163/15685411-00003233; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Hutchinson MC, 2017, METHODS ECOL EVOL, V8, P932, DOI 10.1111/2041-210X.12736; Jenkins W., 1964, PLANT DIS REPORTER, V48; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Kirjanova E. S, 1951, TRUDY ZOOL INST AKAD, V9, P625; Kumari S, 2010, EUR J PLANT PATHOL, V127, P493, DOI 10.1007/s10658-010-9614-0; Lamberti F., 2004, Nematologia Mediterranea, V32, P53; Lamberti F., 1991, Nematologia Mediterranea, V19, P311; Lamberti F., 1979, Nematologia Mediterranea, V7, P51; Lamberti F, 2000, RUSS J NEMATOL, V8, P65; Lamberti F, 2002, RUSS J NEMATOL, V10, P99; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lazarova S, 2019, EUR J PLANT PATHOL, V153, P441, DOI 10.1007/s10658-018-1571-z; Lazarova S, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.574.8037; Lazarova SS, 2006, J NEMATOL, V38, P404; Lazarova SS, 2016, NEMATOLOGY, V18, P615, DOI 10.1163/15685411-00002982; Lima MB, 1965, THESIS; LOOF PAA, 1990, SYST PARASITOL, V16, P35, DOI 10.1007/BF00009600; LORDELLO L. G. E., 1961, REV BRASIL BIOL, V21, P363; Luc M, 1998, FUND APPL NEMATOL, V21, P475; Maneesakorn P, 2011, MOL PHYLOGENET EVOL, V59, P271, DOI 10.1016/j.ympev.2011.02.012; Micoletzky H., 1922, ARCH NATURGESCH, V7, P59; Nunn G.B., 1992, NEMATODE MOL EVOLUTI; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Orlando V, 2016, NEMATOLOGY, V18, P1015, DOI 10.1163/15685411-00003012; Palomares-Rius JE, 2016, MOL ECOL, V25, P6225, DOI 10.1111/mec.13904; Pedram M., 2018, PLANT PARASIT NEMAT, P627; Pedram M, 2012, NEMATOLOGY, V14, P427, DOI 10.1163/156854111X610272; Repasi V, 2008, HELMINTHOLOGIA, V45, P96, DOI 10.2478/s11687-008-0018-z; Robbins Robert T., 1996, Russian Journal of Nematology, V4, P163; Roca F., 1989, Nematologia Mediterranea, V17, P151; Romanenko ND, 1981, TEZISY DOKLADOV PERV, P68; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenblueth M, 2012, J EVOLUTION BIOL, V25, P2357, DOI 10.1111/j.1420-9101.2012.02611.x; SCHLESNER H, 1987, SYST APPL MICROBIOL, V10, P54, DOI 10.1016/S0723-2020(87)80010-3; Siddiqi M.R, 1977, Nematologia Mediterranea, V5, P133; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; STALEY JT, 1976, A VAN LEEUW J MICROB, V42, P333, DOI 10.1007/BF00394132; Subbotin SA, 2000, NEMATOLOGY, V2, P591, DOI 10.1163/156854100509484; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TARJAN AC, 1969, NEMATOLOGICA, V15, P241, DOI 10.1163/187529269X00678; Taylor C.E., 1997, NEMATODE VECTORS PLA; THORNE G, 1950, P HELM SOC WASH, V17, P27; Thorne G., 1939, CAPITA ZOOLOGICA, V8; THORNE GERALD, 1935, PROC HELMINTH SOC WASHINGTON, V2, P96; Tulaganov A. T, 1938, T UZBEKSKOGO GOSUDAR, V12, P1; Vandekerckhove TTM, 2002, APPL ENVIRON MICROB, V68, P3121, DOI 10.1128/AEM.68.6.3121-3125.2002; Vandekerckhove TTM, 2000, INT J SYST EVOL MICR, V50, P2197, DOI 10.1099/00207713-50-6-2197; WILLIAMS BD, 1992, GENETICS, V131, P609	77	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2019	14	6							e0217506	10.1371/journal.pone.0217506	http://dx.doi.org/10.1371/journal.pone.0217506			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IT5DV	31242223	Green Submitted, Green Published, gold			2022-12-26	WOS:000482883600010
J	Desheva, Y; Leontieva, G; Kramskaya, T; Grabovskaya, KB; Karev, V; Mamontov, A; Nazarov, P; Suvorov, A				Desheva, Yulia; Leontieva, Galina; Kramskaya, Tatiana; Grabovskaya, Kornelia B.; Karev, Vadim; Mamontov, Andery; Nazarov, Petr; Suvorov, Alexander			Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; PNEUMOCOCCAL PNEUMONIA; LETHAL SYNERGISM; MOUSE MODEL; PATHOGENESIS; EFFICACY; ANTIGEN; PROTEIN	Although many influenza-related deaths are attributable to secondary bacterial infection with S. pneumoniae, vaccines that simultaneously protect against influenza and pneumococcal infection are currently not developed. The aim of our study was to evaluate the possibility to prevent post-influenza pneumococcal infection using an associated vaccine based on live influenza vaccine (LAIV) combined with recombinant polypeptides derived from superficial factors of Group B streptococcus (GBS) determining pathogenicity. We demonstrated in a model of post-influenza pneumococcal pneumonia that intranasal pneumococcal super-infection seriously complicated the course of A/Shanghai/2/2013(H7N9) CDC-RG virus infection in mice. Associated immunization using LAIV and GBS vaccine (GBSV) prevented post-influenza pneumococcal pneumonia better than mono-LAIV or GBSV immunization. At the same time, parenteral pneumococcal post-influenza infection of immune mice was more severe in the groups immunized using recombinant GBS peptides which can be explained by antibody-dependent enhancement of infection. In this case, the introduction of blockers of histamine receptors type 1 and 2 reduced the burden of secondary pneumococcal infection.	[Desheva, Yulia; Leontieva, Galina; Kramskaya, Tatiana; Grabovskaya, Kornelia B.; Mamontov, Andery; Nazarov, Petr; Suvorov, Alexander] Fed State Budgetary Sci Inst, Inst Expt Med, St Petersburg, Russia; [Desheva, Yulia; Suvorov, Alexander] St Petersburg State Univ, St Petersburg, Russia; [Karev, Vadim] Fed State Budgetary Inst, Res Inst Childrens Dis, St Petersburg, Russia	Institute of Experimental Medicine; Saint Petersburg State University	Desheva, Y (corresponding author), Fed State Budgetary Sci Inst, Inst Expt Med, St Petersburg, Russia.; Desheva, Y (corresponding author), St Petersburg State Univ, St Petersburg, Russia.	desheva@mail.ru	Leontieva, Galina/AAH-1660-2019; Karev, Vadim/AAW-5343-2020; Desheva, Yulia/I-1493-2013; Kramskaya, Tatiana/AAH-2447-2021; Mamontov, Andrey/AAW-5342-2020; Nazarov, Peter/O-1528-2015; Suvorov, Alexander/J-6921-2013	Leontieva, Galina/0000-0002-9876-6594; Desheva, Yulia/0000-0001-9794-3520; Mamontov, Andrey/0000-0002-5901-6942; Nazarov, Peter/0000-0002-4169-9968; Suvorov, Alexander/0000-0003-2312-5589				Birger RB, 2015, TRENDS MICROBIOL, V23, P537, DOI 10.1016/j.tim.2015.05.002; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07; Borges MB, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007721; Chalmers JD, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0242-0; Coelingh K, 2015, EXPERT REV VACCINES, V14, P1331, DOI 10.1586/14760584.2015.1078732; Czako R, 2018, VACCINE, V36, P1871, DOI 10.1016/j.vaccine.2018.02.061; Desheva Yulia A, 2016, Open Microbiol J, V10, P168; Diavatopoulos DA, 2010, FASEB J, V24, P1789, DOI 10.1096/fj.09-146779; Dortet L, 2009, DIAGN MICR INFEC DIS, V65, P49, DOI 10.1016/j.diagmicrobio.2009.05.009; Gupalova T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196564; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Hattori Mizuki, 2016, Intensive Care Med Exp, V4, P36; He XS, 2015, J INFECT DIS, V211, P1051, DOI 10.1093/infdis/jiu580; Silva JVJ, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759021, 10.1590/s1678-9946201759021]; Jose RJ, 2015, CURR OPIN PULM MED, V21, P212, DOI 10.1097/MCP.0000000000000150; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; Metzger DW, 2015, J INFECT DIS, V212, P445, DOI 10.1093/infdis/jiv066; Mina MJ, 2013, J INFECT DIS, V208, P1281, DOI 10.1093/infdis/jit317; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Seo SU, 2012, VACCINE, V30, P6816, DOI 10.1016/j.vaccine.2012.09.015; Suvorov A, 2004, INDIAN J MED RES, V119, P228; Tan GS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005578; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vorobieva EI, 2005, FOLIA MICROBIOL, V50, P172, DOI 10.1007/BF02931468; Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100; Wu NH, 2015, J GEN VIROL, V96, P2557, DOI 10.1099/jgv.0.000223	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218544	10.1371/journal.pone.0218544	http://dx.doi.org/10.1371/journal.pone.0218544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237893	gold, Green Submitted, Green Published			2022-12-26	WOS:000484856000024
J	Joo, S; Park, P; Park, S				Joo, Sungbae; Park, Phillip; Park, Sangkyu			Applicability of propidium monoazide (PMA) for discrimination between living and dead phytoplankton cells	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; PREFERENTIAL DETECTION; MEMBRANE-PERMEABILITY; POPULATION-DYNAMICS; SELECTIVE DETECTION; ETHIDIUM MONOAZIDE; FOOD SELECTION; VIABILITY; PCR; WATER	Propidium monoazide (PMA) is a highly selective dye that penetrates only membrane-compromised, dead microbial cells and inhibits both DNA extraction and amplification. PMA has been widely used for discrimination between living and dead microbial cells; however, the application of PMA in phytoplankton studies has been limited. In this study, we attempted to evaluate its applicability for the discrimination of viable phytoplankton. We tested PMA on seven phytoplankton species, Microcystis aeruginosa, Anabaena sp., Aphanizomenon sp., Synechocystis sp., Cryptomonas ovata, Scenedesmus obliquus, and Nitzschia apiculata as representatives of the major phytoplankton taxa Cyanobacteria (first four species), Chlorophyta, Cryptophyta, and Bacillariophyta, respectively. Our results showed that application of PMA to phytoplankton living in freshwater has the potential to distinguish viable from dead cells as in microbial studies. Particularly, PMA differentiated viable from dead cells in cyanobacterial species rather than in other phytoplankton taxa under our experimental conditions. However, our results also showed that it may be necessary to adjust various conditions affecting PMA treatment efficiency to expand its applicability to other phytoplankton. Although all factors contributing to the effects of PMA could not be evaluated, our study showed the applicability of PMA-based molecular approaches, which can be convenient quantitative methods for distinguishing living from dead phytoplankton in freshwater ecosystems. Setting optimal treatment conditions for other phytoplankton species may increase the efficacy of PMA-based molecular approaches.	[Joo, Sungbae] Natl Inst Ecol, Div Basic Res, Seocheon, South Korea; [Park, Phillip; Park, Sangkyu] Ajou Univ, Dept Biol Sci, Suwon, South Korea	National Institute of Ecology; Ajou University	Park, S (corresponding author), Ajou Univ, Dept Biol Sci, Suwon, South Korea.	daphnia@ajou.ac.kr		Park, Sangkyu/0000-0003-3049-0728; Joo, Sungbae/0000-0002-8472-7682	Basic Science Research Program [2009-0073291]; National Research Foundation of Korea	Basic Science Research Program; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by the Basic Science Research Program (no. 2009-0073291) of the National Research Foundation of Korea.	Agusti S, 2002, LIMNOL OCEANOGR, V47, P818, DOI 10.4319/lo.2002.47.3.0818; Bae S, 2009, WATER RES, V43, P4850, DOI 10.1016/j.watres.2009.06.053; Betournay S, 2007, J PHYCOL, V43, P609, DOI 10.1111/j.1529-8817.2007.00350.x; Brett MT, 2000, LIMNOL OCEANOGR, V45, P1564, DOI 10.4319/lo.2000.45.7.1564; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Contreras PJ, 2011, J MICROBIOL METH, V87, P89, DOI 10.1016/j.mimet.2011.07.016; COWLES TJ, 1988, MAR BIOL, V100, P41, DOI 10.1007/BF00392953; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15; Desneux J, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0505-6; DONAGHAY PL, 1979, MAR BIOL, V52, P137, DOI 10.1007/BF00390421; Emerson JB, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0285-3; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; JASSBY AD, 1974, LIMNOL OCEANOGR, V19, P618, DOI 10.4319/lo.1974.19.4.0618; KNOECHEL R, 1978, LIMNOL OCEANOGR, V23, P195, DOI 10.4319/lo.1978.23.2.0195; Lee DY, 1997, J PHYCOL, V33, P991, DOI 10.1111/j.0022-3646.1997.00991.x; Liebich V, 2012, AQUATIC INVASIONS; Luo JF, 2010, APPL MICROBIOL BIOT, V86, P377, DOI 10.1007/s00253-009-2373-1; Marie D., 2005, ALGAL CULTURING TECH, P253, DOI DOI 10.1016/B978-012088426-1/50018-4; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Miotto P, 2012, EUR RESPIR J, V39, P1269, DOI 10.1183/09031936.00124711; MullerNavarra D, 1996, J PLANKTON RES, V18, P1137, DOI 10.1093/plankt/18.7.1137; Nkuipou-Kenfack E, 2013, J MICROBIOL METH, V93, P20, DOI 10.1016/j.mimet.2013.01.018; Nocker A, 2009, FEMS MICROBIOL LETT, V291, P137, DOI 10.1111/j.1574-6968.2008.01429.x; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Nocker A, 2009, J MICROBIOL METH, V76, P253, DOI 10.1016/j.mimet.2008.11.004; Pan Y, 2007, APPL ENVIRON MICROB, V73, P8028, DOI 10.1128/AEM.01198-07; Rappe MS, 1998, APPL ENVIRON MICROB, V64, P294; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; RCore Team, 2020, R LANG ENV STAT COMP; Reavie ED, 2010, J GREAT LAKES RES, V36, P540, DOI 10.1016/j.jglr.2010.05.007; REYNOLDS CS, 1982, J PLANKTON RES, V4, P561, DOI 10.1093/plankt/4.3.561; Roges GB, 2008, DIAGN MICR INFEC DIS, V62, P133, DOI 10.1016/j.diagmicrobio.2008.06.011; Roth P, 2017, DIATOM RES, V32, P341, DOI 10.1080/0269249X.2017.1365014; Schulze K, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-118; SELVIN R, 1988, Biological Oceanography, V6, P505; Soejima T, 2012, J DAIRY SCI, V95, P3634, DOI 10.3168/jds.2012-5360; Soejima T, 2011, ANAL BIOCHEM, V418, P37, DOI 10.1016/j.ab.2011.06.027; Sterner Robert W., 1998, Aquatic Ecology, V32, P261, DOI 10.1023/A:1009949400573; Stiller JW, 2005, MOL ECOL NOTES, V5, P1, DOI 10.1111/j.1471-8286.2004.00805.x; Tsolaki E, 2010, J CHEM TECHNOL BIOT, V85, P19, DOI 10.1002/jctb.2276; Veldhuis MJW, 2001, EUR J PHYCOL, V36, P167, DOI 10.1080/09670260110001735318; Wang L, 2009, J APPL MICROBIOL, V107, P1719, DOI 10.1111/j.1365-2672.2009.04358.x; WILLIAMS RJ, 1988, ESTUAR COAST SHELF S, V26, P409, DOI 10.1016/0272-7714(88)90021-2; Zetsche EM, 2012, J PLANKTON RES, V34, P493, DOI 10.1093/plankt/fbs018; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	47	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218924	10.1371/journal.pone.0218924	http://dx.doi.org/10.1371/journal.pone.0218924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237931	Green Published, Green Submitted, gold			2022-12-26	WOS:000484856000051
J	Rahmalia, A; Price, MH; Hartantri, Y; Alisjahbana, B; Wisaksana, R; van Crevel, R; van der Ven, AJAM				Rahmalia, Annisa; Price, Michael Holton; Hartantri, Yovita; Alisjahbana, Bachti; Wisaksana, Rudi; van Crevel, Reinout; van der Ven, Andre J. A. M.			Are there differences in HIV retention in care between female and male patients in Indonesia? A multi-state analysis of a retrospective cohort study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY INITIATION; FOLLOW-UP; GENDER-DIFFERENCES; TREATMENT OUTCOMES; INFECTED ADULTS; SEX-DIFFERENCES; CD4 COUNT; MORTALITY; IMPACT; SURVIVAL	Background Little is known about HIV treatment outcomes in Indonesia, which has one of the most rapidly growing HIV epidemics worldwide. Methods We examined possible differences in loss to follow-up (LTFU) and survival between HIV-infected females and males over a 7-year period in an HIV clinic in Bandung, West Java. Data imputation was performed on missing covariates and a multi-state Cox regression was used to investigate the effects of sex and other covariates on patient transitions among four states: (1) clinic enrollment with HIV, (2) initiation/continuation/re-initiation of antiretroviral therapy (ART), (3) LTFU, and (4) death. Results We followed 3215 patients (33% females), for a total of 8430 person-years. ART was used by 59% of patients at some point. One-year retention was 73% for females and 77% for males (p = 0.06). One-year survival was 98% for both females and males (p = 0.15). Females experienced a higher relative hazard to transition from HIV to LTFU (adjusted hazard ratio 1.21; 95% confidence interval 1.00-1.45), but this decreased after adjustments for clinical variables (aHR 0.94; 95% CI 0.79-1.11). Similarly, a lower relative hazard in females to transition from ART to death (aHR 0.59; 95% CI 0.35-0.99) decreased after adjustments for demographic variables. Conclusion This Indonesian cohort has low ART uptake and poor overall pre- and post-ART retention. Female-male differences in survival and retention were gone after adjusting for clinical and sociodemographic factors such as CD4 count and education level. Efforts should be made to improve retention among patients with lower education.	[Rahmalia, Annisa; Hartantri, Yovita; Alisjahbana, Bachti; Wisaksana, Rudi] Univ Padjadjaran, Fac Med, Infect Dis Res Ctr, Bandung, Indonesia; [Rahmalia, Annisa; van Crevel, Reinout; van der Ven, Andre J. A. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Price, Michael Holton] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Price, Michael Holton] Santa Fe Inst, Santa Fe, NM 87501 USA; [Hartantri, Yovita; Alisjahbana, Bachti; Wisaksana, Rudi] Hasan Sadikin Gen Hosp, Dept Internal Med, Bandung, Indonesia	Universitas Padjadjaran; Radboud University Nijmegen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; The Santa Fe Institute; Dr Hasan Sadikin General Hospital	Rahmalia, A (corresponding author), Univ Padjadjaran, Fac Med, Infect Dis Res Ctr, Bandung, Indonesia.; Rahmalia, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.	Annisa.Rahmalia@radboudumc.nl	van Crevel, reinout/A-6636-2010	van Crevel, reinout/0000-0002-6233-6410; Rahmalia, Annisa/0000-0001-8154-2765	European Commission [SANTE/2005/105-033]; Netherlands Fellowship Programme; Radboud University; Royal Dutch Academy of Arts and Science (KNAW); VIDI from the Netherlands Foundation of Scientific Research (NWO)	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Fellowship Programme; Radboud University; Royal Dutch Academy of Arts and Science (KNAW); VIDI from the Netherlands Foundation of Scientific Research (NWO)	Data collection was partially supported by 'IMPACT' (Integrated management of Prevention And Care and Treatment of HIV/AIDS), a collaborative research and implementation program of Padjadjaran University, Bandung, Indonesia; Maastrict University and Radboud University Nijmegen, The Netherlands; and University of Antwerp, Belgium. The European Commission (SANTE/2005/105-033) funded IMPACT. AR received PhD funding from Netherlands Fellowship Programme and conducted this study as part of her PhD, https://www.studyinholland.nl/study/scholarships/highlighted-scholarships/orangeknowledge-programme/netherlands-fellowship-programmes; RW has a fellowship from Radboud University; BA has a post-doc fellowship from the Royal Dutch Academy of Arts and Science (KNAW); RvC has a VIDI grant from the Netherlands Foundation of Scientific Research (NWO). No other authors received specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall S, 2016, CURR OPIN HIV AIDS, V11, P501, DOI 10.1097/COH.0000000000000301; Afriandi Irvan, 2009, Acta Med Indones, V41 Suppl 1, P75; Alvarez-Uria G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19251; Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; Bateganya MH, 2015, JAIDS-J ACQ IMM DEF, V68, pS368, DOI 10.1097/QAI.0000000000000519; Beckham SW, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21106; Beer L, 2014, AIDS EDUC PREV, V26, P521, DOI 10.1521/aeap.2014.26.6.521; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Burch LS, 2016, LANCET PUBLIC HEALTH, V1, pE26, DOI 10.1016/S2468-2667(16)30002-0; Burkey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P41, DOI 10.1097/QAI.0000000000000094; Carriquiry G, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20016; de Oliveira RDC, 2013, CAD SAUDE PUBLICA, V29, P801, DOI [10.1590/S0102-311X2013000800017, 10.1590/S0102-311X2013000400017]; Castilho JL, 2014, AIDS RES HUM RETROV, V30, P446, DOI [10.1089/aid.2013.0208, 10.1089/AID.2013.0208]; Coelho L, 2016, LANCET HIV, V3, pE490, DOI 10.1016/S2352-3018(16)30052-2; Cornell M, 2014, JAIDS-J ACQ IMM DEF, V67, pE67, DOI 10.1097/QAI.0000000000000269; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Culbert GJ, 2017, RES REP TROP MED, V8, P25, DOI [10.2147/RRTM.S126131, 10.2147/rrtm.s126131]; da Silva M, 2015, AIDS BEHAV, V19, P666, DOI 10.1007/s10461-014-0874-0; Dalhatu I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165528; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Eguzo KN, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/867827; Farahani M, 2010, LANCET, V2, P44; Farewell VT, 2014, LIFETIME DATA ANAL, V20, P51, DOI 10.1007/s10985-012-9236-2; Flynn AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189055; Fox M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069300; Ganiem AR, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18821; Graham SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059480; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Grimsrud AT, 2013, J CLIN EPIDEMIOL, V66, P1006, DOI 10.1016/j.jclinepi.2013.03.013; Guy R, 2013, AIDS PATIENT CARE ST, V27, P681, DOI 10.1089/apc.2012.0439; Gwynn RC, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0898-9; Hegdahl HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148502; Hickey MD, 2016, AIDS CARE, V28, P1386, DOI 10.1080/09540121.2016.1179253; Hill T, 2010, J CLIN EPIDEMIOL, V63, P1101, DOI 10.1016/j.jclinepi.2009.12.007; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Indonesia D and ICM of H, 2014, HIV AIDS SITUATION A; Inguane CA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20846; Januraga PP., 2018, LANCET HIV, V3018, P1; Jespersen S, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20243; Jiamsakul A, 2016, TROP MED INT HEALTH, P1; Jiamsakul A, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18911; Kempf MC, 2009, JAIDS-J ACQ IMM DEF, V52, P336, DOI 10.1097/QAI.0b013e3181b628be; Koenig SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142101; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Lee MP, 2015, AIDS PATIENT CARE ST, V29, P229, DOI 10.1089/apc.2014.0232; Lodi S, 2014, AIDS, V28, P2297, DOI 10.1097/QAD.0000000000000410; Maskew M, 2013, J WOMENS HEALTH, V22, P113, DOI 10.1089/jwh.2012.3585; Matsumoto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139594; Meira-Machado L, 2008, STAT METHODS MED RES, P1; Meloni ST, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu055; Menzaghi B, 2014, BIOMED PHARMACOTHER, V68, P385, DOI 10.1016/j.biopha.2014.01.007; Morgan R, 2016, HEALTH POLICY PLANN, V31, P1069, DOI 10.1093/heapol/czw037; Mosha F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-38; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Nelwan EJ, 2015, SE ASIAN J TROP MED, V46, P880; Nugroho A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191255; Plazy M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006927; Podlekareva DN, 2009, AIDS, V23, P2485, DOI 10.1097/QAD.0b013e3283326879; Pontororing GJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-362; Poudel KC, 2018, LANCET HIV, V3018, P1; R Core Team, 2014, R LANGUAGE ENV STAT; Rahmalia Annisa, 2015, BMC Res Notes, V8, P757, DOI 10.1186/s13104-015-1748-x; Rana AI, 2015, AIDS CARE, V27, P679, DOI 10.1080/09540121.2015.1005002; Republic of Indonesia Ministry of Health, 2014, EST PROJ HIV AIDS IN; Riono P, 2004, AIDS EDUC PREV, V16, P78, DOI 10.1521/aeap.16.3.5.78.35531; Santiago-rodriguez EJ, 2014, ANEMIA COHORT HIV IN, P1; Schoni-Affolter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027919; Shepherd BE, 2013, AM J EPIDEMIOL, V178, P819, DOI 10.1093/aje/kwt030; Sia D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3783-5; Simard EP, 2012, ARCH INTERN MED, V172, P1591, DOI 10.1001/archinternmed.2012.4508; Siregar AYM, 2016, ACTA MED INDONES, V48, P207; Smith LR, 2012, AIDS PATIENT CARE ST, V26, P344, DOI 10.1089/apc.2011.0388; Sri Utami, 2017, INT J STD AIDS, V28, P1199, DOI 10.1177/0956462417692942; Takarinda KC, 2015, INT J INFECT DIS, V30, P98, DOI 10.1016/j.ijid.2014.11.009; Teasdale CA, 2015, JAIDS-J ACQ IMM DEF, V68, P314, DOI 10.1097/QAI.0000000000000432; Umeh OC, 2006, EXPERT OPIN DRUG MET, V2, P273, DOI 10.1517/17425255.2.2.273; UNAIDS, 90 90 90 AMB TREATM; UNAIDS, 2017, ENDING AIDS PROGRESS; UNAIDS, 2017, COUNTR FACTSH IND 20, P1; UNESCO, 2012, INT STAND CLASS ED; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vinikoor MJ, 2014, AIDS RES HUM RETROV, V30, P949, DOI [10.1089/aid.2014.0046, 10.1089/AID.2014.0046]; Westergaard RP, 2013, AIDS, V27, P2559, DOI 10.1097/QAD.0b013e328363bff2; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, 2012, RET HIV PROGR; Wisaksana R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-213; Wisaksana Rudi, 2009, Acta Med Indones, V41 Suppl 1, P45; Wisaksana R, 2010, ADDICTION, V105, P1055, DOI 10.1111/j.1360-0443.2010.02898.x; Yang GLL, 2015, ASIA-PAC J PUBLIC HE, V27, p86S, DOI 10.1177/1010539514548758; Yehia BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129376; Zhou JL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/375217; Zwiener I, 2011, DTSCH ARZTEBL INT, V108, P163, DOI [10.3238/arztebl.2011.0163, 10.3238/arztebl.2010.0163]	94	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218781	10.1371/journal.pone.0218781	http://dx.doi.org/10.1371/journal.pone.0218781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3BT	31237899	Green Published, Green Submitted, gold			2022-12-26	WOS:000484856000040
J	Subramanian, S; Hilscher, R; Gakunga, R; Munoz, B; Ogola, E				Subramanian, Sujha; Hilscher, Rainer; Gakunga, Robai; Munoz, Breda; Ogola, Elijah			Cost-effectiveness of risk stratified medication management for reducing premature cardiovascular mortality in Kenya	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; STROKE; DEATH; HYPERTENSION; DISABILITY; PREVENTION; DISEASE; PROFILE; AFRICA	Background Cardiovascular disease (CVD) is a major contributor to the burden from non-communicable diseases in Sub-Saharan Africa and hypertension is the leading risk factor for CVD. The objective of this modeling study is to assess the cost-effectiveness of a risk stratified approach to medication management in Kenya in order to achieve adequate blood pressure control to reduce CVD events. Methods We developed a microsimulation model to evaluate CVD risk over the lifetime of a cohort of individuals. Risk groups were assigned utilizing modified Framingham study distributions based on individual level risk factors from the Kenya STEPwise survey which collected details on blood pressure, blood glucose, tobacco and alcohol use and cholesterol levels. We stratified individuals into 4 risk groups: very low, low, moderate and high risk. Mortality could occur due to acute CVD events, subsequent future events (for individual who survive the initial event) and other causes. We present cost and DALYs gained due to medication management for men and women 25 to 69 years. Results Treating high risk individuals only was generally more cost-effective that treating high and moderate risk individuals. At the anticipated base levels of effectiveness, medication management was only cost-effective under the low cost scenario. The incremental cost per DALY gained with low cost ranged from $1,505 to $3,608, which is well under $4,785 (3 times GPD per capita) threshold for Kenya. Under the low cost scenario, even lower levels of effectiveness of medication management are likely to be cost-effective for high-risk men and women. Conclusions In Kenya, our results indicate that the risk stratified approach to treating hypertension may be cost-effective especially for men and women at a high risk for CVD events, but these results are highly sensitive to the cost of medications. Medication management would require significant financial investment and therefore other interventions, including lifestyle changes, should be evaluated especially for those with elevated blood pressure and overall 10-year risk that is less than 20%.	[Subramanian, Sujha; Hilscher, Rainer; Gakunga, Robai; Munoz, Breda] RTI Int, Waltham, MA 02452 USA; [Ogola, Elijah] Univ Nairobi, Nairobi, Kenya; [Ogola, Elijah] Kenyatta Natl Hosp, Nairobi, Kenya	Research Triangle Institute; University of Nairobi; Kenyatta National Hospital	Subramanian, S (corresponding author), RTI Int, Waltham, MA 02452 USA.	ssubramanian@rti.org		Hilscher, Rainer/0000-0002-5004-4584	RTI International	RTI International	This study was funded by RTI International. This publication was supported by RTI International. Its content is solely the responsibility of the authors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 2015, KENYA STEPWISE SURVE; Attaei M, 2017, LANCET, V389, P1294, DOI 10.1016/S0140-6736(17)30864-4; Bloomfield GS, 2013, CURR CARDIOL REV, V9, P157, DOI 10.2174/1573403X11309020008; Capewell S, 2006, HEART, V92, P1563, DOI 10.1136/hrt.2005.085399; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Gaziano TA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-240; Government of Kenya Ministry of Health, 2002, CLIN GUID DIAGN TREA; Hacihasanoglu R., 2009, Turk Silahli Kuvvetleri,  Koruyucu Hekimlik Bulteni, V8, P167; Hardie K, 2004, STROKE, V35, P731, DOI 10.1161/01.STR.0000116183.50167.D9; Hemingway H, 2003, BRIT MED J, V327, P895, DOI 10.1136/bmj.327.7420.895; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Kenya Ministry of Health and HealthHeart Africa, 2015, PROT ID MAN HYP AD P; Knobler H, 2017, QJM-INT J MED, V110, P421, DOI 10.1093/qjmed/hcw141; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2002, ARCH INTERN MED, V162, P2405, DOI 10.1001/archinte.162.21.2405; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mathenge W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-569; Mudzi W, 2012, SAMJ S AFR MED J, V102, P765, DOI [10.7196/SAMJ.5742, 10.7196/samj.5742]; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Ogeng'o JA, 2010, ACTA CARDIOL, V65, P613, DOI 10.1080/AC.65.6.2059856; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Owolabi MO, 2015, CARDIOVASC J AFR, V26, pS27, DOI 10.5830/CVJA-2015-038; Perman Gaston, 2011, Cost Eff Resour Alloc, V9, P4, DOI 10.1186/1478-7547-9-4; Rosendaal NTA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157925; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Subramanian S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190113; Touze E, 2005, STROKE, V36, P2748, DOI 10.1161/01.STR.0000190118.02275.33; van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2199, DOI 10.1016/j.jacc.2017.11.005; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2013, WHODCOWHD20132; WHO, KEN LIF TABL; Wilson DE, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/835716; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; World Health Organization, 2014, TOP 10 CAUS DEATH	42	6	6	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2019	14	6							e0218256	10.1371/journal.pone.0218256	http://dx.doi.org/10.1371/journal.pone.0218256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3BT	31237910	Green Published, gold, Green Submitted			2022-12-26	WOS:000484856000018
J	Marashi, A; Pour, SG; Li, V; Rissel, C; Girosi, F				Marashi, Amir; Pour, Shima Ghassem; Li, Vincy; Rissel, Chris; Girosi, Federico			The association between physical activity and hospital payments for acute admissions in the Australian population aged 45 and over	PLOS ONE			English	Article							HEALTH-CARE EXPENDITURE; RETRANSFORMATION; MODELS; PROFILE; COSTS; ADO	Physical activity (PA) is a key component of a healthy life, and it is hypothesised that individuals with higher levels of PA utilise fewer hospital resources. Quantifying the association between PA and hospital resource use is of interest to both payers and planners but estimates of its size in the general population are rare. In this paper we provide estimates of the association between PA and payments to hospitals in the Australian population over age 45. We use data from 45 and Up Study, a survey that contains health and lifestyle factors information about approximately 260,000 individuals over age 45 living in NSW, linked to hospital and death data. The linked data set allows to define a unique indicator for the level of PA over the week prior to the survey interview and to calculate payments to hospitals over the next year. We use Coarsened Exact Matching and multivariate analysis to study the relationship between PA and hospital payments, controlling for chronic health conditions, risk factors, standard socioeconomic variables and death. Our results clearly indicate that there is a statistically significant association between PA and lower hospital payments. While the size of the association depends to some extent on the covariates used in the model the conclusions are robust to changes in model specification. We also perform a sub-group analysis and show that the cost savings associated with PA are significantly larger for older and lower income populations. This study shows that if one is interested in lowering hospital expenditures then increasing PA levels is a policy that has the potential of being effective. It also shows that one does not need to target the entire population to achieve cost savings but can limit the intervention to the older population and/or the one in the lowest socioeconomic status.	[Marashi, Amir; Girosi, Federico] Western Sydney Univ, Translat Hlth Res Inst, Sydney, NSW, Australia; [Marashi, Amir; Girosi, Federico] Capital Markets CRC, Sydney, NSW, Australia; [Marashi, Amir; Girosi, Federico] Digital Hlth CRC, Sydney, NSW, Australia; [Pour, Shima Ghassem] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Li, Vincy; Rissel, Chris] NSW Minist Hlth, Off Prevent Hlth, Sydney, NSW, Australia	Western Sydney University; University of Sydney	Marashi, A (corresponding author), Western Sydney Univ, Translat Hlth Res Inst, Sydney, NSW, Australia.; Marashi, A (corresponding author), Capital Markets CRC, Sydney, NSW, Australia.; Marashi, A (corresponding author), Digital Hlth CRC, Sydney, NSW, Australia.	amarashi@cmcrc.com	Rissel, Chris/ABA-5881-2020; Rissel, Chris/AAH-2423-2019	Rissel, Chris/0000-0002-2156-8581; Girosi, Federico/0000-0003-3937-2285	Capital Markets Cooperative Research Centre (CMCRC) Limited; Capital Markets CRC; NSW Health	Capital Markets Cooperative Research Centre (CMCRC) Limited; Capital Markets CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NSW Health	This research is funded by the Capital Markets Cooperative Research Centre (CMCRC) Limited with the following URL: https://www.cmcrc.com. The recipient of the award is AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We also thank Capital Markets CRC and NSW Health for their generous support for this research.	Ai CR, 2000, J HEALTH ECON, V19, P697, DOI 10.1016/S0167-6296(00)00046-1; Amarasinghe Anura K, 2010, Cost Eff Resour Alloc, V8, P10, DOI 10.1186/1478-7547-8-10; Andreyeva Tatiana, 2006, J Phys Act Health, V3, pS6, DOI 10.1123/jpah.3.s1.s6; [Anonymous], 2018, HEALTHCARE COSTS UNS; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Bishop Y. M., 2007, DISCRETE MULTIVARIAT; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Cobiac LJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000110; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; ELLEY CR, 2004, NZ MED J, V117, P8; Ellis RP, 2013, HEALTH ECON, V22, P1093, DOI 10.1002/hec.2916; Felder S, 2001, CARDIOVASC DRUG THER, V15, P345, DOI 10.1023/A:1012714800014; Fisher Koren L, 2015, J Aging Res, V2015, P425354, DOI 10.1155/2015/425354; Frew EJ, 2014, BRIT J SPORT MED, V48, P207, DOI 10.1136/bjsports-2012-091202; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Iacus SM, 2011, J AM STAT ASSOC, V106, P345, DOI 10.1198/jasa.2011.tm09599; Independent Hospital Pricing Authority, 2012, NAT EFF PRIC DET 201; Irvine KA, 2011, HETEROSKEDASTICITY R, V22, DOI 10.1071/NB10061; Irvine Katie A, 2011, N S W Public Health Bull, V22, P17, DOI 10.1071/NB10061; JENKINSON C, 1993, BRIT MED J PUBLISHIN, V306; Jones A.M., 2009, MODELS HLTH CARE; Jones AM, 2000, HANDB ECON, V17, P265; Kang SW, 2017, PREV MED, V96, P101, DOI 10.1016/j.ypmed.2016.12.043; Kardamanidis K, 2007, MED J AUSTRALIA, V187, P383, DOI 10.5694/j.1326-5377.2007.tb01306.x; Khoo J, 2018, AUST HEALTH REV, V42, P600, DOI 10.1071/AH17046; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Min JY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010136; Moran JL, 2007, J EVAL CLIN PRACT, V13, P381, DOI 10.1111/j.1365-2753.2006.00711.x; Muller-Riemenschneider F, 2009, BRIT J SPORT MED, V43, P70, DOI 10.1136/bjsm.2008.053728; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Neuman P, 2015, HEALTH AFFAIR, V34, P335, DOI 10.1377/hlthaff.2014.1371; Peeters GMEE, 2018, J SCI MED SPORT, V21, P604, DOI 10.1016/j.jsams.2017.10.022; Productivity Commission, 2009, RES REPORT; QIN S, 2011, COMP MATCHING PROPER; Qin S., 2011, BRIT J SPORT MED; Rocca P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2079-5; Sari N, 2011, MATURITAS, V70, P285, DOI 10.1016/j.maturitas.2011.08.004; SHAW KM, 2016, PREVENTING CHRONIC D; SIMS J, 2006, NATL PHYS ACTIVITY R, P1; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; 2003, ACTIVE AUSTR SURVEY; 2017, 6401 0 CONSUMER PRIC	46	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2019	14	6							e0218394	10.1371/journal.pone.0218394	http://dx.doi.org/10.1371/journal.pone.0218394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3QN	31233519	Green Submitted, Green Published, gold			2022-12-26	WOS:000484896700016
